data_6tiq_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6tiq _Structure_validation_residue.Date_analyzed 2019-11-29 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.878 -0.786 . . . . 73.14 108.878 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.79 HG23 ' HA ' ' A' ' 121' ' ' GLU . 2.2 t -107.59 109.0 62.32 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 74.44 110.898 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 5.3 Cg_exo -77.4 164.77 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.251 2.634 . . . . 74.44 111.633 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.59 70.09 2.05 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.839 2.359 . . . . 74.32 111.825 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.737 ' HB ' HD22 ' A' ' 150' ' ' LEU . 20.6 p -70.13 -42.29 72.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 61.1 111.056 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.562 ' HB3' HG21 ' A' ' 143' ' ' VAL . 29.6 p90 -54.92 -30.58 58.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 71.34 111.538 174.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.83 46.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.524 . . . . 75.01 110.61 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.94 -9.63 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 71.43 109.834 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 150' ' ' LEU . 81.3 mt -70.69 -34.51 72.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.781 -0.645 . . . . 75.11 110.983 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . -129.05 0.03 6.03 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.593 -1.289 . . . . 72.21 114.83 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.577 ' HG3' ' N ' ' A' ' 13' ' ' SER . 4.8 pttm -62.43 -46.22 89.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.781 1.29 . . . . 74.51 110.505 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.577 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 5.0 p -66.54 -49.46 66.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.345 0.593 . . . . 71.33 111.168 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.72 69.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.308 -0.86 . . . . 71.23 112.438 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -59.86 -38.9 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.883 0.327 . . . . 71.23 111.883 -171.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.95 -47.44 71.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.873 0.368 . . . . 74.4 110.959 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.613 HG12 ' HB2' ' A' ' 222' ' ' ALA . 25.1 m -82.74 -27.53 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.435 0.532 . . . . 74.11 112.435 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.15 -31.31 65.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.627 0.251 . . . . 74.0 111.462 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.9 m -59.78 135.44 57.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.389 -0.369 . . . . 73.45 110.704 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.51 -53.98 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 65.31 111.249 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.88 46.86 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.759 -0.734 . . . . 75.12 111.617 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.45 93.47 6.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.617 0.722 . . . . 72.22 111.031 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.01 124.83 7.73 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.789 -0.719 . . . . 73.32 111.84 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -84.25 10.96 9.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.6 0.238 . . . . 73.2 111.596 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.9 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 92.7 13.85 56.15 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.363 -0.923 . . . . 74.3 111.608 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.94 179.42 4.33 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.572 0.701 . . . . 75.21 112.747 -171.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.657 HD12 HD13 ' A' ' 277' ' ' LEU . 35.1 mm -102.06 130.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.785 -1.098 . . . . 64.2 110.407 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.588 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 1.0 OUTLIER -103.81 134.63 46.79 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.455 -0.943 . . . . 75.33 108.455 176.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 16.5 tp -121.56 147.83 45.29 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.677 -0.409 . . . . 71.43 110.853 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.787 ' HB3' ' HG2' ' A' ' 280' ' ' GLU . 12.3 t70 -153.72 127.9 9.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.294 -0.866 . . . . 73.31 108.919 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 281' ' ' PHE . 8.9 tp -137.46 125.02 22.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.346 -0.612 . . . . 72.11 109.346 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 23.3 ttmt -133.12 124.69 28.01 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.46 . . . . 74.15 110.683 -175.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.656 HG23 ' HB1' ' A' ' 283' ' ' ALA . 80.6 p -120.64 123.61 43.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.631 . . . . 72.32 109.705 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 284' ' ' LEU . 91.0 mttt -112.17 139.46 47.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.273 0.559 . . . . 71.14 112.14 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 43.1 t -139.17 137.18 35.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.835 -1.172 . . . . 75.4 107.835 168.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -82.12 34.97 0.42 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.616 0.722 . . . . 71.2 109.902 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.7 OUTLIER -120.5 18.71 12.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.477 -0.783 . . . . 73.31 111.424 -177.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 97.76 -3.4 60.81 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.194 -1.162 . . . . 73.54 110.194 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.546 ' C ' HD12 ' A' ' 39' ' ' LEU . 3.4 tm? -99.65 127.22 45.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.762 -0.375 . . . . 73.31 111.717 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 22.0 tt0 -141.6 129.22 21.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.969 -0.752 . . . . 75.2 108.969 163.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.438 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 74.5 t80 -124.78 127.05 46.61 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.267 -0.896 . . . . 65.13 110.872 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.886 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.5 m -128.58 131.53 48.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.092 0.473 . . . . 74.22 111.682 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 17.1 m -120.3 123.02 42.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.854 . . . . 75.02 108.693 171.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.3 p -139.65 157.65 45.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.378 -0.529 . . . . 75.31 111.093 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 158.83 -175.22 35.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.539 -1.315 . . . . 73.13 113.567 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 p -137.03 138.5 40.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.617 -0.292 . . . . 74.32 110.249 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 54' ' ' VAL . . . -135.27 129.12 33.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.781 0.324 . . . . 71.24 110.709 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.422 ' CB ' ' HB3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -90.67 113.72 25.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 74.23 109.153 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -84.84 7.33 21.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.181 0.808 . . . . 70.21 113.181 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -74.13 -46.26 43.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.71 -0.396 . . . . 74.43 110.405 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -126.36 -81.33 0.61 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.749 -0.463 . . . . 73.11 109.749 171.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' HG21 ' A' ' 52' ' ' THR . 5.5 t -172.69 84.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.949 0.88 . . . . 65.12 110.296 175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 16.6 tppt? -126.25 86.53 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 73.55 109.449 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 47' ' ' ALA . 25.9 t -109.22 120.04 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.017 -0.538 . . . . 71.24 110.821 -175.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -137.67 124.6 21.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.893 -0.594 . . . . 62.1 109.56 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 45' ' ' GLY . . . -155.57 -155.43 7.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.539 -0.838 . . . . 72.35 111.958 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 33.4 t -148.03 150.99 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.185 0.517 . . . . 74.44 110.177 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -119.96 125.06 47.48 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.65 -0.87 . . . . 70.52 108.65 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 3.4 mp0 -109.04 118.87 37.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.454 -0.793 . . . . 75.33 110.93 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -99.55 117.72 34.56 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.794 -1.558 . . . . 74.04 106.794 164.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.764 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 74.3 tttt -127.37 150.28 49.68 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.363 0.602 . . . . 74.45 110.311 -171.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.876 ' HB2' ' HB2' ' A' ' 71' ' ' PHE . 99.6 m-85 -126.72 121.42 31.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.879 -0.601 . . . . 74.11 110.155 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.3 ptm85 -121.27 106.1 11.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.789 0.804 . . . . 75.04 111.376 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 t90 -117.02 104.64 11.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.869 -1.06 . . . . 75.21 109.583 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 m 73.55 132.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.615 0.572 . . . . 73.43 110.508 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.9 mp0 -50.95 -59.98 3.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.858 -0.61 . . . . 71.03 110.911 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.03 67.37 0.7 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.702 -0.681 . . . . 75.54 109.383 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 -85.58 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.608 -0.806 . . . . 35.1 112.847 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.98 130.53 52.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 74.44 111.807 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.8 m -137.72 112.36 8.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 74.5 110.561 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.876 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 8.9 m-85 -102.73 122.4 44.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.609 -0.515 . . . . 73.13 109.609 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 m -119.93 117.29 27.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.64 -0.424 . . . . 73.31 111.76 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.6 123.65 45.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 75.21 109.099 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 10.3 ptmm? -142.86 140.18 31.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.288 -0.565 . . . . 74.41 110.969 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.403 ' CD1' ' HG ' ' A' ' 81' ' ' LEU . 31.5 t90 -129.85 130.08 44.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.092 -0.504 . . . . 75.4 110.132 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 57' ' ' SER . 15.8 m120 -93.46 150.92 20.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 70.11 110.756 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -63.82 -20.43 65.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 73.02 109.553 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.77 -4.13 29.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.092 -0.958 . . . . 75.12 110.344 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.7 t30 82.31 4.64 1.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.015 0.926 . . . . 73.34 111.113 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.676 ' HB ' ' HB2' ' A' ' 103' ' ' PHE . 18.9 p -80.76 143.86 32.57 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 116.129 -0.487 . . . . 74.03 109.803 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 103' ' ' PHE . 3.3 mp -122.88 113.59 19.34 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.761 -1.176 . . . . 75.22 113.872 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.62 131.12 10.08 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 119.771 -1.204 . . . . 73.41 113.686 -170.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.913 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 91.0 m -136.25 140.17 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.641 0.258 . . . . 74.32 110.745 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.87 108.83 3.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.484 HG13 ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -116.59 120.65 65.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.005 0.431 . . . . 71.34 109.987 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.6 m -110.53 135.8 50.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.996 -0.547 . . . . 73.42 111.772 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.2 125.33 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.178 -0.919 . . . . 74.11 109.738 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.53 130.03 35.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.546 -0.539 . . . . 75.15 109.546 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.55 133.16 36.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.785 -0.45 . . . . 75.32 109.785 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -91.53 -21.69 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.33 -0.396 . . . . 62.04 111.47 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.97 -51.08 11.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.964 -0.754 . . . . 74.21 108.964 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.06 7.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 73.33 109.823 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.718 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -62.49 124.63 21.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 75.41 110.514 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' ' HZ1' ' A' ' 119' ' ' LYS . . . 100.12 1.62 55.91 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.705 -0.76 . . . . 74.15 112.322 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.725 HD21 ' HD1' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -98.86 124.35 43.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 75.41 109.871 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.23 123.19 40.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 74.3 110.53 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.7 mm? -112.97 125.61 54.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.619 -0.512 . . . . 74.33 109.619 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.918 HG21 ' HB3' ' A' ' 115' ' ' LYS . 1.1 t -132.52 136.24 46.51 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.232 0.539 . . . . 74.42 110.637 173.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -104.78 120.67 41.94 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.88 -0.785 . . . . 74.1 108.88 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.51 151.9 26.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.561 -0.745 . . . . 73.53 110.976 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.913 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 22.3 m -128.11 131.92 49.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.5 -0.773 . . . . 74.41 109.251 172.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -91.64 141.94 28.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.392 -0.822 . . . . 74.23 108.859 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.763 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 2.3 p90 -95.51 98.01 10.21 Favored 'General case' 0 C--O 1.188 -2.171 0 N-CA-C 114.824 1.416 . . . . 74.11 114.824 -161.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 60.7 p -76.89 124.15 87.5 Favored Pre-proline 0 N--CA 1.465 0.31 0 O-C-N 121.091 -1.006 . . . . 63.11 112.974 -164.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 33.9 Cg_exo -61.72 -54.97 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.205 2.603 . . . . 72.35 113.16 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -106.14 -30.78 9.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 53.13 111.28 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -62.64 -48.72 78.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.369 . . . . 75.24 111.686 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.24 -14.95 59.53 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.037 -0.601 . . . . 63.33 111.841 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -97.22 130.69 44.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.205 -0.665 . . . . 75.34 109.205 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.61 150.27 36.46 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.056 -0.658 . . . . 72.31 109.54 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' A' ' 101' ' ' SER . 66.0 t30 -116.51 156.17 27.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 65.41 109.957 -174.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.43 126.54 49.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.909 0.861 . . . . 72.44 112.347 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.441 ' HZ3' ' CG ' ' A' ' 128' ' ' ASP . 28.0 ttpp -128.38 140.61 51.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.537 -1.211 . . . . 74.41 108.656 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -112.48 124.23 68.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.002 -0.74 . . . . 74.52 109.002 -178.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.918 ' HB3' HG21 ' A' ' 98' ' ' THR . 84.4 tttt -120.08 119.67 34.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.508 -0.769 . . . . 65.21 109.752 -171.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.9 m -122.67 137.08 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.335 -0.393 . . . . 63.04 110.951 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.22 122.62 3.35 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.819 -0.705 . . . . 71.14 112.421 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.725 ' HD1' HD21 ' A' ' 95' ' ' LEU . 81.8 t80 -117.59 128.49 55.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.238 -0.653 . . . . 75.15 109.238 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.731 ' HB3' HG11 ' A' ' 3' ' ' VAL . 26.3 mtmm -109.13 123.16 48.75 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.894 -0.722 . . . . 75.04 110.54 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -104.69 147.83 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.3 -1.37 . . . . 75.24 107.3 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.79 ' HA ' HG23 ' A' ' 3' ' ' VAL . 10.5 pt-20 -52.37 -28.48 19.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.489 0.551 . . . . 72.33 112.489 -167.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -100.84 -31.94 10.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.468 0.544 . . . . 71.01 112.468 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.944 HG22 ' H ' ' A' ' 145' ' ' GLY . 16.6 pt -142.89 154.23 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 118.594 0.634 . . . . 74.04 112.254 -170.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.73 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 3.5 t-20 -110.14 128.9 55.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.698 -0.683 . . . . 72.43 111.231 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 142' ' ' LEU . 4.6 mm? -110.84 135.73 50.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.515 -0.311 . . . . 74.5 110.174 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.4 125.8 3.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.529 -0.843 . . . . 73.22 112.511 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.8 m -113.45 117.81 32.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.763 -0.458 . . . . 73.43 109.763 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.441 ' CG ' ' HZ3' ' A' ' 113' ' ' LYS . 38.9 t0 -126.09 117.57 23.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.955 0.407 . . . . 73.02 110.1 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.718 ' HG3' HG13 ' A' ' 138' ' ' ILE . 60.8 ttp -119.67 118.15 30.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.919 0.39 . . . . 75.11 111.563 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.21 120.18 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.366 -0.605 . . . . 70.33 109.366 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.531 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 85.5 t80 -95.03 104.66 16.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.065 0.46 . . . . 72.32 111.674 -172.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.499 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 20.3 t70 -97.99 149.4 22.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 74.2 108.904 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -68.6 -35.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.734 -0.212 . . . . 72.41 111.101 -174.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.52 -20.13 20.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 52.21 111.403 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.86 98.71 0.12 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.366 -0.921 . . . . 73.14 112.662 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.531 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 37.9 Cg_endo -67.19 150.79 81.88 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.577 2.185 . . . . 74.12 112.43 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -115.13 128.84 56.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.442 -0.577 . . . . 75.14 109.442 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.718 HG13 ' HG3' ' A' ' 129' ' ' MET . 3.9 mp -109.73 118.34 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.354 -0.609 . . . . 63.33 109.354 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -112.19 132.49 54.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.337 0.589 . . . . 75.24 110.308 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.63 132.66 10.99 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.389 -0.823 . . . . 74.41 111.343 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.11 134.76 55.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.961 -0.385 . . . . 71.31 109.961 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.733 HD11 HD11 ' A' ' 123' ' ' ILE . 6.3 tp -137.97 122.33 18.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.207 0.527 . . . . 74.35 110.164 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 97.8 t -107.89 130.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.23 -0.895 . . . . 65.23 108.937 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 1.6 mm? -108.14 137.24 46.46 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.258 -0.645 . . . . 74.32 109.258 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.944 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -130.49 119.36 2.73 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 115.527 -0.76 . . . . 61.3 111.46 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 149' ' ' TRP . 1.8 p90 -142.28 147.78 36.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.523 . . . . 73.01 109.589 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 7.0 mp0 -35.24 102.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.575 0.954 . . . . 70.03 113.575 -169.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.31 -33.92 5.31 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.0 -1.0 . . . . 63.21 113.7 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.486 ' HB2' ' CE1' ' A' ' 146' ' ' TYR . 78.1 m95 -106.01 143.28 34.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.63 0.728 . . . . 73.33 112.193 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.737 HD22 ' HB ' ' A' ' 6' ' ' THR . 1.9 tm? -124.75 136.68 54.07 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 72.3 107.985 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . . . -139.02 162.15 35.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.682 0.277 . . . . 75.24 110.692 -175.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -159.88 145.49 11.37 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.373 -0.691 . . . . 72.13 111.373 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.495 ' OH ' HD21 ' A' ' 142' ' ' LEU . 39.8 p90 -146.72 127.39 14.26 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.694 0.747 . . . . 75.14 111.673 165.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 0.9 OUTLIER -115.72 121.64 43.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.421 -0.809 . . . . 72.23 109.163 177.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 94.8 mmm -121.6 140.15 52.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.176 -0.305 . . . . 73.11 110.176 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 3.8 m-20 -110.3 119.14 38.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.763 -0.458 . . . . 74.21 109.763 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.23 117.27 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.568 -0.53 . . . . 74.11 109.568 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.459 ' OE1' ' HE3' ' A' ' 161' ' ' LYS . 15.0 tt0 -98.54 105.55 17.71 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-O 121.094 0.473 . . . . 71.13 110.107 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.3 m -70.42 -20.81 62.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.3 -1.773 . . . . 74.24 111.124 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.418 ' HB3' ' HG2' ' A' ' 158' ' ' GLU . . . -59.7 -28.65 67.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.924 0.869 . . . . 72.31 109.155 173.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.459 ' HE3' ' OE1' ' A' ' 158' ' ' GLU . 78.8 mttt -117.72 -157.77 0.68 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.311 -1.366 . . . . 73.02 107.311 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.7 p -109.29 26.74 10.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.85 -0.426 . . . . 63.1 109.85 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -141.97 154.32 44.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.24 -1.384 . . . . 73.42 114.591 -154.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 93.9 t -74.37 131.61 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 114.721 -1.127 . . . . 70.44 110.206 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 33.1 m -98.63 -34.22 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.627 -0.26 . . . . 72.22 111.488 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.4 ' H ' ' HB2' ' A' ' 156' ' ' ASN . 14.1 mm100 -138.59 134.68 34.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.183 -0.303 . . . . 73.4 110.183 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.7 p -120.84 109.46 15.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.198 0.523 . . . . 74.23 110.561 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 26.6 m-80 -109.31 138.45 45.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 5.7 t80 -138.68 149.35 45.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.421 -0.512 . . . . 74.24 110.419 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -149.9 136.8 19.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.178 0.513 . . . . 74.14 110.733 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 10.2 t -145.88 154.07 13.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 64.32 108.427 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 180' ' ' LEU . . . 166.02 -170.72 40.86 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 118.855 -1.641 . . . . 64.53 113.602 169.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.73 153.39 48.49 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.43 -0.385 . . . . 71.31 110.301 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.482 ' HZ1' ' HB3' ' A' ' 174' ' ' LYS . 8.5 mtpm? -114.26 126.55 55.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.182 0.515 . . . . 73.4 110.414 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 m -126.29 163.27 23.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.545 -0.752 . . . . 73.34 109.142 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.44 -57.29 3.65 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.765 0.654 . . . . 73.32 112.765 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -109.2 -8.92 15.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 75.13 111.447 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.7 132.09 46.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.898 0.38 . . . . 71.1 111.451 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 83.4 mt-30 -125.98 124.06 39.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.146 -0.687 . . . . 72.43 109.146 173.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.605 HD12 HG13 ' A' ' 194' ' ' ILE . 3.6 tt -120.3 128.49 53.34 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.557 . . . . 72.24 110.948 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 77.6 m-70 -132.05 116.81 17.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.618 -0.719 . . . . 74.01 111.206 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.653 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 29.6 m -83.09 118.56 23.64 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.788 -0.819 . . . . 75.45 108.788 172.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.1 140.97 49.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.167 0.508 . . . . 74.34 111.12 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.523 HG21 ' CB ' ' A' ' 190' ' ' PHE . 70.2 t -124.62 128.14 73.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.574 -0.739 . . . . 72.24 110.798 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -115.46 97.29 6.08 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.241 -0.891 . . . . 75.12 108.652 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 30.2 t70 62.49 178.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.919 -1.037 . . . . 71.03 109.573 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.93 58.43 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.958 -0.857 . . . . 72.2 110.958 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 211' ' ' THR . 56.4 m -87.52 -28.1 22.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 112.564 0.579 . . . . 75.24 112.564 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -141.07 119.42 12.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.402 -0.919 . . . . 74.32 112.443 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.523 ' CB ' HG21 ' A' ' 184' ' ' VAL . 19.1 p90 -134.89 126.09 28.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.446 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.757 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -158.84 -162.6 12.07 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 120.491 -0.861 . . . . 70.43 112.388 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -137.74 152.01 21.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.737 -0.744 . . . . 52.34 112.752 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 15.0 m -125.15 138.28 54.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.711 0.291 . . . . 63.44 110.603 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.605 HG13 HD12 ' A' ' 180' ' ' LEU . 4.4 mp -123.72 124.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.272 -0.422 . . . . 70.14 109.896 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 6.6 t80 -108.47 116.37 31.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.73 -0.841 . . . . 75.14 108.73 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.461 HE21 ' HB2' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -128.5 134.58 48.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.936 0.398 . . . . 73.53 111.011 -177.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.601 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 56.2 mtpt -108.02 127.52 53.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.428 -0.351 . . . . 71.52 110.549 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.44 110.61 27.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -49.8 111.79 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.398 -0.819 . . . . 72.53 112.349 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 200' ' ' LYS . 34.0 ttmt 72.84 1.39 4.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.329 -0.851 . . . . 74.52 112.257 170.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -103.73 -73.14 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 74.41 110.148 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 225' ' ' TYR . 3.2 pp -162.96 170.8 17.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.663 -0.699 . . . . 74.24 109.619 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.601 ' HG3' ' HG2' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -125.52 134.64 51.93 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.941 -0.392 . . . . 71.44 109.941 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.0 m -124.03 142.54 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.136 0.493 . . . . 72.44 111.44 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -130.33 136.18 48.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.966 -0.561 . . . . 72.24 110.154 175.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 221' ' ' ILE . 75.6 t -112.41 134.47 54.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 73.32 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -133.74 126.31 30.42 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.452 -0.573 . . . . 62.32 109.452 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.3 pt? -147.14 135.09 21.36 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.617 -0.433 . . . . 72.23 110.69 174.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.757 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -134.58 149.57 50.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.645 . . . . 71.01 111.432 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -100.05 130.87 46.25 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.0 t -109.91 124.53 51.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.657 . . . . 75.1 110.894 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.57 58.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 73.02 111.442 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 129.95 -54.04 0.79 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.635 -0.986 . . . . 63.35 110.635 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.707 ' HB2' HD22 ' A' ' 216' ' ' ASN . 47.9 m-80 -139.04 172.41 12.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.219 -1.03 . . . . 75.32 108.219 172.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -81.57 67.66 7.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.973 0.416 . . . . 75.15 110.887 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.707 HD22 ' HB2' ' A' ' 214' ' ' ASN . 25.2 m-80 -102.78 129.21 49.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 74.23 110.727 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 m -108.63 123.51 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.334 -0.617 . . . . 74.5 109.334 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 41.7 ttm-85 -101.13 114.81 29.11 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.764 -0.828 . . . . 75.21 108.764 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 239' ' ' ASN . 83.7 t80 -117.8 136.62 53.29 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.507 0.194 . . . . 74.04 110.761 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.67 140.45 7.43 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.792 -0.718 . . . . 70.14 111.825 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.939 HG21 HG21 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -131.1 136.86 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 71.44 110.799 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.613 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -128.81 139.78 52.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.01 -0.541 . . . . 62.44 110.23 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.1 126.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.591 0.234 . . . . 75.42 110.584 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 17.2 pttm -102.53 119.52 38.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.845 0.831 . . . . 75.41 110.314 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.557 ' HD2' ' HB3' ' A' ' 202' ' ' LEU . 37.5 t80 -112.3 116.54 30.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.274 -1.33 . . . . 74.22 110.156 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -111.48 121.27 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.188 0.518 . . . . 64.11 111.252 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.9 pt -110.26 -27.41 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.305 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.499 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 19.2 t70 -135.15 143.24 44.98 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.57 -0.53 . . . . 74.24 109.57 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.53 -29.22 58.96 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.573 2.182 . . . . 70.52 112.487 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -103.56 4.12 35.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.375 -0.375 . . . . 74.42 111.307 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 228' ' ' ASP . . . -143.6 121.27 11.84 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.394 0.616 . . . . 71.5 111.872 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -139.87 128.65 23.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.781 -0.645 . . . . 72.42 109.539 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.07 125.14 50.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.002 -0.279 . . . . 71.41 110.543 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 224' ' ' LYS . 14.2 m -116.47 118.08 31.69 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 62.12 110.043 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -122.98 141.52 51.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.789 -0.364 . . . . 75.51 110.971 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.05 144.24 38.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.316 -0.402 . . . . 73.51 110.229 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.437 HG23 HG13 ' A' ' 243' ' ' ILE . 9.1 p -131.56 142.61 42.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.751 -0.463 . . . . 65.11 109.751 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -107.42 150.57 26.61 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.068 -0.716 . . . . 74.41 109.068 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 219' ' ' PHE . 6.2 t30 -58.87 -11.78 3.69 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.782 0.676 . . . . 73.42 112.147 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.608 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m -78.66 15.36 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.54 -0.541 . . . . 75.41 109.54 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.4 m 68.45 28.27 6.08 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 115.137 -0.938 . . . . 73.12 110.554 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.608 ' HG ' ' HB2' ' A' ' 240' ' ' SER . 42.7 mt -100.36 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.561 -0.456 . . . . 75.41 110.627 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.437 HG13 HG23 ' A' ' 237' ' ' VAL . 1.7 mp -108.51 115.41 49.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 120.879 -0.329 . . . . 62.44 110.173 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -123.59 133.39 8.87 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.929 -0.653 . . . . 71.04 112.301 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.509 ' HG ' ' HH ' ' A' ' 247' ' ' TYR . 0.0 OUTLIER -128.06 150.72 49.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.341 0.591 . . . . 64.25 111.593 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -132.32 121.65 3.06 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 114.991 -1.004 . . . . 61.12 110.777 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.509 ' HH ' ' HG ' ' A' ' 245' ' ' LEU . 32.0 m-85 -103.59 115.66 30.92 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.921 -0.4 . . . . 73.43 109.921 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.6 m -98.31 115.51 28.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.842 0.353 . . . . 72.51 110.211 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -126.19 128.92 48.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.096 -0.502 . . . . 73.44 109.903 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.1 m -95.09 119.12 33.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.739 0.304 . . . . 44.34 110.33 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 3.0 mm? -108.1 86.04 2.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 72.41 109.793 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 251' ' ' LEU . 0.0 OUTLIER 71.55 156.06 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.445 -0.798 . . . . 73.54 110.546 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.0 95.81 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.703 2.269 . . . . 73.01 112.854 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 142.18 -19.43 2.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.486 -0.864 . . . . 72.34 112.865 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.49 122.02 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.077 0.465 . . . . 73.43 111.903 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 43.1 mtmt -112.07 126.27 54.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 74.44 109.975 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -100.93 124.01 45.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.507 -0.553 . . . . 73.35 109.507 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 36.9 m -120.34 111.02 17.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 72.54 110.54 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.884 HD22 HD21 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -97.73 123.59 41.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.212 -1.033 . . . . 74.23 108.212 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 21.8 m -130.21 140.6 50.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.647 0.26 . . . . 65.35 110.462 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.489 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -154.89 128.8 8.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.644 -0.253 . . . . 73.12 110.942 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 274' ' ' LYS . 2.3 tm? -101.68 117.07 34.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.46 -0.941 . . . . 74.33 108.46 173.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.41 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.6 mm? -100.02 109.95 22.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.781 -0.645 . . . . 74.21 109.547 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.461 ' N ' HG12 ' A' ' 268' ' ' VAL . 2.9 m-20 -69.67 103.75 2.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.824 . . . . 75.51 109.522 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.65 -8.45 7.54 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.097 -0.956 . . . . 62.11 112.581 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 267' ' ' ASN . 48.3 tptt -64.99 -28.63 69.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.547 -0.538 . . . . 74.23 109.547 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 266' ' ' LYS . 44.5 t-20 157.38 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.604 1.19 . . . . 72.22 108.697 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 264' ' ' ASP . 0.1 OUTLIER -65.44 -45.15 93.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 112.918 0.71 . . . . 73.23 112.918 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.03 -44.87 91.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.676 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.96 -13.09 16.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.829 0.307 . . . . 70.21 111.829 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -103.34 -14.23 26.51 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.048 -1.072 . . . . 74.42 112.768 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 106.98 153.83 19.6 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.621 -0.799 . . . . 73.43 112.434 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -110.87 147.23 35.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.355 -0.98 . . . . 73.32 108.355 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.721 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.9 mmtm -94.0 134.96 35.85 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.335 -1.357 . . . . 74.45 107.335 173.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.9 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.5 tm? -135.29 136.12 41.37 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.255 0.55 . . . . 64.32 110.907 -170.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.451 ' N ' HD11 ' A' ' 275' ' ' LEU . . . -140.59 117.16 1.23 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 110.52 -1.032 . . . . 71.55 110.52 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.884 HD21 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -112.21 122.3 47.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.926 -1.139 . . . . 73.0 107.926 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -129.36 137.34 9.51 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.148 -1.025 . . . . 72.3 112.995 -170.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -114.07 130.55 56.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.936 -0.764 . . . . 73.13 108.936 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.787 ' HG2' ' HB3' ' A' ' 30' ' ' ASP . 50.8 mt-10 -121.02 112.1 18.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.812 -0.44 . . . . 75.11 109.812 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.728 ' HB3' HD11 ' A' ' 31' ' ' LEU . 14.7 t80 -103.53 141.92 35.17 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.854 -0.795 . . . . 74.24 108.854 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.74 141.89 40.97 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.884 0.373 . . . . 73.51 111.348 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 33' ' ' THR . . . -123.6 110.4 14.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.55 . . . . 74.43 109.679 172.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' A' ' 34' ' ' LYS . 4.2 mm? -124.09 -47.35 1.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.491 -0.777 . . . . 64.53 109.822 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.423 -0.799 . . . . 74.43 109.285 176.12 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.45 -0.574 . . . . 74.13 109.45 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.826 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 4.5 p -110.68 135.85 20.71 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.797 -0.638 . . . . 71.0 111.12 -171.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.98 155.38 15.04 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.586 2.191 . . . . 74.1 110.973 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.99 101.16 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.925 1.75 . . . . 71.21 111.956 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.661 ' HB ' HD21 ' A' ' 150' ' ' LEU . 6.7 p -73.48 -19.3 60.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.64 . . . . 74.05 110.411 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.605 ' HB2' HG22 ' A' ' 143' ' ' VAL . 90.2 t80 -56.55 -24.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.999 -1.001 . . . . 75.51 110.441 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.22 -26.12 33.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 61.33 110.057 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.724 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 18.6 t70 -82.99 -14.8 53.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.856 -0.611 . . . . 71.54 109.447 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 1.035 HD21 ' HA3' ' A' ' 152' ' ' GLY . 2.3 tp -55.85 -34.39 65.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.802 -1.09 . . . . 74.22 110.637 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.562 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . -136.25 21.9 3.44 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 65.04 111.705 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 4.7 ttpm? -56.71 -56.08 25.99 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.418 . . . . 74.5 111.178 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.17 -38.1 89.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.65 -0.704 . . . . 73.35 110.681 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.27 80.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 73.11 112.417 -174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 98.7 mtt180 -57.88 -42.23 84.19 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.635 0.606 . . . . 75.41 112.635 -170.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.07 -37.89 86.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 74.45 110.507 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.83 -34.77 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.918 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -72.32 -42.6 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 73.24 111.814 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -126.9 57.68 1.45 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.994 0.902 . . . . 74.01 110.652 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 21' ' ' GLY . 45.3 tptt -75.16 177.31 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.501 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 20' ' ' LYS . . . -64.5 116.62 9.26 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.554 -0.832 . . . . 71.14 111.68 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.73 173.98 6.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 73.31 110.761 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.929 ' HA3' ' HB3' ' A' ' 274' ' ' LYS . . . -83.14 88.17 1.49 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.749 -0.738 . . . . 63.34 112.786 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -93.26 -4.33 52.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.033 -0.358 . . . . 74.52 110.033 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.5 79.36 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.933 -0.576 . . . . 71.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.31 155.15 39.18 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 122.162 0.982 . . . . 71.42 112.797 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.952 HG21 HD21 ' A' ' 277' ' ' LEU . 43.6 mm -94.03 121.25 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.704 -1.589 . . . . 75.53 107.809 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 6.5 mtpm? -114.83 139.44 49.75 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.852 -0.339 . . . . 74.15 110.71 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tt -142.84 142.66 31.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.081 173.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -144.66 128.05 16.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.61 0.719 . . . . 75.21 110.434 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 281' ' ' PHE . 11.8 tp -120.84 126.75 50.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.896 -1.047 . . . . 74.24 110.33 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 2.0 ptmm? -121.8 124.49 44.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.483 0.659 . . . . 70.13 110.514 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.697 ' HB ' ' HB1' ' A' ' 283' ' ' ALA . 3.6 t -110.68 121.86 46.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.084 -1.08 . . . . 74.23 108.084 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HB3' ' HG3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -143.41 139.05 29.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.791 0.805 . . . . 74.51 112.706 -170.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 37' ' ' ASN . 23.1 t -139.32 137.93 36.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.944 -1.873 . . . . 72.02 105.944 168.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -79.62 44.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.044 0.926 . . . . 70.03 111.128 -171.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 35' ' ' SER . 1.4 m-20 -98.37 19.41 14.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.966 -1.47 . . . . 75.4 107.431 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 95.62 -7.05 68.09 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.495 -1.23 . . . . 74.32 113.253 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 39' ' ' LEU . 3.4 mm? -102.77 128.41 49.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.252 1.026 . . . . 73.31 113.489 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 25.6 tt0 -140.56 117.84 11.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.898 -0.779 . . . . 65.04 108.898 160.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 87.9 t80 -108.16 120.54 42.62 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.955 -0.466 . . . . 75.33 109.812 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.557 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 34.0 m -120.85 115.95 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 75.45 110.48 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -114.41 123.54 49.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.547 -0.538 . . . . 70.15 109.547 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 20.1 m -117.69 133.89 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 63.44 110.378 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.63 125.33 2.71 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.832 -0.699 . . . . 73.31 111.606 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.6 m -119.69 133.99 55.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 73.24 109.037 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.43 146.46 44.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.158 0.504 . . . . 75.53 111.858 -173.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -68.87 142.91 54.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.503 -0.771 . . . . 64.34 109.157 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -57.88 -21.76 44.75 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.209 0.528 . . . . 74.22 111.271 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.75 7.46 33.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 75.34 110.632 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.9 p 50.05 25.66 1.78 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.383 1.073 . . . . 64.3 113.318 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 p -99.72 -18.44 17.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 73.41 111.712 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -134.93 108.64 8.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.183 -0.673 . . . . 72.15 109.183 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 t -125.3 120.77 58.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.026 0.441 . . . . 74.03 110.742 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -111.22 126.49 54.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.146 0.498 . . . . 73.42 110.359 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.26 155.49 16.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.855 -0.688 . . . . 73.11 112.425 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.9 m -143.65 126.78 16.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.438 -0.949 . . . . 74.12 108.438 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -121.3 124.61 45.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.38 -0.528 . . . . 75.0 110.479 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 44.2 mt-10 -114.82 118.71 34.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.92 -0.582 . . . . 73.03 110.122 174.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 m -97.7 117.2 31.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.472 -1.307 . . . . 75.34 107.472 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 24.3 mtpp -121.93 139.38 53.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.325 0.583 . . . . 73.4 110.554 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 76.5 m-85 -109.67 120.82 43.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.416 -0.811 . . . . 73.11 109.082 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -118.04 109.16 16.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.258 0.551 . . . . 64.14 111.304 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 20.0 t90 -112.9 92.46 4.02 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.201 -0.909 . . . . 74.21 109.514 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 67' ' ' TYR . 10.8 m 71.63 151.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.134 0.896 . . . . 55.03 111.393 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.44 -38.21 63.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.561 0.696 . . . . 72.31 110.08 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.447 ' H ' HG22 ' A' ' 65' ' ' THR . 14.0 p90 -121.43 103.04 8.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 74.24 109.121 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.39 -102.07 0.17 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.225 -0.988 . . . . 72.32 112.141 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.7 mm? -117.51 136.55 53.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.322 0.582 . . . . 74.34 112.293 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -135.39 112.23 10.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.198 -0.91 . . . . 75.14 109.327 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.618 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 56.2 t80 -117.32 132.5 56.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.771 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 58.7 m -128.67 117.65 21.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.777 -0.192 . . . . 72.22 111.408 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -103.31 121.14 42.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.879 -1.156 . . . . 73.12 107.879 167.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -123.36 102.37 7.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.967 -0.56 . . . . 74.35 110.856 -168.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.855 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 67.9 t90 -96.67 132.84 41.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 74.25 109.889 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -119.76 165.82 14.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.852 -0.425 . . . . 74.11 109.852 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.7 t -64.84 -6.3 7.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.02 0.438 . . . . 74.53 111.932 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -79.82 -3.28 47.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.57 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 14.7 m120 73.97 18.64 3.22 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.92 0.763 . . . . 74.1 110.028 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.6 m -102.93 135.92 43.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 72.35 110.487 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.855 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 4.8 mp -112.79 119.71 38.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.246 -0.434 . . . . 72.32 110.412 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 130.55 10.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.74 -0.743 . . . . 62.33 111.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.3 m -112.78 107.48 16.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.011 0.434 . . . . 73.13 111.144 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.771 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 21.7 tt0 -105.39 127.8 53.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.588 -0.733 . . . . 63.15 109.885 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -130.02 120.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.364 -0.606 . . . . 64.41 109.364 169.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 24.6 m -126.36 129.24 48.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.685 -0.689 . . . . 55.53 110.229 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.02 134.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 74.3 111.253 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.486 ' OE2' ' HG3' ' A' ' 96' ' ' LYS . 67.8 mm-40 -96.46 118.86 33.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.55 -0.908 . . . . 73.34 108.55 172.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.27 122.9 28.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 73.44 109.822 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -85.56 -27.58 25.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.235 -0.438 . . . . 73.53 110.99 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.37 -44.8 42.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.295 -0.631 . . . . 74.14 109.295 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -99.61 67.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.516 -0.92 . . . . 71.52 108.516 170.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -49.95 131.23 22.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 65.34 111.759 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.477 ' HA2' ' HD2' ' A' ' 119' ' ' LYS . . . 102.85 -15.16 55.78 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.11 -0.95 . . . . 71.12 112.444 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -78.96 121.07 24.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.15 0.475 . . . . 71.11 111.126 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HG3' ' OE2' ' A' ' 88' ' ' GLU . 48.9 tttp -118.06 111.78 19.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.571 -0.741 . . . . 74.43 109.574 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.615 HD12 HG21 ' A' ' 116' ' ' THR . 1.9 mm? -103.53 128.53 50.74 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.875 -0.417 . . . . 73.51 109.875 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 10.5 m -128.82 122.65 30.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.458 -0.337 . . . . 73.4 111.375 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.596 ' CE2' HD11 ' A' ' 114' ' ' ILE . 47.4 m-85 -119.55 115.67 24.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.477 -0.564 . . . . 75.02 109.477 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.1 t70 -115.42 122.05 44.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.55 -0.537 . . . . 73.15 109.55 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -134.83 121.69 20.99 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.061 0.457 . . . . 65.11 110.455 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 m -99.29 121.93 41.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.01 -0.541 . . . . 62.04 109.915 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.35 119.37 39.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 72.31 109.716 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 m -115.16 102.37 54.67 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.894 -0.41 . . . . 63.45 109.894 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.73 -33.04 28.71 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.559 2.173 . . . . 65.53 111.51 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -83.67 -46.11 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.643 -0.708 . . . . 75.24 111.102 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -70.25 -36.26 74.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.877 0.37 . . . . 75.23 110.806 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.26 -18.34 57.57 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.033 -0.603 . . . . 72.12 112.487 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.607 ' HZ3' ' HB3' ' A' ' 109' ' ' LYS . 8.0 mtpm? -82.62 123.89 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.138 0.495 . . . . 75.35 110.568 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HB2' ' HZ2' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -115.22 116.56 28.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.92 -0.77 . . . . 75.45 108.92 173.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -120.1 144.37 47.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.417 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.85 141.0 36.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.376 -0.375 . . . . 75.03 110.597 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -128.82 142.56 50.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.908 -0.404 . . . . 74.42 109.908 175.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 99' ' ' PHE . 2.2 tp -118.07 117.68 55.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.885 -0.598 . . . . 74.31 110.08 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.713 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 27.9 ttpp -115.19 119.76 37.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.049 -0.523 . . . . 64.31 110.029 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.615 HG21 HD12 ' A' ' 97' ' ' LEU . 17.6 p -113.04 116.95 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.327 -0.62 . . . . 75.45 109.327 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.438 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -136.09 116.65 1.5 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.86 -1.162 . . . . 64.23 112.728 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.667 ' HB3' HD21 ' A' ' 95' ' ' LEU . 21.4 p90 -108.1 122.67 47.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.583 -0.525 . . . . 73.52 109.583 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -109.29 123.59 49.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.547 0.689 . . . . 71.44 110.965 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -106.25 165.02 11.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.741 -1.118 . . . . 75.31 109.256 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.826 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 10.4 pt-20 -52.65 -29.81 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.273 0.842 . . . . 71.13 113.273 -167.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -120.42 -6.1 9.81 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.924 -0.71 . . . . 63.15 112.502 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.37 126.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.424 -0.91 . . . . 74.44 113.011 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.804 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.8 OUTLIER -100.94 121.57 41.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.725 -0.671 . . . . 74.44 110.783 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.501 HD11 HD11 ' A' ' 142' ' ' LEU . 3.9 mm? -112.05 126.69 55.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.229 0.212 . . . . 73.33 110.577 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.438 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.1 118.64 1.96 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.574 -0.822 . . . . 52.21 112.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 63.0 m -112.3 109.25 18.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.369 . . . . 73.12 110.51 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 4.3 t70 -108.82 146.01 34.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.832 -0.622 . . . . 71.41 110.125 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.481 ' HG3' HD13 ' A' ' 138' ' ' ILE . 22.2 ttt -135.96 117.21 14.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.045 -0.354 . . . . 72.44 110.045 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -100.22 117.35 34.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.512 -0.551 . . . . 73.53 109.512 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -98.18 122.98 42.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.121 0.486 . . . . 62.34 112.17 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -117.29 148.26 41.84 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.295 -1.002 . . . . 75.15 108.295 166.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.736 ' H ' HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -65.78 -19.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.108 0.41 . . . . 72.45 112.108 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.65 -12.26 29.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.32 . . . . 61.33 111.21 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.89 122.8 0.63 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 64.44 112.394 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 5.8 Cg_endo -87.3 145.78 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.602 2.868 . . . . 72.54 112.923 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 p -117.82 148.33 42.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.87 -0.605 . . . . 75.42 110.385 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.834 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 41.6 mm -107.55 118.39 55.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 110.265 -0.272 . . . . 73.11 110.265 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 155' ' ' MET . 70.6 mtm180 -105.7 116.9 32.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.127 0.489 . . . . 75.43 109.969 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.02 134.07 11.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.102 -1.046 . . . . 74.11 111.982 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.22 127.66 40.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.404 . . . . 73.32 110.557 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.501 HD11 HD11 ' A' ' 125' ' ' LEU . 13.0 tp -132.51 124.23 28.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 74.23 110.12 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.804 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 36.1 t -123.79 120.78 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.486 . . . . 75.33 110.539 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.428 HD13 ' HG ' ' A' ' 142' ' ' LEU . 4.9 mp -110.62 140.7 44.7 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.388 -0.369 . . . . 75.1 110.214 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.88 119.17 4.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.949 -0.643 . . . . 65.31 112.857 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 78.3 m-85 -128.21 148.23 50.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.867 -0.79 . . . . 71.22 108.867 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -53.48 103.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 72.13 110.781 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.06 -32.94 6.71 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.247 -0.888 . . . . 74.52 112.497 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 93.4 m95 -108.06 123.45 48.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.721 0.638 . . . . 72.33 112.721 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' A' ' 6' ' ' THR . 2.0 tm? -113.99 137.35 51.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.31 -1.737 . . . . 73.01 106.31 170.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -135.73 132.83 37.34 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.954 -0.699 . . . . 64.34 110.813 -167.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.035 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -132.57 132.77 6.76 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.369 -0.919 . . . . 74.41 112.045 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.447 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 53.4 m-85 -132.49 118.2 18.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.636 -0.505 . . . . 74.31 109.636 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 1.9 mp0 -120.35 144.27 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.0 -0.546 . . . . 72.2 109.989 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 23.5 ptp -145.3 147.47 32.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.66 0.266 . . . . 75.15 110.578 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 8.3 t30 -113.95 117.37 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.219 -0.659 . . . . 75.42 109.219 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.834 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 69.7 t80 -94.59 125.18 39.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.61 -0.723 . . . . 72.53 111.062 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' A' ' 161' ' ' LYS . 44.8 tt0 -91.29 103.98 16.58 Favored 'General case' 0 C--O 1.266 1.929 0 CA-C-N 115.104 -0.953 . . . . 74.04 109.384 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.28 -18.61 63.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.774 -2.012 . . . . 71.23 111.646 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.92 75.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.879 0.847 . . . . 65.13 108.907 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.514 ' HD3' ' OE2' ' A' ' 158' ' ' GLU . 2.0 mptm? -111.55 -159.37 0.68 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 74.34 107.996 168.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.3 m -107.9 28.67 8.0 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 122.252 -0.28 . . . . 64.34 110.287 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 158' ' ' GLU . 28.9 mtm180 -132.15 171.69 13.33 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 118.94 -1.104 . . . . 70.11 111.797 -163.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.6 m -103.06 133.01 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.389 -0.967 . . . . 75.04 108.389 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 p -99.89 1.38 42.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.067 0.46 . . . . 72.2 111.501 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.592 ' HG3' ' HB2' ' A' ' 186' ' ' ASP . 35.7 tt0 -150.87 130.82 13.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 71.31 109.687 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 m -121.78 112.87 18.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.857 -0.611 . . . . 72.12 109.936 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 84.0 m-20 -107.32 127.97 54.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.432 -0.581 . . . . 75.12 109.432 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.621 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.6 m-85 -121.39 153.01 38.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.286 -0.566 . . . . 74.52 111.065 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -148.67 128.53 13.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.504 -0.771 . . . . 72.41 109.833 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.1 t -125.81 126.17 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.501 -0.555 . . . . 74.12 109.501 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -117.32 130.58 8.94 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.624 -0.798 . . . . 73.01 112.713 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -113.03 120.2 40.53 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.557 -1.275 . . . . 74.54 107.557 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -118.02 126.86 53.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.693 0.759 . . . . 74.41 112.797 -167.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 178' ' ' PHE . 23.8 m -131.89 162.56 30.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.31 -1.367 . . . . 74.14 107.31 169.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -46.76 -50.65 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.537 0.569 . . . . 61.24 112.537 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 7.9 pt-20 -116.16 10.95 15.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.094 0.473 . . . . 75.51 111.544 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.744 ' HD1' ' HG2' ' A' ' 196' ' ' GLN . 61.2 t80 -137.13 121.28 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.193 -0.458 . . . . 64.53 110.526 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -133.61 122.75 23.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.208 0.528 . . . . 73.0 110.605 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.74 HD11 HG13 ' A' ' 194' ' ' ILE . 3.2 tt -111.91 131.98 55.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.388 -0.597 . . . . 74.14 109.388 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -129.85 115.16 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.195 0.521 . . . . 74.54 109.982 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 27.4 m -86.25 135.41 33.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.397 -0.819 . . . . 73.4 109.088 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -128.66 138.1 51.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.227 0.536 . . . . 75.23 111.087 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 53.6 t -132.13 128.42 59.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 72.25 110.133 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -115.17 95.63 5.29 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.896 -0.779 . . . . 75.22 108.896 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.592 ' HB2' ' HG3' ' A' ' 166' ' ' GLN . 29.8 t0 58.46 -174.0 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.842 -1.072 . . . . 75.35 109.793 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -75.69 -6.73 82.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.617 -0.801 . . . . 72.01 111.783 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 186' ' ' ASP . 7.2 t -89.59 -27.42 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.455 0.539 . . . . 75.25 112.455 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.45 114.26 15.33 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 119.911 -0.716 . . . . 71.31 111.023 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -133.83 132.85 40.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.783 0.325 . . . . 72.3 110.583 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -166.34 -159.31 11.98 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.785 -0.721 . . . . 63.12 112.088 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.19 153.78 24.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.889 -0.672 . . . . 64.11 111.979 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.0 m -126.8 139.34 53.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.087 0.47 . . . . 73.21 110.255 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.74 HG13 HD11 ' A' ' 180' ' ' LEU . 4.5 mp -119.47 129.72 74.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.874 -0.603 . . . . 75.5 109.724 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -125.19 119.13 27.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.395 -0.594 . . . . 74.33 109.395 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.744 ' HG2' ' HD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -125.56 120.04 29.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.156 -0.475 . . . . 73.31 110.405 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.905 ' HG3' ' HG2' ' A' ' 203' ' ' GLU . 58.1 tttm -106.11 116.03 31.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.295 -0.631 . . . . 74.41 109.295 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.535 HG11 ' H ' ' A' ' 200' ' ' LYS . 16.1 t -86.33 143.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.714 -0.846 . . . . 72.53 108.714 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -73.36 6.33 3.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.61 0.719 . . . . 73.41 110.508 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.535 ' H ' HG11 ' A' ' 198' ' ' VAL . 49.0 tptt -98.19 37.71 1.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.062 -0.972 . . . . 74.23 108.911 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 200' ' ' LYS . 34.6 mmtp 75.95 -55.54 0.6 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.992 -1.004 . . . . 75.42 112.884 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.14 132.62 53.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.768 0.794 . . . . 73.2 112.752 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.905 ' HG2' ' HG3' ' A' ' 197' ' ' LYS . 31.3 mt-10 -110.7 142.97 41.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.611 -1.177 . . . . 75.43 109.303 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.9 m -131.68 138.99 48.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.661 -0.245 . . . . 62.42 110.58 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -131.01 148.94 52.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.655 -0.248 . . . . 72.32 110.657 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.788 HG21 HG23 ' A' ' 221' ' ' ILE . 92.1 t -135.11 140.45 45.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.998 -0.371 . . . . 73.42 109.998 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -124.76 127.07 46.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.76 0.314 . . . . 74.11 110.513 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.01 136.57 54.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.619 . . . . 71.14 110.016 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -148.21 129.58 14.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.371 -0.377 . . . . 73.42 110.22 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -114.66 126.78 55.28 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.989 -0.745 . . . . 74.24 108.989 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 188' ' ' THR . 6.4 t -101.82 112.99 25.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.441 0.639 . . . . 72.42 109.638 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.24 126.42 27.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.303 -0.862 . . . . 75.4 110.922 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 156.44 -78.55 0.19 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.789 . . . . 61.24 112.484 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.76 50.52 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.43 . . . . 71.04 111.367 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.0 m 58.54 18.88 6.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.955 0.724 . . . . 70.12 112.955 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.451 ' HB3' ' CG2' ' A' ' 211' ' ' THR . 48.1 t-20 -75.94 114.31 14.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 74.34 110.053 -176.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.5 m -113.34 130.87 56.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.778 -0.646 . . . . 72.05 110.862 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -106.04 125.89 51.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 74.34 110.121 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 239' ' ' ASN . 9.5 t80 -130.44 141.52 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.233 -0.894 . . . . 72.2 109.25 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.27 147.78 15.66 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.445 -0.883 . . . . 73.44 112.0 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.788 HG23 HG21 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -128.24 144.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.725 0.298 . . . . 75.31 110.213 177.036 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -130.51 142.25 50.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.979 -0.555 . . . . 73.04 110.851 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -116.42 135.16 54.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.798 -0.637 . . . . 63.11 109.627 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 64.6 tttt -129.63 117.32 20.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.283 -0.417 . . . . 74.43 110.285 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -132.78 125.85 31.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.042 0.448 . . . . 74.44 111.005 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -91.92 100.77 13.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.042 -0.725 . . . . 74.23 109.042 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 17.4 tt -71.03 -30.2 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 74.13 111.061 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.7 ' HB2' ' HD2' ' A' ' 229' ' ' PRO . 3.4 p30 -156.22 164.07 22.7 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.722 -0.844 . . . . 71.4 108.722 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.7 ' HD2' ' HB2' ' A' ' 228' ' ' ASP . 13.6 Cg_endo -56.26 -20.42 31.78 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.865 2.377 . . . . 70.24 114.53 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -104.62 -19.42 13.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.904 -0.318 . . . . 62.31 111.58 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.493 ' HB3' ' HG3' ' A' ' 249' ' ' GLN . . . -124.3 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.322 0.582 . . . . 73.22 112.312 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.4 m -125.09 133.34 52.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.637 -0.711 . . . . 71.23 110.262 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -114.42 133.15 55.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.88 0.371 . . . . 73.32 110.159 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 11.3 p -137.97 149.33 46.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.123 -0.489 . . . . 72.14 110.42 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -144.55 155.99 43.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.867 -0.42 . . . . 74.44 109.867 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -144.87 149.64 35.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.441 . . . . 73.53 111.067 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 1.2 t -127.28 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.774 -0.648 . . . . 74.33 110.017 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.7 m120 -106.06 150.16 26.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.106 -0.497 . . . . 74.42 109.956 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 219' ' ' PHE . 22.5 p-10 -45.07 -32.24 1.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.807 1.317 . . . . 75.12 113.692 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.645 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 19.7 m -82.23 25.64 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.873 0.368 . . . . 73.5 110.748 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 22.2 m 69.84 31.1 3.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.591 -0.731 . . . . 72.22 110.863 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.691 ' HB3' HD11 ' A' ' 262' ' ' LEU . 5.2 mp -88.17 126.95 35.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 120.686 -0.406 . . . . 73.13 110.618 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.694 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.88 116.65 53.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 123.884 0.74 . . . . 73.14 109.859 -177.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.481 ' HA3' HD22 ' A' ' 262' ' ' LEU . . . -129.84 151.87 19.46 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.157 -1.021 . . . . 75.44 112.929 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -136.7 154.22 50.67 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.431 . . . . 74.13 110.952 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.71 120.76 1.32 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.253 -0.739 . . . . 62.43 111.253 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -112.36 119.07 37.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.992 -0.373 . . . . 73.24 109.992 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -119.73 121.93 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.471 0.653 . . . . 72.13 110.661 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 231' ' ' ALA . 24.7 tt0 -123.9 131.07 53.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.854 -0.612 . . . . 73.22 109.802 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.0 m -87.21 114.37 23.76 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.435 -0.348 . . . . 73.43 110.456 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.772 ' HG ' ' HD2' ' A' ' 253' ' ' PRO . 19.2 tp -75.71 139.7 42.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.555 -0.906 . . . . 74.12 108.555 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -55.94 -43.94 99.46 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.787 1.032 . . . . 75.41 113.787 -168.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.772 ' HD2' ' HG ' ' A' ' 251' ' ' LEU . 72.4 Cg_exo -43.8 -64.33 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 75.23 113.703 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 163.95 38.65 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 120.721 -0.752 . . . . 64.41 111.696 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.681 HD11 ' HB3' ' A' ' 279' ' ' LEU . 1.8 tp -143.46 122.2 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.821 -0.437 . . . . 71.01 109.821 -174.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.515 ' CG ' ' HB2' ' A' ' 280' ' ' GLU . 12.7 ptmm? -106.63 133.19 51.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.455 0.645 . . . . 74.24 110.534 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.7 tp -99.91 124.14 44.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.755 -1.111 . . . . 72.01 110.025 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.7 t -125.45 112.54 16.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.645 0.736 . . . . 73.05 110.671 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.552 HD21 HD13 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -100.17 124.78 45.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.893 -1.151 . . . . 74.03 107.893 175.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 p -129.94 139.55 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.981 0.42 . . . . 73.43 111.006 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.5 128.64 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 75.5 110.2 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -110.25 121.69 45.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.98 . . . . 71.52 108.353 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.868 ' HB3' HG13 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -102.28 109.47 21.15 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.991 -0.744 . . . . 64.52 108.991 176.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.992 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 1.7 m-20 -68.64 106.09 2.49 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.69 -1.226 . . . . 65.32 107.69 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.521 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -53.49 -24.85 25.54 Favored Glycine 0 C--N 1.32 -0.355 0 O-C-N 123.517 0.511 . . . . 73.23 113.48 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.12 -26.48 19.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.672 0.272 . . . . 74.03 111.039 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.992 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 7.2 m-20 -96.69 -30.8 13.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.463 -0.335 . . . . 75.53 111.882 -173.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 263' ' ' LEU . 21.7 m -62.95 -18.68 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 71.51 111.216 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -62.19 -31.08 71.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 73.33 109.783 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.27 9.99 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 74.21 110.63 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.17 15.94 63.73 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.969 -0.56 . . . . 71.34 112.985 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.69 96.12 2.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 61.13 112.479 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -110.18 142.82 41.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.082 -0.34 . . . . 74.23 110.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.929 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 58.4 mttm -101.06 134.48 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.006 -0.739 . . . . 75.51 109.006 170.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.31 132.42 37.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.795 -0.446 . . . . 73.32 109.795 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.469 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -148.07 132.69 4.32 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.872 -0.68 . . . . 62.44 111.611 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.952 HD21 HG21 ' A' ' 27' ' ' ILE . 45.4 tp -114.77 145.65 41.86 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 74.24 110.722 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.601 ' H ' HD11 ' A' ' 277' ' ' LEU . . . -142.32 125.47 2.67 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 70.13 112.006 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.681 ' HB3' HD11 ' A' ' 255' ' ' ILE . 2.9 mm? -109.23 129.25 55.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.112 -0.699 . . . . 73.41 109.112 170.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.515 ' HB2' ' CG ' ' A' ' 256' ' ' LYS . 20.9 mt-10 -113.91 110.69 20.49 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.089 -0.708 . . . . 74.35 109.089 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -116.77 135.16 53.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.096 0.475 . . . . 74.04 110.155 -173.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -130.96 112.67 13.16 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.899 -0.778 . . . . 74.52 108.899 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 33' ' ' THR . . . -83.03 107.55 15.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 55.35 109.833 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 283' ' ' ALA . 3.4 mm? -137.9 -61.11 0.63 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.988 -1.006 . . . . 64.45 109.071 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.991 -0.528 . . . . 71.23 109.8 177.102 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.713 0.292 . . . . 74.21 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.925 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 3.8 t -116.02 114.77 41.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.978 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.88 175.07 11.85 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.702 2.268 . . . . 74.31 111.993 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 13.2 Cg_exo -70.79 85.13 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.443 2.095 . . . . 75.15 111.298 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 p -69.38 -34.35 74.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 74.41 111.54 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.589 ' HB3' HG21 ' A' ' 143' ' ' VAL . 10.9 p90 -61.24 -28.71 69.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.139 0.495 . . . . 74.21 110.983 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -84.86 -20.78 30.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 73.12 110.892 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -102.43 -0.12 32.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.177 0.989 . . . . 53.04 108.48 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.962 HD21 ' HA3' ' A' ' 152' ' ' GLY . 8.6 tp -58.04 -24.12 57.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.618 -1.628 . . . . 71.33 110.519 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.64 51.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.619 -0.719 . . . . 62.14 111.916 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 13.8 ptmm? -62.38 -44.04 97.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.653 0.264 . . . . 74.43 111.504 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -65.23 -38.95 91.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.182 0.515 . . . . 74.31 110.971 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' HB2' ' A' ' 193' ' ' SER . . . -70.08 -43.79 70.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 64.51 111.95 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.647 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 5.4 ptm180 -61.2 -28.38 69.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.477 -0.329 . . . . 73.41 111.104 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.89 -42.48 84.73 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.375 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -82.68 -31.46 9.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.794 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 94.6 t80 -71.47 -22.64 61.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 74.03 112.323 -174.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -29.86 117.04 0.13 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.213 0.946 . . . . 75.54 113.352 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -80.42 -9.47 59.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.075 -0.966 . . . . 74.13 110.235 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.94 91.28 1.22 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.045 -0.822 . . . . 64.41 111.045 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -84.13 169.83 14.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.884 0.373 . . . . 72.32 111.055 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.4 112.39 3.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.097 -0.573 . . . . 63.11 112.656 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -92.99 14.46 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.696 0.284 . . . . 73.34 110.905 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.7 13.57 53.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 71.14 112.065 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.05 160.05 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.025 0.917 . . . . 71.44 112.376 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.68 HG13 HD23 ' A' ' 277' ' ' LEU . 1.7 mp -104.28 127.55 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.071 -1.422 . . . . 72.21 108.789 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -106.87 142.21 36.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.681 0.277 . . . . 71.43 110.47 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.68 148.17 46.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.298 -0.41 . . . . 74.31 110.031 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.56 ' CG ' ' HZ3' ' A' ' 32' ' ' LYS . 13.8 t70 -155.16 134.62 12.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 74.45 109.95 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.687 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.871 -0.418 . . . . 73.33 109.871 -178.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HZ3' ' CG ' ' A' ' 30' ' ' ASP . 11.2 mptt -126.05 125.35 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.916 0.389 . . . . 73.5 110.087 170.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -137.68 120.04 15.85 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.025 -0.732 . . . . 74.35 109.025 170.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HE3' HD23 ' A' ' 284' ' ' LEU . 17.9 ptpt -133.41 144.58 49.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.546 . . . . 70.33 111.93 -176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.591 ' HB2' HD11 ' A' ' 39' ' ' LEU . 18.8 m -141.21 164.83 29.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 73.41 109.297 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -80.03 26.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.968 0.413 . . . . 72.44 110.995 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.474 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 7.6 t-20 -107.28 21.08 18.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.116 0.484 . . . . 71.03 110.286 -173.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.748 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 77.11 -6.73 40.69 Favored Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.745 -0.74 . . . . 72.33 113.176 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.671 HD13 ' O ' ' A' ' 39' ' ' LEU . 2.0 pp -102.44 132.94 48.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.837 0.68 . . . . 73.11 112.837 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.03 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 39.3 mt-10 -137.2 124.88 22.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 72.34 109.124 165.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -107.06 120.13 41.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.1 -0.333 . . . . 75.31 110.1 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.832 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 29.5 m -128.77 132.16 47.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 71.4 111.125 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.0 t -125.04 135.28 52.58 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.749 -0.834 . . . . 75.34 108.749 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -148.56 125.76 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.007 -0.277 . . . . 74.3 110.708 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.89 168.22 40.99 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.951 -1.119 . . . . 34.45 113.001 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -137.48 135.53 36.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.448 -0.575 . . . . 74.35 109.448 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.7 ' HB2' HG23 ' A' ' 54' ' ' VAL . . . -149.94 150.62 32.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.266 0.555 . . . . 75.44 111.973 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -71.68 139.53 49.24 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.245 -1.02 . . . . 74.3 108.245 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -67.99 -8.55 38.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.41 0.624 . . . . 65.54 111.144 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -82.34 -3.25 55.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.75 -0.659 . . . . 72.23 109.968 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.9 p 54.48 21.01 3.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.181 0.992 . . . . 55.05 112.651 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 p -91.92 -26.65 18.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 74.51 110.976 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.41 95.99 4.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.502 -0.555 . . . . 75.21 109.502 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.7 HG23 ' HB2' ' A' ' 47' ' ' ALA . 44.8 t -125.61 124.15 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.917 -0.583 . . . . 75.31 110.773 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 126.0 25.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.369 -0.604 . . . . 75.22 109.369 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.92 -178.01 37.9 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.263 -0.97 . . . . 72.02 112.786 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.506 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 5.0 p -138.4 153.23 48.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.169 0.509 . . . . 64.31 111.057 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.72 124.02 45.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.264 -1.384 . . . . 74.12 107.264 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.832 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 46.0 mt-10 -110.16 118.06 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.965 -0.561 . . . . 71.02 110.302 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -103.52 120.16 40.31 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.021 -1.103 . . . . 72.43 108.021 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.03 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 59.7 mttm -118.41 147.18 43.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.117 -0.492 . . . . 75.11 109.772 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.748 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 67.2 m-85 -118.12 120.18 36.98 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.959 -0.564 . . . . 72.21 109.634 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.607 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 14.6 ttm180 -114.09 106.84 14.86 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.505 0.669 . . . . 73.13 111.606 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -115.2 91.86 3.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.739 -1.119 . . . . 75.33 109.003 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 93.2 m 69.33 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.903 0.752 . . . . 70.5 111.286 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.04 129.03 39.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 75.43 110.5 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.608 ' HD2' ' HG3' ' A' ' 88' ' ' GLU . 32.2 m-85 62.57 35.05 14.66 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.613 -0.722 . . . . 75.32 110.587 -173.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.03 -90.52 0.97 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.655 -1.378 . . . . 72.52 109.655 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 69' ' ' LEU . 2.1 mm? -122.75 129.42 51.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.313 0.578 . . . . 74.24 111.199 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.6 p -137.78 121.4 17.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.261 -0.881 . . . . 72.4 110.371 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -122.39 123.48 41.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.534 -0.543 . . . . 74.34 109.534 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.697 ' HB ' ' HG2' ' A' ' 61' ' ' LYS . 7.4 p -128.3 130.63 48.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.853 -0.739 . . . . 71.33 111.123 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 35.7 tt0 -109.88 121.67 45.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.448 -0.575 . . . . 75.42 109.448 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -109.65 94.21 4.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.74 -0.467 . . . . 73.04 109.74 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.943 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 32.2 t90 -96.7 128.17 43.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.487 -0.324 . . . . 73.34 110.416 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 1.9 m-20 -106.61 134.21 50.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.862 -0.792 . . . . 71.23 108.862 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.8 m -72.11 -27.56 62.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.716 0.769 . . . . 71.11 109.764 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.54 -24.32 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.813 -1.085 . . . . 74.24 111.836 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.425 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 13.4 t-20 -131.16 -108.71 0.26 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.408 -0.517 . . . . 73.02 112.181 -171.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 104' ' ' SER . 16.4 p -115.46 144.58 43.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.006 0.743 . . . . 75.14 113.006 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.943 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -98.8 119.76 38.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.867 -0.79 . . . . 72.53 108.867 166.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.42 120.95 4.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.423 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -104.4 114.0 27.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.682 0.277 . . . . 72.43 110.576 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 13.6 pt-20 -120.06 132.71 55.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.073 0.463 . . . . 65.54 110.495 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.26 121.77 65.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.837 -0.619 . . . . 71.53 109.357 177.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -117.88 123.04 44.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.657 -0.702 . . . . 74.54 110.805 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -129.45 132.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 74.33 110.354 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.608 ' HG3' ' HD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -91.91 118.73 31.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.164 -1.421 . . . . 71.21 107.164 172.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 8.5 t70 -56.05 124.05 16.47 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.503 0.502 . . . . 73.04 111.081 -168.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -67.21 -23.31 65.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.874 -0.603 . . . . 75.02 111.222 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.99 -51.58 4.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.711 -0.478 . . . . 74.12 109.711 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.32 77.8 3.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.52 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 89' ' ' ASP . 30.0 mmm180 -63.26 128.45 35.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.961 -0.563 . . . . 75.14 110.031 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.57 44.03 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.24 -0.744 . . . . 74.43 111.24 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 118' ' ' TYR . 20.8 tp -123.19 120.24 32.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.213 -0.662 . . . . 71.13 109.213 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -118.01 121.0 39.51 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.989 -0.55 . . . . 73.41 109.764 -173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -104.64 127.09 52.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.709 . . . . 74.31 109.991 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 93.5 m -129.2 118.62 22.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.256 -0.429 . . . . 74.51 110.552 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -111.32 115.8 29.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.267 -0.642 . . . . 74.5 109.267 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 3.0 p30 -117.47 151.03 37.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.297 0.57 . . . . 73.14 110.613 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.496 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 50.4 m -142.13 121.49 13.15 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 71.0 110.033 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -102.93 122.23 44.16 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.872 -0.603 . . . . 64.44 109.546 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.55 ' HD2' HD21 ' A' ' 81' ' ' LEU . 82.4 t80 -110.24 130.54 55.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.718 -0.475 . . . . 70.21 109.718 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 80' ' ' THR . 35.5 t -106.99 106.94 59.65 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 74.24 109.9 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 37.2 Cg_endo -66.58 -16.09 49.69 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.7 2.267 . . . . 74.22 111.992 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -74.52 -38.46 62.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 75.35 110.874 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 109' ' ' LYS . 3.0 t -108.31 -27.96 9.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.351 . . . . 63.34 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 2.89 67.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.748 -0.739 . . . . 71.44 112.227 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.569 ' H ' HG22 ' A' ' 107' ' ' THR . 51.2 mtmt -89.08 148.4 23.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 73.55 110.956 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 61.7 tttm -123.08 136.94 55.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 75.54 109.939 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -119.6 122.81 42.41 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.891 -0.411 . . . . 74.21 109.891 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.83 129.72 56.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.249 -0.432 . . . . 64.25 110.6 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.791 ' HG2' ' HA ' ' A' ' 130' ' ' ASP . 35.9 mtmm -127.85 138.47 52.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.336 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.8 tp -116.56 117.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.479 0.657 . . . . 71.34 110.166 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 46.0 mttp -107.32 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.223 -0.899 . . . . 72.23 110.959 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -123.73 117.62 25.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.902 -0.777 . . . . 71.32 108.902 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.08 114.99 2.19 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.201 -1.0 . . . . 74.03 112.731 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.428 ' HB3' HD13 ' A' ' 95' ' ' LEU . 5.1 p90 -109.79 122.65 47.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.367 0.603 . . . . 72.52 109.753 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.925 ' HD3' ' HB ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.538 -0.756 . . . . 74.03 112.186 -173.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 46.1 mmt-85 -106.45 152.93 22.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.668 -1.234 . . . . 74.34 107.668 165.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -29.57 59.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.955 0.724 . . . . 73.41 112.955 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.4 -5.94 15.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.001 0.371 . . . . 75.21 112.001 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.429 ' CG2' ' HB2' ' A' ' 120' ' ' ARG . 9.0 tp -145.61 123.51 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.248 0.547 . . . . 73.14 111.48 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.619 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 4.1 t30 -119.97 117.05 27.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.2 -0.312 . . . . 74.5 110.53 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.0 mm? -112.97 127.1 56.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.909 0.385 . . . . 74.55 110.923 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.84 118.31 2.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.909 -0.587 . . . . 55.42 111.773 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.9 m -105.21 120.72 42.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.767 0.318 . . . . 73.1 110.678 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -114.85 117.4 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 75.23 110.162 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 77.6 mmm -99.02 117.07 32.71 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.441 -0.577 . . . . 64.14 109.441 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.791 ' HA ' ' HG2' ' A' ' 113' ' ' LYS . 11.0 t70 -102.81 118.5 36.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 72.23 110.696 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -97.84 97.85 9.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.436 -0.347 . . . . 72.51 110.844 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -105.1 144.38 31.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.972 -0.751 . . . . 70.05 108.972 170.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.02 -34.67 53.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.108 0.48 . . . . 75.24 111.977 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.22 -18.0 59.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.181 -0.463 . . . . 64.31 111.546 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.17 118.61 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.871 -0.681 . . . . 74.22 112.148 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.26 126.75 21.76 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.797 2.331 . . . . 74.34 112.04 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.9 m -107.63 150.82 26.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.275 -0.421 . . . . 72.44 110.363 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 33.4 mm -107.02 116.9 51.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.481 -0.562 . . . . 74.53 109.481 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -111.54 123.18 49.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.403 0.621 . . . . 73.15 110.348 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.34 132.93 11.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.307 -0.949 . . . . 73.31 111.959 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.27 23.76 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.197 -0.668 . . . . 74.41 109.197 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 143' ' ' VAL . 14.9 tp -124.16 131.67 53.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.107 -0.497 . . . . 75.02 110.608 -175.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 34.1 t -131.38 129.66 62.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.196 -0.456 . . . . 72.33 110.037 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.424 HD13 ' HE1' ' A' ' 153' ' ' TYR . 6.2 mp -109.48 138.66 45.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.117 -0.697 . . . . 64.04 109.117 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.533 ' HA2' HD22 ' A' ' 150' ' ' LEU . . . -119.55 119.32 4.23 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 121.04 -0.6 . . . . 75.11 112.888 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 63.4 t80 -126.99 149.07 50.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.684 -1.228 . . . . 75.02 107.684 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -49.31 101.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 74.52 111.55 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.48 -30.78 7.39 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.822 -0.626 . . . . 72.41 112.744 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 39.0 m95 -104.7 126.8 52.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 73.54 111.523 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.7 ' HB3' HD11 ' A' ' 10' ' ' LEU . 20.1 mt -120.32 146.98 45.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.022 0.439 . . . . 75.5 110.285 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -137.1 127.37 26.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.014 -0.736 . . . . 74.33 109.014 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.962 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -131.51 142.46 13.85 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.375 -0.917 . . . . 63.5 111.717 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.663 ' HD2' ' HD2' ' A' ' 169' ' ' PHE . 64.3 m-85 -136.0 121.76 19.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.743 0.306 . . . . 75.33 110.375 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.808 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 23.5 mp0 -106.05 122.58 46.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.961 -0.755 . . . . 65.4 108.961 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 49.1 ttm -127.96 141.87 51.41 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.735 -0.386 . . . . 75.45 110.464 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.481 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 51.5 t-20 -130.74 117.41 19.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.406 -0.59 . . . . 64.43 109.406 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.754 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 63.4 t80 -95.16 120.77 35.96 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.491 0.494 . . . . 72.01 110.053 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.54 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 43.4 tt0 -99.03 99.59 10.64 Favored 'General case' 0 C--O 1.26 1.649 0 CA-C-O 121.548 0.689 . . . . 73.31 110.678 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -70.59 -22.23 62.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 113.542 -1.663 . . . . 75.44 110.794 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.12 69.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.793 0.806 . . . . 71.4 109.119 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 162' ' ' SER . 21.5 tptp -113.41 -158.56 0.66 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.437 -1.32 . . . . 73.42 107.437 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.657 ' H ' ' HG3' ' A' ' 161' ' ' LYS . 17.2 m -108.72 28.08 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.918 -0.488 . . . . 55.23 110.813 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 163' ' ' ARG . 2.4 ptm180 -157.01 160.77 39.32 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.053 -1.059 . . . . 75.11 111.954 -164.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.6 m -74.0 133.4 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.165 -1.05 . . . . 75.13 108.165 169.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.7 t -93.39 -14.83 26.34 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.951 -0.3 . . . . 75.05 110.273 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.705 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 19.6 mt-30 -142.21 132.74 25.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.399 0.618 . . . . 72.42 111.796 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -123.0 105.98 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.058 -0.974 . . . . 74.42 109.388 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.808 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 13.7 m120 -114.42 136.06 53.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 72.1 110.176 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.663 ' HD2' ' HD2' ' A' ' 153' ' ' TYR . 36.5 m-85 -130.42 140.71 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 75.12 110.053 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.587 ' HB3' ' CE1' ' A' ' 181' ' ' HIS . . . -142.69 129.03 19.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.832 0.348 . . . . 73.5 110.282 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 45.8 t -124.54 127.13 72.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.004 -0.739 . . . . 75.44 109.004 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -140.49 115.39 1.05 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.85 -1.167 . . . . 75.41 112.293 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.442 ' CE2' HD23 ' A' ' 180' ' ' LEU . 54.2 p90 -115.47 134.48 55.05 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.422 -0.511 . . . . 74.14 110.241 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -119.25 124.95 47.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.311 -0.859 . . . . 70.31 110.225 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 51.1 m -134.78 112.69 10.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.893 -0.323 . . . . 74.32 110.301 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.6 t70 43.12 -87.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.35 1.031 . . . . 74.3 113.752 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 10.2 pt-20 -101.86 -12.13 18.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.213 0.449 . . . . 74.3 112.213 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.448 ' HD2' ' HG2' ' A' ' 196' ' ' GLN . 74.6 t80 -119.18 117.19 28.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 74.52 111.247 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -123.84 124.36 42.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 72.45 109.584 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.596 HD11 HG13 ' A' ' 194' ' ' ILE . 3.1 tt -119.49 135.41 54.78 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.512 -0.475 . . . . 75.54 110.677 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.587 ' CE1' ' HB3' ' A' ' 170' ' ' ALA . 47.7 t60 -129.75 115.11 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.373 -0.83 . . . . 75.42 110.225 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.0 m -92.48 142.8 27.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.492 -0.929 . . . . 75.35 108.492 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.15 139.83 33.98 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 64.34 110.754 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.35 121.06 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.714 -0.675 . . . . 64.33 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 75.2 m-20 -103.62 94.24 5.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.374 -0.83 . . . . 74.54 109.276 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.705 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 12.1 m-20 65.83 -169.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.836 -1.074 . . . . 71.22 110.907 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.436 ' O ' ' HB1' ' A' ' 212' ' ' ALA . . . -76.49 -6.5 84.32 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.425 -0.893 . . . . 72.12 111.714 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.2 m -96.8 -25.56 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.616 0.598 . . . . 74.24 112.616 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.4 tt0 -129.72 113.98 15.41 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.062 -0.655 . . . . 74.01 111.54 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -121.86 124.74 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.933 -0.765 . . . . 73.04 108.933 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.45 -160.75 11.36 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.788 -1.196 . . . . 72.33 112.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.66 175.8 44.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.539 -0.838 . . . . 75.15 112.389 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 26.2 m -148.68 138.09 21.87 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.391 -0.596 . . . . 61.43 109.391 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.738 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.6 mp -121.2 137.18 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.532 -0.544 . . . . 71.52 109.532 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -121.6 119.92 33.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.787 -0.82 . . . . 72.34 108.787 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.448 ' HG2' ' HD2' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -124.97 111.07 14.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.714 -0.847 . . . . 75.04 108.714 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 60.1 tttp -97.23 119.48 35.82 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.811 -0.631 . . . . 74.0 109.745 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.84 146.0 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.467 -1.308 . . . . 74.42 107.467 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -74.54 56.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.769 0.795 . . . . 75.5 110.997 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.459 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 67.8 mttm -152.85 -146.78 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.848 -1.524 . . . . 75.3 108.028 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.79 ' HB3' ' HB3' ' A' ' 226' ' ' GLN . 1.2 mptm? -103.01 26.16 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.315 0.578 . . . . 75.51 109.587 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.55 110.32 19.06 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.464 -0.789 . . . . 75.23 110.269 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.929 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 12.8 mm-40 -107.01 134.39 50.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 74.14 109.795 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.5 m -123.38 143.11 50.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 64.2 109.919 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.762 ' HB1' ' HB3' ' A' ' 222' ' ' ALA . . . -142.32 158.58 43.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 65.15 111.114 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.738 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 71.5 t -132.45 141.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.533 -0.543 . . . . 64.15 109.533 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.46 125.4 16.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.038 -0.727 . . . . 64.32 109.038 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.62 HD12 ' HD1' ' A' ' 219' ' ' PHE . 2.5 pt? -146.6 150.65 35.9 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.415 -0.514 . . . . 73.14 111.036 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.38 130.88 22.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 75.42 110.194 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.654 ' HB2' HG22 ' A' ' 217' ' ' THR . 9.4 t90 -125.28 135.11 52.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.606 -0.724 . . . . 74.13 109.489 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.895 HG22 ' HB3' ' A' ' 214' ' ' ASN . 3.9 t -95.27 113.95 25.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.355 0.598 . . . . 72.34 110.457 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 187' ' ' GLY . . . -64.94 144.71 57.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 72.35 110.846 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.58 -2.72 86.33 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.675 -0.97 . . . . 62.31 110.675 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.895 ' HB3' HG22 ' A' ' 211' ' ' THR . 37.2 t-20 -138.28 159.18 42.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.332 -0.988 . . . . 64.45 108.332 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.1 t -93.41 -9.29 39.12 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.174 -0.329 . . . . 73.14 110.542 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.97 108.92 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.213 0.53 . . . . 70.14 110.951 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.654 HG22 ' HB2' ' A' ' 210' ' ' TRP . 28.1 m -117.13 135.07 54.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.281 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -126.1 117.5 23.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.899 -0.32 . . . . 74.24 110.255 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.62 ' HD1' HD12 ' A' ' 208' ' ' LEU . 74.5 t80 -113.27 138.42 50.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.567 -0.742 . . . . 74.41 109.241 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.82 157.21 26.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.527 -0.844 . . . . 42.41 112.705 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.65 136.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 73.31 109.649 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.762 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -114.51 152.66 31.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.783 -0.451 . . . . 53.11 109.783 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.78 140.2 34.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.397 -0.365 . . . . 75.32 110.498 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.929 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 28.9 ttmt -123.1 113.84 19.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.128 -0.693 . . . . 63.13 109.128 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -105.2 116.47 32.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.48 -0.327 . . . . 71.51 110.535 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.79 ' HB3' ' HB3' ' A' ' 201' ' ' LYS . 63.1 tt0 -91.99 104.17 16.61 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.461 -0.94 . . . . 72.43 108.461 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.83 -49.06 60.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.472 -0.785 . . . . 75.35 110.991 -172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.741 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.1 t70 -164.78 -59.64 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 74.42 111.491 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 72.1 Cg_endo -89.38 -139.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.023 1.815 . . . . 72.34 113.443 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.432 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 1.8 m-20 -92.13 13.38 19.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.815 -1.084 . . . . 71.13 110.37 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.09 124.93 45.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 72.14 110.154 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.625 ' HB2' HG21 ' A' ' 248' ' ' THR . 59.6 m -113.09 145.09 41.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.191 -0.913 . . . . 74.44 110.173 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.24 125.98 39.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.962 -1.125 . . . . 75.11 107.962 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.8 t -106.45 144.56 32.95 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.166 -0.47 . . . . 72.15 110.013 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -148.57 147.69 29.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.34 -0.391 . . . . 75.3 110.431 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -148.01 138.53 22.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.132 -0.692 . . . . 73.21 109.132 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.33 152.92 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 242' ' ' LEU . 11.7 p30 -133.4 152.43 51.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.965 -0.694 . . . . 75.31 110.777 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.58 5.02 0.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.539 -1.209 . . . . 72.22 112.982 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.596 ' HB3' HD13 ' A' ' 242' ' ' LEU . 32.3 t -89.01 13.83 12.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.506 -0.924 . . . . 74.34 108.506 170.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 49.9 m 69.26 31.72 3.83 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 114.626 -1.17 . . . . 70.32 111.357 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.988 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 10.2 mp -99.75 142.62 31.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.287 -0.565 . . . . 74.23 111.202 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -125.59 118.0 51.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.695 -0.684 . . . . 73.12 110.317 -169.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.07 143.57 16.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.739 -0.743 . . . . 74.23 112.436 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.37 156.72 43.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.845 0.355 . . . . 73.34 110.153 176.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.92 -177.73 36.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.435 -0.888 . . . . 51.13 113.049 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.655 ' HB3' HE21 ' A' ' 249' ' ' GLN . 87.6 m-85 -117.15 115.93 26.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.603 -0.517 . . . . 72.42 109.603 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 232' ' ' CYS . 6.3 t -111.06 113.93 26.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.075 -0.713 . . . . 74.44 109.075 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.655 HE21 ' HB3' ' A' ' 247' ' ' TYR . 53.2 mt-30 -132.82 150.4 52.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.222 -0.444 . . . . 65.31 111.463 -168.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 8.9 t -124.78 132.83 53.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.117 -1.068 . . . . 73.42 108.117 167.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 255' ' ' ILE . 36.8 tp -72.27 -65.15 0.81 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.5 -0.48 . . . . 65.44 109.851 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.703 ' HB2' ' HZ3' ' A' ' 252' ' ' LYS . 0.5 OUTLIER 174.72 -57.91 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.466 -0.788 . . . . 73.33 110.137 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 83.5 Cg_endo -80.4 52.35 4.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.308 2.005 . . . . 64.42 113.403 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.96 64.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.666 -0.778 . . . . 75.44 112.596 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.619 HD12 HD21 ' A' ' 251' ' ' LEU . 61.7 mt -107.27 122.25 61.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 122.733 -0.275 . . . . 70.14 110.262 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.658 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 17.2 tptm -121.17 122.64 40.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.645 . . . . 74.42 110.75 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.76 124.08 51.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.136 -0.938 . . . . 73.42 109.815 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.401 ' O ' HD13 ' A' ' 277' ' ' LEU . 38.0 m -119.75 110.22 16.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.177 0.513 . . . . 74.22 110.743 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.585 HD23 HD12 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -111.13 125.77 54.13 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.86 -1.163 . . . . 72.24 107.86 173.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.9 p -139.08 141.01 38.18 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.762 -0.375 . . . . 64.11 110.742 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.42 127.62 19.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.325 -0.62 . . . . 64.53 109.325 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.696 HD23 HD21 ' A' ' 242' ' ' LEU . 0.4 OUTLIER -108.75 128.91 55.29 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.445 0.641 . . . . 74.3 109.466 177.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.855 ' HB3' HG12 ' A' ' 268' ' ' VAL . 1.4 mm? -102.1 106.96 17.91 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.252 -0.885 . . . . 74.34 108.957 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.988 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 6.3 t70 -73.48 98.99 2.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.754 -1.112 . . . . 62.43 108.329 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.83 -9.36 3.67 Favored Glycine 0 C--N 1.314 -0.673 0 CA-C-N 115.725 -0.671 . . . . 74.35 113.38 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 264' ' ' ASP . 84.6 tttt -92.46 -21.84 19.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.867 -0.166 . . . . 73.23 111.025 -174.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.89 -23.74 0.92 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.441 1.115 . . . . 74.1 110.831 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.9 ' HB ' ' O ' ' A' ' 264' ' ' ASP . 1.0 OUTLIER -63.21 -26.7 41.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 113.748 -1.569 . . . . 73.13 112.844 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.48 -26.32 68.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.055 -0.52 . . . . 73.25 110.274 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -88.29 -16.5 32.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.196 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.63 -1.2 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.521 -0.847 . . . . 63.11 113.637 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.86 51.79 4.36 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.561 -0.828 . . . . 75.33 113.046 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.877 ' HA ' HG21 ' A' ' 268' ' ' VAL . 0.6 OUTLIER -78.31 144.44 36.09 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.767 0.318 . . . . 72.3 111.389 -175.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.51 138.18 38.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 74.23 110.878 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -128.32 144.13 51.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 74.44 109.699 -174.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.567 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -146.32 119.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.933 -0.651 . . . . 55.43 111.821 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.68 HD23 HG13 ' A' ' 27' ' ' ILE . 54.0 tp -114.68 146.93 40.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 72.12 110.874 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.77 124.47 1.67 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.893 -0.594 . . . . 70.22 111.693 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.4 HD22 HD22 ' A' ' 277' ' ' LEU . 2.8 mm? -111.04 130.28 55.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.065 -0.717 . . . . 63.4 109.065 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.658 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 16.9 pt-20 -137.1 122.73 19.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.467 0.651 . . . . 72.02 110.459 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.687 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.2 m-85 -114.43 110.48 19.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.863 -0.791 . . . . 74.45 108.863 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.54 111.0 19.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.103 0.477 . . . . 74.13 111.497 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -104.19 109.75 21.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.453 -0.943 . . . . 73.32 108.453 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.494 HD23 ' HE3' ' A' ' 34' ' ' LYS . 56.9 mt -120.34 -98.42 0.45 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.381 -0.372 . . . . 74.11 111.535 -171.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.492 -0.766 . . . . 74.21 109.981 -176.562 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.523 -0.547 . . . . 53.34 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.77 ' HB ' ' HD2' ' A' ' 119' ' ' LYS . 16.3 t -117.89 117.09 35.82 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.924 -0.58 . . . . 74.42 110.705 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.43 161.9 14.88 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.539 2.159 . . . . 73.31 111.433 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 102.75 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.354 2.036 . . . . 74.52 111.63 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.547 ' HB ' HG11 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -70.09 -42.67 72.41 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.943 -0.571 . . . . 75.5 111.01 -176.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.882 ' HA ' ' HB3' ' A' ' 10' ' ' LEU . 64.4 t80 -50.15 -25.82 3.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.467 0.707 . . . . 74.52 111.68 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -76.65 -17.61 59.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.929 -0.578 . . . . 51.02 110.487 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -105.89 -31.36 8.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.547 -1.279 . . . . 61.35 107.547 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.882 ' HB3' ' HA ' ' A' ' 7' ' ' TYR . 2.5 tt -58.4 -36.09 73.02 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.351 -2.204 . . . . 73.24 110.738 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.12 -21.89 0.14 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 119.181 -1.485 . . . . 74.45 115.753 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.666 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 16.8 ttmm -57.15 -52.59 64.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.448 1.124 . . . . 74.45 112.358 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -56.62 -38.81 72.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.114 0.483 . . . . 72.4 111.073 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.755 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . . . -70.3 -42.65 71.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.563 -0.744 . . . . 72.04 111.156 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 5.2 tmm_? -59.66 -34.59 73.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.125 -0.488 . . . . 73.12 111.385 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -47.15 84.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 73.31 111.635 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HA ' ' HE1' ' A' ' 22' ' ' TYR . 78.9 t -82.7 -32.03 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.922 0.391 . . . . 72.52 110.966 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.447 ' HA ' ' ND2' ' A' ' 207' ' ' ASN . 86.8 t80 -60.54 -35.36 75.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 73.23 112.171 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -79.43 131.0 35.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 72.33 111.464 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.918 ' H ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -69.87 151.05 46.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.009 -0.996 . . . . 64.14 110.236 175.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.75 78.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.853 -0.689 . . . . 55.43 112.291 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.526 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 72.1 m-85 -70.28 -23.36 62.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.609 0.242 . . . . 74.33 111.454 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -123.72 133.25 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.798 -0.715 . . . . 73.33 111.756 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -104.21 2.12 31.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.085 0.469 . . . . 72.42 110.687 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.95 12.57 57.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.919 -0.658 . . . . 63.44 112.172 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.56 158.65 17.05 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 122.592 1.187 . . . . 75.34 113.656 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.787 HG22 HD13 ' A' ' 277' ' ' LEU . 46.2 mm -105.63 121.82 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 113.016 -1.902 . . . . 72.22 108.924 173.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 25.2 ttpp -109.64 129.07 55.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 75.42 110.65 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tm? -128.43 127.39 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.338 -0.986 . . . . 74.31 108.338 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.0 p30 -142.94 140.92 31.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.223 0.535 . . . . 73.14 110.989 175.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 42' ' ' THR . 7.2 tp -127.06 124.38 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.13 -0.941 . . . . 75.12 109.87 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 ptmm? -127.35 125.78 41.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.756 . . . . 70.0 110.385 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.5 ' HB ' ' HB1' ' A' ' 283' ' ' ALA . 9.9 t -131.73 132.21 43.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.8 -0.636 . . . . 75.13 110.221 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 28.9 mtpp -111.77 132.04 54.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.206 -0.664 . . . . 74.53 109.206 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 17.6 m -133.6 169.21 17.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 72.11 110.446 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -86.5 158.74 19.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.052 -0.522 . . . . 74.14 109.704 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.29 55.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.607 0.567 . . . . 71.54 111.991 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 85.16 -5.16 84.05 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 116.108 1.203 . . . . 73.24 116.108 168.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 2.7 mm? -100.31 124.75 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.024 1.912 . . . . 71.31 112.769 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.831 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 35.9 mt-10 -142.35 139.87 31.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 71.31 108.542 159.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 33' ' ' THR . 90.3 t80 -131.51 121.84 25.14 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 122.061 -0.399 . . . . 71.14 110.547 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.731 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 18.2 m -127.33 131.38 50.43 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.991 0.424 . . . . 73.43 110.488 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -126.51 126.19 43.31 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.06 -0.718 . . . . 63.12 109.06 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 p -126.54 126.22 43.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 72.32 111.159 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.04 139.7 9.16 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 74.1 112.36 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 p -132.21 136.59 47.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.058 0.456 . . . . 72.22 110.67 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.8 51.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.793 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -84.83 137.89 32.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.542 -0.54 . . . . 73.35 109.542 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.3 m -80.33 -27.5 38.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.005 0.431 . . . . 64.12 110.991 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.13 -71.37 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 74.23 110.52 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 p -93.24 159.82 15.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.249 -0.432 . . . . 53.44 110.603 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -79.81 88.48 5.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.468 0.652 . . . . 75.01 110.34 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -138.0 104.46 5.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 73.34 109.518 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.31 119.6 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.145 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -114.05 126.24 54.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.839 -0.619 . . . . 75.25 109.777 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.73 123.84 3.63 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.476 -0.869 . . . . 53.24 112.415 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 p -114.1 142.65 45.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.68 -0.489 . . . . 71.03 109.68 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -121.31 123.33 41.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.955 -0.757 . . . . 72.24 108.955 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.731 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 2.1 pm0 -114.16 118.97 35.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.076 0.941 . . . . 73.33 111.226 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -99.25 120.94 40.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.597 -1.183 . . . . 65.31 108.947 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.831 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 43.6 mtpt -112.56 126.92 55.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.219 0.533 . . . . 74.45 110.814 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 84.4 m-85 -103.3 120.28 40.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.55 -0.907 . . . . 75.25 108.55 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.504 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 36.0 ttt180 -110.71 108.2 18.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 73.23 110.742 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.485 ' HE3' ' HB3' ' A' ' 69' ' ' LEU . 5.3 m-90 -107.09 99.35 8.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.791 -0.64 . . . . 74.23 110.577 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 m 70.59 133.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.512 -0.767 . . . . 74.21 111.084 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.6 pm0 -64.73 124.58 22.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 62.14 110.559 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 63.4 35.49 12.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.433 -0.803 . . . . 74.04 111.077 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.37 -77.77 0.38 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.207 -0.757 . . . . 74.22 111.207 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.8 mm? -124.86 132.63 53.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.095 0.474 . . . . 75.11 111.378 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.34 112.59 11.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.83 -0.623 . . . . 74.23 110.248 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.546 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 58.5 t80 -111.6 120.26 41.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.007 -0.542 . . . . 73.53 109.745 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 t -124.27 117.29 24.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.308 0.575 . . . . 75.3 110.93 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 34.5 tt0 -102.76 120.62 40.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 71.45 109.697 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -107.19 113.98 27.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 75.01 110.336 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.859 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 70.4 t90 -103.1 134.89 45.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.776 -0.453 . . . . 70.01 109.776 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -110.22 156.19 21.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 73.13 109.481 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -61.35 -16.0 41.69 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.832 0.678 . . . . 70.3 112.832 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.6 -1.47 57.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.828 -0.169 . . . . 54.43 111.333 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 87.81 11.51 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.241 1.016 . . . . 73.21 112.432 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -81.83 126.38 31.8 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.775 -0.37 . . . . 53.44 110.099 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.859 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -105.63 119.48 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.33 -0.395 . . . . 71.03 110.155 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.83 98.65 0.92 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.352 -1.099 . . . . 71.1 110.352 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.525 ' HB ' ' HG3' ' A' ' 73' ' ' GLU . 9.7 t -106.63 120.86 43.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.516 0.674 . . . . 74.54 111.641 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 40.5 tt0 -109.3 123.47 49.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.376 -0.829 . . . . 61.04 110.169 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.546 ' HB ' ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -112.58 124.13 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 73.05 109.496 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 m -111.4 130.04 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 72.32 111.17 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 5.9 t -110.45 120.28 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.556 -0.747 . . . . 74.31 109.51 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.88 116.98 34.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.243 -0.28 . . . . 63.51 110.243 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 52.19 62.99 2.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.596 -0.729 . . . . 73.4 111.326 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.659 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 23.7 tp60 -62.42 -74.7 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.606 . . . . 75.11 111.24 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.659 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 88.5 mt -115.61 -31.93 5.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 64.44 110.111 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.92 125.64 51.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 72.11 110.268 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.554 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -63.64 135.38 56.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.124 0.488 . . . . 74.54 110.822 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.72 -15.23 58.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.556 -0.747 . . . . 72.15 112.257 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.2 131.4 36.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.501 . . . . 73.15 111.442 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -119.25 111.08 17.77 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.613 -0.884 . . . . 74.32 108.613 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -103.65 127.47 51.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.493 -0.558 . . . . 72.41 109.493 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.875 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 21.9 m -127.84 119.25 25.25 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.642 0.258 . . . . 74.13 110.579 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 82.5 m-85 -117.46 114.95 24.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.593 . . . . 73.3 109.4 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.962 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.9 t70 -111.14 122.65 48.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.183 -0.673 . . . . 75.04 109.183 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -118.2 120.47 37.8 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.016 0.436 . . . . 65.13 110.01 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' A' ' 111' ' ' ASN . 53.7 m -109.55 121.48 45.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.138 -0.483 . . . . 74.12 109.922 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -123.66 125.07 44.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.968 -0.56 . . . . 75.33 110.186 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 t -114.03 101.75 54.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 109.683 -0.488 . . . . 75.1 109.683 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.05 -9.16 19.25 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.932 2.421 . . . . 75.04 110.577 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -72.03 -55.48 7.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.887 -1.051 . . . . 74.45 109.89 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.5 t -103.92 -19.77 14.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 72.24 111.556 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.16 22.79 18.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.691 -0.766 . . . . 52.1 112.604 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -95.35 146.49 24.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.537 0.208 . . . . 75.31 110.774 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 140.66 45.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.873 0.368 . . . . 75.33 110.023 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.2 m120 -128.81 132.57 47.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.3 110.376 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -111.0 114.76 28.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.047 -0.524 . . . . 72.21 110.106 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 56.8 tttp -113.25 135.39 53.88 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.485 -0.561 . . . . 64.44 109.485 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -136.37 135.66 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 74.52 110.053 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.875 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.6 ttpm? -131.2 121.36 24.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.187 0.518 . . . . 75.43 110.582 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 p -112.63 121.17 44.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.437 -0.801 . . . . 73.51 109.278 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.46 154.52 21.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.004 -1.093 . . . . 71.3 112.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.38 116.64 21.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.454 -0.943 . . . . 75.45 108.454 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.77 ' HD2' ' HB ' ' A' ' 3' ' ' VAL . 24.4 pttm -110.18 121.94 46.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.42 0.628 . . . . 75.32 111.252 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.6 mpt_? -107.48 148.63 28.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.954 -1.128 . . . . 71.54 107.954 168.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.34 -27.9 50.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.986 0.422 . . . . 72.03 110.972 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -93.08 -31.2 14.92 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.272 0.471 . . . . 74.32 112.272 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.481 HD11 ' N ' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -144.21 132.32 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.822 -0.751 . . . . 74.34 110.974 -167.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.719 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 7.4 t30 -120.92 125.65 48.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.366 0.506 . . . . 74.13 112.366 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.94 131.64 55.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.936 -0.574 . . . . 63.35 110.049 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -141.38 117.07 1.17 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.331 -0.938 . . . . 53.33 112.626 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 42.0 t -109.78 108.57 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.323 . . . . 64.1 110.483 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.712 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 10.7 t70 -108.29 138.55 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 55.11 109.592 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.541 ' HG2' HG13 ' A' ' 138' ' ' ILE . 73.7 mtm -138.14 128.04 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.819 -0.551 . . . . 73.43 111.241 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -97.73 117.27 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.187 -0.672 . . . . 64.12 109.187 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -97.02 114.87 26.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.174 0.511 . . . . 74.24 111.048 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.3 153.9 45.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.595 -0.891 . . . . 72.51 108.595 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.8 pp -69.62 -17.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 73.25 111.1 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.56 -10.38 57.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.781 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.87 125.25 1.79 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.775 -0.726 . . . . 74.14 112.374 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 6.3 Cg_exo -80.03 122.07 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.23 2.62 . . . . 74.53 111.921 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 m -97.2 135.73 38.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.014 -0.365 . . . . 74.25 110.014 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.541 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -106.1 119.27 55.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.133 0.492 . . . . 75.04 110.026 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -117.62 111.73 19.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.945 -0.571 . . . . 75.14 109.98 -174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.46 132.99 11.3 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.907 -1.14 . . . . 73.4 112.096 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 116.36 24.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.186 0.517 . . . . 75.1 109.946 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.467 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.1 tp -116.87 123.58 47.4 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 74.44 109.889 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.719 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 53.0 t -117.01 128.76 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.415 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -107.78 137.9 44.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.259 -1.015 . . . . 74.25 108.259 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.37 121.05 2.33 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.312 -0.947 . . . . 54.32 113.529 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.14 149.36 41.41 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.072 -1.084 . . . . 74.32 108.072 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.47 105.15 0.08 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.655 0.741 . . . . 73.4 111.718 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.39 -32.18 7.85 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.273 -0.876 . . . . 64.35 112.441 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -105.35 122.47 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.777 0.322 . . . . 72.54 111.602 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mt -115.05 136.32 53.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.684 -1.228 . . . . 73.24 107.684 163.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.639 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . . . -136.28 152.72 51.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.592 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -157.21 133.18 3.47 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.193 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.66 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 67.8 m-85 -124.02 114.68 20.07 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.429 -0.582 . . . . 74.44 109.429 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -105.45 120.88 42.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.697 -0.683 . . . . 73.22 109.71 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.402 ' SD ' HG11 ' A' ' 164' ' ' VAL . 58.4 ttp -132.48 129.0 38.62 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.42 -0.355 . . . . 74.44 110.444 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.449 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 73.6 m-20 -111.16 115.87 30.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.912 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.5 t80 -97.28 127.1 42.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.993 -1.003 . . . . 75.12 110.273 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -94.39 100.23 12.29 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-N 115.858 -0.61 . . . . 72.11 109.593 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 -19.95 62.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.769 -1.56 . . . . 74.05 111.008 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.72 77.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.613 -0.884 . . . . 51.31 108.613 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -102.77 -160.45 0.78 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.296 -1.32 . . . . 74.22 108.026 167.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.1 m -109.48 27.07 9.92 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.047 -0.408 . . . . 74.53 110.929 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -163.24 161.64 24.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 118.912 -1.115 . . . . 74.32 111.596 -165.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.912 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -72.95 136.1 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.137 0.494 . . . . 74.0 109.865 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.1 t -93.61 -23.45 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.897 -0.592 . . . . 75.14 110.317 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -140.1 132.88 29.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.61 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 p -121.07 109.31 14.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.805 -0.634 . . . . 75.22 110.274 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -111.69 127.56 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.387 0.613 . . . . 70.04 110.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.66 ' HD2' ' HD1' ' A' ' 153' ' ' TYR . 80.0 m-85 -121.03 144.29 48.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.701 -0.481 . . . . 74.34 109.701 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -147.26 137.25 23.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.524 0.678 . . . . 64.41 111.091 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.997 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 99.5 t -133.44 152.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.267 -1.012 . . . . 74.51 108.267 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 181' ' ' HIS . . . -147.88 123.16 1.66 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.101 -1.047 . . . . 61.34 112.271 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.07 120.59 42.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.171 -0.677 . . . . 75.53 109.171 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.04 126.86 53.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.793 0.806 . . . . 74.22 111.867 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -116.94 163.26 16.47 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.78 -1.563 . . . . 74.43 106.78 168.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -53.64 -42.08 67.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.239 0.459 . . . . 64.43 112.239 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -107.3 -14.02 14.98 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.288 0.477 . . . . 74.41 112.288 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.472 ' HD2' ' NE2' ' A' ' 196' ' ' GLN . 7.5 m-85 -132.11 120.85 22.89 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.125 -0.359 . . . . 75.31 110.941 -173.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -135.19 124.08 24.03 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.785 -0.366 . . . . 72.25 110.683 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.77 ' HB2' ' HA ' ' A' ' 194' ' ' ILE . 0.0 OUTLIER -124.53 138.43 54.33 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.775 -0.578 . . . . 74.34 110.472 175.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.755 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 95.3 m-70 -115.46 117.85 31.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 74.44 110.385 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.997 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 90.0 m -78.79 122.84 26.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 71.25 109.685 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.35 139.66 53.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.369 0.604 . . . . 72.42 111.432 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 90.3 t -131.2 117.1 35.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.594 -0.73 . . . . 74.15 110.146 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.28 105.67 15.81 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.9 -0.778 . . . . 72.14 108.9 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 26.8 t70 63.36 -172.4 0.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.539 -0.755 . . . . 73.3 108.968 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.436 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -79.52 -6.76 88.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 64.42 110.842 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 211' ' ' THR . 1.2 p -88.68 -24.49 22.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.416 0.895 . . . . 73.14 113.416 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.26 110.67 11.28 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.876 0.762 . . . . 73.31 111.111 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -121.48 124.63 44.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.005 -0.543 . . . . 75.32 109.999 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -176.42 -149.75 7.78 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.545 -1.312 . . . . 60.12 113.672 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.54 175.07 35.68 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.291 -0.723 . . . . 70.01 111.291 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.538 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 55.9 m -148.3 138.42 22.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.095 0.448 . . . . 74.43 110.032 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 1.006 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.1 mp -117.88 129.73 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.833 0.349 . . . . 74.33 110.681 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -108.18 120.04 41.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.388 -0.967 . . . . 75.31 108.388 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 1.007 HE21 ' HA ' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -120.48 132.18 55.09 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.085 0.402 . . . . 74.11 112.085 -172.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -103.51 108.79 20.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.166 -0.679 . . . . 75.21 109.166 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.856 ' HB ' HD11 ' A' ' 202' ' ' LEU . 59.5 t -95.23 -26.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.39 0.614 . . . . 74.55 109.762 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -158.47 -179.92 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.236 -1.024 . . . . 74.31 108.236 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.36 -40.83 75.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.455 0.539 . . . . 72.3 112.455 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -126.78 13.53 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.014 0.435 . . . . 74.24 111.072 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.856 HD11 ' HB ' ' A' ' 198' ' ' VAL . 2.3 tm? -107.12 103.03 12.33 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 75.51 108.664 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.402 ' CD ' ' HZ2' ' A' ' 224' ' ' LYS . 13.2 pt-20 -117.6 153.92 32.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.784 -0.644 . . . . 54.51 110.159 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 196' ' ' GLN . 16.6 m -130.06 149.6 51.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.988 -0.551 . . . . 71.21 109.92 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.54 136.15 50.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 60.4 109.672 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 1.006 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -119.82 136.87 55.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.646 -0.706 . . . . 75.55 111.005 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 18' ' ' PHE . 20.1 t-20 -114.31 127.66 55.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 62.51 110.436 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 208' ' ' LEU . 1.7 mm? -130.94 129.71 42.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.18 -0.674 . . . . 74.51 109.18 171.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.439 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -156.49 149.01 23.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.13 0.49 . . . . 74.31 111.193 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -131.19 124.92 31.67 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.154 -0.684 . . . . 73.12 109.154 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.7 t -101.83 117.88 35.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.397 0.618 . . . . 74.54 110.132 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.76 130.85 47.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.597 -0.729 . . . . 75.25 110.835 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -15.84 27.5 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.919 -0.657 . . . . 75.12 111.789 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -138.86 150.16 45.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.148 -0.316 . . . . 73.12 110.148 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.8 m -86.28 -16.47 37.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.408 -0.36 . . . . 71.33 111.067 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -67.79 111.21 4.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.0 0.429 . . . . 73.32 110.825 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.0 t -87.99 138.43 31.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.536 -0.913 . . . . 74.02 108.536 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 30.0 mtt-85 -88.28 116.67 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.292 -0.633 . . . . 74.04 109.292 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -115.17 129.37 56.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.864 -1.162 . . . . 73.41 107.864 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -141.11 150.85 22.12 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.895 -1.145 . . . . 70.14 112.46 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.917 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 3.5 mp -132.58 132.35 59.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.017 -1.105 . . . . 72.45 108.017 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.802 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . . . -124.93 130.23 51.94 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.328 1.018 . . . . 75.1 109.837 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.644 ' H ' ' HB2' ' A' ' 236' ' ' LYS . . . -113.87 126.34 55.07 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.117 -0.633 . . . . 75.21 111.187 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.402 ' HZ2' ' CD ' ' A' ' 203' ' ' GLU . 24.1 ttpp -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 72.04 110.71 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.613 ' HD1' HD12 ' A' ' 227' ' ' ILE . 90.6 t80 -120.81 127.85 52.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 71.12 110.077 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.878 ' HB3' ' HB2' ' A' ' 201' ' ' LYS . 29.2 tt0 -79.92 100.88 8.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.962 -0.563 . . . . 74.22 109.537 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.613 HD12 ' HD1' ' A' ' 225' ' ' TYR . 26.2 mm -68.82 -42.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.869 0.842 . . . . 74.21 109.297 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -137.05 146.77 56.09 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.533 -1.284 . . . . 74.14 107.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -44.97 -25.63 1.73 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.88 2.387 . . . . 65.34 114.185 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.87 -3.32 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.348 0.499 . . . . 75.12 112.348 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.76 123.42 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 71.43 112.002 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 35.7 m -120.76 122.64 40.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 74.24 110.399 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.729 ' HD2' ' HB3' ' A' ' 247' ' ' TYR . 87.6 t80 -104.7 133.13 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.06 -0.348 . . . . 75.0 110.06 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 12.5 p -131.0 140.62 50.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 64.45 111.487 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -156.66 136.71 12.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 71.34 109.127 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.917 ' HB3' ' O ' ' A' ' 221' ' ' ILE . 2.7 mmtm -173.29 179.0 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.865 0.466 . . . . 74.05 110.908 166.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 242' ' ' LEU . 12.7 p -122.8 152.03 27.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.129 0.49 . . . . 70.34 111.674 -160.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -109.01 150.74 27.32 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.889 -0.596 . . . . 71.44 110.324 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 241' ' ' SER . 4.4 t-20 -39.46 -33.54 0.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.477 1.511 . . . . 75.21 114.03 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 13.5 m -77.52 24.55 0.2 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.562 0.22 . . . . 74.1 110.651 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.3 p 58.0 29.54 17.86 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.563 1.145 . . . . 75.12 110.937 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 1.061 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.1 mp -99.39 128.98 45.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 116.221 -0.445 . . . . 73.03 111.926 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.867 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.42 116.35 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.699 -0.682 . . . . 73.13 110.525 -171.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.58 133.46 11.59 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.743 -0.742 . . . . 74.24 112.419 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.8 pp -134.23 149.06 50.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 70.41 109.98 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.72 145.86 11.14 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.885 -0.674 . . . . 65.22 111.776 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.729 ' HB3' ' HD2' ' A' ' 233' ' ' PHE . 22.1 p90 -124.61 122.34 37.26 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.297 0.57 . . . . 74.1 110.097 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 10.0 t -111.62 124.25 51.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.341 -0.845 . . . . 73.04 109.445 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -135.77 124.26 23.52 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.58 -0.737 . . . . 73.42 110.487 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 2.3 t -78.64 103.86 8.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.818 -1.178 . . . . 74.41 107.818 171.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.92 -54.5 44.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.511 -0.768 . . . . 73.5 109.654 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.596 ' HB2' HD11 ' A' ' 255' ' ' ILE . 96.8 mttt -145.17 152.16 50.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 106.93 -1.508 . . . . 74.43 106.93 174.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.61 98.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.51 2.14 . . . . 70.15 112.566 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.32 -24.44 2.94 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.889 -0.596 . . . . 74.3 112.662 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.596 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -134.34 122.08 39.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.394 0.616 . . . . 73.45 112.002 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.831 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 14.8 ptpt -114.13 133.28 55.68 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 72.42 110.299 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.71 126.89 52.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.25 -0.886 . . . . 72.15 109.713 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.8 t -127.51 111.0 13.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.556 0.693 . . . . 75.12 110.423 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.68 123.22 45.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 175.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 26.4 t -131.95 140.86 49.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.894 0.378 . . . . 65.23 110.039 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.72 128.48 20.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.914 -0.584 . . . . 73.13 110.433 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.79 HD13 HD21 ' A' ' 242' ' ' LEU . 2.3 tm? -102.48 117.67 35.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.511 -1.292 . . . . 73.03 107.511 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.867 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.3 mm? -92.72 107.71 19.42 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.559 -1.274 . . . . 73.14 107.559 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.061 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.1 m-20 -70.46 104.02 2.62 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.356 -0.979 . . . . 73.12 108.356 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.28 -19.1 38.31 Favored Glycine 0 C--O 1.229 -0.166 0 CA-C-N 115.94 -0.573 . . . . 75.33 112.497 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.36 -24.19 20.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.368 . . . . 73.35 111.016 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 93.8 m-20 -113.34 -30.54 6.87 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.645 0.98 . . . . 72.21 113.645 -170.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 263' ' ' LEU . 30.8 m -62.62 -26.41 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.041 0.756 . . . . 63.54 113.041 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -70.31 -23.72 62.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.961 0.41 . . . . 72.43 110.369 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.81 6.02 36.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 72.52 110.123 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.65 102.54 0.79 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.752 -0.658 . . . . 54.35 111.831 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 165.15 78.68 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.258 -0.972 . . . . 62.21 112.519 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -113.48 146.68 39.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.504 -0.554 . . . . 75.34 109.504 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 74.2 mmtt -95.39 137.69 34.09 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.586 -0.446 . . . . 74.35 110.231 -175.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 276' ' ' GLY . 1.4 tm? -117.7 134.5 54.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.179 -0.464 . . . . 65.35 109.91 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.463 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -135.17 104.27 0.5 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.959 -0.856 . . . . 74.13 110.959 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 259' ' ' LEU . 2.4 tm? -114.76 130.95 56.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.51 -0.552 . . . . 74.31 109.51 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.499 ' N ' HD23 ' A' ' 277' ' ' LEU . . . -143.24 136.75 7.19 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.175 -1.012 . . . . 64.44 112.888 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.581 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.6 mm? -114.91 131.08 56.99 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.325 -0.62 . . . . 75.34 109.325 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.831 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 52.6 mt-10 -111.82 112.12 23.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.418 -0.586 . . . . 74.12 109.418 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -99.2 125.15 44.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.809 -1.182 . . . . 73.45 107.809 177.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.442 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 75.4 mt-30 -132.53 116.87 17.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.127 0.489 . . . . 72.33 109.985 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.5 ' HB1' ' HB ' ' A' ' 33' ' ' THR . . . -115.61 131.97 56.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.809 -0.632 . . . . 73.24 110.471 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 285' ' ' GLU . 65.9 mt -122.09 -45.17 2.25 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.062 -0.718 . . . . 74.21 109.062 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 284' ' ' LEU . 42.5 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.633 -1.167 . . . . 63.51 109.395 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.045 0.45 . . . . 73.4 110.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.622 HG22 ' HA ' ' A' ' 121' ' ' GLU . 21.3 t -118.58 101.98 50.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 71.22 109.735 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 4.4 Cg_exo -77.54 138.63 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.006 2.471 . . . . 73.11 112.075 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 35.2 Cg_exo -61.94 91.15 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.814 2.343 . . . . 74.13 111.683 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p -81.24 -15.99 54.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.684 -0.689 . . . . 74.13 111.321 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.766 ' HB3' HG21 ' A' ' 143' ' ' VAL . 45.8 p90 -62.75 -24.78 67.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.538 0.685 . . . . 74.11 109.677 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.79 -30.0 58.93 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.157 -0.929 . . . . 75.25 110.855 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -104.26 9.34 36.05 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 119.978 -0.689 . . . . 62.35 111.717 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.521 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 94.8 mt -56.78 -35.68 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.377 . . . . 72.44 111.721 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.32 39.8 0.7 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.705 -1.236 . . . . 50.22 114.162 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -69.17 -48.68 61.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.896 0.848 . . . . 75.4 109.7 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -64.36 -38.37 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 73.03 110.971 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.17 -35.55 74.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 70.41 111.987 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -58.11 -38.07 75.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 74.15 112.177 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.85 -42.9 80.64 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.912 0.338 . . . . 74.25 111.912 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 t -84.47 -32.41 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.297 0.48 . . . . 64.44 112.297 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.96 -21.69 63.23 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.623 0.601 . . . . 73.31 112.623 -171.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 p -57.84 152.61 15.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 75.45 112.493 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HZ2' ' CD ' ' A' ' 189' ' ' GLU . 2.8 mptp? -86.37 -21.29 27.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.577 -0.738 . . . . 74.43 109.185 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.73 113.29 1.74 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.016 -0.993 . . . . 63.44 111.132 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.441 ' HB2' HD21 ' A' ' 262' ' ' LEU . 81.7 m-85 -85.79 -14.36 45.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.098 0.475 . . . . 71.42 110.688 -176.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.48 118.58 4.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.042 -0.823 . . . . 65.24 111.042 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -80.21 -4.67 54.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.94 0.37 . . . . 74.14 111.341 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.94 -3.57 69.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.273 -0.489 . . . . 65.21 113.262 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.7 pp -149.07 -178.12 6.2 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.707 0.765 . . . . 74.3 112.555 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.863 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -99.88 133.13 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.529 -1.214 . . . . 72.31 109.689 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.577 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.0 ttpp -124.87 146.26 49.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.768 -0.456 . . . . 72.2 109.768 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tm? -131.9 128.33 38.35 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.71 -0.478 . . . . 65.1 109.71 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 11.1 m-20 -134.32 120.37 19.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.11 -0.7 . . . . 75.02 109.11 171.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 tp -140.88 128.23 21.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 65.4 110.477 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 15.3 ptpt -118.14 127.29 53.63 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.972 0.415 . . . . 74.11 111.103 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.661 HG22 ' HB2' ' A' ' 283' ' ' ALA . 38.7 p -89.7 121.69 32.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.338 -0.986 . . . . 63.03 108.338 168.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -105.04 132.04 51.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.325 0.583 . . . . 73.34 111.784 -169.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 28.8 t -138.97 141.05 38.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.293 -0.867 . . . . 64.45 108.851 172.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.9 13.96 21.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.47 0.653 . . . . 75.53 109.586 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.92 37.18 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.364 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.47 -9.64 76.94 Favored Glycine 0 C--O 1.221 -0.694 0 CA-C-O 119.008 -0.884 . . . . 60.31 114.976 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -103.9 127.57 51.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 119.279 1.54 . . . . 73.3 112.84 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 37.6 tt0 -141.74 117.59 10.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.48 -0.934 . . . . 75.31 108.48 158.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 93.4 m-85 -107.08 120.36 41.87 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.225 -0.59 . . . . 72.51 110.296 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 68.4 m -112.85 117.32 31.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.116 0.484 . . . . 74.42 110.665 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 p -105.03 124.28 49.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.826 -0.624 . . . . 75.31 109.502 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.0 t -133.86 125.99 29.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.827 -0.434 . . . . 72.12 109.827 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 159.09 27.92 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.375 -0.917 . . . . 64.34 112.411 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -129.32 134.77 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.746 -0.464 . . . . 73.43 109.746 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.606 ' HB3' HG13 ' A' ' 54' ' ' VAL . . . -129.81 127.68 40.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.136 0.493 . . . . 72.44 111.018 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 50' ' ' GLU . 45.9 m-80 -90.92 144.86 25.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.387 -0.824 . . . . 72.54 109.885 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -70.19 18.87 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.315 0.579 . . . . 54.22 111.921 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 48' ' ' ASN . 21.7 mm-40 -89.25 -167.24 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 73.22 110.075 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -68.13 90.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.64 -0.254 . . . . 74.34 111.54 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p 48.21 45.71 19.9 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.117 0.567 . . . . 75.43 112.246 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -91.12 75.78 6.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 70.23 109.61 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 47' ' ' ALA . 13.3 t -120.54 123.51 70.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.162 -0.926 . . . . 74.4 110.859 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.7 p -109.44 137.04 47.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.085 -0.507 . . . . 64.34 109.669 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.94 136.41 8.82 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.464 -0.874 . . . . 73.31 112.773 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 p -127.63 145.18 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.878 -0.416 . . . . 65.3 109.878 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -120.68 124.97 46.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.708 -0.479 . . . . 74.41 109.708 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.7 tt0 -107.01 118.19 36.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.076 -0.712 . . . . 70.44 109.076 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.2 m -100.45 119.85 39.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.195 -0.668 . . . . 71.22 109.195 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 42.3 mtpt -121.66 127.58 50.95 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.057 0.456 . . . . 75.42 110.408 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 94.6 m-85 -106.89 120.79 43.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.897 -0.592 . . . . 73.21 109.653 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 17.5 tpt180 -111.8 106.99 15.89 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.534 0.683 . . . . 75.32 110.643 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.43 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 40.0 t-105 -105.59 108.16 19.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.574 -1.194 . . . . 75.14 109.876 -174.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -58.6 -36.24 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.221 -0.899 . . . . 74.31 111.943 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.43 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 14.3 mm-40 -66.25 120.46 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.437 -0.347 . . . . 75.43 110.324 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 74.57 -44.55 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.015 0.822 . . . . 74.52 111.384 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.95 64.45 0.46 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.904 -0.665 . . . . 64.32 111.899 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.02 134.72 53.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.867 0.365 . . . . 71.5 110.839 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 29.6 m -136.19 112.66 9.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.384 . . . . 73.43 110.647 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 77.6 t80 -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.683 -0.488 . . . . 74.23 109.683 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 84' ' ' GLU . 60.9 p -125.66 116.03 21.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.853 0.359 . . . . 54.22 111.011 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.93 122.42 37.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.106 -0.331 . . . . 74.21 110.106 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 55.8 tttm -113.21 116.76 30.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 71.23 111.122 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -103.6 131.78 50.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 74.53 110.395 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -101.69 161.8 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 73.14 111.063 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.5 m -62.29 -22.21 65.84 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.584 0.707 . . . . 74.43 110.215 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -72.23 -4.0 26.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.22 -0.9 . . . . 75.5 111.177 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 10.4 m-80 69.64 40.95 1.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.493 0.663 . . . . 75.45 110.677 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -114.35 135.47 54.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.373 -0.83 . . . . 74.35 109.613 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.1 mm? -99.59 135.87 40.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.609 -0.723 . . . . 75.45 110.872 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.22 89.93 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.504 -1.039 . . . . 72.34 110.504 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -95.48 105.43 17.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.862 0.363 . . . . 72.54 111.773 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.549 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 26.2 mt-10 -110.07 131.6 54.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.18 -0.464 . . . . 70.02 109.895 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -119.36 121.78 67.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.005 -0.739 . . . . 74.14 109.005 173.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.0 m -112.0 124.31 52.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.296 0.569 . . . . 74.33 111.664 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 66.6 t -111.03 121.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.136 -0.938 . . . . 75.25 109.663 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.32 142.67 28.18 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.77 -0.826 . . . . 63.13 108.77 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 94' ' ' GLY . 5.1 p-10 -49.69 143.89 6.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.216 0.821 . . . . 70.25 113.216 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -126.99 -56.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.814 -1.084 . . . . 73.51 108.974 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.45 -67.05 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.661 -0.7 . . . . 72.15 109.582 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 86.77 5.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 73.14 110.187 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -52.92 135.43 36.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.443 -0.798 . . . . 74.4 111.702 -177.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . 102.9 -22.91 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.577 -0.738 . . . . 72.43 113.726 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 35.8 tp -80.69 131.56 35.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.329 1.065 . . . . 65.24 112.18 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -123.73 120.63 33.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.917 -0.583 . . . . 74.1 109.72 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.737 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -109.89 129.8 55.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.689 0.281 . . . . 74.21 110.434 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.911 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.2 m -131.27 119.89 22.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.661 0.267 . . . . 74.3 110.456 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.542 ' HB2' HG21 ' A' ' 85' ' ' ILE . 80.6 m-85 -111.19 115.41 29.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.759 -0.46 . . . . 75.5 109.759 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.748 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 2.3 t70 -109.39 136.01 49.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.48 . . . . 74.4 110.343 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.0 m -144.08 122.74 12.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.022 0.439 . . . . 63.23 110.881 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 22.8 t -95.97 125.55 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.401 -0.592 . . . . 70.22 109.401 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 98.6 m-85 -111.48 123.56 50.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.818 -0.628 . . . . 74.23 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -115.58 103.14 54.19 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 70.31 109.465 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.53 -19.15 63.52 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.354 2.703 . . . . 73.2 113.007 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -57.12 -48.11 79.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 64.51 110.811 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.6 m -109.28 -21.71 12.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.314 0.578 . . . . 74.33 111.011 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.03 23.84 43.55 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.848 -0.901 . . . . 73.31 110.848 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.76 148.1 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 75.23 111.852 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.27 116.47 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.167 -0.924 . . . . 72.02 109.165 172.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -118.41 121.16 39.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.876 -1.157 . . . . 73.53 107.876 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.19 149.67 46.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.65 0.611 . . . . 73.31 112.65 -165.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 54.0 mttp -115.23 138.01 51.4 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.149 -1.056 . . . . 71.52 108.149 169.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.882 HG23 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -114.96 119.39 61.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.565 -0.902 . . . . 72.45 108.565 174.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.911 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 22.9 tttp -115.11 119.5 36.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.631 -0.713 . . . . 64.02 109.631 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.5 m -127.94 116.83 20.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.438 -0.578 . . . . 70.33 109.438 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -137.1 122.94 2.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.94 -1.124 . . . . 63.33 112.009 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -107.4 135.41 48.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.316 0.579 . . . . 74.52 110.349 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -109.31 120.43 42.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.925 -1.034 . . . . 74.41 110.142 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 123' ' ' ILE . 8.3 tpt180 -108.52 157.73 18.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.939 -1.134 . . . . 65.32 107.939 169.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.622 ' HA ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -54.32 -29.27 47.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.723 0.638 . . . . 73.05 112.723 -170.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -112.37 -12.19 13.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 64.43 112.381 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 142' ' ' LEU . 9.8 tp -143.45 132.8 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.821 -0.752 . . . . 71.4 112.47 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.437 HD21 ' N ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -118.76 119.16 33.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.811 -0.44 . . . . 74.14 109.811 179.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.458 HD11 HD12 ' A' ' 142' ' ' LEU . 3.9 mm? -111.87 119.96 40.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.277 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.88 127.51 5.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.673 -0.775 . . . . 64.44 112.872 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.0 m -111.08 121.61 45.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.619 -0.511 . . . . 74.41 109.619 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 t70 -124.23 117.69 25.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.169 -0.678 . . . . 65.11 109.169 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.882 ' HB3' HG23 ' A' ' 114' ' ' ILE . 36.1 ttm -118.33 130.38 55.99 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.854 -0.529 . . . . 72.22 111.668 -172.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.35 118.78 31.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.223 -0.444 . . . . 63.31 110.725 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.637 ' HE2' ' HB ' ' A' ' 114' ' ' ILE . 92.6 m-85 -96.26 96.53 8.84 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.855 -1.165 . . . . 75.45 107.855 167.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -136.72 155.44 49.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.271 -0.422 . . . . 74.4 110.587 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -30.0 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 74.44 110.97 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.08 -14.08 60.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.049 0.452 . . . . 75.44 110.859 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.67 128.49 2.18 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.626 -0.797 . . . . 73.53 112.731 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.81 118.56 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.604 2.203 . . . . 75.43 110.653 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -125.96 144.77 50.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.866 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.05 118.15 54.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.324 0.583 . . . . 60.44 109.842 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 21.5 ttp-105 -106.94 129.8 54.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.618 -0.719 . . . . 74.54 109.799 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.33 133.23 11.38 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.312 -0.947 . . . . 73.32 111.875 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -126.07 116.47 21.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.758 -0.46 . . . . 61.14 109.758 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 123' ' ' ILE . 8.8 tp -120.62 123.94 44.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.666 -0.494 . . . . 74.3 109.666 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 7' ' ' TYR . 94.0 t -127.41 129.41 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.312 -0.404 . . . . 72.35 110.715 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.622 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.54 136.72 48.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.973 -0.751 . . . . 72.13 108.973 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.67 118.93 4.18 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.598 -0.81 . . . . 55.21 112.07 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -141.58 147.35 37.53 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 75.33 109.475 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.64 101.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 70.42 111.703 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 174' ' ' LYS . . . 88.22 -32.35 4.43 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.098 -0.955 . . . . 74.34 112.692 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -105.92 122.37 45.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 73.43 111.175 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 151' ' ' ALA . 5.3 tp -138.42 135.1 34.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.359 -0.608 . . . . 74.23 109.359 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -136.73 132.54 34.97 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.843 -0.343 . . . . 72.55 111.227 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.521 ' HA3' ' CD1' ' A' ' 10' ' ' LEU . . . -132.98 133.82 7.22 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.971 -0.633 . . . . 71.01 112.034 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.525 ' HA ' ' HD2' ' A' ' 169' ' ' PHE . 22.6 m-85 -122.8 119.7 31.36 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.421 -0.585 . . . . 72.41 109.421 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -118.63 130.22 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 75.34 110.077 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 21.8 ptp -143.73 143.74 31.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.162 -0.472 . . . . 72.4 110.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -112.36 118.41 35.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.231 -1.026 . . . . 71.23 108.231 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -107.23 118.36 36.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.74 -0.467 . . . . 75.44 109.74 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -86.83 95.35 9.83 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.589 -0.893 . . . . 74.34 108.589 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 m -72.57 -25.16 61.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 113.532 -1.667 . . . . 73.31 111.435 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.55 -31.16 69.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.719 0.771 . . . . 54.44 109.083 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -109.9 -159.79 0.69 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.378 -1.283 . . . . 74.22 108.112 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.0 p -109.47 26.77 10.26 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.132 -0.355 . . . . 72.53 111.111 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 mtp85 -133.66 171.25 14.38 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 114.828 1.418 . . . . 71.21 114.828 -160.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.1 t -104.37 132.22 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.286 -1.325 . . . . 73.52 108.651 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -94.38 -33.91 12.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 72.41 111.245 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -151.87 132.74 14.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.435 -0.348 . . . . 73.05 110.102 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.9 t -124.34 106.94 10.64 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.417 -0.586 . . . . 73.44 109.417 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.91 135.17 55.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.306 0.574 . . . . 75.31 110.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.525 ' HD2' ' HA ' ' A' ' 153' ' ' TYR . 57.5 m-85 -125.83 155.9 40.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.242 -0.436 . . . . 72.41 110.555 -176.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 10' ' ' LEU . . . -150.65 127.96 11.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.158 -0.473 . . . . 73.53 109.795 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 63.7 t -129.77 127.59 64.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.918 0.39 . . . . 75.24 110.491 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.02 111.25 4.19 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.05 -0.82 . . . . 61.54 111.05 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -112.06 120.44 41.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.794 -0.817 . . . . 73.44 108.794 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 11.5 tmtt? -103.23 126.5 50.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.373 0.606 . . . . 74.34 109.89 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 3.9 m -116.91 164.08 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.913 -1.04 . . . . 70.3 108.398 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -34.13 -66.82 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.177 0.806 . . . . 71.52 113.177 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.89 13.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.898 -0.321 . . . . 72.14 111.694 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.499 ' HD1' ' NE2' ' A' ' 196' ' ' GLN . 10.3 m-85 -126.5 137.97 53.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.577 -0.283 . . . . 74.01 110.269 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -122.11 122.73 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.832 -0.747 . . . . 74.32 109.81 170.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.472 HD22 ' HG1' ' A' ' 182' ' ' THR . 4.9 tt -123.77 139.19 54.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.737 -0.665 . . . . 73.55 111.068 -172.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.821 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 58.4 m80 -116.45 117.13 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.225 -0.443 . . . . 73.42 110.36 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.472 ' HG1' HD22 ' A' ' 180' ' ' LEU . 30.6 m -96.02 110.83 23.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.228 -0.656 . . . . 72.42 109.228 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -124.42 160.63 27.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 53.51 110.919 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.521 HG22 ' HD1' ' A' ' 190' ' ' PHE . 16.6 t -131.72 124.4 53.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.872 -0.604 . . . . 73.15 109.764 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 30.2 t30 -99.89 95.45 6.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.622 -0.717 . . . . 54.23 109.705 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.63 178.82 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.282 -0.872 . . . . 71.34 109.381 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.21 -7.14 71.09 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.075 -1.06 . . . . 73.44 111.404 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.9 m -95.01 -25.71 16.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.762 0.653 . . . . 71.52 112.762 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.423 ' CD ' ' HZ2' ' A' ' 20' ' ' LYS . 43.2 tt0 -132.38 145.05 50.95 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.467 -0.771 . . . . 61.41 111.957 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.521 ' HD1' HG22 ' A' ' 184' ' ' VAL . 22.9 m-85 -117.17 150.27 39.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.459 -0.941 . . . . 72.42 108.459 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.32 155.81 24.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.176 -1.012 . . . . 62.14 113.491 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -141.14 126.0 2.95 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.271 -0.732 . . . . 52.15 111.271 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 46.8 t -112.1 136.6 51.26 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.895 0.379 . . . . 74.4 110.075 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.726 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.6 mm -120.53 124.3 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.868 -0.606 . . . . 63.51 109.542 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 0.3 OUTLIER -118.23 121.47 40.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.425 -0.583 . . . . 75.42 109.425 173.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.499 ' NE2' ' HD1' ' A' ' 178' ' ' PHE . 14.5 mm100 -124.45 132.04 53.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 72.2 111.635 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -86.53 122.57 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.216 -0.661 . . . . 74.02 109.216 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.5 m -136.22 173.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.317 -0.401 . . . . 71.23 110.896 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -97.51 -41.92 7.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 72.53 110.098 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -69.93 -33.19 71.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 73.12 112.345 -177.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 94.1 mttt -123.54 11.77 9.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.264 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 -85.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.787 0.679 . . . . 73.01 110.892 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.819 ' HG3' ' HB3' ' A' ' 224' ' ' LYS . 9.5 pt-20 -127.1 128.75 46.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.171 -0.678 . . . . 74.33 109.171 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' A' ' 196' ' ' GLN . 15.4 t -123.44 148.82 45.78 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.374 -0.53 . . . . 75.44 110.419 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.45 136.59 49.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.67 -0.696 . . . . 73.02 110.964 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.807 HG22 HG22 ' A' ' 221' ' ' ILE . 61.1 t -118.8 137.96 51.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.447 -0.797 . . . . 72.0 109.159 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.424 ' OD1' ' HA3' ' A' ' 220' ' ' GLY . 2.9 p-10 -124.6 134.19 53.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 71.33 110.715 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.46 141.36 49.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.054 -0.976 . . . . 75.54 109.397 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -142.21 130.61 22.38 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.036 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.9 122.37 37.18 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.906 -0.405 . . . . 74.44 109.906 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 27.0 m -95.21 107.96 20.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.584 -0.524 . . . . 74.25 109.584 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.16 146.21 48.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.723 -0.671 . . . . 74.45 111.162 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.95 -46.42 3.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.134 -0.555 . . . . 73.24 112.261 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 216' ' ' ASN . 21.1 t-20 -86.59 -21.2 26.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.896 0.379 . . . . 75.32 110.271 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.5 m 66.74 17.42 10.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.577 -0.738 . . . . 73.02 110.758 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.424 ' HB2' ' OD1' ' A' ' 214' ' ' ASN . 53.7 t-20 -69.48 121.18 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 73.41 109.526 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.3 m -113.71 122.56 47.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.069 0.461 . . . . 73.22 110.031 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 37.4 mmt180 -105.31 125.0 50.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.959 -0.564 . . . . 74.43 109.924 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.735 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 46.9 m-85 -113.9 133.6 55.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.909 -0.775 . . . . 65.43 108.909 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.424 ' HA3' ' OD1' ' A' ' 207' ' ' ASN . . . -145.03 141.15 9.66 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.31 -0.948 . . . . 52.43 112.044 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.807 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -132.36 133.3 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 75.14 110.857 178.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -132.51 138.37 47.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.875 -0.602 . . . . 65.33 111.062 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.65 125.56 54.28 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.84 -0.43 . . . . 53.23 109.84 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.819 ' HB3' ' HG3' ' A' ' 203' ' ' GLU . 4.3 ttpp -113.34 113.32 25.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.252 0.549 . . . . 63.44 109.691 -177.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -131.9 116.54 17.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 74.32 110.144 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 12.0 pt20 -85.07 103.1 13.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.382 0.61 . . . . 72.5 109.987 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.3 -29.33 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.487 -0.779 . . . . 61.41 110.561 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.684 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 23.2 m-20 -123.47 163.29 35.28 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.625 . . . . 72.41 109.542 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.21 -29.73 64.52 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.172 1.915 . . . . 73.43 111.916 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.47 ' HB2' ' HG1' ' A' ' 250' ' ' THR . 8.9 p-10 -109.81 -2.27 17.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 65.51 111.607 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' A' ' 228' ' ' ASP . . . -134.7 124.53 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.476 . . . . 73.13 111.891 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 43.3 t -123.43 135.41 54.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 71.34 109.668 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -115.79 133.61 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.126 0.489 . . . . 75.12 110.534 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.3 p -125.26 123.85 40.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.912 -0.585 . . . . 65.25 110.325 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -107.6 140.01 41.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.323 -0.991 . . . . 71.42 108.323 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -148.88 150.07 32.34 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.828 -0.349 . . . . 74.23 110.745 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 10.0 p -145.64 142.91 21.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 73.21 109.943 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 15.4 t-20 -105.31 149.45 26.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.475 -0.784 . . . . 73.45 109.11 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.735 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 20.8 t-20 -57.04 -21.59 32.35 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.996 0.81 . . . . 50.31 112.251 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.5 p -79.24 21.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.958 0.409 . . . . 72.14 110.842 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 239' ' ' ASN . 25.9 t 68.59 31.28 4.79 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.461 -0.79 . . . . 63.12 110.641 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.833 ' HB3' HD12 ' A' ' 262' ' ' LEU . 36.1 mt -99.73 116.01 30.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.344 -0.542 . . . . 71.04 110.468 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.76 117.83 45.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 N-CA-C 109.896 -0.409 . . . . 75.35 109.896 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.41 141.46 16.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.013 -0.613 . . . . 61.01 113.21 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 260' ' ' SER . 8.0 mt -116.18 137.95 51.69 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -141.4 120.71 1.73 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.32 -0.943 . . . . 72.11 111.875 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.5 115.42 18.11 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.847 -0.427 . . . . 73.12 109.847 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -114.74 130.57 56.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.15 0.5 . . . . 63.22 110.351 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 58.1 tt0 -143.66 131.65 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.938 -0.574 . . . . 75.12 110.289 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.47 ' HG1' ' HB2' ' A' ' 230' ' ' ASP . 23.2 p -78.67 129.1 34.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.591 0.234 . . . . 71.43 110.89 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 251' ' ' LEU . 1.6 pp -140.8 145.23 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.864 -0.421 . . . . 75.41 109.864 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 92.3 mttt 67.74 156.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 123.619 0.574 . . . . 74.13 110.51 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 36.3 Cg_endo -66.71 86.7 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.21 1.94 . . . . 74.21 113.366 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.752 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 105.46 29.54 5.03 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.904 -0.665 . . . . 74.1 113.926 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 251' ' ' LEU . 64.7 mt -132.76 133.95 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 117.384 0.592 . . . . 74.3 110.72 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 36.4 ttpt -111.14 133.63 53.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.76 0.314 . . . . 74.53 110.323 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.3 tp -98.06 132.57 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 74.05 109.765 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 15.3 m -126.06 111.15 14.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.347 -0.388 . . . . 75.3 110.201 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.962 HD23 HD21 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.09 124.58 47.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.664 -0.865 . . . . 74.12 108.664 176.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 45.0 m -133.63 140.41 47.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.907 0.384 . . . . 64.35 110.435 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.013 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.833 HD12 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -106.87 115.91 31.01 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.082 -0.71 . . . . 72.23 109.082 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.569 ' HB3' HG13 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -95.0 106.25 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.48 -1.304 . . . . 73.13 107.48 175.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 42.7 m-20 -71.95 104.77 3.62 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.759 -0.83 . . . . 73.42 108.759 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.62 -20.66 25.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.246 -0.502 . . . . 42.42 112.996 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -90.8 -3.51 57.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.811 0.338 . . . . 74.44 110.936 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 62.9 t30 -133.03 -35.53 1.05 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.754 0.65 . . . . 73.35 112.754 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 263' ' ' LEU . 29.4 m -62.46 -18.41 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.747 0.647 . . . . 74.44 112.747 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -68.38 -25.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 73.41 110.324 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.33 -5.98 24.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.431 0.634 . . . . 75.31 110.005 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 91.95 103.48 1.42 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.608 -0.724 . . . . 72.02 111.809 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 173.81 85.62 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.54 -0.838 . . . . 72.31 112.17 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -113.47 147.18 38.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.881 -0.414 . . . . 73.45 109.881 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 7.1 mmpt? -95.15 137.08 34.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.062 -0.718 . . . . 72.04 109.062 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.75 127.61 54.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.82 -0.437 . . . . 73.51 109.82 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.55 104.96 0.83 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.56 -1.016 . . . . 43.41 110.56 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.962 HD21 HD23 ' A' ' 259' ' ' LEU . 3.2 tm? -113.76 125.35 54.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.905 -0.776 . . . . 75.44 108.905 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -145.68 133.64 5.1 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.6 -1.286 . . . . 54.2 112.98 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.684 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.3 mm? -108.7 128.01 54.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.248 -1.019 . . . . 71.04 108.248 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 10.5 pt-20 -140.86 137.92 33.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 119.328 -0.368 . . . . 63.45 110.594 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.752 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.6 OUTLIER 166.56 -148.96 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.124 0.89 . . . . 75.52 111.213 168.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 22.3 pt20 -137.68 119.11 14.76 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.208 -0.451 . . . . 71.13 110.776 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -82.58 109.98 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.169 0.509 . . . . 73.41 110.004 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -125.29 164.04 21.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.768 -0.651 . . . . 71.33 110.542 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.551 -0.907 . . . . 75.3 108.551 178.302 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.849 0.356 . . . . 75.21 111.448 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 76.5 t -123.18 124.63 26.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 74.11 109.948 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 31.2 Cg_exo -59.42 143.83 99.59 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.097 2.531 . . . . 73.33 112.835 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 4.9 Cg_exo -77.17 69.17 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.198 2.599 . . . . 74.35 111.283 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -68.46 -29.61 68.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.802 -0.636 . . . . 72.32 112.075 -173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.847 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.9 p90 -64.56 -26.72 68.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.924 0.392 . . . . 73.23 111.089 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.64 35.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.052 0.453 . . . . 63.14 110.033 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -94.9 4.03 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 74.3 110.949 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 7' ' ' TYR . 92.4 mt -63.94 -33.2 75.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.401 . . . . 73.32 110.216 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 61.91 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.012 -0.613 . . . . 63.21 112.143 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.12 -39.08 79.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 73.12 110.239 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 m -59.24 -36.47 75.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.226 -0.897 . . . . 72.43 111.836 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.47 69.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.324 -0.398 . . . . 75.04 112.052 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -62.33 -31.53 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 74.42 110.934 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 64.35 111.392 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.633 HG13 ' HB1' ' A' ' 222' ' ' ALA . 40.0 t -78.59 -46.18 24.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.966 -0.294 . . . . 72.13 110.797 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' CZ ' ' HD2' ' A' ' 218' ' ' ARG . 90.9 t80 -64.79 -42.6 94.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.17 0.509 . . . . 75.1 110.807 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.579 HG21 ' H ' ' A' ' 20' ' ' LYS . 1.8 m -108.55 -142.98 0.38 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.237 -1.023 . . . . 74.33 108.237 174.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' H ' HG21 ' A' ' 19' ' ' THR . 43.2 mmtm -141.59 106.02 4.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.909 -0.404 . . . . 74.44 109.909 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.73 -44.02 21.53 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.67 -0.972 . . . . 64.42 110.67 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 28' ' ' LYS . 30.0 m-85 -135.15 -179.24 5.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.402 -0.592 . . . . 74.42 109.402 173.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 51.91 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.487 -0.863 . . . . 51.22 112.215 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -103.55 11.01 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.919 0.39 . . . . 75.43 110.819 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.615 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 93.52 13.75 54.81 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.444 -0.884 . . . . 72.12 111.854 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 pp -126.89 179.16 5.53 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-O 122.239 1.019 . . . . 75.53 113.317 -170.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.674 HD12 HD11 ' A' ' 277' ' ' LEU . 29.9 mm -98.58 142.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.888 -1.505 . . . . 73.34 109.855 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.581 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 3.9 tmtm? -122.47 135.82 54.75 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 74.34 109.424 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.0 tp -123.78 148.5 46.6 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.727 -0.389 . . . . 74.32 110.507 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 43' ' ' SER . 10.4 t70 -145.22 127.66 15.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.306 -0.861 . . . . 74.2 108.886 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.709 HD23 ' HB3' ' A' ' 281' ' ' PHE . 0.4 OUTLIER -126.65 124.61 40.26 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.839 -0.8 . . . . 75.13 108.839 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -125.61 138.16 53.92 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.706 -0.479 . . . . 75.35 109.706 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.761 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 33.4 m -136.34 128.71 30.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.697 0.284 . . . . 65.25 110.374 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -104.59 141.84 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 71.11 110.798 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.91 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 31.1 m -134.03 170.02 16.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.099 -0.704 . . . . 73.15 109.099 172.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.98 -62.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.258 0.836 . . . . 73.23 113.258 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -144.23 126.86 16.07 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.177 -0.609 . . . . 73.25 111.654 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.683 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 86.84 -10.5 67.71 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 119.084 -0.842 . . . . 74.11 114.806 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.91 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 3.0 mm? -103.03 129.38 49.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.782 1.291 . . . . 74.3 112.41 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 38.4 tt0 -139.77 118.08 12.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.242 -0.651 . . . . 75.31 109.242 165.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.761 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 66.7 t80 -104.9 121.33 43.47 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.798 -0.361 . . . . 75.04 110.325 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 87.2 m -127.3 128.22 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 72.3 111.385 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.7 t -122.48 132.33 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.824 -0.806 . . . . 70.32 108.824 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 p -134.33 125.61 27.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.104 -0.332 . . . . 71.54 110.104 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.67 151.27 23.19 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.803 -1.189 . . . . 75.44 113.04 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 27.3 m -138.12 134.23 34.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.766 -0.828 . . . . 73.22 108.766 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 54' ' ' VAL . . . -144.39 131.98 21.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.581 -0.448 . . . . 73.54 111.914 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.9 143.85 55.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.633 -0.712 . . . . 74.44 109.164 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 m -54.69 -27.12 38.02 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.451 0.537 . . . . 63.53 112.451 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -88.52 6.56 37.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.152 0.501 . . . . 63.43 110.529 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.5 p 52.41 24.98 3.22 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.812 0.845 . . . . 74.11 112.507 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 p -85.06 -50.81 7.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.192 0.52 . . . . 74.34 111.101 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.61 100.22 9.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.745 -0.835 . . . . 75.32 108.745 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 HG13 ' HB1' ' A' ' 47' ' ' ALA . 15.1 t -125.31 132.65 70.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.466 -0.788 . . . . 72.01 110.798 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 124.7 52.09 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 73.03 108.98 173.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.16 103.84 0.54 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.885 -0.674 . . . . 64.11 111.725 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 t -111.15 139.28 46.66 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.11 0.481 . . . . 73.41 110.177 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.38 124.59 46.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.936 -1.135 . . . . 74.13 107.936 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 56.5 mt-10 -120.24 119.11 32.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.328 0.585 . . . . 74.25 110.331 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 73' ' ' GLU . 5.0 t -110.83 120.59 42.89 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.153 -0.684 . . . . 74.04 109.153 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.854 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 2.7 mptp? -110.21 137.67 47.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 72.31 109.496 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.683 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 18.2 m-85 -115.23 118.86 34.5 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.079 -1.082 . . . . 74.03 108.079 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.529 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ptt180 -131.57 108.41 9.52 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.388 -0.925 . . . . 74.34 111.879 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -95.7 100.74 12.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.124 -1.398 . . . . 75.01 108.745 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m 72.8 124.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.348 1.03 . . . . 65.23 111.556 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.84 130.58 46.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.048 -0.723 . . . . 74.13 109.048 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 63.34 66.15 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.289 -0.634 . . . . 72.3 109.289 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.55 -107.26 0.21 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.972 -0.632 . . . . 73.31 111.578 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.571 ' CD1' HG13 ' A' ' 87' ' ' VAL . 2.0 mm? -117.51 132.75 56.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.236 0.458 . . . . 72.41 112.236 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 60.0 m -136.34 119.18 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.28 0.562 . . . . 72.41 111.204 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 59.0 m-85 -109.87 133.36 53.25 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.972 -0.751 . . . . 73.24 108.972 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -125.14 132.66 53.04 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.509 -0.476 . . . . 73.33 111.573 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 37.3 mt-10 -125.34 123.25 38.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 75.34 109.439 171.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 63.0 tttp -122.76 109.66 14.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.288 -0.264 . . . . 70.44 110.288 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -107.29 134.3 50.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.959 -0.386 . . . . 74.43 109.959 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -120.1 155.13 33.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 73.34 110.529 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -58.24 -22.88 54.01 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.226 0.536 . . . . 75.53 111.38 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.58 ' HB3' HG21 ' A' ' 107' ' ' THR . 46.6 m-20 -71.51 -1.39 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.569 -0.741 . . . . 71.34 111.829 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 20.5 m120 78.98 21.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.543 0.737 . . . . 74.2 109.925 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.853 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 3.6 m -90.72 118.99 30.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.559 -0.746 . . . . 73.43 110.757 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.2 mm? -101.13 118.14 36.41 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.411 -0.359 . . . . 75.23 110.556 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.78 96.14 0.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.606 -0.997 . . . . 63.45 110.606 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -143.59 156.1 44.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.088 0.403 . . . . 74.43 112.088 -169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 mm-40 159.52 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 125.207 1.567 . . . . 64.34 110.047 167.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.55 137.71 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.644 0.609 . . . . 73.25 112.644 -161.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.623 ' HB ' HG23 ' A' ' 98' ' ' THR . 12.8 t -129.38 140.39 51.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.977 0.418 . . . . 74.21 110.946 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 97' ' ' LEU . 6.2 m -117.88 138.44 48.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.11 -0.496 . . . . 74.31 109.834 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -114.42 116.57 29.11 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.507 -0.477 . . . . 74.32 110.827 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 93' ' ' ARG . 7.3 p-10 39.71 31.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.679 1.191 . . . . 72.22 113.612 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -75.2 -47.84 26.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 72.21 109.957 176.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -70.07 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.197 -0.668 . . . . 74.22 109.197 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -99.2 122.72 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.219 -0.446 . . . . 73.03 110.2 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 10.1 tpp85 -63.66 124.87 22.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.289 -0.414 . . . . 73.02 110.559 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.526 ' H ' ' HB3' ' A' ' 89' ' ' ASP . . . 97.0 -22.74 39.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.058 -0.591 . . . . 72.41 112.093 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 39.6 tp -89.92 136.93 32.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.009 0.433 . . . . 74.13 110.244 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.929 ' HE3' ' HD2' ' A' ' 119' ' ' LYS . 63.8 mmtt -121.66 116.5 24.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.186 -0.672 . . . . 74.2 109.186 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.695 ' HB2' HG21 ' A' ' 87' ' ' VAL . 2.4 mm? -108.0 127.52 53.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.937 -0.394 . . . . 73.51 109.937 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.908 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.3 m -129.35 119.55 24.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 72.12 111.42 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.559 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 87.4 m-85 -104.82 121.09 42.93 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.983 -1.118 . . . . 73.14 107.983 171.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 9.4 t70 -130.45 127.54 39.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.83 0.706 . . . . 73.54 109.35 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 p -140.24 130.68 25.39 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.275 -0.97 . . . . 75.31 112.156 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 45.1 t -113.32 122.27 46.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.57 -0.741 . . . . 52.2 109.448 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.672 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 36.5 p90 -138.03 119.24 14.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.877 0.846 . . . . 71.35 112.162 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.853 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 43.3 t -132.24 137.02 29.08 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.592 -1.186 . . . . 74.22 109.244 166.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.89 -1.85 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.626 2.217 . . . . 63.34 111.183 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -110.2 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.676 -0.693 . . . . 73.24 110.173 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.58 HG21 ' HB3' ' A' ' 78' ' ' ASP . 3.3 t -146.89 133.86 20.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.433 -0.951 . . . . 75.44 108.433 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.4 ' HA3' HG23 ' A' ' 80' ' ' THR . . . 100.07 36.03 4.31 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 118.33 -1.891 . . . . 71.12 111.2 -164.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 104' ' ' SER . 11.7 mptt -55.61 155.95 5.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.481 0.658 . . . . 72.34 112.143 -168.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.672 ' HG3' ' HB3' ' A' ' 103' ' ' PHE . 52.7 tttp -71.03 115.06 9.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.856 -1.065 . . . . 74.24 111.869 -159.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -133.44 132.8 41.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.455 -1.248 . . . . 72.24 109.167 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.58 127.9 54.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.032 -0.531 . . . . 62.42 110.593 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 30.6 mmtp -111.82 137.29 49.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.01 -0.541 . . . . 75.32 110.126 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.429 HG22 ' CG ' ' A' ' 129' ' ' MET . 3.4 tp -120.58 116.9 51.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.878 -0.786 . . . . 73.23 108.878 171.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.908 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.1 ttmp? -114.79 121.26 42.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.251 -0.886 . . . . 74.21 110.048 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.4 t -116.61 118.15 31.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.344 0.593 . . . . 75.0 109.448 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.95 151.5 17.02 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.749 -0.739 . . . . 60.21 112.087 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -132.87 127.68 34.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.316 -0.624 . . . . 73.43 109.316 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.929 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 68.3 mttm -110.77 120.26 41.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.139 -0.624 . . . . 74.44 111.465 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.655 ' HB2' HG21 ' A' ' 123' ' ' ILE . 80.5 mtp180 -109.58 162.56 14.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.079 -0.964 . . . . 75.23 108.612 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.54 -38.87 60.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.404 0.52 . . . . 65.32 112.404 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -120.86 8.27 10.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.569 -0.287 . . . . 65.31 111.737 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.754 HD13 ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -139.58 131.39 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.178 0.514 . . . . 74.04 111.234 -173.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.4 t30 -122.15 119.4 31.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.044 -0.526 . . . . 71.21 110.764 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.636 HD11 HD11 ' A' ' 142' ' ' LEU . 4.5 mm? -110.66 134.26 52.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 72.43 109.368 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.77 116.01 0.83 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.338 -0.934 . . . . 75.31 112.217 176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 73.5 m -110.33 107.45 17.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.999 0.428 . . . . 74.51 110.54 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 27.3 t70 -111.91 118.35 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.685 -0.689 . . . . 74.23 109.313 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.429 ' CG ' HG22 ' A' ' 114' ' ' ILE . 23.8 ptp -129.25 147.97 51.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.673 -0.811 . . . . 65.32 112.061 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 3.1 m-20 -76.04 119.72 20.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.535 -1.283 . . . . 75.45 107.535 174.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -86.53 109.41 19.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.265 0.839 . . . . 73.23 113.265 -163.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HA ' ' HG3' ' A' ' 136' ' ' PRO . 20.1 t70 43.34 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.87 1.433 . . . . 74.54 114.87 161.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -60.95 -26.15 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.663 0.616 . . . . 75.5 112.663 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.496 ' N ' HD13 ' A' ' 133' ' ' ILE . . . -93.21 -5.18 50.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.048 0.452 . . . . 75.5 110.57 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.05 109.79 3.31 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.042 -0.823 . . . . 70.14 111.042 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 132' ' ' ASP . 27.4 Cg_exo -61.38 100.62 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.802 2.335 . . . . 74.14 112.553 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 45.0 t -126.87 128.77 47.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 74.42 108.943 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.98 117.12 52.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.184 -0.606 . . . . 73.2 110.868 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 156' ' ' ASN . 24.1 mtt180 -108.08 121.64 45.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.021 -0.733 . . . . 74.2 109.021 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.68 131.55 10.45 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.791 -1.195 . . . . 73.15 111.603 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -122.24 116.24 23.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.764 -0.458 . . . . 74.31 109.764 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.636 HD11 HD11 ' A' ' 125' ' ' LEU . 12.9 tp -122.24 124.53 44.01 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.262 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 7' ' ' TYR . 57.3 t -122.38 121.86 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 75.02 109.983 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.754 ' HG ' HD13 ' A' ' 123' ' ' ILE . 4.3 mp -109.11 137.21 47.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.091 -0.707 . . . . 74.12 109.091 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.507 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -122.38 119.0 3.82 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.617 -0.801 . . . . 75.52 112.847 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.425 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 47.5 m-85 -129.71 147.56 51.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.402 -1.333 . . . . 74.51 107.402 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -56.45 101.2 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.452 0.644 . . . . 75.25 111.059 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.733 ' HA2' ' HB3' ' A' ' 174' ' ' LYS . . . 104.09 -33.49 6.53 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.984 -1.007 . . . . 63.32 112.107 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 2.2 m-90 -107.01 120.26 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.212 -0.581 . . . . 73.5 111.898 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.507 HD23 ' HA2' ' A' ' 145' ' ' GLY . 7.6 mt -123.2 138.17 54.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.274 -0.421 . . . . 73.2 109.892 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -143.06 124.38 14.65 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.875 -0.33 . . . . 71.12 110.174 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.8 131.71 4.42 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.503 -0.856 . . . . 73.5 111.405 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 37.9 p90 -142.65 144.66 32.87 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.095 -0.642 . . . . 74.42 111.952 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 77.2 mt-30 -111.87 121.74 45.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.052 -0.976 . . . . 74.3 109.303 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 87.8 mtp -118.94 129.84 55.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.874 -0.787 . . . . 64.5 108.874 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -109.99 114.56 28.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.969 -0.752 . . . . 74.54 108.969 -177.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.648 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 25.1 m-85 -94.34 118.49 31.7 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 74.45 110.355 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.448 ' OE1' ' HG3' ' A' ' 161' ' ' LYS . 38.0 tt0 -86.71 100.68 12.65 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 108.967 -0.753 . . . . 73.52 108.967 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 m -70.56 -17.46 62.92 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.334 -1.757 . . . . 75.13 111.355 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.85 92.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.341 -0.985 . . . . 71.2 108.341 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.448 ' HG3' ' OE1' ' A' ' 158' ' ' GLU . 61.4 mttp -99.95 -159.5 0.74 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.538 -1.21 . . . . 75.44 108.299 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 p -109.15 28.44 8.5 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.221 -0.3 . . . . 62.21 110.528 172.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -151.7 150.58 30.38 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 119.086 -1.045 . . . . 74.13 112.249 -161.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.3 m -74.3 134.95 28.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.079 0.466 . . . . 74.3 110.325 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 9.4 t -95.45 -23.12 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.999 -0.546 . . . . 74.21 111.03 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -139.72 132.63 29.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 75.52 110.617 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.412 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 14.4 m -122.34 129.91 52.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.492 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.94 121.41 21.63 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.964 -0.384 . . . . 73.42 109.964 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.678 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 91.2 m-85 -121.01 140.48 51.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.827 0.346 . . . . 70.24 110.964 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.91 128.58 24.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.132 0.491 . . . . 64.42 110.077 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.671 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -127.19 150.15 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.495 -0.557 . . . . 72.25 109.495 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.46 120.06 2.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.114 -0.565 . . . . 55.23 111.868 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -113.29 120.73 42.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.861 0.362 . . . . 74.23 110.085 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.733 ' HB3' ' HA2' ' A' ' 148' ' ' GLY . 29.7 ttmt -104.68 123.9 48.42 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.433 -0.58 . . . . 63.42 109.433 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.9 m -134.42 114.09 12.54 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.513 -0.551 . . . . 64.24 109.513 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 47.66 -93.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.816 0.673 . . . . 73.43 112.816 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -111.48 6.41 20.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.02 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.841 ' HD2' HE22 ' A' ' 196' ' ' GLN . 7.2 m-85 -113.34 127.37 56.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.503 -0.317 . . . . 72.21 110.794 -173.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.892 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.1 mm-40 -112.06 124.61 52.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.667 -0.864 . . . . 74.24 108.667 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.406 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 5.6 tt -122.22 134.09 54.71 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.725 -0.609 . . . . 73.51 110.577 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 41.0 t60 -119.97 116.7 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.876 -0.602 . . . . 71.13 110.575 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.671 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 12.3 m -90.46 141.01 29.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.988 -0.745 . . . . 74.45 108.988 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -142.4 138.77 31.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.358 -0.537 . . . . 74.05 111.187 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.678 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 61.0 t -132.39 125.8 54.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.41 -0.814 . . . . 75.42 110.067 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 26.2 t-20 -117.06 107.76 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.249 -0.648 . . . . 75.35 109.249 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.5 t70 62.93 -171.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.919 -0.771 . . . . 74.21 108.919 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.93 -6.33 89.16 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.452 -0.88 . . . . 73.02 111.356 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.5 m -97.83 -25.68 14.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.836 0.68 . . . . 74.41 112.836 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 3.7 tp10 -118.21 113.68 21.89 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.603 -0.686 . . . . 72.52 110.751 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.569 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 42.4 p90 -135.56 132.1 36.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.775 -0.37 . . . . 74.3 110.735 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.682 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -169.83 -158.91 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.238 -0.982 . . . . 73.44 113.404 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.14 178.43 23.85 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.527 -0.368 . . . . 63.54 112.528 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 181' ' ' HIS . 18.8 m -149.84 147.43 27.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.654 -0.499 . . . . 70.11 109.654 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.6 mp -128.79 124.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.659 0.266 . . . . 75.41 110.942 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.892 ' HB2' ' HB2' ' A' ' 179' ' ' GLN . 43.8 m-85 -108.19 123.66 49.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.667 -0.494 . . . . 75.35 109.667 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.983 HE21 ' HA ' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -120.7 124.67 45.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.313 -0.403 . . . . 73.15 111.763 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 203' ' ' GLU . 11.6 mmtp -96.0 107.51 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 73.51 109.532 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.89 92.43 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.911 -0.586 . . . . 72.52 110.642 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.7 26.5 11.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.255 -0.884 . . . . 64.33 111.553 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 68.41 5.12 4.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.345 -0.843 . . . . 73.53 112.539 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.42 -38.87 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 75.42 111.117 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.56 151.99 40.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.411 . . . . 73.2 110.759 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.41 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 41.6 tt0 -117.11 132.21 56.72 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.814 -0.81 . . . . 74.32 108.814 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -123.06 143.16 50.14 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.211 -0.292 . . . . 75.34 110.211 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 222' ' ' ALA . . . -129.66 136.39 49.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.123 0.487 . . . . 75.45 110.848 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 193' ' ' SER . 39.3 t -112.89 130.91 65.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.652 . . . . 75.14 109.538 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 18' ' ' PHE . 14.2 m120 -114.52 128.95 56.6 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.277 -0.638 . . . . 73.23 109.277 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.699 HD12 ' HD2' ' A' ' 219' ' ' PHE . 5.5 tp -146.92 134.29 20.73 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.409 -0.359 . . . . 72.15 110.357 -170.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.682 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -157.74 150.44 22.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.849 0.357 . . . . 54.41 111.466 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.547 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 29.4 t-105 -115.79 133.03 56.44 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.985 -0.746 . . . . 73.11 108.985 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.829 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 20.9 m -95.54 108.23 20.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.709 -0.478 . . . . 74.35 109.709 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.569 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.62 147.5 49.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.79 . . . . 74.54 111.706 -174.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.03 -74.74 0.21 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.717 -0.674 . . . . 63.31 111.677 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -173.8 85.07 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 74.05 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.829 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 49.0 m -156.7 165.85 35.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.716 . . . . 75.13 109.415 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.05 160.01 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.921 -0.4 . . . . 63.03 109.921 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.547 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 9.2 t -78.7 134.46 37.1 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.591 -0.522 . . . . 63.33 109.591 174.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.464 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 20.5 mtt180 -92.21 117.72 30.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.881 -0.415 . . . . 75.55 109.881 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.699 ' HD2' HD12 ' A' ' 208' ' ' LEU . 33.9 t80 -114.13 148.82 36.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.564 -0.532 . . . . 73.2 109.564 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.58 152.35 23.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.459 -0.877 . . . . 74.32 112.578 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.512 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.3 mp -135.92 130.23 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.816 -0.439 . . . . 72.01 109.816 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.633 ' HB1' HG13 ' A' ' 17' ' ' VAL . . . -120.99 154.29 36.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.835 -0.432 . . . . 73.45 109.835 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -138.44 124.31 19.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.906 0.384 . . . . 62.52 110.313 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -111.26 113.68 26.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.559 -0.904 . . . . 65.21 108.559 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -113.51 114.07 26.01 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.044 0.45 . . . . 74.45 110.037 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.662 ' H ' ' NE2' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -91.07 117.26 29.45 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.761 -0.829 . . . . 71.04 108.761 173.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 228' ' ' ASP . 3.2 mp -69.17 -53.28 26.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 73.23 109.546 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 227' ' ' ILE . 22.4 t70 172.66 -48.96 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 O-C-N 124.006 0.816 . . . . 71.4 110.929 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.522 ' HB2' ' H ' ' A' ' 230' ' ' ASP . 86.1 Cg_endo -78.42 -144.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.337 2.024 . . . . 72.44 113.331 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.522 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 4.1 t0 -93.39 16.41 13.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 72.43 110.463 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.38 123.89 44.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.545 -0.752 . . . . 53.14 110.237 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.8 143.45 50.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 72.43 110.308 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -97.03 129.84 44.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.053 -0.521 . . . . 74.31 109.696 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -121.15 119.27 31.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.013 0.435 . . . . 63.25 110.135 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -123.5 152.14 42.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.078 -0.51 . . . . 64.41 110.012 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 19.9 ptpt -153.26 140.67 19.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.922 -0.399 . . . . 73.53 109.922 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 9.9 p -132.91 141.16 45.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.073 0.463 . . . . 64.51 109.959 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.637 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 20.7 m120 -108.46 150.22 27.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.126 -0.488 . . . . 62.24 109.796 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 241' ' ' SER . 9.0 p30 -50.51 -27.39 6.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.252 0.97 . . . . 74.45 113.241 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.616 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 6.0 m -82.03 24.51 0.63 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.581 . . . . 73.12 109.938 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.462 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 57.6 m 66.05 39.33 4.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.926 -1.034 . . . . 75.03 111.297 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.764 HD23 HD13 ' A' ' 262' ' ' LEU . 5.5 mp -91.76 121.72 33.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 120.545 -0.462 . . . . 73.22 111.141 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.54 115.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 O-C-N 123.62 0.575 . . . . 75.44 110.024 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.83 133.54 9.46 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.55 -0.833 . . . . 63.2 113.082 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -140.92 141.36 34.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.969 0.414 . . . . 73.55 110.201 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.97 165.51 36.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.358 -0.925 . . . . 64.11 112.547 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -129.87 129.95 44.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.055 0.455 . . . . 75.11 110.462 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.554 HG21 HG21 ' A' ' 258' ' ' THR . 19.8 p -113.46 115.61 28.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.702 . . . . 74.21 109.725 177.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.3 132.88 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 73.22 111.617 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 17.5 m -77.81 120.45 22.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.976 -0.556 . . . . 61.45 109.591 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.437 ' HB3' HG21 ' A' ' 255' ' ' ILE . 16.1 tp -81.27 -55.28 4.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.582 0.706 . . . . 75.41 109.213 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 255' ' ' ILE . 5.9 mtpm? -136.66 158.08 73.84 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.894 -1.15 . . . . 72.53 107.894 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.05 90.4 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.701 1.601 . . . . 74.45 110.422 171.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 282' ' ' GLN . . . 137.39 -9.51 3.78 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.848 -0.692 . . . . 75.51 111.786 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.545 HG22 ' HB2' ' A' ' 252' ' ' LYS . 6.5 tp -148.51 122.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.575 0.702 . . . . 73.01 111.464 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.56 135.25 53.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.591 -0.731 . . . . 74.44 110.527 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.65 126.76 45.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.465 -0.789 . . . . 72.35 110.419 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.554 HG21 HG21 ' A' ' 248' ' ' THR . 86.5 m -118.15 111.45 18.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 74.51 110.808 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.925 HD23 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -115.4 129.19 56.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.576 -0.898 . . . . 75.31 108.576 175.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.638 ' O ' ' HB2' ' A' ' 275' ' ' LEU . 11.0 t -151.11 146.25 26.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.51 . . . . 64.42 109.624 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.563 ' HA ' ' CB ' ' A' ' 275' ' ' LEU . . . -139.72 127.51 21.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.636 0.255 . . . . 74.21 110.511 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.764 HD13 HD23 ' A' ' 242' ' ' LEU . 2.2 tm? -112.92 118.31 34.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.593 -0.891 . . . . 75.42 108.593 176.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.646 ' HB3' HG13 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -101.45 110.07 22.0 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.603 -0.888 . . . . 64.23 108.603 176.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.71 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 1.9 m-20 -68.65 104.34 1.95 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.85 -1.167 . . . . 71.41 107.85 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.3 -27.37 46.79 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.908 -0.587 . . . . 70.2 113.298 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -90.84 -20.14 22.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.718 0.294 . . . . 73.23 110.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.71 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 66.2 t30 -101.89 -36.1 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.654 -0.248 . . . . 54.42 111.398 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 263' ' ' LEU . 34.7 m -63.18 -18.72 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.722 0.267 . . . . 74.52 111.722 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.65 -44.75 85.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.796 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.59 10.23 37.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.943 0.401 . . . . 74.42 110.837 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.63 97.88 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.023 -0.608 . . . . 50.14 111.979 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.421 ' HA3' ' ND2' ' A' ' 267' ' ' ASN . . . -175.99 75.63 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.824 -0.703 . . . . 71.3 112.143 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -113.73 145.96 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 122.413 0.285 . . . . 74.31 110.269 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.59 131.18 48.13 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.117 -0.697 . . . . 71.34 109.117 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 260' ' ' SER . 0.4 OUTLIER -140.68 158.12 44.43 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 72.52 113.974 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.56 117.19 3.53 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 114.552 -1.204 . . . . 74.33 111.317 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.925 HD23 HD23 ' A' ' 259' ' ' LEU . 2.2 tm? -114.36 121.87 44.95 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.909 -1.145 . . . . 75.11 107.909 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -142.46 137.28 7.71 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.89 -1.148 . . . . 75.22 113.309 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.39 130.51 55.67 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.306 -0.627 . . . . 71.12 109.306 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.32 111.18 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.627 -0.509 . . . . 72.14 109.627 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.709 ' HB3' HD23 ' A' ' 31' ' ' LEU . 42.3 t80 -112.99 110.33 20.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 74.43 109.812 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.718 HE21 HD23 ' A' ' 284' ' ' LEU . 49.9 tt0 -114.49 110.21 19.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.876 -0.602 . . . . 72.44 109.677 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -92.34 110.91 22.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.241 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.718 HD23 HE21 ' A' ' 282' ' ' GLN . 55.7 mt -108.69 97.66 7.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 75.33 110.41 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.594 -0.717 . . . . 75.24 109.127 176.828 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.774 0.321 . . . . 72.54 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 121' ' ' GLU . 11.5 t -116.61 112.91 40.69 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 63.3 109.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.66 166.95 22.38 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.231 2.621 . . . . 63.0 112.786 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 81.95 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.924 2.416 . . . . 74.12 111.789 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.0 p -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.484 -0.78 . . . . 64.1 111.386 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -60.48 -29.87 69.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.914 -0.584 . . . . 63.12 111.572 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.53 -19.57 38.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 70.24 110.965 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.98 13.68 33.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.41 0.624 . . . . 73.3 110.008 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 150' ' ' LEU . 72.4 mt -66.09 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.911 -0.586 . . . . 74.25 110.578 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.89 75.12 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.083 -0.58 . . . . 71.14 112.05 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -44.89 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.933 -0.395 . . . . 74.04 109.933 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p -56.4 -36.91 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.64 -0.709 . . . . 74.44 111.541 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.72 -37.6 73.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 74.53 111.376 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -63.26 -37.94 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.612 0.244 . . . . 62.13 111.147 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.09 -49.1 63.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.598 . . . . 71.23 110.69 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.615 HG21 ' CB ' ' A' ' 205' ' ' ALA . 79.0 t -84.58 -47.77 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.695 0.998 . . . . 73.43 113.695 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.17 -28.08 67.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.589 0.589 . . . . 74.1 112.589 -166.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -73.88 -16.79 61.11 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.819 -0.352 . . . . 75.43 110.96 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 0.1 OUTLIER 64.51 -82.61 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.262 -0.644 . . . . 75.14 109.262 -170.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.19 165.43 12.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.819 -1.312 . . . . 74.4 109.819 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.889 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 2.0 t80 -57.12 -44.94 83.76 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.904 -0.776 . . . . 74.44 108.904 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.72 28.45 56.88 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.219 -0.9 . . . . 73.4 114.422 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.546 ' HD2' ' HB2' ' A' ' 26' ' ' LEU . 56.3 t80 -87.78 -4.97 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.415 0.626 . . . . 74.03 109.455 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.457 ' C ' HD11 ' A' ' 26' ' ' LEU . . . 75.31 0.99 63.19 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.378 -0.828 . . . . 72.11 112.41 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.752 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 mp -134.55 178.76 6.74 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.262 1.029 . . . . 72.22 112.358 -172.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.633 HG23 HD12 ' A' ' 277' ' ' LEU . 12.5 mm -103.69 122.43 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.579 -1.646 . . . . 74.54 107.988 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 34.9 mtmt -120.73 126.93 51.42 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.07 -0.652 . . . . 72.23 110.97 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.488 HD13 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tt -120.47 143.48 48.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.784 -0.644 . . . . 71.0 110.554 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.3 p30 -138.84 140.26 38.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.147 0.499 . . . . 75.25 109.844 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 281' ' ' PHE . 14.5 tp -125.43 123.56 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.595 -0.729 . . . . 75.53 109.338 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -117.1 123.77 47.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 75.04 110.032 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.732 ' HB ' ' HB1' ' A' ' 283' ' ' ALA . 2.1 t -137.88 122.4 18.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.695 -0.684 . . . . 73.21 110.19 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -104.45 158.21 16.63 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.616 -0.434 . . . . 65.24 110.316 177.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -134.24 135.95 43.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.286 -0.635 . . . . 74.13 109.286 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 39.64 -99.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.357 1.035 . . . . 73.42 112.333 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.592 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 9.4 p30 -147.57 149.13 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.144 -0.687 . . . . 75.41 109.144 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 75.64 -11.02 10.88 Favored Glycine 0 C--O 1.213 -1.199 0 CA-C-O 119.236 -0.758 . . . . 74.32 114.187 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.52 127.25 52.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 119.457 1.629 . . . . 73.4 112.158 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.827 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 27.5 tt0 -142.53 118.85 10.84 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.98 -0.378 . . . . 73.21 109.98 162.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.531 ' HB3' HG22 ' A' ' 33' ' ' THR . 67.3 t80 -97.31 121.45 39.21 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.183 -0.673 . . . . 74.01 109.183 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.731 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.6 m -120.79 115.91 24.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.228 0.537 . . . . 73.52 110.772 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 34.6 t -107.88 134.46 50.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 74.25 109.43 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.2 m -135.05 126.94 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 71.22 110.331 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 130.26 5.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.453 -0.879 . . . . 64.43 111.846 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.2 m -111.42 133.46 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.474 -0.565 . . . . 53.32 109.474 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.71 135.0 37.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.729 -0.214 . . . . 72.22 110.578 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.752 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 54.2 t30 -69.28 143.07 53.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.783 -0.451 . . . . 74.11 109.783 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -64.62 124.32 21.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.486 . . . . 75.32 111.24 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 73.23 -65.41 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.313 -0.858 . . . . 74.14 111.11 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 3.1 m -78.5 113.13 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.213 -0.662 . . . . 65.24 109.213 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.0 p -75.44 93.08 2.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.068 0.766 . . . . 74.23 113.068 -168.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -113.78 99.6 7.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.868 -1.16 . . . . 75.13 107.868 165.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 46' ' ' SER . 13.9 t -114.21 120.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.818 -0.628 . . . . 71.21 111.115 -171.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -109.74 142.77 40.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.628 -0.715 . . . . 74.53 109.25 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.71 128.39 8.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.802 -0.713 . . . . 74.24 112.773 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.8 m -116.05 127.06 54.58 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.688 -0.856 . . . . 73.24 108.688 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.5 tm? -120.84 123.84 43.57 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.42 -0.585 . . . . 74.02 109.42 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.731 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 43.0 mt-10 -110.36 118.53 36.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.843 -0.617 . . . . 54.01 109.691 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 73' ' ' GLU . 9.1 t -98.75 119.94 38.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.624 -1.25 . . . . 71.11 107.624 172.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 28.0 ttmt -125.27 138.74 54.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.36 0.6 . . . . 74.24 111.261 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 98.9 m-85 -104.28 120.73 41.83 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.287 -0.87 . . . . 75.14 108.913 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.827 ' HG3' ' HB2' ' A' ' 40' ' ' GLU . 12.4 mtp85 -83.85 133.07 34.76 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.722 0.772 . . . . 72.44 111.304 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.86 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 8.8 p-90 -80.33 74.85 7.17 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 112.807 -1.997 . . . . 73.11 115.674 -161.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 37' ' ' ASN . 2.7 m -124.83 -17.8 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.655 -0.702 . . . . 75.23 111.03 -172.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.28 -36.12 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 75.15 109.881 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HB3' HD11 ' A' ' 69' ' ' LEU . 15.1 t80 -162.14 18.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 74.43 109.278 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.555 ' O ' HD12 ' A' ' 69' ' ' LEU . . . 80.81 56.59 3.06 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.072 -0.811 . . . . 55.43 111.072 -172.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.86 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 5.7 mp -139.59 127.98 22.79 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 113.749 1.018 . . . . 75.25 113.749 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.504 ' HG1' ' HB3' ' A' ' 64' ' ' TRP . 3.8 m -117.09 132.98 56.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.92 -0.488 . . . . 75.01 110.944 -173.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.583 ' HB3' ' HD2' ' A' ' 62' ' ' TYR . 44.7 t80 -123.19 120.36 32.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.981 -0.748 . . . . 62.44 108.981 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -126.7 117.29 22.42 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.813 -0.355 . . . . 75.41 110.915 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.5 tt0 -104.44 120.63 41.67 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.836 -0.802 . . . . 63.1 108.836 172.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -106.46 92.86 4.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.834 -0.621 . . . . 74.4 109.777 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.832 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 60.8 t90 -95.78 131.37 42.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.863 -0.335 . . . . 74.44 110.549 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.23 142.87 35.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.804 -0.813 . . . . 73.2 108.804 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.5 t -59.2 -9.82 2.42 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.618 0.97 . . . . 74.31 113.618 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 5.5 m-20 -71.24 -41.13 70.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.107 -0.237 . . . . 72.34 110.773 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 28.8 t-20 149.55 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.439 1.087 . . . . 73.1 109.745 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -80.7 132.19 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.645 . . . . 75.43 111.467 -173.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.832 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.8 pt? -124.28 146.5 48.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 71.31 110.681 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.57 117.05 4.08 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.517 -0.633 . . . . 71.33 111.517 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 100' ' ' ASP . 29.2 m -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.601 0.239 . . . . 71.43 110.734 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -125.13 108.37 11.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 70.45 110.118 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.04 129.66 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 74.35 110.699 -178.316 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 70' ' ' THR . 44.8 p -118.37 134.39 55.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 75.14 110.741 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.683 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 m -116.66 131.67 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.631 -0.507 . . . . 74.34 109.631 172.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 122.86 48.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 175.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 93' ' ' ARG . 35.6 t0 70.01 85.15 0.14 Allowed 'General case' 0 C--O 1.223 -0.323 0 O-C-N 124.029 0.831 . . . . 73.12 109.983 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 90' ' ' GLN . 6.6 tp60 -102.98 5.16 38.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.457 -0.942 . . . . 75.3 108.457 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.5 tp 178.6 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.354 -1.294 . . . . 74.24 108.89 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.6 126.07 16.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.076 -0.965 . . . . 62.53 109.796 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -64.03 135.85 56.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 75.42 111.076 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.23 -14.78 54.95 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.003 -0.839 . . . . 73.33 111.003 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.24 126.22 38.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 73.23 109.293 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.3 ttpp -122.05 111.16 16.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.694 -0.685 . . . . 75.52 110.319 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HB2' HG23 ' A' ' 87' ' ' VAL . 2.1 mm? -101.23 127.64 47.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.221 -0.659 . . . . 71.5 109.221 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 31.9 m -129.46 124.92 35.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.94 0.4 . . . . 62.33 111.437 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.28 116.05 31.29 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.234 -0.654 . . . . 73.51 109.234 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.2 t70 -111.68 133.51 53.87 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.003 -0.74 . . . . 75.03 109.003 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 m -141.44 121.87 14.07 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.941 0.4 . . . . 74.54 110.734 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 22.8 t -96.07 121.55 37.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.749 -1.204 . . . . 73.41 107.749 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.6 131.27 27.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.236 0.541 . . . . 73.22 111.22 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 16.5 m -119.8 103.43 45.89 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.542 -0.754 . . . . 74.45 109.293 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' ' OD1' ' A' ' 79' ' ' ASN . 47.6 Cg_exo -56.89 -33.91 95.92 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.972 2.448 . . . . 73.14 112.908 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -84.47 -40.47 17.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 71.02 111.01 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 104' ' ' SER . 5.8 m -81.99 -32.86 30.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.227 -0.442 . . . . 71.31 112.126 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 1.93 68.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.59 -0.814 . . . . 63.1 111.855 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.96 129.07 38.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.601 0.239 . . . . 73.15 110.426 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -139.39 122.27 16.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 75.22 110.464 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.736 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 8.5 m120 -121.54 123.51 42.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.924 -0.58 . . . . 74.55 109.812 172.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.91 113.8 27.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.067 -0.515 . . . . 71.52 109.68 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 4.8 ttmp? -122.67 138.1 54.71 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.05 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 tp -129.3 117.4 43.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.203 0.525 . . . . 72.41 110.16 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 1.7 mtpp -105.72 118.75 37.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 64.41 109.009 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 t -114.47 118.48 33.91 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.18 0.514 . . . . 63.41 109.739 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.93 118.24 2.96 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.466 -0.874 . . . . 71.11 112.184 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -106.76 117.59 34.45 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.018 -0.734 . . . . 72.42 109.018 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' HB3' HG11 ' A' ' 3' ' ' VAL . 42.5 mtmt -109.22 122.11 46.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.31 0.576 . . . . 73.32 110.383 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -106.39 146.55 30.33 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.604 -1.628 . . . . 73.1 106.604 165.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.572 ' HG3' HG22 ' A' ' 3' ' ' VAL . 2.2 mt-10 -55.23 -27.46 46.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.861 0.362 . . . . 75.21 111.758 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -88.99 -35.67 16.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 70.44 111.679 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.728 HD11 HD11 ' A' ' 142' ' ' LEU . 8.7 tp -145.36 127.52 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 121.015 -0.274 . . . . 73.33 111.623 -167.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.545 HD22 ' HB ' ' A' ' 143' ' ' VAL . 3.6 p-10 -122.53 128.44 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.694 0.759 . . . . 73.4 111.807 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.468 HD13 HD12 ' A' ' 142' ' ' LEU . 4.5 mm? -112.52 131.36 55.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.86 -1.064 . . . . 75.22 110.062 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.62 117.07 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.555 -0.831 . . . . 73.34 112.3 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.9 t -112.29 109.12 18.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.088 0.47 . . . . 70.32 110.135 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 115' ' ' LYS . 17.1 t70 -104.02 117.89 35.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.004 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.417 ' HG2' HG13 ' A' ' 138' ' ' ILE . 58.8 mtm -118.12 117.84 30.26 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.838 -0.345 . . . . 75.13 110.903 -176.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.451 ' HB2' ' HE3' ' A' ' 113' ' ' LYS . 30.4 t70 -107.87 120.42 42.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 63.11 110.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -94.47 109.68 21.53 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.26 -0.427 . . . . 75.24 110.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -116.24 156.39 26.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 71.23 109.501 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.88 -17.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 111.961 0.356 . . . . 73.52 111.961 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.11 -17.37 32.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.117 0.484 . . . . 54.0 110.337 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.73 123.55 1.39 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.919 -0.657 . . . . 72.42 111.902 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.3 136.09 49.64 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.629 2.219 . . . . 65.42 112.135 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -117.12 137.57 52.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.54 . . . . 63.32 109.963 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.5 mp -107.46 117.98 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 73.15 110.158 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' HD2' ' OD2' ' A' ' 128' ' ' ASP . 71.6 mtt180 -105.93 111.61 24.33 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.929 -0.767 . . . . 75.23 108.929 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.62 133.36 11.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.094 -1.05 . . . . 72.44 112.108 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.41 116.63 20.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.225 0.536 . . . . 75.1 110.275 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.728 HD11 HD11 ' A' ' 123' ' ' ILE . 8.6 tp -116.04 127.07 54.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.711 -0.677 . . . . 74.32 109.979 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.545 ' HB ' HD22 ' A' ' 124' ' ' ASN . 56.6 t -128.03 134.47 65.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.065 0.46 . . . . 74.31 110.625 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.652 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.0 mp -109.41 137.04 47.87 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.648 -0.871 . . . . 74.4 108.648 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.75 121.03 5.12 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 123.819 0.699 . . . . 53.53 113.59 -173.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.01 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 92.2 m-85 -133.92 149.93 51.3 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.373 -0.973 . . . . 71.43 108.373 173.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.79 93.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.04 0.448 . . . . 75.51 111.339 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.09 47.72 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.999 -0.546 . . . . 43.53 112.336 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 1.01 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 18.8 m95 -105.83 122.38 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.348 -0.241 . . . . 72.33 110.348 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.448 ' HB3' HD23 ' A' ' 10' ' ' LEU . 19.9 mt -128.51 136.96 51.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.865 0.364 . . . . 74.12 111.142 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -127.63 128.61 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 71.55 110.253 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -132.97 133.04 6.82 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.437 -0.887 . . . . 71.51 113.373 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.2 119.29 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.744 -0.465 . . . . 75.11 109.744 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 77.9 mt-30 -113.07 121.62 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.22 0.533 . . . . 73.25 109.569 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.773 ' HE2' HG13 ' A' ' 164' ' ' VAL . 90.4 mtp -133.92 135.82 43.84 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.623 -0.51 . . . . 72.43 109.623 -176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.72 ' HB2' ' HB2' ' A' ' 166' ' ' GLN . 0.9 OUTLIER -111.56 117.54 33.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.566 -0.531 . . . . 73.04 109.566 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.832 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 14.1 m-85 -94.18 130.57 40.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.203 -0.908 . . . . 74.31 110.276 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 163' ' ' ARG . 11.9 pt-20 -96.52 124.78 40.62 Favored 'General case' 0 C--O 1.264 1.839 0 CA-C-O 121.307 0.575 . . . . 74.22 109.843 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -70.64 -16.67 62.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 113.258 -1.792 . . . . 73.44 111.511 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.25 -43.71 98.44 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.657 -0.868 . . . . 74.11 108.657 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -98.86 -159.58 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.546 -1.279 . . . . 74.42 107.546 165.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.6 m -109.52 27.31 9.69 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.825 -0.547 . . . . 71.34 109.552 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 35.8 ttm180 -151.77 160.16 43.68 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 118.513 -1.275 . . . . 75.33 112.915 -155.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.832 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -78.95 135.91 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.29 0.567 . . . . 63.54 111.369 -177.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -33.68 12.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 75.42 109.684 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.72 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 49.4 mt-30 -108.26 133.0 53.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.686 -0.688 . . . . 72.23 110.715 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.4 m -121.2 109.95 15.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 41.43 109.263 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 10.7 m120 -113.8 126.82 55.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.885 -0.783 . . . . 72.44 108.885 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 94.0 m-85 -121.51 142.68 49.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.004 -0.678 . . . . 71.15 111.149 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.431 ' HB2' ' HE1' ' A' ' 181' ' ' HIS . . . -143.29 127.38 17.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.912 -0.585 . . . . 60.43 110.247 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 67.3 t -125.38 134.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.067 -0.346 . . . . 74.11 110.067 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -112.35 102.62 1.37 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.288 -0.725 . . . . 63.51 111.288 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -112.79 119.42 37.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.799 -0.815 . . . . 73.23 108.799 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -112.37 125.94 54.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 74.24 111.422 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.2 m -120.84 154.48 35.73 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.379 -1.341 . . . . 73.52 107.379 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.23 -45.13 53.68 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.37 0.507 . . . . 71.43 112.37 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -113.61 0.26 14.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.02 -0.272 . . . . 64.33 111.401 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -136.75 114.86 11.54 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.497 -0.319 . . . . 64.25 110.769 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.71 123.49 49.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.33 -0.619 . . . . 75.43 109.33 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.778 HD11 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -117.74 131.07 56.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.171 0.51 . . . . 72.24 111.132 -176.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.531 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 72.3 t60 -115.58 115.12 25.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.622 -0.717 . . . . 72.33 109.483 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.651 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 8.6 m -82.78 139.94 33.28 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.903 -1.147 . . . . 73.31 107.903 173.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.9 t30 -146.05 138.98 25.74 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.935 -0.706 . . . . 72.12 111.887 -173.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 59.4 t -131.55 120.94 46.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.482 -0.781 . . . . 73.21 109.962 172.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.03 111.15 21.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.59 -0.732 . . . . 73.01 110.154 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.509 ' H ' ' ND2' ' A' ' 168' ' ' ASN . 5.0 t70 63.4 -168.58 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.817 -1.083 . . . . 74.13 109.29 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.64 -6.93 89.06 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.589 -0.815 . . . . 63.33 112.218 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 211' ' ' THR . 19.0 p -102.39 -28.35 12.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.786 1.032 . . . . 74.24 113.786 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.14 115.41 28.81 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.582 -0.847 . . . . 61.24 112.185 -172.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -120.77 126.3 49.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.06 -0.973 . . . . 71.42 109.665 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.76 -122.51 0.87 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.544 -0.836 . . . . 74.1 112.262 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 158.17 -160.67 31.03 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.617 -0.801 . . . . 74.13 112.587 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.9 t -148.05 139.15 23.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.699 -0.482 . . . . 70.21 109.699 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.778 HG13 HD11 ' A' ' 180' ' ' LEU . 4.2 mp -119.9 135.49 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.123 -0.325 . . . . 64.53 110.123 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.772 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 38.8 t80 -122.3 118.35 28.3 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 74.23 109.836 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.34 134.58 49.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.642 -0.503 . . . . 71.04 109.642 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -99.73 127.12 45.86 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 72.24 110.569 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.519 HG11 ' HD3' ' A' ' 200' ' ' LYS . 10.8 t -102.53 139.38 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.707 -0.849 . . . . 75.04 108.707 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.24 34.28 0.25 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.424 0.631 . . . . 64.3 112.621 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.519 ' HD3' HG11 ' A' ' 198' ' ' VAL . 2.5 mptp? -96.83 14.51 24.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.125 -1.065 . . . . 74.42 108.125 164.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 65.84 20.79 11.44 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.028 -0.987 . . . . 73.13 109.89 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.13 129.8 48.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.073 -0.967 . . . . 74.33 110.197 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.772 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 28.9 mt-10 -104.92 129.83 53.22 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.961 -1.126 . . . . 73.23 107.961 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -122.14 138.17 54.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.821 -0.352 . . . . 74.55 110.632 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.615 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -134.81 149.83 50.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.243 -0.435 . . . . 73.14 111.044 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 221' ' ' ILE . 83.2 t -131.13 143.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.656 -0.702 . . . . 75.52 110.357 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -114.61 132.41 56.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.004 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 208' ' ' LEU . 2.1 mm? -125.17 129.48 50.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.21 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.01 127.71 12.47 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.078 -0.341 . . . . 61.34 110.078 171.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.506 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 2.3 t90 -118.75 133.34 55.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.999 -0.741 . . . . 75.1 108.999 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 188' ' ' THR . 31.6 m -93.89 103.02 15.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.184 0.516 . . . . 60.31 109.767 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.71 127.11 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.397 -0.82 . . . . 74.22 110.612 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.4 43.68 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.21 -0.756 . . . . 71.05 111.21 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -126.8 155.84 42.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.008 -0.738 . . . . 74.25 109.008 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.0 m -95.4 -9.8 31.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.155 0.428 . . . . 62.4 112.155 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -91.54 131.53 36.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.889 0.376 . . . . 74.03 110.613 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.506 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 7.9 t -107.19 139.13 42.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.288 0.566 . . . . 75.13 110.19 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -89.06 127.27 35.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.633 . . . . 74.32 109.997 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.532 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 93.9 m-85 -112.35 150.9 30.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.704 -0.68 . . . . 74.32 109.823 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.95 143.17 10.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.749 -0.94 . . . . 73.35 110.749 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.633 HG22 HG23 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -137.78 134.07 45.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 117.316 0.558 . . . . 71.15 110.583 177.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.522 ' CB ' ' HG2' ' A' ' 236' ' ' LYS . . . -126.29 142.17 51.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.885 -0.598 . . . . 65.22 111.388 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.09 124.06 51.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.74 -0.664 . . . . 74.53 109.456 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.614 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 21.3 tptp -113.93 114.02 25.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.328 -0.851 . . . . 75.45 109.425 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.56 121.14 32.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.045 0.45 . . . . 64.43 110.738 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -91.36 99.28 12.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.712 -0.677 . . . . 75.4 109.756 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.6 -35.41 7.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.939 -0.573 . . . . 71.13 111.416 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.448 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -140.21 154.76 70.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 75.31 109.295 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 10.1 Cg_endo -52.52 -26.39 28.59 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.113 2.542 . . . . 73.51 113.309 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -107.97 -15.39 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.613 0.227 . . . . 71.34 111.613 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.26 123.68 40.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.015 0.436 . . . . 71.44 111.84 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.9 t -133.75 121.85 22.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 70.12 109.832 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -101.23 134.35 44.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.655 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 24.3 p -132.01 121.31 23.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.341 -0.391 . . . . 74.23 110.889 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.6 140.16 43.75 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.495 -0.557 . . . . 70.02 109.495 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' A' ' 222' ' ' ALA . 71.6 mttt -137.92 150.68 47.28 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.044 -0.354 . . . . 72.34 110.044 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.498 HG12 HG12 ' A' ' 221' ' ' ILE . 8.7 p -144.69 143.88 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.119 0.485 . . . . 72.55 110.873 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 25.7 t-20 -105.03 148.9 26.26 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.433 -0.803 . . . . 75.3 109.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.532 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 64.4 t30 -46.65 -31.22 2.74 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.849 1.343 . . . . 73.54 113.378 -174.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.583 ' HB2' HD11 ' A' ' 242' ' ' LEU . 19.3 m -80.01 19.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.979 0.419 . . . . 61.31 110.603 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 239' ' ' ASN . 56.0 m 68.67 34.2 3.54 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.467 -0.788 . . . . 70.14 111.19 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.833 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.2 mp -98.84 131.81 44.67 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 120.389 -0.524 . . . . 75.33 111.605 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 243' ' ' ILE . 2.3 mp -109.66 116.95 53.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.837 -0.62 . . . . 64.41 110.264 -169.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.85 133.55 11.4 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.617 -0.801 . . . . 45.1 111.947 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.621 HD21 ' H ' ' A' ' 245' ' ' LEU . 2.3 pt? -118.66 134.39 55.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.817 -0.438 . . . . 75.43 109.817 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.1 121.39 2.71 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.796 -0.716 . . . . 35.31 112.14 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.87 115.79 30.76 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.453 -0.573 . . . . 73.43 109.453 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.0 m -109.05 112.85 25.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.176 0.513 . . . . 62.45 110.205 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.91 134.11 55.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 74.23 110.189 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 15.6 m -122.54 98.25 5.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.084 -0.507 . . . . 75.15 109.706 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.748 ' HB2' HG23 ' A' ' 255' ' ' ILE . 3.2 mm? -88.97 77.37 7.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.345 -0.613 . . . . 72.32 109.345 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.604 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 30.7 mmtp 68.37 166.63 0.12 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.343 -0.844 . . . . 73.02 110.136 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 55.7 Cg_endo -70.9 57.68 2.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.359 2.04 . . . . 73.5 112.178 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -147.94 -45.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.834 -0.621 . . . . 73.13 112.097 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.748 HG23 ' HB2' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -132.26 124.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.78 0.8 . . . . 74.2 110.67 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 57.2 tttt -119.61 131.9 55.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.99 -1.004 . . . . 75.24 110.092 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.02 125.54 49.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.839 -0.618 . . . . 71.22 110.466 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.2 t -128.87 111.59 13.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.627 0.727 . . . . 70.51 110.46 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.704 HD22 ' HG ' ' A' ' 277' ' ' LEU . 0.1 OUTLIER -106.3 124.49 49.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.41 -0.959 . . . . 72.33 108.41 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 46.8 p -140.79 140.73 34.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.198 -0.601 . . . . 74.11 110.999 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 245' ' ' LEU . . . -144.89 146.69 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.985 -0.552 . . . . 75.32 110.088 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.818 HD12 HD21 ' A' ' 242' ' ' LEU . 2.0 tm? -114.6 116.58 28.98 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.653 -0.869 . . . . 73.41 108.653 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.464 HD22 HD22 ' A' ' 245' ' ' LEU . 1.0 OUTLIER -92.13 107.35 19.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.911 -1.144 . . . . 73.45 107.911 173.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.833 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -70.79 104.92 3.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.259 -1.015 . . . . 74.43 108.259 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.7 -22.92 34.77 Favored Glycine 0 N--CA 1.459 0.211 0 C-N-CA 121.16 -0.543 . . . . 52.4 112.2 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -90.68 -15.73 29.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.257 -0.471 . . . . 75.21 111.798 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 17.5 t-20 -117.41 -38.37 3.34 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.227 0.455 . . . . 73.23 112.227 -174.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 264' ' ' ASP . 30.7 m -61.87 -17.79 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.103 0.408 . . . . 64.11 112.103 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -59.81 -32.67 70.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.053 0.454 . . . . 72.52 110.314 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.99 -16.57 15.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 71.01 110.277 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.32 119.52 3.28 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.81 -0.632 . . . . 50.31 111.827 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 149.73 82.7 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.462 -0.875 . . . . 50.31 112.413 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -113.61 150.13 33.57 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.698 -0.482 . . . . 71.24 109.698 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.1 mptt -91.73 137.11 32.63 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.682 -0.859 . . . . 74.23 108.682 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -120.53 137.72 54.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.151 -0.477 . . . . 74.51 109.845 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.889 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -144.15 112.68 0.69 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 111.045 -0.822 . . . . 73.44 111.045 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.704 ' HG ' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -113.96 143.51 44.6 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.29 -0.564 . . . . 74.54 109.512 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -140.56 124.43 2.61 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.387 -0.824 . . . . 55.43 111.362 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.488 ' HB2' HD13 ' A' ' 29' ' ' LEU . 3.0 mm? -113.41 131.2 56.09 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.624 -0.88 . . . . 73.41 108.624 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 69.3 tt0 -125.42 116.14 21.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.133 0.492 . . . . 64.4 110.038 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.553 ' HB3' HD12 ' A' ' 31' ' ' LEU . 50.1 m-85 -105.33 138.57 41.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.678 -0.692 . . . . 65.24 109.782 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.467 ' HB3' HD21 ' A' ' 284' ' ' LEU . 75.8 mt-30 -130.85 114.03 14.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.451 -0.795 . . . . 74.22 110.209 -176.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.732 ' HB1' ' HB ' ' A' ' 33' ' ' THR . . . -104.8 107.45 18.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.209 -0.664 . . . . 65.34 109.209 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.495 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.3 mm? -139.27 -3.27 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.421 -0.808 . . . . 71.12 110.171 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.59 -0.719 . . . . 72.23 109.885 -178.205 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.095 0.474 . . . . 75.41 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 119' ' ' LYS . 7.9 p -147.81 134.86 10.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.17 -0.678 . . . . 73.1 109.17 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.65 133.85 51.35 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.282 2.655 . . . . 74.12 113.664 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.13 75.32 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.142 2.561 . . . . 63.1 110.893 172.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -76.4 -11.85 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.565 -0.743 . . . . 75.44 111.928 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' HB3' HG23 ' A' ' 143' ' ' VAL . 21.7 p90 -60.15 -22.12 62.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.314 0.578 . . . . 70.34 110.039 171.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -27.25 61.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.709 -0.678 . . . . 73.34 109.747 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -84.74 -14.12 49.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.056 -0.52 . . . . 72.2 110.091 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.541 ' HB3' ' CB ' ' A' ' 170' ' ' ALA . 61.0 mt -76.89 -35.56 57.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.385 -0.825 . . . . 73.14 110.575 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 -61.45 0.23 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.386 -0.911 . . . . 74.5 114.025 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.75 -43.87 81.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.922 0.361 . . . . 75.42 111.338 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.1 t -62.09 -46.37 89.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.862 -0.608 . . . . 65.02 110.961 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.91 73.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.071 -0.513 . . . . 72.11 111.776 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -59.32 -30.11 68.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.24 112.243 -173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.59 -44.5 85.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.935 0.398 . . . . 75.14 110.452 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 222' ' ' ALA . 61.8 t -82.41 -35.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.939 -0.573 . . . . 72.44 110.962 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -68.84 -23.05 64.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.946 -0.57 . . . . 75.12 111.533 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.8 p -76.03 93.05 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.313 0.578 . . . . 71.14 111.085 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.32 79.13 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.761 . . . . 74.44 112.214 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.4 63.92 3.11 Favored Glycine 0 C--N 1.335 0.479 0 O-C-N 123.984 0.803 . . . . 64.4 114.692 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -88.88 83.09 6.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.184 0.516 . . . . 75.3 110.732 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.3 121.84 5.77 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.531 -0.759 . . . . 53.12 111.465 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.81 5.61 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.645 0.239 . . . . 73.4 111.645 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.91 59.51 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.771 -0.728 . . . . 61.32 112.691 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 46' ' ' SER . 1.5 pp -129.04 -179.34 5.06 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.59 0.959 . . . . 74.54 113.59 -170.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.688 HG21 HD22 ' A' ' 277' ' ' LEU . 40.7 mm -99.1 132.79 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.061 -1.427 . . . . 75.21 109.802 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 17.9 ptpt -118.55 153.52 34.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.022 0.439 . . . . 73.1 109.906 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.8 HD11 ' HB2' ' A' ' 279' ' ' LEU . 1.3 tp -141.13 143.86 34.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.289 -0.414 . . . . 71.5 111.442 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 8.1 t70 -137.38 124.28 21.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.617 -1.253 . . . . 71.44 107.617 168.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.3 tm? -136.72 124.16 22.08 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.388 -0.597 . . . . 73.03 109.388 -175.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 29.6 mtmm -116.77 124.51 49.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 72.23 110.572 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.458 ' HG1' ' HB1' ' A' ' 283' ' ' ALA . 86.1 m -121.22 125.36 46.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.897 -0.592 . . . . 75.14 109.538 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -113.35 145.55 40.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.794 0.331 . . . . 71.13 110.335 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 21.7 m -139.21 138.19 36.65 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.48 -0.563 . . . . 73.22 109.48 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 49.21 -120.12 1.34 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.802 0.689 . . . . 74.43 110.572 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -136.27 152.24 50.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.725 -0.472 . . . . 50.55 109.725 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 79.29 -9.3 41.5 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 119.335 -0.703 . . . . 53.43 113.648 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -101.64 128.55 47.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.613 1.207 . . . . 74.15 112.043 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 29.0 tt0 -141.02 117.12 10.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 74.1 109.66 164.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 92.1 t80 -99.05 121.93 41.63 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.546 -0.538 . . . . 65.54 109.546 176.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.798 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 6.8 m -125.5 125.21 42.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.083 0.468 . . . . 74.43 111.521 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -112.43 123.84 51.17 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.775 -0.824 . . . . 72.13 108.775 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 22.1 m -137.85 125.66 22.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.203 -0.295 . . . . 62.11 110.203 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 178.9 42.33 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.328 -1.415 . . . . 75.12 113.442 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.543 ' HB3' HD11 ' A' ' 26' ' ' LEU . 21.9 m -138.01 134.82 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.687 -0.486 . . . . 64.23 109.687 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB1' HG13 ' A' ' 54' ' ' VAL . . . -139.8 132.8 29.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.918 0.39 . . . . 72.14 111.25 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.06 120.96 37.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.894 -0.593 . . . . 71.45 109.409 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 m -84.52 -33.42 23.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 72.32 110.751 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -63.61 -59.4 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 75.35 110.027 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 m -112.52 111.31 22.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.228 -0.656 . . . . 72.41 109.228 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p -55.92 95.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.156 0.799 . . . . 64.32 113.156 -171.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -145.58 117.36 8.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.36 -0.978 . . . . 74.35 108.36 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG13 ' HB1' ' A' ' 47' ' ' ALA . 32.1 t -121.97 125.32 72.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.934 0.397 . . . . 75.31 110.821 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.6 m -109.54 125.08 52.14 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.493 -0.929 . . . . 75.04 108.493 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.56 5.33 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.947 -1.12 . . . . 73.24 113.267 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 75' ' ' TRP . 19.3 m -118.96 134.07 55.42 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.068 -0.715 . . . . 61.41 109.068 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -119.74 123.24 43.28 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.519 -0.919 . . . . 74.42 108.519 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.798 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 mt-10 -110.83 119.31 38.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.9 -0.591 . . . . 73.45 110.217 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -98.59 117.76 33.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.733 -1.21 . . . . 74.01 107.733 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.807 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 38.2 mttp -116.56 139.87 50.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.256 0.551 . . . . 72.53 110.75 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 96.6 m-85 -115.34 120.09 38.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.249 -0.887 . . . . 73.1 108.887 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.6 ptp180 -119.03 106.39 12.37 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 121.755 0.788 . . . . 74.1 111.224 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -116.11 92.67 3.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.919 -1.037 . . . . 74.12 109.994 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -81.22 1.22 33.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.748 -0.66 . . . . 72.12 111.448 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.43 14.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.524 0.678 . . . . 64.54 109.986 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -159.02 -49.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.875 -1.057 . . . . 74.23 108.578 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.366 -0.834 . . . . 73.33 111.306 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.477 ' CD1' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -106.93 131.86 53.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.796 0.331 . . . . 75.13 111.147 -174.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.9 m -129.99 111.93 13.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.002 -0.545 . . . . 74.05 109.993 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.651 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 33.4 t80 -112.88 123.76 51.05 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.547 -0.538 . . . . 75.23 109.547 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.4 m -128.63 116.77 20.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.808 0.337 . . . . 75.34 111.018 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.38 121.52 45.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.892 -0.781 . . . . 71.54 108.892 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.696 ' HB3' ' HG2' ' A' ' 59' ' ' GLU . 17.4 ptmt -128.01 114.39 17.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.92 0.39 . . . . 65.31 111.442 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.656 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 78.6 t90 -99.9 139.23 35.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.524 -0.547 . . . . 72.4 109.524 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -119.7 160.86 21.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.422 -0.354 . . . . 71.32 110.276 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 p -62.41 -14.12 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.062 0.458 . . . . 72.32 111.95 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.682 ' HB3' HG21 ' A' ' 80' ' ' THR . 35.4 t70 -71.23 -4.75 27.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 71.04 110.108 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER 77.85 -3.3 2.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.122 -0.944 . . . . 62.41 110.019 -176.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.682 HG21 ' HB3' ' A' ' 78' ' ' ASP . 13.4 t -83.68 133.37 34.81 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.938 -0.574 . . . . 71.23 109.891 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.656 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 2.2 pt? -123.0 142.88 50.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.047 -0.524 . . . . 74.44 110.104 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.58 123.92 5.64 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.965 -0.636 . . . . 73.24 112.333 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 23.5 m -97.34 90.1 4.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.284 0.564 . . . . 74.44 109.679 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -91.57 110.0 21.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.123 -0.944 . . . . 71.43 109.482 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 99' ' ' PHE . 13.0 pt -124.36 134.84 65.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.734 0.778 . . . . 74.13 110.867 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -123.5 122.27 37.79 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.192 -0.913 . . . . 74.31 108.746 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 97' ' ' LEU . 8.0 m -113.69 120.77 64.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.079 -0.51 . . . . 73.44 110.106 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -107.77 131.57 54.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.549 -0.908 . . . . 74.14 108.549 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -76.6 134.65 39.3 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.362 -0.535 . . . . 53.04 111.355 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.419 -0.809 . . . . 65.32 111.077 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.27 -53.22 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.687 -0.486 . . . . 73.23 109.687 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 71.87 10.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.34 110.719 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -63.37 133.35 53.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 73.5 110.219 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.5 -9.43 58.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.544 -0.836 . . . . 65.5 111.317 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.4 111.21 23.85 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.1 -0.704 . . . . 75.22 109.1 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -126.23 130.25 50.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.132 0.491 . . . . 75.54 110.404 177.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.666 HD12 HG21 ' A' ' 116' ' ' THR . 1.3 mm? -101.63 131.06 48.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.019 -0.537 . . . . 72.23 109.626 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -106.4 117.76 34.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.08 0.466 . . . . 62.24 110.494 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.766 ' HD1' ' HB ' ' A' ' 114' ' ' ILE . 82.3 t80 -126.21 115.95 20.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.279 -0.873 . . . . 75.54 110.295 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.678 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 1.3 t70 -112.18 138.6 48.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.765 -0.652 . . . . 64.53 110.768 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.535 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 33.2 m -126.93 120.74 29.89 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.951 -0.759 . . . . 60.31 108.951 169.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 4.7 t -127.49 121.89 31.94 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.918 -0.401 . . . . 72.24 109.918 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 80' ' ' THR . 69.6 m-85 -125.45 120.51 31.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.557 -0.292 . . . . 74.31 110.285 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.2 t -123.05 103.14 36.71 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.29 -0.414 . . . . 63.13 109.961 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.74 -25.32 46.4 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.972 2.448 . . . . 73.44 111.387 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -67.06 -37.44 84.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 63.14 110.329 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.754 ' HB ' ' HG2' ' A' ' 109' ' ' LYS . 5.2 m -88.18 -28.25 21.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.148 0.499 . . . . 75.01 110.104 175.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.67 4.19 83.02 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.229 -0.748 . . . . 70.14 111.229 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.754 ' HG2' ' HB ' ' A' ' 107' ' ' THR . 21.3 pttm -94.96 148.63 22.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.154 0.502 . . . . 73.24 111.472 -175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HB2' ' HZ1' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -125.43 122.74 37.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.316 -0.856 . . . . 75.23 109.236 174.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 17.8 m120 -119.61 137.79 53.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 75.5 110.521 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -140.15 123.3 16.78 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.616 -0.513 . . . . 73.34 109.616 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.678 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -117.58 131.92 56.6 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.539 -0.864 . . . . 75.54 109.204 176.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.766 ' HB ' ' HD1' ' A' ' 99' ' ' PHE . 4.0 tp -140.09 114.66 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.635 -0.506 . . . . 74.43 109.635 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.943 ' HB3' ' O ' ' A' ' 127' ' ' CYS 0.461 13.1 tttt -154.41 170.12 22.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 116.128 1.899 . . . . 75.42 116.128 160.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.666 HG21 HD12 ' A' ' 97' ' ' LEU . 77.1 p -101.18 130.16 47.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.311 -1.313 . . . . 70.25 110.956 -163.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.89 123.81 5.87 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.534 -0.841 . . . . 71.01 112.238 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.439 ' C ' ' HD2' ' A' ' 119' ' ' LYS . 35.5 p90 -124.9 128.09 48.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.62 0.724 . . . . 72.4 110.282 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.674 ' HD3' ' HD3' ' A' ' 96' ' ' LYS . 3.8 mptp? -111.38 122.7 48.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.672 -0.695 . . . . 75.55 110.929 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HB2' HG23 ' A' ' 123' ' ' ILE . 31.0 mtp180 -108.36 158.02 17.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.798 -0.637 . . . . 74.23 110.694 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.68 -32.8 44.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.39 0.885 . . . . 70.31 113.39 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -119.15 -6.33 10.42 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.73 -0.388 . . . . 74.42 111.297 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -144.4 123.3 6.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.52 0.676 . . . . 74.32 110.6 -173.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.757 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.9 t-20 -104.64 115.45 30.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.03 -0.532 . . . . 64.34 109.582 -175.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.05 130.06 56.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.516 0.674 . . . . 72.42 111.761 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.47 115.9 1.61 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.316 -0.856 . . . . 53.01 111.37 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.943 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 59.4 m -112.66 126.1 55.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.824 -0.806 . . . . 65.31 108.824 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.736 ' HA ' ' CB ' ' A' ' 115' ' ' LYS . 1.1 m-20 -128.92 133.22 47.79 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.843 1.339 . . . . 72.11 111.364 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.892 ' H ' ' HB2' ' A' ' 115' ' ' LYS . 60.1 ttp -107.39 118.39 36.59 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 119.413 -0.915 . . . . 73.43 109.791 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 9.2 t70 -106.2 115.3 29.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.739 -0.467 . . . . 73.11 109.739 -175.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 92.3 t80 -97.87 117.78 32.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.839 -0.344 . . . . 75.22 111.125 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.505 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 22.5 t70 -115.02 157.03 24.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.872 -0.788 . . . . 75.5 108.872 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.19 -17.19 21.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 111.705 0.261 . . . . 72.33 111.705 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.23 -19.34 24.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 71.31 111.073 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 168.93 148.45 5.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.528 -0.844 . . . . 74.3 112.527 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.47 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 2.8 Cg_endo -85.67 114.51 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.571 2.847 . . . . 75.12 111.749 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 m -104.0 144.44 31.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.018 -0.537 . . . . 74.54 110.612 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.35 118.52 55.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.41 -0.589 . . . . 74.01 109.41 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -103.57 126.31 50.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.773 -0.649 . . . . 75.03 110.23 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.14 132.02 10.1 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.181 -1.009 . . . . 74.31 111.643 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.09 116.09 23.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.713 -0.477 . . . . 74.52 109.713 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.803 HD11 HD11 ' A' ' 123' ' ' ILE . 15.2 tp -124.26 124.53 42.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.356 -0.384 . . . . 75.23 110.621 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.757 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 46.5 t -125.1 128.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 73.32 109.821 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.56 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.2 mp -109.51 138.69 45.5 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.728 -0.841 . . . . 73.4 108.728 176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.9 117.55 1.58 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.109 -1.043 . . . . 75.11 111.778 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.31 123.28 18.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.883 -0.327 . . . . 74.52 111.056 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 40.34 39.02 0.62 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.058 1.132 . . . . 73.14 114.058 171.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.09 6.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.26 -0.971 . . . . 71.33 113.512 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -98.66 137.01 37.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.904 0.852 . . . . 74.53 111.416 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 mt -115.59 140.17 49.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.442 -1.254 . . . . 74.41 110.56 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -127.17 125.88 41.88 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.275 -0.639 . . . . 61.3 109.275 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.63 134.02 7.59 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.26 -0.972 . . . . 52.54 112.572 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.472 ' HD2' ' CD2' ' A' ' 169' ' ' PHE . 13.7 m-85 -134.68 120.54 19.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.387 -0.407 . . . . 72.41 109.973 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.416 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . 73.1 mt-30 -119.92 123.12 42.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.426 0.631 . . . . 62.31 110.01 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -130.58 136.13 48.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.863 -0.608 . . . . 75.14 110.288 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -114.75 118.88 34.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.702 -0.481 . . . . 74.51 109.702 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 86.3 t80 -107.15 123.33 48.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.811 -0.631 . . . . 75.2 110.798 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -94.98 126.35 40.26 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.479 -0.563 . . . . 74.34 109.479 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 41.8 p -73.71 -48.24 33.47 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.083 -0.962 . . . . 72.02 112.993 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -65.58 -44.57 86.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.237 0.541 . . . . 73.32 110.189 -172.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 38.7 ttpt -101.64 112.91 25.63 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.941 -1.874 . . . . 74.3 105.941 160.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.4 p -75.5 38.07 0.14 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.355 1.243 . . . . 70.21 114.355 -152.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.553 ' HG2' ' N ' ' A' ' 164' ' ' VAL . 26.0 ttm180 -139.92 157.88 44.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.916 0.389 . . . . 74.11 111.085 -166.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 85.7 t -72.51 122.13 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.448 -0.945 . . . . 75.5 108.448 170.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.6 m -93.81 -31.08 14.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.354 -0.385 . . . . 73.42 110.826 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -132.94 129.7 38.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 74.13 110.321 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.5 m -124.75 106.67 10.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.562 -0.744 . . . . 74.51 109.632 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 154' ' ' GLN . 10.0 p30 -118.14 146.79 43.91 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.459 -0.496 . . . . 63.1 109.886 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' HD2' ' A' ' 153' ' ' TYR . 69.1 m-85 -135.21 162.1 33.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.45 -0.341 . . . . 75.22 110.648 -173.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 71.43 110.616 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.814 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 98.5 t -138.45 136.95 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.415 . . . . 73.23 109.878 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.73 111.28 1.9 Allowed Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.614 -0.803 . . . . 60.12 111.317 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.551 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 19.5 t80 -113.28 128.85 56.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.252 0.526 . . . . 62.31 109.976 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -102.15 130.82 48.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.981 0.896 . . . . 74.21 112.564 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 7.8 m -131.1 145.54 52.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 65.43 105.765 164.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.95 -30.25 67.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.328 0.513 . . . . 73.44 112.303 -168.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.08 -0.23 12.79 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.292 -0.255 . . . . 74.13 111.567 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.609 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 53.4 m-85 -136.84 119.93 16.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 75.35 110.57 -174.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -110.91 123.65 50.55 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.018 -0.426 . . . . 73.11 110.162 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 173' ' ' TYR . 2.0 tp -102.68 126.9 49.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.998 0.428 . . . . 61.31 110.077 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -118.55 114.83 23.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.627 -0.879 . . . . 75.31 108.627 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.814 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 26.6 m -99.94 137.57 38.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.406 -0.59 . . . . 53.44 109.406 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -136.97 139.05 41.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.137 0.494 . . . . 64.23 110.995 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 190' ' ' PHE . 84.2 t -128.04 111.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 63.5 109.546 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -96.54 103.8 15.73 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 108.672 -0.862 . . . . 71.23 108.672 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 188' ' ' THR . 23.1 t70 64.82 172.61 0.2 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.03 -0.987 . . . . 70.02 109.64 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.8 56.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.435 -0.888 . . . . 40.04 111.785 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 186' ' ' ASP . 14.4 t -97.41 -24.14 15.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 113.14 0.792 . . . . 75.14 113.14 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.29 117.47 19.85 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.423 1.01 . . . . 62.42 111.33 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.452 ' HB2' HG23 ' A' ' 184' ' ' VAL . 41.8 p90 -134.03 138.47 45.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.593 -0.276 . . . . 74.21 110.766 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . -163.45 -163.88 17.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.788 -0.72 . . . . 72.3 112.369 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.88 176.73 30.9 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 120.78 -0.724 . . . . 74.23 112.095 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 34.8 t -147.29 142.59 27.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.046 0.423 . . . . 75.21 110.881 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 194' ' ' ILE . 4.1 mp -119.31 118.4 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.194 -0.669 . . . . 70.51 109.194 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.405 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 9.2 t80 -108.24 121.07 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.588 -0.523 . . . . 72.5 109.588 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -116.96 126.69 53.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.424 -0.584 . . . . 73.34 109.424 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.645 ' HG2' ' HG2' ' A' ' 203' ' ' GLU . 2.9 tmtp? -108.69 114.17 27.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.982 -0.554 . . . . 64.12 110.24 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.44 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 43.6 t -73.89 159.75 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.462 -0.335 . . . . 75.22 110.319 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.401 ' N ' HG12 ' A' ' 198' ' ' VAL . 0.9 OUTLIER -57.62 -45.53 85.25 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.527 0.203 . . . . 73.42 111.041 178.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 172.47 13.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.906 -0.776 . . . . 73.35 108.906 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -78.08 70.1 4.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.756 0.788 . . . . 74.4 111.423 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.733 HD12 ' HD2' ' A' ' 225' ' ' TYR . 58.5 tp -133.58 113.01 11.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.465 -1.243 . . . . 75.0 108.759 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.645 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.6 mt-10 -117.12 129.09 55.74 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.512 -0.551 . . . . 55.21 109.512 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -124.36 139.41 53.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.725 0.298 . . . . 65.52 110.968 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.405 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -130.97 136.4 48.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.349 -0.387 . . . . 64.13 110.677 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 193' ' ' SER . 54.6 t -113.71 126.08 71.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.471 -0.566 . . . . 74.24 109.471 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.1 136.17 53.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.507 0.67 . . . . 74.45 111.004 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.439 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -119.55 141.1 49.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.029 -0.987 . . . . 63.32 109.325 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.11 130.37 25.18 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.283 -0.417 . . . . 64.2 110.872 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -116.48 132.84 56.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.981 -0.748 . . . . 74.1 108.981 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 10.1 t -114.2 122.72 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 65.14 110.691 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.64 135.62 57.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 74.44 111.14 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.38 -28.94 5.63 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.622 -0.717 . . . . 65.11 111.474 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.06 149.26 30.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.094 -0.706 . . . . 75.42 109.094 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.6 m -79.15 42.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.079 0.466 . . . . 70.54 110.667 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.57 120.88 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.156 -0.474 . . . . 75.45 110.573 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.6 t -105.8 136.89 44.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.14 0.495 . . . . 74.31 109.943 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.4 mmm-85 -102.0 138.19 39.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.445 -0.576 . . . . 75.22 109.445 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.568 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 66.0 m-85 -114.7 146.9 40.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.982 -0.377 . . . . 75.5 109.982 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.88 146.23 15.21 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.34 -0.704 . . . . 62.44 111.34 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.6 mp -132.14 129.5 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.94 0.37 . . . . 74.41 110.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.415 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -118.57 138.9 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.117 -0.327 . . . . 72.33 110.117 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.97 125.8 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.922 0.391 . . . . 74.53 110.813 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -115.44 114.34 24.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.74 -0.664 . . . . 73.24 109.909 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.733 ' HD2' HD12 ' A' ' 202' ' ' LEU . 36.6 t80 -117.7 120.05 36.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.477 -0.564 . . . . 73.44 109.477 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.563 HE21 ' HA ' ' A' ' 229' ' ' PRO . 52.7 tt0 -112.25 112.22 23.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.952 0.406 . . . . 70.33 110.652 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 227' ' ' ILE . 3.7 mp -86.82 -55.51 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 71.24 109.711 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -106.1 153.86 39.96 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 73.53 109.606 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.563 ' HA ' HE21 ' A' ' 226' ' ' GLN . 21.0 Cg_endo -60.33 -23.82 75.63 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.549 2.166 . . . . 75.54 112.79 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -102.61 -9.27 20.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.587 -0.279 . . . . 75.23 111.342 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.85 122.67 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 73.32 111.348 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.47 142.32 51.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.878 -0.601 . . . . 72.44 110.651 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -108.43 125.77 52.14 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.251 -0.648 . . . . 71.1 109.251 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.5 t -126.45 117.15 22.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.818 -0.438 . . . . 74.1 109.818 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -124.74 155.86 38.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.367 -0.379 . . . . 62.54 110.324 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER -154.25 139.84 17.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.478 . . . . 71.42 109.857 175.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 243' ' ' ILE . 7.9 p -128.64 144.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 63.13 110.406 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -108.46 148.79 29.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.066 -0.516 . . . . 73.42 109.96 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 8.0 t30 -65.22 -3.78 4.35 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.182 0.808 . . . . 75.32 113.182 -170.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.634 ' HB2' HD12 ' A' ' 242' ' ' LEU . 9.6 m -85.76 17.06 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.946 -0.761 . . . . 73.34 108.946 172.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.588 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 51.0 m 69.77 30.45 3.82 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.691 -1.14 . . . . 74.21 111.585 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.841 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.7 mp -99.08 125.47 44.6 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 120.683 -0.407 . . . . 75.42 111.735 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.523 ' HA ' HG21 ' A' ' 237' ' ' VAL . 1.8 mp -113.2 115.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.721 -0.672 . . . . 74.23 110.506 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -111.08 133.78 11.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.74 -0.743 . . . . 75.31 111.748 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.56 151.71 50.57 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.687 -0.302 . . . . 75.13 110.527 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -146.45 137.8 7.03 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.63 -0.795 . . . . 73.15 113.026 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -103.63 120.19 40.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.742 -0.836 . . . . 74.43 108.742 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 2.0 m -121.93 115.76 23.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.737 0.303 . . . . 74.24 111.035 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -134.74 141.84 46.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.58 -0.282 . . . . 73.21 110.707 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.0 m -76.32 124.82 28.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.609 -0.515 . . . . 74.15 109.609 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 252' ' ' LYS . 17.9 tp -105.92 172.65 6.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.108 0.48 . . . . 74.44 111.804 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.602 ' H ' ' HG ' ' A' ' 251' ' ' LEU . 44.2 tptt -49.53 -54.54 29.73 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.998 1.11 . . . . 72.32 113.998 -172.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 13.1 Cg_exo -70.73 9.07 0.82 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.611 2.207 . . . . 74.15 114.295 -171.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 82.86 29.36 35.1 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.386 -0.911 . . . . 54.21 111.824 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 2.7 pp -121.94 146.02 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.447 -0.377 . . . . 74.5 110.35 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.57 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 73.7 tttt -91.64 126.17 36.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 75.53 108.864 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.6 tp -97.8 123.58 41.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.927 -0.398 . . . . 75.21 109.927 -176.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.4 m -124.75 111.5 15.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.789 -0.641 . . . . 75.12 110.543 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.619 ' CD2' HD12 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -98.92 122.8 42.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.553 -1.277 . . . . 74.21 107.553 170.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.8 m -131.47 143.91 50.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.932 0.396 . . . . 75.14 111.16 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.44 132.36 19.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 74.0 110.732 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.831 HD12 HD21 ' A' ' 242' ' ' LEU . 2.7 tm? -104.35 113.12 26.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.25 -1.018 . . . . 64.12 108.25 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.661 ' HB3' HG13 ' A' ' 268' ' ' VAL . 1.2 mm? -91.66 108.92 20.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.92 -1.141 . . . . 74.42 107.92 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.841 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 9.9 t0 -71.48 105.07 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.586 -1.265 . . . . 75.24 107.586 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.82 -25.03 43.4 Favored Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.907 -0.588 . . . . 64.14 113.497 -170.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -91.85 -26.63 18.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.627 0.251 . . . . 62.52 111.201 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 63.2 t30 -98.69 -28.57 13.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 75.13 112.357 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.678 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 26.9 m -62.51 -17.82 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.665 0.269 . . . . 74.25 111.315 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -55.57 -37.79 68.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.271 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.57 9.75 37.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 63.21 110.838 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.44 74.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.004 -0.617 . . . . 72.51 112.598 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.678 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -142.57 86.52 0.19 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.937 -0.649 . . . . 42.23 111.919 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -113.23 143.52 44.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.444 0.164 . . . . 72.42 110.642 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 65.5 mttm -97.47 137.91 35.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.252 -0.647 . . . . 75.33 109.252 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -121.94 142.55 50.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.814 -0.439 . . . . 74.33 109.814 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.524 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -157.37 123.81 1.33 Allowed Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.54 -0.838 . . . . 71.13 111.504 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.688 HD22 HG21 ' A' ' 27' ' ' ILE . 7.4 tt -114.05 145.2 41.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.005 -0.739 . . . . 74.45 109.005 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -149.4 125.37 1.99 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.944 -1.122 . . . . 75.53 113.012 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.8 ' HB2' HD11 ' A' ' 29' ' ' LEU . 2.1 mm? -99.18 128.0 45.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.418 -0.956 . . . . 75.24 108.418 168.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 13.8 pt-20 -140.05 125.07 18.55 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.045 -0.354 . . . . 72.43 110.045 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.662 ' HB3' ' HA ' ' A' ' 255' ' ' ILE . 1.3 t80 172.72 -142.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 73.52 111.547 170.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.488 ' HB3' HD22 ' A' ' 284' ' ' LEU . 74.9 mt-30 -136.32 122.07 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.28 -0.418 . . . . 72.31 111.396 -166.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.458 ' HB1' ' HG1' ' A' ' 33' ' ' THR . . . -90.93 109.02 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.942 -0.762 . . . . 65.44 108.942 173.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' A' ' 282' ' ' GLN . 2.9 mm? -131.75 158.92 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.12 -0.491 . . . . 73.15 110.709 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.938 -0.764 . . . . 75.5 108.938 176.298 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB3' ' HA2' ' A' ' 94' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.094 0.473 . . . . 71.33 112.096 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 119' ' ' LYS . 23.1 t -125.46 127.58 24.89 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 71.15 110.178 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.98 123.23 9.54 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.494 2.796 . . . . 73.34 112.599 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.41 85.4 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.699 2.266 . . . . 73.52 112.564 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 5.5 p -72.0 -13.27 61.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 74.3 110.208 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.504 ' HE1' HE21 ' A' ' 154' ' ' GLN . 51.8 t80 -53.74 -34.98 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.995 -1.002 . . . . 72.41 110.126 169.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.22 -27.18 30.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 74.32 110.673 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 6' ' ' THR . 2.2 m-20 -85.22 0.98 50.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.589 -0.732 . . . . 75.5 111.196 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.67 -34.48 77.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 75.23 110.386 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.52 59.81 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.544 -0.836 . . . . 64.32 112.699 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -59.26 -53.28 60.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 73.42 110.839 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -55.53 -36.48 66.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.634 -0.712 . . . . 71.14 112.132 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.57 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 72.13 112.205 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -67.79 -40.1 83.98 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 73.24 110.682 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -68.73 -44.43 73.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.675 -0.693 . . . . 72.01 110.979 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 p -68.98 -26.67 32.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.128 0.49 . . . . 74.02 110.435 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.99 -39.91 83.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.944 -0.571 . . . . 75.24 109.727 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 58.26 39.36 25.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.78 -0.646 . . . . 74.13 111.248 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 67.82 4.39 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.954 -0.567 . . . . 72.52 111.451 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.09 -78.27 0.68 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.164 -0.541 . . . . 44.32 112.695 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -122.09 170.08 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.812 0.339 . . . . 72.02 111.03 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 122.54 6.79 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.826 -0.702 . . . . 73.11 111.621 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' HD1' HD11 ' A' ' 26' ' ' LEU . 22.2 t80 -89.35 2.91 53.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.127 0.489 . . . . 73.15 110.894 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.01 59.25 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.579 -0.82 . . . . 50.44 112.72 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 9.3 mp -102.0 156.07 17.77 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.625 0.726 . . . . 74.31 112.288 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.684 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -104.71 122.04 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.402 -1.272 . . . . 75.22 108.74 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -102.74 127.78 49.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.877 -0.601 . . . . 75.15 110.59 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.31 126.65 53.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.337 -0.986 . . . . 73.2 108.337 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.587 ' HB3' ' HD1' ' A' ' 281' ' ' PHE . 4.5 t0 -142.49 133.08 25.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.303 -0.999 . . . . 74.14 108.303 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 1.082 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -139.12 123.98 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.755 0.252 . . . . 74.21 110.575 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 32.1 ttpt -121.15 122.56 40.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.221 0.534 . . . . 75.53 110.28 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -138.82 120.66 15.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.308 -0.86 . . . . 74.05 109.381 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 40' ' ' GLU . 3.5 pttp -144.28 155.16 43.72 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.856 -0.738 . . . . 64.12 111.684 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -133.68 169.54 16.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.805 . . . . 74.23 109.782 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -89.07 13.79 12.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.056 0.391 . . . . 75.43 112.056 -172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.07 52.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.685 0.254 . . . . 72.11 111.685 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.94 -7.59 50.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 118.896 -0.947 . . . . 63.14 115.232 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.9 126.65 47.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.307 1.553 . . . . 73.31 112.186 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.93 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 23.9 mt-10 -139.36 118.49 12.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.308 -0.627 . . . . 75.15 109.308 165.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.98 126.07 53.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 74.23 111.244 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.9 m -126.17 117.11 22.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 70.22 110.655 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -116.63 133.54 55.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.714 -0.476 . . . . 74.04 109.714 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 31.7 m -139.96 149.93 43.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.911 0.386 . . . . 73.24 110.805 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.7 129.41 2.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.105 -0.569 . . . . 64.1 111.847 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -112.89 133.84 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.758 -0.83 . . . . 70.14 108.758 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.72 129.91 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.04 0.448 . . . . 71.42 111.208 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.631 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 37.7 t-20 -91.11 143.73 26.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.55 -0.908 . . . . 62.24 108.55 177.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -65.12 -6.34 8.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.877 0.325 . . . . 75.1 111.877 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.15 168.12 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.428 -0.582 . . . . 74.51 109.428 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -52.65 -69.25 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.322 0.86 . . . . 65.3 113.322 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.8 m -122.3 92.18 3.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.314 0.578 . . . . 75.35 111.72 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 9.3 tmtm? -154.67 78.83 1.07 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.204 -1.035 . . . . 75.35 108.204 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.72 120.5 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.216 -0.902 . . . . 73.14 109.479 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -110.31 124.57 51.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.33 -0.395 . . . . 72.21 109.97 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.3 154.37 16.87 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.716 -0.754 . . . . 73.41 112.206 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 20.1 m -146.19 126.52 13.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.65 -0.5 . . . . 70.13 109.65 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -125.34 125.86 44.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.525 -0.546 . . . . 71.25 109.525 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 38.1 tt0 -129.53 126.19 38.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.035 0.445 . . . . 74.31 110.628 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.44 ' HB ' ' CG ' ' A' ' 73' ' ' GLU . 3.9 m -120.1 129.45 54.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.851 -0.613 . . . . 72.02 109.758 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.93 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 68.6 mttm -117.52 133.99 55.36 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.856 -0.424 . . . . 74.43 109.856 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 50.1 m-85 -101.89 119.78 39.33 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.406 -0.961 . . . . 73.22 108.406 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.539 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.6 ttm180 -121.08 110.77 16.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 119.943 -0.703 . . . . 74.54 112.741 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -91.9 136.14 33.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.724 -1.125 . . . . 64.21 109.443 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -75.46 -11.57 60.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 74.44 112.695 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.84 106.27 2.63 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.081 -0.34 . . . . 75.1 110.081 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 66.87 -68.07 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.019 0.824 . . . . 74.3 110.476 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 88' ' ' GLU . . . 154.66 72.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.672 -0.971 . . . . 63.12 110.672 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 63' ' ' ARG . 4.1 mm? -101.12 131.39 47.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.213 -0.292 . . . . 75.13 110.213 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 23.0 m -136.19 118.55 15.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.442 -0.344 . . . . 65.23 111.352 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.426 ' HB3' ' HD1' ' A' ' 62' ' ' TYR . 69.8 t80 -96.63 121.93 39.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.668 -0.864 . . . . 74.33 108.668 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 83' ' ' THR . 96.3 m -113.46 126.54 55.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.172 0.51 . . . . 75.34 112.158 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' CG ' ' HB ' ' A' ' 60' ' ' THR . 3.1 pt-20 -118.82 139.23 51.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.078 -0.964 . . . . 61.33 109.006 169.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.0 ttpp -142.01 142.41 32.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.917 -0.771 . . . . 74.22 108.917 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 129.73 35.82 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.088 -0.645 . . . . 75.11 111.69 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -116.18 135.96 53.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.65 -0.87 . . . . 71.33 108.65 165.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -35.77 74.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.133 0.492 . . . . 73.04 111.221 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.57 -34.83 10.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.775 -0.648 . . . . 65.42 111.723 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -104.71 -104.17 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.663 -0.415 . . . . 74.13 111.814 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -116.43 145.33 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.544 0.687 . . . . 75.43 112.777 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -106.19 131.59 53.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.224 -1.028 . . . . 73.22 108.224 168.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.86 148.28 17.97 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.652 -0.785 . . . . 74.35 112.77 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 72' ' ' THR . 88.0 m -156.45 143.98 19.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.099 -0.704 . . . . 74.24 109.099 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 4.7 mm-40 165.36 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.19 0.931 . . . . 71.22 110.632 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.518 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.54 138.29 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 74.24 112.231 -162.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 70' ' ' THR . 25.7 m -122.85 123.46 41.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.134 -0.484 . . . . 75.23 109.906 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.412 HG23 HD21 ' A' ' 69' ' ' LEU . 6.6 p -130.16 137.44 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 73.24 111.336 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HG2' ' HA3' ' A' ' 68' ' ' GLY . 12.8 pt-20 -125.79 151.31 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.12 -0.232 . . . . 70.51 111.458 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.502 ' OD2' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER 66.92 1.19 2.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.809 1.04 . . . . 73.51 113.809 171.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.88 -58.85 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.172 -0.211 . . . . 70.13 111.412 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.431 ' HB3' HD23 ' A' ' 95' ' ' LEU . 58.9 tp -74.62 -49.26 22.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.001 0.429 . . . . 75.4 110.519 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.879 -0.6 . . . . 71.0 110.033 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 7.3 mpt_? -63.82 127.71 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 74.43 110.411 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 2' ' ' ALA . . . 101.23 -7.47 56.67 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.668 -0.777 . . . . 72.53 112.436 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 91' ' ' LEU . 50.7 tp -94.56 129.78 41.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.18 0.514 . . . . 74.14 110.957 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -122.25 111.99 17.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.391 -0.822 . . . . 74.02 109.872 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -104.98 126.78 52.4 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.149 -0.686 . . . . 74.12 109.149 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.842 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 19.8 m -125.67 119.26 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.013 0.435 . . . . 63.53 110.851 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.624 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 56.1 m-85 -113.42 119.53 37.94 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.608 -0.886 . . . . 74.14 108.608 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 12.1 m-20 -125.32 122.79 37.86 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.729 0.643 . . . . 73.4 109.383 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -115.11 122.56 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.157 -0.617 . . . . 72.11 110.112 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.3 m -111.43 122.77 48.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 73.54 110.423 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' HD2' ' HG2' ' A' ' 110' ' ' LYS . 74.7 t80 -110.21 129.7 55.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.448 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 45.4 t -104.42 128.16 27.58 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.205 -0.665 . . . . 70.12 109.205 175.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 36.0 Cg_exo -60.58 -20.32 64.02 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.652 2.234 . . . . 71.2 111.786 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -78.7 116.69 19.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.538 -0.755 . . . . 71.4 110.611 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.4 p 56.01 12.39 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.266 1.026 . . . . 74.12 113.664 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.48 74.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.553 -0.832 . . . . 70.32 112.393 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 104' ' ' SER . 57.3 tttp -65.2 123.93 20.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.32 111.247 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HG2' ' HD2' ' A' ' 103' ' ' PHE . 97.1 mttt -112.13 136.32 51.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 75.32 110.71 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.4 121.61 38.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.694 -0.854 . . . . 73.2 108.694 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.27 133.53 55.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.278 . . . . 73.02 111.264 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 8.6 mtpm? -117.0 136.98 52.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.859 0.361 . . . . 74.4 110.72 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.646 HG21 ' HB3' ' A' ' 129' ' ' MET . 2.8 tp -134.18 116.01 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.706 -0.679 . . . . 73.43 109.602 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 35.7 ttmt -114.58 121.75 44.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.675 -0.693 . . . . 71.05 110.524 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.5 t -114.54 117.18 30.2 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.055 -0.72 . . . . 64.13 109.055 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.557 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.07 123.31 4.78 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.456 -0.878 . . . . 64.32 112.549 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.07 117.3 33.71 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.25 -0.648 . . . . 75.54 109.25 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 1.018 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -110.19 119.13 38.27 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.404 0.621 . . . . 73.52 109.878 177.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.626 ' HB2' HG21 ' A' ' 123' ' ' ILE . 17.7 mmm-85 -108.36 163.67 12.99 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.031 -0.986 . . . . 75.04 108.943 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -53.09 -34.19 55.53 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.551 0.532 . . . . 74.43 112.186 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.01 -0.77 10.52 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.4 0.519 . . . . 65.02 112.4 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 120' ' ' ARG . 3.6 tp -145.49 120.72 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.937 -0.705 . . . . 73.24 111.463 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 1.018 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 7.2 p30 -129.44 116.12 18.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 63.1 111.136 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.774 ' HB3' HD12 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -129.65 144.42 51.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.106 0.479 . . . . 64.53 111.112 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.557 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -142.42 131.15 4.55 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.538 -0.755 . . . . 61.24 112.243 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.7 m -110.1 114.75 28.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.825 0.345 . . . . 62.32 110.54 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 32.4 t70 -106.63 116.14 31.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.265 -0.642 . . . . 74.13 109.265 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.646 ' HB3' HG21 ' A' ' 114' ' ' ILE . 25.7 ttt -97.67 122.78 41.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 75.33 110.615 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.88 116.74 31.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.353 -0.61 . . . . 62.12 109.353 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -97.3 115.07 26.98 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.918 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.83 149.8 36.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.919 -0.771 . . . . 75.1 108.919 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -32.33 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.679 0.276 . . . . 74.41 110.625 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.08 -18.33 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 75.5 111.1 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.58 116.6 0.37 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.754 . . . . 74.31 112.517 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.16 144.83 34.08 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.026 2.484 . . . . 72.33 111.883 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 m -124.13 146.62 48.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.492 -0.322 . . . . 55.32 110.474 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 30.9 mm -107.53 116.13 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.766 -0.457 . . . . 75.33 109.766 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -110.16 110.33 21.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.974 0.416 . . . . 73.15 110.223 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.94 133.58 11.52 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.209 -0.996 . . . . 74.15 112.318 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.93 113.77 18.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.201 0.524 . . . . 64.2 109.905 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 125' ' ' LEU . 7.3 tp -115.67 123.74 49.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.611 -0.722 . . . . 74.31 110.351 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.432 HG23 ' HA ' ' A' ' 7' ' ' TYR . 59.5 t -123.0 124.02 69.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.178 -0.465 . . . . 75.04 110.104 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.53 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.17 138.2 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.029 -0.73 . . . . 75.32 109.029 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 150' ' ' LEU . . . -119.47 119.16 4.19 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.747 -0.74 . . . . 75.54 113.039 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.795 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 55.3 m-85 -112.75 150.44 31.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.2 -1.407 . . . . 74.44 107.2 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -49.08 94.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.154 0.434 . . . . 75.24 111.386 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.55 -30.87 9.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.912 -0.585 . . . . 74.21 112.786 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.795 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 59.1 m95 -101.88 144.7 30.19 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.42 -0.459 . . . . 73.44 111.038 -173.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.454 HD21 ' HA2' ' A' ' 145' ' ' GLY . 16.3 mt -136.33 142.62 43.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.76 0.314 . . . . 73.23 111.424 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.26 126.13 24.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 71.51 109.943 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -131.9 133.54 7.21 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.655 -0.783 . . . . 70.25 112.157 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.558 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 92.1 m-85 -127.71 119.33 25.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.771 0.32 . . . . 75.53 110.723 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.504 HE21 ' HE1' ' A' ' 7' ' ' TYR . 85.8 mt-30 -106.52 123.04 47.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.215 -0.661 . . . . 74.1 109.215 173.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -137.44 129.8 29.56 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.549 -0.296 . . . . 70.41 110.255 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -112.57 118.98 36.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.502 -0.555 . . . . 70.25 109.502 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.849 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 27.7 m-85 -91.87 129.49 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 75.41 110.52 -173.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.628 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 23.8 tt0 -97.49 110.5 23.04 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 109.277 -0.638 . . . . 72.34 109.277 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -70.28 -16.04 62.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 112.777 -2.01 . . . . 71.21 111.822 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.86 66.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.871 0.843 . . . . 71.41 109.088 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -122.83 -153.97 0.58 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.36 -1.348 . . . . 75.33 107.36 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 p -107.31 28.3 8.23 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.916 -0.49 . . . . 71.3 110.452 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.523 ' HB2' ' HG3' ' A' ' 161' ' ' LYS . 14.4 mmt180 -139.75 149.11 43.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.051 -1.06 . . . . 75.13 112.355 -161.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.21 136.58 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.569 -0.53 . . . . 72.5 109.569 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 6.6 t -93.43 -23.52 18.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.903 -0.59 . . . . 71.34 110.41 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -141.14 133.19 27.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.25 110.599 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 2.7 m -121.89 115.91 23.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.574 -0.739 . . . . 74.2 109.759 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 51.7 t30 -118.77 120.46 37.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.881 -0.785 . . . . 73.43 108.881 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.688 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 24.8 m-85 -120.87 140.86 51.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.403 -0.519 . . . . 75.44 110.298 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.522 ' HB3' ' CE1' ' A' ' 181' ' ' HIS . . . -143.09 127.19 17.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.185 -0.461 . . . . 55.53 110.49 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.622 ' HB ' ' CG2' ' A' ' 182' ' ' THR . 49.0 t -126.39 136.97 59.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.866 -0.42 . . . . 74.25 109.866 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.55 124.81 7.0 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.22 -0.514 . . . . 52.31 112.111 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.57 125.6 54.44 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.327 -0.62 . . . . 74.31 109.327 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -102.94 125.63 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.379 0.609 . . . . 74.51 111.255 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.545 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 19.7 p -131.19 164.92 24.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.076 -0.965 . . . . 74.32 108.41 171.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.41 -46.93 76.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.248 0.462 . . . . 63.14 112.248 -170.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.408 ' HG3' HE22 ' A' ' 196' ' ' GLN . 3.7 tp10 -102.45 -22.79 14.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.691 -0.404 . . . . 74.05 111.778 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.545 ' HB2' ' OG1' ' A' ' 175' ' ' THR . 47.5 m-85 -113.51 135.82 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.101 0.477 . . . . 75.42 111.604 -172.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -111.07 122.68 48.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.732 -1.21 . . . . 75.11 107.732 165.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.69 136.94 53.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.32 0.581 . . . . 62.42 111.174 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' A' ' 170' ' ' ALA . 13.3 t60 -126.68 113.72 17.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.227 -0.897 . . . . 75.35 109.061 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.699 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 7.3 t -93.66 141.45 28.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.329 -0.989 . . . . 73.41 108.329 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -133.6 140.1 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 72.41 109.991 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 41.5 t -126.87 120.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.065 -0.516 . . . . 72.11 111.013 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.748 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.2 t30 -99.32 90.0 4.4 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.6 0.714 . . . . 74.24 109.092 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 3.1 t70 55.73 -161.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.002 -1.454 . . . . 73.44 110.944 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.598 -0.81 . . . . 64.23 112.157 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.7 m -93.52 -25.56 17.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.627 0.603 . . . . 73.3 112.627 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 32.8 tt0 -134.49 124.42 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.601 -0.84 . . . . 74.33 112.364 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -121.18 126.2 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.188 -0.914 . . . . 74.31 108.545 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.24 -172.56 19.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.773 -1.204 . . . . 71.31 113.395 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.23 172.94 31.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.716 -0.554 . . . . 74.44 111.716 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 33.1 m -148.27 142.29 25.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.238 -0.282 . . . . 71.22 110.238 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 10.6 mm -119.52 118.82 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 74.15 109.4 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -108.24 120.98 43.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.417 -0.586 . . . . 74.33 109.417 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.749 ' HB3' ' HB2' ' A' ' 199' ' ' ASN . 0.0 OUTLIER -121.78 111.69 17.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.787 -0.642 . . . . 71.31 111.41 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -89.85 130.8 36.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 169.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 197' ' ' LYS . 10.3 m 58.95 36.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.923 0.868 . . . . 75.34 110.95 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.749 ' HB2' ' HB3' ' A' ' 196' ' ' GLN . 14.5 t30 -52.54 -50.35 63.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.68 -1.145 . . . . 72.34 108.827 170.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -144.31 71.19 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.73 -1.123 . . . . 75.43 107.981 169.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 70.25 -41.74 0.5 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.005 -0.998 . . . . 70.43 112.427 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.748 HD11 ' H ' ' A' ' 226' ' ' GLN . 2.5 mm? -92.74 -161.05 0.8 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.925 0.393 . . . . 75.45 111.089 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 224' ' ' LYS . 45.3 mt-10 -111.82 153.33 26.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.527 -0.306 . . . . 74.34 110.565 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -147.68 143.84 27.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.495 -0.321 . . . . 74.41 110.279 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -134.61 136.76 43.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.83 0.347 . . . . 70.2 110.407 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 45.1 t -123.25 145.42 30.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.074 -0.512 . . . . 74.54 110.088 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -131.98 136.28 47.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.876 0.37 . . . . 72.51 110.481 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.32 140.98 51.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 74.23 109.629 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 218' ' ' ARG . . . -140.5 128.91 22.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.966 0.412 . . . . 63.24 111.399 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.401 ' HE3' ' HG1' ' A' ' 217' ' ' THR . 29.3 t-105 -115.39 132.88 56.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.737 -0.838 . . . . 75.32 108.737 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 12.3 t -116.5 132.54 56.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.801 -0.444 . . . . 71.25 109.801 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.04 150.37 25.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.765 . . . . 74.04 111.457 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.01 15.07 13.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.464 -0.874 . . . . 64.14 112.392 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.26 87.34 0.11 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.268 0.556 . . . . 70.32 111.328 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.0 t -146.49 171.95 14.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 71.21 109.862 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.76 159.63 23.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.736 -0.468 . . . . 73.32 109.736 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.401 ' HG1' ' HE3' ' A' ' 210' ' ' TRP . 11.4 m -77.29 135.79 38.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.745 0.307 . . . . 61.23 110.329 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 209' ' ' ALA . 55.2 mtm180 -88.96 136.39 33.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.923 -0.399 . . . . 73.34 109.923 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 239' ' ' ASN . 79.7 m-85 -114.52 138.96 49.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.905 -0.589 . . . . 74.43 110.658 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.49 139.67 10.21 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.612 -0.995 . . . . 74.45 110.612 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.492 ' HB ' HG12 ' A' ' 237' ' ' VAL . 5.0 mp -136.14 130.48 48.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.2 0.5 . . . . 73.32 110.504 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.1 129.41 50.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.796 -0.446 . . . . 64.33 109.796 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.25 139.71 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.601 0.239 . . . . 72.34 110.59 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 203' ' ' GLU . 43.9 mtmt -117.28 114.75 24.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.437 ' HA ' ' HG ' ' A' ' 202' ' ' LEU . 47.4 m-85 -100.76 115.34 30.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.211 -0.662 . . . . 63.15 109.211 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.748 ' H ' HD11 ' A' ' 202' ' ' LEU . 35.7 tt0 -86.7 99.62 11.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.161 -0.472 . . . . 74.44 110.029 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.82 -37.31 12.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.499 0.666 . . . . 75.33 109.685 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.74 145.52 19.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.106 -0.952 . . . . 74.42 109.18 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.51 -30.73 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.955 2.437 . . . . 75.12 113.454 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.46 -18.62 21.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.085 0.402 . . . . 73.1 112.085 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.71 122.75 20.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.237 0.541 . . . . 50.33 111.797 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 52.0 t -124.49 136.44 54.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.21 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -99.99 128.82 46.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.743 -0.466 . . . . 74.32 109.743 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.9 m -113.95 152.79 30.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.844 0.354 . . . . 64.24 110.503 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -140.66 141.21 35.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.357 -0.609 . . . . 73.42 109.357 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 54.9 mtmt -134.46 154.51 51.37 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.309 -0.256 . . . . 75.42 110.309 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.1 p -149.98 147.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.966 0.413 . . . . 73.13 110.663 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.7 t-20 -117.63 149.55 40.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.655 -0.868 . . . . 74.23 108.655 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . 0.1 OUTLIER -56.63 -17.61 9.28 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.88 0.696 . . . . 74.22 112.88 -172.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 49.2 m -83.22 23.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.455 0.169 . . . . 71.04 111.021 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 50.1 m 64.9 39.66 5.8 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.299 0.571 . . . . 73.12 110.449 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.942 ' HB3' HD13 ' A' ' 262' ' ' LEU . 46.1 mt -98.15 115.61 28.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.748 -0.66 . . . . 75.45 109.5 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.9 OUTLIER -105.34 117.62 51.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 109.841 -0.429 . . . . 73.23 109.841 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -120.4 162.12 14.45 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.825 -0.702 . . . . 73.41 112.723 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 2.6 pp -142.01 160.39 40.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.032 -0.358 . . . . 72.25 110.032 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -150.54 150.86 22.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.751 -0.738 . . . . 71.44 112.905 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 258' ' ' THR . 81.7 m-85 -123.16 115.96 22.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.561 -0.533 . . . . 63.22 109.561 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 20.0 m -113.0 114.0 26.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.739 -0.467 . . . . 74.0 109.739 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -135.45 127.62 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 65.52 110.548 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 32.1 m -88.53 128.55 35.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.551 0.215 . . . . 74.04 110.468 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.459 HD21 ' HG3' ' A' ' 252' ' ' LYS . 3.3 tt -122.24 88.92 3.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.215 -0.661 . . . . 74.35 109.215 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.459 ' HG3' HD21 ' A' ' 251' ' ' LEU . 94.1 mttt 68.99 166.06 0.13 Allowed Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 115.545 -0.752 . . . . 74.21 111.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.09 71.77 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.64 2.227 . . . . 65.44 112.351 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.32 -59.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.062 -0.589 . . . . 74.2 111.885 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 279' ' ' LEU . 0.0 OUTLIER -119.24 122.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 71.44 111.992 -171.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 1.021 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 66.4 mttm -92.28 135.45 34.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.209 -1.034 . . . . 60.4 108.209 163.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.82 123.41 41.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.25 -0.648 . . . . 75.54 109.25 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 48.6 m -122.47 111.12 16.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.454 0.645 . . . . 73.35 110.462 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.723 HD23 HD22 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -100.21 125.62 46.4 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.664 -1.235 . . . . 74.44 107.664 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 60.1 m -131.44 140.02 49.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 75.11 110.927 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.77 139.83 26.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.817 -0.438 . . . . 73.33 109.817 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.942 HD13 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -118.4 121.99 41.7 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.816 -0.809 . . . . 71.21 108.816 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.643 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -103.08 106.72 17.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.605 -0.887 . . . . 74.53 108.605 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.949 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 5.3 t70 -72.92 98.0 2.39 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.318 -0.993 . . . . 63.14 108.318 172.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.45 -8.46 2.66 Favored Glycine 0 C--N 1.307 -1.076 0 CA-C-N 115.078 -0.965 . . . . 54.14 114.044 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 264' ' ' ASP . 34.6 ttmt -93.42 -15.83 25.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.444 0.164 . . . . 73.24 110.981 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -152.84 -28.63 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.657 0.741 . . . . 74.45 110.906 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.949 ' HB ' ' O ' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -54.12 -22.25 7.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.595 -1.184 . . . . 64.42 113.021 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -55.9 -20.57 16.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.666 -0.697 . . . . 73.02 111.459 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.56 -16.58 59.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 73.24 111.43 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.35 -0.53 14.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 65.14 113.168 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -93.09 63.93 2.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 72.33 112.3 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 263' ' ' LEU . 4.0 p-80 -79.27 147.92 32.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.68 -0.118 . . . . 74.45 110.68 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -95.3 138.02 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.533 -0.467 . . . . 71.43 109.759 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -132.84 140.57 48.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 75.31 110.631 -170.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.534 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -142.07 131.53 4.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.549 -0.62 . . . . 73.14 111.549 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.723 HD22 HD23 ' A' ' 259' ' ' LEU . 3.4 tm? -115.75 137.57 51.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.967 -0.753 . . . . 72.4 108.967 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.415 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -150.96 140.51 7.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.075 -1.059 . . . . 74.31 113.144 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 255' ' ' ILE . 2.4 mm? -110.85 129.98 55.71 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.625 -0.88 . . . . 75.34 108.625 172.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 1.021 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 21.7 mm-40 -101.84 112.04 24.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.312 1.053 . . . . 73.43 112.997 -168.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 1.082 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 34.4 p90 -29.21 44.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 119.971 3.323 . . . . 71.51 119.971 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.85 ' HG2' ' HG3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -113.9 104.91 12.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 122.424 2.375 . . . . 75.02 112.332 -175.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.62 106.26 8.61 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.554 -0.906 . . . . 75.02 108.554 163.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -155.12 -166.06 2.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.383 -0.826 . . . . 63.22 109.122 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.778 -0.63 . . . . 74.33 109.739 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.994 0.426 . . . . 74.01 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 119' ' ' LYS . 7.9 t -80.31 119.67 77.13 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.67 -0.695 . . . . 74.22 109.678 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.68 162.34 42.43 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.902 2.401 . . . . 73.33 112.824 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.63 79.85 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.764 2.31 . . . . 74.33 111.003 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.553 ' HB ' ' CG1' ' A' ' 143' ' ' VAL . 26.7 p -69.84 -46.95 64.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.434 -0.803 . . . . 73.31 111.995 -172.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -58.37 -28.4 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.058 -0.519 . . . . 73.34 111.41 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.26 -22.99 35.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.094 0.473 . . . . 74.41 110.839 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.27 -15.66 45.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.843 -0.617 . . . . 71.23 109.737 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.573 HD23 HG13 ' A' ' 143' ' ' VAL . 75.1 mt -63.72 -29.23 70.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.65 -0.705 . . . . 65.3 110.263 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.49 62.96 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.73 -0.668 . . . . 50.1 112.263 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 64.0 tttp -63.87 -49.4 72.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 72.13 110.183 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 m -64.55 -38.32 90.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.296 0.569 . . . . 72.41 110.529 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.439 -0.801 . . . . 75.44 112.254 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.632 ' HG3' ' N ' ' A' ' 16' ' ' ASP . 1.7 ptt180 -59.7 -36.99 77.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.563 0.22 . . . . 71.2 111.171 -175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.632 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 69.7 m-20 -68.47 -37.0 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 72.11 110.677 -175.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -72.43 -40.42 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 70.15 110.809 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -70.71 -33.75 71.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.812 -0.631 . . . . 74.41 110.983 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 m -70.04 133.72 47.51 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.71 -0.478 . . . . 74.11 109.71 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -69.53 79.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.72 0.772 . . . . 72.21 111.632 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.98 70.42 2.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.28 -0.728 . . . . 55.35 111.28 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' A' ' 274' ' ' LYS . 17.7 p90 -85.04 -53.62 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.568 0.223 . . . . 74.33 110.884 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.56 129.39 4.17 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.661 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -104.33 5.64 34.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.297 0.57 . . . . 73.15 110.463 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 89.39 12.6 62.8 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.543 -1.023 . . . . 74.2 110.543 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 46' ' ' SER . 0.5 OUTLIER -102.78 153.5 20.1 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.943 -0.628 . . . . 73.22 111.423 -169.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.754 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.8 mp -106.9 124.46 62.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.002 -0.999 . . . . 73.54 110.545 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.8 tptm -102.06 119.47 38.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.484 -0.562 . . . . 72.41 109.484 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -113.84 128.63 56.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.005 0.431 . . . . 75.01 110.132 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -120.76 136.35 54.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.735 . . . . 73.21 109.066 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.882 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -133.39 123.84 26.07 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.197 -0.668 . . . . 74.12 109.197 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 14.3 pttm -137.08 125.58 23.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.203 0.525 . . . . 75.54 111.498 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 18.9 m -109.71 121.27 44.84 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.512 -0.922 . . . . 74.34 108.512 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -109.82 124.45 51.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.933 -0.307 . . . . 74.25 111.165 -170.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.796 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 12.2 t -140.41 169.66 17.26 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.277 -1.008 . . . . 71.22 108.277 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.21 179.83 4.25 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.091 -0.707 . . . . 72.42 109.091 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.59 43.63 7.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.14 0.495 . . . . 75.41 111.27 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 94.49 -4.84 70.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 116.984 1.554 . . . . 74.34 116.984 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.796 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -100.2 124.13 45.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 120.971 2.385 . . . . 73.21 112.141 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.866 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.9 tt0 -143.08 118.02 9.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.987 -0.746 . . . . 73.04 108.987 162.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.752 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 97.4 m-85 -108.34 121.78 45.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.546 -0.462 . . . . 73.55 110.473 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 33.0 m -125.19 132.65 52.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.104 0.478 . . . . 75.53 111.062 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 44.3 t -125.32 143.11 51.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.729 -0.841 . . . . 75.31 108.729 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m -135.67 126.55 27.56 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.04 -0.356 . . . . 71.11 110.04 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 56' ' ' GLY . . . -141.78 157.13 26.21 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.171 -1.014 . . . . 73.11 112.47 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.519 ' HB3' HD21 ' A' ' 26' ' ' LEU . 39.8 m -131.82 139.27 48.81 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.978 -0.749 . . . . 73.42 108.978 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -119.46 129.08 54.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.224 0.535 . . . . 72.14 110.574 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.83 145.93 24.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.043 -0.98 . . . . 72.32 108.852 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.06 76.19 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.371 0.605 . . . . 74.53 111.457 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -167.22 154.14 8.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.915 -1.143 . . . . 74.14 107.915 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.7 m -56.22 -45.94 79.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.097 0.777 . . . . 74.23 113.097 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.3 p -129.29 47.31 2.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 72.13 112.496 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 32.0 mmtp -123.33 73.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.384 0.612 . . . . 73.35 110.991 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.57 120.57 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.47 -0.787 . . . . 74.01 109.633 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -109.2 126.53 53.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.709 -0.478 . . . . 71.35 109.709 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 45' ' ' GLY . . . -132.74 170.72 21.94 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.343 -0.932 . . . . 74.2 113.07 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.5 m -147.56 157.66 43.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.421 -0.585 . . . . 74.54 109.421 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -120.22 125.02 47.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 75.0 109.371 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.8 tt0 -118.82 119.25 33.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.582 -0.736 . . . . 72.53 109.504 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 m -110.23 120.02 41.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.431 -0.349 . . . . 74.23 110.527 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.866 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mptt -106.61 131.45 53.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.224 0.535 . . . . 70.54 110.359 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.5 m-85 -103.21 118.48 36.87 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.305 -1.369 . . . . 74.23 107.305 170.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 33.3 ttm-85 -113.46 109.69 19.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.424 0.631 . . . . 75.42 111.876 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.21 91.2 8.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.161 -0.927 . . . . 71.54 109.254 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -16.42 61.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.299 -0.864 . . . . 71.21 110.679 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.89 -41.31 87.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.193 -0.912 . . . . 74.41 111.031 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.468 ' HB2' ' HG ' ' A' ' 69' ' ' LEU . 67.6 m-85 -108.14 -33.94 7.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.33 111.186 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.615 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 101.95 44.44 1.91 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.947 -0.861 . . . . 53.41 110.947 -173.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 87' ' ' VAL . 13.4 mt -126.91 147.21 50.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.804 -0.443 . . . . 75.44 109.804 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -136.57 135.3 38.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.691 0.281 . . . . 75.53 111.13 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 70.1 t80 -115.17 120.73 40.72 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.429 -0.582 . . . . 74.25 109.429 173.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.765 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 17.7 m -109.57 117.74 34.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.236 -0.438 . . . . 71.2 110.305 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -109.15 120.34 42.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.355 -0.609 . . . . 72.31 109.355 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -107.81 97.6 7.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.095 -0.502 . . . . 71.0 109.7 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.594 ' HD1' HD13 ' A' ' 81' ' ' LEU . 46.4 t90 -100.35 131.84 46.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.345 0.593 . . . . 74.22 111.279 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.38 154.11 35.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.521 -0.763 . . . . 43.23 109.861 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 m -57.6 -18.4 19.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.016 0.436 . . . . 74.14 111.9 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 20.2 t70 -67.57 -3.86 10.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.095 -0.502 . . . . 73.44 110.906 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 8.1 m120 79.66 22.84 0.51 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.876 0.87 . . . . 75.3 110.02 -175.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 25.7 m -88.83 118.14 28.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.54 -0.754 . . . . 73.04 111.015 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.594 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.8 mm? -97.19 118.37 33.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 63.41 109.213 172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.68 92.83 0.85 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.512 -0.851 . . . . 71.04 111.21 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 p -91.39 103.5 16.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.986 0.422 . . . . 74.13 111.414 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 25.4 tt0 -106.73 111.63 24.25 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.456 -0.793 . . . . 70.25 109.565 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.9 121.52 64.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.437 -0.579 . . . . 74.34 109.437 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.656 ' HB ' HG22 ' A' ' 98' ' ' THR . 14.3 t -128.2 129.66 46.81 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.54 0.686 . . . . 73.22 111.537 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.653 ' HA ' HD21 ' A' ' 69' ' ' LEU . 32.5 m -111.01 129.89 65.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.417 -0.81 . . . . 74.24 109.631 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.28 118.71 36.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 71.11 112.131 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 47.27 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.319 1.012 . . . . 73.24 112.804 171.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -116.97 -92.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.317 -0.401 . . . . 74.34 110.09 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.2 -44.72 7.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.982 -0.747 . . . . 74.14 108.982 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.65 103.71 5.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 74.44 109.376 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.83 124.26 21.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.693 -0.685 . . . . 74.3 110.756 -173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.77 5.73 87.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.869 -0.681 . . . . 70.21 113.085 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 128.16 38.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.238 0.519 . . . . 71.35 111.638 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -118.28 111.39 18.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.61 -0.885 . . . . 73.34 108.61 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.618 ' HB2' HG21 ' A' ' 87' ' ' VAL . 2.2 mm? -102.52 124.78 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.514 -0.551 . . . . 73.3 109.514 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 7.8 m -131.21 119.69 22.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.54 -0.3 . . . . 71.04 111.015 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -111.2 115.32 29.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.473 -0.566 . . . . 72.13 109.473 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -112.02 122.63 48.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.189 -0.459 . . . . 62.4 109.775 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.4 t -138.16 123.83 19.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.43 -0.508 . . . . 74.24 111.004 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 13.0 m -104.17 122.69 45.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.064 -0.516 . . . . 71.13 110.264 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.81 124.87 48.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.556 -0.293 . . . . 74.04 110.786 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.9 t -127.6 102.42 22.97 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.437 -0.579 . . . . 74.11 109.437 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.23 -9.13 22.93 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.074 2.516 . . . . 74.15 112.755 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -78.52 -40.12 36.1 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.034 -0.358 . . . . 75.34 110.034 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 p -100.22 -25.61 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 73.0 111.171 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.936 -0.575 . . . . 74.23 111.897 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -79.12 123.93 27.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 74.23 111.275 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -132.66 124.63 28.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.934 -0.575 . . . . 74.11 109.495 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 101' ' ' SER . 7.4 m120 -120.45 128.37 53.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.825 -0.625 . . . . 65.12 110.353 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -114.07 114.79 26.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.259 -0.428 . . . . 75.43 110.366 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.433 ' HG3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -111.13 136.95 49.43 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.158 -0.682 . . . . 74.13 109.158 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -119.47 117.62 54.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 72.03 109.833 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.692 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.2 tttp -115.26 119.13 35.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.495 -0.775 . . . . 74.13 109.285 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -127.2 118.59 24.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.679 -0.489 . . . . 65.22 109.679 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.471 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -127.13 122.84 4.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.333 -0.937 . . . . 74.55 112.577 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -110.0 121.03 44.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.375 0.607 . . . . 74.24 109.501 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.704 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.6 124.23 51.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.649 -0.705 . . . . 72.41 110.673 179.231 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.456 ' HG3' ' H ' ' A' ' 121' ' ' GLU . 10.0 tpp180 -104.96 167.68 9.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.559 -1.274 . . . . 75.41 107.559 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' H ' ' HG3' ' A' ' 120' ' ' ARG . 37.7 tt0 -53.16 -33.33 52.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.475 0.546 . . . . 74.1 112.475 -167.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -120.25 0.32 10.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.801 0.667 . . . . 71.41 112.801 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 142' ' ' LEU . 7.7 tt -145.25 136.01 19.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 O-C-N 121.74 -0.6 . . . . 74.14 111.985 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.711 ' O ' HD21 ' A' ' 142' ' ' LEU . 5.4 t30 -129.19 109.84 11.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.088 -0.645 . . . . 74.43 111.308 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 1.115 ' HG ' ' HG ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -112.89 142.48 45.51 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.449 0.642 . . . . 75.31 111.719 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.471 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -143.33 127.06 2.97 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.78 -1.1 . . . . 51.42 112.737 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.22 111.85 24.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.952 -0.388 . . . . 73.32 109.952 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -113.52 118.23 33.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.495 -0.557 . . . . 73.32 109.495 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.633 ' HG2' HG13 ' A' ' 138' ' ' ILE . 59.3 mtt -120.94 119.37 32.39 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.747 -0.381 . . . . 72.04 111.391 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.433 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 15.3 m-20 -90.65 118.39 30.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 109.811 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 74.3 t80 -96.87 104.55 16.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.966 0.412 . . . . 74.55 110.014 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.26 157.27 30.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.865 -0.607 . . . . 70.31 109.717 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 134' ' ' ALA . 2.2 pp -73.85 -15.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.209 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.43 ' N ' HD11 ' A' ' 133' ' ' ILE . . . -88.88 -17.59 29.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.013 0.435 . . . . 74.14 110.714 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.44 117.54 0.67 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.926 -0.654 . . . . 73.12 112.08 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 56.1 Cg_endo -72.01 134.36 23.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.463 2.109 . . . . 72.0 111.781 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -119.37 144.14 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.458 -0.337 . . . . 75.41 110.397 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.633 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -107.29 117.12 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.459 -0.571 . . . . 75.44 109.459 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -114.63 113.85 24.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.745 -0.661 . . . . 75.2 109.532 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.71 129.57 9.35 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.375 -1.393 . . . . 71.14 111.365 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . . . -124.7 118.72 27.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.651 0.263 . . . . 72.42 110.704 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 1.115 ' HG ' ' HG ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -117.08 144.76 44.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.332 -0.394 . . . . 73.33 110.624 175.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.703 ' H ' HD21 ' A' ' 142' ' ' LEU . 45.4 t -128.5 115.43 37.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.52 -1.289 . . . . 74.32 107.52 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.807 HD21 HD12 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -120.93 137.27 54.69 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.547 -1.206 . . . . 74.14 110.117 -169.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.54 135.7 13.06 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 120.604 -0.808 . . . . 50.12 113.2 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -143.8 125.36 14.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.011 0.434 . . . . 74.24 111.4 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 59.22 23.35 11.68 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.987 0.736 . . . . 73.01 112.987 168.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.69 -18.18 51.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.378 -0.915 . . . . 74.42 113.062 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -105.17 146.65 28.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.891 -0.411 . . . . 72.31 109.891 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.529 HD22 HG11 ' A' ' 143' ' ' VAL . 5.0 mt -108.9 148.39 30.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 72.41 110.637 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 144' ' ' LEU . . . -141.85 124.26 15.72 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.73 -1.211 . . . . 72.33 107.73 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.56 ' CA ' ' HA ' ' A' ' 143' ' ' VAL . . . -156.05 131.82 3.15 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.58 -0.819 . . . . 74.23 111.965 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.984 ' CB ' ' HA ' ' A' ' 169' ' ' PHE 0.423 0.1 OUTLIER -165.06 171.76 13.48 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 116.209 1.929 . . . . 74.11 116.209 167.326 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.605 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 26.4 pt20 -106.85 134.37 50.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.416 -1.72 . . . . 72.52 111.498 -166.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.8 ttp -110.84 141.53 44.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 74.2 109.576 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.516 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 43.4 m-80 -114.51 117.92 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.024 -0.27 . . . . 72.11 110.351 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.793 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 74.1 t80 -102.08 122.27 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.684 -0.689 . . . . 74.12 110.759 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 163' ' ' ARG . 32.4 tt0 -88.78 99.93 12.75 Favored 'General case' 0 C--O 1.259 1.574 0 CA-C-N 115.567 -0.742 . . . . 71.2 109.044 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.447 HG22 ' HE1' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -70.29 -19.98 63.06 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 113.446 -1.706 . . . . 73.4 111.664 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.18 -26.65 64.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.047 0.927 . . . . 71.22 108.732 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -122.39 -157.5 0.74 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.136 -1.393 . . . . 75.13 107.839 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -107.64 27.76 8.84 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.32 -0.622 . . . . 71.12 109.32 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -133.64 129.36 36.77 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.64 -0.824 . . . . 72.02 112.857 -159.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.793 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.8 m -73.54 136.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 168.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 2.0 m -90.01 -34.53 15.94 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.518 -0.473 . . . . 72.32 110.371 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -149.89 133.29 16.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 73.33 110.017 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.7 m -103.14 111.76 24.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.557 -0.905 . . . . 73.32 108.557 172.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.919 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 46.5 m-20 -106.4 121.67 44.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.863 -0.791 . . . . 73.22 108.863 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.984 ' HA ' ' CB ' ' A' ' 153' ' ' TYR . 51.4 p90 -131.17 138.94 49.65 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.057 0.848 . . . . 74.12 111.31 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.834 ' H ' ' HB2' ' A' ' 153' ' ' TYR . . . -130.25 145.84 51.8 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 120.883 0.373 . . . . 71.41 110.547 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 151' ' ' ALA . 48.8 t -127.56 131.28 70.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.276 -0.42 . . . . 75.14 110.635 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.3 95.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.655 -0.978 . . . . 72.3 110.655 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -110.92 119.62 39.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.853 -0.795 . . . . 72.25 108.853 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.433 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 34.0 mtmm -114.84 127.92 56.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.331 -0.395 . . . . 75.43 111.46 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.409 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 56.7 m -132.09 113.44 13.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.137 -0.483 . . . . 75.01 110.347 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 40.4 -93.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.266 1.21 . . . . 75.51 114.266 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.1 -11.85 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.672 0.619 . . . . 74.45 112.672 -170.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.409 ' CZ ' ' HB ' ' A' ' 175' ' ' THR . 48.4 p90 -129.97 135.94 48.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.622 0.725 . . . . 74.5 111.615 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.433 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 75.8 mt-30 -114.46 123.18 48.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.231 -0.895 . . . . 72.31 108.924 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.24 137.55 33.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.281 0.562 . . . . 74.33 111.081 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -123.8 115.67 21.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.052 -0.976 . . . . 74.13 108.689 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 43.8 m -124.54 115.46 20.9 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.658 -0.417 . . . . 74.25 110.086 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.43 140.62 50.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.371 0.605 . . . . 71.44 109.852 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 6.4 t -126.31 130.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.521 -0.763 . . . . 73.21 110.757 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.841 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 11.9 m-20 -105.51 93.69 4.8 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.383 -0.969 . . . . 75.21 108.383 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 34.0 t70 61.47 -179.53 0.12 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.633 -0.506 . . . . 74.41 109.633 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -71.48 -6.35 61.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.795 -0.717 . . . . 63.41 112.174 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.8 p -96.4 -26.17 15.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.055 0.761 . . . . 74.2 113.055 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 24.8 mt-10 -118.45 124.99 48.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 119.697 -0.801 . . . . 74.44 112.23 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.8 125.52 53.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.398 -0.819 . . . . 75.52 109.745 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.18 113.52 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.899 -0.667 . . . . 73.32 112.089 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.99 139.28 15.02 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.934 -0.65 . . . . 64.55 111.883 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 14.5 m -140.52 138.39 34.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.914 0.388 . . . . 64.43 110.03 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.407 HD11 ' C ' ' A' ' 193' ' ' SER . 3.3 mp -124.56 128.33 73.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.666 -0.494 . . . . 74.21 109.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.543 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 42.9 t80 -106.67 119.75 40.14 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.622 -0.881 . . . . 75.3 108.622 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -122.51 131.1 53.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.414 -0.587 . . . . 74.54 109.414 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 197' ' ' LYS . 24.9 ttpp -103.29 109.05 20.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.786 -0.643 . . . . 73.34 109.678 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.547 HG22 ' HG ' ' A' ' 202' ' ' LEU . 0.0 OUTLIER -93.2 -17.36 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-O 121.555 0.693 . . . . 75.22 109.82 -176.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 14.2 t-20 -163.86 158.17 19.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.917 -1.038 . . . . 72.13 108.324 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.601 ' HB3' ' HZ2' ' A' ' 200' ' ' LYS . 10.2 mtpm? -63.67 -13.24 41.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.014 0.435 . . . . 75.04 111.071 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 226' ' ' GLN . 19.0 tttp -116.05 3.98 13.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.001 -0.545 . . . . 75.11 110.642 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.547 ' HG ' HG22 ' A' ' 198' ' ' VAL . 47.8 tp -140.29 108.98 5.92 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.766 0.793 . . . . 74.1 111.307 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.543 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 24.7 mt-10 -115.32 137.84 51.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.953 -1.021 . . . . 63.31 110.192 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 p -123.68 151.17 43.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.122 -0.325 . . . . 74.43 110.122 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -140.11 139.03 35.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.015 0.436 . . . . 73.14 111.306 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 193' ' ' SER . 53.3 t -112.11 137.43 44.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.313 -0.625 . . . . 73.33 109.313 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -132.84 128.34 36.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.263 -0.643 . . . . 65.23 109.263 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.6 pt? -147.89 130.61 16.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.412 0.625 . . . . 74.44 111.082 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.2 132.87 55.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.33 -0.85 . . . . 75.2 110.363 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.773 ' HB2' HG21 ' A' ' 217' ' ' THR . 19.3 t90 -130.7 131.7 44.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.569 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 11.9 m -104.7 113.49 27.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.763 -0.653 . . . . 71.13 109.649 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.81 127.54 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.903 -0.406 . . . . 71.44 109.903 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.93 17.65 57.54 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 43.24 111.537 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' A' ' 215' ' ' SER . 12.0 t-20 -129.93 -153.86 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.772 -0.825 . . . . 64.43 108.772 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.48 ' H ' ' CG ' ' A' ' 214' ' ' ASN . 17.2 m -85.95 -154.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.066 0.46 . . . . 71.44 111.747 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.72 163.47 7.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.497 -0.774 . . . . 72.1 112.553 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.773 HG21 ' HB2' ' A' ' 210' ' ' TRP . 32.7 m -76.39 134.55 39.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.605 -0.725 . . . . 74.13 109.18 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 69.3 mtt85 -101.05 116.12 32.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.723 -0.473 . . . . 71.44 109.723 -173.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.42 ' HD2' HD12 ' A' ' 208' ' ' LEU . 65.8 t80 -113.5 149.67 34.01 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.608 0.568 . . . . 74.2 110.493 -172.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -158.93 150.6 21.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.211 -0.519 . . . . 62.13 112.2 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.4 130.53 72.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.902 -0.407 . . . . 72.45 109.902 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -119.5 154.52 33.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.811 0.339 . . . . 74.01 110.303 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.67 125.71 18.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.174 -0.467 . . . . 73.23 110.23 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.432 ' HZ2' ' CD ' ' A' ' 203' ' ' GLU . 10.3 ttmt -112.38 114.06 26.58 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.62 -0.511 . . . . 73.55 109.62 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.436 ' HD2' HD12 ' A' ' 202' ' ' LEU . 74.8 t80 -113.73 116.29 29.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.448 -0.575 . . . . 75.14 109.448 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.508 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 3.6 pt20 -95.94 99.58 11.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.716 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.4 tt -69.44 -24.92 28.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.527 0.68 . . . . 74.05 109.521 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 230' ' ' ASP . 18.9 t70 -166.6 146.31 4.93 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.199 -1.037 . . . . 75.01 108.199 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.1 12.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.793 2.329 . . . . 73.4 113.399 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 228' ' ' ASP . 23.3 t70 -104.92 -29.34 10.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.44 110.067 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.33 125.86 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 73.13 110.831 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 56.1 m -124.04 142.23 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.129 0.49 . . . . 73.43 110.755 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -108.86 127.33 53.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.213 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 5.5 p -129.39 117.21 20.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 64.15 110.965 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.43 158.67 23.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.111 -0.329 . . . . 75.12 110.111 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 26.2 pttm -152.94 141.86 21.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.019 0.438 . . . . 74.13 110.849 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 242' ' ' LEU . 8.8 p -128.66 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 72.33 109.814 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.8 m120 -107.91 150.56 26.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.752 -0.462 . . . . 73.02 109.752 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 241' ' ' SER . 24.7 t-20 -64.73 -8.79 16.13 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.672 0.607 . . . . 75.34 111.534 -176.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.45 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 13.3 m -80.82 14.67 2.07 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.824 -0.436 . . . . 75.54 109.824 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.4 m 68.31 36.83 2.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.256 -0.883 . . . . 72.35 110.702 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.827 ' HB3' HD11 ' A' ' 262' ' ' LEU . 40.5 mt -99.29 115.61 29.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 75.22 109.697 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.2 OUTLIER -112.29 116.7 53.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.65 -0.42 . . . . 71.32 110.503 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -135.61 152.21 20.87 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.123 -1.036 . . . . 74.21 113.526 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -127.96 156.12 43.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 71.33 110.737 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -143.42 143.59 12.59 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.993 -0.622 . . . . 74.32 112.157 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 258' ' ' THR . 63.8 m-85 -114.47 115.6 27.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.784 -0.451 . . . . 72.44 109.784 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 17.9 m -109.91 114.38 27.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.504 -0.554 . . . . 75.01 109.504 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -135.53 143.18 45.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.757 0.313 . . . . 62.22 110.801 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.8 t -107.54 116.18 31.49 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.051 -0.722 . . . . 65.51 109.051 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 3.8 mm? -70.34 173.57 6.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.861 -0.609 . . . . 74.41 110.518 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.608 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 20.8 mtpp -67.63 -44.97 45.56 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.25 -0.432 . . . . 75.3 110.852 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 16.8 Cg_exo -70.37 -174.49 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.887 1.725 . . . . 65.24 111.025 165.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -81.35 69.6 3.25 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.701 -0.762 . . . . 75.22 112.393 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.487 HG12 ' CD2' ' A' ' 281' ' ' PHE . 37.6 mt -136.81 124.78 33.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 122.652 -0.322 . . . . 74.21 111.02 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 280' ' ' GLU . 51.3 mttp -109.99 113.37 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.273 -0.64 . . . . 74.41 109.273 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.91 130.57 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.264 -0.426 . . . . 74.12 110.665 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 25.3 m -125.17 111.43 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 74.2 110.147 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.898 HD21 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -105.03 125.39 50.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.022 -1.103 . . . . 71.14 108.022 176.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 53.2 m -134.17 140.8 46.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.972 0.415 . . . . 70.55 111.406 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.67 128.01 19.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.92 -0.582 . . . . 74.44 109.648 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 242' ' ' LEU . 3.0 tm? -110.03 113.35 25.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.932 -0.766 . . . . 71.42 108.932 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.576 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.089 -1.078 . . . . 65.33 108.089 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.547 ' HA ' HD23 ' A' ' 242' ' ' LEU . 10.7 t70 -72.49 103.61 3.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.242 -0.89 . . . . 75.11 108.937 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.6 38.24 Favored Glycine 0 N--CA 1.458 0.118 0 O-C-N 123.395 0.434 . . . . 64.22 113.617 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -91.03 -26.99 18.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.568 0.223 . . . . 72.44 111.304 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.423 ' ND2' ' HA3' ' A' ' 272' ' ' GLY . 64.1 t30 -115.19 -22.83 9.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.813 0.671 . . . . 74.3 112.813 -171.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 264' ' ' ASP . 29.4 m -62.17 -18.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.977 -0.452 . . . . 73.31 111.499 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.46 -39.73 80.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.123 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.51 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 52.32 110.862 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.57 89.29 1.69 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.826 -0.702 . . . . 74.52 111.673 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -157.92 38.83 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.812 -0.708 . . . . 55.41 112.137 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -80.05 145.7 32.33 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.221 -0.288 . . . . 74.3 110.221 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.3 mptt -96.72 138.07 34.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.173 -0.677 . . . . 74.22 109.173 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.437 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 tm? -125.93 131.14 52.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.961 -0.385 . . . . 71.34 109.961 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.414 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -137.08 125.21 3.31 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.473 -0.87 . . . . 44.53 112.092 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.898 HD23 HD21 ' A' ' 259' ' ' LEU . 3.2 tm? -114.96 138.1 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.771 -0.825 . . . . 74.25 108.771 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -158.18 122.21 1.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.349 -0.929 . . . . 74.45 111.13 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -144.91 138.87 27.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.015 0.436 . . . . 73.22 112.04 -175.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.551 ' CG ' ' HB2' ' A' ' 256' ' ' LYS . 6.8 pt-20 -110.71 120.66 43.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 75.21 110.502 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.882 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.7 t80 -98.78 118.7 36.1 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.991 -0.744 . . . . 75.33 108.991 175.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 4.1 pt20 -111.65 111.67 22.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.456 0.646 . . . . 73.11 110.447 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.65 111.59 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 75.32 109.592 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.99 135.91 53.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.942 -0.572 . . . . 73.04 109.771 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.106 -0.473 . . . . 61.32 110.757 -179.659 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.072 0.463 . . . . 60.24 111.917 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.16 125.63 91.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.222 -0.899 . . . . 73.44 111.369 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -63.65 165.01 19.27 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.383 2.722 . . . . 65.42 112.565 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.84 71.33 4.15 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.204 2.603 . . . . 71.4 112.407 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.782 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.4 p -70.36 -48.84 54.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 74.41 111.606 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.563 ' HB2' HG23 ' A' ' 143' ' ' VAL . 70.9 t80 -60.84 -26.08 67.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.901 -0.59 . . . . 64.12 110.866 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -82.08 -10.76 59.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 64.13 111.351 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.441 ' CG ' ' HE2' ' A' ' 181' ' ' HIS . 23.6 t70 -92.31 -22.3 19.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.01 0.433 . . . . 74.14 111.136 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.99 -35.34 71.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.716 0.636 . . . . 75.52 112.716 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.53 15.65 8.56 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 119.917 -1.135 . . . . 65.22 114.114 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 8' ' ' ALA . 33.5 mmtm -63.98 -54.77 29.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.347 0.574 . . . . 74.24 111.713 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -63.36 -38.72 92.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 65.34 110.949 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.13 68.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 65.04 111.825 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -69.05 -35.72 76.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 65.14 111.297 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.11 -45.26 81.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.905 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.36 -25.34 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.461 . . . . 44.23 110.991 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -59.87 -39.82 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 74.43 110.806 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -89.34 36.16 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.295 0.569 . . . . 51.44 110.282 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -52.47 114.48 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.27 -0.877 . . . . 74.53 111.84 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.74 96.97 1.45 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.651 -0.704 . . . . 75.3 112.362 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -133.0 -166.49 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.475 -0.565 . . . . 72.42 109.475 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.13 89.08 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.701 -0.761 . . . . 74.52 111.731 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -100.26 -3.77 30.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.492 . . . . 74.03 110.076 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.59 61.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.977 -0.63 . . . . 71.22 113.07 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.721 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 3.5 pp -147.8 179.76 7.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 113.459 0.911 . . . . 70.33 113.459 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 277' ' ' LEU . 28.7 mm -100.91 122.93 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.876 -1.511 . . . . 64.25 109.061 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.519 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.4 ttmm -120.76 121.25 37.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 73.34 110.517 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 279' ' ' LEU . 2.6 tt -113.59 142.05 46.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.563 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -135.46 128.37 31.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.381 -0.827 . . . . 64.33 109.466 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 18.3 tp -122.07 123.73 42.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 74.4 110.551 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -108.14 125.07 51.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.69 . . . . 75.12 109.406 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.75 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 39.4 m -128.45 121.82 29.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.589 0.233 . . . . 75.25 110.988 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 53.2 mtmt -137.39 123.74 20.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 73.23 110.531 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.584 ' H ' HD12 ' A' ' 39' ' ' LEU . 50.4 m -143.09 155.8 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 74.31 109.855 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 49.53 -131.28 1.86 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.593 0.558 . . . . 74.32 111.589 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.23 134.91 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.519 0.676 . . . . 63.4 111.493 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 93.15 -11.46 71.84 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.044 -0.98 . . . . 71.05 114.449 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.584 HD12 ' H ' ' A' ' 35' ' ' SER . 3.4 pp -103.96 133.86 48.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 118.646 1.223 . . . . 75.23 111.985 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.946 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 39.8 tt0 -138.5 128.71 25.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.886 . . . . 71.12 108.609 161.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.75 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 84.1 m-85 -118.28 121.73 41.16 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.877 -0.515 . . . . 74.02 110.828 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.957 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 21.2 m -117.11 115.81 26.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 71.42 109.814 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.55 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 27.5 t -112.65 123.67 50.82 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.358 . . . . 74.54 110.035 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 51.1 m -119.43 125.95 50.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.119 0.485 . . . . 72.31 110.312 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.5 117.48 2.26 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.613 -0.803 . . . . 75.34 111.475 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.6 m -112.67 133.94 54.45 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.733 -0.387 . . . . 62.34 109.983 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -135.55 126.66 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.44 -0.578 . . . . 72.55 109.44 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.721 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 7.4 t-20 -78.28 134.89 37.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.396 -173.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -96.36 -19.31 19.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.092 0.472 . . . . 71.23 110.97 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.91 -53.79 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.283 0.563 . . . . 74.31 109.751 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 35.1 m -122.2 105.6 10.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.226 -0.657 . . . . 70.24 109.226 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -52.6 102.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.937 0.718 . . . . 74.51 112.937 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -154.76 135.67 13.73 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.025 -1.102 . . . . 75.55 108.025 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.26 132.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.01 0.434 . . . . 72.23 111.222 -174.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -123.97 126.15 45.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 75.24 110.096 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.25 135.24 12.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.843 -0.694 . . . . 62.41 112.565 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 16.9 m -125.65 125.92 43.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.623 -0.88 . . . . 71.44 108.623 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.96 124.51 45.08 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.685 -0.487 . . . . 72.21 109.685 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.957 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 41.7 tt0 -106.77 117.87 35.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.155 0.502 . . . . 72.21 109.77 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 15.6 m -93.27 119.31 32.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.043 -1.095 . . . . 75.11 108.043 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.946 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.8 tptm -122.85 138.01 54.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.142 0.496 . . . . 75.15 109.763 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.748 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 86.5 m-85 -116.69 120.76 39.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.864 -0.791 . . . . 75.31 108.864 172.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.496 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.0 ptm85 -115.73 105.86 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.124 -0.63 . . . . 64.14 110.586 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.858 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 76.0 t90 -112.43 106.06 14.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 64.2 110.088 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 m 66.46 153.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.58 1.175 . . . . 75.43 111.273 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -64.04 102.82 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.27 -0.423 . . . . 75.13 109.927 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 t80 63.73 81.47 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 72.41 110.875 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.47 -75.09 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.369 -1.092 . . . . 74.35 110.369 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.858 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 2.0 mm? -113.09 131.42 55.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.854 0.359 . . . . 73.01 110.794 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 p -135.19 112.66 10.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.716 . . . . 62.11 110.337 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 21.7 t80 -109.68 121.34 44.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.503 -0.554 . . . . 75.5 109.503 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 m -116.69 127.71 54.66 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.2 0.313 . . . . 74.32 110.753 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 28.1 tt0 -130.66 121.29 25.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.511 -0.551 . . . . 75.24 109.511 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -111.22 97.83 7.06 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.037 -0.727 . . . . 73.4 109.037 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.926 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 41.5 t90 -108.8 129.71 55.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.176 -0.466 . . . . 74.21 111.466 -174.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -105.95 139.28 40.74 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.981 -0.748 . . . . 72.05 108.981 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -60.05 -36.67 77.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.639 0.607 . . . . 72.54 112.639 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -111.07 -23.82 10.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 64.11 112.066 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.578 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 2.5 t-20 -104.0 -106.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.265 -0.574 . . . . 75.04 112.427 -169.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 p -116.43 144.64 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.765 0.654 . . . . 75.55 112.765 -170.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.926 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -111.69 123.28 49.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.718 -0.475 . . . . 73.33 109.718 166.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.41 121.99 5.23 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.597 -0.729 . . . . 40.32 111.487 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.691 ' HB ' ' HB3' ' A' ' 101' ' ' SER . 23.2 m -109.11 142.91 39.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.828 0.346 . . . . 74.1 111.059 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.54 113.73 7.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.808 -0.633 . . . . 74.24 109.406 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.489 HG13 ' H ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -112.27 136.41 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.801 -0.444 . . . . 73.34 109.801 179.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.8 m -128.54 124.03 34.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 61.31 110.292 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 2.7 p -125.83 120.54 57.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.38 0.61 . . . . 64.25 111.051 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.26 118.54 35.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.157 -1.423 . . . . 65.2 107.157 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 11.6 t70 -55.91 133.35 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.515 -0.474 . . . . 73.23 110.681 -173.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 19.7 pt20 -68.95 -25.35 64.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 64.33 111.75 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.469 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 85.6 mt -108.83 -52.2 2.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.128 0.49 . . . . 71.51 109.908 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.13 10.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 75.54 110.235 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' HD3' ' O ' ' A' ' 89' ' ' ASP . 36.3 mmt180 -59.72 135.14 57.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 73.32 109.899 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.656 ' HA2' ' HG3' ' A' ' 119' ' ' LYS . . . 102.49 7.18 46.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.633 -0.794 . . . . 74.43 111.492 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.48 114.75 22.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.629 -0.878 . . . . 75.23 108.629 173.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 10.4 ttpp -122.49 111.8 17.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.934 -0.575 . . . . 63.22 110.705 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.506 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.8 mm? -97.55 130.85 44.57 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.819 -0.808 . . . . 74.11 108.819 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -130.46 133.7 46.51 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.32 -0.4 . . . . 73.23 110.986 -177.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' H ' HG13 ' A' ' 85' ' ' ILE . 76.8 t80 -124.52 129.62 50.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.396 -0.366 . . . . 73.31 110.232 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 113' ' ' LYS . 6.3 m-20 -115.83 133.81 55.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.132 -0.485 . . . . 72.42 109.891 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.691 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 30.1 t -130.21 137.29 49.99 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.949 -0.389 . . . . 72.32 109.949 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -135.06 121.63 20.65 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.976 -0.379 . . . . 73.22 109.976 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.707 ' HD1' HD22 ' A' ' 81' ' ' LEU . 75.4 t80 -134.52 137.14 43.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 74.11 110.608 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.413 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 5.1 m -114.29 103.74 54.93 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.944 -0.571 . . . . 75.31 110.017 176.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 32.8 Cg_endo -65.46 152.14 82.82 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.533 2.155 . . . . 73.45 111.477 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.61 25.34 14.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.666 0.746 . . . . 74.22 109.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 m -140.3 -55.12 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.757 -0.656 . . . . 74.51 110.341 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.9 4.1 57.9 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 74.55 112.714 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -87.91 122.75 31.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.311 -0.625 . . . . 75.31 109.311 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 21.6 ptmt -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.101 0.477 . . . . 75.25 110.714 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -121.6 122.64 40.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.427 -0.806 . . . . 75.41 109.559 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 114.77 29.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.052 -0.522 . . . . 74.34 109.621 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.852 ' HG3' ' HB3' ' A' ' 130' ' ' ASP . 28.1 ttmt -118.38 135.4 54.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.234 0.54 . . . . 73.44 110.665 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.854 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 4.2 tp -129.99 132.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 107.739 -1.208 . . . . 74.43 107.739 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.826 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 16.6 ttpt -132.28 119.16 20.4 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 124.987 1.43 . . . . 74.51 110.662 -169.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.935 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 69.9 m -116.99 120.02 37.09 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 119.313 0.96 . . . . 73.13 111.251 -175.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.76 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -131.5 138.93 10.53 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.647 -1.263 . . . . 73.54 113.172 -174.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -115.27 130.65 56.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.435 -0.95 . . . . 75.14 108.435 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -110.58 122.29 47.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.616 0.722 . . . . 75.14 111.039 -175.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -105.65 153.17 22.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.358 -1.292 . . . . 64.54 107.825 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.44 -29.97 51.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.239 0.459 . . . . 74.04 112.239 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -108.95 -17.1 14.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.509 -0.314 . . . . 64.53 111.394 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -144.87 124.66 6.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.043 0.386 . . . . 75.31 112.043 -170.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.913 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.8 OUTLIER -112.79 116.66 30.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.197 -0.314 . . . . 74.44 110.523 176.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 142' ' ' LEU . 3.0 mm? -119.48 124.45 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.54 0.21 . . . . 75.45 111.04 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.76 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -136.57 114.16 1.13 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.943 -1.123 . . . . 53.03 113.029 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.1 t -116.97 122.98 45.81 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.941 -0.392 . . . . 63.42 109.941 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.935 ' HB2' ' H ' ' A' ' 116' ' ' THR 0.319 0.9 OUTLIER -154.15 169.91 22.47 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.659 -1.276 . . . . 75.22 112.924 159.588 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.0 mtt -101.79 140.09 36.54 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.781 0.324 . . . . 73.41 111.115 -162.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.852 ' HB3' ' HG3' ' A' ' 113' ' ' LYS . 9.9 p-10 -119.54 125.8 49.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 74.52 111.022 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.23 96.55 9.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.606 -0.516 . . . . 73.24 109.606 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.514 ' OD2' HG13 ' A' ' 133' ' ' ILE . 7.8 t70 -99.73 -165.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.789 -0.819 . . . . 73.44 108.789 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.514 HG13 ' OD2' ' A' ' 132' ' ' ASP . 2.9 pp -72.94 -13.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 74.35 110.421 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.62 4.69 52.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 73.53 110.569 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.47 -155.13 20.86 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.05 -0.595 . . . . 74.44 111.925 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.57 96.55 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.023 2.482 . . . . 51.41 112.094 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.419 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 16.0 m -92.96 162.89 13.88 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.992 -0.549 . . . . 74.45 109.636 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 36.2 mm -107.99 117.48 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.931 -0.396 . . . . 74.33 109.931 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.7 tpt180 -106.0 111.34 23.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.34 0.59 . . . . 75.22 110.338 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.16 10.09 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.987 -1.101 . . . . 75.22 111.524 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.25 116.84 23.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.974 0.416 . . . . 74.14 110.402 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 125' ' ' LEU . 8.2 tp -117.18 125.36 51.08 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.577 . . . . 75.24 110.637 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.913 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 77.4 t -117.45 133.89 62.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.11 0.481 . . . . 71.3 110.277 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.65 HD22 ' HB1' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -108.42 138.38 44.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.791 -0.818 . . . . 75.42 108.791 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.08 118.24 2.37 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.51 -0.852 . . . . 71.44 113.146 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 75.9 t80 -145.0 148.99 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.066 -0.346 . . . . 75.24 110.066 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -45.01 105.52 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.986 0.422 . . . . 74.32 111.866 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.13 -31.38 6.02 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.81 -0.632 . . . . 71.12 112.726 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 72.3 m95 -104.84 120.93 42.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 74.44 111.118 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.782 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -124.58 136.91 54.35 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.628 -1.249 . . . . 72.14 107.628 173.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 144' ' ' LEU . . . -143.1 160.79 39.74 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.628 -0.429 . . . . 72.05 110.877 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.58 137.2 5.46 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.833 -0.621 . . . . 65.42 111.566 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -143.83 118.35 9.73 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 122.539 -0.389 . . . . 75.54 110.229 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.776 ' HG3' ' HB2' ' A' ' 168' ' ' ASN . 12.2 pt20 -119.13 125.89 50.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.454 0.645 . . . . 75.44 111.02 176.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.602 ' HE2' HG12 ' A' ' 164' ' ' VAL . 81.7 mtp -118.3 142.68 47.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.822 -0.626 . . . . 71.12 109.998 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 50.8 t-20 -113.38 118.46 34.61 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.996 -0.742 . . . . 73.31 108.996 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.715 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.6 m-85 -94.4 120.39 34.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.665 -0.698 . . . . 74.32 111.029 -175.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 57.7 tt0 -87.34 103.2 15.25 Favored 'General case' 0 C--O 1.26 1.639 0 CA-C-O 121.469 0.652 . . . . 74.04 109.284 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 t -70.24 -14.51 62.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 113.127 -1.851 . . . . 71.32 111.904 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.8 68.23 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.559 0.695 . . . . 74.43 109.157 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.63 -147.68 0.4 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.532 -1.285 . . . . 75.23 107.532 162.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.7 m -107.94 28.18 8.49 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.46 -0.775 . . . . 60.34 111.155 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -132.39 145.49 51.27 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.419 -1.313 . . . . 74.11 111.562 -163.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.64 134.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.092 0.473 . . . . 65.14 109.804 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 7.5 t -95.44 -9.79 31.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.126 -0.488 . . . . 75.12 111.016 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 39.3 mm-40 -149.94 132.25 15.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.869 0.366 . . . . 73.1 110.841 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.8 m -121.9 105.79 10.66 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.743 -0.662 . . . . 70.24 109.507 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.776 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 13.9 m120 -110.33 123.91 50.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 75.42 109.844 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.761 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 45.9 t80 -120.4 149.99 41.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.224 -0.443 . . . . 72.44 109.867 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -144.33 142.31 30.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.069 0.461 . . . . 72.43 110.858 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.569 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -131.12 136.9 56.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.157 -0.474 . . . . 75.51 110.193 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.04 96.1 0.33 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.007 -0.837 . . . . 71.11 111.007 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -109.67 121.68 45.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.399 -0.593 . . . . 71.51 109.399 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.41 127.64 48.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.486 -0.779 . . . . 73.25 110.547 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 42.0 m -131.73 111.49 11.7 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.292 -0.632 . . . . 74.34 109.292 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.58 -87.42 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.379 1.049 . . . . 74.12 113.678 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.87 3.48 22.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.252 0.549 . . . . 73.11 111.416 -172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -112.86 126.57 55.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 73.43 110.134 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.741 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 55.0 mm-40 -121.16 123.68 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.173 -0.306 . . . . 71.31 110.173 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.9 tp -118.66 134.85 54.81 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.15 -0.344 . . . . 74.22 111.035 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 9' ' ' ASP . 28.7 m80 -130.6 117.3 19.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 62.33 110.414 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 19.9 m -112.47 143.52 43.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.962 -0.385 . . . . 72.05 109.962 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -141.52 139.95 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 74.1 110.383 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 169' ' ' PHE . 56.0 t -126.36 131.27 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.163 -0.471 . . . . 72.34 111.606 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 9.1 t30 -110.94 96.01 5.9 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.35 -0.841 . . . . 72.34 109.565 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 5.7 t70 62.09 -166.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.9 -1.046 . . . . 74.03 110.345 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -80.62 -6.67 89.21 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.05 -0.595 . . . . 64.41 111.839 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.7 p -94.13 -27.23 16.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.981 0.734 . . . . 73.03 112.981 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 38.8 mt-10 -134.48 125.04 26.59 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.934 -0.706 . . . . 73.23 111.201 -175.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.721 ' HB2' HG21 ' A' ' 184' ' ' VAL . 25.9 p90 -133.87 133.1 41.12 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.188 -0.605 . . . . 75.4 109.443 171.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -135.79 159.21 24.15 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.566 -0.826 . . . . 50.33 112.522 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -136.63 164.76 25.15 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.424 -0.67 . . . . 73.11 111.424 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 26.9 t -143.56 136.91 28.02 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.0 -0.741 . . . . 72.33 109.0 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 3.4 mp -120.31 117.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 75.55 109.743 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.741 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 84.2 t80 -108.04 120.76 43.25 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.513 0.673 . . . . 75.42 110.428 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -115.61 111.91 21.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.925 -1.034 . . . . 74.03 108.992 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 195' ' ' TYR . 84.1 tttt -103.93 107.19 17.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.141 -0.482 . . . . 75.11 109.973 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.47 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.183 -0.673 . . . . 72.45 109.183 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -76.24 10.08 2.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.301 0.572 . . . . 64.3 110.879 -173.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -109.3 -10.37 14.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.776 -0.647 . . . . 72.13 109.361 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -134.93 -68.55 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 74.2 110.528 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -167.99 165.94 13.42 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.92 0.39 . . . . 75.51 110.484 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -109.75 128.2 55.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.797 -0.816 . . . . 73.12 108.797 173.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 t -138.57 155.02 48.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.064 0.459 . . . . 72.32 111.377 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.85 148.05 36.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.723 -0.671 . . . . 75.3 110.61 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 193' ' ' SER . 55.7 t -110.86 138.23 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.033 -0.53 . . . . 61.2 109.617 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -113.9 127.8 56.13 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.284 -1.006 . . . . 62.11 108.284 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 219' ' ' PHE . 7.3 tp -144.56 140.88 29.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.558 -0.292 . . . . 72.12 110.3 -168.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.559 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -157.23 142.34 17.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.825 0.345 . . . . 73.21 111.223 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.504 ' HE3' ' HZ ' ' A' ' 190' ' ' PHE . 16.6 t90 -130.83 135.3 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.125 0.488 . . . . 74.31 110.071 173.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 53.2 m -94.47 105.31 17.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.43 -0.805 . . . . 74.44 109.971 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.76 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 73.31 111.127 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.24 -87.72 0.4 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.164 -0.774 . . . . 73.51 111.164 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -149.12 104.3 3.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.024 0.44 . . . . 73.43 110.484 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.9 t -176.4 149.0 0.79 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.08 159.34 29.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.226 -0.657 . . . . 75.02 109.226 173.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 8.8 t -77.58 123.24 26.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.076 -0.713 . . . . 75.43 109.076 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.444 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 1.1 tpp180 -94.18 115.06 27.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.589 -0.732 . . . . 75.33 109.262 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.67 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 52.1 p90 -120.42 160.33 23.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 74.0 111.49 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.39 157.49 28.86 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.298 -0.864 . . . . 65.24 111.355 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.634 ' HB ' HG11 ' A' ' 237' ' ' VAL . 55.9 mt -132.25 135.15 58.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.964 0.382 . . . . 74.51 110.298 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -128.47 129.84 46.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.918 -0.401 . . . . 74.05 109.918 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -128.24 133.05 48.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.747 0.308 . . . . 64.35 111.061 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.3 114.53 26.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.62 . . . . 75.31 109.629 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -128.9 119.36 24.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 73.3 110.726 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -76.59 124.61 27.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.71 -0.478 . . . . 75.41 109.71 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 63.4 mt -70.48 -55.79 13.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.388 -0.369 . . . . 75.11 110.306 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.856 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 34.0 t70 -172.45 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.019 -0.537 . . . . 75.32 111.771 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 56.7 Cg_endo -95.05 -101.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.372 2.048 . . . . 72.13 113.524 -172.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.93 3.92 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 73.45 111.227 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -123.07 131.98 53.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.238 0.542 . . . . 75.35 111.748 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.58 142.16 50.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 72.32 109.264 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -104.31 131.41 51.68 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.837 -0.431 . . . . 74.1 109.837 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 57.8 p -116.6 120.96 40.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.051 0.453 . . . . 74.44 110.087 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.88 42.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.218 -0.66 . . . . 71.32 109.218 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 44.4 mttp -144.22 141.57 29.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.664 -0.495 . . . . 72.4 109.664 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.634 HG11 ' HB ' ' A' ' 221' ' ' ILE . 4.4 p -137.24 158.65 35.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.357 -0.609 . . . . 73.23 109.357 174.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 14.3 t30 -135.5 150.57 49.81 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.196 -0.457 . . . . 72.35 110.087 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.67 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 5.8 p30 -46.44 -32.51 3.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.957 1.095 . . . . 72.33 113.957 -173.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.531 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 5.6 m -78.92 23.37 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.596 0.236 . . . . 71.44 111.097 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 239' ' ' ASN . 20.4 m 64.53 36.27 8.76 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 121.371 0.605 . . . . 70.14 109.849 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 1.037 ' HB3' HD13 ' A' ' 262' ' ' LEU . 22.9 mt -98.04 116.71 30.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.729 -0.669 . . . . 73.3 110.075 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.69 116.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 75.33 110.007 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.12 133.47 9.64 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.576 -0.821 . . . . 75.21 112.685 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.465 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -119.37 154.25 33.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.376 -0.231 . . . . 71.43 110.376 178.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -149.24 134.32 4.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.444 -0.884 . . . . 70.43 112.675 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 258' ' ' THR . 59.1 m-85 -103.59 116.99 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.564 -0.532 . . . . 75.1 109.564 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.915 HG22 ' HB ' ' A' ' 258' ' ' THR . 3.2 m -117.36 115.25 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.121 -0.49 . . . . 74.42 110.31 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.99 150.73 44.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 75.52 111.83 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 19.6 m -83.37 128.41 34.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.864 -0.607 . . . . 75.33 110.155 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.783 HD23 HG12 ' A' ' 255' ' ' ILE . 3.3 mm? -73.73 -82.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.133 0.42 . . . . 72.24 112.133 -173.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 1.008 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 35.3 tttp -140.97 -62.67 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.948 -0.389 . . . . 74.51 109.948 -175.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 1.008 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 3.6 Cg_exo -79.45 -161.52 0.15 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.858 1.705 . . . . 71.14 110.861 166.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -80.82 62.21 4.43 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.663 -0.78 . . . . 73.53 113.162 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.783 HG12 HD23 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -136.49 142.26 38.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.084 0.468 . . . . 74.41 109.762 173.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.542 ' HG2' HG23 ' A' ' 248' ' ' THR . 36.0 ttpt -121.96 127.28 50.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.761 -0.654 . . . . 74.42 110.261 -176.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.581 ' HB2' HD22 ' A' ' 251' ' ' LEU . 28.6 tp -100.55 132.69 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 74.03 110.106 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.915 ' HB ' HG22 ' A' ' 248' ' ' THR . 7.7 t -129.52 112.48 13.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.615 0.722 . . . . 75.42 111.01 176.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.952 HD23 HD22 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -98.1 123.61 42.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.131 -1.063 . . . . 73.2 108.131 176.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 21.8 p -131.6 148.73 52.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.193 0.52 . . . . 73.3 111.454 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.419 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -140.89 133.15 28.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.732 -0.667 . . . . 74.01 109.907 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 1.037 HD13 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -102.88 121.28 42.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 74.52 109.133 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.562 ' HB3' HG13 ' A' ' 268' ' ' VAL . 1.4 mm? -104.1 108.01 19.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.431 -0.952 . . . . 74.4 108.431 175.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.493 ' O ' HG22 ' A' ' 268' ' ' VAL . 2.9 m-20 -71.59 103.87 3.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.906 -0.775 . . . . 72.53 108.906 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.77 -22.25 32.67 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.12 -0.562 . . . . 73.32 113.03 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -85.92 -23.47 26.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.671 0.272 . . . . 74.01 111.262 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -115.61 -28.26 6.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.78 0.659 . . . . 73.32 112.78 -172.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 263' ' ' LEU . 24.6 m -62.82 -18.78 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.901 0.334 . . . . 64.31 111.901 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.6 -33.06 70.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 73.21 109.808 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.32 8.56 38.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.517 -0.765 . . . . 63.53 110.955 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.84 89.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.088 -0.577 . . . . 74.42 112.067 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.19 88.01 0.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.323 -0.942 . . . . 75.44 112.701 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -109.16 145.52 35.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.185 -0.302 . . . . 74.35 110.185 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -103.85 137.89 41.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.009 -0.737 . . . . 72.5 109.009 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 276' ' ' GLY . 1.3 tm? -110.11 137.9 47.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.647 0.261 . . . . 54.53 110.328 -174.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.505 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -138.52 126.23 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.42 -0.672 . . . . 75.03 111.42 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.952 HD22 HD23 ' A' ' 259' ' ' LEU . 2.7 tm? -120.77 129.28 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.814 -0.439 . . . . 73.42 109.814 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -131.95 145.87 17.55 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.479 -0.867 . . . . 73.54 112.975 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.445 ' HB2' HD11 ' A' ' 29' ' ' LEU . 2.2 mm? -123.71 132.3 53.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.46 -0.57 . . . . 74.42 109.46 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -112.87 111.91 23.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.439 -0.578 . . . . 64.12 109.439 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 5.2 m-85 -102.32 141.48 35.09 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.115 -0.698 . . . . 75.14 109.115 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 284' ' ' LEU . 46.2 mt-30 -135.75 121.4 19.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.848 0.356 . . . . 74.03 110.566 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -105.35 109.26 21.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.206 -0.664 . . . . 74.21 109.206 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 282' ' ' GLN . 3.5 mm? -130.6 176.77 7.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.698 -0.683 . . . . 73.31 110.366 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.708 -0.678 . . . . 74.41 109.827 178.623 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 75.43 110.314 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HB3' ' A' ' 119' ' ' LYS . 2.2 t -82.15 115.19 56.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.688 -0.687 . . . . 74.53 109.643 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 6.6 Cg_endo -87.41 157.14 8.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.299 2.666 . . . . 74.33 113.157 -174.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 3.6 Cg_exo -75.92 64.62 6.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.135 2.556 . . . . 73.22 111.324 173.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.809 ' HB ' HD21 ' A' ' 150' ' ' LEU . 4.8 p -78.19 -18.97 54.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 73.14 111.548 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.462 ' HE2' HE21 ' A' ' 154' ' ' GLN . 81.0 t80 -56.11 -22.76 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 74.0 110.326 170.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.51 -25.62 54.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.456 -0.793 . . . . 73.5 109.569 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.623 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 39.5 m-20 -85.86 -10.94 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.99 -0.745 . . . . 75.11 108.99 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.885 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -77.1 -34.86 56.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.766 -1.106 . . . . 74.11 110.857 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.24 -47.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.934 -1.127 . . . . 55.15 113.701 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -55.43 -53.91 50.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.674 0.62 . . . . 73.51 112.674 -170.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 t -63.95 -48.47 76.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 71.3 111.474 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.78 60.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 73.12 111.794 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 1.022 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 99.2 mtt180 -60.37 -24.82 65.4 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.708 0.633 . . . . 73.22 112.708 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.36 -41.51 76.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 71.11 110.752 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.509 ' HB ' ' ND2' ' A' ' 207' ' ' ASN . 66.8 t -83.73 -37.41 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.164 0.507 . . . . 70.44 110.315 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 1.022 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 89.6 t80 -63.56 -24.51 67.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.123 -0.944 . . . . 74.15 112.497 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -65.42 156.08 33.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 72.45 111.613 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.746 ' HD2' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.95 25.46 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.674 -0.693 . . . . 72.03 110.397 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.94 95.67 0.49 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.686 -0.688 . . . . 63.53 112.278 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -104.07 -162.4 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.797 -0.816 . . . . 74.55 108.797 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.55 108.18 2.38 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.142 -1.027 . . . . 41.24 111.131 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -80.7 -2.98 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.797 0.299 . . . . 75.12 111.573 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 12.79 83.81 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.458 -0.877 . . . . 61.45 112.434 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -142.35 179.97 6.62 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.866 0.841 . . . . 73.54 112.632 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.685 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -106.91 129.52 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.148 -1.387 . . . . 74.03 109.859 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 8.9 ttpt -102.78 135.99 43.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.407 -0.59 . . . . 74.5 109.407 174.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.9 tp -133.5 139.7 46.81 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.872 -0.331 . . . . 64.11 110.169 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.3 p30 -151.3 135.01 16.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 61.34 109.951 173.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.4 tp -128.31 124.14 35.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.509 -0.769 . . . . 75.53 109.679 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.547 ' N ' HD11 ' A' ' 31' ' ' LEU . 68.9 tttt -120.92 124.69 45.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.276 -0.874 . . . . 70.32 109.37 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.512 HG23 ' HB1' ' A' ' 283' ' ' ALA . 34.2 m -128.6 120.6 26.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.626 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -144.6 155.88 43.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.811 -0.756 . . . . 74.22 112.597 -176.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.4 t -139.92 154.31 47.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.523 -1.217 . . . . 74.04 107.991 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.27 20.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.991 0.424 . . . . 63.41 111.262 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' SER . 66.0 t30 -110.65 30.08 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.544 0.688 . . . . 75.33 110.212 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 96.39 1.17 60.83 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.864 -0.607 . . . . 72.03 112.513 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.0 tp -100.68 125.9 47.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.699 0.629 . . . . 64.42 112.699 -173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.836 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 28.0 mt-10 -142.32 118.17 10.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.962 -0.384 . . . . 74.13 109.962 160.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 50.4 m-85 -111.87 124.87 53.29 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.871 -0.518 . . . . 74.2 110.308 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.958 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 19.0 m -126.85 118.61 24.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.741 0.305 . . . . 73.4 111.383 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 29.0 t -120.35 123.6 43.5 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.273 -0.64 . . . . 73.23 109.273 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -134.73 130.44 36.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 73.14 111.468 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.43 148.02 19.38 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.507 -0.854 . . . . 64.33 112.541 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 m -119.83 134.17 55.33 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.821 -0.807 . . . . 73.31 108.821 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.662 ' HB1' HG13 ' A' ' 54' ' ' VAL . . . -154.85 141.29 18.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.984 0.421 . . . . 75.41 111.804 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 145.96 51.53 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.184 -0.672 . . . . 72.43 109.184 172.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -43.82 -39.74 4.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.538 0.524 . . . . 75.11 111.95 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -103.41 165.87 10.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.342 -0.614 . . . . 54.13 109.342 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -70.55 61.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.342 0.591 . . . . 70.1 112.052 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -97.84 -39.93 8.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 74.2 110.352 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -165.42 116.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 74.14 109.918 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.662 HG13 ' HB1' ' A' ' 47' ' ' ALA . 39.6 t -125.63 119.62 55.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.93 -0.577 . . . . 72.15 109.938 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -120.47 126.54 50.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.845 -0.428 . . . . 74.31 109.845 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 148.16 18.84 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.198 -1.001 . . . . 74.12 113.258 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 6.6 p -146.31 147.2 31.12 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.792 -0.447 . . . . 61.2 109.792 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 59' ' ' GLU . 1.8 tp -122.09 149.33 43.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.176 0.512 . . . . 75.22 111.196 -176.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.958 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 37.7 mt-10 -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.257 -0.883 . . . . 75.23 109.421 172.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.9 m -95.62 118.31 32.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.889 -1.152 . . . . 74.12 107.889 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 26.5 mttp -126.07 145.68 50.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.411 0.624 . . . . 75.14 110.911 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 70' ' ' THR . 74.3 m-85 -120.7 120.33 35.38 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.476 -0.935 . . . . 63.41 108.476 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.836 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 8.8 tpt180 -114.73 108.26 16.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 74.24 111.136 -173.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -113.51 102.69 10.54 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.434 -0.803 . . . . 75.55 110.754 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m 63.81 72.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.941 -1.027 . . . . 72.34 112.409 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.85 ' HG3' ' H ' ' A' ' 67' ' ' TYR . 9.7 pt-20 30.3 -92.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.449 1.1 . . . . 74.22 113.764 173.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.85 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 93.9 m-85 -87.11 86.87 7.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.224 -0.658 . . . . 73.03 109.224 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.81 -94.1 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.353 -0.699 . . . . 71.43 111.353 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD13 HG22 ' A' ' 87' ' ' VAL . 3.5 mm? -125.4 131.59 52.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.038 0.447 . . . . 74.31 111.488 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.685 HG21 ' HB ' ' A' ' 86' ' ' THR . 4.8 t -136.97 113.19 9.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.796 -0.638 . . . . 74.32 109.781 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 72.3 m-85 -98.2 132.26 43.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 73.11 109.527 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 84' ' ' GLU . 96.9 m -127.91 136.57 51.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.923 0.392 . . . . 75.51 111.757 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.69 121.13 24.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.949 -0.759 . . . . 73.54 108.949 165.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -106.88 109.73 21.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.771 -0.65 . . . . 75.11 109.581 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.644 ' HD1' HD13 ' A' ' 81' ' ' LEU . 77.1 t90 -109.7 133.92 52.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.425 -0.352 . . . . 74.41 110.492 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' HB3' ' OG1' ' A' ' 80' ' ' THR . 8.5 t30 -114.72 152.88 31.27 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.582 -0.525 . . . . 73.4 109.582 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 m -54.28 -22.15 11.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.116 0.484 . . . . 73.51 112.301 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.5 m-20 -68.69 -2.67 9.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.117 -0.492 . . . . 74.12 111.986 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 12.2 m120 77.8 27.69 0.58 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.461 0.704 . . . . 73.53 110.125 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 104' ' ' SER . 1.8 p -93.19 124.52 37.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.599 -0.728 . . . . 74.35 110.987 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.644 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.9 mm? -101.56 119.2 38.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.307 -0.86 . . . . 74.23 110.3 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.54 91.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.552 -0.832 . . . . 75.41 111.512 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 t -90.65 123.04 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 73.41 110.448 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 40.5 tt0 -135.3 118.69 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.983 -0.553 . . . . 74.35 110.027 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -112.03 138.68 39.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.709 0.29 . . . . 74.12 110.368 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.685 ' HB ' HG21 ' A' ' 70' ' ' THR . 25.8 m -122.73 123.63 41.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.297 0.57 . . . . 74.23 111.353 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.444 HG22 HD13 ' A' ' 69' ' ' LEU . 34.1 t -111.89 123.89 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.09 -0.959 . . . . 73.53 109.036 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -110.21 142.17 42.14 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.765 -0.457 . . . . 75.22 109.765 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 81.47 -66.5 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.95 0.781 . . . . 72.31 109.952 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.31 -78.11 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.29 0.636 . . . . 71.1 111.206 175.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -130.88 -58.73 1.01 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 74.31 109.624 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.23 27.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.857 -0.611 . . . . 72.43 109.399 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 5.8 ppt_? -52.97 132.67 37.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.467 0.651 . . . . 73.5 111.832 -175.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 119' ' ' LYS . . . 101.54 -12.43 58.19 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.593 -0.73 . . . . 75.25 112.08 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.637 HD21 ' HD1' ' A' ' 118' ' ' TYR . 1.0 OUTLIER -86.92 119.9 27.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.83 -0.804 . . . . 74.23 108.83 176.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.401 ' O ' HD11 ' A' ' 97' ' ' LEU . 54.7 pttt -123.06 144.47 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 74.44 110.658 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -122.38 126.87 48.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.551 -0.75 . . . . 75.23 109.286 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.843 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 15.2 m -130.0 118.28 21.34 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.682 -0.407 . . . . 72.4 109.982 176.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 50.4 t80 -120.33 115.56 23.8 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.777 -0.369 . . . . 75.45 110.442 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 10.4 t70 -115.0 137.85 51.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.668 -0.696 . . . . 71.12 109.373 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -142.2 121.81 13.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.963 0.411 . . . . 72.21 110.06 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 41.4 m -103.04 121.71 43.14 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.715 -0.675 . . . . 75.24 109.803 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -120.88 128.82 53.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 73.55 109.523 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.525 ' HB3' HG21 ' A' ' 80' ' ' THR . 47.6 p -119.86 103.14 46.12 Favored Pre-proline 0 C--N 1.315 -0.919 0 C-N-CA 120.828 -0.349 . . . . 65.23 110.551 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 21.0 Cg_exo -67.11 -22.89 46.64 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.452 2.102 . . . . 74.25 111.256 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -85.48 -49.12 8.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 73.11 110.992 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -81.88 -36.73 27.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.392 . . . . 74.03 111.296 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.44 -3.44 61.43 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.139 -0.553 . . . . 53.05 113.191 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.76 148.69 22.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.165 0.507 . . . . 71.11 111.628 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -123.82 148.58 46.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.805 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -144.07 122.49 12.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.967 -0.383 . . . . 62.13 109.967 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.08 129.89 55.62 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.798 -0.445 . . . . 73.12 109.798 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 129' ' ' MET . 7.9 ttmm -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.694 -0.484 . . . . 72.12 109.694 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.3 tp -132.32 129.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.108 0.48 . . . . 75.23 111.07 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 50.1 mttp -111.19 121.66 45.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.35 -0.841 . . . . 73.3 109.706 176.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -116.27 117.95 31.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.57 -0.9 . . . . 75.43 108.57 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.81 135.45 11.47 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.39 -0.909 . . . . 51.42 112.473 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.637 ' HD1' HD21 ' A' ' 95' ' ' LEU . 76.9 t80 -121.65 118.43 29.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.844 -0.799 . . . . 75.41 108.844 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.858 ' HB3' HG12 ' A' ' 3' ' ' VAL . 37.5 mtmm -108.07 122.93 47.88 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.041 -0.663 . . . . 73.23 110.642 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -105.38 154.91 19.65 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.556 -1.276 . . . . 75.24 107.556 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.662 ' HA ' HG21 ' A' ' 3' ' ' VAL . 2.0 tp10 -52.74 -29.84 29.24 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.674 0.62 . . . . 72.33 112.674 -165.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -102.39 -26.14 13.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.105 0.78 . . . . 72.15 113.105 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.794 HG22 ' H ' ' A' ' 145' ' ' GLY . 19.2 pt -142.22 153.35 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.927 -0.709 . . . . 71.24 112.242 -171.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.634 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 1.7 m-20 -112.3 128.94 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.263 -0.88 . . . . 74.33 111.457 -172.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 118' ' ' TYR . 4.5 mm? -111.37 137.69 48.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.608 0.242 . . . . 73.42 110.616 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.38 121.17 1.34 Allowed Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.959 -0.639 . . . . 65.11 112.493 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.4 m -113.35 116.44 29.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.894 0.347 . . . . 73.3 111.815 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -97.81 143.16 28.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.804 -0.634 . . . . 72.33 110.128 175.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.513 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 65.3 mtt -133.74 118.4 18.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.168 -0.308 . . . . 74.12 110.168 174.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 1.9 m-20 -99.38 119.26 37.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 72.14 110.067 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.9 97.94 10.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.479 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -120.58 156.99 30.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 74.14 108.988 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.858 HD13 ' H ' ' A' ' 133' ' ' ILE . 1.1 mp -75.08 -30.25 23.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.133 0.492 . . . . 74.4 109.986 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.0 -9.93 59.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 73.13 111.042 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' HA3' ' HB1' ' A' ' 160' ' ' ALA . . . 155.15 133.09 1.67 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.534 -0.841 . . . . 74.45 112.666 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 7.8 Cg_exo -74.23 119.1 5.65 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.122 2.548 . . . . 74.44 111.651 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.669 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 9.3 t -103.46 131.07 50.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.164 -0.471 . . . . 64.1 110.091 -177.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mp -115.77 118.51 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.55 -0.46 . . . . 65.3 110.09 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.709 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 24.7 mtt180 -107.42 115.19 29.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.859 -0.423 . . . . 75.53 109.859 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.36 131.67 10.64 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.505 -1.331 . . . . 65.54 111.083 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.54 115.7 19.94 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.079 0.466 . . . . 72.33 109.977 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.583 HD13 HD13 ' A' ' 123' ' ' ILE . 5.9 tp -117.66 122.9 44.79 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.761 -0.654 . . . . 72.13 109.813 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.712 HG23 HD23 ' A' ' 10' ' ' LEU . 54.5 t -108.55 130.28 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.853 -0.612 . . . . 73.11 109.743 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.3 mm? -108.14 136.48 47.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.957 -0.757 . . . . 74.41 108.957 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.794 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -115.96 119.2 4.47 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.275 -0.875 . . . . 60.52 112.743 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.948 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 34.0 m-85 -123.46 149.64 44.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.304 -0.999 . . . . 74.05 108.304 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.78 100.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.96 0.41 . . . . 72.03 110.96 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 174' ' ' LYS . . . 90.84 -24.12 19.63 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.974 -0.557 . . . . 60.35 112.372 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.948 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.6 m0 -105.37 131.81 52.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.107 0.48 . . . . 74.24 110.783 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.809 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.4 tm? -117.33 149.07 41.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.736 -0.839 . . . . 65.43 108.736 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -151.28 154.53 36.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.646 -0.421 . . . . 74.35 110.058 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.885 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -158.41 135.66 4.38 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.744 -0.662 . . . . 54.23 111.576 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.4 115.18 21.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.44 -0.578 . . . . 72.41 109.44 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.906 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 87.7 mt-30 -99.42 121.86 41.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.728 -0.471 . . . . 72.25 109.728 166.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.9 ttm -127.17 128.58 46.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.698 -0.482 . . . . 74.32 109.698 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 24.7 m-80 -112.65 119.13 37.05 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.548 -0.538 . . . . 75.14 109.548 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.9 m-85 -94.35 127.05 39.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.095 -0.502 . . . . 75.41 110.805 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.77 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.9 tp10 -97.42 98.48 9.99 Favored 'General case' 0 C--O 1.26 1.631 0 N-CA-C 109.269 -0.641 . . . . 74.34 109.269 174.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -72.59 -17.59 61.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.641 -1.618 . . . . 73.21 111.209 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.435 ' HB1' ' HA3' ' A' ' 135' ' ' GLY . . . -63.1 -29.08 70.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.732 -0.84 . . . . 75.55 108.732 173.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -111.17 -160.26 0.71 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.16 -1.382 . . . . 70.24 107.839 169.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 p -108.45 28.76 8.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.551 -0.536 . . . . 53.24 109.551 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 25.0 tpt180 -142.95 145.78 33.33 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 119.812 -0.755 . . . . 75.31 111.378 -160.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.5 m -73.22 136.7 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.777 -0.823 . . . . 72.51 108.777 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.77 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 8.8 t -92.2 -24.36 19.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.217 -0.447 . . . . 75.52 110.869 -171.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.564 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 93.4 mt-30 -144.8 133.16 21.81 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.616 0.246 . . . . 63.24 110.711 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.2 m -114.54 106.27 14.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.532 -0.544 . . . . 75.24 109.532 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.906 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 54.5 m-20 -106.99 129.93 54.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.46 . . . . 73.14 109.926 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.36 144.52 48.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.474 -0.33 . . . . 74.43 110.445 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -142.43 128.65 19.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.862 0.363 . . . . 74.02 110.169 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.58 128.54 60.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 73.3 109.409 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.81 109.17 1.69 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.804 -0.712 . . . . 73.25 112.05 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.75 119.95 39.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.064 -1.087 . . . . 74.34 108.064 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.798 ' HB2' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -136.21 144.83 45.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.182 0.991 . . . . 75.05 113.557 -171.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.421 ' HB ' ' OE2' ' A' ' 177' ' ' GLU . 3.7 m -109.9 163.88 13.12 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.582 -1.636 . . . . 75.34 106.582 167.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -27.4 60.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.849 0.685 . . . . 72.15 112.849 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' OE2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -108.16 -20.51 13.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.569 0.581 . . . . 72.44 112.569 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -130.83 119.02 21.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.799 0.333 . . . . 72.34 111.074 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.798 ' HG2' ' HB2' ' A' ' 174' ' ' LYS . 45.1 mt-30 -116.35 124.31 49.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.496 -0.32 . . . . 71.42 110.418 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -107.9 132.24 53.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.063 0.458 . . . . 75.32 110.234 174.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.623 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 41.6 m-70 -125.03 116.81 22.72 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.252 -0.647 . . . . 74.42 109.252 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 28.7 m -99.39 123.0 43.29 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.717 -0.475 . . . . 74.3 109.717 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -121.24 139.73 52.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.01 0.433 . . . . 71.5 109.963 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 78.2 t -131.12 124.79 56.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.762 -0.654 . . . . 74.23 109.591 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 92.4 m-20 -106.88 106.42 16.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 74.13 109.36 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 28.0 t70 59.64 -168.76 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.914 -1.039 . . . . 72.31 109.424 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.539 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -79.54 -6.35 89.01 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.542 -0.837 . . . . 71.43 112.128 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 211' ' ' THR . 26.9 p -101.28 -27.02 13.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.639 0.977 . . . . 74.52 113.639 -172.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.6 tt0 -113.1 115.15 27.85 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 119.274 -0.97 . . . . 71.54 111.909 -174.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.58 131.06 57.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 75.24 109.64 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -174.25 -139.82 3.08 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.552 -0.833 . . . . 64.33 112.107 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.86 -150.61 22.9 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.23 -0.986 . . . . 63.0 112.865 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 28.5 t -142.78 144.54 32.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.147 0.498 . . . . 71.22 110.97 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 17.3 mm -118.9 115.77 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.856 -0.794 . . . . 73.23 108.856 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.666 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 26.1 t80 -111.6 119.7 39.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.612 0.244 . . . . 73.45 110.652 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.671 ' CG ' ' HB2' ' A' ' 199' ' ' ASN . 23.0 tp60 -127.81 128.49 45.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.505 -0.316 . . . . 73.33 110.34 176.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.57 ' O ' HG21 ' A' ' 198' ' ' VAL . 19.0 ptpt -103.1 132.41 49.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.674 -0.239 . . . . 75.51 110.933 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.57 HG21 ' O ' ' A' ' 197' ' ' LYS . 3.9 m 64.85 23.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.495 1.518 . . . . 75.44 112.423 176.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.802 HD21 ' HG3' ' A' ' 200' ' ' LYS . 9.1 t30 -65.31 -48.62 72.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 64.51 110.764 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.802 ' HG3' HD21 ' A' ' 199' ' ' ASN . 98.7 mttt -125.18 -84.47 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.491 -0.322 . . . . 73.41 111.05 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -86.83 -66.18 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.461 -0.336 . . . . 74.31 110.449 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.2 tp -145.73 -84.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 73.33 110.164 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 224' ' ' LYS . 2.6 tp10 -107.25 142.03 37.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 13.5 t -143.38 138.67 29.57 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.19 -0.604 . . . . 73.42 110.775 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -138.61 137.29 36.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.778 -0.646 . . . . 60.34 110.678 -178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 70.5 t -111.32 140.65 29.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.116 -0.698 . . . . 73.22 109.116 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.509 ' ND2' ' HB ' ' A' ' 17' ' ' VAL . 18.5 m-80 -138.27 131.51 30.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.674 -0.491 . . . . 75.12 109.674 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.87 151.7 37.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.824 0.345 . . . . 72.45 111.789 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.534 ' HB1' ' CE2' ' A' ' 18' ' ' PHE . . . -141.07 134.54 29.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 74.02 110.334 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -128.71 123.41 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 73.25 110.384 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 188' ' ' THR . 1.0 OUTLIER -99.89 103.56 15.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.369 0.604 . . . . 73.24 110.473 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.29 136.69 56.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.07 -0.968 . . . . 61.32 111.8 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.24 -28.12 15.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.932 -0.651 . . . . 72.34 113.207 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -132.79 -47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.87 0.692 . . . . 64.33 112.87 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.8 t -110.67 -179.04 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.375 0.607 . . . . 70.33 111.861 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -102.94 166.12 10.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.957 -1.02 . . . . 74.3 109.983 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 25.7 m -74.91 123.17 24.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.422 -0.584 . . . . 65.01 109.422 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -114.16 117.15 30.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.394 -0.595 . . . . 74.42 109.394 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -124.24 145.74 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.386 0.612 . . . . 72.02 111.306 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.36 13.8 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.898 -1.046 . . . . 62.44 111.229 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.3 mp -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.941 -0.392 . . . . 72.23 109.941 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -116.41 145.15 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.946 0.403 . . . . 63.45 110.855 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -129.04 126.54 39.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.933 -0.576 . . . . 62.34 109.792 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.488 ' HG2' ' SG ' ' A' ' 232' ' ' CYS . 22.8 ttmm -118.17 112.41 20.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 75.41 109.427 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 233' ' ' PHE . 5.7 p90 -135.09 118.8 17.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 74.23 112.389 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 0.2 OUTLIER -88.01 112.36 22.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.805 -1.183 . . . . 73.24 107.805 172.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.22 -55.36 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.375 0.88 . . . . 73.31 113.375 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.719 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 13.5 t70 -138.73 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 75.24 112.953 -164.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 62.4 Cg_endo -90.96 -139.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.161 1.908 . . . . 74.02 112.834 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.3 p-10 -92.56 12.22 23.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.213 -0.903 . . . . 74.32 109.498 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.517 ' CB ' ' HG2' ' A' ' 249' ' ' GLN . . . -121.46 123.69 42.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.634 0.73 . . . . 73.31 111.65 -169.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.488 ' SG ' ' HG2' ' A' ' 224' ' ' LYS . 44.8 t -97.29 128.17 43.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.634 -1.166 . . . . 64.12 108.318 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.472 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 53.0 m-85 -96.18 126.45 41.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.779 -0.452 . . . . 75.53 109.779 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 19.6 m -126.38 117.15 22.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 70.32 109.93 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -122.76 141.63 51.6 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.956 -0.387 . . . . 63.31 109.956 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 62.6 pttt -137.9 140.22 40.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.035 0.445 . . . . 75.34 110.401 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 243' ' ' ILE . 5.5 p -122.98 140.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.569 -0.53 . . . . 74.0 109.569 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -105.21 148.03 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.085 -0.709 . . . . 75.15 109.085 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 241' ' ' SER . 26.9 p-10 -68.97 2.58 2.56 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.48 0.548 . . . . 74.22 112.48 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.607 ' HB2' HD12 ' A' ' 242' ' ' LEU . 14.7 m -82.81 12.74 4.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.902 -0.777 . . . . 74.1 108.902 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.5 m 69.89 28.79 4.17 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.955 -1.021 . . . . 73.34 110.948 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.831 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.9 mp -101.15 129.39 47.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.902 0.334 . . . . 72.14 111.902 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.47 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -118.61 116.49 51.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.706 -0.679 . . . . 74.34 110.099 -169.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.99 133.81 7.94 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.276 -0.964 . . . . 53.04 113.12 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.493 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -123.94 156.54 36.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.693 0.282 . . . . 65.41 110.483 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.67 149.46 20.95 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.543 -0.836 . . . . 73.33 113.158 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.822 ' HD1' ' HB3' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -106.63 118.1 35.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.107 -0.701 . . . . 74.43 109.107 177.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 28.9 m -104.49 115.14 29.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.439 -0.578 . . . . 75.41 109.439 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.517 ' HG2' ' CB ' ' A' ' 231' ' ' ALA . 10.9 mt-30 -112.41 133.16 54.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.003 0.43 . . . . 70.32 111.013 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 11.7 m -104.16 102.51 12.23 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.884 -0.784 . . . . 71.14 108.884 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.842 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 8.9 mp -75.24 179.3 5.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.857 0.36 . . . . 75.31 110.855 -174.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.558 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 1.4 tppp? -60.68 -52.52 71.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 74.41 111.09 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.566 ' HG2' HG12 ' A' ' 255' ' ' ILE . 72.3 Cg_endo -80.2 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.811 1.674 . . . . 73.43 111.617 172.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -75.94 64.58 2.68 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.915 -0.659 . . . . 74.33 112.553 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mm -123.74 123.97 68.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.537 0.208 . . . . 74.03 110.869 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.76 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 26.6 ttmt -115.46 114.17 24.69 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.299 -0.63 . . . . 74.45 109.299 171.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.444 HD12 HD11 ' A' ' 279' ' ' LEU . 13.9 tp -100.33 124.55 45.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.623 -0.717 . . . . 72.21 109.959 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.4 m -122.22 110.21 15.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.152 0.501 . . . . 75.14 110.793 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.978 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -106.85 123.58 48.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.464 -1.31 . . . . 75.51 107.464 173.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.7 p -137.72 150.62 47.45 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.64 -0.424 . . . . 71.21 111.228 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.55 128.68 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 74.22 110.35 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.799 HD12 HD23 ' A' ' 242' ' ' LEU . 2.6 tm? -104.81 115.89 31.07 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.354 -0.98 . . . . 71.33 108.354 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.79 ' HB3' HG13 ' A' ' 268' ' ' VAL . 1.3 mm? -92.27 108.77 20.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.353 -0.98 . . . . 75.42 108.353 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.831 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m-20 -70.45 111.02 5.69 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.4 -0.963 . . . . 71.34 108.4 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.23 -27.68 40.17 Favored Glycine 0 C--N 1.319 -0.397 0 C-N-CA 121.207 -0.521 . . . . 63.31 112.995 -173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.747 ' HZ1' ' HB2' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -91.79 -27.48 17.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.679 0.276 . . . . 75.41 111.19 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.812 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 14.4 m120 -92.46 -35.33 13.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.201 0.445 . . . . 70.23 112.201 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.79 HG13 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -63.04 -18.24 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.681 0.277 . . . . 73.32 111.649 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.71 -29.89 71.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.334 0.587 . . . . 54.44 109.653 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.22 0.18 31.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.541 -0.754 . . . . 74.03 110.594 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.34 8.06 57.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 74.41 113.066 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.33 86.92 1.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 70.3 112.567 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -114.39 144.9 42.55 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.76 -0.259 . . . . 74.23 110.537 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.494 ' HZ1' ' CG ' ' A' ' 264' ' ' ASP . 59.1 mttp -99.24 138.02 36.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 64.44 111.179 -175.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.541 HD11 ' N ' ' A' ' 276' ' ' GLY . 1.2 tm? -113.05 139.4 48.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.818 -0.438 . . . . 74.14 109.818 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.541 ' N ' HD11 ' A' ' 275' ' ' LEU . . . -138.06 117.8 1.53 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.883 -0.675 . . . . 74.31 111.631 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.978 HD23 HD22 ' A' ' 259' ' ' LEU . 3.0 tm? -115.51 141.97 47.35 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.418 -0.586 . . . . 75.01 109.418 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.575 ' H ' HD21 ' A' ' 277' ' ' LEU . . . -153.31 129.37 2.68 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.381 -0.914 . . . . 75.42 113.11 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.772 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.7 mm? -112.49 131.52 55.54 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.874 -0.417 . . . . 73.42 109.874 172.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.76 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -124.06 112.01 16.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.736 0.779 . . . . 74.44 109.897 173.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.595 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -98.19 135.91 39.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.433 -1.258 . . . . 72.42 108.76 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.495 ' N ' ' HD2' ' A' ' 281' ' ' PHE . 7.4 tp60 -133.47 112.13 11.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 75.11 109.818 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.512 ' HB1' HG23 ' A' ' 33' ' ' THR . . . -114.98 114.19 25.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.037 -0.529 . . . . 64.3 110.021 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.7 mt -120.53 115.97 24.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 74.31 110.598 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.379 -0.82 . . . . 74.51 109.868 178.103 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.512 ' CA ' ' HA2' ' A' ' 94' ' ' GLY . . . . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 120.706 0.288 . . . . 73.24 111.325 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 1.089 HG23 ' HB3' ' A' ' 119' ' ' LYS . 27.7 m -94.88 145.2 29.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.174 -0.466 . . . . 71.22 111.135 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 32.5 Cg_exo -58.88 161.69 14.9 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.481 2.121 . . . . 73.11 110.361 172.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.95 92.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.313 2.009 . . . . 65.21 112.385 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 p -67.02 -25.84 66.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.284 -0.416 . . . . 73.44 111.854 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.792 ' HB3' HG23 ' A' ' 143' ' ' VAL . 16.6 p90 -65.13 -29.25 70.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 72.25 110.922 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.72 -12.64 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.484 0.659 . . . . 62.33 109.986 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -104.26 -7.14 20.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.559 -0.904 . . . . 64.45 108.559 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.927 HD12 ' HB3' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -57.79 -33.78 68.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.786 -1.552 . . . . 75.44 110.83 178.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.72 63.61 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.082 -0.58 . . . . 63.4 112.175 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -62.05 -39.86 93.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.667 0.387 . . . . 75.43 111.753 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 m -61.0 -36.71 80.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 63.11 112.188 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.8 82.37 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.749 0.648 . . . . 74.3 112.749 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -67.74 -33.83 75.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.88 -0.328 . . . . 75.21 111.463 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 26.3 t70 -65.91 -47.99 72.93 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.5 -0.555 . . . . 71.2 109.5 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.733 HG11 ' HB2' ' A' ' 222' ' ' ALA . 11.3 t -58.22 -33.49 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.956 -0.566 . . . . 73.4 111.566 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.472 ' HD2' ' HB2' ' A' ' 207' ' ' ASN . 66.9 t80 -60.69 -39.52 88.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 73.4 111.695 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.418 HG21 ' CD1' ' A' ' 18' ' ' PHE . 1.1 p -131.42 12.19 4.97 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.335 0.865 . . . . 74.14 113.335 -172.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 34.4 tttp -65.38 -38.7 90.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.166 0.507 . . . . 75.44 110.65 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.34 45.79 1.27 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.852 -0.69 . . . . 60.24 111.765 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.29 130.29 42.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.479 -0.563 . . . . 74.43 109.479 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.81 113.63 3.69 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.79 -0.719 . . . . 62.25 112.548 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -84.46 -3.67 58.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.792 0.33 . . . . 75.43 111.063 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.51 85.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.14 -0.552 . . . . 61.2 113.344 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 46' ' ' SER . 2.1 pp -147.21 179.89 7.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.047 0.758 . . . . 70.35 113.047 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 HD13 ' A' ' 277' ' ' LEU . 37.6 mm -100.59 124.47 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.368 -1.287 . . . . 72.43 109.55 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 33.3 ttpt -107.53 121.82 45.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.97 -0.382 . . . . 75.33 109.97 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.47 128.04 56.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.417 -0.586 . . . . 74.13 109.417 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.8 136.67 51.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.039 -0.726 . . . . 73.24 109.039 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.582 HD13 ' HD1' ' A' ' 281' ' ' PHE . 12.1 tp -137.04 124.62 22.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.931 0.396 . . . . 63.34 110.341 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -116.97 125.44 51.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.449 -0.574 . . . . 71.23 109.449 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 25.4 m -126.06 149.51 48.83 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.335 -0.393 . . . . 73.14 110.5 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -125.15 144.41 50.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.754 0.311 . . . . 73.44 110.878 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 52.3 m -140.75 158.28 44.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.31 -0.405 . . . . 60.44 110.995 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 28.3 tt0 -76.46 99.1 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 71.54 111.91 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.725 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t30 160.44 26.59 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.631 1.172 . . . . 65.31 107.861 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.65 18.05 79.35 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.273 -0.876 . . . . 74.23 110.991 -172.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.725 ' HG ' ' HB3' ' A' ' 37' ' ' ASN . 3.1 mt -86.74 134.33 33.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.758 0.79 . . . . 73.41 112.916 -167.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.65 130.61 30.27 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.012 -1.449 . . . . 73.32 109.173 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.664 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 93.7 m-85 -115.65 121.54 42.86 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.854 -0.425 . . . . 75.24 109.854 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.872 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 23.7 m -115.94 116.48 28.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.091 0.472 . . . . 63.22 110.058 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 25.2 t -113.15 131.31 55.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.708 -0.678 . . . . 75.15 109.726 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -130.97 135.63 47.81 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.686 -0.487 . . . . 44.22 109.686 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.62 110.13 0.43 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.611 -0.804 . . . . 73.02 112.067 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.419 ' HB3' HD11 ' A' ' 26' ' ' LEU . 15.2 m -108.39 133.18 52.94 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.67 -0.863 . . . . 71.2 108.67 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.454 ' HB1' HG11 ' A' ' 54' ' ' VAL . . . -151.57 136.7 17.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.235 0.54 . . . . 72.02 111.24 -174.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -80.87 129.27 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 74.23 108.748 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.8 m -62.46 -20.9 65.01 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.973 0.416 . . . . 64.1 111.675 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -84.46 6.05 24.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.156 0.503 . . . . 74.04 110.204 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 p 49.24 72.0 0.34 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.68 0.792 . . . . 75.5 112.098 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -126.74 -30.87 2.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.253 -0.885 . . . . 74.23 110.172 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -149.13 113.85 5.36 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.101 -0.703 . . . . 71.32 109.101 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.454 HG11 ' HB1' ' A' ' 47' ' ' ALA . 25.7 t -125.99 127.47 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 72.13 109.843 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -134.18 137.61 44.57 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.958 -0.386 . . . . 75.41 109.958 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -142.49 154.82 25.39 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.29 -0.957 . . . . 72.24 112.884 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.728 ' HB2' HG21 ' A' ' 77' ' ' THR . 26.7 t -146.73 148.68 32.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.226 -0.657 . . . . 72.3 109.226 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.622 HD12 ' HG3' ' A' ' 74' ' ' LYS . 1.7 tm? -146.57 125.47 12.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.872 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 11.7 pt-20 -125.84 131.36 52.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.266 0.555 . . . . 63.11 110.195 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.412 HG23 ' CE1' ' A' ' 41' ' ' PHE . 48.3 m -107.62 119.4 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.813 -0.81 . . . . 75.31 108.813 172.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 19.9 mtpp -112.07 126.94 55.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 75.21 110.586 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.623 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.9 m-85 -110.77 120.97 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.36 -0.607 . . . . 73.01 109.36 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.708 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 39.5 mtp180 -114.61 110.9 20.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.809 0.814 . . . . 75.42 110.696 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -111.02 117.2 32.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.077 -1.42 . . . . 72.33 109.062 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m 73.64 122.85 0.04 OUTLIER 'General case' 0 C--O 1.231 0.108 0 O-C-N 124.021 0.826 . . . . 65.52 109.734 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.9 mp0 -63.01 106.47 0.84 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.037 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 87.2 m-85 68.0 84.77 0.15 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.207 -0.906 . . . . 71.44 109.37 -170.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.81 -83.05 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.309 -0.86 . . . . 71.14 111.443 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.8 mm? -121.26 131.71 54.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.985 0.421 . . . . 73.41 111.151 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 42.1 m -136.77 119.11 15.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.731 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 7.9 m-85 -107.98 133.38 52.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.239 -0.437 . . . . 75.31 110.115 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -128.35 119.44 25.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.074 0.397 . . . . 74.2 110.816 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 8.0 pt-20 -131.63 170.46 14.73 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.2 0.444 . . . . 72.54 112.2 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.622 ' HG3' HD12 ' A' ' 58' ' ' LEU . 72.5 mmtt 118.73 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.057 1.743 . . . . 72.13 113.452 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.518 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 13.2 t90 -135.0 143.57 46.89 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.484 0.55 . . . . 75.31 112.484 -163.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 78' ' ' ASP . 4.9 t30 -119.38 159.23 24.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.951 -0.568 . . . . 74.22 111.112 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.728 HG21 ' HB2' ' A' ' 57' ' ' SER . 17.9 p -61.67 -17.99 57.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.296 0.85 . . . . 73.04 113.296 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.433 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 5.5 m-20 -78.65 -1.61 35.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.658 -0.246 . . . . 74.22 110.89 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 78.9 13.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.762 0.825 . . . . 72.34 109.687 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -86.7 134.89 33.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.306 -0.861 . . . . 74.22 110.058 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.1 mp -107.72 161.09 15.2 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.375 -0.972 . . . . 74.42 108.375 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.653 ' HA3' ' HA ' ' A' ' 102' ' ' SER . . . 148.23 -167.68 28.99 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.277 -1.439 . . . . 61.11 113.141 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 2.3 t -157.9 152.29 24.67 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.637 -0.282 . . . . 73.22 110.494 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.951 ' HA ' ' HB3' ' A' ' 100' ' ' ASP . 10.4 pt-20 -127.45 136.28 51.59 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 125.166 1.541 . . . . 74.42 109.678 171.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 99' ' ' PHE . 1.7 pp -111.4 133.11 58.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 118.658 -1.217 . . . . 73.3 110.815 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.933 ' HB ' ' HE3' ' A' ' 96' ' ' LYS . 21.1 p -114.8 137.52 51.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.727 -0.67 . . . . 74.53 110.783 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.75 135.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.32 -0.4 . . . . 73.34 110.672 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.05 127.33 36.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.378 -0.601 . . . . 74.13 109.378 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 27.1 t70 -69.94 156.64 38.8 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.248 0.547 . . . . 74.41 111.601 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -95.56 -37.31 10.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.5 -0.773 . . . . 72.4 110.831 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.64 -55.07 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 74.24 111.018 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.8 64.32 5.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.772 -0.825 . . . . 74.51 108.772 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -48.88 126.53 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 74.23 111.221 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.512 ' HA2' ' CA ' ' A' ' 2' ' ' ALA . . . 104.1 -4.25 44.94 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.69 -0.687 . . . . 52.31 112.204 -173.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 89' ' ' ASP . 52.7 tp -79.72 130.43 35.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.686 . . . . 75.43 109.146 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.933 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 55.9 tptt -121.72 111.15 16.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.658 -0.701 . . . . 73.42 109.732 -174.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.664 HD11 HG22 ' A' ' 116' ' ' THR . 1.1 mm? -112.77 125.71 54.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.365 -0.605 . . . . 64.22 109.365 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.867 ' HB ' HG21 ' A' ' 86' ' ' THR . 1.8 t -131.92 118.98 20.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.306 -0.558 . . . . 73.44 112.219 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.936 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 88.1 t80 -127.39 114.23 17.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 75.42 109.407 174.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.951 ' HB3' ' HA ' ' A' ' 84' ' ' GLU 0.355 1.2 t70 -153.82 172.95 16.55 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 120.845 -1.159 . . . . 64.24 112.804 159.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.75 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 23.3 t -116.78 147.79 41.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.931 0.396 . . . . 63.54 110.687 -165.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.653 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 33.4 t -114.8 134.81 54.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 75.31 110.368 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -95.52 124.9 39.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.059 0.457 . . . . 74.2 110.252 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.3 m -109.61 115.2 56.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 74.43 110.75 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.22 -7.81 18.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.184 2.589 . . . . 75.41 112.326 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -55.92 -50.81 69.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.743 -0.662 . . . . 75.32 111.01 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 p -129.36 -2.67 4.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.854 0.359 . . . . 71.3 111.65 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.92 11.68 81.02 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.664 -0.779 . . . . 72.45 111.734 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.831 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -94.35 149.08 21.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.693 -0.254 . . . . 71.43 110.567 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -106.94 135.98 47.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.04 0.448 . . . . 74.12 110.405 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -119.54 122.9 42.66 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.443 -0.947 . . . . 75.21 108.443 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.75 ' HA ' ' HA ' ' A' ' 101' ' ' SER . . . -104.45 147.16 27.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.942 0.401 . . . . 65.34 111.596 -168.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.686 ' HZ3' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -121.65 137.56 54.7 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.473 0.654 . . . . 74.52 110.433 177.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.936 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 2.5 tp -127.77 115.86 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.385 -1.279 . . . . 73.41 109.359 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.759 ' HB3' HG23 ' A' ' 98' ' ' THR . 4.4 ttmp? -113.65 121.27 43.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.725 -0.67 . . . . 74.3 110.579 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.664 HG22 HD11 ' A' ' 97' ' ' LEU . 21.7 p -112.68 117.29 31.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.367 -0.605 . . . . 62.12 109.367 175.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.82 134.93 5.34 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.052 -1.07 . . . . 73.34 112.885 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -107.51 125.36 51.18 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.616 -0.512 . . . . 65.53 109.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 1.089 ' HB3' HG23 ' A' ' 3' ' ' VAL . 41.7 mttp -110.26 121.78 46.09 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 121.182 0.515 . . . . 75.23 110.852 -173.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 120' ' ' ARG . 6.4 mmt180 -108.89 152.5 24.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.202 -0.908 . . . . 75.32 109.317 169.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.847 ' HA ' HG11 ' A' ' 3' ' ' VAL . 8.8 tm-20 -50.88 -27.93 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.907 0.883 . . . . 75.33 111.317 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -110.9 -15.4 13.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.091 -0.504 . . . . 74.33 112.143 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' HB3' ' A' ' 144' ' ' LEU . 16.6 tt -149.29 122.12 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 118.813 -1.155 . . . . 74.52 113.482 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.409 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 1.6 t30 -102.83 119.01 38.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.445 -0.798 . . . . 72.43 110.793 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 142' ' ' LEU . 3.1 mm? -112.43 111.9 23.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.166 -0.679 . . . . 73.31 109.166 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.11 118.58 2.44 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.991 -1.1 . . . . 74.24 113.103 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.8 t -110.66 111.22 22.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.935 0.398 . . . . 75.23 110.204 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.643 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 13.6 t70 -100.7 134.74 43.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 75.14 109.728 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.83 117.78 24.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.838 0.352 . . . . 73.14 110.119 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.32 119.22 37.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -82.45 96.9 8.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.903 0.382 . . . . 74.34 111.007 -171.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.559 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 13.0 t70 -96.82 145.31 25.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 72.44 109.638 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.404 HD11 ' C ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -70.7 -29.17 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.544 -175.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.72 58.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.944 0.402 . . . . 70.22 110.923 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.56 108.3 0.51 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.583 -0.607 . . . . 72.3 111.583 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.559 ' HA ' ' H ' ' A' ' 132' ' ' ASP . 77.0 Cg_exo -48.24 123.51 9.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.268 2.645 . . . . 72.42 112.755 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 t -84.68 136.67 33.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.251 -0.648 . . . . 63.34 109.251 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 45.5 mm -105.57 117.04 50.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 65.32 109.467 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -116.19 109.64 17.72 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.28 -0.637 . . . . 74.11 109.28 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.0 133.54 11.61 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.907 -1.139 . . . . 53.54 112.157 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.21 114.08 21.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.418 0.628 . . . . 75.02 109.491 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 144' ' ' LEU . 18.1 tp -116.47 122.94 46.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.362 -0.836 . . . . 75.3 109.569 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.792 HG23 ' HB3' ' A' ' 7' ' ' TYR . 48.3 t -133.9 120.26 35.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.958 -0.386 . . . . 75.25 109.958 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -126.78 139.29 53.23 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.532 -0.867 . . . . 74.24 110.718 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -120.86 128.41 7.41 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 114.674 -1.148 . . . . 75.3 111.837 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -112.59 149.16 33.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.396 -1.705 . . . . 74.21 106.396 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -47.7 95.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 61.4 112.243 -171.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.3 -33.09 5.73 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.133 -0.94 . . . . 72.43 112.867 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' HD1' ' HB2' ' A' ' 173' ' ' TYR . 2.5 m0 -106.47 146.88 30.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.847 0.323 . . . . 74.34 111.463 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.927 ' HB3' HD12 ' A' ' 10' ' ' LEU . 7.5 mt -130.81 136.56 48.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.815 -0.809 . . . . 73.1 108.815 167.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 144' ' ' LEU . . . -130.52 127.4 39.07 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.861 -0.422 . . . . 72.35 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.574 ' N ' HD21 ' A' ' 10' ' ' LEU . . . -131.85 133.54 7.21 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.986 -0.626 . . . . 75.11 111.791 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -129.36 118.72 22.68 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.212 -0.494 . . . . 75.34 110.538 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -111.6 121.83 46.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 75.53 109.508 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -135.48 146.69 48.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.065 -0.346 . . . . 74.2 110.065 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.666 HD22 ' HB3' ' A' ' 166' ' ' GLN . 7.3 p30 -124.35 119.01 28.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.645 0.736 . . . . 71.12 110.966 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.8 t80 -97.03 123.1 40.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.527 -1.215 . . . . 72.22 109.298 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.676 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 25.0 tt0 -94.04 105.25 17.26 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.747 -0.464 . . . . 74.3 109.747 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.78 -22.09 62.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 113.687 -1.597 . . . . 74.51 111.149 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.23 77.83 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.595 -0.891 . . . . 71.3 108.595 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.676 ' H ' ' HG2' ' A' ' 158' ' ' GLU . 17.6 ttmm -98.89 -164.91 1.18 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.92 -1.511 . . . . 73.21 106.92 169.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.44 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 15.5 m -110.38 25.52 11.69 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.223 -0.923 . . . . 73.1 110.509 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -155.31 151.28 27.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 119.398 -0.921 . . . . 74.33 112.727 -160.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.81 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -74.77 135.72 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.105 -1.072 . . . . 72.53 108.105 168.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -93.99 -32.84 13.68 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.421 -0.512 . . . . 74.51 110.929 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.666 ' HB3' HD22 ' A' ' 156' ' ' ASN . 35.3 tt0 -151.38 133.52 15.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 75.4 111.066 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 m -118.69 120.22 36.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 75.03 109.984 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 185' ' ' ASN . 39.3 m-80 -116.82 121.95 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.806 -0.813 . . . . 72.03 108.806 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -139.8 155.48 47.25 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.567 -0.853 . . . . 61.25 111.797 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 10' ' ' LEU . . . -144.81 152.71 40.74 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.616 -0.72 . . . . 75.0 110.23 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 42.9 t -130.21 151.63 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.613 -1.254 . . . . 72.51 107.613 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -158.04 111.03 0.47 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.029 -1.081 . . . . 72.54 112.197 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.407 ' HB2' ' HD1' ' A' ' 149' ' ' TRP . 39.2 p90 -113.39 138.36 50.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.428 0.632 . . . . 74.43 110.957 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -104.63 127.17 52.31 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.695 -1.139 . . . . 73.13 110.486 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 178' ' ' PHE . 33.5 m -127.12 162.54 25.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.555 -0.906 . . . . 74.42 108.555 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.61 -54.7 11.1 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.522 0.564 . . . . 73.32 112.522 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.28 -21.93 13.44 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.896 -0.322 . . . . 65.33 111.698 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.519 ' O ' ' HB ' ' A' ' 175' ' ' THR . 91.4 m-85 -124.69 142.84 51.1 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.805 0.336 . . . . 74.33 110.913 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 29.2 tt0 -135.23 122.9 22.22 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.206 -1.035 . . . . 72.21 108.206 172.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.5 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 8.8 tt -121.54 137.45 54.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.987 -0.685 . . . . 64.43 111.2 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 19.9 t-80 -127.3 114.8 18.07 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.248 -0.887 . . . . 73.15 110.573 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -81.51 148.31 29.25 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.804 -0.813 . . . . 63.23 108.804 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 181' ' ' HIS . 8.3 t30 -147.93 137.02 22.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.3 -0.56 . . . . 74.13 111.25 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.9 t -133.78 123.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.554 -0.748 . . . . 70.23 110.068 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' A' ' 168' ' ' ASN . 11.7 m120 -117.08 112.44 20.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.641 -0.709 . . . . 74.42 109.529 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.514 ' HA ' ' HG3' ' A' ' 166' ' ' GLN . 21.0 t70 63.7 -173.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.418 -0.81 . . . . 74.44 109.072 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.9 -6.0 89.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.395 -0.907 . . . . 43.21 111.101 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.2 m -97.03 -26.95 14.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.0 0.741 . . . . 64.21 113.0 -171.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -116.5 111.15 19.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.523 0.601 . . . . 72.13 110.427 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -127.63 123.62 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 74.41 109.371 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -174.13 -144.87 4.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.802 -1.19 . . . . 65.41 113.33 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -166.23 -172.08 33.13 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.613 -0.804 . . . . 44.0 113.038 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 4.1 m -148.76 139.0 22.39 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.544 0.738 . . . . 73.54 109.12 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.1 mp -124.23 117.45 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 121.2 -0.2 . . . . 75.44 110.464 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 205' ' ' ALA . 11.6 t80 -108.41 120.33 42.09 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.542 -0.54 . . . . 73.14 109.542 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -125.72 133.05 52.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.472 -0.331 . . . . 74.23 110.45 -175.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -101.15 114.41 28.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.477 -0.329 . . . . 73.43 110.378 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 199' ' ' ASN . 8.3 t -73.77 171.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.373 -0.603 . . . . 71.33 109.373 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.573 ' H ' HG12 ' A' ' 198' ' ' VAL . 12.9 m120 -66.11 -30.87 71.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.756 0.312 . . . . 44.13 111.31 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 202' ' ' LEU . 4.7 mptp? -92.81 -164.51 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 75.51 110.846 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -79.11 39.09 0.37 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 73.44 110.496 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.954 ' HG ' ' HB3' ' A' ' 225' ' ' TYR . 4.5 tt -120.92 122.01 39.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 73.44 109.661 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.86 130.54 53.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.98 -0.555 . . . . 74.24 109.658 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.0 t -121.64 153.75 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.863 0.363 . . . . 73.4 110.63 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.02 147.79 37.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.498 0.666 . . . . 74.45 111.55 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.838 HG21 HG21 ' A' ' 221' ' ' ILE . 71.3 t -112.13 132.79 59.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.158 -0.928 . . . . 72.01 109.517 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.3 p-10 -114.2 127.3 55.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.934 -1.136 . . . . 71.52 107.934 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 tp -144.15 129.58 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.556 -0.458 . . . . 71.31 110.819 -169.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.434 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -150.57 129.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.534 . . . . 71.21 111.216 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.627 ' CZ2' ' HA ' ' A' ' 215' ' ' SER . 3.5 t-105 -95.1 125.33 39.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.281 -1.007 . . . . 62.42 108.281 174.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 t -101.56 123.02 44.9 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.495 0.664 . . . . 74.05 110.312 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.7 127.32 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 71.35 111.533 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 153.96 -70.51 0.29 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.875 -0.89 . . . . 70.45 110.875 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.9 -166.01 1.43 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.387 -0.597 . . . . 75.04 109.387 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.627 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . 64.6 m -95.57 24.8 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.094 0.474 . . . . 74.23 110.808 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.07 111.82 20.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 73.34 109.779 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.6 t -99.82 135.97 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.05 0.452 . . . . 74.31 110.007 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -96.5 115.12 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.459 -0.571 . . . . 74.21 109.459 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.566 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 47.6 p90 -119.64 154.95 33.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.846 0.355 . . . . 75.31 110.736 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.39 23.12 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.849 -0.691 . . . . 73.31 111.943 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.838 HG21 HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -135.49 140.64 44.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 121.035 -0.266 . . . . 74.34 110.458 177.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.733 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -133.69 131.13 39.13 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.345 0.403 . . . . 74.5 110.706 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.56 125.14 53.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.393 -0.367 . . . . 74.21 110.186 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 224' ' ' LYS . 8.9 mtmp? -112.02 114.08 26.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 73.04 109.218 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.954 ' HB3' ' HG ' ' A' ' 202' ' ' LEU . 7.9 p90 -127.03 124.63 39.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.435 0.636 . . . . 71.51 111.24 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -82.32 106.87 14.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.048 -0.978 . . . . 72.32 108.946 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.542 HG22 ' HE1' ' A' ' 233' ' ' PHE . 14.8 tt -70.11 -43.98 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.692 0.627 . . . . 74.23 112.692 -167.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.778 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 14.4 t70 -171.79 -63.56 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.311 0.486 . . . . 75.24 112.311 -175.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 78.4 Cg_endo -93.4 -127.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.281 1.987 . . . . 73.11 112.911 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.483 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.5 p-10 -92.35 12.63 21.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.708 -0.678 . . . . 73.11 110.829 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.24 133.1 55.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.456 0.646 . . . . 62.14 111.322 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -121.36 140.26 52.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.833 -1.076 . . . . 54.21 109.34 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.542 ' HE1' HG22 ' A' ' 227' ' ' ILE . 88.1 m-85 -106.45 126.74 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.123 -0.325 . . . . 72.4 110.123 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 15.0 m -120.59 117.63 28.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.484 . . . . 74.22 110.067 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -118.42 140.48 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.829 -0.434 . . . . 62.05 109.829 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.814 ' HB2' ' HZ2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -143.74 148.03 35.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 74.44 111.251 -177.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.512 HG12 HG12 ' A' ' 221' ' ' ILE . 7.0 p -122.58 148.57 26.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 116.32 -0.4 . . . . 64.25 110.113 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -110.45 150.04 29.43 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.254 0.972 . . . . 71.05 109.591 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.566 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 6.8 p30 -37.98 -36.39 0.2 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.61 1.564 . . . . 71.32 114.815 -172.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.671 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.1 m -81.83 21.19 0.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.772 0.32 . . . . 64.4 111.033 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.3 m 68.43 31.54 4.9 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.634 -0.712 . . . . 74.22 111.203 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.829 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.6 mp -96.86 129.53 44.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.566 -0.454 . . . . 72.54 111.536 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -111.49 116.52 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.3 0.572 . . . . 75.32 110.834 -172.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -116.28 133.72 10.95 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.739 -0.664 . . . . 73.22 111.867 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 245' ' ' LEU . 1.3 pp -119.9 146.51 45.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.42 . . . . 61.02 110.678 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -134.17 133.44 6.87 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.612 -0.722 . . . . 73.31 111.778 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.706 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 19.4 m-85 -102.86 114.48 28.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.666 -0.864 . . . . 73.54 108.666 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 22.1 m -116.84 114.95 24.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.811 0.339 . . . . 71.42 110.417 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -132.45 137.51 47.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.854 0.359 . . . . 74.22 110.676 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.9 m -112.37 95.71 5.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.001 -0.545 . . . . 73.01 110.159 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 43.7 tp -82.05 88.34 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.268 -0.642 . . . . 75.02 109.268 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 75.1 mmtt 67.93 163.82 0.13 Allowed Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.259 -0.882 . . . . 74.13 110.273 -175.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 40.8 Cg_endo -69.23 64.29 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.355 2.037 . . . . 71.14 112.3 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -158.68 -45.43 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.911 -0.586 . . . . 74.45 112.315 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.6 mt -124.08 121.44 62.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 64.15 111.652 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 280' ' ' GLU . 37.1 ttmt -117.47 115.44 25.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.367 -0.605 . . . . 64.12 109.367 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.5 tp -100.44 130.53 46.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.424 -0.353 . . . . 73.44 110.521 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 30.0 m -129.98 111.25 12.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.554 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.913 HD23 HD21 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.21 122.84 44.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.892 -1.151 . . . . 75.13 107.892 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.9 m -124.39 139.58 53.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.971 0.415 . . . . 73.14 110.854 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -143.92 127.77 17.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.99 -0.55 . . . . 73.24 110.248 177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.731 HD13 HD21 ' A' ' 242' ' ' LEU . 2.7 tm? -101.62 118.04 36.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.361 -0.977 . . . . 74.12 108.361 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -97.7 110.95 23.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.605 -0.887 . . . . 64.41 108.605 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.829 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.9 m-20 -68.62 102.34 1.47 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.711 -0.848 . . . . 72.44 108.711 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.9 -10.06 43.65 Favored Glycine 0 C--N 1.321 -0.293 0 CA-C-N 115.64 -0.709 . . . . 75.42 111.844 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -90.59 -25.34 20.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.206 -0.497 . . . . 73.43 111.092 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -161.5 24.25 0.12 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.105 1.52 . . . . 74.43 115.105 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 264' ' ' ASP . 0.2 OUTLIER -64.18 -46.47 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 120.079 1.309 . . . . 73.42 112.878 176.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.43 -25.92 62.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.067 0.461 . . . . 61.53 110.594 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.87 2.37 32.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 52.54 111.067 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.63 -103.12 0.34 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.141 -1.028 . . . . 71.2 112.856 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -158.78 167.28 34.69 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.082 -1.056 . . . . 64.01 113.223 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -111.47 150.12 30.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.66 -0.77 . . . . 73.52 109.593 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 43.6 mttm -93.7 137.18 33.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.689 -0.856 . . . . 71.03 108.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.7 tm? -125.66 133.06 52.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.755 0.312 . . . . 72.21 110.294 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.46 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.24 122.39 2.18 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.062 -0.815 . . . . 61.35 111.062 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.913 HD21 HD23 ' A' ' 259' ' ' LEU . 2.2 tm? -115.82 125.32 52.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.644 -0.502 . . . . 71.13 109.644 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -134.9 138.43 10.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.429 -0.891 . . . . 70.14 112.895 -175.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.85 132.39 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.777 -0.453 . . . . 74.31 109.777 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.71 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 46.4 mt-10 -109.85 110.88 22.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.812 -0.81 . . . . 75.23 108.812 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.582 ' HD1' HD13 ' A' ' 31' ' ' LEU . 16.4 t80 -104.16 141.6 35.96 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.589 -0.893 . . . . 74.14 108.589 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -135.56 119.79 17.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.935 0.398 . . . . 72.51 110.639 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.22 108.43 19.05 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.156 -0.683 . . . . 53.04 109.156 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.2 mt -121.13 -69.02 0.86 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.843 -0.799 . . . . 65.45 108.843 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 114.679 -1.146 . . . . 73.3 108.532 177.228 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.683 0.278 . . . . 72.41 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.709 ' HB ' ' HE2' ' A' ' 119' ' ' LYS . 60.5 t -67.43 125.99 91.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.037 -0.529 . . . . 72.11 110.332 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.23 153.98 36.87 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.39 2.727 . . . . 75.3 113.279 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.03 64.34 6.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.114 2.543 . . . . 75.45 112.047 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.565 ' HB ' HD22 ' A' ' 150' ' ' LEU . 14.9 p -69.63 -37.74 76.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.466 -0.788 . . . . 75.31 111.096 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.693 ' HB3' HG23 ' A' ' 143' ' ' VAL . 3.5 p90 -64.12 -22.03 66.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 72.31 111.278 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.69 -19.79 44.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.066 -0.516 . . . . 73.4 110.367 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.49 11.91 37.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.032 0.92 . . . . 71.32 109.333 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.967 HD23 ' HA3' ' A' ' 152' ' ' GLY . 3.3 tp -76.53 -14.3 60.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.007 -0.997 . . . . 74.31 110.849 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.66 26.23 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.44 -0.886 . . . . 75.14 113.291 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -68.93 -50.17 51.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.151 0.476 . . . . 73.11 110.525 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -57.34 -38.86 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.836 -0.62 . . . . 74.22 111.027 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.65 72.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 72.32 111.402 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.77 -39.91 84.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.6 -0.273 . . . . 74.33 111.518 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.556 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 14.7 t70 -58.59 -49.83 76.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.642 -0.254 . . . . 73.12 111.353 -175.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -70.23 -31.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.015 0.436 . . . . 73.21 110.867 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -72.64 -32.19 65.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 74.03 110.71 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -81.87 -25.84 34.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 65.12 110.73 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HD3' ' O ' ' A' ' 16' ' ' ASP . 1.9 mptm? -85.17 20.06 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 63.35 110.865 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.594 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -99.61 -19.47 20.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 63.35 113.286 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -87.16 138.28 31.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.267 0.556 . . . . 74.21 112.141 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -152.35 109.65 0.42 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.22 -0.9 . . . . 63.04 111.709 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -103.73 14.99 29.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.785 0.326 . . . . 74.42 111.005 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.33 14.61 53.52 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 109.226 -1.55 . . . . 72.42 109.226 -166.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 46' ' ' SER . 5.3 tt -99.47 145.6 27.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.944 -1.128 . . . . 73.21 110.688 -168.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.553 HD13 HD11 ' A' ' 277' ' ' LEU . 28.3 mm -102.49 125.26 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.986 -1.006 . . . . 75.21 110.198 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -107.79 120.01 41.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.332 -0.618 . . . . 75.43 109.332 175.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 279' ' ' LEU . 22.5 tp -114.44 147.56 39.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.837 0.351 . . . . 73.1 110.554 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.566 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.6 t70 -150.82 131.65 14.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 74.25 109.768 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.931 HD21 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -126.84 123.59 37.67 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 97.1 mttt -132.65 124.97 29.29 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.839 -0.344 . . . . 74.23 110.988 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 41' ' ' PHE . 8.8 t -135.83 129.95 33.2 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.285 -0.635 . . . . 54.02 109.285 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.705 ' HB3' HH12 ' A' ' 63' ' ' ARG . 90.3 mttt -118.3 131.17 56.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.965 -0.562 . . . . 72.43 109.969 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -132.91 150.26 52.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.238 -0.437 . . . . 60.45 110.513 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.91 2.37 46.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.799 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -100.08 24.75 8.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 64.31 111.521 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.3 -5.89 82.64 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.328 -0.939 . . . . 64.42 113.451 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.42 127.78 46.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.179 0.99 . . . . 74.32 111.764 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.3 117.6 11.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.507 -0.923 . . . . 74.43 108.507 164.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HB2' HG22 ' A' ' 33' ' ' THR . 96.0 m-85 -110.32 125.6 53.34 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.588 -0.445 . . . . 75.04 110.768 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 20.6 m -125.18 116.11 21.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 61.52 109.934 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 6.4 m -108.76 123.28 48.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.051 -0.722 . . . . 75.21 109.051 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -130.03 126.41 37.64 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.006 -0.368 . . . . 74.05 110.006 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.14 156.66 26.97 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.946 -1.121 . . . . 73.25 112.576 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.566 ' HB3' HD21 ' A' ' 26' ' ' LEU . 16.6 m -137.98 132.35 32.15 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.308 -0.627 . . . . 55.22 109.308 176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.32 130.04 19.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.862 0.363 . . . . 71.42 110.593 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 46.1 t30 -80.64 142.02 34.39 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.444 -0.576 . . . . 74.44 109.444 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -64.04 -19.37 65.16 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.968 0.413 . . . . 74.3 111.255 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -70.62 -13.6 62.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 73.12 110.442 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m 71.56 -3.52 2.12 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.726 -0.67 . . . . 74.12 111.726 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -73.06 -27.46 61.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.217 -0.447 . . . . 71.12 110.981 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.28 101.66 6.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 71.21 110.034 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.66 120.69 58.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.985 -0.552 . . . . 74.4 110.11 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -131.3 125.03 31.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.955 -0.387 . . . . 65.43 109.955 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.83 155.19 20.06 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.266 -0.969 . . . . 75.23 112.409 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 p -146.8 141.21 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.111 0.482 . . . . 74.53 110.441 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.38 122.54 42.03 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.926 -1.139 . . . . 73.25 107.926 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 28.0 mt-10 -116.98 119.96 36.91 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.956 -0.565 . . . . 74.03 109.82 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -109.78 120.99 44.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.724 -0.671 . . . . 70.15 109.841 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 42.9 tttp -117.08 132.51 56.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.067 -0.716 . . . . 71.1 109.067 176.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.692 ' O ' ' HA ' ' A' ' 70' ' ' THR . 37.9 t80 -100.19 121.6 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.044 -1.095 . . . . 75.35 108.044 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.705 HH12 ' HB3' ' A' ' 34' ' ' LYS . 10.6 ttp180 -123.72 107.3 11.31 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.538 0.685 . . . . 74.55 111.094 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -113.55 115.58 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.79 -1.096 . . . . 75.22 108.886 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m 70.93 139.13 0.04 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.961 0.788 . . . . 72.53 109.59 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.58 101.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.692 -0.485 . . . . 71.53 109.692 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.24 68.92 0.59 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.378 -0.828 . . . . 72.14 110.684 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.04 -76.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.382 -1.087 . . . . 74.34 110.382 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -122.11 130.18 53.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.743 0.306 . . . . 74.1 110.247 173.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.778 HG22 ' HB ' ' A' ' 86' ' ' THR . 9.0 t -138.44 135.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.425 0.631 . . . . 75.41 112.089 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 85.2 m-85 -105.75 133.77 49.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.844 -0.798 . . . . 74.43 108.844 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.4 m -120.84 119.31 32.29 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.71 -0.396 . . . . 75.45 111.465 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 28.1 mt-10 -130.96 152.2 50.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.668 -0.697 . . . . 74.12 109.803 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.63 ' HB2' ' HZ3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -160.43 104.38 1.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 73.42 110.917 178.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.966 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 48.8 t90 -98.53 127.94 44.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.298 -0.41 . . . . 71.15 110.358 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.86 136.84 38.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.488 -0.93 . . . . 71.01 108.488 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -61.8 -25.83 67.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 73.24 111.862 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.7 -38.17 5.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.118 0.784 . . . . 72.12 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.27 -90.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.347 0.869 . . . . 55.31 113.347 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 m -85.22 123.6 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.811 0.671 . . . . 73.33 112.811 -166.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.966 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -108.48 119.07 38.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.624 -0.51 . . . . 75.52 109.624 168.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -115.53 156.61 15.54 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.643 -0.789 . . . . 41.11 112.776 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 9.8 t -172.88 148.72 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.681 -0.489 . . . . 74.42 109.681 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.641 ' HB2' ' HA ' ' A' ' 100' ' ' ASP . 12.2 mm-40 165.58 -155.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.585 1.154 . . . . 73.4 110.491 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.466 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -131.58 138.97 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.49 0.552 . . . . 74.32 112.49 -165.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.778 ' HB ' HG22 ' A' ' 70' ' ' THR . 23.1 m -127.77 131.75 49.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.337 -0.392 . . . . 54.41 110.003 175.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 97' ' ' LEU . 3.9 p -129.95 129.8 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 64.41 111.672 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.56 117.87 30.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.278 -1.008 . . . . 73.44 108.278 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -87.28 140.18 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.26 -0.576 . . . . 71.42 111.642 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.84 -25.85 15.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.279 -0.873 . . . . 74.42 110.655 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.9 tp -67.13 -57.23 7.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.032 -0.729 . . . . 75.34 109.032 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.54 76.17 5.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.298 -1.001 . . . . 72.33 108.298 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.67 123.11 13.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.554 -0.748 . . . . 74.3 110.683 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . 100.6 -0.91 55.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.665 -0.698 . . . . 73.42 112.319 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.3 tp -91.41 131.1 37.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 75.53 110.201 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -121.68 111.24 16.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.328 -0.851 . . . . 72.34 109.85 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HB2' HG12 ' A' ' 87' ' ' VAL . 1.9 mm? -100.79 126.34 47.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.083 -0.71 . . . . 72.35 109.083 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 23.6 m -128.87 118.34 22.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.119 0.485 . . . . 75.3 111.749 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.619 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 77.7 m-85 -111.06 116.22 30.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.85 -1.167 . . . . 74.13 107.85 170.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.641 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.5 p-10 -130.56 128.19 40.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.846 0.355 . . . . 73.44 110.575 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 t -119.57 148.81 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.732 0.301 . . . . 64.14 110.528 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.409 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 7.9 p -133.04 134.54 44.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.301 -0.409 . . . . 73.22 110.478 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.655 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 9.8 m-85 -111.21 138.94 47.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.207 -0.294 . . . . 75.03 110.207 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.2 p -122.47 107.85 34.05 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.834 0.35 . . . . 64.21 110.195 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.91 -1.13 9.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.986 2.457 . . . . 74.33 112.76 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -63.86 -61.59 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.38 0.609 . . . . 73.52 109.51 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 109' ' ' LYS . 42.7 m -91.76 -27.27 18.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.283 -0.871 . . . . 71.44 109.958 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.5 9.4 60.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.666 -0.778 . . . . 54.31 111.843 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.568 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -94.16 148.94 21.69 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.802 0.334 . . . . 64.3 110.617 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.427 ' CB ' ' HD1' ' A' ' 103' ' ' PHE . 18.6 ptpt -114.23 152.74 30.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 73.41 110.796 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.568 ' OD1' ' HE2' ' A' ' 109' ' ' LYS . 2.8 m-20 -116.7 122.58 44.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.952 -0.758 . . . . 73.53 108.952 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.33 114.92 29.33 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.343 -0.614 . . . . 72.14 109.343 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.41 ' HD2' ' OD2' ' A' ' 130' ' ' ASP . 50.1 tttm -115.03 137.98 51.38 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.211 0.529 . . . . 74.23 110.606 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 129' ' ' MET . 3.2 tp -127.3 126.0 66.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.431 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 24.4 ttpp -118.9 120.31 36.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.202 0.525 . . . . 74.35 110.208 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.8 p -107.34 116.89 32.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.604 -0.887 . . . . 73.53 108.604 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.37 135.78 8.19 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.985 -1.103 . . . . 42.32 112.106 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -126.78 124.81 40.56 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.442 -0.577 . . . . 75.55 109.442 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.709 ' HE2' ' HB ' ' A' ' 3' ' ' VAL . 15.9 ptmt -109.08 121.71 45.73 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.486 0.66 . . . . 72.44 109.921 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -104.56 155.92 18.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.013 -1.106 . . . . 74.4 108.013 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -54.68 -28.57 48.52 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.416 0.447 . . . . 74.21 112.184 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.34 -15.38 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.548 -0.296 . . . . 74.43 111.692 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.524 HD13 HD13 ' A' ' 142' ' ' LEU . 9.1 tp -146.35 135.56 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.601 -0.44 . . . . 75.01 111.74 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.72 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 43.8 t30 -122.63 120.86 34.99 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.764 -0.585 . . . . 75.41 111.737 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.4 127.03 53.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.696 0.284 . . . . 73.14 111.213 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.39 125.64 4.08 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.037 -0.601 . . . . 54.21 112.047 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 49.7 m -113.32 112.11 23.14 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.578 -0.366 . . . . 63.41 111.275 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.636 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 9.9 m-20 -96.2 147.46 23.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 73.44 109.994 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.488 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.5 ttt -139.77 120.41 14.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.627 -0.261 . . . . 75.44 110.543 173.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' A' ' 113' ' ' LYS . 35.4 m-20 -90.72 117.45 29.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.762 -0.829 . . . . 73.44 108.762 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.18 97.53 9.26 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.079 0.466 . . . . 73.13 110.142 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.03 150.23 26.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.629 -0.714 . . . . 55.34 109.212 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.718 ' H ' HD12 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -72.27 -19.9 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.98 0.363 . . . . 74.24 111.98 -175.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.56 -18.96 21.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 74.4 111.047 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.8 128.93 1.03 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.519 -0.848 . . . . 73.21 112.578 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.0 150.56 26.65 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.77 2.314 . . . . 74.42 112.657 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 m -126.8 134.01 50.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.566 . . . . 71.14 110.08 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 118.72 56.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.017 0.437 . . . . 75.5 109.87 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 12.1 ttp180 -111.24 130.18 55.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.622 -0.51 . . . . 71.44 109.622 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.19 132.49 10.94 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.993 -1.099 . . . . 73.33 111.406 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.84 115.47 23.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.361 -0.607 . . . . 75.22 109.361 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 123' ' ' ILE . 8.9 tp -121.0 124.31 44.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.989 -0.55 . . . . 74.32 110.383 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.72 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 77.3 t -110.92 131.78 61.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 75.51 109.809 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.921 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.5 mm? -108.22 137.6 45.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.347 -0.842 . . . . 75.13 108.93 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -125.86 117.38 2.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.582 -0.736 . . . . 42.22 111.537 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.705 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 90.0 m-85 -136.32 148.42 47.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.022 -0.733 . . . . 74.2 109.022 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.69 99.84 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 73.52 110.673 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.97 -30.87 9.53 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.564 -0.744 . . . . 74.32 111.866 -176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 85.5 m95 -105.95 122.06 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.221 0.534 . . . . 74.52 111.703 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.565 HD22 ' HB ' ' A' ' 6' ' ' THR . 1.6 tm? -110.61 149.37 30.51 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.828 -1.545 . . . . 73.53 106.828 172.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -157.44 160.14 38.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.67 -0.812 . . . . 73.35 111.248 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.967 ' HA3' HD23 ' A' ' 10' ' ' LEU . . . -156.8 133.34 3.58 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.047 -0.979 . . . . 62.43 110.882 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.438 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 34.0 m-85 -130.75 117.81 19.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.087 0.47 . . . . 74.04 110.205 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 168' ' ' ASN . 39.7 mt-30 -113.77 129.06 56.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.639 -0.71 . . . . 74.04 109.976 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.4 133.59 34.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.534 -0.303 . . . . 73.42 110.2 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 6.7 t30 -113.67 119.43 37.4 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.753 -0.462 . . . . 73.54 109.753 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 83.5 t80 -105.4 124.06 48.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.107 -0.497 . . . . 74.3 110.249 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.421 ' OE1' ' HE2' ' A' ' 161' ' ' LYS . 35.3 tt0 -86.96 97.73 10.86 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.672 -0.862 . . . . 75.41 108.672 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.1 m -71.53 -21.88 61.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 113.673 -1.603 . . . . 72.31 111.188 173.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.01 69.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.735 -0.839 . . . . 72.0 108.735 172.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.588 ' HG2' ' H ' ' A' ' 162' ' ' SER . 17.0 ttmm -112.9 -157.45 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.52 -1.289 . . . . 74.34 107.52 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.588 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 5.6 p -109.74 27.67 9.34 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 122.034 -0.416 . . . . 64.12 111.703 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -143.83 147.65 34.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 117.747 -1.581 . . . . 75.43 114.406 -161.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 69.4 t -73.75 124.26 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.265 -0.88 . . . . 62.23 109.456 171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.8 p -95.94 -31.97 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.629 -0.26 . . . . 74.03 111.581 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 64.2 mt-30 -127.31 131.71 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.743 0.306 . . . . 72.11 110.785 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.562 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 17.7 m -121.86 129.35 52.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.754 -0.461 . . . . 65.25 109.754 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 27.9 t-20 -136.87 121.33 18.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.766 -0.457 . . . . 73.42 109.766 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.64 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 46.4 m-85 -121.78 140.63 52.11 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.948 -0.301 . . . . 72.33 110.59 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.65 139.6 38.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.323 -0.399 . . . . 64.31 110.706 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 12.4 t -132.3 152.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.187 -0.672 . . . . 72.41 109.187 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.18 116.83 1.36 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.804 -0.712 . . . . 74.1 112.037 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -113.39 121.23 43.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.807 -0.812 . . . . 71.41 108.807 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 129.72 56.5 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.983 0.896 . . . . 74.15 111.892 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.9 m -110.13 161.8 15.21 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 106.591 -1.633 . . . . 75.53 106.591 166.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -57.51 -46.61 83.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.076 0.398 . . . . 73.43 111.9 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -106.18 -1.68 23.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.7 0.259 . . . . 71.01 111.7 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.2 117.42 14.52 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 110.489 -0.189 . . . . 75.55 110.489 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -118.86 124.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.145 -0.622 . . . . 74.52 110.987 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.8 tt -118.9 138.1 52.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.548 0.689 . . . . 74.23 111.652 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.793 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 64.2 m80 -114.72 150.51 35.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.124 -0.944 . . . . 74.21 108.98 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.568 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 27.8 m -123.33 138.68 54.56 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.265 -0.642 . . . . 73.31 109.265 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -134.27 140.97 46.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 73.22 111.322 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 47.0 t -133.47 115.55 22.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.283 -0.871 . . . . 72.4 110.019 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.0 t30 -103.62 99.46 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.384 0.611 . . . . 75.22 110.059 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 46.0 m-20 58.01 -161.48 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.886 -1.052 . . . . 73.41 110.804 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.52 -5.24 87.95 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.263 -0.881 . . . . 74.12 111.056 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 25.1 p -88.54 -24.65 22.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.039 0.755 . . . . 73.01 113.039 -173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.767 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 5.2 tm-20 -136.25 125.98 25.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.801 -0.36 . . . . 75.1 111.154 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.4 123.92 26.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 75.45 109.198 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.71 -146.2 4.82 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.238 -0.982 . . . . 61.24 113.003 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -172.82 -171.16 37.32 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.859 -0.686 . . . . 64.34 112.962 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.793 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 41.3 t -147.19 140.13 25.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.283 -0.636 . . . . 74.21 109.283 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.9 mp -120.13 118.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 110.07 -0.344 . . . . 75.25 110.07 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -108.91 120.42 42.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.301 0.572 . . . . 75.52 109.796 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 196' ' ' GLN . 11.1 mm100 -123.02 112.59 17.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.45 -0.795 . . . . 64.4 110.812 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.68 127.76 54.26 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.097 -0.705 . . . . 75.35 109.097 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 202' ' ' LEU . 1.1 m -111.57 151.79 13.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.091 0.472 . . . . 64.43 110.473 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -63.4 -20.19 65.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 71.34 111.829 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.79 47.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.363 0.505 . . . . 71.45 112.363 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 226' ' ' GLN . 48.9 mmtm 64.58 23.23 12.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 65.33 113.08 169.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.677 ' HG ' ' HB2' ' A' ' 225' ' ' TYR . 7.2 tt -126.79 134.61 50.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 74.04 110.764 -174.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -126.28 134.96 51.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.144 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 223' ' ' ALA . 24.7 m -122.91 141.75 51.56 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.324 -0.251 . . . . 64.31 110.324 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.41 135.58 48.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.235 0.541 . . . . 70.44 110.412 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.732 HG21 HG23 ' A' ' 221' ' ' ILE . 93.2 t -114.6 132.87 62.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.62 -0.718 . . . . 73.22 110.036 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -113.61 126.98 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.181 -1.044 . . . . 73.35 108.181 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 218' ' ' ARG . 5.0 tp -140.8 128.77 21.94 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 110.133 -0.321 . . . . 63.31 110.133 -170.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.41 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.96 135.83 19.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.0 0.428 . . . . 75.11 111.696 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -111.23 124.16 51.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.812 -0.631 . . . . 74.44 109.633 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.8 p -95.66 112.92 24.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 73.45 110.901 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.39 143.79 52.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 73.45 110.437 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.99 -18.19 50.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.978 -0.849 . . . . 73.31 110.978 -173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -136.36 164.24 28.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.395 -0.403 . . . . 71.41 110.136 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.6 p -92.46 16.4 11.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.416 0.627 . . . . 74.55 109.483 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.02 111.01 17.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.285 -0.87 . . . . 72.43 111.637 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 25.1 m -96.17 122.67 39.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.204 -1.036 . . . . 61.22 108.204 168.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.408 ' O ' HD11 ' A' ' 208' ' ' LEU . 28.8 mmm180 -105.52 116.9 32.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.542 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 23.9 p90 -114.03 152.53 30.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.243 0.544 . . . . 74.54 110.387 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.67 140.38 7.63 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.921 -1.036 . . . . 72.55 110.724 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.732 HG23 HG21 ' A' ' 206' ' ' VAL . 15.8 pt -131.74 134.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.729 0.265 . . . . 72.32 110.512 -177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -138.63 130.07 27.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.827 0.346 . . . . 62.03 110.583 174.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -120.85 125.66 48.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.53 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -107.24 114.96 29.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.509 0.671 . . . . 75.45 110.025 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.677 ' HB2' ' HG ' ' A' ' 202' ' ' LEU . 45.3 t80 -129.17 126.84 40.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.227 -0.897 . . . . 74.11 110.542 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.402 ' CG ' ' HB3' ' A' ' 201' ' ' LYS . 16.8 pt20 -77.14 123.75 26.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.373 -0.603 . . . . 70.25 109.373 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 233' ' ' PHE . 73.7 mt -70.14 -55.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.933 -0.576 . . . . 75.43 111.22 -172.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.619 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.2 t70 177.07 -54.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 123.66 0.6 . . . . 72.31 110.806 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 96.5 Cg_endo -83.75 -133.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.984 1.789 . . . . 74.3 112.051 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.437 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 9.8 m-20 -92.39 11.83 24.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 72.25 110.709 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.1 133.8 54.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.54 . . . . 75.02 111.082 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.89 142.14 47.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.182 -0.917 . . . . 74.23 109.43 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.466 ' HB2' HD12 ' A' ' 227' ' ' ILE . 70.9 t80 -106.78 132.38 52.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.183 0.516 . . . . 72.44 110.262 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 17.7 m -123.12 127.2 48.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.528 -0.76 . . . . 64.44 110.028 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -111.94 141.35 45.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.65 -0.5 . . . . 70.02 109.65 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 20.9 pttm -141.1 153.87 45.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.521 0.2 . . . . 74.31 110.868 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.62 HG13 HG12 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -147.47 155.15 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 75.22 110.187 175.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.744 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.1 t-20 -125.55 148.01 49.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.899 -0.778 . . . . 64.5 108.899 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.542 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 7.6 t30 -41.29 -37.64 1.01 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.645 1.216 . . . . 75.22 113.36 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.1 m -78.49 27.45 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.752 -0.204 . . . . 63.04 111.285 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.7 p 57.93 40.83 25.36 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.956 0.902 . . . . 65.44 110.605 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.798 ' HB3' HD13 ' A' ' 262' ' ' LEU . 56.4 mt -97.75 117.09 31.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.802 -0.635 . . . . 75.21 109.744 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.541 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.9 mp -103.27 117.99 49.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 109.776 -0.453 . . . . 74.34 109.776 -174.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.52 148.25 17.58 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.358 -0.925 . . . . 64.13 113.122 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.72 150.62 38.78 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.675 -0.861 . . . . 74.13 108.675 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.33 123.17 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.533 -0.841 . . . . 61.2 111.591 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.37 116.27 19.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.235 0.54 . . . . 75.45 110.225 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.8 t -116.05 136.72 52.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.543 -0.753 . . . . 74.54 110.732 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -132.87 134.28 44.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 74.51 110.68 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.424 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.2 t -89.03 115.34 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.943 -0.762 . . . . 73.23 108.943 172.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.42 ' N ' HD13 ' A' ' 251' ' ' LEU . 5.6 mp -75.19 -59.24 2.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.585 0.707 . . . . 64.14 109.517 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -119.73 149.69 48.87 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 106.991 -1.485 . . . . 72.32 106.991 171.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.8 99.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.391 2.061 . . . . 74.21 112.181 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.19 -22.05 6.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.769 -0.65 . . . . 72.12 112.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 252' ' ' LYS . 3.4 mp -106.26 119.25 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.376 -0.485 . . . . 75.5 109.981 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -120.62 120.65 36.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.679 . . . . 74.31 111.473 -172.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.2 tp -100.95 128.57 46.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.101 -0.703 . . . . 71.42 109.101 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.4 t -126.16 113.99 17.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.518 0.675 . . . . 73.32 111.125 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.933 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -99.64 124.12 44.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.21 -1.033 . . . . 75.52 108.21 175.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 22.6 t -127.32 143.16 51.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.945 0.402 . . . . 74.15 110.079 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.48 154.52 45.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.804 -0.443 . . . . 65.0 109.804 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 242' ' ' LEU . 1.9 tm? -130.84 118.59 20.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.341 -0.985 . . . . 73.21 108.341 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.609 ' HB3' HG12 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -97.4 106.69 19.05 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.343 -1.355 . . . . 74.31 107.343 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 5.2 m-20 -71.62 105.76 3.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.126 -0.694 . . . . 71.33 109.126 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.14 -13.89 10.28 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.256 -0.497 . . . . 65.22 112.885 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.47 -18.39 26.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.728 0.299 . . . . 65.13 110.946 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 4.2 m-20 -120.89 -41.31 2.56 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.72 0.637 . . . . 73.41 112.72 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.609 HG12 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -59.35 -25.81 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.429 0.529 . . . . 75.35 112.429 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . 0.413 HD21 ' HA ' ' A' ' 269' ' ' ASN . 2.4 t-20 -63.59 -30.36 71.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 72.03 110.431 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.34 -16.76 15.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 52.22 110.677 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.95 94.58 1.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.019 -0.537 . . . . 64.33 112.265 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 177.93 86.43 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.661 -0.78 . . . . 74.52 112.498 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -113.98 144.65 42.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.658 0.266 . . . . 65.24 110.639 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 25.6 mmtp -97.35 144.11 27.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.507 -0.315 . . . . 72.31 110.238 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -134.85 126.28 28.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.835 0.35 . . . . 72.24 110.105 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 126.78 5.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 71.24 111.419 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.933 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -115.26 134.02 55.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.739 -0.467 . . . . 72.24 109.739 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -137.59 144.57 16.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.419 -0.896 . . . . 54.53 113.25 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.688 ' HB2' HD11 ' A' ' 29' ' ' LEU . 2.3 mm? -123.98 131.43 53.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.419 -0.585 . . . . 73.24 109.419 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.72 112.22 15.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.346 -0.613 . . . . 73.52 109.346 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.931 ' HB2' HD21 ' A' ' 31' ' ' LEU . 93.6 m-85 -106.9 106.38 16.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.112 -0.495 . . . . 74.52 110.308 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.526 ' HG2' HD22 ' A' ' 284' ' ' LEU . 29.7 tt0 -99.73 110.62 23.01 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.474 -0.565 . . . . 74.45 109.474 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -97.95 108.67 21.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.419 0.628 . . . . 63.31 110.967 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.526 HD22 ' HG2' ' A' ' 282' ' ' GLN . 3.0 mm? -135.14 -38.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.837 -1.074 . . . . 75.23 108.779 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.825 -1.08 . . . . 74.14 109.519 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.178 -0.304 . . . . 75.41 110.178 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 119' ' ' LYS . 21.3 t 64.47 96.97 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.548 -0.751 . . . . 51.35 111.242 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.9 Cg_endo -69.42 142.23 48.84 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.794 2.329 . . . . 74.32 112.388 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 19.3 Cg_exo -66.39 90.96 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.807 2.338 . . . . 74.15 111.974 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.502 ' HB ' HD21 ' A' ' 150' ' ' LEU . 2.3 p -84.17 -2.57 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.443 0.639 . . . . 73.25 110.781 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -57.92 -24.63 58.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 72.23 109.753 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.98 -26.21 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 75.52 110.078 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.41 -4.53 48.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 71.33 110.574 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 150' ' ' LEU . 66.3 mt -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 74.4 110.905 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.32 40.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.543 -1.313 . . . . 54.31 114.247 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -57.95 -54.57 45.47 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.462 0.631 . . . . 75.45 109.669 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 p -58.72 -39.33 80.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.568 -0.742 . . . . 72.32 111.676 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.39 70.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.532 -0.304 . . . . 72.32 111.195 -176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -68.02 -36.23 79.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 73.13 110.588 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.43 -48.69 63.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.373 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.26 -39.33 78.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.445 -0.343 . . . . 74.23 111.213 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.8 -41.35 78.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.939 -0.393 . . . . 75.41 109.939 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m 70.78 94.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.378 -0.828 . . . . 73.51 111.998 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -110.76 -12.22 14.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 72.54 110.548 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.85 1.2 89.01 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.864 -0.684 . . . . 40.13 112.536 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.64 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 87.8 m-85 -133.84 144.17 48.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.344 -0.613 . . . . 75.11 109.344 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.94 34.0 0.4 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.182 -1.008 . . . . 71.02 112.796 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.2 -1.79 38.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.259 0.552 . . . . 75.32 109.973 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 83.78 12.95 76.44 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.254 -1.139 . . . . 74.04 110.254 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.639 HD12 ' HA ' ' A' ' 48' ' ' ASN . 6.8 tp -131.24 179.22 6.14 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.664 0.745 . . . . 75.11 112.015 -169.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.918 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -110.26 147.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.815 -1.084 . . . . 75.45 109.492 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 14.6 ptpt -138.41 154.38 48.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 71.24 109.577 171.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.681 HD13 ' HB2' ' A' ' 279' ' ' LEU . 3.7 tt -140.09 145.09 37.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.695 0.284 . . . . 73.52 111.12 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -131.11 128.35 39.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.553 0.692 . . . . 73.44 109.901 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -108.43 124.5 50.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.267 -0.879 . . . . 71.34 108.879 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -125.56 123.33 38.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.798 0.332 . . . . 73.13 110.122 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.9 m -137.95 121.56 17.37 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.643 -0.873 . . . . 72.2 108.643 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -137.07 143.82 42.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.551 0.691 . . . . 75.24 112.276 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -139.1 137.49 36.22 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.949 -1.13 . . . . 61.33 107.949 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.75 49.32 1.32 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.846 0.832 . . . . 74.53 110.756 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -122.46 22.64 9.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.677 -1.147 . . . . 72.14 109.099 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 91.14 -8.24 79.79 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 119.4 -0.667 . . . . 62.23 113.751 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.69 127.38 48.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.514 1.157 . . . . 73.42 112.643 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 22.9 mt-10 -139.54 118.85 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.891 -0.411 . . . . 75.43 109.891 165.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.95 121.31 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.79 0.329 . . . . 72.23 110.271 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.831 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.4 m -126.95 132.37 50.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 75.42 111.18 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 m -125.36 140.45 52.8 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.39 -0.596 . . . . 54.34 109.39 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.8 m -147.57 126.11 12.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.785 0.326 . . . . 75.5 110.479 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.643 ' HA3' ' HA2' ' A' ' 56' ' ' GLY . . . -164.17 -167.14 24.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 73.2 112.25 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 39.0 m -127.59 158.54 37.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 70.3 110.505 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -135.08 135.58 41.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 75.22 110.328 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.639 ' HA ' HD12 ' A' ' 26' ' ' LEU . 24.4 t-20 -76.23 138.06 40.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.977 -0.556 . . . . 61.1 109.648 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.445 ' HA ' HD13 ' A' ' 27' ' ' ILE . 1.9 m -46.63 138.95 5.54 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.14 0.9 . . . . 72.4 111.983 -176.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 72.05 29.74 2.3 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.899 0.749 . . . . 72.03 110.321 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p 49.95 37.73 14.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.651 0.781 . . . . 73.21 112.037 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -72.61 -35.14 67.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.268 -0.423 . . . . 75.23 111.39 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -160.5 118.73 2.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.935 -0.395 . . . . 73.03 109.935 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 47' ' ' ALA . 24.5 t -117.01 120.97 66.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.844 0.354 . . . . 71.5 110.282 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.8 m -136.79 129.55 30.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.272 -0.422 . . . . 74.51 110.359 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.643 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -138.94 153.94 22.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.244 -0.979 . . . . 63.22 113.092 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 14.1 p -101.54 163.54 12.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.431 -0.581 . . . . 70.35 109.431 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tp -121.03 150.19 41.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.515 0.674 . . . . 74.31 112.044 -170.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.831 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 61.8 mt-10 -126.94 120.07 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.981 -1.009 . . . . 72.2 108.832 174.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -103.52 118.82 37.63 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 34.1 mtmm -117.23 144.02 45.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.149 0.5 . . . . 74.31 110.322 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 32.9 m-85 -116.19 120.15 38.06 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.775 -0.824 . . . . 72.41 108.775 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.538 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 20.5 ttm-85 -106.72 107.27 18.21 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.56 0.695 . . . . 75.13 111.084 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 68.4 t-105 -114.35 107.62 15.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.375 -1.284 . . . . 75.14 110.12 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -94.28 66.78 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.322 0.582 . . . . 75.33 111.93 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -85.19 -37.36 20.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.791 -1.188 . . . . 72.5 107.791 166.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.466 ' CB ' ' HA ' ' A' ' 90' ' ' GLN . 3.7 m-85 -157.34 -43.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.153 -1.385 . . . . 74.43 108.717 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.8 74.81 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.5 -0.773 . . . . 75.25 112.072 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -111.44 130.05 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 75.24 110.502 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 41.7 m -137.93 113.15 9.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.033 -0.531 . . . . 73.31 110.434 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 43.4 t80 -99.65 132.08 45.22 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.857 -0.794 . . . . 73.33 108.857 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 28.6 m -128.05 121.4 29.61 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.023 0.44 . . . . 74.03 111.661 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.63 120.54 42.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.715 -0.846 . . . . 71.12 108.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.47 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 26.1 ttpt -113.46 94.83 5.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.14 -0.482 . . . . 70.32 109.803 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.499 ' O ' ' HB2' ' A' ' 57' ' ' SER . 3.9 t90 -100.15 127.08 46.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.259 -0.428 . . . . 75.24 109.878 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 15.3 m120 -105.46 166.99 10.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 75.13 110.477 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 p -67.5 -16.53 64.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.133 0.492 . . . . 73.2 111.593 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 13.4 m-20 -78.72 -2.53 39.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.642 . . . . 73.31 110.559 175.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.433 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 54.5 m-80 77.81 14.63 1.63 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.479 -0.782 . . . . 75.41 111.935 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -89.13 141.25 28.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.599 -0.519 . . . . 73.41 109.599 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.04 119.35 34.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.376 -0.375 . . . . 75.24 110.488 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.86 105.99 3.35 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.787 -0.925 . . . . 71.42 110.787 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -94.74 104.94 16.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.034 0.445 . . . . 75.24 110.501 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.723 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 40.7 mt-10 -110.84 125.46 53.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.627 -0.715 . . . . 64.12 110.363 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.558 HG23 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -113.95 120.94 65.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.653 -0.869 . . . . 74.14 108.653 171.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.1 m -120.92 123.61 42.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.851 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.77 120.45 50.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 71.53 109.971 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 96' ' ' LYS . 43.9 mt-10 -125.24 136.14 53.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.499 -0.318 . . . . 75.12 110.66 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.679 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 m-20 63.68 23.66 13.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.765 -0.652 . . . . 73.42 112.046 168.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.466 ' HA ' ' CB ' ' A' ' 67' ' ' TYR . 56.5 tt0 -63.98 -79.31 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 73.34 111.227 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.93 -73.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 73.13 109.604 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.32 96.46 9.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.609 -0.515 . . . . 72.3 109.609 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.679 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 29.1 ptt180 -57.24 137.17 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 75.12 110.744 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' A' ' 119' ' ' LYS . . . 103.02 -24.45 30.5 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.032 -0.985 . . . . 63.11 111.432 -169.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.34 -0.506 . . . . 71.33 109.711 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.589 ' HG2' ' HA3' ' A' ' 117' ' ' GLY . 10.2 ptpp? -121.33 131.76 54.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 65.43 109.809 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 96' ' ' LYS . 2.1 mm? -124.53 126.34 45.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.566 -0.531 . . . . 64.41 109.566 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.776 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 18.5 m -130.19 119.02 22.29 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.519 -0.31 . . . . 75.32 110.346 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.558 ' HB3' HG23 ' A' ' 85' ' ' ILE . 86.6 t80 -109.72 114.93 28.93 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.624 -0.51 . . . . 71.24 109.624 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.717 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 4.1 t70 -110.86 122.62 48.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.576 -0.738 . . . . 71.41 109.55 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 8.9 t -126.31 120.41 29.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.81 -0.441 . . . . 74.51 109.81 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 18.5 m -95.8 122.16 38.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.317 -0.623 . . . . 64.4 109.317 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -120.79 119.28 32.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 74.21 110.328 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 t -120.02 103.15 45.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.31 -0.626 . . . . 75.21 109.31 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.44 -37.54 38.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.093 2.529 . . . . 54.43 112.873 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -60.25 -40.7 91.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 64.1 111.879 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 p -96.26 -29.2 14.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.867 0.365 . . . . 75.25 111.338 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.3 59.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.113 -0.795 . . . . 73.42 111.113 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 137.05 33.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.849 0.356 . . . . 74.32 110.726 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 102' ' ' SER . 60.1 pttt -144.8 129.47 18.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.844 -0.616 . . . . 71.01 109.99 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 101' ' ' SER . 19.0 m120 -119.97 149.84 41.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 72.03 109.385 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.83 122.49 17.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.352 -0.24 . . . . 75.35 110.352 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 14.0 pttp -128.37 147.56 50.64 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.26 -0.274 . . . . 75.43 110.26 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.61 126.36 68.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.777 0.799 . . . . 75.34 110.263 -177.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HD3' ' HB2' ' A' ' 128' ' ' ASP . 2.8 tppp? -99.61 120.73 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.843 -1.071 . . . . 72.11 109.442 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.453 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 8.5 m -118.54 118.94 33.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.393 -0.595 . . . . 73.34 109.393 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA3' ' HG2' ' A' ' 96' ' ' LYS . . . -129.53 148.14 18.19 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.754 -1.213 . . . . 63.33 113.966 -173.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -125.57 121.73 34.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.021 -0.589 . . . . 74.42 109.496 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.63 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 9.7 mtmp? -117.84 121.66 41.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.317 0.579 . . . . 73.52 111.977 -177.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.584 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 22.3 tpp180 -108.6 164.22 12.55 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.532 -1.284 . . . . 73.33 107.532 165.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -55.55 -30.41 60.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.194 0.452 . . . . 74.43 112.167 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -116.76 8.07 13.6 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.901 -0.32 . . . . 74.12 111.365 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.584 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 2.1 mm -138.61 124.97 25.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.94 0.4 . . . . 72.23 111.708 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.756 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 52.3 t30 -123.45 116.16 22.77 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.344 -0.542 . . . . 73.14 110.572 175.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.451 HD21 HD12 ' A' ' 142' ' ' LEU . 3.6 mm? -109.88 137.26 47.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 74.43 110.298 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.49 114.66 0.69 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.77 -0.729 . . . . 63.21 112.169 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.453 ' SG ' ' HB ' ' A' ' 116' ' ' THR . 22.3 p -112.59 116.8 30.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.095 0.448 . . . . 65.1 110.655 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.822 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 21.1 t70 -113.76 122.28 46.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 71.3 109.995 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 21.6 ptp -115.24 118.84 34.44 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.19 -0.3 . . . . 74.25 110.19 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.489 ' HA ' ' CB ' ' A' ' 113' ' ' LYS . 3.9 p30 -106.77 127.21 53.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.488 0.661 . . . . 74.22 111.267 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.509 ' HD2' ' HG3' ' A' ' 136' ' ' PRO . 85.1 t80 -78.05 103.69 8.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.696 . . . . 74.11 110.074 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 22.0 t70 -92.09 161.64 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.51 -0.922 . . . . 65.24 108.51 172.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.588 ' N ' HD13 ' A' ' 133' ' ' ILE . 2.5 mp -66.3 -28.76 44.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 70.42 110.125 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.07 54.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 71.53 110.625 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 132' ' ' ASP . . . 145.1 154.98 6.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 64.23 112.624 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.509 ' HG3' ' HD2' ' A' ' 131' ' ' PHE . 14.9 Cg_exo -69.11 113.72 3.36 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.193 2.595 . . . . 72.21 112.86 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.7 t -82.23 141.5 32.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.957 -0.565 . . . . 72.1 109.561 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 40.9 mm -107.21 116.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.564 -0.455 . . . . 64.41 110.126 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -115.31 111.39 20.82 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.922 0.392 . . . . 72.53 109.994 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.35 132.78 11.1 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.867 -1.159 . . . . 70.35 112.311 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB1' HE21 ' A' ' 154' ' ' GLN . . . -128.99 115.92 18.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.223 0.535 . . . . 74.11 110.261 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 143' ' ' VAL . 6.8 tp -116.85 123.89 48.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.674 -0.694 . . . . 74.12 110.245 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 88.8 t -110.64 131.37 61.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.956 -0.565 . . . . 75.54 110.061 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.754 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.74 137.24 46.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.242 -0.651 . . . . 74.44 109.242 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.8 121.01 5.43 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.707 -0.679 . . . . 74.2 112.337 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.863 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 79.0 m-85 -127.36 149.73 49.93 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.574 -0.528 . . . . 74.25 109.574 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -49.81 96.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.812 0.339 . . . . 73.2 111.051 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 174' ' ' LYS . . . 88.55 -26.1 8.59 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.194 -0.457 . . . . 73.23 112.706 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.863 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 4.1 m0 -104.54 146.29 29.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.28 0.562 . . . . 74.42 110.96 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 144' ' ' LEU . 2.6 tm? -134.18 145.21 49.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.727 -0.842 . . . . 75.41 108.727 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -144.13 161.4 38.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.579 -0.7 . . . . 64.4 111.373 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -155.99 133.78 3.84 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.317 -0.401 . . . . 53.2 112.562 -176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.537 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 98.3 m-85 -125.1 119.21 27.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.476 -0.564 . . . . 75.51 109.476 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 35.5 tt0 -128.56 122.25 30.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.018 0.437 . . . . 72.41 110.327 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 16.9 ptp -135.32 142.5 45.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.002 0.43 . . . . 74.2 111.027 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.438 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 16.5 m-80 -113.13 117.66 32.58 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.034 -0.728 . . . . 74.45 109.034 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 71.1 t80 -94.13 121.85 36.06 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 123.642 0.777 . . . . 75.15 110.95 -176.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.6 tp10 -89.28 108.87 19.87 Favored 'General case' 0 C--O 1.264 1.82 0 CA-C-N 115.557 -0.747 . . . . 71.52 109.877 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -71.52 -17.02 62.35 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 112.923 -1.944 . . . . 73.41 111.974 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.85 67.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.819 0.819 . . . . 73.12 109.112 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -118.05 -156.09 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.363 -1.29 . . . . 73.23 108.022 167.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -105.9 30.13 6.09 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.299 -0.63 . . . . 73.24 109.299 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 15.6 mmm180 -136.65 141.51 43.18 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.446 -0.902 . . . . 73.52 112.159 -161.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.864 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 4.6 m -73.66 136.19 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.235 -0.654 . . . . 73.32 109.235 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 3.0 t -91.64 -22.68 20.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.157 0.503 . . . . 71.11 110.143 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.74 132.27 20.93 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 72.53 109.577 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.6 p -121.18 105.97 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.135 0.493 . . . . 74.5 109.946 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 20.5 m120 -107.16 135.52 48.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.544 0.687 . . . . 74.5 110.889 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.537 ' HD1' ' HD2' ' A' ' 153' ' ' TYR . 60.2 m-85 -121.78 143.89 49.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.832 -0.622 . . . . 75.43 109.927 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.75 132.89 33.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.46 -0.336 . . . . 72.04 110.537 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 43.1 t -129.87 126.48 62.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.001 -0.37 . . . . 64.34 110.001 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.21 100.36 1.21 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.692 -0.963 . . . . 72.14 110.692 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.619 ' HB3' ' CD2' ' A' ' 180' ' ' LEU . 75.3 t80 -109.46 120.44 42.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.559 -0.904 . . . . 73.11 108.559 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 148' ' ' GLY . 13.0 ttmm -127.72 126.1 41.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.731 -1.122 . . . . 74.15 111.327 -167.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 39.8 m -132.96 110.39 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.795 -1.187 . . . . 62.41 107.795 160.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 25.37 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.023 1.49 . . . . 71.42 115.023 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -89.18 -7.84 54.82 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.852 0.686 . . . . 75.12 112.852 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -123.32 115.66 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 75.42 111.06 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -136.94 143.29 42.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 72.01 111.043 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.619 ' CD2' ' HB3' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -123.92 141.94 51.58 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-O 122.522 1.153 . . . . 62.34 111.495 163.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 36.2 m80 -104.75 112.47 25.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.369 -2.196 . . . . 72.12 106.551 165.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 38.4 m -96.17 135.93 37.32 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.215 -0.661 . . . . 74.13 109.215 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.8 p30 -133.86 138.86 45.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.415 0.626 . . . . 72.21 110.124 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 54.2 t -127.56 125.62 65.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.34 -0.845 . . . . 62.2 109.837 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.851 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 63.1 t30 -103.92 90.01 3.48 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.048 -0.723 . . . . 74.02 109.048 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.97 -173.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.704 -1.134 . . . . 75.04 110.136 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.0 -7.42 70.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.365 -0.921 . . . . 72.12 112.335 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.8 p -95.47 -24.32 16.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.023 0.749 . . . . 72.0 113.023 -174.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.851 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 65.9 tt0 -129.48 125.23 35.92 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.89 -0.724 . . . . 64.53 111.125 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -134.88 140.25 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.638 0.256 . . . . 75.02 110.397 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -167.91 -163.32 21.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.457 -0.878 . . . . 65.11 112.895 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -164.85 -174.3 34.43 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.696 -0.562 . . . . 53.12 111.696 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 180' ' ' LEU . 41.0 m -148.76 136.95 20.99 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.617 -0.882 . . . . 63.44 108.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.3 mm -117.61 117.67 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.343 -0.543 . . . . 64.34 110.621 -171.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -107.53 119.42 39.36 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -125.0 131.16 53.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.53 -0.544 . . . . 71.44 109.53 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -107.56 114.97 29.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.42 -0.355 . . . . 75.34 111.582 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 202' ' ' LEU . 58.8 t -88.76 132.39 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.625 -0.879 . . . . 74.24 108.625 171.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.4 -25.9 62.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.948 0.351 . . . . 75.52 111.948 -173.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.425 ' H ' HG11 ' A' ' 198' ' ' VAL . 58.9 mtmt -84.6 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 73.23 111.653 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.05 24.43 14.5 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.625 0.77 . . . . 75.53 112.69 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.539 ' HG ' ' HD2' ' A' ' 225' ' ' TYR . 4.7 tt -110.58 108.99 19.12 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.163 -0.68 . . . . 63.15 109.163 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.71 ' HB2' ' HG3' ' A' ' 224' ' ' LYS . 39.5 mt-10 -106.65 137.04 45.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.522 -0.548 . . . . 75.23 109.522 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.6 m -122.74 142.55 50.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.655 0.265 . . . . 75.55 110.596 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.54 136.58 49.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.986 -0.552 . . . . 74.4 109.863 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.857 HG23 HG21 ' A' ' 221' ' ' ILE . 39.6 t -111.83 137.07 45.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.004 -0.544 . . . . 70.43 109.62 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -112.75 127.55 56.18 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.557 -0.905 . . . . 71.44 108.557 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 219' ' ' PHE . 3.1 tp -142.64 129.89 20.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.612 -171.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.58 139.11 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 73.21 111.192 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -128.87 132.7 47.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.985 -0.746 . . . . 74.13 108.985 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 m -95.04 107.21 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.918 0.389 . . . . 73.02 110.034 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.75 135.86 55.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.629 -0.714 . . . . 72.43 111.252 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.85 -2.43 66.58 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.163 -0.775 . . . . 72.12 111.163 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -131.01 167.61 18.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.236 -0.482 . . . . 74.31 109.767 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -102.51 -14.23 16.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.969 -0.752 . . . . 64.2 108.969 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.66 110.89 1.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.498 -0.773 . . . . 73.21 110.769 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 15.9 m -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 61.11 109.432 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.539 ' HA ' ' HE ' ' A' ' 218' ' ' ARG . 0.2 OUTLIER -114.63 116.06 28.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.579 -0.448 . . . . 73.31 109.866 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.412 ' HB3' HD12 ' A' ' 208' ' ' LEU . 53.3 p90 -134.14 146.91 50.66 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.972 -0.381 . . . . 72.3 109.972 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.61 160.88 32.27 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.49 -0.862 . . . . 51.14 112.123 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.259 0.552 . . . . 72.35 110.62 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.568 ' HB3' ' HG3' ' A' ' 236' ' ' LYS . . . -117.84 141.43 48.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.169 -0.923 . . . . 74.03 109.911 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -118.12 140.82 49.21 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.399 -0.364 . . . . 72.53 110.429 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 203' ' ' GLU . 14.8 ptmt -125.47 114.66 19.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.836 -0.62 . . . . 74.45 109.5 174.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.539 ' HD2' ' HG ' ' A' ' 202' ' ' LEU . 17.2 t80 -119.22 117.23 28.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.503 -0.772 . . . . 75.14 109.426 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.59 105.9 18.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.176 0.512 . . . . 72.42 109.857 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 13.4 pt -81.69 -33.5 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.506 -0.77 . . . . 73.3 111.067 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.41 162.15 28.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 74.34 109.017 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 -19.14 17.41 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.064 2.51 . . . . 72.11 114.323 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -112.2 7.94 19.67 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.049 -0.26 . . . . 73.21 111.659 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.04 123.64 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.289 0.566 . . . . 65.33 112.21 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -124.09 127.44 47.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 72.31 108.957 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -98.04 133.38 42.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.931 0.396 . . . . 74.33 110.654 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 48.4 t -115.9 138.06 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.844 -0.617 . . . . 51.31 109.994 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -133.12 141.73 48.32 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.467 -0.568 . . . . 75.23 109.467 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 222' ' ' ALA . 3.3 mppt? -133.39 141.42 47.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.771 0.32 . . . . 72.32 110.791 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.574 HG12 HG12 ' A' ' 221' ' ' ILE . 3.7 p -140.49 136.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.218 -0.66 . . . . 73.42 109.218 170.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 13.1 m120 -115.67 152.93 32.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.993 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 241' ' ' SER . 1.1 t-20 -35.12 -42.49 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.967 1.417 . . . . 64.54 114.052 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.45 ' OG ' HD11 ' A' ' 242' ' ' LEU . 2.3 p -78.56 24.58 0.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.839 0.352 . . . . 62.11 111.448 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 239' ' ' ASN . 18.6 t 61.7 37.83 15.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.586 -0.734 . . . . 53.24 109.817 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.966 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 4.6 mp -92.23 140.12 29.94 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.851 -0.613 . . . . 73.55 110.51 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.518 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -122.88 118.74 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.012 -0.54 . . . . 72.05 110.898 -172.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -126.08 155.56 19.3 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.751 -0.738 . . . . 72.34 112.417 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.507 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -138.18 160.65 38.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.065 0.46 . . . . 54.02 110.79 177.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -151.43 141.03 8.24 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.752 -0.658 . . . . 53.33 111.559 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -129.08 115.27 17.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 110.131 -0.322 . . . . 74.14 110.131 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.3 m -109.34 115.7 30.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.326 -0.397 . . . . 74.35 110.015 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.78 145.01 50.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.946 0.403 . . . . 72.21 111.024 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.3 m -108.11 124.47 50.28 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.873 -0.603 . . . . 75.31 110.631 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 2.8 mm? -117.17 147.28 42.6 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.835 -1.172 . . . . 70.4 107.835 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.932 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 32.9 mmtp 61.84 -174.97 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 117.742 0.246 . . . . 75.01 110.439 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.932 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 67.6 Cg_endo -75.69 -2.91 13.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.618 1.546 . . . . 65.14 113.657 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.43 0.25 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.188 -1.482 . . . . 74.44 114.794 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 252' ' ' LYS . 45.4 mm -112.24 120.67 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 117.759 0.78 . . . . 73.31 109.6 174.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 280' ' ' GLU . 0.0 OUTLIER -115.61 118.04 31.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.999 0.428 . . . . 73.34 110.413 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.94 124.31 45.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.994 -0.548 . . . . 64.34 109.776 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.2 m -118.56 110.26 17.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.082 0.468 . . . . 74.2 110.562 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 1.006 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.56 125.5 49.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.786 -1.19 . . . . 74.02 107.786 174.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.6 t -138.56 139.43 38.65 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.435 -0.506 . . . . 63.31 109.864 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 135.74 13.65 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.602 -0.518 . . . . 74.32 109.602 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.756 HD22 HD21 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -124.27 131.63 53.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.394 -0.595 . . . . 75.1 109.394 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.795 ' HB3' HG13 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -106.43 111.19 23.66 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.78 -1.193 . . . . 75.32 107.78 179.063 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.966 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.7 m-20 -71.54 106.96 4.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.871 -0.604 . . . . 72.44 109.418 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.06 -16.79 14.5 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 116.019 -0.537 . . . . 71.44 112.877 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 266' ' ' LYS . 1.6 tmtp? -91.15 -26.95 18.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.879 0.371 . . . . 75.32 110.783 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.661 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 10.3 m120 -106.44 -34.66 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.644 0.609 . . . . 75.15 112.644 -172.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.795 HG13 ' HB3' ' A' ' 263' ' ' LEU . 35.1 m -62.28 -17.49 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.537 0.208 . . . . 73.31 111.558 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.09 -44.65 83.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 75.41 110.722 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.59 -16.74 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.493 . . . . 74.41 110.828 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 123.66 90.52 0.93 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.321 -0.712 . . . . 64.54 111.321 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.613 ' HA3' ' HB3' ' A' ' 267' ' ' ASN . . . -164.7 69.72 0.2 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 73.44 112.358 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.588 ' HB2' HD13 ' A' ' 263' ' ' LEU . 24.0 p-80 -113.17 145.48 40.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.367 -0.605 . . . . 75.23 109.367 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.68 136.85 49.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.477 -0.489 . . . . 75.42 110.131 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -120.58 136.85 54.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.563 -0.744 . . . . 72.12 109.839 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.64 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -138.68 110.54 0.73 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.655 -0.783 . . . . 74.33 111.591 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 1.006 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -112.79 128.19 56.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.745 -0.835 . . . . 75.21 108.745 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.584 ' HA3' ' HE2' ' A' ' 22' ' ' TYR . . . -140.12 131.87 5.27 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.258 -0.973 . . . . 61.23 112.284 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.681 ' HB2' HD13 ' A' ' 29' ' ' LEU . 2.4 mm? -103.45 130.14 50.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.233 -0.654 . . . . 75.35 109.233 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 0.6 OUTLIER -113.73 109.71 19.01 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.881 -1.155 . . . . 72.14 107.881 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.63 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 2.4 t80 -106.39 124.41 49.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.717 -0.674 . . . . 74.24 109.891 -172.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -127.5 109.63 11.93 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.63 ' HB2' ' HE1' ' A' ' 281' ' ' PHE . . . -110.1 111.84 23.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 72.15 111.346 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.61 -70.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 75.45 108.926 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.991 -0.549 . . . . 75.45 109.585 172.691 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.946 0.403 . . . . 54.3 110.252 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 121' ' ' GLU . 13.7 t -120.48 112.16 34.38 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.488 -0.56 . . . . 74.12 109.488 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.9 161.04 19.73 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.035 2.49 . . . . 75.31 112.62 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.68 86.61 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.796 2.331 . . . . 63.32 111.189 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 1.0 ' HB ' HG11 ' A' ' 143' ' ' VAL . 9.2 p -70.18 -53.5 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.358 -0.837 . . . . 64.14 112.826 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -69.07 -23.92 64.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.243 0.544 . . . . 71.21 111.313 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.31 -20.71 36.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.62 . . . . 63.43 111.533 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -91.05 -11.5 38.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 75.43 110.896 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.45 HD12 ' HA3' ' A' ' 152' ' ' GLY . 45.9 mt -58.29 -34.97 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.328 0.492 . . . . 71.24 112.328 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.47 50.87 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.586 -1.292 . . . . 75.24 114.694 168.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -40.24 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.167 -1.049 . . . . 75.22 108.167 171.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -60.97 -35.48 76.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.726 -1.125 . . . . 63.35 110.751 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.07 73.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.12 -0.491 . . . . 62.11 111.883 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -69.61 -31.09 69.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.47 . . . . 74.44 110.51 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.17 -47.39 85.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.69 -0.686 . . . . 75.0 111.804 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.31 -31.4 52.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.95 0.405 . . . . 75.13 110.797 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.655 ' HE2' ' HA3' ' A' ' 220' ' ' GLY . 82.6 t80 -73.03 -41.82 63.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.681 -0.69 . . . . 71.2 111.331 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -83.44 -28.07 29.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.146 -0.479 . . . . 75.14 112.209 -173.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -66.78 91.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.527 . . . . 75.53 110.433 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.42 -23.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.916 -0.874 . . . . 75.35 110.916 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.85 76.16 1.62 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 74.24 110.386 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.94 119.1 4.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.72 -0.753 . . . . 51.44 111.3 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -80.34 8.04 8.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.065 0.459 . . . . 75.32 111.035 -175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.53 13.22 54.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.982 -0.847 . . . . 72.22 110.982 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 2.7 pp -107.45 177.97 4.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.946 0.879 . . . . 71.55 112.749 -173.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 277' ' ' LEU . 1.7 mp -103.0 132.53 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.293 -1.321 . . . . 72.25 110.224 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 26.0 tptp -102.84 118.66 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.965 -1.016 . . . . 75.13 109.193 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.71 128.23 56.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.623 -0.51 . . . . 74.43 109.623 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 43' ' ' SER . 30.6 m-20 -133.28 134.14 43.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.104 0.478 . . . . 71.23 110.373 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.749 HD22 ' HB2' ' A' ' 281' ' ' PHE . 1.2 tm? -123.72 126.01 45.77 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.157 -1.053 . . . . 75.2 108.157 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.9 mtpp -132.29 129.7 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.858 0.361 . . . . 75.23 110.59 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.8 m -136.27 131.64 34.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.134 -0.484 . . . . 71.01 109.839 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -104.98 136.77 43.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 75.33 110.209 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.3 m -139.59 169.27 18.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.002 -0.545 . . . . 72.53 110.168 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.22 178.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 75.32 110.771 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 t30 65.21 24.43 12.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.578 0.704 . . . . 62.44 109.537 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.723 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.32 19.81 79.74 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 120.618 -0.801 . . . . 74.35 111.988 175.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 62' ' ' TYR . 10.2 mt -85.55 137.3 32.97 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.222 1.011 . . . . 71.21 113.266 -171.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.699 ' HB2' HH12 ' A' ' 63' ' ' ARG . 43.4 tt0 -139.51 118.56 12.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.24 -1.8 . . . . 65.43 108.828 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 90.9 m-85 -103.6 120.09 40.2 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.695 -0.483 . . . . 75.33 109.695 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.744 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 25.9 m -126.05 126.07 43.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.234 -0.439 . . . . 75.35 110.397 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 22.8 t -119.66 123.25 43.37 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.858 -0.793 . . . . 74.53 108.858 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -123.78 124.88 43.67 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.081 -0.34 . . . . 75.22 110.081 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.06 153.61 24.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.463 -0.875 . . . . 75.4 111.857 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -137.52 133.92 35.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.919 -0.771 . . . . 75.2 108.919 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.92 129.26 13.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.969 0.414 . . . . 45.24 111.426 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.616 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -102.02 113.93 27.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.403 -0.962 . . . . 74.2 108.403 173.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 m -47.27 103.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.066 0.854 . . . . 74.34 113.069 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.47 17.08 10.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.209 -0.905 . . . . 72.33 112.296 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 48' ' ' ASN . 11.0 m -97.81 8.86 43.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 75.0 110.062 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m 62.91 31.47 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.338 -0.847 . . . . 75.53 111.305 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 53' ' ' LYS . 54.7 mmtt -130.5 83.52 2.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.29 0.566 . . . . 71.22 110.112 175.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.35 120.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.991 -1.004 . . . . 75.43 109.652 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.6 t -133.43 143.4 48.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.14 -0.318 . . . . 70.11 110.14 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.82 141.26 12.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.928 -0.653 . . . . 73.23 112.823 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -132.83 135.06 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.083 0.553 . . . . 73.05 109.663 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -121.74 125.63 47.02 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.239 -0.652 . . . . 72.34 109.239 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.744 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 22.2 tt0 -117.68 120.36 37.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.395 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 3.3 m -113.45 118.37 34.31 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.873 -1.158 . . . . 74.53 107.873 168.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -116.82 120.64 39.15 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.01 -0.676 . . . . 74.41 110.242 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.689 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 1.4 m-85 -107.0 125.56 51.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 70.24 109.699 -175.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.723 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 1.6 mpp_? -129.51 106.49 8.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.328 -0.949 . . . . 73.0 111.807 169.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 49.0 t-105 -88.79 91.82 8.97 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.234 -1.024 . . . . 75.42 108.234 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.65 HG21 ' H ' ' A' ' 67' ' ' TYR . 9.4 m 67.8 141.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.614 -1.176 . . . . 74.33 110.486 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.93 -8.54 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.432 0.634 . . . . 71.44 110.289 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.65 ' H ' HG21 ' A' ' 65' ' ' THR . 81.8 t80 -126.36 86.53 2.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.113 -0.949 . . . . 75.53 108.573 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 88' ' ' GLU . . . 170.91 -101.72 0.17 Allowed Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.705 -0.76 . . . . 73.3 112.383 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.8 mm? -113.65 138.24 50.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.482 0.658 . . . . 71.2 111.77 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.544 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.1 m -135.74 111.31 9.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.191 -0.913 . . . . 74.24 109.469 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.689 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 12.2 t80 -119.77 125.75 49.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.811 0.338 . . . . 74.52 110.422 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.472 ' HB ' ' CG ' ' A' ' 84' ' ' GLU . 28.2 m -110.85 117.65 33.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.937 0.399 . . . . 55.54 110.353 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.587 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 34.7 tt0 -111.94 123.85 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.698 -0.683 . . . . 75.02 109.911 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.8 ptmm? -127.26 133.22 50.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.22 0.533 . . . . 73.02 110.188 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.605 ' CD1' HD22 ' A' ' 81' ' ' LEU . 32.6 t90 -134.04 128.27 33.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.559 -0.534 . . . . 75.51 109.559 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -116.41 133.21 56.28 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.842 -0.743 . . . . 72.33 110.791 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -73.9 -25.71 60.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.739 0.78 . . . . 73.04 110.09 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -96.14 -16.2 21.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.501 -1.227 . . . . 62.43 111.779 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.8 -98.05 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.354 0.872 . . . . 64.51 113.354 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 p -115.85 144.72 43.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.869 1.063 . . . . 71.13 113.869 -166.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -87.94 157.05 19.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.326 -1.361 . . . . 74.14 107.326 165.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 101' ' ' SER . . . -171.01 147.69 10.62 Favored Glycine 0 C--N 1.322 -0.205 0 C-N-CA 119.79 -1.195 . . . . 71.41 113.173 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -148.98 128.52 13.12 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.254 0.222 . . . . 74.44 111.165 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.472 ' CG ' ' HB ' ' A' ' 72' ' ' THR . 15.9 pt-20 -126.41 125.98 43.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 74.52 110.023 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.24 128.3 68.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 74.35 110.439 -176.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.583 ' CG2' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m -118.17 123.91 46.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.113 -0.494 . . . . 73.24 111.248 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.33 137.88 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.126 -0.488 . . . . 75.03 109.828 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 1.1 pp20? -89.52 161.95 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.986 -0.686 . . . . 64.31 110.879 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -95.67 124.73 39.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.813 -0.44 . . . . 71.42 109.813 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.43 ' HA ' ' HH ' ' A' ' 67' ' ' TYR . 1.9 mp0 -68.4 -25.82 65.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 74.13 111.546 -175.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.74 -45.74 5.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.867 0.365 . . . . 74.25 110.248 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -92.01 77.17 5.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.36 -0.607 . . . . 71.32 109.36 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 56.2 mtt180 -64.1 134.65 55.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.349 -0.841 . . . . 71.4 111.623 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 102.14 -12.2 57.27 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.016 -0.993 . . . . 72.54 111.681 -174.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.777 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -85.02 121.3 27.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.604 0.24 . . . . 75.31 110.402 178.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.583 ' HE3' ' CG2' ' A' ' 86' ' ' THR . 29.9 mmmt -121.96 112.05 17.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 73.51 109.443 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 86' ' ' THR . 1.9 mm? -94.85 128.2 41.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.47 . . . . 63.14 109.779 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 1.117 ' HB ' ' HG3' ' A' ' 115' ' ' LYS . 3.3 m -128.45 132.89 48.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.077 0.465 . . . . 75.13 111.534 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 76.7 t80 -117.8 120.63 38.51 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.375 -0.602 . . . . 74.04 109.375 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.402 ' OD2' ' HG2' ' A' ' 113' ' ' LYS . 6.9 t70 -111.62 143.07 43.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.401 . . . . 75.0 110.475 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.426 ' O ' ' HA2' ' A' ' 82' ' ' GLY . 72.9 m -142.86 122.19 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.835 0.35 . . . . 72.43 110.876 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 t -108.04 133.16 52.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.762 -0.829 . . . . 65.22 108.762 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 110' ' ' LYS . 35.6 t80 -122.87 125.13 44.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.819 0.342 . . . . 72.31 110.722 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.7 t -87.38 106.19 10.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.695 -0.854 . . . . 63.13 108.695 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.45 -39.92 79.38 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.04 2.493 . . . . 72.0 112.699 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.48 -49.9 24.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.592 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 m -66.06 -40.67 91.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 74.21 111.304 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.6 -5.7 80.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.89 -0.671 . . . . 71.1 111.791 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -94.62 148.16 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 73.21 110.355 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -126.42 151.33 47.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 75.11 111.019 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -119.25 121.01 38.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.566 -0.743 . . . . 75.42 109.01 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.56 28.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.871 0.367 . . . . 73.22 110.99 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 130' ' ' ASP . 17.3 mmtm -124.22 141.46 52.04 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.174 -0.676 . . . . 74.31 109.174 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.92 117.74 56.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.126 -1.065 . . . . 74.54 108.126 169.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 1.117 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 8.0 ptmt -129.16 119.86 24.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.231 -0.895 . . . . 73.34 110.818 -171.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.0 p -109.23 117.75 34.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.354 -0.839 . . . . 71.41 109.531 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.425 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -128.82 114.23 1.73 Allowed Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.303 -0.951 . . . . 71.03 111.961 -174.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.777 ' HB3' HD22 ' A' ' 95' ' ' LEU . 12.9 p90 -118.77 131.81 56.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.167 0.508 . . . . 75.33 110.458 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.703 ' HE3' ' HB ' ' A' ' 3' ' ' VAL . 8.7 ptmt -109.11 121.32 44.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.576 -0.738 . . . . 74.15 110.213 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -106.72 157.02 18.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.834 ' HA ' HG21 ' A' ' 3' ' ' VAL . 3.8 pm0 -53.22 -28.9 29.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.966 0.728 . . . . 71.24 112.966 -169.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -114.54 -16.03 11.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.884 -0.327 . . . . 71.45 111.542 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.645 HD12 HD11 ' A' ' 142' ' ' LEU . 10.9 tp -145.03 130.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.298 -0.561 . . . . 75.41 111.809 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 124' ' ' ASN . 0.2 OUTLIER -117.95 117.31 28.89 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.058 -0.401 . . . . 63.43 110.637 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.418 ' N ' HD21 ' A' ' 124' ' ' ASN . 3.9 mm? -113.01 128.73 56.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.681 0.277 . . . . 75.23 111.145 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.425 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.43 123.53 3.08 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.528 -0.629 . . . . 72.13 111.528 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 60.3 m -113.78 108.28 16.88 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.678 -0.307 . . . . 64.23 111.091 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.816 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 3.2 m-20 -100.81 117.52 35.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.482 -0.562 . . . . 65.43 109.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 24.2 ptm -98.0 118.64 35.05 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.458 -0.897 . . . . 72.03 109.531 172.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 8.9 t70 -94.52 117.66 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 74.11 109.967 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -97.16 102.68 14.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.071 0.462 . . . . 65.31 111.465 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -105.29 146.72 28.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.171 -1.048 . . . . 74.41 108.171 167.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.563 ' H ' HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -62.68 -22.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.845 0.313 . . . . 74.53 111.845 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.2 -6.67 47.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.572 0.225 . . . . 75.22 111.602 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.452 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 160.82 121.47 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.339 -0.934 . . . . 75.34 112.921 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.452 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 2.9 Cg_exo -74.55 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 61.04 111.802 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -81.99 153.29 26.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.21 -0.45 . . . . 75.02 110.053 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 3.5 mp -107.11 117.43 52.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.945 -0.702 . . . . 73.4 109.94 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.816 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 59.8 ttt-85 -104.68 130.12 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.706 -0.479 . . . . 73.45 109.706 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -116.91 132.14 9.89 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.961 -1.114 . . . . 63.31 111.553 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.73 115.74 21.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.478 -0.564 . . . . 74.43 109.478 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 123' ' ' ILE . 11.6 tp -128.02 122.56 32.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.259 -0.428 . . . . 74.1 110.131 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 1.0 HG11 ' HB ' ' A' ' 6' ' ' THR . 21.8 t -119.59 130.51 73.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.075 0.464 . . . . 75.24 109.851 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.35 138.29 45.92 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 74.13 109.538 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.73 123.43 5.82 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.714 -0.755 . . . . 63.23 112.774 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.809 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 56.0 m-85 -125.9 148.32 49.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.007 -0.738 . . . . 75.34 109.007 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -53.44 102.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.952 0.406 . . . . 71.11 110.413 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.56 -31.1 7.45 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.746 -0.661 . . . . 62.43 112.492 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.809 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.5 m0 -105.89 134.56 48.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 75.33 110.837 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 6' ' ' THR . 3.2 tm? -139.41 134.59 32.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.237 -0.653 . . . . 74.43 109.237 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.97 141.12 23.95 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.821 -0.352 . . . . 74.1 111.664 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -140.33 141.0 11.05 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.965 -0.454 . . . . 74.31 111.965 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.435 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 43.1 m-85 -124.08 121.26 34.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.182 -0.303 . . . . 73.21 110.182 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 2.1 mp0 -114.19 122.15 45.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 74.44 109.284 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.19 145.46 51.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.808 0.337 . . . . 73.1 111.002 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 166' ' ' GLN . 6.0 m-20 -112.55 118.34 34.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.845 -0.798 . . . . 72.22 108.845 175.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.652 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 76.7 t80 -95.64 121.87 37.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.479 -0.782 . . . . 73.51 111.007 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.8 tp10 -79.24 99.34 7.01 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 114.386 -1.279 . . . . 75.04 109.129 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -70.9 -23.83 62.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.442 -1.708 . . . . 71.54 112.212 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.7 -32.18 71.43 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.916 0.865 . . . . 71.21 109.165 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.431 ' HB3' ' H ' ' A' ' 162' ' ' SER . 2.3 mppt? -114.6 -157.5 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.199 -1.364 . . . . 73.11 108.205 170.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 161' ' ' LYS . 35.9 p -107.56 30.72 6.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.407 -0.59 . . . . 71.21 109.407 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.548 ' HA ' ' HE ' ' A' ' 163' ' ' ARG . 3.7 mmp_? -119.55 171.8 8.11 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 119.689 -0.804 . . . . 74.43 112.871 -159.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.61 127.09 59.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.166 -0.679 . . . . 75.52 109.166 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.3 t -95.86 -24.13 16.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.887 0.375 . . . . 75.12 110.935 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 156' ' ' ASN . 32.8 tt0 -145.83 133.04 20.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 75.41 110.645 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 169' ' ' PHE . 17.0 p -122.54 106.43 11.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.109 -0.496 . . . . 71.52 110.617 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 26.0 t-20 -108.37 121.56 45.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.264 -0.643 . . . . 72.23 109.264 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 167' ' ' SER . 29.5 m-85 -123.86 156.83 35.49 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.386 -0.526 . . . . 74.21 111.027 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -150.75 128.25 11.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.963 -0.562 . . . . 73.41 109.796 171.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 27.2 t -143.98 130.44 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.301 -0.629 . . . . 72.32 109.301 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.11 174.74 35.38 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.041 -1.552 . . . . 63.52 114.111 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -134.36 138.05 44.59 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -109.71 127.41 54.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.731 -0.668 . . . . 73.25 111.985 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 29.8 m -131.94 143.14 49.91 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.39 -1.337 . . . . 72.31 107.39 164.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.09 -1.98 6.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.138 0.792 . . . . 64.24 113.138 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.535 ' HG3' ' HD1' ' A' ' 178' ' ' PHE . 9.0 pt-20 -116.64 -26.08 7.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.537 -0.465 . . . . 65.41 111.478 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.535 ' HD1' ' HG3' ' A' ' 177' ' ' GLU . 41.3 p90 -140.87 127.93 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.705 0.288 . . . . 74.22 110.303 173.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.86 124.38 35.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.185 -0.302 . . . . 64.54 110.185 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.602 HD11 HG13 ' A' ' 194' ' ' ILE . 3.9 tt -110.86 128.26 55.72 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.062 -0.655 . . . . 73.44 110.031 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -131.81 115.83 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.906 -0.588 . . . . 75.21 109.769 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 84.8 m -99.51 123.16 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.127 -0.488 . . . . 72.11 110.213 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.3 p30 -119.86 141.49 49.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.142 0.496 . . . . 75.02 110.719 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 79.1 t -119.6 130.02 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.898 -0.592 . . . . 74.33 110.193 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 36.2 m-80 -113.24 106.96 15.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.838 -0.619 . . . . 73.41 109.34 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.01 -165.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.047 -0.979 . . . . 64.04 110.282 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.98 -6.99 89.09 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.385 -0.912 . . . . 73.31 111.947 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.2 p -102.23 -25.2 13.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.98 1.104 . . . . 73.5 113.98 -170.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 39.2 tt0 -120.41 112.74 19.36 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.17 -1.012 . . . . 72.44 112.19 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -106.26 124.88 50.27 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.393 -0.966 . . . . 74.01 108.393 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -136.6 131.6 5.71 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.037 -1.077 . . . . 71.14 113.677 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -114.79 121.76 5.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.115 -0.794 . . . . 72.3 111.115 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m -115.07 137.13 52.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.294 0.547 . . . . 73.35 110.931 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.602 HG13 HD11 ' A' ' 180' ' ' LEU . 4.3 mp -121.87 132.29 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.926 -0.579 . . . . 74.3 109.724 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -108.28 120.1 41.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.787 -0.82 . . . . 72.4 108.787 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -118.08 130.05 55.92 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.862 -0.608 . . . . 75.33 110.845 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -98.72 109.62 22.35 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 74.44 108.34 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.448 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 44.0 t -83.3 -40.22 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.538 0.685 . . . . 73.31 109.774 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 54.3 t30 -155.72 161.64 40.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.792 -1.188 . . . . 71.01 107.792 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.63 126.46 27.71 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt 82.17 -1.01 1.46 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.077 0.86 . . . . 75.33 111.325 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.448 ' HG ' ' HB ' ' A' ' 198' ' ' VAL . 39.9 tp -125.32 99.92 6.28 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.603 0.716 . . . . 72.53 111.015 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -106.43 158.57 16.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.062 -0.972 . . . . 75.31 109.892 -176.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.6 m -152.91 142.87 22.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.18 -0.304 . . . . 73.44 110.18 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -132.11 136.49 47.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.877 0.37 . . . . 74.14 110.94 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.42 131.65 71.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.85 -0.614 . . . . 75.12 110.105 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 27.3 t-20 -119.16 133.26 55.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.935 0.398 . . . . 74.31 110.998 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.465 ' O ' ' HA2' ' A' ' 191' ' ' GLY . 4.1 mm? -118.74 130.24 55.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 74.42 108.715 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.36 129.18 35.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.047 0.451 . . . . 64.4 110.85 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -120.06 129.71 54.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.874 -0.603 . . . . 75.21 109.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.506 ' HB ' ' OD1' ' A' ' 216' ' ' ASN . 29.1 m -95.39 106.8 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.117 0.484 . . . . 70.22 110.007 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.63 136.99 50.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.849 . . . . 74.53 111.393 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -33.77 5.66 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.055 -0.818 . . . . 71.33 111.055 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -125.83 -178.57 4.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.768 -0.456 . . . . 72.05 109.768 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.5 t -109.96 27.11 9.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.408 . . . . 72.24 110.641 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.506 ' OD1' ' HB ' ' A' ' 211' ' ' THR . 23.6 p-10 -81.85 110.82 17.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.793 0.806 . . . . 75.0 110.271 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.8 p -107.87 123.49 48.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.067 -0.97 . . . . 74.24 110.108 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -106.59 116.44 31.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.99 -0.55 . . . . 75.43 109.751 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 37.0 p90 -115.05 146.83 40.88 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.544 -0.462 . . . . 65.33 110.101 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.655 ' HA3' ' HE2' ' A' ' 18' ' ' PHE . . . -146.57 139.87 8.34 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.992 -0.843 . . . . 71.1 110.992 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.2 mp -123.84 128.87 74.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.65 -0.5 . . . . 74.5 109.65 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -122.84 130.34 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.344 0.403 . . . . 73.55 110.407 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.25 126.04 54.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.229 -0.442 . . . . 74.2 109.981 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -113.48 113.3 24.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 73.33 109.904 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -130.89 128.32 40.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.915 0.388 . . . . 74.34 110.553 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 36.5 tt0 -78.72 98.45 6.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 74.41 108.922 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.4 tt -79.22 -24.86 12.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.276 0.56 . . . . 74.55 110.656 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.417 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 3.1 t70 -143.72 148.54 43.33 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.106 -1.072 . . . . 75.51 108.106 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 52.6 Cg_exo -38.2 -40.35 1.15 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.846 3.031 . . . . 71.34 115.211 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 250' ' ' THR . 6.8 m-20 -117.01 11.37 14.26 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.849 0.315 . . . . 74.12 111.849 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -129.73 123.17 30.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 73.23 111.415 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -122.51 127.35 49.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.971 -0.559 . . . . 73.5 110.639 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.85 ' HD1' ' HB3' ' A' ' 247' ' ' TYR . 63.0 t80 -107.58 133.86 51.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.636 -0.711 . . . . 73.32 110.828 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.7 p -122.17 120.77 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 73.14 110.853 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.82 141.32 42.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.366 -0.605 . . . . 71.24 109.366 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 10.8 ptpt -148.19 149.24 31.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.041 0.448 . . . . 73.1 111.694 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.404 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 7.7 p -137.22 148.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.443 -0.344 . . . . 73.54 110.353 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.818 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -114.69 150.06 35.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.836 -0.62 . . . . 73.44 110.123 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 241' ' ' SER . 25.2 t30 -44.72 -36.11 3.0 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.476 1.11 . . . . 74.02 113.016 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 17.8 m -78.94 25.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.714 0.292 . . . . 65.35 111.036 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.9 m 64.93 36.83 7.37 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.616 -0.72 . . . . 73.32 110.238 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 238' ' ' ASN . 26.3 mt -98.69 115.93 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.11 109.879 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 243' ' ' ILE . 3.7 mp -103.26 117.38 48.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 120.539 -0.465 . . . . 74.53 109.925 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -119.91 134.02 10.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.831 -0.699 . . . . 70.43 112.491 177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 260' ' ' SER . 3.0 pp -128.91 141.74 51.17 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.805 -0.443 . . . . 72.43 109.805 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -155.95 121.58 1.11 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.542 -0.837 . . . . 73.34 111.988 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.85 ' HB3' ' HD1' ' A' ' 233' ' ' PHE . 36.2 p90 -114.45 130.85 56.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.255 0.55 . . . . 63.51 110.955 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 258' ' ' THR . 18.2 p -100.19 115.08 29.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.96 -1.018 . . . . 73.0 109.557 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -123.87 123.24 40.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.269 -0.423 . . . . 71.12 110.53 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 230' ' ' ASP . 9.5 m -69.51 111.62 5.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.371 -0.603 . . . . 74.44 109.371 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.49 -47.42 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 74.24 109.479 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.922 ' HB2' HD12 ' A' ' 255' ' ' ILE . 68.0 mttm -142.53 155.94 63.67 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.623 -1.251 . . . . 74.24 107.623 173.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.99 98.44 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.401 2.067 . . . . 74.35 111.79 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.46 -30.07 3.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.961 -0.638 . . . . 55.1 112.197 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.922 HD12 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -124.42 121.87 62.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.707 0.765 . . . . 70.52 111.747 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.91 125.39 52.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.271 -0.877 . . . . 73.13 109.707 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.2 tp -99.89 125.26 45.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.95 -0.568 . . . . 74.21 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.693 ' HB ' HG22 ' A' ' 248' ' ' THR . 6.8 t -117.77 121.42 40.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.486 0.66 . . . . 72.12 110.478 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.648 HD23 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -107.31 123.98 49.12 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.885 -1.154 . . . . 74.34 107.885 176.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 23.5 m -134.18 152.38 51.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.8 0.333 . . . . 72.2 110.482 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.442 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -156.86 131.56 8.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.311 -0.404 . . . . 54.2 110.601 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.738 HD12 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -108.34 114.57 28.53 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.934 -1.136 . . . . 75.35 107.934 174.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.909 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -101.97 105.21 15.96 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.11 -1.441 . . . . 70.55 107.11 174.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.737 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 4.8 p-10 -76.01 98.49 4.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.233 -1.025 . . . . 72.14 108.233 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.35 -9.16 3.02 Favored Glycine 0 C--N 1.321 -0.28 0 CA-C-N 114.106 -1.407 . . . . 63.42 114.371 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -88.04 -20.23 26.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.034 0.445 . . . . 73.3 110.243 -173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.0 -33.9 0.9 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.778 0.799 . . . . 71.3 109.083 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 263' ' ' LEU . 1.8 t -54.09 -29.65 19.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 113.8 -1.546 . . . . 72.31 112.529 176.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.24 -37.15 84.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.596 . . . . 62.23 111.251 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.43 -16.27 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.067 0.395 . . . . 72.23 112.067 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.79 3.85 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.805 -0.712 . . . . 64.55 112.86 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -105.61 149.08 16.65 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 121.164 -0.541 . . . . 74.23 112.716 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.9 ' HB2' HD11 ' A' ' 263' ' ' LEU . 5.5 p-80 -103.83 149.15 25.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.844 -0.678 . . . . 73.4 110.208 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -96.27 138.62 33.61 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.084 -0.646 . . . . 75.42 110.764 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.0 tm? -120.77 144.72 48.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.676 -0.693 . . . . 70.13 110.443 -169.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.571 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -133.0 118.49 2.17 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.364 -0.694 . . . . 71.32 111.364 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.648 HD23 HD23 ' A' ' 259' ' ' LEU . 3.1 tm? -114.41 123.84 50.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.915 -0.772 . . . . 72.24 108.915 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -136.27 147.04 19.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.739 -1.219 . . . . 73.52 113.588 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.68 131.45 51.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.016 -0.735 . . . . 62.54 109.016 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -115.66 111.77 21.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.35 -0.611 . . . . 72.02 109.35 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.749 ' HB2' HD22 ' A' ' 31' ' ' LEU . 13.0 m-85 -95.32 101.85 13.61 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.686 -0.688 . . . . 72.51 109.22 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -103.73 110.93 23.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.966 -0.561 . . . . 75.42 110.031 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.37 110.06 21.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.857 -0.61 . . . . 75.11 109.712 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 61.5 mt -125.79 179.16 5.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.682 -0.69 . . . . 62.43 109.818 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.186 -0.672 . . . . 71.44 109.186 176.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.754 -0.461 . . . . 73.52 109.754 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.656 HG13 ' HB2' ' A' ' 119' ' ' LYS . 6.2 t -110.66 102.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 74.35 110.523 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 159.27 37.63 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.628 2.219 . . . . 71.04 112.076 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.89 85.6 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.653 2.236 . . . . 72.12 111.626 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.9 p -75.16 -29.17 60.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.042 -0.526 . . . . 63.4 111.303 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.449 ' HB2' HG23 ' A' ' 143' ' ' VAL . 73.2 t80 -57.45 -40.09 77.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.23 0.538 . . . . 74.41 110.796 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.3 -24.05 34.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 74.11 110.4 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.21 8.32 33.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.701 . . . . 72.5 110.505 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.16 -14.89 61.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 74.25 110.422 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . 140.31 64.72 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 121.1 -0.571 . . . . 72.53 112.396 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -65.96 -43.1 88.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.988 0.394 . . . . 75.33 109.972 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -59.44 -38.75 81.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 75.05 110.489 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.09 74.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 70.31 111.032 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 48.3 mtp85 -64.73 -29.84 70.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 75.5 111.161 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.19 -37.55 72.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.292 0.567 . . . . 73.31 110.425 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.53 ' HA ' ' CE ' ' A' ' 236' ' ' LYS . 13.6 t -83.26 -36.38 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 74.2 111.035 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.53 -41.82 65.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.659 . . . . 73.24 112.327 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 15' ' ' ARG . 3.5 t -95.45 172.69 7.93 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.972 -0.291 . . . . 64.3 110.504 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -79.99 73.6 6.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.626 0.726 . . . . 74.02 110.977 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.48 36.27 3.96 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.579 -0.737 . . . . 63.02 111.496 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.609 ' HA ' ' OG ' ' A' ' 260' ' ' SER . 15.4 p90 -147.9 136.06 21.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.287 . . . . 73.24 110.788 -176.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.31 64.92 3.39 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.034 -0.53 . . . . 43.11 113.235 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.61 -3.74 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 75.53 110.842 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.22 -1.87 78.89 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.011 -0.54 . . . . 74.52 112.898 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -147.98 -179.6 7.03 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.088 0.947 . . . . 71.31 113.441 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.582 HG23 HD12 ' A' ' 277' ' ' LEU . 36.8 mm -102.82 122.94 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.693 -1.594 . . . . 73.42 108.717 174.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.637 ' HB2' ' HZ1' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -118.22 124.99 49.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.324 0.583 . . . . 74.15 110.432 178.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.877 HD11 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tp -124.19 144.12 50.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.0 -0.546 . . . . 75.21 110.057 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.8 p30 -144.66 140.03 28.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.116 0.484 . . . . 71.21 110.028 171.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.756 HD12 ' HD1' ' A' ' 281' ' ' PHE . 16.0 tp -119.07 123.32 44.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.351 -0.84 . . . . 74.32 109.494 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 4.1 ptpp? -116.64 124.41 49.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.476 -0.783 . . . . 75.24 109.841 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' HB2' ' A' ' 283' ' ' ALA . 45.4 m -123.16 121.57 36.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.692 -0.686 . . . . 74.3 110.089 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.56 123.41 47.31 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.413 -0.515 . . . . 75.01 109.954 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 48.0 t -141.81 146.99 36.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 72.21 109.615 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.91 -148.09 0.49 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.421 0.451 . . . . 65.12 111.247 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.71 136.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.036 -0.529 . . . . 70.23 110.281 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.51 -9.24 36.36 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 118.799 -1.001 . . . . 74.12 115.243 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -100.57 127.47 46.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.465 1.633 . . . . 71.23 112.547 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.13 118.11 11.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.762 -0.829 . . . . 65.04 108.762 162.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -100.64 120.79 40.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.63 -0.508 . . . . 74.33 109.63 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 10.5 m -125.91 116.89 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.882 0.372 . . . . 75.1 110.848 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 10.6 t -111.61 122.47 47.89 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.635 -0.876 . . . . 75.42 108.635 174.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -129.71 126.75 38.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.928 0.394 . . . . 41.34 110.301 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.47 16.08 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.757 -0.735 . . . . 71.43 111.773 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.4 m -125.02 134.32 52.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.49 -0.559 . . . . 74.51 109.49 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 54' ' ' VAL . . . -137.02 128.56 28.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.005 0.431 . . . . 74.51 110.725 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 18.4 m120 -75.4 113.06 12.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.32 -0.622 . . . . 64.14 109.32 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.405 ' HB ' HG12 ' A' ' 27' ' ' ILE . 8.8 t -63.71 132.41 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 73.31 111.0 -174.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 60.48 15.07 5.27 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.165 -0.925 . . . . 71.23 111.05 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.481 ' HB ' ' CB ' ' A' ' 48' ' ' ASN . 5.1 m -119.84 -10.13 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 73.35 110.43 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.415 ' HG1' ' C ' ' A' ' 51' ' ' THR . 71.5 p 52.94 34.81 17.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.574 0.75 . . . . 72.01 112.679 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 35.3 mmtp -113.19 102.05 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.053 -0.721 . . . . 73.33 109.053 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG11 ' HB1' ' A' ' 47' ' ' ALA . 13.7 t -123.78 123.42 67.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.123 -0.489 . . . . 74.11 111.661 -170.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -111.03 125.69 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 73.33 109.243 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.07 136.96 11.56 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.609 -0.805 . . . . 75.14 112.396 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 p -137.04 153.75 50.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.917 0.389 . . . . 75.0 110.56 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -127.27 124.79 39.66 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.142 -0.688 . . . . 75.54 109.142 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.935 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 87.0 mt-10 -108.41 119.97 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.298 -0.41 . . . . 53.11 110.386 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.628 ' HG1' ' HB2' ' A' ' 73' ' ' GLU . 20.5 p -99.19 117.7 34.24 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.007 -1.109 . . . . 74.53 108.007 168.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.745 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.6 ttmp? -119.93 131.3 55.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.571 -0.529 . . . . 74.42 109.571 -174.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.737 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 25.8 m-85 -108.27 121.43 44.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.902 -0.59 . . . . 75.22 109.989 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.584 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 tmm_? -103.9 104.66 14.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.732 -0.84 . . . . 73.54 108.732 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.451 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 7.3 t-105 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.158 -0.928 . . . . 74.31 111.657 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 67' ' ' TYR . 25.1 m 69.84 144.99 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.93 0.769 . . . . 64.5 112.151 173.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -82.21 12.02 4.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.505 . . . . 62.52 111.145 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.412 ' H ' HG23 ' A' ' 65' ' ' THR . 54.3 m-85 -102.4 -46.8 4.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.481 -0.327 . . . . 72.21 110.424 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.436 ' C ' HD11 ' A' ' 69' ' ' LEU . . . 144.95 71.86 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.125 -1.035 . . . . 70.31 113.393 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.637 ' HG ' ' HA ' ' A' ' 87' ' ' VAL . 8.3 mp -112.44 134.81 53.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.094 -0.651 . . . . 70.32 110.453 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -136.64 112.07 9.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.774 -0.648 . . . . 61.11 110.24 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 32.4 t80 -106.11 122.12 45.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.399 -0.593 . . . . 75.41 109.399 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 14.8 m -117.15 117.36 29.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.798 0.332 . . . . 74.33 111.275 -175.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.628 ' HB2' ' HG1' ' A' ' 60' ' ' THR . 43.3 mt-10 -103.14 120.42 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 62.14 108.452 168.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.915 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 3.4 tmtp? -114.53 98.04 6.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.95 -0.568 . . . . 64.24 109.592 -174.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.556 ' HE1' ' HA ' ' A' ' 79' ' ' ASN . 2.1 t90 -99.51 129.02 45.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.212 -0.449 . . . . 75.23 110.422 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 39.5 t30 -97.78 154.24 17.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.221 -0.659 . . . . 63.33 109.221 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -65.31 -17.51 64.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.93 0.395 . . . . 73.02 111.348 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 12.8 m-20 -80.58 -1.28 41.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.054 -0.521 . . . . 72.04 110.371 174.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.556 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 4.1 m-20 77.7 35.16 0.31 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.979 0.912 . . . . 75.14 110.959 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 11.2 m -85.42 117.68 24.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.604 -0.725 . . . . 74.31 109.601 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.4 124.23 39.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.992 0.425 . . . . 73.35 111.352 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.85 109.31 2.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.745 -0.942 . . . . 65.23 110.745 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 m -104.62 99.64 9.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.918 0.359 . . . . 72.42 110.958 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.659 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 28.4 tt0 -111.73 132.26 54.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 72.42 110.209 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.8 tt -129.4 126.14 63.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 73.23 111.077 173.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.6 m -116.14 123.73 48.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.009 -0.541 . . . . 60.32 109.827 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.637 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 2.7 p -128.54 121.88 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.371 -0.233 . . . . 73.03 110.371 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 96' ' ' LYS . 44.3 mt-10 -99.0 137.52 37.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 75.12 110.798 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.77 151.82 27.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 74.14 111.274 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.01 -38.94 14.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.545 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.74 -45.69 13.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.57 0.7 . . . . 74.32 109.477 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -87.17 66.56 9.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.324 -0.853 . . . . 74.41 108.83 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.695 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -53.4 124.7 15.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 73.41 110.378 -177.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.48 -3.82 56.53 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.429 -0.891 . . . . 65.43 112.57 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.6 HD22 ' HD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -81.81 117.34 22.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.493 -0.558 . . . . 73.51 109.493 175.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.527 ' HG2' ' HG2' ' A' ' 88' ' ' GLU . 26.6 mtpp -116.35 110.65 18.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 74.52 109.083 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.494 HD12 HG23 ' A' ' 116' ' ' THR . 2.0 mm? -99.93 126.29 46.06 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.37 -0.604 . . . . 75.41 109.37 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.784 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 28.4 m -130.16 119.17 22.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.95 0.405 . . . . 74.33 110.61 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -115.32 113.26 23.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.516 -0.92 . . . . 75.31 108.516 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.508 ' OD1' ' HD2' ' A' ' 113' ' ' LYS . 9.8 p-10 -120.77 134.39 55.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.317 0.579 . . . . 75.1 110.109 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 14.9 m -131.2 134.32 46.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.777 -0.647 . . . . 74.52 111.289 -175.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.3 t -95.27 122.0 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.082 -1.081 . . . . 61.3 108.082 172.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' HD1' ' HB3' ' A' ' 110' ' ' LYS . 82.1 t80 -127.51 129.52 47.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.217 0.532 . . . . 75.54 110.642 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.8 m -120.45 103.2 44.48 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.787 -0.642 . . . . 75.22 109.737 176.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.97 -16.42 55.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.023 2.482 . . . . 64.23 112.978 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -66.35 -45.15 81.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.966 0.412 . . . . 74.54 110.607 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.3 p -105.16 -13.54 15.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.89 -0.595 . . . . 75.13 111.571 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.95 85.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 73.53 111.531 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.463 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 87.0 tttt -74.2 137.9 43.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 75.23 111.123 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.91 132.81 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 72.34 110.706 177.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.562 HD21 ' HA ' ' A' ' 132' ' ' ASP . 16.3 m120 -120.33 122.93 41.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 74.13 109.494 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.94 126.86 52.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.136 0.493 . . . . 43.2 111.419 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.508 ' HD2' ' OD1' ' A' ' 100' ' ' ASP . 57.0 mttm -121.14 138.44 54.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.424 -0.584 . . . . 73.45 109.424 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mm -119.75 117.79 54.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.101 0.476 . . . . 74.13 110.524 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.784 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 40.3 mttp -115.02 119.81 37.73 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.8 -0.636 . . . . 72.51 109.729 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.494 HG23 HD12 ' A' ' 97' ' ' LEU . 27.8 p -116.36 117.61 30.44 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.078 -0.51 . . . . 73.25 110.125 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.83 130.27 9.42 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.55 -0.833 . . . . 72.31 112.034 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.6 ' HD1' HD22 ' A' ' 95' ' ' LEU . 71.4 t80 -123.14 115.26 21.5 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.027 -0.731 . . . . 73.44 109.027 174.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HB2' HG13 ' A' ' 3' ' ' VAL . 22.0 pttm -111.69 122.64 48.34 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.605 -0.838 . . . . 75.44 110.962 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.477 ' HB3' HG21 ' A' ' 123' ' ' ILE . 37.6 ttm180 -106.29 169.13 8.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.757 -1.201 . . . . 72.23 107.757 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.634 ' HA ' HG22 ' A' ' 3' ' ' VAL . 41.5 tp10 -53.28 -34.1 55.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 73.42 112.219 -167.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.445 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 92.9 m-70 -119.96 3.85 10.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 113.189 0.811 . . . . 75.32 113.189 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.477 HG21 ' HB3' ' A' ' 120' ' ' ARG . 18.8 tt -144.82 147.89 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.248 -0.981 . . . . 73.22 112.235 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.473 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -123.6 124.33 42.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.032 0.444 . . . . 72.43 110.8 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 142' ' ' LEU . 4.2 mm? -111.06 139.89 46.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.129 -0.487 . . . . 75.42 109.975 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.17 116.83 0.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.598 -0.81 . . . . 63.45 112.14 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 60.9 m -112.1 115.28 28.61 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.545 -0.385 . . . . 73.53 110.377 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.96 116.84 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 75.25 110.472 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 44.9 mtt -103.59 117.59 34.77 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.686 -0.857 . . . . 73.14 108.686 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.17 114.8 29.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.431 -0.507 . . . . 75.12 109.928 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 53.0 t80 -99.29 97.56 8.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.954 0.406 . . . . 73.5 110.419 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.562 ' HA ' HD21 ' A' ' 111' ' ' ASN . 12.6 t70 -101.18 144.22 30.32 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.113 -1.069 . . . . 72.45 108.113 170.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -65.64 -25.74 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.78 -0.452 . . . . 73.21 109.78 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.05 -1.42 57.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 73.2 111.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.19 108.19 0.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.368 -0.92 . . . . 70.51 113.024 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 2.3 Cg_endo -82.58 126.76 4.78 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.352 2.701 . . . . 70.52 112.096 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 p -126.49 162.94 24.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.812 0.339 . . . . 74.32 111.227 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 49.4 mm -108.9 123.58 64.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.479 -0.328 . . . . 74.54 110.65 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.06 113.23 21.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.931 0.396 . . . . 71.41 109.945 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.83 11.18 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.069 -1.062 . . . . 75.12 111.817 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.15 116.83 26.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.036 0.446 . . . . 71.12 110.015 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -116.51 123.83 48.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.142 -0.481 . . . . 72.33 110.289 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 93.8 t -111.94 129.4 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 73.13 109.975 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.32 138.45 43.5 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.002 -0.74 . . . . 75.55 109.002 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 122' ' ' HIS . . . -117.78 118.55 4.12 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.439 -0.886 . . . . 72.43 112.641 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.546 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 25.0 t80 -131.66 146.42 52.17 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.483 -1.303 . . . . 73.31 107.483 175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.1 101.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.099 0.476 . . . . 75.15 111.403 -176.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.72 -31.2 8.11 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.378 -0.828 . . . . 64.25 112.512 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 33.3 m0 -105.12 122.81 46.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.62 0.248 . . . . 75.1 111.471 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.55 137.65 46.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 73.01 110.105 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -129.96 158.18 40.26 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.852 -0.425 . . . . 62.14 109.852 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -157.46 132.86 3.33 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.395 -0.682 . . . . 63.22 111.395 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.575 ' CD1' ' HD1' ' A' ' 169' ' ' PHE . 21.7 m-85 -127.13 118.96 25.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 117.271 0.535 . . . . 74.2 109.841 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.805 ' HG3' ' HB3' ' A' ' 168' ' ' ASN . 26.8 pt20 -105.55 122.86 46.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.655 0.741 . . . . 71.41 109.771 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 ptm -126.67 140.49 52.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 70.01 110.666 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 22.0 t-20 -113.2 117.66 32.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.712 -0.477 . . . . 71.44 109.712 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.823 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 87.9 t80 -100.86 129.12 46.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.687 -0.688 . . . . 74.32 109.822 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.772 ' HG3' ' H ' ' A' ' 161' ' ' LYS . 9.0 tp10 -99.81 103.31 14.92 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 115.851 -0.613 . . . . 74.25 109.803 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 m -70.89 -27.01 63.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.548 -1.66 . . . . 73.03 111.327 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.05 75.05 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.777 0.799 . . . . 75.11 108.909 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.772 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 48.1 mmtm -95.28 -162.61 0.96 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.681 -1.229 . . . . 74.05 107.681 167.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -109.48 22.12 16.17 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.91 -0.494 . . . . 73.53 110.836 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -166.28 165.66 17.23 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 118.56 -1.256 . . . . 75.32 113.411 -163.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.823 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -77.7 136.39 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.66 -0.7 . . . . 71.45 110.096 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.1 m -94.63 -21.59 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 74.32 110.516 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' ASN . 22.0 tt0 -133.47 132.28 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 74.11 111.14 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -122.79 105.95 10.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.546 -0.752 . . . . 73.13 109.539 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.805 ' HB3' ' HG3' ' A' ' 154' ' ' GLN . 11.8 t-20 -117.09 128.84 55.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.928 -0.397 . . . . 73.14 109.928 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.575 ' HD1' ' CD1' ' A' ' 153' ' ' TYR . 47.4 m-85 -121.8 149.82 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.61 -0.268 . . . . 74.22 110.751 -173.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.573 ' HB2' ' CE1' ' A' ' 181' ' ' HIS . . . -151.84 137.76 18.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.65 -0.25 . . . . 65.33 110.908 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 182' ' ' THR . 63.7 t -135.03 127.07 47.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.439 -0.578 . . . . 63.52 109.439 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.37 108.46 0.88 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.103 -0.799 . . . . 62.41 111.103 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.516 ' CZ ' HD23 ' A' ' 180' ' ' LEU . 28.7 p90 -127.63 151.51 48.85 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.52 -0.872 . . . . 74.33 111.936 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.685 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 95.9 mttt -118.34 138.19 52.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.116 -1.402 . . . . 75.31 110.498 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -131.78 113.44 13.52 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.66 -0.867 . . . . 75.44 108.66 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.47 -95.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.823 0.702 . . . . 60.14 112.402 -172.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 197' ' ' LYS . 11.8 mm-40 -108.39 4.79 24.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.793 0.33 . . . . 75.12 111.235 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.84 122.5 47.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.42 -0.215 . . . . 73.5 110.42 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.685 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 3.8 mt-30 -135.9 123.17 21.79 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 119.48 -0.295 . . . . 62.43 110.606 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.569 ' O ' ' HA2' ' A' ' 172' ' ' GLY 0.262 0.0 OUTLIER -127.86 144.13 51.1 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.264 1.03 . . . . 74.13 113.728 171.396 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.573 ' CE1' ' HB2' ' A' ' 170' ' ' ALA . 22.0 t60 -108.38 114.29 28.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.117 -1.856 . . . . 73.11 108.587 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.638 HG21 ' HB ' ' A' ' 171' ' ' VAL . 14.0 t -96.83 157.94 15.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.153 -1.055 . . . . 61.33 108.153 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -147.95 149.71 32.7 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.722 -0.391 . . . . 75.41 110.157 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -131.41 116.03 30.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.509 -0.552 . . . . 73.34 109.509 170.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 57.7 t30 -94.33 97.02 9.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.591 -0.731 . . . . 74.23 109.812 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.23 -165.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.053 -0.976 . . . . 72.24 110.787 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.87 89.48 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.85 -0.691 . . . . 74.15 112.104 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -102.09 -25.72 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.157 0.799 . . . . 73.21 113.157 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.767 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 38.3 tt0 -129.82 139.92 51.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 119.698 -0.801 . . . . 74.51 113.066 -170.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.36 153.91 21.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.342 -0.844 . . . . 75.32 108.82 172.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -149.64 162.92 29.22 Favored Glycine 0 C--N 1.314 -0.654 0 C-N-CA 120.669 -0.776 . . . . 72.4 112.629 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -159.1 154.82 25.9 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.609 -0.596 . . . . 61.44 111.609 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.0 m -148.73 135.18 19.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.93 -0.767 . . . . 72.41 108.93 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.0 mp -123.15 124.51 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 73.14 110.15 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.781 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -112.61 119.86 39.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 73.41 109.932 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.491 ' HB3' ' CG2' ' A' ' 204' ' ' THR . 22.1 tp60 -108.82 111.92 23.9 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.112 -0.699 . . . . 73.24 109.112 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.584 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 8.7 tmtm? -97.28 108.62 21.38 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.534 -0.913 . . . . 63.53 108.534 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.798 ' HB ' ' HB3' ' A' ' 201' ' ' LYS . 15.0 t -77.94 123.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.181 -1.044 . . . . 70.01 108.181 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -38.95 -60.57 0.84 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.445 1.09 . . . . 65.32 112.234 -170.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -123.42 83.87 2.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.967 0.413 . . . . 72.5 109.913 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.798 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 20.2 tptm -167.99 -90.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 74.41 109.654 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.798 ' HB3' ' HD1' ' A' ' 225' ' ' TYR . 0.0 OUTLIER -163.18 -176.18 4.69 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.654 0.264 . . . . 71.05 110.525 173.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.781 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 3.2 mp0 -108.18 131.86 54.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 73.41 109.741 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 196' ' ' GLN . 15.0 t -122.15 150.0 42.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.234 -0.654 . . . . 75.34 109.234 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 222' ' ' ALA . . . -129.79 159.38 36.7 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.489 0.661 . . . . 74.54 111.408 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 221' ' ' ILE . 2.3 t -132.58 124.86 52.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.382 -1.281 . . . . 70.53 108.428 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -114.64 131.07 56.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 70.33 109.197 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.618 HD13 ' HD1' ' A' ' 219' ' ' PHE . 5.0 tp -147.06 136.28 22.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.023 -0.535 . . . . 71.32 110.448 -171.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.451 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -154.97 132.03 10.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.665 0.269 . . . . 52.24 110.693 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -130.96 118.45 20.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.1 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 1.4 m -94.76 108.7 20.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.069 -0.514 . . . . 75.32 109.918 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.06 130.37 43.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 75.32 110.683 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.46 1.42 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.384 -0.686 . . . . 63.11 111.384 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.36 88.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.234 0.54 . . . . 73.54 111.39 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 62.5 m -144.32 167.03 23.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.574 . . . . 72.13 110.134 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.87 124.1 22.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 63.25 110.25 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 23.5 p -77.73 123.29 26.5 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.097 0.475 . . . . 72.11 110.024 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.526 ' O ' HD11 ' A' ' 208' ' ' LEU . 63.7 mtt85 -89.6 113.02 24.4 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.408 -0.59 . . . . 73.43 109.408 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.618 ' HD1' HD13 ' A' ' 208' ' ' LEU . 93.4 t80 -126.62 136.39 52.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.981 -0.748 . . . . 74.51 108.981 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.38 162.78 33.57 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.033 -1.079 . . . . 70.35 112.474 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.622 HG12 HG11 ' A' ' 237' ' ' VAL . 0.1 OUTLIER -137.72 147.55 26.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.008 0.432 . . . . 73.12 109.969 176.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -136.99 157.75 46.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.656 -0.702 . . . . 71.31 110.564 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -141.57 126.27 17.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.685 0.278 . . . . 63.03 111.016 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 69.2 mttm -108.02 112.98 25.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.771 -0.826 . . . . 74.21 108.771 172.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.798 ' HD1' ' HB3' ' A' ' 202' ' ' LEU . 30.0 t80 -114.15 119.0 35.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.725 . . . . 75.35 111.471 -172.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -76.45 104.42 6.96 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.861 -1.163 . . . . 73.01 107.861 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.13 -56.69 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.142 -0.481 . . . . 72.03 111.513 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.614 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 35.8 t70 178.32 -54.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 74.25 111.145 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 89.5 Cg_endo -83.16 -142.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.936 1.757 . . . . 74.44 112.586 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 14.7 p-10 -91.97 10.98 26.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 72.13 110.324 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 132.78 54.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.712 -0.676 . . . . 71.45 110.533 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 248' ' ' THR . 11.9 p -122.23 142.6 50.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.45 -0.795 . . . . 73.24 109.813 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -101.94 132.89 47.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 62.42 110.008 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 52.0 p -122.95 120.74 34.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.952 0.406 . . . . 64.31 110.448 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.14 152.8 24.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.507 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.53 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 60.2 mttp -139.89 142.43 36.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.093 -0.706 . . . . 63.22 109.093 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.622 HG11 HG12 ' A' ' 221' ' ' ILE . 3.6 p -140.85 137.74 34.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.369 -0.532 . . . . 73.15 109.995 174.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.671 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 12.8 m120 -109.01 149.57 29.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.511 . . . . 74.01 110.045 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 219' ' ' PHE . 7.9 p30 -55.02 -24.18 23.23 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.257 0.973 . . . . 63.45 112.525 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.659 ' HB2' HD11 ' A' ' 242' ' ' LEU . 9.5 m -79.59 20.5 0.57 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 70.45 110.165 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 239' ' ' ASN . 40.7 m 65.97 36.99 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.352 -0.84 . . . . 75.33 110.771 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.857 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.3 mp -97.44 138.26 35.15 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.458 -0.497 . . . . 70.13 111.223 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 243' ' ' ILE . 3.0 mp -113.3 117.9 56.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.588 -0.733 . . . . 75.03 109.993 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.13 138.1 12.33 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.595 -0.812 . . . . 74.31 111.886 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.53 139.48 42.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 73.12 110.159 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.28 146.23 17.29 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.844 -0.693 . . . . 63.14 112.204 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.72 126.83 55.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.066 -0.346 . . . . 75.42 110.066 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.462 ' HB ' ' SG ' ' A' ' 232' ' ' CYS . 11.7 m -120.92 114.71 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 74.31 109.699 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.65 ' HB3' ' HB3' ' A' ' 257' ' ' LEU . 48.1 tt0 -125.28 138.9 54.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.364 -0.38 . . . . 75.32 110.535 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 2.5 t -121.98 92.84 3.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.503 0.668 . . . . 75.34 110.032 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.796 ' HB3' HG23 ' A' ' 255' ' ' ILE . 53.6 tp -88.81 66.12 7.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.883 -0.599 . . . . 74.02 109.431 -175.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.444 ' HG3' ' HD2' ' A' ' 253' ' ' PRO . 40.9 ttmt 69.38 150.86 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.115 -0.948 . . . . 73.31 109.908 -174.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 252' ' ' LYS . 51.4 Cg_exo -54.44 84.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.324 2.016 . . . . 75.44 111.642 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.426 ' HA2' ' HG3' ' A' ' 282' ' ' GLN . . . -178.6 -35.21 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.112 -0.949 . . . . 65.15 110.793 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.796 HG23 ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -149.08 122.3 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.75 0.786 . . . . 64.43 110.82 176.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -116.99 131.65 56.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.056 -0.975 . . . . 75.4 109.827 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 28.8 tp -102.93 122.12 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.723 -0.473 . . . . 74.44 109.723 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.2 t -135.22 109.98 8.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 55.11 110.512 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.595 ' HB3' HD21 ' A' ' 277' ' ' LEU . 1.6 pp -135.08 158.38 44.5 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.085 -0.646 . . . . 72.53 110.54 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.609 ' OG ' ' HA ' ' A' ' 22' ' ' TYR . 20.1 p -148.99 143.39 26.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.827 -0.624 . . . . 74.43 110.262 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.436 ' HB2' HD22 ' A' ' 275' ' ' LEU . . . -139.55 130.2 25.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.221 -0.659 . . . . 71.12 109.221 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.847 HD23 HD21 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -119.91 127.34 52.6 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.633 0.73 . . . . 74.44 110.084 179.518 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.864 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -101.74 109.68 21.51 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.23 -1.396 . . . . 54.13 107.23 176.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.857 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 10.5 t0 -72.25 106.87 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.405 -0.961 . . . . 64.51 108.405 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.48 -21.43 27.5 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.367 -0.444 . . . . 72.11 113.115 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -90.95 -20.16 22.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.741 0.305 . . . . 71.14 110.786 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 29.3 t-20 -110.5 -29.06 8.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.914 0.388 . . . . 71.23 111.942 -173.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.864 HG11 ' HB3' ' A' ' 263' ' ' LEU . 23.0 m -63.27 -16.55 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.063 -0.398 . . . . 73.44 111.804 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -53.93 -35.93 62.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.928 -0.397 . . . . 75.45 109.928 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -96.89 -16.78 20.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 61.23 110.53 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 117.62 7.21 12.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.8 -0.714 . . . . 74.41 113.176 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -70.2 85.71 0.32 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 70.22 113.041 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.542 ' HB2' HD13 ' A' ' 263' ' ' LEU . 55.8 p-80 -113.96 138.89 49.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.098 -0.334 . . . . 74.45 110.098 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 9.5 mmpt? -105.76 137.44 43.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.276 -0.268 . . . . 75.11 110.276 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -129.26 132.54 47.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.57 -0.286 . . . . 74.2 110.275 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.486 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -138.89 118.95 1.65 Allowed Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.541 -0.624 . . . . 55.21 111.541 174.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 259' ' ' LEU . 1.7 tm? -118.57 124.59 47.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.903 0.352 . . . . 73.12 110.09 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -132.56 141.0 12.31 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.547 -0.835 . . . . 62.3 113.442 -177.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.877 ' HB2' HD11 ' A' ' 29' ' ' LEU . 2.4 mm? -122.7 132.4 54.23 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.523 0.201 . . . . 74.35 110.908 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -105.43 111.54 24.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 73.32 109.169 167.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.756 ' HD1' HD12 ' A' ' 31' ' ' LEU . 5.6 t80 -107.64 133.68 51.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.436 -0.95 . . . . 75.22 108.436 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 pt20 -137.4 125.49 22.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.288 0.566 . . . . 74.42 111.758 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.441 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -106.36 112.4 25.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.514 -0.766 . . . . 73.53 109.493 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 74.9 mt -115.42 156.87 24.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.921 -0.581 . . . . 75.4 110.134 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 109.127 -0.694 . . . . 72.4 109.127 178.287 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.365 0.602 . . . . 70.43 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 1.0 HG11 ' HB3' ' A' ' 119' ' ' LYS . 9.9 p -88.09 142.81 32.2 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.191 -0.913 . . . . 75.24 110.087 -174.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 85.0 Cg_exo -48.47 146.66 10.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.167 2.578 . . . . 73.52 112.926 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 7.6 Cg_exo -72.08 91.58 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.97 2.447 . . . . 74.34 112.49 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -76.36 -20.22 57.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.504 . . . . 70.1 110.134 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.655 ' HA ' HG21 ' A' ' 143' ' ' VAL . 63.7 t80 -56.64 -38.36 72.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 73.41 110.081 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.56 -28.26 28.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.771 -0.649 . . . . 70.45 110.573 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.67 6.37 35.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.794 -0.639 . . . . 74.15 110.708 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.584 HD22 HG11 ' A' ' 143' ' ' VAL . 89.3 mt -60.78 -15.93 35.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.39 0.614 . . . . 71.11 109.823 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.681 ' HA3' ' HB2' ' A' ' 181' ' ' HIS . . . 164.72 57.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.099 -1.201 . . . . 75.11 110.099 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 14.2 tmtt? -56.16 -54.32 46.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.875 0.47 . . . . 74.0 111.54 -170.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -65.19 -42.15 93.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.091 0.472 . . . . 60.14 111.485 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 -36.5 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 73.43 112.423 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' O ' HG21 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.23 -31.45 70.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 72.21 111.574 -173.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 2.3 m-20 -65.75 -41.85 91.61 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 121.248 -0.181 . . . . 62.31 111.343 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.81 -38.97 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.329 0.585 . . . . 63.15 110.113 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -72.91 -41.39 64.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.442 -0.799 . . . . 73.03 112.186 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 20' ' ' LYS . 14.4 t -94.66 -6.6 42.98 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.321 0.489 . . . . 64.35 112.321 -173.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 13.7 mptt -101.41 28.34 5.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 70.55 110.405 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.04 134.14 36.98 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.903 -0.665 . . . . 73.34 112.117 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.876 ' HB3' ' HD2' ' A' ' 274' ' ' LYS . 96.3 m-85 72.01 -57.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.498 0.719 . . . . 73.31 111.771 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.14 155.53 12.78 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.498 -1.041 . . . . 74.32 110.498 -173.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -83.18 -4.46 58.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.232 0.516 . . . . 73.45 111.174 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.99 4.0 84.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.945 -0.645 . . . . 72.23 113.377 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.5 pp -148.91 -177.83 6.02 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 122.199 1.0 . . . . 74.22 113.013 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.832 HG22 HD21 ' A' ' 277' ' ' LEU . 25.6 mm -90.97 129.06 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 113.858 -1.519 . . . . 74.43 109.637 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 87.5 tttt -118.18 133.23 56.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.786 0.327 . . . . 73.43 110.372 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.7 tp -117.52 149.65 40.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.855 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 11.5 t70 -142.37 139.78 31.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.282 -0.872 . . . . 71.33 108.88 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -134.74 127.67 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.845 -0.428 . . . . 73.21 109.845 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -123.51 125.67 45.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.964 -0.754 . . . . 74.41 108.964 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.887 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 19.2 m -137.71 141.7 41.04 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.146 -0.222 . . . . 74.41 111.205 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -103.03 140.01 37.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.801 -0.444 . . . . 74.25 109.801 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.5 m -139.56 174.38 10.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.561 -0.533 . . . . 74.24 109.561 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -30.54 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 72.32 111.836 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -44.77 130.02 7.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.41 0.624 . . . . 73.3 111.929 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 89.19 -10.65 72.25 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.196 -0.911 . . . . 70.11 113.555 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.14 129.01 53.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.659 1.23 . . . . 75.32 111.488 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.99 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 34.2 tt0 -139.57 146.8 40.3 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.572 -0.899 . . . . 75.04 108.572 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.887 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 59.4 t80 -121.42 121.31 37.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.686 0.279 . . . . 75.34 110.776 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.853 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.0 m -126.08 132.39 51.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 75.2 110.322 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 19.4 m -132.28 143.25 49.76 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.975 -0.453 . . . . 75.22 110.799 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -143.27 125.95 15.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.029 -0.36 . . . . 75.12 110.029 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.8 152.46 20.31 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.428 -0.891 . . . . 55.2 111.914 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -128.45 133.27 48.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.19 -0.67 . . . . 64.34 109.19 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -138.1 130.94 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.922 0.391 . . . . 73.11 111.533 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.58 142.93 42.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.881 -0.6 . . . . 64.22 109.42 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 t -75.36 141.75 43.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.727 0.298 . . . . 73.53 110.956 -176.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 mp0 73.12 -74.38 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.481 0.712 . . . . 74.14 111.93 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.38 139.0 45.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.399 . . . . 72.14 111.468 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 m -74.74 80.25 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.2 0.524 . . . . 62.3 111.916 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -126.3 93.93 3.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.362 -0.607 . . . . 75.0 109.362 172.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 64.3 110.458 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 m -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 61.44 108.876 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.96 125.08 6.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.518 -0.849 . . . . 51.11 112.763 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 m -109.31 134.02 52.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.265 -0.642 . . . . 73.32 109.265 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.11 124.68 46.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.834 -0.802 . . . . 73.51 108.834 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.853 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -107.96 117.35 33.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.536 0.684 . . . . 71.43 110.285 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 m -93.54 118.89 31.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.027 -1.101 . . . . 74.15 108.027 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.99 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 13.6 tptm -112.34 135.31 53.18 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.572 -0.451 . . . . 74.11 109.878 -173.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.834 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 81.0 m-85 -118.91 120.69 38.05 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.906 -0.776 . . . . 73.32 108.906 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.1 ttm-85 -122.91 109.27 13.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 73.14 111.533 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' LEU . 70.6 m95 -106.65 93.59 4.66 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.993 -1.003 . . . . 74.23 108.943 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -67.73 -38.29 83.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.058 . . . . 73.12 112.516 -170.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 tp10 -86.42 61.62 6.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.38 0.609 . . . . 65.32 111.235 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.579 ' HD1' HD23 ' A' ' 69' ' ' LEU . 47.9 t80 172.38 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.409 -1.269 . . . . 73.52 108.456 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.07 49.75 0.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.465 -0.789 . . . . 74.03 111.927 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.579 HD23 ' HD1' ' A' ' 67' ' ' TYR . 1.5 mm? -114.67 131.83 56.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.076 0.465 . . . . 75.32 111.228 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.2 m -134.43 112.73 11.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.669 -0.696 . . . . 73.21 110.28 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.834 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 16.0 t80 -109.46 125.4 52.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.942 -0.572 . . . . 74.2 109.572 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 5.0 m -121.42 117.1 26.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.742 0.305 . . . . 75.23 110.655 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.706 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.4 tt0 -101.76 119.87 39.46 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.002 -0.74 . . . . 75.21 109.002 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 15.8 ttmm -107.99 86.67 2.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.421 -0.585 . . . . 75.41 109.421 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.722 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 11.9 t90 -101.06 129.42 46.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.127 -0.488 . . . . 75.44 111.088 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -108.07 164.1 12.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.551 . . . . 73.44 109.825 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -68.89 -18.23 64.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.278 0.561 . . . . 73.43 110.51 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 25.0 t70 -74.28 -4.4 35.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 73.22 109.94 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 10.8 m120 74.76 9.52 4.11 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.969 -1.014 . . . . 72.12 110.644 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 117.37 21.83 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 72.01 109.518 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.722 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.9 pt? -123.02 136.98 55.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 73.04 111.374 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.61 106.28 2.28 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.251 -0.886 . . . . 74.31 111.237 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.0 m -85.78 100.06 11.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.861 0.362 . . . . 72.54 110.664 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 35.2 mt-10 -99.11 108.04 20.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 41.42 109.722 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.4 pp -112.18 137.92 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.518 -0.473 . . . . 72.42 110.584 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.1 m -129.21 128.55 43.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.581 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.01 125.72 74.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.968 0.413 . . . . 74.33 110.316 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -90.28 127.91 36.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 73.54 109.295 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 t70 -82.92 144.05 30.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.885 -0.413 . . . . 73.4 109.885 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.63 -21.56 15.22 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.076 -0.25 . . . . 75.24 111.367 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.0 tp -71.49 -45.52 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 74.01 109.302 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.32 75.31 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.486 -0.779 . . . . 73.43 109.786 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 35.6 ttm180 -61.46 135.36 57.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.19 0.519 . . . . 73.0 110.25 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.9 55.76 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.606 -0.998 . . . . 74.3 110.606 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.54 112.78 25.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.491 -1.3 . . . . 71.23 107.491 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 138.75 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.128 0.49 . . . . 74.35 110.054 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.34 127.27 51.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.497 -0.927 . . . . 74.42 108.497 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 1.025 HG22 ' HB2' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -125.96 130.37 51.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.178 0.513 . . . . 74.42 110.064 -176.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.438 ' CZ ' ' HB1' ' A' ' 112' ' ' ALA . 31.4 t80 -123.63 123.04 39.68 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.942 -0.762 . . . . 73.33 108.942 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 81.4 m-20 -108.54 121.25 44.59 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.372 -0.603 . . . . 72.14 109.372 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -111.51 120.79 43.33 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.816 -0.354 . . . . 72.25 110.152 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.5 m -101.54 120.05 39.71 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.624 -0.88 . . . . 73.35 108.624 175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.651 ' HD2' ' HB3' ' A' ' 110' ' ' LYS . 49.2 t80 -134.91 137.97 43.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.037 0.446 . . . . 72.52 110.652 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 m -127.96 102.49 21.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.853 -0.612 . . . . 75.04 109.734 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 36.5 Cg_exo -59.32 -34.25 97.79 Favored 'Trans proline' 0 N--CA 1.466 -0.09 0 C-N-CA 122.454 2.103 . . . . 73.52 111.417 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.69 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 73.55 111.175 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.3 m -76.9 -23.25 52.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.698 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.42 2.27 73.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.668 -0.777 . . . . 74.42 112.976 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.72 148.36 22.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 71.11 111.858 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 19.1 ptmt -145.88 124.98 12.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 74.2 110.612 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.57 140.27 51.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.509 -0.552 . . . . 74.22 109.509 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -119.51 130.67 55.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.056 0.455 . . . . 75.32 111.365 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.595 ' HG2' ' OD1' ' A' ' 130' ' ' ASP . 42.6 mttm -114.37 136.44 52.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.664 -0.495 . . . . 74.53 109.664 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.684 HG21 ' HE1' ' A' ' 129' ' ' MET . 4.0 tp -120.6 117.93 54.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.433 0.635 . . . . 65.44 109.585 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 1.025 ' HB2' HG22 ' A' ' 98' ' ' THR . 21.4 mtpt -122.93 134.83 54.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.698 -0.683 . . . . 71.14 110.7 -170.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -112.17 127.91 56.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.276 -0.638 . . . . 74.31 109.276 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.91 126.04 4.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.105 -1.045 . . . . 74.34 112.748 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.99 133.86 47.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.099 -0.334 . . . . 75.33 110.099 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 1.0 ' HB3' HG11 ' A' ' 3' ' ' VAL . 76.5 mttt -122.01 122.72 39.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.775 0.797 . . . . 63.14 111.464 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.842 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 18.9 tpt180 -110.26 162.18 14.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.517 -1.22 . . . . 74.0 108.089 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HA ' HG23 ' A' ' 3' ' ' VAL . 1.2 pm0 -58.48 -27.9 64.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.54 0.609 . . . . 73.42 110.932 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -107.97 3.16 23.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.177 -0.465 . . . . 73.42 111.526 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.842 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 15.5 mm -139.15 131.54 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.765 0.654 . . . . 74.44 112.765 -169.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.92 111.95 19.68 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.818 -1.179 . . . . 74.44 107.818 163.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.624 HD13 HD12 ' A' ' 142' ' ' LEU . 4.8 tp -128.32 124.6 36.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.996 0.427 . . . . 73.22 111.389 -175.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.72 115.39 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.944 -0.646 . . . . 74.02 111.975 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 63.2 m -114.43 116.4 28.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.82 -0.223 . . . . 72.3 110.467 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.636 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 3.3 p30 -105.76 122.74 46.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.431 0.634 . . . . 73.03 110.643 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.684 ' HE1' HG21 ' A' ' 114' ' ' ILE . 67.4 mtm -104.41 117.67 34.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 74.31 109.5 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.595 ' OD1' ' HG2' ' A' ' 113' ' ' LYS . 15.7 t0 -106.1 120.48 41.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.237 -0.438 . . . . 74.03 111.25 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -93.89 97.25 10.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.303 0.573 . . . . 74.53 109.708 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.25 143.88 32.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.469 -0.787 . . . . 60.52 109.242 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.94 -12.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 72.35 112.513 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.95 -9.43 37.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 72.03 110.981 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.48 120.75 1.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.92 -0.657 . . . . 75.42 112.231 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 29.2 Cg_exo -61.94 131.19 33.87 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.851 2.367 . . . . 72.43 112.37 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.4 m -126.55 129.95 49.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.942 -0.572 . . . . 53.32 110.182 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.2 mp -107.57 124.95 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.015 -0.365 . . . . 73.14 110.015 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.89 112.97 24.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.445 -0.576 . . . . 75.14 109.445 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 127' ' ' CYS . . . -111.69 131.93 10.55 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.722 -1.228 . . . . 73.14 111.757 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.88 116.8 23.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 62.54 110.26 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.624 HD12 HD13 ' A' ' 125' ' ' LEU . 12.2 tp -122.57 123.64 41.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 73.52 110.344 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 7' ' ' TYR . 86.1 t -122.49 124.96 71.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.352 -0.84 . . . . 72.41 109.692 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.15 137.69 46.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 73.13 108.711 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.508 ' HA2' HD22 ' A' ' 150' ' ' LEU . . . -129.43 132.71 7.21 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.868 -1.158 . . . . 75.14 114.177 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 73.8 t80 -136.16 147.27 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.34 -0.985 . . . . 75.44 108.34 171.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -39.28 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.497 0.925 . . . . 71.34 113.497 -174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.92 -35.19 4.92 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.205 -0.907 . . . . 74.4 113.668 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 146' ' ' TYR . 55.9 p-90 -110.57 138.83 46.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.082 0.941 . . . . 72.23 112.014 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.508 HD22 ' HA2' ' A' ' 145' ' ' GLY . 12.9 mt -127.19 137.25 52.89 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 75.51 110.186 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.66 124.41 23.89 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.847 -0.427 . . . . 71.23 109.847 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.418 ' HA3' HG23 ' A' ' 143' ' ' VAL . . . -141.83 151.21 22.62 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.439 -0.886 . . . . 65.2 111.937 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -145.31 133.31 21.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.252 0.549 . . . . 75.13 111.867 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.25 123.75 44.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.301 -0.863 . . . . 74.4 109.417 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 45.9 ttm -119.46 134.26 55.3 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.987 -0.375 . . . . 75.25 109.987 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -111.59 119.0 37.26 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.24 0.543 . . . . 75.3 110.373 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 138' ' ' ILE . 69.1 m-85 -98.56 127.0 44.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.121 -0.945 . . . . 74.43 110.47 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.593 ' HB2' ' OG1' ' A' ' 165' ' ' THR . 81.7 tt0 -99.7 98.99 9.77 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 109.513 -0.551 . . . . 75.14 109.513 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.5 m -72.25 -17.56 61.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 113.949 -1.478 . . . . 70.24 111.278 171.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.03 -27.0 65.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.697 -0.853 . . . . 63.52 108.697 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.86 -153.51 0.57 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.214 -1.357 . . . . 71.04 108.095 168.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.7 p -109.79 28.0 9.01 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.93 -0.481 . . . . 74.25 112.098 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -140.87 171.54 13.93 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 118.035 -1.466 . . . . 64.35 114.433 -160.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -93.81 127.76 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.661 -1.154 . . . . 70.11 108.813 170.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.593 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 1.7 m -96.06 -36.24 11.08 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.227 -0.589 . . . . 55.51 111.196 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -130.13 133.19 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.065 -0.516 . . . . 74.4 110.307 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -119.42 107.0 12.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.111 -0.7 . . . . 74.43 109.111 173.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -105.95 133.1 51.22 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.655 -0.498 . . . . 73.32 109.655 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.617 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.8 m-85 -121.99 146.98 46.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.396 -0.365 . . . . 70.41 110.468 -176.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -140.1 128.96 23.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.126 0.488 . . . . 73.44 109.998 176.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 39.6 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.506 -0.553 . . . . 74.44 109.506 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -121.95 135.57 10.47 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.376 -0.916 . . . . 52.33 112.597 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.543 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 68.4 t80 -117.12 120.32 37.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.561 -1.274 . . . . 73.33 107.561 171.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -115.41 121.64 43.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.032 0.92 . . . . 73.23 112.099 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 42.6 m -136.33 163.21 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.469 -1.678 . . . . 72.31 106.469 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.471 ' HB2' ' OE2' ' A' ' 177' ' ' GLU . 6.3 m-20 -63.28 -43.38 98.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.414 1.006 . . . . 73.32 110.363 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.471 ' OE2' ' HB2' ' A' ' 176' ' ' ASP . 2.2 mp0 -85.96 -21.81 27.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 75.41 111.251 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.734 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 54.3 m-85 -119.22 115.35 24.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.524 -0.307 . . . . 74.34 111.359 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 1.5 mp0 -118.7 121.46 40.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.934 -0.765 . . . . 73.22 108.934 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.855 HD13 HG13 ' A' ' 194' ' ' ILE . 2.3 tt -124.11 131.9 53.59 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.574 -0.451 . . . . 75.03 110.553 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.681 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 19.5 t-80 -129.13 114.52 16.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.181 -0.463 . . . . 64.22 110.543 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.642 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 57.3 m -95.58 137.59 34.43 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.327 -0.99 . . . . 75.12 108.327 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -132.67 138.64 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.585 -0.446 . . . . 71.52 110.477 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 74.7 t -133.05 131.39 58.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.962 -0.563 . . . . 72.31 110.625 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 8.0 t30 -117.19 96.82 5.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.682 -0.859 . . . . 70.43 108.682 174.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 9.6 t70 59.4 -162.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.169 -0.923 . . . . 71.11 109.656 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -80.26 -7.01 88.94 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 74.25 112.53 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 211' ' ' THR . 13.2 m -95.63 -26.94 15.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.726 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 mp0 -119.48 114.77 22.8 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.84 -0.538 . . . . 64.24 111.286 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.474 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 28.1 p90 -135.67 129.14 32.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.782 0.325 . . . . 75.12 110.192 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.9 175.38 36.73 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.398 -0.906 . . . . 75.15 112.462 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -147.78 141.25 9.06 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.97 -0.633 . . . . 62.23 112.061 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 8.7 t -122.29 138.28 54.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.87 -0.418 . . . . 75.32 109.87 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.855 HG13 HD13 ' A' ' 180' ' ' LEU . 4.5 mp -120.21 122.72 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.918 -0.583 . . . . 74.22 109.953 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.529 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 59.5 t80 -108.09 120.42 42.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.851 -0.796 . . . . 73.51 108.851 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -121.29 116.52 25.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.9 -0.591 . . . . 73.12 111.136 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.97 116.72 24.37 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.346 -0.983 . . . . 74.22 108.346 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.489 HG11 ' N ' ' A' ' 199' ' ' ASN . 21.4 t -76.32 168.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.631 -0.507 . . . . 75.32 109.631 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.489 ' N ' HG11 ' A' ' 198' ' ' VAL . 16.6 t-20 -59.84 -37.1 78.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.109 0.48 . . . . 64.52 110.234 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.99 171.19 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.216 -0.661 . . . . 74.02 109.216 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 201' ' ' LYS . 36.7 mmtm -80.11 61.8 4.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.79 0.805 . . . . 74.41 111.464 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.434 HD21 ' N ' ' A' ' 203' ' ' GLU . 5.6 tt -137.02 132.37 34.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.322 -1.308 . . . . 74.23 107.753 175.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.434 ' N ' HD21 ' A' ' 202' ' ' LEU . 31.2 mt-10 -119.08 145.65 45.75 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.503 -0.555 . . . . 70.31 109.503 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.7 t -133.71 152.56 51.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.603 -0.439 . . . . 73.13 110.5 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.19 135.21 47.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.212 0.529 . . . . 65.15 110.153 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 193' ' ' SER . 33.9 t -121.87 125.63 73.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.484 -0.78 . . . . 74.13 109.603 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.79 127.68 54.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.74 0.305 . . . . 75.14 110.926 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -119.13 130.48 55.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 73.15 109.725 174.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 218' ' ' ARG . . . -132.71 129.68 39.05 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.627 -0.508 . . . . 61.13 109.627 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -127.04 121.52 31.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.478 -0.564 . . . . 73.31 109.478 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.626 HG22 ' HB2' ' A' ' 215' ' ' SER . 5.4 t -106.24 117.87 35.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.616 0.722 . . . . 61.01 109.578 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.474 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.33 150.33 39.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.989 -1.005 . . . . 74.12 111.932 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 118.39 24.11 3.28 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.635 -0.711 . . . . 75.52 111.831 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.9 29.59 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.341 0.591 . . . . 63.13 110.471 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.626 ' HB2' HG22 ' A' ' 211' ' ' THR . 9.9 m -83.46 -170.34 3.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.48 -0.782 . . . . 75.44 110.537 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.61 149.62 38.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.376 -0.374 . . . . 70.21 110.6 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 38.7 m -95.91 123.0 39.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.681 -0.859 . . . . 64.11 108.681 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.475 ' HB3' ' HB1' ' A' ' 209' ' ' ALA . 43.7 ttt180 -101.2 117.62 35.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.392 -0.367 . . . . 74.43 110.808 -171.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.636 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 40.7 p90 -114.87 154.1 29.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.067 -0.515 . . . . 73.42 110.194 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.0 140.31 7.67 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.194 -0.762 . . . . 74.41 111.194 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.86 128.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.711 -0.477 . . . . 75.43 109.711 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 236' ' ' LYS . . . -122.23 133.05 54.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.363 0.414 . . . . 72.24 110.555 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.0 124.91 53.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.787 -0.449 . . . . 52.12 109.787 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.115 -0.493 . . . . 75.52 109.922 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -128.03 133.07 49.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.113 0.482 . . . . 74.3 110.537 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.71 97.68 9.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.697 -0.683 . . . . 72.15 109.266 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.8 tt -71.78 -23.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.043 0.925 . . . . 75.44 108.529 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.72 137.91 13.45 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.199 -1.364 . . . . 72.34 107.525 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.18 -15.91 11.73 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 122.902 2.401 . . . . 72.41 113.814 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.39 -22.3 19.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.813 0.339 . . . . 74.11 111.256 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.51 128.76 36.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.152 0.501 . . . . 72.22 111.83 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.3 m -104.85 119.71 39.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 63.43 110.429 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -100.55 133.51 44.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 75.42 110.651 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 38.8 t -131.16 117.81 19.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 75.51 111.515 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.93 40.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.914 -0.772 . . . . 71.22 108.914 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 222' ' ' ALA . 9.8 pttm -152.66 159.52 43.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 74.31 112.231 -171.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 5.0 p -143.5 154.25 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 75.23 109.438 176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 20.0 t-20 -130.75 153.82 48.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.683 -0.235 . . . . 72.5 110.87 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.636 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 32.5 t30 -38.05 -41.83 0.6 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.972 1.309 . . . . 73.4 113.661 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.4 t -78.17 24.37 0.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 73.45 111.051 -173.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.9 m 65.32 36.47 6.92 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 72.21 109.725 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.975 ' HB3' HD13 ' A' ' 262' ' ' LEU . 25.4 mt -93.6 115.39 27.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 74.31 110.098 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.5 mp -100.29 116.55 43.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.928 -0.767 . . . . 75.2 108.928 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -128.18 140.28 11.68 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.059 -1.067 . . . . 73.21 113.571 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.513 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -122.13 148.34 45.03 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.386 -0.598 . . . . 74.02 109.386 172.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -162.92 122.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.573 -0.822 . . . . 70.42 112.241 -177.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -118.47 133.07 56.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.274 0.559 . . . . 75.44 110.758 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.1 m -110.9 120.04 41.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.068 -0.969 . . . . 75.14 109.896 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -114.24 130.28 56.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.861 0.363 . . . . 65.21 110.136 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.5 p -104.79 107.7 18.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.819 -0.628 . . . . 74.2 109.909 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 4.1 mm? -71.18 173.87 7.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.854 0.359 . . . . 53.32 110.909 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -47.87 57.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.046 -0.524 . . . . 75.4 110.65 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 13.5 Cg_exo -70.96 -177.62 2.36 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.619 1.546 . . . . 72.24 110.68 169.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -76.84 50.3 2.95 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.556 -0.831 . . . . 71.32 112.791 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 48.5 mt -108.75 121.42 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.408 -0.466 . . . . 75.11 110.338 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.637 ' HB3' ' CG ' ' A' ' 280' ' ' GLU . 68.7 tttt -110.53 119.2 38.39 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.247 -0.433 . . . . 74.43 109.895 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 15.3 tp -101.66 126.78 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.437 -0.801 . . . . 74.22 109.983 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.445 ' O ' HD11 ' A' ' 277' ' ' LEU . 19.5 m -132.05 109.77 10.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.867 0.365 . . . . 74.41 110.376 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.635 ' CD2' HD13 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -112.77 125.14 54.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.768 -0.826 . . . . 75.12 108.768 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 51.4 m -138.99 148.81 43.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.782 0.325 . . . . 75.15 110.532 175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.06 128.69 17.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.69 -0.485 . . . . 62.43 109.69 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.975 HD13 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -111.44 118.31 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.205 -0.665 . . . . 73.45 109.205 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.681 ' HB3' HG13 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -98.05 107.43 19.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.797 -1.186 . . . . 74.55 107.797 174.394 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.726 ' OD1' ' HG2' ' A' ' 266' ' ' LYS . 19.0 t0 -71.53 104.41 3.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.53 -0.915 . . . . 65.41 108.53 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.39 -27.1 39.52 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 115.709 -0.678 . . . . 64.31 114.159 -171.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.726 ' HG2' ' OD1' ' A' ' 264' ' ' ASP . 23.7 pttm -91.98 -13.55 30.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.078 0.439 . . . . 64.44 111.123 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.693 ' OD1' ' HA3' ' A' ' 272' ' ' GLY . 10.9 t-20 -116.22 -26.81 7.07 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.001 0.371 . . . . 71.45 112.001 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 263' ' ' LEU . 24.1 m -62.07 -17.86 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 O-C-N 122.166 -0.334 . . . . 73.43 110.917 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -59.29 -29.37 67.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.773 -0.649 . . . . 75.21 109.999 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -100.04 -16.98 17.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 75.25 110.637 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.19 13.82 6.83 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.933 -0.651 . . . . 62.44 113.064 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.693 ' HA3' ' OD1' ' A' ' 267' ' ' ASN . . . -85.83 79.52 1.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.663 -0.78 . . . . 73.43 113.125 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.414 ' HB2' HD13 ' A' ' 263' ' ' LEU . 8.2 p80 -114.22 142.09 46.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.52 -0.548 . . . . 75.34 109.52 175.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' A' ' 22' ' ' TYR . 80.2 mttt -110.61 143.1 41.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.399 -0.52 . . . . 73.31 111.49 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 276' ' ' GLY . 1.5 tm? -115.5 137.97 51.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.884 . . . . 74.21 108.866 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.482 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -134.51 104.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.507 -0.854 . . . . 73.12 111.521 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.832 HD21 HG22 ' A' ' 27' ' ' ILE . 40.1 tp -114.12 145.46 41.6 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.33 -0.548 . . . . 73.24 110.677 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.689 ' H ' HD11 ' A' ' 277' ' ' LEU . . . -150.33 124.1 1.68 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.197 -0.911 . . . . 53.41 111.479 178.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.33 131.89 56.3 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.748 -0.834 . . . . 73.31 108.748 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.637 ' CG ' ' HB3' ' A' ' 256' ' ' LYS . 8.7 pt-20 -125.22 115.18 20.0 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.861 -0.736 . . . . 61.45 110.369 171.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.748 ' HB3' HD22 ' A' ' 31' ' ' LEU . 57.3 t80 -99.83 106.19 18.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.948 -1.024 . . . . 74.45 109.812 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -102.56 111.95 24.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.893 -0.594 . . . . 64.11 110.043 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -111.94 126.2 54.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.958 -0.564 . . . . 72.24 110.459 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.44 0.34 16.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.367 0.603 . . . . 74.32 110.243 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.585 -0.734 . . . . 75.51 109.731 179.398 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.743 -0.466 . . . . 71.4 109.743 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 120' ' ' ARG . 9.1 p -163.33 137.06 4.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.409 -0.589 . . . . 74.12 109.409 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 27.4 Cg_exo -63.56 131.92 33.49 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.888 2.392 . . . . 71.33 113.397 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.57 99.84 1.18 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.917 2.411 . . . . 71.11 111.565 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.486 ' HB ' HD13 ' A' ' 150' ' ' LEU . 5.2 p -94.82 -2.75 50.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.351 -0.386 . . . . 73.42 111.865 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' HB3' HG23 ' A' ' 143' ' ' VAL . 6.1 p90 -62.25 -21.32 65.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.66 0.743 . . . . 75.32 109.973 170.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.25 54.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.135 -0.939 . . . . 73.34 110.143 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.627 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 51.4 m-20 -91.58 -1.9 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 72.43 109.943 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 1.101 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -76.39 -34.04 58.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.173 -0.921 . . . . 73.12 111.67 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.23 -36.07 0.51 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.08 -1.057 . . . . 74.51 113.892 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.77 -41.73 78.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.967 0.383 . . . . 73.41 111.981 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 m -58.15 -46.38 85.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.034 0.445 . . . . 74.43 111.244 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -35.03 72.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.934 -0.575 . . . . 71.42 111.4 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -58.55 -35.91 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 75.13 112.79 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.37 -49.87 75.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.978 0.418 . . . . 72.33 111.387 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 207' ' ' ASN . 2.8 t -85.21 -31.5 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 73.54 111.149 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB2' ' ND2' ' A' ' 207' ' ' ASN . 88.0 t80 -66.91 -38.24 85.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.189 -0.459 . . . . 75.23 112.001 -174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -57.24 150.85 16.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 74.43 111.191 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -116.59 -13.52 10.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.213 0.53 . . . . 72.1 110.224 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.77 51.76 4.48 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.607 -0.724 . . . . 63.42 111.755 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.6 -36.94 74.82 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.408 0.623 . . . . 74.34 109.582 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.05 101.58 0.44 Allowed Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.014 -0.994 . . . . 71.12 111.05 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -81.28 -3.81 53.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 75.11 110.14 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.89 7.33 78.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.815 -0.629 . . . . 71.21 112.643 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mp -123.34 168.36 12.6 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.966 0.889 . . . . 75.14 112.435 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.9 mp -108.27 124.14 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.047 -1.433 . . . . 71.11 108.925 174.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -105.61 136.31 45.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.963 0.411 . . . . 74.32 111.03 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.76 129.04 56.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.21 -1.033 . . . . 74.41 108.21 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.56 133.93 48.5 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.807 -0.812 . . . . 55.25 108.807 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.621 HD13 ' HD2' ' A' ' 281' ' ' PHE . 16.9 tp -138.41 126.02 22.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.21 111.78 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -114.86 127.25 55.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.55 109.6 172.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.78 HG22 ' HB3' ' A' ' 41' ' ' PHE . 7.6 t -137.21 150.96 48.23 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.535 -0.466 . . . . 74.11 110.386 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 284' ' ' LEU . 18.3 ttmm -133.08 148.71 52.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.376 -0.374 . . . . 74.41 110.016 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -140.13 136.62 33.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.769 -0.196 . . . . 70.32 110.509 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 39.84 -97.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.294 1.038 . . . . 74.01 113.254 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -154.76 141.24 18.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.854 -0.795 . . . . 72.32 108.854 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 88.51 -9.08 77.12 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.586 -0.34 . . . . 52.22 112.71 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.21 128.03 48.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.658 0.729 . . . . 75.23 111.803 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.93 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 3.5 tp10 -141.03 118.9 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.911 -1.144 . . . . 75.3 107.911 165.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.78 ' HB3' HG22 ' A' ' 33' ' ' THR . 59.3 t80 -116.96 124.86 50.41 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.25 -0.906 . . . . 74.0 111.107 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.7 m -126.84 117.73 23.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 71.0 110.911 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -116.25 127.23 54.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.607 -0.27 . . . . 75.31 110.297 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -125.9 126.06 43.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 73.54 109.933 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.45 138.17 8.01 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.224 -0.989 . . . . 74.1 111.858 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -121.01 133.18 55.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.889 -0.411 . . . . 70.44 109.889 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 135.31 45.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.133 0.492 . . . . 73.13 111.161 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.814 ' HB3' ' HB3' ' A' ' 53' ' ' LYS . 39.1 t30 -77.27 147.19 36.43 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.347 -0.842 . . . . 74.1 109.41 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -44.93 -37.66 4.12 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.987 0.423 . . . . 75.42 111.02 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.93 123.58 27.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.212 -0.662 . . . . 73.24 109.212 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -68.72 -5.3 19.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.241 0.544 . . . . 71.14 111.826 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -83.59 5.33 24.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.117 0.484 . . . . 74.21 110.85 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.814 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 31.2 tptt -137.64 84.38 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 64.3 110.346 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.81 132.56 70.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.696 0.284 . . . . 73.43 110.785 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -125.16 142.69 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.22 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.19 155.72 22.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.102 -1.047 . . . . 74.31 113.206 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 m -146.31 127.33 14.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.343 -0.614 . . . . 55.21 109.343 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.568 HD12 ' HG3' ' A' ' 74' ' ' LYS . 2.0 tm? -121.46 127.14 50.79 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.164 -0.31 . . . . 74.35 110.164 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 45.5 mt-10 -116.7 118.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.752 -0.658 . . . . 74.5 110.14 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.473 ' HG1' ' HG2' ' A' ' 74' ' ' LYS . 27.6 m -100.42 118.73 37.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.24 -1.022 . . . . 64.42 108.24 171.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.93 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 66.0 mttm -113.68 133.51 55.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.21 0.529 . . . . 72.34 110.543 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.732 ' HD2' ' HB2' ' A' ' 71' ' ' PHE . 38.4 m-85 -101.13 119.65 39.06 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.794 -1.187 . . . . 73.34 107.794 172.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.488 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 9.9 ttm180 -115.57 106.0 13.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.606 0.717 . . . . 75.34 109.971 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -113.7 104.14 11.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.516 -1.22 . . . . 75.54 109.335 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.7 p 60.57 126.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.692 1.245 . . . . 73.14 112.326 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -60.72 130.31 45.86 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.11 -0.7 . . . . 74.21 109.11 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 62.12 75.67 0.4 Allowed 'General case' 0 C--N 1.332 -0.183 0 O-C-N 123.825 0.703 . . . . 71.01 109.598 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.95 -101.63 0.15 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.31 -0.859 . . . . 45.44 111.777 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD1' ' HB ' ' A' ' 87' ' ' VAL . 4.0 mm? -121.34 131.96 54.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.137 0.494 . . . . 64.13 112.325 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.61 HG22 ' HB ' ' A' ' 86' ' ' THR . 4.1 t -137.3 119.01 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 74.0 110.033 171.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.732 ' HB2' ' HD2' ' A' ' 62' ' ' TYR . 34.5 m-85 -114.81 121.58 43.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.671 -0.241 . . . . 72.34 110.435 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 83' ' ' THR . 57.6 m -109.96 115.56 30.01 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.997 -0.281 . . . . 72.33 110.585 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.91 143.69 47.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.681 -0.408 . . . . 75.45 111.619 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HG3' HD12 ' A' ' 58' ' ' LEU . 20.5 mmtt 159.41 -119.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.65 1.219 . . . . 72.04 111.479 162.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.77 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 15.5 t90 -135.18 140.31 45.25 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.588 -0.445 . . . . 75.44 112.081 -164.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -110.18 164.14 12.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 73.44 110.836 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 t -69.9 -7.37 39.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 75.23 111.328 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 14.1 m-20 -80.0 -2.27 43.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.856 -0.611 . . . . 75.11 110.39 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.501 HD22 ' HG2' ' A' ' 105' ' ' PRO . 9.0 t30 81.71 -8.53 1.32 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.96 0.788 . . . . 74.03 109.936 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.4 m -85.25 140.15 31.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.344 -0.844 . . . . 75.43 110.398 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.77 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -92.52 126.56 37.66 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.337 -0.616 . . . . 74.22 109.337 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.35 13.67 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.172 -1.013 . . . . 65.51 113.044 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.1 t -136.16 104.41 5.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.743 0.782 . . . . 71.53 110.736 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 43.9 tt0 -106.78 115.66 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.194 -0.912 . . . . 74.43 109.448 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -111.77 137.98 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 74.4 110.62 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.664 HG22 ' HB ' ' A' ' 98' ' ' THR . 16.9 m -129.17 129.92 45.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.899 0.38 . . . . 74.22 111.246 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.49 ' HB ' ' CD1' ' A' ' 69' ' ' LEU . 2.8 p -129.24 124.89 61.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.724 -0.671 . . . . 74.52 110.23 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -113.53 122.68 48.0 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.405 -0.591 . . . . 71.22 109.405 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.37 151.84 19.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.191 0.519 . . . . 64.22 111.85 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -102.21 -24.1 13.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.731 -0.668 . . . . 74.33 110.661 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.46 -56.88 8.83 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.449 -1.315 . . . . 74.53 107.449 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.45 61.2 6.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.27 -1.011 . . . . 74.55 108.27 167.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -53.03 124.4 14.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.061 -0.972 . . . . 75.14 112.612 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 100.98 -16.45 57.31 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.083 -0.962 . . . . 65.01 112.093 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 118' ' ' TYR . 3.1 tm? -92.5 123.82 36.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.606 -0.516 . . . . 64.23 109.606 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.76 51.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.74 -0.664 . . . . 74.02 109.668 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -116.24 125.71 52.59 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.114 -0.699 . . . . 73.32 109.114 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.664 ' HB ' HG22 ' A' ' 86' ' ' THR . 0.5 OUTLIER -130.49 119.91 23.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.195 0.521 . . . . 75.43 110.279 176.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.438 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 91.9 t80 -123.91 125.43 44.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.535 -0.757 . . . . 75.31 110.372 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 4.5 t70 -109.72 131.99 54.55 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.024 -0.534 . . . . 74.14 109.714 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.8 t -126.0 120.86 31.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.38 -0.6 . . . . 62.12 109.38 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.0 m -109.99 122.14 46.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.959 -0.564 . . . . 73.15 110.048 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.87 119.85 39.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.006 0.431 . . . . 74.21 110.714 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.2 t -99.77 139.77 21.06 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 108.506 -0.924 . . . . 71.24 108.506 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.501 ' HG2' HD22 ' A' ' 79' ' ' ASN . 31.3 Cg_exo -62.12 41.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 124.127 3.218 . . . . 71.32 114.832 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -123.86 150.02 45.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 73.41 108.822 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.0 m -66.55 105.19 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.099 0.475 . . . . 75.42 111.292 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.42 68.56 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.994 -0.622 . . . . 61.23 112.869 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -94.97 111.64 23.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.072 0.463 . . . . 75.23 109.945 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.47 143.57 26.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.869 -0.605 . . . . 74.33 110.618 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.37 122.47 40.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.049 -0.523 . . . . 75.03 109.705 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -129.13 141.8 51.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.976 -0.289 . . . . 74.43 111.389 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -124.68 137.38 54.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.947 -0.761 . . . . 64.34 108.947 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 5.0 tp -124.75 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.188 0.518 . . . . 74.13 110.218 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -116.45 120.96 40.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.837 -0.62 . . . . 74.23 110.467 -178.118 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -107.19 116.89 32.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.599 -0.728 . . . . 74.43 109.083 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.521 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -133.74 125.71 4.04 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.694 -1.241 . . . . 72.34 113.145 -172.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.722 ' HB3' HD21 ' A' ' 95' ' ' LEU . 6.3 p90 -117.01 136.64 52.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.192 0.52 . . . . 74.2 110.032 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 43.6 pttt -119.74 124.66 46.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.866 0.841 . . . . 74.13 111.58 -175.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.491 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.3 mmt180 -100.32 166.37 11.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.256 -1.338 . . . . 74.44 109.06 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.11 -27.25 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.762 0.825 . . . . 75.44 112.813 -172.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -118.36 -12.1 9.93 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.699 0.629 . . . . 74.11 112.699 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.457 HG23 ' HA ' ' A' ' 144' ' ' LEU . 19.5 pt -142.76 145.72 22.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.612 -0.835 . . . . 74.54 111.815 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.604 ' N ' HD21 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -129.02 115.82 18.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.759 -0.46 . . . . 75.42 109.759 178.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.485 ' HB3' HD12 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -130.52 143.07 50.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.331 -0.547 . . . . 73.04 111.634 -175.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.521 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -141.57 138.75 8.91 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 61.01 112.621 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 67.9 m -108.66 112.38 24.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.013 -0.365 . . . . 73.33 110.013 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 9.6 t70 -104.47 148.17 26.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.046 -0.525 . . . . 55.44 110.088 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.1 mtm -131.38 118.31 20.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.312 -0.625 . . . . 75.42 109.312 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -89.78 115.74 27.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.945 -0.761 . . . . 75.41 108.945 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -97.12 99.71 11.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.956 -0.565 . . . . 75.21 110.962 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.55 145.69 37.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.983 -1.117 . . . . 74.25 107.983 169.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.788 ' H ' HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -64.68 -21.67 29.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.613 0.244 . . . . 72.3 111.536 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.53 -18.83 34.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.542 0.21 . . . . 65.2 111.101 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.5 105.66 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.868 -0.682 . . . . 74.1 112.799 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.2 109.45 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.092 2.528 . . . . 61.52 111.366 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -99.09 160.55 14.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.522 -0.308 . . . . 73.43 110.946 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mp -107.38 118.38 55.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.672 -0.411 . . . . 74.21 110.036 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 33.8 ttp180 -115.2 111.15 20.54 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.076 0.465 . . . . 74.31 110.102 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.95 144.29 17.3 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.955 -1.117 . . . . 54.22 112.382 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -137.6 114.71 10.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.127 0.489 . . . . 73.3 110.184 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 125' ' ' LEU . 4.2 tp -117.68 123.16 45.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.968 -0.56 . . . . 72.14 109.701 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 7' ' ' TYR . 5.2 t -119.24 121.51 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.494 . . . . 75.05 110.293 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.457 ' HA ' HG23 ' A' ' 123' ' ' ILE . 5.0 mp -108.08 138.64 44.0 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.425 -0.583 . . . . 60.22 109.425 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.45 119.31 4.24 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.607 -0.724 . . . . 73.45 111.358 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.639 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 56.4 t80 -118.16 148.97 41.82 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.299 -1.0 . . . . 72.54 108.299 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -52.79 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.344 0.592 . . . . 74.44 110.973 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.04 -32.74 7.21 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.144 -0.935 . . . . 73.24 112.493 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 90.9 m95 -106.52 146.39 30.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.285 0.846 . . . . 74.4 113.285 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.486 HD13 ' HB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -128.91 142.62 50.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.775 -1.194 . . . . 75.0 107.775 168.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -155.65 123.87 5.83 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.443 -0.577 . . . . 61.45 109.443 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.101 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -142.16 142.14 11.5 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.945 -1.121 . . . . 71.35 111.872 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 36.1 m-85 -123.47 117.17 24.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.032 -0.359 . . . . 75.32 110.032 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.28 122.58 43.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.525 -0.546 . . . . 72.32 109.525 166.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.707 ' HB2' HG22 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -137.2 143.69 42.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.682 0.277 . . . . 73.1 110.485 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.492 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 t30 -118.62 118.88 32.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 65.02 110.471 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.919 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 93.1 m-85 -91.85 121.25 33.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.109 -0.951 . . . . 75.12 110.192 -175.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.37 109.89 14.14 Favored 'General case' 0 C--O 1.254 1.325 0 CA-C-N 114.449 -1.251 . . . . 75.1 109.172 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -71.72 -21.51 61.76 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 125.354 1.659 . . . . 74.04 111.775 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.31 -31.8 71.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.392 -0.966 . . . . 75.31 108.392 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -107.92 -161.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.979 -1.464 . . . . 73.2 107.984 168.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.9 m -111.04 26.76 10.37 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 121.89 -0.506 . . . . 64.42 110.476 171.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -149.31 150.31 32.3 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.99 1.108 . . . . 73.24 113.99 -159.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 p -73.16 128.91 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.537 -0.756 . . . . 72.44 110.231 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 3.9 p -102.49 -33.9 9.34 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.638 -0.71 . . . . 74.13 111.526 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -112.67 129.21 56.48 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.626 -0.43 . . . . 62.23 110.175 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.3 m -124.34 115.33 20.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.033 -0.531 . . . . 75.04 110.665 173.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 7.8 t30 -125.97 120.25 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.96 -0.756 . . . . 72.32 108.96 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -138.34 165.21 27.33 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.741 -0.784 . . . . 71.43 111.921 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.19 133.31 35.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.326 -0.852 . . . . 71.33 110.767 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.51 127.09 64.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.007 -0.738 . . . . 62.01 109.007 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.58 166.79 26.07 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 119.735 -1.221 . . . . 61.14 112.831 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.602 ' CE1' HD23 ' A' ' 180' ' ' LEU . 37.4 p90 -138.55 140.4 39.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.168 0.509 . . . . 74.41 110.649 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -103.4 132.62 49.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.132 -0.94 . . . . 74.22 109.935 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 m -131.37 163.2 28.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.782 -0.821 . . . . 74.41 108.782 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -51.75 -50.29 60.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.7 0.285 . . . . 74.21 111.541 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.703 ' HA ' ' HE3' ' A' ' 197' ' ' LYS . 27.0 mm-40 -101.41 -22.51 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.184 0.438 . . . . 74.05 112.184 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 194' ' ' ILE . 72.7 t80 -124.29 144.89 49.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.666 0.27 . . . . 75.03 111.681 -170.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 5.1 tp-100 -135.61 122.4 21.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.947 -0.39 . . . . 75.15 109.947 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.655 HD11 HG13 ' A' ' 194' ' ' ILE . 3.8 tt -125.88 138.15 53.78 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.261 -0.575 . . . . 73.31 111.786 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.627 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 12.4 m170 -128.31 114.17 16.56 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.889 -0.782 . . . . 72.44 108.889 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 95.0 m -90.86 141.42 28.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.856 -0.424 . . . . 72.31 109.856 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -129.83 141.22 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.992 0.425 . . . . 73.21 110.737 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 5.4 t -130.95 128.36 62.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.296 -0.411 . . . . 74.12 111.042 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 0.2 OUTLIER -109.14 90.85 3.42 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.645 -0.872 . . . . 73.21 108.645 176.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 60.65 -169.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 71.45 111.718 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.83 -5.59 86.65 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.42 -0.809 . . . . 62.31 111.981 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 24.2 m -94.32 -27.1 16.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.64 0.607 . . . . 74.21 112.64 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 51.5 mt-10 -135.02 129.6 34.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.931 -0.708 . . . . 74.34 112.223 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.441 ' HD2' HG23 ' A' ' 184' ' ' VAL . 44.3 m-85 -127.23 143.84 51.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.619 -0.718 . . . . 72.25 109.713 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . 179.74 -138.24 3.36 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.778 -0.725 . . . . 74.54 112.101 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 152.6 -155.61 26.23 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.168 -1.015 . . . . 71.45 113.037 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.1 p -142.09 138.55 31.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.291 0.567 . . . . 74.34 110.817 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.797 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.1 mp -119.8 118.76 58.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.645 -0.707 . . . . 72.15 109.612 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.437 ' HB3' ' HB3' ' A' ' 179' ' ' GLN . 44.8 t80 -108.71 119.69 40.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.108 0.48 . . . . 65.53 110.025 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.57 131.54 52.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.743 -0.662 . . . . 75.15 109.776 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.703 ' HE3' ' HA ' ' A' ' 177' ' ' GLU . 18.1 pttp -107.55 127.36 53.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 73.5 110.943 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 202' ' ' LEU . 47.6 t -82.99 155.74 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 74.24 109.446 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -61.77 -45.04 95.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.893 0.378 . . . . 65.41 110.083 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.66 148.35 48.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.722 -1.214 . . . . 74.44 107.722 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -63.41 86.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.562 0.696 . . . . 74.51 112.457 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 198' ' ' VAL . 36.2 mt -144.24 115.16 7.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.57 -1.195 . . . . 74.14 108.551 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.46 128.94 52.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.776 -0.824 . . . . 52.31 108.776 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -123.46 138.33 54.61 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.702 -0.399 . . . . 73.33 111.212 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.39 135.5 48.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.024 -0.535 . . . . 75.43 110.177 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.874 HG21 HG23 ' A' ' 221' ' ' ILE . 87.9 t -114.58 136.22 51.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.663 -0.699 . . . . 75.44 109.612 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.747 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 28.7 t-20 -114.71 132.34 56.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.802 0.334 . . . . 72.15 110.402 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.479 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -122.58 136.49 54.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.651 -0.704 . . . . 74.5 110.443 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.97 127.13 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.005 -0.543 . . . . 65.24 109.63 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.679 ' HB2' HG21 ' A' ' 217' ' ' THR . 28.4 t90 -130.72 126.11 35.62 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.529 -0.305 . . . . 75.1 110.472 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 215' ' ' SER . 3.5 t -101.29 116.39 32.68 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 73.42 109.823 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.48 141.26 56.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.335 -0.848 . . . . 74.04 111.158 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 128.36 31.49 0.67 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.864 -0.684 . . . . 75.51 111.655 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 67.36 12.16 8.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.875 0.47 . . . . 63.1 111.826 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.558 ' HB2' HG21 ' A' ' 211' ' ' THR . 17.8 m -80.45 160.84 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 74.22 109.777 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -77.66 153.37 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.379 . . . . 74.24 111.122 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 210' ' ' TRP . 26.4 m -84.54 131.23 34.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.555 . . . . 74.31 109.744 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -88.54 116.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.947 -0.76 . . . . 75.12 108.947 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 54.5 p90 -123.44 141.34 52.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -144.83 141.53 10.07 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.226 -0.75 . . . . 74.22 111.226 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.874 HG23 HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -119.53 130.54 73.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.879 0.371 . . . . 72.53 110.426 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -129.82 129.48 44.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.605 -0.725 . . . . 72.15 109.954 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -117.97 129.15 55.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.288 -0.415 . . . . 71.2 110.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -115.66 115.83 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.021 -0.733 . . . . 73.05 109.021 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 233' ' ' PHE . 3.9 p90 -132.78 119.25 20.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.248 0.547 . . . . 73.34 111.77 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 35.4 tt0 -89.54 97.94 11.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 73.24 109.075 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -97.15 -24.62 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 73.32 109.668 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 4.6 t70 -114.63 137.22 22.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.653 -0.869 . . . . 72.15 108.653 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -34.97 -51.89 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.381 3.388 . . . . 74.31 115.214 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -107.23 4.78 27.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.902 0.334 . . . . 75.32 111.902 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -124.73 122.58 37.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.453 0.644 . . . . 73.4 111.958 -175.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 50.7 t -113.18 119.09 36.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 75.2 108.84 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.501 ' HB2' ' CE2' ' A' ' 225' ' ' TYR . 57.6 m-85 -100.2 132.13 45.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.434 -0.348 . . . . 64.55 110.272 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 21.1 t -121.75 140.91 51.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.046 0.45 . . . . 62.1 110.349 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -127.16 140.8 52.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.095 -0.705 . . . . 74.33 109.095 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 48.3 mttm -135.6 141.4 45.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.693 -0.484 . . . . 73.24 109.693 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.576 HG12 HG12 ' A' ' 221' ' ' ILE . 5.4 p -140.6 140.13 34.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.488 -0.485 . . . . 74.04 110.028 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.564 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -107.27 150.36 26.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.573 -0.74 . . . . 75.22 110.381 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 241' ' ' SER . 28.3 p-10 -43.9 -33.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.95 1.406 . . . . 74.51 114.064 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.475 ' HB3' HD11 ' A' ' 242' ' ' LEU . 17.9 t -82.08 21.95 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 70.31 110.024 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.527 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 50.1 m 68.5 36.33 2.95 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 115.232 -0.894 . . . . 74.23 111.265 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.819 HD21 HD13 ' A' ' 262' ' ' LEU . 7.2 mp -95.68 125.45 40.28 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.309 -0.556 . . . . 74.43 111.316 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.52 116.57 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.659 -0.701 . . . . 75.44 110.022 -170.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -126.35 145.76 15.9 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.55 -0.833 . . . . 60.2 112.654 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.489 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -118.39 148.91 42.05 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.062 0.458 . . . . 63.3 110.247 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.94 121.79 2.42 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.604 -0.726 . . . . 61.45 111.544 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -108.13 118.84 37.8 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.963 -0.384 . . . . 74.24 109.963 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.626 HG21 HG23 ' A' ' 258' ' ' THR . 14.1 p -113.6 112.86 24.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 72.33 109.895 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 257' ' ' LEU . 22.4 mp0 -118.97 124.83 47.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.937 -0.574 . . . . 72.35 110.168 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 26.0 m -95.91 88.53 4.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.92 -0.77 . . . . 75.52 108.92 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 44.8 tp -82.04 78.25 8.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.733 . . . . 75.45 109.511 -175.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 0.5 OUTLIER 68.1 152.71 0.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.058 -0.974 . . . . 74.31 109.901 -172.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.17 74.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.481 2.12 . . . . 64.51 112.059 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.64 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.34 -0.845 . . . . 72.51 111.441 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.2 122.0 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 74.23 110.695 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 30.8 tttp -117.87 122.01 42.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.532 -0.544 . . . . 64.44 109.532 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 249' ' ' GLN . 52.3 tp -100.26 131.22 46.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.309 -0.405 . . . . 73.22 110.009 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.626 HG23 HG21 ' A' ' 248' ' ' THR . 18.5 p -128.91 110.87 12.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.326 0.584 . . . . 71.43 110.558 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.858 HD23 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -108.9 125.54 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.453 -0.943 . . . . 75.52 108.453 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.2 m -135.38 138.86 43.73 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.61 -0.436 . . . . 72.44 110.359 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.434 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -148.05 128.07 13.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.111 -0.495 . . . . 72.11 109.766 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.819 HD13 HD21 ' A' ' 242' ' ' LEU . 2.4 tm? -111.44 115.22 28.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.474 -0.936 . . . . 75.42 108.474 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.575 ' HB3' HG12 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -92.24 108.49 19.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.54 -1.282 . . . . 73.04 107.54 174.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.812 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -69.79 105.06 2.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.888 -0.782 . . . . 71.31 108.888 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -59.84 -15.72 35.91 Favored Glycine 0 C--N 1.32 -0.31 0 C-N-CA 121.222 -0.513 . . . . 72.33 112.638 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -90.16 -25.83 20.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.747 0.308 . . . . 75.33 110.767 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 19.5 m120 -115.81 -27.96 6.86 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.362 0.875 . . . . 75.24 113.362 -170.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 263' ' ' LEU . 27.8 m -62.62 -19.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 117.965 0.348 . . . . 73.3 111.522 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.72 -40.73 84.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.996 -0.547 . . . . 74.53 110.574 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.94 -16.38 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 72.22 110.96 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.15 79.39 0.87 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.913 -0.66 . . . . 71.44 112.238 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.509 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -159.27 87.34 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.865 -0.683 . . . . 61.23 112.235 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.08 147.07 39.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.373 -0.232 . . . . 72.2 110.373 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.5 mmtm -96.19 137.9 34.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.592 -0.522 . . . . 73.24 109.592 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -130.03 126.74 38.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.002 0.429 . . . . 72.22 110.245 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.41 117.74 2.21 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.892 -0.671 . . . . 71.23 111.473 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.858 HD23 HD23 ' A' ' 259' ' ' LEU . 3.1 tm? -115.12 135.85 53.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.181 -0.674 . . . . 72.52 109.181 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.35 137.91 6.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.107 -1.044 . . . . 74.43 112.984 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.78 131.38 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.6 -0.889 . . . . 71.02 108.6 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 26.5 tt0 -114.95 111.31 20.97 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.59 -0.893 . . . . 72.42 108.59 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.621 ' HD2' HD13 ' A' ' 31' ' ' LEU . 26.3 t80 -112.83 145.86 39.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.799 -0.637 . . . . 73.53 109.805 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -138.04 142.89 40.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.86 0.362 . . . . 71.23 110.295 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.549 ' O ' HD21 ' A' ' 284' ' ' LEU . . . -122.83 107.29 11.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.463 -0.569 . . . . 73.23 109.463 172.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.549 HD21 ' O ' ' A' ' 283' ' ' ALA . 1.7 mm? -138.62 -0.57 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.229 -0.896 . . . . 53.42 109.676 -176.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.942 -1.026 . . . . 74.24 109.759 -172.566 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.973 -0.38 . . . . 65.12 109.973 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 14.9 p -100.52 131.96 23.07 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.965 -0.383 . . . . 72.21 109.965 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.75 143.51 99.62 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 75.11 111.836 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.93 89.66 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.582 2.188 . . . . 72.44 112.14 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.3 p -70.78 -30.91 67.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.684 -0.689 . . . . 74.43 110.724 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.748 ' HB3' HG23 ' A' ' 143' ' ' VAL . 30.5 p90 -61.05 -26.37 67.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.567 . . . . 70.15 110.892 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.4 -19.46 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.107 -0.497 . . . . 64.14 110.751 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.894 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 14.5 t70 -93.99 -13.77 26.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.383 . . . . 74.21 110.318 -177.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.579 HD12 HG22 ' A' ' 143' ' ' VAL . 86.8 mt -57.62 -36.09 71.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.22 0.533 . . . . 73.21 110.001 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.9 30.68 4.32 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.298 -0.864 . . . . 54.01 111.523 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.894 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 5.0 tppp? -61.84 -57.89 10.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.458 . . . . 73.34 110.191 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -67.02 -39.11 86.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.542 -0.754 . . . . 73.33 110.258 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.76 93.47 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.071 -0.968 . . . . 61.24 112.633 -171.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -60.68 -39.93 90.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.665 0.211 . . . . 75.34 111.405 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 38.5 t70 -68.16 -36.65 79.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 65.41 111.036 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.507 ' CG1' ' HB2' ' A' ' 207' ' ' ASN . 26.9 t -84.03 -46.62 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.202 0.445 . . . . 74.5 112.202 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -72.38 -43.47 63.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.814 0.34 . . . . 75.33 110.906 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.6 p -111.97 71.94 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.141 0.972 . . . . 72.55 108.48 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 18.8 pttm -85.86 173.11 10.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.925 -1.489 . . . . 74.25 112.563 -166.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.58 97.11 0.2 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.517 -1.033 . . . . 63.35 110.517 170.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -115.81 146.03 42.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.827 0.346 . . . . 74.32 110.305 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -72.23 90.12 0.52 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.763 -0.732 . . . . 72.51 111.918 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -80.68 -3.81 52.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.153 0.501 . . . . 65.54 110.308 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.93 58.19 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.627 -0.797 . . . . 73.5 113.57 174.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 pp -140.66 171.79 13.62 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.553 1.168 . . . . 74.23 113.862 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.906 HG23 HD12 ' A' ' 277' ' ' LEU . 33.3 mm -105.75 122.07 58.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 113.121 -1.854 . . . . 71.41 108.945 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.674 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 11.2 pttp -126.65 154.31 44.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.186 0.517 . . . . 75.41 110.644 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -148.03 149.86 32.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.753 -0.832 . . . . 75.12 108.753 169.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 43' ' ' SER . 3.4 p-10 -139.49 131.02 27.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.786 0.803 . . . . 73.2 111.419 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.6 OUTLIER -94.16 124.85 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.577 -1.192 . . . . 73.11 108.487 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.671 ' HB3' ' HZ3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -126.4 124.48 40.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 73.31 110.554 178.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 283' ' ' ALA . 88.3 m -137.07 120.96 17.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.535 -0.757 . . . . 71.42 109.121 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -136.78 126.12 24.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.107 0.48 . . . . 73.33 110.366 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.0 m -137.07 138.51 40.47 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.923 -0.769 . . . . 75.3 108.923 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' A' ' 65' ' ' THR . 49.3 mt-10 -77.76 61.68 2.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.959 0.885 . . . . 64.54 110.194 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -137.61 18.92 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.149 -1.387 . . . . 75.13 108.341 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.8 -8.55 79.64 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.21 -0.904 . . . . 63.12 113.943 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.4 126.02 48.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.777 1.288 . . . . 64.45 111.986 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.951 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 19.8 tt0 -142.68 126.48 17.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.381 -0.6 . . . . 75.01 109.381 166.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.5 127.82 38.08 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.031 -0.418 . . . . 75.01 111.56 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.8 m -127.38 116.78 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 60.33 110.344 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.4 t -118.01 122.88 44.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.59 -0.522 . . . . 64.51 109.59 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 m -120.72 126.76 50.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.669 0.271 . . . . 74.21 110.912 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.98 134.94 8.09 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.719 -0.753 . . . . 72.43 111.96 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -121.57 135.37 55.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.73 -0.47 . . . . 72.51 109.73 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.98 129.32 29.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.278 0.561 . . . . 72.31 111.614 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.779 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m120 -93.7 124.27 37.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.368 -0.833 . . . . 73.33 109.399 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 p -82.5 19.36 1.28 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.263 0.468 . . . . 75.41 112.263 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.05 -42.17 76.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.172 0.511 . . . . 73.21 109.799 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.757 HG21 ' H ' ' A' ' 52' ' ' THR . 1.6 t -160.15 -73.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 72.13 109.647 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.757 ' H ' HG21 ' A' ' 51' ' ' THR . 37.8 m -156.41 86.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.737 -0.468 . . . . 62.25 109.737 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.779 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 46.7 tptt -128.9 91.71 3.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.65 -0.5 . . . . 74.24 109.65 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.3 121.09 63.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.204 -0.453 . . . . 62.35 111.178 -174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 p -110.36 140.31 44.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.77 -0.65 . . . . 74.14 109.984 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.39 19.46 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.316 -0.945 . . . . 75.24 112.753 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -141.88 133.06 26.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.864 -0.791 . . . . 64.21 108.864 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.79 124.53 44.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.757 -0.461 . . . . 74.34 109.757 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -113.72 118.37 34.13 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.102 -0.499 . . . . 74.41 109.659 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -110.77 122.82 48.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.913 -0.773 . . . . 74.33 108.913 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.951 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 72.1 mttt -129.4 134.78 48.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.298 0.57 . . . . 72.12 111.337 -172.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.629 ' HE1' ' HD1' ' A' ' 64' ' ' TRP . 49.4 t80 -106.81 119.51 39.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.485 -0.931 . . . . 71.42 108.485 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.497 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 63.6 ttm-85 -118.55 110.18 17.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.356 0.598 . . . . 75.14 111.654 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.629 ' HD1' ' HE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.58 125.17 35.54 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 114.948 -1.024 . . . . 74.33 109.811 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -81.0 -178.71 7.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 125.047 1.467 . . . . 74.25 111.915 -172.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.637 ' H ' HG23 ' A' ' 65' ' ' THR . 49.4 mt-10 71.99 -50.27 0.69 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.662 0.785 . . . . 73.41 110.937 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -95.06 -139.94 0.24 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.682 -1.229 . . . . 72.42 107.682 169.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.8 67.8 0.42 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.115 -0.794 . . . . 73.42 111.115 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -100.42 129.53 46.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.806 -0.757 . . . . 73.11 110.609 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.5 m -138.31 111.99 8.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.404 -0.362 . . . . 65.21 110.886 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -104.49 119.17 38.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.43 -0.952 . . . . 70.33 108.43 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.434 HG23 ' HB3' ' A' ' 61' ' ' LYS . 11.9 p -128.53 138.08 52.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.953 0.406 . . . . 73.42 111.87 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 43.1 mt-10 -117.54 120.63 38.65 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.809 -0.811 . . . . 72.13 108.809 166.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 7.0 pttp -110.83 105.4 14.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.355 0.598 . . . . 73.12 109.948 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -98.51 133.18 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.142 -0.936 . . . . 75.01 111.161 -174.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -110.47 143.55 40.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.937 -0.764 . . . . 70.52 108.937 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.8 t -56.4 -18.43 11.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.028 0.531 . . . . 74.33 112.149 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 24.7 t70 -67.21 -6.64 18.98 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.797 0.332 . . . . 72.35 110.738 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 51.7 m-80 79.79 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.155 0.982 . . . . 74.54 110.058 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -114.84 117.79 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.377 -0.829 . . . . 75.22 110.301 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.79 119.59 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.101 -0.333 . . . . 73.01 110.101 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -107.24 88.1 0.52 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.609 -0.805 . . . . 64.42 111.775 175.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.571 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 35.8 m -84.32 101.17 11.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.208 0.527 . . . . 75.22 110.275 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 3.7 tm-20 -114.75 128.25 56.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.604 -0.726 . . . . 75.51 109.683 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.98 121.74 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.297 0.57 . . . . 74.0 110.571 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.7 m -107.32 129.02 54.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 72.14 109.93 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.16 119.55 49.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.265 0.555 . . . . 73.54 110.842 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.57 118.98 36.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.629 -1.249 . . . . 71.14 107.629 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.71 169.34 11.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.681 0.753 . . . . 73.23 112.341 -166.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -111.91 -2.03 15.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.998 -1.001 . . . . 71.22 110.229 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.401 ' HB3' ' OD1' ' A' ' 89' ' ' ASP . 53.2 tp -85.08 -55.43 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 74.23 110.026 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -118.81 79.63 1.42 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.978 -0.749 . . . . 75.33 108.978 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -47.39 129.08 12.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.475 -0.784 . . . . 74.31 112.435 -171.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.45 -4.25 47.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.205 -0.907 . . . . 70.52 111.973 -173.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -88.02 114.76 24.95 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.825 -0.435 . . . . 71.24 109.825 175.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.07 121.03 36.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 73.43 110.119 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.5 mm? -109.46 127.66 54.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.457 -0.792 . . . . 62.25 109.245 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.878 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.2 t -129.13 128.92 44.44 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 73.32 109.984 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.744 ' HD2' HG12 ' A' ' 114' ' ' ILE . 80.4 t80 -121.38 125.84 47.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.842 -0.617 . . . . 73.45 110.242 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 2.1 m-20 -108.23 121.72 45.46 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.765 -0.458 . . . . 65.12 109.765 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.571 ' OG ' ' HB ' ' A' ' 83' ' ' THR . 8.5 p -115.67 120.18 38.53 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.533 -0.543 . . . . 71.53 109.533 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.3 m -101.34 121.43 41.89 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.858 -0.61 . . . . 65.34 109.528 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -128.46 119.76 25.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.075 -0.512 . . . . 75.44 109.737 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -113.71 103.44 55.33 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.252 -0.431 . . . . 74.3 111.085 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.63 -14.31 34.97 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.209 2.606 . . . . 74.33 112.938 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.429 ' OD1' ' HB2' ' A' ' 104' ' ' SER . 24.9 p30 -72.07 -21.0 61.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.924 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 p -126.54 -37.54 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.992 -0.549 . . . . 74.21 111.016 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.24 50.02 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.021 -0.609 . . . . 71.03 112.471 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -87.59 145.82 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 75.45 110.811 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.31 125.52 46.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.142 -0.688 . . . . 73.54 109.142 171.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -118.84 126.22 51.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.72 -0.474 . . . . 73.3 109.72 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.31 124.49 49.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.907 -0.588 . . . . 63.14 111.367 -173.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.68 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 54.8 mttp -111.55 136.24 51.01 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.101 -1.074 . . . . 73.21 108.101 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.749 HG21 ' HB2' ' A' ' 129' ' ' MET . 0.4 OUTLIER -125.28 130.95 72.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.325 -0.62 . . . . 62.45 109.325 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.878 ' HB2' HG23 ' A' ' 98' ' ' THR . 3.1 mptp? -123.42 120.73 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.605 -0.517 . . . . 75.41 109.605 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 t -114.21 116.31 28.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.628 -0.879 . . . . 72.45 108.628 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.464 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -130.08 121.66 3.44 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 119.541 -1.314 . . . . 72.4 112.574 -174.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -111.96 117.6 33.15 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.971 -0.751 . . . . 73.21 108.971 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -109.93 122.19 46.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.694 -0.684 . . . . 75.15 109.284 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -106.65 157.01 18.02 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.401 -0.592 . . . . 75.25 109.401 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.716 ' HG3' ' HD2' ' A' ' 122' ' ' HIS . 7.7 pt-20 -51.68 -27.03 10.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.634 0.774 . . . . 73.43 112.784 -172.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.716 ' HD2' ' HG3' ' A' ' 121' ' ' GLU . 66.5 m-70 -106.22 -24.09 12.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.212 0.449 . . . . 72.13 112.212 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.719 HD13 HD11 ' A' ' 142' ' ' LEU . 17.7 tt -147.25 141.61 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 120.324 -0.55 . . . . 71.11 111.992 -173.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.631 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -110.59 117.78 34.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.735 0.302 . . . . 73.31 111.717 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.524 HD11 HD12 ' A' ' 142' ' ' LEU . 4.3 mm? -111.7 137.49 49.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.821 0.343 . . . . 74.42 111.104 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.464 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -146.25 131.03 3.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.88 -0.676 . . . . 62.3 112.692 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 58.1 m -113.35 119.7 38.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.966 0.412 . . . . 75.3 110.851 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -105.29 136.39 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.898 -0.592 . . . . 71.13 110.289 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.749 ' HB2' HG21 ' A' ' 114' ' ' ILE . 64.9 mtt -133.86 121.49 21.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.954 -0.388 . . . . 73.34 109.954 174.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.41 120.13 41.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.038 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -93.35 105.73 17.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.277 0.56 . . . . 73.33 111.069 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.53 172.87 7.65 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.767 -0.827 . . . . 64.44 108.767 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.794 HD13 ' H ' ' A' ' 133' ' ' ILE . 3.5 mp -67.07 -33.12 61.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.309 -0.626 . . . . 70.23 109.309 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.47 -15.29 59.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.545 -0.752 . . . . 75.42 110.951 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.55 178.9 17.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.4 -0.905 . . . . 45.31 112.692 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -87.93 128.81 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.91 2.406 . . . . 75.43 112.812 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 t -99.36 140.75 33.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 73.45 108.757 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.82 118.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.551 -0.459 . . . . 73.3 111.071 -171.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.812 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 40.9 mtp180 -110.12 125.46 53.02 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.885 -0.783 . . . . 72.3 108.885 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.58 10.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 119.709 -1.234 . . . . 65.4 111.444 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.54 116.02 19.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.13 0.491 . . . . 63.42 110.926 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.719 HD11 HD13 ' A' ' 123' ' ' ILE . 6.6 tp -121.81 124.64 44.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 75.52 110.642 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.748 HG23 ' HB3' ' A' ' 7' ' ' TYR . 86.1 t -112.37 129.56 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.302 -0.863 . . . . 75.44 109.87 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.859 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 1.4 mm? -108.28 138.61 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.53 -0.759 . . . . 75.11 109.896 -170.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.22 118.53 5.59 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.561 -0.745 . . . . 75.34 112.058 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.796 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 86.5 m-85 -127.87 148.4 50.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 75.3 109.723 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.71 98.42 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.481 -0.327 . . . . 72.54 111.054 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.13 -21.51 20.05 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 116.29 -0.414 . . . . 74.42 112.756 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.796 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 24.8 m95 -105.54 131.82 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 75.2 111.209 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.4 mt -112.12 136.51 51.4 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.385 -0.598 . . . . 73.41 109.385 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.859 ' HB1' ' HB2' ' A' ' 144' ' ' LEU . . . -131.77 153.25 50.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.285 -0.416 . . . . 60.52 110.038 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -158.46 133.99 3.66 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.937 -0.865 . . . . 44.34 110.937 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -142.43 121.82 13.17 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.712 -0.795 . . . . 71.22 110.184 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.712 ' HG2' ' HB3' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -117.72 120.19 37.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.956 0.884 . . . . 71.13 110.102 176.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.415 ' C ' HD21 ' A' ' 156' ' ' ASN . 15.1 ptt? -117.72 133.46 55.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.153 -0.93 . . . . 74.31 109.304 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.591 HD21 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -110.54 116.53 31.52 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.781 -0.822 . . . . 74.53 108.781 -173.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 45.4 m-85 -94.36 118.38 31.52 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 123.577 0.548 . . . . 71.4 110.105 -176.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.962 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.3 tp10 -91.21 102.17 14.9 Favored 'General case' 0 C--O 1.262 1.752 0 CA-C-N 115.831 -0.622 . . . . 71.53 109.596 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 m -70.52 -25.2 63.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 112.893 -1.958 . . . . 74.54 110.93 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.87 71.84 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.01 -0.737 . . . . 62.13 109.01 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.632 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 69.6 mmtt -104.72 -163.41 0.96 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.844 -1.169 . . . . 73.1 107.844 170.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.3 t -108.35 26.37 10.54 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 121.838 -0.539 . . . . 74.13 110.294 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.3 172.2 11.33 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 118.89 -1.124 . . . . 74.05 111.542 -166.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.11 135.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 73.44 110.168 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.962 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.4 t -94.41 -21.48 18.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.946 -0.57 . . . . 75.13 110.815 -174.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.429 ' HG3' HG21 ' A' ' 165' ' ' THR . 46.2 mt-30 -143.58 134.66 25.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.854 0.359 . . . . 75.24 110.314 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -117.74 106.75 13.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.211 -0.45 . . . . 75.35 109.984 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.712 ' HB3' ' HG2' ' A' ' 154' ' ' GLN . 2.7 t-20 -115.94 122.58 45.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.69 -0.485 . . . . 74.22 109.69 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 90.1 m-85 -122.05 156.74 32.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.53 -0.305 . . . . 74.2 110.518 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -152.0 129.0 11.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.041 0.448 . . . . 62.41 110.888 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.89 125.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.637 -0.875 . . . . 75.23 108.637 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -142.11 109.16 0.56 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.934 -1.126 . . . . 74.23 112.507 -176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.707 ' CZ ' HD22 ' A' ' 180' ' ' LEU . 11.4 p90 -114.16 133.34 55.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.036 -0.728 . . . . 74.35 109.036 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -132.55 130.86 40.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.963 -1.017 . . . . 74.13 113.066 -162.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 m -121.01 155.51 34.17 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.111 -1.44 . . . . 74.21 107.111 166.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -49.75 -46.45 50.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 75.11 112.417 -170.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.45 -22.98 20.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.665 0.617 . . . . 72.05 112.665 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.73 119.72 15.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.325 0.583 . . . . 74.41 111.895 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -135.28 143.01 46.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.739 -0.664 . . . . 72.44 109.984 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.931 ' HB3' HG13 ' A' ' 194' ' ' ILE 0.256 0.0 OUTLIER -127.45 139.0 53.1 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.382 1.087 . . . . 75.23 111.503 159.274 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 45.3 m-70 -124.05 115.59 21.42 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.707 -2.042 . . . . 73.25 107.228 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 23.8 m -111.93 134.79 53.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.479 -0.328 . . . . 73.21 110.489 -173.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -118.75 140.21 50.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.34 -0.615 . . . . 72.02 109.34 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 25.5 t -121.56 118.61 56.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.239 -0.437 . . . . 44.0 110.959 -176.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.644 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 80.5 m-20 -97.68 91.09 5.23 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.079 -0.964 . . . . 73.15 108.96 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 58.42 -168.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.754 -1.112 . . . . 73.51 110.214 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.83 86.9 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.275 -0.964 . . . . 71.33 111.216 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.5 m -89.38 -26.75 20.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.566 0.58 . . . . 75.22 112.566 -172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 40.4 tt0 -139.14 117.61 12.08 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 119.779 -0.768 . . . . 63.42 112.255 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -109.18 126.21 53.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 73.32 109.374 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -129.23 109.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.844 -0.693 . . . . 73.35 112.503 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -105.63 131.77 10.8 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.735 -0.745 . . . . 71.42 111.725 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.6 t -119.06 137.8 53.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.895 -0.409 . . . . 74.04 109.895 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 1.03 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.5 mp -118.91 132.56 68.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.445 . . . . 75.31 109.894 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.462 ' HH ' ' CD ' ' A' ' 203' ' ' GLU . 4.4 t80 -111.76 119.9 40.18 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.352 -0.981 . . . . 74.42 108.352 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.411 ' HB3' ' HB ' ' A' ' 204' ' ' THR . 0.3 OUTLIER -122.39 112.43 18.07 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.184 -0.673 . . . . 70.51 109.184 -176.201 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -98.19 113.37 25.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.848 -0.615 . . . . 75.2 109.688 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 200' ' ' LYS . 47.9 t -80.63 150.16 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 65.34 109.129 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -61.13 -22.21 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 71.53 111.368 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 4.4 mptp? -91.27 -165.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.567 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.99 46.16 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.839 0.352 . . . . 74.53 110.665 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.555 ' HG ' ' HD1' ' A' ' 225' ' ' TYR . 3.7 tt -132.51 119.81 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.109 0.48 . . . . 75.51 110.248 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.462 ' CD ' ' HH ' ' A' ' 195' ' ' TYR . 49.0 mt-10 -111.53 138.41 48.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.113 -0.699 . . . . 62.52 109.113 171.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 196' ' ' GLN . 35.1 m -122.13 139.73 53.39 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.464 -0.569 . . . . 73.54 109.464 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -129.74 136.95 50.25 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.942 0.401 . . . . 65.2 110.16 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 1.03 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 10.3 t -115.32 137.06 50.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.886 -0.597 . . . . 75.32 110.323 -176.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.507 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 27.1 t-20 -120.77 127.41 51.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.034 0.445 . . . . 74.45 110.965 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.5 mm? -122.78 129.75 52.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.363 -0.835 . . . . 73.12 109.57 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -132.75 126.22 31.95 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.618 -0.433 . . . . 72.01 109.865 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -131.68 124.22 29.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.03 0.443 . . . . 74.22 110.69 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.88 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 1.1 p -104.46 103.58 13.3 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.676 -0.693 . . . . 70.0 110.523 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.34 127.8 33.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.846 -0.615 . . . . 74.54 110.553 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.2 27.11 73.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.066 -0.587 . . . . 71.25 112.178 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.88 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 10.7 t-20 -138.77 -147.36 0.23 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.533 -0.914 . . . . 73.22 108.533 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 214' ' ' ASN . 51.5 m -77.58 178.72 7.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.176 0.512 . . . . 72.01 112.329 -176.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.65 154.74 24.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.178 -0.919 . . . . 73.34 111.786 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.2 t -78.4 139.82 38.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 71.32 110.406 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.402 ' HD3' ' N ' ' A' ' 218' ' ' ARG . 0.3 OUTLIER -107.41 135.16 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.188 -0.46 . . . . 74.25 109.981 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -130.74 135.57 47.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.137 -0.483 . . . . 71.03 109.77 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.22 171.66 32.8 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.845 -0.693 . . . . 75.11 111.716 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -138.37 147.56 25.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.958 0.409 . . . . 72.03 111.333 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -128.93 130.42 46.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.485 -0.779 . . . . 73.42 109.933 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -115.76 128.53 55.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.63 0.252 . . . . 73.54 111.128 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 2.4 ttmp? -109.04 116.06 31.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 75.34 109.377 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.555 ' HD1' ' HG ' ' A' ' 202' ' ' LEU . 10.8 t80 -119.0 131.96 56.03 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.957 0.408 . . . . 73.41 110.389 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -96.73 99.62 11.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 65.21 110.132 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 227' ' ' ILE . 0.2 OUTLIER -94.38 -28.87 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.267 -0.424 . . . . 72.13 111.133 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.6 141.13 19.72 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.642 -0.503 . . . . 65.21 109.642 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.3 -30.62 20.37 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.158 2.572 . . . . 74.22 113.524 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.06 -9.46 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.111 0.412 . . . . 71.31 112.111 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.63 136.63 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.978 0.362 . . . . 65.42 111.978 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -131.26 142.42 50.14 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.32 -0.4 . . . . 64.51 110.538 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.11 134.15 52.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 70.41 111.052 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 46.5 p -130.97 118.36 20.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.993 -0.549 . . . . 42.34 110.622 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.12 141.5 41.23 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.743 -0.466 . . . . 73.34 109.743 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -142.34 140.92 32.28 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.868 -0.333 . . . . 75.21 110.787 -177.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 242' ' ' LEU . 9.4 p -140.55 146.53 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.513 -0.312 . . . . 74.33 110.284 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -115.92 150.05 37.74 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.65 -0.704 . . . . 71.33 109.664 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' A' ' 241' ' ' SER . 27.2 p-10 -53.82 -18.55 3.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.952 0.783 . . . . 73.33 112.83 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.473 ' HB3' ' HG ' ' A' ' 242' ' ' LEU . 34.4 t -78.85 21.37 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.713 0.292 . . . . 72.35 110.54 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 239' ' ' ASN . 46.1 t 64.31 32.24 12.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.198 0.523 . . . . 65.43 109.746 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.574 ' HB3' HD11 ' A' ' 262' ' ' LEU . 58.5 mt -99.07 114.71 27.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.436 -0.506 . . . . 73.04 109.981 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.751 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -109.68 117.96 55.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.929 0.395 . . . . 73.0 110.57 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -116.92 139.71 15.33 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.935 -0.65 . . . . 61.35 113.126 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.16 127.81 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.819 -0.808 . . . . 71.44 108.819 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -139.85 132.36 5.54 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.942 -1.123 . . . . 70.2 112.641 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -129.17 133.61 47.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.087 0.47 . . . . 74.0 110.16 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 13.5 t -123.21 136.15 54.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.013 -0.539 . . . . 73.54 109.776 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -142.69 149.12 38.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.295 -0.411 . . . . 74.52 110.665 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 13.8 m -98.89 121.71 41.19 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.455 ' CB ' HG21 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.38 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.286 0.366 . . . . 75.25 110.817 -173.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.722 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 63.3 mttm -150.37 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.58 -0.282 . . . . 74.22 111.558 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.722 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 3.0 Cg_exo -75.0 -76.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.91 1.74 . . . . 75.53 112.767 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -152.63 28.72 0.85 Allowed Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.85 -0.691 . . . . 71.32 112.038 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.493 HD11 ' CE2' ' A' ' 281' ' ' PHE . 1.0 OUTLIER -106.99 122.42 61.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.104 0.478 . . . . 72.34 110.485 -178.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -104.04 130.73 51.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.682 -0.69 . . . . 72.21 109.839 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.4 tp -98.39 124.37 43.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.213 -0.662 . . . . 64.43 109.213 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.8 m -116.11 110.33 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.933 -0.576 . . . . 73.44 109.907 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.824 HD23 HD22 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -114.23 124.82 52.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.919 -0.771 . . . . 75.45 108.919 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 62.8 m -138.65 139.95 38.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.812 0.339 . . . . 64.14 110.282 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.07 127.83 20.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.801 -0.444 . . . . 74.32 109.801 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.1 tm? -107.61 121.8 45.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.43 -0.952 . . . . 73.5 108.43 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.751 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.1 mm? -98.78 106.16 18.4 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.847 -1.168 . . . . 61.44 107.847 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.553 ' HA ' HD23 ' A' ' 242' ' ' LEU . 4.8 m-20 -72.54 106.26 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.614 -0.884 . . . . 75.13 108.614 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.52 -22.56 24.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.991 -0.623 . . . . 75.01 113.121 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -90.88 -3.38 57.39 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.996 0.427 . . . . 74.34 111.193 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 47.4 t-20 -123.79 -44.67 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.816 0.341 . . . . 63.25 110.969 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 263' ' ' LEU . 26.5 m -61.24 -18.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.259 0.466 . . . . 74.31 112.259 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.02 -38.98 88.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.795 0.331 . . . . 72.43 110.443 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.49 29.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.539 . . . . 71.13 110.915 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.02 100.83 2.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.715 -0.755 . . . . 72.54 112.071 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.59 77.17 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.775 -0.726 . . . . 75.4 112.082 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -87.39 144.23 26.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 74.33 109.819 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 65.2 mttm -97.38 137.02 37.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.522 . . . . 74.11 109.887 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 276' ' ' GLY . 1.8 tm? -125.77 131.7 52.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.805 -0.634 . . . . 75.35 110.044 -173.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -125.2 113.07 1.84 Allowed Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.505 -1.038 . . . . 72.04 110.505 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.906 HD12 HG23 ' A' ' 27' ' ' ILE . 3.4 tm? -114.38 134.87 54.67 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 72.44 109.668 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -148.58 125.89 2.16 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.095 -1.05 . . . . 41.1 113.172 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 2.5 mm? -102.29 131.92 48.58 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.166 -0.679 . . . . 74.22 109.166 171.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 51.9 mt-10 -115.57 110.87 19.85 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.571 -0.529 . . . . 65.35 109.571 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.728 ' HB2' HD22 ' A' ' 31' ' ' LEU . 89.4 m-85 -101.26 100.98 11.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.933 -0.576 . . . . 72.31 110.483 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 52.9 tt0 -92.07 111.96 23.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.264 -0.643 . . . . 74.23 109.264 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 33' ' ' THR . . . -107.77 111.25 23.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.095 0.474 . . . . 73.05 110.985 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.12 133.75 55.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.709 -0.678 . . . . 74.04 109.322 173.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.43 -0.795 . . . . 72.13 110.7 -174.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' HB3' ' A' ' 121' ' ' GLU . 61.1 mtt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.966 0.413 . . . . 71.31 110.877 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.5 88.56 2.76 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.878 -0.786 . . . . 73.14 108.878 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.79 HG23 ' HA ' ' A' ' 121' ' ' GLU . 2.2 t -107.59 109.0 62.32 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 74.44 110.898 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 5.3 Cg_exo -77.4 164.77 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.251 2.634 . . . . 74.44 111.633 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.59 70.09 2.05 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.839 2.359 . . . . 74.32 111.825 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.737 ' HB ' HD22 ' A' ' 150' ' ' LEU . 20.6 p -70.13 -42.29 72.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 61.1 111.056 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.562 ' HB3' HG21 ' A' ' 143' ' ' VAL . 29.6 p90 -54.92 -30.58 58.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 71.34 111.538 174.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.83 46.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.524 . . . . 75.01 110.61 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.94 -9.63 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 71.43 109.834 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 150' ' ' LEU . 81.3 mt -70.69 -34.51 72.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.781 -0.645 . . . . 75.11 110.983 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . -129.05 0.03 6.03 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.593 -1.289 . . . . 72.21 114.83 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.577 ' HG3' ' N ' ' A' ' 13' ' ' SER . 4.8 pttm -62.43 -46.22 89.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.781 1.29 . . . . 74.51 110.505 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.577 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 5.0 p -66.54 -49.46 66.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.345 0.593 . . . . 71.33 111.168 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.72 69.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.308 -0.86 . . . . 71.23 112.438 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -59.86 -38.9 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.883 0.327 . . . . 71.23 111.883 -171.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.95 -47.44 71.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.873 0.368 . . . . 74.4 110.959 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.613 HG12 ' HB2' ' A' ' 222' ' ' ALA . 25.1 m -82.74 -27.53 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.435 0.532 . . . . 74.11 112.435 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.15 -31.31 65.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.627 0.251 . . . . 74.0 111.462 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.9 m -59.78 135.44 57.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.389 -0.369 . . . . 73.45 110.704 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.51 -53.98 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 65.31 111.249 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.88 46.86 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.759 -0.734 . . . . 75.12 111.617 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.45 93.47 6.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.617 0.722 . . . . 72.22 111.031 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.01 124.83 7.73 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.789 -0.719 . . . . 73.32 111.84 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -84.25 10.96 9.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.6 0.238 . . . . 73.2 111.596 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.9 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 92.7 13.85 56.15 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.363 -0.923 . . . . 74.3 111.608 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.94 179.42 4.33 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.572 0.701 . . . . 75.21 112.747 -171.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.657 HD12 HD13 ' A' ' 277' ' ' LEU . 35.1 mm -102.06 130.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.785 -1.098 . . . . 64.2 110.407 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.588 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 1.0 OUTLIER -103.81 134.63 46.79 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.455 -0.943 . . . . 75.33 108.455 176.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 16.5 tp -121.56 147.83 45.29 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.677 -0.409 . . . . 71.43 110.853 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.787 ' HB3' ' HG2' ' A' ' 280' ' ' GLU . 12.3 t70 -153.72 127.9 9.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.294 -0.866 . . . . 73.31 108.919 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 281' ' ' PHE . 8.9 tp -137.46 125.02 22.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.346 -0.612 . . . . 72.11 109.346 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 23.3 ttmt -133.12 124.69 28.01 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.46 . . . . 74.15 110.683 -175.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.656 HG23 ' HB1' ' A' ' 283' ' ' ALA . 80.6 p -120.64 123.61 43.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.631 . . . . 72.32 109.705 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 284' ' ' LEU . 91.0 mttt -112.17 139.46 47.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.273 0.559 . . . . 71.14 112.14 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 43.1 t -139.17 137.18 35.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.835 -1.172 . . . . 75.4 107.835 168.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -82.12 34.97 0.42 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.616 0.722 . . . . 71.2 109.902 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.7 OUTLIER -120.5 18.71 12.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.477 -0.783 . . . . 73.31 111.424 -177.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 97.76 -3.4 60.81 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.194 -1.162 . . . . 73.54 110.194 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.546 ' C ' HD12 ' A' ' 39' ' ' LEU . 3.4 tm? -99.65 127.22 45.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.762 -0.375 . . . . 73.31 111.717 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 22.0 tt0 -141.6 129.22 21.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.969 -0.752 . . . . 75.2 108.969 163.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.438 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 74.5 t80 -124.78 127.05 46.61 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.267 -0.896 . . . . 65.13 110.872 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.886 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.5 m -128.58 131.53 48.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.092 0.473 . . . . 74.22 111.682 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 17.1 m -120.3 123.02 42.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.854 . . . . 75.02 108.693 171.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.3 p -139.65 157.65 45.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.378 -0.529 . . . . 75.31 111.093 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 158.83 -175.22 35.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.539 -1.315 . . . . 73.13 113.567 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 p -137.03 138.5 40.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.617 -0.292 . . . . 74.32 110.249 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 54' ' ' VAL . . . -135.27 129.12 33.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.781 0.324 . . . . 71.24 110.709 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.422 ' CB ' ' HB3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -90.67 113.72 25.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 74.23 109.153 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -84.84 7.33 21.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.181 0.808 . . . . 70.21 113.181 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -74.13 -46.26 43.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.71 -0.396 . . . . 74.43 110.405 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -126.36 -81.33 0.61 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.749 -0.463 . . . . 73.11 109.749 171.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' HG21 ' A' ' 52' ' ' THR . 5.5 t -172.69 84.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.949 0.88 . . . . 65.12 110.296 175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 16.6 tppt? -126.25 86.53 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 73.55 109.449 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 47' ' ' ALA . 25.9 t -109.22 120.04 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.017 -0.538 . . . . 71.24 110.821 -175.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -137.67 124.6 21.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.893 -0.594 . . . . 62.1 109.56 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 45' ' ' GLY . . . -155.57 -155.43 7.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.539 -0.838 . . . . 72.35 111.958 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 33.4 t -148.03 150.99 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.185 0.517 . . . . 74.44 110.177 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -119.96 125.06 47.48 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.65 -0.87 . . . . 70.52 108.65 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 3.4 mp0 -109.04 118.87 37.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.454 -0.793 . . . . 75.33 110.93 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -99.55 117.72 34.56 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.794 -1.558 . . . . 74.04 106.794 164.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.764 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 74.3 tttt -127.37 150.28 49.68 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.363 0.602 . . . . 74.45 110.311 -171.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.876 ' HB2' ' HB2' ' A' ' 71' ' ' PHE . 99.6 m-85 -126.72 121.42 31.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.879 -0.601 . . . . 74.11 110.155 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.3 ptm85 -121.27 106.1 11.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.789 0.804 . . . . 75.04 111.376 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 t90 -117.02 104.64 11.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.869 -1.06 . . . . 75.21 109.583 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 m 73.55 132.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.615 0.572 . . . . 73.43 110.508 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.9 mp0 -50.95 -59.98 3.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.858 -0.61 . . . . 71.03 110.911 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.03 67.37 0.7 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.702 -0.681 . . . . 75.54 109.383 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 -85.58 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.608 -0.806 . . . . 35.1 112.847 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.98 130.53 52.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 74.44 111.807 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.8 m -137.72 112.36 8.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 74.5 110.561 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.876 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 8.9 m-85 -102.73 122.4 44.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.609 -0.515 . . . . 73.13 109.609 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 m -119.93 117.29 27.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.64 -0.424 . . . . 73.31 111.76 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.6 123.65 45.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 75.21 109.099 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 10.3 ptmm? -142.86 140.18 31.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.288 -0.565 . . . . 74.41 110.969 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.403 ' CD1' ' HG ' ' A' ' 81' ' ' LEU . 31.5 t90 -129.85 130.08 44.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.092 -0.504 . . . . 75.4 110.132 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 57' ' ' SER . 15.8 m120 -93.46 150.92 20.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 70.11 110.756 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -63.82 -20.43 65.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 73.02 109.553 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.77 -4.13 29.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.092 -0.958 . . . . 75.12 110.344 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.7 t30 82.31 4.64 1.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.015 0.926 . . . . 73.34 111.113 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.676 ' HB ' ' HB2' ' A' ' 103' ' ' PHE . 18.9 p -80.76 143.86 32.57 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 116.129 -0.487 . . . . 74.03 109.803 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 103' ' ' PHE . 3.3 mp -122.88 113.59 19.34 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.761 -1.176 . . . . 75.22 113.872 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.62 131.12 10.08 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 119.771 -1.204 . . . . 73.41 113.686 -170.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.913 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 91.0 m -136.25 140.17 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.641 0.258 . . . . 74.32 110.745 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.87 108.83 3.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.484 HG13 ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -116.59 120.65 65.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.005 0.431 . . . . 71.34 109.987 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.6 m -110.53 135.8 50.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.996 -0.547 . . . . 73.42 111.772 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.2 125.33 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.178 -0.919 . . . . 74.11 109.738 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.53 130.03 35.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.546 -0.539 . . . . 75.15 109.546 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.55 133.16 36.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.785 -0.45 . . . . 75.32 109.785 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -91.53 -21.69 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.33 -0.396 . . . . 62.04 111.47 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.97 -51.08 11.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.964 -0.754 . . . . 74.21 108.964 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.06 7.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 73.33 109.823 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.718 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -62.49 124.63 21.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 75.41 110.514 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' ' HZ1' ' A' ' 119' ' ' LYS . . . 100.12 1.62 55.91 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.705 -0.76 . . . . 74.15 112.322 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.725 HD21 ' HD1' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -98.86 124.35 43.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 75.41 109.871 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.23 123.19 40.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 74.3 110.53 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.7 mm? -112.97 125.61 54.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.619 -0.512 . . . . 74.33 109.619 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.918 HG21 ' HB3' ' A' ' 115' ' ' LYS . 1.1 t -132.52 136.24 46.51 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.232 0.539 . . . . 74.42 110.637 173.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -104.78 120.67 41.94 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.88 -0.785 . . . . 74.1 108.88 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.51 151.9 26.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.561 -0.745 . . . . 73.53 110.976 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.913 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 22.3 m -128.11 131.92 49.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.5 -0.773 . . . . 74.41 109.251 172.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -91.64 141.94 28.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.392 -0.822 . . . . 74.23 108.859 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.763 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 2.3 p90 -95.51 98.01 10.21 Favored 'General case' 0 C--O 1.188 -2.171 0 N-CA-C 114.824 1.416 . . . . 74.11 114.824 -161.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 60.7 p -76.89 124.15 87.5 Favored Pre-proline 0 N--CA 1.465 0.31 0 O-C-N 121.091 -1.006 . . . . 63.11 112.974 -164.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 33.9 Cg_exo -61.72 -54.97 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.205 2.603 . . . . 72.35 113.16 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -106.14 -30.78 9.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 53.13 111.28 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -62.64 -48.72 78.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.369 . . . . 75.24 111.686 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.24 -14.95 59.53 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.037 -0.601 . . . . 63.33 111.841 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -97.22 130.69 44.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.205 -0.665 . . . . 75.34 109.205 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.61 150.27 36.46 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.056 -0.658 . . . . 72.31 109.54 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' A' ' 101' ' ' SER . 66.0 t30 -116.51 156.17 27.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 65.41 109.957 -174.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.43 126.54 49.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.909 0.861 . . . . 72.44 112.347 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.441 ' HZ3' ' CG ' ' A' ' 128' ' ' ASP . 28.0 ttpp -128.38 140.61 51.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.537 -1.211 . . . . 74.41 108.656 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -112.48 124.23 68.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.002 -0.74 . . . . 74.52 109.002 -178.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.918 ' HB3' HG21 ' A' ' 98' ' ' THR . 84.4 tttt -120.08 119.67 34.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.508 -0.769 . . . . 65.21 109.752 -171.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.9 m -122.67 137.08 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.335 -0.393 . . . . 63.04 110.951 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.22 122.62 3.35 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.819 -0.705 . . . . 71.14 112.421 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.725 ' HD1' HD21 ' A' ' 95' ' ' LEU . 81.8 t80 -117.59 128.49 55.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.238 -0.653 . . . . 75.15 109.238 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.731 ' HB3' HG11 ' A' ' 3' ' ' VAL . 26.3 mtmm -109.13 123.16 48.75 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.894 -0.722 . . . . 75.04 110.54 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -104.69 147.83 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.3 -1.37 . . . . 75.24 107.3 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.79 ' HA ' HG23 ' A' ' 3' ' ' VAL . 10.5 pt-20 -52.37 -28.48 19.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.489 0.551 . . . . 72.33 112.489 -167.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -100.84 -31.94 10.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.468 0.544 . . . . 71.01 112.468 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.944 HG22 ' H ' ' A' ' 145' ' ' GLY . 16.6 pt -142.89 154.23 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 118.594 0.634 . . . . 74.04 112.254 -170.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.73 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 3.5 t-20 -110.14 128.9 55.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.698 -0.683 . . . . 72.43 111.231 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 142' ' ' LEU . 4.6 mm? -110.84 135.73 50.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.515 -0.311 . . . . 74.5 110.174 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.4 125.8 3.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.529 -0.843 . . . . 73.22 112.511 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.8 m -113.45 117.81 32.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.763 -0.458 . . . . 73.43 109.763 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.441 ' CG ' ' HZ3' ' A' ' 113' ' ' LYS . 38.9 t0 -126.09 117.57 23.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.955 0.407 . . . . 73.02 110.1 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.718 ' HG3' HG13 ' A' ' 138' ' ' ILE . 60.8 ttp -119.67 118.15 30.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.919 0.39 . . . . 75.11 111.563 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.21 120.18 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.366 -0.605 . . . . 70.33 109.366 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.531 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 85.5 t80 -95.03 104.66 16.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.065 0.46 . . . . 72.32 111.674 -172.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.499 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 20.3 t70 -97.99 149.4 22.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 74.2 108.904 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -68.6 -35.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.734 -0.212 . . . . 72.41 111.101 -174.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.52 -20.13 20.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 52.21 111.403 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.86 98.71 0.12 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.366 -0.921 . . . . 73.14 112.662 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.531 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 37.9 Cg_endo -67.19 150.79 81.88 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.577 2.185 . . . . 74.12 112.43 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -115.13 128.84 56.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.442 -0.577 . . . . 75.14 109.442 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.718 HG13 ' HG3' ' A' ' 129' ' ' MET . 3.9 mp -109.73 118.34 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.354 -0.609 . . . . 63.33 109.354 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -112.19 132.49 54.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.337 0.589 . . . . 75.24 110.308 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.63 132.66 10.99 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.389 -0.823 . . . . 74.41 111.343 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.11 134.76 55.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.961 -0.385 . . . . 71.31 109.961 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.733 HD11 HD11 ' A' ' 123' ' ' ILE . 6.3 tp -137.97 122.33 18.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.207 0.527 . . . . 74.35 110.164 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 97.8 t -107.89 130.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.23 -0.895 . . . . 65.23 108.937 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 1.6 mm? -108.14 137.24 46.46 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.258 -0.645 . . . . 74.32 109.258 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.944 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -130.49 119.36 2.73 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 115.527 -0.76 . . . . 61.3 111.46 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 149' ' ' TRP . 1.8 p90 -142.28 147.78 36.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.523 . . . . 73.01 109.589 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 7.0 mp0 -35.24 102.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.575 0.954 . . . . 70.03 113.575 -169.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.31 -33.92 5.31 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.0 -1.0 . . . . 63.21 113.7 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.486 ' HB2' ' CE1' ' A' ' 146' ' ' TYR . 78.1 m95 -106.01 143.28 34.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.63 0.728 . . . . 73.33 112.193 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.737 HD22 ' HB ' ' A' ' 6' ' ' THR . 1.9 tm? -124.75 136.68 54.07 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 72.3 107.985 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . . . -139.02 162.15 35.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.682 0.277 . . . . 75.24 110.692 -175.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -159.88 145.49 11.37 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.373 -0.691 . . . . 72.13 111.373 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.495 ' OH ' HD21 ' A' ' 142' ' ' LEU . 39.8 p90 -146.72 127.39 14.26 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.694 0.747 . . . . 75.14 111.673 165.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 0.9 OUTLIER -115.72 121.64 43.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.421 -0.809 . . . . 72.23 109.163 177.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 94.8 mmm -121.6 140.15 52.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.176 -0.305 . . . . 73.11 110.176 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 3.8 m-20 -110.3 119.14 38.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.763 -0.458 . . . . 74.21 109.763 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.23 117.27 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.568 -0.53 . . . . 74.11 109.568 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.459 ' OE1' ' HE3' ' A' ' 161' ' ' LYS . 15.0 tt0 -98.54 105.55 17.71 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-O 121.094 0.473 . . . . 71.13 110.107 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.3 m -70.42 -20.81 62.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.3 -1.773 . . . . 74.24 111.124 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.418 ' HB3' ' HG2' ' A' ' 158' ' ' GLU . . . -59.7 -28.65 67.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.924 0.869 . . . . 72.31 109.155 173.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.459 ' HE3' ' OE1' ' A' ' 158' ' ' GLU . 78.8 mttt -117.72 -157.77 0.68 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.311 -1.366 . . . . 73.02 107.311 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.7 p -109.29 26.74 10.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.85 -0.426 . . . . 63.1 109.85 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -141.97 154.32 44.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.24 -1.384 . . . . 73.42 114.591 -154.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 93.9 t -74.37 131.61 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 114.721 -1.127 . . . . 70.44 110.206 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 33.1 m -98.63 -34.22 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.627 -0.26 . . . . 72.22 111.488 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.4 ' H ' ' HB2' ' A' ' 156' ' ' ASN . 14.1 mm100 -138.59 134.68 34.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.183 -0.303 . . . . 73.4 110.183 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.7 p -120.84 109.46 15.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.198 0.523 . . . . 74.23 110.561 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 26.6 m-80 -109.31 138.45 45.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 5.7 t80 -138.68 149.35 45.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.421 -0.512 . . . . 74.24 110.419 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -149.9 136.8 19.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.178 0.513 . . . . 74.14 110.733 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 10.2 t -145.88 154.07 13.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 64.32 108.427 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 180' ' ' LEU . . . 166.02 -170.72 40.86 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 118.855 -1.641 . . . . 64.53 113.602 169.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.73 153.39 48.49 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.43 -0.385 . . . . 71.31 110.301 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.482 ' HZ1' ' HB3' ' A' ' 174' ' ' LYS . 8.5 mtpm? -114.26 126.55 55.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.182 0.515 . . . . 73.4 110.414 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 m -126.29 163.27 23.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.545 -0.752 . . . . 73.34 109.142 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.44 -57.29 3.65 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.765 0.654 . . . . 73.32 112.765 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -109.2 -8.92 15.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 75.13 111.447 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.7 132.09 46.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.898 0.38 . . . . 71.1 111.451 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 83.4 mt-30 -125.98 124.06 39.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.146 -0.687 . . . . 72.43 109.146 173.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.605 HD12 HG13 ' A' ' 194' ' ' ILE . 3.6 tt -120.3 128.49 53.34 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.557 . . . . 72.24 110.948 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 77.6 m-70 -132.05 116.81 17.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.618 -0.719 . . . . 74.01 111.206 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.653 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 29.6 m -83.09 118.56 23.64 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.788 -0.819 . . . . 75.45 108.788 172.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.1 140.97 49.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.167 0.508 . . . . 74.34 111.12 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.523 HG21 ' CB ' ' A' ' 190' ' ' PHE . 70.2 t -124.62 128.14 73.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.574 -0.739 . . . . 72.24 110.798 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -115.46 97.29 6.08 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.241 -0.891 . . . . 75.12 108.652 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 30.2 t70 62.49 178.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.919 -1.037 . . . . 71.03 109.573 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.93 58.43 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.958 -0.857 . . . . 72.2 110.958 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 211' ' ' THR . 56.4 m -87.52 -28.1 22.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 112.564 0.579 . . . . 75.24 112.564 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -141.07 119.42 12.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.402 -0.919 . . . . 74.32 112.443 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.523 ' CB ' HG21 ' A' ' 184' ' ' VAL . 19.1 p90 -134.89 126.09 28.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.446 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.757 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -158.84 -162.6 12.07 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 120.491 -0.861 . . . . 70.43 112.388 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -137.74 152.01 21.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.737 -0.744 . . . . 52.34 112.752 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 15.0 m -125.15 138.28 54.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.711 0.291 . . . . 63.44 110.603 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.605 HG13 HD12 ' A' ' 180' ' ' LEU . 4.4 mp -123.72 124.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.272 -0.422 . . . . 70.14 109.896 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 6.6 t80 -108.47 116.37 31.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.73 -0.841 . . . . 75.14 108.73 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.461 HE21 ' HB2' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -128.5 134.58 48.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.936 0.398 . . . . 73.53 111.011 -177.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.601 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 56.2 mtpt -108.02 127.52 53.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.428 -0.351 . . . . 71.52 110.549 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.44 110.61 27.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -49.8 111.79 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.398 -0.819 . . . . 72.53 112.349 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 200' ' ' LYS . 34.0 ttmt 72.84 1.39 4.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.329 -0.851 . . . . 74.52 112.257 170.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -103.73 -73.14 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 74.41 110.148 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 225' ' ' TYR . 3.2 pp -162.96 170.8 17.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.663 -0.699 . . . . 74.24 109.619 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.601 ' HG3' ' HG2' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -125.52 134.64 51.93 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.941 -0.392 . . . . 71.44 109.941 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.0 m -124.03 142.54 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.136 0.493 . . . . 72.44 111.44 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -130.33 136.18 48.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.966 -0.561 . . . . 72.24 110.154 175.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 221' ' ' ILE . 75.6 t -112.41 134.47 54.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 73.32 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -133.74 126.31 30.42 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.452 -0.573 . . . . 62.32 109.452 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.3 pt? -147.14 135.09 21.36 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.617 -0.433 . . . . 72.23 110.69 174.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.757 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -134.58 149.57 50.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.645 . . . . 71.01 111.432 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -100.05 130.87 46.25 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.0 t -109.91 124.53 51.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.657 . . . . 75.1 110.894 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.57 58.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 73.02 111.442 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 129.95 -54.04 0.79 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.635 -0.986 . . . . 63.35 110.635 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.707 ' HB2' HD22 ' A' ' 216' ' ' ASN . 47.9 m-80 -139.04 172.41 12.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.219 -1.03 . . . . 75.32 108.219 172.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -81.57 67.66 7.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.973 0.416 . . . . 75.15 110.887 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.707 HD22 ' HB2' ' A' ' 214' ' ' ASN . 25.2 m-80 -102.78 129.21 49.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 74.23 110.727 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 m -108.63 123.51 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.334 -0.617 . . . . 74.5 109.334 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 41.7 ttm-85 -101.13 114.81 29.11 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.764 -0.828 . . . . 75.21 108.764 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 239' ' ' ASN . 83.7 t80 -117.8 136.62 53.29 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.507 0.194 . . . . 74.04 110.761 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.67 140.45 7.43 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.792 -0.718 . . . . 70.14 111.825 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.939 HG21 HG21 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -131.1 136.86 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 71.44 110.799 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.613 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -128.81 139.78 52.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.01 -0.541 . . . . 62.44 110.23 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.1 126.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.591 0.234 . . . . 75.42 110.584 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 17.2 pttm -102.53 119.52 38.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.845 0.831 . . . . 75.41 110.314 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.557 ' HD2' ' HB3' ' A' ' 202' ' ' LEU . 37.5 t80 -112.3 116.54 30.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.274 -1.33 . . . . 74.22 110.156 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -111.48 121.27 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.188 0.518 . . . . 64.11 111.252 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.9 pt -110.26 -27.41 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.305 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.499 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 19.2 t70 -135.15 143.24 44.98 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.57 -0.53 . . . . 74.24 109.57 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.53 -29.22 58.96 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.573 2.182 . . . . 70.52 112.487 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -103.56 4.12 35.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.375 -0.375 . . . . 74.42 111.307 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 228' ' ' ASP . . . -143.6 121.27 11.84 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.394 0.616 . . . . 71.5 111.872 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -139.87 128.65 23.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.781 -0.645 . . . . 72.42 109.539 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.07 125.14 50.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.002 -0.279 . . . . 71.41 110.543 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 224' ' ' LYS . 14.2 m -116.47 118.08 31.69 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 62.12 110.043 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -122.98 141.52 51.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.789 -0.364 . . . . 75.51 110.971 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.05 144.24 38.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.316 -0.402 . . . . 73.51 110.229 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.437 HG23 HG13 ' A' ' 243' ' ' ILE . 9.1 p -131.56 142.61 42.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.751 -0.463 . . . . 65.11 109.751 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -107.42 150.57 26.61 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.068 -0.716 . . . . 74.41 109.068 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 219' ' ' PHE . 6.2 t30 -58.87 -11.78 3.69 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.782 0.676 . . . . 73.42 112.147 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.608 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m -78.66 15.36 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.54 -0.541 . . . . 75.41 109.54 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.4 m 68.45 28.27 6.08 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 115.137 -0.938 . . . . 73.12 110.554 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.608 ' HG ' ' HB2' ' A' ' 240' ' ' SER . 42.7 mt -100.36 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.561 -0.456 . . . . 75.41 110.627 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.437 HG13 HG23 ' A' ' 237' ' ' VAL . 1.7 mp -108.51 115.41 49.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 120.879 -0.329 . . . . 62.44 110.173 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -123.59 133.39 8.87 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.929 -0.653 . . . . 71.04 112.301 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.509 ' HG ' ' HH ' ' A' ' 247' ' ' TYR . 0.0 OUTLIER -128.06 150.72 49.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.341 0.591 . . . . 64.25 111.593 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -132.32 121.65 3.06 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 114.991 -1.004 . . . . 61.12 110.777 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.509 ' HH ' ' HG ' ' A' ' 245' ' ' LEU . 32.0 m-85 -103.59 115.66 30.92 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.921 -0.4 . . . . 73.43 109.921 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.6 m -98.31 115.51 28.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.842 0.353 . . . . 72.51 110.211 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -126.19 128.92 48.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.096 -0.502 . . . . 73.44 109.903 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.1 m -95.09 119.12 33.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.739 0.304 . . . . 44.34 110.33 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 3.0 mm? -108.1 86.04 2.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 72.41 109.793 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 251' ' ' LEU . 0.0 OUTLIER 71.55 156.06 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.445 -0.798 . . . . 73.54 110.546 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.0 95.81 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.703 2.269 . . . . 73.01 112.854 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 142.18 -19.43 2.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.486 -0.864 . . . . 72.34 112.865 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.49 122.02 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.077 0.465 . . . . 73.43 111.903 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 43.1 mtmt -112.07 126.27 54.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 74.44 109.975 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -100.93 124.01 45.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.507 -0.553 . . . . 73.35 109.507 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 36.9 m -120.34 111.02 17.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 72.54 110.54 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.884 HD22 HD21 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -97.73 123.59 41.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.212 -1.033 . . . . 74.23 108.212 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 21.8 m -130.21 140.6 50.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.647 0.26 . . . . 65.35 110.462 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.489 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -154.89 128.8 8.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.644 -0.253 . . . . 73.12 110.942 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 274' ' ' LYS . 2.3 tm? -101.68 117.07 34.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.46 -0.941 . . . . 74.33 108.46 173.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.41 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.6 mm? -100.02 109.95 22.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.781 -0.645 . . . . 74.21 109.547 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.461 ' N ' HG12 ' A' ' 268' ' ' VAL . 2.9 m-20 -69.67 103.75 2.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.824 . . . . 75.51 109.522 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.65 -8.45 7.54 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.097 -0.956 . . . . 62.11 112.581 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 267' ' ' ASN . 48.3 tptt -64.99 -28.63 69.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.547 -0.538 . . . . 74.23 109.547 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 266' ' ' LYS . 44.5 t-20 157.38 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.604 1.19 . . . . 72.22 108.697 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 264' ' ' ASP . 0.1 OUTLIER -65.44 -45.15 93.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 112.918 0.71 . . . . 73.23 112.918 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.03 -44.87 91.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.676 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.96 -13.09 16.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.829 0.307 . . . . 70.21 111.829 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -103.34 -14.23 26.51 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.048 -1.072 . . . . 74.42 112.768 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 106.98 153.83 19.6 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.621 -0.799 . . . . 73.43 112.434 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -110.87 147.23 35.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.355 -0.98 . . . . 73.32 108.355 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.721 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.9 mmtm -94.0 134.96 35.85 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.335 -1.357 . . . . 74.45 107.335 173.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.9 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.5 tm? -135.29 136.12 41.37 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.255 0.55 . . . . 64.32 110.907 -170.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.451 ' N ' HD11 ' A' ' 275' ' ' LEU . . . -140.59 117.16 1.23 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 110.52 -1.032 . . . . 71.55 110.52 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.884 HD21 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -112.21 122.3 47.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.926 -1.139 . . . . 73.0 107.926 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -129.36 137.34 9.51 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.148 -1.025 . . . . 72.3 112.995 -170.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -114.07 130.55 56.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.936 -0.764 . . . . 73.13 108.936 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.787 ' HG2' ' HB3' ' A' ' 30' ' ' ASP . 50.8 mt-10 -121.02 112.1 18.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.812 -0.44 . . . . 75.11 109.812 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.728 ' HB3' HD11 ' A' ' 31' ' ' LEU . 14.7 t80 -103.53 141.92 35.17 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.854 -0.795 . . . . 74.24 108.854 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.74 141.89 40.97 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.884 0.373 . . . . 73.51 111.348 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 33' ' ' THR . . . -123.6 110.4 14.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.55 . . . . 74.43 109.679 172.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' A' ' 34' ' ' LYS . 4.2 mm? -124.09 -47.35 1.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.491 -0.777 . . . . 64.53 109.822 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.423 -0.799 . . . . 74.43 109.285 176.12 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.572 ' HE3' ' HA ' ' A' ' 120' ' ' ARG . 62.0 mtp . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.727 0.299 . . . . 74.3 111.525 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.49 79.65 1.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.45 -0.574 . . . . 74.13 109.45 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.826 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 4.5 p -110.68 135.85 20.71 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.797 -0.638 . . . . 71.0 111.12 -171.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.98 155.38 15.04 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.586 2.191 . . . . 74.1 110.973 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.99 101.16 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.925 1.75 . . . . 71.21 111.956 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.661 ' HB ' HD21 ' A' ' 150' ' ' LEU . 6.7 p -73.48 -19.3 60.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.64 . . . . 74.05 110.411 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.605 ' HB2' HG22 ' A' ' 143' ' ' VAL . 90.2 t80 -56.55 -24.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.999 -1.001 . . . . 75.51 110.441 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.22 -26.12 33.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 61.33 110.057 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.724 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 18.6 t70 -82.99 -14.8 53.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.856 -0.611 . . . . 71.54 109.447 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 1.035 HD21 ' HA3' ' A' ' 152' ' ' GLY . 2.3 tp -55.85 -34.39 65.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.802 -1.09 . . . . 74.22 110.637 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.562 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . -136.25 21.9 3.44 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 65.04 111.705 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 4.7 ttpm? -56.71 -56.08 25.99 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.418 . . . . 74.5 111.178 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.17 -38.1 89.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.65 -0.704 . . . . 73.35 110.681 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.27 80.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 73.11 112.417 -174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 98.7 mtt180 -57.88 -42.23 84.19 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.635 0.606 . . . . 75.41 112.635 -170.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.07 -37.89 86.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 74.45 110.507 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.83 -34.77 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.918 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -72.32 -42.6 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 73.24 111.814 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -126.9 57.68 1.45 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.994 0.902 . . . . 74.01 110.652 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 21' ' ' GLY . 45.3 tptt -75.16 177.31 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.501 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 20' ' ' LYS . . . -64.5 116.62 9.26 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.554 -0.832 . . . . 71.14 111.68 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.73 173.98 6.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 73.31 110.761 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.929 ' HA3' ' HB3' ' A' ' 274' ' ' LYS . . . -83.14 88.17 1.49 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.749 -0.738 . . . . 63.34 112.786 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -93.26 -4.33 52.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.033 -0.358 . . . . 74.52 110.033 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.5 79.36 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.933 -0.576 . . . . 71.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.31 155.15 39.18 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 122.162 0.982 . . . . 71.42 112.797 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.952 HG21 HD21 ' A' ' 277' ' ' LEU . 43.6 mm -94.03 121.25 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.704 -1.589 . . . . 75.53 107.809 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 6.5 mtpm? -114.83 139.44 49.75 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.852 -0.339 . . . . 74.15 110.71 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tt -142.84 142.66 31.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.081 173.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -144.66 128.05 16.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.61 0.719 . . . . 75.21 110.434 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 281' ' ' PHE . 11.8 tp -120.84 126.75 50.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.896 -1.047 . . . . 74.24 110.33 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 2.0 ptmm? -121.8 124.49 44.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.483 0.659 . . . . 70.13 110.514 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.697 ' HB ' ' HB1' ' A' ' 283' ' ' ALA . 3.6 t -110.68 121.86 46.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.084 -1.08 . . . . 74.23 108.084 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HB3' ' HG3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -143.41 139.05 29.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.791 0.805 . . . . 74.51 112.706 -170.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 37' ' ' ASN . 23.1 t -139.32 137.93 36.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.944 -1.873 . . . . 72.02 105.944 168.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -79.62 44.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.044 0.926 . . . . 70.03 111.128 -171.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 35' ' ' SER . 1.4 m-20 -98.37 19.41 14.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.966 -1.47 . . . . 75.4 107.431 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 95.62 -7.05 68.09 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.495 -1.23 . . . . 74.32 113.253 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 39' ' ' LEU . 3.4 mm? -102.77 128.41 49.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.252 1.026 . . . . 73.31 113.489 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 25.6 tt0 -140.56 117.84 11.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.898 -0.779 . . . . 65.04 108.898 160.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 87.9 t80 -108.16 120.54 42.62 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.955 -0.466 . . . . 75.33 109.812 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.557 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 34.0 m -120.85 115.95 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 75.45 110.48 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -114.41 123.54 49.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.547 -0.538 . . . . 70.15 109.547 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 20.1 m -117.69 133.89 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 63.44 110.378 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.63 125.33 2.71 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.832 -0.699 . . . . 73.31 111.606 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.6 m -119.69 133.99 55.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 73.24 109.037 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.43 146.46 44.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.158 0.504 . . . . 75.53 111.858 -173.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -68.87 142.91 54.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.503 -0.771 . . . . 64.34 109.157 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -57.88 -21.76 44.75 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.209 0.528 . . . . 74.22 111.271 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.75 7.46 33.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 75.34 110.632 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.9 p 50.05 25.66 1.78 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.383 1.073 . . . . 64.3 113.318 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 p -99.72 -18.44 17.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 73.41 111.712 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -134.93 108.64 8.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.183 -0.673 . . . . 72.15 109.183 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 t -125.3 120.77 58.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.026 0.441 . . . . 74.03 110.742 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -111.22 126.49 54.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.146 0.498 . . . . 73.42 110.359 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.26 155.49 16.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.855 -0.688 . . . . 73.11 112.425 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.9 m -143.65 126.78 16.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.438 -0.949 . . . . 74.12 108.438 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -121.3 124.61 45.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.38 -0.528 . . . . 75.0 110.479 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 44.2 mt-10 -114.82 118.71 34.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.92 -0.582 . . . . 73.03 110.122 174.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 m -97.7 117.2 31.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.472 -1.307 . . . . 75.34 107.472 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 24.3 mtpp -121.93 139.38 53.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.325 0.583 . . . . 73.4 110.554 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 76.5 m-85 -109.67 120.82 43.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.416 -0.811 . . . . 73.11 109.082 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -118.04 109.16 16.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.258 0.551 . . . . 64.14 111.304 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 20.0 t90 -112.9 92.46 4.02 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.201 -0.909 . . . . 74.21 109.514 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 67' ' ' TYR . 10.8 m 71.63 151.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.134 0.896 . . . . 55.03 111.393 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.44 -38.21 63.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.561 0.696 . . . . 72.31 110.08 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.447 ' H ' HG22 ' A' ' 65' ' ' THR . 14.0 p90 -121.43 103.04 8.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 74.24 109.121 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.39 -102.07 0.17 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.225 -0.988 . . . . 72.32 112.141 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.7 mm? -117.51 136.55 53.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.322 0.582 . . . . 74.34 112.293 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -135.39 112.23 10.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.198 -0.91 . . . . 75.14 109.327 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.618 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 56.2 t80 -117.32 132.5 56.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.771 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 58.7 m -128.67 117.65 21.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.777 -0.192 . . . . 72.22 111.408 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -103.31 121.14 42.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.879 -1.156 . . . . 73.12 107.879 167.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -123.36 102.37 7.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.967 -0.56 . . . . 74.35 110.856 -168.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.855 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 67.9 t90 -96.67 132.84 41.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 74.25 109.889 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -119.76 165.82 14.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.852 -0.425 . . . . 74.11 109.852 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.7 t -64.84 -6.3 7.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.02 0.438 . . . . 74.53 111.932 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -79.82 -3.28 47.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.57 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 14.7 m120 73.97 18.64 3.22 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.92 0.763 . . . . 74.1 110.028 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.6 m -102.93 135.92 43.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 72.35 110.487 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.855 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 4.8 mp -112.79 119.71 38.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.246 -0.434 . . . . 72.32 110.412 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 130.55 10.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.74 -0.743 . . . . 62.33 111.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.3 m -112.78 107.48 16.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.011 0.434 . . . . 73.13 111.144 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.771 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 21.7 tt0 -105.39 127.8 53.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.588 -0.733 . . . . 63.15 109.885 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -130.02 120.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.364 -0.606 . . . . 64.41 109.364 169.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 24.6 m -126.36 129.24 48.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.685 -0.689 . . . . 55.53 110.229 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.02 134.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 74.3 111.253 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.486 ' OE2' ' HG3' ' A' ' 96' ' ' LYS . 67.8 mm-40 -96.46 118.86 33.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.55 -0.908 . . . . 73.34 108.55 172.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.27 122.9 28.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 73.44 109.822 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -85.56 -27.58 25.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.235 -0.438 . . . . 73.53 110.99 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.37 -44.8 42.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.295 -0.631 . . . . 74.14 109.295 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -99.61 67.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.516 -0.92 . . . . 71.52 108.516 170.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -49.95 131.23 22.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 65.34 111.759 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.477 ' HA2' ' HD2' ' A' ' 119' ' ' LYS . . . 102.85 -15.16 55.78 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.11 -0.95 . . . . 71.12 112.444 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -78.96 121.07 24.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.15 0.475 . . . . 71.11 111.126 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HG3' ' OE2' ' A' ' 88' ' ' GLU . 48.9 tttp -118.06 111.78 19.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.571 -0.741 . . . . 74.43 109.574 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.615 HD12 HG21 ' A' ' 116' ' ' THR . 1.9 mm? -103.53 128.53 50.74 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.875 -0.417 . . . . 73.51 109.875 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 10.5 m -128.82 122.65 30.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.458 -0.337 . . . . 73.4 111.375 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.596 ' CE2' HD11 ' A' ' 114' ' ' ILE . 47.4 m-85 -119.55 115.67 24.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.477 -0.564 . . . . 75.02 109.477 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.1 t70 -115.42 122.05 44.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.55 -0.537 . . . . 73.15 109.55 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -134.83 121.69 20.99 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.061 0.457 . . . . 65.11 110.455 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 m -99.29 121.93 41.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.01 -0.541 . . . . 62.04 109.915 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.35 119.37 39.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 72.31 109.716 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 m -115.16 102.37 54.67 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.894 -0.41 . . . . 63.45 109.894 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.73 -33.04 28.71 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.559 2.173 . . . . 65.53 111.51 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -83.67 -46.11 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.643 -0.708 . . . . 75.24 111.102 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -70.25 -36.26 74.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.877 0.37 . . . . 75.23 110.806 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.26 -18.34 57.57 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.033 -0.603 . . . . 72.12 112.487 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.607 ' HZ3' ' HB3' ' A' ' 109' ' ' LYS . 8.0 mtpm? -82.62 123.89 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.138 0.495 . . . . 75.35 110.568 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HB2' ' HZ2' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -115.22 116.56 28.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.92 -0.77 . . . . 75.45 108.92 173.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -120.1 144.37 47.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.417 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.85 141.0 36.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.376 -0.375 . . . . 75.03 110.597 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -128.82 142.56 50.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.908 -0.404 . . . . 74.42 109.908 175.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 99' ' ' PHE . 2.2 tp -118.07 117.68 55.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.885 -0.598 . . . . 74.31 110.08 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.713 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 27.9 ttpp -115.19 119.76 37.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.049 -0.523 . . . . 64.31 110.029 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.615 HG21 HD12 ' A' ' 97' ' ' LEU . 17.6 p -113.04 116.95 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.327 -0.62 . . . . 75.45 109.327 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.438 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -136.09 116.65 1.5 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.86 -1.162 . . . . 64.23 112.728 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.667 ' HB3' HD21 ' A' ' 95' ' ' LEU . 21.4 p90 -108.1 122.67 47.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.583 -0.525 . . . . 73.52 109.583 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -109.29 123.59 49.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.547 0.689 . . . . 71.44 110.965 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.572 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 28.2 ttm180 -106.25 165.02 11.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.741 -1.118 . . . . 75.31 109.256 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.826 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 10.4 pt-20 -52.65 -29.81 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.273 0.842 . . . . 71.13 113.273 -167.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -120.42 -6.1 9.81 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.924 -0.71 . . . . 63.15 112.502 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.37 126.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.424 -0.91 . . . . 74.44 113.011 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.804 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.8 OUTLIER -100.94 121.57 41.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.725 -0.671 . . . . 74.44 110.783 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.501 HD11 HD11 ' A' ' 142' ' ' LEU . 3.9 mm? -112.05 126.69 55.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.229 0.212 . . . . 73.33 110.577 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.438 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.1 118.64 1.96 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.574 -0.822 . . . . 52.21 112.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 63.0 m -112.3 109.25 18.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.369 . . . . 73.12 110.51 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 4.3 t70 -108.82 146.01 34.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.832 -0.622 . . . . 71.41 110.125 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.481 ' HG3' HD13 ' A' ' 138' ' ' ILE . 22.2 ttt -135.96 117.21 14.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.045 -0.354 . . . . 72.44 110.045 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -100.22 117.35 34.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.512 -0.551 . . . . 73.53 109.512 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -98.18 122.98 42.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.121 0.486 . . . . 62.34 112.17 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -117.29 148.26 41.84 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.295 -1.002 . . . . 75.15 108.295 166.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.736 ' H ' HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -65.78 -19.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.108 0.41 . . . . 72.45 112.108 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.65 -12.26 29.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.32 . . . . 61.33 111.21 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.89 122.8 0.63 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 64.44 112.394 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 5.8 Cg_endo -87.3 145.78 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.602 2.868 . . . . 72.54 112.923 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 p -117.82 148.33 42.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.87 -0.605 . . . . 75.42 110.385 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.834 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 41.6 mm -107.55 118.39 55.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 110.265 -0.272 . . . . 73.11 110.265 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 155' ' ' MET . 70.6 mtm180 -105.7 116.9 32.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.127 0.489 . . . . 75.43 109.969 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.02 134.07 11.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.102 -1.046 . . . . 74.11 111.982 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.22 127.66 40.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.404 . . . . 73.32 110.557 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.501 HD11 HD11 ' A' ' 125' ' ' LEU . 13.0 tp -132.51 124.23 28.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 74.23 110.12 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.804 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 36.1 t -123.79 120.78 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.486 . . . . 75.33 110.539 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.428 HD13 ' HG ' ' A' ' 142' ' ' LEU . 4.9 mp -110.62 140.7 44.7 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.388 -0.369 . . . . 75.1 110.214 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.88 119.17 4.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.949 -0.643 . . . . 65.31 112.857 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 78.3 m-85 -128.21 148.23 50.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.867 -0.79 . . . . 71.22 108.867 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -53.48 103.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 72.13 110.781 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.06 -32.94 6.71 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.247 -0.888 . . . . 74.52 112.497 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 93.4 m95 -108.06 123.45 48.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.721 0.638 . . . . 72.33 112.721 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' A' ' 6' ' ' THR . 2.0 tm? -113.99 137.35 51.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.31 -1.737 . . . . 73.01 106.31 170.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -135.73 132.83 37.34 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.954 -0.699 . . . . 64.34 110.813 -167.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.035 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -132.57 132.77 6.76 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.369 -0.919 . . . . 74.41 112.045 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.447 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 53.4 m-85 -132.49 118.2 18.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.636 -0.505 . . . . 74.31 109.636 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 1.9 mp0 -120.35 144.27 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.0 -0.546 . . . . 72.2 109.989 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 23.5 ptp -145.3 147.47 32.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.66 0.266 . . . . 75.15 110.578 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 8.3 t30 -113.95 117.37 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.219 -0.659 . . . . 75.42 109.219 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.834 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 69.7 t80 -94.59 125.18 39.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.61 -0.723 . . . . 72.53 111.062 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' A' ' 161' ' ' LYS . 44.8 tt0 -91.29 103.98 16.58 Favored 'General case' 0 C--O 1.266 1.929 0 CA-C-N 115.104 -0.953 . . . . 74.04 109.384 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.28 -18.61 63.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.774 -2.012 . . . . 71.23 111.646 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.92 75.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.879 0.847 . . . . 65.13 108.907 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.514 ' HD3' ' OE2' ' A' ' 158' ' ' GLU . 2.0 mptm? -111.55 -159.37 0.68 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 74.34 107.996 168.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.3 m -107.9 28.67 8.0 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 122.252 -0.28 . . . . 64.34 110.287 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 158' ' ' GLU . 28.9 mtm180 -132.15 171.69 13.33 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 118.94 -1.104 . . . . 70.11 111.797 -163.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.6 m -103.06 133.01 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.389 -0.967 . . . . 75.04 108.389 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 p -99.89 1.38 42.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.067 0.46 . . . . 72.2 111.501 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.592 ' HG3' ' HB2' ' A' ' 186' ' ' ASP . 35.7 tt0 -150.87 130.82 13.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 71.31 109.687 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 m -121.78 112.87 18.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.857 -0.611 . . . . 72.12 109.936 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 84.0 m-20 -107.32 127.97 54.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.432 -0.581 . . . . 75.12 109.432 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.621 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.6 m-85 -121.39 153.01 38.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.286 -0.566 . . . . 74.52 111.065 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -148.67 128.53 13.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.504 -0.771 . . . . 72.41 109.833 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.1 t -125.81 126.17 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.501 -0.555 . . . . 74.12 109.501 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -117.32 130.58 8.94 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.624 -0.798 . . . . 73.01 112.713 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -113.03 120.2 40.53 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.557 -1.275 . . . . 74.54 107.557 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -118.02 126.86 53.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.693 0.759 . . . . 74.41 112.797 -167.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 178' ' ' PHE . 23.8 m -131.89 162.56 30.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.31 -1.367 . . . . 74.14 107.31 169.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -46.76 -50.65 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.537 0.569 . . . . 61.24 112.537 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 7.9 pt-20 -116.16 10.95 15.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.094 0.473 . . . . 75.51 111.544 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.744 ' HD1' ' HG2' ' A' ' 196' ' ' GLN . 61.2 t80 -137.13 121.28 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.193 -0.458 . . . . 64.53 110.526 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -133.61 122.75 23.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.208 0.528 . . . . 73.0 110.605 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.74 HD11 HG13 ' A' ' 194' ' ' ILE . 3.2 tt -111.91 131.98 55.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.388 -0.597 . . . . 74.14 109.388 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -129.85 115.16 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.195 0.521 . . . . 74.54 109.982 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 27.4 m -86.25 135.41 33.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.397 -0.819 . . . . 73.4 109.088 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -128.66 138.1 51.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.227 0.536 . . . . 75.23 111.087 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 53.6 t -132.13 128.42 59.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 72.25 110.133 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -115.17 95.63 5.29 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.896 -0.779 . . . . 75.22 108.896 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.592 ' HB2' ' HG3' ' A' ' 166' ' ' GLN . 29.8 t0 58.46 -174.0 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.842 -1.072 . . . . 75.35 109.793 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -75.69 -6.73 82.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.617 -0.801 . . . . 72.01 111.783 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 186' ' ' ASP . 7.2 t -89.59 -27.42 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.455 0.539 . . . . 75.25 112.455 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.45 114.26 15.33 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 119.911 -0.716 . . . . 71.31 111.023 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -133.83 132.85 40.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.783 0.325 . . . . 72.3 110.583 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -166.34 -159.31 11.98 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.785 -0.721 . . . . 63.12 112.088 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.19 153.78 24.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.889 -0.672 . . . . 64.11 111.979 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.0 m -126.8 139.34 53.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.087 0.47 . . . . 73.21 110.255 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.74 HG13 HD11 ' A' ' 180' ' ' LEU . 4.5 mp -119.47 129.72 74.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.874 -0.603 . . . . 75.5 109.724 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -125.19 119.13 27.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.395 -0.594 . . . . 74.33 109.395 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.744 ' HG2' ' HD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -125.56 120.04 29.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.156 -0.475 . . . . 73.31 110.405 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.905 ' HG3' ' HG2' ' A' ' 203' ' ' GLU . 58.1 tttm -106.11 116.03 31.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.295 -0.631 . . . . 74.41 109.295 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.535 HG11 ' H ' ' A' ' 200' ' ' LYS . 16.1 t -86.33 143.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.714 -0.846 . . . . 72.53 108.714 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -73.36 6.33 3.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.61 0.719 . . . . 73.41 110.508 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.535 ' H ' HG11 ' A' ' 198' ' ' VAL . 49.0 tptt -98.19 37.71 1.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.062 -0.972 . . . . 74.23 108.911 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 200' ' ' LYS . 34.6 mmtp 75.95 -55.54 0.6 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.992 -1.004 . . . . 75.42 112.884 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.14 132.62 53.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.768 0.794 . . . . 73.2 112.752 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.905 ' HG2' ' HG3' ' A' ' 197' ' ' LYS . 31.3 mt-10 -110.7 142.97 41.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.611 -1.177 . . . . 75.43 109.303 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.9 m -131.68 138.99 48.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.661 -0.245 . . . . 62.42 110.58 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -131.01 148.94 52.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.655 -0.248 . . . . 72.32 110.657 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.788 HG21 HG23 ' A' ' 221' ' ' ILE . 92.1 t -135.11 140.45 45.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.998 -0.371 . . . . 73.42 109.998 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -124.76 127.07 46.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.76 0.314 . . . . 74.11 110.513 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.01 136.57 54.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.619 . . . . 71.14 110.016 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -148.21 129.58 14.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.371 -0.377 . . . . 73.42 110.22 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -114.66 126.78 55.28 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.989 -0.745 . . . . 74.24 108.989 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 188' ' ' THR . 6.4 t -101.82 112.99 25.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.441 0.639 . . . . 72.42 109.638 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.24 126.42 27.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.303 -0.862 . . . . 75.4 110.922 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 156.44 -78.55 0.19 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.789 . . . . 61.24 112.484 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.76 50.52 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.43 . . . . 71.04 111.367 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.0 m 58.54 18.88 6.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.955 0.724 . . . . 70.12 112.955 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.451 ' HB3' ' CG2' ' A' ' 211' ' ' THR . 48.1 t-20 -75.94 114.31 14.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 74.34 110.053 -176.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.5 m -113.34 130.87 56.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.778 -0.646 . . . . 72.05 110.862 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -106.04 125.89 51.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 74.34 110.121 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 239' ' ' ASN . 9.5 t80 -130.44 141.52 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.233 -0.894 . . . . 72.2 109.25 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.27 147.78 15.66 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.445 -0.883 . . . . 73.44 112.0 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.788 HG23 HG21 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -128.24 144.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.725 0.298 . . . . 75.31 110.213 177.036 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -130.51 142.25 50.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.979 -0.555 . . . . 73.04 110.851 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -116.42 135.16 54.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.798 -0.637 . . . . 63.11 109.627 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 64.6 tttt -129.63 117.32 20.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.283 -0.417 . . . . 74.43 110.285 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -132.78 125.85 31.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.042 0.448 . . . . 74.44 111.005 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -91.92 100.77 13.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.042 -0.725 . . . . 74.23 109.042 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 17.4 tt -71.03 -30.2 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 74.13 111.061 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.7 ' HB2' ' HD2' ' A' ' 229' ' ' PRO . 3.4 p30 -156.22 164.07 22.7 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.722 -0.844 . . . . 71.4 108.722 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.7 ' HD2' ' HB2' ' A' ' 228' ' ' ASP . 13.6 Cg_endo -56.26 -20.42 31.78 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.865 2.377 . . . . 70.24 114.53 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -104.62 -19.42 13.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.904 -0.318 . . . . 62.31 111.58 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.493 ' HB3' ' HG3' ' A' ' 249' ' ' GLN . . . -124.3 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.322 0.582 . . . . 73.22 112.312 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.4 m -125.09 133.34 52.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.637 -0.711 . . . . 71.23 110.262 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -114.42 133.15 55.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.88 0.371 . . . . 73.32 110.159 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 11.3 p -137.97 149.33 46.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.123 -0.489 . . . . 72.14 110.42 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -144.55 155.99 43.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.867 -0.42 . . . . 74.44 109.867 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -144.87 149.64 35.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.441 . . . . 73.53 111.067 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 1.2 t -127.28 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.774 -0.648 . . . . 74.33 110.017 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.7 m120 -106.06 150.16 26.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.106 -0.497 . . . . 74.42 109.956 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 219' ' ' PHE . 22.5 p-10 -45.07 -32.24 1.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.807 1.317 . . . . 75.12 113.692 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.645 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 19.7 m -82.23 25.64 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.873 0.368 . . . . 73.5 110.748 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 22.2 m 69.84 31.1 3.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.591 -0.731 . . . . 72.22 110.863 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.691 ' HB3' HD11 ' A' ' 262' ' ' LEU . 5.2 mp -88.17 126.95 35.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 120.686 -0.406 . . . . 73.13 110.618 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.694 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.88 116.65 53.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 123.884 0.74 . . . . 73.14 109.859 -177.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.481 ' HA3' HD22 ' A' ' 262' ' ' LEU . . . -129.84 151.87 19.46 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.157 -1.021 . . . . 75.44 112.929 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -136.7 154.22 50.67 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.431 . . . . 74.13 110.952 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.71 120.76 1.32 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.253 -0.739 . . . . 62.43 111.253 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -112.36 119.07 37.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.992 -0.373 . . . . 73.24 109.992 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -119.73 121.93 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.471 0.653 . . . . 72.13 110.661 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 231' ' ' ALA . 24.7 tt0 -123.9 131.07 53.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.854 -0.612 . . . . 73.22 109.802 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.0 m -87.21 114.37 23.76 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.435 -0.348 . . . . 73.43 110.456 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.772 ' HG ' ' HD2' ' A' ' 253' ' ' PRO . 19.2 tp -75.71 139.7 42.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.555 -0.906 . . . . 74.12 108.555 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -55.94 -43.94 99.46 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.787 1.032 . . . . 75.41 113.787 -168.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.772 ' HD2' ' HG ' ' A' ' 251' ' ' LEU . 72.4 Cg_exo -43.8 -64.33 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 75.23 113.703 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 163.95 38.65 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 120.721 -0.752 . . . . 64.41 111.696 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.681 HD11 ' HB3' ' A' ' 279' ' ' LEU . 1.8 tp -143.46 122.2 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.821 -0.437 . . . . 71.01 109.821 -174.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.515 ' CG ' ' HB2' ' A' ' 280' ' ' GLU . 12.7 ptmm? -106.63 133.19 51.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.455 0.645 . . . . 74.24 110.534 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.7 tp -99.91 124.14 44.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.755 -1.111 . . . . 72.01 110.025 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.7 t -125.45 112.54 16.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.645 0.736 . . . . 73.05 110.671 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.552 HD21 HD13 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -100.17 124.78 45.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.893 -1.151 . . . . 74.03 107.893 175.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 p -129.94 139.55 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.981 0.42 . . . . 73.43 111.006 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.5 128.64 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 75.5 110.2 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -110.25 121.69 45.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.98 . . . . 71.52 108.353 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.868 ' HB3' HG13 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -102.28 109.47 21.15 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.991 -0.744 . . . . 64.52 108.991 176.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.992 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 1.7 m-20 -68.64 106.09 2.49 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.69 -1.226 . . . . 65.32 107.69 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.521 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -53.49 -24.85 25.54 Favored Glycine 0 C--N 1.32 -0.355 0 O-C-N 123.517 0.511 . . . . 73.23 113.48 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.12 -26.48 19.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.672 0.272 . . . . 74.03 111.039 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.992 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 7.2 m-20 -96.69 -30.8 13.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.463 -0.335 . . . . 75.53 111.882 -173.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 263' ' ' LEU . 21.7 m -62.95 -18.68 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 71.51 111.216 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -62.19 -31.08 71.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 73.33 109.783 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.27 9.99 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 74.21 110.63 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.17 15.94 63.73 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.969 -0.56 . . . . 71.34 112.985 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.69 96.12 2.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 61.13 112.479 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -110.18 142.82 41.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.082 -0.34 . . . . 74.23 110.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.929 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 58.4 mttm -101.06 134.48 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.006 -0.739 . . . . 75.51 109.006 170.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.31 132.42 37.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.795 -0.446 . . . . 73.32 109.795 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.469 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -148.07 132.69 4.32 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.872 -0.68 . . . . 62.44 111.611 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.952 HD21 HG21 ' A' ' 27' ' ' ILE . 45.4 tp -114.77 145.65 41.86 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 74.24 110.722 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.601 ' H ' HD11 ' A' ' 277' ' ' LEU . . . -142.32 125.47 2.67 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 70.13 112.006 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.681 ' HB3' HD11 ' A' ' 255' ' ' ILE . 2.9 mm? -109.23 129.25 55.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.112 -0.699 . . . . 73.41 109.112 170.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.515 ' HB2' ' CG ' ' A' ' 256' ' ' LYS . 20.9 mt-10 -113.91 110.69 20.49 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.089 -0.708 . . . . 74.35 109.089 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -116.77 135.16 53.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.096 0.475 . . . . 74.04 110.155 -173.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -130.96 112.67 13.16 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.899 -0.778 . . . . 74.52 108.899 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 33' ' ' THR . . . -83.03 107.55 15.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 55.35 109.833 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.521 HD23 ' O ' ' A' ' 283' ' ' ALA . 3.4 mm? -137.9 -61.11 0.63 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.988 -1.006 . . . . 64.45 109.071 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.991 -0.528 . . . . 71.23 109.8 177.102 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.657 0.265 . . . . 73.42 111.274 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.32 148.68 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.316 . . . . 74.21 110.893 -175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.925 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 3.8 t -116.02 114.77 41.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.978 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.88 175.07 11.85 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.702 2.268 . . . . 74.31 111.993 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 13.2 Cg_exo -70.79 85.13 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.443 2.095 . . . . 75.15 111.298 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 p -69.38 -34.35 74.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 74.41 111.54 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.589 ' HB3' HG21 ' A' ' 143' ' ' VAL . 10.9 p90 -61.24 -28.71 69.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.139 0.495 . . . . 74.21 110.983 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -84.86 -20.78 30.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 73.12 110.892 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -102.43 -0.12 32.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.177 0.989 . . . . 53.04 108.48 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.962 HD21 ' HA3' ' A' ' 152' ' ' GLY . 8.6 tp -58.04 -24.12 57.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.618 -1.628 . . . . 71.33 110.519 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.64 51.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.619 -0.719 . . . . 62.14 111.916 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 13.8 ptmm? -62.38 -44.04 97.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.653 0.264 . . . . 74.43 111.504 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -65.23 -38.95 91.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.182 0.515 . . . . 74.31 110.971 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' HB2' ' A' ' 193' ' ' SER . . . -70.08 -43.79 70.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 64.51 111.95 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.647 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 5.4 ptm180 -61.2 -28.38 69.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.477 -0.329 . . . . 73.41 111.104 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.89 -42.48 84.73 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.375 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -82.68 -31.46 9.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.794 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 94.6 t80 -71.47 -22.64 61.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 74.03 112.323 -174.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -29.86 117.04 0.13 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.213 0.946 . . . . 75.54 113.352 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -80.42 -9.47 59.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.075 -0.966 . . . . 74.13 110.235 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.94 91.28 1.22 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.045 -0.822 . . . . 64.41 111.045 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -84.13 169.83 14.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.884 0.373 . . . . 72.32 111.055 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.4 112.39 3.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.097 -0.573 . . . . 63.11 112.656 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -92.99 14.46 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.696 0.284 . . . . 73.34 110.905 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.7 13.57 53.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 71.14 112.065 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.05 160.05 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.025 0.917 . . . . 71.44 112.376 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.68 HG13 HD23 ' A' ' 277' ' ' LEU . 1.7 mp -104.28 127.55 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.071 -1.422 . . . . 72.21 108.789 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -106.87 142.21 36.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.681 0.277 . . . . 71.43 110.47 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.68 148.17 46.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.298 -0.41 . . . . 74.31 110.031 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.56 ' CG ' ' HZ3' ' A' ' 32' ' ' LYS . 13.8 t70 -155.16 134.62 12.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 74.45 109.95 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.687 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.871 -0.418 . . . . 73.33 109.871 -178.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HZ3' ' CG ' ' A' ' 30' ' ' ASP . 11.2 mptt -126.05 125.35 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.916 0.389 . . . . 73.5 110.087 170.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -137.68 120.04 15.85 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.025 -0.732 . . . . 74.35 109.025 170.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HE3' HD23 ' A' ' 284' ' ' LEU . 17.9 ptpt -133.41 144.58 49.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.546 . . . . 70.33 111.93 -176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.591 ' HB2' HD11 ' A' ' 39' ' ' LEU . 18.8 m -141.21 164.83 29.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 73.41 109.297 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -80.03 26.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.968 0.413 . . . . 72.44 110.995 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.474 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 7.6 t-20 -107.28 21.08 18.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.116 0.484 . . . . 71.03 110.286 -173.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.748 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 77.11 -6.73 40.69 Favored Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.745 -0.74 . . . . 72.33 113.176 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.671 HD13 ' O ' ' A' ' 39' ' ' LEU . 2.0 pp -102.44 132.94 48.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.837 0.68 . . . . 73.11 112.837 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.03 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 39.3 mt-10 -137.2 124.88 22.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 72.34 109.124 165.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -107.06 120.13 41.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.1 -0.333 . . . . 75.31 110.1 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.832 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 29.5 m -128.77 132.16 47.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 71.4 111.125 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.0 t -125.04 135.28 52.58 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.749 -0.834 . . . . 75.34 108.749 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -148.56 125.76 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.007 -0.277 . . . . 74.3 110.708 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.89 168.22 40.99 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.951 -1.119 . . . . 34.45 113.001 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -137.48 135.53 36.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.448 -0.575 . . . . 74.35 109.448 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.7 ' HB2' HG23 ' A' ' 54' ' ' VAL . . . -149.94 150.62 32.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.266 0.555 . . . . 75.44 111.973 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -71.68 139.53 49.24 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.245 -1.02 . . . . 74.3 108.245 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -67.99 -8.55 38.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.41 0.624 . . . . 65.54 111.144 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -82.34 -3.25 55.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.75 -0.659 . . . . 72.23 109.968 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.9 p 54.48 21.01 3.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.181 0.992 . . . . 55.05 112.651 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 p -91.92 -26.65 18.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 74.51 110.976 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.41 95.99 4.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.502 -0.555 . . . . 75.21 109.502 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.7 HG23 ' HB2' ' A' ' 47' ' ' ALA . 44.8 t -125.61 124.15 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.917 -0.583 . . . . 75.31 110.773 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 126.0 25.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.369 -0.604 . . . . 75.22 109.369 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.92 -178.01 37.9 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.263 -0.97 . . . . 72.02 112.786 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.506 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 5.0 p -138.4 153.23 48.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.169 0.509 . . . . 64.31 111.057 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.72 124.02 45.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.264 -1.384 . . . . 74.12 107.264 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.832 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 46.0 mt-10 -110.16 118.06 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.965 -0.561 . . . . 71.02 110.302 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -103.52 120.16 40.31 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.021 -1.103 . . . . 72.43 108.021 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.03 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 59.7 mttm -118.41 147.18 43.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.117 -0.492 . . . . 75.11 109.772 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.748 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 67.2 m-85 -118.12 120.18 36.98 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.959 -0.564 . . . . 72.21 109.634 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.607 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 14.6 ttm180 -114.09 106.84 14.86 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.505 0.669 . . . . 73.13 111.606 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -115.2 91.86 3.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.739 -1.119 . . . . 75.33 109.003 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 93.2 m 69.33 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.903 0.752 . . . . 70.5 111.286 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.04 129.03 39.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 75.43 110.5 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.608 ' HD2' ' HG3' ' A' ' 88' ' ' GLU . 32.2 m-85 62.57 35.05 14.66 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.613 -0.722 . . . . 75.32 110.587 -173.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.03 -90.52 0.97 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.655 -1.378 . . . . 72.52 109.655 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 69' ' ' LEU . 2.1 mm? -122.75 129.42 51.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.313 0.578 . . . . 74.24 111.199 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.6 p -137.78 121.4 17.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.261 -0.881 . . . . 72.4 110.371 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -122.39 123.48 41.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.534 -0.543 . . . . 74.34 109.534 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.697 ' HB ' ' HG2' ' A' ' 61' ' ' LYS . 7.4 p -128.3 130.63 48.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.853 -0.739 . . . . 71.33 111.123 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 35.7 tt0 -109.88 121.67 45.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.448 -0.575 . . . . 75.42 109.448 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -109.65 94.21 4.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.74 -0.467 . . . . 73.04 109.74 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.943 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 32.2 t90 -96.7 128.17 43.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.487 -0.324 . . . . 73.34 110.416 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 1.9 m-20 -106.61 134.21 50.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.862 -0.792 . . . . 71.23 108.862 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.8 m -72.11 -27.56 62.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.716 0.769 . . . . 71.11 109.764 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.54 -24.32 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.813 -1.085 . . . . 74.24 111.836 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.425 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 13.4 t-20 -131.16 -108.71 0.26 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.408 -0.517 . . . . 73.02 112.181 -171.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 104' ' ' SER . 16.4 p -115.46 144.58 43.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.006 0.743 . . . . 75.14 113.006 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.943 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -98.8 119.76 38.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.867 -0.79 . . . . 72.53 108.867 166.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.42 120.95 4.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.423 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -104.4 114.0 27.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.682 0.277 . . . . 72.43 110.576 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 13.6 pt-20 -120.06 132.71 55.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.073 0.463 . . . . 65.54 110.495 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.26 121.77 65.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.837 -0.619 . . . . 71.53 109.357 177.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -117.88 123.04 44.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.657 -0.702 . . . . 74.54 110.805 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -129.45 132.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 74.33 110.354 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.608 ' HG3' ' HD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -91.91 118.73 31.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.164 -1.421 . . . . 71.21 107.164 172.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 8.5 t70 -56.05 124.05 16.47 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.503 0.502 . . . . 73.04 111.081 -168.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -67.21 -23.31 65.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.874 -0.603 . . . . 75.02 111.222 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.99 -51.58 4.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.711 -0.478 . . . . 74.12 109.711 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.32 77.8 3.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.52 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 89' ' ' ASP . 30.0 mmm180 -63.26 128.45 35.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.961 -0.563 . . . . 75.14 110.031 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.57 44.03 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.24 -0.744 . . . . 74.43 111.24 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 118' ' ' TYR . 20.8 tp -123.19 120.24 32.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.213 -0.662 . . . . 71.13 109.213 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -118.01 121.0 39.51 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.989 -0.55 . . . . 73.41 109.764 -173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -104.64 127.09 52.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.709 . . . . 74.31 109.991 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 93.5 m -129.2 118.62 22.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.256 -0.429 . . . . 74.51 110.552 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -111.32 115.8 29.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.267 -0.642 . . . . 74.5 109.267 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 3.0 p30 -117.47 151.03 37.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.297 0.57 . . . . 73.14 110.613 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.496 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 50.4 m -142.13 121.49 13.15 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 71.0 110.033 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -102.93 122.23 44.16 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.872 -0.603 . . . . 64.44 109.546 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.55 ' HD2' HD21 ' A' ' 81' ' ' LEU . 82.4 t80 -110.24 130.54 55.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.718 -0.475 . . . . 70.21 109.718 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 80' ' ' THR . 35.5 t -106.99 106.94 59.65 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 74.24 109.9 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 37.2 Cg_endo -66.58 -16.09 49.69 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.7 2.267 . . . . 74.22 111.992 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -74.52 -38.46 62.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 75.35 110.874 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 109' ' ' LYS . 3.0 t -108.31 -27.96 9.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.351 . . . . 63.34 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 2.89 67.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.748 -0.739 . . . . 71.44 112.227 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.569 ' H ' HG22 ' A' ' 107' ' ' THR . 51.2 mtmt -89.08 148.4 23.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 73.55 110.956 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 61.7 tttm -123.08 136.94 55.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 75.54 109.939 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -119.6 122.81 42.41 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.891 -0.411 . . . . 74.21 109.891 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.83 129.72 56.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.249 -0.432 . . . . 64.25 110.6 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.791 ' HG2' ' HA ' ' A' ' 130' ' ' ASP . 35.9 mtmm -127.85 138.47 52.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.336 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.8 tp -116.56 117.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.479 0.657 . . . . 71.34 110.166 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 46.0 mttp -107.32 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.223 -0.899 . . . . 72.23 110.959 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -123.73 117.62 25.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.902 -0.777 . . . . 71.32 108.902 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.08 114.99 2.19 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.201 -1.0 . . . . 74.03 112.731 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.428 ' HB3' HD13 ' A' ' 95' ' ' LEU . 5.1 p90 -109.79 122.65 47.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.367 0.603 . . . . 72.52 109.753 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.925 ' HD3' ' HB ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.538 -0.756 . . . . 74.03 112.186 -173.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 46.1 mmt-85 -106.45 152.93 22.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.668 -1.234 . . . . 74.34 107.668 165.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -29.57 59.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.955 0.724 . . . . 73.41 112.955 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.4 -5.94 15.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.001 0.371 . . . . 75.21 112.001 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.429 ' CG2' ' HB2' ' A' ' 120' ' ' ARG . 9.0 tp -145.61 123.51 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.248 0.547 . . . . 73.14 111.48 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.619 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 4.1 t30 -119.97 117.05 27.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.2 -0.312 . . . . 74.5 110.53 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.0 mm? -112.97 127.1 56.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.909 0.385 . . . . 74.55 110.923 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.84 118.31 2.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.909 -0.587 . . . . 55.42 111.773 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.9 m -105.21 120.72 42.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.767 0.318 . . . . 73.1 110.678 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -114.85 117.4 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 75.23 110.162 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 77.6 mmm -99.02 117.07 32.71 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.441 -0.577 . . . . 64.14 109.441 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.791 ' HA ' ' HG2' ' A' ' 113' ' ' LYS . 11.0 t70 -102.81 118.5 36.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 72.23 110.696 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -97.84 97.85 9.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.436 -0.347 . . . . 72.51 110.844 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -105.1 144.38 31.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.972 -0.751 . . . . 70.05 108.972 170.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.02 -34.67 53.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.108 0.48 . . . . 75.24 111.977 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.22 -18.0 59.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.181 -0.463 . . . . 64.31 111.546 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.17 118.61 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.871 -0.681 . . . . 74.22 112.148 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.26 126.75 21.76 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.797 2.331 . . . . 74.34 112.04 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.9 m -107.63 150.82 26.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.275 -0.421 . . . . 72.44 110.363 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 33.4 mm -107.02 116.9 51.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.481 -0.562 . . . . 74.53 109.481 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -111.54 123.18 49.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.403 0.621 . . . . 73.15 110.348 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.34 132.93 11.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.307 -0.949 . . . . 73.31 111.959 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.27 23.76 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.197 -0.668 . . . . 74.41 109.197 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 143' ' ' VAL . 14.9 tp -124.16 131.67 53.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.107 -0.497 . . . . 75.02 110.608 -175.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 34.1 t -131.38 129.66 62.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.196 -0.456 . . . . 72.33 110.037 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.424 HD13 ' HE1' ' A' ' 153' ' ' TYR . 6.2 mp -109.48 138.66 45.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.117 -0.697 . . . . 64.04 109.117 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.533 ' HA2' HD22 ' A' ' 150' ' ' LEU . . . -119.55 119.32 4.23 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 121.04 -0.6 . . . . 75.11 112.888 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 63.4 t80 -126.99 149.07 50.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.684 -1.228 . . . . 75.02 107.684 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -49.31 101.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 74.52 111.55 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.48 -30.78 7.39 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.822 -0.626 . . . . 72.41 112.744 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 39.0 m95 -104.7 126.8 52.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 73.54 111.523 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.7 ' HB3' HD11 ' A' ' 10' ' ' LEU . 20.1 mt -120.32 146.98 45.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.022 0.439 . . . . 75.5 110.285 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -137.1 127.37 26.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.014 -0.736 . . . . 74.33 109.014 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.962 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -131.51 142.46 13.85 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.375 -0.917 . . . . 63.5 111.717 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.663 ' HD2' ' HD2' ' A' ' 169' ' ' PHE . 64.3 m-85 -136.0 121.76 19.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.743 0.306 . . . . 75.33 110.375 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.808 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 23.5 mp0 -106.05 122.58 46.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.961 -0.755 . . . . 65.4 108.961 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 49.1 ttm -127.96 141.87 51.41 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.735 -0.386 . . . . 75.45 110.464 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.481 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 51.5 t-20 -130.74 117.41 19.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.406 -0.59 . . . . 64.43 109.406 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.754 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 63.4 t80 -95.16 120.77 35.96 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.491 0.494 . . . . 72.01 110.053 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.54 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 43.4 tt0 -99.03 99.59 10.64 Favored 'General case' 0 C--O 1.26 1.649 0 CA-C-O 121.548 0.689 . . . . 73.31 110.678 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -70.59 -22.23 62.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 113.542 -1.663 . . . . 75.44 110.794 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.12 69.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.793 0.806 . . . . 71.4 109.119 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 162' ' ' SER . 21.5 tptp -113.41 -158.56 0.66 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.437 -1.32 . . . . 73.42 107.437 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.657 ' H ' ' HG3' ' A' ' 161' ' ' LYS . 17.2 m -108.72 28.08 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.918 -0.488 . . . . 55.23 110.813 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 163' ' ' ARG . 2.4 ptm180 -157.01 160.77 39.32 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.053 -1.059 . . . . 75.11 111.954 -164.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.6 m -74.0 133.4 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.165 -1.05 . . . . 75.13 108.165 169.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.7 t -93.39 -14.83 26.34 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.951 -0.3 . . . . 75.05 110.273 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.705 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 19.6 mt-30 -142.21 132.74 25.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.399 0.618 . . . . 72.42 111.796 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -123.0 105.98 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.058 -0.974 . . . . 74.42 109.388 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.808 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 13.7 m120 -114.42 136.06 53.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 72.1 110.176 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.663 ' HD2' ' HD2' ' A' ' 153' ' ' TYR . 36.5 m-85 -130.42 140.71 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 75.12 110.053 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.587 ' HB3' ' CE1' ' A' ' 181' ' ' HIS . . . -142.69 129.03 19.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.832 0.348 . . . . 73.5 110.282 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 45.8 t -124.54 127.13 72.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.004 -0.739 . . . . 75.44 109.004 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -140.49 115.39 1.05 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.85 -1.167 . . . . 75.41 112.293 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.442 ' CE2' HD23 ' A' ' 180' ' ' LEU . 54.2 p90 -115.47 134.48 55.05 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.422 -0.511 . . . . 74.14 110.241 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -119.25 124.95 47.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.311 -0.859 . . . . 70.31 110.225 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 51.1 m -134.78 112.69 10.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.893 -0.323 . . . . 74.32 110.301 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.6 t70 43.12 -87.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.35 1.031 . . . . 74.3 113.752 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 10.2 pt-20 -101.86 -12.13 18.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.213 0.449 . . . . 74.3 112.213 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.448 ' HD2' ' HG2' ' A' ' 196' ' ' GLN . 74.6 t80 -119.18 117.19 28.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 74.52 111.247 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -123.84 124.36 42.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 72.45 109.584 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.596 HD11 HG13 ' A' ' 194' ' ' ILE . 3.1 tt -119.49 135.41 54.78 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.512 -0.475 . . . . 75.54 110.677 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.587 ' CE1' ' HB3' ' A' ' 170' ' ' ALA . 47.7 t60 -129.75 115.11 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.373 -0.83 . . . . 75.42 110.225 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.0 m -92.48 142.8 27.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.492 -0.929 . . . . 75.35 108.492 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.15 139.83 33.98 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 64.34 110.754 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.35 121.06 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.714 -0.675 . . . . 64.33 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 75.2 m-20 -103.62 94.24 5.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.374 -0.83 . . . . 74.54 109.276 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.705 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 12.1 m-20 65.83 -169.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.836 -1.074 . . . . 71.22 110.907 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.436 ' O ' ' HB1' ' A' ' 212' ' ' ALA . . . -76.49 -6.5 84.32 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.425 -0.893 . . . . 72.12 111.714 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.2 m -96.8 -25.56 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.616 0.598 . . . . 74.24 112.616 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.4 tt0 -129.72 113.98 15.41 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.062 -0.655 . . . . 74.01 111.54 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -121.86 124.74 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.933 -0.765 . . . . 73.04 108.933 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.45 -160.75 11.36 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.788 -1.196 . . . . 72.33 112.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.66 175.8 44.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.539 -0.838 . . . . 75.15 112.389 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 26.2 m -148.68 138.09 21.87 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.391 -0.596 . . . . 61.43 109.391 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.738 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.6 mp -121.2 137.18 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.532 -0.544 . . . . 71.52 109.532 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -121.6 119.92 33.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.787 -0.82 . . . . 72.34 108.787 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.448 ' HG2' ' HD2' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -124.97 111.07 14.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.714 -0.847 . . . . 75.04 108.714 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 60.1 tttp -97.23 119.48 35.82 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.811 -0.631 . . . . 74.0 109.745 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.84 146.0 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.467 -1.308 . . . . 74.42 107.467 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -74.54 56.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.769 0.795 . . . . 75.5 110.997 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.459 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 67.8 mttm -152.85 -146.78 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.848 -1.524 . . . . 75.3 108.028 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.79 ' HB3' ' HB3' ' A' ' 226' ' ' GLN . 1.2 mptm? -103.01 26.16 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.315 0.578 . . . . 75.51 109.587 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.55 110.32 19.06 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.464 -0.789 . . . . 75.23 110.269 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.929 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 12.8 mm-40 -107.01 134.39 50.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 74.14 109.795 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.5 m -123.38 143.11 50.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 64.2 109.919 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.762 ' HB1' ' HB3' ' A' ' 222' ' ' ALA . . . -142.32 158.58 43.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 65.15 111.114 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.738 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 71.5 t -132.45 141.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.533 -0.543 . . . . 64.15 109.533 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.46 125.4 16.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.038 -0.727 . . . . 64.32 109.038 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.62 HD12 ' HD1' ' A' ' 219' ' ' PHE . 2.5 pt? -146.6 150.65 35.9 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.415 -0.514 . . . . 73.14 111.036 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.38 130.88 22.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 75.42 110.194 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.654 ' HB2' HG22 ' A' ' 217' ' ' THR . 9.4 t90 -125.28 135.11 52.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.606 -0.724 . . . . 74.13 109.489 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.895 HG22 ' HB3' ' A' ' 214' ' ' ASN . 3.9 t -95.27 113.95 25.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.355 0.598 . . . . 72.34 110.457 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 187' ' ' GLY . . . -64.94 144.71 57.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 72.35 110.846 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.58 -2.72 86.33 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.675 -0.97 . . . . 62.31 110.675 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.895 ' HB3' HG22 ' A' ' 211' ' ' THR . 37.2 t-20 -138.28 159.18 42.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.332 -0.988 . . . . 64.45 108.332 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.1 t -93.41 -9.29 39.12 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.174 -0.329 . . . . 73.14 110.542 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.97 108.92 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.213 0.53 . . . . 70.14 110.951 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.654 HG22 ' HB2' ' A' ' 210' ' ' TRP . 28.1 m -117.13 135.07 54.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.281 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -126.1 117.5 23.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.899 -0.32 . . . . 74.24 110.255 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.62 ' HD1' HD12 ' A' ' 208' ' ' LEU . 74.5 t80 -113.27 138.42 50.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.567 -0.742 . . . . 74.41 109.241 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.82 157.21 26.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.527 -0.844 . . . . 42.41 112.705 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.65 136.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 73.31 109.649 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.762 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -114.51 152.66 31.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.783 -0.451 . . . . 53.11 109.783 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.78 140.2 34.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.397 -0.365 . . . . 75.32 110.498 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.929 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 28.9 ttmt -123.1 113.84 19.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.128 -0.693 . . . . 63.13 109.128 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -105.2 116.47 32.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.48 -0.327 . . . . 71.51 110.535 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.79 ' HB3' ' HB3' ' A' ' 201' ' ' LYS . 63.1 tt0 -91.99 104.17 16.61 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.461 -0.94 . . . . 72.43 108.461 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.83 -49.06 60.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.472 -0.785 . . . . 75.35 110.991 -172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.741 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.1 t70 -164.78 -59.64 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 74.42 111.491 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 72.1 Cg_endo -89.38 -139.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.023 1.815 . . . . 72.34 113.443 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.432 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 1.8 m-20 -92.13 13.38 19.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.815 -1.084 . . . . 71.13 110.37 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.09 124.93 45.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 72.14 110.154 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.625 ' HB2' HG21 ' A' ' 248' ' ' THR . 59.6 m -113.09 145.09 41.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.191 -0.913 . . . . 74.44 110.173 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.24 125.98 39.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.962 -1.125 . . . . 75.11 107.962 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.8 t -106.45 144.56 32.95 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.166 -0.47 . . . . 72.15 110.013 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -148.57 147.69 29.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.34 -0.391 . . . . 75.3 110.431 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -148.01 138.53 22.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.132 -0.692 . . . . 73.21 109.132 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.33 152.92 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 242' ' ' LEU . 11.7 p30 -133.4 152.43 51.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.965 -0.694 . . . . 75.31 110.777 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.58 5.02 0.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.539 -1.209 . . . . 72.22 112.982 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.596 ' HB3' HD13 ' A' ' 242' ' ' LEU . 32.3 t -89.01 13.83 12.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.506 -0.924 . . . . 74.34 108.506 170.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 49.9 m 69.26 31.72 3.83 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 114.626 -1.17 . . . . 70.32 111.357 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.988 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 10.2 mp -99.75 142.62 31.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.287 -0.565 . . . . 74.23 111.202 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -125.59 118.0 51.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.695 -0.684 . . . . 73.12 110.317 -169.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.07 143.57 16.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.739 -0.743 . . . . 74.23 112.436 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.37 156.72 43.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.845 0.355 . . . . 73.34 110.153 176.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.92 -177.73 36.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.435 -0.888 . . . . 51.13 113.049 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.655 ' HB3' HE21 ' A' ' 249' ' ' GLN . 87.6 m-85 -117.15 115.93 26.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.603 -0.517 . . . . 72.42 109.603 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 232' ' ' CYS . 6.3 t -111.06 113.93 26.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.075 -0.713 . . . . 74.44 109.075 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.655 HE21 ' HB3' ' A' ' 247' ' ' TYR . 53.2 mt-30 -132.82 150.4 52.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.222 -0.444 . . . . 65.31 111.463 -168.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 8.9 t -124.78 132.83 53.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.117 -1.068 . . . . 73.42 108.117 167.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 255' ' ' ILE . 36.8 tp -72.27 -65.15 0.81 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.5 -0.48 . . . . 65.44 109.851 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.703 ' HB2' ' HZ3' ' A' ' 252' ' ' LYS . 0.5 OUTLIER 174.72 -57.91 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.466 -0.788 . . . . 73.33 110.137 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 83.5 Cg_endo -80.4 52.35 4.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.308 2.005 . . . . 64.42 113.403 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.96 64.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.666 -0.778 . . . . 75.44 112.596 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.619 HD12 HD21 ' A' ' 251' ' ' LEU . 61.7 mt -107.27 122.25 61.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 122.733 -0.275 . . . . 70.14 110.262 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.658 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 17.2 tptm -121.17 122.64 40.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.645 . . . . 74.42 110.75 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.76 124.08 51.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.136 -0.938 . . . . 73.42 109.815 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.401 ' O ' HD13 ' A' ' 277' ' ' LEU . 38.0 m -119.75 110.22 16.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.177 0.513 . . . . 74.22 110.743 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.585 HD23 HD12 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -111.13 125.77 54.13 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.86 -1.163 . . . . 72.24 107.86 173.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.9 p -139.08 141.01 38.18 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.762 -0.375 . . . . 64.11 110.742 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.42 127.62 19.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.325 -0.62 . . . . 64.53 109.325 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.696 HD23 HD21 ' A' ' 242' ' ' LEU . 0.4 OUTLIER -108.75 128.91 55.29 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.445 0.641 . . . . 74.3 109.466 177.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.855 ' HB3' HG12 ' A' ' 268' ' ' VAL . 1.4 mm? -102.1 106.96 17.91 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.252 -0.885 . . . . 74.34 108.957 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.988 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 6.3 t70 -73.48 98.99 2.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.754 -1.112 . . . . 62.43 108.329 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.83 -9.36 3.67 Favored Glycine 0 C--N 1.314 -0.673 0 CA-C-N 115.725 -0.671 . . . . 74.35 113.38 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 264' ' ' ASP . 84.6 tttt -92.46 -21.84 19.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.867 -0.166 . . . . 73.23 111.025 -174.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.89 -23.74 0.92 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.441 1.115 . . . . 74.1 110.831 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.9 ' HB ' ' O ' ' A' ' 264' ' ' ASP . 1.0 OUTLIER -63.21 -26.7 41.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 113.748 -1.569 . . . . 73.13 112.844 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.48 -26.32 68.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.055 -0.52 . . . . 73.25 110.274 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -88.29 -16.5 32.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.196 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.63 -1.2 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.521 -0.847 . . . . 63.11 113.637 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.86 51.79 4.36 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.561 -0.828 . . . . 75.33 113.046 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.877 ' HA ' HG21 ' A' ' 268' ' ' VAL . 0.6 OUTLIER -78.31 144.44 36.09 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.767 0.318 . . . . 72.3 111.389 -175.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.51 138.18 38.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 74.23 110.878 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -128.32 144.13 51.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 74.44 109.699 -174.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.567 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -146.32 119.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.933 -0.651 . . . . 55.43 111.821 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.68 HD23 HG13 ' A' ' 27' ' ' ILE . 54.0 tp -114.68 146.93 40.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 72.12 110.874 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.77 124.47 1.67 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.893 -0.594 . . . . 70.22 111.693 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.4 HD22 HD22 ' A' ' 277' ' ' LEU . 2.8 mm? -111.04 130.28 55.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.065 -0.717 . . . . 63.4 109.065 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.658 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 16.9 pt-20 -137.1 122.73 19.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.467 0.651 . . . . 72.02 110.459 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.687 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.2 m-85 -114.43 110.48 19.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.863 -0.791 . . . . 74.45 108.863 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.54 111.0 19.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.103 0.477 . . . . 74.13 111.497 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -104.19 109.75 21.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.453 -0.943 . . . . 73.32 108.453 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.494 HD23 ' HE3' ' A' ' 34' ' ' LYS . 56.9 mt -120.34 -98.42 0.45 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.381 -0.372 . . . . 74.11 111.535 -171.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.492 -0.766 . . . . 74.21 109.981 -176.562 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.193 0.521 . . . . 74.21 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.72 94.92 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.523 -0.547 . . . . 53.34 109.523 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.77 ' HB ' ' HD2' ' A' ' 119' ' ' LYS . 16.3 t -117.89 117.09 35.82 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.924 -0.58 . . . . 74.42 110.705 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.43 161.9 14.88 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.539 2.159 . . . . 73.31 111.433 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 102.75 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.354 2.036 . . . . 74.52 111.63 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.547 ' HB ' HG11 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -70.09 -42.67 72.41 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.943 -0.571 . . . . 75.5 111.01 -176.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.882 ' HA ' ' HB3' ' A' ' 10' ' ' LEU . 64.4 t80 -50.15 -25.82 3.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.467 0.707 . . . . 74.52 111.68 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -76.65 -17.61 59.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.929 -0.578 . . . . 51.02 110.487 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -105.89 -31.36 8.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.547 -1.279 . . . . 61.35 107.547 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.882 ' HB3' ' HA ' ' A' ' 7' ' ' TYR . 2.5 tt -58.4 -36.09 73.02 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.351 -2.204 . . . . 73.24 110.738 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.12 -21.89 0.14 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 119.181 -1.485 . . . . 74.45 115.753 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.666 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 16.8 ttmm -57.15 -52.59 64.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.448 1.124 . . . . 74.45 112.358 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -56.62 -38.81 72.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.114 0.483 . . . . 72.4 111.073 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.755 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . . . -70.3 -42.65 71.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.563 -0.744 . . . . 72.04 111.156 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 5.2 tmm_? -59.66 -34.59 73.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.125 -0.488 . . . . 73.12 111.385 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -47.15 84.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 73.31 111.635 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HA ' ' HE1' ' A' ' 22' ' ' TYR . 78.9 t -82.7 -32.03 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.922 0.391 . . . . 72.52 110.966 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.447 ' HA ' ' ND2' ' A' ' 207' ' ' ASN . 86.8 t80 -60.54 -35.36 75.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 73.23 112.171 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -79.43 131.0 35.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 72.33 111.464 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.918 ' H ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -69.87 151.05 46.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.009 -0.996 . . . . 64.14 110.236 175.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.75 78.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.853 -0.689 . . . . 55.43 112.291 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.526 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 72.1 m-85 -70.28 -23.36 62.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.609 0.242 . . . . 74.33 111.454 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -123.72 133.25 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.798 -0.715 . . . . 73.33 111.756 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -104.21 2.12 31.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.085 0.469 . . . . 72.42 110.687 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.95 12.57 57.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.919 -0.658 . . . . 63.44 112.172 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.56 158.65 17.05 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 122.592 1.187 . . . . 75.34 113.656 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.787 HG22 HD13 ' A' ' 277' ' ' LEU . 46.2 mm -105.63 121.82 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 113.016 -1.902 . . . . 72.22 108.924 173.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 25.2 ttpp -109.64 129.07 55.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 75.42 110.65 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tm? -128.43 127.39 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.338 -0.986 . . . . 74.31 108.338 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.0 p30 -142.94 140.92 31.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.223 0.535 . . . . 73.14 110.989 175.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 42' ' ' THR . 7.2 tp -127.06 124.38 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.13 -0.941 . . . . 75.12 109.87 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 ptmm? -127.35 125.78 41.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.756 . . . . 70.0 110.385 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.5 ' HB ' ' HB1' ' A' ' 283' ' ' ALA . 9.9 t -131.73 132.21 43.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.8 -0.636 . . . . 75.13 110.221 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 28.9 mtpp -111.77 132.04 54.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.206 -0.664 . . . . 74.53 109.206 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 17.6 m -133.6 169.21 17.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 72.11 110.446 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -86.5 158.74 19.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.052 -0.522 . . . . 74.14 109.704 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.29 55.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.607 0.567 . . . . 71.54 111.991 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 85.16 -5.16 84.05 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 116.108 1.203 . . . . 73.24 116.108 168.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 2.7 mm? -100.31 124.75 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.024 1.912 . . . . 71.31 112.769 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.831 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 35.9 mt-10 -142.35 139.87 31.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 71.31 108.542 159.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 33' ' ' THR . 90.3 t80 -131.51 121.84 25.14 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 122.061 -0.399 . . . . 71.14 110.547 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.731 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 18.2 m -127.33 131.38 50.43 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.991 0.424 . . . . 73.43 110.488 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -126.51 126.19 43.31 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.06 -0.718 . . . . 63.12 109.06 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 p -126.54 126.22 43.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 72.32 111.159 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.04 139.7 9.16 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 74.1 112.36 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 p -132.21 136.59 47.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.058 0.456 . . . . 72.22 110.67 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.8 51.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.793 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -84.83 137.89 32.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.542 -0.54 . . . . 73.35 109.542 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.3 m -80.33 -27.5 38.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.005 0.431 . . . . 64.12 110.991 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.13 -71.37 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 74.23 110.52 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 p -93.24 159.82 15.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.249 -0.432 . . . . 53.44 110.603 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -79.81 88.48 5.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.468 0.652 . . . . 75.01 110.34 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -138.0 104.46 5.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 73.34 109.518 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.31 119.6 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.145 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -114.05 126.24 54.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.839 -0.619 . . . . 75.25 109.777 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.73 123.84 3.63 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.476 -0.869 . . . . 53.24 112.415 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 p -114.1 142.65 45.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.68 -0.489 . . . . 71.03 109.68 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -121.31 123.33 41.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.955 -0.757 . . . . 72.24 108.955 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.731 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 2.1 pm0 -114.16 118.97 35.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.076 0.941 . . . . 73.33 111.226 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -99.25 120.94 40.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.597 -1.183 . . . . 65.31 108.947 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.831 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 43.6 mtpt -112.56 126.92 55.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.219 0.533 . . . . 74.45 110.814 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 84.4 m-85 -103.3 120.28 40.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.55 -0.907 . . . . 75.25 108.55 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.504 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 36.0 ttt180 -110.71 108.2 18.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 73.23 110.742 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.485 ' HE3' ' HB3' ' A' ' 69' ' ' LEU . 5.3 m-90 -107.09 99.35 8.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.791 -0.64 . . . . 74.23 110.577 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 m 70.59 133.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.512 -0.767 . . . . 74.21 111.084 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.6 pm0 -64.73 124.58 22.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 62.14 110.559 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 63.4 35.49 12.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.433 -0.803 . . . . 74.04 111.077 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.37 -77.77 0.38 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.207 -0.757 . . . . 74.22 111.207 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.8 mm? -124.86 132.63 53.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.095 0.474 . . . . 75.11 111.378 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.34 112.59 11.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.83 -0.623 . . . . 74.23 110.248 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.546 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 58.5 t80 -111.6 120.26 41.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.007 -0.542 . . . . 73.53 109.745 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 t -124.27 117.29 24.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.308 0.575 . . . . 75.3 110.93 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 34.5 tt0 -102.76 120.62 40.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 71.45 109.697 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -107.19 113.98 27.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 75.01 110.336 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.859 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 70.4 t90 -103.1 134.89 45.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.776 -0.453 . . . . 70.01 109.776 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -110.22 156.19 21.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 73.13 109.481 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -61.35 -16.0 41.69 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.832 0.678 . . . . 70.3 112.832 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.6 -1.47 57.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.828 -0.169 . . . . 54.43 111.333 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 87.81 11.51 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.241 1.016 . . . . 73.21 112.432 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -81.83 126.38 31.8 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.775 -0.37 . . . . 53.44 110.099 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.859 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -105.63 119.48 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.33 -0.395 . . . . 71.03 110.155 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.83 98.65 0.92 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.352 -1.099 . . . . 71.1 110.352 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.525 ' HB ' ' HG3' ' A' ' 73' ' ' GLU . 9.7 t -106.63 120.86 43.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.516 0.674 . . . . 74.54 111.641 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 40.5 tt0 -109.3 123.47 49.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.376 -0.829 . . . . 61.04 110.169 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.546 ' HB ' ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -112.58 124.13 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 73.05 109.496 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 m -111.4 130.04 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 72.32 111.17 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 5.9 t -110.45 120.28 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.556 -0.747 . . . . 74.31 109.51 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.88 116.98 34.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.243 -0.28 . . . . 63.51 110.243 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 52.19 62.99 2.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.596 -0.729 . . . . 73.4 111.326 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.659 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 23.7 tp60 -62.42 -74.7 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.606 . . . . 75.11 111.24 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.659 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 88.5 mt -115.61 -31.93 5.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 64.44 110.111 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.92 125.64 51.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 72.11 110.268 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.554 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -63.64 135.38 56.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.124 0.488 . . . . 74.54 110.822 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.72 -15.23 58.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.556 -0.747 . . . . 72.15 112.257 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.2 131.4 36.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.501 . . . . 73.15 111.442 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -119.25 111.08 17.77 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.613 -0.884 . . . . 74.32 108.613 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -103.65 127.47 51.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.493 -0.558 . . . . 72.41 109.493 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.875 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 21.9 m -127.84 119.25 25.25 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.642 0.258 . . . . 74.13 110.579 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 82.5 m-85 -117.46 114.95 24.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.593 . . . . 73.3 109.4 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.962 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.9 t70 -111.14 122.65 48.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.183 -0.673 . . . . 75.04 109.183 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -118.2 120.47 37.8 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.016 0.436 . . . . 65.13 110.01 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' A' ' 111' ' ' ASN . 53.7 m -109.55 121.48 45.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.138 -0.483 . . . . 74.12 109.922 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -123.66 125.07 44.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.968 -0.56 . . . . 75.33 110.186 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 t -114.03 101.75 54.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 109.683 -0.488 . . . . 75.1 109.683 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.05 -9.16 19.25 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.932 2.421 . . . . 75.04 110.577 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -72.03 -55.48 7.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.887 -1.051 . . . . 74.45 109.89 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.5 t -103.92 -19.77 14.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 72.24 111.556 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.16 22.79 18.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.691 -0.766 . . . . 52.1 112.604 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -95.35 146.49 24.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.537 0.208 . . . . 75.31 110.774 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 140.66 45.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.873 0.368 . . . . 75.33 110.023 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.2 m120 -128.81 132.57 47.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.3 110.376 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -111.0 114.76 28.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.047 -0.524 . . . . 72.21 110.106 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 56.8 tttp -113.25 135.39 53.88 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.485 -0.561 . . . . 64.44 109.485 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -136.37 135.66 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 74.52 110.053 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.875 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.6 ttpm? -131.2 121.36 24.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.187 0.518 . . . . 75.43 110.582 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 p -112.63 121.17 44.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.437 -0.801 . . . . 73.51 109.278 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.46 154.52 21.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.004 -1.093 . . . . 71.3 112.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.38 116.64 21.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.454 -0.943 . . . . 75.45 108.454 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.77 ' HD2' ' HB ' ' A' ' 3' ' ' VAL . 24.4 pttm -110.18 121.94 46.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.42 0.628 . . . . 75.32 111.252 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.6 mpt_? -107.48 148.63 28.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.954 -1.128 . . . . 71.54 107.954 168.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.34 -27.9 50.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.986 0.422 . . . . 72.03 110.972 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -93.08 -31.2 14.92 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.272 0.471 . . . . 74.32 112.272 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.481 HD11 ' N ' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -144.21 132.32 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.822 -0.751 . . . . 74.34 110.974 -167.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.719 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 7.4 t30 -120.92 125.65 48.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.366 0.506 . . . . 74.13 112.366 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.94 131.64 55.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.936 -0.574 . . . . 63.35 110.049 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -141.38 117.07 1.17 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.331 -0.938 . . . . 53.33 112.626 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 42.0 t -109.78 108.57 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.323 . . . . 64.1 110.483 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.712 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 10.7 t70 -108.29 138.55 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 55.11 109.592 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.541 ' HG2' HG13 ' A' ' 138' ' ' ILE . 73.7 mtm -138.14 128.04 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.819 -0.551 . . . . 73.43 111.241 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -97.73 117.27 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.187 -0.672 . . . . 64.12 109.187 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -97.02 114.87 26.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.174 0.511 . . . . 74.24 111.048 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.3 153.9 45.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.595 -0.891 . . . . 72.51 108.595 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.8 pp -69.62 -17.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 73.25 111.1 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.56 -10.38 57.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.781 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.87 125.25 1.79 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.775 -0.726 . . . . 74.14 112.374 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 6.3 Cg_exo -80.03 122.07 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.23 2.62 . . . . 74.53 111.921 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 m -97.2 135.73 38.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.014 -0.365 . . . . 74.25 110.014 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.541 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -106.1 119.27 55.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.133 0.492 . . . . 75.04 110.026 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -117.62 111.73 19.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.945 -0.571 . . . . 75.14 109.98 -174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.46 132.99 11.3 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.907 -1.14 . . . . 73.4 112.096 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 116.36 24.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.186 0.517 . . . . 75.1 109.946 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.467 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.1 tp -116.87 123.58 47.4 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 74.44 109.889 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.719 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 53.0 t -117.01 128.76 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.415 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -107.78 137.9 44.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.259 -1.015 . . . . 74.25 108.259 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.37 121.05 2.33 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.312 -0.947 . . . . 54.32 113.529 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.14 149.36 41.41 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.072 -1.084 . . . . 74.32 108.072 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.47 105.15 0.08 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.655 0.741 . . . . 73.4 111.718 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.39 -32.18 7.85 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.273 -0.876 . . . . 64.35 112.441 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -105.35 122.47 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.777 0.322 . . . . 72.54 111.602 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mt -115.05 136.32 53.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.684 -1.228 . . . . 73.24 107.684 163.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.639 ' HB2' ' HB2' ' A' ' 144' ' ' LEU . . . -136.28 152.72 51.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.592 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -157.21 133.18 3.47 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.193 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.66 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 67.8 m-85 -124.02 114.68 20.07 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.429 -0.582 . . . . 74.44 109.429 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -105.45 120.88 42.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.697 -0.683 . . . . 73.22 109.71 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.402 ' SD ' HG11 ' A' ' 164' ' ' VAL . 58.4 ttp -132.48 129.0 38.62 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.42 -0.355 . . . . 74.44 110.444 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.449 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 73.6 m-20 -111.16 115.87 30.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.912 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.5 t80 -97.28 127.1 42.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.993 -1.003 . . . . 75.12 110.273 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -94.39 100.23 12.29 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-N 115.858 -0.61 . . . . 72.11 109.593 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 -19.95 62.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.769 -1.56 . . . . 74.05 111.008 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.72 77.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.613 -0.884 . . . . 51.31 108.613 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -102.77 -160.45 0.78 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.296 -1.32 . . . . 74.22 108.026 167.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.1 m -109.48 27.07 9.92 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.047 -0.408 . . . . 74.53 110.929 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -163.24 161.64 24.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 118.912 -1.115 . . . . 74.32 111.596 -165.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.912 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -72.95 136.1 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.137 0.494 . . . . 74.0 109.865 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.1 t -93.61 -23.45 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.897 -0.592 . . . . 75.14 110.317 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -140.1 132.88 29.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.61 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 p -121.07 109.31 14.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.805 -0.634 . . . . 75.22 110.274 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -111.69 127.56 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.387 0.613 . . . . 70.04 110.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.66 ' HD2' ' HD1' ' A' ' 153' ' ' TYR . 80.0 m-85 -121.03 144.29 48.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.701 -0.481 . . . . 74.34 109.701 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -147.26 137.25 23.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.524 0.678 . . . . 64.41 111.091 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.997 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 99.5 t -133.44 152.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.267 -1.012 . . . . 74.51 108.267 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 181' ' ' HIS . . . -147.88 123.16 1.66 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.101 -1.047 . . . . 61.34 112.271 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.07 120.59 42.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.171 -0.677 . . . . 75.53 109.171 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.04 126.86 53.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.793 0.806 . . . . 74.22 111.867 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -116.94 163.26 16.47 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.78 -1.563 . . . . 74.43 106.78 168.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -53.64 -42.08 67.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.239 0.459 . . . . 64.43 112.239 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -107.3 -14.02 14.98 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.288 0.477 . . . . 74.41 112.288 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.472 ' HD2' ' NE2' ' A' ' 196' ' ' GLN . 7.5 m-85 -132.11 120.85 22.89 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.125 -0.359 . . . . 75.31 110.941 -173.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -135.19 124.08 24.03 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.785 -0.366 . . . . 72.25 110.683 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.77 ' HB2' ' HA ' ' A' ' 194' ' ' ILE . 0.0 OUTLIER -124.53 138.43 54.33 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.775 -0.578 . . . . 74.34 110.472 175.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.755 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 95.3 m-70 -115.46 117.85 31.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 74.44 110.385 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.997 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 90.0 m -78.79 122.84 26.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 71.25 109.685 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.35 139.66 53.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.369 0.604 . . . . 72.42 111.432 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 90.3 t -131.2 117.1 35.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.594 -0.73 . . . . 74.15 110.146 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.28 105.67 15.81 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.9 -0.778 . . . . 72.14 108.9 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 26.8 t70 63.36 -172.4 0.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.539 -0.755 . . . . 73.3 108.968 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.436 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -79.52 -6.76 88.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 64.42 110.842 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 211' ' ' THR . 1.2 p -88.68 -24.49 22.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.416 0.895 . . . . 73.14 113.416 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.26 110.67 11.28 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.876 0.762 . . . . 73.31 111.111 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -121.48 124.63 44.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.005 -0.543 . . . . 75.32 109.999 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -176.42 -149.75 7.78 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.545 -1.312 . . . . 60.12 113.672 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.54 175.07 35.68 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.291 -0.723 . . . . 70.01 111.291 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.538 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 55.9 m -148.3 138.42 22.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.095 0.448 . . . . 74.43 110.032 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 1.006 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.1 mp -117.88 129.73 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.833 0.349 . . . . 74.33 110.681 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -108.18 120.04 41.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.388 -0.967 . . . . 75.31 108.388 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 1.007 HE21 ' HA ' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -120.48 132.18 55.09 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.085 0.402 . . . . 74.11 112.085 -172.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -103.51 108.79 20.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.166 -0.679 . . . . 75.21 109.166 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.856 ' HB ' HD11 ' A' ' 202' ' ' LEU . 59.5 t -95.23 -26.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.39 0.614 . . . . 74.55 109.762 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -158.47 -179.92 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.236 -1.024 . . . . 74.31 108.236 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.36 -40.83 75.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.455 0.539 . . . . 72.3 112.455 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -126.78 13.53 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.014 0.435 . . . . 74.24 111.072 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.856 HD11 ' HB ' ' A' ' 198' ' ' VAL . 2.3 tm? -107.12 103.03 12.33 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 75.51 108.664 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.402 ' CD ' ' HZ2' ' A' ' 224' ' ' LYS . 13.2 pt-20 -117.6 153.92 32.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.784 -0.644 . . . . 54.51 110.159 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 196' ' ' GLN . 16.6 m -130.06 149.6 51.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.988 -0.551 . . . . 71.21 109.92 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.54 136.15 50.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 60.4 109.672 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 1.006 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -119.82 136.87 55.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.646 -0.706 . . . . 75.55 111.005 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 18' ' ' PHE . 20.1 t-20 -114.31 127.66 55.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 62.51 110.436 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 208' ' ' LEU . 1.7 mm? -130.94 129.71 42.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.18 -0.674 . . . . 74.51 109.18 171.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.439 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -156.49 149.01 23.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.13 0.49 . . . . 74.31 111.193 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -131.19 124.92 31.67 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.154 -0.684 . . . . 73.12 109.154 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.7 t -101.83 117.88 35.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.397 0.618 . . . . 74.54 110.132 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.76 130.85 47.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.597 -0.729 . . . . 75.25 110.835 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -15.84 27.5 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.919 -0.657 . . . . 75.12 111.789 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -138.86 150.16 45.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.148 -0.316 . . . . 73.12 110.148 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.8 m -86.28 -16.47 37.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.408 -0.36 . . . . 71.33 111.067 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -67.79 111.21 4.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.0 0.429 . . . . 73.32 110.825 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.0 t -87.99 138.43 31.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.536 -0.913 . . . . 74.02 108.536 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 30.0 mtt-85 -88.28 116.67 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.292 -0.633 . . . . 74.04 109.292 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -115.17 129.37 56.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.864 -1.162 . . . . 73.41 107.864 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -141.11 150.85 22.12 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.895 -1.145 . . . . 70.14 112.46 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.917 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 3.5 mp -132.58 132.35 59.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.017 -1.105 . . . . 72.45 108.017 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.802 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . . . -124.93 130.23 51.94 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.328 1.018 . . . . 75.1 109.837 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.644 ' H ' ' HB2' ' A' ' 236' ' ' LYS . . . -113.87 126.34 55.07 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.117 -0.633 . . . . 75.21 111.187 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.402 ' HZ2' ' CD ' ' A' ' 203' ' ' GLU . 24.1 ttpp -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 72.04 110.71 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.613 ' HD1' HD12 ' A' ' 227' ' ' ILE . 90.6 t80 -120.81 127.85 52.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 71.12 110.077 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.878 ' HB3' ' HB2' ' A' ' 201' ' ' LYS . 29.2 tt0 -79.92 100.88 8.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.962 -0.563 . . . . 74.22 109.537 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.613 HD12 ' HD1' ' A' ' 225' ' ' TYR . 26.2 mm -68.82 -42.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.869 0.842 . . . . 74.21 109.297 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -137.05 146.77 56.09 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.533 -1.284 . . . . 74.14 107.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -44.97 -25.63 1.73 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.88 2.387 . . . . 65.34 114.185 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.87 -3.32 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.348 0.499 . . . . 75.12 112.348 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.76 123.42 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 71.43 112.002 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 35.7 m -120.76 122.64 40.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 74.24 110.399 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.729 ' HD2' ' HB3' ' A' ' 247' ' ' TYR . 87.6 t80 -104.7 133.13 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.06 -0.348 . . . . 75.0 110.06 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 12.5 p -131.0 140.62 50.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 64.45 111.487 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -156.66 136.71 12.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 71.34 109.127 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.917 ' HB3' ' O ' ' A' ' 221' ' ' ILE . 2.7 mmtm -173.29 179.0 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.865 0.466 . . . . 74.05 110.908 166.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 242' ' ' LEU . 12.7 p -122.8 152.03 27.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.129 0.49 . . . . 70.34 111.674 -160.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -109.01 150.74 27.32 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.889 -0.596 . . . . 71.44 110.324 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 241' ' ' SER . 4.4 t-20 -39.46 -33.54 0.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.477 1.511 . . . . 75.21 114.03 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 13.5 m -77.52 24.55 0.2 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.562 0.22 . . . . 74.1 110.651 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.3 p 58.0 29.54 17.86 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.563 1.145 . . . . 75.12 110.937 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 1.061 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.1 mp -99.39 128.98 45.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 116.221 -0.445 . . . . 73.03 111.926 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.867 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.42 116.35 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.699 -0.682 . . . . 73.13 110.525 -171.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.58 133.46 11.59 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.743 -0.742 . . . . 74.24 112.419 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.8 pp -134.23 149.06 50.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 70.41 109.98 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.72 145.86 11.14 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.885 -0.674 . . . . 65.22 111.776 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.729 ' HB3' ' HD2' ' A' ' 233' ' ' PHE . 22.1 p90 -124.61 122.34 37.26 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.297 0.57 . . . . 74.1 110.097 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 10.0 t -111.62 124.25 51.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.341 -0.845 . . . . 73.04 109.445 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -135.77 124.26 23.52 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.58 -0.737 . . . . 73.42 110.487 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 2.3 t -78.64 103.86 8.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.818 -1.178 . . . . 74.41 107.818 171.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.92 -54.5 44.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.511 -0.768 . . . . 73.5 109.654 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.596 ' HB2' HD11 ' A' ' 255' ' ' ILE . 96.8 mttt -145.17 152.16 50.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 106.93 -1.508 . . . . 74.43 106.93 174.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.61 98.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.51 2.14 . . . . 70.15 112.566 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.32 -24.44 2.94 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.889 -0.596 . . . . 74.3 112.662 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.596 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -134.34 122.08 39.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.394 0.616 . . . . 73.45 112.002 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.831 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 14.8 ptpt -114.13 133.28 55.68 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 72.42 110.299 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.71 126.89 52.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.25 -0.886 . . . . 72.15 109.713 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.8 t -127.51 111.0 13.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.556 0.693 . . . . 75.12 110.423 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.68 123.22 45.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 175.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 26.4 t -131.95 140.86 49.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.894 0.378 . . . . 65.23 110.039 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.72 128.48 20.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.914 -0.584 . . . . 73.13 110.433 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.79 HD13 HD21 ' A' ' 242' ' ' LEU . 2.3 tm? -102.48 117.67 35.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.511 -1.292 . . . . 73.03 107.511 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.867 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.3 mm? -92.72 107.71 19.42 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.559 -1.274 . . . . 73.14 107.559 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.061 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.1 m-20 -70.46 104.02 2.62 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.356 -0.979 . . . . 73.12 108.356 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.28 -19.1 38.31 Favored Glycine 0 C--O 1.229 -0.166 0 CA-C-N 115.94 -0.573 . . . . 75.33 112.497 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.36 -24.19 20.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.368 . . . . 73.35 111.016 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 93.8 m-20 -113.34 -30.54 6.87 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.645 0.98 . . . . 72.21 113.645 -170.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 263' ' ' LEU . 30.8 m -62.62 -26.41 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.041 0.756 . . . . 63.54 113.041 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -70.31 -23.72 62.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.961 0.41 . . . . 72.43 110.369 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.81 6.02 36.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 72.52 110.123 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.65 102.54 0.79 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.752 -0.658 . . . . 54.35 111.831 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 165.15 78.68 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.258 -0.972 . . . . 62.21 112.519 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -113.48 146.68 39.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.504 -0.554 . . . . 75.34 109.504 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 74.2 mmtt -95.39 137.69 34.09 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.586 -0.446 . . . . 74.35 110.231 -175.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 276' ' ' GLY . 1.4 tm? -117.7 134.5 54.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.179 -0.464 . . . . 65.35 109.91 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.463 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -135.17 104.27 0.5 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.959 -0.856 . . . . 74.13 110.959 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 259' ' ' LEU . 2.4 tm? -114.76 130.95 56.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.51 -0.552 . . . . 74.31 109.51 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.499 ' N ' HD23 ' A' ' 277' ' ' LEU . . . -143.24 136.75 7.19 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.175 -1.012 . . . . 64.44 112.888 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.581 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.6 mm? -114.91 131.08 56.99 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.325 -0.62 . . . . 75.34 109.325 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.831 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 52.6 mt-10 -111.82 112.12 23.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.418 -0.586 . . . . 74.12 109.418 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -99.2 125.15 44.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.809 -1.182 . . . . 73.45 107.809 177.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.442 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 75.4 mt-30 -132.53 116.87 17.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.127 0.489 . . . . 72.33 109.985 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.5 ' HB1' ' HB ' ' A' ' 33' ' ' THR . . . -115.61 131.97 56.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.809 -0.632 . . . . 73.24 110.471 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 285' ' ' GLU . 65.9 mt -122.09 -45.17 2.25 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.062 -0.718 . . . . 74.21 109.062 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 284' ' ' LEU . 42.5 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.633 -1.167 . . . . 63.51 109.395 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' SD ' ' HA ' ' A' ' 4' ' ' PRO . 22.3 ptp . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.762 0.315 . . . . 74.23 110.35 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.01 -35.11 43.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.045 0.45 . . . . 73.4 110.521 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.622 HG22 ' HA ' ' A' ' 121' ' ' GLU . 21.3 t -118.58 101.98 50.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 71.22 109.735 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 4.4 Cg_exo -77.54 138.63 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.006 2.471 . . . . 73.11 112.075 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 35.2 Cg_exo -61.94 91.15 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.814 2.343 . . . . 74.13 111.683 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p -81.24 -15.99 54.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.684 -0.689 . . . . 74.13 111.321 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.766 ' HB3' HG21 ' A' ' 143' ' ' VAL . 45.8 p90 -62.75 -24.78 67.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.538 0.685 . . . . 74.11 109.677 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.79 -30.0 58.93 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.157 -0.929 . . . . 75.25 110.855 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -104.26 9.34 36.05 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 119.978 -0.689 . . . . 62.35 111.717 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.521 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 94.8 mt -56.78 -35.68 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.377 . . . . 72.44 111.721 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.32 39.8 0.7 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.705 -1.236 . . . . 50.22 114.162 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -69.17 -48.68 61.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.896 0.848 . . . . 75.4 109.7 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -64.36 -38.37 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 73.03 110.971 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.17 -35.55 74.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 70.41 111.987 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -58.11 -38.07 75.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 74.15 112.177 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.85 -42.9 80.64 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.912 0.338 . . . . 74.25 111.912 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 t -84.47 -32.41 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.297 0.48 . . . . 64.44 112.297 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.96 -21.69 63.23 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.623 0.601 . . . . 73.31 112.623 -171.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 p -57.84 152.61 15.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 75.45 112.493 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HZ2' ' CD ' ' A' ' 189' ' ' GLU . 2.8 mptp? -86.37 -21.29 27.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.577 -0.738 . . . . 74.43 109.185 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.73 113.29 1.74 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.016 -0.993 . . . . 63.44 111.132 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.441 ' HB2' HD21 ' A' ' 262' ' ' LEU . 81.7 m-85 -85.79 -14.36 45.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.098 0.475 . . . . 71.42 110.688 -176.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.48 118.58 4.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.042 -0.823 . . . . 65.24 111.042 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -80.21 -4.67 54.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.94 0.37 . . . . 74.14 111.341 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.94 -3.57 69.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.273 -0.489 . . . . 65.21 113.262 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.7 pp -149.07 -178.12 6.2 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.707 0.765 . . . . 74.3 112.555 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.863 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -99.88 133.13 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.529 -1.214 . . . . 72.31 109.689 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.577 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.0 ttpp -124.87 146.26 49.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.768 -0.456 . . . . 72.2 109.768 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tm? -131.9 128.33 38.35 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.71 -0.478 . . . . 65.1 109.71 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 11.1 m-20 -134.32 120.37 19.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.11 -0.7 . . . . 75.02 109.11 171.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 tp -140.88 128.23 21.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 65.4 110.477 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 15.3 ptpt -118.14 127.29 53.63 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.972 0.415 . . . . 74.11 111.103 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.661 HG22 ' HB2' ' A' ' 283' ' ' ALA . 38.7 p -89.7 121.69 32.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.338 -0.986 . . . . 63.03 108.338 168.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -105.04 132.04 51.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.325 0.583 . . . . 73.34 111.784 -169.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 28.8 t -138.97 141.05 38.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.293 -0.867 . . . . 64.45 108.851 172.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.9 13.96 21.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.47 0.653 . . . . 75.53 109.586 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.92 37.18 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.364 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.47 -9.64 76.94 Favored Glycine 0 C--O 1.221 -0.694 0 CA-C-O 119.008 -0.884 . . . . 60.31 114.976 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -103.9 127.57 51.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 119.279 1.54 . . . . 73.3 112.84 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 37.6 tt0 -141.74 117.59 10.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.48 -0.934 . . . . 75.31 108.48 158.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 93.4 m-85 -107.08 120.36 41.87 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.225 -0.59 . . . . 72.51 110.296 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 68.4 m -112.85 117.32 31.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.116 0.484 . . . . 74.42 110.665 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 p -105.03 124.28 49.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.826 -0.624 . . . . 75.31 109.502 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.0 t -133.86 125.99 29.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.827 -0.434 . . . . 72.12 109.827 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 159.09 27.92 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.375 -0.917 . . . . 64.34 112.411 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -129.32 134.77 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.746 -0.464 . . . . 73.43 109.746 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.606 ' HB3' HG13 ' A' ' 54' ' ' VAL . . . -129.81 127.68 40.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.136 0.493 . . . . 72.44 111.018 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 50' ' ' GLU . 45.9 m-80 -90.92 144.86 25.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.387 -0.824 . . . . 72.54 109.885 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -70.19 18.87 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.315 0.579 . . . . 54.22 111.921 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 48' ' ' ASN . 21.7 mm-40 -89.25 -167.24 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 73.22 110.075 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -68.13 90.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.64 -0.254 . . . . 74.34 111.54 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p 48.21 45.71 19.9 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.117 0.567 . . . . 75.43 112.246 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -91.12 75.78 6.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 70.23 109.61 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 47' ' ' ALA . 13.3 t -120.54 123.51 70.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.162 -0.926 . . . . 74.4 110.859 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.7 p -109.44 137.04 47.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.085 -0.507 . . . . 64.34 109.669 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.94 136.41 8.82 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.464 -0.874 . . . . 73.31 112.773 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 p -127.63 145.18 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.878 -0.416 . . . . 65.3 109.878 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -120.68 124.97 46.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.708 -0.479 . . . . 74.41 109.708 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.7 tt0 -107.01 118.19 36.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.076 -0.712 . . . . 70.44 109.076 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.2 m -100.45 119.85 39.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.195 -0.668 . . . . 71.22 109.195 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 42.3 mtpt -121.66 127.58 50.95 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.057 0.456 . . . . 75.42 110.408 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 94.6 m-85 -106.89 120.79 43.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.897 -0.592 . . . . 73.21 109.653 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 17.5 tpt180 -111.8 106.99 15.89 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.534 0.683 . . . . 75.32 110.643 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.43 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 40.0 t-105 -105.59 108.16 19.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.574 -1.194 . . . . 75.14 109.876 -174.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -58.6 -36.24 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.221 -0.899 . . . . 74.31 111.943 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.43 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 14.3 mm-40 -66.25 120.46 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.437 -0.347 . . . . 75.43 110.324 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 74.57 -44.55 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.015 0.822 . . . . 74.52 111.384 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.95 64.45 0.46 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.904 -0.665 . . . . 64.32 111.899 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.02 134.72 53.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.867 0.365 . . . . 71.5 110.839 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 29.6 m -136.19 112.66 9.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.384 . . . . 73.43 110.647 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 77.6 t80 -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.683 -0.488 . . . . 74.23 109.683 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 84' ' ' GLU . 60.9 p -125.66 116.03 21.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.853 0.359 . . . . 54.22 111.011 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.93 122.42 37.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.106 -0.331 . . . . 74.21 110.106 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 55.8 tttm -113.21 116.76 30.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 71.23 111.122 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -103.6 131.78 50.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 74.53 110.395 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -101.69 161.8 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 73.14 111.063 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.5 m -62.29 -22.21 65.84 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.584 0.707 . . . . 74.43 110.215 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -72.23 -4.0 26.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.22 -0.9 . . . . 75.5 111.177 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 10.4 m-80 69.64 40.95 1.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.493 0.663 . . . . 75.45 110.677 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -114.35 135.47 54.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.373 -0.83 . . . . 74.35 109.613 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.1 mm? -99.59 135.87 40.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.609 -0.723 . . . . 75.45 110.872 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.22 89.93 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.504 -1.039 . . . . 72.34 110.504 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -95.48 105.43 17.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.862 0.363 . . . . 72.54 111.773 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.549 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 26.2 mt-10 -110.07 131.6 54.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.18 -0.464 . . . . 70.02 109.895 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -119.36 121.78 67.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.005 -0.739 . . . . 74.14 109.005 173.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.0 m -112.0 124.31 52.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.296 0.569 . . . . 74.33 111.664 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 66.6 t -111.03 121.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.136 -0.938 . . . . 75.25 109.663 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.32 142.67 28.18 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.77 -0.826 . . . . 63.13 108.77 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 94' ' ' GLY . 5.1 p-10 -49.69 143.89 6.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.216 0.821 . . . . 70.25 113.216 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -126.99 -56.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.814 -1.084 . . . . 73.51 108.974 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.45 -67.05 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.661 -0.7 . . . . 72.15 109.582 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 86.77 5.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 73.14 110.187 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -52.92 135.43 36.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.443 -0.798 . . . . 74.4 111.702 -177.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . 102.9 -22.91 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.577 -0.738 . . . . 72.43 113.726 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 35.8 tp -80.69 131.56 35.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.329 1.065 . . . . 65.24 112.18 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -123.73 120.63 33.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.917 -0.583 . . . . 74.1 109.72 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.737 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -109.89 129.8 55.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.689 0.281 . . . . 74.21 110.434 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.911 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.2 m -131.27 119.89 22.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.661 0.267 . . . . 74.3 110.456 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.542 ' HB2' HG21 ' A' ' 85' ' ' ILE . 80.6 m-85 -111.19 115.41 29.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.759 -0.46 . . . . 75.5 109.759 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.748 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 2.3 t70 -109.39 136.01 49.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.48 . . . . 74.4 110.343 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.0 m -144.08 122.74 12.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.022 0.439 . . . . 63.23 110.881 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 22.8 t -95.97 125.55 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.401 -0.592 . . . . 70.22 109.401 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 98.6 m-85 -111.48 123.56 50.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.818 -0.628 . . . . 74.23 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -115.58 103.14 54.19 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 70.31 109.465 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.53 -19.15 63.52 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.354 2.703 . . . . 73.2 113.007 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -57.12 -48.11 79.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 64.51 110.811 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.6 m -109.28 -21.71 12.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.314 0.578 . . . . 74.33 111.011 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.03 23.84 43.55 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.848 -0.901 . . . . 73.31 110.848 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.76 148.1 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 75.23 111.852 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.27 116.47 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.167 -0.924 . . . . 72.02 109.165 172.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -118.41 121.16 39.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.876 -1.157 . . . . 73.53 107.876 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.19 149.67 46.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.65 0.611 . . . . 73.31 112.65 -165.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 54.0 mttp -115.23 138.01 51.4 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.149 -1.056 . . . . 71.52 108.149 169.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.882 HG23 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -114.96 119.39 61.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.565 -0.902 . . . . 72.45 108.565 174.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.911 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 22.9 tttp -115.11 119.5 36.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.631 -0.713 . . . . 64.02 109.631 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.5 m -127.94 116.83 20.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.438 -0.578 . . . . 70.33 109.438 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -137.1 122.94 2.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.94 -1.124 . . . . 63.33 112.009 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -107.4 135.41 48.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.316 0.579 . . . . 74.52 110.349 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -109.31 120.43 42.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.925 -1.034 . . . . 74.41 110.142 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 123' ' ' ILE . 8.3 tpt180 -108.52 157.73 18.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.939 -1.134 . . . . 65.32 107.939 169.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.622 ' HA ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -54.32 -29.27 47.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.723 0.638 . . . . 73.05 112.723 -170.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -112.37 -12.19 13.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 64.43 112.381 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 142' ' ' LEU . 9.8 tp -143.45 132.8 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.821 -0.752 . . . . 71.4 112.47 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.437 HD21 ' N ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -118.76 119.16 33.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.811 -0.44 . . . . 74.14 109.811 179.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.458 HD11 HD12 ' A' ' 142' ' ' LEU . 3.9 mm? -111.87 119.96 40.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.277 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.88 127.51 5.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.673 -0.775 . . . . 64.44 112.872 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.0 m -111.08 121.61 45.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.619 -0.511 . . . . 74.41 109.619 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 t70 -124.23 117.69 25.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.169 -0.678 . . . . 65.11 109.169 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.882 ' HB3' HG23 ' A' ' 114' ' ' ILE . 36.1 ttm -118.33 130.38 55.99 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.854 -0.529 . . . . 72.22 111.668 -172.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.35 118.78 31.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.223 -0.444 . . . . 63.31 110.725 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.637 ' HE2' ' HB ' ' A' ' 114' ' ' ILE . 92.6 m-85 -96.26 96.53 8.84 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.855 -1.165 . . . . 75.45 107.855 167.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -136.72 155.44 49.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.271 -0.422 . . . . 74.4 110.587 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -30.0 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 74.44 110.97 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.08 -14.08 60.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.049 0.452 . . . . 75.44 110.859 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.67 128.49 2.18 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.626 -0.797 . . . . 73.53 112.731 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.81 118.56 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.604 2.203 . . . . 75.43 110.653 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -125.96 144.77 50.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.866 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.05 118.15 54.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.324 0.583 . . . . 60.44 109.842 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 21.5 ttp-105 -106.94 129.8 54.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.618 -0.719 . . . . 74.54 109.799 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.33 133.23 11.38 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.312 -0.947 . . . . 73.32 111.875 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -126.07 116.47 21.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.758 -0.46 . . . . 61.14 109.758 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 123' ' ' ILE . 8.8 tp -120.62 123.94 44.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.666 -0.494 . . . . 74.3 109.666 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 7' ' ' TYR . 94.0 t -127.41 129.41 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.312 -0.404 . . . . 72.35 110.715 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.622 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.54 136.72 48.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.973 -0.751 . . . . 72.13 108.973 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.67 118.93 4.18 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.598 -0.81 . . . . 55.21 112.07 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -141.58 147.35 37.53 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 75.33 109.475 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.64 101.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 70.42 111.703 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 174' ' ' LYS . . . 88.22 -32.35 4.43 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.098 -0.955 . . . . 74.34 112.692 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -105.92 122.37 45.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 73.43 111.175 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 151' ' ' ALA . 5.3 tp -138.42 135.1 34.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.359 -0.608 . . . . 74.23 109.359 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -136.73 132.54 34.97 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.843 -0.343 . . . . 72.55 111.227 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.521 ' HA3' ' CD1' ' A' ' 10' ' ' LEU . . . -132.98 133.82 7.22 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.971 -0.633 . . . . 71.01 112.034 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.525 ' HA ' ' HD2' ' A' ' 169' ' ' PHE . 22.6 m-85 -122.8 119.7 31.36 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.421 -0.585 . . . . 72.41 109.421 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -118.63 130.22 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 75.34 110.077 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 21.8 ptp -143.73 143.74 31.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.162 -0.472 . . . . 72.4 110.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -112.36 118.41 35.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.231 -1.026 . . . . 71.23 108.231 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -107.23 118.36 36.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.74 -0.467 . . . . 75.44 109.74 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -86.83 95.35 9.83 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.589 -0.893 . . . . 74.34 108.589 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 m -72.57 -25.16 61.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 113.532 -1.667 . . . . 73.31 111.435 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.55 -31.16 69.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.719 0.771 . . . . 54.44 109.083 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -109.9 -159.79 0.69 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.378 -1.283 . . . . 74.22 108.112 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.0 p -109.47 26.77 10.26 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.132 -0.355 . . . . 72.53 111.111 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 mtp85 -133.66 171.25 14.38 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 114.828 1.418 . . . . 71.21 114.828 -160.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.1 t -104.37 132.22 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.286 -1.325 . . . . 73.52 108.651 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -94.38 -33.91 12.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 72.41 111.245 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -151.87 132.74 14.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.435 -0.348 . . . . 73.05 110.102 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.9 t -124.34 106.94 10.64 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.417 -0.586 . . . . 73.44 109.417 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.91 135.17 55.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.306 0.574 . . . . 75.31 110.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.525 ' HD2' ' HA ' ' A' ' 153' ' ' TYR . 57.5 m-85 -125.83 155.9 40.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.242 -0.436 . . . . 72.41 110.555 -176.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 10' ' ' LEU . . . -150.65 127.96 11.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.158 -0.473 . . . . 73.53 109.795 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 63.7 t -129.77 127.59 64.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.918 0.39 . . . . 75.24 110.491 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.02 111.25 4.19 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.05 -0.82 . . . . 61.54 111.05 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -112.06 120.44 41.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.794 -0.817 . . . . 73.44 108.794 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 11.5 tmtt? -103.23 126.5 50.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.373 0.606 . . . . 74.34 109.89 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 3.9 m -116.91 164.08 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.913 -1.04 . . . . 70.3 108.398 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -34.13 -66.82 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.177 0.806 . . . . 71.52 113.177 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.89 13.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.898 -0.321 . . . . 72.14 111.694 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.499 ' HD1' ' NE2' ' A' ' 196' ' ' GLN . 10.3 m-85 -126.5 137.97 53.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.577 -0.283 . . . . 74.01 110.269 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -122.11 122.73 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.832 -0.747 . . . . 74.32 109.81 170.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.472 HD22 ' HG1' ' A' ' 182' ' ' THR . 4.9 tt -123.77 139.19 54.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.737 -0.665 . . . . 73.55 111.068 -172.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.821 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 58.4 m80 -116.45 117.13 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.225 -0.443 . . . . 73.42 110.36 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.472 ' HG1' HD22 ' A' ' 180' ' ' LEU . 30.6 m -96.02 110.83 23.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.228 -0.656 . . . . 72.42 109.228 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -124.42 160.63 27.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 53.51 110.919 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.521 HG22 ' HD1' ' A' ' 190' ' ' PHE . 16.6 t -131.72 124.4 53.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.872 -0.604 . . . . 73.15 109.764 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 30.2 t30 -99.89 95.45 6.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.622 -0.717 . . . . 54.23 109.705 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.63 178.82 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.282 -0.872 . . . . 71.34 109.381 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.21 -7.14 71.09 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.075 -1.06 . . . . 73.44 111.404 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.9 m -95.01 -25.71 16.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.762 0.653 . . . . 71.52 112.762 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.423 ' CD ' ' HZ2' ' A' ' 20' ' ' LYS . 43.2 tt0 -132.38 145.05 50.95 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.467 -0.771 . . . . 61.41 111.957 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.521 ' HD1' HG22 ' A' ' 184' ' ' VAL . 22.9 m-85 -117.17 150.27 39.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.459 -0.941 . . . . 72.42 108.459 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.32 155.81 24.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.176 -1.012 . . . . 62.14 113.491 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -141.14 126.0 2.95 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.271 -0.732 . . . . 52.15 111.271 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 46.8 t -112.1 136.6 51.26 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.895 0.379 . . . . 74.4 110.075 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.726 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.6 mm -120.53 124.3 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.868 -0.606 . . . . 63.51 109.542 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 0.3 OUTLIER -118.23 121.47 40.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.425 -0.583 . . . . 75.42 109.425 173.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.499 ' NE2' ' HD1' ' A' ' 178' ' ' PHE . 14.5 mm100 -124.45 132.04 53.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 72.2 111.635 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -86.53 122.57 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.216 -0.661 . . . . 74.02 109.216 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.5 m -136.22 173.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.317 -0.401 . . . . 71.23 110.896 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -97.51 -41.92 7.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 72.53 110.098 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -69.93 -33.19 71.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 73.12 112.345 -177.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 94.1 mttt -123.54 11.77 9.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.264 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 -85.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.787 0.679 . . . . 73.01 110.892 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.819 ' HG3' ' HB3' ' A' ' 224' ' ' LYS . 9.5 pt-20 -127.1 128.75 46.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.171 -0.678 . . . . 74.33 109.171 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' A' ' 196' ' ' GLN . 15.4 t -123.44 148.82 45.78 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.374 -0.53 . . . . 75.44 110.419 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.45 136.59 49.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.67 -0.696 . . . . 73.02 110.964 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.807 HG22 HG22 ' A' ' 221' ' ' ILE . 61.1 t -118.8 137.96 51.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.447 -0.797 . . . . 72.0 109.159 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.424 ' OD1' ' HA3' ' A' ' 220' ' ' GLY . 2.9 p-10 -124.6 134.19 53.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 71.33 110.715 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.46 141.36 49.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.054 -0.976 . . . . 75.54 109.397 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -142.21 130.61 22.38 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.036 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.9 122.37 37.18 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.906 -0.405 . . . . 74.44 109.906 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 27.0 m -95.21 107.96 20.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.584 -0.524 . . . . 74.25 109.584 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.16 146.21 48.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.723 -0.671 . . . . 74.45 111.162 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.95 -46.42 3.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.134 -0.555 . . . . 73.24 112.261 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 216' ' ' ASN . 21.1 t-20 -86.59 -21.2 26.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.896 0.379 . . . . 75.32 110.271 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.5 m 66.74 17.42 10.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.577 -0.738 . . . . 73.02 110.758 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.424 ' HB2' ' OD1' ' A' ' 214' ' ' ASN . 53.7 t-20 -69.48 121.18 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 73.41 109.526 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.3 m -113.71 122.56 47.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.069 0.461 . . . . 73.22 110.031 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 37.4 mmt180 -105.31 125.0 50.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.959 -0.564 . . . . 74.43 109.924 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.735 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 46.9 m-85 -113.9 133.6 55.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.909 -0.775 . . . . 65.43 108.909 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.424 ' HA3' ' OD1' ' A' ' 207' ' ' ASN . . . -145.03 141.15 9.66 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.31 -0.948 . . . . 52.43 112.044 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.807 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -132.36 133.3 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 75.14 110.857 178.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -132.51 138.37 47.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.875 -0.602 . . . . 65.33 111.062 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.65 125.56 54.28 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.84 -0.43 . . . . 53.23 109.84 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.819 ' HB3' ' HG3' ' A' ' 203' ' ' GLU . 4.3 ttpp -113.34 113.32 25.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.252 0.549 . . . . 63.44 109.691 -177.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -131.9 116.54 17.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 74.32 110.144 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 12.0 pt20 -85.07 103.1 13.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.382 0.61 . . . . 72.5 109.987 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.3 -29.33 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.487 -0.779 . . . . 61.41 110.561 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.684 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 23.2 m-20 -123.47 163.29 35.28 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.625 . . . . 72.41 109.542 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.21 -29.73 64.52 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.172 1.915 . . . . 73.43 111.916 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.47 ' HB2' ' HG1' ' A' ' 250' ' ' THR . 8.9 p-10 -109.81 -2.27 17.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 65.51 111.607 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' A' ' 228' ' ' ASP . . . -134.7 124.53 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.476 . . . . 73.13 111.891 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 43.3 t -123.43 135.41 54.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 71.34 109.668 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -115.79 133.61 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.126 0.489 . . . . 75.12 110.534 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.3 p -125.26 123.85 40.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.912 -0.585 . . . . 65.25 110.325 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -107.6 140.01 41.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.323 -0.991 . . . . 71.42 108.323 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -148.88 150.07 32.34 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.828 -0.349 . . . . 74.23 110.745 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 10.0 p -145.64 142.91 21.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 73.21 109.943 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 15.4 t-20 -105.31 149.45 26.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.475 -0.784 . . . . 73.45 109.11 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.735 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 20.8 t-20 -57.04 -21.59 32.35 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.996 0.81 . . . . 50.31 112.251 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.5 p -79.24 21.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.958 0.409 . . . . 72.14 110.842 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 239' ' ' ASN . 25.9 t 68.59 31.28 4.79 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.461 -0.79 . . . . 63.12 110.641 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.833 ' HB3' HD12 ' A' ' 262' ' ' LEU . 36.1 mt -99.73 116.01 30.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.344 -0.542 . . . . 71.04 110.468 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.76 117.83 45.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 N-CA-C 109.896 -0.409 . . . . 75.35 109.896 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.41 141.46 16.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.013 -0.613 . . . . 61.01 113.21 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 260' ' ' SER . 8.0 mt -116.18 137.95 51.69 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -141.4 120.71 1.73 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.32 -0.943 . . . . 72.11 111.875 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.5 115.42 18.11 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.847 -0.427 . . . . 73.12 109.847 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -114.74 130.57 56.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.15 0.5 . . . . 63.22 110.351 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 58.1 tt0 -143.66 131.65 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.938 -0.574 . . . . 75.12 110.289 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.47 ' HG1' ' HB2' ' A' ' 230' ' ' ASP . 23.2 p -78.67 129.1 34.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.591 0.234 . . . . 71.43 110.89 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 251' ' ' LEU . 1.6 pp -140.8 145.23 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.864 -0.421 . . . . 75.41 109.864 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 92.3 mttt 67.74 156.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 123.619 0.574 . . . . 74.13 110.51 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 36.3 Cg_endo -66.71 86.7 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.21 1.94 . . . . 74.21 113.366 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.752 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 105.46 29.54 5.03 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.904 -0.665 . . . . 74.1 113.926 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 251' ' ' LEU . 64.7 mt -132.76 133.95 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 117.384 0.592 . . . . 74.3 110.72 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 36.4 ttpt -111.14 133.63 53.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.76 0.314 . . . . 74.53 110.323 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.3 tp -98.06 132.57 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 74.05 109.765 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 15.3 m -126.06 111.15 14.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.347 -0.388 . . . . 75.3 110.201 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.962 HD23 HD21 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.09 124.58 47.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.664 -0.865 . . . . 74.12 108.664 176.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 45.0 m -133.63 140.41 47.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.907 0.384 . . . . 64.35 110.435 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.013 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.833 HD12 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -106.87 115.91 31.01 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.082 -0.71 . . . . 72.23 109.082 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.569 ' HB3' HG13 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -95.0 106.25 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.48 -1.304 . . . . 73.13 107.48 175.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 42.7 m-20 -71.95 104.77 3.62 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.759 -0.83 . . . . 73.42 108.759 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.62 -20.66 25.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.246 -0.502 . . . . 42.42 112.996 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -90.8 -3.51 57.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.811 0.338 . . . . 74.44 110.936 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 62.9 t30 -133.03 -35.53 1.05 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.754 0.65 . . . . 73.35 112.754 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 263' ' ' LEU . 29.4 m -62.46 -18.41 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.747 0.647 . . . . 74.44 112.747 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -68.38 -25.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 73.41 110.324 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.33 -5.98 24.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.431 0.634 . . . . 75.31 110.005 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 91.95 103.48 1.42 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.608 -0.724 . . . . 72.02 111.809 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 173.81 85.62 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.54 -0.838 . . . . 72.31 112.17 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -113.47 147.18 38.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.881 -0.414 . . . . 73.45 109.881 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 7.1 mmpt? -95.15 137.08 34.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.062 -0.718 . . . . 72.04 109.062 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.75 127.61 54.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.82 -0.437 . . . . 73.51 109.82 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.55 104.96 0.83 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.56 -1.016 . . . . 43.41 110.56 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.962 HD21 HD23 ' A' ' 259' ' ' LEU . 3.2 tm? -113.76 125.35 54.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.905 -0.776 . . . . 75.44 108.905 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -145.68 133.64 5.1 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.6 -1.286 . . . . 54.2 112.98 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.684 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.3 mm? -108.7 128.01 54.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.248 -1.019 . . . . 71.04 108.248 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 10.5 pt-20 -140.86 137.92 33.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 119.328 -0.368 . . . . 63.45 110.594 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.752 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.6 OUTLIER 166.56 -148.96 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.124 0.89 . . . . 75.52 111.213 168.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 22.3 pt20 -137.68 119.11 14.76 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.208 -0.451 . . . . 71.13 110.776 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -82.58 109.98 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.169 0.509 . . . . 73.41 110.004 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -125.29 164.04 21.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.768 -0.651 . . . . 71.33 110.542 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.551 -0.907 . . . . 75.3 108.551 178.302 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.96 -0.385 . . . . 73.25 109.96 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.14 116.08 8.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.44 . . . . 75.21 111.448 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 76.5 t -123.18 124.63 26.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 74.11 109.948 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 31.2 Cg_exo -59.42 143.83 99.59 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.097 2.531 . . . . 73.33 112.835 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 4.9 Cg_exo -77.17 69.17 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.198 2.599 . . . . 74.35 111.283 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -68.46 -29.61 68.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.802 -0.636 . . . . 72.32 112.075 -173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.847 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.9 p90 -64.56 -26.72 68.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.924 0.392 . . . . 73.23 111.089 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.64 35.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.052 0.453 . . . . 63.14 110.033 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -94.9 4.03 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 74.3 110.949 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 7' ' ' TYR . 92.4 mt -63.94 -33.2 75.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.401 . . . . 73.32 110.216 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 61.91 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.012 -0.613 . . . . 63.21 112.143 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.12 -39.08 79.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 73.12 110.239 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 m -59.24 -36.47 75.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.226 -0.897 . . . . 72.43 111.836 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.47 69.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.324 -0.398 . . . . 75.04 112.052 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -62.33 -31.53 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 74.42 110.934 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 64.35 111.392 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.633 HG13 ' HB1' ' A' ' 222' ' ' ALA . 40.0 t -78.59 -46.18 24.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.966 -0.294 . . . . 72.13 110.797 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' CZ ' ' HD2' ' A' ' 218' ' ' ARG . 90.9 t80 -64.79 -42.6 94.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.17 0.509 . . . . 75.1 110.807 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.579 HG21 ' H ' ' A' ' 20' ' ' LYS . 1.8 m -108.55 -142.98 0.38 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.237 -1.023 . . . . 74.33 108.237 174.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' H ' HG21 ' A' ' 19' ' ' THR . 43.2 mmtm -141.59 106.02 4.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.909 -0.404 . . . . 74.44 109.909 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.73 -44.02 21.53 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.67 -0.972 . . . . 64.42 110.67 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 28' ' ' LYS . 30.0 m-85 -135.15 -179.24 5.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.402 -0.592 . . . . 74.42 109.402 173.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 51.91 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.487 -0.863 . . . . 51.22 112.215 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -103.55 11.01 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.919 0.39 . . . . 75.43 110.819 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.615 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 93.52 13.75 54.81 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.444 -0.884 . . . . 72.12 111.854 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 pp -126.89 179.16 5.53 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-O 122.239 1.019 . . . . 75.53 113.317 -170.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.674 HD12 HD11 ' A' ' 277' ' ' LEU . 29.9 mm -98.58 142.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.888 -1.505 . . . . 73.34 109.855 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.581 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 3.9 tmtm? -122.47 135.82 54.75 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 74.34 109.424 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.0 tp -123.78 148.5 46.6 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.727 -0.389 . . . . 74.32 110.507 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 43' ' ' SER . 10.4 t70 -145.22 127.66 15.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.306 -0.861 . . . . 74.2 108.886 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.709 HD23 ' HB3' ' A' ' 281' ' ' PHE . 0.4 OUTLIER -126.65 124.61 40.26 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.839 -0.8 . . . . 75.13 108.839 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -125.61 138.16 53.92 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.706 -0.479 . . . . 75.35 109.706 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.761 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 33.4 m -136.34 128.71 30.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.697 0.284 . . . . 65.25 110.374 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -104.59 141.84 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 71.11 110.798 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.91 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 31.1 m -134.03 170.02 16.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.099 -0.704 . . . . 73.15 109.099 172.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.98 -62.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.258 0.836 . . . . 73.23 113.258 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -144.23 126.86 16.07 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.177 -0.609 . . . . 73.25 111.654 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.683 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 86.84 -10.5 67.71 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 119.084 -0.842 . . . . 74.11 114.806 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.91 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 3.0 mm? -103.03 129.38 49.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.782 1.291 . . . . 74.3 112.41 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 38.4 tt0 -139.77 118.08 12.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.242 -0.651 . . . . 75.31 109.242 165.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.761 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 66.7 t80 -104.9 121.33 43.47 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.798 -0.361 . . . . 75.04 110.325 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 87.2 m -127.3 128.22 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 72.3 111.385 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.7 t -122.48 132.33 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.824 -0.806 . . . . 70.32 108.824 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 p -134.33 125.61 27.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.104 -0.332 . . . . 71.54 110.104 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.67 151.27 23.19 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.803 -1.189 . . . . 75.44 113.04 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 27.3 m -138.12 134.23 34.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.766 -0.828 . . . . 73.22 108.766 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 54' ' ' VAL . . . -144.39 131.98 21.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.581 -0.448 . . . . 73.54 111.914 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.9 143.85 55.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.633 -0.712 . . . . 74.44 109.164 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 m -54.69 -27.12 38.02 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.451 0.537 . . . . 63.53 112.451 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -88.52 6.56 37.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.152 0.501 . . . . 63.43 110.529 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.5 p 52.41 24.98 3.22 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.812 0.845 . . . . 74.11 112.507 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 p -85.06 -50.81 7.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.192 0.52 . . . . 74.34 111.101 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.61 100.22 9.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.745 -0.835 . . . . 75.32 108.745 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 HG13 ' HB1' ' A' ' 47' ' ' ALA . 15.1 t -125.31 132.65 70.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.466 -0.788 . . . . 72.01 110.798 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 124.7 52.09 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 73.03 108.98 173.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.16 103.84 0.54 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.885 -0.674 . . . . 64.11 111.725 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 t -111.15 139.28 46.66 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.11 0.481 . . . . 73.41 110.177 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.38 124.59 46.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.936 -1.135 . . . . 74.13 107.936 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 56.5 mt-10 -120.24 119.11 32.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.328 0.585 . . . . 74.25 110.331 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 73' ' ' GLU . 5.0 t -110.83 120.59 42.89 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.153 -0.684 . . . . 74.04 109.153 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.854 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 2.7 mptp? -110.21 137.67 47.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 72.31 109.496 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.683 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 18.2 m-85 -115.23 118.86 34.5 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.079 -1.082 . . . . 74.03 108.079 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.529 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ptt180 -131.57 108.41 9.52 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.388 -0.925 . . . . 74.34 111.879 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -95.7 100.74 12.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.124 -1.398 . . . . 75.01 108.745 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m 72.8 124.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.348 1.03 . . . . 65.23 111.556 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.84 130.58 46.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.048 -0.723 . . . . 74.13 109.048 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 63.34 66.15 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.289 -0.634 . . . . 72.3 109.289 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.55 -107.26 0.21 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.972 -0.632 . . . . 73.31 111.578 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.571 ' CD1' HG13 ' A' ' 87' ' ' VAL . 2.0 mm? -117.51 132.75 56.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.236 0.458 . . . . 72.41 112.236 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 60.0 m -136.34 119.18 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.28 0.562 . . . . 72.41 111.204 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 59.0 m-85 -109.87 133.36 53.25 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.972 -0.751 . . . . 73.24 108.972 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -125.14 132.66 53.04 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.509 -0.476 . . . . 73.33 111.573 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 37.3 mt-10 -125.34 123.25 38.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 75.34 109.439 171.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 63.0 tttp -122.76 109.66 14.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.288 -0.264 . . . . 70.44 110.288 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -107.29 134.3 50.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.959 -0.386 . . . . 74.43 109.959 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -120.1 155.13 33.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 73.34 110.529 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -58.24 -22.88 54.01 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.226 0.536 . . . . 75.53 111.38 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.58 ' HB3' HG21 ' A' ' 107' ' ' THR . 46.6 m-20 -71.51 -1.39 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.569 -0.741 . . . . 71.34 111.829 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 20.5 m120 78.98 21.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.543 0.737 . . . . 74.2 109.925 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.853 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 3.6 m -90.72 118.99 30.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.559 -0.746 . . . . 73.43 110.757 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.2 mm? -101.13 118.14 36.41 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.411 -0.359 . . . . 75.23 110.556 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.78 96.14 0.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.606 -0.997 . . . . 63.45 110.606 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -143.59 156.1 44.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.088 0.403 . . . . 74.43 112.088 -169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 mm-40 159.52 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 125.207 1.567 . . . . 64.34 110.047 167.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.55 137.71 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.644 0.609 . . . . 73.25 112.644 -161.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.623 ' HB ' HG23 ' A' ' 98' ' ' THR . 12.8 t -129.38 140.39 51.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.977 0.418 . . . . 74.21 110.946 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 97' ' ' LEU . 6.2 m -117.88 138.44 48.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.11 -0.496 . . . . 74.31 109.834 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -114.42 116.57 29.11 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.507 -0.477 . . . . 74.32 110.827 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 93' ' ' ARG . 7.3 p-10 39.71 31.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.679 1.191 . . . . 72.22 113.612 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -75.2 -47.84 26.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 72.21 109.957 176.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -70.07 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.197 -0.668 . . . . 74.22 109.197 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -99.2 122.72 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.219 -0.446 . . . . 73.03 110.2 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 10.1 tpp85 -63.66 124.87 22.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.289 -0.414 . . . . 73.02 110.559 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.526 ' H ' ' HB3' ' A' ' 89' ' ' ASP . . . 97.0 -22.74 39.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.058 -0.591 . . . . 72.41 112.093 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 39.6 tp -89.92 136.93 32.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.009 0.433 . . . . 74.13 110.244 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.929 ' HE3' ' HD2' ' A' ' 119' ' ' LYS . 63.8 mmtt -121.66 116.5 24.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.186 -0.672 . . . . 74.2 109.186 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.695 ' HB2' HG21 ' A' ' 87' ' ' VAL . 2.4 mm? -108.0 127.52 53.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.937 -0.394 . . . . 73.51 109.937 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.908 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.3 m -129.35 119.55 24.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 72.12 111.42 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.559 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 87.4 m-85 -104.82 121.09 42.93 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.983 -1.118 . . . . 73.14 107.983 171.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 9.4 t70 -130.45 127.54 39.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.83 0.706 . . . . 73.54 109.35 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 p -140.24 130.68 25.39 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.275 -0.97 . . . . 75.31 112.156 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 45.1 t -113.32 122.27 46.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.57 -0.741 . . . . 52.2 109.448 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.672 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 36.5 p90 -138.03 119.24 14.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.877 0.846 . . . . 71.35 112.162 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.853 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 43.3 t -132.24 137.02 29.08 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.592 -1.186 . . . . 74.22 109.244 166.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.89 -1.85 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.626 2.217 . . . . 63.34 111.183 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -110.2 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.676 -0.693 . . . . 73.24 110.173 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.58 HG21 ' HB3' ' A' ' 78' ' ' ASP . 3.3 t -146.89 133.86 20.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.433 -0.951 . . . . 75.44 108.433 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.4 ' HA3' HG23 ' A' ' 80' ' ' THR . . . 100.07 36.03 4.31 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 118.33 -1.891 . . . . 71.12 111.2 -164.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 104' ' ' SER . 11.7 mptt -55.61 155.95 5.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.481 0.658 . . . . 72.34 112.143 -168.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.672 ' HG3' ' HB3' ' A' ' 103' ' ' PHE . 52.7 tttp -71.03 115.06 9.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.856 -1.065 . . . . 74.24 111.869 -159.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -133.44 132.8 41.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.455 -1.248 . . . . 72.24 109.167 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.58 127.9 54.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.032 -0.531 . . . . 62.42 110.593 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 30.6 mmtp -111.82 137.29 49.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.01 -0.541 . . . . 75.32 110.126 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.429 HG22 ' CG ' ' A' ' 129' ' ' MET . 3.4 tp -120.58 116.9 51.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.878 -0.786 . . . . 73.23 108.878 171.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.908 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.1 ttmp? -114.79 121.26 42.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.251 -0.886 . . . . 74.21 110.048 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.4 t -116.61 118.15 31.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.344 0.593 . . . . 75.0 109.448 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.95 151.5 17.02 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.749 -0.739 . . . . 60.21 112.087 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -132.87 127.68 34.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.316 -0.624 . . . . 73.43 109.316 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.929 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 68.3 mttm -110.77 120.26 41.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.139 -0.624 . . . . 74.44 111.465 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.655 ' HB2' HG21 ' A' ' 123' ' ' ILE . 80.5 mtp180 -109.58 162.56 14.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.079 -0.964 . . . . 75.23 108.612 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.54 -38.87 60.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.404 0.52 . . . . 65.32 112.404 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -120.86 8.27 10.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.569 -0.287 . . . . 65.31 111.737 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.754 HD13 ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -139.58 131.39 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.178 0.514 . . . . 74.04 111.234 -173.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.4 t30 -122.15 119.4 31.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.044 -0.526 . . . . 71.21 110.764 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.636 HD11 HD11 ' A' ' 142' ' ' LEU . 4.5 mm? -110.66 134.26 52.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 72.43 109.368 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.77 116.01 0.83 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.338 -0.934 . . . . 75.31 112.217 176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 73.5 m -110.33 107.45 17.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.999 0.428 . . . . 74.51 110.54 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 27.3 t70 -111.91 118.35 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.685 -0.689 . . . . 74.23 109.313 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.429 ' CG ' HG22 ' A' ' 114' ' ' ILE . 23.8 ptp -129.25 147.97 51.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.673 -0.811 . . . . 65.32 112.061 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 3.1 m-20 -76.04 119.72 20.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.535 -1.283 . . . . 75.45 107.535 174.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -86.53 109.41 19.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.265 0.839 . . . . 73.23 113.265 -163.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HA ' ' HG3' ' A' ' 136' ' ' PRO . 20.1 t70 43.34 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.87 1.433 . . . . 74.54 114.87 161.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -60.95 -26.15 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.663 0.616 . . . . 75.5 112.663 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.496 ' N ' HD13 ' A' ' 133' ' ' ILE . . . -93.21 -5.18 50.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.048 0.452 . . . . 75.5 110.57 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.05 109.79 3.31 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.042 -0.823 . . . . 70.14 111.042 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 132' ' ' ASP . 27.4 Cg_exo -61.38 100.62 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.802 2.335 . . . . 74.14 112.553 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 45.0 t -126.87 128.77 47.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 74.42 108.943 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.98 117.12 52.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.184 -0.606 . . . . 73.2 110.868 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 156' ' ' ASN . 24.1 mtt180 -108.08 121.64 45.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.021 -0.733 . . . . 74.2 109.021 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.68 131.55 10.45 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.791 -1.195 . . . . 73.15 111.603 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -122.24 116.24 23.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.764 -0.458 . . . . 74.31 109.764 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.636 HD11 HD11 ' A' ' 125' ' ' LEU . 12.9 tp -122.24 124.53 44.01 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.262 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 7' ' ' TYR . 57.3 t -122.38 121.86 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 75.02 109.983 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.754 ' HG ' HD13 ' A' ' 123' ' ' ILE . 4.3 mp -109.11 137.21 47.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.091 -0.707 . . . . 74.12 109.091 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.507 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -122.38 119.0 3.82 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.617 -0.801 . . . . 75.52 112.847 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.425 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 47.5 m-85 -129.71 147.56 51.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.402 -1.333 . . . . 74.51 107.402 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -56.45 101.2 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.452 0.644 . . . . 75.25 111.059 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.733 ' HA2' ' HB3' ' A' ' 174' ' ' LYS . . . 104.09 -33.49 6.53 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.984 -1.007 . . . . 63.32 112.107 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 2.2 m-90 -107.01 120.26 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.212 -0.581 . . . . 73.5 111.898 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.507 HD23 ' HA2' ' A' ' 145' ' ' GLY . 7.6 mt -123.2 138.17 54.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.274 -0.421 . . . . 73.2 109.892 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -143.06 124.38 14.65 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.875 -0.33 . . . . 71.12 110.174 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.8 131.71 4.42 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.503 -0.856 . . . . 73.5 111.405 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 37.9 p90 -142.65 144.66 32.87 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.095 -0.642 . . . . 74.42 111.952 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 77.2 mt-30 -111.87 121.74 45.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.052 -0.976 . . . . 74.3 109.303 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 87.8 mtp -118.94 129.84 55.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.874 -0.787 . . . . 64.5 108.874 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -109.99 114.56 28.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.969 -0.752 . . . . 74.54 108.969 -177.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.648 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 25.1 m-85 -94.34 118.49 31.7 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 74.45 110.355 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.448 ' OE1' ' HG3' ' A' ' 161' ' ' LYS . 38.0 tt0 -86.71 100.68 12.65 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 108.967 -0.753 . . . . 73.52 108.967 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 m -70.56 -17.46 62.92 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.334 -1.757 . . . . 75.13 111.355 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.85 92.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.341 -0.985 . . . . 71.2 108.341 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.448 ' HG3' ' OE1' ' A' ' 158' ' ' GLU . 61.4 mttp -99.95 -159.5 0.74 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.538 -1.21 . . . . 75.44 108.299 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 p -109.15 28.44 8.5 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.221 -0.3 . . . . 62.21 110.528 172.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -151.7 150.58 30.38 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 119.086 -1.045 . . . . 74.13 112.249 -161.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.3 m -74.3 134.95 28.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.079 0.466 . . . . 74.3 110.325 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 9.4 t -95.45 -23.12 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.999 -0.546 . . . . 74.21 111.03 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -139.72 132.63 29.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 75.52 110.617 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.412 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 14.4 m -122.34 129.91 52.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.492 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.94 121.41 21.63 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.964 -0.384 . . . . 73.42 109.964 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.678 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 91.2 m-85 -121.01 140.48 51.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.827 0.346 . . . . 70.24 110.964 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.91 128.58 24.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.132 0.491 . . . . 64.42 110.077 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.671 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -127.19 150.15 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.495 -0.557 . . . . 72.25 109.495 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.46 120.06 2.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.114 -0.565 . . . . 55.23 111.868 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -113.29 120.73 42.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.861 0.362 . . . . 74.23 110.085 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.733 ' HB3' ' HA2' ' A' ' 148' ' ' GLY . 29.7 ttmt -104.68 123.9 48.42 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.433 -0.58 . . . . 63.42 109.433 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.9 m -134.42 114.09 12.54 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.513 -0.551 . . . . 64.24 109.513 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 47.66 -93.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.816 0.673 . . . . 73.43 112.816 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -111.48 6.41 20.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.02 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.841 ' HD2' HE22 ' A' ' 196' ' ' GLN . 7.2 m-85 -113.34 127.37 56.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.503 -0.317 . . . . 72.21 110.794 -173.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.892 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.1 mm-40 -112.06 124.61 52.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.667 -0.864 . . . . 74.24 108.667 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.406 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 5.6 tt -122.22 134.09 54.71 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.725 -0.609 . . . . 73.51 110.577 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 41.0 t60 -119.97 116.7 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.876 -0.602 . . . . 71.13 110.575 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.671 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 12.3 m -90.46 141.01 29.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.988 -0.745 . . . . 74.45 108.988 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -142.4 138.77 31.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.358 -0.537 . . . . 74.05 111.187 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.678 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 61.0 t -132.39 125.8 54.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.41 -0.814 . . . . 75.42 110.067 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 26.2 t-20 -117.06 107.76 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.249 -0.648 . . . . 75.35 109.249 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.5 t70 62.93 -171.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.919 -0.771 . . . . 74.21 108.919 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.93 -6.33 89.16 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.452 -0.88 . . . . 73.02 111.356 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.5 m -97.83 -25.68 14.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.836 0.68 . . . . 74.41 112.836 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 3.7 tp10 -118.21 113.68 21.89 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.603 -0.686 . . . . 72.52 110.751 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.569 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 42.4 p90 -135.56 132.1 36.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.775 -0.37 . . . . 74.3 110.735 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.682 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -169.83 -158.91 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.238 -0.982 . . . . 73.44 113.404 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.14 178.43 23.85 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.527 -0.368 . . . . 63.54 112.528 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 181' ' ' HIS . 18.8 m -149.84 147.43 27.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.654 -0.499 . . . . 70.11 109.654 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.6 mp -128.79 124.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.659 0.266 . . . . 75.41 110.942 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.892 ' HB2' ' HB2' ' A' ' 179' ' ' GLN . 43.8 m-85 -108.19 123.66 49.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.667 -0.494 . . . . 75.35 109.667 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.983 HE21 ' HA ' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -120.7 124.67 45.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.313 -0.403 . . . . 73.15 111.763 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 203' ' ' GLU . 11.6 mmtp -96.0 107.51 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 73.51 109.532 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.89 92.43 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.911 -0.586 . . . . 72.52 110.642 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.7 26.5 11.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.255 -0.884 . . . . 64.33 111.553 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 68.41 5.12 4.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.345 -0.843 . . . . 73.53 112.539 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.42 -38.87 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 75.42 111.117 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.56 151.99 40.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.411 . . . . 73.2 110.759 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.41 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 41.6 tt0 -117.11 132.21 56.72 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.814 -0.81 . . . . 74.32 108.814 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -123.06 143.16 50.14 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.211 -0.292 . . . . 75.34 110.211 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 222' ' ' ALA . . . -129.66 136.39 49.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.123 0.487 . . . . 75.45 110.848 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 193' ' ' SER . 39.3 t -112.89 130.91 65.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.652 . . . . 75.14 109.538 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 18' ' ' PHE . 14.2 m120 -114.52 128.95 56.6 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.277 -0.638 . . . . 73.23 109.277 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.699 HD12 ' HD2' ' A' ' 219' ' ' PHE . 5.5 tp -146.92 134.29 20.73 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.409 -0.359 . . . . 72.15 110.357 -170.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.682 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -157.74 150.44 22.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.849 0.357 . . . . 54.41 111.466 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.547 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 29.4 t-105 -115.79 133.03 56.44 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.985 -0.746 . . . . 73.11 108.985 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.829 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 20.9 m -95.54 108.23 20.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.709 -0.478 . . . . 74.35 109.709 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.569 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.62 147.5 49.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.79 . . . . 74.54 111.706 -174.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.03 -74.74 0.21 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.717 -0.674 . . . . 63.31 111.677 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -173.8 85.07 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 74.05 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.829 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 49.0 m -156.7 165.85 35.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.716 . . . . 75.13 109.415 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.05 160.01 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.921 -0.4 . . . . 63.03 109.921 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.547 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 9.2 t -78.7 134.46 37.1 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.591 -0.522 . . . . 63.33 109.591 174.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.464 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 20.5 mtt180 -92.21 117.72 30.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.881 -0.415 . . . . 75.55 109.881 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.699 ' HD2' HD12 ' A' ' 208' ' ' LEU . 33.9 t80 -114.13 148.82 36.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.564 -0.532 . . . . 73.2 109.564 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.58 152.35 23.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.459 -0.877 . . . . 74.32 112.578 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.512 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.3 mp -135.92 130.23 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.816 -0.439 . . . . 72.01 109.816 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.633 ' HB1' HG13 ' A' ' 17' ' ' VAL . . . -120.99 154.29 36.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.835 -0.432 . . . . 73.45 109.835 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -138.44 124.31 19.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.906 0.384 . . . . 62.52 110.313 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -111.26 113.68 26.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.559 -0.904 . . . . 65.21 108.559 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -113.51 114.07 26.01 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.044 0.45 . . . . 74.45 110.037 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.662 ' H ' ' NE2' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -91.07 117.26 29.45 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.761 -0.829 . . . . 71.04 108.761 173.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 228' ' ' ASP . 3.2 mp -69.17 -53.28 26.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 73.23 109.546 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 227' ' ' ILE . 22.4 t70 172.66 -48.96 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 O-C-N 124.006 0.816 . . . . 71.4 110.929 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.522 ' HB2' ' H ' ' A' ' 230' ' ' ASP . 86.1 Cg_endo -78.42 -144.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.337 2.024 . . . . 72.44 113.331 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.522 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 4.1 t0 -93.39 16.41 13.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 72.43 110.463 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.38 123.89 44.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.545 -0.752 . . . . 53.14 110.237 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.8 143.45 50.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 72.43 110.308 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -97.03 129.84 44.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.053 -0.521 . . . . 74.31 109.696 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -121.15 119.27 31.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.013 0.435 . . . . 63.25 110.135 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -123.5 152.14 42.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.078 -0.51 . . . . 64.41 110.012 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 19.9 ptpt -153.26 140.67 19.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.922 -0.399 . . . . 73.53 109.922 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 9.9 p -132.91 141.16 45.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.073 0.463 . . . . 64.51 109.959 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.637 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 20.7 m120 -108.46 150.22 27.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.126 -0.488 . . . . 62.24 109.796 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 241' ' ' SER . 9.0 p30 -50.51 -27.39 6.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.252 0.97 . . . . 74.45 113.241 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.616 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 6.0 m -82.03 24.51 0.63 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.581 . . . . 73.12 109.938 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.462 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 57.6 m 66.05 39.33 4.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.926 -1.034 . . . . 75.03 111.297 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.764 HD23 HD13 ' A' ' 262' ' ' LEU . 5.5 mp -91.76 121.72 33.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 120.545 -0.462 . . . . 73.22 111.141 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.54 115.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 O-C-N 123.62 0.575 . . . . 75.44 110.024 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.83 133.54 9.46 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.55 -0.833 . . . . 63.2 113.082 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -140.92 141.36 34.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.969 0.414 . . . . 73.55 110.201 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.97 165.51 36.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.358 -0.925 . . . . 64.11 112.547 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -129.87 129.95 44.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.055 0.455 . . . . 75.11 110.462 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.554 HG21 HG21 ' A' ' 258' ' ' THR . 19.8 p -113.46 115.61 28.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.702 . . . . 74.21 109.725 177.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.3 132.88 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 73.22 111.617 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 17.5 m -77.81 120.45 22.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.976 -0.556 . . . . 61.45 109.591 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.437 ' HB3' HG21 ' A' ' 255' ' ' ILE . 16.1 tp -81.27 -55.28 4.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.582 0.706 . . . . 75.41 109.213 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 255' ' ' ILE . 5.9 mtpm? -136.66 158.08 73.84 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.894 -1.15 . . . . 72.53 107.894 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.05 90.4 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.701 1.601 . . . . 74.45 110.422 171.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 282' ' ' GLN . . . 137.39 -9.51 3.78 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.848 -0.692 . . . . 75.51 111.786 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.545 HG22 ' HB2' ' A' ' 252' ' ' LYS . 6.5 tp -148.51 122.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.575 0.702 . . . . 73.01 111.464 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.56 135.25 53.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.591 -0.731 . . . . 74.44 110.527 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.65 126.76 45.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.465 -0.789 . . . . 72.35 110.419 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.554 HG21 HG21 ' A' ' 248' ' ' THR . 86.5 m -118.15 111.45 18.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 74.51 110.808 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.925 HD23 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -115.4 129.19 56.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.576 -0.898 . . . . 75.31 108.576 175.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.638 ' O ' ' HB2' ' A' ' 275' ' ' LEU . 11.0 t -151.11 146.25 26.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.51 . . . . 64.42 109.624 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.563 ' HA ' ' CB ' ' A' ' 275' ' ' LEU . . . -139.72 127.51 21.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.636 0.255 . . . . 74.21 110.511 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.764 HD13 HD23 ' A' ' 242' ' ' LEU . 2.2 tm? -112.92 118.31 34.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.593 -0.891 . . . . 75.42 108.593 176.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.646 ' HB3' HG13 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -101.45 110.07 22.0 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.603 -0.888 . . . . 64.23 108.603 176.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.71 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 1.9 m-20 -68.65 104.34 1.95 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.85 -1.167 . . . . 71.41 107.85 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.3 -27.37 46.79 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.908 -0.587 . . . . 70.2 113.298 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -90.84 -20.14 22.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.718 0.294 . . . . 73.23 110.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.71 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 66.2 t30 -101.89 -36.1 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.654 -0.248 . . . . 54.42 111.398 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 263' ' ' LEU . 34.7 m -63.18 -18.72 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.722 0.267 . . . . 74.52 111.722 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.65 -44.75 85.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.796 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.59 10.23 37.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.943 0.401 . . . . 74.42 110.837 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.63 97.88 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.023 -0.608 . . . . 50.14 111.979 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.421 ' HA3' ' ND2' ' A' ' 267' ' ' ASN . . . -175.99 75.63 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.824 -0.703 . . . . 71.3 112.143 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -113.73 145.96 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 122.413 0.285 . . . . 74.31 110.269 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.59 131.18 48.13 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.117 -0.697 . . . . 71.34 109.117 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 260' ' ' SER . 0.4 OUTLIER -140.68 158.12 44.43 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 72.52 113.974 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.56 117.19 3.53 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 114.552 -1.204 . . . . 74.33 111.317 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.925 HD23 HD23 ' A' ' 259' ' ' LEU . 2.2 tm? -114.36 121.87 44.95 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.909 -1.145 . . . . 75.11 107.909 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -142.46 137.28 7.71 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.89 -1.148 . . . . 75.22 113.309 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.39 130.51 55.67 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.306 -0.627 . . . . 71.12 109.306 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.32 111.18 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.627 -0.509 . . . . 72.14 109.627 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.709 ' HB3' HD23 ' A' ' 31' ' ' LEU . 42.3 t80 -112.99 110.33 20.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 74.43 109.812 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.718 HE21 HD23 ' A' ' 284' ' ' LEU . 49.9 tt0 -114.49 110.21 19.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.876 -0.602 . . . . 72.44 109.677 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -92.34 110.91 22.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.241 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.718 HD23 HE21 ' A' ' 282' ' ' GLN . 55.7 mt -108.69 97.66 7.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 75.33 110.41 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.594 -0.717 . . . . 75.24 109.127 176.828 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.665 ' HA ' ' HG3' ' A' ' 93' ' ' ARG . 72.5 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.337 0.113 . . . . 72.32 110.769 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.13 106.08 17.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.774 0.321 . . . . 72.54 110.491 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 121' ' ' GLU . 11.5 t -116.61 112.91 40.69 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 63.3 109.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.66 166.95 22.38 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.231 2.621 . . . . 63.0 112.786 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 81.95 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.924 2.416 . . . . 74.12 111.789 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.0 p -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.484 -0.78 . . . . 64.1 111.386 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -60.48 -29.87 69.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.914 -0.584 . . . . 63.12 111.572 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.53 -19.57 38.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 70.24 110.965 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.98 13.68 33.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.41 0.624 . . . . 73.3 110.008 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 150' ' ' LEU . 72.4 mt -66.09 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.911 -0.586 . . . . 74.25 110.578 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.89 75.12 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.083 -0.58 . . . . 71.14 112.05 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -44.89 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.933 -0.395 . . . . 74.04 109.933 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p -56.4 -36.91 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.64 -0.709 . . . . 74.44 111.541 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.72 -37.6 73.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 74.53 111.376 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -63.26 -37.94 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.612 0.244 . . . . 62.13 111.147 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.09 -49.1 63.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.598 . . . . 71.23 110.69 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.615 HG21 ' CB ' ' A' ' 205' ' ' ALA . 79.0 t -84.58 -47.77 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.695 0.998 . . . . 73.43 113.695 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.17 -28.08 67.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.589 0.589 . . . . 74.1 112.589 -166.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -73.88 -16.79 61.11 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.819 -0.352 . . . . 75.43 110.96 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 0.1 OUTLIER 64.51 -82.61 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.262 -0.644 . . . . 75.14 109.262 -170.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.19 165.43 12.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.819 -1.312 . . . . 74.4 109.819 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.889 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 2.0 t80 -57.12 -44.94 83.76 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.904 -0.776 . . . . 74.44 108.904 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.72 28.45 56.88 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.219 -0.9 . . . . 73.4 114.422 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.546 ' HD2' ' HB2' ' A' ' 26' ' ' LEU . 56.3 t80 -87.78 -4.97 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.415 0.626 . . . . 74.03 109.455 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.457 ' C ' HD11 ' A' ' 26' ' ' LEU . . . 75.31 0.99 63.19 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.378 -0.828 . . . . 72.11 112.41 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.752 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 mp -134.55 178.76 6.74 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.262 1.029 . . . . 72.22 112.358 -172.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.633 HG23 HD12 ' A' ' 277' ' ' LEU . 12.5 mm -103.69 122.43 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.579 -1.646 . . . . 74.54 107.988 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 34.9 mtmt -120.73 126.93 51.42 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.07 -0.652 . . . . 72.23 110.97 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.488 HD13 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tt -120.47 143.48 48.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.784 -0.644 . . . . 71.0 110.554 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.3 p30 -138.84 140.26 38.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.147 0.499 . . . . 75.25 109.844 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 281' ' ' PHE . 14.5 tp -125.43 123.56 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.595 -0.729 . . . . 75.53 109.338 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -117.1 123.77 47.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 75.04 110.032 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.732 ' HB ' ' HB1' ' A' ' 283' ' ' ALA . 2.1 t -137.88 122.4 18.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.695 -0.684 . . . . 73.21 110.19 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -104.45 158.21 16.63 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.616 -0.434 . . . . 65.24 110.316 177.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -134.24 135.95 43.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.286 -0.635 . . . . 74.13 109.286 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 39.64 -99.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.357 1.035 . . . . 73.42 112.333 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.592 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 9.4 p30 -147.57 149.13 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.144 -0.687 . . . . 75.41 109.144 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 75.64 -11.02 10.88 Favored Glycine 0 C--O 1.213 -1.199 0 CA-C-O 119.236 -0.758 . . . . 74.32 114.187 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.52 127.25 52.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 119.457 1.629 . . . . 73.4 112.158 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.827 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 27.5 tt0 -142.53 118.85 10.84 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.98 -0.378 . . . . 73.21 109.98 162.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.531 ' HB3' HG22 ' A' ' 33' ' ' THR . 67.3 t80 -97.31 121.45 39.21 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.183 -0.673 . . . . 74.01 109.183 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.731 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.6 m -120.79 115.91 24.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.228 0.537 . . . . 73.52 110.772 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 34.6 t -107.88 134.46 50.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 74.25 109.43 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.2 m -135.05 126.94 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 71.22 110.331 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 130.26 5.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.453 -0.879 . . . . 64.43 111.846 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.2 m -111.42 133.46 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.474 -0.565 . . . . 53.32 109.474 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.71 135.0 37.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.729 -0.214 . . . . 72.22 110.578 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.752 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 54.2 t30 -69.28 143.07 53.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.783 -0.451 . . . . 74.11 109.783 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -64.62 124.32 21.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.486 . . . . 75.32 111.24 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 73.23 -65.41 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.313 -0.858 . . . . 74.14 111.11 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 3.1 m -78.5 113.13 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.213 -0.662 . . . . 65.24 109.213 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.0 p -75.44 93.08 2.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.068 0.766 . . . . 74.23 113.068 -168.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -113.78 99.6 7.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.868 -1.16 . . . . 75.13 107.868 165.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 46' ' ' SER . 13.9 t -114.21 120.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.818 -0.628 . . . . 71.21 111.115 -171.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -109.74 142.77 40.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.628 -0.715 . . . . 74.53 109.25 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.71 128.39 8.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.802 -0.713 . . . . 74.24 112.773 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.8 m -116.05 127.06 54.58 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.688 -0.856 . . . . 73.24 108.688 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.5 tm? -120.84 123.84 43.57 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.42 -0.585 . . . . 74.02 109.42 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.731 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 43.0 mt-10 -110.36 118.53 36.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.843 -0.617 . . . . 54.01 109.691 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 73' ' ' GLU . 9.1 t -98.75 119.94 38.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.624 -1.25 . . . . 71.11 107.624 172.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 28.0 ttmt -125.27 138.74 54.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.36 0.6 . . . . 74.24 111.261 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 98.9 m-85 -104.28 120.73 41.83 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.287 -0.87 . . . . 75.14 108.913 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.827 ' HG3' ' HB2' ' A' ' 40' ' ' GLU . 12.4 mtp85 -83.85 133.07 34.76 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.722 0.772 . . . . 72.44 111.304 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.86 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 8.8 p-90 -80.33 74.85 7.17 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 112.807 -1.997 . . . . 73.11 115.674 -161.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 37' ' ' ASN . 2.7 m -124.83 -17.8 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.655 -0.702 . . . . 75.23 111.03 -172.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.28 -36.12 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 75.15 109.881 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HB3' HD11 ' A' ' 69' ' ' LEU . 15.1 t80 -162.14 18.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 74.43 109.278 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.555 ' O ' HD12 ' A' ' 69' ' ' LEU . . . 80.81 56.59 3.06 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.072 -0.811 . . . . 55.43 111.072 -172.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.86 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 5.7 mp -139.59 127.98 22.79 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 113.749 1.018 . . . . 75.25 113.749 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.504 ' HG1' ' HB3' ' A' ' 64' ' ' TRP . 3.8 m -117.09 132.98 56.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.92 -0.488 . . . . 75.01 110.944 -173.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.583 ' HB3' ' HD2' ' A' ' 62' ' ' TYR . 44.7 t80 -123.19 120.36 32.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.981 -0.748 . . . . 62.44 108.981 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -126.7 117.29 22.42 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.813 -0.355 . . . . 75.41 110.915 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.5 tt0 -104.44 120.63 41.67 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.836 -0.802 . . . . 63.1 108.836 172.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -106.46 92.86 4.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.834 -0.621 . . . . 74.4 109.777 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.832 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 60.8 t90 -95.78 131.37 42.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.863 -0.335 . . . . 74.44 110.549 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.23 142.87 35.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.804 -0.813 . . . . 73.2 108.804 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.5 t -59.2 -9.82 2.42 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.618 0.97 . . . . 74.31 113.618 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 5.5 m-20 -71.24 -41.13 70.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.107 -0.237 . . . . 72.34 110.773 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 28.8 t-20 149.55 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.439 1.087 . . . . 73.1 109.745 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -80.7 132.19 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.645 . . . . 75.43 111.467 -173.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.832 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.8 pt? -124.28 146.5 48.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 71.31 110.681 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.57 117.05 4.08 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.517 -0.633 . . . . 71.33 111.517 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 100' ' ' ASP . 29.2 m -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.601 0.239 . . . . 71.43 110.734 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -125.13 108.37 11.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 70.45 110.118 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.04 129.66 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 74.35 110.699 -178.316 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 70' ' ' THR . 44.8 p -118.37 134.39 55.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 75.14 110.741 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.683 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 m -116.66 131.67 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.631 -0.507 . . . . 74.34 109.631 172.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 122.86 48.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 175.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 93' ' ' ARG . 35.6 t0 70.01 85.15 0.14 Allowed 'General case' 0 C--O 1.223 -0.323 0 O-C-N 124.029 0.831 . . . . 73.12 109.983 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 90' ' ' GLN . 6.6 tp60 -102.98 5.16 38.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.457 -0.942 . . . . 75.3 108.457 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.5 tp 178.6 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.354 -1.294 . . . . 74.24 108.89 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.6 126.07 16.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.076 -0.965 . . . . 62.53 109.796 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.665 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -64.03 135.85 56.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 75.42 111.076 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.23 -14.78 54.95 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.003 -0.839 . . . . 73.33 111.003 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.24 126.22 38.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 73.23 109.293 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.3 ttpp -122.05 111.16 16.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.694 -0.685 . . . . 75.52 110.319 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HB2' HG23 ' A' ' 87' ' ' VAL . 2.1 mm? -101.23 127.64 47.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.221 -0.659 . . . . 71.5 109.221 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 31.9 m -129.46 124.92 35.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.94 0.4 . . . . 62.33 111.437 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.28 116.05 31.29 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.234 -0.654 . . . . 73.51 109.234 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.2 t70 -111.68 133.51 53.87 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.003 -0.74 . . . . 75.03 109.003 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 m -141.44 121.87 14.07 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.941 0.4 . . . . 74.54 110.734 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 22.8 t -96.07 121.55 37.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.749 -1.204 . . . . 73.41 107.749 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.6 131.27 27.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.236 0.541 . . . . 73.22 111.22 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 16.5 m -119.8 103.43 45.89 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.542 -0.754 . . . . 74.45 109.293 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' ' OD1' ' A' ' 79' ' ' ASN . 47.6 Cg_exo -56.89 -33.91 95.92 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.972 2.448 . . . . 73.14 112.908 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -84.47 -40.47 17.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 71.02 111.01 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 104' ' ' SER . 5.8 m -81.99 -32.86 30.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.227 -0.442 . . . . 71.31 112.126 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 1.93 68.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.59 -0.814 . . . . 63.1 111.855 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.96 129.07 38.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.601 0.239 . . . . 73.15 110.426 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -139.39 122.27 16.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 75.22 110.464 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.736 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 8.5 m120 -121.54 123.51 42.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.924 -0.58 . . . . 74.55 109.812 172.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.91 113.8 27.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.067 -0.515 . . . . 71.52 109.68 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 4.8 ttmp? -122.67 138.1 54.71 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.05 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 tp -129.3 117.4 43.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.203 0.525 . . . . 72.41 110.16 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 1.7 mtpp -105.72 118.75 37.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 64.41 109.009 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 t -114.47 118.48 33.91 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.18 0.514 . . . . 63.41 109.739 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.93 118.24 2.96 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.466 -0.874 . . . . 71.11 112.184 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -106.76 117.59 34.45 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.018 -0.734 . . . . 72.42 109.018 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' HB3' HG11 ' A' ' 3' ' ' VAL . 42.5 mtmt -109.22 122.11 46.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.31 0.576 . . . . 73.32 110.383 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -106.39 146.55 30.33 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.604 -1.628 . . . . 73.1 106.604 165.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.572 ' HG3' HG22 ' A' ' 3' ' ' VAL . 2.2 mt-10 -55.23 -27.46 46.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.861 0.362 . . . . 75.21 111.758 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -88.99 -35.67 16.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 70.44 111.679 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.728 HD11 HD11 ' A' ' 142' ' ' LEU . 8.7 tp -145.36 127.52 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 121.015 -0.274 . . . . 73.33 111.623 -167.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.545 HD22 ' HB ' ' A' ' 143' ' ' VAL . 3.6 p-10 -122.53 128.44 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.694 0.759 . . . . 73.4 111.807 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.468 HD13 HD12 ' A' ' 142' ' ' LEU . 4.5 mm? -112.52 131.36 55.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.86 -1.064 . . . . 75.22 110.062 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.62 117.07 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.555 -0.831 . . . . 73.34 112.3 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.9 t -112.29 109.12 18.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.088 0.47 . . . . 70.32 110.135 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 115' ' ' LYS . 17.1 t70 -104.02 117.89 35.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.004 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.417 ' HG2' HG13 ' A' ' 138' ' ' ILE . 58.8 mtm -118.12 117.84 30.26 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.838 -0.345 . . . . 75.13 110.903 -176.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.451 ' HB2' ' HE3' ' A' ' 113' ' ' LYS . 30.4 t70 -107.87 120.42 42.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 63.11 110.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -94.47 109.68 21.53 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.26 -0.427 . . . . 75.24 110.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -116.24 156.39 26.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 71.23 109.501 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.88 -17.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 111.961 0.356 . . . . 73.52 111.961 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.11 -17.37 32.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.117 0.484 . . . . 54.0 110.337 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.73 123.55 1.39 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.919 -0.657 . . . . 72.42 111.902 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.3 136.09 49.64 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.629 2.219 . . . . 65.42 112.135 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -117.12 137.57 52.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.54 . . . . 63.32 109.963 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.5 mp -107.46 117.98 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 73.15 110.158 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' HD2' ' OD2' ' A' ' 128' ' ' ASP . 71.6 mtt180 -105.93 111.61 24.33 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.929 -0.767 . . . . 75.23 108.929 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.62 133.36 11.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.094 -1.05 . . . . 72.44 112.108 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.41 116.63 20.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.225 0.536 . . . . 75.1 110.275 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.728 HD11 HD11 ' A' ' 123' ' ' ILE . 8.6 tp -116.04 127.07 54.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.711 -0.677 . . . . 74.32 109.979 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.545 ' HB ' HD22 ' A' ' 124' ' ' ASN . 56.6 t -128.03 134.47 65.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.065 0.46 . . . . 74.31 110.625 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.652 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.0 mp -109.41 137.04 47.87 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.648 -0.871 . . . . 74.4 108.648 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.75 121.03 5.12 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 123.819 0.699 . . . . 53.53 113.59 -173.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.01 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 92.2 m-85 -133.92 149.93 51.3 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.373 -0.973 . . . . 71.43 108.373 173.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.79 93.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.04 0.448 . . . . 75.51 111.339 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.09 47.72 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.999 -0.546 . . . . 43.53 112.336 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 1.01 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 18.8 m95 -105.83 122.38 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.348 -0.241 . . . . 72.33 110.348 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.448 ' HB3' HD23 ' A' ' 10' ' ' LEU . 19.9 mt -128.51 136.96 51.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.865 0.364 . . . . 74.12 111.142 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -127.63 128.61 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 71.55 110.253 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -132.97 133.04 6.82 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.437 -0.887 . . . . 71.51 113.373 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.2 119.29 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.744 -0.465 . . . . 75.11 109.744 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 77.9 mt-30 -113.07 121.62 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.22 0.533 . . . . 73.25 109.569 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.773 ' HE2' HG13 ' A' ' 164' ' ' VAL . 90.4 mtp -133.92 135.82 43.84 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.623 -0.51 . . . . 72.43 109.623 -176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.72 ' HB2' ' HB2' ' A' ' 166' ' ' GLN . 0.9 OUTLIER -111.56 117.54 33.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.566 -0.531 . . . . 73.04 109.566 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.832 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 14.1 m-85 -94.18 130.57 40.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.203 -0.908 . . . . 74.31 110.276 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 163' ' ' ARG . 11.9 pt-20 -96.52 124.78 40.62 Favored 'General case' 0 C--O 1.264 1.839 0 CA-C-O 121.307 0.575 . . . . 74.22 109.843 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -70.64 -16.67 62.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 113.258 -1.792 . . . . 73.44 111.511 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.25 -43.71 98.44 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.657 -0.868 . . . . 74.11 108.657 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -98.86 -159.58 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.546 -1.279 . . . . 74.42 107.546 165.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.6 m -109.52 27.31 9.69 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.825 -0.547 . . . . 71.34 109.552 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 35.8 ttm180 -151.77 160.16 43.68 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 118.513 -1.275 . . . . 75.33 112.915 -155.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.832 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -78.95 135.91 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.29 0.567 . . . . 63.54 111.369 -177.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -33.68 12.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 75.42 109.684 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.72 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 49.4 mt-30 -108.26 133.0 53.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.686 -0.688 . . . . 72.23 110.715 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.4 m -121.2 109.95 15.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 41.43 109.263 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 10.7 m120 -113.8 126.82 55.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.885 -0.783 . . . . 72.44 108.885 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 94.0 m-85 -121.51 142.68 49.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.004 -0.678 . . . . 71.15 111.149 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.431 ' HB2' ' HE1' ' A' ' 181' ' ' HIS . . . -143.29 127.38 17.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.912 -0.585 . . . . 60.43 110.247 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.651 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 67.3 t -125.38 134.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.067 -0.346 . . . . 74.11 110.067 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -112.35 102.62 1.37 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.288 -0.725 . . . . 63.51 111.288 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -112.79 119.42 37.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.799 -0.815 . . . . 73.23 108.799 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -112.37 125.94 54.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 74.24 111.422 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.2 m -120.84 154.48 35.73 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.379 -1.341 . . . . 73.52 107.379 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.23 -45.13 53.68 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.37 0.507 . . . . 71.43 112.37 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -113.61 0.26 14.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.02 -0.272 . . . . 64.33 111.401 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -136.75 114.86 11.54 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.497 -0.319 . . . . 64.25 110.769 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.71 123.49 49.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.33 -0.619 . . . . 75.43 109.33 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.778 HD11 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -117.74 131.07 56.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.171 0.51 . . . . 72.24 111.132 -176.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.531 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 72.3 t60 -115.58 115.12 25.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.622 -0.717 . . . . 72.33 109.483 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.651 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 8.6 m -82.78 139.94 33.28 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.903 -1.147 . . . . 73.31 107.903 173.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.9 t30 -146.05 138.98 25.74 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.935 -0.706 . . . . 72.12 111.887 -173.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 59.4 t -131.55 120.94 46.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.482 -0.781 . . . . 73.21 109.962 172.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.03 111.15 21.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.59 -0.732 . . . . 73.01 110.154 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.509 ' H ' ' ND2' ' A' ' 168' ' ' ASN . 5.0 t70 63.4 -168.58 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.817 -1.083 . . . . 74.13 109.29 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.64 -6.93 89.06 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.589 -0.815 . . . . 63.33 112.218 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 211' ' ' THR . 19.0 p -102.39 -28.35 12.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.786 1.032 . . . . 74.24 113.786 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.14 115.41 28.81 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.582 -0.847 . . . . 61.24 112.185 -172.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -120.77 126.3 49.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.06 -0.973 . . . . 71.42 109.665 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.76 -122.51 0.87 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.544 -0.836 . . . . 74.1 112.262 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 158.17 -160.67 31.03 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.617 -0.801 . . . . 74.13 112.587 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.9 t -148.05 139.15 23.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.699 -0.482 . . . . 70.21 109.699 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.778 HG13 HD11 ' A' ' 180' ' ' LEU . 4.2 mp -119.9 135.49 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.123 -0.325 . . . . 64.53 110.123 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.772 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 38.8 t80 -122.3 118.35 28.3 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 74.23 109.836 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.34 134.58 49.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.642 -0.503 . . . . 71.04 109.642 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -99.73 127.12 45.86 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 72.24 110.569 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.519 HG11 ' HD3' ' A' ' 200' ' ' LYS . 10.8 t -102.53 139.38 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.707 -0.849 . . . . 75.04 108.707 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.24 34.28 0.25 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.424 0.631 . . . . 64.3 112.621 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.519 ' HD3' HG11 ' A' ' 198' ' ' VAL . 2.5 mptp? -96.83 14.51 24.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.125 -1.065 . . . . 74.42 108.125 164.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 65.84 20.79 11.44 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.028 -0.987 . . . . 73.13 109.89 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.13 129.8 48.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.073 -0.967 . . . . 74.33 110.197 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.772 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 28.9 mt-10 -104.92 129.83 53.22 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.961 -1.126 . . . . 73.23 107.961 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -122.14 138.17 54.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.821 -0.352 . . . . 74.55 110.632 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.615 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -134.81 149.83 50.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.243 -0.435 . . . . 73.14 111.044 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 221' ' ' ILE . 83.2 t -131.13 143.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.656 -0.702 . . . . 75.52 110.357 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -114.61 132.41 56.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.004 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 208' ' ' LEU . 2.1 mm? -125.17 129.48 50.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.21 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.01 127.71 12.47 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.078 -0.341 . . . . 61.34 110.078 171.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.506 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 2.3 t90 -118.75 133.34 55.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.999 -0.741 . . . . 75.1 108.999 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 188' ' ' THR . 31.6 m -93.89 103.02 15.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.184 0.516 . . . . 60.31 109.767 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.71 127.11 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.397 -0.82 . . . . 74.22 110.612 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.4 43.68 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.21 -0.756 . . . . 71.05 111.21 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -126.8 155.84 42.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.008 -0.738 . . . . 74.25 109.008 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.0 m -95.4 -9.8 31.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.155 0.428 . . . . 62.4 112.155 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -91.54 131.53 36.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.889 0.376 . . . . 74.03 110.613 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.506 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 7.9 t -107.19 139.13 42.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.288 0.566 . . . . 75.13 110.19 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -89.06 127.27 35.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.633 . . . . 74.32 109.997 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.532 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 93.9 m-85 -112.35 150.9 30.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.704 -0.68 . . . . 74.32 109.823 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.95 143.17 10.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.749 -0.94 . . . . 73.35 110.749 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.633 HG22 HG23 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -137.78 134.07 45.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 117.316 0.558 . . . . 71.15 110.583 177.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.522 ' CB ' ' HG2' ' A' ' 236' ' ' LYS . . . -126.29 142.17 51.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.885 -0.598 . . . . 65.22 111.388 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.09 124.06 51.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.74 -0.664 . . . . 74.53 109.456 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.614 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 21.3 tptp -113.93 114.02 25.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.328 -0.851 . . . . 75.45 109.425 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.56 121.14 32.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.045 0.45 . . . . 64.43 110.738 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -91.36 99.28 12.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.712 -0.677 . . . . 75.4 109.756 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.6 -35.41 7.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.939 -0.573 . . . . 71.13 111.416 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.448 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -140.21 154.76 70.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 75.31 109.295 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 10.1 Cg_endo -52.52 -26.39 28.59 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.113 2.542 . . . . 73.51 113.309 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -107.97 -15.39 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.613 0.227 . . . . 71.34 111.613 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.26 123.68 40.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.015 0.436 . . . . 71.44 111.84 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.9 t -133.75 121.85 22.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 70.12 109.832 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -101.23 134.35 44.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.655 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 24.3 p -132.01 121.31 23.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.341 -0.391 . . . . 74.23 110.889 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.6 140.16 43.75 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.495 -0.557 . . . . 70.02 109.495 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' A' ' 222' ' ' ALA . 71.6 mttt -137.92 150.68 47.28 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.044 -0.354 . . . . 72.34 110.044 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.498 HG12 HG12 ' A' ' 221' ' ' ILE . 8.7 p -144.69 143.88 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.119 0.485 . . . . 72.55 110.873 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 25.7 t-20 -105.03 148.9 26.26 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.433 -0.803 . . . . 75.3 109.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.532 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 64.4 t30 -46.65 -31.22 2.74 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.849 1.343 . . . . 73.54 113.378 -174.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.583 ' HB2' HD11 ' A' ' 242' ' ' LEU . 19.3 m -80.01 19.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.979 0.419 . . . . 61.31 110.603 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 239' ' ' ASN . 56.0 m 68.67 34.2 3.54 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.467 -0.788 . . . . 70.14 111.19 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.833 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.2 mp -98.84 131.81 44.67 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 120.389 -0.524 . . . . 75.33 111.605 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 243' ' ' ILE . 2.3 mp -109.66 116.95 53.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.837 -0.62 . . . . 64.41 110.264 -169.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.85 133.55 11.4 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.617 -0.801 . . . . 45.1 111.947 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.621 HD21 ' H ' ' A' ' 245' ' ' LEU . 2.3 pt? -118.66 134.39 55.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.817 -0.438 . . . . 75.43 109.817 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.1 121.39 2.71 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.796 -0.716 . . . . 35.31 112.14 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.87 115.79 30.76 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.453 -0.573 . . . . 73.43 109.453 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.0 m -109.05 112.85 25.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.176 0.513 . . . . 62.45 110.205 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.91 134.11 55.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 74.23 110.189 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 15.6 m -122.54 98.25 5.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.084 -0.507 . . . . 75.15 109.706 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.748 ' HB2' HG23 ' A' ' 255' ' ' ILE . 3.2 mm? -88.97 77.37 7.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.345 -0.613 . . . . 72.32 109.345 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.604 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 30.7 mmtp 68.37 166.63 0.12 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.343 -0.844 . . . . 73.02 110.136 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 55.7 Cg_endo -70.9 57.68 2.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.359 2.04 . . . . 73.5 112.178 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -147.94 -45.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.834 -0.621 . . . . 73.13 112.097 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.748 HG23 ' HB2' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -132.26 124.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.78 0.8 . . . . 74.2 110.67 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 57.2 tttt -119.61 131.9 55.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.99 -1.004 . . . . 75.24 110.092 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.02 125.54 49.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.839 -0.618 . . . . 71.22 110.466 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.2 t -128.87 111.59 13.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.627 0.727 . . . . 70.51 110.46 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.704 HD22 ' HG ' ' A' ' 277' ' ' LEU . 0.1 OUTLIER -106.3 124.49 49.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.41 -0.959 . . . . 72.33 108.41 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 46.8 p -140.79 140.73 34.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.198 -0.601 . . . . 74.11 110.999 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 245' ' ' LEU . . . -144.89 146.69 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.985 -0.552 . . . . 75.32 110.088 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.818 HD12 HD21 ' A' ' 242' ' ' LEU . 2.0 tm? -114.6 116.58 28.98 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.653 -0.869 . . . . 73.41 108.653 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.464 HD22 HD22 ' A' ' 245' ' ' LEU . 1.0 OUTLIER -92.13 107.35 19.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.911 -1.144 . . . . 73.45 107.911 173.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.833 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -70.79 104.92 3.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.259 -1.015 . . . . 74.43 108.259 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.7 -22.92 34.77 Favored Glycine 0 N--CA 1.459 0.211 0 C-N-CA 121.16 -0.543 . . . . 52.4 112.2 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -90.68 -15.73 29.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.257 -0.471 . . . . 75.21 111.798 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 17.5 t-20 -117.41 -38.37 3.34 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.227 0.455 . . . . 73.23 112.227 -174.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 264' ' ' ASP . 30.7 m -61.87 -17.79 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.103 0.408 . . . . 64.11 112.103 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -59.81 -32.67 70.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.053 0.454 . . . . 72.52 110.314 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.99 -16.57 15.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 71.01 110.277 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.32 119.52 3.28 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.81 -0.632 . . . . 50.31 111.827 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 149.73 82.7 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.462 -0.875 . . . . 50.31 112.413 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -113.61 150.13 33.57 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.698 -0.482 . . . . 71.24 109.698 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.1 mptt -91.73 137.11 32.63 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.682 -0.859 . . . . 74.23 108.682 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -120.53 137.72 54.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.151 -0.477 . . . . 74.51 109.845 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.889 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -144.15 112.68 0.69 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 111.045 -0.822 . . . . 73.44 111.045 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.704 ' HG ' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -113.96 143.51 44.6 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.29 -0.564 . . . . 74.54 109.512 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -140.56 124.43 2.61 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.387 -0.824 . . . . 55.43 111.362 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.488 ' HB2' HD13 ' A' ' 29' ' ' LEU . 3.0 mm? -113.41 131.2 56.09 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.624 -0.88 . . . . 73.41 108.624 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 69.3 tt0 -125.42 116.14 21.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.133 0.492 . . . . 64.4 110.038 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.553 ' HB3' HD12 ' A' ' 31' ' ' LEU . 50.1 m-85 -105.33 138.57 41.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.678 -0.692 . . . . 65.24 109.782 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.467 ' HB3' HD21 ' A' ' 284' ' ' LEU . 75.8 mt-30 -130.85 114.03 14.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.451 -0.795 . . . . 74.22 110.209 -176.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.732 ' HB1' ' HB ' ' A' ' 33' ' ' THR . . . -104.8 107.45 18.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.209 -0.664 . . . . 65.34 109.209 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.495 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.3 mm? -139.27 -3.27 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.421 -0.808 . . . . 71.12 110.171 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.59 -0.719 . . . . 72.23 109.885 -178.205 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.932 -0.396 . . . . 75.22 109.932 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.27 125.73 44.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.095 0.474 . . . . 75.41 110.915 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 119' ' ' LYS . 7.9 p -147.81 134.86 10.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.17 -0.678 . . . . 73.1 109.17 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.65 133.85 51.35 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.282 2.655 . . . . 74.12 113.664 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.13 75.32 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.142 2.561 . . . . 63.1 110.893 172.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -76.4 -11.85 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.565 -0.743 . . . . 75.44 111.928 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' HB3' HG23 ' A' ' 143' ' ' VAL . 21.7 p90 -60.15 -22.12 62.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.314 0.578 . . . . 70.34 110.039 171.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -27.25 61.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.709 -0.678 . . . . 73.34 109.747 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -84.74 -14.12 49.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.056 -0.52 . . . . 72.2 110.091 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.541 ' HB3' ' CB ' ' A' ' 170' ' ' ALA . 61.0 mt -76.89 -35.56 57.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.385 -0.825 . . . . 73.14 110.575 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 -61.45 0.23 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.386 -0.911 . . . . 74.5 114.025 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.75 -43.87 81.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.922 0.361 . . . . 75.42 111.338 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.1 t -62.09 -46.37 89.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.862 -0.608 . . . . 65.02 110.961 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.91 73.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.071 -0.513 . . . . 72.11 111.776 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -59.32 -30.11 68.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.24 112.243 -173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.59 -44.5 85.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.935 0.398 . . . . 75.14 110.452 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 222' ' ' ALA . 61.8 t -82.41 -35.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.939 -0.573 . . . . 72.44 110.962 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -68.84 -23.05 64.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.946 -0.57 . . . . 75.12 111.533 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.8 p -76.03 93.05 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.313 0.578 . . . . 71.14 111.085 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.32 79.13 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.761 . . . . 74.44 112.214 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.4 63.92 3.11 Favored Glycine 0 C--N 1.335 0.479 0 O-C-N 123.984 0.803 . . . . 64.4 114.692 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -88.88 83.09 6.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.184 0.516 . . . . 75.3 110.732 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.3 121.84 5.77 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.531 -0.759 . . . . 53.12 111.465 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.81 5.61 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.645 0.239 . . . . 73.4 111.645 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.91 59.51 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.771 -0.728 . . . . 61.32 112.691 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 46' ' ' SER . 1.5 pp -129.04 -179.34 5.06 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.59 0.959 . . . . 74.54 113.59 -170.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.688 HG21 HD22 ' A' ' 277' ' ' LEU . 40.7 mm -99.1 132.79 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.061 -1.427 . . . . 75.21 109.802 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 17.9 ptpt -118.55 153.52 34.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.022 0.439 . . . . 73.1 109.906 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.8 HD11 ' HB2' ' A' ' 279' ' ' LEU . 1.3 tp -141.13 143.86 34.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.289 -0.414 . . . . 71.5 111.442 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 8.1 t70 -137.38 124.28 21.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.617 -1.253 . . . . 71.44 107.617 168.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.3 tm? -136.72 124.16 22.08 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.388 -0.597 . . . . 73.03 109.388 -175.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 29.6 mtmm -116.77 124.51 49.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 72.23 110.572 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.458 ' HG1' ' HB1' ' A' ' 283' ' ' ALA . 86.1 m -121.22 125.36 46.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.897 -0.592 . . . . 75.14 109.538 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -113.35 145.55 40.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.794 0.331 . . . . 71.13 110.335 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 21.7 m -139.21 138.19 36.65 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.48 -0.563 . . . . 73.22 109.48 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 49.21 -120.12 1.34 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.802 0.689 . . . . 74.43 110.572 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -136.27 152.24 50.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.725 -0.472 . . . . 50.55 109.725 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 79.29 -9.3 41.5 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 119.335 -0.703 . . . . 53.43 113.648 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -101.64 128.55 47.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.613 1.207 . . . . 74.15 112.043 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 29.0 tt0 -141.02 117.12 10.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 74.1 109.66 164.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 92.1 t80 -99.05 121.93 41.63 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.546 -0.538 . . . . 65.54 109.546 176.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.798 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 6.8 m -125.5 125.21 42.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.083 0.468 . . . . 74.43 111.521 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -112.43 123.84 51.17 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.775 -0.824 . . . . 72.13 108.775 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 22.1 m -137.85 125.66 22.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.203 -0.295 . . . . 62.11 110.203 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 178.9 42.33 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.328 -1.415 . . . . 75.12 113.442 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.543 ' HB3' HD11 ' A' ' 26' ' ' LEU . 21.9 m -138.01 134.82 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.687 -0.486 . . . . 64.23 109.687 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB1' HG13 ' A' ' 54' ' ' VAL . . . -139.8 132.8 29.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.918 0.39 . . . . 72.14 111.25 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.06 120.96 37.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.894 -0.593 . . . . 71.45 109.409 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 m -84.52 -33.42 23.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 72.32 110.751 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -63.61 -59.4 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 75.35 110.027 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 m -112.52 111.31 22.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.228 -0.656 . . . . 72.41 109.228 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p -55.92 95.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.156 0.799 . . . . 64.32 113.156 -171.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -145.58 117.36 8.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.36 -0.978 . . . . 74.35 108.36 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG13 ' HB1' ' A' ' 47' ' ' ALA . 32.1 t -121.97 125.32 72.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.934 0.397 . . . . 75.31 110.821 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.6 m -109.54 125.08 52.14 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.493 -0.929 . . . . 75.04 108.493 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.56 5.33 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.947 -1.12 . . . . 73.24 113.267 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 75' ' ' TRP . 19.3 m -118.96 134.07 55.42 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.068 -0.715 . . . . 61.41 109.068 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -119.74 123.24 43.28 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.519 -0.919 . . . . 74.42 108.519 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.798 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 mt-10 -110.83 119.31 38.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.9 -0.591 . . . . 73.45 110.217 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -98.59 117.76 33.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.733 -1.21 . . . . 74.01 107.733 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.807 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 38.2 mttp -116.56 139.87 50.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.256 0.551 . . . . 72.53 110.75 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 96.6 m-85 -115.34 120.09 38.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.249 -0.887 . . . . 73.1 108.887 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.6 ptp180 -119.03 106.39 12.37 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 121.755 0.788 . . . . 74.1 111.224 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -116.11 92.67 3.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.919 -1.037 . . . . 74.12 109.994 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -81.22 1.22 33.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.748 -0.66 . . . . 72.12 111.448 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.43 14.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.524 0.678 . . . . 64.54 109.986 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -159.02 -49.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.875 -1.057 . . . . 74.23 108.578 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.366 -0.834 . . . . 73.33 111.306 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.477 ' CD1' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -106.93 131.86 53.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.796 0.331 . . . . 75.13 111.147 -174.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.9 m -129.99 111.93 13.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.002 -0.545 . . . . 74.05 109.993 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.651 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 33.4 t80 -112.88 123.76 51.05 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.547 -0.538 . . . . 75.23 109.547 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.4 m -128.63 116.77 20.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.808 0.337 . . . . 75.34 111.018 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.38 121.52 45.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.892 -0.781 . . . . 71.54 108.892 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.696 ' HB3' ' HG2' ' A' ' 59' ' ' GLU . 17.4 ptmt -128.01 114.39 17.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.92 0.39 . . . . 65.31 111.442 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.656 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 78.6 t90 -99.9 139.23 35.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.524 -0.547 . . . . 72.4 109.524 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -119.7 160.86 21.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.422 -0.354 . . . . 71.32 110.276 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 p -62.41 -14.12 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.062 0.458 . . . . 72.32 111.95 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.682 ' HB3' HG21 ' A' ' 80' ' ' THR . 35.4 t70 -71.23 -4.75 27.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 71.04 110.108 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER 77.85 -3.3 2.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.122 -0.944 . . . . 62.41 110.019 -176.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.682 HG21 ' HB3' ' A' ' 78' ' ' ASP . 13.4 t -83.68 133.37 34.81 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.938 -0.574 . . . . 71.23 109.891 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.656 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 2.2 pt? -123.0 142.88 50.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.047 -0.524 . . . . 74.44 110.104 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.58 123.92 5.64 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.965 -0.636 . . . . 73.24 112.333 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 23.5 m -97.34 90.1 4.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.284 0.564 . . . . 74.44 109.679 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -91.57 110.0 21.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.123 -0.944 . . . . 71.43 109.482 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 99' ' ' PHE . 13.0 pt -124.36 134.84 65.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.734 0.778 . . . . 74.13 110.867 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -123.5 122.27 37.79 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.192 -0.913 . . . . 74.31 108.746 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 97' ' ' LEU . 8.0 m -113.69 120.77 64.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.079 -0.51 . . . . 73.44 110.106 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -107.77 131.57 54.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.549 -0.908 . . . . 74.14 108.549 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -76.6 134.65 39.3 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.362 -0.535 . . . . 53.04 111.355 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.419 -0.809 . . . . 65.32 111.077 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.27 -53.22 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.687 -0.486 . . . . 73.23 109.687 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 71.87 10.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.34 110.719 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -63.37 133.35 53.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 73.5 110.219 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.5 -9.43 58.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.544 -0.836 . . . . 65.5 111.317 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.4 111.21 23.85 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.1 -0.704 . . . . 75.22 109.1 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -126.23 130.25 50.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.132 0.491 . . . . 75.54 110.404 177.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.666 HD12 HG21 ' A' ' 116' ' ' THR . 1.3 mm? -101.63 131.06 48.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.019 -0.537 . . . . 72.23 109.626 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -106.4 117.76 34.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.08 0.466 . . . . 62.24 110.494 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.766 ' HD1' ' HB ' ' A' ' 114' ' ' ILE . 82.3 t80 -126.21 115.95 20.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.279 -0.873 . . . . 75.54 110.295 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.678 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 1.3 t70 -112.18 138.6 48.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.765 -0.652 . . . . 64.53 110.768 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.535 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 33.2 m -126.93 120.74 29.89 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.951 -0.759 . . . . 60.31 108.951 169.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 4.7 t -127.49 121.89 31.94 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.918 -0.401 . . . . 72.24 109.918 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 80' ' ' THR . 69.6 m-85 -125.45 120.51 31.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.557 -0.292 . . . . 74.31 110.285 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.2 t -123.05 103.14 36.71 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.29 -0.414 . . . . 63.13 109.961 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.74 -25.32 46.4 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.972 2.448 . . . . 73.44 111.387 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -67.06 -37.44 84.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 63.14 110.329 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.754 ' HB ' ' HG2' ' A' ' 109' ' ' LYS . 5.2 m -88.18 -28.25 21.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.148 0.499 . . . . 75.01 110.104 175.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.67 4.19 83.02 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.229 -0.748 . . . . 70.14 111.229 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.754 ' HG2' ' HB ' ' A' ' 107' ' ' THR . 21.3 pttm -94.96 148.63 22.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.154 0.502 . . . . 73.24 111.472 -175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HB2' ' HZ1' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -125.43 122.74 37.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.316 -0.856 . . . . 75.23 109.236 174.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 17.8 m120 -119.61 137.79 53.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 75.5 110.521 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -140.15 123.3 16.78 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.616 -0.513 . . . . 73.34 109.616 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.678 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -117.58 131.92 56.6 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.539 -0.864 . . . . 75.54 109.204 176.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.766 ' HB ' ' HD1' ' A' ' 99' ' ' PHE . 4.0 tp -140.09 114.66 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.635 -0.506 . . . . 74.43 109.635 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.943 ' HB3' ' O ' ' A' ' 127' ' ' CYS 0.461 13.1 tttt -154.41 170.12 22.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 116.128 1.899 . . . . 75.42 116.128 160.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.666 HG21 HD12 ' A' ' 97' ' ' LEU . 77.1 p -101.18 130.16 47.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.311 -1.313 . . . . 70.25 110.956 -163.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.89 123.81 5.87 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.534 -0.841 . . . . 71.01 112.238 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.439 ' C ' ' HD2' ' A' ' 119' ' ' LYS . 35.5 p90 -124.9 128.09 48.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.62 0.724 . . . . 72.4 110.282 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.674 ' HD3' ' HD3' ' A' ' 96' ' ' LYS . 3.8 mptp? -111.38 122.7 48.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.672 -0.695 . . . . 75.55 110.929 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HB2' HG23 ' A' ' 123' ' ' ILE . 31.0 mtp180 -108.36 158.02 17.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.798 -0.637 . . . . 74.23 110.694 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.68 -32.8 44.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.39 0.885 . . . . 70.31 113.39 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -119.15 -6.33 10.42 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.73 -0.388 . . . . 74.42 111.297 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.803 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -144.4 123.3 6.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.52 0.676 . . . . 74.32 110.6 -173.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.757 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.9 t-20 -104.64 115.45 30.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.03 -0.532 . . . . 64.34 109.582 -175.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.05 130.06 56.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.516 0.674 . . . . 72.42 111.761 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.47 115.9 1.61 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.316 -0.856 . . . . 53.01 111.37 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.943 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 59.4 m -112.66 126.1 55.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.824 -0.806 . . . . 65.31 108.824 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.736 ' HA ' ' CB ' ' A' ' 115' ' ' LYS . 1.1 m-20 -128.92 133.22 47.79 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.843 1.339 . . . . 72.11 111.364 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.892 ' H ' ' HB2' ' A' ' 115' ' ' LYS . 60.1 ttp -107.39 118.39 36.59 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 119.413 -0.915 . . . . 73.43 109.791 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 9.2 t70 -106.2 115.3 29.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.739 -0.467 . . . . 73.11 109.739 -175.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 92.3 t80 -97.87 117.78 32.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.839 -0.344 . . . . 75.22 111.125 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.505 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 22.5 t70 -115.02 157.03 24.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.872 -0.788 . . . . 75.5 108.872 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.19 -17.19 21.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 111.705 0.261 . . . . 72.33 111.705 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.23 -19.34 24.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 71.31 111.073 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 168.93 148.45 5.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.528 -0.844 . . . . 74.3 112.527 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.47 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 2.8 Cg_endo -85.67 114.51 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.571 2.847 . . . . 75.12 111.749 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 m -104.0 144.44 31.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.018 -0.537 . . . . 74.54 110.612 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.35 118.52 55.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.41 -0.589 . . . . 74.01 109.41 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -103.57 126.31 50.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.773 -0.649 . . . . 75.03 110.23 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.14 132.02 10.1 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.181 -1.009 . . . . 74.31 111.643 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.09 116.09 23.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.713 -0.477 . . . . 74.52 109.713 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.803 HD11 HD11 ' A' ' 123' ' ' ILE . 15.2 tp -124.26 124.53 42.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.356 -0.384 . . . . 75.23 110.621 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.757 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 46.5 t -125.1 128.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 73.32 109.821 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.56 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.2 mp -109.51 138.69 45.5 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.728 -0.841 . . . . 73.4 108.728 176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.9 117.55 1.58 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.109 -1.043 . . . . 75.11 111.778 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.31 123.28 18.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.883 -0.327 . . . . 74.52 111.056 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 40.34 39.02 0.62 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.058 1.132 . . . . 73.14 114.058 171.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.09 6.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.26 -0.971 . . . . 71.33 113.512 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -98.66 137.01 37.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.904 0.852 . . . . 74.53 111.416 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 mt -115.59 140.17 49.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.442 -1.254 . . . . 74.41 110.56 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -127.17 125.88 41.88 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.275 -0.639 . . . . 61.3 109.275 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.63 134.02 7.59 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.26 -0.972 . . . . 52.54 112.572 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.472 ' HD2' ' CD2' ' A' ' 169' ' ' PHE . 13.7 m-85 -134.68 120.54 19.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.387 -0.407 . . . . 72.41 109.973 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.416 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . 73.1 mt-30 -119.92 123.12 42.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.426 0.631 . . . . 62.31 110.01 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -130.58 136.13 48.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.863 -0.608 . . . . 75.14 110.288 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -114.75 118.88 34.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.702 -0.481 . . . . 74.51 109.702 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 86.3 t80 -107.15 123.33 48.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.811 -0.631 . . . . 75.2 110.798 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -94.98 126.35 40.26 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.479 -0.563 . . . . 74.34 109.479 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 41.8 p -73.71 -48.24 33.47 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.083 -0.962 . . . . 72.02 112.993 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -65.58 -44.57 86.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.237 0.541 . . . . 73.32 110.189 -172.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 38.7 ttpt -101.64 112.91 25.63 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.941 -1.874 . . . . 74.3 105.941 160.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.4 p -75.5 38.07 0.14 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.355 1.243 . . . . 70.21 114.355 -152.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.553 ' HG2' ' N ' ' A' ' 164' ' ' VAL . 26.0 ttm180 -139.92 157.88 44.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.916 0.389 . . . . 74.11 111.085 -166.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 85.7 t -72.51 122.13 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.448 -0.945 . . . . 75.5 108.448 170.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.6 m -93.81 -31.08 14.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.354 -0.385 . . . . 73.42 110.826 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -132.94 129.7 38.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 74.13 110.321 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.5 m -124.75 106.67 10.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.562 -0.744 . . . . 74.51 109.632 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 154' ' ' GLN . 10.0 p30 -118.14 146.79 43.91 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.459 -0.496 . . . . 63.1 109.886 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' HD2' ' A' ' 153' ' ' TYR . 69.1 m-85 -135.21 162.1 33.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.45 -0.341 . . . . 75.22 110.648 -173.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 71.43 110.616 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.814 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 98.5 t -138.45 136.95 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.415 . . . . 73.23 109.878 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.73 111.28 1.9 Allowed Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.614 -0.803 . . . . 60.12 111.317 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.551 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 19.5 t80 -113.28 128.85 56.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.252 0.526 . . . . 62.31 109.976 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -102.15 130.82 48.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.981 0.896 . . . . 74.21 112.564 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 7.8 m -131.1 145.54 52.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 65.43 105.765 164.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.95 -30.25 67.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.328 0.513 . . . . 73.44 112.303 -168.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.08 -0.23 12.79 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.292 -0.255 . . . . 74.13 111.567 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.609 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 53.4 m-85 -136.84 119.93 16.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 75.35 110.57 -174.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -110.91 123.65 50.55 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.018 -0.426 . . . . 73.11 110.162 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 173' ' ' TYR . 2.0 tp -102.68 126.9 49.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.998 0.428 . . . . 61.31 110.077 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -118.55 114.83 23.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.627 -0.879 . . . . 75.31 108.627 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.814 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 26.6 m -99.94 137.57 38.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.406 -0.59 . . . . 53.44 109.406 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -136.97 139.05 41.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.137 0.494 . . . . 64.23 110.995 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 190' ' ' PHE . 84.2 t -128.04 111.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 63.5 109.546 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -96.54 103.8 15.73 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 108.672 -0.862 . . . . 71.23 108.672 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 188' ' ' THR . 23.1 t70 64.82 172.61 0.2 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.03 -0.987 . . . . 70.02 109.64 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.8 56.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.435 -0.888 . . . . 40.04 111.785 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 186' ' ' ASP . 14.4 t -97.41 -24.14 15.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 113.14 0.792 . . . . 75.14 113.14 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.29 117.47 19.85 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.423 1.01 . . . . 62.42 111.33 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.452 ' HB2' HG23 ' A' ' 184' ' ' VAL . 41.8 p90 -134.03 138.47 45.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.593 -0.276 . . . . 74.21 110.766 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . -163.45 -163.88 17.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.788 -0.72 . . . . 72.3 112.369 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.88 176.73 30.9 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 120.78 -0.724 . . . . 74.23 112.095 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 34.8 t -147.29 142.59 27.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.046 0.423 . . . . 75.21 110.881 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 194' ' ' ILE . 4.1 mp -119.31 118.4 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.194 -0.669 . . . . 70.51 109.194 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.405 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 9.2 t80 -108.24 121.07 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.588 -0.523 . . . . 72.5 109.588 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -116.96 126.69 53.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.424 -0.584 . . . . 73.34 109.424 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.645 ' HG2' ' HG2' ' A' ' 203' ' ' GLU . 2.9 tmtp? -108.69 114.17 27.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.982 -0.554 . . . . 64.12 110.24 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.44 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 43.6 t -73.89 159.75 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.462 -0.335 . . . . 75.22 110.319 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.401 ' N ' HG12 ' A' ' 198' ' ' VAL . 0.9 OUTLIER -57.62 -45.53 85.25 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.527 0.203 . . . . 73.42 111.041 178.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 172.47 13.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.906 -0.776 . . . . 73.35 108.906 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -78.08 70.1 4.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.756 0.788 . . . . 74.4 111.423 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.733 HD12 ' HD2' ' A' ' 225' ' ' TYR . 58.5 tp -133.58 113.01 11.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.465 -1.243 . . . . 75.0 108.759 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.645 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.6 mt-10 -117.12 129.09 55.74 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.512 -0.551 . . . . 55.21 109.512 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -124.36 139.41 53.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.725 0.298 . . . . 65.52 110.968 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.405 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -130.97 136.4 48.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.349 -0.387 . . . . 64.13 110.677 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 193' ' ' SER . 54.6 t -113.71 126.08 71.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.471 -0.566 . . . . 74.24 109.471 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.1 136.17 53.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.507 0.67 . . . . 74.45 111.004 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.439 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -119.55 141.1 49.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.029 -0.987 . . . . 63.32 109.325 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.11 130.37 25.18 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.283 -0.417 . . . . 64.2 110.872 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -116.48 132.84 56.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.981 -0.748 . . . . 74.1 108.981 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 10.1 t -114.2 122.72 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 65.14 110.691 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.64 135.62 57.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 74.44 111.14 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.38 -28.94 5.63 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.622 -0.717 . . . . 65.11 111.474 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.06 149.26 30.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.094 -0.706 . . . . 75.42 109.094 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.6 m -79.15 42.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.079 0.466 . . . . 70.54 110.667 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.57 120.88 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.156 -0.474 . . . . 75.45 110.573 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.6 t -105.8 136.89 44.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.14 0.495 . . . . 74.31 109.943 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.4 mmm-85 -102.0 138.19 39.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.445 -0.576 . . . . 75.22 109.445 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.568 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 66.0 m-85 -114.7 146.9 40.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.982 -0.377 . . . . 75.5 109.982 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.88 146.23 15.21 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.34 -0.704 . . . . 62.44 111.34 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.6 mp -132.14 129.5 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.94 0.37 . . . . 74.41 110.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.415 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -118.57 138.9 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.117 -0.327 . . . . 72.33 110.117 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.97 125.8 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.922 0.391 . . . . 74.53 110.813 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -115.44 114.34 24.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.74 -0.664 . . . . 73.24 109.909 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.733 ' HD2' HD12 ' A' ' 202' ' ' LEU . 36.6 t80 -117.7 120.05 36.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.477 -0.564 . . . . 73.44 109.477 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.563 HE21 ' HA ' ' A' ' 229' ' ' PRO . 52.7 tt0 -112.25 112.22 23.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.952 0.406 . . . . 70.33 110.652 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 227' ' ' ILE . 3.7 mp -86.82 -55.51 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 71.24 109.711 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -106.1 153.86 39.96 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 73.53 109.606 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.563 ' HA ' HE21 ' A' ' 226' ' ' GLN . 21.0 Cg_endo -60.33 -23.82 75.63 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.549 2.166 . . . . 75.54 112.79 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -102.61 -9.27 20.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.587 -0.279 . . . . 75.23 111.342 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.85 122.67 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 73.32 111.348 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.47 142.32 51.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.878 -0.601 . . . . 72.44 110.651 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -108.43 125.77 52.14 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.251 -0.648 . . . . 71.1 109.251 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.5 t -126.45 117.15 22.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.818 -0.438 . . . . 74.1 109.818 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -124.74 155.86 38.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.367 -0.379 . . . . 62.54 110.324 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER -154.25 139.84 17.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.478 . . . . 71.42 109.857 175.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 243' ' ' ILE . 7.9 p -128.64 144.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 63.13 110.406 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -108.46 148.79 29.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.066 -0.516 . . . . 73.42 109.96 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 8.0 t30 -65.22 -3.78 4.35 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.182 0.808 . . . . 75.32 113.182 -170.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.634 ' HB2' HD12 ' A' ' 242' ' ' LEU . 9.6 m -85.76 17.06 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.946 -0.761 . . . . 73.34 108.946 172.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.588 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 51.0 m 69.77 30.45 3.82 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.691 -1.14 . . . . 74.21 111.585 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.841 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.7 mp -99.08 125.47 44.6 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 120.683 -0.407 . . . . 75.42 111.735 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.523 ' HA ' HG21 ' A' ' 237' ' ' VAL . 1.8 mp -113.2 115.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.721 -0.672 . . . . 74.23 110.506 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -111.08 133.78 11.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.74 -0.743 . . . . 75.31 111.748 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.56 151.71 50.57 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.687 -0.302 . . . . 75.13 110.527 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -146.45 137.8 7.03 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.63 -0.795 . . . . 73.15 113.026 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -103.63 120.19 40.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.742 -0.836 . . . . 74.43 108.742 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 2.0 m -121.93 115.76 23.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.737 0.303 . . . . 74.24 111.035 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -134.74 141.84 46.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.58 -0.282 . . . . 73.21 110.707 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.0 m -76.32 124.82 28.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.609 -0.515 . . . . 74.15 109.609 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 252' ' ' LYS . 17.9 tp -105.92 172.65 6.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.108 0.48 . . . . 74.44 111.804 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.602 ' H ' ' HG ' ' A' ' 251' ' ' LEU . 44.2 tptt -49.53 -54.54 29.73 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.998 1.11 . . . . 72.32 113.998 -172.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 13.1 Cg_exo -70.73 9.07 0.82 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.611 2.207 . . . . 74.15 114.295 -171.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 82.86 29.36 35.1 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.386 -0.911 . . . . 54.21 111.824 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 2.7 pp -121.94 146.02 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.447 -0.377 . . . . 74.5 110.35 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.57 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 73.7 tttt -91.64 126.17 36.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 75.53 108.864 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.6 tp -97.8 123.58 41.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.927 -0.398 . . . . 75.21 109.927 -176.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.4 m -124.75 111.5 15.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.789 -0.641 . . . . 75.12 110.543 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.619 ' CD2' HD12 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -98.92 122.8 42.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.553 -1.277 . . . . 74.21 107.553 170.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.8 m -131.47 143.91 50.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.932 0.396 . . . . 75.14 111.16 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.44 132.36 19.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 74.0 110.732 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.831 HD12 HD21 ' A' ' 242' ' ' LEU . 2.7 tm? -104.35 113.12 26.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.25 -1.018 . . . . 64.12 108.25 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.661 ' HB3' HG13 ' A' ' 268' ' ' VAL . 1.2 mm? -91.66 108.92 20.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.92 -1.141 . . . . 74.42 107.92 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.841 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 9.9 t0 -71.48 105.07 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.586 -1.265 . . . . 75.24 107.586 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.82 -25.03 43.4 Favored Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.907 -0.588 . . . . 64.14 113.497 -170.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -91.85 -26.63 18.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.627 0.251 . . . . 62.52 111.201 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 63.2 t30 -98.69 -28.57 13.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 75.13 112.357 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.678 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 26.9 m -62.51 -17.82 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.665 0.269 . . . . 74.25 111.315 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -55.57 -37.79 68.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.271 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.57 9.75 37.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 63.21 110.838 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.44 74.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.004 -0.617 . . . . 72.51 112.598 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.678 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -142.57 86.52 0.19 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.937 -0.649 . . . . 42.23 111.919 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -113.23 143.52 44.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.444 0.164 . . . . 72.42 110.642 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 65.5 mttm -97.47 137.91 35.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.252 -0.647 . . . . 75.33 109.252 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -121.94 142.55 50.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.814 -0.439 . . . . 74.33 109.814 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.524 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -157.37 123.81 1.33 Allowed Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.54 -0.838 . . . . 71.13 111.504 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.688 HD22 HG21 ' A' ' 27' ' ' ILE . 7.4 tt -114.05 145.2 41.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.005 -0.739 . . . . 74.45 109.005 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -149.4 125.37 1.99 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.944 -1.122 . . . . 75.53 113.012 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.8 ' HB2' HD11 ' A' ' 29' ' ' LEU . 2.1 mm? -99.18 128.0 45.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.418 -0.956 . . . . 75.24 108.418 168.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 13.8 pt-20 -140.05 125.07 18.55 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.045 -0.354 . . . . 72.43 110.045 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.662 ' HB3' ' HA ' ' A' ' 255' ' ' ILE . 1.3 t80 172.72 -142.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 73.52 111.547 170.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.488 ' HB3' HD22 ' A' ' 284' ' ' LEU . 74.9 mt-30 -136.32 122.07 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.28 -0.418 . . . . 72.31 111.396 -166.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.458 ' HB1' ' HG1' ' A' ' 33' ' ' THR . . . -90.93 109.02 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.942 -0.762 . . . . 65.44 108.942 173.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' A' ' 282' ' ' GLN . 2.9 mm? -131.75 158.92 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.12 -0.491 . . . . 73.15 110.709 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.938 -0.764 . . . . 75.5 108.938 176.298 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.973 -0.38 . . . . 71.23 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB3' ' HA2' ' A' ' 94' ' ' GLY . . . -88.89 -87.63 0.16 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.094 0.473 . . . . 71.33 112.096 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 119' ' ' LYS . 23.1 t -125.46 127.58 24.89 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 71.15 110.178 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.98 123.23 9.54 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.494 2.796 . . . . 73.34 112.599 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.41 85.4 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.699 2.266 . . . . 73.52 112.564 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 5.5 p -72.0 -13.27 61.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 74.3 110.208 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.504 ' HE1' HE21 ' A' ' 154' ' ' GLN . 51.8 t80 -53.74 -34.98 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.995 -1.002 . . . . 72.41 110.126 169.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.22 -27.18 30.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 74.32 110.673 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 6' ' ' THR . 2.2 m-20 -85.22 0.98 50.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.589 -0.732 . . . . 75.5 111.196 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.67 -34.48 77.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 75.23 110.386 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.52 59.81 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.544 -0.836 . . . . 64.32 112.699 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -59.26 -53.28 60.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 73.42 110.839 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -55.53 -36.48 66.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.634 -0.712 . . . . 71.14 112.132 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.57 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 72.13 112.205 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -67.79 -40.1 83.98 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 73.24 110.682 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -68.73 -44.43 73.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.675 -0.693 . . . . 72.01 110.979 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 p -68.98 -26.67 32.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.128 0.49 . . . . 74.02 110.435 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.99 -39.91 83.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.944 -0.571 . . . . 75.24 109.727 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 58.26 39.36 25.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.78 -0.646 . . . . 74.13 111.248 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 67.82 4.39 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.954 -0.567 . . . . 72.52 111.451 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.09 -78.27 0.68 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.164 -0.541 . . . . 44.32 112.695 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -122.09 170.08 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.812 0.339 . . . . 72.02 111.03 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 122.54 6.79 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.826 -0.702 . . . . 73.11 111.621 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' HD1' HD11 ' A' ' 26' ' ' LEU . 22.2 t80 -89.35 2.91 53.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.127 0.489 . . . . 73.15 110.894 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.01 59.25 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.579 -0.82 . . . . 50.44 112.72 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 9.3 mp -102.0 156.07 17.77 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.625 0.726 . . . . 74.31 112.288 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.684 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -104.71 122.04 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.402 -1.272 . . . . 75.22 108.74 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -102.74 127.78 49.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.877 -0.601 . . . . 75.15 110.59 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.31 126.65 53.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.337 -0.986 . . . . 73.2 108.337 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.587 ' HB3' ' HD1' ' A' ' 281' ' ' PHE . 4.5 t0 -142.49 133.08 25.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.303 -0.999 . . . . 74.14 108.303 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 1.082 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -139.12 123.98 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.755 0.252 . . . . 74.21 110.575 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 32.1 ttpt -121.15 122.56 40.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.221 0.534 . . . . 75.53 110.28 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -138.82 120.66 15.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.308 -0.86 . . . . 74.05 109.381 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 40' ' ' GLU . 3.5 pttp -144.28 155.16 43.72 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.856 -0.738 . . . . 64.12 111.684 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -133.68 169.54 16.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.805 . . . . 74.23 109.782 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -89.07 13.79 12.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.056 0.391 . . . . 75.43 112.056 -172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.07 52.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.685 0.254 . . . . 72.11 111.685 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.94 -7.59 50.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 118.896 -0.947 . . . . 63.14 115.232 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.9 126.65 47.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.307 1.553 . . . . 73.31 112.186 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.93 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 23.9 mt-10 -139.36 118.49 12.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.308 -0.627 . . . . 75.15 109.308 165.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.98 126.07 53.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 74.23 111.244 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.9 m -126.17 117.11 22.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 70.22 110.655 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -116.63 133.54 55.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.714 -0.476 . . . . 74.04 109.714 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 31.7 m -139.96 149.93 43.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.911 0.386 . . . . 73.24 110.805 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.7 129.41 2.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.105 -0.569 . . . . 64.1 111.847 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -112.89 133.84 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.758 -0.83 . . . . 70.14 108.758 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.72 129.91 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.04 0.448 . . . . 71.42 111.208 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.631 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 37.7 t-20 -91.11 143.73 26.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.55 -0.908 . . . . 62.24 108.55 177.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -65.12 -6.34 8.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.877 0.325 . . . . 75.1 111.877 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.15 168.12 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.428 -0.582 . . . . 74.51 109.428 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -52.65 -69.25 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.322 0.86 . . . . 65.3 113.322 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.8 m -122.3 92.18 3.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.314 0.578 . . . . 75.35 111.72 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 9.3 tmtm? -154.67 78.83 1.07 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.204 -1.035 . . . . 75.35 108.204 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.72 120.5 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.216 -0.902 . . . . 73.14 109.479 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -110.31 124.57 51.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.33 -0.395 . . . . 72.21 109.97 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.3 154.37 16.87 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.716 -0.754 . . . . 73.41 112.206 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 20.1 m -146.19 126.52 13.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.65 -0.5 . . . . 70.13 109.65 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -125.34 125.86 44.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.525 -0.546 . . . . 71.25 109.525 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 38.1 tt0 -129.53 126.19 38.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.035 0.445 . . . . 74.31 110.628 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.44 ' HB ' ' CG ' ' A' ' 73' ' ' GLU . 3.9 m -120.1 129.45 54.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.851 -0.613 . . . . 72.02 109.758 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.93 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 68.6 mttm -117.52 133.99 55.36 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.856 -0.424 . . . . 74.43 109.856 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 50.1 m-85 -101.89 119.78 39.33 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.406 -0.961 . . . . 73.22 108.406 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.539 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.6 ttm180 -121.08 110.77 16.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 119.943 -0.703 . . . . 74.54 112.741 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -91.9 136.14 33.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.724 -1.125 . . . . 64.21 109.443 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -75.46 -11.57 60.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 74.44 112.695 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.84 106.27 2.63 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.081 -0.34 . . . . 75.1 110.081 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 66.87 -68.07 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.019 0.824 . . . . 74.3 110.476 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 88' ' ' GLU . . . 154.66 72.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.672 -0.971 . . . . 63.12 110.672 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 63' ' ' ARG . 4.1 mm? -101.12 131.39 47.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.213 -0.292 . . . . 75.13 110.213 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 23.0 m -136.19 118.55 15.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.442 -0.344 . . . . 65.23 111.352 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.426 ' HB3' ' HD1' ' A' ' 62' ' ' TYR . 69.8 t80 -96.63 121.93 39.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.668 -0.864 . . . . 74.33 108.668 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 83' ' ' THR . 96.3 m -113.46 126.54 55.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.172 0.51 . . . . 75.34 112.158 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' CG ' ' HB ' ' A' ' 60' ' ' THR . 3.1 pt-20 -118.82 139.23 51.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.078 -0.964 . . . . 61.33 109.006 169.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.0 ttpp -142.01 142.41 32.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.917 -0.771 . . . . 74.22 108.917 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 129.73 35.82 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.088 -0.645 . . . . 75.11 111.69 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -116.18 135.96 53.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.65 -0.87 . . . . 71.33 108.65 165.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -35.77 74.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.133 0.492 . . . . 73.04 111.221 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.57 -34.83 10.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.775 -0.648 . . . . 65.42 111.723 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -104.71 -104.17 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.663 -0.415 . . . . 74.13 111.814 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -116.43 145.33 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.544 0.687 . . . . 75.43 112.777 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -106.19 131.59 53.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.224 -1.028 . . . . 73.22 108.224 168.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.86 148.28 17.97 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.652 -0.785 . . . . 74.35 112.77 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 72' ' ' THR . 88.0 m -156.45 143.98 19.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.099 -0.704 . . . . 74.24 109.099 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 4.7 mm-40 165.36 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.19 0.931 . . . . 71.22 110.632 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.518 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.54 138.29 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 74.24 112.231 -162.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 70' ' ' THR . 25.7 m -122.85 123.46 41.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.134 -0.484 . . . . 75.23 109.906 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.412 HG23 HD21 ' A' ' 69' ' ' LEU . 6.6 p -130.16 137.44 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 73.24 111.336 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HG2' ' HA3' ' A' ' 68' ' ' GLY . 12.8 pt-20 -125.79 151.31 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.12 -0.232 . . . . 70.51 111.458 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.502 ' OD2' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER 66.92 1.19 2.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.809 1.04 . . . . 73.51 113.809 171.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.88 -58.85 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.172 -0.211 . . . . 70.13 111.412 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.431 ' HB3' HD23 ' A' ' 95' ' ' LEU . 58.9 tp -74.62 -49.26 22.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.001 0.429 . . . . 75.4 110.519 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.879 -0.6 . . . . 71.0 110.033 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 7.3 mpt_? -63.82 127.71 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 74.43 110.411 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 2' ' ' ALA . . . 101.23 -7.47 56.67 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.668 -0.777 . . . . 72.53 112.436 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 91' ' ' LEU . 50.7 tp -94.56 129.78 41.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.18 0.514 . . . . 74.14 110.957 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -122.25 111.99 17.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.391 -0.822 . . . . 74.02 109.872 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -104.98 126.78 52.4 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.149 -0.686 . . . . 74.12 109.149 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.842 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 19.8 m -125.67 119.26 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.013 0.435 . . . . 63.53 110.851 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.624 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 56.1 m-85 -113.42 119.53 37.94 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.608 -0.886 . . . . 74.14 108.608 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 12.1 m-20 -125.32 122.79 37.86 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.729 0.643 . . . . 73.4 109.383 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -115.11 122.56 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.157 -0.617 . . . . 72.11 110.112 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.3 m -111.43 122.77 48.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 73.54 110.423 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' HD2' ' HG2' ' A' ' 110' ' ' LYS . 74.7 t80 -110.21 129.7 55.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.448 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 45.4 t -104.42 128.16 27.58 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.205 -0.665 . . . . 70.12 109.205 175.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 36.0 Cg_exo -60.58 -20.32 64.02 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.652 2.234 . . . . 71.2 111.786 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -78.7 116.69 19.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.538 -0.755 . . . . 71.4 110.611 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.4 p 56.01 12.39 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.266 1.026 . . . . 74.12 113.664 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.48 74.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.553 -0.832 . . . . 70.32 112.393 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 104' ' ' SER . 57.3 tttp -65.2 123.93 20.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.32 111.247 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HG2' ' HD2' ' A' ' 103' ' ' PHE . 97.1 mttt -112.13 136.32 51.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 75.32 110.71 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.4 121.61 38.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.694 -0.854 . . . . 73.2 108.694 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.27 133.53 55.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.278 . . . . 73.02 111.264 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 8.6 mtpm? -117.0 136.98 52.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.859 0.361 . . . . 74.4 110.72 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.646 HG21 ' HB3' ' A' ' 129' ' ' MET . 2.8 tp -134.18 116.01 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.706 -0.679 . . . . 73.43 109.602 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 35.7 ttmt -114.58 121.75 44.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.675 -0.693 . . . . 71.05 110.524 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.5 t -114.54 117.18 30.2 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.055 -0.72 . . . . 64.13 109.055 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.557 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.07 123.31 4.78 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.456 -0.878 . . . . 64.32 112.549 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.07 117.3 33.71 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.25 -0.648 . . . . 75.54 109.25 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 1.018 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -110.19 119.13 38.27 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.404 0.621 . . . . 73.52 109.878 177.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.626 ' HB2' HG21 ' A' ' 123' ' ' ILE . 17.7 mmm-85 -108.36 163.67 12.99 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.031 -0.986 . . . . 75.04 108.943 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -53.09 -34.19 55.53 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.551 0.532 . . . . 74.43 112.186 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.01 -0.77 10.52 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.4 0.519 . . . . 65.02 112.4 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 120' ' ' ARG . 3.6 tp -145.49 120.72 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.937 -0.705 . . . . 73.24 111.463 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 1.018 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 7.2 p30 -129.44 116.12 18.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 63.1 111.136 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.774 ' HB3' HD12 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -129.65 144.42 51.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.106 0.479 . . . . 64.53 111.112 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.557 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -142.42 131.15 4.55 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.538 -0.755 . . . . 61.24 112.243 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.7 m -110.1 114.75 28.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.825 0.345 . . . . 62.32 110.54 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 32.4 t70 -106.63 116.14 31.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.265 -0.642 . . . . 74.13 109.265 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.646 ' HB3' HG21 ' A' ' 114' ' ' ILE . 25.7 ttt -97.67 122.78 41.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 75.33 110.615 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.88 116.74 31.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.353 -0.61 . . . . 62.12 109.353 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -97.3 115.07 26.98 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.918 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.83 149.8 36.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.919 -0.771 . . . . 75.1 108.919 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -32.33 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.679 0.276 . . . . 74.41 110.625 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.08 -18.33 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 75.5 111.1 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.58 116.6 0.37 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.754 . . . . 74.31 112.517 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.16 144.83 34.08 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.026 2.484 . . . . 72.33 111.883 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 m -124.13 146.62 48.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.492 -0.322 . . . . 55.32 110.474 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 30.9 mm -107.53 116.13 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.766 -0.457 . . . . 75.33 109.766 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -110.16 110.33 21.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.974 0.416 . . . . 73.15 110.223 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.94 133.58 11.52 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.209 -0.996 . . . . 74.15 112.318 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.93 113.77 18.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.201 0.524 . . . . 64.2 109.905 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 125' ' ' LEU . 7.3 tp -115.67 123.74 49.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.611 -0.722 . . . . 74.31 110.351 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.432 HG23 ' HA ' ' A' ' 7' ' ' TYR . 59.5 t -123.0 124.02 69.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.178 -0.465 . . . . 75.04 110.104 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.53 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.17 138.2 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.029 -0.73 . . . . 75.32 109.029 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 150' ' ' LEU . . . -119.47 119.16 4.19 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.747 -0.74 . . . . 75.54 113.039 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.795 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 55.3 m-85 -112.75 150.44 31.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.2 -1.407 . . . . 74.44 107.2 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -49.08 94.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.154 0.434 . . . . 75.24 111.386 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.55 -30.87 9.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.912 -0.585 . . . . 74.21 112.786 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.795 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 59.1 m95 -101.88 144.7 30.19 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.42 -0.459 . . . . 73.44 111.038 -173.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.454 HD21 ' HA2' ' A' ' 145' ' ' GLY . 16.3 mt -136.33 142.62 43.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.76 0.314 . . . . 73.23 111.424 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.26 126.13 24.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 71.51 109.943 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -131.9 133.54 7.21 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.655 -0.783 . . . . 70.25 112.157 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.558 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 92.1 m-85 -127.71 119.33 25.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.771 0.32 . . . . 75.53 110.723 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.504 HE21 ' HE1' ' A' ' 7' ' ' TYR . 85.8 mt-30 -106.52 123.04 47.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.215 -0.661 . . . . 74.1 109.215 173.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -137.44 129.8 29.56 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.549 -0.296 . . . . 70.41 110.255 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -112.57 118.98 36.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.502 -0.555 . . . . 70.25 109.502 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.849 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 27.7 m-85 -91.87 129.49 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 75.41 110.52 -173.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.628 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 23.8 tt0 -97.49 110.5 23.04 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 109.277 -0.638 . . . . 72.34 109.277 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -70.28 -16.04 62.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 112.777 -2.01 . . . . 71.21 111.822 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.86 66.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.871 0.843 . . . . 71.41 109.088 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -122.83 -153.97 0.58 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.36 -1.348 . . . . 75.33 107.36 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 p -107.31 28.3 8.23 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.916 -0.49 . . . . 71.3 110.452 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.523 ' HB2' ' HG3' ' A' ' 161' ' ' LYS . 14.4 mmt180 -139.75 149.11 43.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.051 -1.06 . . . . 75.13 112.355 -161.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.21 136.58 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.569 -0.53 . . . . 72.5 109.569 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 6.6 t -93.43 -23.52 18.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.903 -0.59 . . . . 71.34 110.41 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -141.14 133.19 27.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.25 110.599 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 2.7 m -121.89 115.91 23.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.574 -0.739 . . . . 74.2 109.759 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 51.7 t30 -118.77 120.46 37.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.881 -0.785 . . . . 73.43 108.881 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.688 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 24.8 m-85 -120.87 140.86 51.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.403 -0.519 . . . . 75.44 110.298 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.522 ' HB3' ' CE1' ' A' ' 181' ' ' HIS . . . -143.09 127.19 17.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.185 -0.461 . . . . 55.53 110.49 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.622 ' HB ' ' CG2' ' A' ' 182' ' ' THR . 49.0 t -126.39 136.97 59.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.866 -0.42 . . . . 74.25 109.866 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.55 124.81 7.0 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.22 -0.514 . . . . 52.31 112.111 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.57 125.6 54.44 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.327 -0.62 . . . . 74.31 109.327 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -102.94 125.63 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.379 0.609 . . . . 74.51 111.255 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.545 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 19.7 p -131.19 164.92 24.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.076 -0.965 . . . . 74.32 108.41 171.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.41 -46.93 76.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.248 0.462 . . . . 63.14 112.248 -170.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.408 ' HG3' HE22 ' A' ' 196' ' ' GLN . 3.7 tp10 -102.45 -22.79 14.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.691 -0.404 . . . . 74.05 111.778 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.545 ' HB2' ' OG1' ' A' ' 175' ' ' THR . 47.5 m-85 -113.51 135.82 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.101 0.477 . . . . 75.42 111.604 -172.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -111.07 122.68 48.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.732 -1.21 . . . . 75.11 107.732 165.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.69 136.94 53.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.32 0.581 . . . . 62.42 111.174 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' A' ' 170' ' ' ALA . 13.3 t60 -126.68 113.72 17.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.227 -0.897 . . . . 75.35 109.061 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.699 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 7.3 t -93.66 141.45 28.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.329 -0.989 . . . . 73.41 108.329 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -133.6 140.1 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 72.41 109.991 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 41.5 t -126.87 120.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.065 -0.516 . . . . 72.11 111.013 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.748 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.2 t30 -99.32 90.0 4.4 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.6 0.714 . . . . 74.24 109.092 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 3.1 t70 55.73 -161.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.002 -1.454 . . . . 73.44 110.944 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.598 -0.81 . . . . 64.23 112.157 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.7 m -93.52 -25.56 17.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.627 0.603 . . . . 73.3 112.627 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 32.8 tt0 -134.49 124.42 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.601 -0.84 . . . . 74.33 112.364 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -121.18 126.2 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.188 -0.914 . . . . 74.31 108.545 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.24 -172.56 19.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.773 -1.204 . . . . 71.31 113.395 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.23 172.94 31.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.716 -0.554 . . . . 74.44 111.716 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 33.1 m -148.27 142.29 25.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.238 -0.282 . . . . 71.22 110.238 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 10.6 mm -119.52 118.82 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 74.15 109.4 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -108.24 120.98 43.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.417 -0.586 . . . . 74.33 109.417 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.749 ' HB3' ' HB2' ' A' ' 199' ' ' ASN . 0.0 OUTLIER -121.78 111.69 17.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.787 -0.642 . . . . 71.31 111.41 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -89.85 130.8 36.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 169.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 197' ' ' LYS . 10.3 m 58.95 36.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.923 0.868 . . . . 75.34 110.95 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.749 ' HB2' ' HB3' ' A' ' 196' ' ' GLN . 14.5 t30 -52.54 -50.35 63.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.68 -1.145 . . . . 72.34 108.827 170.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -144.31 71.19 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.73 -1.123 . . . . 75.43 107.981 169.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 70.25 -41.74 0.5 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.005 -0.998 . . . . 70.43 112.427 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.748 HD11 ' H ' ' A' ' 226' ' ' GLN . 2.5 mm? -92.74 -161.05 0.8 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.925 0.393 . . . . 75.45 111.089 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 224' ' ' LYS . 45.3 mt-10 -111.82 153.33 26.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.527 -0.306 . . . . 74.34 110.565 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -147.68 143.84 27.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.495 -0.321 . . . . 74.41 110.279 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -134.61 136.76 43.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.83 0.347 . . . . 70.2 110.407 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 45.1 t -123.25 145.42 30.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.074 -0.512 . . . . 74.54 110.088 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -131.98 136.28 47.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.876 0.37 . . . . 72.51 110.481 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.32 140.98 51.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 74.23 109.629 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 218' ' ' ARG . . . -140.5 128.91 22.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.966 0.412 . . . . 63.24 111.399 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.401 ' HE3' ' HG1' ' A' ' 217' ' ' THR . 29.3 t-105 -115.39 132.88 56.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.737 -0.838 . . . . 75.32 108.737 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 12.3 t -116.5 132.54 56.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.801 -0.444 . . . . 71.25 109.801 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.04 150.37 25.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.765 . . . . 74.04 111.457 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.01 15.07 13.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.464 -0.874 . . . . 64.14 112.392 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.26 87.34 0.11 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.268 0.556 . . . . 70.32 111.328 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.0 t -146.49 171.95 14.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 71.21 109.862 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.76 159.63 23.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.736 -0.468 . . . . 73.32 109.736 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.401 ' HG1' ' HE3' ' A' ' 210' ' ' TRP . 11.4 m -77.29 135.79 38.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.745 0.307 . . . . 61.23 110.329 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 209' ' ' ALA . 55.2 mtm180 -88.96 136.39 33.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.923 -0.399 . . . . 73.34 109.923 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 239' ' ' ASN . 79.7 m-85 -114.52 138.96 49.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.905 -0.589 . . . . 74.43 110.658 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.49 139.67 10.21 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.612 -0.995 . . . . 74.45 110.612 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.492 ' HB ' HG12 ' A' ' 237' ' ' VAL . 5.0 mp -136.14 130.48 48.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.2 0.5 . . . . 73.32 110.504 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.1 129.41 50.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.796 -0.446 . . . . 64.33 109.796 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.25 139.71 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.601 0.239 . . . . 72.34 110.59 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 203' ' ' GLU . 43.9 mtmt -117.28 114.75 24.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.437 ' HA ' ' HG ' ' A' ' 202' ' ' LEU . 47.4 m-85 -100.76 115.34 30.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.211 -0.662 . . . . 63.15 109.211 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.748 ' H ' HD11 ' A' ' 202' ' ' LEU . 35.7 tt0 -86.7 99.62 11.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.161 -0.472 . . . . 74.44 110.029 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.82 -37.31 12.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.499 0.666 . . . . 75.33 109.685 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.74 145.52 19.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.106 -0.952 . . . . 74.42 109.18 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.51 -30.73 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.955 2.437 . . . . 75.12 113.454 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.46 -18.62 21.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.085 0.402 . . . . 73.1 112.085 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.71 122.75 20.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.237 0.541 . . . . 50.33 111.797 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 52.0 t -124.49 136.44 54.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.21 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -99.99 128.82 46.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.743 -0.466 . . . . 74.32 109.743 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.9 m -113.95 152.79 30.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.844 0.354 . . . . 64.24 110.503 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -140.66 141.21 35.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.357 -0.609 . . . . 73.42 109.357 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 54.9 mtmt -134.46 154.51 51.37 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.309 -0.256 . . . . 75.42 110.309 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.1 p -149.98 147.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.966 0.413 . . . . 73.13 110.663 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.7 t-20 -117.63 149.55 40.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.655 -0.868 . . . . 74.23 108.655 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . 0.1 OUTLIER -56.63 -17.61 9.28 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.88 0.696 . . . . 74.22 112.88 -172.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 49.2 m -83.22 23.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.455 0.169 . . . . 71.04 111.021 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 50.1 m 64.9 39.66 5.8 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.299 0.571 . . . . 73.12 110.449 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.942 ' HB3' HD13 ' A' ' 262' ' ' LEU . 46.1 mt -98.15 115.61 28.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.748 -0.66 . . . . 75.45 109.5 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.9 OUTLIER -105.34 117.62 51.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 109.841 -0.429 . . . . 73.23 109.841 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -120.4 162.12 14.45 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.825 -0.702 . . . . 73.41 112.723 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 2.6 pp -142.01 160.39 40.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.032 -0.358 . . . . 72.25 110.032 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -150.54 150.86 22.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.751 -0.738 . . . . 71.44 112.905 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 258' ' ' THR . 81.7 m-85 -123.16 115.96 22.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.561 -0.533 . . . . 63.22 109.561 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 20.0 m -113.0 114.0 26.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.739 -0.467 . . . . 74.0 109.739 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -135.45 127.62 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 65.52 110.548 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 32.1 m -88.53 128.55 35.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.551 0.215 . . . . 74.04 110.468 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.459 HD21 ' HG3' ' A' ' 252' ' ' LYS . 3.3 tt -122.24 88.92 3.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.215 -0.661 . . . . 74.35 109.215 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.459 ' HG3' HD21 ' A' ' 251' ' ' LEU . 94.1 mttt 68.99 166.06 0.13 Allowed Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 115.545 -0.752 . . . . 74.21 111.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.09 71.77 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.64 2.227 . . . . 65.44 112.351 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.32 -59.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.062 -0.589 . . . . 74.2 111.885 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 279' ' ' LEU . 0.0 OUTLIER -119.24 122.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 71.44 111.992 -171.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 1.021 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 66.4 mttm -92.28 135.45 34.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.209 -1.034 . . . . 60.4 108.209 163.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.82 123.41 41.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.25 -0.648 . . . . 75.54 109.25 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 48.6 m -122.47 111.12 16.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.454 0.645 . . . . 73.35 110.462 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.723 HD23 HD22 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -100.21 125.62 46.4 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.664 -1.235 . . . . 74.44 107.664 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 60.1 m -131.44 140.02 49.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 75.11 110.927 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.77 139.83 26.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.817 -0.438 . . . . 73.33 109.817 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.942 HD13 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -118.4 121.99 41.7 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.816 -0.809 . . . . 71.21 108.816 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.643 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -103.08 106.72 17.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.605 -0.887 . . . . 74.53 108.605 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.949 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 5.3 t70 -72.92 98.0 2.39 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.318 -0.993 . . . . 63.14 108.318 172.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.45 -8.46 2.66 Favored Glycine 0 C--N 1.307 -1.076 0 CA-C-N 115.078 -0.965 . . . . 54.14 114.044 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 264' ' ' ASP . 34.6 ttmt -93.42 -15.83 25.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.444 0.164 . . . . 73.24 110.981 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -152.84 -28.63 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.657 0.741 . . . . 74.45 110.906 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.949 ' HB ' ' O ' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -54.12 -22.25 7.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.595 -1.184 . . . . 64.42 113.021 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -55.9 -20.57 16.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.666 -0.697 . . . . 73.02 111.459 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.56 -16.58 59.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 73.24 111.43 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.35 -0.53 14.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 65.14 113.168 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -93.09 63.93 2.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 72.33 112.3 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 263' ' ' LEU . 4.0 p-80 -79.27 147.92 32.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.68 -0.118 . . . . 74.45 110.68 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -95.3 138.02 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.533 -0.467 . . . . 71.43 109.759 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -132.84 140.57 48.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 75.31 110.631 -170.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.534 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -142.07 131.53 4.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.549 -0.62 . . . . 73.14 111.549 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.723 HD22 HD23 ' A' ' 259' ' ' LEU . 3.4 tm? -115.75 137.57 51.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.967 -0.753 . . . . 72.4 108.967 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.415 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -150.96 140.51 7.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.075 -1.059 . . . . 74.31 113.144 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 255' ' ' ILE . 2.4 mm? -110.85 129.98 55.71 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.625 -0.88 . . . . 75.34 108.625 172.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 1.021 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 21.7 mm-40 -101.84 112.04 24.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.312 1.053 . . . . 73.43 112.997 -168.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 1.082 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 34.4 p90 -29.21 44.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 119.971 3.323 . . . . 71.51 119.971 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.85 ' HG2' ' HG3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -113.9 104.91 12.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 122.424 2.375 . . . . 75.02 112.332 -175.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.62 106.26 8.61 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.554 -0.906 . . . . 75.02 108.554 163.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -155.12 -166.06 2.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.383 -0.826 . . . . 63.22 109.122 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.778 -0.63 . . . . 74.33 109.739 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttm . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.084 0.469 . . . . 73.4 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.35 93.52 5.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.083 -0.508 . . . . 74.01 110.614 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 119' ' ' LYS . 7.9 t -80.31 119.67 77.13 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.67 -0.695 . . . . 74.22 109.678 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.68 162.34 42.43 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.902 2.401 . . . . 73.33 112.824 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.63 79.85 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.764 2.31 . . . . 74.33 111.003 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.553 ' HB ' ' CG1' ' A' ' 143' ' ' VAL . 26.7 p -69.84 -46.95 64.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.434 -0.803 . . . . 73.31 111.995 -172.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -58.37 -28.4 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.058 -0.519 . . . . 73.34 111.41 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.26 -22.99 35.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.094 0.473 . . . . 74.41 110.839 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.27 -15.66 45.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.843 -0.617 . . . . 71.23 109.737 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.573 HD23 HG13 ' A' ' 143' ' ' VAL . 75.1 mt -63.72 -29.23 70.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.65 -0.705 . . . . 65.3 110.263 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.49 62.96 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.73 -0.668 . . . . 50.1 112.263 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 64.0 tttp -63.87 -49.4 72.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 72.13 110.183 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 m -64.55 -38.32 90.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.296 0.569 . . . . 72.41 110.529 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.439 -0.801 . . . . 75.44 112.254 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.632 ' HG3' ' N ' ' A' ' 16' ' ' ASP . 1.7 ptt180 -59.7 -36.99 77.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.563 0.22 . . . . 71.2 111.171 -175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.632 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 69.7 m-20 -68.47 -37.0 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 72.11 110.677 -175.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -72.43 -40.42 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 70.15 110.809 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -70.71 -33.75 71.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.812 -0.631 . . . . 74.41 110.983 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 m -70.04 133.72 47.51 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.71 -0.478 . . . . 74.11 109.71 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -69.53 79.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.72 0.772 . . . . 72.21 111.632 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.98 70.42 2.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.28 -0.728 . . . . 55.35 111.28 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' A' ' 274' ' ' LYS . 17.7 p90 -85.04 -53.62 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.568 0.223 . . . . 74.33 110.884 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.56 129.39 4.17 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.661 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -104.33 5.64 34.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.297 0.57 . . . . 73.15 110.463 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 89.39 12.6 62.8 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.543 -1.023 . . . . 74.2 110.543 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 46' ' ' SER . 0.5 OUTLIER -102.78 153.5 20.1 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.943 -0.628 . . . . 73.22 111.423 -169.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.754 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.8 mp -106.9 124.46 62.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.002 -0.999 . . . . 73.54 110.545 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.8 tptm -102.06 119.47 38.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.484 -0.562 . . . . 72.41 109.484 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -113.84 128.63 56.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.005 0.431 . . . . 75.01 110.132 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -120.76 136.35 54.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.735 . . . . 73.21 109.066 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.882 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -133.39 123.84 26.07 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.197 -0.668 . . . . 74.12 109.197 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 14.3 pttm -137.08 125.58 23.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.203 0.525 . . . . 75.54 111.498 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 18.9 m -109.71 121.27 44.84 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.512 -0.922 . . . . 74.34 108.512 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -109.82 124.45 51.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.933 -0.307 . . . . 74.25 111.165 -170.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.796 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 12.2 t -140.41 169.66 17.26 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.277 -1.008 . . . . 71.22 108.277 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.21 179.83 4.25 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.091 -0.707 . . . . 72.42 109.091 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.59 43.63 7.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.14 0.495 . . . . 75.41 111.27 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 94.49 -4.84 70.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 116.984 1.554 . . . . 74.34 116.984 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.796 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -100.2 124.13 45.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 120.971 2.385 . . . . 73.21 112.141 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.866 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.9 tt0 -143.08 118.02 9.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.987 -0.746 . . . . 73.04 108.987 162.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.752 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 97.4 m-85 -108.34 121.78 45.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.546 -0.462 . . . . 73.55 110.473 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 33.0 m -125.19 132.65 52.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.104 0.478 . . . . 75.53 111.062 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 44.3 t -125.32 143.11 51.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.729 -0.841 . . . . 75.31 108.729 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m -135.67 126.55 27.56 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.04 -0.356 . . . . 71.11 110.04 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 56' ' ' GLY . . . -141.78 157.13 26.21 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.171 -1.014 . . . . 73.11 112.47 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.519 ' HB3' HD21 ' A' ' 26' ' ' LEU . 39.8 m -131.82 139.27 48.81 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.978 -0.749 . . . . 73.42 108.978 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -119.46 129.08 54.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.224 0.535 . . . . 72.14 110.574 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.83 145.93 24.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.043 -0.98 . . . . 72.32 108.852 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.06 76.19 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.371 0.605 . . . . 74.53 111.457 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -167.22 154.14 8.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.915 -1.143 . . . . 74.14 107.915 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.7 m -56.22 -45.94 79.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.097 0.777 . . . . 74.23 113.097 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.3 p -129.29 47.31 2.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 72.13 112.496 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 32.0 mmtp -123.33 73.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.384 0.612 . . . . 73.35 110.991 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.57 120.57 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.47 -0.787 . . . . 74.01 109.633 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -109.2 126.53 53.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.709 -0.478 . . . . 71.35 109.709 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' HA2' ' HA2' ' A' ' 45' ' ' GLY . . . -132.74 170.72 21.94 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.343 -0.932 . . . . 74.2 113.07 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.5 m -147.56 157.66 43.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.421 -0.585 . . . . 74.54 109.421 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -120.22 125.02 47.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 75.0 109.371 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.8 tt0 -118.82 119.25 33.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.582 -0.736 . . . . 72.53 109.504 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 m -110.23 120.02 41.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.431 -0.349 . . . . 74.23 110.527 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.866 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mptt -106.61 131.45 53.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.224 0.535 . . . . 70.54 110.359 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.5 m-85 -103.21 118.48 36.87 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.305 -1.369 . . . . 74.23 107.305 170.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 33.3 ttm-85 -113.46 109.69 19.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.424 0.631 . . . . 75.42 111.876 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.21 91.2 8.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.161 -0.927 . . . . 71.54 109.254 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -16.42 61.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.299 -0.864 . . . . 71.21 110.679 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.89 -41.31 87.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.193 -0.912 . . . . 74.41 111.031 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.468 ' HB2' ' HG ' ' A' ' 69' ' ' LEU . 67.6 m-85 -108.14 -33.94 7.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.33 111.186 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.615 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 101.95 44.44 1.91 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.947 -0.861 . . . . 53.41 110.947 -173.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 87' ' ' VAL . 13.4 mt -126.91 147.21 50.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.804 -0.443 . . . . 75.44 109.804 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -136.57 135.3 38.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.691 0.281 . . . . 75.53 111.13 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 70.1 t80 -115.17 120.73 40.72 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.429 -0.582 . . . . 74.25 109.429 173.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.765 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 17.7 m -109.57 117.74 34.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.236 -0.438 . . . . 71.2 110.305 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -109.15 120.34 42.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.355 -0.609 . . . . 72.31 109.355 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -107.81 97.6 7.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.095 -0.502 . . . . 71.0 109.7 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.594 ' HD1' HD13 ' A' ' 81' ' ' LEU . 46.4 t90 -100.35 131.84 46.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.345 0.593 . . . . 74.22 111.279 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.38 154.11 35.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.521 -0.763 . . . . 43.23 109.861 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 m -57.6 -18.4 19.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.016 0.436 . . . . 74.14 111.9 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 20.2 t70 -67.57 -3.86 10.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.095 -0.502 . . . . 73.44 110.906 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 8.1 m120 79.66 22.84 0.51 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.876 0.87 . . . . 75.3 110.02 -175.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 25.7 m -88.83 118.14 28.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.54 -0.754 . . . . 73.04 111.015 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.594 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.8 mm? -97.19 118.37 33.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 63.41 109.213 172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.68 92.83 0.85 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.512 -0.851 . . . . 71.04 111.21 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 p -91.39 103.5 16.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.986 0.422 . . . . 74.13 111.414 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 25.4 tt0 -106.73 111.63 24.25 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.456 -0.793 . . . . 70.25 109.565 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.9 121.52 64.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.437 -0.579 . . . . 74.34 109.437 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.656 ' HB ' HG22 ' A' ' 98' ' ' THR . 14.3 t -128.2 129.66 46.81 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.54 0.686 . . . . 73.22 111.537 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.653 ' HA ' HD21 ' A' ' 69' ' ' LEU . 32.5 m -111.01 129.89 65.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.417 -0.81 . . . . 74.24 109.631 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.28 118.71 36.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 71.11 112.131 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 47.27 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.319 1.012 . . . . 73.24 112.804 171.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -116.97 -92.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.317 -0.401 . . . . 74.34 110.09 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.2 -44.72 7.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.982 -0.747 . . . . 74.14 108.982 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.65 103.71 5.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 74.44 109.376 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.83 124.26 21.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.693 -0.685 . . . . 74.3 110.756 -173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.77 5.73 87.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.869 -0.681 . . . . 70.21 113.085 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 128.16 38.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.238 0.519 . . . . 71.35 111.638 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -118.28 111.39 18.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.61 -0.885 . . . . 73.34 108.61 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.618 ' HB2' HG21 ' A' ' 87' ' ' VAL . 2.2 mm? -102.52 124.78 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.514 -0.551 . . . . 73.3 109.514 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 7.8 m -131.21 119.69 22.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.54 -0.3 . . . . 71.04 111.015 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -111.2 115.32 29.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.473 -0.566 . . . . 72.13 109.473 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -112.02 122.63 48.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.189 -0.459 . . . . 62.4 109.775 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.4 t -138.16 123.83 19.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.43 -0.508 . . . . 74.24 111.004 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 13.0 m -104.17 122.69 45.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.064 -0.516 . . . . 71.13 110.264 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.81 124.87 48.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.556 -0.293 . . . . 74.04 110.786 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.9 t -127.6 102.42 22.97 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.437 -0.579 . . . . 74.11 109.437 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.23 -9.13 22.93 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.074 2.516 . . . . 74.15 112.755 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -78.52 -40.12 36.1 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.034 -0.358 . . . . 75.34 110.034 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 p -100.22 -25.61 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 73.0 111.171 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.936 -0.575 . . . . 74.23 111.897 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -79.12 123.93 27.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 74.23 111.275 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -132.66 124.63 28.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.934 -0.575 . . . . 74.11 109.495 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 101' ' ' SER . 7.4 m120 -120.45 128.37 53.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.825 -0.625 . . . . 65.12 110.353 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -114.07 114.79 26.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.259 -0.428 . . . . 75.43 110.366 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.433 ' HG3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -111.13 136.95 49.43 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.158 -0.682 . . . . 74.13 109.158 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -119.47 117.62 54.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 72.03 109.833 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.692 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.2 tttp -115.26 119.13 35.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.495 -0.775 . . . . 74.13 109.285 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -127.2 118.59 24.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.679 -0.489 . . . . 65.22 109.679 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.471 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -127.13 122.84 4.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.333 -0.937 . . . . 74.55 112.577 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -110.0 121.03 44.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.375 0.607 . . . . 74.24 109.501 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.704 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.6 124.23 51.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.649 -0.705 . . . . 72.41 110.673 179.231 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.456 ' HG3' ' H ' ' A' ' 121' ' ' GLU . 10.0 tpp180 -104.96 167.68 9.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.559 -1.274 . . . . 75.41 107.559 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' H ' ' HG3' ' A' ' 120' ' ' ARG . 37.7 tt0 -53.16 -33.33 52.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.475 0.546 . . . . 74.1 112.475 -167.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -120.25 0.32 10.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.801 0.667 . . . . 71.41 112.801 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 142' ' ' LEU . 7.7 tt -145.25 136.01 19.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 O-C-N 121.74 -0.6 . . . . 74.14 111.985 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.711 ' O ' HD21 ' A' ' 142' ' ' LEU . 5.4 t30 -129.19 109.84 11.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.088 -0.645 . . . . 74.43 111.308 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 1.115 ' HG ' ' HG ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -112.89 142.48 45.51 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.449 0.642 . . . . 75.31 111.719 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.471 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -143.33 127.06 2.97 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.78 -1.1 . . . . 51.42 112.737 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.22 111.85 24.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.952 -0.388 . . . . 73.32 109.952 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -113.52 118.23 33.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.495 -0.557 . . . . 73.32 109.495 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.633 ' HG2' HG13 ' A' ' 138' ' ' ILE . 59.3 mtt -120.94 119.37 32.39 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.747 -0.381 . . . . 72.04 111.391 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.433 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 15.3 m-20 -90.65 118.39 30.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 109.811 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 74.3 t80 -96.87 104.55 16.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.966 0.412 . . . . 74.55 110.014 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.26 157.27 30.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.865 -0.607 . . . . 70.31 109.717 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 134' ' ' ALA . 2.2 pp -73.85 -15.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.209 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.43 ' N ' HD11 ' A' ' 133' ' ' ILE . . . -88.88 -17.59 29.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.013 0.435 . . . . 74.14 110.714 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.44 117.54 0.67 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.926 -0.654 . . . . 73.12 112.08 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 56.1 Cg_endo -72.01 134.36 23.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.463 2.109 . . . . 72.0 111.781 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -119.37 144.14 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.458 -0.337 . . . . 75.41 110.397 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.633 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -107.29 117.12 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.459 -0.571 . . . . 75.44 109.459 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -114.63 113.85 24.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.745 -0.661 . . . . 75.2 109.532 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.71 129.57 9.35 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.375 -1.393 . . . . 71.14 111.365 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . . . -124.7 118.72 27.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.651 0.263 . . . . 72.42 110.704 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 1.115 ' HG ' ' HG ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -117.08 144.76 44.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.332 -0.394 . . . . 73.33 110.624 175.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.703 ' H ' HD21 ' A' ' 142' ' ' LEU . 45.4 t -128.5 115.43 37.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.52 -1.289 . . . . 74.32 107.52 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.807 HD21 HD12 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -120.93 137.27 54.69 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.547 -1.206 . . . . 74.14 110.117 -169.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.54 135.7 13.06 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 120.604 -0.808 . . . . 50.12 113.2 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -143.8 125.36 14.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.011 0.434 . . . . 74.24 111.4 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 59.22 23.35 11.68 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.987 0.736 . . . . 73.01 112.987 168.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.69 -18.18 51.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.378 -0.915 . . . . 74.42 113.062 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -105.17 146.65 28.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.891 -0.411 . . . . 72.31 109.891 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.529 HD22 HG11 ' A' ' 143' ' ' VAL . 5.0 mt -108.9 148.39 30.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 72.41 110.637 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 144' ' ' LEU . . . -141.85 124.26 15.72 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.73 -1.211 . . . . 72.33 107.73 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.56 ' CA ' ' HA ' ' A' ' 143' ' ' VAL . . . -156.05 131.82 3.15 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.58 -0.819 . . . . 74.23 111.965 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.984 ' CB ' ' HA ' ' A' ' 169' ' ' PHE 0.423 0.1 OUTLIER -165.06 171.76 13.48 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 116.209 1.929 . . . . 74.11 116.209 167.326 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.605 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 26.4 pt20 -106.85 134.37 50.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.416 -1.72 . . . . 72.52 111.498 -166.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.8 ttp -110.84 141.53 44.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 74.2 109.576 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.516 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 43.4 m-80 -114.51 117.92 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.024 -0.27 . . . . 72.11 110.351 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.793 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 74.1 t80 -102.08 122.27 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.684 -0.689 . . . . 74.12 110.759 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 163' ' ' ARG . 32.4 tt0 -88.78 99.93 12.75 Favored 'General case' 0 C--O 1.259 1.574 0 CA-C-N 115.567 -0.742 . . . . 71.2 109.044 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.447 HG22 ' HE1' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -70.29 -19.98 63.06 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 113.446 -1.706 . . . . 73.4 111.664 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.18 -26.65 64.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.047 0.927 . . . . 71.22 108.732 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -122.39 -157.5 0.74 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.136 -1.393 . . . . 75.13 107.839 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -107.64 27.76 8.84 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.32 -0.622 . . . . 71.12 109.32 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -133.64 129.36 36.77 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.64 -0.824 . . . . 72.02 112.857 -159.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.793 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.8 m -73.54 136.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 168.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 2.0 m -90.01 -34.53 15.94 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.518 -0.473 . . . . 72.32 110.371 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -149.89 133.29 16.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 73.33 110.017 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.7 m -103.14 111.76 24.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.557 -0.905 . . . . 73.32 108.557 172.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.919 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 46.5 m-20 -106.4 121.67 44.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.863 -0.791 . . . . 73.22 108.863 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.984 ' HA ' ' CB ' ' A' ' 153' ' ' TYR . 51.4 p90 -131.17 138.94 49.65 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.057 0.848 . . . . 74.12 111.31 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.834 ' H ' ' HB2' ' A' ' 153' ' ' TYR . . . -130.25 145.84 51.8 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 120.883 0.373 . . . . 71.41 110.547 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 151' ' ' ALA . 48.8 t -127.56 131.28 70.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.276 -0.42 . . . . 75.14 110.635 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.3 95.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.655 -0.978 . . . . 72.3 110.655 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -110.92 119.62 39.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.853 -0.795 . . . . 72.25 108.853 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.433 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 34.0 mtmm -114.84 127.92 56.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.331 -0.395 . . . . 75.43 111.46 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.409 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 56.7 m -132.09 113.44 13.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.137 -0.483 . . . . 75.01 110.347 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 40.4 -93.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.266 1.21 . . . . 75.51 114.266 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.1 -11.85 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.672 0.619 . . . . 74.45 112.672 -170.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.409 ' CZ ' ' HB ' ' A' ' 175' ' ' THR . 48.4 p90 -129.97 135.94 48.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.622 0.725 . . . . 74.5 111.615 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.433 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 75.8 mt-30 -114.46 123.18 48.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.231 -0.895 . . . . 72.31 108.924 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.24 137.55 33.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.281 0.562 . . . . 74.33 111.081 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -123.8 115.67 21.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.052 -0.976 . . . . 74.13 108.689 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 43.8 m -124.54 115.46 20.9 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.658 -0.417 . . . . 74.25 110.086 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.43 140.62 50.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.371 0.605 . . . . 71.44 109.852 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 6.4 t -126.31 130.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.521 -0.763 . . . . 73.21 110.757 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.841 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 11.9 m-20 -105.51 93.69 4.8 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.383 -0.969 . . . . 75.21 108.383 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 34.0 t70 61.47 -179.53 0.12 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.633 -0.506 . . . . 74.41 109.633 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -71.48 -6.35 61.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.795 -0.717 . . . . 63.41 112.174 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.8 p -96.4 -26.17 15.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.055 0.761 . . . . 74.2 113.055 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 24.8 mt-10 -118.45 124.99 48.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 119.697 -0.801 . . . . 74.44 112.23 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.8 125.52 53.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.398 -0.819 . . . . 75.52 109.745 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.18 113.52 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.899 -0.667 . . . . 73.32 112.089 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.99 139.28 15.02 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.934 -0.65 . . . . 64.55 111.883 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 14.5 m -140.52 138.39 34.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.914 0.388 . . . . 64.43 110.03 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.407 HD11 ' C ' ' A' ' 193' ' ' SER . 3.3 mp -124.56 128.33 73.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.666 -0.494 . . . . 74.21 109.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.543 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 42.9 t80 -106.67 119.75 40.14 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.622 -0.881 . . . . 75.3 108.622 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -122.51 131.1 53.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.414 -0.587 . . . . 74.54 109.414 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 197' ' ' LYS . 24.9 ttpp -103.29 109.05 20.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.786 -0.643 . . . . 73.34 109.678 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.547 HG22 ' HG ' ' A' ' 202' ' ' LEU . 0.0 OUTLIER -93.2 -17.36 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-O 121.555 0.693 . . . . 75.22 109.82 -176.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 14.2 t-20 -163.86 158.17 19.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.917 -1.038 . . . . 72.13 108.324 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.601 ' HB3' ' HZ2' ' A' ' 200' ' ' LYS . 10.2 mtpm? -63.67 -13.24 41.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.014 0.435 . . . . 75.04 111.071 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 226' ' ' GLN . 19.0 tttp -116.05 3.98 13.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.001 -0.545 . . . . 75.11 110.642 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.547 ' HG ' HG22 ' A' ' 198' ' ' VAL . 47.8 tp -140.29 108.98 5.92 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.766 0.793 . . . . 74.1 111.307 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.543 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 24.7 mt-10 -115.32 137.84 51.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.953 -1.021 . . . . 63.31 110.192 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 p -123.68 151.17 43.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.122 -0.325 . . . . 74.43 110.122 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -140.11 139.03 35.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.015 0.436 . . . . 73.14 111.306 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 193' ' ' SER . 53.3 t -112.11 137.43 44.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.313 -0.625 . . . . 73.33 109.313 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -132.84 128.34 36.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.263 -0.643 . . . . 65.23 109.263 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.6 pt? -147.89 130.61 16.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.412 0.625 . . . . 74.44 111.082 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.2 132.87 55.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.33 -0.85 . . . . 75.2 110.363 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.773 ' HB2' HG21 ' A' ' 217' ' ' THR . 19.3 t90 -130.7 131.7 44.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.569 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 11.9 m -104.7 113.49 27.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.763 -0.653 . . . . 71.13 109.649 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.81 127.54 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.903 -0.406 . . . . 71.44 109.903 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.93 17.65 57.54 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 43.24 111.537 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' A' ' 215' ' ' SER . 12.0 t-20 -129.93 -153.86 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.772 -0.825 . . . . 64.43 108.772 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.48 ' H ' ' CG ' ' A' ' 214' ' ' ASN . 17.2 m -85.95 -154.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.066 0.46 . . . . 71.44 111.747 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.72 163.47 7.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.497 -0.774 . . . . 72.1 112.553 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.773 HG21 ' HB2' ' A' ' 210' ' ' TRP . 32.7 m -76.39 134.55 39.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.605 -0.725 . . . . 74.13 109.18 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 69.3 mtt85 -101.05 116.12 32.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.723 -0.473 . . . . 71.44 109.723 -173.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.42 ' HD2' HD12 ' A' ' 208' ' ' LEU . 65.8 t80 -113.5 149.67 34.01 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.608 0.568 . . . . 74.2 110.493 -172.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -158.93 150.6 21.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.211 -0.519 . . . . 62.13 112.2 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.4 130.53 72.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.902 -0.407 . . . . 72.45 109.902 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -119.5 154.52 33.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.811 0.339 . . . . 74.01 110.303 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.67 125.71 18.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.174 -0.467 . . . . 73.23 110.23 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.432 ' HZ2' ' CD ' ' A' ' 203' ' ' GLU . 10.3 ttmt -112.38 114.06 26.58 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.62 -0.511 . . . . 73.55 109.62 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.436 ' HD2' HD12 ' A' ' 202' ' ' LEU . 74.8 t80 -113.73 116.29 29.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.448 -0.575 . . . . 75.14 109.448 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.508 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 3.6 pt20 -95.94 99.58 11.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.716 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.4 tt -69.44 -24.92 28.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.527 0.68 . . . . 74.05 109.521 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 230' ' ' ASP . 18.9 t70 -166.6 146.31 4.93 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.199 -1.037 . . . . 75.01 108.199 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.1 12.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.793 2.329 . . . . 73.4 113.399 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 228' ' ' ASP . 23.3 t70 -104.92 -29.34 10.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.44 110.067 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.33 125.86 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 73.13 110.831 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 56.1 m -124.04 142.23 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.129 0.49 . . . . 73.43 110.755 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -108.86 127.33 53.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.213 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 5.5 p -129.39 117.21 20.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 64.15 110.965 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.43 158.67 23.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.111 -0.329 . . . . 75.12 110.111 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 26.2 pttm -152.94 141.86 21.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.019 0.438 . . . . 74.13 110.849 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 242' ' ' LEU . 8.8 p -128.66 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 72.33 109.814 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.8 m120 -107.91 150.56 26.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.752 -0.462 . . . . 73.02 109.752 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 241' ' ' SER . 24.7 t-20 -64.73 -8.79 16.13 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.672 0.607 . . . . 75.34 111.534 -176.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.45 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 13.3 m -80.82 14.67 2.07 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.824 -0.436 . . . . 75.54 109.824 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.4 m 68.31 36.83 2.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.256 -0.883 . . . . 72.35 110.702 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.827 ' HB3' HD11 ' A' ' 262' ' ' LEU . 40.5 mt -99.29 115.61 29.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 75.22 109.697 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.2 OUTLIER -112.29 116.7 53.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.65 -0.42 . . . . 71.32 110.503 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -135.61 152.21 20.87 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.123 -1.036 . . . . 74.21 113.526 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -127.96 156.12 43.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 71.33 110.737 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -143.42 143.59 12.59 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.993 -0.622 . . . . 74.32 112.157 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 258' ' ' THR . 63.8 m-85 -114.47 115.6 27.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.784 -0.451 . . . . 72.44 109.784 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 17.9 m -109.91 114.38 27.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.504 -0.554 . . . . 75.01 109.504 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -135.53 143.18 45.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.757 0.313 . . . . 62.22 110.801 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.8 t -107.54 116.18 31.49 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.051 -0.722 . . . . 65.51 109.051 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 3.8 mm? -70.34 173.57 6.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.861 -0.609 . . . . 74.41 110.518 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.608 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 20.8 mtpp -67.63 -44.97 45.56 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.25 -0.432 . . . . 75.3 110.852 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 16.8 Cg_exo -70.37 -174.49 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.887 1.725 . . . . 65.24 111.025 165.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -81.35 69.6 3.25 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.701 -0.762 . . . . 75.22 112.393 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.487 HG12 ' CD2' ' A' ' 281' ' ' PHE . 37.6 mt -136.81 124.78 33.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 122.652 -0.322 . . . . 74.21 111.02 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 280' ' ' GLU . 51.3 mttp -109.99 113.37 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.273 -0.64 . . . . 74.41 109.273 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.91 130.57 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.264 -0.426 . . . . 74.12 110.665 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 25.3 m -125.17 111.43 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 74.2 110.147 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.898 HD21 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -105.03 125.39 50.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.022 -1.103 . . . . 71.14 108.022 176.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 53.2 m -134.17 140.8 46.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.972 0.415 . . . . 70.55 111.406 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.67 128.01 19.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.92 -0.582 . . . . 74.44 109.648 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 242' ' ' LEU . 3.0 tm? -110.03 113.35 25.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.932 -0.766 . . . . 71.42 108.932 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.576 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.089 -1.078 . . . . 65.33 108.089 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.547 ' HA ' HD23 ' A' ' 242' ' ' LEU . 10.7 t70 -72.49 103.61 3.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.242 -0.89 . . . . 75.11 108.937 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.6 38.24 Favored Glycine 0 N--CA 1.458 0.118 0 O-C-N 123.395 0.434 . . . . 64.22 113.617 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -91.03 -26.99 18.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.568 0.223 . . . . 72.44 111.304 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.423 ' ND2' ' HA3' ' A' ' 272' ' ' GLY . 64.1 t30 -115.19 -22.83 9.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.813 0.671 . . . . 74.3 112.813 -171.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 264' ' ' ASP . 29.4 m -62.17 -18.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.977 -0.452 . . . . 73.31 111.499 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.46 -39.73 80.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.123 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.51 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 52.32 110.862 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.57 89.29 1.69 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.826 -0.702 . . . . 74.52 111.673 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -157.92 38.83 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.812 -0.708 . . . . 55.41 112.137 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -80.05 145.7 32.33 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.221 -0.288 . . . . 74.3 110.221 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.3 mptt -96.72 138.07 34.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.173 -0.677 . . . . 74.22 109.173 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.437 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 tm? -125.93 131.14 52.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.961 -0.385 . . . . 71.34 109.961 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.414 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -137.08 125.21 3.31 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.473 -0.87 . . . . 44.53 112.092 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.898 HD23 HD21 ' A' ' 259' ' ' LEU . 3.2 tm? -114.96 138.1 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.771 -0.825 . . . . 74.25 108.771 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -158.18 122.21 1.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.349 -0.929 . . . . 74.45 111.13 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -144.91 138.87 27.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.015 0.436 . . . . 73.22 112.04 -175.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.551 ' CG ' ' HB2' ' A' ' 256' ' ' LYS . 6.8 pt-20 -110.71 120.66 43.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 75.21 110.502 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.882 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.7 t80 -98.78 118.7 36.1 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.991 -0.744 . . . . 75.33 108.991 175.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 4.1 pt20 -111.65 111.67 22.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.456 0.646 . . . . 73.11 110.447 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.65 111.59 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 75.32 109.592 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.99 135.91 53.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.942 -0.572 . . . . 73.04 109.771 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.106 -0.473 . . . . 61.32 110.757 -179.659 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 25.1 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.346 -0.242 . . . . 71.43 110.346 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.438 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -49.49 130.67 20.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.072 0.463 . . . . 60.24 111.917 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.16 125.63 91.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.222 -0.899 . . . . 73.44 111.369 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -63.65 165.01 19.27 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.383 2.722 . . . . 65.42 112.565 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.84 71.33 4.15 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.204 2.603 . . . . 71.4 112.407 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.782 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.4 p -70.36 -48.84 54.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 74.41 111.606 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.563 ' HB2' HG23 ' A' ' 143' ' ' VAL . 70.9 t80 -60.84 -26.08 67.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.901 -0.59 . . . . 64.12 110.866 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -82.08 -10.76 59.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 64.13 111.351 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.441 ' CG ' ' HE2' ' A' ' 181' ' ' HIS . 23.6 t70 -92.31 -22.3 19.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.01 0.433 . . . . 74.14 111.136 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.99 -35.34 71.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.716 0.636 . . . . 75.52 112.716 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.53 15.65 8.56 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 119.917 -1.135 . . . . 65.22 114.114 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 8' ' ' ALA . 33.5 mmtm -63.98 -54.77 29.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.347 0.574 . . . . 74.24 111.713 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -63.36 -38.72 92.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 65.34 110.949 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.13 68.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 65.04 111.825 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -69.05 -35.72 76.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 65.14 111.297 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.11 -45.26 81.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.905 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.36 -25.34 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.461 . . . . 44.23 110.991 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -59.87 -39.82 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 74.43 110.806 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -89.34 36.16 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.295 0.569 . . . . 51.44 110.282 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -52.47 114.48 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.27 -0.877 . . . . 74.53 111.84 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.74 96.97 1.45 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.651 -0.704 . . . . 75.3 112.362 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -133.0 -166.49 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.475 -0.565 . . . . 72.42 109.475 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.13 89.08 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.701 -0.761 . . . . 74.52 111.731 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -100.26 -3.77 30.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.492 . . . . 74.03 110.076 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.59 61.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.977 -0.63 . . . . 71.22 113.07 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.721 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 3.5 pp -147.8 179.76 7.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 113.459 0.911 . . . . 70.33 113.459 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 277' ' ' LEU . 28.7 mm -100.91 122.93 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.876 -1.511 . . . . 64.25 109.061 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.4 ttmm -120.76 121.25 37.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 73.34 110.517 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 279' ' ' LEU . 2.6 tt -113.59 142.05 46.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.563 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -135.46 128.37 31.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.381 -0.827 . . . . 64.33 109.466 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 18.3 tp -122.07 123.73 42.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 74.4 110.551 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -108.14 125.07 51.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.69 . . . . 75.12 109.406 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.75 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 39.4 m -128.45 121.82 29.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.589 0.233 . . . . 75.25 110.988 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 53.2 mtmt -137.39 123.74 20.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 73.23 110.531 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.584 ' H ' HD12 ' A' ' 39' ' ' LEU . 50.4 m -143.09 155.8 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 74.31 109.855 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 49.53 -131.28 1.86 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.593 0.558 . . . . 74.32 111.589 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.23 134.91 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.519 0.676 . . . . 63.4 111.493 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 93.15 -11.46 71.84 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.044 -0.98 . . . . 71.05 114.449 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.584 HD12 ' H ' ' A' ' 35' ' ' SER . 3.4 pp -103.96 133.86 48.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 118.646 1.223 . . . . 75.23 111.985 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.946 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 39.8 tt0 -138.5 128.71 25.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.886 . . . . 71.12 108.609 161.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.75 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 84.1 m-85 -118.28 121.73 41.16 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.877 -0.515 . . . . 74.02 110.828 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.957 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 21.2 m -117.11 115.81 26.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 71.42 109.814 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.55 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 27.5 t -112.65 123.67 50.82 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.358 . . . . 74.54 110.035 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 51.1 m -119.43 125.95 50.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.119 0.485 . . . . 72.31 110.312 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.5 117.48 2.26 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.613 -0.803 . . . . 75.34 111.475 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.6 m -112.67 133.94 54.45 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.733 -0.387 . . . . 62.34 109.983 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -135.55 126.66 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.44 -0.578 . . . . 72.55 109.44 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.721 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 7.4 t-20 -78.28 134.89 37.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.396 -173.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -96.36 -19.31 19.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.092 0.472 . . . . 71.23 110.97 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.91 -53.79 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.283 0.563 . . . . 74.31 109.751 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 35.1 m -122.2 105.6 10.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.226 -0.657 . . . . 70.24 109.226 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -52.6 102.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.937 0.718 . . . . 74.51 112.937 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -154.76 135.67 13.73 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.025 -1.102 . . . . 75.55 108.025 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.26 132.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.01 0.434 . . . . 72.23 111.222 -174.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -123.97 126.15 45.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 75.24 110.096 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.25 135.24 12.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.843 -0.694 . . . . 62.41 112.565 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 16.9 m -125.65 125.92 43.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.623 -0.88 . . . . 71.44 108.623 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.96 124.51 45.08 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.685 -0.487 . . . . 72.21 109.685 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.957 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 41.7 tt0 -106.77 117.87 35.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.155 0.502 . . . . 72.21 109.77 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 15.6 m -93.27 119.31 32.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.043 -1.095 . . . . 75.11 108.043 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.946 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.8 tptm -122.85 138.01 54.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.142 0.496 . . . . 75.15 109.763 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.748 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 86.5 m-85 -116.69 120.76 39.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.864 -0.791 . . . . 75.31 108.864 172.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.496 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.0 ptm85 -115.73 105.86 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.124 -0.63 . . . . 64.14 110.586 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.858 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 76.0 t90 -112.43 106.06 14.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 64.2 110.088 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 m 66.46 153.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.58 1.175 . . . . 75.43 111.273 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -64.04 102.82 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.27 -0.423 . . . . 75.13 109.927 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 t80 63.73 81.47 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 72.41 110.875 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.47 -75.09 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.369 -1.092 . . . . 74.35 110.369 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.858 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 2.0 mm? -113.09 131.42 55.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.854 0.359 . . . . 73.01 110.794 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 p -135.19 112.66 10.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.716 . . . . 62.11 110.337 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 21.7 t80 -109.68 121.34 44.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.503 -0.554 . . . . 75.5 109.503 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 m -116.69 127.71 54.66 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.2 0.313 . . . . 74.32 110.753 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 28.1 tt0 -130.66 121.29 25.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.511 -0.551 . . . . 75.24 109.511 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -111.22 97.83 7.06 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.037 -0.727 . . . . 73.4 109.037 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.926 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 41.5 t90 -108.8 129.71 55.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.176 -0.466 . . . . 74.21 111.466 -174.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -105.95 139.28 40.74 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.981 -0.748 . . . . 72.05 108.981 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -60.05 -36.67 77.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.639 0.607 . . . . 72.54 112.639 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -111.07 -23.82 10.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 64.11 112.066 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.578 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 2.5 t-20 -104.0 -106.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.265 -0.574 . . . . 75.04 112.427 -169.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 p -116.43 144.64 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.765 0.654 . . . . 75.55 112.765 -170.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.926 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -111.69 123.28 49.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.718 -0.475 . . . . 73.33 109.718 166.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.41 121.99 5.23 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.597 -0.729 . . . . 40.32 111.487 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.691 ' HB ' ' HB3' ' A' ' 101' ' ' SER . 23.2 m -109.11 142.91 39.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.828 0.346 . . . . 74.1 111.059 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.54 113.73 7.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.808 -0.633 . . . . 74.24 109.406 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.489 HG13 ' H ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -112.27 136.41 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.801 -0.444 . . . . 73.34 109.801 179.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.8 m -128.54 124.03 34.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 61.31 110.292 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 2.7 p -125.83 120.54 57.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.38 0.61 . . . . 64.25 111.051 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.26 118.54 35.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.157 -1.423 . . . . 65.2 107.157 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 11.6 t70 -55.91 133.35 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.515 -0.474 . . . . 73.23 110.681 -173.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 19.7 pt20 -68.95 -25.35 64.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 64.33 111.75 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.469 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 85.6 mt -108.83 -52.2 2.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.128 0.49 . . . . 71.51 109.908 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.13 10.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 75.54 110.235 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' HD3' ' O ' ' A' ' 89' ' ' ASP . 36.3 mmt180 -59.72 135.14 57.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 73.32 109.899 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.656 ' HA2' ' HG3' ' A' ' 119' ' ' LYS . . . 102.49 7.18 46.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.633 -0.794 . . . . 74.43 111.492 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.48 114.75 22.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.629 -0.878 . . . . 75.23 108.629 173.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 10.4 ttpp -122.49 111.8 17.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.934 -0.575 . . . . 63.22 110.705 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.506 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.8 mm? -97.55 130.85 44.57 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.819 -0.808 . . . . 74.11 108.819 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -130.46 133.7 46.51 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.32 -0.4 . . . . 73.23 110.986 -177.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' H ' HG13 ' A' ' 85' ' ' ILE . 76.8 t80 -124.52 129.62 50.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.396 -0.366 . . . . 73.31 110.232 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 113' ' ' LYS . 6.3 m-20 -115.83 133.81 55.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.132 -0.485 . . . . 72.42 109.891 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.691 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 30.1 t -130.21 137.29 49.99 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.949 -0.389 . . . . 72.32 109.949 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -135.06 121.63 20.65 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.976 -0.379 . . . . 73.22 109.976 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.707 ' HD1' HD22 ' A' ' 81' ' ' LEU . 75.4 t80 -134.52 137.14 43.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 74.11 110.608 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.413 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 5.1 m -114.29 103.74 54.93 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.944 -0.571 . . . . 75.31 110.017 176.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 32.8 Cg_endo -65.46 152.14 82.82 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.533 2.155 . . . . 73.45 111.477 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.61 25.34 14.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.666 0.746 . . . . 74.22 109.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 m -140.3 -55.12 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.757 -0.656 . . . . 74.51 110.341 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.9 4.1 57.9 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 74.55 112.714 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -87.91 122.75 31.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.311 -0.625 . . . . 75.31 109.311 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 21.6 ptmt -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.101 0.477 . . . . 75.25 110.714 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -121.6 122.64 40.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.427 -0.806 . . . . 75.41 109.559 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 114.77 29.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.052 -0.522 . . . . 74.34 109.621 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.852 ' HG3' ' HB3' ' A' ' 130' ' ' ASP . 28.1 ttmt -118.38 135.4 54.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.234 0.54 . . . . 73.44 110.665 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.854 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 4.2 tp -129.99 132.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 107.739 -1.208 . . . . 74.43 107.739 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.826 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 16.6 ttpt -132.28 119.16 20.4 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 124.987 1.43 . . . . 74.51 110.662 -169.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.935 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 69.9 m -116.99 120.02 37.09 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 119.313 0.96 . . . . 73.13 111.251 -175.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.76 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -131.5 138.93 10.53 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.647 -1.263 . . . . 73.54 113.172 -174.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -115.27 130.65 56.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.435 -0.95 . . . . 75.14 108.435 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -110.58 122.29 47.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.616 0.722 . . . . 75.14 111.039 -175.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -105.65 153.17 22.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.358 -1.292 . . . . 64.54 107.825 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.44 -29.97 51.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.239 0.459 . . . . 74.04 112.239 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -108.95 -17.1 14.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.509 -0.314 . . . . 64.53 111.394 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -144.87 124.66 6.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.043 0.386 . . . . 75.31 112.043 -170.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.913 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.8 OUTLIER -112.79 116.66 30.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.197 -0.314 . . . . 74.44 110.523 176.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 142' ' ' LEU . 3.0 mm? -119.48 124.45 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.54 0.21 . . . . 75.45 111.04 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.76 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -136.57 114.16 1.13 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.943 -1.123 . . . . 53.03 113.029 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.1 t -116.97 122.98 45.81 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.941 -0.392 . . . . 63.42 109.941 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.935 ' HB2' ' H ' ' A' ' 116' ' ' THR 0.319 0.9 OUTLIER -154.15 169.91 22.47 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.659 -1.276 . . . . 75.22 112.924 159.588 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.0 mtt -101.79 140.09 36.54 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.781 0.324 . . . . 73.41 111.115 -162.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.852 ' HB3' ' HG3' ' A' ' 113' ' ' LYS . 9.9 p-10 -119.54 125.8 49.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 74.52 111.022 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.23 96.55 9.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.606 -0.516 . . . . 73.24 109.606 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.514 ' OD2' HG13 ' A' ' 133' ' ' ILE . 7.8 t70 -99.73 -165.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.789 -0.819 . . . . 73.44 108.789 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.514 HG13 ' OD2' ' A' ' 132' ' ' ASP . 2.9 pp -72.94 -13.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 74.35 110.421 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.62 4.69 52.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 73.53 110.569 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.47 -155.13 20.86 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.05 -0.595 . . . . 74.44 111.925 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.57 96.55 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.023 2.482 . . . . 51.41 112.094 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.419 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 16.0 m -92.96 162.89 13.88 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.992 -0.549 . . . . 74.45 109.636 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 36.2 mm -107.99 117.48 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.931 -0.396 . . . . 74.33 109.931 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.7 tpt180 -106.0 111.34 23.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.34 0.59 . . . . 75.22 110.338 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.16 10.09 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.987 -1.101 . . . . 75.22 111.524 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.25 116.84 23.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.974 0.416 . . . . 74.14 110.402 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 125' ' ' LEU . 8.2 tp -117.18 125.36 51.08 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.577 . . . . 75.24 110.637 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.913 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 77.4 t -117.45 133.89 62.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.11 0.481 . . . . 71.3 110.277 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.65 HD22 ' HB1' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -108.42 138.38 44.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.791 -0.818 . . . . 75.42 108.791 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.08 118.24 2.37 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.51 -0.852 . . . . 71.44 113.146 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 75.9 t80 -145.0 148.99 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.066 -0.346 . . . . 75.24 110.066 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -45.01 105.52 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.986 0.422 . . . . 74.32 111.866 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.13 -31.38 6.02 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.81 -0.632 . . . . 71.12 112.726 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 72.3 m95 -104.84 120.93 42.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 74.44 111.118 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.782 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -124.58 136.91 54.35 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.628 -1.249 . . . . 72.14 107.628 173.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 144' ' ' LEU . . . -143.1 160.79 39.74 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.628 -0.429 . . . . 72.05 110.877 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.58 137.2 5.46 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.833 -0.621 . . . . 65.42 111.566 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -143.83 118.35 9.73 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 122.539 -0.389 . . . . 75.54 110.229 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.776 ' HG3' ' HB2' ' A' ' 168' ' ' ASN . 12.2 pt20 -119.13 125.89 50.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.454 0.645 . . . . 75.44 111.02 176.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.602 ' HE2' HG12 ' A' ' 164' ' ' VAL . 81.7 mtp -118.3 142.68 47.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.822 -0.626 . . . . 71.12 109.998 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 50.8 t-20 -113.38 118.46 34.61 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.996 -0.742 . . . . 73.31 108.996 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.715 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.6 m-85 -94.4 120.39 34.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.665 -0.698 . . . . 74.32 111.029 -175.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 57.7 tt0 -87.34 103.2 15.25 Favored 'General case' 0 C--O 1.26 1.639 0 CA-C-O 121.469 0.652 . . . . 74.04 109.284 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 t -70.24 -14.51 62.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 113.127 -1.851 . . . . 71.32 111.904 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.8 68.23 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.559 0.695 . . . . 74.43 109.157 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.63 -147.68 0.4 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.532 -1.285 . . . . 75.23 107.532 162.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.7 m -107.94 28.18 8.49 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.46 -0.775 . . . . 60.34 111.155 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -132.39 145.49 51.27 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.419 -1.313 . . . . 74.11 111.562 -163.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.64 134.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.092 0.473 . . . . 65.14 109.804 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 7.5 t -95.44 -9.79 31.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.126 -0.488 . . . . 75.12 111.016 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 39.3 mm-40 -149.94 132.25 15.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.869 0.366 . . . . 73.1 110.841 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.8 m -121.9 105.79 10.66 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.743 -0.662 . . . . 70.24 109.507 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.776 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 13.9 m120 -110.33 123.91 50.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 75.42 109.844 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.761 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 45.9 t80 -120.4 149.99 41.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.224 -0.443 . . . . 72.44 109.867 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -144.33 142.31 30.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.069 0.461 . . . . 72.43 110.858 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.569 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -131.12 136.9 56.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.157 -0.474 . . . . 75.51 110.193 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.04 96.1 0.33 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.007 -0.837 . . . . 71.11 111.007 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -109.67 121.68 45.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.399 -0.593 . . . . 71.51 109.399 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.41 127.64 48.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.486 -0.779 . . . . 73.25 110.547 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 42.0 m -131.73 111.49 11.7 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.292 -0.632 . . . . 74.34 109.292 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.58 -87.42 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.379 1.049 . . . . 74.12 113.678 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.87 3.48 22.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.252 0.549 . . . . 73.11 111.416 -172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -112.86 126.57 55.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 73.43 110.134 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.741 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 55.0 mm-40 -121.16 123.68 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.173 -0.306 . . . . 71.31 110.173 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.9 tp -118.66 134.85 54.81 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.15 -0.344 . . . . 74.22 111.035 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 9' ' ' ASP . 28.7 m80 -130.6 117.3 19.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 62.33 110.414 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 19.9 m -112.47 143.52 43.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.962 -0.385 . . . . 72.05 109.962 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -141.52 139.95 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 74.1 110.383 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 169' ' ' PHE . 56.0 t -126.36 131.27 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.163 -0.471 . . . . 72.34 111.606 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 9.1 t30 -110.94 96.01 5.9 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.35 -0.841 . . . . 72.34 109.565 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 5.7 t70 62.09 -166.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.9 -1.046 . . . . 74.03 110.345 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -80.62 -6.67 89.21 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.05 -0.595 . . . . 64.41 111.839 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.7 p -94.13 -27.23 16.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.981 0.734 . . . . 73.03 112.981 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 38.8 mt-10 -134.48 125.04 26.59 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.934 -0.706 . . . . 73.23 111.201 -175.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.721 ' HB2' HG21 ' A' ' 184' ' ' VAL . 25.9 p90 -133.87 133.1 41.12 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.188 -0.605 . . . . 75.4 109.443 171.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -135.79 159.21 24.15 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.566 -0.826 . . . . 50.33 112.522 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -136.63 164.76 25.15 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.424 -0.67 . . . . 73.11 111.424 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 26.9 t -143.56 136.91 28.02 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.0 -0.741 . . . . 72.33 109.0 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 3.4 mp -120.31 117.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 75.55 109.743 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.741 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 84.2 t80 -108.04 120.76 43.25 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.513 0.673 . . . . 75.42 110.428 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -115.61 111.91 21.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.925 -1.034 . . . . 74.03 108.992 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 195' ' ' TYR . 84.1 tttt -103.93 107.19 17.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.141 -0.482 . . . . 75.11 109.973 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.47 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.183 -0.673 . . . . 72.45 109.183 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -76.24 10.08 2.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.301 0.572 . . . . 64.3 110.879 -173.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -109.3 -10.37 14.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.776 -0.647 . . . . 72.13 109.361 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -134.93 -68.55 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 74.2 110.528 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -167.99 165.94 13.42 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.92 0.39 . . . . 75.51 110.484 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -109.75 128.2 55.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.797 -0.816 . . . . 73.12 108.797 173.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 t -138.57 155.02 48.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.064 0.459 . . . . 72.32 111.377 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.85 148.05 36.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.723 -0.671 . . . . 75.3 110.61 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 193' ' ' SER . 55.7 t -110.86 138.23 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.033 -0.53 . . . . 61.2 109.617 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -113.9 127.8 56.13 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.284 -1.006 . . . . 62.11 108.284 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 219' ' ' PHE . 7.3 tp -144.56 140.88 29.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.558 -0.292 . . . . 72.12 110.3 -168.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.559 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -157.23 142.34 17.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.825 0.345 . . . . 73.21 111.223 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.504 ' HE3' ' HZ ' ' A' ' 190' ' ' PHE . 16.6 t90 -130.83 135.3 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.125 0.488 . . . . 74.31 110.071 173.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 53.2 m -94.47 105.31 17.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.43 -0.805 . . . . 74.44 109.971 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.76 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 73.31 111.127 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.24 -87.72 0.4 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.164 -0.774 . . . . 73.51 111.164 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -149.12 104.3 3.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.024 0.44 . . . . 73.43 110.484 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.9 t -176.4 149.0 0.79 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.08 159.34 29.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.226 -0.657 . . . . 75.02 109.226 173.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 8.8 t -77.58 123.24 26.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.076 -0.713 . . . . 75.43 109.076 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.444 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 1.1 tpp180 -94.18 115.06 27.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.589 -0.732 . . . . 75.33 109.262 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.67 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 52.1 p90 -120.42 160.33 23.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 74.0 111.49 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.39 157.49 28.86 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.298 -0.864 . . . . 65.24 111.355 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.634 ' HB ' HG11 ' A' ' 237' ' ' VAL . 55.9 mt -132.25 135.15 58.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.964 0.382 . . . . 74.51 110.298 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -128.47 129.84 46.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.918 -0.401 . . . . 74.05 109.918 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -128.24 133.05 48.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.747 0.308 . . . . 64.35 111.061 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.3 114.53 26.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.62 . . . . 75.31 109.629 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -128.9 119.36 24.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 73.3 110.726 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -76.59 124.61 27.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.71 -0.478 . . . . 75.41 109.71 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 63.4 mt -70.48 -55.79 13.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.388 -0.369 . . . . 75.11 110.306 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.856 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 34.0 t70 -172.45 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.019 -0.537 . . . . 75.32 111.771 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 56.7 Cg_endo -95.05 -101.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.372 2.048 . . . . 72.13 113.524 -172.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.93 3.92 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 73.45 111.227 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -123.07 131.98 53.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.238 0.542 . . . . 75.35 111.748 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.58 142.16 50.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 72.32 109.264 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -104.31 131.41 51.68 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.837 -0.431 . . . . 74.1 109.837 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 57.8 p -116.6 120.96 40.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.051 0.453 . . . . 74.44 110.087 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.88 42.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.218 -0.66 . . . . 71.32 109.218 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 44.4 mttp -144.22 141.57 29.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.664 -0.495 . . . . 72.4 109.664 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.634 HG11 ' HB ' ' A' ' 221' ' ' ILE . 4.4 p -137.24 158.65 35.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.357 -0.609 . . . . 73.23 109.357 174.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 14.3 t30 -135.5 150.57 49.81 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.196 -0.457 . . . . 72.35 110.087 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.67 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 5.8 p30 -46.44 -32.51 3.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.957 1.095 . . . . 72.33 113.957 -173.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.531 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 5.6 m -78.92 23.37 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.596 0.236 . . . . 71.44 111.097 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 239' ' ' ASN . 20.4 m 64.53 36.27 8.76 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 121.371 0.605 . . . . 70.14 109.849 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 1.037 ' HB3' HD13 ' A' ' 262' ' ' LEU . 22.9 mt -98.04 116.71 30.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.729 -0.669 . . . . 73.3 110.075 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.69 116.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 75.33 110.007 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.12 133.47 9.64 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.576 -0.821 . . . . 75.21 112.685 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.465 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -119.37 154.25 33.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.376 -0.231 . . . . 71.43 110.376 178.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -149.24 134.32 4.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.444 -0.884 . . . . 70.43 112.675 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 258' ' ' THR . 59.1 m-85 -103.59 116.99 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.564 -0.532 . . . . 75.1 109.564 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.915 HG22 ' HB ' ' A' ' 258' ' ' THR . 3.2 m -117.36 115.25 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.121 -0.49 . . . . 74.42 110.31 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.99 150.73 44.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 75.52 111.83 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 19.6 m -83.37 128.41 34.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.864 -0.607 . . . . 75.33 110.155 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.783 HD23 HG12 ' A' ' 255' ' ' ILE . 3.3 mm? -73.73 -82.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.133 0.42 . . . . 72.24 112.133 -173.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 1.008 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 35.3 tttp -140.97 -62.67 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.948 -0.389 . . . . 74.51 109.948 -175.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 1.008 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 3.6 Cg_exo -79.45 -161.52 0.15 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.858 1.705 . . . . 71.14 110.861 166.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -80.82 62.21 4.43 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.663 -0.78 . . . . 73.53 113.162 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.783 HG12 HD23 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -136.49 142.26 38.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.084 0.468 . . . . 74.41 109.762 173.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.542 ' HG2' HG23 ' A' ' 248' ' ' THR . 36.0 ttpt -121.96 127.28 50.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.761 -0.654 . . . . 74.42 110.261 -176.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.581 ' HB2' HD22 ' A' ' 251' ' ' LEU . 28.6 tp -100.55 132.69 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 74.03 110.106 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.915 ' HB ' HG22 ' A' ' 248' ' ' THR . 7.7 t -129.52 112.48 13.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.615 0.722 . . . . 75.42 111.01 176.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.952 HD23 HD22 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -98.1 123.61 42.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.131 -1.063 . . . . 73.2 108.131 176.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 21.8 p -131.6 148.73 52.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.193 0.52 . . . . 73.3 111.454 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.419 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -140.89 133.15 28.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.732 -0.667 . . . . 74.01 109.907 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 1.037 HD13 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -102.88 121.28 42.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 74.52 109.133 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.562 ' HB3' HG13 ' A' ' 268' ' ' VAL . 1.4 mm? -104.1 108.01 19.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.431 -0.952 . . . . 74.4 108.431 175.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.493 ' O ' HG22 ' A' ' 268' ' ' VAL . 2.9 m-20 -71.59 103.87 3.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.906 -0.775 . . . . 72.53 108.906 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.77 -22.25 32.67 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.12 -0.562 . . . . 73.32 113.03 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -85.92 -23.47 26.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.671 0.272 . . . . 74.01 111.262 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -115.61 -28.26 6.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.78 0.659 . . . . 73.32 112.78 -172.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 263' ' ' LEU . 24.6 m -62.82 -18.78 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.901 0.334 . . . . 64.31 111.901 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.6 -33.06 70.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 73.21 109.808 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.32 8.56 38.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.517 -0.765 . . . . 63.53 110.955 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.84 89.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.088 -0.577 . . . . 74.42 112.067 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.19 88.01 0.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.323 -0.942 . . . . 75.44 112.701 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -109.16 145.52 35.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.185 -0.302 . . . . 74.35 110.185 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -103.85 137.89 41.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.009 -0.737 . . . . 72.5 109.009 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 276' ' ' GLY . 1.3 tm? -110.11 137.9 47.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.647 0.261 . . . . 54.53 110.328 -174.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.505 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -138.52 126.23 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.42 -0.672 . . . . 75.03 111.42 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.952 HD22 HD23 ' A' ' 259' ' ' LEU . 2.7 tm? -120.77 129.28 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.814 -0.439 . . . . 73.42 109.814 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -131.95 145.87 17.55 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.479 -0.867 . . . . 73.54 112.975 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.445 ' HB2' HD11 ' A' ' 29' ' ' LEU . 2.2 mm? -123.71 132.3 53.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.46 -0.57 . . . . 74.42 109.46 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -112.87 111.91 23.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.439 -0.578 . . . . 64.12 109.439 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 5.2 m-85 -102.32 141.48 35.09 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.115 -0.698 . . . . 75.14 109.115 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 284' ' ' LEU . 46.2 mt-30 -135.75 121.4 19.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.848 0.356 . . . . 74.03 110.566 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -105.35 109.26 21.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.206 -0.664 . . . . 74.21 109.206 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 282' ' ' GLN . 3.5 mm? -130.6 176.77 7.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.698 -0.683 . . . . 73.31 110.366 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.708 -0.678 . . . . 74.41 109.827 178.623 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.741 0.305 . . . . 75.24 110.486 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.74 -0.22 54.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.967 0.413 . . . . 75.43 110.314 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG12 ' HB3' ' A' ' 119' ' ' LYS . 2.2 t -82.15 115.19 56.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.688 -0.687 . . . . 74.53 109.643 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 6.6 Cg_endo -87.41 157.14 8.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.299 2.666 . . . . 74.33 113.157 -174.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 3.6 Cg_exo -75.92 64.62 6.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.135 2.556 . . . . 73.22 111.324 173.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.809 ' HB ' HD21 ' A' ' 150' ' ' LEU . 4.8 p -78.19 -18.97 54.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 73.14 111.548 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' HE2' HE21 ' A' ' 154' ' ' GLN . 81.0 t80 -56.11 -22.76 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 74.0 110.326 170.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.51 -25.62 54.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.456 -0.793 . . . . 73.5 109.569 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.623 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 39.5 m-20 -85.86 -10.94 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.99 -0.745 . . . . 75.11 108.99 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.885 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -77.1 -34.86 56.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.766 -1.106 . . . . 74.11 110.857 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.24 -47.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.934 -1.127 . . . . 55.15 113.701 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -55.43 -53.91 50.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.674 0.62 . . . . 73.51 112.674 -170.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 t -63.95 -48.47 76.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 71.3 111.474 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.78 60.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 73.12 111.794 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 1.022 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 99.2 mtt180 -60.37 -24.82 65.4 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.708 0.633 . . . . 73.22 112.708 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.36 -41.51 76.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 71.11 110.752 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' HB ' ' ND2' ' A' ' 207' ' ' ASN . 66.8 t -83.73 -37.41 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.164 0.507 . . . . 70.44 110.315 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 1.022 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 89.6 t80 -63.56 -24.51 67.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.123 -0.944 . . . . 74.15 112.497 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -65.42 156.08 33.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 72.45 111.613 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.746 ' HD2' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.95 25.46 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.674 -0.693 . . . . 72.03 110.397 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.94 95.67 0.49 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.686 -0.688 . . . . 63.53 112.278 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -104.07 -162.4 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.797 -0.816 . . . . 74.55 108.797 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.55 108.18 2.38 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.142 -1.027 . . . . 41.24 111.131 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -80.7 -2.98 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.797 0.299 . . . . 75.12 111.573 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 12.79 83.81 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.458 -0.877 . . . . 61.45 112.434 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -142.35 179.97 6.62 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.866 0.841 . . . . 73.54 112.632 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.685 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -106.91 129.52 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.148 -1.387 . . . . 74.03 109.859 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 8.9 ttpt -102.78 135.99 43.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.407 -0.59 . . . . 74.5 109.407 174.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.9 tp -133.5 139.7 46.81 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.872 -0.331 . . . . 64.11 110.169 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.3 p30 -151.3 135.01 16.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 61.34 109.951 173.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.4 tp -128.31 124.14 35.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.509 -0.769 . . . . 75.53 109.679 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.547 ' N ' HD11 ' A' ' 31' ' ' LEU . 68.9 tttt -120.92 124.69 45.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.276 -0.874 . . . . 70.32 109.37 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.512 HG23 ' HB1' ' A' ' 283' ' ' ALA . 34.2 m -128.6 120.6 26.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.626 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -144.6 155.88 43.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.811 -0.756 . . . . 74.22 112.597 -176.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.4 t -139.92 154.31 47.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.523 -1.217 . . . . 74.04 107.991 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.27 20.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.991 0.424 . . . . 63.41 111.262 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' SER . 66.0 t30 -110.65 30.08 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.544 0.688 . . . . 75.33 110.212 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 96.39 1.17 60.83 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.864 -0.607 . . . . 72.03 112.513 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.0 tp -100.68 125.9 47.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.699 0.629 . . . . 64.42 112.699 -173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.836 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 28.0 mt-10 -142.32 118.17 10.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.962 -0.384 . . . . 74.13 109.962 160.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 50.4 m-85 -111.87 124.87 53.29 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.871 -0.518 . . . . 74.2 110.308 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.958 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 19.0 m -126.85 118.61 24.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.741 0.305 . . . . 73.4 111.383 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 29.0 t -120.35 123.6 43.5 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.273 -0.64 . . . . 73.23 109.273 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -134.73 130.44 36.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 73.14 111.468 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.43 148.02 19.38 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.507 -0.854 . . . . 64.33 112.541 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 m -119.83 134.17 55.33 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.821 -0.807 . . . . 73.31 108.821 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.662 ' HB1' HG13 ' A' ' 54' ' ' VAL . . . -154.85 141.29 18.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.984 0.421 . . . . 75.41 111.804 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 145.96 51.53 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.184 -0.672 . . . . 72.43 109.184 172.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -43.82 -39.74 4.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.538 0.524 . . . . 75.11 111.95 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -103.41 165.87 10.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.342 -0.614 . . . . 54.13 109.342 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -70.55 61.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.342 0.591 . . . . 70.1 112.052 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -97.84 -39.93 8.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 74.2 110.352 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -165.42 116.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 74.14 109.918 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.662 HG13 ' HB1' ' A' ' 47' ' ' ALA . 39.6 t -125.63 119.62 55.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.93 -0.577 . . . . 72.15 109.938 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -120.47 126.54 50.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.845 -0.428 . . . . 74.31 109.845 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 148.16 18.84 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.198 -1.001 . . . . 74.12 113.258 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 6.6 p -146.31 147.2 31.12 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.792 -0.447 . . . . 61.2 109.792 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 59' ' ' GLU . 1.8 tp -122.09 149.33 43.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.176 0.512 . . . . 75.22 111.196 -176.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.958 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 37.7 mt-10 -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.257 -0.883 . . . . 75.23 109.421 172.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.9 m -95.62 118.31 32.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.889 -1.152 . . . . 74.12 107.889 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 26.5 mttp -126.07 145.68 50.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.411 0.624 . . . . 75.14 110.911 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 70' ' ' THR . 74.3 m-85 -120.7 120.33 35.38 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.476 -0.935 . . . . 63.41 108.476 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.836 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 8.8 tpt180 -114.73 108.26 16.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 74.24 111.136 -173.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -113.51 102.69 10.54 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.434 -0.803 . . . . 75.55 110.754 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m 63.81 72.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.941 -1.027 . . . . 72.34 112.409 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.85 ' HG3' ' H ' ' A' ' 67' ' ' TYR . 9.7 pt-20 30.3 -92.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.449 1.1 . . . . 74.22 113.764 173.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.85 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 93.9 m-85 -87.11 86.87 7.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.224 -0.658 . . . . 73.03 109.224 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.81 -94.1 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.353 -0.699 . . . . 71.43 111.353 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD13 HG22 ' A' ' 87' ' ' VAL . 3.5 mm? -125.4 131.59 52.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.038 0.447 . . . . 74.31 111.488 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.685 HG21 ' HB ' ' A' ' 86' ' ' THR . 4.8 t -136.97 113.19 9.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.796 -0.638 . . . . 74.32 109.781 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 72.3 m-85 -98.2 132.26 43.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 73.11 109.527 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 84' ' ' GLU . 96.9 m -127.91 136.57 51.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.923 0.392 . . . . 75.51 111.757 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.69 121.13 24.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.949 -0.759 . . . . 73.54 108.949 165.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -106.88 109.73 21.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.771 -0.65 . . . . 75.11 109.581 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.644 ' HD1' HD13 ' A' ' 81' ' ' LEU . 77.1 t90 -109.7 133.92 52.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.425 -0.352 . . . . 74.41 110.492 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' HB3' ' OG1' ' A' ' 80' ' ' THR . 8.5 t30 -114.72 152.88 31.27 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.582 -0.525 . . . . 73.4 109.582 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 m -54.28 -22.15 11.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.116 0.484 . . . . 73.51 112.301 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.5 m-20 -68.69 -2.67 9.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.117 -0.492 . . . . 74.12 111.986 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 12.2 m120 77.8 27.69 0.58 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.461 0.704 . . . . 73.53 110.125 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 104' ' ' SER . 1.8 p -93.19 124.52 37.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.599 -0.728 . . . . 74.35 110.987 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.644 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.9 mm? -101.56 119.2 38.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.307 -0.86 . . . . 74.23 110.3 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.54 91.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.552 -0.832 . . . . 75.41 111.512 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 t -90.65 123.04 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 73.41 110.448 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 40.5 tt0 -135.3 118.69 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.983 -0.553 . . . . 74.35 110.027 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -112.03 138.68 39.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.709 0.29 . . . . 74.12 110.368 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.685 ' HB ' HG21 ' A' ' 70' ' ' THR . 25.8 m -122.73 123.63 41.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.297 0.57 . . . . 74.23 111.353 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.444 HG22 HD13 ' A' ' 69' ' ' LEU . 34.1 t -111.89 123.89 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.09 -0.959 . . . . 73.53 109.036 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -110.21 142.17 42.14 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.765 -0.457 . . . . 75.22 109.765 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 81.47 -66.5 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.95 0.781 . . . . 72.31 109.952 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.31 -78.11 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.29 0.636 . . . . 71.1 111.206 175.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -130.88 -58.73 1.01 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 74.31 109.624 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.23 27.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.857 -0.611 . . . . 72.43 109.399 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 5.8 ppt_? -52.97 132.67 37.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.467 0.651 . . . . 73.5 111.832 -175.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 119' ' ' LYS . . . 101.54 -12.43 58.19 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.593 -0.73 . . . . 75.25 112.08 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.637 HD21 ' HD1' ' A' ' 118' ' ' TYR . 1.0 OUTLIER -86.92 119.9 27.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.83 -0.804 . . . . 74.23 108.83 176.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' O ' HD11 ' A' ' 97' ' ' LEU . 54.7 pttt -123.06 144.47 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 74.44 110.658 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -122.38 126.87 48.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.551 -0.75 . . . . 75.23 109.286 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.843 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 15.2 m -130.0 118.28 21.34 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.682 -0.407 . . . . 72.4 109.982 176.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 50.4 t80 -120.33 115.56 23.8 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.777 -0.369 . . . . 75.45 110.442 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 10.4 t70 -115.0 137.85 51.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.668 -0.696 . . . . 71.12 109.373 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -142.2 121.81 13.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.963 0.411 . . . . 72.21 110.06 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 41.4 m -103.04 121.71 43.14 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.715 -0.675 . . . . 75.24 109.803 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -120.88 128.82 53.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 73.55 109.523 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.525 ' HB3' HG21 ' A' ' 80' ' ' THR . 47.6 p -119.86 103.14 46.12 Favored Pre-proline 0 C--N 1.315 -0.919 0 C-N-CA 120.828 -0.349 . . . . 65.23 110.551 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 21.0 Cg_exo -67.11 -22.89 46.64 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.452 2.102 . . . . 74.25 111.256 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -85.48 -49.12 8.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 73.11 110.992 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -81.88 -36.73 27.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.392 . . . . 74.03 111.296 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.44 -3.44 61.43 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.139 -0.553 . . . . 53.05 113.191 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.76 148.69 22.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.165 0.507 . . . . 71.11 111.628 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -123.82 148.58 46.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.805 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -144.07 122.49 12.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.967 -0.383 . . . . 62.13 109.967 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.08 129.89 55.62 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.798 -0.445 . . . . 73.12 109.798 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 129' ' ' MET . 7.9 ttmm -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.694 -0.484 . . . . 72.12 109.694 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.3 tp -132.32 129.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.108 0.48 . . . . 75.23 111.07 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 50.1 mttp -111.19 121.66 45.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.35 -0.841 . . . . 73.3 109.706 176.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -116.27 117.95 31.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.57 -0.9 . . . . 75.43 108.57 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.81 135.45 11.47 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.39 -0.909 . . . . 51.42 112.473 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.637 ' HD1' HD21 ' A' ' 95' ' ' LEU . 76.9 t80 -121.65 118.43 29.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.844 -0.799 . . . . 75.41 108.844 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.858 ' HB3' HG12 ' A' ' 3' ' ' VAL . 37.5 mtmm -108.07 122.93 47.88 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.041 -0.663 . . . . 73.23 110.642 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -105.38 154.91 19.65 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.556 -1.276 . . . . 75.24 107.556 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.662 ' HA ' HG21 ' A' ' 3' ' ' VAL . 2.0 tp10 -52.74 -29.84 29.24 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.674 0.62 . . . . 72.33 112.674 -165.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -102.39 -26.14 13.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.105 0.78 . . . . 72.15 113.105 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.794 HG22 ' H ' ' A' ' 145' ' ' GLY . 19.2 pt -142.22 153.35 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.927 -0.709 . . . . 71.24 112.242 -171.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.634 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 1.7 m-20 -112.3 128.94 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.263 -0.88 . . . . 74.33 111.457 -172.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 118' ' ' TYR . 4.5 mm? -111.37 137.69 48.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.608 0.242 . . . . 73.42 110.616 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.38 121.17 1.34 Allowed Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.959 -0.639 . . . . 65.11 112.493 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.4 m -113.35 116.44 29.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.894 0.347 . . . . 73.3 111.815 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -97.81 143.16 28.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.804 -0.634 . . . . 72.33 110.128 175.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.513 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 65.3 mtt -133.74 118.4 18.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.168 -0.308 . . . . 74.12 110.168 174.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 1.9 m-20 -99.38 119.26 37.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 72.14 110.067 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.9 97.94 10.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.479 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -120.58 156.99 30.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 74.14 108.988 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.858 HD13 ' H ' ' A' ' 133' ' ' ILE . 1.1 mp -75.08 -30.25 23.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.133 0.492 . . . . 74.4 109.986 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.0 -9.93 59.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 73.13 111.042 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' HA3' ' HB1' ' A' ' 160' ' ' ALA . . . 155.15 133.09 1.67 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.534 -0.841 . . . . 74.45 112.666 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 7.8 Cg_exo -74.23 119.1 5.65 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.122 2.548 . . . . 74.44 111.651 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.669 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 9.3 t -103.46 131.07 50.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.164 -0.471 . . . . 64.1 110.091 -177.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mp -115.77 118.51 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.55 -0.46 . . . . 65.3 110.09 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.709 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 24.7 mtt180 -107.42 115.19 29.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.859 -0.423 . . . . 75.53 109.859 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.36 131.67 10.64 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.505 -1.331 . . . . 65.54 111.083 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.54 115.7 19.94 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.079 0.466 . . . . 72.33 109.977 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.583 HD13 HD13 ' A' ' 123' ' ' ILE . 5.9 tp -117.66 122.9 44.79 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.761 -0.654 . . . . 72.13 109.813 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.712 HG23 HD23 ' A' ' 10' ' ' LEU . 54.5 t -108.55 130.28 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.853 -0.612 . . . . 73.11 109.743 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.3 mm? -108.14 136.48 47.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.957 -0.757 . . . . 74.41 108.957 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.794 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -115.96 119.2 4.47 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.275 -0.875 . . . . 60.52 112.743 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.948 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 34.0 m-85 -123.46 149.64 44.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.304 -0.999 . . . . 74.05 108.304 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.78 100.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.96 0.41 . . . . 72.03 110.96 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 174' ' ' LYS . . . 90.84 -24.12 19.63 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.974 -0.557 . . . . 60.35 112.372 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.948 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.6 m0 -105.37 131.81 52.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.107 0.48 . . . . 74.24 110.783 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.809 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.4 tm? -117.33 149.07 41.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.736 -0.839 . . . . 65.43 108.736 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -151.28 154.53 36.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.646 -0.421 . . . . 74.35 110.058 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.885 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -158.41 135.66 4.38 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.744 -0.662 . . . . 54.23 111.576 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.4 115.18 21.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.44 -0.578 . . . . 72.41 109.44 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.906 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 87.7 mt-30 -99.42 121.86 41.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.728 -0.471 . . . . 72.25 109.728 166.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.9 ttm -127.17 128.58 46.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.698 -0.482 . . . . 74.32 109.698 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 24.7 m-80 -112.65 119.13 37.05 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.548 -0.538 . . . . 75.14 109.548 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.9 m-85 -94.35 127.05 39.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.095 -0.502 . . . . 75.41 110.805 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.77 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.9 tp10 -97.42 98.48 9.99 Favored 'General case' 0 C--O 1.26 1.631 0 N-CA-C 109.269 -0.641 . . . . 74.34 109.269 174.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -72.59 -17.59 61.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.641 -1.618 . . . . 73.21 111.209 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.435 ' HB1' ' HA3' ' A' ' 135' ' ' GLY . . . -63.1 -29.08 70.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.732 -0.84 . . . . 75.55 108.732 173.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -111.17 -160.26 0.71 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.16 -1.382 . . . . 70.24 107.839 169.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 p -108.45 28.76 8.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.551 -0.536 . . . . 53.24 109.551 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 25.0 tpt180 -142.95 145.78 33.33 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 119.812 -0.755 . . . . 75.31 111.378 -160.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.5 m -73.22 136.7 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.777 -0.823 . . . . 72.51 108.777 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.77 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 8.8 t -92.2 -24.36 19.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.217 -0.447 . . . . 75.52 110.869 -171.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.564 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 93.4 mt-30 -144.8 133.16 21.81 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.616 0.246 . . . . 63.24 110.711 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.2 m -114.54 106.27 14.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.532 -0.544 . . . . 75.24 109.532 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.906 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 54.5 m-20 -106.99 129.93 54.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.46 . . . . 73.14 109.926 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.36 144.52 48.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.474 -0.33 . . . . 74.43 110.445 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -142.43 128.65 19.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.862 0.363 . . . . 74.02 110.169 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.58 128.54 60.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 73.3 109.409 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.81 109.17 1.69 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.804 -0.712 . . . . 73.25 112.05 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.75 119.95 39.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.064 -1.087 . . . . 74.34 108.064 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.798 ' HB2' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -136.21 144.83 45.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.182 0.991 . . . . 75.05 113.557 -171.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.421 ' HB ' ' OE2' ' A' ' 177' ' ' GLU . 3.7 m -109.9 163.88 13.12 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.582 -1.636 . . . . 75.34 106.582 167.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -27.4 60.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.849 0.685 . . . . 72.15 112.849 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' OE2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -108.16 -20.51 13.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.569 0.581 . . . . 72.44 112.569 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -130.83 119.02 21.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.799 0.333 . . . . 72.34 111.074 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.798 ' HG2' ' HB2' ' A' ' 174' ' ' LYS . 45.1 mt-30 -116.35 124.31 49.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.496 -0.32 . . . . 71.42 110.418 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -107.9 132.24 53.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.063 0.458 . . . . 75.32 110.234 174.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.623 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 41.6 m-70 -125.03 116.81 22.72 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.252 -0.647 . . . . 74.42 109.252 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 28.7 m -99.39 123.0 43.29 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.717 -0.475 . . . . 74.3 109.717 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -121.24 139.73 52.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.01 0.433 . . . . 71.5 109.963 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 78.2 t -131.12 124.79 56.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.762 -0.654 . . . . 74.23 109.591 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 92.4 m-20 -106.88 106.42 16.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 74.13 109.36 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 28.0 t70 59.64 -168.76 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.914 -1.039 . . . . 72.31 109.424 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.539 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -79.54 -6.35 89.01 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.542 -0.837 . . . . 71.43 112.128 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 211' ' ' THR . 26.9 p -101.28 -27.02 13.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.639 0.977 . . . . 74.52 113.639 -172.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.6 tt0 -113.1 115.15 27.85 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 119.274 -0.97 . . . . 71.54 111.909 -174.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.58 131.06 57.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 75.24 109.64 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -174.25 -139.82 3.08 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.552 -0.833 . . . . 64.33 112.107 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.86 -150.61 22.9 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.23 -0.986 . . . . 63.0 112.865 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 28.5 t -142.78 144.54 32.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.147 0.498 . . . . 71.22 110.97 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 17.3 mm -118.9 115.77 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.856 -0.794 . . . . 73.23 108.856 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.666 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 26.1 t80 -111.6 119.7 39.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.612 0.244 . . . . 73.45 110.652 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.671 ' CG ' ' HB2' ' A' ' 199' ' ' ASN . 23.0 tp60 -127.81 128.49 45.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.505 -0.316 . . . . 73.33 110.34 176.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.57 ' O ' HG21 ' A' ' 198' ' ' VAL . 19.0 ptpt -103.1 132.41 49.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.674 -0.239 . . . . 75.51 110.933 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.57 HG21 ' O ' ' A' ' 197' ' ' LYS . 3.9 m 64.85 23.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.495 1.518 . . . . 75.44 112.423 176.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.802 HD21 ' HG3' ' A' ' 200' ' ' LYS . 9.1 t30 -65.31 -48.62 72.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 64.51 110.764 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.802 ' HG3' HD21 ' A' ' 199' ' ' ASN . 98.7 mttt -125.18 -84.47 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.491 -0.322 . . . . 73.41 111.05 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -86.83 -66.18 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.461 -0.336 . . . . 74.31 110.449 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.2 tp -145.73 -84.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 73.33 110.164 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 224' ' ' LYS . 2.6 tp10 -107.25 142.03 37.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 13.5 t -143.38 138.67 29.57 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.19 -0.604 . . . . 73.42 110.775 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -138.61 137.29 36.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.778 -0.646 . . . . 60.34 110.678 -178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 70.5 t -111.32 140.65 29.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.116 -0.698 . . . . 73.22 109.116 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.509 ' ND2' ' HB ' ' A' ' 17' ' ' VAL . 18.5 m-80 -138.27 131.51 30.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.674 -0.491 . . . . 75.12 109.674 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.87 151.7 37.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.824 0.345 . . . . 72.45 111.789 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.534 ' HB1' ' CE2' ' A' ' 18' ' ' PHE . . . -141.07 134.54 29.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 74.02 110.334 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -128.71 123.41 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 73.25 110.384 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 188' ' ' THR . 1.0 OUTLIER -99.89 103.56 15.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.369 0.604 . . . . 73.24 110.473 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.29 136.69 56.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.07 -0.968 . . . . 61.32 111.8 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.24 -28.12 15.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.932 -0.651 . . . . 72.34 113.207 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -132.79 -47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.87 0.692 . . . . 64.33 112.87 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.8 t -110.67 -179.04 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.375 0.607 . . . . 70.33 111.861 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -102.94 166.12 10.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.957 -1.02 . . . . 74.3 109.983 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 25.7 m -74.91 123.17 24.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.422 -0.584 . . . . 65.01 109.422 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -114.16 117.15 30.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.394 -0.595 . . . . 74.42 109.394 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -124.24 145.74 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.386 0.612 . . . . 72.02 111.306 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.36 13.8 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.898 -1.046 . . . . 62.44 111.229 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.3 mp -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.941 -0.392 . . . . 72.23 109.941 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -116.41 145.15 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.946 0.403 . . . . 63.45 110.855 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -129.04 126.54 39.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.933 -0.576 . . . . 62.34 109.792 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.488 ' HG2' ' SG ' ' A' ' 232' ' ' CYS . 22.8 ttmm -118.17 112.41 20.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 75.41 109.427 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 233' ' ' PHE . 5.7 p90 -135.09 118.8 17.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 74.23 112.389 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 0.2 OUTLIER -88.01 112.36 22.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.805 -1.183 . . . . 73.24 107.805 172.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.22 -55.36 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.375 0.88 . . . . 73.31 113.375 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.719 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 13.5 t70 -138.73 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 75.24 112.953 -164.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 62.4 Cg_endo -90.96 -139.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.161 1.908 . . . . 74.02 112.834 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.3 p-10 -92.56 12.22 23.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.213 -0.903 . . . . 74.32 109.498 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.517 ' CB ' ' HG2' ' A' ' 249' ' ' GLN . . . -121.46 123.69 42.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.634 0.73 . . . . 73.31 111.65 -169.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.488 ' SG ' ' HG2' ' A' ' 224' ' ' LYS . 44.8 t -97.29 128.17 43.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.634 -1.166 . . . . 64.12 108.318 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.472 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 53.0 m-85 -96.18 126.45 41.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.779 -0.452 . . . . 75.53 109.779 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 19.6 m -126.38 117.15 22.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 70.32 109.93 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -122.76 141.63 51.6 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.956 -0.387 . . . . 63.31 109.956 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 62.6 pttt -137.9 140.22 40.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.035 0.445 . . . . 75.34 110.401 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 243' ' ' ILE . 5.5 p -122.98 140.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.569 -0.53 . . . . 74.0 109.569 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -105.21 148.03 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.085 -0.709 . . . . 75.15 109.085 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 241' ' ' SER . 26.9 p-10 -68.97 2.58 2.56 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.48 0.548 . . . . 74.22 112.48 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.607 ' HB2' HD12 ' A' ' 242' ' ' LEU . 14.7 m -82.81 12.74 4.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.902 -0.777 . . . . 74.1 108.902 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.5 m 69.89 28.79 4.17 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.955 -1.021 . . . . 73.34 110.948 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.831 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.9 mp -101.15 129.39 47.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.902 0.334 . . . . 72.14 111.902 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.47 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -118.61 116.49 51.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.706 -0.679 . . . . 74.34 110.099 -169.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.99 133.81 7.94 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.276 -0.964 . . . . 53.04 113.12 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.493 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -123.94 156.54 36.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.693 0.282 . . . . 65.41 110.483 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.67 149.46 20.95 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.543 -0.836 . . . . 73.33 113.158 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.822 ' HD1' ' HB3' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -106.63 118.1 35.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.107 -0.701 . . . . 74.43 109.107 177.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 28.9 m -104.49 115.14 29.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.439 -0.578 . . . . 75.41 109.439 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.517 ' HG2' ' CB ' ' A' ' 231' ' ' ALA . 10.9 mt-30 -112.41 133.16 54.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.003 0.43 . . . . 70.32 111.013 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 11.7 m -104.16 102.51 12.23 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.884 -0.784 . . . . 71.14 108.884 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.842 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 8.9 mp -75.24 179.3 5.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.857 0.36 . . . . 75.31 110.855 -174.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.558 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 1.4 tppp? -60.68 -52.52 71.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 74.41 111.09 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.566 ' HG2' HG12 ' A' ' 255' ' ' ILE . 72.3 Cg_endo -80.2 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.811 1.674 . . . . 73.43 111.617 172.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -75.94 64.58 2.68 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.915 -0.659 . . . . 74.33 112.553 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mm -123.74 123.97 68.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.537 0.208 . . . . 74.03 110.869 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.76 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 26.6 ttmt -115.46 114.17 24.69 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.299 -0.63 . . . . 74.45 109.299 171.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.444 HD12 HD11 ' A' ' 279' ' ' LEU . 13.9 tp -100.33 124.55 45.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.623 -0.717 . . . . 72.21 109.959 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.4 m -122.22 110.21 15.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.152 0.501 . . . . 75.14 110.793 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.978 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -106.85 123.58 48.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.464 -1.31 . . . . 75.51 107.464 173.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.7 p -137.72 150.62 47.45 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.64 -0.424 . . . . 71.21 111.228 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.55 128.68 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 74.22 110.35 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.799 HD12 HD23 ' A' ' 242' ' ' LEU . 2.6 tm? -104.81 115.89 31.07 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.354 -0.98 . . . . 71.33 108.354 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.79 ' HB3' HG13 ' A' ' 268' ' ' VAL . 1.3 mm? -92.27 108.77 20.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.353 -0.98 . . . . 75.42 108.353 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.831 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m-20 -70.45 111.02 5.69 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.4 -0.963 . . . . 71.34 108.4 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.23 -27.68 40.17 Favored Glycine 0 C--N 1.319 -0.397 0 C-N-CA 121.207 -0.521 . . . . 63.31 112.995 -173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.747 ' HZ1' ' HB2' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -91.79 -27.48 17.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.679 0.276 . . . . 75.41 111.19 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.812 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 14.4 m120 -92.46 -35.33 13.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.201 0.445 . . . . 70.23 112.201 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.79 HG13 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -63.04 -18.24 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.681 0.277 . . . . 73.32 111.649 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.71 -29.89 71.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.334 0.587 . . . . 54.44 109.653 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.22 0.18 31.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.541 -0.754 . . . . 74.03 110.594 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.34 8.06 57.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 74.41 113.066 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.33 86.92 1.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 70.3 112.567 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -114.39 144.9 42.55 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.76 -0.259 . . . . 74.23 110.537 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.494 ' HZ1' ' CG ' ' A' ' 264' ' ' ASP . 59.1 mttp -99.24 138.02 36.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 64.44 111.179 -175.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.541 HD11 ' N ' ' A' ' 276' ' ' GLY . 1.2 tm? -113.05 139.4 48.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.818 -0.438 . . . . 74.14 109.818 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.541 ' N ' HD11 ' A' ' 275' ' ' LEU . . . -138.06 117.8 1.53 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.883 -0.675 . . . . 74.31 111.631 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.978 HD23 HD22 ' A' ' 259' ' ' LEU . 3.0 tm? -115.51 141.97 47.35 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.418 -0.586 . . . . 75.01 109.418 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.575 ' H ' HD21 ' A' ' 277' ' ' LEU . . . -153.31 129.37 2.68 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.381 -0.914 . . . . 75.42 113.11 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.772 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.7 mm? -112.49 131.52 55.54 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.874 -0.417 . . . . 73.42 109.874 172.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.76 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -124.06 112.01 16.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.736 0.779 . . . . 74.44 109.897 173.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.595 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -98.19 135.91 39.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.433 -1.258 . . . . 72.42 108.76 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.495 ' N ' ' HD2' ' A' ' 281' ' ' PHE . 7.4 tp60 -133.47 112.13 11.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 75.11 109.818 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.512 ' HB1' HG23 ' A' ' 33' ' ' THR . . . -114.98 114.19 25.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.037 -0.529 . . . . 64.3 110.021 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.7 mt -120.53 115.97 24.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 74.31 110.598 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.379 -0.82 . . . . 74.51 109.868 178.103 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.668 -0.493 . . . . 74.04 109.668 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.512 ' CA ' ' HA2' ' A' ' 94' ' ' GLY . . . -74.8 121.16 21.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.706 0.288 . . . . 73.24 111.325 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 1.089 HG23 ' HB3' ' A' ' 119' ' ' LYS . 27.7 m -94.88 145.2 29.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.174 -0.466 . . . . 71.22 111.135 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 32.5 Cg_exo -58.88 161.69 14.9 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.481 2.121 . . . . 73.11 110.361 172.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.95 92.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.313 2.009 . . . . 65.21 112.385 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 p -67.02 -25.84 66.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.284 -0.416 . . . . 73.44 111.854 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.792 ' HB3' HG23 ' A' ' 143' ' ' VAL . 16.6 p90 -65.13 -29.25 70.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 72.25 110.922 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.72 -12.64 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.484 0.659 . . . . 62.33 109.986 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -104.26 -7.14 20.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.559 -0.904 . . . . 64.45 108.559 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.927 HD12 ' HB3' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -57.79 -33.78 68.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.786 -1.552 . . . . 75.44 110.83 178.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.72 63.61 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.082 -0.58 . . . . 63.4 112.175 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -62.05 -39.86 93.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.667 0.387 . . . . 75.43 111.753 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 m -61.0 -36.71 80.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 63.11 112.188 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.8 82.37 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.749 0.648 . . . . 74.3 112.749 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -67.74 -33.83 75.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.88 -0.328 . . . . 75.21 111.463 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 26.3 t70 -65.91 -47.99 72.93 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.5 -0.555 . . . . 71.2 109.5 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.733 HG11 ' HB2' ' A' ' 222' ' ' ALA . 11.3 t -58.22 -33.49 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.956 -0.566 . . . . 73.4 111.566 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.472 ' HD2' ' HB2' ' A' ' 207' ' ' ASN . 66.9 t80 -60.69 -39.52 88.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 73.4 111.695 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.418 HG21 ' CD1' ' A' ' 18' ' ' PHE . 1.1 p -131.42 12.19 4.97 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.335 0.865 . . . . 74.14 113.335 -172.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 34.4 tttp -65.38 -38.7 90.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.166 0.507 . . . . 75.44 110.65 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.34 45.79 1.27 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.852 -0.69 . . . . 60.24 111.765 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.29 130.29 42.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.479 -0.563 . . . . 74.43 109.479 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.81 113.63 3.69 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.79 -0.719 . . . . 62.25 112.548 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -84.46 -3.67 58.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.792 0.33 . . . . 75.43 111.063 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.51 85.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.14 -0.552 . . . . 61.2 113.344 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 46' ' ' SER . 2.1 pp -147.21 179.89 7.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.047 0.758 . . . . 70.35 113.047 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 HD13 ' A' ' 277' ' ' LEU . 37.6 mm -100.59 124.47 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.368 -1.287 . . . . 72.43 109.55 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 33.3 ttpt -107.53 121.82 45.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.97 -0.382 . . . . 75.33 109.97 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.47 128.04 56.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.417 -0.586 . . . . 74.13 109.417 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.8 136.67 51.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.039 -0.726 . . . . 73.24 109.039 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.582 HD13 ' HD1' ' A' ' 281' ' ' PHE . 12.1 tp -137.04 124.62 22.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.931 0.396 . . . . 63.34 110.341 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -116.97 125.44 51.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.449 -0.574 . . . . 71.23 109.449 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 25.4 m -126.06 149.51 48.83 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.335 -0.393 . . . . 73.14 110.5 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -125.15 144.41 50.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.754 0.311 . . . . 73.44 110.878 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 52.3 m -140.75 158.28 44.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.31 -0.405 . . . . 60.44 110.995 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 28.3 tt0 -76.46 99.1 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 71.54 111.91 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.725 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t30 160.44 26.59 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.631 1.172 . . . . 65.31 107.861 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.65 18.05 79.35 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.273 -0.876 . . . . 74.23 110.991 -172.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.725 ' HG ' ' HB3' ' A' ' 37' ' ' ASN . 3.1 mt -86.74 134.33 33.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.758 0.79 . . . . 73.41 112.916 -167.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.65 130.61 30.27 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.012 -1.449 . . . . 73.32 109.173 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.664 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 93.7 m-85 -115.65 121.54 42.86 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.854 -0.425 . . . . 75.24 109.854 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.872 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 23.7 m -115.94 116.48 28.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.091 0.472 . . . . 63.22 110.058 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 25.2 t -113.15 131.31 55.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.708 -0.678 . . . . 75.15 109.726 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -130.97 135.63 47.81 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.686 -0.487 . . . . 44.22 109.686 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.62 110.13 0.43 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.611 -0.804 . . . . 73.02 112.067 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.419 ' HB3' HD11 ' A' ' 26' ' ' LEU . 15.2 m -108.39 133.18 52.94 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.67 -0.863 . . . . 71.2 108.67 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.454 ' HB1' HG11 ' A' ' 54' ' ' VAL . . . -151.57 136.7 17.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.235 0.54 . . . . 72.02 111.24 -174.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -80.87 129.27 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 74.23 108.748 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.8 m -62.46 -20.9 65.01 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.973 0.416 . . . . 64.1 111.675 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -84.46 6.05 24.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.156 0.503 . . . . 74.04 110.204 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 p 49.24 72.0 0.34 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.68 0.792 . . . . 75.5 112.098 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -126.74 -30.87 2.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.253 -0.885 . . . . 74.23 110.172 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -149.13 113.85 5.36 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.101 -0.703 . . . . 71.32 109.101 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.454 HG11 ' HB1' ' A' ' 47' ' ' ALA . 25.7 t -125.99 127.47 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 72.13 109.843 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -134.18 137.61 44.57 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.958 -0.386 . . . . 75.41 109.958 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -142.49 154.82 25.39 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.29 -0.957 . . . . 72.24 112.884 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.728 ' HB2' HG21 ' A' ' 77' ' ' THR . 26.7 t -146.73 148.68 32.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.226 -0.657 . . . . 72.3 109.226 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.622 HD12 ' HG3' ' A' ' 74' ' ' LYS . 1.7 tm? -146.57 125.47 12.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.872 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 11.7 pt-20 -125.84 131.36 52.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.266 0.555 . . . . 63.11 110.195 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.412 HG23 ' CE1' ' A' ' 41' ' ' PHE . 48.3 m -107.62 119.4 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.813 -0.81 . . . . 75.31 108.813 172.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 19.9 mtpp -112.07 126.94 55.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 75.21 110.586 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.623 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.9 m-85 -110.77 120.97 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.36 -0.607 . . . . 73.01 109.36 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.708 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 39.5 mtp180 -114.61 110.9 20.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.809 0.814 . . . . 75.42 110.696 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -111.02 117.2 32.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.077 -1.42 . . . . 72.33 109.062 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m 73.64 122.85 0.04 OUTLIER 'General case' 0 C--O 1.231 0.108 0 O-C-N 124.021 0.826 . . . . 65.52 109.734 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.9 mp0 -63.01 106.47 0.84 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.037 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 87.2 m-85 68.0 84.77 0.15 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.207 -0.906 . . . . 71.44 109.37 -170.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.81 -83.05 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.309 -0.86 . . . . 71.14 111.443 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.8 mm? -121.26 131.71 54.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.985 0.421 . . . . 73.41 111.151 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 42.1 m -136.77 119.11 15.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.731 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 7.9 m-85 -107.98 133.38 52.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.239 -0.437 . . . . 75.31 110.115 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -128.35 119.44 25.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.074 0.397 . . . . 74.2 110.816 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 8.0 pt-20 -131.63 170.46 14.73 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.2 0.444 . . . . 72.54 112.2 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.622 ' HG3' HD12 ' A' ' 58' ' ' LEU . 72.5 mmtt 118.73 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.057 1.743 . . . . 72.13 113.452 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.518 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 13.2 t90 -135.0 143.57 46.89 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.484 0.55 . . . . 75.31 112.484 -163.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 78' ' ' ASP . 4.9 t30 -119.38 159.23 24.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.951 -0.568 . . . . 74.22 111.112 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.728 HG21 ' HB2' ' A' ' 57' ' ' SER . 17.9 p -61.67 -17.99 57.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.296 0.85 . . . . 73.04 113.296 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.433 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 5.5 m-20 -78.65 -1.61 35.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.658 -0.246 . . . . 74.22 110.89 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 78.9 13.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.762 0.825 . . . . 72.34 109.687 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -86.7 134.89 33.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.306 -0.861 . . . . 74.22 110.058 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.1 mp -107.72 161.09 15.2 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.375 -0.972 . . . . 74.42 108.375 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.653 ' HA3' ' HA ' ' A' ' 102' ' ' SER . . . 148.23 -167.68 28.99 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.277 -1.439 . . . . 61.11 113.141 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 2.3 t -157.9 152.29 24.67 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.637 -0.282 . . . . 73.22 110.494 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.951 ' HA ' ' HB3' ' A' ' 100' ' ' ASP . 10.4 pt-20 -127.45 136.28 51.59 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 125.166 1.541 . . . . 74.42 109.678 171.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 99' ' ' PHE . 1.7 pp -111.4 133.11 58.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 118.658 -1.217 . . . . 73.3 110.815 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.933 ' HB ' ' HE3' ' A' ' 96' ' ' LYS . 21.1 p -114.8 137.52 51.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.727 -0.67 . . . . 74.53 110.783 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.75 135.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.32 -0.4 . . . . 73.34 110.672 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.05 127.33 36.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.378 -0.601 . . . . 74.13 109.378 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 27.1 t70 -69.94 156.64 38.8 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.248 0.547 . . . . 74.41 111.601 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -95.56 -37.31 10.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.5 -0.773 . . . . 72.4 110.831 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.64 -55.07 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 74.24 111.018 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.8 64.32 5.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.772 -0.825 . . . . 74.51 108.772 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -48.88 126.53 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 74.23 111.221 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.512 ' HA2' ' CA ' ' A' ' 2' ' ' ALA . . . 104.1 -4.25 44.94 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.69 -0.687 . . . . 52.31 112.204 -173.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 89' ' ' ASP . 52.7 tp -79.72 130.43 35.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.686 . . . . 75.43 109.146 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.933 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 55.9 tptt -121.72 111.15 16.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.658 -0.701 . . . . 73.42 109.732 -174.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.664 HD11 HG22 ' A' ' 116' ' ' THR . 1.1 mm? -112.77 125.71 54.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.365 -0.605 . . . . 64.22 109.365 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.867 ' HB ' HG21 ' A' ' 86' ' ' THR . 1.8 t -131.92 118.98 20.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.306 -0.558 . . . . 73.44 112.219 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.936 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 88.1 t80 -127.39 114.23 17.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 75.42 109.407 174.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.951 ' HB3' ' HA ' ' A' ' 84' ' ' GLU 0.355 1.2 t70 -153.82 172.95 16.55 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 120.845 -1.159 . . . . 64.24 112.804 159.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.75 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 23.3 t -116.78 147.79 41.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.931 0.396 . . . . 63.54 110.687 -165.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.653 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 33.4 t -114.8 134.81 54.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 75.31 110.368 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -95.52 124.9 39.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.059 0.457 . . . . 74.2 110.252 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.3 m -109.61 115.2 56.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 74.43 110.75 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.22 -7.81 18.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.184 2.589 . . . . 75.41 112.326 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -55.92 -50.81 69.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.743 -0.662 . . . . 75.32 111.01 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 p -129.36 -2.67 4.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.854 0.359 . . . . 71.3 111.65 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.92 11.68 81.02 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.664 -0.779 . . . . 72.45 111.734 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.831 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -94.35 149.08 21.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.693 -0.254 . . . . 71.43 110.567 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -106.94 135.98 47.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.04 0.448 . . . . 74.12 110.405 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -119.54 122.9 42.66 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.443 -0.947 . . . . 75.21 108.443 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.75 ' HA ' ' HA ' ' A' ' 101' ' ' SER . . . -104.45 147.16 27.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.942 0.401 . . . . 65.34 111.596 -168.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.686 ' HZ3' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -121.65 137.56 54.7 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.473 0.654 . . . . 74.52 110.433 177.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.936 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 2.5 tp -127.77 115.86 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.385 -1.279 . . . . 73.41 109.359 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.759 ' HB3' HG23 ' A' ' 98' ' ' THR . 4.4 ttmp? -113.65 121.27 43.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.725 -0.67 . . . . 74.3 110.579 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.664 HG22 HD11 ' A' ' 97' ' ' LEU . 21.7 p -112.68 117.29 31.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.367 -0.605 . . . . 62.12 109.367 175.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.82 134.93 5.34 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.052 -1.07 . . . . 73.34 112.885 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -107.51 125.36 51.18 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.616 -0.512 . . . . 65.53 109.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 1.089 ' HB3' HG23 ' A' ' 3' ' ' VAL . 41.7 mttp -110.26 121.78 46.09 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 121.182 0.515 . . . . 75.23 110.852 -173.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 120' ' ' ARG . 6.4 mmt180 -108.89 152.5 24.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.202 -0.908 . . . . 75.32 109.317 169.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.847 ' HA ' HG11 ' A' ' 3' ' ' VAL . 8.8 tm-20 -50.88 -27.93 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.907 0.883 . . . . 75.33 111.317 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -110.9 -15.4 13.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.091 -0.504 . . . . 74.33 112.143 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' HB3' ' A' ' 144' ' ' LEU . 16.6 tt -149.29 122.12 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 118.813 -1.155 . . . . 74.52 113.482 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.409 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 1.6 t30 -102.83 119.01 38.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.445 -0.798 . . . . 72.43 110.793 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 142' ' ' LEU . 3.1 mm? -112.43 111.9 23.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.166 -0.679 . . . . 73.31 109.166 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.11 118.58 2.44 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.991 -1.1 . . . . 74.24 113.103 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.8 t -110.66 111.22 22.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.935 0.398 . . . . 75.23 110.204 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.643 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 13.6 t70 -100.7 134.74 43.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 75.14 109.728 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.83 117.78 24.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.838 0.352 . . . . 73.14 110.119 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.32 119.22 37.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -82.45 96.9 8.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.903 0.382 . . . . 74.34 111.007 -171.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.559 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 13.0 t70 -96.82 145.31 25.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 72.44 109.638 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.404 HD11 ' C ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -70.7 -29.17 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.544 -175.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.72 58.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.944 0.402 . . . . 70.22 110.923 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.56 108.3 0.51 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.583 -0.607 . . . . 72.3 111.583 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.559 ' HA ' ' H ' ' A' ' 132' ' ' ASP . 77.0 Cg_exo -48.24 123.51 9.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.268 2.645 . . . . 72.42 112.755 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 t -84.68 136.67 33.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.251 -0.648 . . . . 63.34 109.251 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 45.5 mm -105.57 117.04 50.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 65.32 109.467 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -116.19 109.64 17.72 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.28 -0.637 . . . . 74.11 109.28 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.0 133.54 11.61 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.907 -1.139 . . . . 53.54 112.157 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.21 114.08 21.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.418 0.628 . . . . 75.02 109.491 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 144' ' ' LEU . 18.1 tp -116.47 122.94 46.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.362 -0.836 . . . . 75.3 109.569 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.792 HG23 ' HB3' ' A' ' 7' ' ' TYR . 48.3 t -133.9 120.26 35.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.958 -0.386 . . . . 75.25 109.958 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -126.78 139.29 53.23 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.532 -0.867 . . . . 74.24 110.718 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -120.86 128.41 7.41 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 114.674 -1.148 . . . . 75.3 111.837 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -112.59 149.16 33.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.396 -1.705 . . . . 74.21 106.396 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -47.7 95.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 61.4 112.243 -171.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.3 -33.09 5.73 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.133 -0.94 . . . . 72.43 112.867 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' HD1' ' HB2' ' A' ' 173' ' ' TYR . 2.5 m0 -106.47 146.88 30.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.847 0.323 . . . . 74.34 111.463 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.927 ' HB3' HD12 ' A' ' 10' ' ' LEU . 7.5 mt -130.81 136.56 48.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.815 -0.809 . . . . 73.1 108.815 167.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 144' ' ' LEU . . . -130.52 127.4 39.07 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.861 -0.422 . . . . 72.35 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.574 ' N ' HD21 ' A' ' 10' ' ' LEU . . . -131.85 133.54 7.21 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.986 -0.626 . . . . 75.11 111.791 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -129.36 118.72 22.68 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.212 -0.494 . . . . 75.34 110.538 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -111.6 121.83 46.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 75.53 109.508 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -135.48 146.69 48.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.065 -0.346 . . . . 74.2 110.065 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.666 HD22 ' HB3' ' A' ' 166' ' ' GLN . 7.3 p30 -124.35 119.01 28.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.645 0.736 . . . . 71.12 110.966 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.8 t80 -97.03 123.1 40.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.527 -1.215 . . . . 72.22 109.298 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.676 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 25.0 tt0 -94.04 105.25 17.26 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.747 -0.464 . . . . 74.3 109.747 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.78 -22.09 62.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 113.687 -1.597 . . . . 74.51 111.149 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.23 77.83 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.595 -0.891 . . . . 71.3 108.595 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.676 ' H ' ' HG2' ' A' ' 158' ' ' GLU . 17.6 ttmm -98.89 -164.91 1.18 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.92 -1.511 . . . . 73.21 106.92 169.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.44 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 15.5 m -110.38 25.52 11.69 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.223 -0.923 . . . . 73.1 110.509 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -155.31 151.28 27.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 119.398 -0.921 . . . . 74.33 112.727 -160.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.81 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -74.77 135.72 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.105 -1.072 . . . . 72.53 108.105 168.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -93.99 -32.84 13.68 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.421 -0.512 . . . . 74.51 110.929 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.666 ' HB3' HD22 ' A' ' 156' ' ' ASN . 35.3 tt0 -151.38 133.52 15.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 75.4 111.066 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 m -118.69 120.22 36.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 75.03 109.984 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 185' ' ' ASN . 39.3 m-80 -116.82 121.95 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.806 -0.813 . . . . 72.03 108.806 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -139.8 155.48 47.25 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.567 -0.853 . . . . 61.25 111.797 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 10' ' ' LEU . . . -144.81 152.71 40.74 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.616 -0.72 . . . . 75.0 110.23 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 42.9 t -130.21 151.63 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.613 -1.254 . . . . 72.51 107.613 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -158.04 111.03 0.47 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.029 -1.081 . . . . 72.54 112.197 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.407 ' HB2' ' HD1' ' A' ' 149' ' ' TRP . 39.2 p90 -113.39 138.36 50.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.428 0.632 . . . . 74.43 110.957 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -104.63 127.17 52.31 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.695 -1.139 . . . . 73.13 110.486 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 178' ' ' PHE . 33.5 m -127.12 162.54 25.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.555 -0.906 . . . . 74.42 108.555 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.61 -54.7 11.1 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.522 0.564 . . . . 73.32 112.522 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.28 -21.93 13.44 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.896 -0.322 . . . . 65.33 111.698 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.519 ' O ' ' HB ' ' A' ' 175' ' ' THR . 91.4 m-85 -124.69 142.84 51.1 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.805 0.336 . . . . 74.33 110.913 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 29.2 tt0 -135.23 122.9 22.22 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.206 -1.035 . . . . 72.21 108.206 172.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.5 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 8.8 tt -121.54 137.45 54.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.987 -0.685 . . . . 64.43 111.2 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 19.9 t-80 -127.3 114.8 18.07 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.248 -0.887 . . . . 73.15 110.573 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -81.51 148.31 29.25 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.804 -0.813 . . . . 63.23 108.804 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 181' ' ' HIS . 8.3 t30 -147.93 137.02 22.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.3 -0.56 . . . . 74.13 111.25 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.9 t -133.78 123.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.554 -0.748 . . . . 70.23 110.068 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' A' ' 168' ' ' ASN . 11.7 m120 -117.08 112.44 20.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.641 -0.709 . . . . 74.42 109.529 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.514 ' HA ' ' HG3' ' A' ' 166' ' ' GLN . 21.0 t70 63.7 -173.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.418 -0.81 . . . . 74.44 109.072 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.9 -6.0 89.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.395 -0.907 . . . . 43.21 111.101 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.2 m -97.03 -26.95 14.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.0 0.741 . . . . 64.21 113.0 -171.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -116.5 111.15 19.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.523 0.601 . . . . 72.13 110.427 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -127.63 123.62 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 74.41 109.371 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -174.13 -144.87 4.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.802 -1.19 . . . . 65.41 113.33 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -166.23 -172.08 33.13 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.613 -0.804 . . . . 44.0 113.038 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 4.1 m -148.76 139.0 22.39 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.544 0.738 . . . . 73.54 109.12 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.1 mp -124.23 117.45 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 121.2 -0.2 . . . . 75.44 110.464 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 205' ' ' ALA . 11.6 t80 -108.41 120.33 42.09 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.542 -0.54 . . . . 73.14 109.542 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -125.72 133.05 52.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.472 -0.331 . . . . 74.23 110.45 -175.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -101.15 114.41 28.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.477 -0.329 . . . . 73.43 110.378 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 199' ' ' ASN . 8.3 t -73.77 171.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.373 -0.603 . . . . 71.33 109.373 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.573 ' H ' HG12 ' A' ' 198' ' ' VAL . 12.9 m120 -66.11 -30.87 71.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.756 0.312 . . . . 44.13 111.31 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 202' ' ' LEU . 4.7 mptp? -92.81 -164.51 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 75.51 110.846 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -79.11 39.09 0.37 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 73.44 110.496 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.954 ' HG ' ' HB3' ' A' ' 225' ' ' TYR . 4.5 tt -120.92 122.01 39.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 73.44 109.661 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.86 130.54 53.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.98 -0.555 . . . . 74.24 109.658 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.0 t -121.64 153.75 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.863 0.363 . . . . 73.4 110.63 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.02 147.79 37.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.498 0.666 . . . . 74.45 111.55 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.838 HG21 HG21 ' A' ' 221' ' ' ILE . 71.3 t -112.13 132.79 59.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.158 -0.928 . . . . 72.01 109.517 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.3 p-10 -114.2 127.3 55.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.934 -1.136 . . . . 71.52 107.934 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 tp -144.15 129.58 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.556 -0.458 . . . . 71.31 110.819 -169.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.434 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -150.57 129.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.534 . . . . 71.21 111.216 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.627 ' CZ2' ' HA ' ' A' ' 215' ' ' SER . 3.5 t-105 -95.1 125.33 39.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.281 -1.007 . . . . 62.42 108.281 174.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 t -101.56 123.02 44.9 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.495 0.664 . . . . 74.05 110.312 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.7 127.32 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 71.35 111.533 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 153.96 -70.51 0.29 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.875 -0.89 . . . . 70.45 110.875 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.9 -166.01 1.43 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.387 -0.597 . . . . 75.04 109.387 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.627 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . 64.6 m -95.57 24.8 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.094 0.474 . . . . 74.23 110.808 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.07 111.82 20.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 73.34 109.779 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.6 t -99.82 135.97 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.05 0.452 . . . . 74.31 110.007 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -96.5 115.12 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.459 -0.571 . . . . 74.21 109.459 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.566 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 47.6 p90 -119.64 154.95 33.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.846 0.355 . . . . 75.31 110.736 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.39 23.12 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.849 -0.691 . . . . 73.31 111.943 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.838 HG21 HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -135.49 140.64 44.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 121.035 -0.266 . . . . 74.34 110.458 177.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.733 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -133.69 131.13 39.13 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.345 0.403 . . . . 74.5 110.706 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.56 125.14 53.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.393 -0.367 . . . . 74.21 110.186 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 224' ' ' LYS . 8.9 mtmp? -112.02 114.08 26.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 73.04 109.218 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.954 ' HB3' ' HG ' ' A' ' 202' ' ' LEU . 7.9 p90 -127.03 124.63 39.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.435 0.636 . . . . 71.51 111.24 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -82.32 106.87 14.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.048 -0.978 . . . . 72.32 108.946 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.542 HG22 ' HE1' ' A' ' 233' ' ' PHE . 14.8 tt -70.11 -43.98 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.692 0.627 . . . . 74.23 112.692 -167.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.778 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 14.4 t70 -171.79 -63.56 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.311 0.486 . . . . 75.24 112.311 -175.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 78.4 Cg_endo -93.4 -127.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.281 1.987 . . . . 73.11 112.911 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.483 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.5 p-10 -92.35 12.63 21.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.708 -0.678 . . . . 73.11 110.829 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.24 133.1 55.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.456 0.646 . . . . 62.14 111.322 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -121.36 140.26 52.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.833 -1.076 . . . . 54.21 109.34 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.542 ' HE1' HG22 ' A' ' 227' ' ' ILE . 88.1 m-85 -106.45 126.74 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.123 -0.325 . . . . 72.4 110.123 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 15.0 m -120.59 117.63 28.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.484 . . . . 74.22 110.067 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -118.42 140.48 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.829 -0.434 . . . . 62.05 109.829 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.814 ' HB2' ' HZ2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -143.74 148.03 35.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 74.44 111.251 -177.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.512 HG12 HG12 ' A' ' 221' ' ' ILE . 7.0 p -122.58 148.57 26.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 116.32 -0.4 . . . . 64.25 110.113 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -110.45 150.04 29.43 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.254 0.972 . . . . 71.05 109.591 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.566 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 6.8 p30 -37.98 -36.39 0.2 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.61 1.564 . . . . 71.32 114.815 -172.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.671 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.1 m -81.83 21.19 0.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.772 0.32 . . . . 64.4 111.033 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.3 m 68.43 31.54 4.9 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.634 -0.712 . . . . 74.22 111.203 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.829 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.6 mp -96.86 129.53 44.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.566 -0.454 . . . . 72.54 111.536 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -111.49 116.52 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.3 0.572 . . . . 75.32 110.834 -172.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -116.28 133.72 10.95 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.739 -0.664 . . . . 73.22 111.867 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 245' ' ' LEU . 1.3 pp -119.9 146.51 45.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.42 . . . . 61.02 110.678 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -134.17 133.44 6.87 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.612 -0.722 . . . . 73.31 111.778 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.706 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 19.4 m-85 -102.86 114.48 28.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.666 -0.864 . . . . 73.54 108.666 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 22.1 m -116.84 114.95 24.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.811 0.339 . . . . 71.42 110.417 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -132.45 137.51 47.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.854 0.359 . . . . 74.22 110.676 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.9 m -112.37 95.71 5.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.001 -0.545 . . . . 73.01 110.159 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 43.7 tp -82.05 88.34 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.268 -0.642 . . . . 75.02 109.268 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 75.1 mmtt 67.93 163.82 0.13 Allowed Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.259 -0.882 . . . . 74.13 110.273 -175.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 40.8 Cg_endo -69.23 64.29 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.355 2.037 . . . . 71.14 112.3 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -158.68 -45.43 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.911 -0.586 . . . . 74.45 112.315 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.6 mt -124.08 121.44 62.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 64.15 111.652 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.71 ' HB3' ' HB2' ' A' ' 280' ' ' GLU . 37.1 ttmt -117.47 115.44 25.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.367 -0.605 . . . . 64.12 109.367 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.5 tp -100.44 130.53 46.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.424 -0.353 . . . . 73.44 110.521 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 30.0 m -129.98 111.25 12.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.554 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.913 HD23 HD21 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.21 122.84 44.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.892 -1.151 . . . . 75.13 107.892 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.9 m -124.39 139.58 53.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.971 0.415 . . . . 73.14 110.854 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -143.92 127.77 17.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.99 -0.55 . . . . 73.24 110.248 177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.731 HD13 HD21 ' A' ' 242' ' ' LEU . 2.7 tm? -101.62 118.04 36.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.361 -0.977 . . . . 74.12 108.361 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -97.7 110.95 23.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.605 -0.887 . . . . 64.41 108.605 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.829 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.9 m-20 -68.62 102.34 1.47 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.711 -0.848 . . . . 72.44 108.711 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.9 -10.06 43.65 Favored Glycine 0 C--N 1.321 -0.293 0 CA-C-N 115.64 -0.709 . . . . 75.42 111.844 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -90.59 -25.34 20.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.206 -0.497 . . . . 73.43 111.092 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -161.5 24.25 0.12 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.105 1.52 . . . . 74.43 115.105 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 264' ' ' ASP . 0.2 OUTLIER -64.18 -46.47 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 120.079 1.309 . . . . 73.42 112.878 176.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.43 -25.92 62.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.067 0.461 . . . . 61.53 110.594 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.87 2.37 32.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 52.54 111.067 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.63 -103.12 0.34 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.141 -1.028 . . . . 71.2 112.856 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -158.78 167.28 34.69 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.082 -1.056 . . . . 64.01 113.223 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -111.47 150.12 30.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.66 -0.77 . . . . 73.52 109.593 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 43.6 mttm -93.7 137.18 33.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.689 -0.856 . . . . 71.03 108.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.7 tm? -125.66 133.06 52.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.755 0.312 . . . . 72.21 110.294 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.46 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.24 122.39 2.18 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.062 -0.815 . . . . 61.35 111.062 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.913 HD21 HD23 ' A' ' 259' ' ' LEU . 2.2 tm? -115.82 125.32 52.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.644 -0.502 . . . . 71.13 109.644 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -134.9 138.43 10.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.429 -0.891 . . . . 70.14 112.895 -175.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.85 132.39 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.777 -0.453 . . . . 74.31 109.777 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.71 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 46.4 mt-10 -109.85 110.88 22.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.812 -0.81 . . . . 75.23 108.812 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.582 ' HD1' HD13 ' A' ' 31' ' ' LEU . 16.4 t80 -104.16 141.6 35.96 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.589 -0.893 . . . . 74.14 108.589 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -135.56 119.79 17.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.935 0.398 . . . . 72.51 110.639 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.22 108.43 19.05 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.156 -0.683 . . . . 53.04 109.156 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.2 mt -121.13 -69.02 0.86 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.843 -0.799 . . . . 65.45 108.843 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 114.679 -1.146 . . . . 73.3 108.532 177.228 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.347 0.118 . . . . 74.31 111.034 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.58 145.43 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.683 0.278 . . . . 72.41 110.69 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.709 ' HB ' ' HE2' ' A' ' 119' ' ' LYS . 60.5 t -67.43 125.99 91.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.037 -0.529 . . . . 72.11 110.332 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.23 153.98 36.87 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.39 2.727 . . . . 75.3 113.279 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.03 64.34 6.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.114 2.543 . . . . 75.45 112.047 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.565 ' HB ' HD22 ' A' ' 150' ' ' LEU . 14.9 p -69.63 -37.74 76.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.466 -0.788 . . . . 75.31 111.096 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.693 ' HB3' HG23 ' A' ' 143' ' ' VAL . 3.5 p90 -64.12 -22.03 66.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 72.31 111.278 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.69 -19.79 44.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.066 -0.516 . . . . 73.4 110.367 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.49 11.91 37.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.032 0.92 . . . . 71.32 109.333 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.967 HD23 ' HA3' ' A' ' 152' ' ' GLY . 3.3 tp -76.53 -14.3 60.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.007 -0.997 . . . . 74.31 110.849 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.66 26.23 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.44 -0.886 . . . . 75.14 113.291 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -68.93 -50.17 51.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.151 0.476 . . . . 73.11 110.525 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -57.34 -38.86 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.836 -0.62 . . . . 74.22 111.027 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.65 72.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 72.32 111.402 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.77 -39.91 84.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.6 -0.273 . . . . 74.33 111.518 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.556 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 14.7 t70 -58.59 -49.83 76.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.642 -0.254 . . . . 73.12 111.353 -175.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -70.23 -31.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.015 0.436 . . . . 73.21 110.867 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -72.64 -32.19 65.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 74.03 110.71 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -81.87 -25.84 34.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 65.12 110.73 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HD3' ' O ' ' A' ' 16' ' ' ASP . 1.9 mptm? -85.17 20.06 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 63.35 110.865 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.594 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -99.61 -19.47 20.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 63.35 113.286 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -87.16 138.28 31.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.267 0.556 . . . . 74.21 112.141 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -152.35 109.65 0.42 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.22 -0.9 . . . . 63.04 111.709 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -103.73 14.99 29.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.785 0.326 . . . . 74.42 111.005 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.33 14.61 53.52 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 109.226 -1.55 . . . . 72.42 109.226 -166.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 46' ' ' SER . 5.3 tt -99.47 145.6 27.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.944 -1.128 . . . . 73.21 110.688 -168.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.553 HD13 HD11 ' A' ' 277' ' ' LEU . 28.3 mm -102.49 125.26 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.986 -1.006 . . . . 75.21 110.198 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -107.79 120.01 41.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.332 -0.618 . . . . 75.43 109.332 175.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 279' ' ' LEU . 22.5 tp -114.44 147.56 39.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.837 0.351 . . . . 73.1 110.554 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.566 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.6 t70 -150.82 131.65 14.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 74.25 109.768 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.931 HD21 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -126.84 123.59 37.67 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 97.1 mttt -132.65 124.97 29.29 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.839 -0.344 . . . . 74.23 110.988 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 41' ' ' PHE . 8.8 t -135.83 129.95 33.2 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.285 -0.635 . . . . 54.02 109.285 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.705 ' HB3' HH12 ' A' ' 63' ' ' ARG . 90.3 mttt -118.3 131.17 56.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.965 -0.562 . . . . 72.43 109.969 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -132.91 150.26 52.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.238 -0.437 . . . . 60.45 110.513 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.91 2.37 46.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.799 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -100.08 24.75 8.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 64.31 111.521 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.3 -5.89 82.64 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.328 -0.939 . . . . 64.42 113.451 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.42 127.78 46.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.179 0.99 . . . . 74.32 111.764 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.3 117.6 11.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.507 -0.923 . . . . 74.43 108.507 164.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HB2' HG22 ' A' ' 33' ' ' THR . 96.0 m-85 -110.32 125.6 53.34 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.588 -0.445 . . . . 75.04 110.768 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 20.6 m -125.18 116.11 21.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 61.52 109.934 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 6.4 m -108.76 123.28 48.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.051 -0.722 . . . . 75.21 109.051 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -130.03 126.41 37.64 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.006 -0.368 . . . . 74.05 110.006 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.14 156.66 26.97 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.946 -1.121 . . . . 73.25 112.576 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.566 ' HB3' HD21 ' A' ' 26' ' ' LEU . 16.6 m -137.98 132.35 32.15 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.308 -0.627 . . . . 55.22 109.308 176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.32 130.04 19.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.862 0.363 . . . . 71.42 110.593 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 46.1 t30 -80.64 142.02 34.39 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.444 -0.576 . . . . 74.44 109.444 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -64.04 -19.37 65.16 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.968 0.413 . . . . 74.3 111.255 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -70.62 -13.6 62.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 73.12 110.442 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m 71.56 -3.52 2.12 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.726 -0.67 . . . . 74.12 111.726 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -73.06 -27.46 61.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.217 -0.447 . . . . 71.12 110.981 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.28 101.66 6.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 71.21 110.034 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.66 120.69 58.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.985 -0.552 . . . . 74.4 110.11 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -131.3 125.03 31.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.955 -0.387 . . . . 65.43 109.955 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.83 155.19 20.06 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.266 -0.969 . . . . 75.23 112.409 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 p -146.8 141.21 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.111 0.482 . . . . 74.53 110.441 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.38 122.54 42.03 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.926 -1.139 . . . . 73.25 107.926 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 28.0 mt-10 -116.98 119.96 36.91 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.956 -0.565 . . . . 74.03 109.82 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -109.78 120.99 44.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.724 -0.671 . . . . 70.15 109.841 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 42.9 tttp -117.08 132.51 56.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.067 -0.716 . . . . 71.1 109.067 176.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.692 ' O ' ' HA ' ' A' ' 70' ' ' THR . 37.9 t80 -100.19 121.6 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.044 -1.095 . . . . 75.35 108.044 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.705 HH12 ' HB3' ' A' ' 34' ' ' LYS . 10.6 ttp180 -123.72 107.3 11.31 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.538 0.685 . . . . 74.55 111.094 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -113.55 115.58 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.79 -1.096 . . . . 75.22 108.886 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m 70.93 139.13 0.04 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.961 0.788 . . . . 72.53 109.59 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.58 101.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.692 -0.485 . . . . 71.53 109.692 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.24 68.92 0.59 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.378 -0.828 . . . . 72.14 110.684 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.04 -76.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.382 -1.087 . . . . 74.34 110.382 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -122.11 130.18 53.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.743 0.306 . . . . 74.1 110.247 173.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.778 HG22 ' HB ' ' A' ' 86' ' ' THR . 9.0 t -138.44 135.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.425 0.631 . . . . 75.41 112.089 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 85.2 m-85 -105.75 133.77 49.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.844 -0.798 . . . . 74.43 108.844 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.4 m -120.84 119.31 32.29 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.71 -0.396 . . . . 75.45 111.465 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 28.1 mt-10 -130.96 152.2 50.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.668 -0.697 . . . . 74.12 109.803 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.63 ' HB2' ' HZ3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -160.43 104.38 1.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 73.42 110.917 178.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.966 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 48.8 t90 -98.53 127.94 44.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.298 -0.41 . . . . 71.15 110.358 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.86 136.84 38.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.488 -0.93 . . . . 71.01 108.488 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -61.8 -25.83 67.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 73.24 111.862 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.7 -38.17 5.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.118 0.784 . . . . 72.12 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.27 -90.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.347 0.869 . . . . 55.31 113.347 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 m -85.22 123.6 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.811 0.671 . . . . 73.33 112.811 -166.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.966 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -108.48 119.07 38.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.624 -0.51 . . . . 75.52 109.624 168.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -115.53 156.61 15.54 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.643 -0.789 . . . . 41.11 112.776 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 9.8 t -172.88 148.72 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.681 -0.489 . . . . 74.42 109.681 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.641 ' HB2' ' HA ' ' A' ' 100' ' ' ASP . 12.2 mm-40 165.58 -155.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.585 1.154 . . . . 73.4 110.491 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.466 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -131.58 138.97 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.49 0.552 . . . . 74.32 112.49 -165.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.778 ' HB ' HG22 ' A' ' 70' ' ' THR . 23.1 m -127.77 131.75 49.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.337 -0.392 . . . . 54.41 110.003 175.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 97' ' ' LEU . 3.9 p -129.95 129.8 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 64.41 111.672 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.56 117.87 30.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.278 -1.008 . . . . 73.44 108.278 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -87.28 140.18 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.26 -0.576 . . . . 71.42 111.642 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.84 -25.85 15.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.279 -0.873 . . . . 74.42 110.655 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.9 tp -67.13 -57.23 7.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.032 -0.729 . . . . 75.34 109.032 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.54 76.17 5.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.298 -1.001 . . . . 72.33 108.298 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.67 123.11 13.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.554 -0.748 . . . . 74.3 110.683 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . 100.6 -0.91 55.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.665 -0.698 . . . . 73.42 112.319 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.3 tp -91.41 131.1 37.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 75.53 110.201 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -121.68 111.24 16.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.328 -0.851 . . . . 72.34 109.85 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HB2' HG12 ' A' ' 87' ' ' VAL . 1.9 mm? -100.79 126.34 47.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.083 -0.71 . . . . 72.35 109.083 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 23.6 m -128.87 118.34 22.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.119 0.485 . . . . 75.3 111.749 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.619 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 77.7 m-85 -111.06 116.22 30.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.85 -1.167 . . . . 74.13 107.85 170.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.641 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.5 p-10 -130.56 128.19 40.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.846 0.355 . . . . 73.44 110.575 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 t -119.57 148.81 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.732 0.301 . . . . 64.14 110.528 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.409 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 7.9 p -133.04 134.54 44.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.301 -0.409 . . . . 73.22 110.478 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.655 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 9.8 m-85 -111.21 138.94 47.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.207 -0.294 . . . . 75.03 110.207 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.2 p -122.47 107.85 34.05 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.834 0.35 . . . . 64.21 110.195 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.91 -1.13 9.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.986 2.457 . . . . 74.33 112.76 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -63.86 -61.59 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.38 0.609 . . . . 73.52 109.51 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 109' ' ' LYS . 42.7 m -91.76 -27.27 18.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.283 -0.871 . . . . 71.44 109.958 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.5 9.4 60.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.666 -0.778 . . . . 54.31 111.843 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.568 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -94.16 148.94 21.69 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.802 0.334 . . . . 64.3 110.617 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' CB ' ' HD1' ' A' ' 103' ' ' PHE . 18.6 ptpt -114.23 152.74 30.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 73.41 110.796 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.568 ' OD1' ' HE2' ' A' ' 109' ' ' LYS . 2.8 m-20 -116.7 122.58 44.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.952 -0.758 . . . . 73.53 108.952 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.33 114.92 29.33 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.343 -0.614 . . . . 72.14 109.343 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.41 ' HD2' ' OD2' ' A' ' 130' ' ' ASP . 50.1 tttm -115.03 137.98 51.38 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.211 0.529 . . . . 74.23 110.606 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 129' ' ' MET . 3.2 tp -127.3 126.0 66.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.431 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 24.4 ttpp -118.9 120.31 36.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.202 0.525 . . . . 74.35 110.208 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.8 p -107.34 116.89 32.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.604 -0.887 . . . . 73.53 108.604 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.37 135.78 8.19 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.985 -1.103 . . . . 42.32 112.106 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -126.78 124.81 40.56 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.442 -0.577 . . . . 75.55 109.442 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.709 ' HE2' ' HB ' ' A' ' 3' ' ' VAL . 15.9 ptmt -109.08 121.71 45.73 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.486 0.66 . . . . 72.44 109.921 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -104.56 155.92 18.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.013 -1.106 . . . . 74.4 108.013 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -54.68 -28.57 48.52 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.416 0.447 . . . . 74.21 112.184 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.34 -15.38 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.548 -0.296 . . . . 74.43 111.692 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.524 HD13 HD13 ' A' ' 142' ' ' LEU . 9.1 tp -146.35 135.56 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.601 -0.44 . . . . 75.01 111.74 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.72 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 43.8 t30 -122.63 120.86 34.99 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.764 -0.585 . . . . 75.41 111.737 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.4 127.03 53.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.696 0.284 . . . . 73.14 111.213 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.39 125.64 4.08 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.037 -0.601 . . . . 54.21 112.047 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 49.7 m -113.32 112.11 23.14 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.578 -0.366 . . . . 63.41 111.275 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.636 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 9.9 m-20 -96.2 147.46 23.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 73.44 109.994 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.488 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.5 ttt -139.77 120.41 14.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.627 -0.261 . . . . 75.44 110.543 173.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' A' ' 113' ' ' LYS . 35.4 m-20 -90.72 117.45 29.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.762 -0.829 . . . . 73.44 108.762 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.18 97.53 9.26 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.079 0.466 . . . . 73.13 110.142 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.03 150.23 26.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.629 -0.714 . . . . 55.34 109.212 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.718 ' H ' HD12 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -72.27 -19.9 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.98 0.363 . . . . 74.24 111.98 -175.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.56 -18.96 21.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 74.4 111.047 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.8 128.93 1.03 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.519 -0.848 . . . . 73.21 112.578 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.0 150.56 26.65 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.77 2.314 . . . . 74.42 112.657 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 m -126.8 134.01 50.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.566 . . . . 71.14 110.08 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 118.72 56.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.017 0.437 . . . . 75.5 109.87 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 12.1 ttp180 -111.24 130.18 55.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.622 -0.51 . . . . 71.44 109.622 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.19 132.49 10.94 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.993 -1.099 . . . . 73.33 111.406 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.84 115.47 23.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.361 -0.607 . . . . 75.22 109.361 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 123' ' ' ILE . 8.9 tp -121.0 124.31 44.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.989 -0.55 . . . . 74.32 110.383 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.72 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 77.3 t -110.92 131.78 61.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 75.51 109.809 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.921 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.5 mm? -108.22 137.6 45.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.347 -0.842 . . . . 75.13 108.93 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -125.86 117.38 2.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.582 -0.736 . . . . 42.22 111.537 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.705 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 90.0 m-85 -136.32 148.42 47.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.022 -0.733 . . . . 74.2 109.022 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.69 99.84 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 73.52 110.673 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.97 -30.87 9.53 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.564 -0.744 . . . . 74.32 111.866 -176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 85.5 m95 -105.95 122.06 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.221 0.534 . . . . 74.52 111.703 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.565 HD22 ' HB ' ' A' ' 6' ' ' THR . 1.6 tm? -110.61 149.37 30.51 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.828 -1.545 . . . . 73.53 106.828 172.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -157.44 160.14 38.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.67 -0.812 . . . . 73.35 111.248 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.967 ' HA3' HD23 ' A' ' 10' ' ' LEU . . . -156.8 133.34 3.58 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.047 -0.979 . . . . 62.43 110.882 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.438 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 34.0 m-85 -130.75 117.81 19.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.087 0.47 . . . . 74.04 110.205 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 168' ' ' ASN . 39.7 mt-30 -113.77 129.06 56.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.639 -0.71 . . . . 74.04 109.976 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.4 133.59 34.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.534 -0.303 . . . . 73.42 110.2 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 6.7 t30 -113.67 119.43 37.4 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.753 -0.462 . . . . 73.54 109.753 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 83.5 t80 -105.4 124.06 48.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.107 -0.497 . . . . 74.3 110.249 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.421 ' OE1' ' HE2' ' A' ' 161' ' ' LYS . 35.3 tt0 -86.96 97.73 10.86 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.672 -0.862 . . . . 75.41 108.672 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.1 m -71.53 -21.88 61.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 113.673 -1.603 . . . . 72.31 111.188 173.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.01 69.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.735 -0.839 . . . . 72.0 108.735 172.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.588 ' HG2' ' H ' ' A' ' 162' ' ' SER . 17.0 ttmm -112.9 -157.45 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.52 -1.289 . . . . 74.34 107.52 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.588 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 5.6 p -109.74 27.67 9.34 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 122.034 -0.416 . . . . 64.12 111.703 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -143.83 147.65 34.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 117.747 -1.581 . . . . 75.43 114.406 -161.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 69.4 t -73.75 124.26 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.265 -0.88 . . . . 62.23 109.456 171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.8 p -95.94 -31.97 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.629 -0.26 . . . . 74.03 111.581 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 64.2 mt-30 -127.31 131.71 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.743 0.306 . . . . 72.11 110.785 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.562 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 17.7 m -121.86 129.35 52.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.754 -0.461 . . . . 65.25 109.754 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 27.9 t-20 -136.87 121.33 18.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.766 -0.457 . . . . 73.42 109.766 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.64 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 46.4 m-85 -121.78 140.63 52.11 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.948 -0.301 . . . . 72.33 110.59 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.65 139.6 38.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.323 -0.399 . . . . 64.31 110.706 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 12.4 t -132.3 152.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.187 -0.672 . . . . 72.41 109.187 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.18 116.83 1.36 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.804 -0.712 . . . . 74.1 112.037 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -113.39 121.23 43.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.807 -0.812 . . . . 71.41 108.807 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 129.72 56.5 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.983 0.896 . . . . 74.15 111.892 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.9 m -110.13 161.8 15.21 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 106.591 -1.633 . . . . 75.53 106.591 166.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -57.51 -46.61 83.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.076 0.398 . . . . 73.43 111.9 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -106.18 -1.68 23.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.7 0.259 . . . . 71.01 111.7 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.2 117.42 14.52 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 110.489 -0.189 . . . . 75.55 110.489 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -118.86 124.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.145 -0.622 . . . . 74.52 110.987 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.8 tt -118.9 138.1 52.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.548 0.689 . . . . 74.23 111.652 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.793 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 64.2 m80 -114.72 150.51 35.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.124 -0.944 . . . . 74.21 108.98 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.568 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 27.8 m -123.33 138.68 54.56 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.265 -0.642 . . . . 73.31 109.265 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -134.27 140.97 46.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 73.22 111.322 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 47.0 t -133.47 115.55 22.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.283 -0.871 . . . . 72.4 110.019 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.0 t30 -103.62 99.46 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.384 0.611 . . . . 75.22 110.059 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 46.0 m-20 58.01 -161.48 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.886 -1.052 . . . . 73.41 110.804 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.52 -5.24 87.95 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.263 -0.881 . . . . 74.12 111.056 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 25.1 p -88.54 -24.65 22.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.039 0.755 . . . . 73.01 113.039 -173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.767 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 5.2 tm-20 -136.25 125.98 25.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.801 -0.36 . . . . 75.1 111.154 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.4 123.92 26.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 75.45 109.198 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.71 -146.2 4.82 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.238 -0.982 . . . . 61.24 113.003 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -172.82 -171.16 37.32 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.859 -0.686 . . . . 64.34 112.962 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.793 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 41.3 t -147.19 140.13 25.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.283 -0.636 . . . . 74.21 109.283 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.9 mp -120.13 118.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 110.07 -0.344 . . . . 75.25 110.07 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -108.91 120.42 42.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.301 0.572 . . . . 75.52 109.796 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 196' ' ' GLN . 11.1 mm100 -123.02 112.59 17.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.45 -0.795 . . . . 64.4 110.812 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.68 127.76 54.26 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.097 -0.705 . . . . 75.35 109.097 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 202' ' ' LEU . 1.1 m -111.57 151.79 13.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.091 0.472 . . . . 64.43 110.473 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -63.4 -20.19 65.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 71.34 111.829 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.79 47.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.363 0.505 . . . . 71.45 112.363 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 226' ' ' GLN . 48.9 mmtm 64.58 23.23 12.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 65.33 113.08 169.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.677 ' HG ' ' HB2' ' A' ' 225' ' ' TYR . 7.2 tt -126.79 134.61 50.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 74.04 110.764 -174.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -126.28 134.96 51.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.144 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 223' ' ' ALA . 24.7 m -122.91 141.75 51.56 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.324 -0.251 . . . . 64.31 110.324 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.41 135.58 48.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.235 0.541 . . . . 70.44 110.412 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.732 HG21 HG23 ' A' ' 221' ' ' ILE . 93.2 t -114.6 132.87 62.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.62 -0.718 . . . . 73.22 110.036 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -113.61 126.98 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.181 -1.044 . . . . 73.35 108.181 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 218' ' ' ARG . 5.0 tp -140.8 128.77 21.94 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 110.133 -0.321 . . . . 63.31 110.133 -170.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.41 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.96 135.83 19.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.0 0.428 . . . . 75.11 111.696 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -111.23 124.16 51.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.812 -0.631 . . . . 74.44 109.633 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.8 p -95.66 112.92 24.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 73.45 110.901 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.39 143.79 52.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 73.45 110.437 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.99 -18.19 50.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.978 -0.849 . . . . 73.31 110.978 -173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -136.36 164.24 28.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.395 -0.403 . . . . 71.41 110.136 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.6 p -92.46 16.4 11.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.416 0.627 . . . . 74.55 109.483 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.02 111.01 17.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.285 -0.87 . . . . 72.43 111.637 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 25.1 m -96.17 122.67 39.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.204 -1.036 . . . . 61.22 108.204 168.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.408 ' O ' HD11 ' A' ' 208' ' ' LEU . 28.8 mmm180 -105.52 116.9 32.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.542 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 23.9 p90 -114.03 152.53 30.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.243 0.544 . . . . 74.54 110.387 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.67 140.38 7.63 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.921 -1.036 . . . . 72.55 110.724 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.732 HG23 HG21 ' A' ' 206' ' ' VAL . 15.8 pt -131.74 134.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.729 0.265 . . . . 72.32 110.512 -177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -138.63 130.07 27.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.827 0.346 . . . . 62.03 110.583 174.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -120.85 125.66 48.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.53 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -107.24 114.96 29.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.509 0.671 . . . . 75.45 110.025 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.677 ' HB2' ' HG ' ' A' ' 202' ' ' LEU . 45.3 t80 -129.17 126.84 40.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.227 -0.897 . . . . 74.11 110.542 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.402 ' CG ' ' HB3' ' A' ' 201' ' ' LYS . 16.8 pt20 -77.14 123.75 26.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.373 -0.603 . . . . 70.25 109.373 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 233' ' ' PHE . 73.7 mt -70.14 -55.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.933 -0.576 . . . . 75.43 111.22 -172.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.619 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.2 t70 177.07 -54.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 123.66 0.6 . . . . 72.31 110.806 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 96.5 Cg_endo -83.75 -133.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.984 1.789 . . . . 74.3 112.051 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.437 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 9.8 m-20 -92.39 11.83 24.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 72.25 110.709 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.1 133.8 54.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.54 . . . . 75.02 111.082 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.89 142.14 47.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.182 -0.917 . . . . 74.23 109.43 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.466 ' HB2' HD12 ' A' ' 227' ' ' ILE . 70.9 t80 -106.78 132.38 52.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.183 0.516 . . . . 72.44 110.262 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 17.7 m -123.12 127.2 48.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.528 -0.76 . . . . 64.44 110.028 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -111.94 141.35 45.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.65 -0.5 . . . . 70.02 109.65 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 20.9 pttm -141.1 153.87 45.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.521 0.2 . . . . 74.31 110.868 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.62 HG13 HG12 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -147.47 155.15 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 75.22 110.187 175.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.744 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.1 t-20 -125.55 148.01 49.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.899 -0.778 . . . . 64.5 108.899 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.542 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 7.6 t30 -41.29 -37.64 1.01 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.645 1.216 . . . . 75.22 113.36 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.1 m -78.49 27.45 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.752 -0.204 . . . . 63.04 111.285 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.7 p 57.93 40.83 25.36 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.956 0.902 . . . . 65.44 110.605 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.798 ' HB3' HD13 ' A' ' 262' ' ' LEU . 56.4 mt -97.75 117.09 31.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.802 -0.635 . . . . 75.21 109.744 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.541 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.9 mp -103.27 117.99 49.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 109.776 -0.453 . . . . 74.34 109.776 -174.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.52 148.25 17.58 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.358 -0.925 . . . . 64.13 113.122 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.72 150.62 38.78 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.675 -0.861 . . . . 74.13 108.675 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.33 123.17 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.533 -0.841 . . . . 61.2 111.591 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.37 116.27 19.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.235 0.54 . . . . 75.45 110.225 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.8 t -116.05 136.72 52.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.543 -0.753 . . . . 74.54 110.732 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -132.87 134.28 44.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 74.51 110.68 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.424 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.2 t -89.03 115.34 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.943 -0.762 . . . . 73.23 108.943 172.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.42 ' N ' HD13 ' A' ' 251' ' ' LEU . 5.6 mp -75.19 -59.24 2.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.585 0.707 . . . . 64.14 109.517 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -119.73 149.69 48.87 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 106.991 -1.485 . . . . 72.32 106.991 171.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.8 99.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.391 2.061 . . . . 74.21 112.181 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.19 -22.05 6.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.769 -0.65 . . . . 72.12 112.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 252' ' ' LYS . 3.4 mp -106.26 119.25 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.376 -0.485 . . . . 75.5 109.981 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -120.62 120.65 36.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.679 . . . . 74.31 111.473 -172.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.2 tp -100.95 128.57 46.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.101 -0.703 . . . . 71.42 109.101 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.4 t -126.16 113.99 17.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.518 0.675 . . . . 73.32 111.125 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.933 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -99.64 124.12 44.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.21 -1.033 . . . . 75.52 108.21 175.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 22.6 t -127.32 143.16 51.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.945 0.402 . . . . 74.15 110.079 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.48 154.52 45.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.804 -0.443 . . . . 65.0 109.804 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 242' ' ' LEU . 1.9 tm? -130.84 118.59 20.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.341 -0.985 . . . . 73.21 108.341 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.609 ' HB3' HG12 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -97.4 106.69 19.05 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.343 -1.355 . . . . 74.31 107.343 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 5.2 m-20 -71.62 105.76 3.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.126 -0.694 . . . . 71.33 109.126 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.14 -13.89 10.28 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.256 -0.497 . . . . 65.22 112.885 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.47 -18.39 26.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.728 0.299 . . . . 65.13 110.946 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 4.2 m-20 -120.89 -41.31 2.56 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.72 0.637 . . . . 73.41 112.72 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.609 HG12 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -59.35 -25.81 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.429 0.529 . . . . 75.35 112.429 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.413 HD21 ' HA ' ' A' ' 269' ' ' ASN . 2.4 t-20 -63.59 -30.36 71.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 72.03 110.431 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.34 -16.76 15.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 52.22 110.677 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.95 94.58 1.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.019 -0.537 . . . . 64.33 112.265 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 177.93 86.43 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.661 -0.78 . . . . 74.52 112.498 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -113.98 144.65 42.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.658 0.266 . . . . 65.24 110.639 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 25.6 mmtp -97.35 144.11 27.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.507 -0.315 . . . . 72.31 110.238 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -134.85 126.28 28.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.835 0.35 . . . . 72.24 110.105 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 126.78 5.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 71.24 111.419 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.933 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -115.26 134.02 55.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.739 -0.467 . . . . 72.24 109.739 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -137.59 144.57 16.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.419 -0.896 . . . . 54.53 113.25 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.688 ' HB2' HD11 ' A' ' 29' ' ' LEU . 2.3 mm? -123.98 131.43 53.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.419 -0.585 . . . . 73.24 109.419 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.72 112.22 15.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.346 -0.613 . . . . 73.52 109.346 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.931 ' HB2' HD21 ' A' ' 31' ' ' LEU . 93.6 m-85 -106.9 106.38 16.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.112 -0.495 . . . . 74.52 110.308 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.526 ' HG2' HD22 ' A' ' 284' ' ' LEU . 29.7 tt0 -99.73 110.62 23.01 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.474 -0.565 . . . . 74.45 109.474 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -97.95 108.67 21.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.419 0.628 . . . . 63.31 110.967 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.526 HD22 ' HG2' ' A' ' 282' ' ' GLN . 3.0 mm? -135.14 -38.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.837 -1.074 . . . . 75.23 108.779 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.825 -1.08 . . . . 74.14 109.519 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.743 0.306 . . . . 73.53 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.6 -44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.359 . . . . 75.41 110.178 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 119' ' ' LYS . 21.3 t 64.47 96.97 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.548 -0.751 . . . . 51.35 111.242 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.9 Cg_endo -69.42 142.23 48.84 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.794 2.329 . . . . 74.32 112.388 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 19.3 Cg_exo -66.39 90.96 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.807 2.338 . . . . 74.15 111.974 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.502 ' HB ' HD21 ' A' ' 150' ' ' LEU . 2.3 p -84.17 -2.57 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.443 0.639 . . . . 73.25 110.781 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -57.92 -24.63 58.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 72.23 109.753 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.98 -26.21 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 75.52 110.078 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.41 -4.53 48.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 71.33 110.574 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 150' ' ' LEU . 66.3 mt -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 74.4 110.905 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.32 40.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.543 -1.313 . . . . 54.31 114.247 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -57.95 -54.57 45.47 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.462 0.631 . . . . 75.45 109.669 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 p -58.72 -39.33 80.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.568 -0.742 . . . . 72.32 111.676 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.39 70.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.532 -0.304 . . . . 72.32 111.195 -176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -68.02 -36.23 79.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 73.13 110.588 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.43 -48.69 63.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.373 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.26 -39.33 78.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.445 -0.343 . . . . 74.23 111.213 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.8 -41.35 78.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.939 -0.393 . . . . 75.41 109.939 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m 70.78 94.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.378 -0.828 . . . . 73.51 111.998 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -110.76 -12.22 14.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 72.54 110.548 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.85 1.2 89.01 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.864 -0.684 . . . . 40.13 112.536 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.64 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 87.8 m-85 -133.84 144.17 48.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.344 -0.613 . . . . 75.11 109.344 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.94 34.0 0.4 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.182 -1.008 . . . . 71.02 112.796 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.2 -1.79 38.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.259 0.552 . . . . 75.32 109.973 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 83.78 12.95 76.44 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.254 -1.139 . . . . 74.04 110.254 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.639 HD12 ' HA ' ' A' ' 48' ' ' ASN . 6.8 tp -131.24 179.22 6.14 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.664 0.745 . . . . 75.11 112.015 -169.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.918 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -110.26 147.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.815 -1.084 . . . . 75.45 109.492 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 14.6 ptpt -138.41 154.38 48.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 71.24 109.577 171.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.681 HD13 ' HB2' ' A' ' 279' ' ' LEU . 3.7 tt -140.09 145.09 37.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.695 0.284 . . . . 73.52 111.12 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -131.11 128.35 39.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.553 0.692 . . . . 73.44 109.901 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -108.43 124.5 50.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.267 -0.879 . . . . 71.34 108.879 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -125.56 123.33 38.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.798 0.332 . . . . 73.13 110.122 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.9 m -137.95 121.56 17.37 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.643 -0.873 . . . . 72.2 108.643 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -137.07 143.82 42.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.551 0.691 . . . . 75.24 112.276 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -139.1 137.49 36.22 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.949 -1.13 . . . . 61.33 107.949 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.75 49.32 1.32 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.846 0.832 . . . . 74.53 110.756 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -122.46 22.64 9.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.677 -1.147 . . . . 72.14 109.099 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 91.14 -8.24 79.79 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 119.4 -0.667 . . . . 62.23 113.751 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.69 127.38 48.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.514 1.157 . . . . 73.42 112.643 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 22.9 mt-10 -139.54 118.85 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.891 -0.411 . . . . 75.43 109.891 165.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.95 121.31 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.79 0.329 . . . . 72.23 110.271 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.831 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.4 m -126.95 132.37 50.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 75.42 111.18 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 m -125.36 140.45 52.8 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.39 -0.596 . . . . 54.34 109.39 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.8 m -147.57 126.11 12.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.785 0.326 . . . . 75.5 110.479 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.643 ' HA3' ' HA2' ' A' ' 56' ' ' GLY . . . -164.17 -167.14 24.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 73.2 112.25 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 39.0 m -127.59 158.54 37.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 70.3 110.505 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -135.08 135.58 41.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 75.22 110.328 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.639 ' HA ' HD12 ' A' ' 26' ' ' LEU . 24.4 t-20 -76.23 138.06 40.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.977 -0.556 . . . . 61.1 109.648 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.445 ' HA ' HD13 ' A' ' 27' ' ' ILE . 1.9 m -46.63 138.95 5.54 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.14 0.9 . . . . 72.4 111.983 -176.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 72.05 29.74 2.3 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.899 0.749 . . . . 72.03 110.321 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p 49.95 37.73 14.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.651 0.781 . . . . 73.21 112.037 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -72.61 -35.14 67.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.268 -0.423 . . . . 75.23 111.39 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -160.5 118.73 2.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.935 -0.395 . . . . 73.03 109.935 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 47' ' ' ALA . 24.5 t -117.01 120.97 66.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.844 0.354 . . . . 71.5 110.282 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.8 m -136.79 129.55 30.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.272 -0.422 . . . . 74.51 110.359 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.643 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -138.94 153.94 22.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.244 -0.979 . . . . 63.22 113.092 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 14.1 p -101.54 163.54 12.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.431 -0.581 . . . . 70.35 109.431 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tp -121.03 150.19 41.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.515 0.674 . . . . 74.31 112.044 -170.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.831 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 61.8 mt-10 -126.94 120.07 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.981 -1.009 . . . . 72.2 108.832 174.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -103.52 118.82 37.63 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 34.1 mtmm -117.23 144.02 45.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.149 0.5 . . . . 74.31 110.322 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 32.9 m-85 -116.19 120.15 38.06 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.775 -0.824 . . . . 72.41 108.775 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.538 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 20.5 ttm-85 -106.72 107.27 18.21 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.56 0.695 . . . . 75.13 111.084 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 68.4 t-105 -114.35 107.62 15.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.375 -1.284 . . . . 75.14 110.12 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -94.28 66.78 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.322 0.582 . . . . 75.33 111.93 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -85.19 -37.36 20.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.791 -1.188 . . . . 72.5 107.791 166.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.466 ' CB ' ' HA ' ' A' ' 90' ' ' GLN . 3.7 m-85 -157.34 -43.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.153 -1.385 . . . . 74.43 108.717 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.8 74.81 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.5 -0.773 . . . . 75.25 112.072 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -111.44 130.05 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 75.24 110.502 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 41.7 m -137.93 113.15 9.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.033 -0.531 . . . . 73.31 110.434 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 43.4 t80 -99.65 132.08 45.22 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.857 -0.794 . . . . 73.33 108.857 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 28.6 m -128.05 121.4 29.61 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.023 0.44 . . . . 74.03 111.661 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.63 120.54 42.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.715 -0.846 . . . . 71.12 108.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.47 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 26.1 ttpt -113.46 94.83 5.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.14 -0.482 . . . . 70.32 109.803 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.499 ' O ' ' HB2' ' A' ' 57' ' ' SER . 3.9 t90 -100.15 127.08 46.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.259 -0.428 . . . . 75.24 109.878 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 15.3 m120 -105.46 166.99 10.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 75.13 110.477 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 p -67.5 -16.53 64.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.133 0.492 . . . . 73.2 111.593 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 13.4 m-20 -78.72 -2.53 39.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.642 . . . . 73.31 110.559 175.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.433 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 54.5 m-80 77.81 14.63 1.63 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.479 -0.782 . . . . 75.41 111.935 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -89.13 141.25 28.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.599 -0.519 . . . . 73.41 109.599 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.04 119.35 34.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.376 -0.375 . . . . 75.24 110.488 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.86 105.99 3.35 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.787 -0.925 . . . . 71.42 110.787 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -94.74 104.94 16.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.034 0.445 . . . . 75.24 110.501 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.723 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 40.7 mt-10 -110.84 125.46 53.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.627 -0.715 . . . . 64.12 110.363 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.558 HG23 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -113.95 120.94 65.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.653 -0.869 . . . . 74.14 108.653 171.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.1 m -120.92 123.61 42.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.851 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.77 120.45 50.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 71.53 109.971 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 96' ' ' LYS . 43.9 mt-10 -125.24 136.14 53.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.499 -0.318 . . . . 75.12 110.66 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.679 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 m-20 63.68 23.66 13.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.765 -0.652 . . . . 73.42 112.046 168.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.466 ' HA ' ' CB ' ' A' ' 67' ' ' TYR . 56.5 tt0 -63.98 -79.31 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 73.34 111.227 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.93 -73.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 73.13 109.604 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.32 96.46 9.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.609 -0.515 . . . . 72.3 109.609 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.679 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 29.1 ptt180 -57.24 137.17 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 75.12 110.744 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' A' ' 119' ' ' LYS . . . 103.02 -24.45 30.5 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.032 -0.985 . . . . 63.11 111.432 -169.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.34 -0.506 . . . . 71.33 109.711 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.589 ' HG2' ' HA3' ' A' ' 117' ' ' GLY . 10.2 ptpp? -121.33 131.76 54.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 65.43 109.809 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 96' ' ' LYS . 2.1 mm? -124.53 126.34 45.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.566 -0.531 . . . . 64.41 109.566 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.776 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 18.5 m -130.19 119.02 22.29 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.519 -0.31 . . . . 75.32 110.346 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.558 ' HB3' HG23 ' A' ' 85' ' ' ILE . 86.6 t80 -109.72 114.93 28.93 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.624 -0.51 . . . . 71.24 109.624 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.717 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 4.1 t70 -110.86 122.62 48.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.576 -0.738 . . . . 71.41 109.55 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 8.9 t -126.31 120.41 29.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.81 -0.441 . . . . 74.51 109.81 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 18.5 m -95.8 122.16 38.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.317 -0.623 . . . . 64.4 109.317 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -120.79 119.28 32.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 74.21 110.328 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 t -120.02 103.15 45.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.31 -0.626 . . . . 75.21 109.31 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.44 -37.54 38.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.093 2.529 . . . . 54.43 112.873 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -60.25 -40.7 91.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 64.1 111.879 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 p -96.26 -29.2 14.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.867 0.365 . . . . 75.25 111.338 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.3 59.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.113 -0.795 . . . . 73.42 111.113 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 137.05 33.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.849 0.356 . . . . 74.32 110.726 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 102' ' ' SER . 60.1 pttt -144.8 129.47 18.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.844 -0.616 . . . . 71.01 109.99 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 101' ' ' SER . 19.0 m120 -119.97 149.84 41.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 72.03 109.385 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.83 122.49 17.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.352 -0.24 . . . . 75.35 110.352 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 14.0 pttp -128.37 147.56 50.64 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.26 -0.274 . . . . 75.43 110.26 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.61 126.36 68.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.777 0.799 . . . . 75.34 110.263 -177.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HD3' ' HB2' ' A' ' 128' ' ' ASP . 2.8 tppp? -99.61 120.73 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.843 -1.071 . . . . 72.11 109.442 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.453 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 8.5 m -118.54 118.94 33.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.393 -0.595 . . . . 73.34 109.393 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA3' ' HG2' ' A' ' 96' ' ' LYS . . . -129.53 148.14 18.19 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.754 -1.213 . . . . 63.33 113.966 -173.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -125.57 121.73 34.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.021 -0.589 . . . . 74.42 109.496 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.63 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 9.7 mtmp? -117.84 121.66 41.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.317 0.579 . . . . 73.52 111.977 -177.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.584 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 22.3 tpp180 -108.6 164.22 12.55 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.532 -1.284 . . . . 73.33 107.532 165.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -55.55 -30.41 60.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.194 0.452 . . . . 74.43 112.167 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -116.76 8.07 13.6 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.901 -0.32 . . . . 74.12 111.365 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.584 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 2.1 mm -138.61 124.97 25.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.94 0.4 . . . . 72.23 111.708 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.756 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 52.3 t30 -123.45 116.16 22.77 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.344 -0.542 . . . . 73.14 110.572 175.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.451 HD21 HD12 ' A' ' 142' ' ' LEU . 3.6 mm? -109.88 137.26 47.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 74.43 110.298 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.49 114.66 0.69 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.77 -0.729 . . . . 63.21 112.169 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.453 ' SG ' ' HB ' ' A' ' 116' ' ' THR . 22.3 p -112.59 116.8 30.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.095 0.448 . . . . 65.1 110.655 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.822 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 21.1 t70 -113.76 122.28 46.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 71.3 109.995 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 21.6 ptp -115.24 118.84 34.44 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.19 -0.3 . . . . 74.25 110.19 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.489 ' HA ' ' CB ' ' A' ' 113' ' ' LYS . 3.9 p30 -106.77 127.21 53.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.488 0.661 . . . . 74.22 111.267 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.509 ' HD2' ' HG3' ' A' ' 136' ' ' PRO . 85.1 t80 -78.05 103.69 8.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.696 . . . . 74.11 110.074 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 22.0 t70 -92.09 161.64 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.51 -0.922 . . . . 65.24 108.51 172.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.588 ' N ' HD13 ' A' ' 133' ' ' ILE . 2.5 mp -66.3 -28.76 44.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 70.42 110.125 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.07 54.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 71.53 110.625 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 132' ' ' ASP . . . 145.1 154.98 6.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 64.23 112.624 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.509 ' HG3' ' HD2' ' A' ' 131' ' ' PHE . 14.9 Cg_exo -69.11 113.72 3.36 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.193 2.595 . . . . 72.21 112.86 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.7 t -82.23 141.5 32.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.957 -0.565 . . . . 72.1 109.561 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 40.9 mm -107.21 116.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.564 -0.455 . . . . 64.41 110.126 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -115.31 111.39 20.82 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.922 0.392 . . . . 72.53 109.994 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.35 132.78 11.1 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.867 -1.159 . . . . 70.35 112.311 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB1' HE21 ' A' ' 154' ' ' GLN . . . -128.99 115.92 18.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.223 0.535 . . . . 74.11 110.261 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 143' ' ' VAL . 6.8 tp -116.85 123.89 48.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.674 -0.694 . . . . 74.12 110.245 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 88.8 t -110.64 131.37 61.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.956 -0.565 . . . . 75.54 110.061 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.754 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.74 137.24 46.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.242 -0.651 . . . . 74.44 109.242 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.8 121.01 5.43 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.707 -0.679 . . . . 74.2 112.337 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.863 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 79.0 m-85 -127.36 149.73 49.93 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.574 -0.528 . . . . 74.25 109.574 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -49.81 96.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.812 0.339 . . . . 73.2 111.051 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 174' ' ' LYS . . . 88.55 -26.1 8.59 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.194 -0.457 . . . . 73.23 112.706 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.863 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 4.1 m0 -104.54 146.29 29.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.28 0.562 . . . . 74.42 110.96 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 144' ' ' LEU . 2.6 tm? -134.18 145.21 49.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.727 -0.842 . . . . 75.41 108.727 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -144.13 161.4 38.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.579 -0.7 . . . . 64.4 111.373 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -155.99 133.78 3.84 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.317 -0.401 . . . . 53.2 112.562 -176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.537 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 98.3 m-85 -125.1 119.21 27.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.476 -0.564 . . . . 75.51 109.476 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 35.5 tt0 -128.56 122.25 30.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.018 0.437 . . . . 72.41 110.327 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 16.9 ptp -135.32 142.5 45.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.002 0.43 . . . . 74.2 111.027 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.438 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 16.5 m-80 -113.13 117.66 32.58 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.034 -0.728 . . . . 74.45 109.034 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 71.1 t80 -94.13 121.85 36.06 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 123.642 0.777 . . . . 75.15 110.95 -176.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.6 tp10 -89.28 108.87 19.87 Favored 'General case' 0 C--O 1.264 1.82 0 CA-C-N 115.557 -0.747 . . . . 71.52 109.877 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -71.52 -17.02 62.35 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 112.923 -1.944 . . . . 73.41 111.974 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.85 67.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.819 0.819 . . . . 73.12 109.112 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -118.05 -156.09 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.363 -1.29 . . . . 73.23 108.022 167.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -105.9 30.13 6.09 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.299 -0.63 . . . . 73.24 109.299 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 15.6 mmm180 -136.65 141.51 43.18 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.446 -0.902 . . . . 73.52 112.159 -161.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.864 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 4.6 m -73.66 136.19 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.235 -0.654 . . . . 73.32 109.235 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 3.0 t -91.64 -22.68 20.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.157 0.503 . . . . 71.11 110.143 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.74 132.27 20.93 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 72.53 109.577 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.6 p -121.18 105.97 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.135 0.493 . . . . 74.5 109.946 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 20.5 m120 -107.16 135.52 48.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.544 0.687 . . . . 74.5 110.889 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.537 ' HD1' ' HD2' ' A' ' 153' ' ' TYR . 60.2 m-85 -121.78 143.89 49.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.832 -0.622 . . . . 75.43 109.927 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.75 132.89 33.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.46 -0.336 . . . . 72.04 110.537 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 43.1 t -129.87 126.48 62.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.001 -0.37 . . . . 64.34 110.001 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.21 100.36 1.21 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.692 -0.963 . . . . 72.14 110.692 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.619 ' HB3' ' CD2' ' A' ' 180' ' ' LEU . 75.3 t80 -109.46 120.44 42.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.559 -0.904 . . . . 73.11 108.559 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 148' ' ' GLY . 13.0 ttmm -127.72 126.1 41.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.731 -1.122 . . . . 74.15 111.327 -167.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 39.8 m -132.96 110.39 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.795 -1.187 . . . . 62.41 107.795 160.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 25.37 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.023 1.49 . . . . 71.42 115.023 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -89.18 -7.84 54.82 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.852 0.686 . . . . 75.12 112.852 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -123.32 115.66 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 75.42 111.06 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -136.94 143.29 42.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 72.01 111.043 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.619 ' CD2' ' HB3' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -123.92 141.94 51.58 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-O 122.522 1.153 . . . . 62.34 111.495 163.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 36.2 m80 -104.75 112.47 25.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.369 -2.196 . . . . 72.12 106.551 165.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 38.4 m -96.17 135.93 37.32 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.215 -0.661 . . . . 74.13 109.215 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.8 p30 -133.86 138.86 45.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.415 0.626 . . . . 72.21 110.124 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 54.2 t -127.56 125.62 65.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.34 -0.845 . . . . 62.2 109.837 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.851 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 63.1 t30 -103.92 90.01 3.48 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.048 -0.723 . . . . 74.02 109.048 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.97 -173.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.704 -1.134 . . . . 75.04 110.136 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.0 -7.42 70.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.365 -0.921 . . . . 72.12 112.335 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.8 p -95.47 -24.32 16.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.023 0.749 . . . . 72.0 113.023 -174.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.851 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 65.9 tt0 -129.48 125.23 35.92 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.89 -0.724 . . . . 64.53 111.125 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -134.88 140.25 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.638 0.256 . . . . 75.02 110.397 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -167.91 -163.32 21.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.457 -0.878 . . . . 65.11 112.895 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -164.85 -174.3 34.43 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.696 -0.562 . . . . 53.12 111.696 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 180' ' ' LEU . 41.0 m -148.76 136.95 20.99 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.617 -0.882 . . . . 63.44 108.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.3 mm -117.61 117.67 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.343 -0.543 . . . . 64.34 110.621 -171.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -107.53 119.42 39.36 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -125.0 131.16 53.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.53 -0.544 . . . . 71.44 109.53 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -107.56 114.97 29.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.42 -0.355 . . . . 75.34 111.582 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 202' ' ' LEU . 58.8 t -88.76 132.39 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.625 -0.879 . . . . 74.24 108.625 171.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.4 -25.9 62.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.948 0.351 . . . . 75.52 111.948 -173.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.425 ' H ' HG11 ' A' ' 198' ' ' VAL . 58.9 mtmt -84.6 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 73.23 111.653 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.05 24.43 14.5 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.625 0.77 . . . . 75.53 112.69 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.539 ' HG ' ' HD2' ' A' ' 225' ' ' TYR . 4.7 tt -110.58 108.99 19.12 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.163 -0.68 . . . . 63.15 109.163 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.71 ' HB2' ' HG3' ' A' ' 224' ' ' LYS . 39.5 mt-10 -106.65 137.04 45.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.522 -0.548 . . . . 75.23 109.522 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.6 m -122.74 142.55 50.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.655 0.265 . . . . 75.55 110.596 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.54 136.58 49.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.986 -0.552 . . . . 74.4 109.863 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.857 HG23 HG21 ' A' ' 221' ' ' ILE . 39.6 t -111.83 137.07 45.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.004 -0.544 . . . . 70.43 109.62 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -112.75 127.55 56.18 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.557 -0.905 . . . . 71.44 108.557 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 219' ' ' PHE . 3.1 tp -142.64 129.89 20.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.612 -171.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.58 139.11 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 73.21 111.192 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -128.87 132.7 47.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.985 -0.746 . . . . 74.13 108.985 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 m -95.04 107.21 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.918 0.389 . . . . 73.02 110.034 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.75 135.86 55.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.629 -0.714 . . . . 72.43 111.252 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.85 -2.43 66.58 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.163 -0.775 . . . . 72.12 111.163 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -131.01 167.61 18.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.236 -0.482 . . . . 74.31 109.767 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -102.51 -14.23 16.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.969 -0.752 . . . . 64.2 108.969 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.66 110.89 1.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.498 -0.773 . . . . 73.21 110.769 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 15.9 m -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 61.11 109.432 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.539 ' HA ' ' HE ' ' A' ' 218' ' ' ARG . 0.2 OUTLIER -114.63 116.06 28.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.579 -0.448 . . . . 73.31 109.866 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.412 ' HB3' HD12 ' A' ' 208' ' ' LEU . 53.3 p90 -134.14 146.91 50.66 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.972 -0.381 . . . . 72.3 109.972 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.61 160.88 32.27 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.49 -0.862 . . . . 51.14 112.123 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.259 0.552 . . . . 72.35 110.62 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.568 ' HB3' ' HG3' ' A' ' 236' ' ' LYS . . . -117.84 141.43 48.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.169 -0.923 . . . . 74.03 109.911 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -118.12 140.82 49.21 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.399 -0.364 . . . . 72.53 110.429 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 203' ' ' GLU . 14.8 ptmt -125.47 114.66 19.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.836 -0.62 . . . . 74.45 109.5 174.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.539 ' HD2' ' HG ' ' A' ' 202' ' ' LEU . 17.2 t80 -119.22 117.23 28.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.503 -0.772 . . . . 75.14 109.426 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.59 105.9 18.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.176 0.512 . . . . 72.42 109.857 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 13.4 pt -81.69 -33.5 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.506 -0.77 . . . . 73.3 111.067 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.41 162.15 28.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 74.34 109.017 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 -19.14 17.41 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.064 2.51 . . . . 72.11 114.323 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -112.2 7.94 19.67 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.049 -0.26 . . . . 73.21 111.659 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.04 123.64 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.289 0.566 . . . . 65.33 112.21 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -124.09 127.44 47.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 72.31 108.957 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -98.04 133.38 42.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.931 0.396 . . . . 74.33 110.654 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 48.4 t -115.9 138.06 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.844 -0.617 . . . . 51.31 109.994 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -133.12 141.73 48.32 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.467 -0.568 . . . . 75.23 109.467 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 222' ' ' ALA . 3.3 mppt? -133.39 141.42 47.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.771 0.32 . . . . 72.32 110.791 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.574 HG12 HG12 ' A' ' 221' ' ' ILE . 3.7 p -140.49 136.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.218 -0.66 . . . . 73.42 109.218 170.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 13.1 m120 -115.67 152.93 32.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.993 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 241' ' ' SER . 1.1 t-20 -35.12 -42.49 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.967 1.417 . . . . 64.54 114.052 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.45 ' OG ' HD11 ' A' ' 242' ' ' LEU . 2.3 p -78.56 24.58 0.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.839 0.352 . . . . 62.11 111.448 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 239' ' ' ASN . 18.6 t 61.7 37.83 15.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.586 -0.734 . . . . 53.24 109.817 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.966 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 4.6 mp -92.23 140.12 29.94 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.851 -0.613 . . . . 73.55 110.51 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.518 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -122.88 118.74 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.012 -0.54 . . . . 72.05 110.898 -172.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -126.08 155.56 19.3 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.751 -0.738 . . . . 72.34 112.417 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.507 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -138.18 160.65 38.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.065 0.46 . . . . 54.02 110.79 177.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -151.43 141.03 8.24 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.752 -0.658 . . . . 53.33 111.559 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -129.08 115.27 17.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 110.131 -0.322 . . . . 74.14 110.131 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.3 m -109.34 115.7 30.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.326 -0.397 . . . . 74.35 110.015 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.78 145.01 50.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.946 0.403 . . . . 72.21 111.024 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.3 m -108.11 124.47 50.28 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.873 -0.603 . . . . 75.31 110.631 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 2.8 mm? -117.17 147.28 42.6 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.835 -1.172 . . . . 70.4 107.835 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.932 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 32.9 mmtp 61.84 -174.97 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 117.742 0.246 . . . . 75.01 110.439 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.932 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 67.6 Cg_endo -75.69 -2.91 13.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.618 1.546 . . . . 65.14 113.657 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.43 0.25 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.188 -1.482 . . . . 74.44 114.794 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 252' ' ' LYS . 45.4 mm -112.24 120.67 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 117.759 0.78 . . . . 73.31 109.6 174.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 280' ' ' GLU . 0.0 OUTLIER -115.61 118.04 31.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.999 0.428 . . . . 73.34 110.413 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.94 124.31 45.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.994 -0.548 . . . . 64.34 109.776 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.2 m -118.56 110.26 17.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.082 0.468 . . . . 74.2 110.562 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 1.006 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.56 125.5 49.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.786 -1.19 . . . . 74.02 107.786 174.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.6 t -138.56 139.43 38.65 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.435 -0.506 . . . . 63.31 109.864 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 135.74 13.65 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.602 -0.518 . . . . 74.32 109.602 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.756 HD22 HD21 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -124.27 131.63 53.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.394 -0.595 . . . . 75.1 109.394 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.795 ' HB3' HG13 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -106.43 111.19 23.66 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.78 -1.193 . . . . 75.32 107.78 179.063 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.966 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.7 m-20 -71.54 106.96 4.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.871 -0.604 . . . . 72.44 109.418 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.06 -16.79 14.5 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 116.019 -0.537 . . . . 71.44 112.877 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 266' ' ' LYS . 1.6 tmtp? -91.15 -26.95 18.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.879 0.371 . . . . 75.32 110.783 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.661 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 10.3 m120 -106.44 -34.66 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.644 0.609 . . . . 75.15 112.644 -172.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.795 HG13 ' HB3' ' A' ' 263' ' ' LEU . 35.1 m -62.28 -17.49 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.537 0.208 . . . . 73.31 111.558 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.09 -44.65 83.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 75.41 110.722 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.59 -16.74 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.493 . . . . 74.41 110.828 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 123.66 90.52 0.93 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.321 -0.712 . . . . 64.54 111.321 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.613 ' HA3' ' HB3' ' A' ' 267' ' ' ASN . . . -164.7 69.72 0.2 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 73.44 112.358 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.588 ' HB2' HD13 ' A' ' 263' ' ' LEU . 24.0 p-80 -113.17 145.48 40.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.367 -0.605 . . . . 75.23 109.367 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.68 136.85 49.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.477 -0.489 . . . . 75.42 110.131 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -120.58 136.85 54.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.563 -0.744 . . . . 72.12 109.839 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.64 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -138.68 110.54 0.73 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.655 -0.783 . . . . 74.33 111.591 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 1.006 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -112.79 128.19 56.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.745 -0.835 . . . . 75.21 108.745 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.584 ' HA3' ' HE2' ' A' ' 22' ' ' TYR . . . -140.12 131.87 5.27 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.258 -0.973 . . . . 61.23 112.284 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.681 ' HB2' HD13 ' A' ' 29' ' ' LEU . 2.4 mm? -103.45 130.14 50.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.233 -0.654 . . . . 75.35 109.233 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 0.6 OUTLIER -113.73 109.71 19.01 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.881 -1.155 . . . . 72.14 107.881 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.63 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 2.4 t80 -106.39 124.41 49.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.717 -0.674 . . . . 74.24 109.891 -172.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -127.5 109.63 11.93 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.63 ' HB2' ' HE1' ' A' ' 281' ' ' PHE . . . -110.1 111.84 23.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 72.15 111.346 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.61 -70.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 75.45 108.926 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.991 -0.549 . . . . 75.45 109.585 172.691 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.763 0.316 . . . . 71.23 110.386 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.29 -64.44 1.22 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.185 -0.461 . . . . 54.3 110.252 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 121' ' ' GLU . 13.7 t -120.48 112.16 34.38 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.488 -0.56 . . . . 74.12 109.488 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.9 161.04 19.73 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.035 2.49 . . . . 75.31 112.62 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.68 86.61 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.796 2.331 . . . . 63.32 111.189 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 1.0 ' HB ' HG11 ' A' ' 143' ' ' VAL . 9.2 p -70.18 -53.5 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.358 -0.837 . . . . 64.14 112.826 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -69.07 -23.92 64.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.243 0.544 . . . . 71.21 111.313 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.31 -20.71 36.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.62 . . . . 63.43 111.533 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -91.05 -11.5 38.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 75.43 110.896 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.45 HD12 ' HA3' ' A' ' 152' ' ' GLY . 45.9 mt -58.29 -34.97 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.328 0.492 . . . . 71.24 112.328 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.47 50.87 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.586 -1.292 . . . . 75.24 114.694 168.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -40.24 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.167 -1.049 . . . . 75.22 108.167 171.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -60.97 -35.48 76.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.726 -1.125 . . . . 63.35 110.751 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.07 73.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.12 -0.491 . . . . 62.11 111.883 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -69.61 -31.09 69.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.47 . . . . 74.44 110.51 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.17 -47.39 85.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.69 -0.686 . . . . 75.0 111.804 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.31 -31.4 52.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.95 0.405 . . . . 75.13 110.797 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.655 ' HE2' ' HA3' ' A' ' 220' ' ' GLY . 82.6 t80 -73.03 -41.82 63.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.681 -0.69 . . . . 71.2 111.331 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -83.44 -28.07 29.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.146 -0.479 . . . . 75.14 112.209 -173.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -66.78 91.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.527 . . . . 75.53 110.433 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.42 -23.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.916 -0.874 . . . . 75.35 110.916 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.85 76.16 1.62 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 74.24 110.386 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.94 119.1 4.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.72 -0.753 . . . . 51.44 111.3 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -80.34 8.04 8.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.065 0.459 . . . . 75.32 111.035 -175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.53 13.22 54.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.982 -0.847 . . . . 72.22 110.982 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 2.7 pp -107.45 177.97 4.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.946 0.879 . . . . 71.55 112.749 -173.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 277' ' ' LEU . 1.7 mp -103.0 132.53 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.293 -1.321 . . . . 72.25 110.224 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 26.0 tptp -102.84 118.66 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.965 -1.016 . . . . 75.13 109.193 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.71 128.23 56.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.623 -0.51 . . . . 74.43 109.623 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 43' ' ' SER . 30.6 m-20 -133.28 134.14 43.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.104 0.478 . . . . 71.23 110.373 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.749 HD22 ' HB2' ' A' ' 281' ' ' PHE . 1.2 tm? -123.72 126.01 45.77 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.157 -1.053 . . . . 75.2 108.157 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.9 mtpp -132.29 129.7 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.858 0.361 . . . . 75.23 110.59 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.8 m -136.27 131.64 34.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.134 -0.484 . . . . 71.01 109.839 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -104.98 136.77 43.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 75.33 110.209 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.3 m -139.59 169.27 18.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.002 -0.545 . . . . 72.53 110.168 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.22 178.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 75.32 110.771 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 t30 65.21 24.43 12.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.578 0.704 . . . . 62.44 109.537 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.723 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.32 19.81 79.74 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 120.618 -0.801 . . . . 74.35 111.988 175.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 62' ' ' TYR . 10.2 mt -85.55 137.3 32.97 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.222 1.011 . . . . 71.21 113.266 -171.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.699 ' HB2' HH12 ' A' ' 63' ' ' ARG . 43.4 tt0 -139.51 118.56 12.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.24 -1.8 . . . . 65.43 108.828 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 90.9 m-85 -103.6 120.09 40.2 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.695 -0.483 . . . . 75.33 109.695 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.744 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 25.9 m -126.05 126.07 43.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.234 -0.439 . . . . 75.35 110.397 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 22.8 t -119.66 123.25 43.37 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.858 -0.793 . . . . 74.53 108.858 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -123.78 124.88 43.67 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.081 -0.34 . . . . 75.22 110.081 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.06 153.61 24.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.463 -0.875 . . . . 75.4 111.857 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -137.52 133.92 35.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.919 -0.771 . . . . 75.2 108.919 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.92 129.26 13.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.969 0.414 . . . . 45.24 111.426 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.616 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -102.02 113.93 27.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.403 -0.962 . . . . 74.2 108.403 173.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 m -47.27 103.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.066 0.854 . . . . 74.34 113.069 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.47 17.08 10.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.209 -0.905 . . . . 72.33 112.296 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 48' ' ' ASN . 11.0 m -97.81 8.86 43.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 75.0 110.062 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m 62.91 31.47 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.338 -0.847 . . . . 75.53 111.305 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 53' ' ' LYS . 54.7 mmtt -130.5 83.52 2.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.29 0.566 . . . . 71.22 110.112 175.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.35 120.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.991 -1.004 . . . . 75.43 109.652 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.6 t -133.43 143.4 48.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.14 -0.318 . . . . 70.11 110.14 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.82 141.26 12.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.928 -0.653 . . . . 73.23 112.823 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -132.83 135.06 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.083 0.553 . . . . 73.05 109.663 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -121.74 125.63 47.02 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.239 -0.652 . . . . 72.34 109.239 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.744 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 22.2 tt0 -117.68 120.36 37.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.395 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 3.3 m -113.45 118.37 34.31 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.873 -1.158 . . . . 74.53 107.873 168.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -116.82 120.64 39.15 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.01 -0.676 . . . . 74.41 110.242 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.689 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 1.4 m-85 -107.0 125.56 51.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 70.24 109.699 -175.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.723 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 1.6 mpp_? -129.51 106.49 8.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.328 -0.949 . . . . 73.0 111.807 169.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 49.0 t-105 -88.79 91.82 8.97 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.234 -1.024 . . . . 75.42 108.234 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.65 HG21 ' H ' ' A' ' 67' ' ' TYR . 9.4 m 67.8 141.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.614 -1.176 . . . . 74.33 110.486 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.93 -8.54 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.432 0.634 . . . . 71.44 110.289 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.65 ' H ' HG21 ' A' ' 65' ' ' THR . 81.8 t80 -126.36 86.53 2.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.113 -0.949 . . . . 75.53 108.573 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 88' ' ' GLU . . . 170.91 -101.72 0.17 Allowed Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.705 -0.76 . . . . 73.3 112.383 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.8 mm? -113.65 138.24 50.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.482 0.658 . . . . 71.2 111.77 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.544 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.1 m -135.74 111.31 9.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.191 -0.913 . . . . 74.24 109.469 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.689 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 12.2 t80 -119.77 125.75 49.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.811 0.338 . . . . 74.52 110.422 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.472 ' HB ' ' CG ' ' A' ' 84' ' ' GLU . 28.2 m -110.85 117.65 33.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.937 0.399 . . . . 55.54 110.353 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.587 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 34.7 tt0 -111.94 123.85 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.698 -0.683 . . . . 75.02 109.911 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.8 ptmm? -127.26 133.22 50.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.22 0.533 . . . . 73.02 110.188 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.605 ' CD1' HD22 ' A' ' 81' ' ' LEU . 32.6 t90 -134.04 128.27 33.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.559 -0.534 . . . . 75.51 109.559 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -116.41 133.21 56.28 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.842 -0.743 . . . . 72.33 110.791 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -73.9 -25.71 60.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.739 0.78 . . . . 73.04 110.09 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -96.14 -16.2 21.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.501 -1.227 . . . . 62.43 111.779 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.8 -98.05 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.354 0.872 . . . . 64.51 113.354 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 p -115.85 144.72 43.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.869 1.063 . . . . 71.13 113.869 -166.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -87.94 157.05 19.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.326 -1.361 . . . . 74.14 107.326 165.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 101' ' ' SER . . . -171.01 147.69 10.62 Favored Glycine 0 C--N 1.322 -0.205 0 C-N-CA 119.79 -1.195 . . . . 71.41 113.173 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -148.98 128.52 13.12 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.254 0.222 . . . . 74.44 111.165 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' CG ' ' HB ' ' A' ' 72' ' ' THR . 15.9 pt-20 -126.41 125.98 43.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 74.52 110.023 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.24 128.3 68.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 74.35 110.439 -176.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.583 ' CG2' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m -118.17 123.91 46.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.113 -0.494 . . . . 73.24 111.248 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.33 137.88 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.126 -0.488 . . . . 75.03 109.828 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 1.1 pp20? -89.52 161.95 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.986 -0.686 . . . . 64.31 110.879 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -95.67 124.73 39.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.813 -0.44 . . . . 71.42 109.813 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.43 ' HA ' ' HH ' ' A' ' 67' ' ' TYR . 1.9 mp0 -68.4 -25.82 65.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 74.13 111.546 -175.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.74 -45.74 5.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.867 0.365 . . . . 74.25 110.248 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -92.01 77.17 5.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.36 -0.607 . . . . 71.32 109.36 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 56.2 mtt180 -64.1 134.65 55.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.349 -0.841 . . . . 71.4 111.623 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 102.14 -12.2 57.27 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.016 -0.993 . . . . 72.54 111.681 -174.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.777 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -85.02 121.3 27.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.604 0.24 . . . . 75.31 110.402 178.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.583 ' HE3' ' CG2' ' A' ' 86' ' ' THR . 29.9 mmmt -121.96 112.05 17.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 73.51 109.443 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 86' ' ' THR . 1.9 mm? -94.85 128.2 41.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.47 . . . . 63.14 109.779 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 1.117 ' HB ' ' HG3' ' A' ' 115' ' ' LYS . 3.3 m -128.45 132.89 48.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.077 0.465 . . . . 75.13 111.534 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 76.7 t80 -117.8 120.63 38.51 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.375 -0.602 . . . . 74.04 109.375 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' OD2' ' HG2' ' A' ' 113' ' ' LYS . 6.9 t70 -111.62 143.07 43.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.401 . . . . 75.0 110.475 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.426 ' O ' ' HA2' ' A' ' 82' ' ' GLY . 72.9 m -142.86 122.19 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.835 0.35 . . . . 72.43 110.876 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 t -108.04 133.16 52.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.762 -0.829 . . . . 65.22 108.762 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 110' ' ' LYS . 35.6 t80 -122.87 125.13 44.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.819 0.342 . . . . 72.31 110.722 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.7 t -87.38 106.19 10.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.695 -0.854 . . . . 63.13 108.695 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.45 -39.92 79.38 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.04 2.493 . . . . 72.0 112.699 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.48 -49.9 24.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.592 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 m -66.06 -40.67 91.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 74.21 111.304 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.6 -5.7 80.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.89 -0.671 . . . . 71.1 111.791 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -94.62 148.16 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 73.21 110.355 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -126.42 151.33 47.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 75.11 111.019 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -119.25 121.01 38.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.566 -0.743 . . . . 75.42 109.01 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.56 28.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.871 0.367 . . . . 73.22 110.99 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 130' ' ' ASP . 17.3 mmtm -124.22 141.46 52.04 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.174 -0.676 . . . . 74.31 109.174 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.92 117.74 56.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.126 -1.065 . . . . 74.54 108.126 169.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 1.117 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 8.0 ptmt -129.16 119.86 24.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.231 -0.895 . . . . 73.34 110.818 -171.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.0 p -109.23 117.75 34.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.354 -0.839 . . . . 71.41 109.531 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.425 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -128.82 114.23 1.73 Allowed Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.303 -0.951 . . . . 71.03 111.961 -174.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.777 ' HB3' HD22 ' A' ' 95' ' ' LEU . 12.9 p90 -118.77 131.81 56.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.167 0.508 . . . . 75.33 110.458 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.703 ' HE3' ' HB ' ' A' ' 3' ' ' VAL . 8.7 ptmt -109.11 121.32 44.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.576 -0.738 . . . . 74.15 110.213 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -106.72 157.02 18.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.834 ' HA ' HG21 ' A' ' 3' ' ' VAL . 3.8 pm0 -53.22 -28.9 29.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.966 0.728 . . . . 71.24 112.966 -169.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -114.54 -16.03 11.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.884 -0.327 . . . . 71.45 111.542 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.645 HD12 HD11 ' A' ' 142' ' ' LEU . 10.9 tp -145.03 130.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.298 -0.561 . . . . 75.41 111.809 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 124' ' ' ASN . 0.2 OUTLIER -117.95 117.31 28.89 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.058 -0.401 . . . . 63.43 110.637 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.418 ' N ' HD21 ' A' ' 124' ' ' ASN . 3.9 mm? -113.01 128.73 56.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.681 0.277 . . . . 75.23 111.145 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.425 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.43 123.53 3.08 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.528 -0.629 . . . . 72.13 111.528 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 60.3 m -113.78 108.28 16.88 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.678 -0.307 . . . . 64.23 111.091 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.816 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 3.2 m-20 -100.81 117.52 35.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.482 -0.562 . . . . 65.43 109.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 24.2 ptm -98.0 118.64 35.05 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.458 -0.897 . . . . 72.03 109.531 172.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 8.9 t70 -94.52 117.66 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 74.11 109.967 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -97.16 102.68 14.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.071 0.462 . . . . 65.31 111.465 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -105.29 146.72 28.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.171 -1.048 . . . . 74.41 108.171 167.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.563 ' H ' HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -62.68 -22.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.845 0.313 . . . . 74.53 111.845 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.2 -6.67 47.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.572 0.225 . . . . 75.22 111.602 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.452 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 160.82 121.47 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.339 -0.934 . . . . 75.34 112.921 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.452 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 2.9 Cg_exo -74.55 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 61.04 111.802 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -81.99 153.29 26.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.21 -0.45 . . . . 75.02 110.053 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 3.5 mp -107.11 117.43 52.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.945 -0.702 . . . . 73.4 109.94 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.816 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 59.8 ttt-85 -104.68 130.12 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.706 -0.479 . . . . 73.45 109.706 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -116.91 132.14 9.89 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.961 -1.114 . . . . 63.31 111.553 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.73 115.74 21.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.478 -0.564 . . . . 74.43 109.478 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 123' ' ' ILE . 11.6 tp -128.02 122.56 32.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.259 -0.428 . . . . 74.1 110.131 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 1.0 HG11 ' HB ' ' A' ' 6' ' ' THR . 21.8 t -119.59 130.51 73.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.075 0.464 . . . . 75.24 109.851 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.35 138.29 45.92 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 74.13 109.538 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.73 123.43 5.82 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.714 -0.755 . . . . 63.23 112.774 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.809 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 56.0 m-85 -125.9 148.32 49.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.007 -0.738 . . . . 75.34 109.007 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -53.44 102.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.952 0.406 . . . . 71.11 110.413 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.56 -31.1 7.45 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.746 -0.661 . . . . 62.43 112.492 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.809 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.5 m0 -105.89 134.56 48.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 75.33 110.837 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 6' ' ' THR . 3.2 tm? -139.41 134.59 32.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.237 -0.653 . . . . 74.43 109.237 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.97 141.12 23.95 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.821 -0.352 . . . . 74.1 111.664 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -140.33 141.0 11.05 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.965 -0.454 . . . . 74.31 111.965 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.435 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 43.1 m-85 -124.08 121.26 34.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.182 -0.303 . . . . 73.21 110.182 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 2.1 mp0 -114.19 122.15 45.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 74.44 109.284 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.19 145.46 51.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.808 0.337 . . . . 73.1 111.002 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 166' ' ' GLN . 6.0 m-20 -112.55 118.34 34.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.845 -0.798 . . . . 72.22 108.845 175.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.652 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 76.7 t80 -95.64 121.87 37.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.479 -0.782 . . . . 73.51 111.007 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.8 tp10 -79.24 99.34 7.01 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 114.386 -1.279 . . . . 75.04 109.129 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -70.9 -23.83 62.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.442 -1.708 . . . . 71.54 112.212 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.7 -32.18 71.43 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.916 0.865 . . . . 71.21 109.165 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.431 ' HB3' ' H ' ' A' ' 162' ' ' SER . 2.3 mppt? -114.6 -157.5 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.199 -1.364 . . . . 73.11 108.205 170.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 161' ' ' LYS . 35.9 p -107.56 30.72 6.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.407 -0.59 . . . . 71.21 109.407 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.548 ' HA ' ' HE ' ' A' ' 163' ' ' ARG . 3.7 mmp_? -119.55 171.8 8.11 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 119.689 -0.804 . . . . 74.43 112.871 -159.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.61 127.09 59.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.166 -0.679 . . . . 75.52 109.166 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.3 t -95.86 -24.13 16.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.887 0.375 . . . . 75.12 110.935 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 156' ' ' ASN . 32.8 tt0 -145.83 133.04 20.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 75.41 110.645 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 169' ' ' PHE . 17.0 p -122.54 106.43 11.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.109 -0.496 . . . . 71.52 110.617 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 26.0 t-20 -108.37 121.56 45.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.264 -0.643 . . . . 72.23 109.264 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 167' ' ' SER . 29.5 m-85 -123.86 156.83 35.49 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.386 -0.526 . . . . 74.21 111.027 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -150.75 128.25 11.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.963 -0.562 . . . . 73.41 109.796 171.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 27.2 t -143.98 130.44 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.301 -0.629 . . . . 72.32 109.301 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.11 174.74 35.38 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.041 -1.552 . . . . 63.52 114.111 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -134.36 138.05 44.59 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -109.71 127.41 54.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.731 -0.668 . . . . 73.25 111.985 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 29.8 m -131.94 143.14 49.91 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.39 -1.337 . . . . 72.31 107.39 164.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.09 -1.98 6.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.138 0.792 . . . . 64.24 113.138 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.535 ' HG3' ' HD1' ' A' ' 178' ' ' PHE . 9.0 pt-20 -116.64 -26.08 7.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.537 -0.465 . . . . 65.41 111.478 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.535 ' HD1' ' HG3' ' A' ' 177' ' ' GLU . 41.3 p90 -140.87 127.93 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.705 0.288 . . . . 74.22 110.303 173.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.86 124.38 35.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.185 -0.302 . . . . 64.54 110.185 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.602 HD11 HG13 ' A' ' 194' ' ' ILE . 3.9 tt -110.86 128.26 55.72 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.062 -0.655 . . . . 73.44 110.031 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -131.81 115.83 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.906 -0.588 . . . . 75.21 109.769 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 84.8 m -99.51 123.16 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.127 -0.488 . . . . 72.11 110.213 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.3 p30 -119.86 141.49 49.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.142 0.496 . . . . 75.02 110.719 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 79.1 t -119.6 130.02 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.898 -0.592 . . . . 74.33 110.193 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 36.2 m-80 -113.24 106.96 15.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.838 -0.619 . . . . 73.41 109.34 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.01 -165.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.047 -0.979 . . . . 64.04 110.282 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.98 -6.99 89.09 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.385 -0.912 . . . . 73.31 111.947 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.2 p -102.23 -25.2 13.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.98 1.104 . . . . 73.5 113.98 -170.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 39.2 tt0 -120.41 112.74 19.36 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.17 -1.012 . . . . 72.44 112.19 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -106.26 124.88 50.27 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.393 -0.966 . . . . 74.01 108.393 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -136.6 131.6 5.71 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.037 -1.077 . . . . 71.14 113.677 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -114.79 121.76 5.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.115 -0.794 . . . . 72.3 111.115 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m -115.07 137.13 52.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.294 0.547 . . . . 73.35 110.931 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.602 HG13 HD11 ' A' ' 180' ' ' LEU . 4.3 mp -121.87 132.29 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.926 -0.579 . . . . 74.3 109.724 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -108.28 120.1 41.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.787 -0.82 . . . . 72.4 108.787 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -118.08 130.05 55.92 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.862 -0.608 . . . . 75.33 110.845 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -98.72 109.62 22.35 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 74.44 108.34 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.448 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 44.0 t -83.3 -40.22 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.538 0.685 . . . . 73.31 109.774 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 54.3 t30 -155.72 161.64 40.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.792 -1.188 . . . . 71.01 107.792 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.63 126.46 27.71 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt 82.17 -1.01 1.46 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.077 0.86 . . . . 75.33 111.325 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.448 ' HG ' ' HB ' ' A' ' 198' ' ' VAL . 39.9 tp -125.32 99.92 6.28 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.603 0.716 . . . . 72.53 111.015 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -106.43 158.57 16.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.062 -0.972 . . . . 75.31 109.892 -176.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.6 m -152.91 142.87 22.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.18 -0.304 . . . . 73.44 110.18 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -132.11 136.49 47.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.877 0.37 . . . . 74.14 110.94 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.42 131.65 71.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.85 -0.614 . . . . 75.12 110.105 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 27.3 t-20 -119.16 133.26 55.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.935 0.398 . . . . 74.31 110.998 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.465 ' O ' ' HA2' ' A' ' 191' ' ' GLY . 4.1 mm? -118.74 130.24 55.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 74.42 108.715 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.36 129.18 35.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.047 0.451 . . . . 64.4 110.85 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -120.06 129.71 54.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.874 -0.603 . . . . 75.21 109.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.506 ' HB ' ' OD1' ' A' ' 216' ' ' ASN . 29.1 m -95.39 106.8 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.117 0.484 . . . . 70.22 110.007 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.63 136.99 50.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.849 . . . . 74.53 111.393 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -33.77 5.66 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.055 -0.818 . . . . 71.33 111.055 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -125.83 -178.57 4.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.768 -0.456 . . . . 72.05 109.768 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.5 t -109.96 27.11 9.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.408 . . . . 72.24 110.641 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.506 ' OD1' ' HB ' ' A' ' 211' ' ' THR . 23.6 p-10 -81.85 110.82 17.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.793 0.806 . . . . 75.0 110.271 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.8 p -107.87 123.49 48.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.067 -0.97 . . . . 74.24 110.108 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -106.59 116.44 31.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.99 -0.55 . . . . 75.43 109.751 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 37.0 p90 -115.05 146.83 40.88 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.544 -0.462 . . . . 65.33 110.101 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.655 ' HA3' ' HE2' ' A' ' 18' ' ' PHE . . . -146.57 139.87 8.34 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.992 -0.843 . . . . 71.1 110.992 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.2 mp -123.84 128.87 74.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.65 -0.5 . . . . 74.5 109.65 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -122.84 130.34 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.344 0.403 . . . . 73.55 110.407 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.25 126.04 54.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.229 -0.442 . . . . 74.2 109.981 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -113.48 113.3 24.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 73.33 109.904 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -130.89 128.32 40.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.915 0.388 . . . . 74.34 110.553 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 36.5 tt0 -78.72 98.45 6.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 74.41 108.922 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.4 tt -79.22 -24.86 12.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.276 0.56 . . . . 74.55 110.656 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.417 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 3.1 t70 -143.72 148.54 43.33 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.106 -1.072 . . . . 75.51 108.106 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 52.6 Cg_exo -38.2 -40.35 1.15 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.846 3.031 . . . . 71.34 115.211 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 250' ' ' THR . 6.8 m-20 -117.01 11.37 14.26 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.849 0.315 . . . . 74.12 111.849 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -129.73 123.17 30.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 73.23 111.415 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -122.51 127.35 49.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.971 -0.559 . . . . 73.5 110.639 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.85 ' HD1' ' HB3' ' A' ' 247' ' ' TYR . 63.0 t80 -107.58 133.86 51.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.636 -0.711 . . . . 73.32 110.828 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.7 p -122.17 120.77 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 73.14 110.853 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.82 141.32 42.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.366 -0.605 . . . . 71.24 109.366 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 10.8 ptpt -148.19 149.24 31.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.041 0.448 . . . . 73.1 111.694 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.404 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 7.7 p -137.22 148.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.443 -0.344 . . . . 73.54 110.353 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.818 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -114.69 150.06 35.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.836 -0.62 . . . . 73.44 110.123 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 241' ' ' SER . 25.2 t30 -44.72 -36.11 3.0 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.476 1.11 . . . . 74.02 113.016 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 17.8 m -78.94 25.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.714 0.292 . . . . 65.35 111.036 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.9 m 64.93 36.83 7.37 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.616 -0.72 . . . . 73.32 110.238 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 238' ' ' ASN . 26.3 mt -98.69 115.93 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.11 109.879 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 243' ' ' ILE . 3.7 mp -103.26 117.38 48.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 120.539 -0.465 . . . . 74.53 109.925 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -119.91 134.02 10.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.831 -0.699 . . . . 70.43 112.491 177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 260' ' ' SER . 3.0 pp -128.91 141.74 51.17 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.805 -0.443 . . . . 72.43 109.805 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -155.95 121.58 1.11 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.542 -0.837 . . . . 73.34 111.988 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.85 ' HB3' ' HD1' ' A' ' 233' ' ' PHE . 36.2 p90 -114.45 130.85 56.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.255 0.55 . . . . 63.51 110.955 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 258' ' ' THR . 18.2 p -100.19 115.08 29.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.96 -1.018 . . . . 73.0 109.557 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -123.87 123.24 40.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.269 -0.423 . . . . 71.12 110.53 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 230' ' ' ASP . 9.5 m -69.51 111.62 5.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.371 -0.603 . . . . 74.44 109.371 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.49 -47.42 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 74.24 109.479 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.922 ' HB2' HD12 ' A' ' 255' ' ' ILE . 68.0 mttm -142.53 155.94 63.67 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.623 -1.251 . . . . 74.24 107.623 173.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.99 98.44 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.401 2.067 . . . . 74.35 111.79 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.46 -30.07 3.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.961 -0.638 . . . . 55.1 112.197 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.922 HD12 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -124.42 121.87 62.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.707 0.765 . . . . 70.52 111.747 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.91 125.39 52.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.271 -0.877 . . . . 73.13 109.707 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.2 tp -99.89 125.26 45.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.95 -0.568 . . . . 74.21 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.693 ' HB ' HG22 ' A' ' 248' ' ' THR . 6.8 t -117.77 121.42 40.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.486 0.66 . . . . 72.12 110.478 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.648 HD23 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -107.31 123.98 49.12 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.885 -1.154 . . . . 74.34 107.885 176.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 23.5 m -134.18 152.38 51.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.8 0.333 . . . . 72.2 110.482 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.442 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -156.86 131.56 8.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.311 -0.404 . . . . 54.2 110.601 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.738 HD12 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -108.34 114.57 28.53 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.934 -1.136 . . . . 75.35 107.934 174.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.909 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -101.97 105.21 15.96 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.11 -1.441 . . . . 70.55 107.11 174.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.737 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 4.8 p-10 -76.01 98.49 4.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.233 -1.025 . . . . 72.14 108.233 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.35 -9.16 3.02 Favored Glycine 0 C--N 1.321 -0.28 0 CA-C-N 114.106 -1.407 . . . . 63.42 114.371 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -88.04 -20.23 26.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.034 0.445 . . . . 73.3 110.243 -173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.0 -33.9 0.9 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.778 0.799 . . . . 71.3 109.083 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 263' ' ' LEU . 1.8 t -54.09 -29.65 19.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 113.8 -1.546 . . . . 72.31 112.529 176.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.24 -37.15 84.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.596 . . . . 62.23 111.251 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.43 -16.27 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.067 0.395 . . . . 72.23 112.067 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.79 3.85 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.805 -0.712 . . . . 64.55 112.86 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -105.61 149.08 16.65 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 121.164 -0.541 . . . . 74.23 112.716 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.9 ' HB2' HD11 ' A' ' 263' ' ' LEU . 5.5 p-80 -103.83 149.15 25.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.844 -0.678 . . . . 73.4 110.208 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -96.27 138.62 33.61 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.084 -0.646 . . . . 75.42 110.764 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.0 tm? -120.77 144.72 48.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.676 -0.693 . . . . 70.13 110.443 -169.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.571 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -133.0 118.49 2.17 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.364 -0.694 . . . . 71.32 111.364 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.648 HD23 HD23 ' A' ' 259' ' ' LEU . 3.1 tm? -114.41 123.84 50.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.915 -0.772 . . . . 72.24 108.915 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -136.27 147.04 19.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.739 -1.219 . . . . 73.52 113.588 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.68 131.45 51.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.016 -0.735 . . . . 62.54 109.016 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -115.66 111.77 21.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.35 -0.611 . . . . 72.02 109.35 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.749 ' HB2' HD22 ' A' ' 31' ' ' LEU . 13.0 m-85 -95.32 101.85 13.61 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.686 -0.688 . . . . 72.51 109.22 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -103.73 110.93 23.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.966 -0.561 . . . . 75.42 110.031 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.37 110.06 21.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.857 -0.61 . . . . 75.11 109.712 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 61.5 mt -125.79 179.16 5.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.682 -0.69 . . . . 62.43 109.818 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.186 -0.672 . . . . 71.44 109.186 176.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.861 0.362 . . . . 75.34 110.229 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 85.25 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.754 -0.461 . . . . 73.52 109.754 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.656 HG13 ' HB2' ' A' ' 119' ' ' LYS . 6.2 t -110.66 102.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 74.35 110.523 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 159.27 37.63 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.628 2.219 . . . . 71.04 112.076 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.89 85.6 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.653 2.236 . . . . 72.12 111.626 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.9 p -75.16 -29.17 60.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.042 -0.526 . . . . 63.4 111.303 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' HB2' HG23 ' A' ' 143' ' ' VAL . 73.2 t80 -57.45 -40.09 77.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.23 0.538 . . . . 74.41 110.796 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.3 -24.05 34.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 74.11 110.4 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.21 8.32 33.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.701 . . . . 72.5 110.505 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.16 -14.89 61.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 74.25 110.422 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . 140.31 64.72 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 121.1 -0.571 . . . . 72.53 112.396 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -65.96 -43.1 88.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.988 0.394 . . . . 75.33 109.972 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -59.44 -38.75 81.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 75.05 110.489 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.09 74.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 70.31 111.032 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 48.3 mtp85 -64.73 -29.84 70.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 75.5 111.161 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.19 -37.55 72.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.292 0.567 . . . . 73.31 110.425 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.53 ' HA ' ' CE ' ' A' ' 236' ' ' LYS . 13.6 t -83.26 -36.38 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 74.2 111.035 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.53 -41.82 65.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.659 . . . . 73.24 112.327 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 15' ' ' ARG . 3.5 t -95.45 172.69 7.93 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.972 -0.291 . . . . 64.3 110.504 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -79.99 73.6 6.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.626 0.726 . . . . 74.02 110.977 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.48 36.27 3.96 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.579 -0.737 . . . . 63.02 111.496 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.609 ' HA ' ' OG ' ' A' ' 260' ' ' SER . 15.4 p90 -147.9 136.06 21.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.287 . . . . 73.24 110.788 -176.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.31 64.92 3.39 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.034 -0.53 . . . . 43.11 113.235 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.61 -3.74 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 75.53 110.842 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.22 -1.87 78.89 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.011 -0.54 . . . . 74.52 112.898 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -147.98 -179.6 7.03 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.088 0.947 . . . . 71.31 113.441 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.582 HG23 HD12 ' A' ' 277' ' ' LEU . 36.8 mm -102.82 122.94 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.693 -1.594 . . . . 73.42 108.717 174.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.637 ' HB2' ' HZ1' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -118.22 124.99 49.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.324 0.583 . . . . 74.15 110.432 178.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.877 HD11 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tp -124.19 144.12 50.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.0 -0.546 . . . . 75.21 110.057 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.8 p30 -144.66 140.03 28.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.116 0.484 . . . . 71.21 110.028 171.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.756 HD12 ' HD1' ' A' ' 281' ' ' PHE . 16.0 tp -119.07 123.32 44.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.351 -0.84 . . . . 74.32 109.494 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 4.1 ptpp? -116.64 124.41 49.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.476 -0.783 . . . . 75.24 109.841 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' HB2' ' A' ' 283' ' ' ALA . 45.4 m -123.16 121.57 36.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.692 -0.686 . . . . 74.3 110.089 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.56 123.41 47.31 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.413 -0.515 . . . . 75.01 109.954 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 48.0 t -141.81 146.99 36.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 72.21 109.615 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.91 -148.09 0.49 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.421 0.451 . . . . 65.12 111.247 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.71 136.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.036 -0.529 . . . . 70.23 110.281 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.51 -9.24 36.36 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 118.799 -1.001 . . . . 74.12 115.243 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -100.57 127.47 46.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.465 1.633 . . . . 71.23 112.547 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.13 118.11 11.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.762 -0.829 . . . . 65.04 108.762 162.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -100.64 120.79 40.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.63 -0.508 . . . . 74.33 109.63 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 10.5 m -125.91 116.89 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.882 0.372 . . . . 75.1 110.848 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 10.6 t -111.61 122.47 47.89 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.635 -0.876 . . . . 75.42 108.635 174.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -129.71 126.75 38.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.928 0.394 . . . . 41.34 110.301 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.47 16.08 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.757 -0.735 . . . . 71.43 111.773 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.4 m -125.02 134.32 52.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.49 -0.559 . . . . 74.51 109.49 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 54' ' ' VAL . . . -137.02 128.56 28.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.005 0.431 . . . . 74.51 110.725 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 18.4 m120 -75.4 113.06 12.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.32 -0.622 . . . . 64.14 109.32 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.405 ' HB ' HG12 ' A' ' 27' ' ' ILE . 8.8 t -63.71 132.41 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 73.31 111.0 -174.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 60.48 15.07 5.27 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.165 -0.925 . . . . 71.23 111.05 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.481 ' HB ' ' CB ' ' A' ' 48' ' ' ASN . 5.1 m -119.84 -10.13 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 73.35 110.43 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.415 ' HG1' ' C ' ' A' ' 51' ' ' THR . 71.5 p 52.94 34.81 17.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.574 0.75 . . . . 72.01 112.679 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 35.3 mmtp -113.19 102.05 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.053 -0.721 . . . . 73.33 109.053 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG11 ' HB1' ' A' ' 47' ' ' ALA . 13.7 t -123.78 123.42 67.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.123 -0.489 . . . . 74.11 111.661 -170.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -111.03 125.69 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 73.33 109.243 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.07 136.96 11.56 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.609 -0.805 . . . . 75.14 112.396 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 p -137.04 153.75 50.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.917 0.389 . . . . 75.0 110.56 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -127.27 124.79 39.66 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.142 -0.688 . . . . 75.54 109.142 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.935 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 87.0 mt-10 -108.41 119.97 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.298 -0.41 . . . . 53.11 110.386 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.628 ' HG1' ' HB2' ' A' ' 73' ' ' GLU . 20.5 p -99.19 117.7 34.24 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.007 -1.109 . . . . 74.53 108.007 168.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.745 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.6 ttmp? -119.93 131.3 55.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.571 -0.529 . . . . 74.42 109.571 -174.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.737 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 25.8 m-85 -108.27 121.43 44.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.902 -0.59 . . . . 75.22 109.989 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.584 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 tmm_? -103.9 104.66 14.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.732 -0.84 . . . . 73.54 108.732 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.451 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 7.3 t-105 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.158 -0.928 . . . . 74.31 111.657 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 67' ' ' TYR . 25.1 m 69.84 144.99 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.93 0.769 . . . . 64.5 112.151 173.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -82.21 12.02 4.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.505 . . . . 62.52 111.145 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' H ' HG23 ' A' ' 65' ' ' THR . 54.3 m-85 -102.4 -46.8 4.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.481 -0.327 . . . . 72.21 110.424 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.436 ' C ' HD11 ' A' ' 69' ' ' LEU . . . 144.95 71.86 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.125 -1.035 . . . . 70.31 113.393 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.637 ' HG ' ' HA ' ' A' ' 87' ' ' VAL . 8.3 mp -112.44 134.81 53.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.094 -0.651 . . . . 70.32 110.453 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -136.64 112.07 9.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.774 -0.648 . . . . 61.11 110.24 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 32.4 t80 -106.11 122.12 45.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.399 -0.593 . . . . 75.41 109.399 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 14.8 m -117.15 117.36 29.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.798 0.332 . . . . 74.33 111.275 -175.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.628 ' HB2' ' HG1' ' A' ' 60' ' ' THR . 43.3 mt-10 -103.14 120.42 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 62.14 108.452 168.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.915 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 3.4 tmtp? -114.53 98.04 6.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.95 -0.568 . . . . 64.24 109.592 -174.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.556 ' HE1' ' HA ' ' A' ' 79' ' ' ASN . 2.1 t90 -99.51 129.02 45.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.212 -0.449 . . . . 75.23 110.422 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 39.5 t30 -97.78 154.24 17.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.221 -0.659 . . . . 63.33 109.221 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -65.31 -17.51 64.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.93 0.395 . . . . 73.02 111.348 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 12.8 m-20 -80.58 -1.28 41.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.054 -0.521 . . . . 72.04 110.371 174.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.556 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 4.1 m-20 77.7 35.16 0.31 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.979 0.912 . . . . 75.14 110.959 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 11.2 m -85.42 117.68 24.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.604 -0.725 . . . . 74.31 109.601 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.4 124.23 39.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.992 0.425 . . . . 73.35 111.352 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.85 109.31 2.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.745 -0.942 . . . . 65.23 110.745 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 m -104.62 99.64 9.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.918 0.359 . . . . 72.42 110.958 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.659 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 28.4 tt0 -111.73 132.26 54.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 72.42 110.209 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.8 tt -129.4 126.14 63.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 73.23 111.077 173.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.6 m -116.14 123.73 48.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.009 -0.541 . . . . 60.32 109.827 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.637 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 2.7 p -128.54 121.88 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.371 -0.233 . . . . 73.03 110.371 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 96' ' ' LYS . 44.3 mt-10 -99.0 137.52 37.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 75.12 110.798 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.77 151.82 27.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 74.14 111.274 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.01 -38.94 14.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.545 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.74 -45.69 13.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.57 0.7 . . . . 74.32 109.477 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -87.17 66.56 9.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.324 -0.853 . . . . 74.41 108.83 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.695 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -53.4 124.7 15.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 73.41 110.378 -177.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.48 -3.82 56.53 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.429 -0.891 . . . . 65.43 112.57 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.6 HD22 ' HD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -81.81 117.34 22.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.493 -0.558 . . . . 73.51 109.493 175.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.527 ' HG2' ' HG2' ' A' ' 88' ' ' GLU . 26.6 mtpp -116.35 110.65 18.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 74.52 109.083 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.494 HD12 HG23 ' A' ' 116' ' ' THR . 2.0 mm? -99.93 126.29 46.06 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.37 -0.604 . . . . 75.41 109.37 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.784 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 28.4 m -130.16 119.17 22.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.95 0.405 . . . . 74.33 110.61 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -115.32 113.26 23.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.516 -0.92 . . . . 75.31 108.516 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.508 ' OD1' ' HD2' ' A' ' 113' ' ' LYS . 9.8 p-10 -120.77 134.39 55.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.317 0.579 . . . . 75.1 110.109 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 14.9 m -131.2 134.32 46.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.777 -0.647 . . . . 74.52 111.289 -175.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.3 t -95.27 122.0 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.082 -1.081 . . . . 61.3 108.082 172.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' HD1' ' HB3' ' A' ' 110' ' ' LYS . 82.1 t80 -127.51 129.52 47.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.217 0.532 . . . . 75.54 110.642 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.8 m -120.45 103.2 44.48 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.787 -0.642 . . . . 75.22 109.737 176.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.97 -16.42 55.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.023 2.482 . . . . 64.23 112.978 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -66.35 -45.15 81.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.966 0.412 . . . . 74.54 110.607 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.3 p -105.16 -13.54 15.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.89 -0.595 . . . . 75.13 111.571 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.95 85.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 73.53 111.531 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.463 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 87.0 tttt -74.2 137.9 43.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 75.23 111.123 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.91 132.81 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 72.34 110.706 177.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.562 HD21 ' HA ' ' A' ' 132' ' ' ASP . 16.3 m120 -120.33 122.93 41.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 74.13 109.494 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.94 126.86 52.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.136 0.493 . . . . 43.2 111.419 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.508 ' HD2' ' OD1' ' A' ' 100' ' ' ASP . 57.0 mttm -121.14 138.44 54.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.424 -0.584 . . . . 73.45 109.424 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mm -119.75 117.79 54.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.101 0.476 . . . . 74.13 110.524 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.784 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 40.3 mttp -115.02 119.81 37.73 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.8 -0.636 . . . . 72.51 109.729 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.494 HG23 HD12 ' A' ' 97' ' ' LEU . 27.8 p -116.36 117.61 30.44 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.078 -0.51 . . . . 73.25 110.125 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.83 130.27 9.42 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.55 -0.833 . . . . 72.31 112.034 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.6 ' HD1' HD22 ' A' ' 95' ' ' LEU . 71.4 t80 -123.14 115.26 21.5 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.027 -0.731 . . . . 73.44 109.027 174.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HB2' HG13 ' A' ' 3' ' ' VAL . 22.0 pttm -111.69 122.64 48.34 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.605 -0.838 . . . . 75.44 110.962 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.477 ' HB3' HG21 ' A' ' 123' ' ' ILE . 37.6 ttm180 -106.29 169.13 8.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.757 -1.201 . . . . 72.23 107.757 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.634 ' HA ' HG22 ' A' ' 3' ' ' VAL . 41.5 tp10 -53.28 -34.1 55.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 73.42 112.219 -167.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.445 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 92.9 m-70 -119.96 3.85 10.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 113.189 0.811 . . . . 75.32 113.189 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.477 HG21 ' HB3' ' A' ' 120' ' ' ARG . 18.8 tt -144.82 147.89 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.248 -0.981 . . . . 73.22 112.235 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.473 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -123.6 124.33 42.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.032 0.444 . . . . 72.43 110.8 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 142' ' ' LEU . 4.2 mm? -111.06 139.89 46.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.129 -0.487 . . . . 75.42 109.975 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.17 116.83 0.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.598 -0.81 . . . . 63.45 112.14 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 60.9 m -112.1 115.28 28.61 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.545 -0.385 . . . . 73.53 110.377 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.96 116.84 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 75.25 110.472 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 44.9 mtt -103.59 117.59 34.77 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.686 -0.857 . . . . 73.14 108.686 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.17 114.8 29.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.431 -0.507 . . . . 75.12 109.928 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 53.0 t80 -99.29 97.56 8.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.954 0.406 . . . . 73.5 110.419 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.562 ' HA ' HD21 ' A' ' 111' ' ' ASN . 12.6 t70 -101.18 144.22 30.32 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.113 -1.069 . . . . 72.45 108.113 170.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -65.64 -25.74 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.78 -0.452 . . . . 73.21 109.78 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.05 -1.42 57.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 73.2 111.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.19 108.19 0.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.368 -0.92 . . . . 70.51 113.024 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 2.3 Cg_endo -82.58 126.76 4.78 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.352 2.701 . . . . 70.52 112.096 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 p -126.49 162.94 24.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.812 0.339 . . . . 74.32 111.227 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 49.4 mm -108.9 123.58 64.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.479 -0.328 . . . . 74.54 110.65 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.06 113.23 21.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.931 0.396 . . . . 71.41 109.945 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.83 11.18 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.069 -1.062 . . . . 75.12 111.817 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.15 116.83 26.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.036 0.446 . . . . 71.12 110.015 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -116.51 123.83 48.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.142 -0.481 . . . . 72.33 110.289 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 93.8 t -111.94 129.4 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 73.13 109.975 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.32 138.45 43.5 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.002 -0.74 . . . . 75.55 109.002 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 122' ' ' HIS . . . -117.78 118.55 4.12 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.439 -0.886 . . . . 72.43 112.641 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.546 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 25.0 t80 -131.66 146.42 52.17 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.483 -1.303 . . . . 73.31 107.483 175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.1 101.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.099 0.476 . . . . 75.15 111.403 -176.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.72 -31.2 8.11 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.378 -0.828 . . . . 64.25 112.512 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 33.3 m0 -105.12 122.81 46.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.62 0.248 . . . . 75.1 111.471 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.55 137.65 46.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 73.01 110.105 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -129.96 158.18 40.26 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.852 -0.425 . . . . 62.14 109.852 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -157.46 132.86 3.33 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.395 -0.682 . . . . 63.22 111.395 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.575 ' CD1' ' HD1' ' A' ' 169' ' ' PHE . 21.7 m-85 -127.13 118.96 25.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 117.271 0.535 . . . . 74.2 109.841 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.805 ' HG3' ' HB3' ' A' ' 168' ' ' ASN . 26.8 pt20 -105.55 122.86 46.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.655 0.741 . . . . 71.41 109.771 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 ptm -126.67 140.49 52.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 70.01 110.666 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 22.0 t-20 -113.2 117.66 32.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.712 -0.477 . . . . 71.44 109.712 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.823 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 87.9 t80 -100.86 129.12 46.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.687 -0.688 . . . . 74.32 109.822 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.772 ' HG3' ' H ' ' A' ' 161' ' ' LYS . 9.0 tp10 -99.81 103.31 14.92 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 115.851 -0.613 . . . . 74.25 109.803 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 m -70.89 -27.01 63.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.548 -1.66 . . . . 73.03 111.327 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.05 75.05 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.777 0.799 . . . . 75.11 108.909 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.772 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 48.1 mmtm -95.28 -162.61 0.96 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.681 -1.229 . . . . 74.05 107.681 167.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -109.48 22.12 16.17 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.91 -0.494 . . . . 73.53 110.836 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -166.28 165.66 17.23 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 118.56 -1.256 . . . . 75.32 113.411 -163.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.823 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -77.7 136.39 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.66 -0.7 . . . . 71.45 110.096 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.1 m -94.63 -21.59 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 74.32 110.516 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 156' ' ' ASN . 22.0 tt0 -133.47 132.28 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 74.11 111.14 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -122.79 105.95 10.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.546 -0.752 . . . . 73.13 109.539 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.805 ' HB3' ' HG3' ' A' ' 154' ' ' GLN . 11.8 t-20 -117.09 128.84 55.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.928 -0.397 . . . . 73.14 109.928 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.575 ' HD1' ' CD1' ' A' ' 153' ' ' TYR . 47.4 m-85 -121.8 149.82 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.61 -0.268 . . . . 74.22 110.751 -173.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.573 ' HB2' ' CE1' ' A' ' 181' ' ' HIS . . . -151.84 137.76 18.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.65 -0.25 . . . . 65.33 110.908 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 182' ' ' THR . 63.7 t -135.03 127.07 47.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.439 -0.578 . . . . 63.52 109.439 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.37 108.46 0.88 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.103 -0.799 . . . . 62.41 111.103 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.516 ' CZ ' HD23 ' A' ' 180' ' ' LEU . 28.7 p90 -127.63 151.51 48.85 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.52 -0.872 . . . . 74.33 111.936 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.685 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 95.9 mttt -118.34 138.19 52.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.116 -1.402 . . . . 75.31 110.498 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -131.78 113.44 13.52 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.66 -0.867 . . . . 75.44 108.66 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.47 -95.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.823 0.702 . . . . 60.14 112.402 -172.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 197' ' ' LYS . 11.8 mm-40 -108.39 4.79 24.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.793 0.33 . . . . 75.12 111.235 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.84 122.5 47.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.42 -0.215 . . . . 73.5 110.42 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.685 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 3.8 mt-30 -135.9 123.17 21.79 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 119.48 -0.295 . . . . 62.43 110.606 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.569 ' O ' ' HA2' ' A' ' 172' ' ' GLY 0.262 0.0 OUTLIER -127.86 144.13 51.1 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.264 1.03 . . . . 74.13 113.728 171.396 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.573 ' CE1' ' HB2' ' A' ' 170' ' ' ALA . 22.0 t60 -108.38 114.29 28.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.117 -1.856 . . . . 73.11 108.587 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.638 HG21 ' HB ' ' A' ' 171' ' ' VAL . 14.0 t -96.83 157.94 15.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.153 -1.055 . . . . 61.33 108.153 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -147.95 149.71 32.7 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.722 -0.391 . . . . 75.41 110.157 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -131.41 116.03 30.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.509 -0.552 . . . . 73.34 109.509 170.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 57.7 t30 -94.33 97.02 9.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.591 -0.731 . . . . 74.23 109.812 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.23 -165.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.053 -0.976 . . . . 72.24 110.787 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.87 89.48 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.85 -0.691 . . . . 74.15 112.104 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -102.09 -25.72 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.157 0.799 . . . . 73.21 113.157 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.767 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 38.3 tt0 -129.82 139.92 51.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 119.698 -0.801 . . . . 74.51 113.066 -170.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.36 153.91 21.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.342 -0.844 . . . . 75.32 108.82 172.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -149.64 162.92 29.22 Favored Glycine 0 C--N 1.314 -0.654 0 C-N-CA 120.669 -0.776 . . . . 72.4 112.629 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -159.1 154.82 25.9 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.609 -0.596 . . . . 61.44 111.609 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.0 m -148.73 135.18 19.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.93 -0.767 . . . . 72.41 108.93 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.0 mp -123.15 124.51 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 73.14 110.15 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.781 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -112.61 119.86 39.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 73.41 109.932 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.491 ' HB3' ' CG2' ' A' ' 204' ' ' THR . 22.1 tp60 -108.82 111.92 23.9 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.112 -0.699 . . . . 73.24 109.112 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.584 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 8.7 tmtm? -97.28 108.62 21.38 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.534 -0.913 . . . . 63.53 108.534 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.798 ' HB ' ' HB3' ' A' ' 201' ' ' LYS . 15.0 t -77.94 123.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.181 -1.044 . . . . 70.01 108.181 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -38.95 -60.57 0.84 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.445 1.09 . . . . 65.32 112.234 -170.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -123.42 83.87 2.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.967 0.413 . . . . 72.5 109.913 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.798 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 20.2 tptm -167.99 -90.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 74.41 109.654 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.798 ' HB3' ' HD1' ' A' ' 225' ' ' TYR . 0.0 OUTLIER -163.18 -176.18 4.69 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.654 0.264 . . . . 71.05 110.525 173.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.781 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 3.2 mp0 -108.18 131.86 54.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 73.41 109.741 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 196' ' ' GLN . 15.0 t -122.15 150.0 42.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.234 -0.654 . . . . 75.34 109.234 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 222' ' ' ALA . . . -129.79 159.38 36.7 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.489 0.661 . . . . 74.54 111.408 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 221' ' ' ILE . 2.3 t -132.58 124.86 52.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.382 -1.281 . . . . 70.53 108.428 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -114.64 131.07 56.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 70.33 109.197 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.618 HD13 ' HD1' ' A' ' 219' ' ' PHE . 5.0 tp -147.06 136.28 22.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.023 -0.535 . . . . 71.32 110.448 -171.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.451 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -154.97 132.03 10.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.665 0.269 . . . . 52.24 110.693 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -130.96 118.45 20.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.1 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 1.4 m -94.76 108.7 20.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.069 -0.514 . . . . 75.32 109.918 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.06 130.37 43.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 75.32 110.683 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.46 1.42 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.384 -0.686 . . . . 63.11 111.384 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.36 88.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.234 0.54 . . . . 73.54 111.39 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 62.5 m -144.32 167.03 23.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.574 . . . . 72.13 110.134 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.87 124.1 22.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 63.25 110.25 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 23.5 p -77.73 123.29 26.5 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.097 0.475 . . . . 72.11 110.024 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.526 ' O ' HD11 ' A' ' 208' ' ' LEU . 63.7 mtt85 -89.6 113.02 24.4 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.408 -0.59 . . . . 73.43 109.408 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.618 ' HD1' HD13 ' A' ' 208' ' ' LEU . 93.4 t80 -126.62 136.39 52.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.981 -0.748 . . . . 74.51 108.981 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.38 162.78 33.57 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.033 -1.079 . . . . 70.35 112.474 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.622 HG12 HG11 ' A' ' 237' ' ' VAL . 0.1 OUTLIER -137.72 147.55 26.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.008 0.432 . . . . 73.12 109.969 176.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -136.99 157.75 46.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.656 -0.702 . . . . 71.31 110.564 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -141.57 126.27 17.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.685 0.278 . . . . 63.03 111.016 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 69.2 mttm -108.02 112.98 25.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.771 -0.826 . . . . 74.21 108.771 172.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.798 ' HD1' ' HB3' ' A' ' 202' ' ' LEU . 30.0 t80 -114.15 119.0 35.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.725 . . . . 75.35 111.471 -172.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -76.45 104.42 6.96 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.861 -1.163 . . . . 73.01 107.861 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.13 -56.69 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.142 -0.481 . . . . 72.03 111.513 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.614 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 35.8 t70 178.32 -54.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 74.25 111.145 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 89.5 Cg_endo -83.16 -142.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.936 1.757 . . . . 74.44 112.586 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 14.7 p-10 -91.97 10.98 26.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 72.13 110.324 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 132.78 54.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.712 -0.676 . . . . 71.45 110.533 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 248' ' ' THR . 11.9 p -122.23 142.6 50.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.45 -0.795 . . . . 73.24 109.813 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -101.94 132.89 47.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 62.42 110.008 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 52.0 p -122.95 120.74 34.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.952 0.406 . . . . 64.31 110.448 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.14 152.8 24.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.507 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.53 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 60.2 mttp -139.89 142.43 36.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.093 -0.706 . . . . 63.22 109.093 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.622 HG11 HG12 ' A' ' 221' ' ' ILE . 3.6 p -140.85 137.74 34.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.369 -0.532 . . . . 73.15 109.995 174.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.671 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 12.8 m120 -109.01 149.57 29.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.511 . . . . 74.01 110.045 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 219' ' ' PHE . 7.9 p30 -55.02 -24.18 23.23 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.257 0.973 . . . . 63.45 112.525 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.659 ' HB2' HD11 ' A' ' 242' ' ' LEU . 9.5 m -79.59 20.5 0.57 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 70.45 110.165 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 239' ' ' ASN . 40.7 m 65.97 36.99 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.352 -0.84 . . . . 75.33 110.771 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.857 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.3 mp -97.44 138.26 35.15 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.458 -0.497 . . . . 70.13 111.223 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 243' ' ' ILE . 3.0 mp -113.3 117.9 56.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.588 -0.733 . . . . 75.03 109.993 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.13 138.1 12.33 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.595 -0.812 . . . . 74.31 111.886 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.53 139.48 42.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 73.12 110.159 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.28 146.23 17.29 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.844 -0.693 . . . . 63.14 112.204 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.72 126.83 55.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.066 -0.346 . . . . 75.42 110.066 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.462 ' HB ' ' SG ' ' A' ' 232' ' ' CYS . 11.7 m -120.92 114.71 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 74.31 109.699 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.65 ' HB3' ' HB3' ' A' ' 257' ' ' LEU . 48.1 tt0 -125.28 138.9 54.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.364 -0.38 . . . . 75.32 110.535 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 2.5 t -121.98 92.84 3.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.503 0.668 . . . . 75.34 110.032 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.796 ' HB3' HG23 ' A' ' 255' ' ' ILE . 53.6 tp -88.81 66.12 7.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.883 -0.599 . . . . 74.02 109.431 -175.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.444 ' HG3' ' HD2' ' A' ' 253' ' ' PRO . 40.9 ttmt 69.38 150.86 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.115 -0.948 . . . . 73.31 109.908 -174.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 252' ' ' LYS . 51.4 Cg_exo -54.44 84.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.324 2.016 . . . . 75.44 111.642 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.426 ' HA2' ' HG3' ' A' ' 282' ' ' GLN . . . -178.6 -35.21 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.112 -0.949 . . . . 65.15 110.793 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.796 HG23 ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -149.08 122.3 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.75 0.786 . . . . 64.43 110.82 176.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -116.99 131.65 56.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.056 -0.975 . . . . 75.4 109.827 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 28.8 tp -102.93 122.12 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.723 -0.473 . . . . 74.44 109.723 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.2 t -135.22 109.98 8.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 55.11 110.512 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.595 ' HB3' HD21 ' A' ' 277' ' ' LEU . 1.6 pp -135.08 158.38 44.5 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.085 -0.646 . . . . 72.53 110.54 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.609 ' OG ' ' HA ' ' A' ' 22' ' ' TYR . 20.1 p -148.99 143.39 26.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.827 -0.624 . . . . 74.43 110.262 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.436 ' HB2' HD22 ' A' ' 275' ' ' LEU . . . -139.55 130.2 25.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.221 -0.659 . . . . 71.12 109.221 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.847 HD23 HD21 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -119.91 127.34 52.6 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.633 0.73 . . . . 74.44 110.084 179.518 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.864 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -101.74 109.68 21.51 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.23 -1.396 . . . . 54.13 107.23 176.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.857 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 10.5 t0 -72.25 106.87 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.405 -0.961 . . . . 64.51 108.405 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.48 -21.43 27.5 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.367 -0.444 . . . . 72.11 113.115 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -90.95 -20.16 22.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.741 0.305 . . . . 71.14 110.786 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 29.3 t-20 -110.5 -29.06 8.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.914 0.388 . . . . 71.23 111.942 -173.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.864 HG11 ' HB3' ' A' ' 263' ' ' LEU . 23.0 m -63.27 -16.55 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.063 -0.398 . . . . 73.44 111.804 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -53.93 -35.93 62.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.928 -0.397 . . . . 75.45 109.928 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -96.89 -16.78 20.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 61.23 110.53 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 117.62 7.21 12.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.8 -0.714 . . . . 74.41 113.176 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -70.2 85.71 0.32 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 70.22 113.041 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.542 ' HB2' HD13 ' A' ' 263' ' ' LEU . 55.8 p-80 -113.96 138.89 49.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.098 -0.334 . . . . 74.45 110.098 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 9.5 mmpt? -105.76 137.44 43.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.276 -0.268 . . . . 75.11 110.276 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -129.26 132.54 47.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.57 -0.286 . . . . 74.2 110.275 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.486 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -138.89 118.95 1.65 Allowed Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.541 -0.624 . . . . 55.21 111.541 174.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 259' ' ' LEU . 1.7 tm? -118.57 124.59 47.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.903 0.352 . . . . 73.12 110.09 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -132.56 141.0 12.31 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.547 -0.835 . . . . 62.3 113.442 -177.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.877 ' HB2' HD11 ' A' ' 29' ' ' LEU . 2.4 mm? -122.7 132.4 54.23 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.523 0.201 . . . . 74.35 110.908 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -105.43 111.54 24.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 73.32 109.169 167.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.756 ' HD1' HD12 ' A' ' 31' ' ' LEU . 5.6 t80 -107.64 133.68 51.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.436 -0.95 . . . . 75.22 108.436 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 pt20 -137.4 125.49 22.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.288 0.566 . . . . 74.42 111.758 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.441 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -106.36 112.4 25.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.514 -0.766 . . . . 73.53 109.493 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 74.9 mt -115.42 156.87 24.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.921 -0.581 . . . . 75.4 110.134 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 109.127 -0.694 . . . . 72.4 109.127 178.287 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.586 ' H2 ' ' HA3' ' A' ' 94' ' ' GLY . 1.5 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.26 -0.274 . . . . 71.44 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.18 73.57 8.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.365 0.602 . . . . 70.43 109.457 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 1.0 HG11 ' HB3' ' A' ' 119' ' ' LYS . 9.9 p -88.09 142.81 32.2 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.191 -0.913 . . . . 75.24 110.087 -174.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 85.0 Cg_exo -48.47 146.66 10.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.167 2.578 . . . . 73.52 112.926 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 7.6 Cg_exo -72.08 91.58 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.97 2.447 . . . . 74.34 112.49 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -76.36 -20.22 57.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.504 . . . . 70.1 110.134 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.655 ' HA ' HG21 ' A' ' 143' ' ' VAL . 63.7 t80 -56.64 -38.36 72.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 73.41 110.081 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.56 -28.26 28.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.771 -0.649 . . . . 70.45 110.573 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.67 6.37 35.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.794 -0.639 . . . . 74.15 110.708 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.584 HD22 HG11 ' A' ' 143' ' ' VAL . 89.3 mt -60.78 -15.93 35.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.39 0.614 . . . . 71.11 109.823 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.681 ' HA3' ' HB2' ' A' ' 181' ' ' HIS . . . 164.72 57.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.099 -1.201 . . . . 75.11 110.099 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 14.2 tmtt? -56.16 -54.32 46.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.875 0.47 . . . . 74.0 111.54 -170.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -65.19 -42.15 93.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.091 0.472 . . . . 60.14 111.485 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 -36.5 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 73.43 112.423 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' O ' HG21 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.23 -31.45 70.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 72.21 111.574 -173.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 2.3 m-20 -65.75 -41.85 91.61 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 121.248 -0.181 . . . . 62.31 111.343 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.81 -38.97 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.329 0.585 . . . . 63.15 110.113 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -72.91 -41.39 64.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.442 -0.799 . . . . 73.03 112.186 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 20' ' ' LYS . 14.4 t -94.66 -6.6 42.98 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.321 0.489 . . . . 64.35 112.321 -173.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 13.7 mptt -101.41 28.34 5.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 70.55 110.405 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.04 134.14 36.98 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.903 -0.665 . . . . 73.34 112.117 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.876 ' HB3' ' HD2' ' A' ' 274' ' ' LYS . 96.3 m-85 72.01 -57.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.498 0.719 . . . . 73.31 111.771 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.14 155.53 12.78 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.498 -1.041 . . . . 74.32 110.498 -173.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -83.18 -4.46 58.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.232 0.516 . . . . 73.45 111.174 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.99 4.0 84.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.945 -0.645 . . . . 72.23 113.377 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.5 pp -148.91 -177.83 6.02 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 122.199 1.0 . . . . 74.22 113.013 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.832 HG22 HD21 ' A' ' 277' ' ' LEU . 25.6 mm -90.97 129.06 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 113.858 -1.519 . . . . 74.43 109.637 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 87.5 tttt -118.18 133.23 56.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.786 0.327 . . . . 73.43 110.372 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.7 tp -117.52 149.65 40.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.855 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 11.5 t70 -142.37 139.78 31.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.282 -0.872 . . . . 71.33 108.88 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -134.74 127.67 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.845 -0.428 . . . . 73.21 109.845 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -123.51 125.67 45.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.964 -0.754 . . . . 74.41 108.964 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.887 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 19.2 m -137.71 141.7 41.04 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.146 -0.222 . . . . 74.41 111.205 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -103.03 140.01 37.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.801 -0.444 . . . . 74.25 109.801 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.5 m -139.56 174.38 10.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.561 -0.533 . . . . 74.24 109.561 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -30.54 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 72.32 111.836 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -44.77 130.02 7.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.41 0.624 . . . . 73.3 111.929 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 89.19 -10.65 72.25 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.196 -0.911 . . . . 70.11 113.555 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.14 129.01 53.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.659 1.23 . . . . 75.32 111.488 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.99 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 34.2 tt0 -139.57 146.8 40.3 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.572 -0.899 . . . . 75.04 108.572 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.887 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 59.4 t80 -121.42 121.31 37.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.686 0.279 . . . . 75.34 110.776 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.853 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.0 m -126.08 132.39 51.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 75.2 110.322 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 19.4 m -132.28 143.25 49.76 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.975 -0.453 . . . . 75.22 110.799 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -143.27 125.95 15.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.029 -0.36 . . . . 75.12 110.029 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.8 152.46 20.31 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.428 -0.891 . . . . 55.2 111.914 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -128.45 133.27 48.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.19 -0.67 . . . . 64.34 109.19 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -138.1 130.94 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.922 0.391 . . . . 73.11 111.533 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.58 142.93 42.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.881 -0.6 . . . . 64.22 109.42 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 t -75.36 141.75 43.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.727 0.298 . . . . 73.53 110.956 -176.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 mp0 73.12 -74.38 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.481 0.712 . . . . 74.14 111.93 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.38 139.0 45.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.399 . . . . 72.14 111.468 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 m -74.74 80.25 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.2 0.524 . . . . 62.3 111.916 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -126.3 93.93 3.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.362 -0.607 . . . . 75.0 109.362 172.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 64.3 110.458 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 m -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 61.44 108.876 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.96 125.08 6.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.518 -0.849 . . . . 51.11 112.763 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 m -109.31 134.02 52.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.265 -0.642 . . . . 73.32 109.265 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.11 124.68 46.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.834 -0.802 . . . . 73.51 108.834 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.853 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -107.96 117.35 33.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.536 0.684 . . . . 71.43 110.285 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 m -93.54 118.89 31.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.027 -1.101 . . . . 74.15 108.027 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.99 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 13.6 tptm -112.34 135.31 53.18 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.572 -0.451 . . . . 74.11 109.878 -173.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.834 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 81.0 m-85 -118.91 120.69 38.05 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.906 -0.776 . . . . 73.32 108.906 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.1 ttm-85 -122.91 109.27 13.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 73.14 111.533 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' LEU . 70.6 m95 -106.65 93.59 4.66 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.993 -1.003 . . . . 74.23 108.943 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -67.73 -38.29 83.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.058 . . . . 73.12 112.516 -170.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 tp10 -86.42 61.62 6.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.38 0.609 . . . . 65.32 111.235 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.579 ' HD1' HD23 ' A' ' 69' ' ' LEU . 47.9 t80 172.38 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.409 -1.269 . . . . 73.52 108.456 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.07 49.75 0.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.465 -0.789 . . . . 74.03 111.927 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.579 HD23 ' HD1' ' A' ' 67' ' ' TYR . 1.5 mm? -114.67 131.83 56.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.076 0.465 . . . . 75.32 111.228 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.2 m -134.43 112.73 11.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.669 -0.696 . . . . 73.21 110.28 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.834 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 16.0 t80 -109.46 125.4 52.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.942 -0.572 . . . . 74.2 109.572 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 5.0 m -121.42 117.1 26.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.742 0.305 . . . . 75.23 110.655 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.706 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.4 tt0 -101.76 119.87 39.46 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.002 -0.74 . . . . 75.21 109.002 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 15.8 ttmm -107.99 86.67 2.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.421 -0.585 . . . . 75.41 109.421 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.722 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 11.9 t90 -101.06 129.42 46.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.127 -0.488 . . . . 75.44 111.088 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -108.07 164.1 12.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.551 . . . . 73.44 109.825 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -68.89 -18.23 64.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.278 0.561 . . . . 73.43 110.51 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 25.0 t70 -74.28 -4.4 35.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 73.22 109.94 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 10.8 m120 74.76 9.52 4.11 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.969 -1.014 . . . . 72.12 110.644 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 117.37 21.83 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 72.01 109.518 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.722 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.9 pt? -123.02 136.98 55.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 73.04 111.374 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.61 106.28 2.28 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.251 -0.886 . . . . 74.31 111.237 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.0 m -85.78 100.06 11.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.861 0.362 . . . . 72.54 110.664 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 35.2 mt-10 -99.11 108.04 20.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 41.42 109.722 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.4 pp -112.18 137.92 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.518 -0.473 . . . . 72.42 110.584 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.1 m -129.21 128.55 43.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.581 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.01 125.72 74.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.968 0.413 . . . . 74.33 110.316 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -90.28 127.91 36.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 73.54 109.295 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 t70 -82.92 144.05 30.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.885 -0.413 . . . . 73.4 109.885 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.63 -21.56 15.22 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.076 -0.25 . . . . 75.24 111.367 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.0 tp -71.49 -45.52 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 74.01 109.302 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.32 75.31 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.486 -0.779 . . . . 73.43 109.786 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 35.6 ttm180 -61.46 135.36 57.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.19 0.519 . . . . 73.0 110.25 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.586 ' HA3' ' H2 ' ' A' ' 1' ' ' MET . . . 102.99 -10.9 55.76 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.606 -0.998 . . . . 74.3 110.606 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.54 112.78 25.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.491 -1.3 . . . . 71.23 107.491 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 138.75 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.128 0.49 . . . . 74.35 110.054 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.34 127.27 51.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.497 -0.927 . . . . 74.42 108.497 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 1.025 HG22 ' HB2' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -125.96 130.37 51.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.178 0.513 . . . . 74.42 110.064 -176.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.438 ' CZ ' ' HB1' ' A' ' 112' ' ' ALA . 31.4 t80 -123.63 123.04 39.68 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.942 -0.762 . . . . 73.33 108.942 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 81.4 m-20 -108.54 121.25 44.59 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.372 -0.603 . . . . 72.14 109.372 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -111.51 120.79 43.33 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.816 -0.354 . . . . 72.25 110.152 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.5 m -101.54 120.05 39.71 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.624 -0.88 . . . . 73.35 108.624 175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.651 ' HD2' ' HB3' ' A' ' 110' ' ' LYS . 49.2 t80 -134.91 137.97 43.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.037 0.446 . . . . 72.52 110.652 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 m -127.96 102.49 21.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.853 -0.612 . . . . 75.04 109.734 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 36.5 Cg_exo -59.32 -34.25 97.79 Favored 'Trans proline' 0 N--CA 1.466 -0.09 0 C-N-CA 122.454 2.103 . . . . 73.52 111.417 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.69 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 73.55 111.175 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.3 m -76.9 -23.25 52.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.698 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.42 2.27 73.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.668 -0.777 . . . . 74.42 112.976 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.72 148.36 22.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 71.11 111.858 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 19.1 ptmt -145.88 124.98 12.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 74.2 110.612 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.57 140.27 51.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.509 -0.552 . . . . 74.22 109.509 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -119.51 130.67 55.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.056 0.455 . . . . 75.32 111.365 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.595 ' HG2' ' OD1' ' A' ' 130' ' ' ASP . 42.6 mttm -114.37 136.44 52.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.664 -0.495 . . . . 74.53 109.664 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.684 HG21 ' HE1' ' A' ' 129' ' ' MET . 4.0 tp -120.6 117.93 54.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.433 0.635 . . . . 65.44 109.585 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 1.025 ' HB2' HG22 ' A' ' 98' ' ' THR . 21.4 mtpt -122.93 134.83 54.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.698 -0.683 . . . . 71.14 110.7 -170.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -112.17 127.91 56.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.276 -0.638 . . . . 74.31 109.276 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.91 126.04 4.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.105 -1.045 . . . . 74.34 112.748 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.99 133.86 47.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.099 -0.334 . . . . 75.33 110.099 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 1.0 ' HB3' HG11 ' A' ' 3' ' ' VAL . 76.5 mttt -122.01 122.72 39.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.775 0.797 . . . . 63.14 111.464 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.842 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 18.9 tpt180 -110.26 162.18 14.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.517 -1.22 . . . . 74.0 108.089 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HA ' HG23 ' A' ' 3' ' ' VAL . 1.2 pm0 -58.48 -27.9 64.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.54 0.609 . . . . 73.42 110.932 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -107.97 3.16 23.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.177 -0.465 . . . . 73.42 111.526 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.842 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 15.5 mm -139.15 131.54 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.765 0.654 . . . . 74.44 112.765 -169.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.92 111.95 19.68 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.818 -1.179 . . . . 74.44 107.818 163.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.624 HD13 HD12 ' A' ' 142' ' ' LEU . 4.8 tp -128.32 124.6 36.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.996 0.427 . . . . 73.22 111.389 -175.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.72 115.39 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.944 -0.646 . . . . 74.02 111.975 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 63.2 m -114.43 116.4 28.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.82 -0.223 . . . . 72.3 110.467 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.636 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 3.3 p30 -105.76 122.74 46.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.431 0.634 . . . . 73.03 110.643 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.684 ' HE1' HG21 ' A' ' 114' ' ' ILE . 67.4 mtm -104.41 117.67 34.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 74.31 109.5 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.595 ' OD1' ' HG2' ' A' ' 113' ' ' LYS . 15.7 t0 -106.1 120.48 41.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.237 -0.438 . . . . 74.03 111.25 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -93.89 97.25 10.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.303 0.573 . . . . 74.53 109.708 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.25 143.88 32.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.469 -0.787 . . . . 60.52 109.242 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.94 -12.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 72.35 112.513 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.95 -9.43 37.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 72.03 110.981 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.48 120.75 1.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.92 -0.657 . . . . 75.42 112.231 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 29.2 Cg_exo -61.94 131.19 33.87 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.851 2.367 . . . . 72.43 112.37 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.4 m -126.55 129.95 49.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.942 -0.572 . . . . 53.32 110.182 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.2 mp -107.57 124.95 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.015 -0.365 . . . . 73.14 110.015 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.89 112.97 24.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.445 -0.576 . . . . 75.14 109.445 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 127' ' ' CYS . . . -111.69 131.93 10.55 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.722 -1.228 . . . . 73.14 111.757 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.88 116.8 23.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 62.54 110.26 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.624 HD12 HD13 ' A' ' 125' ' ' LEU . 12.2 tp -122.57 123.64 41.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 73.52 110.344 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 7' ' ' TYR . 86.1 t -122.49 124.96 71.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.352 -0.84 . . . . 72.41 109.692 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.15 137.69 46.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 73.13 108.711 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.508 ' HA2' HD22 ' A' ' 150' ' ' LEU . . . -129.43 132.71 7.21 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.868 -1.158 . . . . 75.14 114.177 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 73.8 t80 -136.16 147.27 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.34 -0.985 . . . . 75.44 108.34 171.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -39.28 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.497 0.925 . . . . 71.34 113.497 -174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.92 -35.19 4.92 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.205 -0.907 . . . . 74.4 113.668 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 146' ' ' TYR . 55.9 p-90 -110.57 138.83 46.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.082 0.941 . . . . 72.23 112.014 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.508 HD22 ' HA2' ' A' ' 145' ' ' GLY . 12.9 mt -127.19 137.25 52.89 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 75.51 110.186 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.66 124.41 23.89 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.847 -0.427 . . . . 71.23 109.847 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.418 ' HA3' HG23 ' A' ' 143' ' ' VAL . . . -141.83 151.21 22.62 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.439 -0.886 . . . . 65.2 111.937 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -145.31 133.31 21.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.252 0.549 . . . . 75.13 111.867 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.25 123.75 44.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.301 -0.863 . . . . 74.4 109.417 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 45.9 ttm -119.46 134.26 55.3 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.987 -0.375 . . . . 75.25 109.987 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -111.59 119.0 37.26 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.24 0.543 . . . . 75.3 110.373 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 138' ' ' ILE . 69.1 m-85 -98.56 127.0 44.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.121 -0.945 . . . . 74.43 110.47 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.593 ' HB2' ' OG1' ' A' ' 165' ' ' THR . 81.7 tt0 -99.7 98.99 9.77 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 109.513 -0.551 . . . . 75.14 109.513 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.5 m -72.25 -17.56 61.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 113.949 -1.478 . . . . 70.24 111.278 171.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.03 -27.0 65.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.697 -0.853 . . . . 63.52 108.697 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.86 -153.51 0.57 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.214 -1.357 . . . . 71.04 108.095 168.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.7 p -109.79 28.0 9.01 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.93 -0.481 . . . . 74.25 112.098 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -140.87 171.54 13.93 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 118.035 -1.466 . . . . 64.35 114.433 -160.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -93.81 127.76 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.661 -1.154 . . . . 70.11 108.813 170.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.593 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 1.7 m -96.06 -36.24 11.08 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.227 -0.589 . . . . 55.51 111.196 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -130.13 133.19 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.065 -0.516 . . . . 74.4 110.307 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -119.42 107.0 12.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.111 -0.7 . . . . 74.43 109.111 173.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -105.95 133.1 51.22 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.655 -0.498 . . . . 73.32 109.655 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.617 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.8 m-85 -121.99 146.98 46.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.396 -0.365 . . . . 70.41 110.468 -176.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -140.1 128.96 23.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.126 0.488 . . . . 73.44 109.998 176.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 39.6 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.506 -0.553 . . . . 74.44 109.506 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -121.95 135.57 10.47 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.376 -0.916 . . . . 52.33 112.597 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.543 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 68.4 t80 -117.12 120.32 37.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.561 -1.274 . . . . 73.33 107.561 171.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -115.41 121.64 43.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.032 0.92 . . . . 73.23 112.099 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 42.6 m -136.33 163.21 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.469 -1.678 . . . . 72.31 106.469 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.471 ' HB2' ' OE2' ' A' ' 177' ' ' GLU . 6.3 m-20 -63.28 -43.38 98.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.414 1.006 . . . . 73.32 110.363 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.471 ' OE2' ' HB2' ' A' ' 176' ' ' ASP . 2.2 mp0 -85.96 -21.81 27.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 75.41 111.251 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.734 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 54.3 m-85 -119.22 115.35 24.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.524 -0.307 . . . . 74.34 111.359 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 1.5 mp0 -118.7 121.46 40.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.934 -0.765 . . . . 73.22 108.934 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.855 HD13 HG13 ' A' ' 194' ' ' ILE . 2.3 tt -124.11 131.9 53.59 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.574 -0.451 . . . . 75.03 110.553 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.681 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 19.5 t-80 -129.13 114.52 16.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.181 -0.463 . . . . 64.22 110.543 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.642 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 57.3 m -95.58 137.59 34.43 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.327 -0.99 . . . . 75.12 108.327 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -132.67 138.64 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.585 -0.446 . . . . 71.52 110.477 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 74.7 t -133.05 131.39 58.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.962 -0.563 . . . . 72.31 110.625 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 8.0 t30 -117.19 96.82 5.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.682 -0.859 . . . . 70.43 108.682 174.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 9.6 t70 59.4 -162.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.169 -0.923 . . . . 71.11 109.656 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -80.26 -7.01 88.94 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 74.25 112.53 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 211' ' ' THR . 13.2 m -95.63 -26.94 15.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.726 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 mp0 -119.48 114.77 22.8 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.84 -0.538 . . . . 64.24 111.286 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.474 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 28.1 p90 -135.67 129.14 32.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.782 0.325 . . . . 75.12 110.192 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.9 175.38 36.73 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.398 -0.906 . . . . 75.15 112.462 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -147.78 141.25 9.06 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.97 -0.633 . . . . 62.23 112.061 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 8.7 t -122.29 138.28 54.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.87 -0.418 . . . . 75.32 109.87 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.855 HG13 HD13 ' A' ' 180' ' ' LEU . 4.5 mp -120.21 122.72 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.918 -0.583 . . . . 74.22 109.953 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.529 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 59.5 t80 -108.09 120.42 42.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.851 -0.796 . . . . 73.51 108.851 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -121.29 116.52 25.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.9 -0.591 . . . . 73.12 111.136 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.97 116.72 24.37 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.346 -0.983 . . . . 74.22 108.346 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.489 HG11 ' N ' ' A' ' 199' ' ' ASN . 21.4 t -76.32 168.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.631 -0.507 . . . . 75.32 109.631 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.489 ' N ' HG11 ' A' ' 198' ' ' VAL . 16.6 t-20 -59.84 -37.1 78.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.109 0.48 . . . . 64.52 110.234 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.99 171.19 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.216 -0.661 . . . . 74.02 109.216 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 201' ' ' LYS . 36.7 mmtm -80.11 61.8 4.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.79 0.805 . . . . 74.41 111.464 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.434 HD21 ' N ' ' A' ' 203' ' ' GLU . 5.6 tt -137.02 132.37 34.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.322 -1.308 . . . . 74.23 107.753 175.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.434 ' N ' HD21 ' A' ' 202' ' ' LEU . 31.2 mt-10 -119.08 145.65 45.75 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.503 -0.555 . . . . 70.31 109.503 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.7 t -133.71 152.56 51.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.603 -0.439 . . . . 73.13 110.5 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.19 135.21 47.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.212 0.529 . . . . 65.15 110.153 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 193' ' ' SER . 33.9 t -121.87 125.63 73.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.484 -0.78 . . . . 74.13 109.603 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.79 127.68 54.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.74 0.305 . . . . 75.14 110.926 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -119.13 130.48 55.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 73.15 109.725 174.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 218' ' ' ARG . . . -132.71 129.68 39.05 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.627 -0.508 . . . . 61.13 109.627 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -127.04 121.52 31.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.478 -0.564 . . . . 73.31 109.478 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.626 HG22 ' HB2' ' A' ' 215' ' ' SER . 5.4 t -106.24 117.87 35.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.616 0.722 . . . . 61.01 109.578 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.474 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.33 150.33 39.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.989 -1.005 . . . . 74.12 111.932 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 118.39 24.11 3.28 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.635 -0.711 . . . . 75.52 111.831 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.9 29.59 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.341 0.591 . . . . 63.13 110.471 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.626 ' HB2' HG22 ' A' ' 211' ' ' THR . 9.9 m -83.46 -170.34 3.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.48 -0.782 . . . . 75.44 110.537 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.61 149.62 38.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.376 -0.374 . . . . 70.21 110.6 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 38.7 m -95.91 123.0 39.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.681 -0.859 . . . . 64.11 108.681 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.475 ' HB3' ' HB1' ' A' ' 209' ' ' ALA . 43.7 ttt180 -101.2 117.62 35.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.392 -0.367 . . . . 74.43 110.808 -171.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.636 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 40.7 p90 -114.87 154.1 29.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.067 -0.515 . . . . 73.42 110.194 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.0 140.31 7.67 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.194 -0.762 . . . . 74.41 111.194 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.86 128.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.711 -0.477 . . . . 75.43 109.711 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 236' ' ' LYS . . . -122.23 133.05 54.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.363 0.414 . . . . 72.24 110.555 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.0 124.91 53.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.787 -0.449 . . . . 52.12 109.787 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.115 -0.493 . . . . 75.52 109.922 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -128.03 133.07 49.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.113 0.482 . . . . 74.3 110.537 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.71 97.68 9.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.697 -0.683 . . . . 72.15 109.266 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.8 tt -71.78 -23.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.043 0.925 . . . . 75.44 108.529 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.72 137.91 13.45 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.199 -1.364 . . . . 72.34 107.525 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.18 -15.91 11.73 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 122.902 2.401 . . . . 72.41 113.814 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.39 -22.3 19.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.813 0.339 . . . . 74.11 111.256 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.51 128.76 36.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.152 0.501 . . . . 72.22 111.83 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.3 m -104.85 119.71 39.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 63.43 110.429 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -100.55 133.51 44.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 75.42 110.651 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 38.8 t -131.16 117.81 19.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 75.51 111.515 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.93 40.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.914 -0.772 . . . . 71.22 108.914 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 222' ' ' ALA . 9.8 pttm -152.66 159.52 43.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 74.31 112.231 -171.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 5.0 p -143.5 154.25 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 75.23 109.438 176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 20.0 t-20 -130.75 153.82 48.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.683 -0.235 . . . . 72.5 110.87 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.636 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 32.5 t30 -38.05 -41.83 0.6 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.972 1.309 . . . . 73.4 113.661 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.4 t -78.17 24.37 0.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 73.45 111.051 -173.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.9 m 65.32 36.47 6.92 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 72.21 109.725 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.975 ' HB3' HD13 ' A' ' 262' ' ' LEU . 25.4 mt -93.6 115.39 27.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 74.31 110.098 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.5 mp -100.29 116.55 43.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.928 -0.767 . . . . 75.2 108.928 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -128.18 140.28 11.68 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.059 -1.067 . . . . 73.21 113.571 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.513 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -122.13 148.34 45.03 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.386 -0.598 . . . . 74.02 109.386 172.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -162.92 122.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.573 -0.822 . . . . 70.42 112.241 -177.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -118.47 133.07 56.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.274 0.559 . . . . 75.44 110.758 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.1 m -110.9 120.04 41.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.068 -0.969 . . . . 75.14 109.896 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -114.24 130.28 56.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.861 0.363 . . . . 65.21 110.136 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.5 p -104.79 107.7 18.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.819 -0.628 . . . . 74.2 109.909 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 4.1 mm? -71.18 173.87 7.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.854 0.359 . . . . 53.32 110.909 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -47.87 57.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.046 -0.524 . . . . 75.4 110.65 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 13.5 Cg_exo -70.96 -177.62 2.36 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.619 1.546 . . . . 72.24 110.68 169.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -76.84 50.3 2.95 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.556 -0.831 . . . . 71.32 112.791 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 48.5 mt -108.75 121.42 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.408 -0.466 . . . . 75.11 110.338 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.637 ' HB3' ' CG ' ' A' ' 280' ' ' GLU . 68.7 tttt -110.53 119.2 38.39 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.247 -0.433 . . . . 74.43 109.895 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 15.3 tp -101.66 126.78 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.437 -0.801 . . . . 74.22 109.983 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.445 ' O ' HD11 ' A' ' 277' ' ' LEU . 19.5 m -132.05 109.77 10.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.867 0.365 . . . . 74.41 110.376 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.635 ' CD2' HD13 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -112.77 125.14 54.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.768 -0.826 . . . . 75.12 108.768 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 51.4 m -138.99 148.81 43.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.782 0.325 . . . . 75.15 110.532 175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.06 128.69 17.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.69 -0.485 . . . . 62.43 109.69 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.975 HD13 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -111.44 118.31 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.205 -0.665 . . . . 73.45 109.205 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.681 ' HB3' HG13 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -98.05 107.43 19.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.797 -1.186 . . . . 74.55 107.797 174.394 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.726 ' OD1' ' HG2' ' A' ' 266' ' ' LYS . 19.0 t0 -71.53 104.41 3.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.53 -0.915 . . . . 65.41 108.53 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.39 -27.1 39.52 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 115.709 -0.678 . . . . 64.31 114.159 -171.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.726 ' HG2' ' OD1' ' A' ' 264' ' ' ASP . 23.7 pttm -91.98 -13.55 30.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.078 0.439 . . . . 64.44 111.123 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.693 ' OD1' ' HA3' ' A' ' 272' ' ' GLY . 10.9 t-20 -116.22 -26.81 7.07 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.001 0.371 . . . . 71.45 112.001 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 263' ' ' LEU . 24.1 m -62.07 -17.86 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 O-C-N 122.166 -0.334 . . . . 73.43 110.917 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -59.29 -29.37 67.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.773 -0.649 . . . . 75.21 109.999 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -100.04 -16.98 17.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 75.25 110.637 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.19 13.82 6.83 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.933 -0.651 . . . . 62.44 113.064 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.693 ' HA3' ' OD1' ' A' ' 267' ' ' ASN . . . -85.83 79.52 1.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.663 -0.78 . . . . 73.43 113.125 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.414 ' HB2' HD13 ' A' ' 263' ' ' LEU . 8.2 p80 -114.22 142.09 46.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.52 -0.548 . . . . 75.34 109.52 175.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.876 ' HD2' ' HB3' ' A' ' 22' ' ' TYR . 80.2 mttt -110.61 143.1 41.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.399 -0.52 . . . . 73.31 111.49 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 276' ' ' GLY . 1.5 tm? -115.5 137.97 51.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.884 . . . . 74.21 108.866 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.482 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -134.51 104.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.507 -0.854 . . . . 73.12 111.521 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.832 HD21 HG22 ' A' ' 27' ' ' ILE . 40.1 tp -114.12 145.46 41.6 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.33 -0.548 . . . . 73.24 110.677 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.689 ' H ' HD11 ' A' ' 277' ' ' LEU . . . -150.33 124.1 1.68 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.197 -0.911 . . . . 53.41 111.479 178.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.33 131.89 56.3 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.748 -0.834 . . . . 73.31 108.748 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.637 ' CG ' ' HB3' ' A' ' 256' ' ' LYS . 8.7 pt-20 -125.22 115.18 20.0 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.861 -0.736 . . . . 61.45 110.369 171.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.748 ' HB3' HD22 ' A' ' 31' ' ' LEU . 57.3 t80 -99.83 106.19 18.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.948 -1.024 . . . . 74.45 109.812 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -102.56 111.95 24.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.893 -0.594 . . . . 64.11 110.043 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -111.94 126.2 54.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.958 -0.564 . . . . 72.24 110.459 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.44 0.34 16.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.367 0.603 . . . . 74.32 110.243 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.585 -0.734 . . . . 75.51 109.731 179.398 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG3' ' HB2' ' A' ' 93' ' ' ARG . 26.3 ttt . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.573 0.225 . . . . 71.22 110.451 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.83 104.77 16.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.743 -0.466 . . . . 71.4 109.743 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 120' ' ' ARG . 9.1 p -163.33 137.06 4.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.409 -0.589 . . . . 74.12 109.409 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 27.4 Cg_exo -63.56 131.92 33.49 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.888 2.392 . . . . 71.33 113.397 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.57 99.84 1.18 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.917 2.411 . . . . 71.11 111.565 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.486 ' HB ' HD13 ' A' ' 150' ' ' LEU . 5.2 p -94.82 -2.75 50.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.351 -0.386 . . . . 73.42 111.865 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' HB3' HG23 ' A' ' 143' ' ' VAL . 6.1 p90 -62.25 -21.32 65.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.66 0.743 . . . . 75.32 109.973 170.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.25 54.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.135 -0.939 . . . . 73.34 110.143 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.627 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 51.4 m-20 -91.58 -1.9 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 72.43 109.943 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 1.101 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -76.39 -34.04 58.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.173 -0.921 . . . . 73.12 111.67 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.23 -36.07 0.51 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.08 -1.057 . . . . 74.51 113.892 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.77 -41.73 78.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.967 0.383 . . . . 73.41 111.981 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 m -58.15 -46.38 85.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.034 0.445 . . . . 74.43 111.244 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -35.03 72.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.934 -0.575 . . . . 71.42 111.4 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -58.55 -35.91 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 75.13 112.79 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.37 -49.87 75.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.978 0.418 . . . . 72.33 111.387 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 207' ' ' ASN . 2.8 t -85.21 -31.5 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 73.54 111.149 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB2' ' ND2' ' A' ' 207' ' ' ASN . 88.0 t80 -66.91 -38.24 85.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.189 -0.459 . . . . 75.23 112.001 -174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -57.24 150.85 16.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 74.43 111.191 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -116.59 -13.52 10.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.213 0.53 . . . . 72.1 110.224 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.77 51.76 4.48 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.607 -0.724 . . . . 63.42 111.755 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.6 -36.94 74.82 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.408 0.623 . . . . 74.34 109.582 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.05 101.58 0.44 Allowed Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.014 -0.994 . . . . 71.12 111.05 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -81.28 -3.81 53.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 75.11 110.14 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.89 7.33 78.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.815 -0.629 . . . . 71.21 112.643 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mp -123.34 168.36 12.6 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.966 0.889 . . . . 75.14 112.435 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.9 mp -108.27 124.14 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.047 -1.433 . . . . 71.11 108.925 174.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -105.61 136.31 45.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.963 0.411 . . . . 74.32 111.03 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.76 129.04 56.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.21 -1.033 . . . . 74.41 108.21 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.56 133.93 48.5 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.807 -0.812 . . . . 55.25 108.807 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.621 HD13 ' HD2' ' A' ' 281' ' ' PHE . 16.9 tp -138.41 126.02 22.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.21 111.78 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -114.86 127.25 55.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.55 109.6 172.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.78 HG22 ' HB3' ' A' ' 41' ' ' PHE . 7.6 t -137.21 150.96 48.23 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.535 -0.466 . . . . 74.11 110.386 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 284' ' ' LEU . 18.3 ttmm -133.08 148.71 52.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.376 -0.374 . . . . 74.41 110.016 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -140.13 136.62 33.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.769 -0.196 . . . . 70.32 110.509 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 39.84 -97.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.294 1.038 . . . . 74.01 113.254 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -154.76 141.24 18.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.854 -0.795 . . . . 72.32 108.854 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 88.51 -9.08 77.12 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.586 -0.34 . . . . 52.22 112.71 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.21 128.03 48.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.658 0.729 . . . . 75.23 111.803 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.93 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 3.5 tp10 -141.03 118.9 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.911 -1.144 . . . . 75.3 107.911 165.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.78 ' HB3' HG22 ' A' ' 33' ' ' THR . 59.3 t80 -116.96 124.86 50.41 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.25 -0.906 . . . . 74.0 111.107 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.7 m -126.84 117.73 23.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 71.0 110.911 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -116.25 127.23 54.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.607 -0.27 . . . . 75.31 110.297 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -125.9 126.06 43.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 73.54 109.933 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.45 138.17 8.01 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.224 -0.989 . . . . 74.1 111.858 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -121.01 133.18 55.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.889 -0.411 . . . . 70.44 109.889 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 135.31 45.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.133 0.492 . . . . 73.13 111.161 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.814 ' HB3' ' HB3' ' A' ' 53' ' ' LYS . 39.1 t30 -77.27 147.19 36.43 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.347 -0.842 . . . . 74.1 109.41 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -44.93 -37.66 4.12 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.987 0.423 . . . . 75.42 111.02 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.93 123.58 27.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.212 -0.662 . . . . 73.24 109.212 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -68.72 -5.3 19.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.241 0.544 . . . . 71.14 111.826 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -83.59 5.33 24.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.117 0.484 . . . . 74.21 110.85 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.814 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 31.2 tptt -137.64 84.38 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 64.3 110.346 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.81 132.56 70.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.696 0.284 . . . . 73.43 110.785 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -125.16 142.69 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.22 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.19 155.72 22.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.102 -1.047 . . . . 74.31 113.206 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 m -146.31 127.33 14.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.343 -0.614 . . . . 55.21 109.343 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.568 HD12 ' HG3' ' A' ' 74' ' ' LYS . 2.0 tm? -121.46 127.14 50.79 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.164 -0.31 . . . . 74.35 110.164 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 45.5 mt-10 -116.7 118.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.752 -0.658 . . . . 74.5 110.14 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.473 ' HG1' ' HG2' ' A' ' 74' ' ' LYS . 27.6 m -100.42 118.73 37.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.24 -1.022 . . . . 64.42 108.24 171.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.93 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 66.0 mttm -113.68 133.51 55.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.21 0.529 . . . . 72.34 110.543 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.732 ' HD2' ' HB2' ' A' ' 71' ' ' PHE . 38.4 m-85 -101.13 119.65 39.06 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.794 -1.187 . . . . 73.34 107.794 172.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 9.9 ttm180 -115.57 106.0 13.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.606 0.717 . . . . 75.34 109.971 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -113.7 104.14 11.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.516 -1.22 . . . . 75.54 109.335 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.7 p 60.57 126.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.692 1.245 . . . . 73.14 112.326 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -60.72 130.31 45.86 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.11 -0.7 . . . . 74.21 109.11 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 62.12 75.67 0.4 Allowed 'General case' 0 C--N 1.332 -0.183 0 O-C-N 123.825 0.703 . . . . 71.01 109.598 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.95 -101.63 0.15 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.31 -0.859 . . . . 45.44 111.777 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD1' ' HB ' ' A' ' 87' ' ' VAL . 4.0 mm? -121.34 131.96 54.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.137 0.494 . . . . 64.13 112.325 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.61 HG22 ' HB ' ' A' ' 86' ' ' THR . 4.1 t -137.3 119.01 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 74.0 110.033 171.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.732 ' HB2' ' HD2' ' A' ' 62' ' ' TYR . 34.5 m-85 -114.81 121.58 43.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.671 -0.241 . . . . 72.34 110.435 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 83' ' ' THR . 57.6 m -109.96 115.56 30.01 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.997 -0.281 . . . . 72.33 110.585 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.91 143.69 47.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.681 -0.408 . . . . 75.45 111.619 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HG3' HD12 ' A' ' 58' ' ' LEU . 20.5 mmtt 159.41 -119.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.65 1.219 . . . . 72.04 111.479 162.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.77 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 15.5 t90 -135.18 140.31 45.25 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.588 -0.445 . . . . 75.44 112.081 -164.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -110.18 164.14 12.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 73.44 110.836 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 t -69.9 -7.37 39.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 75.23 111.328 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 14.1 m-20 -80.0 -2.27 43.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.856 -0.611 . . . . 75.11 110.39 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.501 HD22 ' HG2' ' A' ' 105' ' ' PRO . 9.0 t30 81.71 -8.53 1.32 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.96 0.788 . . . . 74.03 109.936 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.4 m -85.25 140.15 31.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.344 -0.844 . . . . 75.43 110.398 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.77 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -92.52 126.56 37.66 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.337 -0.616 . . . . 74.22 109.337 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.35 13.67 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.172 -1.013 . . . . 65.51 113.044 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.1 t -136.16 104.41 5.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.743 0.782 . . . . 71.53 110.736 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 43.9 tt0 -106.78 115.66 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.194 -0.912 . . . . 74.43 109.448 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -111.77 137.98 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 74.4 110.62 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.664 HG22 ' HB ' ' A' ' 98' ' ' THR . 16.9 m -129.17 129.92 45.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.899 0.38 . . . . 74.22 111.246 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.49 ' HB ' ' CD1' ' A' ' 69' ' ' LEU . 2.8 p -129.24 124.89 61.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.724 -0.671 . . . . 74.52 110.23 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -113.53 122.68 48.0 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.405 -0.591 . . . . 71.22 109.405 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.37 151.84 19.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.191 0.519 . . . . 64.22 111.85 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -102.21 -24.1 13.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.731 -0.668 . . . . 74.33 110.661 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.46 -56.88 8.83 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.449 -1.315 . . . . 74.53 107.449 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.45 61.2 6.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.27 -1.011 . . . . 74.55 108.27 167.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 14.5 ptp180 -53.03 124.4 14.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.061 -0.972 . . . . 75.14 112.612 -171.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 100.98 -16.45 57.31 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.083 -0.962 . . . . 65.01 112.093 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 118' ' ' TYR . 3.1 tm? -92.5 123.82 36.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.606 -0.516 . . . . 64.23 109.606 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.76 51.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.74 -0.664 . . . . 74.02 109.668 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -116.24 125.71 52.59 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.114 -0.699 . . . . 73.32 109.114 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.664 ' HB ' HG22 ' A' ' 86' ' ' THR . 0.5 OUTLIER -130.49 119.91 23.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.195 0.521 . . . . 75.43 110.279 176.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.438 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 91.9 t80 -123.91 125.43 44.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.535 -0.757 . . . . 75.31 110.372 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 4.5 t70 -109.72 131.99 54.55 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.024 -0.534 . . . . 74.14 109.714 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.8 t -126.0 120.86 31.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.38 -0.6 . . . . 62.12 109.38 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.0 m -109.99 122.14 46.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.959 -0.564 . . . . 73.15 110.048 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.87 119.85 39.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.006 0.431 . . . . 74.21 110.714 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.2 t -99.77 139.77 21.06 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 108.506 -0.924 . . . . 71.24 108.506 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.501 ' HG2' HD22 ' A' ' 79' ' ' ASN . 31.3 Cg_exo -62.12 41.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 124.127 3.218 . . . . 71.32 114.832 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -123.86 150.02 45.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 73.41 108.822 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.0 m -66.55 105.19 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.099 0.475 . . . . 75.42 111.292 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.42 68.56 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.994 -0.622 . . . . 61.23 112.869 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -94.97 111.64 23.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.072 0.463 . . . . 75.23 109.945 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.47 143.57 26.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.869 -0.605 . . . . 74.33 110.618 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.37 122.47 40.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.049 -0.523 . . . . 75.03 109.705 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -129.13 141.8 51.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.976 -0.289 . . . . 74.43 111.389 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -124.68 137.38 54.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.947 -0.761 . . . . 64.34 108.947 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 5.0 tp -124.75 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.188 0.518 . . . . 74.13 110.218 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -116.45 120.96 40.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.837 -0.62 . . . . 74.23 110.467 -178.118 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -107.19 116.89 32.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.599 -0.728 . . . . 74.43 109.083 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.521 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -133.74 125.71 4.04 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.694 -1.241 . . . . 72.34 113.145 -172.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.722 ' HB3' HD21 ' A' ' 95' ' ' LEU . 6.3 p90 -117.01 136.64 52.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.192 0.52 . . . . 74.2 110.032 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 43.6 pttt -119.74 124.66 46.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.866 0.841 . . . . 74.13 111.58 -175.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.491 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.3 mmt180 -100.32 166.37 11.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.256 -1.338 . . . . 74.44 109.06 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.11 -27.25 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.762 0.825 . . . . 75.44 112.813 -172.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -118.36 -12.1 9.93 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.699 0.629 . . . . 74.11 112.699 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.457 HG23 ' HA ' ' A' ' 144' ' ' LEU . 19.5 pt -142.76 145.72 22.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.612 -0.835 . . . . 74.54 111.815 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.604 ' N ' HD21 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -129.02 115.82 18.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.759 -0.46 . . . . 75.42 109.759 178.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.485 ' HB3' HD12 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -130.52 143.07 50.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.331 -0.547 . . . . 73.04 111.634 -175.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.521 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -141.57 138.75 8.91 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 61.01 112.621 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 67.9 m -108.66 112.38 24.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.013 -0.365 . . . . 73.33 110.013 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 9.6 t70 -104.47 148.17 26.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.046 -0.525 . . . . 55.44 110.088 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.1 mtm -131.38 118.31 20.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.312 -0.625 . . . . 75.42 109.312 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -89.78 115.74 27.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.945 -0.761 . . . . 75.41 108.945 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -97.12 99.71 11.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.956 -0.565 . . . . 75.21 110.962 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.55 145.69 37.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.983 -1.117 . . . . 74.25 107.983 169.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.788 ' H ' HD11 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -64.68 -21.67 29.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.613 0.244 . . . . 72.3 111.536 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.53 -18.83 34.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.542 0.21 . . . . 65.2 111.101 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.5 105.66 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.868 -0.682 . . . . 74.1 112.799 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.2 109.45 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.092 2.528 . . . . 61.52 111.366 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -99.09 160.55 14.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.522 -0.308 . . . . 73.43 110.946 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mp -107.38 118.38 55.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.672 -0.411 . . . . 74.21 110.036 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 33.8 ttp180 -115.2 111.15 20.54 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.076 0.465 . . . . 74.31 110.102 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.95 144.29 17.3 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.955 -1.117 . . . . 54.22 112.382 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -137.6 114.71 10.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.127 0.489 . . . . 73.3 110.184 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' A' ' 125' ' ' LEU . 4.2 tp -117.68 123.16 45.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.968 -0.56 . . . . 72.14 109.701 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 7' ' ' TYR . 5.2 t -119.24 121.51 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.494 . . . . 75.05 110.293 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.457 ' HA ' HG23 ' A' ' 123' ' ' ILE . 5.0 mp -108.08 138.64 44.0 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.425 -0.583 . . . . 60.22 109.425 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.45 119.31 4.24 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.607 -0.724 . . . . 73.45 111.358 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.639 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 56.4 t80 -118.16 148.97 41.82 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.299 -1.0 . . . . 72.54 108.299 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -52.79 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.344 0.592 . . . . 74.44 110.973 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.04 -32.74 7.21 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.144 -0.935 . . . . 73.24 112.493 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 90.9 m95 -106.52 146.39 30.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.285 0.846 . . . . 74.4 113.285 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.486 HD13 ' HB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -128.91 142.62 50.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.775 -1.194 . . . . 75.0 107.775 168.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -155.65 123.87 5.83 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.443 -0.577 . . . . 61.45 109.443 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.101 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -142.16 142.14 11.5 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.945 -1.121 . . . . 71.35 111.872 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 36.1 m-85 -123.47 117.17 24.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.032 -0.359 . . . . 75.32 110.032 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.28 122.58 43.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.525 -0.546 . . . . 72.32 109.525 166.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.707 ' HB2' HG22 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -137.2 143.69 42.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.682 0.277 . . . . 73.1 110.485 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.492 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 t30 -118.62 118.88 32.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 65.02 110.471 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.919 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 93.1 m-85 -91.85 121.25 33.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.109 -0.951 . . . . 75.12 110.192 -175.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.37 109.89 14.14 Favored 'General case' 0 C--O 1.254 1.325 0 CA-C-N 114.449 -1.251 . . . . 75.1 109.172 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -71.72 -21.51 61.76 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 125.354 1.659 . . . . 74.04 111.775 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.31 -31.8 71.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.392 -0.966 . . . . 75.31 108.392 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -107.92 -161.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.979 -1.464 . . . . 73.2 107.984 168.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.9 m -111.04 26.76 10.37 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 121.89 -0.506 . . . . 64.42 110.476 171.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -149.31 150.31 32.3 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.99 1.108 . . . . 73.24 113.99 -159.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 p -73.16 128.91 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.537 -0.756 . . . . 72.44 110.231 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 3.9 p -102.49 -33.9 9.34 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.638 -0.71 . . . . 74.13 111.526 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -112.67 129.21 56.48 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.626 -0.43 . . . . 62.23 110.175 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.3 m -124.34 115.33 20.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.033 -0.531 . . . . 75.04 110.665 173.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 7.8 t30 -125.97 120.25 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.96 -0.756 . . . . 72.32 108.96 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -138.34 165.21 27.33 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.741 -0.784 . . . . 71.43 111.921 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.19 133.31 35.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.326 -0.852 . . . . 71.33 110.767 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.51 127.09 64.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.007 -0.738 . . . . 62.01 109.007 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.58 166.79 26.07 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 119.735 -1.221 . . . . 61.14 112.831 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.602 ' CE1' HD23 ' A' ' 180' ' ' LEU . 37.4 p90 -138.55 140.4 39.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.168 0.509 . . . . 74.41 110.649 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -103.4 132.62 49.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.132 -0.94 . . . . 74.22 109.935 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 m -131.37 163.2 28.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.782 -0.821 . . . . 74.41 108.782 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -51.75 -50.29 60.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.7 0.285 . . . . 74.21 111.541 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.703 ' HA ' ' HE3' ' A' ' 197' ' ' LYS . 27.0 mm-40 -101.41 -22.51 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.184 0.438 . . . . 74.05 112.184 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 194' ' ' ILE . 72.7 t80 -124.29 144.89 49.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.666 0.27 . . . . 75.03 111.681 -170.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 5.1 tp-100 -135.61 122.4 21.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.947 -0.39 . . . . 75.15 109.947 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.655 HD11 HG13 ' A' ' 194' ' ' ILE . 3.8 tt -125.88 138.15 53.78 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.261 -0.575 . . . . 73.31 111.786 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.627 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 12.4 m170 -128.31 114.17 16.56 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.889 -0.782 . . . . 72.44 108.889 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 95.0 m -90.86 141.42 28.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.856 -0.424 . . . . 72.31 109.856 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -129.83 141.22 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.992 0.425 . . . . 73.21 110.737 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 5.4 t -130.95 128.36 62.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.296 -0.411 . . . . 74.12 111.042 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 0.2 OUTLIER -109.14 90.85 3.42 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.645 -0.872 . . . . 73.21 108.645 176.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 60.65 -169.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 71.45 111.718 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.83 -5.59 86.65 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.42 -0.809 . . . . 62.31 111.981 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 24.2 m -94.32 -27.1 16.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.64 0.607 . . . . 74.21 112.64 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 51.5 mt-10 -135.02 129.6 34.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.931 -0.708 . . . . 74.34 112.223 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.441 ' HD2' HG23 ' A' ' 184' ' ' VAL . 44.3 m-85 -127.23 143.84 51.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.619 -0.718 . . . . 72.25 109.713 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . 179.74 -138.24 3.36 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.778 -0.725 . . . . 74.54 112.101 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 152.6 -155.61 26.23 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.168 -1.015 . . . . 71.45 113.037 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.1 p -142.09 138.55 31.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.291 0.567 . . . . 74.34 110.817 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.797 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.1 mp -119.8 118.76 58.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.645 -0.707 . . . . 72.15 109.612 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.437 ' HB3' ' HB3' ' A' ' 179' ' ' GLN . 44.8 t80 -108.71 119.69 40.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.108 0.48 . . . . 65.53 110.025 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.57 131.54 52.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.743 -0.662 . . . . 75.15 109.776 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.703 ' HE3' ' HA ' ' A' ' 177' ' ' GLU . 18.1 pttp -107.55 127.36 53.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 73.5 110.943 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 202' ' ' LEU . 47.6 t -82.99 155.74 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 74.24 109.446 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -61.77 -45.04 95.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.893 0.378 . . . . 65.41 110.083 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.66 148.35 48.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.722 -1.214 . . . . 74.44 107.722 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -63.41 86.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.562 0.696 . . . . 74.51 112.457 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 198' ' ' VAL . 36.2 mt -144.24 115.16 7.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.57 -1.195 . . . . 74.14 108.551 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.46 128.94 52.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.776 -0.824 . . . . 52.31 108.776 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -123.46 138.33 54.61 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.702 -0.399 . . . . 73.33 111.212 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.39 135.5 48.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.024 -0.535 . . . . 75.43 110.177 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.874 HG21 HG23 ' A' ' 221' ' ' ILE . 87.9 t -114.58 136.22 51.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.663 -0.699 . . . . 75.44 109.612 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.747 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 28.7 t-20 -114.71 132.34 56.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.802 0.334 . . . . 72.15 110.402 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.479 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -122.58 136.49 54.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.651 -0.704 . . . . 74.5 110.443 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.97 127.13 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.005 -0.543 . . . . 65.24 109.63 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.679 ' HB2' HG21 ' A' ' 217' ' ' THR . 28.4 t90 -130.72 126.11 35.62 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.529 -0.305 . . . . 75.1 110.472 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 215' ' ' SER . 3.5 t -101.29 116.39 32.68 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 73.42 109.823 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.48 141.26 56.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.335 -0.848 . . . . 74.04 111.158 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 128.36 31.49 0.67 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.864 -0.684 . . . . 75.51 111.655 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 67.36 12.16 8.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.875 0.47 . . . . 63.1 111.826 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.558 ' HB2' HG21 ' A' ' 211' ' ' THR . 17.8 m -80.45 160.84 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 74.22 109.777 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -77.66 153.37 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.379 . . . . 74.24 111.122 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 210' ' ' TRP . 26.4 m -84.54 131.23 34.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.555 . . . . 74.31 109.744 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -88.54 116.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.947 -0.76 . . . . 75.12 108.947 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 54.5 p90 -123.44 141.34 52.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -144.83 141.53 10.07 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.226 -0.75 . . . . 74.22 111.226 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.874 HG23 HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -119.53 130.54 73.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.879 0.371 . . . . 72.53 110.426 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -129.82 129.48 44.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.605 -0.725 . . . . 72.15 109.954 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -117.97 129.15 55.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.288 -0.415 . . . . 71.2 110.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -115.66 115.83 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.021 -0.733 . . . . 73.05 109.021 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 233' ' ' PHE . 3.9 p90 -132.78 119.25 20.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.248 0.547 . . . . 73.34 111.77 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 35.4 tt0 -89.54 97.94 11.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 73.24 109.075 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -97.15 -24.62 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 73.32 109.668 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 4.6 t70 -114.63 137.22 22.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.653 -0.869 . . . . 72.15 108.653 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -34.97 -51.89 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.381 3.388 . . . . 74.31 115.214 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -107.23 4.78 27.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.902 0.334 . . . . 75.32 111.902 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -124.73 122.58 37.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.453 0.644 . . . . 73.4 111.958 -175.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 50.7 t -113.18 119.09 36.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 75.2 108.84 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.501 ' HB2' ' CE2' ' A' ' 225' ' ' TYR . 57.6 m-85 -100.2 132.13 45.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.434 -0.348 . . . . 64.55 110.272 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 21.1 t -121.75 140.91 51.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.046 0.45 . . . . 62.1 110.349 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -127.16 140.8 52.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.095 -0.705 . . . . 74.33 109.095 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 48.3 mttm -135.6 141.4 45.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.693 -0.484 . . . . 73.24 109.693 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.576 HG12 HG12 ' A' ' 221' ' ' ILE . 5.4 p -140.6 140.13 34.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.488 -0.485 . . . . 74.04 110.028 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.564 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -107.27 150.36 26.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.573 -0.74 . . . . 75.22 110.381 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 241' ' ' SER . 28.3 p-10 -43.9 -33.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.95 1.406 . . . . 74.51 114.064 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.475 ' HB3' HD11 ' A' ' 242' ' ' LEU . 17.9 t -82.08 21.95 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 70.31 110.024 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.527 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 50.1 m 68.5 36.33 2.95 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 115.232 -0.894 . . . . 74.23 111.265 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.819 HD21 HD13 ' A' ' 262' ' ' LEU . 7.2 mp -95.68 125.45 40.28 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.309 -0.556 . . . . 74.43 111.316 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.52 116.57 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.659 -0.701 . . . . 75.44 110.022 -170.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -126.35 145.76 15.9 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.55 -0.833 . . . . 60.2 112.654 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.489 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -118.39 148.91 42.05 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.062 0.458 . . . . 63.3 110.247 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.94 121.79 2.42 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.604 -0.726 . . . . 61.45 111.544 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -108.13 118.84 37.8 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.963 -0.384 . . . . 74.24 109.963 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.626 HG21 HG23 ' A' ' 258' ' ' THR . 14.1 p -113.6 112.86 24.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 72.33 109.895 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 257' ' ' LEU . 22.4 mp0 -118.97 124.83 47.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.937 -0.574 . . . . 72.35 110.168 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 26.0 m -95.91 88.53 4.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.92 -0.77 . . . . 75.52 108.92 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 44.8 tp -82.04 78.25 8.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.733 . . . . 75.45 109.511 -175.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 0.5 OUTLIER 68.1 152.71 0.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.058 -0.974 . . . . 74.31 109.901 -172.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.17 74.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.481 2.12 . . . . 64.51 112.059 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.64 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.34 -0.845 . . . . 72.51 111.441 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.2 122.0 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 74.23 110.695 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 30.8 tttp -117.87 122.01 42.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.532 -0.544 . . . . 64.44 109.532 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 249' ' ' GLN . 52.3 tp -100.26 131.22 46.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.309 -0.405 . . . . 73.22 110.009 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.626 HG23 HG21 ' A' ' 248' ' ' THR . 18.5 p -128.91 110.87 12.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.326 0.584 . . . . 71.43 110.558 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.858 HD23 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -108.9 125.54 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.453 -0.943 . . . . 75.52 108.453 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.2 m -135.38 138.86 43.73 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.61 -0.436 . . . . 72.44 110.359 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.434 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -148.05 128.07 13.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.111 -0.495 . . . . 72.11 109.766 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.819 HD13 HD21 ' A' ' 242' ' ' LEU . 2.4 tm? -111.44 115.22 28.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.474 -0.936 . . . . 75.42 108.474 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.575 ' HB3' HG12 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -92.24 108.49 19.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.54 -1.282 . . . . 73.04 107.54 174.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.812 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -69.79 105.06 2.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.888 -0.782 . . . . 71.31 108.888 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -59.84 -15.72 35.91 Favored Glycine 0 C--N 1.32 -0.31 0 C-N-CA 121.222 -0.513 . . . . 72.33 112.638 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -90.16 -25.83 20.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.747 0.308 . . . . 75.33 110.767 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 19.5 m120 -115.81 -27.96 6.86 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.362 0.875 . . . . 75.24 113.362 -170.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 263' ' ' LEU . 27.8 m -62.62 -19.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 117.965 0.348 . . . . 73.3 111.522 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.72 -40.73 84.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.996 -0.547 . . . . 74.53 110.574 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.94 -16.38 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 72.22 110.96 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.15 79.39 0.87 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.913 -0.66 . . . . 71.44 112.238 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.509 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -159.27 87.34 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.865 -0.683 . . . . 61.23 112.235 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.08 147.07 39.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.373 -0.232 . . . . 72.2 110.373 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.5 mmtm -96.19 137.9 34.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.592 -0.522 . . . . 73.24 109.592 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -130.03 126.74 38.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.002 0.429 . . . . 72.22 110.245 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.41 117.74 2.21 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.892 -0.671 . . . . 71.23 111.473 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.858 HD23 HD23 ' A' ' 259' ' ' LEU . 3.1 tm? -115.12 135.85 53.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.181 -0.674 . . . . 72.52 109.181 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.35 137.91 6.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.107 -1.044 . . . . 74.43 112.984 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.78 131.38 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.6 -0.889 . . . . 71.02 108.6 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 26.5 tt0 -114.95 111.31 20.97 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.59 -0.893 . . . . 72.42 108.59 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.621 ' HD2' HD13 ' A' ' 31' ' ' LEU . 26.3 t80 -112.83 145.86 39.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.799 -0.637 . . . . 73.53 109.805 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -138.04 142.89 40.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.86 0.362 . . . . 71.23 110.295 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.549 ' O ' HD21 ' A' ' 284' ' ' LEU . . . -122.83 107.29 11.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.463 -0.569 . . . . 73.23 109.463 172.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.549 HD21 ' O ' ' A' ' 283' ' ' ALA . 1.7 mm? -138.62 -0.57 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.229 -0.896 . . . . 53.42 109.676 -176.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.942 -1.026 . . . . 74.24 109.759 -172.566 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 tpp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.011 0.434 . . . . 74.44 110.36 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.84 178.49 4.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 65.12 109.973 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 14.9 p -100.52 131.96 23.07 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.965 -0.383 . . . . 72.21 109.965 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.75 143.51 99.62 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 75.11 111.836 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.93 89.66 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.582 2.188 . . . . 72.44 112.14 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.3 p -70.78 -30.91 67.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.684 -0.689 . . . . 74.43 110.724 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.748 ' HB3' HG23 ' A' ' 143' ' ' VAL . 30.5 p90 -61.05 -26.37 67.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.567 . . . . 70.15 110.892 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.4 -19.46 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.107 -0.497 . . . . 64.14 110.751 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.894 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 14.5 t70 -93.99 -13.77 26.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.383 . . . . 74.21 110.318 -177.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.579 HD12 HG22 ' A' ' 143' ' ' VAL . 86.8 mt -57.62 -36.09 71.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.22 0.533 . . . . 73.21 110.001 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.9 30.68 4.32 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.298 -0.864 . . . . 54.01 111.523 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.894 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 5.0 tppp? -61.84 -57.89 10.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.458 . . . . 73.34 110.191 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -67.02 -39.11 86.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.542 -0.754 . . . . 73.33 110.258 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.76 93.47 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.071 -0.968 . . . . 61.24 112.633 -171.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -60.68 -39.93 90.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.665 0.211 . . . . 75.34 111.405 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 38.5 t70 -68.16 -36.65 79.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 65.41 111.036 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.507 ' CG1' ' HB2' ' A' ' 207' ' ' ASN . 26.9 t -84.03 -46.62 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.202 0.445 . . . . 74.5 112.202 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -72.38 -43.47 63.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.814 0.34 . . . . 75.33 110.906 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.6 p -111.97 71.94 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.141 0.972 . . . . 72.55 108.48 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 18.8 pttm -85.86 173.11 10.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.925 -1.489 . . . . 74.25 112.563 -166.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.58 97.11 0.2 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.517 -1.033 . . . . 63.35 110.517 170.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -115.81 146.03 42.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.827 0.346 . . . . 74.32 110.305 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -72.23 90.12 0.52 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.763 -0.732 . . . . 72.51 111.918 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -80.68 -3.81 52.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.153 0.501 . . . . 65.54 110.308 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.93 58.19 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.627 -0.797 . . . . 73.5 113.57 174.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 pp -140.66 171.79 13.62 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.553 1.168 . . . . 74.23 113.862 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.906 HG23 HD12 ' A' ' 277' ' ' LEU . 33.3 mm -105.75 122.07 58.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 113.121 -1.854 . . . . 71.41 108.945 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.674 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 11.2 pttp -126.65 154.31 44.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.186 0.517 . . . . 75.41 110.644 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -148.03 149.86 32.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.753 -0.832 . . . . 75.12 108.753 169.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 43' ' ' SER . 3.4 p-10 -139.49 131.02 27.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.786 0.803 . . . . 73.2 111.419 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.6 OUTLIER -94.16 124.85 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.577 -1.192 . . . . 73.11 108.487 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.671 ' HB3' ' HZ3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -126.4 124.48 40.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 73.31 110.554 178.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 283' ' ' ALA . 88.3 m -137.07 120.96 17.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.535 -0.757 . . . . 71.42 109.121 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -136.78 126.12 24.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.107 0.48 . . . . 73.33 110.366 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.0 m -137.07 138.51 40.47 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.923 -0.769 . . . . 75.3 108.923 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' A' ' 65' ' ' THR . 49.3 mt-10 -77.76 61.68 2.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.959 0.885 . . . . 64.54 110.194 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -137.61 18.92 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.149 -1.387 . . . . 75.13 108.341 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.8 -8.55 79.64 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.21 -0.904 . . . . 63.12 113.943 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.4 126.02 48.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.777 1.288 . . . . 64.45 111.986 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.951 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 19.8 tt0 -142.68 126.48 17.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.381 -0.6 . . . . 75.01 109.381 166.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.5 127.82 38.08 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.031 -0.418 . . . . 75.01 111.56 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.8 m -127.38 116.78 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 60.33 110.344 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.4 t -118.01 122.88 44.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.59 -0.522 . . . . 64.51 109.59 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 m -120.72 126.76 50.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.669 0.271 . . . . 74.21 110.912 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.98 134.94 8.09 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.719 -0.753 . . . . 72.43 111.96 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -121.57 135.37 55.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.73 -0.47 . . . . 72.51 109.73 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.98 129.32 29.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.278 0.561 . . . . 72.31 111.614 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.779 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m120 -93.7 124.27 37.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.368 -0.833 . . . . 73.33 109.399 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 p -82.5 19.36 1.28 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.263 0.468 . . . . 75.41 112.263 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.05 -42.17 76.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.172 0.511 . . . . 73.21 109.799 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.757 HG21 ' H ' ' A' ' 52' ' ' THR . 1.6 t -160.15 -73.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 72.13 109.647 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.757 ' H ' HG21 ' A' ' 51' ' ' THR . 37.8 m -156.41 86.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.737 -0.468 . . . . 62.25 109.737 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.779 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 46.7 tptt -128.9 91.71 3.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.65 -0.5 . . . . 74.24 109.65 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.3 121.09 63.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.204 -0.453 . . . . 62.35 111.178 -174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 p -110.36 140.31 44.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.77 -0.65 . . . . 74.14 109.984 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.39 19.46 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.316 -0.945 . . . . 75.24 112.753 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -141.88 133.06 26.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.864 -0.791 . . . . 64.21 108.864 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.79 124.53 44.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.757 -0.461 . . . . 74.34 109.757 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -113.72 118.37 34.13 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.102 -0.499 . . . . 74.41 109.659 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -110.77 122.82 48.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.913 -0.773 . . . . 74.33 108.913 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.951 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 72.1 mttt -129.4 134.78 48.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.298 0.57 . . . . 72.12 111.337 -172.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.629 ' HE1' ' HD1' ' A' ' 64' ' ' TRP . 49.4 t80 -106.81 119.51 39.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.485 -0.931 . . . . 71.42 108.485 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.497 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 63.6 ttm-85 -118.55 110.18 17.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.356 0.598 . . . . 75.14 111.654 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.629 ' HD1' ' HE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.58 125.17 35.54 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 114.948 -1.024 . . . . 74.33 109.811 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -81.0 -178.71 7.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 125.047 1.467 . . . . 74.25 111.915 -172.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.637 ' H ' HG23 ' A' ' 65' ' ' THR . 49.4 mt-10 71.99 -50.27 0.69 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.662 0.785 . . . . 73.41 110.937 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -95.06 -139.94 0.24 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.682 -1.229 . . . . 72.42 107.682 169.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.8 67.8 0.42 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.115 -0.794 . . . . 73.42 111.115 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -100.42 129.53 46.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.806 -0.757 . . . . 73.11 110.609 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.5 m -138.31 111.99 8.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.404 -0.362 . . . . 65.21 110.886 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -104.49 119.17 38.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.43 -0.952 . . . . 70.33 108.43 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.434 HG23 ' HB3' ' A' ' 61' ' ' LYS . 11.9 p -128.53 138.08 52.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.953 0.406 . . . . 73.42 111.87 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 43.1 mt-10 -117.54 120.63 38.65 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.809 -0.811 . . . . 72.13 108.809 166.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 7.0 pttp -110.83 105.4 14.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.355 0.598 . . . . 73.12 109.948 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -98.51 133.18 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.142 -0.936 . . . . 75.01 111.161 -174.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -110.47 143.55 40.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.937 -0.764 . . . . 70.52 108.937 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.8 t -56.4 -18.43 11.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.028 0.531 . . . . 74.33 112.149 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 24.7 t70 -67.21 -6.64 18.98 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.797 0.332 . . . . 72.35 110.738 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 51.7 m-80 79.79 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.155 0.982 . . . . 74.54 110.058 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -114.84 117.79 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.377 -0.829 . . . . 75.22 110.301 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.79 119.59 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.101 -0.333 . . . . 73.01 110.101 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -107.24 88.1 0.52 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.609 -0.805 . . . . 64.42 111.775 175.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.571 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 35.8 m -84.32 101.17 11.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.208 0.527 . . . . 75.22 110.275 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 3.7 tm-20 -114.75 128.25 56.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.604 -0.726 . . . . 75.51 109.683 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.98 121.74 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.297 0.57 . . . . 74.0 110.571 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.7 m -107.32 129.02 54.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 72.14 109.93 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.16 119.55 49.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.265 0.555 . . . . 73.54 110.842 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.57 118.98 36.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.629 -1.249 . . . . 71.14 107.629 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.71 169.34 11.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.681 0.753 . . . . 73.23 112.341 -166.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -111.91 -2.03 15.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.998 -1.001 . . . . 71.22 110.229 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.401 ' HB3' ' OD1' ' A' ' 89' ' ' ASP . 53.2 tp -85.08 -55.43 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 74.23 110.026 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -118.81 79.63 1.42 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.978 -0.749 . . . . 75.33 108.978 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -47.39 129.08 12.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.475 -0.784 . . . . 74.31 112.435 -171.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.45 -4.25 47.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.205 -0.907 . . . . 70.52 111.973 -173.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -88.02 114.76 24.95 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.825 -0.435 . . . . 71.24 109.825 175.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.07 121.03 36.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 73.43 110.119 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.5 mm? -109.46 127.66 54.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.457 -0.792 . . . . 62.25 109.245 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.878 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.2 t -129.13 128.92 44.44 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 73.32 109.984 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.744 ' HD2' HG12 ' A' ' 114' ' ' ILE . 80.4 t80 -121.38 125.84 47.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.842 -0.617 . . . . 73.45 110.242 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 2.1 m-20 -108.23 121.72 45.46 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.765 -0.458 . . . . 65.12 109.765 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.571 ' OG ' ' HB ' ' A' ' 83' ' ' THR . 8.5 p -115.67 120.18 38.53 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.533 -0.543 . . . . 71.53 109.533 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.3 m -101.34 121.43 41.89 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.858 -0.61 . . . . 65.34 109.528 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -128.46 119.76 25.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.075 -0.512 . . . . 75.44 109.737 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -113.71 103.44 55.33 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.252 -0.431 . . . . 74.3 111.085 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.63 -14.31 34.97 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.209 2.606 . . . . 74.33 112.938 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.429 ' OD1' ' HB2' ' A' ' 104' ' ' SER . 24.9 p30 -72.07 -21.0 61.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.924 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 p -126.54 -37.54 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.992 -0.549 . . . . 74.21 111.016 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.24 50.02 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.021 -0.609 . . . . 71.03 112.471 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -87.59 145.82 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 75.45 110.811 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.31 125.52 46.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.142 -0.688 . . . . 73.54 109.142 171.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -118.84 126.22 51.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.72 -0.474 . . . . 73.3 109.72 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.31 124.49 49.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.907 -0.588 . . . . 63.14 111.367 -173.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.68 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 54.8 mttp -111.55 136.24 51.01 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.101 -1.074 . . . . 73.21 108.101 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.749 HG21 ' HB2' ' A' ' 129' ' ' MET . 0.4 OUTLIER -125.28 130.95 72.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.325 -0.62 . . . . 62.45 109.325 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.878 ' HB2' HG23 ' A' ' 98' ' ' THR . 3.1 mptp? -123.42 120.73 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.605 -0.517 . . . . 75.41 109.605 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 t -114.21 116.31 28.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.628 -0.879 . . . . 72.45 108.628 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.464 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -130.08 121.66 3.44 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 119.541 -1.314 . . . . 72.4 112.574 -174.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -111.96 117.6 33.15 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.971 -0.751 . . . . 73.21 108.971 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -109.93 122.19 46.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.694 -0.684 . . . . 75.15 109.284 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -106.65 157.01 18.02 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.401 -0.592 . . . . 75.25 109.401 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.716 ' HG3' ' HD2' ' A' ' 122' ' ' HIS . 7.7 pt-20 -51.68 -27.03 10.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.634 0.774 . . . . 73.43 112.784 -172.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.716 ' HD2' ' HG3' ' A' ' 121' ' ' GLU . 66.5 m-70 -106.22 -24.09 12.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.212 0.449 . . . . 72.13 112.212 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.719 HD13 HD11 ' A' ' 142' ' ' LEU . 17.7 tt -147.25 141.61 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 120.324 -0.55 . . . . 71.11 111.992 -173.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.631 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -110.59 117.78 34.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.735 0.302 . . . . 73.31 111.717 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.524 HD11 HD12 ' A' ' 142' ' ' LEU . 4.3 mm? -111.7 137.49 49.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.821 0.343 . . . . 74.42 111.104 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.464 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -146.25 131.03 3.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.88 -0.676 . . . . 62.3 112.692 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 58.1 m -113.35 119.7 38.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.966 0.412 . . . . 75.3 110.851 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -105.29 136.39 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.898 -0.592 . . . . 71.13 110.289 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.749 ' HB2' HG21 ' A' ' 114' ' ' ILE . 64.9 mtt -133.86 121.49 21.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.954 -0.388 . . . . 73.34 109.954 174.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.41 120.13 41.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.038 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -93.35 105.73 17.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.277 0.56 . . . . 73.33 111.069 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.53 172.87 7.65 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.767 -0.827 . . . . 64.44 108.767 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.794 HD13 ' H ' ' A' ' 133' ' ' ILE . 3.5 mp -67.07 -33.12 61.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.309 -0.626 . . . . 70.23 109.309 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.47 -15.29 59.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.545 -0.752 . . . . 75.42 110.951 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.55 178.9 17.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.4 -0.905 . . . . 45.31 112.692 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -87.93 128.81 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.91 2.406 . . . . 75.43 112.812 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 t -99.36 140.75 33.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 73.45 108.757 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.82 118.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.551 -0.459 . . . . 73.3 111.071 -171.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.812 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 40.9 mtp180 -110.12 125.46 53.02 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.885 -0.783 . . . . 72.3 108.885 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.58 10.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 119.709 -1.234 . . . . 65.4 111.444 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.54 116.02 19.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.13 0.491 . . . . 63.42 110.926 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.719 HD11 HD13 ' A' ' 123' ' ' ILE . 6.6 tp -121.81 124.64 44.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 75.52 110.642 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.748 HG23 ' HB3' ' A' ' 7' ' ' TYR . 86.1 t -112.37 129.56 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.302 -0.863 . . . . 75.44 109.87 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.859 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 1.4 mm? -108.28 138.61 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.53 -0.759 . . . . 75.11 109.896 -170.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.22 118.53 5.59 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.561 -0.745 . . . . 75.34 112.058 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.796 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 86.5 m-85 -127.87 148.4 50.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 75.3 109.723 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.71 98.42 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.481 -0.327 . . . . 72.54 111.054 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.13 -21.51 20.05 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 116.29 -0.414 . . . . 74.42 112.756 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.796 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 24.8 m95 -105.54 131.82 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 75.2 111.209 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.4 mt -112.12 136.51 51.4 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.385 -0.598 . . . . 73.41 109.385 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.859 ' HB1' ' HB2' ' A' ' 144' ' ' LEU . . . -131.77 153.25 50.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.285 -0.416 . . . . 60.52 110.038 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -158.46 133.99 3.66 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.937 -0.865 . . . . 44.34 110.937 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -142.43 121.82 13.17 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.712 -0.795 . . . . 71.22 110.184 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.712 ' HG2' ' HB3' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -117.72 120.19 37.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.956 0.884 . . . . 71.13 110.102 176.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.415 ' C ' HD21 ' A' ' 156' ' ' ASN . 15.1 ptt? -117.72 133.46 55.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.153 -0.93 . . . . 74.31 109.304 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.591 HD21 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -110.54 116.53 31.52 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.781 -0.822 . . . . 74.53 108.781 -173.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 45.4 m-85 -94.36 118.38 31.52 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 123.577 0.548 . . . . 71.4 110.105 -176.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.962 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.3 tp10 -91.21 102.17 14.9 Favored 'General case' 0 C--O 1.262 1.752 0 CA-C-N 115.831 -0.622 . . . . 71.53 109.596 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 m -70.52 -25.2 63.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 112.893 -1.958 . . . . 74.54 110.93 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.87 71.84 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.01 -0.737 . . . . 62.13 109.01 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.632 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 69.6 mmtt -104.72 -163.41 0.96 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.844 -1.169 . . . . 73.1 107.844 170.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.3 t -108.35 26.37 10.54 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 121.838 -0.539 . . . . 74.13 110.294 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.3 172.2 11.33 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 118.89 -1.124 . . . . 74.05 111.542 -166.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.11 135.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 73.44 110.168 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.962 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.4 t -94.41 -21.48 18.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.946 -0.57 . . . . 75.13 110.815 -174.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.429 ' HG3' HG21 ' A' ' 165' ' ' THR . 46.2 mt-30 -143.58 134.66 25.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.854 0.359 . . . . 75.24 110.314 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -117.74 106.75 13.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.211 -0.45 . . . . 75.35 109.984 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.712 ' HB3' ' HG2' ' A' ' 154' ' ' GLN . 2.7 t-20 -115.94 122.58 45.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.69 -0.485 . . . . 74.22 109.69 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 90.1 m-85 -122.05 156.74 32.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.53 -0.305 . . . . 74.2 110.518 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -152.0 129.0 11.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.041 0.448 . . . . 62.41 110.888 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.89 125.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.637 -0.875 . . . . 75.23 108.637 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -142.11 109.16 0.56 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.934 -1.126 . . . . 74.23 112.507 -176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.707 ' CZ ' HD22 ' A' ' 180' ' ' LEU . 11.4 p90 -114.16 133.34 55.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.036 -0.728 . . . . 74.35 109.036 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -132.55 130.86 40.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.963 -1.017 . . . . 74.13 113.066 -162.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 m -121.01 155.51 34.17 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.111 -1.44 . . . . 74.21 107.111 166.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -49.75 -46.45 50.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 75.11 112.417 -170.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.45 -22.98 20.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.665 0.617 . . . . 72.05 112.665 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.73 119.72 15.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.325 0.583 . . . . 74.41 111.895 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -135.28 143.01 46.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.739 -0.664 . . . . 72.44 109.984 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.931 ' HB3' HG13 ' A' ' 194' ' ' ILE 0.256 0.0 OUTLIER -127.45 139.0 53.1 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.382 1.087 . . . . 75.23 111.503 159.274 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 45.3 m-70 -124.05 115.59 21.42 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.707 -2.042 . . . . 73.25 107.228 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 23.8 m -111.93 134.79 53.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.479 -0.328 . . . . 73.21 110.489 -173.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -118.75 140.21 50.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.34 -0.615 . . . . 72.02 109.34 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 25.5 t -121.56 118.61 56.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.239 -0.437 . . . . 44.0 110.959 -176.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.644 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 80.5 m-20 -97.68 91.09 5.23 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.079 -0.964 . . . . 73.15 108.96 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 58.42 -168.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.754 -1.112 . . . . 73.51 110.214 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.83 86.9 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.275 -0.964 . . . . 71.33 111.216 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.5 m -89.38 -26.75 20.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.566 0.58 . . . . 75.22 112.566 -172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 40.4 tt0 -139.14 117.61 12.08 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 119.779 -0.768 . . . . 63.42 112.255 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -109.18 126.21 53.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 73.32 109.374 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -129.23 109.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.844 -0.693 . . . . 73.35 112.503 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -105.63 131.77 10.8 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.735 -0.745 . . . . 71.42 111.725 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.6 t -119.06 137.8 53.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.895 -0.409 . . . . 74.04 109.895 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 1.03 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.5 mp -118.91 132.56 68.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.445 . . . . 75.31 109.894 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.462 ' HH ' ' CD ' ' A' ' 203' ' ' GLU . 4.4 t80 -111.76 119.9 40.18 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.352 -0.981 . . . . 74.42 108.352 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.411 ' HB3' ' HB ' ' A' ' 204' ' ' THR . 0.3 OUTLIER -122.39 112.43 18.07 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.184 -0.673 . . . . 70.51 109.184 -176.201 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -98.19 113.37 25.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.848 -0.615 . . . . 75.2 109.688 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 200' ' ' LYS . 47.9 t -80.63 150.16 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 65.34 109.129 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -61.13 -22.21 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 71.53 111.368 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 4.4 mptp? -91.27 -165.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.567 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.99 46.16 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.839 0.352 . . . . 74.53 110.665 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.555 ' HG ' ' HD1' ' A' ' 225' ' ' TYR . 3.7 tt -132.51 119.81 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.109 0.48 . . . . 75.51 110.248 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.462 ' CD ' ' HH ' ' A' ' 195' ' ' TYR . 49.0 mt-10 -111.53 138.41 48.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.113 -0.699 . . . . 62.52 109.113 171.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 196' ' ' GLN . 35.1 m -122.13 139.73 53.39 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.464 -0.569 . . . . 73.54 109.464 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -129.74 136.95 50.25 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.942 0.401 . . . . 65.2 110.16 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 1.03 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 10.3 t -115.32 137.06 50.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.886 -0.597 . . . . 75.32 110.323 -176.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.507 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 27.1 t-20 -120.77 127.41 51.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.034 0.445 . . . . 74.45 110.965 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.5 mm? -122.78 129.75 52.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.363 -0.835 . . . . 73.12 109.57 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -132.75 126.22 31.95 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.618 -0.433 . . . . 72.01 109.865 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -131.68 124.22 29.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.03 0.443 . . . . 74.22 110.69 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.88 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 1.1 p -104.46 103.58 13.3 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.676 -0.693 . . . . 70.0 110.523 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.34 127.8 33.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.846 -0.615 . . . . 74.54 110.553 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.2 27.11 73.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.066 -0.587 . . . . 71.25 112.178 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.88 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 10.7 t-20 -138.77 -147.36 0.23 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.533 -0.914 . . . . 73.22 108.533 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 214' ' ' ASN . 51.5 m -77.58 178.72 7.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.176 0.512 . . . . 72.01 112.329 -176.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.65 154.74 24.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.178 -0.919 . . . . 73.34 111.786 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.2 t -78.4 139.82 38.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 71.32 110.406 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.402 ' HD3' ' N ' ' A' ' 218' ' ' ARG . 0.3 OUTLIER -107.41 135.16 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.188 -0.46 . . . . 74.25 109.981 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -130.74 135.57 47.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.137 -0.483 . . . . 71.03 109.77 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.22 171.66 32.8 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.845 -0.693 . . . . 75.11 111.716 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -138.37 147.56 25.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.958 0.409 . . . . 72.03 111.333 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -128.93 130.42 46.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.485 -0.779 . . . . 73.42 109.933 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -115.76 128.53 55.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.63 0.252 . . . . 73.54 111.128 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 2.4 ttmp? -109.04 116.06 31.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 75.34 109.377 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.555 ' HD1' ' HG ' ' A' ' 202' ' ' LEU . 10.8 t80 -119.0 131.96 56.03 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.957 0.408 . . . . 73.41 110.389 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -96.73 99.62 11.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 65.21 110.132 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 227' ' ' ILE . 0.2 OUTLIER -94.38 -28.87 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.267 -0.424 . . . . 72.13 111.133 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.6 141.13 19.72 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.642 -0.503 . . . . 65.21 109.642 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.3 -30.62 20.37 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.158 2.572 . . . . 74.22 113.524 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.06 -9.46 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.111 0.412 . . . . 71.31 112.111 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.63 136.63 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.978 0.362 . . . . 65.42 111.978 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -131.26 142.42 50.14 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.32 -0.4 . . . . 64.51 110.538 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.11 134.15 52.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 70.41 111.052 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 46.5 p -130.97 118.36 20.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.993 -0.549 . . . . 42.34 110.622 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.12 141.5 41.23 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.743 -0.466 . . . . 73.34 109.743 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -142.34 140.92 32.28 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.868 -0.333 . . . . 75.21 110.787 -177.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 242' ' ' LEU . 9.4 p -140.55 146.53 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.513 -0.312 . . . . 74.33 110.284 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -115.92 150.05 37.74 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.65 -0.704 . . . . 71.33 109.664 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' A' ' 241' ' ' SER . 27.2 p-10 -53.82 -18.55 3.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.952 0.783 . . . . 73.33 112.83 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.473 ' HB3' ' HG ' ' A' ' 242' ' ' LEU . 34.4 t -78.85 21.37 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.713 0.292 . . . . 72.35 110.54 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 239' ' ' ASN . 46.1 t 64.31 32.24 12.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.198 0.523 . . . . 65.43 109.746 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.574 ' HB3' HD11 ' A' ' 262' ' ' LEU . 58.5 mt -99.07 114.71 27.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.436 -0.506 . . . . 73.04 109.981 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.751 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -109.68 117.96 55.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.929 0.395 . . . . 73.0 110.57 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -116.92 139.71 15.33 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.935 -0.65 . . . . 61.35 113.126 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.16 127.81 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.819 -0.808 . . . . 71.44 108.819 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -139.85 132.36 5.54 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.942 -1.123 . . . . 70.2 112.641 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -129.17 133.61 47.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.087 0.47 . . . . 74.0 110.16 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 13.5 t -123.21 136.15 54.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.013 -0.539 . . . . 73.54 109.776 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -142.69 149.12 38.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.295 -0.411 . . . . 74.52 110.665 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 13.8 m -98.89 121.71 41.19 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.455 ' CB ' HG21 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.38 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.286 0.366 . . . . 75.25 110.817 -173.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.722 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 63.3 mttm -150.37 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.58 -0.282 . . . . 74.22 111.558 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.722 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 3.0 Cg_exo -75.0 -76.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.91 1.74 . . . . 75.53 112.767 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -152.63 28.72 0.85 Allowed Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.85 -0.691 . . . . 71.32 112.038 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.493 HD11 ' CE2' ' A' ' 281' ' ' PHE . 1.0 OUTLIER -106.99 122.42 61.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.104 0.478 . . . . 72.34 110.485 -178.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -104.04 130.73 51.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.682 -0.69 . . . . 72.21 109.839 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.4 tp -98.39 124.37 43.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.213 -0.662 . . . . 64.43 109.213 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.8 m -116.11 110.33 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.933 -0.576 . . . . 73.44 109.907 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.824 HD23 HD22 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -114.23 124.82 52.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.919 -0.771 . . . . 75.45 108.919 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 62.8 m -138.65 139.95 38.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.812 0.339 . . . . 64.14 110.282 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.07 127.83 20.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.801 -0.444 . . . . 74.32 109.801 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.1 tm? -107.61 121.8 45.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.43 -0.952 . . . . 73.5 108.43 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.751 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.1 mm? -98.78 106.16 18.4 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.847 -1.168 . . . . 61.44 107.847 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.553 ' HA ' HD23 ' A' ' 242' ' ' LEU . 4.8 m-20 -72.54 106.26 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.614 -0.884 . . . . 75.13 108.614 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.52 -22.56 24.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.991 -0.623 . . . . 75.01 113.121 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -90.88 -3.38 57.39 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.996 0.427 . . . . 74.34 111.193 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 47.4 t-20 -123.79 -44.67 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.816 0.341 . . . . 63.25 110.969 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 263' ' ' LEU . 26.5 m -61.24 -18.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.259 0.466 . . . . 74.31 112.259 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.02 -38.98 88.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.795 0.331 . . . . 72.43 110.443 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.49 29.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.539 . . . . 71.13 110.915 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.02 100.83 2.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.715 -0.755 . . . . 72.54 112.071 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.59 77.17 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.775 -0.726 . . . . 75.4 112.082 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -87.39 144.23 26.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 74.33 109.819 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 65.2 mttm -97.38 137.02 37.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.522 . . . . 74.11 109.887 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 276' ' ' GLY . 1.8 tm? -125.77 131.7 52.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.805 -0.634 . . . . 75.35 110.044 -173.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -125.2 113.07 1.84 Allowed Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.505 -1.038 . . . . 72.04 110.505 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.906 HD12 HG23 ' A' ' 27' ' ' ILE . 3.4 tm? -114.38 134.87 54.67 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 72.44 109.668 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -148.58 125.89 2.16 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.095 -1.05 . . . . 41.1 113.172 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 2.5 mm? -102.29 131.92 48.58 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.166 -0.679 . . . . 74.22 109.166 171.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 51.9 mt-10 -115.57 110.87 19.85 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.571 -0.529 . . . . 65.35 109.571 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.728 ' HB2' HD22 ' A' ' 31' ' ' LEU . 89.4 m-85 -101.26 100.98 11.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.933 -0.576 . . . . 72.31 110.483 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 52.9 tt0 -92.07 111.96 23.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.264 -0.643 . . . . 74.23 109.264 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 33' ' ' THR . . . -107.77 111.25 23.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.095 0.474 . . . . 73.05 110.985 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.12 133.75 55.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.709 -0.678 . . . . 74.04 109.322 173.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.43 -0.795 . . . . 72.13 110.7 -174.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.878 -0.786 . . . . 73.14 108.878 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.815 HG22 ' HA ' ' A' ' 121' ' ' GLU . 2.2 t -107.59 109.0 62.32 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 74.44 110.898 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 5.3 Cg_exo -77.4 164.77 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.251 2.634 . . . . 74.44 111.633 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.59 70.09 2.05 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.839 2.359 . . . . 74.32 111.825 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.738 ' HB ' HD21 ' A' ' 150' ' ' LEU . 20.6 p -70.13 -42.29 72.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 61.1 111.056 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.602 ' HB3' HG21 ' A' ' 143' ' ' VAL . 29.6 p90 -54.92 -30.58 58.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 71.12 111.538 174.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.83 46.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.524 . . . . 75.01 110.61 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.94 -9.63 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 71.43 109.834 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 150' ' ' LEU . 81.3 mt -70.69 -34.51 72.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.781 -0.645 . . . . 75.11 110.983 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . -129.05 0.03 6.03 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.593 -1.289 . . . . 72.21 114.83 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.572 ' HG3' ' N ' ' A' ' 13' ' ' SER . 4.8 pttm -62.43 -46.22 89.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.781 1.29 . . . . 74.51 110.505 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.572 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 5.0 p -66.54 -49.46 66.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.345 0.593 . . . . 71.33 111.168 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.72 69.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.308 -0.86 . . . . 71.23 112.438 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -59.86 -38.9 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.883 0.327 . . . . 71.23 111.883 -171.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.95 -47.44 71.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.873 0.368 . . . . 73.45 110.959 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 222' ' ' ALA . 25.1 m -82.74 -27.53 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.435 0.532 . . . . 72.31 112.435 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.15 -31.31 65.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.627 0.251 . . . . 74.0 111.462 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.9 m -59.78 135.44 57.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.389 -0.369 . . . . 73.45 110.704 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.51 -53.98 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 63.34 111.249 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.88 46.86 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.759 -0.734 . . . . 52.41 111.617 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.45 93.47 6.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.617 0.722 . . . . 55.33 111.031 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.01 124.83 7.73 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.789 -0.719 . . . . 73.32 111.84 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -84.25 10.96 9.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.6 0.238 . . . . 71.25 111.596 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.92 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 92.7 13.85 56.15 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.363 -0.923 . . . . 72.23 111.608 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 46' ' ' SER . 1.5 pp -101.94 179.42 4.33 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.572 0.701 . . . . 72.1 112.747 -171.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 277' ' ' LEU . 35.1 mm -102.06 130.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.785 -1.098 . . . . 64.14 110.407 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.601 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 1.0 OUTLIER -103.81 134.63 46.79 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.455 -0.943 . . . . 75.33 108.455 176.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.538 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 16.5 tp -121.56 147.83 45.29 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.677 -0.409 . . . . 71.43 110.853 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.812 ' HB3' ' HG2' ' A' ' 280' ' ' GLU . 12.3 t70 -153.72 127.9 9.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.294 -0.866 . . . . 73.31 108.919 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.734 HD13 ' HB3' ' A' ' 281' ' ' PHE . 8.9 tp -137.46 125.02 22.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.346 -0.612 . . . . 72.11 109.346 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 23.3 ttmt -133.12 124.69 28.01 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.46 . . . . 73.41 110.683 -175.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.717 HG22 ' HB3' ' A' ' 283' ' ' ALA . 80.6 p -120.64 123.61 43.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.631 . . . . 72.32 109.705 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HB2' HD13 ' A' ' 284' ' ' LEU . 91.0 mttt -112.17 139.46 47.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.273 0.559 . . . . 61.41 112.14 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 43.1 t -139.17 137.18 35.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.835 -1.172 . . . . 75.4 107.835 168.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -82.12 34.97 0.42 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.616 0.722 . . . . 71.2 109.902 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 35' ' ' SER . 5.4 m-20 -120.5 18.71 12.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.477 -0.783 . . . . 71.32 111.424 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 97.76 -3.4 60.81 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.194 -1.162 . . . . 61.52 110.194 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 3.4 tm? -99.65 127.22 45.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.762 -0.375 . . . . 73.31 111.717 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.758 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 22.0 tt0 -141.6 129.22 21.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.969 -0.752 . . . . 75.2 108.969 163.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.456 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 74.5 t80 -124.78 127.05 46.61 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.267 -0.896 . . . . 65.13 110.872 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.903 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.5 m -128.58 131.53 48.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.092 0.473 . . . . 74.22 111.682 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 17.1 m -120.3 123.02 42.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.854 . . . . 75.02 108.693 171.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.3 p -139.65 157.65 45.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.378 -0.529 . . . . 65.34 111.093 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 158.83 -175.22 35.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.539 -1.315 . . . . 52.23 113.567 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 26' ' ' LEU . 12.1 p -137.03 138.5 40.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.617 -0.292 . . . . 74.32 110.249 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HB1' HG22 ' A' ' 54' ' ' VAL . . . -135.27 129.12 33.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.781 0.324 . . . . 71.24 110.709 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' A' ' 53' ' ' LYS . 8.3 t-20 -90.67 113.72 25.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 50.5 109.153 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -84.84 7.33 21.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.181 0.808 . . . . 70.21 113.181 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -74.13 -46.26 43.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.71 -0.396 . . . . 70.14 110.405 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -126.36 -81.33 0.61 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.749 -0.463 . . . . 71.22 109.749 171.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -172.69 84.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.949 0.88 . . . . 65.12 110.296 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 16.6 tppt? -126.25 86.53 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 73.24 109.449 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG22 ' HB1' ' A' ' 47' ' ' ALA . 25.9 t -109.22 120.04 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.017 -0.538 . . . . 63.32 110.821 -175.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -137.67 124.6 21.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.893 -0.594 . . . . 62.1 109.56 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 45' ' ' GLY . . . -155.57 -155.43 7.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.539 -0.838 . . . . 72.35 111.958 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -148.03 150.99 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.185 0.517 . . . . 72.31 110.177 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -119.96 125.06 47.48 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.65 -0.87 . . . . 65.14 108.65 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.903 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 3.4 mp0 -109.04 118.87 37.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.454 -0.793 . . . . 71.24 110.93 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -99.55 117.72 34.56 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.794 -1.558 . . . . 74.04 106.794 164.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.758 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 74.3 tttt -127.37 150.28 49.68 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.363 0.602 . . . . 74.45 110.311 -171.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.86 ' HB2' ' HB2' ' A' ' 71' ' ' PHE . 99.6 m-85 -126.72 121.42 31.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.879 -0.601 . . . . 74.11 110.155 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.3 ptm85 -121.27 106.1 11.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.789 0.804 . . . . 54.23 111.376 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 t90 -117.02 104.64 11.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.869 -1.06 . . . . 75.21 109.583 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 m 73.55 132.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.615 0.572 . . . . 64.05 110.508 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.9 mp0 -50.95 -59.98 3.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.858 -0.61 . . . . 71.03 110.911 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.03 67.37 0.7 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.702 -0.681 . . . . 71.41 109.383 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 -85.58 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.608 -0.806 . . . . 35.1 112.847 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.98 130.53 52.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 74.44 111.807 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.8 m -137.72 112.36 8.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 72.25 110.561 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 8.9 m-85 -102.73 122.4 44.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.609 -0.515 . . . . 61.31 109.609 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 m -119.93 117.29 27.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.64 -0.424 . . . . 73.31 111.76 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.6 123.65 45.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 75.21 109.099 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 59' ' ' GLU . 10.3 ptmm? -142.86 140.18 31.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.288 -0.565 . . . . 62.13 110.969 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.412 ' CD1' ' HG ' ' A' ' 81' ' ' LEU . 31.5 t90 -129.85 130.08 44.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.092 -0.504 . . . . 73.12 110.132 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -93.46 150.92 20.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 63.13 110.756 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -63.82 -20.43 65.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 73.02 109.553 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.77 -4.13 29.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.092 -0.958 . . . . 75.0 110.344 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.7 t30 82.31 4.64 1.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.015 0.926 . . . . 63.53 111.113 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 103' ' ' PHE . 18.9 p -80.76 143.86 32.57 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 116.129 -0.487 . . . . 65.42 109.803 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 103' ' ' PHE . 3.3 mp -122.88 113.59 19.34 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.761 -1.176 . . . . 75.22 113.872 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.62 131.12 10.08 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 119.771 -1.204 . . . . 73.41 113.686 -170.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.902 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 91.0 m -136.25 140.17 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.641 0.258 . . . . 34.34 110.745 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.87 108.83 3.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.503 HG13 ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -116.59 120.65 65.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.005 0.431 . . . . 35.12 109.987 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.6 m -110.53 135.8 50.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.996 -0.547 . . . . 70.13 111.772 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.2 125.33 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.178 -0.919 . . . . 74.11 109.738 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.53 130.03 35.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.546 -0.539 . . . . 75.15 109.546 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.55 133.16 36.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.785 -0.45 . . . . 75.32 109.785 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -91.53 -21.69 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.33 -0.396 . . . . 62.04 111.47 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.97 -51.08 11.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.964 -0.754 . . . . 70.21 108.964 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.06 7.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 42.32 109.823 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.778 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -62.49 124.63 21.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 71.25 110.514 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . 100.12 1.62 55.91 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.705 -0.76 . . . . 74.15 112.322 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.712 HD23 ' HD1' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -98.86 124.35 43.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 64.43 109.871 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.23 123.19 40.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 63.31 110.53 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.475 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.7 mm? -112.97 125.61 54.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.619 -0.512 . . . . 73.1 109.619 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.921 HG23 ' HB3' ' A' ' 115' ' ' LYS . 1.1 t -132.52 136.24 46.51 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.232 0.539 . . . . 64.21 110.637 173.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -104.78 120.67 41.94 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.88 -0.785 . . . . 74.1 108.88 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.51 151.9 26.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.561 -0.745 . . . . 72.3 110.976 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.902 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 22.3 m -128.11 131.92 49.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.5 -0.773 . . . . 74.41 109.251 172.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -91.64 141.94 28.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.392 -0.822 . . . . 63.34 108.859 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.69 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 2.3 p90 -95.51 98.01 10.21 Favored 'General case' 0 C--O 1.188 -2.171 0 N-CA-C 114.824 1.416 . . . . 74.11 114.824 -161.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.502 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 60.7 p -76.89 124.15 87.5 Favored Pre-proline 0 N--CA 1.465 0.31 0 O-C-N 121.091 -1.006 . . . . 55.25 112.974 -164.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 33.9 Cg_exo -61.72 -54.97 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.205 2.603 . . . . 72.35 113.16 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -106.14 -30.78 9.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 53.13 111.28 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -62.64 -48.72 78.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.369 . . . . 35.21 111.686 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.24 -14.95 59.53 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.037 -0.601 . . . . 63.33 111.841 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -97.22 130.69 44.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.205 -0.665 . . . . 75.34 109.205 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.61 150.27 36.46 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.056 -0.658 . . . . 64.23 109.54 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 101' ' ' SER . 66.0 t30 -116.51 156.17 27.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 65.41 109.957 -174.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.43 126.54 49.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.909 0.861 . . . . 72.44 112.347 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.518 ' HZ3' ' CG ' ' A' ' 128' ' ' ASP . 28.0 ttpp -128.38 140.61 51.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.537 -1.211 . . . . 72.03 108.656 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.506 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -112.48 124.23 68.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.002 -0.74 . . . . 73.23 109.002 -178.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.921 ' HB3' HG23 ' A' ' 98' ' ' THR . 84.4 tttt -120.08 119.67 34.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.508 -0.769 . . . . 54.35 109.752 -171.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.9 m -122.67 137.08 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.335 -0.393 . . . . 63.04 110.951 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.22 122.62 3.35 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.819 -0.705 . . . . 71.14 112.421 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.712 ' HD1' HD23 ' A' ' 95' ' ' LEU . 81.8 t80 -117.59 128.49 55.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.238 -0.653 . . . . 45.31 109.238 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.73 ' HB3' HG11 ' A' ' 3' ' ' VAL . 26.3 mtmm -109.13 123.16 48.75 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.894 -0.722 . . . . 75.04 110.54 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -104.69 147.83 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.3 -1.37 . . . . 64.24 107.3 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.815 ' HA ' HG22 ' A' ' 3' ' ' VAL . 10.5 pt-20 -52.37 -28.48 19.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.489 0.551 . . . . 71.14 112.489 -167.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -100.84 -31.94 10.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.468 0.544 . . . . 71.01 112.468 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.987 HG22 ' H ' ' A' ' 145' ' ' GLY . 16.6 pt -142.89 154.23 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 118.594 0.634 . . . . 74.04 112.254 -170.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.748 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 3.5 t-20 -110.14 128.9 55.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.698 -0.683 . . . . 72.43 111.231 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 142' ' ' LEU . 4.6 mm? -110.84 135.73 50.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.515 -0.311 . . . . 73.32 110.174 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.4 125.8 3.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.529 -0.843 . . . . 73.22 112.511 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.8 m -113.45 117.81 32.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.763 -0.458 . . . . 73.32 109.763 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.518 ' CG ' ' HZ3' ' A' ' 113' ' ' LYS . 38.9 t0 -126.09 117.57 23.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.955 0.407 . . . . 73.02 110.1 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.701 ' HG3' HG13 ' A' ' 138' ' ' ILE . 60.8 ttp -119.67 118.15 30.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.919 0.39 . . . . 75.11 111.563 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.21 120.18 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.366 -0.605 . . . . 70.33 109.366 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 85.5 t80 -95.03 104.66 16.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.065 0.46 . . . . 63.33 111.674 -172.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.486 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 20.3 t70 -97.99 149.4 22.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 74.2 108.904 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.405 ' C ' HD13 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -68.6 -35.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.734 -0.212 . . . . 72.41 111.101 -174.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.52 -20.13 20.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 52.21 111.403 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.86 98.71 0.12 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.366 -0.921 . . . . 73.14 112.662 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 37.9 Cg_endo -67.19 150.79 81.88 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.577 2.185 . . . . 74.12 112.43 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -115.13 128.84 56.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.442 -0.577 . . . . 51.31 109.442 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.701 HG13 ' HG3' ' A' ' 129' ' ' MET . 3.9 mp -109.73 118.34 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.354 -0.609 . . . . 63.33 109.354 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -112.19 132.49 54.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.337 0.589 . . . . 75.24 110.308 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.63 132.66 10.99 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.389 -0.823 . . . . 62.3 111.343 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.11 134.76 55.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.961 -0.385 . . . . 71.31 109.961 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.766 HD11 HD12 ' A' ' 123' ' ' ILE . 6.3 tp -137.97 122.33 18.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.207 0.527 . . . . 74.35 110.164 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.748 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 97.8 t -107.89 130.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.23 -0.895 . . . . 65.23 108.937 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.6 mm? -108.14 137.24 46.46 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.258 -0.645 . . . . 74.32 109.258 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.987 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -130.49 119.36 2.73 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 115.527 -0.76 . . . . 61.3 111.46 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 149' ' ' TRP . 1.8 p90 -142.28 147.78 36.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.523 . . . . 73.01 109.589 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 7.0 mp0 -35.24 102.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.575 0.954 . . . . 70.03 113.575 -169.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.31 -33.92 5.31 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.0 -1.0 . . . . 63.21 113.7 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.499 ' HB2' ' CE1' ' A' ' 146' ' ' TYR . 78.1 m95 -106.01 143.28 34.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.63 0.728 . . . . 73.33 112.193 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.738 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.9 tm? -124.75 136.68 54.07 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 72.23 107.985 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.87 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -139.02 162.15 35.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.682 0.277 . . . . 65.54 110.692 -175.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -159.88 145.49 11.37 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.373 -0.691 . . . . 72.13 111.373 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.526 ' OH ' HD23 ' A' ' 142' ' ' LEU . 39.8 p90 -146.72 127.39 14.26 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.694 0.747 . . . . 74.03 111.673 165.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 0.9 OUTLIER -115.72 121.64 43.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.421 -0.809 . . . . 72.2 109.163 177.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 94.8 mmm -121.6 140.15 52.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.176 -0.305 . . . . 71.54 110.176 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.474 ' HB2' ' H ' ' A' ' 166' ' ' GLN . 3.8 m-20 -110.3 119.14 38.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.763 -0.458 . . . . 63.33 109.763 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.23 117.27 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.568 -0.53 . . . . 52.33 109.568 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.468 ' HG2' ' HB3' ' A' ' 160' ' ' ALA . 15.0 tt0 -98.54 105.55 17.71 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-O 121.094 0.473 . . . . 71.13 110.107 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.3 m -70.42 -20.81 62.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.3 -1.773 . . . . 72.02 111.124 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 158' ' ' GLU . . . -59.7 -28.65 67.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.924 0.869 . . . . 72.31 109.155 173.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 158' ' ' GLU . 78.8 mttt -117.72 -157.77 0.68 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.311 -1.366 . . . . 71.45 107.311 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.7 p -109.29 26.74 10.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.85 -0.426 . . . . 62.54 109.85 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -141.97 154.32 44.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.24 -1.384 . . . . 70.41 114.591 -154.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 93.9 t -74.37 131.61 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 114.721 -1.127 . . . . 61.14 110.206 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 33.1 m -98.63 -34.22 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.627 -0.26 . . . . 60.43 111.488 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' ' 156' ' ' ASN . 81.1 mm-40 -138.59 134.68 34.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.183 -0.303 . . . . 73.4 110.183 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.7 p -120.84 109.46 15.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.198 0.523 . . . . 74.23 110.561 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 26.6 m-80 -109.31 138.45 45.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 5.7 t80 -138.68 149.35 45.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.421 -0.512 . . . . 74.24 110.419 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -149.9 136.8 19.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.178 0.513 . . . . 60.0 110.733 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 10.2 t -145.88 154.07 13.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 61.11 108.427 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 180' ' ' LEU . . . 166.02 -170.72 40.86 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 118.855 -1.641 . . . . 63.12 113.602 169.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.73 153.39 48.49 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.43 -0.385 . . . . 71.31 110.301 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -114.26 126.55 55.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.182 0.515 . . . . 73.31 110.414 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 m -126.29 163.27 23.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.545 -0.752 . . . . 73.34 109.142 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.44 -57.29 3.65 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.765 0.654 . . . . 73.32 112.765 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -109.2 -8.92 15.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 75.13 111.447 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.7 132.09 46.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.898 0.38 . . . . 71.1 111.451 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 83.4 mt-30 -125.98 124.06 39.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.146 -0.687 . . . . 64.11 109.146 173.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.624 HD12 HG13 ' A' ' 194' ' ' ILE . 3.6 tt -120.3 128.49 53.34 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.557 . . . . 72.24 110.948 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 77.6 m-70 -132.05 116.81 17.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.618 -0.719 . . . . 74.01 111.206 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.68 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 29.6 m -83.09 118.56 23.64 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.788 -0.819 . . . . 75.45 108.788 172.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.1 140.97 49.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.167 0.508 . . . . 64.03 111.12 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 190' ' ' PHE . 70.2 t -124.62 128.14 73.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.574 -0.739 . . . . 72.24 110.798 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -115.46 97.29 6.08 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.241 -0.891 . . . . 73.33 108.652 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 30.2 t70 62.49 178.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.919 -1.037 . . . . 71.03 109.573 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.93 58.43 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.958 -0.857 . . . . 54.43 110.958 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 211' ' ' THR . 56.4 m -87.52 -28.1 22.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 112.564 0.579 . . . . 75.24 112.564 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -141.07 119.42 12.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.402 -0.919 . . . . 74.32 112.443 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.518 ' CB ' HG22 ' A' ' 184' ' ' VAL . 19.1 p90 -134.89 126.09 28.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.446 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.767 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -158.84 -162.6 12.07 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 120.491 -0.861 . . . . 63.24 112.388 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -137.74 152.01 21.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.737 -0.744 . . . . 52.34 112.752 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 15.0 m -125.15 138.28 54.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.711 0.291 . . . . 63.44 110.603 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.624 HG13 HD12 ' A' ' 180' ' ' LEU . 4.4 mp -123.72 124.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.272 -0.422 . . . . 70.14 109.896 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 6.6 t80 -108.47 116.37 31.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.73 -0.841 . . . . 61.22 108.73 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -128.5 134.58 48.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.936 0.398 . . . . 73.53 111.011 -177.316 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.632 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 56.2 mtpt -108.02 127.52 53.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.428 -0.351 . . . . 71.52 110.549 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.44 110.61 27.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -49.8 111.79 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.398 -0.819 . . . . 71.53 112.349 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 200' ' ' LYS . 34.0 ttmt 72.84 1.39 4.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.329 -0.851 . . . . 62.45 112.257 170.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -103.73 -73.14 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 74.41 110.148 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 225' ' ' TYR . 3.2 pp -162.96 170.8 17.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.663 -0.699 . . . . 74.24 109.619 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.632 ' HG3' ' HG2' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -125.52 134.64 51.93 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.941 -0.392 . . . . 71.2 109.941 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.0 m -124.03 142.54 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.136 0.493 . . . . 72.44 111.44 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HB3' HG11 ' A' ' 17' ' ' VAL . . . -130.33 136.18 48.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.966 -0.561 . . . . 71.14 110.154 175.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 221' ' ' ILE . 75.6 t -112.41 134.47 54.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 73.32 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -133.74 126.31 30.42 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.452 -0.573 . . . . 54.31 109.452 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.3 pt? -147.14 135.09 21.36 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.617 -0.433 . . . . 65.11 110.69 174.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.767 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -134.58 149.57 50.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.645 . . . . 71.01 111.432 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -100.05 130.87 46.25 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.0 t -109.91 124.53 51.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.657 . . . . 73.45 110.894 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.57 58.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 73.02 111.442 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 129.95 -54.04 0.79 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.635 -0.986 . . . . 62.14 110.635 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.404 ' HB2' ' OD1' ' A' ' 216' ' ' ASN . 47.9 m-80 -139.04 172.41 12.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.219 -1.03 . . . . 75.32 108.219 172.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -81.57 67.66 7.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.973 0.416 . . . . 75.15 110.887 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.487 ' HB2' HG22 ' A' ' 211' ' ' THR . 15.1 m120 -102.78 129.21 49.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 74.23 110.727 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 m -108.63 123.51 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.334 -0.617 . . . . 74.5 109.334 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 41.7 ttm-85 -101.13 114.81 29.11 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.764 -0.828 . . . . 75.21 108.764 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.58 ' HB3' ' HB2' ' A' ' 239' ' ' ASN . 83.7 t80 -117.8 136.62 53.29 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.507 0.194 . . . . 74.04 110.761 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.67 140.45 7.43 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.792 -0.718 . . . . 64.53 111.825 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.941 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -131.1 136.86 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 71.44 110.799 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.634 ' HB3' HG12 ' A' ' 17' ' ' VAL . . . -128.81 139.78 52.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.01 -0.541 . . . . 62.44 110.23 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.1 126.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.591 0.234 . . . . 75.33 110.584 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 17.2 pttm -102.53 119.52 38.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.845 0.831 . . . . 42.43 110.314 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.561 ' HD2' ' HB3' ' A' ' 202' ' ' LEU . 37.5 t80 -112.3 116.54 30.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.274 -1.33 . . . . 63.21 110.156 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -111.48 121.27 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.188 0.518 . . . . 32.1 111.252 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.9 pt -110.26 -27.41 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.305 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 19.2 t70 -135.15 143.24 44.98 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.57 -0.53 . . . . 74.24 109.57 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.53 -29.22 58.96 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.573 2.182 . . . . 70.52 112.487 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -103.56 4.12 35.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.375 -0.375 . . . . 73.1 111.307 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -143.6 121.27 11.84 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.394 0.616 . . . . 71.5 111.872 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -139.87 128.65 23.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.781 -0.645 . . . . 72.02 109.539 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.07 125.14 50.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.002 -0.279 . . . . 71.33 110.543 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 224' ' ' LYS . 14.2 m -116.47 118.08 31.69 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 52.34 110.043 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -122.98 141.52 51.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.789 -0.364 . . . . 75.51 110.971 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.05 144.24 38.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.316 -0.402 . . . . 73.51 110.229 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 243' ' ' ILE . 9.1 p -131.56 142.61 42.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.751 -0.463 . . . . 54.42 109.751 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -107.42 150.57 26.61 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.068 -0.716 . . . . 73.45 109.068 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 219' ' ' PHE . 6.2 t30 -58.87 -11.78 3.69 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.782 0.676 . . . . 73.42 112.147 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.622 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m -78.66 15.36 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.54 -0.541 . . . . 75.41 109.54 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.4 m 68.45 28.27 6.08 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 115.137 -0.938 . . . . 64.31 110.554 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 240' ' ' SER . 42.7 mt -100.36 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.561 -0.456 . . . . 73.52 110.627 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 237' ' ' VAL . 1.7 mp -108.51 115.41 49.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 120.879 -0.329 . . . . 61.21 110.173 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -123.59 133.39 8.87 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.929 -0.653 . . . . 44.35 112.301 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -128.06 150.72 49.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.341 0.591 . . . . 63.55 111.593 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -132.32 121.65 3.06 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 114.991 -1.004 . . . . 61.12 110.777 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -103.59 115.66 30.92 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.921 -0.4 . . . . 63.34 109.921 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.6 m -98.31 115.51 28.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.842 0.353 . . . . 72.51 110.211 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -126.19 128.92 48.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.096 -0.502 . . . . 63.14 109.903 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.1 m -95.09 119.12 33.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.739 0.304 . . . . 44.14 110.33 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 3.0 mm? -108.1 86.04 2.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 51.1 109.793 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 251' ' ' LEU . 0.0 OUTLIER 71.55 156.06 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.445 -0.798 . . . . 72.43 110.546 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.0 95.81 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.703 2.269 . . . . 73.01 112.854 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 142.18 -19.43 2.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.486 -0.864 . . . . 72.34 112.865 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.49 122.02 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.077 0.465 . . . . 72.21 111.903 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 43.1 mtmt -112.07 126.27 54.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 73.34 109.975 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -100.93 124.01 45.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.507 -0.553 . . . . 73.11 109.507 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 36.9 m -120.34 111.02 17.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 72.54 110.54 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.913 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -97.73 123.59 41.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.212 -1.033 . . . . 74.23 108.212 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 21.8 m -130.21 140.6 50.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.647 0.26 . . . . 51.22 110.462 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.499 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -154.89 128.8 8.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.644 -0.253 . . . . 73.12 110.942 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 274' ' ' LYS . 2.3 tm? -101.68 117.07 34.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.46 -0.941 . . . . 63.4 108.46 173.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.476 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.6 mm? -100.02 109.95 22.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.781 -0.645 . . . . 74.21 109.547 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.456 ' HA ' HD22 ' A' ' 242' ' ' LEU . 2.9 m-20 -69.67 103.75 2.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.824 . . . . 75.51 109.522 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.65 -8.45 7.54 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.097 -0.956 . . . . 52.21 112.581 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 267' ' ' ASN . 48.3 tptt -64.99 -28.63 69.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.547 -0.538 . . . . 61.11 109.547 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 266' ' ' LYS . 44.5 t-20 157.38 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.604 1.19 . . . . 72.22 108.697 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -65.44 -45.15 93.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 112.918 0.71 . . . . 73.23 112.918 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.03 -44.87 91.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.676 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.96 -13.09 16.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.829 0.307 . . . . 44.23 111.829 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -103.34 -14.23 26.51 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.048 -1.072 . . . . 72.34 112.768 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 106.98 153.83 19.6 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.621 -0.799 . . . . 73.43 112.434 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -110.87 147.23 35.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.355 -0.98 . . . . 73.32 108.355 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.9 mmtm -94.0 134.96 35.85 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.335 -1.357 . . . . 64.31 107.335 173.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.92 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.5 tm? -135.29 136.12 41.37 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.255 0.55 . . . . 62.43 110.907 -170.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.461 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.59 117.16 1.23 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 110.52 -1.032 . . . . 65.12 110.52 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.913 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -112.21 122.3 47.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.926 -1.139 . . . . 72.21 107.926 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -129.36 137.34 9.51 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.148 -1.025 . . . . 72.3 112.995 -170.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -114.07 130.55 56.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.936 -0.764 . . . . 71.34 108.936 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.812 ' HG2' ' HB3' ' A' ' 30' ' ' ASP . 50.8 mt-10 -121.02 112.1 18.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.812 -0.44 . . . . 64.32 109.812 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.734 ' HB3' HD13 ' A' ' 31' ' ' LEU . 14.7 t80 -103.53 141.92 35.17 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.854 -0.795 . . . . 71.25 108.854 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.74 141.89 40.97 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.884 0.373 . . . . 51.5 111.348 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.717 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -123.6 110.4 14.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.55 . . . . 74.43 109.679 172.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 34' ' ' LYS . 4.2 mm? -124.09 -47.35 1.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.491 -0.777 . . . . 64.53 109.822 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.423 -0.799 . . . . 74.43 109.285 176.12 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.45 -0.574 . . . . 71.24 109.45 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.825 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 4.5 p -110.68 135.85 20.71 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.797 -0.638 . . . . 71.0 111.12 -171.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.98 155.38 15.04 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.586 2.191 . . . . 74.1 110.973 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HA ' HD22 ' A' ' 124' ' ' ASN . 30.2 Cg_endo -65.99 101.16 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.925 1.75 . . . . 60.35 111.956 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.669 ' HB ' HD21 ' A' ' 150' ' ' LEU . 6.7 p -73.48 -19.3 60.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.64 . . . . 74.05 110.411 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.616 ' HB2' HG21 ' A' ' 143' ' ' VAL . 90.2 t80 -56.55 -24.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.999 -1.001 . . . . 75.51 110.441 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.22 -26.12 33.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 55.43 110.057 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.737 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 18.6 t70 -82.99 -14.8 53.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.856 -0.611 . . . . 71.54 109.447 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.023 HD21 ' HA3' ' A' ' 152' ' ' GLY . 2.3 tp -55.85 -34.39 65.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.802 -1.09 . . . . 74.22 110.637 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.565 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . -136.25 21.9 3.44 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 64.41 111.705 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.737 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 4.7 ttpm? -56.71 -56.08 25.99 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.418 . . . . 74.5 111.178 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.17 -38.1 89.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.65 -0.704 . . . . 73.35 110.681 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.27 80.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 64.41 112.417 -174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 98.7 mtt180 -57.88 -42.23 84.19 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.635 0.606 . . . . 74.14 112.635 -170.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.07 -37.89 86.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 74.45 110.507 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.83 -34.77 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 41.41 110.918 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -72.32 -42.6 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 72.43 111.814 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -126.9 57.68 1.45 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.994 0.902 . . . . 64.02 110.652 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 21' ' ' GLY . 45.3 tptt -75.16 177.31 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.501 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 20' ' ' LYS . . . -64.5 116.62 9.26 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.554 -0.832 . . . . 43.14 111.68 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.73 173.98 6.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 73.31 110.761 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.928 ' HA3' ' HB3' ' A' ' 274' ' ' LYS . . . -83.14 88.17 1.49 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.749 -0.738 . . . . 63.34 112.786 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -93.26 -4.33 52.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.033 -0.358 . . . . 74.52 110.033 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.5 79.36 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.933 -0.576 . . . . 71.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.31 155.15 39.18 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 122.162 0.982 . . . . 71.42 112.797 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.976 HG23 HD23 ' A' ' 277' ' ' LEU . 43.6 mm -94.03 121.25 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.704 -1.589 . . . . 63.45 107.809 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 6.5 mtpm? -114.83 139.44 49.75 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.852 -0.339 . . . . 63.04 110.71 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tt -142.84 142.66 31.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.081 173.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -144.66 128.05 16.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.61 0.719 . . . . 72.34 110.434 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 281' ' ' PHE . 11.8 tp -120.84 126.75 50.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.896 -1.047 . . . . 74.24 110.33 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 2.0 ptmm? -121.8 124.49 44.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.483 0.659 . . . . 62.42 110.514 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 3.6 t -110.68 121.86 46.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.084 -1.08 . . . . 62.1 108.084 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.562 ' HB3' ' HG3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -143.41 139.05 29.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.791 0.805 . . . . 73.41 112.706 -170.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 37' ' ' ASN . 23.1 t -139.32 137.93 36.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.944 -1.873 . . . . 62.23 105.944 168.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -79.62 44.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.044 0.926 . . . . 62.45 111.128 -171.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 35' ' ' SER . 1.4 m-20 -98.37 19.41 14.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.966 -1.47 . . . . 75.4 107.431 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 95.62 -7.05 68.09 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.495 -1.23 . . . . 74.32 113.253 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.4 mm? -102.77 128.41 49.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.252 1.026 . . . . 63.33 113.489 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 25.6 tt0 -140.56 117.84 11.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.898 -0.779 . . . . 65.04 108.898 160.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 87.9 t80 -108.16 120.54 42.62 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.955 -0.466 . . . . 74.34 109.812 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 34.0 m -120.85 115.95 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 72.23 110.48 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -114.41 123.54 49.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.547 -0.538 . . . . 61.41 109.547 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 20.1 m -117.69 133.89 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 63.44 110.378 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.63 125.33 2.71 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.832 -0.699 . . . . 73.31 111.606 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.6 m -119.69 133.99 55.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 72.1 109.037 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -137.43 146.46 44.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.158 0.504 . . . . 35.53 111.858 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -68.87 142.91 54.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.503 -0.771 . . . . 64.34 109.157 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -57.88 -21.76 44.75 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.209 0.528 . . . . 74.22 111.271 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.75 7.46 33.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 64.24 110.632 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.9 p 50.05 25.66 1.78 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.383 1.073 . . . . 64.3 113.318 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 p -99.72 -18.44 17.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 70.52 111.712 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -134.93 108.64 8.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.183 -0.673 . . . . 72.15 109.183 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 47' ' ' ALA . 23.6 t -125.3 120.77 58.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.026 0.441 . . . . 74.03 110.742 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -111.22 126.49 54.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.146 0.498 . . . . 64.41 110.359 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.26 155.49 16.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.855 -0.688 . . . . 73.11 112.425 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.9 m -143.65 126.78 16.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.438 -0.949 . . . . 71.42 108.438 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.9 tm? -121.3 124.61 45.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.38 -0.528 . . . . 75.0 110.479 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 44.2 mt-10 -114.82 118.71 34.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.92 -0.582 . . . . 73.03 110.122 174.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 m -97.7 117.2 31.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.472 -1.307 . . . . 73.31 107.472 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 24.3 mtpp -121.93 139.38 53.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.325 0.583 . . . . 70.44 110.554 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 76.5 m-85 -109.67 120.82 43.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.416 -0.811 . . . . 73.11 109.082 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -118.04 109.16 16.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.258 0.551 . . . . 53.15 111.304 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 20.0 t90 -112.9 92.46 4.02 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.201 -0.909 . . . . 74.21 109.514 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 67' ' ' TYR . 10.8 m 71.63 151.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.134 0.896 . . . . 55.03 111.393 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.44 -38.21 63.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.561 0.696 . . . . 61.01 110.08 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.483 ' H ' HG22 ' A' ' 65' ' ' THR . 14.0 p90 -121.43 103.04 8.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 74.14 109.121 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.39 -102.07 0.17 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.225 -0.988 . . . . 72.32 112.141 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.7 mm? -117.51 136.55 53.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.322 0.582 . . . . 55.01 112.293 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -135.39 112.23 10.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.198 -0.91 . . . . 61.01 109.327 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 56.2 t80 -117.32 132.5 56.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.789 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 58.7 m -128.67 117.65 21.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.777 -0.192 . . . . 55.14 111.408 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -103.31 121.14 42.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.879 -1.156 . . . . 65.1 107.879 167.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -123.36 102.37 7.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.967 -0.56 . . . . 73.05 110.856 -168.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.849 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 67.9 t90 -96.67 132.84 41.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 74.25 109.889 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -119.76 165.82 14.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.852 -0.425 . . . . 63.41 109.852 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.7 t -64.84 -6.3 7.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.02 0.438 . . . . 74.53 111.932 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -79.82 -3.28 47.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.57 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 89.9 m-20 73.97 18.64 3.22 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.92 0.763 . . . . 74.1 110.028 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.6 m -102.93 135.92 43.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 72.35 110.487 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.849 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 4.8 mp -112.79 119.71 38.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.246 -0.434 . . . . 71.14 110.412 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 130.55 10.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.74 -0.743 . . . . 60.14 111.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.3 m -112.78 107.48 16.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.011 0.434 . . . . 60.35 111.144 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.789 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 21.7 tt0 -105.39 127.8 53.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.588 -0.733 . . . . 63.15 109.885 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.59 ' CG2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -130.02 120.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.364 -0.606 . . . . 64.12 109.364 169.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 24.6 m -126.36 129.24 48.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.685 -0.689 . . . . 52.5 110.229 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.02 134.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 70.12 111.253 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' OE2' ' HG3' ' A' ' 96' ' ' LYS . 67.8 mm-40 -96.46 118.86 33.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.55 -0.908 . . . . 62.13 108.55 172.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.27 122.9 28.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 73.12 109.822 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -85.56 -27.58 25.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.235 -0.438 . . . . 71.41 110.99 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.37 -44.8 42.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.295 -0.631 . . . . 53.31 109.295 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -99.61 67.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.516 -0.92 . . . . 62.45 108.516 170.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -49.95 131.23 22.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 52.12 111.759 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA2' ' HD2' ' A' ' 119' ' ' LYS . . . 102.85 -15.16 55.78 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.11 -0.95 . . . . 71.12 112.444 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.696 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -78.96 121.07 24.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.15 0.475 . . . . 64.02 111.126 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.478 ' HG3' ' OE2' ' A' ' 88' ' ' GLU . 48.9 tttp -118.06 111.78 19.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.571 -0.741 . . . . 74.43 109.574 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.632 HD12 HG22 ' A' ' 116' ' ' THR . 1.9 mm? -103.53 128.53 50.74 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.875 -0.417 . . . . 73.51 109.875 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.726 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 10.5 m -128.82 122.65 30.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.458 -0.337 . . . . 71.44 111.375 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.607 ' CE2' HD13 ' A' ' 114' ' ' ILE . 47.4 m-85 -119.55 115.67 24.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.477 -0.564 . . . . 75.02 109.477 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.1 t70 -115.42 122.05 44.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.55 -0.537 . . . . 73.15 109.55 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -134.83 121.69 20.99 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.061 0.457 . . . . 64.42 110.455 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 m -99.29 121.93 41.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.01 -0.541 . . . . 62.04 109.915 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.35 119.37 39.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 72.31 109.716 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 m -115.16 102.37 54.67 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.894 -0.41 . . . . 22.23 109.894 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.73 -33.04 28.71 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.559 2.173 . . . . 65.53 111.51 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -83.67 -46.11 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.643 -0.708 . . . . 75.24 111.102 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -70.25 -36.26 74.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.877 0.37 . . . . 75.23 110.806 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.26 -18.34 57.57 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.033 -0.603 . . . . 72.12 112.487 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.62 123.89 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.138 0.495 . . . . 62.14 110.568 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.22 116.56 28.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.92 -0.77 . . . . 70.13 108.92 173.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 132' ' ' ASP . 10.2 m120 -120.1 144.37 47.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.417 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.85 141.0 36.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.376 -0.375 . . . . 75.03 110.597 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.609 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -128.82 142.56 50.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.908 -0.404 . . . . 73.3 109.908 175.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.607 HD13 ' CE2' ' A' ' 99' ' ' PHE . 2.2 tp -118.07 117.68 55.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.885 -0.598 . . . . 74.02 110.08 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.726 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 27.9 ttpp -115.19 119.76 37.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.049 -0.523 . . . . 62.21 110.029 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.632 HG22 HD12 ' A' ' 97' ' ' LEU . 17.6 p -113.04 116.95 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.327 -0.62 . . . . 75.45 109.327 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.47 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -136.09 116.65 1.5 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.86 -1.162 . . . . 64.23 112.728 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.696 ' HB3' HD22 ' A' ' 95' ' ' LEU . 21.4 p90 -108.1 122.67 47.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.583 -0.525 . . . . 73.52 109.583 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -109.29 123.59 49.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.547 0.689 . . . . 71.44 110.965 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -106.25 165.02 11.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.741 -1.118 . . . . 64.34 109.256 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.825 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 10.4 pt-20 -52.65 -29.81 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.273 0.842 . . . . 51.32 113.273 -167.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -120.42 -6.1 9.81 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.924 -0.71 . . . . 63.15 112.502 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.37 126.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.424 -0.91 . . . . 64.15 113.011 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.818 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.0 m-20 -100.94 121.57 41.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.725 -0.671 . . . . 63.43 110.783 175.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 142' ' ' LEU . 3.9 mm? -112.05 126.69 55.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.229 0.212 . . . . 55.35 110.577 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.47 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.1 118.64 1.96 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.574 -0.822 . . . . 52.21 112.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 63.0 m -112.3 109.25 18.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.369 . . . . 63.03 110.51 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.63 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 4.3 t70 -108.82 146.01 34.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.832 -0.622 . . . . 71.41 110.125 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.484 ' HG3' HD13 ' A' ' 138' ' ' ILE . 22.2 ttt -135.96 117.21 14.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.045 -0.354 . . . . 72.44 110.045 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -100.22 117.35 34.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.512 -0.551 . . . . 73.53 109.512 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -98.18 122.98 42.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.121 0.486 . . . . 62.12 112.17 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.419 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 28.3 t70 -117.29 148.26 41.84 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.295 -1.002 . . . . 75.15 108.295 166.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -65.78 -19.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.108 0.41 . . . . 71.11 112.108 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.65 -12.26 29.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.32 . . . . 42.34 111.21 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.89 122.8 0.63 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 52.23 112.394 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.509 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 5.8 Cg_endo -87.3 145.78 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.602 2.868 . . . . 72.54 112.923 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 p -117.82 148.33 42.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.87 -0.605 . . . . 72.02 110.385 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 41.6 mm -107.55 118.39 55.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 110.265 -0.272 . . . . 64.04 110.265 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 155' ' ' MET . 70.6 mtm180 -105.7 116.9 32.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.127 0.489 . . . . 73.4 109.969 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.02 134.07 11.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.102 -1.046 . . . . 74.11 111.982 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.22 127.66 40.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.404 . . . . 61.34 110.557 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 125' ' ' LEU . 13.0 tp -132.51 124.23 28.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 64.15 110.12 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.818 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 36.1 t -123.79 120.78 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.486 . . . . 75.33 110.539 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' A' ' 142' ' ' LEU . 4.9 mp -110.62 140.7 44.7 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.388 -0.369 . . . . 75.1 110.214 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.88 119.17 4.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.949 -0.643 . . . . 65.24 112.857 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 78.3 m-85 -128.21 148.23 50.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.867 -0.79 . . . . 71.22 108.867 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -53.48 103.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 72.13 110.781 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.06 -32.94 6.71 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.247 -0.888 . . . . 74.52 112.497 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 93.4 m95 -108.06 123.45 48.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.721 0.638 . . . . 72.33 112.721 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.669 HD21 ' HB ' ' A' ' 6' ' ' THR . 2.0 tm? -113.99 137.35 51.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.31 -1.737 . . . . 52.45 106.31 170.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -135.73 132.83 37.34 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.954 -0.699 . . . . 64.12 110.813 -167.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.023 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -132.57 132.77 6.76 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.369 -0.919 . . . . 74.41 112.045 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.449 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 53.4 m-85 -132.49 118.2 18.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.636 -0.505 . . . . 74.31 109.636 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 27.5 mp0 -120.35 144.27 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.0 -0.546 . . . . 71.44 109.989 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.418 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 23.5 ptp -145.3 147.47 32.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.66 0.266 . . . . 64.51 110.578 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.579 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 8.3 t30 -113.95 117.37 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.219 -0.659 . . . . 74.43 109.219 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.86 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 69.7 t80 -94.59 125.18 39.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.61 -0.723 . . . . 72.53 111.062 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 161' ' ' LYS . 44.8 tt0 -91.29 103.98 16.58 Favored 'General case' 0 C--O 1.266 1.929 0 CA-C-N 115.104 -0.953 . . . . 71.41 109.384 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.28 -18.61 63.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.774 -2.012 . . . . 71.23 111.646 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.92 75.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.879 0.847 . . . . 63.21 108.907 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.516 ' HD3' ' OE2' ' A' ' 158' ' ' GLU . 2.0 mptm? -111.55 -159.37 0.68 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 73.41 107.996 168.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.3 m -107.9 28.67 8.0 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 122.252 -0.28 . . . . 62.1 110.287 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 158' ' ' GLU . 28.9 mtm180 -132.15 171.69 13.33 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 118.94 -1.104 . . . . 64.43 111.797 -163.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.6 m -103.06 133.01 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.389 -0.967 . . . . 71.42 108.389 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 p -99.89 1.38 42.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.067 0.46 . . . . 72.2 111.501 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.605 ' HG3' ' HB2' ' A' ' 186' ' ' ASP . 35.7 tt0 -150.87 130.82 13.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 71.31 109.687 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 m -121.78 112.87 18.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.857 -0.611 . . . . 65.11 109.936 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 84.0 m-20 -107.32 127.97 54.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.432 -0.581 . . . . 75.12 109.432 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.619 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.6 m-85 -121.39 153.01 38.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.286 -0.566 . . . . 74.52 111.065 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -148.67 128.53 13.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.504 -0.771 . . . . 71.41 109.833 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.1 t -125.81 126.17 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.501 -0.555 . . . . 70.14 109.501 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -117.32 130.58 8.94 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.624 -0.798 . . . . 63.11 112.713 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -113.03 120.2 40.53 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.557 -1.275 . . . . 73.35 107.557 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HG3' HE21 ' A' ' 179' ' ' GLN . 83.6 tttt -118.02 126.86 53.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.693 0.759 . . . . 74.41 112.797 -167.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 178' ' ' PHE . 23.8 m -131.89 162.56 30.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.31 -1.367 . . . . 64.24 107.31 169.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -46.76 -50.65 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.537 0.569 . . . . 61.24 112.537 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 7.9 pt-20 -116.16 10.95 15.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.094 0.473 . . . . 63.22 111.544 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.744 ' HD1' ' HG2' ' A' ' 196' ' ' GLN . 61.2 t80 -137.13 121.28 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.193 -0.458 . . . . 64.53 110.526 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.435 HE21 ' HG3' ' A' ' 174' ' ' LYS . 87.5 mt-30 -133.61 122.75 23.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.208 0.528 . . . . 71.24 110.605 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.744 HD12 HG13 ' A' ' 194' ' ' ILE . 3.2 tt -111.91 131.98 55.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.388 -0.597 . . . . 74.14 109.388 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -129.85 115.16 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.195 0.521 . . . . 73.24 109.982 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 27.4 m -86.25 135.41 33.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.397 -0.819 . . . . 73.4 109.088 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -128.66 138.1 51.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.227 0.536 . . . . 73.11 111.087 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 53.6 t -132.13 128.42 59.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 64.34 110.133 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -115.17 95.63 5.29 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.896 -0.779 . . . . 75.22 108.896 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.605 ' HB2' ' HG3' ' A' ' 166' ' ' GLN . 29.8 t0 58.46 -174.0 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.842 -1.072 . . . . 75.35 109.793 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -75.69 -6.73 82.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.617 -0.801 . . . . 72.01 111.783 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 186' ' ' ASP . 7.2 t -89.59 -27.42 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.455 0.539 . . . . 64.22 112.455 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.45 114.26 15.33 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 119.911 -0.716 . . . . 52.25 111.023 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -133.83 132.85 40.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.783 0.325 . . . . 72.3 110.583 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -166.34 -159.31 11.98 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.785 -0.721 . . . . 63.12 112.088 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.19 153.78 24.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.889 -0.672 . . . . 64.11 111.979 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.0 m -126.8 139.34 53.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.087 0.47 . . . . 62.41 110.255 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.744 HG13 HD12 ' A' ' 180' ' ' LEU . 4.5 mp -119.47 129.72 74.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.874 -0.603 . . . . 75.35 109.724 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -125.19 119.13 27.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.395 -0.594 . . . . 74.33 109.395 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.744 ' HG2' ' HD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -125.56 120.04 29.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.156 -0.475 . . . . 71.03 110.405 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.916 ' HG3' ' HG2' ' A' ' 203' ' ' GLU . 58.1 tttm -106.11 116.03 31.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.295 -0.631 . . . . 73.53 109.295 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 200' ' ' LYS . 16.1 t -86.33 143.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.714 -0.846 . . . . 72.53 108.714 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -73.36 6.33 3.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.61 0.719 . . . . 73.41 110.508 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.59 ' H ' HG12 ' A' ' 198' ' ' VAL . 49.0 tptt -98.19 37.71 1.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.062 -0.972 . . . . 73.23 108.911 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 200' ' ' LYS . 34.6 mmtp 75.95 -55.54 0.6 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.992 -1.004 . . . . 63.14 112.884 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.14 132.62 53.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.768 0.794 . . . . 73.2 112.752 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.916 ' HG2' ' HG3' ' A' ' 197' ' ' LYS . 31.3 mt-10 -110.7 142.97 41.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.611 -1.177 . . . . 75.43 109.303 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.9 m -131.68 138.99 48.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.661 -0.245 . . . . 52.24 110.58 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -131.01 148.94 52.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.655 -0.248 . . . . 51.33 110.657 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.81 HG22 HG22 ' A' ' 221' ' ' ILE . 92.1 t -135.11 140.45 45.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.998 -0.371 . . . . 65.23 109.998 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -124.76 127.07 46.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.76 0.314 . . . . 71.12 110.513 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.3 mm? -123.01 136.57 54.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.619 . . . . 61.4 110.016 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.416 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.21 129.58 14.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.371 -0.377 . . . . 52.51 110.22 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -114.66 126.78 55.28 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.989 -0.745 . . . . 74.24 108.989 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 188' ' ' THR . 6.4 t -101.82 112.99 25.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.441 0.639 . . . . 60.21 109.638 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.24 126.42 27.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.303 -0.862 . . . . 75.4 110.922 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 156.44 -78.55 0.19 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.789 . . . . 31.32 112.484 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.76 50.52 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.43 . . . . 71.04 111.367 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.0 m 58.54 18.88 6.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.955 0.724 . . . . 70.12 112.955 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.455 ' HB3' ' CG2' ' A' ' 211' ' ' THR . 48.1 t-20 -75.94 114.31 14.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 60.43 110.053 -176.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.5 m -113.34 130.87 56.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.778 -0.646 . . . . 72.05 110.862 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -106.04 125.89 51.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 74.21 110.121 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 239' ' ' ASN . 9.5 t80 -130.44 141.52 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.233 -0.894 . . . . 64.33 109.25 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.27 147.78 15.66 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.445 -0.883 . . . . 73.44 112.0 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.81 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -128.24 144.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.725 0.298 . . . . 75.31 110.213 177.036 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -130.51 142.25 50.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.979 -0.555 . . . . 64.32 110.851 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -116.42 135.16 54.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.798 -0.637 . . . . 62.2 109.627 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 64.6 tttt -129.63 117.32 20.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.283 -0.417 . . . . 64.43 110.285 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -132.78 125.85 31.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.042 0.448 . . . . 54.31 111.005 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -91.92 100.77 13.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.042 -0.725 . . . . 74.23 109.042 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 17.4 tt -71.03 -30.2 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 71.22 111.061 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.715 ' HB2' ' HD2' ' A' ' 229' ' ' PRO . 3.4 p30 -156.22 164.07 22.7 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.722 -0.844 . . . . 71.4 108.722 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 228' ' ' ASP . 13.6 Cg_endo -56.26 -20.42 31.78 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.865 2.377 . . . . 70.24 114.53 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -104.62 -19.42 13.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.904 -0.318 . . . . 62.31 111.58 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -124.3 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.322 0.582 . . . . 63.33 112.312 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.4 m -125.09 133.34 52.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.637 -0.711 . . . . 64.42 110.262 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -114.42 133.15 55.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.88 0.371 . . . . 72.33 110.159 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 11.3 p -137.97 149.33 46.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.123 -0.489 . . . . 72.14 110.42 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -144.55 155.99 43.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.867 -0.42 . . . . 74.44 109.867 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -144.87 149.64 35.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.441 . . . . 61.52 111.067 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 1.2 t -127.28 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.774 -0.648 . . . . 72.35 110.017 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.7 m120 -106.06 150.16 26.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.106 -0.497 . . . . 55.13 109.956 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 219' ' ' PHE . 22.5 p-10 -45.07 -32.24 1.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.807 1.317 . . . . 75.12 113.692 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.659 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 19.7 m -82.23 25.64 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.873 0.368 . . . . 73.5 110.748 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.405 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 22.2 m 69.84 31.1 3.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.591 -0.731 . . . . 63.41 110.863 174.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 262' ' ' LEU . 5.2 mp -88.17 126.95 35.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 120.686 -0.406 . . . . 73.13 110.618 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.71 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.88 116.65 53.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 123.884 0.74 . . . . 73.14 109.859 -177.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 262' ' ' LEU . . . -129.84 151.87 19.46 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.157 -1.021 . . . . 63.13 112.929 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.499 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -136.7 154.22 50.67 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.431 . . . . 72.11 110.952 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.71 120.76 1.32 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.253 -0.739 . . . . 60.22 111.253 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -112.36 119.07 37.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.992 -0.373 . . . . 73.24 109.992 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -119.73 121.93 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.471 0.653 . . . . 71.35 110.661 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 24.7 tt0 -123.9 131.07 53.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.854 -0.612 . . . . 73.22 109.802 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.0 m -87.21 114.37 23.76 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.435 -0.348 . . . . 73.43 110.456 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.796 ' HG ' ' HD2' ' A' ' 253' ' ' PRO . 19.2 tp -75.71 139.7 42.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.555 -0.906 . . . . 71.25 108.555 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -55.94 -43.94 99.46 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.787 1.032 . . . . 73.04 113.787 -168.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.796 ' HD2' ' HG ' ' A' ' 251' ' ' LEU . 72.4 Cg_exo -43.8 -64.33 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 75.23 113.703 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 163.95 38.65 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 120.721 -0.752 . . . . 15.43 111.696 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 279' ' ' LEU . 1.8 tp -143.46 122.2 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.821 -0.437 . . . . 71.01 109.821 -174.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.533 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 12.7 ptmm? -106.63 133.19 51.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.455 0.645 . . . . 74.24 110.534 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.7 tp -99.91 124.14 44.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.755 -1.111 . . . . 63.13 110.025 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.7 t -125.45 112.54 16.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.645 0.736 . . . . 64.32 110.671 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -100.17 124.78 45.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.893 -1.151 . . . . 74.03 107.893 175.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 p -129.94 139.55 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.981 0.42 . . . . 73.43 111.006 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.5 128.64 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 75.5 110.2 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -110.25 121.69 45.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.98 . . . . 64.3 108.353 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.944 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -102.28 109.47 21.15 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.991 -0.744 . . . . 52.23 108.991 176.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.006 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 1.7 m-20 -68.64 106.09 2.49 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.69 -1.226 . . . . 65.32 107.69 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -53.49 -24.85 25.54 Favored Glycine 0 C--N 1.32 -0.355 0 O-C-N 123.517 0.511 . . . . 54.53 113.48 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.12 -26.48 19.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.672 0.272 . . . . 74.03 111.039 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 1.006 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 7.2 m-20 -96.69 -30.8 13.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.463 -0.335 . . . . 74.11 111.882 -173.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.944 HG11 ' HB3' ' A' ' 263' ' ' LEU . 21.7 m -62.95 -18.68 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 71.51 111.216 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -62.19 -31.08 71.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 63.24 109.783 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.27 9.99 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 74.21 110.63 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.17 15.94 63.73 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.969 -0.56 . . . . 71.34 112.985 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.69 96.12 2.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 61.13 112.479 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -110.18 142.82 41.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.082 -0.34 . . . . 74.1 110.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.928 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 58.4 mttm -101.06 134.48 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.006 -0.739 . . . . 75.51 109.006 170.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.31 132.42 37.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.795 -0.446 . . . . 72.44 109.795 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.49 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -148.07 132.69 4.32 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.872 -0.68 . . . . 43.32 111.611 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.976 HD23 HG23 ' A' ' 27' ' ' ILE . 45.4 tp -114.77 145.65 41.86 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 64.22 110.722 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.579 ' H ' HD12 ' A' ' 277' ' ' LEU . . . -142.32 125.47 2.67 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 63.41 112.006 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 255' ' ' ILE . 2.9 mm? -109.23 129.25 55.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.112 -0.699 . . . . 73.31 109.112 170.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.533 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 20.9 mt-10 -113.91 110.69 20.49 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.089 -0.708 . . . . 74.35 109.089 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.561 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -116.77 135.16 53.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.096 0.475 . . . . 73.33 110.155 -173.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -130.96 112.67 13.16 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.899 -0.778 . . . . 74.52 108.899 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.718 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -83.03 107.55 15.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 35.51 109.833 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 283' ' ' ALA . 3.4 mm? -137.9 -61.11 0.63 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.988 -1.006 . . . . 63.45 109.071 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.991 -0.528 . . . . 61.0 109.8 177.102 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.713 0.292 . . . . 74.21 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.941 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 3.8 t -116.02 114.77 41.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.978 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.88 175.07 11.85 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.702 2.268 . . . . 74.31 111.993 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 13.2 Cg_exo -70.79 85.13 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.443 2.095 . . . . 75.15 111.298 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 p -69.38 -34.35 74.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 42.43 111.54 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.598 ' HB3' HG21 ' A' ' 143' ' ' VAL . 10.9 p90 -61.24 -28.71 69.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.139 0.495 . . . . 74.21 110.983 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -84.86 -20.78 30.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 64.34 110.892 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -102.43 -0.12 32.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.177 0.989 . . . . 53.04 108.48 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.857 HD21 ' HA3' ' A' ' 152' ' ' GLY . 8.6 tp -58.04 -24.12 57.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.618 -1.628 . . . . 71.33 110.519 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.64 51.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.619 -0.719 . . . . 52.04 111.916 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 13.8 ptmm? -62.38 -44.04 97.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.653 0.264 . . . . 72.23 111.504 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -65.23 -38.95 91.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.182 0.515 . . . . 74.31 110.971 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 193' ' ' SER . . . -70.08 -43.79 70.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 44.24 111.95 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.67 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 5.4 ptm180 -61.2 -28.38 69.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.477 -0.329 . . . . 73.41 111.104 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.89 -42.48 84.73 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.375 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -82.68 -31.46 9.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 70.44 110.794 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 94.6 t80 -71.47 -22.64 61.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 73.53 112.323 -174.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -29.86 117.04 0.13 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.213 0.946 . . . . 74.34 113.352 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -80.42 -9.47 59.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.075 -0.966 . . . . 74.13 110.235 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.94 91.28 1.22 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.045 -0.822 . . . . 61.42 111.045 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -84.13 169.83 14.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.884 0.373 . . . . 72.32 111.055 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.4 112.39 3.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.097 -0.573 . . . . 63.11 112.656 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.432 ' HB2' HD13 ' A' ' 26' ' ' LEU . 45.7 m-85 -92.99 14.46 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.696 0.284 . . . . 71.1 110.905 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.7 13.57 53.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 54.34 112.065 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD13 ' HB2' ' A' ' 24' ' ' PHE . 10.7 mp -100.05 160.05 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.025 0.917 . . . . 63.45 112.376 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.715 HG13 HD23 ' A' ' 277' ' ' LEU . 1.7 mp -104.28 127.55 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.071 -1.422 . . . . 61.34 108.789 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -106.87 142.21 36.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.681 0.277 . . . . 71.43 110.47 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.68 148.17 46.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.298 -0.41 . . . . 51.43 110.031 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 13.8 t70 -155.16 134.62 12.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 74.45 109.95 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.871 -0.418 . . . . 73.33 109.871 -178.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -126.05 125.35 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.916 0.389 . . . . 73.5 110.087 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -137.68 120.04 15.85 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.025 -0.732 . . . . 63.03 109.025 170.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HE3' HD22 ' A' ' 284' ' ' LEU . 17.9 ptpt -133.41 144.58 49.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.546 . . . . 64.43 111.93 -176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 39' ' ' LEU . 18.8 m -141.21 164.83 29.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 72.24 109.297 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -80.03 26.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.968 0.413 . . . . 72.44 110.995 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 7.6 t-20 -107.28 21.08 18.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.116 0.484 . . . . 53.24 110.286 -173.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 77.11 -6.73 40.69 Favored Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.745 -0.74 . . . . 72.33 113.176 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 39' ' ' LEU . 2.0 pp -102.44 132.94 48.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.837 0.68 . . . . 72.24 112.837 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.066 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 39.3 mt-10 -137.2 124.88 22.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 54.51 109.124 165.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -107.06 120.13 41.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.1 -0.333 . . . . 74.33 110.1 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.861 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 29.5 m -128.77 132.16 47.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 62.24 111.125 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.0 t -125.04 135.28 52.58 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.749 -0.834 . . . . 75.34 108.749 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -148.56 125.76 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.007 -0.277 . . . . 73.13 110.708 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.89 168.22 40.99 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.951 -1.119 . . . . 32.42 113.001 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -137.48 135.53 36.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.448 -0.575 . . . . 74.35 109.448 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -149.94 150.62 32.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.266 0.555 . . . . 75.44 111.973 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -71.68 139.53 49.24 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.245 -1.02 . . . . 74.3 108.245 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -67.99 -8.55 38.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.41 0.624 . . . . 42.12 111.144 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -82.34 -3.25 55.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.75 -0.659 . . . . 71.03 109.968 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.9 p 54.48 21.01 3.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.181 0.992 . . . . 51.2 112.651 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 p -91.92 -26.65 18.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 74.51 110.976 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.41 95.99 4.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.502 -0.555 . . . . 74.21 109.502 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 47' ' ' ALA . 44.8 t -125.61 124.15 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.917 -0.583 . . . . 61.55 110.773 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 126.0 25.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.369 -0.604 . . . . 75.22 109.369 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.92 -178.01 37.9 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.263 -0.97 . . . . 63.55 112.786 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 5.0 p -138.4 153.23 48.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.169 0.509 . . . . 50.31 111.057 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.72 124.02 45.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.264 -1.384 . . . . 74.12 107.264 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.861 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 46.0 mt-10 -110.16 118.06 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.965 -0.561 . . . . 55.52 110.302 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -103.52 120.16 40.31 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.021 -1.103 . . . . 62.45 108.021 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 1.066 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 59.7 mttm -118.41 147.18 43.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.117 -0.492 . . . . 70.1 109.772 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.766 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 67.2 m-85 -118.12 120.18 36.98 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.959 -0.564 . . . . 63.4 109.634 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.606 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 14.6 ttm180 -114.09 106.84 14.86 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.505 0.669 . . . . 73.13 111.606 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -115.2 91.86 3.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.739 -1.119 . . . . 71.52 109.003 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 93.2 m 69.33 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.903 0.752 . . . . 70.5 111.286 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.04 129.03 39.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 73.54 110.5 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HD2' ' HG3' ' A' ' 88' ' ' GLU . 32.2 m-85 62.57 35.05 14.66 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.613 -0.722 . . . . 75.32 110.587 -173.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.03 -90.52 0.97 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.655 -1.378 . . . . 32.25 109.655 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 69' ' ' LEU . 2.1 mm? -122.75 129.42 51.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.313 0.578 . . . . 74.24 111.199 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.6 p -137.78 121.4 17.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.261 -0.881 . . . . 60.52 110.371 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -122.39 123.48 41.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.534 -0.543 . . . . 74.34 109.534 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.71 ' HB ' ' HG2' ' A' ' 61' ' ' LYS . 7.4 p -128.3 130.63 48.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.853 -0.739 . . . . 71.33 111.123 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 35.7 tt0 -109.88 121.67 45.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.448 -0.575 . . . . 75.42 109.448 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -109.65 94.21 4.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.74 -0.467 . . . . 73.04 109.74 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.953 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 32.2 t90 -96.7 128.17 43.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.487 -0.324 . . . . 73.34 110.416 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 1.9 m-20 -106.61 134.21 50.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.862 -0.792 . . . . 71.23 108.862 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.8 m -72.11 -27.56 62.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.716 0.769 . . . . 71.11 109.764 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.54 -24.32 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.813 -1.085 . . . . 74.24 111.836 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.437 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 13.4 t-20 -131.16 -108.71 0.26 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.408 -0.517 . . . . 73.01 112.181 -171.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 104' ' ' SER . 16.4 p -115.46 144.58 43.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.006 0.743 . . . . 75.14 113.006 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.953 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -98.8 119.76 38.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.867 -0.79 . . . . 70.32 108.867 166.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.42 120.95 4.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.423 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -104.4 114.0 27.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.682 0.277 . . . . 72.43 110.576 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 13.6 pt-20 -120.06 132.71 55.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.073 0.463 . . . . 64.11 110.495 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.26 121.77 65.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.837 -0.619 . . . . 63.43 109.357 177.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -117.88 123.04 44.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.657 -0.702 . . . . 74.54 110.805 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -129.45 132.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 74.33 110.354 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.622 ' HG3' ' HD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -91.91 118.73 31.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.164 -1.421 . . . . 71.21 107.164 172.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.522 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 8.5 t70 -56.05 124.05 16.47 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.503 0.502 . . . . 71.35 111.081 -168.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -67.21 -23.31 65.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.874 -0.603 . . . . 74.24 111.222 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.99 -51.58 4.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.711 -0.478 . . . . 73.43 109.711 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.32 77.8 3.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.244 -0.435 . . . . 61.43 110.52 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 89' ' ' ASP . 30.0 mmm180 -63.26 128.45 35.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.961 -0.563 . . . . 75.14 110.031 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.57 44.03 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.24 -0.744 . . . . 74.43 111.24 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 118' ' ' TYR . 20.8 tp -123.19 120.24 32.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.213 -0.662 . . . . 63.33 109.213 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -118.01 121.0 39.51 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.989 -0.55 . . . . 71.31 109.764 -173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -104.64 127.09 52.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.709 . . . . 63.5 109.991 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 93.5 m -129.2 118.62 22.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.256 -0.429 . . . . 73.4 110.552 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -111.32 115.8 29.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.267 -0.642 . . . . 74.5 109.267 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 3.0 p30 -117.47 151.03 37.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.297 0.57 . . . . 71.01 110.613 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.508 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 50.4 m -142.13 121.49 13.15 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 71.0 110.033 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -102.93 122.23 44.16 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.872 -0.603 . . . . 35.21 109.546 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.553 ' HD2' HD21 ' A' ' 81' ' ' LEU . 82.4 t80 -110.24 130.54 55.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.718 -0.475 . . . . 61.04 109.718 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.437 ' HB2' HG22 ' A' ' 80' ' ' THR . 35.5 t -106.99 106.94 59.65 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 74.24 109.9 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 37.2 Cg_endo -66.58 -16.09 49.69 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.7 2.267 . . . . 62.11 111.992 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -74.52 -38.46 62.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 75.35 110.874 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.652 HG23 ' H ' ' A' ' 109' ' ' LYS . 3.0 t -108.31 -27.96 9.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.351 . . . . 63.34 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 2.89 67.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.748 -0.739 . . . . 54.32 112.227 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.652 ' H ' HG23 ' A' ' 107' ' ' THR . 51.2 mtmt -89.08 148.4 23.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 53.24 110.956 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.508 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 61.7 tttm -123.08 136.94 55.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 73.42 109.939 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 101' ' ' SER . 14.4 t-20 -119.6 122.81 42.41 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.891 -0.411 . . . . 74.21 109.891 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.83 129.72 56.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.249 -0.432 . . . . 61.2 110.6 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.801 ' HG2' ' HA ' ' A' ' 130' ' ' ASP . 35.9 mtmm -127.85 138.47 52.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.207 -0.451 . . . . 63.44 110.336 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.8 tp -116.56 117.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.479 0.657 . . . . 53.21 110.166 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 46.0 mttp -107.32 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.223 -0.899 . . . . 72.23 110.959 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -123.73 117.62 25.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.902 -0.777 . . . . 61.4 108.902 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.08 114.99 2.19 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.201 -1.0 . . . . 73.34 112.731 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.446 ' HB3' HD13 ' A' ' 95' ' ' LEU . 5.1 p90 -109.79 122.65 47.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.367 0.603 . . . . 65.24 109.753 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.941 ' HD3' ' HB ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.538 -0.756 . . . . 65.02 112.186 -173.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 46.1 mmt-85 -106.45 152.93 22.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.668 -1.234 . . . . 74.34 107.668 165.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -29.57 59.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.955 0.724 . . . . 73.41 112.955 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.4 -5.94 15.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.001 0.371 . . . . 75.21 112.001 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 120' ' ' ARG . 9.0 tp -145.61 123.51 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.248 0.547 . . . . 63.5 111.48 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.636 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 4.1 t30 -119.97 117.05 27.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.2 -0.312 . . . . 74.5 110.53 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.0 mm? -112.97 127.1 56.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.909 0.385 . . . . 62.22 110.923 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -130.84 118.31 2.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.909 -0.587 . . . . 53.04 111.773 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.9 m -105.21 120.72 42.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.767 0.318 . . . . 73.1 110.678 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -114.85 117.4 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 72.14 110.162 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 77.6 mmm -99.02 117.07 32.71 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.441 -0.577 . . . . 64.14 109.441 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.801 ' HA ' ' HG2' ' A' ' 113' ' ' LYS . 11.0 t70 -102.81 118.5 36.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 72.23 110.696 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -97.84 97.85 9.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.436 -0.347 . . . . 72.51 110.844 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -105.1 144.38 31.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.972 -0.751 . . . . 63.52 108.972 170.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.02 -34.67 53.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.108 0.48 . . . . 71.32 111.977 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.22 -18.0 59.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.181 -0.463 . . . . 62.04 111.546 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.17 118.61 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.871 -0.681 . . . . 74.22 112.148 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.26 126.75 21.76 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.797 2.331 . . . . 62.03 112.04 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.9 m -107.63 150.82 26.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.275 -0.421 . . . . 64.0 110.363 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 33.4 mm -107.02 116.9 51.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.481 -0.562 . . . . 72.13 109.481 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -111.54 123.18 49.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.403 0.621 . . . . 72.4 110.348 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.34 132.93 11.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.307 -0.949 . . . . 73.31 111.959 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.27 23.76 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.197 -0.668 . . . . 64.41 109.197 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 143' ' ' VAL . 14.9 tp -124.16 131.67 53.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.107 -0.497 . . . . 61.55 110.608 -175.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 34.1 t -131.38 129.66 62.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.196 -0.456 . . . . 71.34 110.037 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 6.2 mp -109.48 138.66 45.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.117 -0.697 . . . . 64.04 109.117 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.553 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -119.55 119.32 4.23 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 121.04 -0.6 . . . . 75.11 112.888 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 63.4 t80 -126.99 149.07 50.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.684 -1.228 . . . . 74.33 107.684 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -49.31 101.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 74.52 111.55 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.48 -30.78 7.39 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.822 -0.626 . . . . 72.41 112.744 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 39.0 m95 -104.7 126.8 52.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 73.54 111.523 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.773 ' HB3' HD12 ' A' ' 10' ' ' LEU . 20.1 mt -120.32 146.98 45.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.022 0.439 . . . . 74.04 110.285 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -137.1 127.37 26.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.014 -0.736 . . . . 62.44 109.014 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.857 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -131.51 142.46 13.85 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.375 -0.917 . . . . 63.5 111.717 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.674 ' HD2' ' HD2' ' A' ' 169' ' ' PHE . 64.3 m-85 -136.0 121.76 19.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.743 0.306 . . . . 73.32 110.375 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.822 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 23.5 mp0 -106.05 122.58 46.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.961 -0.755 . . . . 65.4 108.961 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 49.1 ttm -127.96 141.87 51.41 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.735 -0.386 . . . . 73.53 110.464 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 51.5 t-20 -130.74 117.41 19.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.406 -0.59 . . . . 61.13 109.406 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.799 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 63.4 t80 -95.16 120.77 35.96 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.491 0.494 . . . . 72.01 110.053 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 43.4 tt0 -99.03 99.59 10.64 Favored 'General case' 0 C--O 1.26 1.649 0 CA-C-O 121.548 0.689 . . . . 73.31 110.678 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -70.59 -22.23 62.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 113.542 -1.663 . . . . 75.44 110.794 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.12 69.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.793 0.806 . . . . 54.43 109.119 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.653 ' HG3' ' H ' ' A' ' 162' ' ' SER . 21.5 tptp -113.41 -158.56 0.66 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.437 -1.32 . . . . 51.22 107.437 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.653 ' H ' ' HG3' ' A' ' 161' ' ' LYS . 17.2 m -108.72 28.08 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.918 -0.488 . . . . 44.22 110.813 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 163' ' ' ARG . 2.4 ptm180 -157.01 160.77 39.32 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.053 -1.059 . . . . 75.11 111.954 -164.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.6 m -74.0 133.4 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.165 -1.05 . . . . 75.13 108.165 169.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.7 t -93.39 -14.83 26.34 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.951 -0.3 . . . . 75.05 110.273 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.71 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 19.6 mt-30 -142.21 132.74 25.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.399 0.618 . . . . 72.42 111.796 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -123.0 105.98 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.058 -0.974 . . . . 74.42 109.388 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.822 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 80.7 m-20 -114.42 136.06 53.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 64.35 110.176 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.674 ' HD2' ' HD2' ' A' ' 153' ' ' TYR . 36.5 m-85 -130.42 140.71 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 75.12 110.053 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -142.69 129.03 19.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.832 0.348 . . . . 73.5 110.282 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 45.8 t -124.54 127.13 72.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.004 -0.739 . . . . 60.33 109.004 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -140.49 115.39 1.05 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.85 -1.167 . . . . 74.23 112.293 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.49 ' CE2' HD22 ' A' ' 180' ' ' LEU . 54.2 p90 -115.47 134.48 55.05 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.422 -0.511 . . . . 64.11 110.241 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -119.25 124.95 47.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.311 -0.859 . . . . 62.11 110.225 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 51.1 m -134.78 112.69 10.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.893 -0.323 . . . . 74.32 110.301 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.6 t70 43.12 -87.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.35 1.031 . . . . 73.33 113.752 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 10.2 pt-20 -101.86 -12.13 18.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.213 0.449 . . . . 74.3 112.213 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.47 ' HD2' ' HG2' ' A' ' 196' ' ' GLN . 74.6 t80 -119.18 117.19 28.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 74.52 111.247 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -123.84 124.36 42.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 72.45 109.584 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.629 HD12 HG13 ' A' ' 194' ' ' ILE . 3.1 tt -119.49 135.41 54.78 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.512 -0.475 . . . . 74.35 110.677 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.58 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 47.7 t60 -129.75 115.11 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.373 -0.83 . . . . 75.42 110.225 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.0 m -92.48 142.8 27.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.492 -0.929 . . . . 75.35 108.492 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.15 139.83 33.98 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 63.53 110.754 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.35 121.06 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.714 -0.675 . . . . 61.21 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 75.2 m-20 -103.62 94.24 5.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.374 -0.83 . . . . 61.2 109.276 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.71 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 12.1 m-20 65.83 -169.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.836 -1.074 . . . . 71.22 110.907 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 212' ' ' ALA . . . -76.49 -6.5 84.32 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.425 -0.893 . . . . 72.12 111.714 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.2 m -96.8 -25.56 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.616 0.598 . . . . 74.24 112.616 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.4 tt0 -129.72 113.98 15.41 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.062 -0.655 . . . . 74.01 111.54 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -121.86 124.74 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.933 -0.765 . . . . 73.04 108.933 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.45 -160.75 11.36 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.788 -1.196 . . . . 72.33 112.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.66 175.8 44.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.539 -0.838 . . . . 75.15 112.389 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.641 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 26.2 m -148.68 138.09 21.87 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.391 -0.596 . . . . 61.43 109.391 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.76 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.6 mp -121.2 137.18 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.532 -0.544 . . . . 71.44 109.532 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -121.6 119.92 33.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.787 -0.82 . . . . 72.34 108.787 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.47 ' HG2' ' HD2' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -124.97 111.07 14.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.714 -0.847 . . . . 75.04 108.714 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 60.1 tttp -97.23 119.48 35.82 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.811 -0.631 . . . . 74.0 109.745 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.84 146.0 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.467 -1.308 . . . . 74.42 107.467 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -74.54 56.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.769 0.795 . . . . 74.12 110.997 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.461 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 67.8 mttm -152.85 -146.78 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.848 -1.524 . . . . 74.32 108.028 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.801 ' HB3' ' HB3' ' A' ' 226' ' ' GLN . 1.2 mptm? -103.01 26.16 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.315 0.578 . . . . 75.51 109.587 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.55 110.32 19.06 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.464 -0.789 . . . . 75.23 110.269 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.947 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 12.8 mm-40 -107.01 134.39 50.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 52.45 109.795 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.5 m -123.38 143.11 50.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 64.2 109.919 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -142.32 158.58 43.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 65.15 111.114 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.76 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 71.5 t -132.45 141.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.533 -0.543 . . . . 55.31 109.533 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.46 125.4 16.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.038 -0.727 . . . . 64.32 109.038 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.662 HD13 ' HD1' ' A' ' 219' ' ' PHE . 2.5 pt? -146.6 150.65 35.9 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.415 -0.514 . . . . 73.14 111.036 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.38 130.88 22.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 72.02 110.194 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.671 ' HB2' HG23 ' A' ' 217' ' ' THR . 9.4 t90 -125.28 135.11 52.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.606 -0.724 . . . . 70.01 109.489 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.909 HG23 ' HB3' ' A' ' 214' ' ' ASN . 3.9 t -95.27 113.95 25.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.355 0.598 . . . . 72.34 110.457 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -64.94 144.71 57.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 72.35 110.846 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.58 -2.72 86.33 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.675 -0.97 . . . . 52.5 110.675 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.909 ' HB3' HG23 ' A' ' 211' ' ' THR . 37.2 t-20 -138.28 159.18 42.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.332 -0.988 . . . . 54.31 108.332 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.1 t -93.41 -9.29 39.12 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.174 -0.329 . . . . 73.14 110.542 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.97 108.92 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.213 0.53 . . . . 70.14 110.951 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 210' ' ' TRP . 28.1 m -117.13 135.07 54.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.281 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -126.1 117.5 23.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.899 -0.32 . . . . 72.45 110.255 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.662 ' HD1' HD13 ' A' ' 208' ' ' LEU . 74.5 t80 -113.27 138.42 50.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.567 -0.742 . . . . 74.41 109.241 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.82 157.21 26.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.527 -0.844 . . . . 42.41 112.705 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.65 136.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 64.31 109.649 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 205' ' ' ALA . . . -114.51 152.66 31.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.783 -0.451 . . . . 53.11 109.783 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.78 140.2 34.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.397 -0.365 . . . . 75.32 110.498 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.947 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 28.9 ttmt -123.1 113.84 19.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.128 -0.693 . . . . 63.13 109.128 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -105.2 116.47 32.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.48 -0.327 . . . . 71.51 110.535 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.801 ' HB3' ' HB3' ' A' ' 201' ' ' LYS . 63.1 tt0 -91.99 104.17 16.61 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.461 -0.94 . . . . 72.43 108.461 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.83 -49.06 60.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.472 -0.785 . . . . 73.35 110.991 -172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.747 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.1 t70 -164.78 -59.64 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 74.42 111.491 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 72.1 Cg_endo -89.38 -139.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.023 1.815 . . . . 63.35 113.443 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 1.8 m-20 -92.13 13.38 19.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.815 -1.084 . . . . 71.13 110.37 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.09 124.93 45.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 63.25 110.154 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.644 ' HB2' HG23 ' A' ' 248' ' ' THR . 59.6 m -113.09 145.09 41.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.191 -0.913 . . . . 74.44 110.173 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.24 125.98 39.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.962 -1.125 . . . . 75.11 107.962 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.8 t -106.45 144.56 32.95 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.166 -0.47 . . . . 72.15 110.013 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -148.57 147.69 29.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.34 -0.391 . . . . 61.1 110.431 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -148.01 138.53 22.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.132 -0.692 . . . . 63.53 109.132 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.33 152.92 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 242' ' ' LEU . 11.7 p30 -133.4 152.43 51.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.965 -0.694 . . . . 74.02 110.777 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.58 5.02 0.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.539 -1.209 . . . . 64.33 112.982 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.601 ' HB3' HD13 ' A' ' 242' ' ' LEU . 32.3 t -89.01 13.83 12.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.506 -0.924 . . . . 52.21 108.506 170.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 49.9 m 69.26 31.72 3.83 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 114.626 -1.17 . . . . 70.32 111.357 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.999 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 10.2 mp -99.75 142.62 31.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.287 -0.565 . . . . 74.23 111.202 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -125.59 118.0 51.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.695 -0.684 . . . . 63.21 110.317 -169.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.07 143.57 16.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.739 -0.743 . . . . 74.23 112.436 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.37 156.72 43.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.845 0.355 . . . . 71.14 110.153 176.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.92 -177.73 36.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.435 -0.888 . . . . 42.24 113.049 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.15 115.93 26.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.603 -0.517 . . . . 71.12 109.603 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 232' ' ' CYS . 6.3 t -111.06 113.93 26.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.075 -0.713 . . . . 74.44 109.075 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -132.82 150.4 52.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.222 -0.444 . . . . 65.31 111.463 -168.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 8.9 t -124.78 132.83 53.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.117 -1.068 . . . . 71.23 108.117 167.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.636 HD23 HD12 ' A' ' 255' ' ' ILE . 36.8 tp -72.27 -65.15 0.81 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.5 -0.48 . . . . 60.12 109.851 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.654 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 0.5 OUTLIER 174.72 -57.91 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.466 -0.788 . . . . 62.12 110.137 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 83.5 Cg_endo -80.4 52.35 4.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.308 2.005 . . . . 64.42 113.403 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.96 64.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.666 -0.778 . . . . 75.44 112.596 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.636 HD12 HD23 ' A' ' 251' ' ' LEU . 61.7 mt -107.27 122.25 61.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 122.733 -0.275 . . . . 70.14 110.262 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.673 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 17.2 tptm -121.17 122.64 40.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.645 . . . . 74.04 110.75 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.76 124.08 51.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.136 -0.938 . . . . 73.42 109.815 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 277' ' ' LEU . 38.0 m -119.75 110.22 16.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.177 0.513 . . . . 74.22 110.743 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -111.13 125.77 54.13 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.86 -1.163 . . . . 72.24 107.86 173.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.9 p -139.08 141.01 38.18 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.762 -0.375 . . . . 41.32 110.742 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.42 127.62 19.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.325 -0.62 . . . . 63.21 109.325 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.729 HD21 HD23 ' A' ' 242' ' ' LEU . 0.4 OUTLIER -108.75 128.91 55.29 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.445 0.641 . . . . 74.3 109.466 177.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.895 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.4 mm? -102.1 106.96 17.91 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.252 -0.885 . . . . 70.05 108.957 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.999 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 6.3 t70 -73.48 98.99 2.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.754 -1.112 . . . . 62.43 108.329 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.83 -9.36 3.67 Favored Glycine 0 C--N 1.314 -0.673 0 CA-C-N 115.725 -0.671 . . . . 74.35 113.38 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -92.46 -21.84 19.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.867 -0.166 . . . . 65.2 111.025 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.89 -23.74 0.92 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.441 1.115 . . . . 73.41 110.831 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 273' ' ' HIS . 1.0 OUTLIER -63.21 -26.7 41.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 113.748 -1.569 . . . . 61.55 112.844 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.48 -26.32 68.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.055 -0.52 . . . . 73.25 110.274 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -88.29 -16.5 32.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.196 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.63 -1.2 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.521 -0.847 . . . . 43.2 113.637 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.86 51.79 4.36 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.561 -0.828 . . . . 75.33 113.046 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.921 ' HA ' HG22 ' A' ' 268' ' ' VAL . 4.4 p-80 -78.31 144.44 36.09 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.767 0.318 . . . . 72.3 111.389 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.51 138.18 38.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 60.34 110.878 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.575 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -128.32 144.13 51.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 62.0 109.699 -174.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -146.32 119.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.933 -0.651 . . . . 55.43 111.821 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.715 HD23 HG13 ' A' ' 27' ' ' ILE . 54.0 tp -114.68 146.93 40.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 70.45 110.874 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.77 124.47 1.67 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.893 -0.594 . . . . 70.22 111.693 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.434 HD21 HD21 ' A' ' 277' ' ' LEU . 2.8 mm? -111.04 130.28 55.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.065 -0.717 . . . . 63.4 109.065 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.673 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 16.9 pt-20 -137.1 122.73 19.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.467 0.651 . . . . 72.02 110.459 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.681 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.2 m-85 -114.43 110.48 19.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.863 -0.791 . . . . 71.13 108.863 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.54 111.0 19.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.103 0.477 . . . . 63.41 111.497 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -104.19 109.75 21.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.453 -0.943 . . . . 73.32 108.453 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.485 HD22 ' HE3' ' A' ' 34' ' ' LYS . 56.9 mt -120.34 -98.42 0.45 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.381 -0.372 . . . . 71.31 111.535 -171.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.492 -0.766 . . . . 74.21 109.981 -176.562 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.523 -0.547 . . . . 53.34 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.777 ' HB ' ' HD2' ' A' ' 119' ' ' LYS . 16.3 t -117.89 117.09 35.82 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.924 -0.58 . . . . 74.42 110.705 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.43 161.9 14.88 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.539 2.159 . . . . 73.31 111.433 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 102.75 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.354 2.036 . . . . 54.04 111.63 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.539 ' HB ' HG11 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -70.09 -42.67 72.41 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.943 -0.571 . . . . 54.02 111.01 -176.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.918 ' HA ' ' HB3' ' A' ' 10' ' ' LEU . 64.4 t80 -50.15 -25.82 3.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.467 0.707 . . . . 74.52 111.68 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.683 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -76.65 -17.61 59.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.929 -0.578 . . . . 51.02 110.487 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -105.89 -31.36 8.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.547 -1.279 . . . . 61.35 107.547 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.918 ' HB3' ' HA ' ' A' ' 7' ' ' TYR . 2.5 tt -58.4 -36.09 73.02 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.351 -2.204 . . . . 73.24 110.738 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.12 -21.89 0.14 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 119.181 -1.485 . . . . 74.45 115.753 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.683 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 16.8 ttmm -57.15 -52.59 64.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.448 1.124 . . . . 74.33 112.358 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -56.62 -38.81 72.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.114 0.483 . . . . 72.4 111.073 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 181' ' ' HIS . . . -70.3 -42.65 71.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.563 -0.744 . . . . 42.15 111.156 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 5.2 tmm_? -59.66 -34.59 73.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.125 -0.488 . . . . 62.14 111.385 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -47.15 84.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 73.31 111.635 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.521 ' HA ' ' HE1' ' A' ' 22' ' ' TYR . 78.9 t -82.7 -32.03 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.922 0.391 . . . . 51.33 110.966 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 86.8 t80 -60.54 -35.36 75.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 73.23 112.171 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -79.43 131.0 35.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 60.02 111.464 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.974 ' H ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -69.87 151.05 46.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.009 -0.996 . . . . 64.14 110.236 175.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.75 78.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.853 -0.689 . . . . 55.43 112.291 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.521 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 72.1 m-85 -70.28 -23.36 62.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.609 0.242 . . . . 74.33 111.454 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -123.72 133.25 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.798 -0.715 . . . . 73.33 111.756 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -104.21 2.12 31.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.085 0.469 . . . . 72.12 110.687 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.95 12.57 57.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.919 -0.658 . . . . 63.44 112.172 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.56 158.65 17.05 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 122.592 1.187 . . . . 75.34 113.656 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.803 HG23 HD12 ' A' ' 277' ' ' LEU . 46.2 mm -105.63 121.82 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 113.016 -1.902 . . . . 65.14 108.924 173.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 25.2 ttpp -109.64 129.07 55.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 75.42 110.65 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tm? -128.43 127.39 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.338 -0.986 . . . . 74.31 108.338 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.0 p30 -142.94 140.92 31.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.223 0.535 . . . . 73.14 110.989 175.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' THR . 7.2 tp -127.06 124.38 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.13 -0.941 . . . . 73.41 109.87 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 ptmm? -127.35 125.78 41.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.756 . . . . 63.34 110.385 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 9.9 t -131.73 132.21 43.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.8 -0.636 . . . . 75.13 110.221 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 28.9 mtpp -111.77 132.04 54.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.206 -0.664 . . . . 73.21 109.206 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 17.6 m -133.6 169.21 17.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 72.11 110.446 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -86.5 158.74 19.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.052 -0.522 . . . . 73.32 109.704 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.29 55.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.607 0.567 . . . . 71.54 111.991 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 85.16 -5.16 84.05 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 116.108 1.203 . . . . 73.24 116.108 168.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 2.7 mm? -100.31 124.75 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.024 1.912 . . . . 62.45 112.769 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.867 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 35.9 mt-10 -142.35 139.87 31.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 64.03 108.542 159.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.498 ' HB3' ' CG2' ' A' ' 33' ' ' THR . 90.3 t80 -131.51 121.84 25.14 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 122.061 -0.399 . . . . 71.14 110.547 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.769 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 18.2 m -127.33 131.38 50.43 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.991 0.424 . . . . 73.43 110.488 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -126.51 126.19 43.31 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.06 -0.718 . . . . 53.14 109.06 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 p -126.54 126.22 43.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 63.12 111.159 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.04 139.7 9.16 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 53.24 112.36 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 p -132.21 136.59 47.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.058 0.456 . . . . 72.22 110.67 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.8 51.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.793 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -84.83 137.89 32.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.542 -0.54 . . . . 73.35 109.542 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.3 m -80.33 -27.5 38.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.005 0.431 . . . . 62.42 110.991 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.13 -71.37 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 74.23 110.52 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 p -93.24 159.82 15.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.249 -0.432 . . . . 52.31 110.603 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -79.81 88.48 5.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.468 0.652 . . . . 75.01 110.34 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -138.0 104.46 5.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 73.34 109.518 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.31 119.6 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.145 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -114.05 126.24 54.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.839 -0.619 . . . . 75.25 109.777 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.73 123.84 3.63 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.476 -0.869 . . . . 52.13 112.415 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 p -114.1 142.65 45.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.68 -0.489 . . . . 64.22 109.68 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -121.31 123.33 41.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.955 -0.757 . . . . 60.22 108.955 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.769 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 2.1 pm0 -114.16 118.97 35.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.076 0.941 . . . . 73.33 111.226 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -99.25 120.94 40.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.597 -1.183 . . . . 65.31 108.947 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 43.6 mtpt -112.56 126.92 55.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.219 0.533 . . . . 64.11 110.814 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 84.4 m-85 -103.3 120.28 40.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.55 -0.907 . . . . 75.25 108.55 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 36.0 ttt180 -110.71 108.2 18.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 73.23 110.742 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.501 ' HE3' ' HB3' ' A' ' 69' ' ' LEU . 5.3 m-90 -107.09 99.35 8.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.791 -0.64 . . . . 74.2 110.577 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 m 70.59 133.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.512 -0.767 . . . . 64.33 111.084 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.6 pm0 -64.73 124.58 22.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 62.14 110.559 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 63.4 35.49 12.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.433 -0.803 . . . . 73.41 111.077 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.37 -77.77 0.38 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.207 -0.757 . . . . 74.22 111.207 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.8 mm? -124.86 132.63 53.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.095 0.474 . . . . 71.43 111.378 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.34 112.59 11.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.83 -0.623 . . . . 61.22 110.248 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.565 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 58.5 t80 -111.6 120.26 41.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.007 -0.542 . . . . 70.12 109.745 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 t -124.27 117.29 24.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.308 0.575 . . . . 75.3 110.93 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 34.5 tt0 -102.76 120.62 40.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 63.12 109.697 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -107.19 113.98 27.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 63.24 110.336 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.848 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 70.4 t90 -103.1 134.89 45.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.776 -0.453 . . . . 70.01 109.776 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -110.22 156.19 21.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 73.13 109.481 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -61.35 -16.0 41.69 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.832 0.678 . . . . 61.45 112.832 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.6 -1.47 57.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.828 -0.169 . . . . 54.43 111.333 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 87.81 11.51 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.241 1.016 . . . . 72.14 112.432 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -81.83 126.38 31.8 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.775 -0.37 . . . . 44.45 110.099 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.848 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -105.63 119.48 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.33 -0.395 . . . . 60.2 110.155 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.83 98.65 0.92 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.352 -1.099 . . . . 65.15 110.352 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' HG3' ' A' ' 73' ' ' GLU . 9.7 t -106.63 120.86 43.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.516 0.674 . . . . 73.34 111.641 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 40.5 tt0 -109.3 123.47 49.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.376 -0.829 . . . . 52.31 110.169 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.565 ' HB ' ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -112.58 124.13 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 63.35 109.496 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 m -111.4 130.04 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 63.53 111.17 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 5.9 t -110.45 120.28 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.556 -0.747 . . . . 74.31 109.51 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.88 116.98 34.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.243 -0.28 . . . . 63.51 110.243 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 52.19 62.99 2.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.596 -0.729 . . . . 73.4 111.326 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.681 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 23.7 tp60 -62.42 -74.7 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.606 . . . . 75.11 111.24 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.681 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 88.5 mt -115.61 -31.93 5.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 64.44 110.111 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.92 125.64 51.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 64.04 110.268 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -63.64 135.38 56.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.124 0.488 . . . . 74.54 110.822 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.72 -15.23 58.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.556 -0.747 . . . . 72.15 112.257 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.2 131.4 36.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.501 . . . . 73.15 111.442 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -119.25 111.08 17.77 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.613 -0.884 . . . . 74.2 108.613 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -103.65 127.47 51.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.493 -0.558 . . . . 64.35 109.493 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.894 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 21.9 m -127.84 119.25 25.25 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.642 0.258 . . . . 74.13 110.579 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 82.5 m-85 -117.46 114.95 24.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.593 . . . . 70.35 109.4 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.961 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.9 t70 -111.14 122.65 48.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.183 -0.673 . . . . 75.04 109.183 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -118.2 120.47 37.8 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.016 0.436 . . . . 65.13 110.01 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 111' ' ' ASN . 53.7 m -109.55 121.48 45.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.138 -0.483 . . . . 64.31 109.922 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -123.66 125.07 44.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.968 -0.56 . . . . 75.33 110.186 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 t -114.03 101.75 54.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 109.683 -0.488 . . . . 73.12 109.683 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.05 -9.16 19.25 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.932 2.421 . . . . 75.04 110.577 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -72.03 -55.48 7.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.887 -1.051 . . . . 61.23 109.89 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.5 t -103.92 -19.77 14.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 63.54 111.556 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.16 22.79 18.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.691 -0.766 . . . . 52.1 112.604 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HE3' ' OD1' ' A' ' 111' ' ' ASN . 60.6 tttp -95.35 146.49 24.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.537 0.208 . . . . 75.31 110.774 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 140.66 45.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.873 0.368 . . . . 75.33 110.023 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.2 m120 -128.81 132.57 47.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.3 110.376 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -111.0 114.76 28.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.047 -0.524 . . . . 70.22 110.106 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.961 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 56.8 tttp -113.25 135.39 53.88 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.485 -0.561 . . . . 64.44 109.485 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.529 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -136.37 135.66 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 74.52 110.053 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.6 ttpm? -131.2 121.36 24.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.187 0.518 . . . . 75.43 110.582 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 p -112.63 121.17 44.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.437 -0.801 . . . . 73.51 109.278 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.46 154.52 21.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.004 -1.093 . . . . 63.44 112.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.38 116.64 21.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.454 -0.943 . . . . 74.31 108.454 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.777 ' HD2' ' HB ' ' A' ' 3' ' ' VAL . 24.4 pttm -110.18 121.94 46.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.42 0.628 . . . . 75.32 111.252 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.6 mpt_? -107.48 148.63 28.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.954 -1.128 . . . . 63.14 107.954 168.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.34 -27.9 50.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.986 0.422 . . . . 64.35 110.972 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -93.08 -31.2 14.92 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.272 0.471 . . . . 73.41 112.272 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 ' HB2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -144.21 132.32 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.822 -0.751 . . . . 63.31 110.974 -167.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.73 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 7.4 t30 -120.92 125.65 48.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.366 0.506 . . . . 72.51 112.366 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.94 131.64 55.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.936 -0.574 . . . . 63.24 110.049 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -141.38 117.07 1.17 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.331 -0.938 . . . . 43.31 112.626 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 42.0 t -109.78 108.57 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.323 . . . . 31.15 110.483 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.719 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 10.7 t70 -108.29 138.55 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 55.11 109.592 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.543 ' HG2' HG13 ' A' ' 138' ' ' ILE . 73.7 mtm -138.14 128.04 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.819 -0.551 . . . . 62.12 111.241 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -97.73 117.27 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.187 -0.672 . . . . 64.12 109.187 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 84.6 t80 -97.02 114.87 26.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.174 0.511 . . . . 74.24 111.048 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.3 153.9 45.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.595 -0.891 . . . . 72.51 108.595 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.435 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.8 pp -69.62 -17.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 73.25 111.1 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.56 -10.38 57.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.781 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.87 125.25 1.79 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.775 -0.726 . . . . 65.33 112.374 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 6.3 Cg_exo -80.03 122.07 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.23 2.62 . . . . 72.52 111.921 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 m -97.2 135.73 38.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.014 -0.365 . . . . 70.53 110.014 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.543 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -106.1 119.27 55.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.133 0.492 . . . . 64.35 110.026 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -117.62 111.73 19.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.945 -0.571 . . . . 75.14 109.98 -174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.46 132.99 11.3 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.907 -1.14 . . . . 73.4 112.096 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 116.36 24.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.186 0.517 . . . . 75.1 109.946 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.476 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.1 tp -116.87 123.58 47.4 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 73.35 109.889 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 53.0 t -117.01 128.76 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.196 -0.456 . . . . 61.52 110.415 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -107.78 137.9 44.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.259 -1.015 . . . . 74.14 108.259 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.37 121.05 2.33 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.312 -0.947 . . . . 54.32 113.529 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.14 149.36 41.41 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.072 -1.084 . . . . 74.32 108.072 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.47 105.15 0.08 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.655 0.741 . . . . 73.4 111.718 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.39 -32.18 7.85 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.273 -0.876 . . . . 64.12 112.441 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -105.35 122.47 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.777 0.322 . . . . 53.14 111.602 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 150' ' ' LEU . 6.6 mt -115.05 136.32 53.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.684 -1.228 . . . . 55.42 107.684 163.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.657 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -136.28 152.72 51.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.55 ' HA3' HD11 ' A' ' 10' ' ' LEU . . . -157.21 133.18 3.47 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.193 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.664 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 67.8 m-85 -124.02 114.68 20.07 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.429 -0.582 . . . . 74.44 109.429 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -105.45 120.88 42.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.697 -0.683 . . . . 73.22 109.71 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.415 ' SD ' HG11 ' A' ' 164' ' ' VAL . 58.4 ttp -132.48 129.0 38.62 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.42 -0.355 . . . . 74.44 110.444 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.461 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 73.6 m-20 -111.16 115.87 30.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.941 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.5 t80 -97.28 127.1 42.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.993 -1.003 . . . . 75.12 110.273 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 6.6 tp10 -94.39 100.23 12.29 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-N 115.858 -0.61 . . . . 61.42 109.593 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 -19.95 62.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.769 -1.56 . . . . 74.05 111.008 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.72 77.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.613 -0.884 . . . . 24.25 108.613 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -102.77 -160.45 0.78 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.296 -1.32 . . . . 65.14 108.026 167.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.1 m -109.48 27.07 9.92 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.047 -0.408 . . . . 74.53 110.929 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -163.24 161.64 24.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 118.912 -1.115 . . . . 72.22 111.596 -165.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.941 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -72.95 136.1 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.137 0.494 . . . . 74.0 109.865 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 5.1 t -93.61 -23.45 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.897 -0.592 . . . . 75.14 110.317 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -140.1 132.88 29.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.61 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 p -121.07 109.31 14.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.805 -0.634 . . . . 70.13 110.274 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -111.69 127.56 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.387 0.613 . . . . 44.12 110.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.664 ' HD2' ' HD1' ' A' ' 153' ' ' TYR . 80.0 m-85 -121.03 144.29 48.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.701 -0.481 . . . . 74.34 109.701 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -147.26 137.25 23.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.524 0.678 . . . . 42.04 111.091 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.994 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 99.5 t -133.44 152.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.267 -1.012 . . . . 72.12 108.267 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 181' ' ' HIS . . . -147.88 123.16 1.66 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.101 -1.047 . . . . 61.12 112.271 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.07 120.59 42.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.171 -0.677 . . . . 73.44 109.171 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.04 126.86 53.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.793 0.806 . . . . 74.22 111.867 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -116.94 163.26 16.47 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.78 -1.563 . . . . 62.3 106.78 168.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -53.64 -42.08 67.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.239 0.459 . . . . 41.3 112.239 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -107.3 -14.02 14.98 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.288 0.477 . . . . 72.24 112.288 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -132.11 120.85 22.89 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.125 -0.359 . . . . 64.12 110.941 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -135.19 124.08 24.03 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.785 -0.366 . . . . 64.02 110.683 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.785 ' HB2' ' HA ' ' A' ' 194' ' ' ILE . 0.0 OUTLIER -124.53 138.43 54.33 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.775 -0.578 . . . . 65.14 110.472 175.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 95.3 m-70 -115.46 117.85 31.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 74.44 110.385 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.994 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 90.0 m -78.79 122.84 26.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 71.25 109.685 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.35 139.66 53.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.369 0.604 . . . . 72.42 111.432 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 90.3 t -131.2 117.1 35.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.594 -0.73 . . . . 74.15 110.146 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.28 105.67 15.81 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.9 -0.778 . . . . 72.14 108.9 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.8 t70 63.36 -172.4 0.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.539 -0.755 . . . . 73.3 108.968 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.52 -6.76 88.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 64.42 110.842 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 211' ' ' THR . 1.2 p -88.68 -24.49 22.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.416 0.895 . . . . 63.35 113.416 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.26 110.67 11.28 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.876 0.762 . . . . 71.25 111.111 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -121.48 124.63 44.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.005 -0.543 . . . . 74.22 109.999 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -176.42 -149.75 7.78 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.545 -1.312 . . . . 60.12 113.672 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.54 175.07 35.68 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.291 -0.723 . . . . 70.01 111.291 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.496 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 55.9 m -148.3 138.42 22.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.095 0.448 . . . . 74.43 110.032 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 1.012 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.1 mp -117.88 129.73 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.833 0.349 . . . . 74.33 110.681 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -108.18 120.04 41.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.388 -0.967 . . . . 75.24 108.388 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.662 ' HB2' ' HB ' ' A' ' 204' ' ' THR . 13.1 mm-40 -120.48 132.18 55.09 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.085 0.402 . . . . 71.43 112.085 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -103.51 108.79 20.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.166 -0.679 . . . . 73.14 109.166 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.872 ' HB ' HD12 ' A' ' 202' ' ' LEU . 59.5 t -95.23 -26.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.39 0.614 . . . . 62.04 109.762 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -158.47 -179.92 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.236 -1.024 . . . . 64.25 108.236 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.36 -40.83 75.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.455 0.539 . . . . 72.3 112.455 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.91 ' HB2' ' HB3' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -126.78 13.53 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.014 0.435 . . . . 71.21 111.072 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.872 HD12 ' HB ' ' A' ' 198' ' ' VAL . 2.3 tm? -107.12 103.03 12.33 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 75.51 108.664 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -117.6 153.92 32.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.784 -0.644 . . . . 54.51 110.159 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 196' ' ' GLN . 16.6 m -130.06 149.6 51.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.988 -0.551 . . . . 51.33 109.92 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.54 136.15 50.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 53.32 109.672 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 1.012 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -119.82 136.87 55.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.646 -0.706 . . . . 62.44 111.005 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -114.31 127.66 55.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 62.51 110.436 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 208' ' ' LEU . 1.7 mm? -130.94 129.71 42.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.18 -0.674 . . . . 74.51 109.18 171.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.455 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -156.49 149.01 23.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.13 0.49 . . . . 74.31 111.193 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -131.19 124.92 31.67 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.154 -0.684 . . . . 71.21 109.154 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.7 t -101.83 117.88 35.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.397 0.618 . . . . 74.54 110.132 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.76 130.85 47.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.597 -0.729 . . . . 75.25 110.835 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -15.84 27.5 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.919 -0.657 . . . . 43.02 111.789 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -138.86 150.16 45.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.148 -0.316 . . . . 72.05 110.148 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.8 m -86.28 -16.47 37.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.408 -0.36 . . . . 65.43 111.067 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -67.79 111.21 4.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.0 0.429 . . . . 73.32 110.825 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.0 t -87.99 138.43 31.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.536 -0.913 . . . . 63.33 108.536 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 30.0 mtt-85 -88.28 116.67 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.292 -0.633 . . . . 74.04 109.292 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -115.17 129.37 56.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.864 -1.162 . . . . 71.02 107.864 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -141.11 150.85 22.12 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.895 -1.145 . . . . 54.35 112.46 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.933 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 3.5 mp -132.58 132.35 59.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.017 -1.105 . . . . 71.43 108.017 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.829 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . . . -124.93 130.23 51.94 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.328 1.018 . . . . 71.1 109.837 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.598 ' H ' ' HB2' ' A' ' 236' ' ' LYS . . . -113.87 126.34 55.07 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.117 -0.633 . . . . 74.31 111.187 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 62.23 110.71 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.63 ' HD1' HD13 ' A' ' 227' ' ' ILE . 90.6 t80 -120.81 127.85 52.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 71.12 110.077 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.91 ' HB3' ' HB2' ' A' ' 201' ' ' LYS . 34.7 tt0 -79.92 100.88 8.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.962 -0.563 . . . . 74.22 109.537 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.63 HD13 ' HD1' ' A' ' 225' ' ' TYR . 26.2 mm -68.82 -42.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.869 0.842 . . . . 73.11 109.297 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -137.05 146.77 56.09 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.533 -1.284 . . . . 71.13 107.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -44.97 -25.63 1.73 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.88 2.387 . . . . 60.42 114.185 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.87 -3.32 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.348 0.499 . . . . 75.12 112.348 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.76 123.42 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 70.54 112.002 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 35.7 m -120.76 122.64 40.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 74.24 110.399 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.734 ' HD2' ' HB3' ' A' ' 247' ' ' TYR . 87.6 t80 -104.7 133.13 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.06 -0.348 . . . . 73.24 110.06 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 12.5 p -131.0 140.62 50.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 64.45 111.487 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -156.66 136.71 12.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 70.13 109.127 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.933 ' HB3' ' O ' ' A' ' 221' ' ' ILE . 2.7 mmtm -173.29 179.0 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.865 0.466 . . . . 74.05 110.908 166.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.8 152.03 27.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.129 0.49 . . . . 63.11 111.674 -160.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -109.01 150.74 27.32 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.889 -0.596 . . . . 71.24 110.324 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 241' ' ' SER . 4.4 t-20 -39.46 -33.54 0.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.477 1.511 . . . . 72.42 114.03 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 13.5 m -77.52 24.55 0.2 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.562 0.22 . . . . 62.24 110.651 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.3 p 58.0 29.54 17.86 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.563 1.145 . . . . 73.33 110.937 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 1.056 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.1 mp -99.39 128.98 45.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 116.221 -0.445 . . . . 73.03 111.926 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.887 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.42 116.35 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.699 -0.682 . . . . 65.03 110.525 -171.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.58 133.46 11.59 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.743 -0.742 . . . . 74.24 112.419 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.8 pp -134.23 149.06 50.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 62.15 109.98 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.72 145.86 11.14 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.885 -0.674 . . . . 40.32 111.776 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.734 ' HB3' ' HD2' ' A' ' 233' ' ' PHE . 22.1 p90 -124.61 122.34 37.26 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.297 0.57 . . . . 74.1 110.097 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 10.0 t -111.62 124.25 51.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.341 -0.845 . . . . 64.43 109.445 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -135.77 124.26 23.52 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.58 -0.737 . . . . 73.42 110.487 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 2.3 t -78.64 103.86 8.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.818 -1.178 . . . . 74.41 107.818 171.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.92 -54.5 44.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.511 -0.768 . . . . 72.42 109.654 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.605 ' HB2' HD11 ' A' ' 255' ' ' ILE . 96.8 mttt -145.17 152.16 50.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 106.93 -1.508 . . . . 74.43 106.93 174.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.61 98.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.51 2.14 . . . . 51.22 112.566 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.32 -24.44 2.94 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.889 -0.596 . . . . 64.21 112.662 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -134.34 122.08 39.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.394 0.616 . . . . 62.31 112.002 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.859 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 14.8 ptpt -114.13 133.28 55.68 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 72.42 110.299 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.71 126.89 52.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.25 -0.886 . . . . 72.15 109.713 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.8 t -127.51 111.0 13.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.556 0.693 . . . . 72.45 110.423 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.816 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.68 123.22 45.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 175.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 26.4 t -131.95 140.86 49.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.894 0.378 . . . . 53.15 110.039 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.72 128.48 20.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.914 -0.584 . . . . 71.53 110.433 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.755 HD11 HD23 ' A' ' 242' ' ' LEU . 2.3 tm? -102.48 117.67 35.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.511 -1.292 . . . . 65.11 107.511 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.887 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.3 mm? -92.72 107.71 19.42 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.559 -1.274 . . . . 73.14 107.559 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.056 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.1 m-20 -70.46 104.02 2.62 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.356 -0.979 . . . . 53.32 108.356 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.28 -19.1 38.31 Favored Glycine 0 C--O 1.229 -0.166 0 CA-C-N 115.94 -0.573 . . . . 75.33 112.497 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.36 -24.19 20.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.368 . . . . 73.35 111.016 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 93.8 m-20 -113.34 -30.54 6.87 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.645 0.98 . . . . 72.21 113.645 -170.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.449 HG11 ' HB3' ' A' ' 263' ' ' LEU . 30.8 m -62.62 -26.41 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.041 0.756 . . . . 63.14 113.041 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -70.31 -23.72 62.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.961 0.41 . . . . 54.24 110.369 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.81 6.02 36.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 72.52 110.123 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.65 102.54 0.79 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.752 -0.658 . . . . 54.35 111.831 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 165.15 78.68 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.258 -0.972 . . . . 62.21 112.519 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -113.48 146.68 39.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.504 -0.554 . . . . 75.14 109.504 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 74.2 mmtt -95.39 137.69 34.09 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.586 -0.446 . . . . 62.2 110.231 -175.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.4 tm? -117.7 134.5 54.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.179 -0.464 . . . . 65.35 109.91 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.478 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -135.17 104.27 0.5 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.959 -0.856 . . . . 74.13 110.959 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.816 HD23 HD22 ' A' ' 259' ' ' LEU . 2.4 tm? -114.76 130.95 56.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.51 -0.552 . . . . 63.34 109.51 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.506 ' N ' HD22 ' A' ' 277' ' ' LEU . . . -143.24 136.75 7.19 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.175 -1.012 . . . . 35.42 112.888 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.602 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.6 mm? -114.91 131.08 56.99 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.325 -0.62 . . . . 75.34 109.325 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.859 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 52.6 mt-10 -111.82 112.12 23.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.418 -0.586 . . . . 74.12 109.418 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -99.2 125.15 44.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.809 -1.182 . . . . 70.21 107.809 177.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 75.4 mt-30 -132.53 116.87 17.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.127 0.489 . . . . 42.12 109.985 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -115.61 131.97 56.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.809 -0.632 . . . . 45.15 110.471 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 285' ' ' GLU . 65.9 mt -122.09 -45.17 2.25 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.062 -0.718 . . . . 74.21 109.062 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 284' ' ' LEU . 42.5 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.633 -1.167 . . . . 63.51 109.395 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.045 0.45 . . . . 64.33 110.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 121' ' ' GLU . 21.3 t -118.58 101.98 50.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 54.34 109.735 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 4.4 Cg_exo -77.54 138.63 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.006 2.471 . . . . 72.01 112.075 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 35.2 Cg_exo -61.94 91.15 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.814 2.343 . . . . 74.13 111.683 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p -81.24 -15.99 54.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.684 -0.689 . . . . 74.13 111.321 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.853 ' HB3' HG21 ' A' ' 143' ' ' VAL . 45.8 p90 -62.75 -24.78 67.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.538 0.685 . . . . 74.11 109.677 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 12' ' ' LYS . . . -75.79 -30.0 58.93 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.157 -0.929 . . . . 74.05 110.855 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -104.26 9.34 36.05 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 119.978 -0.689 . . . . 62.35 111.717 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.531 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 94.8 mt -56.78 -35.68 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.377 . . . . 71.01 111.721 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.32 39.8 0.7 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.705 -1.236 . . . . 50.22 114.162 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 9.1 mtmp? -69.17 -48.68 61.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.896 0.848 . . . . 75.4 109.7 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -64.36 -38.37 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 71.24 110.971 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.17 -35.55 74.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 70.41 111.987 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -58.11 -38.07 75.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 60.02 112.177 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.85 -42.9 80.64 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.912 0.338 . . . . 74.25 111.912 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 t -84.47 -32.41 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.297 0.48 . . . . 43.14 112.297 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.96 -21.69 63.23 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.623 0.601 . . . . 70.12 112.623 -171.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 p -57.84 152.61 15.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 62.11 112.493 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 2.8 mptp? -86.37 -21.29 27.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.577 -0.738 . . . . 74.43 109.185 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.73 113.29 1.74 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.016 -0.993 . . . . 55.31 111.132 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.442 ' HB2' HD23 ' A' ' 262' ' ' LEU . 81.7 m-85 -85.79 -14.36 45.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.098 0.475 . . . . 71.42 110.688 -176.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.48 118.58 4.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.042 -0.823 . . . . 65.24 111.042 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -80.21 -4.67 54.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.94 0.37 . . . . 74.14 111.341 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.94 -3.57 69.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.273 -0.489 . . . . 64.24 113.262 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.7 pp -149.07 -178.12 6.2 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.707 0.765 . . . . 74.3 112.555 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -99.88 133.13 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.529 -1.214 . . . . 62.01 109.689 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.587 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.0 ttpp -124.87 146.26 49.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.768 -0.456 . . . . 72.2 109.768 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.695 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tm? -131.9 128.33 38.35 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.71 -0.478 . . . . 65.1 109.71 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.665 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 11.1 m-20 -134.32 120.37 19.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.11 -0.7 . . . . 75.02 109.11 171.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 tp -140.88 128.23 21.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 65.4 110.477 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 15.3 ptpt -118.14 127.29 53.63 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.972 0.415 . . . . 72.24 111.103 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 283' ' ' ALA . 38.7 p -89.7 121.69 32.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.338 -0.986 . . . . 63.03 108.338 168.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -105.04 132.04 51.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.325 0.583 . . . . 73.34 111.784 -169.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 28.8 t -138.97 141.05 38.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.293 -0.867 . . . . 64.45 108.851 172.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.9 13.96 21.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.47 0.653 . . . . 75.53 109.586 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.92 37.18 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.364 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.47 -9.64 76.94 Favored Glycine 0 C--O 1.221 -0.694 0 CA-C-O 119.008 -0.884 . . . . 60.31 114.976 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -103.9 127.57 51.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 119.279 1.54 . . . . 73.3 112.84 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 37.6 tt0 -141.74 117.59 10.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.48 -0.934 . . . . 72.33 108.48 158.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 93.4 m-85 -107.08 120.36 41.87 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.225 -0.59 . . . . 72.51 110.296 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 68.4 m -112.85 117.32 31.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.116 0.484 . . . . 74.42 110.665 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 p -105.03 124.28 49.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.826 -0.624 . . . . 75.31 109.502 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.0 t -133.86 125.99 29.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.827 -0.434 . . . . 72.12 109.827 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 159.09 27.92 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.375 -0.917 . . . . 41.22 112.411 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -129.32 134.77 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.746 -0.464 . . . . 52.14 109.746 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.621 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -129.81 127.68 40.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.136 0.493 . . . . 62.52 111.018 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 50' ' ' GLU . 45.9 m-80 -90.92 144.86 25.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.387 -0.824 . . . . 72.54 109.885 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -70.19 18.87 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.315 0.579 . . . . 44.41 111.921 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 48' ' ' ASN . 21.7 mm-40 -89.25 -167.24 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 73.22 110.075 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -68.13 90.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.64 -0.254 . . . . 74.34 111.54 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p 48.21 45.71 19.9 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.117 0.567 . . . . 75.43 112.246 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 29.1 mmmt -91.12 75.78 6.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 70.23 109.61 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 47' ' ' ALA . 13.3 t -120.54 123.51 70.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.162 -0.926 . . . . 64.23 110.859 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.7 p -109.44 137.04 47.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.085 -0.507 . . . . 52.34 109.669 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.94 136.41 8.82 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.464 -0.874 . . . . 71.0 112.773 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 p -127.63 145.18 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.878 -0.416 . . . . 65.3 109.878 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.3 tm? -120.68 124.97 46.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.708 -0.479 . . . . 72.55 109.708 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.7 tt0 -107.01 118.19 36.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.076 -0.712 . . . . 51.33 109.076 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.2 m -100.45 119.85 39.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.195 -0.668 . . . . 71.22 109.195 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 42.3 mtpt -121.66 127.58 50.95 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.057 0.456 . . . . 72.01 110.408 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.72 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 94.6 m-85 -106.89 120.79 43.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.897 -0.592 . . . . 73.21 109.653 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 17.5 tpt180 -111.8 106.99 15.89 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.534 0.683 . . . . 70.1 110.643 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 40.0 t-105 -105.59 108.16 19.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.574 -1.194 . . . . 75.14 109.876 -174.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -58.6 -36.24 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.221 -0.899 . . . . 71.42 111.943 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 14.3 mm-40 -66.25 120.46 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.437 -0.347 . . . . 75.43 110.324 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 74.57 -44.55 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.015 0.822 . . . . 72.12 111.384 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.95 64.45 0.46 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.904 -0.665 . . . . 42.13 111.899 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.02 134.72 53.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.867 0.365 . . . . 71.5 110.839 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 29.6 m -136.19 112.66 9.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.384 . . . . 73.43 110.647 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 77.6 t80 -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.683 -0.488 . . . . 71.13 109.683 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 84' ' ' GLU . 60.9 p -125.66 116.03 21.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.853 0.359 . . . . 54.22 111.011 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 40.7 tt0 -123.93 122.42 37.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.106 -0.331 . . . . 74.21 110.106 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 55.8 tttm -113.21 116.76 30.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 71.04 111.122 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -103.6 131.78 50.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 65.12 110.395 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.424 ' HB2' HG22 ' A' ' 80' ' ' THR . 7.4 m-20 -101.69 161.8 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 73.14 111.063 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.5 m -62.29 -22.21 65.84 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.584 0.707 . . . . 72.4 110.215 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -72.23 -4.0 26.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.22 -0.9 . . . . 71.01 111.177 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 10.4 m-80 69.64 40.95 1.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.493 0.663 . . . . 74.45 110.677 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 76' ' ' ASN . 9.9 t -114.35 135.47 54.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.373 -0.83 . . . . 74.35 109.613 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.1 mm? -99.59 135.87 40.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.609 -0.723 . . . . 71.42 110.872 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -117.22 89.93 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.504 -1.039 . . . . 52.21 110.504 171.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -95.48 105.43 17.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.862 0.363 . . . . 63.44 111.773 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.56 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 26.2 mt-10 -110.07 131.6 54.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.18 -0.464 . . . . 70.02 109.895 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -119.36 121.78 67.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.005 -0.739 . . . . 74.14 109.005 173.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.0 m -112.0 124.31 52.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.296 0.569 . . . . 74.33 111.664 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 66.6 t -111.03 121.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.136 -0.938 . . . . 75.25 109.663 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.32 142.67 28.18 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.77 -0.826 . . . . 32.11 108.77 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 94' ' ' GLY . 5.1 p-10 -49.69 143.89 6.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.216 0.821 . . . . 70.25 113.216 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -126.99 -56.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.814 -1.084 . . . . 73.51 108.974 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.45 -67.05 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.661 -0.7 . . . . 71.14 109.582 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 86.77 5.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 73.0 110.187 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.447 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -52.92 135.43 36.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.443 -0.798 . . . . 74.4 111.702 -177.23 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . 102.9 -22.91 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.577 -0.738 . . . . 63.14 113.726 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 35.8 tp -80.69 131.56 35.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.329 1.065 . . . . 65.24 112.18 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -123.73 120.63 33.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.917 -0.583 . . . . 64.42 109.72 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.753 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -109.89 129.8 55.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.689 0.281 . . . . 74.21 110.434 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.932 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.2 m -131.27 119.89 22.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.661 0.267 . . . . 72.23 110.456 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.538 ' HB2' HG22 ' A' ' 85' ' ' ILE . 80.6 m-85 -111.19 115.41 29.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.759 -0.46 . . . . 75.5 109.759 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 2.3 t70 -109.39 136.01 49.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.48 . . . . 74.4 110.343 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.0 m -144.08 122.74 12.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.022 0.439 . . . . 63.23 110.881 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 22.8 t -95.97 125.55 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.401 -0.592 . . . . 70.22 109.401 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 98.6 m-85 -111.48 123.56 50.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.818 -0.628 . . . . 74.23 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -115.58 103.14 54.19 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 70.31 109.465 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.53 -19.15 63.52 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.354 2.703 . . . . 65.52 113.007 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -57.12 -48.11 79.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 64.51 110.811 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.6 m -109.28 -21.71 12.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.314 0.578 . . . . 64.13 111.011 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.03 23.84 43.55 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.848 -0.901 . . . . 73.31 110.848 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.76 148.1 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 73.21 111.852 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.27 116.47 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.167 -0.924 . . . . 72.02 109.165 172.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -118.41 121.16 39.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.876 -1.157 . . . . 73.53 107.876 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.19 149.67 46.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.65 0.611 . . . . 73.22 112.65 -165.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 54.0 mttp -115.23 138.01 51.4 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.149 -1.056 . . . . 65.51 108.149 169.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.905 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -114.96 119.39 61.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.565 -0.902 . . . . 62.31 108.565 174.313 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.932 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 22.9 tttp -115.11 119.5 36.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.631 -0.713 . . . . 63.44 109.631 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.5 m -127.94 116.83 20.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.438 -0.578 . . . . 64.41 109.438 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -137.1 122.94 2.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.94 -1.124 . . . . 63.33 112.009 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 125' ' ' LEU . 10.5 p90 -107.4 135.41 48.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.316 0.579 . . . . 74.52 110.349 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.417 ' HB3' HG11 ' A' ' 3' ' ' VAL . 19.3 mtmm -109.31 120.43 42.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.925 -1.034 . . . . 74.41 110.142 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.584 ' HB3' HG22 ' A' ' 123' ' ' ILE . 8.3 tpt180 -108.52 157.73 18.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.939 -1.134 . . . . 61.42 107.939 169.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.641 ' HA ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -54.32 -29.27 47.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.723 0.638 . . . . 73.05 112.723 -170.54 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -112.37 -12.19 13.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 64.43 112.381 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 142' ' ' LEU . 9.8 tp -143.45 132.8 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.821 -0.752 . . . . 62.3 112.47 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.442 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 35.4 t-20 -118.76 119.16 33.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.811 -0.44 . . . . 70.3 109.811 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 142' ' ' LEU . 3.9 mm? -111.87 119.96 40.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.229 -0.441 . . . . 73.25 110.277 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.88 127.51 5.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.673 -0.775 . . . . 64.44 112.872 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.0 m -111.08 121.61 45.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.619 -0.511 . . . . 74.41 109.619 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 t70 -124.23 117.69 25.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.169 -0.678 . . . . 65.11 109.169 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.905 ' HB3' HG22 ' A' ' 114' ' ' ILE . 36.1 ttm -118.33 130.38 55.99 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.854 -0.529 . . . . 72.22 111.668 -172.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.35 118.78 31.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.725 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.641 ' HE2' ' HB ' ' A' ' 114' ' ' ILE . 92.6 m-85 -96.26 96.53 8.84 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.855 -1.165 . . . . 72.42 107.855 167.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -136.72 155.44 49.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.271 -0.422 . . . . 63.42 110.587 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -30.0 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 63.34 110.97 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.08 -14.08 60.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.049 0.452 . . . . 75.44 110.859 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.67 128.49 2.18 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.626 -0.797 . . . . 73.13 112.731 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.81 118.56 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.604 2.203 . . . . 70.42 110.653 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -125.96 144.77 50.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.866 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.05 118.15 54.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.324 0.583 . . . . 55.12 109.842 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 21.5 ttp-105 -106.94 129.8 54.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.618 -0.719 . . . . 62.42 109.799 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.33 133.23 11.38 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.312 -0.947 . . . . 73.32 111.875 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -126.07 116.47 21.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.758 -0.46 . . . . 61.14 109.758 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 123' ' ' ILE . 8.8 tp -120.62 123.94 44.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.666 -0.494 . . . . 74.3 109.666 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.853 HG21 ' HB3' ' A' ' 7' ' ' TYR . 94.0 t -127.41 129.41 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.312 -0.404 . . . . 72.35 110.715 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.632 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.54 136.72 48.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.973 -0.751 . . . . 63.32 108.973 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.67 118.93 4.18 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.598 -0.81 . . . . 55.21 112.07 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -141.58 147.35 37.53 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 75.33 109.475 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.64 101.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 70.42 111.703 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 174' ' ' LYS . . . 88.22 -32.35 4.43 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.098 -0.955 . . . . 74.34 112.692 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -105.92 122.37 45.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 73.43 111.175 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 151' ' ' ALA . 5.3 tp -138.42 135.1 34.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.359 -0.608 . . . . 74.23 109.359 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -136.73 132.54 34.97 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.843 -0.343 . . . . 72.03 111.227 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.531 ' HA3' ' CD1' ' A' ' 10' ' ' LEU . . . -132.98 133.82 7.22 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.971 -0.633 . . . . 44.31 112.034 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.535 ' HA ' ' HD2' ' A' ' 169' ' ' PHE . 22.6 m-85 -122.8 119.7 31.36 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.421 -0.585 . . . . 71.22 109.421 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -118.63 130.22 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 75.34 110.077 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 21.8 ptp -143.73 143.74 31.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.162 -0.472 . . . . 53.15 110.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -112.36 118.41 35.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.231 -1.026 . . . . 71.23 108.231 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -107.23 118.36 36.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.74 -0.467 . . . . 54.53 109.74 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -86.83 95.35 9.83 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.589 -0.893 . . . . 74.34 108.589 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 m -72.57 -25.16 61.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 113.532 -1.667 . . . . 70.52 111.435 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.55 -31.16 69.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.719 0.771 . . . . 54.44 109.083 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -109.9 -159.79 0.69 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.378 -1.283 . . . . 72.21 108.112 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.0 p -109.47 26.77 10.26 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.132 -0.355 . . . . 72.53 111.111 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 mtp85 -133.66 171.25 14.38 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 114.828 1.418 . . . . 71.21 114.828 -160.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.1 t -104.37 132.22 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.286 -1.325 . . . . 73.52 108.651 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -94.38 -33.91 12.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 45.33 111.245 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -151.87 132.74 14.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.435 -0.348 . . . . 73.05 110.102 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.9 t -124.34 106.94 10.64 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.417 -0.586 . . . . 73.41 109.417 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.91 135.17 55.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.306 0.574 . . . . 75.31 110.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 153' ' ' TYR . 57.5 m-85 -125.83 155.9 40.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.242 -0.436 . . . . 72.41 110.555 -176.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . . . -150.65 127.96 11.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.158 -0.473 . . . . 73.53 109.795 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 63.7 t -129.77 127.59 64.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.918 0.39 . . . . 75.24 110.491 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.02 111.25 4.19 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.05 -0.82 . . . . 61.54 111.05 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -112.06 120.44 41.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.794 -0.817 . . . . 71.34 108.794 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 11.5 tmtt? -103.23 126.5 50.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.373 0.606 . . . . 74.34 109.89 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 3.9 m -116.91 164.08 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.913 -1.04 . . . . 70.3 108.398 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -34.13 -66.82 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.177 0.806 . . . . 54.24 113.177 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.89 13.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.898 -0.321 . . . . 72.14 111.694 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.497 ' HD1' ' NE2' ' A' ' 196' ' ' GLN . 10.3 m-85 -126.5 137.97 53.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.577 -0.283 . . . . 73.42 110.269 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -122.11 122.73 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.832 -0.747 . . . . 73.2 109.81 170.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 194' ' ' ILE . 4.9 tt -123.77 139.19 54.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.737 -0.665 . . . . 72.31 111.068 -172.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.84 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 96.9 m-70 -116.45 117.13 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.36 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.6 m -96.02 110.83 23.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.228 -0.656 . . . . 71.05 109.228 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -124.42 160.63 27.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 41.11 110.919 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.504 HG22 ' HD1' ' A' ' 190' ' ' PHE . 16.6 t -131.72 124.4 53.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.872 -0.604 . . . . 73.15 109.764 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 30.2 t30 -99.89 95.45 6.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.622 -0.717 . . . . 53.44 109.705 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.63 178.82 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.282 -0.872 . . . . 44.23 109.381 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.21 -7.14 71.09 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.075 -1.06 . . . . 72.21 111.404 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.9 m -95.01 -25.71 16.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.762 0.653 . . . . 71.52 112.762 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 43.2 tt0 -132.38 145.05 50.95 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.467 -0.771 . . . . 61.41 111.957 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.504 ' HD1' HG22 ' A' ' 184' ' ' VAL . 22.9 m-85 -117.17 150.27 39.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.459 -0.941 . . . . 65.41 108.459 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.32 155.81 24.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.176 -1.012 . . . . 62.14 113.491 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -141.14 126.0 2.95 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.271 -0.732 . . . . 52.15 111.271 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.84 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 46.8 t -112.1 136.6 51.26 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.895 0.379 . . . . 51.42 110.075 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.75 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.6 mm -120.53 124.3 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.868 -0.606 . . . . 63.51 109.542 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.457 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 0.3 OUTLIER -118.23 121.47 40.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.425 -0.583 . . . . 75.42 109.425 173.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.497 ' NE2' ' HD1' ' A' ' 178' ' ' PHE . 14.5 mm100 -124.45 132.04 53.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 63.4 111.635 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -86.53 122.57 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.216 -0.661 . . . . 74.02 109.216 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.5 m -136.22 173.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.317 -0.401 . . . . 71.22 110.896 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -97.51 -41.92 7.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 45.11 110.098 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -69.93 -33.19 71.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 73.12 112.345 -177.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.437 ' HB3' ' HB1' ' A' ' 223' ' ' ALA . 94.1 mttt -123.54 11.77 9.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.264 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 -85.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.787 0.679 . . . . 60.43 110.892 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.835 ' HG3' ' HB3' ' A' ' 224' ' ' LYS . 9.5 pt-20 -127.1 128.75 46.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.171 -0.678 . . . . 74.33 109.171 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 196' ' ' GLN . 15.4 t -123.44 148.82 45.78 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.374 -0.53 . . . . 75.44 110.419 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.45 136.59 49.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.67 -0.696 . . . . 63.31 110.964 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.83 HG22 HG22 ' A' ' 221' ' ' ILE . 61.1 t -118.8 137.96 51.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.447 -0.797 . . . . 53.43 109.159 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.416 ' OD1' ' HA3' ' A' ' 220' ' ' GLY . 2.9 p-10 -124.6 134.19 53.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 71.21 110.715 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.46 141.36 49.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.054 -0.976 . . . . 75.54 109.397 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -142.21 130.61 22.38 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.182 -0.463 . . . . 31.21 110.036 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.9 122.37 37.18 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.906 -0.405 . . . . 74.44 109.906 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 216' ' ' ASN . 27.0 m -95.21 107.96 20.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.584 -0.524 . . . . 74.25 109.584 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.16 146.21 48.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.723 -0.671 . . . . 55.54 111.162 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.95 -46.42 3.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.134 -0.555 . . . . 30.2 112.261 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 216' ' ' ASN . 21.1 t-20 -86.59 -21.2 26.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.896 0.379 . . . . 75.32 110.271 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.5 m 66.74 17.42 10.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.577 -0.738 . . . . 61.44 110.758 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.432 ' HB2' ' OD1' ' A' ' 214' ' ' ASN . 53.7 t-20 -69.48 121.18 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 73.41 109.526 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.3 m -113.71 122.56 47.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.069 0.461 . . . . 73.22 110.031 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.747 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 37.4 mmt180 -105.31 125.0 50.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.959 -0.564 . . . . 74.43 109.924 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.755 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 46.9 m-85 -113.9 133.6 55.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.909 -0.775 . . . . 65.13 108.909 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.416 ' HA3' ' OD1' ' A' ' 207' ' ' ASN . . . -145.03 141.15 9.66 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.31 -0.948 . . . . 52.43 112.044 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.83 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -132.36 133.3 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 64.13 110.857 178.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -132.51 138.37 47.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.875 -0.602 . . . . 55.04 111.062 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.65 125.56 54.28 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.84 -0.43 . . . . 53.04 109.84 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.835 ' HB3' ' HG3' ' A' ' 203' ' ' GLU . 4.3 ttpp -113.34 113.32 25.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.252 0.549 . . . . 63.44 109.691 -177.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -131.9 116.54 17.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 74.32 110.144 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.686 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 12.0 pt20 -85.07 103.1 13.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.382 0.61 . . . . 61.21 109.987 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.3 -29.33 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.487 -0.779 . . . . 40.43 110.561 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.723 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 23.2 m-20 -123.47 163.29 35.28 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.625 . . . . 72.41 109.542 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.21 -29.73 64.52 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.172 1.915 . . . . 71.23 111.916 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -109.81 -2.27 17.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 64.14 111.607 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -134.7 124.53 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.476 . . . . 72.41 111.891 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 43.3 t -123.43 135.41 54.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 63.41 109.668 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -115.79 133.61 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.126 0.489 . . . . 62.13 110.534 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.3 p -125.26 123.85 40.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.912 -0.585 . . . . 63.34 110.325 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -107.6 140.01 41.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.323 -0.991 . . . . 54.41 108.323 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -148.88 150.07 32.34 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.828 -0.349 . . . . 74.23 110.745 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 10.0 p -145.64 142.91 21.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 72.13 109.943 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 15.4 t-20 -105.31 149.45 26.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.475 -0.784 . . . . 73.22 109.11 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.755 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 20.8 t-20 -57.04 -21.59 32.35 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.996 0.81 . . . . 43.11 112.251 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.5 p -79.24 21.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.958 0.409 . . . . 54.12 110.842 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 239' ' ' ASN . 25.9 t 68.59 31.28 4.79 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.461 -0.79 . . . . 63.02 110.641 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.892 ' HB3' HD11 ' A' ' 262' ' ' LEU . 36.1 mt -99.73 116.01 30.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.344 -0.542 . . . . 71.04 110.468 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 243' ' ' ILE . 3.4 mp -99.76 117.83 45.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 N-CA-C 109.896 -0.409 . . . . 74.14 109.896 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.41 141.46 16.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.013 -0.613 . . . . 61.01 113.21 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 260' ' ' SER . 8.0 mt -116.18 137.95 51.69 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -141.4 120.71 1.73 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.32 -0.943 . . . . 33.3 111.875 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.5 115.42 18.11 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.847 -0.427 . . . . 73.12 109.847 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -114.74 130.57 56.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.15 0.5 . . . . 63.22 110.351 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 58.1 tt0 -143.66 131.65 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.938 -0.574 . . . . 75.12 110.289 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 23.2 p -78.67 129.1 34.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.591 0.234 . . . . 55.12 110.89 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 251' ' ' LEU . 1.6 pp -140.8 145.23 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.864 -0.421 . . . . 75.41 109.864 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 92.3 mttt 67.74 156.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 123.619 0.574 . . . . 74.01 110.51 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 36.3 Cg_endo -66.71 86.7 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.21 1.94 . . . . 71.05 113.366 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.759 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 105.46 29.54 5.03 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.904 -0.665 . . . . 74.1 113.926 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 251' ' ' LEU . 64.7 mt -132.76 133.95 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 117.384 0.592 . . . . 74.3 110.72 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.14 133.63 53.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.76 0.314 . . . . 43.33 110.323 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.3 tp -98.06 132.57 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 73.14 109.765 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 15.3 m -126.06 111.15 14.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.347 -0.388 . . . . 72.02 110.201 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.977 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.09 124.58 47.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.664 -0.865 . . . . 64.01 108.664 176.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 45.0 m -133.63 140.41 47.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.907 0.384 . . . . 64.35 110.435 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.013 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.892 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -106.87 115.91 31.01 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.082 -0.71 . . . . 64.14 109.082 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.588 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -95.0 106.25 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.48 -1.304 . . . . 54.54 107.48 175.141 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.607 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 42.7 m-20 -71.95 104.77 3.62 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.759 -0.83 . . . . 73.42 108.759 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.62 -20.66 25.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.246 -0.502 . . . . 34.12 112.996 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -90.8 -3.51 57.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.811 0.338 . . . . 70.24 110.936 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.607 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 62.9 t30 -133.03 -35.53 1.05 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.754 0.65 . . . . 73.35 112.754 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' ' 263' ' ' LEU . 29.4 m -62.46 -18.41 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.747 0.647 . . . . 72.14 112.747 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -68.38 -25.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 65.11 110.324 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.33 -5.98 24.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.431 0.634 . . . . 63.25 110.005 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 91.95 103.48 1.42 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.608 -0.724 . . . . 72.02 111.809 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 173.81 85.62 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.54 -0.838 . . . . 72.31 112.17 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -113.47 147.18 38.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.881 -0.414 . . . . 73.45 109.881 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 7.1 mmpt? -95.15 137.08 34.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.062 -0.718 . . . . 64.23 109.062 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.75 127.61 54.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.82 -0.437 . . . . 73.51 109.82 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.55 104.96 0.83 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.56 -1.016 . . . . 34.14 110.56 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.977 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -113.76 125.35 54.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.905 -0.776 . . . . 72.33 108.905 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -145.68 133.64 5.1 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.6 -1.286 . . . . 54.2 112.98 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.695 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.3 mm? -108.7 128.01 54.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.248 -1.019 . . . . 64.33 108.248 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 10.5 pt-20 -140.86 137.92 33.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 119.328 -0.368 . . . . 55.11 110.594 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.759 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.6 OUTLIER 166.56 -148.96 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.124 0.89 . . . . 75.52 111.213 168.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 22.3 pt20 -137.68 119.11 14.76 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.208 -0.451 . . . . 61.12 110.776 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.664 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -82.58 109.98 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.169 0.509 . . . . 60.11 110.004 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 284' ' ' LEU . 3.8 mm? -125.29 164.04 21.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.768 -0.651 . . . . 71.33 110.542 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.551 -0.907 . . . . 74.11 108.551 178.302 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.849 0.356 . . . . 75.21 111.448 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 76.5 t -123.18 124.63 26.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 54.41 109.948 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 31.2 Cg_exo -59.42 143.83 99.59 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.097 2.531 . . . . 62.5 112.835 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 4.9 Cg_exo -77.17 69.17 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.198 2.599 . . . . 74.35 111.283 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -68.46 -29.61 68.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.802 -0.636 . . . . 72.32 112.075 -173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.89 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.9 p90 -64.56 -26.72 68.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.924 0.392 . . . . 73.23 111.089 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.64 35.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.052 0.453 . . . . 63.14 110.033 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -94.9 4.03 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.949 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 ' HA3' ' A' ' 152' ' ' GLY . 92.4 mt -63.94 -33.2 75.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.401 . . . . 73.22 110.216 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 61.91 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.012 -0.613 . . . . 63.21 112.143 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.12 -39.08 79.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 70.45 110.239 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 m -59.24 -36.47 75.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.226 -0.897 . . . . 72.43 111.836 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.47 69.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.324 -0.398 . . . . 52.45 112.052 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -62.33 -31.53 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 72.25 110.934 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 62.2 111.392 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 222' ' ' ALA . 40.0 t -78.59 -46.18 24.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.966 -0.294 . . . . 62.32 110.797 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 218' ' ' ARG . 90.9 t80 -64.79 -42.6 94.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.17 0.509 . . . . 74.31 110.807 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 20' ' ' LYS . 1.8 m -108.55 -142.98 0.38 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.237 -1.023 . . . . 74.33 108.237 174.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.577 ' H ' HG22 ' A' ' 19' ' ' THR . 43.2 mmtm -141.59 106.02 4.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.909 -0.404 . . . . 73.45 109.909 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.73 -44.02 21.53 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.67 -0.972 . . . . 62.42 110.67 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 28' ' ' LYS . 30.0 m-85 -135.15 -179.24 5.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.402 -0.592 . . . . 72.11 109.402 173.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 51.91 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.487 -0.863 . . . . 51.22 112.215 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -103.55 11.01 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.919 0.39 . . . . 71.32 110.819 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.667 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 93.52 13.75 54.81 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.444 -0.884 . . . . 72.12 111.854 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.6 pp -126.89 179.16 5.53 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-O 122.239 1.019 . . . . 75.53 113.317 -170.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.696 HD12 HD12 ' A' ' 277' ' ' LEU . 29.9 mm -98.58 142.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.888 -1.505 . . . . 62.43 109.855 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.595 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 3.9 tmtm? -122.47 135.82 54.75 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 74.34 109.424 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.0 tp -123.78 148.5 46.6 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.727 -0.389 . . . . 74.32 110.507 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 43' ' ' SER . 10.4 t70 -145.22 127.66 15.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.306 -0.861 . . . . 74.2 108.886 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.4 OUTLIER -126.65 124.61 40.26 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.839 -0.8 . . . . 62.13 108.839 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -125.61 138.16 53.92 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.706 -0.479 . . . . 73.01 109.706 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 33.4 m -136.34 128.71 30.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.697 0.284 . . . . 65.25 110.374 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -104.59 141.84 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 70.45 110.798 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.925 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 31.1 m -134.03 170.02 16.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.099 -0.704 . . . . 73.15 109.099 172.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.98 -62.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.258 0.836 . . . . 73.23 113.258 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -144.23 126.86 16.07 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.177 -0.609 . . . . 70.41 111.654 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 86.84 -10.5 67.71 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 119.084 -0.842 . . . . 74.11 114.806 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.925 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 3.0 mm? -103.03 129.38 49.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.782 1.291 . . . . 74.3 112.41 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.872 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 38.4 tt0 -139.77 118.08 12.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.242 -0.651 . . . . 75.31 109.242 165.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.78 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 66.7 t80 -104.9 121.33 43.47 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.798 -0.361 . . . . 75.04 110.325 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 87.2 m -127.3 128.22 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 72.3 111.385 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.7 t -122.48 132.33 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.824 -0.806 . . . . 70.32 108.824 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 p -134.33 125.61 27.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.104 -0.332 . . . . 71.54 110.104 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.67 151.27 23.19 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.803 -1.189 . . . . 65.34 113.04 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 27.3 m -138.12 134.23 34.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.766 -0.828 . . . . 62.44 108.766 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.573 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -144.39 131.98 21.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.581 -0.448 . . . . 70.32 111.914 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.9 143.85 55.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.633 -0.712 . . . . 74.44 109.164 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 m -54.69 -27.12 38.02 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.451 0.537 . . . . 63.53 112.451 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -88.52 6.56 37.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.152 0.501 . . . . 63.43 110.529 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.5 p 52.41 24.98 3.22 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.812 0.845 . . . . 70.23 112.507 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 p -85.06 -50.81 7.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.192 0.52 . . . . 42.33 111.101 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.61 100.22 9.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.745 -0.835 . . . . 75.32 108.745 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 47' ' ' ALA . 15.1 t -125.31 132.65 70.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.466 -0.788 . . . . 54.51 110.798 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 124.7 52.09 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 42.45 108.98 173.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.16 103.84 0.54 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.885 -0.674 . . . . 64.11 111.725 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 t -111.15 139.28 46.66 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.11 0.481 . . . . 73.41 110.177 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.38 124.59 46.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.936 -1.135 . . . . 53.4 107.936 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 56.5 mt-10 -120.24 119.11 32.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.328 0.585 . . . . 73.11 110.331 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' ' 73' ' ' GLU . 5.0 t -110.83 120.59 42.89 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.153 -0.684 . . . . 73.14 109.153 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.872 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 2.7 mptp? -110.21 137.67 47.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 64.11 109.496 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 18.2 m-85 -115.23 118.86 34.5 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.079 -1.082 . . . . 74.03 108.079 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.537 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ptt180 -131.57 108.41 9.52 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.388 -0.925 . . . . 64.12 111.879 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -95.7 100.74 12.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.124 -1.398 . . . . 74.54 108.745 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m 72.8 124.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.348 1.03 . . . . 65.23 111.556 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.84 130.58 46.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.048 -0.723 . . . . 63.11 109.048 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 63.34 66.15 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.289 -0.634 . . . . 72.14 109.289 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.55 -107.26 0.21 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.972 -0.632 . . . . 73.31 111.578 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.582 ' CD1' HG12 ' A' ' 87' ' ' VAL . 2.0 mm? -117.51 132.75 56.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.236 0.458 . . . . 61.41 112.236 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 60.0 m -136.34 119.18 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.28 0.562 . . . . 62.32 111.204 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 59.0 m-85 -109.87 133.36 53.25 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.972 -0.751 . . . . 73.24 108.972 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -125.14 132.66 53.04 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.509 -0.476 . . . . 54.13 111.573 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 37.3 mt-10 -125.34 123.25 38.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 73.21 109.439 171.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.44 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 63.0 tttp -122.76 109.66 14.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.288 -0.264 . . . . 62.43 110.288 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -107.29 134.3 50.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.959 -0.386 . . . . 71.53 109.959 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -120.1 155.13 33.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 73.34 110.529 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -58.24 -22.88 54.01 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.226 0.536 . . . . 74.41 111.38 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HB3' HG23 ' A' ' 107' ' ' THR . 46.6 m-20 -71.51 -1.39 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.569 -0.741 . . . . 71.34 111.829 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 20.5 m120 78.98 21.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.543 0.737 . . . . 71.13 109.925 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.861 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 3.6 m -90.72 118.99 30.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.559 -0.746 . . . . 64.53 110.757 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.2 mm? -101.13 118.14 36.41 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.411 -0.359 . . . . 71.3 110.556 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -116.78 96.14 0.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.606 -0.997 . . . . 41.24 110.606 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -143.59 156.1 44.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.088 0.403 . . . . 72.33 112.088 -169.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 mm-40 159.52 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 125.207 1.567 . . . . 64.32 110.047 167.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.501 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.55 137.71 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.644 0.609 . . . . 62.21 112.644 -161.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 98' ' ' THR . 12.8 t -129.38 140.39 51.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.977 0.418 . . . . 53.21 110.946 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 97' ' ' LEU . 6.2 m -117.88 138.44 48.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.11 -0.496 . . . . 72.34 109.834 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -114.42 116.57 29.11 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.507 -0.477 . . . . 74.32 110.827 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.589 ' HB3' ' H ' ' A' ' 94' ' ' GLY . 7.3 p-10 39.71 31.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.679 1.191 . . . . 72.22 113.612 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -75.2 -47.84 26.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 61.21 109.957 176.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -70.07 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.197 -0.668 . . . . 74.22 109.197 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -99.2 122.72 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.219 -0.446 . . . . 63.11 110.2 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 10.1 tpp85 -63.66 124.87 22.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.289 -0.414 . . . . 73.02 110.559 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.589 ' H ' ' HB3' ' A' ' 89' ' ' ASP . . . 97.0 -22.74 39.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.058 -0.591 . . . . 45.53 112.093 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.6 tp -89.92 136.93 32.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.009 0.433 . . . . 74.13 110.244 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.95 ' HE3' ' HD2' ' A' ' 119' ' ' LYS . 63.8 mmtt -121.66 116.5 24.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.186 -0.672 . . . . 73.03 109.186 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.4 mm? -108.0 127.52 53.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.937 -0.394 . . . . 72.02 109.937 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.916 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.3 m -129.35 119.55 24.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 72.12 111.42 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 87.4 m-85 -104.82 121.09 42.93 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.983 -1.118 . . . . 64.43 107.983 171.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 9.4 t70 -130.45 127.54 39.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.83 0.706 . . . . 72.12 109.35 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 p -140.24 130.68 25.39 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.275 -0.97 . . . . 75.31 112.156 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 45.1 t -113.32 122.27 46.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.57 -0.741 . . . . 43.4 109.448 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.689 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 36.5 p90 -138.03 119.24 14.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.877 0.846 . . . . 71.35 112.162 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.861 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 43.3 t -132.24 137.02 29.08 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.592 -1.186 . . . . 61.11 109.244 166.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 3.4 Cg_exo -81.89 -1.85 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.626 2.217 . . . . 42.42 111.183 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -110.2 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.676 -0.693 . . . . 73.24 110.173 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.589 HG23 ' HB3' ' A' ' 78' ' ' ASP . 3.3 t -146.89 133.86 20.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.433 -0.951 . . . . 71.14 108.433 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' HG23 ' A' ' 80' ' ' THR . . . 100.07 36.03 4.31 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 118.33 -1.891 . . . . 50.21 111.2 -164.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 104' ' ' SER . 11.7 mptt -55.61 155.95 5.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.481 0.658 . . . . 72.34 112.143 -168.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 103' ' ' PHE . 52.7 tttp -71.03 115.06 9.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.856 -1.065 . . . . 72.55 111.869 -159.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -133.44 132.8 41.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.455 -1.248 . . . . 65.31 109.167 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.58 127.9 54.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.032 -0.531 . . . . 62.42 110.593 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 30.6 mmtp -111.82 137.29 49.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.01 -0.541 . . . . 74.42 110.126 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.428 HG23 ' CG ' ' A' ' 129' ' ' MET . 3.4 tp -120.58 116.9 51.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.878 -0.786 . . . . 63.35 108.878 171.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.916 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.1 ttmp? -114.79 121.26 42.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.251 -0.886 . . . . 63.32 110.048 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.4 t -116.61 118.15 31.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.344 0.593 . . . . 61.02 109.448 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.95 151.5 17.02 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.749 -0.739 . . . . 60.21 112.087 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -132.87 127.68 34.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.316 -0.624 . . . . 73.43 109.316 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.95 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 68.3 mttm -110.77 120.26 41.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.139 -0.624 . . . . 71.24 111.465 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.646 ' HB2' HG22 ' A' ' 123' ' ' ILE . 80.5 mtp180 -109.58 162.56 14.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.079 -0.964 . . . . 75.23 108.612 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.54 -38.87 60.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.404 0.52 . . . . 65.32 112.404 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -120.86 8.27 10.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.569 -0.287 . . . . 63.24 111.737 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.755 HD11 ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -139.58 131.39 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.178 0.514 . . . . 74.04 111.234 -173.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.4 t30 -122.15 119.4 31.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.044 -0.526 . . . . 63.4 110.764 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.684 HD13 HD13 ' A' ' 142' ' ' LEU . 4.5 mm? -110.66 134.26 52.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 72.13 109.368 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.77 116.01 0.83 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.338 -0.934 . . . . 75.31 112.217 176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 73.5 m -110.33 107.45 17.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.999 0.428 . . . . 72.4 110.54 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 27.3 t70 -111.91 118.35 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.685 -0.689 . . . . 72.54 109.313 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.428 ' CG ' HG23 ' A' ' 114' ' ' ILE . 23.8 ptp -129.25 147.97 51.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.673 -0.811 . . . . 65.32 112.061 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 3.1 m-20 -76.04 119.72 20.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.535 -1.283 . . . . 75.45 107.535 174.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -86.53 109.41 19.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.265 0.839 . . . . 73.23 113.265 -163.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 136' ' ' PRO . 20.1 t70 43.34 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.87 1.433 . . . . 74.54 114.87 161.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -60.95 -26.15 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.663 0.616 . . . . 74.11 112.663 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -93.21 -5.18 50.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.048 0.452 . . . . 75.5 110.57 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.05 109.79 3.31 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.042 -0.823 . . . . 70.14 111.042 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.542 ' HG3' ' HA ' ' A' ' 132' ' ' ASP . 27.4 Cg_exo -61.38 100.62 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.802 2.335 . . . . 62.42 112.553 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 45.0 t -126.87 128.77 47.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 74.42 108.943 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.98 117.12 52.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.184 -0.606 . . . . 72.34 110.868 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 156' ' ' ASN . 24.1 mtt180 -108.08 121.64 45.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.021 -0.733 . . . . 73.31 109.021 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.68 131.55 10.45 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.791 -1.195 . . . . 73.15 111.603 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -122.24 116.24 23.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.764 -0.458 . . . . 71.12 109.764 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.684 HD13 HD13 ' A' ' 125' ' ' LEU . 12.9 tp -122.24 124.53 44.01 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.262 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.89 HG21 ' HB3' ' A' ' 7' ' ' TYR . 57.3 t -122.38 121.86 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 74.42 109.983 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.755 ' HG ' HD11 ' A' ' 123' ' ' ILE . 4.3 mp -109.11 137.21 47.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.091 -0.707 . . . . 73.21 109.091 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.537 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -122.38 119.0 3.82 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.617 -0.801 . . . . 75.52 112.847 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.425 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 47.5 m-85 -129.71 147.56 51.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.402 -1.333 . . . . 74.51 107.402 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -56.45 101.2 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.452 0.644 . . . . 75.25 111.059 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.758 ' HA2' ' HB3' ' A' ' 174' ' ' LYS . . . 104.09 -33.49 6.53 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.984 -1.007 . . . . 52.32 112.107 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 2.2 m-90 -107.01 120.26 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.212 -0.581 . . . . 73.5 111.898 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.537 HD23 ' HA2' ' A' ' 145' ' ' GLY . 7.6 mt -123.2 138.17 54.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.274 -0.421 . . . . 73.2 109.892 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -143.06 124.38 14.65 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.875 -0.33 . . . . 61.41 110.174 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.8 131.71 4.42 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.503 -0.856 . . . . 71.12 111.405 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 37.9 p90 -142.65 144.66 32.87 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.095 -0.642 . . . . 74.42 111.952 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 77.2 mt-30 -111.87 121.74 45.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.052 -0.976 . . . . 74.3 109.303 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 87.8 mtp -118.94 129.84 55.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.874 -0.787 . . . . 64.5 108.874 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.582 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 2.5 m-20 -109.99 114.56 28.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.969 -0.752 . . . . 74.54 108.969 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 25.1 m-85 -94.34 118.49 31.7 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 74.45 110.355 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 161' ' ' LYS . 38.0 tt0 -86.71 100.68 12.65 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 108.967 -0.753 . . . . 73.52 108.967 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 m -70.56 -17.46 62.92 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.334 -1.757 . . . . 71.31 111.355 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.85 92.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.341 -0.985 . . . . 64.33 108.341 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 158' ' ' GLU . 61.4 mttp -99.95 -159.5 0.74 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.538 -1.21 . . . . 73.54 108.299 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 p -109.15 28.44 8.5 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.221 -0.3 . . . . 55.11 110.528 172.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -151.7 150.58 30.38 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 119.086 -1.045 . . . . 74.13 112.249 -161.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.3 m -74.3 134.95 28.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.079 0.466 . . . . 73.13 110.325 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 9.4 t -95.45 -23.12 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.999 -0.546 . . . . 53.13 111.03 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -139.72 132.63 29.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 75.52 110.617 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.431 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 14.4 m -122.34 129.91 52.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.492 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.94 121.41 21.63 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.964 -0.384 . . . . 73.42 109.964 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.682 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 91.2 m-85 -121.01 140.48 51.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.827 0.346 . . . . 70.24 110.964 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.91 128.58 24.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.132 0.491 . . . . 64.42 110.077 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.669 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -127.19 150.15 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.495 -0.557 . . . . 55.22 109.495 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.46 120.06 2.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.114 -0.565 . . . . 55.23 111.868 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -113.29 120.73 42.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.861 0.362 . . . . 74.02 110.085 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.758 ' HB3' ' HA2' ' A' ' 148' ' ' GLY . 29.7 ttmt -104.68 123.9 48.42 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.433 -0.58 . . . . 63.42 109.433 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.9 m -134.42 114.09 12.54 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.513 -0.551 . . . . 64.24 109.513 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 47.66 -93.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.816 0.673 . . . . 73.43 112.816 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -111.48 6.41 20.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.02 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -113.34 127.37 56.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.503 -0.317 . . . . 72.21 110.794 -173.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.92 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.1 mm-40 -112.06 124.61 52.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.667 -0.864 . . . . 73.13 108.667 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.409 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 5.6 tt -122.22 134.09 54.71 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.725 -0.609 . . . . 73.51 110.577 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 41.0 t60 -119.97 116.7 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.876 -0.602 . . . . 71.13 110.575 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.669 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 12.3 m -90.46 141.01 29.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.988 -0.745 . . . . 74.34 108.988 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -142.4 138.77 31.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.358 -0.537 . . . . 72.22 111.187 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 61.0 t -132.39 125.8 54.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.41 -0.814 . . . . 52.12 110.067 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.61 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 26.2 t-20 -117.06 107.76 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.249 -0.648 . . . . 71.22 109.249 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.5 t70 62.93 -171.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.919 -0.771 . . . . 74.21 108.919 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.93 -6.33 89.16 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.452 -0.88 . . . . 73.02 111.356 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.5 m -97.83 -25.68 14.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.836 0.68 . . . . 73.42 112.836 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 3.7 tp10 -118.21 113.68 21.89 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.603 -0.686 . . . . 72.3 110.751 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 42.4 p90 -135.56 132.1 36.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.775 -0.37 . . . . 74.3 110.735 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -169.83 -158.91 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.238 -0.982 . . . . 64.0 113.404 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.14 178.43 23.85 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.527 -0.368 . . . . 25.44 112.528 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 181' ' ' HIS . 18.8 m -149.84 147.43 27.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.654 -0.499 . . . . 70.11 109.654 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.6 mp -128.79 124.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.659 0.266 . . . . 75.41 110.942 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.92 ' HB2' ' HB2' ' A' ' 179' ' ' GLN . 43.8 m-85 -108.19 123.66 49.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.667 -0.494 . . . . 75.35 109.667 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.49 ' HA ' ' OE1' ' A' ' 196' ' ' GLN . 14.9 mm-40 -120.7 124.67 45.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.313 -0.403 . . . . 71.33 111.763 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 203' ' ' GLU . 11.6 mmtp -96.0 107.51 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 52.43 109.532 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.89 92.43 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.911 -0.586 . . . . 63.13 110.642 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.7 26.5 11.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.255 -0.884 . . . . 52.3 111.553 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 68.41 5.12 4.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.345 -0.843 . . . . 71.41 112.539 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.42 -38.87 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 63.45 111.117 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.56 151.99 40.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.411 . . . . 73.2 110.759 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 41.6 tt0 -117.11 132.21 56.72 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.814 -0.81 . . . . 53.54 108.814 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -123.06 143.16 50.14 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.211 -0.292 . . . . 75.34 110.211 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -129.66 136.39 49.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.123 0.487 . . . . 75.45 110.848 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 193' ' ' SER . 39.3 t -112.89 130.91 65.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.652 . . . . 75.14 109.538 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 18' ' ' PHE . 14.2 m120 -114.52 128.95 56.6 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.277 -0.638 . . . . 73.23 109.277 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.707 HD13 ' HD2' ' A' ' 219' ' ' PHE . 5.5 tp -146.92 134.29 20.73 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.409 -0.359 . . . . 52.24 110.357 -170.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.7 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -157.74 150.44 22.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.849 0.357 . . . . 54.41 111.466 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.552 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 29.4 t-105 -115.79 133.03 56.44 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.985 -0.746 . . . . 70.24 108.985 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.854 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 20.9 m -95.54 108.23 20.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.709 -0.478 . . . . 74.35 109.709 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.589 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.62 147.5 49.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.79 . . . . 63.13 111.706 -174.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.03 -74.74 0.21 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.717 -0.674 . . . . 62.54 111.677 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -173.8 85.07 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 74.05 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.854 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 49.0 m -156.7 165.85 35.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.716 . . . . 64.3 109.415 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.05 160.01 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.921 -0.4 . . . . 43.34 109.921 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.552 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 9.2 t -78.7 134.46 37.1 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.591 -0.522 . . . . 62.41 109.591 174.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.473 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 20.5 mtt180 -92.21 117.72 30.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.881 -0.415 . . . . 73.33 109.881 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.707 ' HD2' HD13 ' A' ' 208' ' ' LEU . 33.9 t80 -114.13 148.82 36.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.564 -0.532 . . . . 73.2 109.564 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.58 152.35 23.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.459 -0.877 . . . . 74.32 112.578 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.506 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.3 mp -135.92 130.23 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.816 -0.439 . . . . 72.01 109.816 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.597 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -120.99 154.29 36.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.835 -0.432 . . . . 65.35 109.835 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -138.44 124.31 19.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.906 0.384 . . . . 62.52 110.313 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -111.26 113.68 26.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.559 -0.904 . . . . 62.41 108.559 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -113.51 114.07 26.01 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.044 0.45 . . . . 74.45 110.037 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.07 117.26 29.45 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.761 -0.829 . . . . 54.54 108.761 173.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 228' ' ' ASP . 3.2 mp -69.17 -53.28 26.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 64.52 109.546 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 227' ' ' ILE . 22.4 t70 172.66 -48.96 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 O-C-N 124.006 0.816 . . . . 71.4 110.929 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 86.1 Cg_endo -78.42 -144.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.337 2.024 . . . . 72.44 113.331 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 4.1 t0 -93.39 16.41 13.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 64.02 110.463 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.38 123.89 44.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.545 -0.752 . . . . 53.14 110.237 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.8 143.45 50.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 72.43 110.308 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -97.03 129.84 44.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.053 -0.521 . . . . 71.13 109.696 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -121.15 119.27 31.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.013 0.435 . . . . 63.25 110.135 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -123.5 152.14 42.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.078 -0.51 . . . . 43.54 110.012 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 19.9 ptpt -153.26 140.67 19.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.922 -0.399 . . . . 73.53 109.922 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 9.9 p -132.91 141.16 45.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.073 0.463 . . . . 55.11 109.959 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.645 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 20.7 m120 -108.46 150.22 27.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.126 -0.488 . . . . 62.24 109.796 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 241' ' ' SER . 9.0 p30 -50.51 -27.39 6.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.252 0.97 . . . . 74.45 113.241 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.625 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 6.0 m -82.03 24.51 0.63 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.581 . . . . 73.12 109.938 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.467 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 57.6 m 66.05 39.33 4.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.926 -1.034 . . . . 75.03 111.297 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.7 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.5 mp -91.76 121.72 33.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 120.545 -0.462 . . . . 61.13 111.141 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 243' ' ' ILE . 2.3 mp -105.54 115.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 O-C-N 123.62 0.575 . . . . 53.13 110.024 -171.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.83 133.54 9.46 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.55 -0.833 . . . . 50.32 113.082 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.521 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -140.92 141.36 34.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.969 0.414 . . . . 73.04 110.201 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 260' ' ' SER . . . -162.97 165.51 36.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.358 -0.925 . . . . 64.11 112.547 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -129.87 129.95 44.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.055 0.455 . . . . 75.11 110.462 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.57 HG22 HG23 ' A' ' 258' ' ' THR . 19.8 p -113.46 115.61 28.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.702 . . . . 55.12 109.725 177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -133.3 132.88 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 64.13 111.617 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 17.5 m -77.81 120.45 22.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.976 -0.556 . . . . 54.21 109.591 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 255' ' ' ILE . 16.1 tp -81.27 -55.28 4.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.582 0.706 . . . . 61.11 109.213 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.556 ' HB2' HG22 ' A' ' 255' ' ' ILE . 5.9 mtpm? -136.66 158.08 73.84 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.894 -1.15 . . . . 53.3 107.894 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.05 90.4 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.701 1.601 . . . . 74.45 110.422 171.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 282' ' ' GLN . . . 137.39 -9.51 3.78 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.848 -0.692 . . . . 62.23 111.786 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.556 HG22 ' HB2' ' A' ' 252' ' ' LYS . 6.5 tp -148.51 122.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.575 0.702 . . . . 73.01 111.464 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.56 135.25 53.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.591 -0.731 . . . . 73.23 110.527 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.65 126.76 45.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.465 -0.789 . . . . 44.54 110.419 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.57 HG23 HG22 ' A' ' 248' ' ' THR . 86.5 m -118.15 111.45 18.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 63.2 110.808 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.955 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -115.4 129.19 56.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.576 -0.898 . . . . 73.3 108.576 175.432 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.65 ' O ' ' HB2' ' A' ' 275' ' ' LEU . 11.0 t -151.11 146.25 26.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.51 . . . . 60.1 109.624 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.563 ' HA ' ' CB ' ' A' ' 275' ' ' LEU . . . -139.72 127.51 21.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.636 0.255 . . . . 74.21 110.511 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.683 HD11 HD23 ' A' ' 242' ' ' LEU . 2.2 tm? -112.92 118.31 34.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.593 -0.891 . . . . 75.42 108.593 176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.695 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -101.45 110.07 22.0 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.603 -0.888 . . . . 64.23 108.603 176.324 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.745 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 1.9 m-20 -68.65 104.34 1.95 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.85 -1.167 . . . . 71.41 107.85 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.3 -27.37 46.79 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.908 -0.587 . . . . 70.2 113.298 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -90.84 -20.14 22.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.718 0.294 . . . . 73.23 110.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.745 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 66.2 t30 -101.89 -36.1 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.654 -0.248 . . . . 44.03 111.398 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.7 m -63.18 -18.72 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.722 0.267 . . . . 65.12 111.722 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.65 -44.75 85.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.14 110.796 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.59 10.23 37.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.943 0.401 . . . . 74.42 110.837 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.63 97.88 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.023 -0.608 . . . . 50.14 111.979 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.435 ' HA3' ' ND2' ' A' ' 267' ' ' ASN . . . -175.99 75.63 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.824 -0.703 . . . . 71.3 112.143 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -113.73 145.96 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 122.413 0.285 . . . . 74.31 110.269 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.59 131.18 48.13 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.117 -0.697 . . . . 71.21 109.117 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.667 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -140.68 158.12 44.43 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 65.23 113.974 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.56 117.19 3.53 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 114.552 -1.204 . . . . 45.2 111.317 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.955 HD23 HD22 ' A' ' 259' ' ' LEU . 2.2 tm? -114.36 121.87 44.95 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.909 -1.145 . . . . 75.11 107.909 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -142.46 137.28 7.71 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.89 -1.148 . . . . 44.52 113.309 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.39 130.51 55.67 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.306 -0.627 . . . . 71.12 109.306 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.32 111.18 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.627 -0.509 . . . . 52.12 109.627 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.72 ' HB3' HD22 ' A' ' 31' ' ' LEU . 42.3 t80 -112.99 110.33 20.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 71.14 109.812 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.525 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 7.7 tt0 -114.49 110.21 19.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.677 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -92.34 110.91 22.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.241 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.7 mt -108.69 97.66 7.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 75.14 110.41 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.594 -0.717 . . . . 75.22 109.127 176.828 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.774 0.321 . . . . 71.13 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 121' ' ' GLU . 11.5 t -116.61 112.91 40.69 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 60.42 109.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.66 166.95 22.38 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.231 2.621 . . . . 41.01 112.786 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 81.95 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.924 2.416 . . . . 74.12 111.789 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.0 p -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.484 -0.78 . . . . 64.1 111.386 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -60.48 -29.87 69.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.914 -0.584 . . . . 63.12 111.572 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.53 -19.57 38.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 52.51 110.965 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.98 13.68 33.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.41 0.624 . . . . 73.3 110.008 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 150' ' ' LEU . 72.4 mt -66.09 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.911 -0.586 . . . . 73.32 110.578 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.89 75.12 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.083 -0.58 . . . . 70.44 112.05 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -44.89 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.933 -0.395 . . . . 72.22 109.933 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p -56.4 -36.91 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.64 -0.709 . . . . 51.4 111.541 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.72 -37.6 73.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 74.53 111.376 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -63.26 -37.94 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.612 0.244 . . . . 62.13 111.147 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.09 -49.1 63.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.598 . . . . 64.3 110.69 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.628 HG21 ' CB ' ' A' ' 205' ' ' ALA . 79.0 t -84.58 -47.77 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.695 0.998 . . . . 71.33 113.695 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.17 -28.08 67.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.589 0.589 . . . . 71.54 112.589 -166.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -73.88 -16.79 61.11 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.819 -0.352 . . . . 75.43 110.96 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 0.1 OUTLIER 64.51 -82.61 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.262 -0.644 . . . . 75.14 109.262 -170.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.19 165.43 12.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.819 -1.312 . . . . 35.42 109.819 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.923 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 2.0 t80 -57.12 -44.94 83.76 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.904 -0.776 . . . . 74.44 108.904 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.72 28.45 56.88 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.219 -0.9 . . . . 63.24 114.422 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.558 ' HD2' ' HB2' ' A' ' 26' ' ' LEU . 56.3 t80 -87.78 -4.97 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.415 0.626 . . . . 74.03 109.455 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' C ' HD12 ' A' ' 26' ' ' LEU . . . 75.31 0.99 63.19 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.378 -0.828 . . . . 53.54 112.41 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 mp -134.55 178.76 6.74 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.262 1.029 . . . . 72.22 112.358 -172.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 277' ' ' LEU . 12.5 mm -103.69 122.43 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.579 -1.646 . . . . 73.15 107.988 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 34.9 mtmt -120.73 126.93 51.42 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.07 -0.652 . . . . 72.23 110.97 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tt -120.47 143.48 48.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.784 -0.644 . . . . 55.34 110.554 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.3 p30 -138.84 140.26 38.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.147 0.499 . . . . 73.31 109.844 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD13 ' HB3' ' A' ' 281' ' ' PHE . 14.5 tp -125.43 123.56 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.595 -0.729 . . . . 72.44 109.338 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -117.1 123.77 47.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 74.53 110.032 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 2.1 t -137.88 122.4 18.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.695 -0.684 . . . . 54.43 110.19 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.471 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -104.45 158.21 16.63 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.616 -0.434 . . . . 64.42 110.316 177.119 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -134.24 135.95 43.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.286 -0.635 . . . . 71.32 109.286 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 39.64 -99.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.357 1.035 . . . . 73.42 112.333 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.601 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 9.4 p30 -147.57 149.13 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.144 -0.687 . . . . 75.41 109.144 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 75.64 -11.02 10.88 Favored Glycine 0 C--O 1.213 -1.199 0 CA-C-O 119.236 -0.758 . . . . 74.32 114.187 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.52 127.25 52.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 119.457 1.629 . . . . 71.34 112.158 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.861 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 27.5 tt0 -142.53 118.85 10.84 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.98 -0.378 . . . . 72.13 109.98 162.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.549 ' HB3' HG23 ' A' ' 33' ' ' THR . 67.3 t80 -97.31 121.45 39.21 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.183 -0.673 . . . . 62.43 109.183 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.6 m -120.79 115.91 24.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.228 0.537 . . . . 73.52 110.772 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 34.6 t -107.88 134.46 50.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 64.11 109.43 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 43.2 m -135.05 126.94 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 71.22 110.331 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 130.26 5.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.453 -0.879 . . . . 64.43 111.846 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.2 m -111.42 133.46 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.474 -0.565 . . . . 44.43 109.474 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.71 135.0 37.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.729 -0.214 . . . . 72.22 110.578 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.766 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 54.2 t30 -69.28 143.07 53.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.783 -0.451 . . . . 74.11 109.783 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -64.62 124.32 21.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.486 . . . . 75.32 111.24 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 73.23 -65.41 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.313 -0.858 . . . . 74.14 111.11 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 3.1 m -78.5 113.13 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.213 -0.662 . . . . 65.24 109.213 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.0 p -75.44 93.08 2.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.068 0.766 . . . . 74.23 113.068 -168.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -113.78 99.6 7.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.868 -1.16 . . . . 75.13 107.868 165.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' SER . 13.9 t -114.21 120.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.818 -0.628 . . . . 71.21 111.115 -171.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -109.74 142.77 40.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.628 -0.715 . . . . 74.53 109.25 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.71 128.39 8.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.802 -0.713 . . . . 74.24 112.773 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.8 m -116.05 127.06 54.58 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.688 -0.856 . . . . 73.24 108.688 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.5 tm? -120.84 123.84 43.57 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.42 -0.585 . . . . 71.03 109.42 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.752 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 43.0 mt-10 -110.36 118.53 36.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.843 -0.617 . . . . 54.01 109.691 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 73' ' ' GLU . 9.1 t -98.75 119.94 38.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.624 -1.25 . . . . 44.11 107.624 172.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 28.0 ttmt -125.27 138.74 54.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.36 0.6 . . . . 74.24 111.261 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 98.9 m-85 -104.28 120.73 41.83 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.287 -0.87 . . . . 74.54 108.913 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.861 ' HG3' ' HB2' ' A' ' 40' ' ' GLU . 12.4 mtp85 -83.85 133.07 34.76 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.722 0.772 . . . . 72.44 111.304 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.747 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 8.8 p-90 -80.33 74.85 7.17 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 112.807 -1.997 . . . . 73.11 115.674 -161.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 37' ' ' ASN . 2.7 m -124.83 -17.8 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.655 -0.702 . . . . 74.14 111.03 -172.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.28 -36.12 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 62.02 109.881 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 69' ' ' LEU . 15.1 t80 -162.14 18.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 74.43 109.278 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.566 ' O ' HD12 ' A' ' 69' ' ' LEU . . . 80.81 56.59 3.06 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.072 -0.811 . . . . 53.43 111.072 -172.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 5.7 mp -139.59 127.98 22.79 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 113.749 1.018 . . . . 73.23 113.749 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.471 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 3.8 m -117.09 132.98 56.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.92 -0.488 . . . . 75.01 110.944 -173.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.572 ' HB3' ' HD2' ' A' ' 62' ' ' TYR . 44.7 t80 -123.19 120.36 32.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.981 -0.748 . . . . 54.43 108.981 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -126.7 117.29 22.42 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.813 -0.355 . . . . 74.41 110.915 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.5 tt0 -104.44 120.63 41.67 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.836 -0.802 . . . . 63.1 108.836 172.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -106.46 92.86 4.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.834 -0.621 . . . . 62.43 109.777 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.836 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 60.8 t90 -95.78 131.37 42.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.863 -0.335 . . . . 74.44 110.549 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.23 142.87 35.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.804 -0.813 . . . . 73.2 108.804 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.5 t -59.2 -9.82 2.42 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.618 0.97 . . . . 74.31 113.618 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 5.5 m-20 -71.24 -41.13 70.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.107 -0.237 . . . . 64.35 110.773 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 28.8 t-20 149.55 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.439 1.087 . . . . 61.24 109.745 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -80.7 132.19 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.645 . . . . 75.43 111.467 -173.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.836 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.8 pt? -124.28 146.5 48.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 62.12 110.681 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.57 117.05 4.08 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.517 -0.633 . . . . 71.33 111.517 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' ASP . 29.2 m -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.601 0.239 . . . . 71.32 110.734 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -125.13 108.37 11.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 63.2 110.118 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.04 129.66 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 74.12 110.699 -178.316 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 70' ' ' THR . 44.8 p -118.37 134.39 55.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 53.12 110.741 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.705 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 m -116.66 131.67 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.631 -0.507 . . . . 72.42 109.631 172.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 122.86 48.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 175.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 93' ' ' ARG . 35.6 t0 70.01 85.15 0.14 Allowed 'General case' 0 C--O 1.223 -0.323 0 O-C-N 124.029 0.831 . . . . 73.12 109.983 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 6.6 tp60 -102.98 5.16 38.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.457 -0.942 . . . . 75.3 108.457 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.5 tp 178.6 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.354 -1.294 . . . . 74.24 108.89 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.6 126.07 16.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.076 -0.965 . . . . 62.53 109.796 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -64.03 135.85 56.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 72.13 111.076 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.23 -14.78 54.95 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.003 -0.839 . . . . 44.31 111.003 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.24 126.22 38.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 73.23 109.293 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.3 ttpp -122.05 111.16 16.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.694 -0.685 . . . . 75.52 110.319 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.1 mm? -101.23 127.64 47.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.221 -0.659 . . . . 54.41 109.221 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 31.9 m -129.46 124.92 35.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.94 0.4 . . . . 62.33 111.437 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.28 116.05 31.29 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.234 -0.654 . . . . 73.51 109.234 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.716 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.2 t70 -111.68 133.51 53.87 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.003 -0.74 . . . . 75.03 109.003 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 24.4 m -141.44 121.87 14.07 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.941 0.4 . . . . 74.54 110.734 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.76 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 22.8 t -96.07 121.55 37.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.749 -1.204 . . . . 64.34 107.749 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.6 131.27 27.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.236 0.541 . . . . 73.22 111.22 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 16.5 m -119.8 103.43 45.89 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.542 -0.754 . . . . 74.45 109.293 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.423 ' HD2' ' OD1' ' A' ' 79' ' ' ASN . 47.6 Cg_exo -56.89 -33.91 95.92 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.972 2.448 . . . . 73.14 112.908 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -84.47 -40.47 17.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 52.55 111.01 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 104' ' ' SER . 5.8 m -81.99 -32.86 30.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.227 -0.442 . . . . 52.22 112.126 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 1.93 68.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.59 -0.814 . . . . 63.1 111.855 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.96 129.07 38.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.601 0.239 . . . . 71.02 110.426 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -139.39 122.27 16.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 73.52 110.464 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.76 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 8.5 m120 -121.54 123.51 42.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.924 -0.58 . . . . 74.55 109.812 172.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.91 113.8 27.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.067 -0.515 . . . . 71.52 109.68 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.716 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 4.8 ttmp? -122.67 138.1 54.71 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.05 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 tp -129.3 117.4 43.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.203 0.525 . . . . 64.31 110.16 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 1.7 mtpp -105.72 118.75 37.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 64.0 109.009 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 t -114.47 118.48 33.91 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.18 0.514 . . . . 63.41 109.739 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.93 118.24 2.96 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.466 -0.874 . . . . 71.11 112.184 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -106.76 117.59 34.45 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.018 -0.734 . . . . 72.42 109.018 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HB3' HG11 ' A' ' 3' ' ' VAL . 42.5 mtmt -109.22 122.11 46.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.31 0.576 . . . . 73.32 110.383 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -106.39 146.55 30.33 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.604 -1.628 . . . . 71.23 106.604 165.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HG3' HG22 ' A' ' 3' ' ' VAL . 2.2 mt-10 -55.23 -27.46 46.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.861 0.362 . . . . 75.21 111.758 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -88.99 -35.67 16.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 65.44 111.679 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 142' ' ' LEU . 8.7 tp -145.36 127.52 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 121.015 -0.274 . . . . 72.45 111.623 -167.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.523 HD21 ' HB ' ' A' ' 143' ' ' VAL . 3.6 p-10 -122.53 128.44 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.694 0.759 . . . . 65.31 111.807 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 142' ' ' LEU . 4.5 mm? -112.52 131.36 55.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.86 -1.064 . . . . 75.22 110.062 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.62 117.07 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.555 -0.831 . . . . 73.34 112.3 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.9 t -112.29 109.12 18.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.088 0.47 . . . . 70.32 110.135 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 115' ' ' LYS . 17.1 t70 -104.02 117.89 35.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.004 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.44 ' HG2' HG13 ' A' ' 138' ' ' ILE . 58.8 mtm -118.12 117.84 30.26 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.838 -0.345 . . . . 50.11 110.903 -176.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.451 ' HB2' ' HE3' ' A' ' 113' ' ' LYS . 30.4 t70 -107.87 120.42 42.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 63.11 110.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -94.47 109.68 21.53 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.26 -0.427 . . . . 73.42 110.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -116.24 156.39 26.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 71.23 109.501 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.8 pp -71.88 -17.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 111.961 0.356 . . . . 73.21 111.961 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.11 -17.37 32.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.117 0.484 . . . . 52.42 110.337 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.73 123.55 1.39 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.919 -0.657 . . . . 72.42 111.902 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.3 136.09 49.64 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.629 2.219 . . . . 61.01 112.135 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -117.12 137.57 52.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.54 . . . . 63.32 109.963 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.5 mp -107.46 117.98 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 70.33 110.158 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HD2' ' OD2' ' A' ' 128' ' ' ASP . 71.6 mtt180 -105.93 111.61 24.33 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.929 -0.767 . . . . 75.13 108.929 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.62 133.36 11.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.094 -1.05 . . . . 72.44 112.108 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.41 116.63 20.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.225 0.536 . . . . 63.5 110.275 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 123' ' ' ILE . 8.6 tp -116.04 127.07 54.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.711 -0.677 . . . . 63.51 109.979 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 56.6 t -128.03 134.47 65.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.065 0.46 . . . . 74.31 110.625 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.0 mp -109.41 137.04 47.87 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.648 -0.871 . . . . 74.4 108.648 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.405 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -115.75 121.03 5.12 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 123.819 0.699 . . . . 53.53 113.59 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 1.055 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 92.2 m-85 -133.92 149.93 51.3 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.373 -0.973 . . . . 71.43 108.373 173.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.79 93.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.04 0.448 . . . . 75.51 111.339 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.09 47.72 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.999 -0.546 . . . . 35.2 112.336 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 1.055 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 18.8 m95 -105.83 122.38 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.348 -0.241 . . . . 72.33 110.348 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.468 ' HB3' HD23 ' A' ' 10' ' ' LEU . 19.9 mt -128.51 136.96 51.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.865 0.364 . . . . 72.44 111.142 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -127.63 128.61 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 55.24 110.253 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -132.97 133.04 6.82 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.437 -0.887 . . . . 71.51 113.373 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.2 119.29 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.744 -0.465 . . . . 75.11 109.744 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 77.9 mt-30 -113.07 121.62 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.22 0.533 . . . . 73.25 109.569 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 90.4 mtp -133.92 135.82 43.84 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.623 -0.51 . . . . 72.43 109.623 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 166' ' ' GLN . 4.6 m-20 -111.56 117.54 33.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.566 -0.531 . . . . 73.04 109.566 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 14.1 m-85 -94.18 130.57 40.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.203 -0.908 . . . . 74.31 110.276 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 163' ' ' ARG . 11.9 pt-20 -96.52 124.78 40.62 Favored 'General case' 0 C--O 1.264 1.839 0 CA-C-O 121.307 0.575 . . . . 74.22 109.843 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -70.64 -16.67 62.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 113.258 -1.792 . . . . 73.44 111.511 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.25 -43.71 98.44 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.657 -0.868 . . . . 74.11 108.657 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -98.86 -159.58 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.546 -1.279 . . . . 74.42 107.546 165.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.6 m -109.52 27.31 9.69 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.825 -0.547 . . . . 71.3 109.552 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 35.8 ttm180 -151.77 160.16 43.68 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 118.513 -1.275 . . . . 65.11 112.915 -155.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.864 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -78.95 135.91 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.29 0.567 . . . . 52.4 111.369 -177.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -33.68 12.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 74.35 109.684 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 49.4 mt-30 -108.26 133.0 53.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.686 -0.688 . . . . 72.23 110.715 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.4 m -121.2 109.95 15.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 32.41 109.263 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 69.0 m-20 -113.8 126.82 55.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.885 -0.783 . . . . 72.44 108.885 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 94.0 m-85 -121.51 142.68 49.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.004 -0.678 . . . . 71.15 111.149 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -143.29 127.38 17.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.912 -0.585 . . . . 42.12 110.247 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 67.3 t -125.38 134.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.067 -0.346 . . . . 74.11 110.067 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -112.35 102.62 1.37 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.288 -0.725 . . . . 63.51 111.288 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -112.79 119.42 37.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.799 -0.815 . . . . 72.44 108.799 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 174' ' ' LYS . 1.4 tmmt? -112.37 125.94 54.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 64.52 111.422 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.2 m -120.84 154.48 35.73 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.379 -1.341 . . . . 63.13 107.379 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.23 -45.13 53.68 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.37 0.507 . . . . 71.43 112.37 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -113.61 0.26 14.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.02 -0.272 . . . . 64.33 111.401 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -136.75 114.86 11.54 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.497 -0.319 . . . . 64.25 110.769 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.71 123.49 49.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.33 -0.619 . . . . 75.31 109.33 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.799 HD12 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -117.74 131.07 56.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.171 0.51 . . . . 65.25 111.132 -176.345 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 72.3 t60 -115.58 115.12 25.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.622 -0.717 . . . . 60.52 109.483 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.646 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 8.6 m -82.78 139.94 33.28 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.903 -1.147 . . . . 73.31 107.903 173.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 12.0 t-20 -146.05 138.98 25.74 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.935 -0.706 . . . . 72.12 111.887 -173.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 59.4 t -131.55 120.94 46.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.482 -0.781 . . . . 62.52 109.962 172.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -112.03 111.15 21.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.59 -0.732 . . . . 73.01 110.154 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.0 t70 63.4 -168.58 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.817 -1.083 . . . . 71.03 109.29 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.64 -6.93 89.06 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.589 -0.815 . . . . 63.33 112.218 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 211' ' ' THR . 19.0 p -102.39 -28.35 12.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.786 1.032 . . . . 52.12 113.786 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.14 115.41 28.81 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.582 -0.847 . . . . 61.11 112.185 -172.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -120.77 126.3 49.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.06 -0.973 . . . . 71.42 109.665 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.76 -122.51 0.87 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.544 -0.836 . . . . 74.1 112.262 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 158.17 -160.67 31.03 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.617 -0.801 . . . . 74.13 112.587 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.9 t -148.05 139.15 23.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.699 -0.482 . . . . 50.53 109.699 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.799 HG13 HD12 ' A' ' 180' ' ' LEU . 4.2 mp -119.9 135.49 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.123 -0.325 . . . . 61.01 110.123 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.778 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 38.8 t80 -122.3 118.35 28.3 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 61.55 109.836 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.34 134.58 49.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.642 -0.503 . . . . 70.43 109.642 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -99.73 127.12 45.86 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 71.24 110.569 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.5 HG12 ' HD3' ' A' ' 200' ' ' LYS . 10.8 t -102.53 139.38 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.707 -0.849 . . . . 70.23 108.707 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.24 34.28 0.25 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.424 0.631 . . . . 64.3 112.621 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.5 ' HD3' HG12 ' A' ' 198' ' ' VAL . 2.5 mptp? -96.83 14.51 24.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.125 -1.065 . . . . 72.43 108.125 164.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 65.84 20.79 11.44 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.028 -0.987 . . . . 60.32 109.89 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.13 129.8 48.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.073 -0.967 . . . . 60.43 110.197 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.778 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 28.9 mt-10 -104.92 129.83 53.22 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.961 -1.126 . . . . 73.23 107.961 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -122.14 138.17 54.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.821 -0.352 . . . . 74.55 110.632 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.628 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -134.81 149.83 50.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.243 -0.435 . . . . 72.03 111.044 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.647 HG22 HG22 ' A' ' 221' ' ' ILE . 83.2 t -131.13 143.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.656 -0.702 . . . . 75.52 110.357 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -114.61 132.41 56.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.004 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 208' ' ' LEU . 2.1 mm? -125.17 129.48 50.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.219 -0.446 . . . . 72.24 110.21 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.01 127.71 12.47 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.078 -0.341 . . . . 61.34 110.078 171.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.506 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 2.3 t90 -118.75 133.34 55.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.999 -0.741 . . . . 74.44 108.999 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 188' ' ' THR . 31.6 m -93.89 103.02 15.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.184 0.516 . . . . 60.31 109.767 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.71 127.11 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.397 -0.82 . . . . 74.22 110.612 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.4 43.68 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.21 -0.756 . . . . 61.03 111.21 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -126.8 155.84 42.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.008 -0.738 . . . . 41.54 109.008 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.0 m -95.4 -9.8 31.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.155 0.428 . . . . 61.53 112.155 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -91.54 131.53 36.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.889 0.376 . . . . 71.44 110.613 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.506 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 7.9 t -107.19 139.13 42.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.288 0.566 . . . . 75.13 110.19 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -89.06 127.27 35.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.633 . . . . 74.32 109.997 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.636 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 93.9 m-85 -112.35 150.9 30.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.704 -0.68 . . . . 64.12 109.823 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.95 143.17 10.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.749 -0.94 . . . . 73.35 110.749 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.647 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -137.78 134.07 45.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 117.316 0.558 . . . . 71.15 110.583 177.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.528 ' CB ' ' HG2' ' A' ' 236' ' ' LYS . . . -126.29 142.17 51.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.885 -0.598 . . . . 65.22 111.388 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.09 124.06 51.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.74 -0.664 . . . . 74.53 109.456 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 21.3 tptp -113.93 114.02 25.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.328 -0.851 . . . . 74.51 109.425 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.56 121.14 32.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.045 0.45 . . . . 62.04 110.738 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 7.5 pt20 -91.36 99.28 12.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.712 -0.677 . . . . 75.4 109.756 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.6 -35.41 7.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.939 -0.573 . . . . 71.13 111.416 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.454 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -140.21 154.76 70.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 75.31 109.295 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 10.1 Cg_endo -52.52 -26.39 28.59 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.113 2.542 . . . . 42.31 113.309 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -107.97 -15.39 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.613 0.227 . . . . 71.34 111.613 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.26 123.68 40.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.015 0.436 . . . . 71.44 111.84 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.9 t -133.75 121.85 22.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 70.12 109.832 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -101.23 134.35 44.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.655 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 24.3 p -132.01 121.31 23.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.341 -0.391 . . . . 74.23 110.889 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.6 140.16 43.75 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.495 -0.557 . . . . 62.05 109.495 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 222' ' ' ALA . 71.6 mttt -137.92 150.68 47.28 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.044 -0.354 . . . . 63.31 110.044 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.513 HG12 HG12 ' A' ' 221' ' ' ILE . 8.7 p -144.69 143.88 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.119 0.485 . . . . 51.54 110.873 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 25.7 t-20 -105.03 148.9 26.26 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.433 -0.803 . . . . 75.3 109.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.636 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 64.4 t30 -46.65 -31.22 2.74 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.849 1.343 . . . . 61.15 113.378 -174.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.619 ' HB2' HD13 ' A' ' 242' ' ' LEU . 19.3 m -80.01 19.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.979 0.419 . . . . 61.31 110.603 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 56.0 m 68.67 34.2 3.54 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.467 -0.788 . . . . 62.1 111.19 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.2 mp -98.84 131.81 44.67 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 120.389 -0.524 . . . . 74.55 111.605 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 243' ' ' ILE . 2.3 mp -109.66 116.95 53.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.837 -0.62 . . . . 64.41 110.264 -169.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -112.85 133.55 11.4 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.617 -0.801 . . . . 45.1 111.947 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.708 ' H ' HD23 ' A' ' 245' ' ' LEU . 2.3 pt? -118.66 134.39 55.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.817 -0.438 . . . . 55.31 109.817 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.1 121.39 2.71 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.796 -0.716 . . . . 35.31 112.14 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.407 ' HE2' HD12 ' A' ' 245' ' ' LEU . 90.4 m-85 -108.87 115.79 30.76 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.453 -0.573 . . . . 73.23 109.453 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.0 m -109.05 112.85 25.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.176 0.513 . . . . 62.45 110.205 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.91 134.11 55.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 73.33 110.189 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 15.6 m -122.54 98.25 5.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.084 -0.507 . . . . 75.15 109.706 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.767 ' HB2' HG23 ' A' ' 255' ' ' ILE . 3.2 mm? -88.97 77.37 7.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.345 -0.613 . . . . 70.54 109.345 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.618 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 30.7 mmtp 68.37 166.63 0.12 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.343 -0.844 . . . . 73.02 110.136 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 55.7 Cg_endo -70.9 57.68 2.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.359 2.04 . . . . 55.03 112.178 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -147.94 -45.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.834 -0.621 . . . . 45.25 112.097 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.767 HG23 ' HB2' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -132.26 124.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.78 0.8 . . . . 73.32 110.67 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 57.2 tttt -119.61 131.9 55.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.99 -1.004 . . . . 74.24 110.092 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.02 125.54 49.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.839 -0.618 . . . . 63.02 110.466 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.2 t -128.87 111.59 13.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.627 0.727 . . . . 70.51 110.46 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.741 HD22 ' HG ' ' A' ' 277' ' ' LEU . 0.1 OUTLIER -106.3 124.49 49.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.41 -0.959 . . . . 72.33 108.41 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 46.8 p -140.79 140.73 34.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.198 -0.601 . . . . 74.11 110.999 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' A' ' 245' ' ' LEU . . . -144.89 146.69 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.985 -0.552 . . . . 75.32 110.088 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 242' ' ' LEU . 2.0 tm? -114.6 116.58 28.98 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.653 -0.869 . . . . 64.42 108.653 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.47 HD21 HD22 ' A' ' 245' ' ' LEU . 1.0 OUTLIER -92.13 107.35 19.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.911 -1.144 . . . . 52.53 107.911 173.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.85 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -70.79 104.92 3.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.259 -1.015 . . . . 73.23 108.259 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.7 -22.92 34.77 Favored Glycine 0 N--CA 1.459 0.211 0 C-N-CA 121.16 -0.543 . . . . 52.4 112.2 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -90.68 -15.73 29.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.257 -0.471 . . . . 65.44 111.798 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 17.5 t-20 -117.41 -38.37 3.34 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.227 0.455 . . . . 70.11 112.227 -174.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 264' ' ' ASP . 30.7 m -61.87 -17.79 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.103 0.408 . . . . 63.32 112.103 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -59.81 -32.67 70.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.053 0.454 . . . . 72.52 110.314 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.99 -16.57 15.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 44.45 110.277 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.32 119.52 3.28 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.81 -0.632 . . . . 50.31 111.827 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 149.73 82.7 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.462 -0.875 . . . . 50.31 112.413 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -113.61 150.13 33.57 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.698 -0.482 . . . . 55.14 109.698 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.1 mptt -91.73 137.11 32.63 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.682 -0.859 . . . . 74.23 108.682 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -120.53 137.72 54.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.151 -0.477 . . . . 55.33 109.845 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.923 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -144.15 112.68 0.69 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 111.045 -0.822 . . . . 64.43 111.045 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.741 ' HG ' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -113.96 143.51 44.6 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.29 -0.564 . . . . 70.41 109.512 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.563 ' H ' HD23 ' A' ' 277' ' ' LEU . . . -140.56 124.43 2.61 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.387 -0.824 . . . . 55.43 111.362 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.511 ' HB2' HD12 ' A' ' 29' ' ' LEU . 3.0 mm? -113.41 131.2 56.09 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.624 -0.88 . . . . 72.13 108.624 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 69.3 tt0 -125.42 116.14 21.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.133 0.492 . . . . 63.53 110.038 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.589 ' HB3' HD13 ' A' ' 31' ' ' LEU . 50.1 m-85 -105.33 138.57 41.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.678 -0.692 . . . . 65.24 109.782 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.498 ' HB3' HD23 ' A' ' 284' ' ' LEU . 75.8 mt-30 -130.85 114.03 14.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.451 -0.795 . . . . 74.22 110.209 -176.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.752 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -104.8 107.45 18.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.209 -0.664 . . . . 61.34 109.209 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.547 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.3 mm? -139.27 -3.27 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.421 -0.808 . . . . 62.12 110.171 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.59 -0.719 . . . . 72.23 109.885 -178.205 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.095 0.474 . . . . 75.31 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.634 ' CG1' ' HB3' ' A' ' 119' ' ' LYS . 7.9 p -147.81 134.86 10.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.17 -0.678 . . . . 73.1 109.17 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 9.6 Cg_endo -52.65 133.85 51.35 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.282 2.655 . . . . 74.12 113.664 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 13.0 Cg_exo -71.13 75.32 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.142 2.561 . . . . 61.12 110.893 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -76.4 -11.85 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.565 -0.743 . . . . 75.44 111.928 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.69 ' HB3' HG21 ' A' ' 143' ' ' VAL . 21.7 p90 -60.15 -22.12 62.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.314 0.578 . . . . 70.34 110.039 171.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -27.25 61.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.709 -0.678 . . . . 73.34 109.747 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -84.74 -14.12 49.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.056 -0.52 . . . . 72.2 110.091 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 170' ' ' ALA . 61.0 mt -76.89 -35.56 57.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.385 -0.825 . . . . 73.14 110.575 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 -61.45 0.23 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.386 -0.911 . . . . 74.5 114.025 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.75 -43.87 81.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.922 0.361 . . . . 71.45 111.338 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.1 t -62.09 -46.37 89.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.862 -0.608 . . . . 65.02 110.961 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.91 73.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.071 -0.513 . . . . 64.2 111.776 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -59.32 -30.11 68.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.12 112.243 -173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.59 -44.5 85.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.935 0.398 . . . . 75.14 110.452 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.41 -35.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.939 -0.573 . . . . 72.44 110.962 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -68.84 -23.05 64.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.946 -0.57 . . . . 74.44 111.533 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.8 p -76.03 93.05 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.313 0.578 . . . . 71.14 111.085 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.32 79.13 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.761 . . . . 74.44 112.214 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.4 63.92 3.11 Favored Glycine 0 C--N 1.335 0.479 0 O-C-N 123.984 0.803 . . . . 64.4 114.692 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -88.88 83.09 6.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.184 0.516 . . . . 74.34 110.732 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.3 121.84 5.77 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.531 -0.759 . . . . 53.12 111.465 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.81 5.61 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.645 0.239 . . . . 72.22 111.645 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.91 59.51 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.771 -0.728 . . . . 41.21 112.691 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 46' ' ' SER . 1.5 pp -129.04 -179.34 5.06 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.59 0.959 . . . . 74.34 113.59 -170.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.705 HG23 HD22 ' A' ' 277' ' ' LEU . 40.7 mm -99.1 132.79 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.061 -1.427 . . . . 75.21 109.802 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 17.9 ptpt -118.55 153.52 34.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.022 0.439 . . . . 72.14 109.906 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.804 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.3 tp -141.13 143.86 34.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.289 -0.414 . . . . 70.41 111.442 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 8.1 t70 -137.38 124.28 21.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.617 -1.253 . . . . 71.44 107.617 168.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.3 tm? -136.72 124.16 22.08 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.388 -0.597 . . . . 71.41 109.388 -175.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 29.6 mtmm -116.77 124.51 49.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 72.23 110.572 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -121.22 125.36 46.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.897 -0.592 . . . . 75.14 109.538 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -113.35 145.55 40.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.794 0.331 . . . . 71.13 110.335 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 21.7 m -139.21 138.19 36.65 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.48 -0.563 . . . . 71.04 109.48 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 49.21 -120.12 1.34 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.802 0.689 . . . . 73.24 110.572 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -136.27 152.24 50.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.725 -0.472 . . . . 50.55 109.725 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.757 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 79.29 -9.3 41.5 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 119.335 -0.703 . . . . 51.03 113.648 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -101.64 128.55 47.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.613 1.207 . . . . 63.33 112.043 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.822 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 29.0 tt0 -141.02 117.12 10.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 74.1 109.66 164.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 92.1 t80 -99.05 121.93 41.63 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.546 -0.538 . . . . 65.54 109.546 176.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 6.8 m -125.5 125.21 42.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.083 0.468 . . . . 74.43 111.521 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -112.43 123.84 51.17 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.775 -0.824 . . . . 62.04 108.775 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 22.1 m -137.85 125.66 22.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.203 -0.295 . . . . 62.11 110.203 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 178.9 42.33 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.328 -1.415 . . . . 55.53 113.442 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 26' ' ' LEU . 21.9 m -138.01 134.82 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.687 -0.486 . . . . 64.23 109.687 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -139.8 132.8 29.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.918 0.39 . . . . 50.53 111.25 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.06 120.96 37.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.894 -0.593 . . . . 64.21 109.409 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 m -84.52 -33.42 23.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 62.24 110.751 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -63.61 -59.4 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 75.35 110.027 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 m -112.52 111.31 22.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.228 -0.656 . . . . 72.41 109.228 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p -55.92 95.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.156 0.799 . . . . 55.24 113.156 -171.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -145.58 117.36 8.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.36 -0.978 . . . . 72.33 108.36 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' HB2' ' A' ' 47' ' ' ALA . 32.1 t -121.97 125.32 72.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.934 0.397 . . . . 71.34 110.821 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.6 m -109.54 125.08 52.14 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.493 -0.929 . . . . 73.02 108.493 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.56 5.33 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.947 -1.12 . . . . 73.24 113.267 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 75' ' ' TRP . 19.3 m -118.96 134.07 55.42 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.068 -0.715 . . . . 61.41 109.068 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -119.74 123.24 43.28 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.519 -0.919 . . . . 74.42 108.519 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.821 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 mt-10 -110.83 119.31 38.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.9 -0.591 . . . . 71.21 110.217 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -98.59 117.76 33.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.733 -1.21 . . . . 74.01 107.733 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.822 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 38.2 mttp -116.56 139.87 50.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.256 0.551 . . . . 62.44 110.75 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.757 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 96.6 m-85 -115.34 120.09 38.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.249 -0.887 . . . . 73.1 108.887 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.6 ptp180 -119.03 106.39 12.37 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 121.755 0.788 . . . . 72.43 111.224 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -116.11 92.67 3.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.919 -1.037 . . . . 74.12 109.994 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -81.22 1.22 33.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.748 -0.66 . . . . 70.4 111.448 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.43 14.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.524 0.678 . . . . 64.54 109.986 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -159.02 -49.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.875 -1.057 . . . . 62.33 108.578 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.366 -0.834 . . . . 72.1 111.306 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' CD1' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -106.93 131.86 53.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.796 0.331 . . . . 75.13 111.147 -174.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.9 m -129.99 111.93 13.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.002 -0.545 . . . . 74.05 109.993 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 33.4 t80 -112.88 123.76 51.05 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.547 -0.538 . . . . 71.45 109.547 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 61' ' ' LYS . 88.4 m -128.63 116.77 20.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.808 0.337 . . . . 74.32 111.018 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.38 121.52 45.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.892 -0.781 . . . . 71.54 108.892 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.711 ' HB3' ' HG2' ' A' ' 59' ' ' GLU . 17.4 ptmt -128.01 114.39 17.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.92 0.39 . . . . 54.45 111.442 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.662 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 78.6 t90 -99.9 139.23 35.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.524 -0.547 . . . . 72.4 109.524 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -119.7 160.86 21.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.422 -0.354 . . . . 51.55 110.276 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 p -62.41 -14.12 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.062 0.458 . . . . 72.32 111.95 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.683 ' HB3' HG22 ' A' ' 80' ' ' THR . 35.4 t70 -71.23 -4.75 27.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 71.04 110.108 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 3.7 m-20 77.85 -3.3 2.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.122 -0.944 . . . . 60.1 110.019 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.683 HG22 ' HB3' ' A' ' 78' ' ' ASP . 13.4 t -83.68 133.37 34.81 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.938 -0.574 . . . . 71.23 109.891 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.662 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 2.2 pt? -123.0 142.88 50.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.047 -0.524 . . . . 74.44 110.104 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.58 123.92 5.64 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.965 -0.636 . . . . 73.13 112.333 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 23.5 m -97.34 90.1 4.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.284 0.564 . . . . 71.44 109.679 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -91.57 110.0 21.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.123 -0.944 . . . . 71.43 109.482 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 85' ' ' ILE . 13.0 pt -124.36 134.84 65.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.734 0.778 . . . . 74.13 110.867 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -123.5 122.27 37.79 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.192 -0.913 . . . . 74.31 108.746 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.59 HG22 ' HB2' ' A' ' 97' ' ' LEU . 8.0 m -113.69 120.77 64.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.079 -0.51 . . . . 72.42 110.106 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -107.77 131.57 54.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.549 -0.908 . . . . 74.14 108.549 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -76.6 134.65 39.3 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.362 -0.535 . . . . 53.04 111.355 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.419 -0.809 . . . . 65.32 111.077 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.27 -53.22 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.687 -0.486 . . . . 63.12 109.687 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 71.87 10.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.34 110.719 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -63.37 133.35 53.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 73.5 110.219 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.5 -9.43 58.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.544 -0.836 . . . . 61.12 111.317 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -105.4 111.21 23.85 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.1 -0.704 . . . . 71.31 109.1 176.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.696 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -126.23 130.25 50.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.132 0.491 . . . . 73.43 110.404 177.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.724 HD12 HG22 ' A' ' 116' ' ' THR . 1.3 mm? -101.63 131.06 48.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.019 -0.537 . . . . 72.23 109.626 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -106.4 117.76 34.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.08 0.466 . . . . 62.24 110.494 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.785 ' HD1' ' HB ' ' A' ' 114' ' ' ILE . 82.3 t80 -126.21 115.95 20.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.279 -0.873 . . . . 75.54 110.295 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.691 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 1.3 t70 -112.18 138.6 48.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.765 -0.652 . . . . 64.53 110.768 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 33.2 m -126.93 120.74 29.89 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.951 -0.759 . . . . 54.14 108.951 169.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 4.7 t -127.49 121.89 31.94 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.918 -0.401 . . . . 72.24 109.918 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' THR . 69.6 m-85 -125.45 120.51 31.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.557 -0.292 . . . . 74.31 110.285 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.2 t -123.05 103.14 36.71 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.29 -0.414 . . . . 61.41 109.961 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.74 -25.32 46.4 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.972 2.448 . . . . 62.11 111.387 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -67.06 -37.44 84.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 63.14 110.329 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.764 ' HB ' ' HG2' ' A' ' 109' ' ' LYS . 5.2 m -88.18 -28.25 21.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.148 0.499 . . . . 75.01 110.104 175.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.67 4.19 83.02 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.229 -0.748 . . . . 70.14 111.229 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.764 ' HG2' ' HB ' ' A' ' 107' ' ' THR . 21.3 pttm -94.96 148.63 22.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.154 0.502 . . . . 54.03 111.472 -175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 122.74 37.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.316 -0.856 . . . . 53.13 109.236 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 17.8 m120 -119.61 137.79 53.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 75.5 110.521 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -140.15 123.3 16.78 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.616 -0.513 . . . . 53.55 109.616 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.691 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -117.58 131.92 56.6 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.539 -0.864 . . . . 74.23 109.204 176.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.785 ' HB ' ' HD1' ' A' ' 99' ' ' PHE . 4.0 tp -140.09 114.66 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.635 -0.506 . . . . 74.43 109.635 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.947 ' HB3' ' O ' ' A' ' 127' ' ' CYS 0.461 13.1 tttt -154.41 170.12 22.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 116.128 1.899 . . . . 51.32 116.128 160.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.724 HG22 HD12 ' A' ' 97' ' ' LEU . 77.1 p -101.18 130.16 47.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.311 -1.313 . . . . 64.31 110.956 -163.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.89 123.81 5.87 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.534 -0.841 . . . . 52.33 112.238 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.444 ' C ' ' HD2' ' A' ' 119' ' ' LYS . 35.5 p90 -124.9 128.09 48.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.62 0.724 . . . . 72.4 110.282 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.696 ' HD3' ' HD3' ' A' ' 96' ' ' LYS . 3.8 mptp? -111.38 122.7 48.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.672 -0.695 . . . . 73.51 110.929 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 31.0 mtp180 -108.36 158.02 17.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.798 -0.637 . . . . 73.4 110.694 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.68 -32.8 44.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.39 0.885 . . . . 70.31 113.39 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -119.15 -6.33 10.42 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.73 -0.388 . . . . 74.42 111.297 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -144.4 123.3 6.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.52 0.676 . . . . 42.53 110.6 -173.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.787 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.9 t-20 -104.64 115.45 30.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.03 -0.532 . . . . 64.34 109.582 -175.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.05 130.06 56.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.516 0.674 . . . . 64.13 111.761 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.47 115.9 1.61 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.316 -0.856 . . . . 42.23 111.37 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.947 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 59.4 m -112.66 126.1 55.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.824 -0.806 . . . . 65.31 108.824 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.765 ' HA ' ' CB ' ' A' ' 115' ' ' LYS . 1.1 m-20 -128.92 133.22 47.79 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.843 1.339 . . . . 62.41 111.364 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.855 ' H ' ' HB2' ' A' ' 115' ' ' LYS . 60.1 ttp -107.39 118.39 36.59 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 119.413 -0.915 . . . . 73.43 109.791 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 9.2 t70 -106.2 115.3 29.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.739 -0.467 . . . . 73.11 109.739 -175.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 92.3 t80 -97.87 117.78 32.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.839 -0.344 . . . . 75.22 111.125 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 22.5 t70 -115.02 157.03 24.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.872 -0.788 . . . . 75.21 108.872 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.47 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.6 pp -69.19 -17.19 21.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 111.705 0.261 . . . . 50.04 111.705 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.23 -19.34 24.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 71.31 111.073 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.482 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 168.93 148.45 5.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.528 -0.844 . . . . 74.3 112.527 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 2.8 Cg_endo -85.67 114.51 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.571 2.847 . . . . 65.12 111.749 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 m -104.0 144.44 31.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.018 -0.537 . . . . 74.54 110.612 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.35 118.52 55.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.41 -0.589 . . . . 71.21 109.41 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 139' ' ' ARG . 39.3 ttp-105 -103.57 126.31 50.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.773 -0.649 . . . . 70.33 110.23 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.14 132.02 10.1 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.181 -1.009 . . . . 74.31 111.643 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.09 116.09 23.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.713 -0.477 . . . . 53.3 109.713 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 123' ' ' ILE . 15.2 tp -124.26 124.53 42.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.356 -0.384 . . . . 74.02 110.621 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 46.5 t -125.1 128.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 72.31 109.821 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.2 mp -109.51 138.69 45.5 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.728 -0.841 . . . . 73.4 108.728 176.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.9 117.55 1.58 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.109 -1.043 . . . . 72.33 111.778 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.31 123.28 18.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.883 -0.327 . . . . 74.52 111.056 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 40.34 39.02 0.62 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.058 1.132 . . . . 73.14 114.058 171.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.09 6.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.26 -0.971 . . . . 71.33 113.512 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -98.66 137.01 37.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.904 0.852 . . . . 74.53 111.416 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 mt -115.59 140.17 49.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.442 -1.254 . . . . 74.41 110.56 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -127.17 125.88 41.88 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.275 -0.639 . . . . 61.3 109.275 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.63 134.02 7.59 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.26 -0.972 . . . . 52.54 112.572 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.472 ' HD2' ' CD2' ' A' ' 169' ' ' PHE . 13.7 m-85 -134.68 120.54 19.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.387 -0.407 . . . . 72.41 109.973 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.421 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . 73.1 mt-30 -119.92 123.12 42.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.426 0.631 . . . . 62.31 110.01 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -130.58 136.13 48.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.863 -0.608 . . . . 73.42 110.288 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -114.75 118.88 34.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.702 -0.481 . . . . 74.51 109.702 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 86.3 t80 -107.15 123.33 48.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.811 -0.631 . . . . 73.42 110.798 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -94.98 126.35 40.26 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.479 -0.563 . . . . 74.34 109.479 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 41.8 p -73.71 -48.24 33.47 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.083 -0.962 . . . . 63.35 112.993 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -65.58 -44.57 86.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.237 0.541 . . . . 62.35 110.189 -172.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 38.7 ttpt -101.64 112.91 25.63 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.941 -1.874 . . . . 73.23 105.941 160.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.4 p -75.5 38.07 0.14 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.355 1.243 . . . . 61.12 114.355 -152.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.567 ' HG2' ' N ' ' A' ' 164' ' ' VAL . 26.0 ttm180 -139.92 157.88 44.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.916 0.389 . . . . 71.23 111.085 -166.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 85.7 t -72.51 122.13 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.448 -0.945 . . . . 73.23 108.448 170.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.6 m -93.81 -31.08 14.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.354 -0.385 . . . . 63.12 110.826 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -132.94 129.7 38.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 64.5 110.321 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.5 m -124.75 106.67 10.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.562 -0.744 . . . . 74.51 109.632 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 154' ' ' GLN . 10.0 p30 -118.14 146.79 43.91 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.459 -0.496 . . . . 43.51 109.886 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' HD2' ' A' ' 153' ' ' TYR . 69.1 m-85 -135.21 162.1 33.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.45 -0.341 . . . . 75.22 110.648 -173.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 71.0 110.616 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.806 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 98.5 t -138.45 136.95 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.415 . . . . 73.23 109.878 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.73 111.28 1.9 Allowed Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.614 -0.803 . . . . 60.12 111.317 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.574 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 19.5 t80 -113.28 128.85 56.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.252 0.526 . . . . 62.31 109.976 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -102.15 130.82 48.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.981 0.896 . . . . 74.21 112.564 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 7.8 m -131.1 145.54 52.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 42.41 105.765 164.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.95 -30.25 67.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.328 0.513 . . . . 73.44 112.303 -168.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.08 -0.23 12.79 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.292 -0.255 . . . . 73.5 111.567 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.608 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 53.4 m-85 -136.84 119.93 16.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 73.35 110.57 -174.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -110.91 123.65 50.55 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.018 -0.426 . . . . 63.52 110.162 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 173' ' ' TYR . 2.0 tp -102.68 126.9 49.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.998 0.428 . . . . 50.21 110.077 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -118.55 114.83 23.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.627 -0.879 . . . . 75.31 108.627 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.806 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 26.6 m -99.94 137.57 38.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.406 -0.59 . . . . 40.41 109.406 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -136.97 139.05 41.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.137 0.494 . . . . 64.23 110.995 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 190' ' ' PHE . 84.2 t -128.04 111.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 63.5 109.546 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -96.54 103.8 15.73 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 108.672 -0.862 . . . . 54.34 108.672 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.435 ' HB3' HG22 ' A' ' 188' ' ' THR . 23.1 t70 64.82 172.61 0.2 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.03 -0.987 . . . . 70.02 109.64 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.8 56.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.435 -0.888 . . . . 34.42 111.785 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 186' ' ' ASP . 14.4 t -97.41 -24.14 15.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 113.14 0.792 . . . . 72.02 113.14 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.29 117.47 19.85 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.423 1.01 . . . . 62.42 111.33 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 184' ' ' VAL . 41.8 p90 -134.03 138.47 45.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.593 -0.276 . . . . 72.35 110.766 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . -163.45 -163.88 17.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.788 -0.72 . . . . 61.32 112.369 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.88 176.73 30.9 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 120.78 -0.724 . . . . 74.23 112.095 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 34.8 t -147.29 142.59 27.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.046 0.423 . . . . 75.21 110.881 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 194' ' ' ILE . 4.1 mp -119.31 118.4 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.194 -0.669 . . . . 70.51 109.194 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 9.2 t80 -108.24 121.07 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.588 -0.523 . . . . 72.5 109.588 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -116.96 126.69 53.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.424 -0.584 . . . . 73.34 109.424 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.647 ' HG2' ' HG2' ' A' ' 203' ' ' GLU . 2.9 tmtp? -108.69 114.17 27.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.982 -0.554 . . . . 51.15 110.24 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.461 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 43.6 t -73.89 159.75 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.462 -0.335 . . . . 73.4 110.319 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.405 ' N ' HG12 ' A' ' 198' ' ' VAL . 5.9 m-20 -57.62 -45.53 85.25 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.527 0.203 . . . . 63.13 111.041 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 172.47 13.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.906 -0.776 . . . . 55.05 108.906 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -78.08 70.1 4.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.756 0.788 . . . . 72.22 111.423 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.744 HD13 ' HD2' ' A' ' 225' ' ' TYR . 58.5 tp -133.58 113.01 11.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.465 -1.243 . . . . 75.0 108.759 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.647 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.6 mt-10 -117.12 129.09 55.74 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.512 -0.551 . . . . 55.21 109.512 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -124.36 139.41 53.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.725 0.298 . . . . 65.23 110.968 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.425 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -130.97 136.4 48.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.349 -0.387 . . . . 64.13 110.677 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 193' ' ' SER . 54.6 t -113.71 126.08 71.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.471 -0.566 . . . . 72.22 109.471 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.1 136.17 53.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.507 0.67 . . . . 74.45 111.004 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -119.55 141.1 49.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.029 -0.987 . . . . 62.5 109.325 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.11 130.37 25.18 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.283 -0.417 . . . . 64.2 110.872 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -116.48 132.84 56.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.981 -0.748 . . . . 71.31 108.981 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 10.1 t -114.2 122.72 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 63.11 110.691 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.64 135.62 57.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 74.44 111.14 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.38 -28.94 5.63 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.622 -0.717 . . . . 65.11 111.474 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.06 149.26 30.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.094 -0.706 . . . . 61.02 109.094 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.6 m -79.15 42.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.079 0.466 . . . . 64.34 110.667 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.57 120.88 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.573 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.6 t -105.8 136.89 44.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.14 0.495 . . . . 74.31 109.943 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.4 mmm-85 -102.0 138.19 39.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.445 -0.576 . . . . 75.22 109.445 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 66.0 m-85 -114.7 146.9 40.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.982 -0.377 . . . . 73.21 109.982 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.88 146.23 15.21 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.34 -0.704 . . . . 62.44 111.34 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.6 mp -132.14 129.5 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.94 0.37 . . . . 71.22 110.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -118.57 138.9 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.117 -0.327 . . . . 72.33 110.117 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.97 125.8 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.922 0.391 . . . . 60.13 110.813 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -115.44 114.34 24.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.74 -0.664 . . . . 73.24 109.909 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.744 ' HD2' HD13 ' A' ' 202' ' ' LEU . 36.6 t80 -117.7 120.05 36.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.477 -0.564 . . . . 73.43 109.477 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 229' ' ' PRO . 52.7 tt0 -112.25 112.22 23.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.952 0.406 . . . . 70.33 110.652 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 227' ' ' ILE . 3.7 mp -86.82 -55.51 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 62.33 109.711 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -106.1 153.86 39.96 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 73.53 109.606 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.639 ' HA ' HE21 ' A' ' 226' ' ' GLN . 21.0 Cg_endo -60.33 -23.82 75.63 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.549 2.166 . . . . 74.31 112.79 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -102.61 -9.27 20.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.587 -0.279 . . . . 75.23 111.342 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.85 122.67 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 73.32 111.348 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.47 142.32 51.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.878 -0.601 . . . . 71.32 110.651 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -108.43 125.77 52.14 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.251 -0.648 . . . . 71.1 109.251 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.5 t -126.45 117.15 22.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.818 -0.438 . . . . 53.14 109.818 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -124.74 155.86 38.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.367 -0.379 . . . . 62.54 110.324 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 0.0 OUTLIER -154.25 139.84 17.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.478 . . . . 63.44 109.857 175.07 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 243' ' ' ILE . 7.9 p -128.64 144.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 63.13 110.406 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -108.46 148.79 29.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.066 -0.516 . . . . 73.42 109.96 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 8.0 t30 -65.22 -3.78 4.35 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.182 0.808 . . . . 63.02 113.182 -170.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.667 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.6 m -85.76 17.06 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.946 -0.761 . . . . 73.34 108.946 172.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.594 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 51.0 m 69.77 30.45 3.82 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.691 -1.14 . . . . 74.21 111.585 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.848 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.7 mp -99.08 125.47 44.6 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 120.683 -0.407 . . . . 75.42 111.735 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.561 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.8 mp -113.2 115.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.721 -0.672 . . . . 74.23 110.506 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -111.08 133.78 11.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.74 -0.743 . . . . 23.43 111.748 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.56 151.71 50.57 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.687 -0.302 . . . . 75.13 110.527 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -146.45 137.8 7.03 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.63 -0.795 . . . . 63.0 113.026 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -103.63 120.19 40.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.742 -0.836 . . . . 64.45 108.742 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 2.0 m -121.93 115.76 23.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.737 0.303 . . . . 74.24 111.035 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -134.74 141.84 46.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.58 -0.282 . . . . 72.02 110.707 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.0 m -76.32 124.82 28.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.609 -0.515 . . . . 63.33 109.609 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.595 ' HG ' ' H ' ' A' ' 252' ' ' LYS . 17.9 tp -105.92 172.65 6.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.108 0.48 . . . . 72.35 111.804 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.595 ' H ' ' HG ' ' A' ' 251' ' ' LEU . 44.2 tptt -49.53 -54.54 29.73 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.998 1.11 . . . . 64.21 113.998 -172.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 13.1 Cg_exo -70.73 9.07 0.82 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.611 2.207 . . . . 61.22 114.295 -171.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 82.86 29.36 35.1 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.386 -0.911 . . . . 41.4 111.824 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 2.7 pp -121.94 146.02 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.447 -0.377 . . . . 70.43 110.35 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.581 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 73.7 tttt -91.64 126.17 36.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 74.52 108.864 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.6 tp -97.8 123.58 41.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.927 -0.398 . . . . 60.34 109.927 -176.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.4 m -124.75 111.5 15.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.789 -0.641 . . . . 65.44 110.543 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.638 ' CD2' HD12 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -98.92 122.8 42.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.553 -1.277 . . . . 74.21 107.553 170.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.8 m -131.47 143.91 50.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.932 0.396 . . . . 63.23 111.16 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.409 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -146.44 132.36 19.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 74.0 110.732 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.772 HD11 HD23 ' A' ' 242' ' ' LEU . 2.7 tm? -104.35 113.12 26.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.25 -1.018 . . . . 54.3 108.25 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.697 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.2 mm? -91.66 108.92 20.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.92 -1.141 . . . . 71.22 107.92 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.848 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 9.9 t0 -71.48 105.07 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.586 -1.265 . . . . 70.13 107.586 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.82 -25.03 43.4 Favored Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.907 -0.588 . . . . 44.31 113.497 -170.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 266' ' ' LYS . 46.0 mtpt -91.85 -26.63 18.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.627 0.251 . . . . 61.33 111.201 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 63.2 t30 -98.69 -28.57 13.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 61.25 112.357 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.738 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 26.9 m -62.51 -17.82 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.665 0.269 . . . . 74.25 111.315 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -55.57 -37.79 68.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.271 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.57 9.75 37.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 62.31 110.838 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.44 74.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.004 -0.617 . . . . 72.51 112.598 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.738 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -142.57 86.52 0.19 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.937 -0.649 . . . . 42.23 111.919 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -113.23 143.52 44.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.444 0.164 . . . . 72.42 110.642 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 65.5 mttm -97.47 137.91 35.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.252 -0.647 . . . . 75.33 109.252 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -121.94 142.55 50.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.814 -0.439 . . . . 74.33 109.814 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -157.37 123.81 1.33 Allowed Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.54 -0.838 . . . . 52.14 111.504 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.705 HD22 HG23 ' A' ' 27' ' ' ILE . 7.4 tt -114.05 145.2 41.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.005 -0.739 . . . . 74.45 109.005 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -149.4 125.37 1.99 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.944 -1.122 . . . . 75.53 113.012 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.804 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.1 mm? -99.18 128.0 45.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.418 -0.956 . . . . 70.5 108.418 168.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 13.8 pt-20 -140.05 125.07 18.55 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.045 -0.354 . . . . 64.41 110.045 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.688 ' HB3' ' HA ' ' A' ' 255' ' ' ILE . 1.3 t80 172.72 -142.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 71.34 111.547 170.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.506 ' HB3' HD23 ' A' ' 284' ' ' LEU . 74.9 mt-30 -136.32 122.07 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.28 -0.418 . . . . 72.31 111.396 -166.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.93 109.02 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.942 -0.762 . . . . 65.44 108.942 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 282' ' ' GLN . 2.9 mm? -131.75 158.92 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.12 -0.491 . . . . 73.15 110.709 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.938 -0.764 . . . . 72.21 108.938 176.298 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.642 ' HB1' ' HA2' ' A' ' 94' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.094 0.473 . . . . 32.55 112.096 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 119' ' ' LYS . 23.1 t -125.46 127.58 24.89 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 55.52 110.178 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.98 123.23 9.54 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.494 2.796 . . . . 65.22 112.599 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.41 85.4 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.699 2.266 . . . . 73.52 112.564 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 5.5 p -72.0 -13.27 61.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 74.3 110.208 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.551 ' HE1' HE21 ' A' ' 154' ' ' GLN . 51.8 t80 -53.74 -34.98 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.995 -1.002 . . . . 72.2 110.126 169.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.22 -27.18 30.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 74.32 110.673 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' THR . 2.2 m-20 -85.22 0.98 50.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.589 -0.732 . . . . 75.5 111.196 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.67 -34.48 77.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 75.23 110.386 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.52 59.81 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.544 -0.836 . . . . 64.32 112.699 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -59.26 -53.28 60.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 62.34 110.839 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -55.53 -36.48 66.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.634 -0.712 . . . . 62.55 112.132 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.57 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 72.13 112.205 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -67.79 -40.1 83.98 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 71.21 110.682 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -68.73 -44.43 73.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.675 -0.693 . . . . 64.11 110.979 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 p -68.98 -26.67 32.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.128 0.49 . . . . 74.02 110.435 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.99 -39.91 83.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.944 -0.571 . . . . 54.33 109.727 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 58.26 39.36 25.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.78 -0.646 . . . . 65.35 111.248 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 67.82 4.39 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.954 -0.567 . . . . 55.3 111.451 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.09 -78.27 0.68 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.164 -0.541 . . . . 44.32 112.695 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -122.09 170.08 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.812 0.339 . . . . 72.02 111.03 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 122.54 6.79 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.826 -0.702 . . . . 73.11 111.621 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' HD1' HD13 ' A' ' 26' ' ' LEU . 22.2 t80 -89.35 2.91 53.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.127 0.489 . . . . 64.3 110.894 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.01 59.25 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.579 -0.82 . . . . 50.44 112.72 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.621 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 9.3 mp -102.0 156.07 17.77 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.625 0.726 . . . . 74.31 112.288 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.687 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -104.71 122.04 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.402 -1.272 . . . . 75.22 108.74 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.7 mtpp -102.74 127.78 49.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.877 -0.601 . . . . 75.15 110.59 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.31 126.65 53.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.337 -0.986 . . . . 73.11 108.337 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.584 ' HB3' ' HD1' ' A' ' 281' ' ' PHE . 4.5 t0 -142.49 133.08 25.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.303 -0.999 . . . . 74.14 108.303 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.013 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -139.12 123.98 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.755 0.252 . . . . 53.21 110.575 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 32.1 ttpt -121.15 122.56 40.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.221 0.534 . . . . 75.53 110.28 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -138.82 120.66 15.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.308 -0.86 . . . . 74.02 109.381 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HB2' ' HG2' ' A' ' 40' ' ' GLU . 3.5 pttp -144.28 155.16 43.72 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.856 -0.738 . . . . 64.12 111.684 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -133.68 169.54 16.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.805 . . . . 61.33 109.782 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -89.07 13.79 12.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.056 0.391 . . . . 74.33 112.056 -172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.07 52.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.685 0.254 . . . . 61.13 111.685 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.94 -7.59 50.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 118.896 -0.947 . . . . 63.14 115.232 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.9 126.65 47.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.307 1.553 . . . . 63.22 112.186 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 23.9 mt-10 -139.36 118.49 12.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.308 -0.627 . . . . 74.44 109.308 165.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.98 126.07 53.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 74.23 111.244 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.9 m -126.17 117.11 22.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 63.43 110.655 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -116.63 133.54 55.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.714 -0.476 . . . . 73.35 109.714 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 31.7 m -139.96 149.93 43.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.911 0.386 . . . . 73.24 110.805 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.7 129.41 2.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.105 -0.569 . . . . 55.31 111.847 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -112.89 133.84 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.758 -0.83 . . . . 60.14 108.758 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.72 129.91 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.04 0.448 . . . . 71.42 111.208 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.621 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 37.7 t-20 -91.11 143.73 26.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.55 -0.908 . . . . 62.24 108.55 177.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -65.12 -6.34 8.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.877 0.325 . . . . 75.1 111.877 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.15 168.12 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.428 -0.582 . . . . 74.51 109.428 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -52.65 -69.25 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.322 0.86 . . . . 65.3 113.322 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.8 m -122.3 92.18 3.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.314 0.578 . . . . 55.1 111.72 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 9.3 tmtm? -154.67 78.83 1.07 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.204 -1.035 . . . . 75.35 108.204 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.72 120.5 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.216 -0.902 . . . . 73.14 109.479 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -110.31 124.57 51.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.33 -0.395 . . . . 62.11 109.97 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.3 154.37 16.87 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.716 -0.754 . . . . 63.1 112.206 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 20.1 m -146.19 126.52 13.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.65 -0.5 . . . . 70.13 109.65 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -125.34 125.86 44.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.525 -0.546 . . . . 71.2 109.525 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 38.1 tt0 -129.53 126.19 38.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.035 0.445 . . . . 74.31 110.628 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 73' ' ' GLU . 3.9 m -120.1 129.45 54.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.851 -0.613 . . . . 64.5 109.758 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 68.6 mttm -117.52 133.99 55.36 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.856 -0.424 . . . . 61.53 109.856 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 50.1 m-85 -101.89 119.78 39.33 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.406 -0.961 . . . . 73.22 108.406 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.6 ttm180 -121.08 110.77 16.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 119.943 -0.703 . . . . 70.43 112.741 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -91.9 136.14 33.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.724 -1.125 . . . . 64.21 109.443 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -75.46 -11.57 60.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 72.13 112.695 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.84 106.27 2.63 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.081 -0.34 . . . . 75.1 110.081 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 66.87 -68.07 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.019 0.824 . . . . 73.42 110.476 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' HA3' ' HG2' ' A' ' 88' ' ' GLU . . . 154.66 72.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.672 -0.971 . . . . 61.23 110.672 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 63' ' ' ARG . 4.1 mm? -101.12 131.39 47.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.213 -0.292 . . . . 62.3 110.213 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 23.0 m -136.19 118.55 15.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.442 -0.344 . . . . 65.23 111.352 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.416 ' HB3' ' HD1' ' A' ' 62' ' ' TYR . 69.8 t80 -96.63 121.93 39.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.668 -0.864 . . . . 74.32 108.668 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 83' ' ' THR . 96.3 m -113.46 126.54 55.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.172 0.51 . . . . 73.24 112.158 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' CG ' ' HB ' ' A' ' 60' ' ' THR . 3.1 pt-20 -118.82 139.23 51.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.078 -0.964 . . . . 55.14 109.006 169.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.0 ttpp -142.01 142.41 32.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.917 -0.771 . . . . 74.22 108.917 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 129.73 35.82 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.088 -0.645 . . . . 75.01 111.69 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -116.18 135.96 53.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.65 -0.87 . . . . 71.33 108.65 165.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -35.77 74.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.133 0.492 . . . . 71.04 111.221 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.57 -34.83 10.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.775 -0.648 . . . . 65.42 111.723 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -104.71 -104.17 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.663 -0.415 . . . . 74.13 111.814 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -116.43 145.33 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.544 0.687 . . . . 73.43 112.777 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -106.19 131.59 53.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.224 -1.028 . . . . 73.22 108.224 168.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.86 148.28 17.97 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.652 -0.785 . . . . 31.14 112.77 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 72' ' ' THR . 88.0 m -156.45 143.98 19.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.099 -0.704 . . . . 50.12 109.099 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.642 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 4.7 mm-40 165.36 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.19 0.931 . . . . 62.12 110.632 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.476 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.54 138.29 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 74.24 112.231 -162.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 70' ' ' THR . 25.7 m -122.85 123.46 41.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.134 -0.484 . . . . 73.1 109.906 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.16 137.44 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 73.24 111.336 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HG2' ' HA3' ' A' ' 68' ' ' GLY . 12.8 pt-20 -125.79 151.31 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.12 -0.232 . . . . 70.51 111.458 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.5 ' OD2' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER 66.92 1.19 2.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.809 1.04 . . . . 73.51 113.809 171.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.88 -58.85 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.172 -0.211 . . . . 70.13 111.412 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.453 ' HB3' HD23 ' A' ' 95' ' ' LEU . 58.9 tp -74.62 -49.26 22.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.001 0.429 . . . . 75.4 110.519 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.879 -0.6 . . . . 65.35 110.033 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 7.3 mpt_? -63.82 127.71 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 65.23 110.411 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.642 ' HA2' ' HB1' ' A' ' 2' ' ' ALA . . . 101.23 -7.47 56.67 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.668 -0.777 . . . . 71.04 112.436 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 91' ' ' LEU . 50.7 tp -94.56 129.78 41.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.18 0.514 . . . . 71.52 110.957 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -122.25 111.99 17.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.391 -0.822 . . . . 74.02 109.872 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -104.98 126.78 52.4 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.149 -0.686 . . . . 74.12 109.149 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.858 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 19.8 m -125.67 119.26 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.013 0.435 . . . . 63.53 110.851 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.642 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 56.1 m-85 -113.42 119.53 37.94 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.608 -0.886 . . . . 74.14 108.608 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 12.1 m-20 -125.32 122.79 37.86 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.729 0.643 . . . . 51.43 109.383 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -115.11 122.56 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.157 -0.617 . . . . 72.11 110.112 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.3 m -111.43 122.77 48.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 73.54 110.423 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.456 ' HD2' ' HG2' ' A' ' 110' ' ' LYS . 74.7 t80 -110.21 129.7 55.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.448 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 45.4 t -104.42 128.16 27.58 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.205 -0.665 . . . . 54.41 109.205 175.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 36.0 Cg_exo -60.58 -20.32 64.02 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.652 2.234 . . . . 71.2 111.786 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -78.7 116.69 19.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.538 -0.755 . . . . 63.11 110.611 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.4 p 56.01 12.39 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.266 1.026 . . . . 74.12 113.664 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.48 74.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.553 -0.832 . . . . 70.12 112.393 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 104' ' ' SER . 57.3 tttp -65.2 123.93 20.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.32 111.247 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' A' ' 103' ' ' PHE . 97.1 mttt -112.13 136.32 51.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 54.35 110.71 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.4 121.61 38.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.694 -0.854 . . . . 73.2 108.694 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.27 133.53 55.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.278 . . . . 50.11 111.264 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 8.6 mtpm? -117.0 136.98 52.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.859 0.361 . . . . 74.4 110.72 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.661 HG23 ' HB3' ' A' ' 129' ' ' MET . 2.8 tp -134.18 116.01 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.706 -0.679 . . . . 73.42 109.602 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 35.7 ttmt -114.58 121.75 44.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.675 -0.693 . . . . 64.31 110.524 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.5 t -114.54 117.18 30.2 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.055 -0.72 . . . . 60.33 109.055 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.07 123.31 4.78 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.456 -0.878 . . . . 63.02 112.549 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.07 117.3 33.71 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.25 -0.648 . . . . 75.54 109.25 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 1.01 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -110.19 119.13 38.27 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.404 0.621 . . . . 73.52 109.878 177.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.637 ' HB2' HG23 ' A' ' 123' ' ' ILE . 17.7 mmm-85 -108.36 163.67 12.99 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.031 -0.986 . . . . 71.22 108.943 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -53.09 -34.19 55.53 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.551 0.532 . . . . 74.43 112.186 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.01 -0.77 10.52 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.4 0.519 . . . . 65.02 112.4 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 120' ' ' ARG . 3.6 tp -145.49 120.72 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.937 -0.705 . . . . 65.15 111.463 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 1.01 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 7.2 p30 -129.44 116.12 18.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 63.1 111.136 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -129.65 144.42 51.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.106 0.479 . . . . 64.0 111.112 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.589 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -142.42 131.15 4.55 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.538 -0.755 . . . . 61.24 112.243 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.7 m -110.1 114.75 28.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.825 0.345 . . . . 62.32 110.54 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 32.4 t70 -106.63 116.14 31.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.265 -0.642 . . . . 74.13 109.265 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.661 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.7 ttt -97.67 122.78 41.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 75.33 110.615 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.88 116.74 31.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.353 -0.61 . . . . 62.12 109.353 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -97.3 115.07 26.98 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.918 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.83 149.8 36.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.919 -0.771 . . . . 74.52 108.919 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -32.33 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.679 0.276 . . . . 72.24 110.625 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.08 -18.33 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 75.5 111.1 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.58 116.6 0.37 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.754 . . . . 74.31 112.517 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.16 144.83 34.08 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.026 2.484 . . . . 72.33 111.883 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 m -124.13 146.62 48.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.492 -0.322 . . . . 55.32 110.474 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 30.9 mm -107.53 116.13 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.766 -0.457 . . . . 73.1 109.766 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -110.16 110.33 21.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.974 0.416 . . . . 72.41 110.223 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.94 133.58 11.52 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.209 -0.996 . . . . 74.15 112.318 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.93 113.77 18.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.201 0.524 . . . . 64.2 109.905 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 125' ' ' LEU . 7.3 tp -115.67 123.74 49.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.611 -0.722 . . . . 73.34 110.351 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 7' ' ' TYR . 59.5 t -123.0 124.02 69.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.104 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.54 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.17 138.2 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.029 -0.73 . . . . 75.31 109.029 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -119.47 119.16 4.19 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.747 -0.74 . . . . 75.54 113.039 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.797 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 55.3 m-85 -112.75 150.44 31.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.2 -1.407 . . . . 74.44 107.2 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -49.08 94.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.154 0.434 . . . . 71.35 111.386 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.55 -30.87 9.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.912 -0.585 . . . . 71.13 112.786 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 59.1 m95 -101.88 144.7 30.19 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.42 -0.459 . . . . 73.41 111.038 -173.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.458 HD23 ' HA2' ' A' ' 145' ' ' GLY . 16.3 mt -136.33 142.62 43.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.76 0.314 . . . . 73.23 111.424 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.26 126.13 24.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 51.25 109.943 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -131.9 133.54 7.21 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.655 -0.783 . . . . 70.25 112.157 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.557 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 92.1 m-85 -127.71 119.33 25.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.771 0.32 . . . . 73.55 110.723 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.551 HE21 ' HE1' ' A' ' 7' ' ' TYR . 85.8 mt-30 -106.52 123.04 47.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.215 -0.661 . . . . 74.1 109.215 173.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -137.44 129.8 29.56 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.549 -0.296 . . . . 65.31 110.255 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.404 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 48.3 t30 -112.57 118.98 36.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.502 -0.555 . . . . 61.13 109.502 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.888 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 27.7 m-85 -91.87 129.49 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 75.41 110.52 -173.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 23.8 tt0 -97.49 110.5 23.04 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 109.277 -0.638 . . . . 72.34 109.277 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -70.28 -16.04 62.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 112.777 -2.01 . . . . 71.21 111.822 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.86 66.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.871 0.843 . . . . 71.24 109.088 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.554 ' HG3' ' HB2' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -122.83 -153.97 0.58 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.36 -1.348 . . . . 74.42 107.36 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 p -107.31 28.3 8.23 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.916 -0.49 . . . . 71.3 110.452 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.554 ' HB2' ' HG3' ' A' ' 161' ' ' LYS . 14.4 mmt180 -139.75 149.11 43.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.051 -1.06 . . . . 72.1 112.355 -161.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.888 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.21 136.58 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.569 -0.53 . . . . 72.5 109.569 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 6.6 t -93.43 -23.52 18.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.903 -0.59 . . . . 71.21 110.41 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -141.14 133.19 27.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 64.25 110.599 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 2.7 m -121.89 115.91 23.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.574 -0.739 . . . . 63.14 109.759 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 51.7 t30 -118.77 120.46 37.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.881 -0.785 . . . . 73.43 108.881 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 24.8 m-85 -120.87 140.86 51.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.403 -0.519 . . . . 75.44 110.298 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -143.09 127.19 17.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.185 -0.461 . . . . 45.54 110.49 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' A' ' 182' ' ' THR . 49.0 t -126.39 136.97 59.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.866 -0.42 . . . . 74.25 109.866 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.55 124.81 7.0 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.22 -0.514 . . . . 52.31 112.111 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.57 125.6 54.44 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.327 -0.62 . . . . 63.14 109.327 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -102.94 125.63 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.379 0.609 . . . . 74.51 111.255 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 19.7 p -131.19 164.92 24.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.076 -0.965 . . . . 71.2 108.41 171.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.41 -46.93 76.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.248 0.462 . . . . 63.14 112.248 -170.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -102.45 -22.79 14.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.691 -0.404 . . . . 74.05 111.778 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.556 ' HB2' ' OG1' ' A' ' 175' ' ' THR . 47.5 m-85 -113.51 135.82 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.101 0.477 . . . . 75.42 111.604 -172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -111.07 122.68 48.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.732 -1.21 . . . . 75.11 107.732 165.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.69 136.94 53.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.32 0.581 . . . . 62.42 111.174 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.531 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 13.3 t60 -126.68 113.72 17.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.227 -0.897 . . . . 72.04 109.061 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.718 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 7.3 t -93.66 141.45 28.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.329 -0.989 . . . . 73.21 108.329 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -133.6 140.1 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 72.41 109.991 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 41.5 t -126.87 120.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.065 -0.516 . . . . 64.3 111.013 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.2 t30 -99.32 90.0 4.4 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.6 0.714 . . . . 74.24 109.092 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 3.1 t70 55.73 -161.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.002 -1.454 . . . . 65.33 110.944 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.598 -0.81 . . . . 64.23 112.157 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.7 m -93.52 -25.56 17.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.627 0.603 . . . . 73.3 112.627 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 32.8 tt0 -134.49 124.42 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.601 -0.84 . . . . 65.14 112.364 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -121.18 126.2 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.188 -0.914 . . . . 71.2 108.545 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.24 -172.56 19.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.773 -1.204 . . . . 71.31 113.395 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.23 172.94 31.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.716 -0.554 . . . . 74.33 111.716 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 33.1 m -148.27 142.29 25.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.238 -0.282 . . . . 44.12 110.238 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.584 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 10.6 mm -119.52 118.82 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 73.11 109.4 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -108.24 120.98 43.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.417 -0.586 . . . . 63.14 109.417 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 199' ' ' ASN . 1.7 mm-40 -121.78 111.69 17.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.787 -0.642 . . . . 71.31 111.41 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.601 ' HD2' ' O ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -89.85 130.8 36.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.485 -0.931 . . . . 73.33 108.485 169.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 197' ' ' LYS . 10.3 m 58.95 36.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.923 0.868 . . . . 75.34 110.95 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 196' ' ' GLN . 14.5 t30 -52.54 -50.35 63.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.68 -1.145 . . . . 63.2 108.827 170.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 200' ' ' LYS . 13.6 tppt? -144.31 71.19 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.73 -1.123 . . . . 75.43 107.981 169.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 70.25 -41.74 0.5 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.005 -0.998 . . . . 54.21 112.427 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.806 HD12 ' H ' ' A' ' 226' ' ' GLN . 2.5 mm? -92.74 -161.05 0.8 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.925 0.393 . . . . 75.45 111.089 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 224' ' ' LYS . 45.3 mt-10 -111.82 153.33 26.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.527 -0.306 . . . . 74.34 110.565 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -147.68 143.84 27.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.495 -0.321 . . . . 74.41 110.279 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -134.61 136.76 43.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.83 0.347 . . . . 70.2 110.407 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 45.1 t -123.25 145.42 30.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.074 -0.512 . . . . 74.54 110.088 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -131.98 136.28 47.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.876 0.37 . . . . 72.51 110.481 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.32 140.98 51.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 63.42 109.629 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -140.5 128.91 22.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.966 0.412 . . . . 41.2 111.399 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -115.39 132.88 56.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.737 -0.838 . . . . 74.31 108.737 174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 12.3 t -116.5 132.54 56.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.801 -0.444 . . . . 71.25 109.801 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.04 150.37 25.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.765 . . . . 70.02 111.457 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.01 15.07 13.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.464 -0.874 . . . . 52.04 112.392 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.26 87.34 0.11 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.268 0.556 . . . . 70.32 111.328 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.0 t -146.49 171.95 14.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 52.11 109.862 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.76 159.63 23.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.736 -0.468 . . . . 71.32 109.736 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.4 m -77.29 135.79 38.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.745 0.307 . . . . 61.23 110.329 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 55.2 mtm180 -88.96 136.39 33.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.923 -0.399 . . . . 73.34 109.923 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.647 ' HB2' ' HB3' ' A' ' 239' ' ' ASN . 79.7 m-85 -114.52 138.96 49.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.658 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.49 139.67 10.21 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.612 -0.995 . . . . 73.4 110.612 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.5 ' HB ' HG12 ' A' ' 237' ' ' VAL . 5.0 mp -136.14 130.48 48.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.2 0.5 . . . . 61.23 110.504 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.1 129.41 50.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.796 -0.446 . . . . 64.33 109.796 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.25 139.71 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.601 0.239 . . . . 62.34 110.59 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 203' ' ' GLU . 43.9 mtmt -117.28 114.75 24.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.465 ' HA ' ' HG ' ' A' ' 202' ' ' LEU . 47.4 m-85 -100.76 115.34 30.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.211 -0.662 . . . . 62.25 109.211 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.806 ' H ' HD12 ' A' ' 202' ' ' LEU . 35.7 tt0 -86.7 99.62 11.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.161 -0.472 . . . . 72.25 110.029 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.82 -37.31 12.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.499 0.666 . . . . 72.52 109.685 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.74 145.52 19.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.106 -0.952 . . . . 74.42 109.18 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.51 -30.73 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.955 2.437 . . . . 75.12 113.454 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.46 -18.62 21.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.085 0.402 . . . . 73.1 112.085 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.71 122.75 20.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.237 0.541 . . . . 50.33 111.797 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 52.0 t -124.49 136.44 54.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.21 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -99.99 128.82 46.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.743 -0.466 . . . . 74.32 109.743 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.9 m -113.95 152.79 30.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.844 0.354 . . . . 63.32 110.503 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -140.66 141.21 35.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.357 -0.609 . . . . 73.15 109.357 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 54.9 mtmt -134.46 154.51 51.37 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.309 -0.256 . . . . 75.42 110.309 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.1 p -149.98 147.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.966 0.413 . . . . 64.45 110.663 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.7 t-20 -117.63 149.55 40.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.655 -0.868 . . . . 61.32 108.655 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . 0.1 OUTLIER -56.63 -17.61 9.28 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.88 0.696 . . . . 65.42 112.88 -172.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 49.2 m -83.22 23.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.455 0.169 . . . . 71.04 111.021 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 50.1 m 64.9 39.66 5.8 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.299 0.571 . . . . 73.12 110.449 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.94 ' HB3' HD11 ' A' ' 262' ' ' LEU . 46.1 mt -98.15 115.61 28.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.748 -0.66 . . . . 73.21 109.5 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.9 OUTLIER -105.34 117.62 51.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 109.841 -0.429 . . . . 72.13 109.841 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -120.4 162.12 14.45 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.825 -0.702 . . . . 73.41 112.723 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 2.6 pp -142.01 160.39 40.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.032 -0.358 . . . . 72.25 110.032 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -150.54 150.86 22.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.751 -0.738 . . . . 71.44 112.905 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 258' ' ' THR . 81.7 m-85 -123.16 115.96 22.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.561 -0.533 . . . . 63.22 109.561 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 20.0 m -113.0 114.0 26.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.739 -0.467 . . . . 74.0 109.739 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -135.45 127.62 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 65.52 110.548 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 32.1 m -88.53 128.55 35.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.551 0.215 . . . . 74.04 110.468 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.463 HD23 ' HG3' ' A' ' 252' ' ' LYS . 3.3 tt -122.24 88.92 3.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.215 -0.661 . . . . 74.35 109.215 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.463 ' HG3' HD23 ' A' ' 251' ' ' LEU . 94.1 mttt 68.99 166.06 0.13 Allowed Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 115.545 -0.752 . . . . 74.21 111.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.09 71.77 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.64 2.227 . . . . 61.21 112.351 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.32 -59.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.062 -0.589 . . . . 64.14 111.885 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 279' ' ' LEU . 0.0 OUTLIER -119.24 122.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 71.44 111.992 -171.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 1.062 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 66.4 mttm -92.28 135.45 34.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.209 -1.034 . . . . 53.32 108.209 163.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.82 123.41 41.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.25 -0.648 . . . . 74.31 109.25 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 48.6 m -122.47 111.12 16.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.454 0.645 . . . . 73.35 110.462 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.728 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -100.21 125.62 46.4 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.664 -1.235 . . . . 64.13 107.664 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 60.1 m -131.44 140.02 49.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 73.44 110.927 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.77 139.83 26.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.817 -0.438 . . . . 73.33 109.817 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.94 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -118.4 121.99 41.7 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.816 -0.809 . . . . 65.32 108.816 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.626 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -103.08 106.72 17.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.605 -0.887 . . . . 74.53 108.605 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.953 ' H ' HG21 ' A' ' 268' ' ' VAL . 5.3 t70 -72.92 98.0 2.39 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.318 -0.993 . . . . 62.15 108.318 172.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.45 -8.46 2.66 Favored Glycine 0 C--N 1.307 -1.076 0 CA-C-N 115.078 -0.965 . . . . 54.14 114.044 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.42 -15.83 25.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.444 0.164 . . . . 60.41 110.981 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -152.84 -28.63 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.657 0.741 . . . . 74.45 110.906 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.953 HG21 ' H ' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -54.12 -22.25 7.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.595 -1.184 . . . . 63.43 113.021 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -55.9 -20.57 16.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.666 -0.697 . . . . 53.34 111.459 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.56 -16.58 59.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 63.42 111.43 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.35 -0.53 14.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 65.14 113.168 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -93.09 63.93 2.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 72.33 112.3 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.545 ' HB2' ' CD1' ' A' ' 263' ' ' LEU . 4.0 p-80 -79.27 147.92 32.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.68 -0.118 . . . . 74.45 110.68 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -95.3 138.02 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.533 -0.467 . . . . 71.43 109.759 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -132.84 140.57 48.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 75.31 110.631 -170.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.54 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -142.07 131.53 4.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.549 -0.62 . . . . 73.14 111.549 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.728 HD23 HD22 ' A' ' 259' ' ' LEU . 3.4 tm? -115.75 137.57 51.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.967 -0.753 . . . . 72.4 108.967 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.423 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -150.96 140.51 7.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.075 -1.059 . . . . 72.4 113.144 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.504 HD12 HD11 ' A' ' 255' ' ' ILE . 2.4 mm? -110.85 129.98 55.71 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.625 -0.88 . . . . 75.34 108.625 172.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 1.062 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 21.7 mm-40 -101.84 112.04 24.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.312 1.053 . . . . 72.3 112.997 -168.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 1.013 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 34.4 p90 -29.21 44.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 119.971 3.323 . . . . 43.2 119.971 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.858 ' HG2' ' HG3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -113.9 104.91 12.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 122.424 2.375 . . . . 74.1 112.332 -175.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.62 106.26 8.61 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.554 -0.906 . . . . 75.02 108.554 163.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -155.12 -166.06 2.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.383 -0.826 . . . . 61.43 109.122 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.778 -0.63 . . . . 74.33 109.739 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.994 0.426 . . . . 74.01 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.737 HG11 ' HB2' ' A' ' 119' ' ' LYS . 7.9 t -80.31 119.67 77.13 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.67 -0.695 . . . . 74.22 109.678 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.68 162.34 42.43 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.902 2.401 . . . . 71.53 112.824 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.63 79.85 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.764 2.31 . . . . 74.33 111.003 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.554 ' HB ' ' CG1' ' A' ' 143' ' ' VAL . 26.7 p -69.84 -46.95 64.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.434 -0.803 . . . . 73.31 111.995 -172.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -58.37 -28.4 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.058 -0.519 . . . . 71.3 111.41 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.26 -22.99 35.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.094 0.473 . . . . 74.41 110.839 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.27 -15.66 45.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.843 -0.617 . . . . 71.23 109.737 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.61 HD21 HG13 ' A' ' 143' ' ' VAL . 75.1 mt -63.72 -29.23 70.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.65 -0.705 . . . . 55.33 110.263 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.49 62.96 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.73 -0.668 . . . . 42.33 112.263 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 64.0 tttp -63.87 -49.4 72.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 65.23 110.183 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 m -64.55 -38.32 90.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.296 0.569 . . . . 72.41 110.529 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.439 -0.801 . . . . 75.44 112.254 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.638 ' HG3' ' N ' ' A' ' 16' ' ' ASP . 1.7 ptt180 -59.7 -36.99 77.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.563 0.22 . . . . 71.2 111.171 -175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.638 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 69.7 m-20 -68.47 -37.0 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 72.11 110.677 -175.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -72.43 -40.42 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 70.15 110.809 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -70.71 -33.75 71.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.812 -0.631 . . . . 71.21 110.983 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 m -70.04 133.72 47.51 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.71 -0.478 . . . . 73.31 109.71 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -69.53 79.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.72 0.772 . . . . 64.1 111.632 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.98 70.42 2.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.28 -0.728 . . . . 55.35 111.28 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' A' ' 274' ' ' LYS . 17.7 p90 -85.04 -53.62 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.568 0.223 . . . . 72.43 110.884 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.56 129.39 4.17 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.661 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -104.33 5.64 34.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.297 0.57 . . . . 71.32 110.463 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 89.39 12.6 62.8 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.543 -1.023 . . . . 72.34 110.543 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 46' ' ' SER . 0.5 OUTLIER -102.78 153.5 20.1 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.943 -0.628 . . . . 62.54 111.423 -169.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.783 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.8 mp -106.9 124.46 62.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.002 -0.999 . . . . 71.33 110.545 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.8 tptm -102.06 119.47 38.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.484 -0.562 . . . . 65.41 109.484 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -113.84 128.63 56.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.005 0.431 . . . . 75.01 110.132 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -120.76 136.35 54.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.735 . . . . 71.22 109.066 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.909 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -133.39 123.84 26.07 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.197 -0.668 . . . . 62.32 109.197 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 14.3 pttm -137.08 125.58 23.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.203 0.525 . . . . 75.54 111.498 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.758 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 18.9 m -109.71 121.27 44.84 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.512 -0.922 . . . . 61.4 108.512 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -109.82 124.45 51.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.933 -0.307 . . . . 74.25 111.165 -170.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.82 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 12.2 t -140.41 169.66 17.26 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.277 -1.008 . . . . 45.24 108.277 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.21 179.83 4.25 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.091 -0.707 . . . . 72.42 109.091 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.59 43.63 7.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.14 0.495 . . . . 75.41 111.27 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 94.49 -4.84 70.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 116.984 1.554 . . . . 73.43 116.984 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.82 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -100.2 124.13 45.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 120.971 2.385 . . . . 73.21 112.141 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.893 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.9 tt0 -143.08 118.02 9.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.987 -0.746 . . . . 52.24 108.987 162.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 97.4 m-85 -108.34 121.78 45.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.546 -0.462 . . . . 73.55 110.473 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 33.0 m -125.19 132.65 52.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.104 0.478 . . . . 72.35 111.062 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.685 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 44.3 t -125.32 143.11 51.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.729 -0.841 . . . . 75.15 108.729 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m -135.67 126.55 27.56 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.04 -0.356 . . . . 51.22 110.04 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.452 ' HA2' ' HA2' ' A' ' 56' ' ' GLY . . . -141.78 157.13 26.21 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.171 -1.014 . . . . 65.4 112.47 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB3' HD21 ' A' ' 26' ' ' LEU . 39.8 m -131.82 139.27 48.81 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.978 -0.749 . . . . 73.42 108.978 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -119.46 129.08 54.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.224 0.535 . . . . 63.14 110.574 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.83 145.93 24.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.043 -0.98 . . . . 60.43 108.852 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.06 76.19 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.371 0.605 . . . . 54.55 111.457 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -167.22 154.14 8.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.915 -1.143 . . . . 73.14 107.915 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.7 m -56.22 -45.94 79.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.097 0.777 . . . . 74.23 113.097 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.3 p -129.29 47.31 2.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 72.13 112.496 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.33 73.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.384 0.612 . . . . 71.14 110.991 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.57 120.57 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.47 -0.787 . . . . 72.13 109.633 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -109.2 126.53 53.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.709 -0.478 . . . . 71.35 109.709 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HA2' ' A' ' 45' ' ' GLY . . . -132.74 170.72 21.94 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.343 -0.932 . . . . 74.2 113.07 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.5 m -147.56 157.66 43.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.421 -0.585 . . . . 74.54 109.421 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 58' ' ' LEU . 1.2 tm? -120.22 125.02 47.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 74.04 109.371 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.8 tt0 -118.82 119.25 33.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.582 -0.736 . . . . 61.42 109.504 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 m -110.23 120.02 41.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.431 -0.349 . . . . 73.34 110.527 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.893 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mptt -106.61 131.45 53.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.224 0.535 . . . . 64.13 110.359 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.5 m-85 -103.21 118.48 36.87 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.305 -1.369 . . . . 74.23 107.305 170.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.447 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 33.3 ttm-85 -113.46 109.69 19.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.424 0.631 . . . . 75.33 111.876 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.21 91.2 8.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.161 -0.927 . . . . 71.54 109.254 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -16.42 61.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.299 -0.864 . . . . 71.21 110.679 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.89 -41.31 87.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.193 -0.912 . . . . 74.41 111.031 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.489 ' HB2' ' HG ' ' A' ' 69' ' ' LEU . 67.6 m-85 -108.14 -33.94 7.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.33 111.186 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.624 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 101.95 44.44 1.91 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.947 -0.861 . . . . 53.41 110.947 -173.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 87' ' ' VAL . 13.4 mt -126.91 147.21 50.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.804 -0.443 . . . . 75.44 109.804 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -136.57 135.3 38.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.691 0.281 . . . . 75.53 111.13 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 70.1 t80 -115.17 120.73 40.72 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.429 -0.582 . . . . 74.25 109.429 173.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 17.7 m -109.57 117.74 34.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.236 -0.438 . . . . 52.33 110.305 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 42.8 tt0 -109.15 120.34 42.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.355 -0.609 . . . . 72.31 109.355 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -107.81 97.6 7.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.095 -0.502 . . . . 71.0 109.7 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.585 ' HD1' HD13 ' A' ' 81' ' ' LEU . 46.4 t90 -100.35 131.84 46.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.345 0.593 . . . . 71.52 111.279 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.38 154.11 35.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.521 -0.763 . . . . 43.23 109.861 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 m -57.6 -18.4 19.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.016 0.436 . . . . 61.12 111.9 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 20.2 t70 -67.57 -3.86 10.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.095 -0.502 . . . . 73.44 110.906 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 77.6 m-20 79.66 22.84 0.51 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.876 0.87 . . . . 70.11 110.02 -175.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 25.7 m -88.83 118.14 28.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.54 -0.754 . . . . 61.31 111.015 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.585 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.8 mm? -97.19 118.37 33.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 63.41 109.213 172.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.68 92.83 0.85 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.512 -0.851 . . . . 43.24 111.21 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 p -91.39 103.5 16.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.986 0.422 . . . . 73.21 111.414 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 25.4 tt0 -106.73 111.63 24.25 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.456 -0.793 . . . . 70.25 109.565 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.9 121.52 64.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.437 -0.579 . . . . 74.34 109.437 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 98' ' ' THR . 14.3 t -128.2 129.66 46.81 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.54 0.686 . . . . 73.22 111.537 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.678 ' HA ' HD22 ' A' ' 69' ' ' LEU . 32.5 m -111.01 129.89 65.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.417 -0.81 . . . . 74.24 109.631 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.28 118.71 36.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 71.11 112.131 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 47.27 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.319 1.012 . . . . 73.24 112.804 171.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.511 ' HB2' ' H ' ' A' ' 91' ' ' LEU . 1.5 mp0 -116.97 -92.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.317 -0.401 . . . . 74.34 110.09 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.511 ' H ' ' HB2' ' A' ' 90' ' ' GLN . 8.1 mp -95.2 -44.72 7.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.982 -0.747 . . . . 71.51 108.982 175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.65 103.71 5.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 63.05 109.376 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.83 124.26 21.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.693 -0.685 . . . . 74.3 110.756 -173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.77 5.73 87.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.869 -0.681 . . . . 61.35 113.085 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 128.16 38.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.238 0.519 . . . . 71.32 111.638 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -118.28 111.39 18.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.61 -0.885 . . . . 64.21 108.61 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.633 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.2 mm? -102.52 124.78 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.514 -0.551 . . . . 54.51 109.514 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 7.8 m -131.21 119.69 22.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.54 -0.3 . . . . 71.04 111.015 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 72.5 t80 -111.2 115.32 29.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.473 -0.566 . . . . 72.13 109.473 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -112.02 122.63 48.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.189 -0.459 . . . . 62.4 109.775 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.4 t -138.16 123.83 19.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.43 -0.508 . . . . 71.54 111.004 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 13.0 m -104.17 122.69 45.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.064 -0.516 . . . . 51.31 110.264 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.81 124.87 48.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.556 -0.293 . . . . 64.25 110.786 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.9 t -127.6 102.42 22.97 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.437 -0.579 . . . . 54.01 109.437 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.23 -9.13 22.93 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.074 2.516 . . . . 74.15 112.755 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -78.52 -40.12 36.1 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.034 -0.358 . . . . 64.22 110.034 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 p -100.22 -25.61 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 73.0 111.171 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.936 -0.575 . . . . 74.23 111.897 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -79.12 123.93 27.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 71.42 111.275 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -132.66 124.63 28.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.934 -0.575 . . . . 73.43 109.495 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 101' ' ' SER . 7.4 m120 -120.45 128.37 53.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.825 -0.625 . . . . 65.12 110.353 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -114.07 114.79 26.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.259 -0.428 . . . . 64.11 110.366 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -111.13 136.95 49.43 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.158 -0.682 . . . . 74.13 109.158 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -119.47 117.62 54.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 72.03 109.833 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.2 tttp -115.26 119.13 35.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.495 -0.775 . . . . 72.44 109.285 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -127.2 118.59 24.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.679 -0.489 . . . . 63.13 109.679 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -127.13 122.84 4.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.333 -0.937 . . . . 63.53 112.577 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -110.0 121.03 44.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.375 0.607 . . . . 74.24 109.501 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.737 ' HB2' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.6 124.23 51.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.649 -0.705 . . . . 64.11 110.673 179.231 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 120' ' ' ARG . 10.0 tpp180 -104.96 167.68 9.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.559 -1.274 . . . . 75.41 107.559 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 120' ' ' ARG . 37.7 tt0 -53.16 -33.33 52.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.475 0.546 . . . . 63.15 112.475 -167.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -120.25 0.32 10.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.801 0.667 . . . . 71.41 112.801 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.926 HG13 HD21 ' A' ' 142' ' ' LEU . 7.7 tt -145.25 136.01 19.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 O-C-N 121.74 -0.6 . . . . 74.14 111.985 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.774 ' O ' HD23 ' A' ' 142' ' ' LEU . 5.4 t30 -129.19 109.84 11.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.088 -0.645 . . . . 62.45 111.308 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.049 ' HG ' ' HG ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -112.89 142.48 45.51 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.449 0.642 . . . . 64.52 111.719 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -143.33 127.06 2.97 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.78 -1.1 . . . . 51.42 112.737 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.22 111.85 24.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.952 -0.388 . . . . 73.32 109.952 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -113.52 118.23 33.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.495 -0.557 . . . . 73.0 109.495 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.635 ' HG2' HG13 ' A' ' 138' ' ' ILE . 59.3 mtt -120.94 119.37 32.39 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.747 -0.381 . . . . 53.43 111.391 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 15.3 m-20 -90.65 118.39 30.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 109.811 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 74.3 t80 -96.87 104.55 16.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.966 0.412 . . . . 65.22 110.014 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.26 157.27 30.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.865 -0.607 . . . . 70.31 109.717 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.2 pp -73.85 -15.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.209 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.441 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -88.88 -17.59 29.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.013 0.435 . . . . 74.14 110.714 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.44 117.54 0.67 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.926 -0.654 . . . . 73.12 112.08 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 56.1 Cg_endo -72.01 134.36 23.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.463 2.109 . . . . 72.0 111.781 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -119.37 144.14 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.458 -0.337 . . . . 75.41 110.397 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -107.29 117.12 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.459 -0.571 . . . . 75.44 109.459 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -114.63 113.85 24.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.745 -0.661 . . . . 74.5 109.532 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.71 129.57 9.35 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.375 -1.393 . . . . 71.14 111.365 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . . . -124.7 118.72 27.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.651 0.263 . . . . 65.03 110.704 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.049 ' HG ' ' HG ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -117.08 144.76 44.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.332 -0.394 . . . . 55.45 110.624 175.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.628 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 45.4 t -128.5 115.43 37.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.52 -1.289 . . . . 74.32 107.52 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -120.93 137.27 54.69 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.547 -1.206 . . . . 74.14 110.117 -169.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.54 135.7 13.06 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 120.604 -0.808 . . . . 50.12 113.2 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -143.8 125.36 14.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.011 0.434 . . . . 73.31 111.4 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 59.22 23.35 11.68 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.987 0.736 . . . . 64.22 112.987 168.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.69 -18.18 51.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.378 -0.915 . . . . 63.41 113.062 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -105.17 146.65 28.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.891 -0.411 . . . . 72.11 109.891 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.541 HD22 HG12 ' A' ' 143' ' ' VAL . 5.0 mt -108.9 148.39 30.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 72.11 110.637 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 144' ' ' LEU . . . -141.85 124.26 15.72 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.73 -1.211 . . . . 54.44 107.73 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -156.05 131.82 3.15 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.58 -0.819 . . . . 74.23 111.965 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.983 ' CB ' ' HA ' ' A' ' 169' ' ' PHE 0.423 0.1 OUTLIER -165.06 171.76 13.48 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 116.209 1.929 . . . . 74.11 116.209 167.326 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 26.4 pt20 -106.85 134.37 50.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.416 -1.72 . . . . 64.35 111.498 -166.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.8 ttp -110.84 141.53 44.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 51.34 109.576 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.53 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 43.4 m-80 -114.51 117.92 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.024 -0.27 . . . . 71.02 110.351 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.851 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 74.1 t80 -102.08 122.27 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.684 -0.689 . . . . 74.12 110.759 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 163' ' ' ARG . 32.4 tt0 -88.78 99.93 12.75 Favored 'General case' 0 C--O 1.259 1.574 0 CA-C-N 115.567 -0.742 . . . . 64.45 109.044 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.46 HG23 ' HE1' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -70.29 -19.98 63.06 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 113.446 -1.706 . . . . 71.12 111.664 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.18 -26.65 64.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.047 0.927 . . . . 62.13 108.732 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -122.39 -157.5 0.74 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.136 -1.393 . . . . 70.43 107.839 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -107.64 27.76 8.84 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.32 -0.622 . . . . 52.53 109.32 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -133.64 129.36 36.77 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.64 -0.824 . . . . 62.51 112.857 -159.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.851 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.8 m -73.54 136.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 168.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 2.0 m -90.01 -34.53 15.94 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.518 -0.473 . . . . 63.54 110.371 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -149.89 133.29 16.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 73.33 110.017 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.7 m -103.14 111.76 24.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.557 -0.905 . . . . 62.5 108.557 172.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.932 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 46.5 m-20 -106.4 121.67 44.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.863 -0.791 . . . . 73.22 108.863 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.983 ' HA ' ' CB ' ' A' ' 153' ' ' TYR . 51.4 p90 -131.17 138.94 49.65 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.057 0.848 . . . . 74.12 111.31 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.779 ' H ' ' HB2' ' A' ' 153' ' ' TYR . . . -130.25 145.84 51.8 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 120.883 0.373 . . . . 71.41 110.547 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 151' ' ' ALA . 48.8 t -127.56 131.28 70.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.276 -0.42 . . . . 75.14 110.635 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.3 95.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.655 -0.978 . . . . 72.3 110.655 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -110.92 119.62 39.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.853 -0.795 . . . . 72.25 108.853 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 34.0 mtmm -114.84 127.92 56.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.331 -0.395 . . . . 73.13 111.46 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 56.7 m -132.09 113.44 13.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.137 -0.483 . . . . 75.01 110.347 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 40.4 -93.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.266 1.21 . . . . 75.51 114.266 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.1 -11.85 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.672 0.619 . . . . 74.3 112.672 -170.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 175' ' ' THR . 48.4 p90 -129.97 135.94 48.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.622 0.725 . . . . 74.5 111.615 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.405 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 75.8 mt-30 -114.46 123.18 48.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.231 -0.895 . . . . 63.42 108.924 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.24 137.55 33.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.281 0.562 . . . . 64.02 111.081 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -123.8 115.67 21.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.052 -0.976 . . . . 74.13 108.689 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 43.8 m -124.54 115.46 20.9 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.658 -0.417 . . . . 74.25 110.086 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.43 140.62 50.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.371 0.605 . . . . 71.44 109.852 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 6.4 t -126.31 130.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.521 -0.763 . . . . 73.14 110.757 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.852 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 11.9 m-20 -105.51 93.69 4.8 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.383 -0.969 . . . . 70.43 108.383 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.0 t70 61.47 -179.53 0.12 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.633 -0.506 . . . . 74.41 109.633 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.48 -6.35 61.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.795 -0.717 . . . . 50.32 112.174 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.8 p -96.4 -26.17 15.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.055 0.761 . . . . 65.23 113.055 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.852 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 24.8 mt-10 -118.45 124.99 48.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 119.697 -0.801 . . . . 63.03 112.23 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.8 125.52 53.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.398 -0.819 . . . . 75.52 109.745 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.18 113.52 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.899 -0.667 . . . . 73.32 112.089 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.99 139.28 15.02 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.934 -0.65 . . . . 64.44 111.883 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 14.5 m -140.52 138.39 34.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.914 0.388 . . . . 62.41 110.03 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.3 mp -124.56 128.33 73.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.666 -0.494 . . . . 62.52 109.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 42.9 t80 -106.67 119.75 40.14 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.622 -0.881 . . . . 75.3 108.622 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -122.51 131.1 53.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.414 -0.587 . . . . 74.54 109.414 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 197' ' ' LYS . 24.9 ttpp -103.29 109.05 20.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.786 -0.643 . . . . 73.34 109.678 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 202' ' ' LEU . 0.0 OUTLIER -93.2 -17.36 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-O 121.555 0.693 . . . . 75.02 109.82 -176.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 14.2 t-20 -163.86 158.17 19.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.917 -1.038 . . . . 72.13 108.324 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -63.67 -13.24 41.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.014 0.435 . . . . 50.13 111.071 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 226' ' ' GLN . 19.0 tttp -116.05 3.98 13.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.001 -0.545 . . . . 54.41 110.642 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.541 ' HG ' HG23 ' A' ' 198' ' ' VAL . 47.8 tp -140.29 108.98 5.92 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.766 0.793 . . . . 62.22 111.307 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.554 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 24.7 mt-10 -115.32 137.84 51.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.953 -1.021 . . . . 63.31 110.192 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 p -123.68 151.17 43.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.122 -0.325 . . . . 71.41 110.122 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -140.11 139.03 35.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.015 0.436 . . . . 73.14 111.306 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 193' ' ' SER . 53.3 t -112.11 137.43 44.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.313 -0.625 . . . . 51.01 109.313 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -132.84 128.34 36.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.263 -0.643 . . . . 65.23 109.263 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.6 pt? -147.89 130.61 16.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.412 0.625 . . . . 74.44 111.082 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.2 132.87 55.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.33 -0.85 . . . . 75.2 110.363 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.779 ' HB2' HG23 ' A' ' 217' ' ' THR . 19.3 t90 -130.7 131.7 44.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.569 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 11.9 m -104.7 113.49 27.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.763 -0.653 . . . . 65.54 109.649 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.81 127.54 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.903 -0.406 . . . . 42.33 109.903 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.93 17.65 57.54 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 31.31 111.537 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 12.0 t-20 -129.93 -153.86 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.772 -0.825 . . . . 64.43 108.772 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 214' ' ' ASN . 17.2 m -85.95 -154.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.066 0.46 . . . . 71.44 111.747 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.72 163.47 7.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.497 -0.774 . . . . 72.1 112.553 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.779 HG23 ' HB2' ' A' ' 210' ' ' TRP . 32.7 m -76.39 134.55 39.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.605 -0.725 . . . . 63.0 109.18 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 69.3 mtt85 -101.05 116.12 32.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.723 -0.473 . . . . 71.44 109.723 -173.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.489 ' HD2' HD13 ' A' ' 208' ' ' LEU . 65.8 t80 -113.5 149.67 34.01 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.608 0.568 . . . . 74.04 110.493 -172.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -158.93 150.6 21.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.211 -0.519 . . . . 23.04 112.2 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.4 130.53 72.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.902 -0.407 . . . . 71.14 109.902 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -119.5 154.52 33.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.811 0.339 . . . . 54.23 110.303 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.67 125.71 18.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.174 -0.467 . . . . 42.1 110.23 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -112.38 114.06 26.58 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.62 -0.511 . . . . 73.55 109.62 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.45 ' HD2' HD13 ' A' ' 202' ' ' LEU . 74.8 t80 -113.73 116.29 29.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.448 -0.575 . . . . 74.12 109.448 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 3.6 pt20 -95.94 99.58 11.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.716 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.4 tt -69.44 -24.92 28.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.527 0.68 . . . . 60.44 109.521 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 230' ' ' ASP . 18.9 t70 -166.6 146.31 4.93 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.199 -1.037 . . . . 75.01 108.199 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 228' ' ' ASP . 27.8 Cg_exo -64.1 12.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.793 2.329 . . . . 73.4 113.399 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 228' ' ' ASP . 23.3 t70 -104.92 -29.34 10.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.44 110.067 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.33 125.86 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 73.13 110.831 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 56.1 m -124.04 142.23 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.129 0.49 . . . . 73.43 110.755 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -108.86 127.33 53.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.213 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 5.5 p -129.39 117.21 20.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 53.42 110.965 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.43 158.67 23.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.111 -0.329 . . . . 75.12 110.111 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 26.2 pttm -152.94 141.86 21.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.019 0.438 . . . . 70.33 110.849 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.8 p -128.66 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 71.41 109.814 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.8 m120 -107.91 150.56 26.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.752 -0.462 . . . . 73.02 109.752 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.73 -8.79 16.13 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.672 0.607 . . . . 75.34 111.534 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.468 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 13.3 m -80.82 14.67 2.07 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.824 -0.436 . . . . 75.54 109.824 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 17.4 m 68.31 36.83 2.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.256 -0.883 . . . . 62.23 110.702 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 262' ' ' LEU . 40.5 mt -99.29 115.61 29.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 63.43 109.697 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.645 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -112.29 116.7 53.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.65 -0.42 . . . . 63.33 110.503 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -135.61 152.21 20.87 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.123 -1.036 . . . . 74.21 113.526 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -127.96 156.12 43.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 71.33 110.737 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -143.42 143.59 12.59 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.993 -0.622 . . . . 74.32 112.157 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 258' ' ' THR . 63.8 m-85 -114.47 115.6 27.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.784 -0.451 . . . . 72.44 109.784 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 17.9 m -109.91 114.38 27.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.504 -0.554 . . . . 75.01 109.504 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -135.53 143.18 45.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.757 0.313 . . . . 62.22 110.801 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.8 t -107.54 116.18 31.49 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.051 -0.722 . . . . 60.44 109.051 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.512 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 3.8 mm? -70.34 173.57 6.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.861 -0.609 . . . . 63.23 110.518 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.614 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 20.8 mtpp -67.63 -44.97 45.56 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.25 -0.432 . . . . 75.3 110.852 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 16.8 Cg_exo -70.37 -174.49 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.887 1.725 . . . . 40.45 111.025 165.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -81.35 69.6 3.25 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.701 -0.762 . . . . 53.22 112.393 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.493 HG12 ' CD2' ' A' ' 281' ' ' PHE . 37.6 mt -136.81 124.78 33.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 122.652 -0.322 . . . . 54.41 111.02 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 280' ' ' GLU . 51.3 mttp -109.99 113.37 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.273 -0.64 . . . . 41.12 109.273 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.91 130.57 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.264 -0.426 . . . . 71.15 110.665 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 25.3 m -125.17 111.43 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 74.2 110.147 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.92 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -105.03 125.39 50.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.022 -1.103 . . . . 62.44 108.022 176.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 53.2 m -134.17 140.8 46.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.972 0.415 . . . . 70.55 111.406 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.67 128.01 19.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.92 -0.582 . . . . 61.3 109.648 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 242' ' ' LEU . 3.0 tm? -110.03 113.35 25.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.932 -0.766 . . . . 63.55 108.932 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.592 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.089 -1.078 . . . . 65.33 108.089 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.563 ' HA ' HD22 ' A' ' 242' ' ' LEU . 10.7 t70 -72.49 103.61 3.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.242 -0.89 . . . . 75.11 108.937 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.6 38.24 Favored Glycine 0 N--CA 1.458 0.118 0 O-C-N 123.395 0.434 . . . . 64.22 113.617 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -91.03 -26.99 18.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.568 0.223 . . . . 72.11 111.304 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.442 ' ND2' ' HA3' ' A' ' 272' ' ' GLY . 64.1 t30 -115.19 -22.83 9.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.813 0.671 . . . . 72.21 112.813 -171.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.531 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 29.4 m -62.17 -18.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.977 -0.452 . . . . 63.51 111.499 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -58.46 -39.73 80.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.123 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.51 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 41.3 110.862 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.57 89.29 1.69 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.826 -0.702 . . . . 41.14 111.673 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.531 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -157.92 38.83 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.812 -0.708 . . . . 52.21 112.137 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -80.05 145.7 32.33 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.221 -0.288 . . . . 74.3 110.221 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.723 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.3 mptt -96.72 138.07 34.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.173 -0.677 . . . . 74.22 109.173 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.453 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 tm? -125.93 131.14 52.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.961 -0.385 . . . . 54.44 109.961 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.437 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -137.08 125.21 3.31 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.473 -0.87 . . . . 40.3 112.092 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.92 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -114.96 138.1 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.771 -0.825 . . . . 73.42 108.771 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -158.18 122.21 1.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.349 -0.929 . . . . 74.45 111.13 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.477 HD13 HD11 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -144.91 138.87 27.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.015 0.436 . . . . 72.32 112.04 -175.077 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.558 ' CG ' ' HB2' ' A' ' 256' ' ' LYS . 6.8 pt-20 -110.71 120.66 43.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 62.35 110.502 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.909 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.7 t80 -98.78 118.7 36.1 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.991 -0.744 . . . . 75.33 108.991 175.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 4.1 pt20 -111.65 111.67 22.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.456 0.646 . . . . 71.42 110.447 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.65 111.59 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 73.11 109.592 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.99 135.91 53.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.942 -0.572 . . . . 63.41 109.771 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.106 -0.473 . . . . 61.32 110.757 -179.659 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.072 0.463 . . . . 44.53 111.917 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 15.9 t -68.16 125.63 91.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.222 -0.899 . . . . 73.41 111.369 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 28.3 Cg_exo -63.65 165.01 19.27 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.383 2.722 . . . . 65.42 112.565 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.84 71.33 4.15 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.204 2.603 . . . . 71.4 112.407 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.803 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.4 p -70.36 -48.84 54.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 74.41 111.606 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' HB2' HG21 ' A' ' 143' ' ' VAL . 70.9 t80 -60.84 -26.08 67.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.901 -0.59 . . . . 54.53 110.866 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -82.08 -10.76 59.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 54.43 111.351 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.31 -22.3 19.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.01 0.433 . . . . 74.12 111.136 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.99 -35.34 71.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.716 0.636 . . . . 72.32 112.716 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.53 15.65 8.56 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 119.917 -1.135 . . . . 53.21 114.114 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 8' ' ' ALA . 33.5 mmtm -63.98 -54.77 29.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.347 0.574 . . . . 74.24 111.713 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -63.36 -38.72 92.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 65.34 110.949 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.13 68.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 65.04 111.825 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -69.05 -35.72 76.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 64.0 111.297 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.11 -45.26 81.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.905 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.36 -25.34 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.461 . . . . 44.23 110.991 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -59.87 -39.82 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 74.43 110.806 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -89.34 36.16 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.295 0.569 . . . . 51.44 110.282 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -52.47 114.48 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.27 -0.877 . . . . 74.02 111.84 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.74 96.97 1.45 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.651 -0.704 . . . . 72.42 112.362 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -133.0 -166.49 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.475 -0.565 . . . . 72.42 109.475 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.13 89.08 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.701 -0.761 . . . . 62.42 111.731 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -100.26 -3.77 30.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.492 . . . . 74.03 110.076 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.59 61.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.977 -0.63 . . . . 71.22 113.07 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.739 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 3.5 pp -147.8 179.76 7.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 113.459 0.911 . . . . 61.24 113.459 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 277' ' ' LEU . 28.7 mm -100.91 122.93 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.876 -1.511 . . . . 63.44 109.061 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.4 ttmm -120.76 121.25 37.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 72.13 110.517 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.6 tt -113.59 142.05 46.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.563 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -135.46 128.37 31.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.381 -0.827 . . . . 52.32 109.466 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 18.3 tp -122.07 123.73 42.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 74.1 110.551 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 63.9 mttp -108.14 125.07 51.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.69 . . . . 55.53 109.406 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.772 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 39.4 m -128.45 121.82 29.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.589 0.233 . . . . 71.33 110.988 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 53.2 mtmt -137.39 123.74 20.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 70.04 110.531 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.603 ' H ' HD11 ' A' ' 39' ' ' LEU . 50.4 m -143.09 155.8 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 55.05 109.855 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 49.53 -131.28 1.86 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.593 0.558 . . . . 73.13 111.589 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.23 134.91 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.519 0.676 . . . . 63.4 111.493 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 93.15 -11.46 71.84 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.044 -0.98 . . . . 70.4 114.449 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.603 HD11 ' H ' ' A' ' 35' ' ' SER . 3.4 pp -103.96 133.86 48.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 118.646 1.223 . . . . 63.32 111.985 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.921 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 39.8 tt0 -138.5 128.71 25.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.886 . . . . 71.12 108.609 161.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.772 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 84.1 m-85 -118.28 121.73 41.16 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.877 -0.515 . . . . 45.5 110.828 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.957 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 21.2 m -117.11 115.81 26.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 71.42 109.814 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 27.5 t -112.65 123.67 50.82 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.358 . . . . 71.44 110.035 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 51.1 m -119.43 125.95 50.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.119 0.485 . . . . 72.31 110.312 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.5 117.48 2.26 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.613 -0.803 . . . . 75.34 111.475 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.6 m -112.67 133.94 54.45 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.733 -0.387 . . . . 44.34 109.983 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -135.55 126.66 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.44 -0.578 . . . . 72.31 109.44 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.739 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 7.4 t-20 -78.28 134.89 37.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.396 -173.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -96.36 -19.31 19.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.092 0.472 . . . . 61.21 110.97 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.91 -53.79 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.283 0.563 . . . . 51.41 109.751 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.563 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 35.1 m -122.2 105.6 10.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.226 -0.657 . . . . 53.44 109.226 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -52.6 102.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.937 0.718 . . . . 62.21 112.937 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -154.76 135.67 13.73 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.025 -1.102 . . . . 72.41 108.025 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.26 132.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.01 0.434 . . . . 54.25 111.222 -174.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -123.97 126.15 45.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 75.24 110.096 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.25 135.24 12.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.843 -0.694 . . . . 60.41 112.565 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 16.9 m -125.65 125.92 43.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.623 -0.88 . . . . 64.12 108.623 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.96 124.51 45.08 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.685 -0.487 . . . . 51.05 109.685 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.957 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 41.7 tt0 -106.77 117.87 35.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.155 0.502 . . . . 71.02 109.77 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 15.6 m -93.27 119.31 32.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.043 -1.095 . . . . 75.11 108.043 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.921 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.8 tptm -122.85 138.01 54.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.142 0.496 . . . . 74.22 109.763 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.763 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 86.5 m-85 -116.69 120.76 39.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.864 -0.791 . . . . 75.31 108.864 172.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.49 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.0 ptm85 -115.73 105.86 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.124 -0.63 . . . . 53.21 110.586 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.875 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 76.0 t90 -112.43 106.06 14.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 64.2 110.088 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 m 66.46 153.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.58 1.175 . . . . 75.43 111.273 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -64.04 102.82 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.27 -0.423 . . . . 75.13 109.927 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 t80 63.73 81.47 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 72.41 110.875 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.47 -75.09 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.369 -1.092 . . . . 44.21 110.369 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 2.0 mm? -113.09 131.42 55.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.854 0.359 . . . . 71.21 110.794 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' HB ' ' A' ' 86' ' ' THR . 6.3 p -135.19 112.66 10.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.716 . . . . 62.11 110.337 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.763 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 21.7 t80 -109.68 121.34 44.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.503 -0.554 . . . . 75.4 109.503 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 m -116.69 127.71 54.66 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.2 0.313 . . . . 74.32 110.753 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 28.1 tt0 -130.66 121.29 25.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.511 -0.551 . . . . 65.34 109.511 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -111.22 97.83 7.06 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.037 -0.727 . . . . 73.05 109.037 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.93 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 41.5 t90 -108.8 129.71 55.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.176 -0.466 . . . . 63.33 111.466 -174.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -105.95 139.28 40.74 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.981 -0.748 . . . . 72.05 108.981 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -60.05 -36.67 77.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.639 0.607 . . . . 43.11 112.639 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -111.07 -23.82 10.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 64.11 112.066 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.573 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 66.6 t30 -104.0 -106.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.265 -0.574 . . . . 75.04 112.427 -169.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 p -116.43 144.64 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.765 0.654 . . . . 75.55 112.765 -170.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.93 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -111.69 123.28 49.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.718 -0.475 . . . . 65.02 109.718 166.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.41 121.99 5.23 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.597 -0.729 . . . . 40.32 111.487 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 101' ' ' SER . 23.2 m -109.11 142.91 39.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.828 0.346 . . . . 62.32 111.059 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.54 113.73 7.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.808 -0.633 . . . . 54.01 109.406 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -112.27 136.41 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.801 -0.444 . . . . 71.44 109.801 179.03 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.403 ' HB ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m -128.54 124.03 34.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 61.05 110.292 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 2.7 p -125.83 120.54 57.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.38 0.61 . . . . 61.4 111.051 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.26 118.54 35.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.157 -1.423 . . . . 65.2 107.157 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 11.6 t70 -55.91 133.35 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.515 -0.474 . . . . 73.23 110.681 -173.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.499 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 19.7 pt20 -68.95 -25.35 64.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 64.33 111.75 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 85.6 mt -108.83 -52.2 2.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.128 0.49 . . . . 53.02 109.908 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.13 10.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 51.12 110.235 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 89' ' ' ASP . 36.3 mmt180 -59.72 135.14 57.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 73.32 109.899 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA2' ' HG3' ' A' ' 119' ' ' LYS . . . 102.49 7.18 46.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.633 -0.794 . . . . 74.43 111.492 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.48 114.75 22.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.629 -0.878 . . . . 75.23 108.629 173.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -122.49 111.8 17.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.934 -0.575 . . . . 61.52 110.705 -174.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.513 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.8 mm? -97.55 130.85 44.57 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.819 -0.808 . . . . 70.44 108.819 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -130.46 133.7 46.51 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.32 -0.4 . . . . 54.52 110.986 -177.242 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.56 ' H ' HG13 ' A' ' 85' ' ' ILE . 76.8 t80 -124.52 129.62 50.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.396 -0.366 . . . . 73.31 110.232 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 113' ' ' LYS . 6.3 m-20 -115.83 133.81 55.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.132 -0.485 . . . . 72.42 109.891 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.705 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 30.1 t -130.21 137.29 49.99 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.949 -0.389 . . . . 72.32 109.949 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -135.06 121.63 20.65 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.976 -0.379 . . . . 73.22 109.976 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' HD1' HD21 ' A' ' 81' ' ' LEU . 75.4 t80 -134.52 137.14 43.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 61.11 110.608 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 5.1 m -114.29 103.74 54.93 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.944 -0.571 . . . . 75.31 110.017 176.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 32.8 Cg_endo -65.46 152.14 82.82 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.533 2.155 . . . . 73.45 111.477 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.61 25.34 14.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.666 0.746 . . . . 73.13 109.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 m -140.3 -55.12 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.757 -0.656 . . . . 74.51 110.341 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.9 4.1 57.9 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 61.53 112.714 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -87.91 122.75 31.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.311 -0.625 . . . . 71.42 109.311 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 21.6 ptmt -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.101 0.477 . . . . 75.25 110.714 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -121.6 122.64 40.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.427 -0.806 . . . . 75.41 109.559 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 114.77 29.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.052 -0.522 . . . . 73.33 109.621 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.87 ' HG3' ' HB3' ' A' ' 130' ' ' ASP . 28.1 ttmt -118.38 135.4 54.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.234 0.54 . . . . 52.11 110.665 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.853 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 4.2 tp -129.99 132.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 107.739 -1.208 . . . . 73.44 107.739 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 16.6 ttpt -132.28 119.16 20.4 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 124.987 1.43 . . . . 64.4 110.662 -169.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.912 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 69.9 m -116.99 120.02 37.09 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 119.313 0.96 . . . . 60.25 111.251 -175.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.791 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -131.5 138.93 10.53 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.647 -1.263 . . . . 73.54 113.172 -174.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -115.27 130.65 56.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.435 -0.95 . . . . 75.14 108.435 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -110.58 122.29 47.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.616 0.722 . . . . 75.14 111.039 -175.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -105.65 153.17 22.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.358 -1.292 . . . . 64.54 107.825 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.44 -29.97 51.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.239 0.459 . . . . 74.04 112.239 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -108.95 -17.1 14.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.509 -0.314 . . . . 64.53 111.394 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -144.87 124.66 6.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.043 0.386 . . . . 74.54 112.043 -170.403 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.943 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 3.6 m-20 -112.79 116.66 30.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.197 -0.314 . . . . 74.44 110.523 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 142' ' ' LEU . 3.0 mm? -119.48 124.45 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.54 0.21 . . . . 73.4 111.04 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.791 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -136.57 114.16 1.13 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.943 -1.123 . . . . 51.44 113.029 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.1 t -116.97 122.98 45.81 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.941 -0.392 . . . . 50.34 109.941 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.912 ' HB2' ' H ' ' A' ' 116' ' ' THR 0.319 0.9 OUTLIER -154.15 169.91 22.47 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.659 -1.276 . . . . 75.22 112.924 159.588 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.0 mtt -101.79 140.09 36.54 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.781 0.324 . . . . 73.41 111.115 -162.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.87 ' HB3' ' HG3' ' A' ' 113' ' ' LYS . 9.9 p-10 -119.54 125.8 49.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 74.12 111.022 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.23 96.55 9.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.606 -0.516 . . . . 73.24 109.606 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.529 ' OD2' HG13 ' A' ' 133' ' ' ILE . 7.8 t70 -99.73 -165.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.789 -0.819 . . . . 73.44 108.789 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.529 HG13 ' OD2' ' A' ' 132' ' ' ASP . 2.9 pp -72.94 -13.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 70.32 110.421 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.62 4.69 52.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 73.53 110.569 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.47 -155.13 20.86 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.05 -0.595 . . . . 74.44 111.925 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.57 96.55 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.023 2.482 . . . . 51.41 112.094 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.438 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 16.0 m -92.96 162.89 13.88 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.992 -0.549 . . . . 55.45 109.636 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 36.2 mm -107.99 117.48 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.931 -0.396 . . . . 72.03 109.931 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.7 tpt180 -106.0 111.34 23.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.34 0.59 . . . . 75.22 110.338 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.16 10.09 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.987 -1.101 . . . . 75.22 111.524 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.25 116.84 23.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.974 0.416 . . . . 51.04 110.402 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -117.18 125.36 51.08 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.577 . . . . 75.24 110.637 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.943 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 77.4 t -117.45 133.89 62.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.11 0.481 . . . . 63.32 110.277 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -108.42 138.38 44.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.791 -0.818 . . . . 64.23 108.791 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.08 118.24 2.37 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.51 -0.852 . . . . 25.33 113.146 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 75.9 t80 -145.0 148.99 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.066 -0.346 . . . . 75.24 110.066 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -45.01 105.52 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.986 0.422 . . . . 74.32 111.866 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.13 -31.38 6.02 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.81 -0.632 . . . . 71.12 112.726 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 72.3 m95 -104.84 120.93 42.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 74.44 111.118 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.803 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -124.58 136.91 54.35 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.628 -1.249 . . . . 72.14 107.628 173.074 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HB3' HD23 ' A' ' 144' ' ' LEU . . . -143.1 160.79 39.74 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.628 -0.429 . . . . 72.05 110.877 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.58 137.2 5.46 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.833 -0.621 . . . . 60.53 111.566 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -143.83 118.35 9.73 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 122.539 -0.389 . . . . 75.31 110.229 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.801 ' HG3' ' HB2' ' A' ' 168' ' ' ASN . 12.2 pt20 -119.13 125.89 50.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.454 0.645 . . . . 75.44 111.02 176.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 81.7 mtp -118.3 142.68 47.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.822 -0.626 . . . . 52.23 109.998 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 50.8 t-20 -113.38 118.46 34.61 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.996 -0.742 . . . . 72.04 108.996 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.757 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.6 m-85 -94.4 120.39 34.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.665 -0.698 . . . . 74.2 111.029 -175.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 57.7 tt0 -87.34 103.2 15.25 Favored 'General case' 0 C--O 1.26 1.639 0 CA-C-O 121.469 0.652 . . . . 74.04 109.284 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 t -70.24 -14.51 62.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 113.127 -1.851 . . . . 71.32 111.904 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.8 68.23 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.559 0.695 . . . . 74.43 109.157 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.63 -147.68 0.4 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.532 -1.285 . . . . 75.23 107.532 162.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.7 m -107.94 28.18 8.49 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.46 -0.775 . . . . 60.34 111.155 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 163' ' ' ARG . 1.1 ptm180 -132.39 145.49 51.27 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.419 -1.313 . . . . 70.54 111.562 -163.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.64 134.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.092 0.473 . . . . 64.13 109.804 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 7.5 t -95.44 -9.79 31.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.126 -0.488 . . . . 75.12 111.016 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 39.3 mm-40 -149.94 132.25 15.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.869 0.366 . . . . 73.1 110.841 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.8 m -121.9 105.79 10.66 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.743 -0.662 . . . . 70.24 109.507 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.801 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 84.7 m-20 -110.33 123.91 50.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 54.34 109.844 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.78 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 45.9 t80 -120.4 149.99 41.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.224 -0.443 . . . . 72.44 109.867 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -144.33 142.31 30.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.069 0.461 . . . . 72.43 110.858 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -131.12 136.9 56.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.157 -0.474 . . . . 74.2 110.193 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.04 96.1 0.33 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.007 -0.837 . . . . 63.1 111.007 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -109.67 121.68 45.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.399 -0.593 . . . . 63.32 109.399 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.41 127.64 48.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.486 -0.779 . . . . 73.21 110.547 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 42.0 m -131.73 111.49 11.7 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.292 -0.632 . . . . 74.34 109.292 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.58 -87.42 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.379 1.049 . . . . 74.12 113.678 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.87 3.48 22.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.252 0.549 . . . . 52.33 111.416 -172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -112.86 126.57 55.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 73.43 110.134 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 55.0 mm-40 -121.16 123.68 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.173 -0.306 . . . . 64.4 110.173 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.9 tp -118.66 134.85 54.81 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.15 -0.344 . . . . 74.22 111.035 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -130.6 117.3 19.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 60.4 110.414 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 19.9 m -112.47 143.52 43.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.962 -0.385 . . . . 63.0 109.962 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -141.52 139.95 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 74.1 110.383 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.78 ' HB ' ' HB3' ' A' ' 169' ' ' PHE . 56.0 t -126.36 131.27 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.163 -0.471 . . . . 62.34 111.606 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 9.1 t30 -110.94 96.01 5.9 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.35 -0.841 . . . . 71.24 109.565 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.7 t70 62.09 -166.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.9 -1.046 . . . . 74.03 110.345 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.62 -6.67 89.21 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.05 -0.595 . . . . 64.41 111.839 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.7 p -94.13 -27.23 16.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.981 0.734 . . . . 73.03 112.981 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 38.8 mt-10 -134.48 125.04 26.59 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.934 -0.706 . . . . 71.12 111.201 -175.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.735 ' HB2' HG22 ' A' ' 184' ' ' VAL . 25.9 p90 -133.87 133.1 41.12 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.188 -0.605 . . . . 71.34 109.443 171.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -135.79 159.21 24.15 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.566 -0.826 . . . . 45.13 112.522 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -136.63 164.76 25.15 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.424 -0.67 . . . . 73.11 111.424 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 26.9 t -143.56 136.91 28.02 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.0 -0.741 . . . . 72.33 109.0 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 3.4 mp -120.31 117.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 75.55 109.743 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.751 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 84.2 t80 -108.04 120.76 43.25 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.513 0.673 . . . . 71.12 110.428 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -115.61 111.91 21.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.925 -1.034 . . . . 74.03 108.992 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 195' ' ' TYR . 84.1 tttt -103.93 107.19 17.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.141 -0.482 . . . . 70.13 109.973 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.47 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.183 -0.673 . . . . 72.45 109.183 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -76.24 10.08 2.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.301 0.572 . . . . 64.01 110.879 -173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -109.3 -10.37 14.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.776 -0.647 . . . . 71.25 109.361 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.435 ' HG3' HD22 ' A' ' 202' ' ' LEU . 15.6 tppt? -134.93 -68.55 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 74.2 110.528 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 201' ' ' LYS . 2.0 pt? -167.99 165.94 13.42 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.92 0.39 . . . . 72.32 110.484 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.435 ' HG3' ' HG3' ' A' ' 197' ' ' LYS . 23.6 mp0 -109.75 128.2 55.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.797 -0.816 . . . . 72.23 108.797 173.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 t -138.57 155.02 48.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.064 0.459 . . . . 72.32 111.377 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.85 148.05 36.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.723 -0.671 . . . . 75.3 110.61 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 193' ' ' SER . 55.7 t -110.86 138.23 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.033 -0.53 . . . . 55.33 109.617 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -113.9 127.8 56.13 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.284 -1.006 . . . . 60.13 108.284 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 219' ' ' PHE . 7.3 tp -144.56 140.88 29.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.558 -0.292 . . . . 64.32 110.3 -168.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.584 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -157.23 142.34 17.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.825 0.345 . . . . 65.24 111.223 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.507 ' HE3' ' HZ ' ' A' ' 190' ' ' PHE . 16.6 t90 -130.83 135.3 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.125 0.488 . . . . 74.31 110.071 173.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 53.2 m -94.47 105.31 17.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.43 -0.805 . . . . 65.23 109.971 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.76 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 70.53 111.127 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.24 -87.72 0.4 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.164 -0.774 . . . . 73.22 111.164 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -149.12 104.3 3.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.024 0.44 . . . . 73.2 110.484 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.9 t -176.4 149.0 0.79 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.08 159.34 29.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.226 -0.657 . . . . 75.02 109.226 173.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 8.8 t -77.58 123.24 26.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.076 -0.713 . . . . 75.43 109.076 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 218' ' ' ARG . 1.1 tpp180 -94.18 115.06 27.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.589 -0.732 . . . . 75.33 109.262 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.746 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 52.1 p90 -120.42 160.33 23.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 61.22 111.49 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.39 157.49 28.86 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.298 -0.864 . . . . 50.13 111.355 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.651 ' HB ' HG12 ' A' ' 237' ' ' VAL . 55.9 mt -132.25 135.15 58.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.964 0.382 . . . . 74.32 110.298 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -128.47 129.84 46.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.918 -0.401 . . . . 52.42 109.918 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -128.24 133.05 48.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.747 0.308 . . . . 61.14 111.061 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.3 114.53 26.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.62 . . . . 75.31 109.629 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -128.9 119.36 24.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 72.21 110.726 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -76.59 124.61 27.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.71 -0.478 . . . . 75.41 109.71 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 63.4 mt -70.48 -55.79 13.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.388 -0.369 . . . . 72.52 110.306 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.849 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 34.0 t70 -172.45 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.019 -0.537 . . . . 54.52 111.771 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 56.7 Cg_endo -95.05 -101.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.372 2.048 . . . . 70.21 113.524 -172.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.93 3.92 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 51.32 111.227 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -123.07 131.98 53.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.238 0.542 . . . . 75.35 111.748 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.58 142.16 50.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 60.4 109.264 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -104.31 131.41 51.68 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.837 -0.431 . . . . 73.2 109.837 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 57.8 p -116.6 120.96 40.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.051 0.453 . . . . 74.44 110.087 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.88 42.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.218 -0.66 . . . . 71.32 109.218 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 44.4 mttp -144.22 141.57 29.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.664 -0.495 . . . . 71.32 109.664 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.651 HG12 ' HB ' ' A' ' 221' ' ' ILE . 4.4 p -137.24 158.65 35.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.357 -0.609 . . . . 73.23 109.357 174.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 14.3 t30 -135.5 150.57 49.81 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.196 -0.457 . . . . 72.35 110.087 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.746 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 2.8 p-10 -46.44 -32.51 3.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.957 1.095 . . . . 72.33 113.957 -173.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.536 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 5.6 m -78.92 23.37 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.596 0.236 . . . . 55.15 111.097 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.4 m 64.53 36.27 8.76 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 121.371 0.605 . . . . 61.52 109.849 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 1.052 ' HB3' HD11 ' A' ' 262' ' ' LEU . 22.9 mt -98.04 116.71 30.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.729 -0.669 . . . . 63.12 110.075 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 243' ' ' ILE . 2.1 mp -106.69 116.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 62.22 110.007 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.12 133.47 9.64 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.576 -0.821 . . . . 75.21 112.685 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.467 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -119.37 154.25 33.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.376 -0.231 . . . . 71.43 110.376 178.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -149.24 134.32 4.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.444 -0.884 . . . . 64.32 112.675 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 258' ' ' THR . 59.1 m-85 -103.59 116.99 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.564 -0.532 . . . . 75.1 109.564 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.934 HG23 ' HB ' ' A' ' 258' ' ' THR . 3.2 m -117.36 115.25 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.121 -0.49 . . . . 74.42 110.31 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.99 150.73 44.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 73.24 111.83 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 19.6 m -83.37 128.41 34.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.864 -0.607 . . . . 61.33 110.155 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.803 HD23 HG12 ' A' ' 255' ' ' ILE . 3.3 mm? -73.73 -82.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.133 0.42 . . . . 64.23 112.133 -173.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 1.027 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 35.3 tttp -140.97 -62.67 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.948 -0.389 . . . . 74.35 109.948 -175.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 1.027 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 3.6 Cg_exo -79.45 -161.52 0.15 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.858 1.705 . . . . 71.14 110.861 166.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -80.82 62.21 4.43 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.663 -0.78 . . . . 73.53 113.162 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.803 HG12 HD23 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -136.49 142.26 38.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.084 0.468 . . . . 74.41 109.762 173.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.545 ' HG2' HG22 ' A' ' 248' ' ' THR . 36.0 ttpt -121.96 127.28 50.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.761 -0.654 . . . . 64.54 110.261 -176.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.609 ' HB2' HD21 ' A' ' 251' ' ' LEU . 28.6 tp -100.55 132.69 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 73.24 110.106 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.934 ' HB ' HG23 ' A' ' 248' ' ' THR . 7.7 t -129.52 112.48 13.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.615 0.722 . . . . 75.42 111.01 176.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.973 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -98.1 123.61 42.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.131 -1.063 . . . . 71.21 108.131 176.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 21.8 p -131.6 148.73 52.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.193 0.52 . . . . 62.34 111.454 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.436 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -140.89 133.15 28.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.732 -0.667 . . . . 65.31 109.907 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.052 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -102.88 121.28 42.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 70.5 109.133 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.596 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.4 mm? -104.1 108.01 19.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.431 -0.952 . . . . 74.4 108.431 175.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 268' ' ' VAL . 2.9 m-20 -71.59 103.87 3.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.906 -0.775 . . . . 72.53 108.906 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.77 -22.25 32.67 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.12 -0.562 . . . . 72.13 113.03 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -85.92 -23.47 26.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.671 0.272 . . . . 74.01 111.262 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 3.8 m-20 -115.61 -28.26 6.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.78 0.659 . . . . 50.41 112.78 -172.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 263' ' ' LEU . 24.6 m -62.82 -18.78 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.901 0.334 . . . . 64.31 111.901 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.6 -33.06 70.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 73.21 109.808 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.32 8.56 38.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.517 -0.765 . . . . 63.53 110.955 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.84 89.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.088 -0.577 . . . . 74.42 112.067 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.19 88.01 0.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.323 -0.942 . . . . 75.44 112.701 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -109.16 145.52 35.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.185 -0.302 . . . . 74.2 110.185 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 274' ' ' LYS . 30.6 tptt -103.85 137.89 41.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.009 -0.737 . . . . 72.5 109.009 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.3 tm? -110.11 137.9 47.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.647 0.261 . . . . 53.01 110.328 -174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.52 126.23 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.42 -0.672 . . . . 75.03 111.42 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.973 HD23 HD22 ' A' ' 259' ' ' LEU . 2.7 tm? -120.77 129.28 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.814 -0.439 . . . . 73.42 109.814 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -131.95 145.87 17.55 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.479 -0.867 . . . . 73.54 112.975 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.459 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.2 mm? -123.71 132.3 53.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.46 -0.57 . . . . 74.42 109.46 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -112.87 111.91 23.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.439 -0.578 . . . . 64.12 109.439 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.51 ' HB3' HD13 ' A' ' 31' ' ' LEU . 5.2 m-85 -102.32 141.48 35.09 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.115 -0.698 . . . . 73.5 109.115 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 284' ' ' LEU . 46.2 mt-30 -135.75 121.4 19.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.848 0.356 . . . . 55.4 110.566 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -105.35 109.26 21.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.206 -0.664 . . . . 65.45 109.206 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 282' ' ' GLN . 3.5 mm? -130.6 176.77 7.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.698 -0.683 . . . . 70.1 110.366 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.708 -0.678 . . . . 74.2 109.827 178.623 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 75.43 110.314 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.841 HG11 ' HB3' ' A' ' 119' ' ' LYS . 2.2 t -82.15 115.19 56.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.688 -0.687 . . . . 70.24 109.643 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 6.6 Cg_endo -87.41 157.14 8.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.299 2.666 . . . . 74.33 113.157 -174.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 3.6 Cg_exo -75.92 64.62 6.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.135 2.556 . . . . 70.41 111.324 173.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.839 ' HB ' HD21 ' A' ' 150' ' ' LEU . 4.8 p -78.19 -18.97 54.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 53.01 111.548 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' HE2' HE21 ' A' ' 154' ' ' GLN . 81.0 t80 -56.11 -22.76 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 74.0 110.326 170.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.51 -25.62 54.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.456 -0.793 . . . . 73.5 109.569 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -85.86 -10.94 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.99 -0.745 . . . . 64.02 108.99 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.844 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -77.1 -34.86 56.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.766 -1.106 . . . . 63.14 110.857 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.24 -47.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.934 -1.127 . . . . 55.15 113.701 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -55.43 -53.91 50.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.674 0.62 . . . . 64.31 112.674 -170.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 t -63.95 -48.47 76.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 71.3 111.474 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.78 60.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 72.41 111.794 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 1.049 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 99.2 mtt180 -60.37 -24.82 65.4 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.708 0.633 . . . . 73.22 112.708 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.36 -41.51 76.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 61.24 110.752 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.512 ' HB ' ' ND2' ' A' ' 207' ' ' ASN . 66.8 t -83.73 -37.41 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.164 0.507 . . . . 42.34 110.315 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.049 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 89.6 t80 -63.56 -24.51 67.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.123 -0.944 . . . . 72.14 112.497 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -65.42 156.08 33.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 43.44 111.613 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.788 ' HD2' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.95 25.46 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.674 -0.693 . . . . 63.35 110.397 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.94 95.67 0.49 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.686 -0.688 . . . . 63.53 112.278 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -104.07 -162.4 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.797 -0.816 . . . . 74.42 108.797 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.55 108.18 2.38 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.142 -1.027 . . . . 23.44 111.131 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -80.7 -2.98 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.797 0.299 . . . . 75.12 111.573 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 12.79 83.81 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.458 -0.877 . . . . 54.15 112.434 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -142.35 179.97 6.62 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.866 0.841 . . . . 73.12 112.632 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.689 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -106.91 129.52 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.148 -1.387 . . . . 71.33 109.859 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 8.9 ttpt -102.78 135.99 43.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.407 -0.59 . . . . 74.5 109.407 174.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.9 tp -133.5 139.7 46.81 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.872 -0.331 . . . . 53.1 110.169 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.3 p30 -151.3 135.01 16.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 61.34 109.951 173.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.4 tp -128.31 124.14 35.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.509 -0.769 . . . . 73.11 109.679 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' N ' HD12 ' A' ' 31' ' ' LEU . 68.9 tttt -120.92 124.69 45.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.276 -0.874 . . . . 60.14 109.37 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 34.2 m -128.6 120.6 26.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.635 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -144.6 155.88 43.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.811 -0.756 . . . . 74.22 112.597 -176.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.4 t -139.92 154.31 47.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.523 -1.217 . . . . 74.04 107.991 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.27 20.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.991 0.424 . . . . 62.13 111.262 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 35' ' ' SER . 66.0 t30 -110.65 30.08 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.544 0.688 . . . . 75.33 110.212 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 96.39 1.17 60.83 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.864 -0.607 . . . . 45.51 112.513 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.0 tp -100.68 125.9 47.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.699 0.629 . . . . 64.24 112.699 -173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.857 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 28.0 mt-10 -142.32 118.17 10.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.962 -0.384 . . . . 65.34 109.962 160.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 50.4 m-85 -111.87 124.87 53.29 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.871 -0.518 . . . . 74.2 110.308 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.978 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 19.0 m -126.85 118.61 24.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.741 0.305 . . . . 73.4 111.383 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 29.0 t -120.35 123.6 43.5 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.273 -0.64 . . . . 73.23 109.273 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -134.73 130.44 36.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 43.21 111.468 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.43 148.02 19.38 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.507 -0.854 . . . . 64.33 112.541 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 m -119.83 134.17 55.33 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.821 -0.807 . . . . 72.41 108.821 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.7 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -154.85 141.29 18.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.984 0.421 . . . . 55.33 111.804 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 145.96 51.53 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.184 -0.672 . . . . 72.43 109.184 172.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -43.82 -39.74 4.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.538 0.524 . . . . 73.44 111.95 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -103.41 165.87 10.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.342 -0.614 . . . . 54.13 109.342 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -70.55 61.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.342 0.591 . . . . 70.1 112.052 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -97.84 -39.93 8.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 73.3 110.352 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -165.42 116.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 62.42 109.918 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.7 HG13 ' HB2' ' A' ' 47' ' ' ALA . 39.6 t -125.63 119.62 55.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.93 -0.577 . . . . 72.15 109.938 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -120.47 126.54 50.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.845 -0.428 . . . . 73.3 109.845 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 148.16 18.84 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.198 -1.001 . . . . 74.12 113.258 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 6.6 p -146.31 147.2 31.12 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.792 -0.447 . . . . 55.42 109.792 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 59' ' ' GLU . 1.8 tp -122.09 149.33 43.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.176 0.512 . . . . 72.42 111.196 -176.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.978 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 37.7 mt-10 -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.257 -0.883 . . . . 75.23 109.421 172.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.9 m -95.62 118.31 32.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.889 -1.152 . . . . 63.23 107.889 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.652 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 26.5 mttp -126.07 145.68 50.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.411 0.624 . . . . 75.14 110.911 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 70' ' ' THR . 74.3 m-85 -120.7 120.33 35.38 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.476 -0.935 . . . . 63.41 108.476 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.857 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 8.8 tpt180 -114.73 108.26 16.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 74.24 111.136 -173.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -113.51 102.69 10.54 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.434 -0.803 . . . . 75.55 110.754 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m 63.81 72.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.941 -1.027 . . . . 72.34 112.409 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.816 ' HG3' ' H ' ' A' ' 67' ' ' TYR . 9.7 pt-20 30.3 -92.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.449 1.1 . . . . 74.03 113.764 173.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.816 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 93.9 m-85 -87.11 86.87 7.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.224 -0.658 . . . . 73.03 109.224 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.81 -94.1 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.353 -0.699 . . . . 71.43 111.353 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 87' ' ' VAL . 3.5 mm? -125.4 131.59 52.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.038 0.447 . . . . 63.51 111.488 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.696 HG23 ' HB ' ' A' ' 86' ' ' THR . 4.8 t -136.97 113.19 9.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.796 -0.638 . . . . 73.35 109.781 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 72.3 m-85 -98.2 132.26 43.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 73.11 109.527 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 84' ' ' GLU . 96.9 m -127.91 136.57 51.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.923 0.392 . . . . 75.51 111.757 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.69 121.13 24.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.949 -0.759 . . . . 73.54 108.949 165.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -106.88 109.73 21.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.771 -0.65 . . . . 72.01 109.581 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.632 ' HD1' HD13 ' A' ' 81' ' ' LEU . 77.1 t90 -109.7 133.92 52.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.425 -0.352 . . . . 74.22 110.492 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.481 ' HB3' ' OG1' ' A' ' 80' ' ' THR . 8.5 t30 -114.72 152.88 31.27 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.582 -0.525 . . . . 53.2 109.582 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 m -54.28 -22.15 11.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.116 0.484 . . . . 73.51 112.301 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.5 m-20 -68.69 -2.67 9.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.117 -0.492 . . . . 74.12 111.986 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.528 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 92.1 m-20 77.8 27.69 0.58 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.461 0.704 . . . . 73.15 110.125 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 104' ' ' SER . 1.8 p -93.19 124.52 37.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.599 -0.728 . . . . 74.35 110.987 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.9 mm? -101.56 119.2 38.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.307 -0.86 . . . . 74.23 110.3 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.54 91.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.552 -0.832 . . . . 75.41 111.512 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 t -90.65 123.04 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 73.41 110.448 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 40.5 tt0 -135.3 118.69 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.983 -0.553 . . . . 74.35 110.027 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -112.03 138.68 39.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.709 0.29 . . . . 74.12 110.368 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.696 ' HB ' HG23 ' A' ' 70' ' ' THR . 25.8 m -122.73 123.63 41.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.297 0.57 . . . . 60.33 111.353 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 HD11 ' A' ' 69' ' ' LEU . 34.1 t -111.89 123.89 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.09 -0.959 . . . . 73.41 109.036 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -110.21 142.17 42.14 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.765 -0.457 . . . . 63.11 109.765 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 81.47 -66.5 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.95 0.781 . . . . 72.31 109.952 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.31 -78.11 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.29 0.636 . . . . 71.1 111.206 175.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -130.88 -58.73 1.01 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 74.31 109.624 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.23 27.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.857 -0.611 . . . . 72.43 109.399 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 5.8 ppt_? -52.97 132.67 37.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.467 0.651 . . . . 73.5 111.832 -175.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 119' ' ' LYS . . . 101.54 -12.43 58.19 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.593 -0.73 . . . . 70.24 112.08 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.646 HD23 ' HD1' ' A' ' 118' ' ' TYR . 1.0 OUTLIER -86.92 119.9 27.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.83 -0.804 . . . . 74.23 108.83 176.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' HD13 ' A' ' 97' ' ' LEU . 54.7 pttt -123.06 144.47 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 74.44 110.658 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -122.38 126.87 48.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.551 -0.75 . . . . 71.21 109.286 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.857 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 15.2 m -130.0 118.28 21.34 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.682 -0.407 . . . . 72.4 109.982 176.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 50.4 t80 -120.33 115.56 23.8 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.777 -0.369 . . . . 74.12 110.442 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 10.4 t70 -115.0 137.85 51.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.668 -0.696 . . . . 71.12 109.373 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -142.2 121.81 13.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.963 0.411 . . . . 72.03 110.06 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 41.4 m -103.04 121.71 43.14 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.715 -0.675 . . . . 63.42 109.803 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -120.88 128.82 53.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 73.55 109.523 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB3' HG22 ' A' ' 80' ' ' THR . 47.6 p -119.86 103.14 46.12 Favored Pre-proline 0 C--N 1.315 -0.919 0 C-N-CA 120.828 -0.349 . . . . 61.15 110.551 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 21.0 Cg_exo -67.11 -22.89 46.64 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.452 2.102 . . . . 60.14 111.256 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -85.48 -49.12 8.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 73.11 110.992 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -81.88 -36.73 27.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.392 . . . . 63.32 111.296 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.44 -3.44 61.43 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.139 -0.553 . . . . 42.2 113.191 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.76 148.69 22.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.165 0.507 . . . . 61.54 111.628 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -123.82 148.58 46.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.805 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -144.07 122.49 12.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.967 -0.383 . . . . 62.13 109.967 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . . . -110.08 129.89 55.62 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.798 -0.445 . . . . 63.02 109.798 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 129' ' ' MET . 7.9 ttmm -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.694 -0.484 . . . . 63.12 109.694 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.3 tp -132.32 129.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.108 0.48 . . . . 62.42 111.07 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 50.1 mttp -111.19 121.66 45.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.35 -0.841 . . . . 63.41 109.706 176.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -116.27 117.95 31.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.57 -0.9 . . . . 75.43 108.57 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.81 135.45 11.47 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.39 -0.909 . . . . 51.42 112.473 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.646 ' HD1' HD23 ' A' ' 95' ' ' LEU . 76.9 t80 -121.65 118.43 29.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.844 -0.799 . . . . 75.41 108.844 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.841 ' HB3' HG11 ' A' ' 3' ' ' VAL . 37.5 mtmm -108.07 122.93 47.88 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.041 -0.663 . . . . 63.55 110.642 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -105.38 154.91 19.65 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.556 -1.276 . . . . 75.24 107.556 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.0 tp10 -52.74 -29.84 29.24 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.674 0.62 . . . . 72.33 112.674 -165.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -102.39 -26.14 13.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.105 0.78 . . . . 64.32 113.105 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.791 HG22 ' H ' ' A' ' 145' ' ' GLY . 19.2 pt -142.22 153.35 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.927 -0.709 . . . . 71.24 112.242 -171.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.633 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 1.7 m-20 -112.3 128.94 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.263 -0.88 . . . . 70.31 111.457 -172.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 118' ' ' TYR . 4.5 mm? -111.37 137.69 48.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.608 0.242 . . . . 73.14 110.616 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.38 121.17 1.34 Allowed Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.959 -0.639 . . . . 65.11 112.493 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.4 m -113.35 116.44 29.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.894 0.347 . . . . 73.3 111.815 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.733 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -97.81 143.16 28.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.804 -0.634 . . . . 72.33 110.128 175.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.521 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 65.3 mtt -133.74 118.4 18.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.168 -0.308 . . . . 74.12 110.168 174.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.691 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 1.9 m-20 -99.38 119.26 37.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 72.14 110.067 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 96.7 m-85 -95.9 97.94 10.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.479 176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -120.58 156.99 30.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 55.23 108.988 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.898 ' H ' HD12 ' A' ' 133' ' ' ILE . 1.1 mp -75.08 -30.25 23.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.133 0.492 . . . . 73.44 109.986 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.0 -9.93 59.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 43.12 111.042 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 155.15 133.09 1.67 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.534 -0.841 . . . . 74.45 112.666 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 7.8 Cg_exo -74.23 119.1 5.65 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.122 2.548 . . . . 74.44 111.651 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.691 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 9.3 t -103.46 131.07 50.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.164 -0.471 . . . . 54.44 110.091 -177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mp -115.77 118.51 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.55 -0.46 . . . . 65.3 110.09 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 24.7 mtt180 -107.42 115.19 29.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.859 -0.423 . . . . 73.05 109.859 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.36 131.67 10.64 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.505 -1.331 . . . . 61.34 111.083 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.54 115.7 19.94 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.079 0.466 . . . . 72.33 109.977 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.578 HD11 HD12 ' A' ' 123' ' ' ILE . 5.9 tp -117.66 122.9 44.79 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.761 -0.654 . . . . 72.13 109.813 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.814 HG22 HD22 ' A' ' 10' ' ' LEU . 54.5 t -108.55 130.28 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.853 -0.612 . . . . 73.11 109.743 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.962 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.3 mm? -108.14 136.48 47.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.957 -0.757 . . . . 74.41 108.957 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.791 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -115.96 119.2 4.47 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.275 -0.875 . . . . 52.41 112.743 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.947 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 34.0 m-85 -123.46 149.64 44.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.304 -0.999 . . . . 74.05 108.304 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.78 100.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.96 0.41 . . . . 62.21 110.96 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 174' ' ' LYS . . . 90.84 -24.12 19.63 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.974 -0.557 . . . . 60.35 112.372 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.947 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.6 m0 -105.37 131.81 52.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.107 0.48 . . . . 64.23 110.783 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.839 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.4 tm? -117.33 149.07 41.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.736 -0.839 . . . . 63.22 108.736 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -151.28 154.53 36.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.646 -0.421 . . . . 74.35 110.058 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.844 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -158.41 135.66 4.38 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.744 -0.662 . . . . 44.45 111.576 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.4 115.18 21.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.44 -0.578 . . . . 71.1 109.44 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.94 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 87.7 mt-30 -99.42 121.86 41.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.728 -0.471 . . . . 72.25 109.728 166.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.9 ttm -127.17 128.58 46.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.698 -0.482 . . . . 74.32 109.698 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 24.7 m-80 -112.65 119.13 37.05 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.548 -0.538 . . . . 75.14 109.548 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.9 m-85 -94.35 127.05 39.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.095 -0.502 . . . . 75.41 110.805 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.794 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.9 tp10 -97.42 98.48 9.99 Favored 'General case' 0 C--O 1.26 1.631 0 N-CA-C 109.269 -0.641 . . . . 63.34 109.269 174.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -72.59 -17.59 61.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.641 -1.618 . . . . 63.45 111.209 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -63.1 -29.08 70.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.732 -0.84 . . . . 75.55 108.732 173.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 13.8 mmmm -111.17 -160.26 0.71 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.16 -1.382 . . . . 70.24 107.839 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 p -108.45 28.76 8.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.551 -0.536 . . . . 53.24 109.551 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 25.0 tpt180 -142.95 145.78 33.33 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 119.812 -0.755 . . . . 75.31 111.378 -160.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.5 m -73.22 136.7 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.777 -0.823 . . . . 54.23 108.777 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.794 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 8.8 t -92.2 -24.36 19.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.869 -171.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.572 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 93.4 mt-30 -144.8 133.16 21.81 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.616 0.246 . . . . 55.1 110.711 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.2 m -114.54 106.27 14.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.532 -0.544 . . . . 75.24 109.532 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.94 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 54.5 m-20 -106.99 129.93 54.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.46 . . . . 73.14 109.926 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.36 144.52 48.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.474 -0.33 . . . . 65.13 110.445 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -142.43 128.65 19.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.862 0.363 . . . . 33.45 110.169 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.58 128.54 60.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 73.3 109.409 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.81 109.17 1.69 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.804 -0.712 . . . . 73.25 112.05 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.75 119.95 39.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.064 -1.087 . . . . 74.34 108.064 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.819 ' HB2' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -136.21 144.83 45.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.182 0.991 . . . . 52.51 113.557 -171.083 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.433 ' HB ' ' OE2' ' A' ' 177' ' ' GLU . 3.7 m -109.9 163.88 13.12 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.582 -1.636 . . . . 75.34 106.582 167.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -27.4 60.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.849 0.685 . . . . 72.15 112.849 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -108.16 -20.51 13.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.569 0.581 . . . . 72.14 112.569 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -130.83 119.02 21.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.799 0.333 . . . . 72.34 111.074 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.819 ' HG2' ' HB2' ' A' ' 174' ' ' LYS . 45.1 mt-30 -116.35 124.31 49.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.496 -0.32 . . . . 71.42 110.418 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -107.9 132.24 53.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.063 0.458 . . . . 74.03 110.234 174.304 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -125.03 116.81 22.72 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.252 -0.647 . . . . 74.42 109.252 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 28.7 m -99.39 123.0 43.29 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.717 -0.475 . . . . 74.3 109.717 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -121.24 139.73 52.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.01 0.433 . . . . 71.5 109.963 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 78.2 t -131.12 124.79 56.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.762 -0.654 . . . . 53.42 109.591 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 92.4 m-20 -106.88 106.42 16.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 61.41 109.36 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 28.0 t70 59.64 -168.76 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.914 -1.039 . . . . 72.31 109.424 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -79.54 -6.35 89.01 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.542 -0.837 . . . . 71.43 112.128 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 211' ' ' THR . 26.9 p -101.28 -27.02 13.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.639 0.977 . . . . 73.21 113.639 -172.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.6 tt0 -113.1 115.15 27.85 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 119.274 -0.97 . . . . 71.54 111.909 -174.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.58 131.06 57.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 75.14 109.64 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -174.25 -139.82 3.08 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.552 -0.833 . . . . 64.33 112.107 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.86 -150.61 22.9 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.23 -0.986 . . . . 63.0 112.865 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 28.5 t -142.78 144.54 32.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.147 0.498 . . . . 71.22 110.97 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.718 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 17.3 mm -118.9 115.77 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.856 -0.794 . . . . 73.23 108.856 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.677 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 26.1 t80 -111.6 119.7 39.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.612 0.244 . . . . 71.25 110.652 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.681 ' CG ' ' HB2' ' A' ' 199' ' ' ASN . 5.0 tp-100 -127.81 128.49 45.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.505 -0.316 . . . . 73.33 110.34 176.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 198' ' ' VAL . 19.0 ptpt -103.1 132.41 49.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.674 -0.239 . . . . 73.12 110.933 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 197' ' ' LYS . 3.9 m 64.85 23.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.495 1.518 . . . . 75.44 112.423 176.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.681 ' HB2' ' CG ' ' A' ' 196' ' ' GLN . 24.9 t-20 -65.31 -48.62 72.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 64.51 110.764 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.414 ' HG3' ' OD1' ' A' ' 199' ' ' ASN . 98.7 mttt -125.18 -84.47 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.491 -0.322 . . . . 72.3 111.05 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -86.83 -66.18 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.461 -0.336 . . . . 74.15 110.449 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.2 tp -145.73 -84.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 64.02 110.164 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 224' ' ' LYS . 2.6 tp10 -107.25 142.03 37.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 13.5 t -143.38 138.67 29.57 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.19 -0.604 . . . . 73.42 110.775 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -138.61 137.29 36.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.778 -0.646 . . . . 54.34 110.678 -178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.718 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 70.5 t -111.32 140.65 29.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.116 -0.698 . . . . 71.31 109.116 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' HB ' ' A' ' 17' ' ' VAL . 18.5 m-80 -138.27 131.51 30.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.674 -0.491 . . . . 75.12 109.674 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.87 151.7 37.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.824 0.345 . . . . 62.55 111.789 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.536 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -141.07 134.54 29.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 71.25 110.334 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 217' ' ' THR . 24.1 t90 -128.71 123.41 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 64.11 110.384 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 188' ' ' THR . 1.0 OUTLIER -99.89 103.56 15.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.369 0.604 . . . . 70.35 110.473 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.29 136.69 56.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.07 -0.968 . . . . 35.1 111.8 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.24 -28.12 15.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.932 -0.651 . . . . 72.34 113.207 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -132.79 -47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.87 0.692 . . . . 45.55 112.87 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.8 t -110.67 -179.04 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.375 0.607 . . . . 70.33 111.861 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -102.94 166.12 10.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.957 -1.02 . . . . 73.4 109.983 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 210' ' ' TRP . 25.7 m -74.91 123.17 24.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.422 -0.584 . . . . 65.01 109.422 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 218' ' ' ARG . 43.2 mtp180 -114.16 117.15 30.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.394 -0.595 . . . . 71.11 109.394 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -124.24 145.74 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.386 0.612 . . . . 63.32 111.306 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.36 13.8 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.898 -1.046 . . . . 62.44 111.229 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.3 mp -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.941 -0.392 . . . . 72.15 109.941 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -116.41 145.15 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.946 0.403 . . . . 44.01 110.855 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -129.04 126.54 39.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.933 -0.576 . . . . 62.34 109.792 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.511 ' HG2' ' SG ' ' A' ' 232' ' ' CYS . 22.8 ttmm -118.17 112.41 20.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 63.34 109.427 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 233' ' ' PHE . 5.7 p90 -135.09 118.8 17.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 74.23 112.389 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 0.2 OUTLIER -88.01 112.36 22.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.805 -1.183 . . . . 72.22 107.805 172.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.22 -55.36 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.375 0.88 . . . . 65.23 113.375 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.733 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 13.5 t70 -138.73 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 75.24 112.953 -164.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 62.4 Cg_endo -90.96 -139.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.161 1.908 . . . . 71.4 112.834 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.453 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.3 p-10 -92.56 12.22 23.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.213 -0.903 . . . . 74.32 109.498 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.519 ' CB ' ' HG2' ' A' ' 249' ' ' GLN . . . -121.46 123.69 42.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.634 0.73 . . . . 73.31 111.65 -169.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.511 ' SG ' ' HG2' ' A' ' 224' ' ' LYS . 44.8 t -97.29 128.17 43.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.634 -1.166 . . . . 64.12 108.318 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.486 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 53.0 m-85 -96.18 126.45 41.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.779 -0.452 . . . . 75.53 109.779 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 19.6 m -126.38 117.15 22.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 70.32 109.93 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -122.76 141.63 51.6 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.956 -0.387 . . . . 60.21 109.956 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 62.6 pttt -137.9 140.22 40.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.035 0.445 . . . . 75.34 110.401 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 243' ' ' ILE . 5.5 p -122.98 140.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.569 -0.53 . . . . 74.0 109.569 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -105.21 148.03 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.085 -0.709 . . . . 75.15 109.085 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.97 2.58 2.56 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.48 0.548 . . . . 74.22 112.48 -172.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.646 ' HB2' HD13 ' A' ' 242' ' ' LEU . 14.7 m -82.81 12.74 4.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.902 -0.777 . . . . 52.21 108.902 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 17.5 m 69.89 28.79 4.17 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.955 -1.021 . . . . 73.34 110.948 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.844 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.9 mp -101.15 129.39 47.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.902 0.334 . . . . 71.55 111.902 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.508 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -118.61 116.49 51.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.706 -0.679 . . . . 72.33 110.099 -169.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -127.99 133.81 7.94 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.276 -0.964 . . . . 53.04 113.12 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 0.0 OUTLIER -123.94 156.54 36.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.693 0.282 . . . . 65.41 110.483 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.67 149.46 20.95 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.543 -0.836 . . . . 73.33 113.158 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.835 ' HD1' ' HB3' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -106.63 118.1 35.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.107 -0.701 . . . . 74.43 109.107 177.623 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 28.9 m -104.49 115.14 29.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.439 -0.578 . . . . 75.41 109.439 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.519 ' HG2' ' CB ' ' A' ' 231' ' ' ALA . 10.9 mt-30 -112.41 133.16 54.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.003 0.43 . . . . 70.32 111.013 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 11.7 m -104.16 102.51 12.23 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.884 -0.784 . . . . 71.14 108.884 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.86 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 8.9 mp -75.24 179.3 5.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.857 0.36 . . . . 44.12 110.855 -174.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 1.4 tppp? -60.68 -52.52 71.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 54.33 111.09 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.598 ' HG2' HG12 ' A' ' 255' ' ' ILE . 72.3 Cg_endo -80.2 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.811 1.674 . . . . 73.43 111.617 172.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -75.94 64.58 2.68 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.915 -0.659 . . . . 74.33 112.553 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.86 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mm -123.74 123.97 68.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.537 0.208 . . . . 54.42 110.869 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.798 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 26.6 ttmt -115.46 114.17 24.69 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.299 -0.63 . . . . 73.5 109.299 171.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 279' ' ' LEU . 13.9 tp -100.33 124.55 45.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.623 -0.717 . . . . 62.41 109.959 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.4 m -122.22 110.21 15.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.152 0.501 . . . . 75.14 110.793 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.989 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -106.85 123.58 48.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.464 -1.31 . . . . 75.51 107.464 173.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.7 p -137.72 150.62 47.45 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.64 -0.424 . . . . 71.21 111.228 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.408 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -145.55 128.68 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.35 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.725 HD11 HD23 ' A' ' 242' ' ' LEU . 2.6 tm? -104.81 115.89 31.07 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.354 -0.98 . . . . 71.33 108.354 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.822 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.3 mm? -92.27 108.77 20.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.353 -0.98 . . . . 73.21 108.353 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.844 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m-20 -70.45 111.02 5.69 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.4 -0.963 . . . . 71.34 108.4 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.23 -27.68 40.17 Favored Glycine 0 C--N 1.319 -0.397 0 C-N-CA 121.207 -0.521 . . . . 41.4 112.995 -173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -91.79 -27.48 17.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.679 0.276 . . . . 75.41 111.19 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.832 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 14.4 m120 -92.46 -35.33 13.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.201 0.445 . . . . 70.23 112.201 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -63.04 -18.24 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.681 0.277 . . . . 60.34 111.649 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.71 -29.89 71.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.334 0.587 . . . . 53.12 109.653 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.22 0.18 31.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.541 -0.754 . . . . 64.15 110.594 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.34 8.06 57.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 74.41 113.066 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.33 86.92 1.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 42.44 112.567 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.444 ' HB3' HG12 ' A' ' 268' ' ' VAL . 31.6 p-80 -114.39 144.9 42.55 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.76 -0.259 . . . . 61.54 110.537 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -99.24 138.02 36.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 63.22 111.179 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.2 tm? -113.05 139.4 48.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.818 -0.438 . . . . 74.14 109.818 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.546 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.06 117.8 1.53 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.883 -0.675 . . . . 64.53 111.631 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.989 HD23 HD22 ' A' ' 259' ' ' LEU . 3.0 tm? -115.51 141.97 47.35 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.418 -0.586 . . . . 71.53 109.418 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.571 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -153.31 129.37 2.68 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.381 -0.914 . . . . 75.42 113.11 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.798 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.7 mm? -112.49 131.52 55.54 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.874 -0.417 . . . . 44.34 109.874 172.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.798 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -124.06 112.01 16.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.736 0.779 . . . . 74.44 109.897 173.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.601 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -98.19 135.91 39.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.433 -1.258 . . . . 71.03 108.76 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.492 ' N ' ' HD2' ' A' ' 281' ' ' PHE . 7.4 tp60 -133.47 112.13 11.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 73.4 109.818 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.98 114.19 25.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.037 -0.529 . . . . 61.04 110.021 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.7 mt -120.53 115.97 24.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 55.03 110.598 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.379 -0.82 . . . . 72.13 109.868 178.103 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.528 ' CA ' ' HA2' ' A' ' 94' ' ' GLY . . . . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 120.706 0.288 . . . . 53.22 111.325 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.079 HG22 ' HB3' ' A' ' 119' ' ' LYS . 27.7 m -94.88 145.2 29.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.174 -0.466 . . . . 53.22 111.135 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 32.5 Cg_exo -58.88 161.69 14.9 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.481 2.121 . . . . 64.52 110.361 172.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.95 92.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.313 2.009 . . . . 65.21 112.385 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 p -67.02 -25.84 66.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.284 -0.416 . . . . 50.11 111.854 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.784 ' HB3' HG21 ' A' ' 143' ' ' VAL . 16.6 p90 -65.13 -29.25 70.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 71.45 110.922 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.72 -12.64 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.484 0.659 . . . . 55.12 109.986 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -104.26 -7.14 20.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.559 -0.904 . . . . 64.45 108.559 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.706 HD12 ' HB3' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -57.79 -33.78 68.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.786 -1.552 . . . . 74.53 110.83 178.389 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.72 63.61 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.082 -0.58 . . . . 50.52 112.175 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -62.05 -39.86 93.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.667 0.387 . . . . 75.43 111.753 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 m -61.0 -36.71 80.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 62.42 112.188 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.8 82.37 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.749 0.648 . . . . 73.24 112.749 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -67.74 -33.83 75.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.88 -0.328 . . . . 44.54 111.463 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 26.3 t70 -65.91 -47.99 72.93 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.5 -0.555 . . . . 70.11 109.5 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 222' ' ' ALA . 11.3 t -58.22 -33.49 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.956 -0.566 . . . . 71.44 111.566 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HD2' ' HB2' ' A' ' 207' ' ' ASN . 66.9 t80 -60.69 -39.52 88.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 64.25 111.695 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 18' ' ' PHE . 1.1 p -131.42 12.19 4.97 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.335 0.865 . . . . 73.41 113.335 -172.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 34.4 tttp -65.38 -38.7 90.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.166 0.507 . . . . 75.44 110.65 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.34 45.79 1.27 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.852 -0.69 . . . . 23.22 111.765 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.29 130.29 42.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.81 113.63 3.69 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.79 -0.719 . . . . 62.25 112.548 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -84.46 -3.67 58.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.792 0.33 . . . . 75.43 111.063 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.51 85.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.14 -0.552 . . . . 61.2 113.344 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 46' ' ' SER . 2.1 pp -147.21 179.89 7.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.047 0.758 . . . . 70.12 113.047 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.664 HD12 HD12 ' A' ' 277' ' ' LEU . 37.6 mm -100.59 124.47 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.368 -1.287 . . . . 72.43 109.55 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 33.3 ttpt -107.53 121.82 45.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.97 -0.382 . . . . 75.33 109.97 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.47 128.04 56.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.417 -0.586 . . . . 65.33 109.417 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.8 136.67 51.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.039 -0.726 . . . . 72.01 109.039 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.567 HD13 ' HD1' ' A' ' 281' ' ' PHE . 12.1 tp -137.04 124.62 22.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.931 0.396 . . . . 62.43 110.341 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' N ' HD12 ' A' ' 31' ' ' LEU . 39.8 tttp -116.97 125.44 51.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.449 -0.574 . . . . 71.04 109.449 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 25.4 m -126.06 149.51 48.83 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.335 -0.393 . . . . 63.33 110.5 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' HD3' HD22 ' A' ' 284' ' ' LEU . 55.0 mtpt -125.15 144.41 50.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.754 0.311 . . . . 63.13 110.878 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 52.3 m -140.75 158.28 44.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.31 -0.405 . . . . 60.44 110.995 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.626 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 28.3 tt0 -76.46 99.1 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.45 111.91 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.745 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t30 160.44 26.59 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.631 1.172 . . . . 52.13 107.861 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.718 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.65 18.05 79.35 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.273 -0.876 . . . . 72.24 110.991 -172.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 37' ' ' ASN . 3.1 mt -86.74 134.33 33.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.758 0.79 . . . . 55.34 112.916 -167.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.65 130.61 30.27 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.012 -1.449 . . . . 71.32 109.173 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 93.7 m-85 -115.65 121.54 42.86 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.854 -0.425 . . . . 74.12 109.854 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.896 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 23.7 m -115.94 116.48 28.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.091 0.472 . . . . 44.51 110.058 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 25.2 t -113.15 131.31 55.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.708 -0.678 . . . . 75.15 109.726 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -130.97 135.63 47.81 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.686 -0.487 . . . . 34.35 109.686 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.62 110.13 0.43 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.611 -0.804 . . . . 73.02 112.067 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.457 ' HB3' HD13 ' A' ' 26' ' ' LEU . 15.2 m -108.39 133.18 52.94 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.67 -0.863 . . . . 71.2 108.67 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.495 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -151.57 136.7 17.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.235 0.54 . . . . 72.02 111.24 -174.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -80.87 129.27 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 74.23 108.748 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.8 m -62.46 -20.9 65.01 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.973 0.416 . . . . 64.1 111.675 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -84.46 6.05 24.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.156 0.503 . . . . 72.14 110.204 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 p 49.24 72.0 0.34 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.68 0.792 . . . . 75.5 112.098 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -126.74 -30.87 2.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.253 -0.885 . . . . 63.3 110.172 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -149.13 113.85 5.36 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.101 -0.703 . . . . 71.11 109.101 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 47' ' ' ALA . 25.7 t -125.99 127.47 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 72.13 109.843 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -134.18 137.61 44.57 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.958 -0.386 . . . . 64.24 109.958 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -142.49 154.82 25.39 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.29 -0.957 . . . . 72.24 112.884 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.765 ' HB2' HG23 ' A' ' 77' ' ' THR . 26.7 t -146.73 148.68 32.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.226 -0.657 . . . . 72.3 109.226 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 74' ' ' LYS . 1.7 tm? -146.57 125.47 12.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.896 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 11.7 pt-20 -125.84 131.36 52.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.266 0.555 . . . . 63.11 110.195 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.419 HG23 ' CE1' ' A' ' 41' ' ' PHE . 48.3 m -107.62 119.4 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.813 -0.81 . . . . 75.31 108.813 172.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 19.9 mtpp -112.07 126.94 55.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 75.21 110.586 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.9 m-85 -110.77 120.97 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.36 -0.607 . . . . 54.34 109.36 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.718 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 39.5 mtp180 -114.61 110.9 20.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.809 0.814 . . . . 75.42 110.696 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -111.02 117.2 32.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.077 -1.42 . . . . 72.33 109.062 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m 73.64 122.85 0.04 OUTLIER 'General case' 0 C--O 1.231 0.108 0 O-C-N 124.021 0.826 . . . . 65.52 109.734 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.9 mp0 -63.01 106.47 0.84 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.037 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 87.2 m-85 68.0 84.77 0.15 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.207 -0.906 . . . . 71.44 109.37 -170.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.81 -83.05 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.309 -0.86 . . . . 71.14 111.443 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.8 mm? -121.26 131.71 54.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.985 0.421 . . . . 71.12 111.151 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 42.1 m -136.77 119.11 15.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.731 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 7.9 m-85 -107.98 133.38 52.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.239 -0.437 . . . . 74.21 110.115 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -128.35 119.44 25.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.074 0.397 . . . . 71.24 110.816 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 8.0 pt-20 -131.63 170.46 14.73 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.2 0.444 . . . . 64.01 112.2 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.625 ' HG3' HD12 ' A' ' 58' ' ' LEU . 72.5 mmtt 118.73 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.057 1.743 . . . . 64.23 113.452 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.535 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 13.2 t90 -135.0 143.57 46.89 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.484 0.55 . . . . 70.21 112.484 -163.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -119.38 159.23 24.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.951 -0.568 . . . . 72.21 111.112 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.765 HG23 ' HB2' ' A' ' 57' ' ' SER . 17.9 p -61.67 -17.99 57.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.296 0.85 . . . . 72.1 113.296 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.65 -1.61 35.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.658 -0.246 . . . . 74.22 110.89 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 78.9 13.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.762 0.825 . . . . 44.11 109.687 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -86.7 134.89 33.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.306 -0.861 . . . . 74.22 110.058 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.1 mp -107.72 161.09 15.2 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.375 -0.972 . . . . 74.42 108.375 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 102' ' ' SER . . . 148.23 -167.68 28.99 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.277 -1.439 . . . . 61.11 113.141 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 2.3 t -157.9 152.29 24.67 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.637 -0.282 . . . . 71.42 110.494 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.941 ' HA ' ' HB3' ' A' ' 100' ' ' ASP . 10.4 pt-20 -127.45 136.28 51.59 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 125.166 1.541 . . . . 71.22 109.678 171.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 99' ' ' PHE . 1.7 pp -111.4 133.11 58.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 118.658 -1.217 . . . . 71.35 110.815 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.93 ' HB ' ' HE3' ' A' ' 96' ' ' LYS . 21.1 p -114.8 137.52 51.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.727 -0.67 . . . . 64.44 110.783 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.75 135.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.32 -0.4 . . . . 73.34 110.672 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.05 127.33 36.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.378 -0.601 . . . . 74.13 109.378 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 27.1 t70 -69.94 156.64 38.8 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.248 0.547 . . . . 74.2 111.601 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -95.56 -37.31 10.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.5 -0.773 . . . . 72.4 110.831 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.64 -55.07 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 74.24 111.018 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.8 64.32 5.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.772 -0.825 . . . . 72.33 108.772 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -48.88 126.53 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 74.23 111.221 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.528 ' HA2' ' CA ' ' A' ' 2' ' ' ALA . . . 104.1 -4.25 44.94 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.69 -0.687 . . . . 52.31 112.204 -173.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 89' ' ' ASP . 52.7 tp -79.72 130.43 35.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.686 . . . . 75.43 109.146 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.93 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 55.9 tptt -121.72 111.15 16.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.658 -0.701 . . . . 70.4 109.732 -174.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 116' ' ' THR . 1.1 mm? -112.77 125.71 54.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.365 -0.605 . . . . 43.05 109.365 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.862 ' HB ' HG22 ' A' ' 86' ' ' THR . 1.8 t -131.92 118.98 20.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.306 -0.558 . . . . 73.44 112.219 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.935 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 88.1 t80 -127.39 114.23 17.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 75.42 109.407 174.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.941 ' HB3' ' HA ' ' A' ' 84' ' ' GLU 0.355 1.2 t70 -153.82 172.95 16.55 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 120.845 -1.159 . . . . 64.24 112.804 159.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.749 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 23.3 t -116.78 147.79 41.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.931 0.396 . . . . 52.32 110.687 -165.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.679 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 33.4 t -114.8 134.81 54.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 75.31 110.368 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -95.52 124.9 39.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.059 0.457 . . . . 72.22 110.252 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 31.3 m -109.61 115.2 56.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 74.43 110.75 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 19.3 Cg_exo -66.22 -7.81 18.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.184 2.589 . . . . 63.0 112.326 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -55.92 -50.81 69.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.743 -0.662 . . . . 75.32 111.01 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 p -129.36 -2.67 4.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.854 0.359 . . . . 71.3 111.65 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.92 11.68 81.02 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.664 -0.779 . . . . 64.31 111.734 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.843 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -94.35 149.08 21.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.693 -0.254 . . . . 71.43 110.567 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -106.94 135.98 47.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.04 0.448 . . . . 74.12 110.405 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -119.54 122.9 42.66 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.443 -0.947 . . . . 75.21 108.443 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.749 ' HA ' ' HA ' ' A' ' 101' ' ' SER . . . -104.45 147.16 27.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.942 0.401 . . . . 64.24 111.596 -168.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -121.65 137.56 54.7 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.473 0.654 . . . . 74.52 110.433 177.649 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.935 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 2.5 tp -127.77 115.86 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.385 -1.279 . . . . 63.31 109.359 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.779 ' HB3' HG23 ' A' ' 98' ' ' THR . 4.4 ttmp? -113.65 121.27 43.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.725 -0.67 . . . . 54.43 110.579 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.68 HG22 HD12 ' A' ' 97' ' ' LEU . 21.7 p -112.68 117.29 31.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.367 -0.605 . . . . 61.52 109.367 175.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.82 134.93 5.34 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.052 -1.07 . . . . 44.54 112.885 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -107.51 125.36 51.18 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.616 -0.512 . . . . 65.53 109.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 1.079 ' HB3' HG22 ' A' ' 3' ' ' VAL . 41.7 mttp -110.26 121.78 46.09 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 121.182 0.515 . . . . 75.23 110.852 -173.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 120' ' ' ARG . 6.4 mmt180 -108.89 152.5 24.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.202 -0.908 . . . . 74.44 109.317 169.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.869 ' HA ' HG11 ' A' ' 3' ' ' VAL . 8.8 tm-20 -50.88 -27.93 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.907 0.883 . . . . 75.33 111.317 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -110.9 -15.4 13.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.091 -0.504 . . . . 74.33 112.143 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 144' ' ' LEU . 16.6 tt -149.29 122.12 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 118.813 -1.155 . . . . 70.14 113.482 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 1.6 t30 -102.83 119.01 38.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.445 -0.798 . . . . 64.21 110.793 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 142' ' ' LEU . 3.1 mm? -112.43 111.9 23.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.166 -0.679 . . . . 73.31 109.166 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.11 118.58 2.44 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.991 -1.1 . . . . 54.33 113.103 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.8 t -110.66 111.22 22.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.935 0.398 . . . . 70.43 110.204 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 13.6 t70 -100.7 134.74 43.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 75.14 109.728 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.83 117.78 24.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.838 0.352 . . . . 73.14 110.119 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.32 119.22 37.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -82.45 96.9 8.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.903 0.382 . . . . 74.34 111.007 -171.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.593 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 13.0 t70 -96.82 145.31 25.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 65.31 109.638 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -29.17 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.544 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.72 58.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.944 0.402 . . . . 70.22 110.923 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.56 108.3 0.51 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.583 -0.607 . . . . 72.3 111.583 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.593 ' HA ' ' H ' ' A' ' 132' ' ' ASP . 77.0 Cg_exo -48.24 123.51 9.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.268 2.645 . . . . 70.14 112.755 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 t -84.68 136.67 33.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.251 -0.648 . . . . 63.34 109.251 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 45.5 mm -105.57 117.04 50.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 62.42 109.467 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -116.19 109.64 17.72 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.28 -0.637 . . . . 72.24 109.28 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.0 133.54 11.61 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.907 -1.139 . . . . 51.04 112.157 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.21 114.08 21.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.418 0.628 . . . . 75.02 109.491 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 144' ' ' LEU . 18.1 tp -116.47 122.94 46.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.362 -0.836 . . . . 72.54 109.569 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' A' ' 7' ' ' TYR . 48.3 t -133.9 120.26 35.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.958 -0.386 . . . . 74.32 109.958 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.665 HD12 HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -126.78 139.29 53.23 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.532 -0.867 . . . . 74.2 110.718 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -120.86 128.41 7.41 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 114.674 -1.148 . . . . 73.31 111.837 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -112.59 149.16 33.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.396 -1.705 . . . . 74.21 106.396 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -47.7 95.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 55.53 112.243 -171.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.3 -33.09 5.73 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.133 -0.94 . . . . 43.32 112.867 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.433 ' HD1' ' HB2' ' A' ' 173' ' ' TYR . 2.5 m0 -106.47 146.88 30.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.847 0.323 . . . . 74.34 111.463 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.706 ' HB3' HD12 ' A' ' 10' ' ' LEU . 7.5 mt -130.81 136.56 48.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.815 -0.809 . . . . 62.35 108.815 167.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.513 ' HB3' ' CD2' ' A' ' 144' ' ' LEU . . . -130.52 127.4 39.07 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.861 -0.422 . . . . 72.35 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.539 ' N ' HD21 ' A' ' 10' ' ' LEU . . . -131.85 133.54 7.21 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.986 -0.626 . . . . 75.11 111.791 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -129.36 118.72 22.68 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.212 -0.494 . . . . 75.34 110.538 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -111.6 121.83 46.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 45.23 109.508 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -135.48 146.69 48.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.065 -0.346 . . . . 74.2 110.065 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 2.0 p-10 -124.35 119.01 28.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.645 0.736 . . . . 71.12 110.966 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.856 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.8 t80 -97.03 123.1 40.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.527 -1.215 . . . . 71.42 109.298 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.708 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 25.0 tt0 -94.04 105.25 17.26 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.747 -0.464 . . . . 71.43 109.747 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.78 -22.09 62.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 113.687 -1.597 . . . . 53.25 111.149 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.23 77.83 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.595 -0.891 . . . . 70.34 108.595 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.708 ' H ' ' HG2' ' A' ' 158' ' ' GLU . 17.6 ttmm -98.89 -164.91 1.18 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.92 -1.511 . . . . 72.41 106.92 169.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 15.5 m -110.38 25.52 11.69 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.223 -0.923 . . . . 71.14 110.509 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -155.31 151.28 27.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 119.398 -0.921 . . . . 74.33 112.727 -160.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.856 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -74.77 135.72 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.105 -1.072 . . . . 71.1 108.105 168.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -93.99 -32.84 13.68 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.421 -0.512 . . . . 74.51 110.929 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 186' ' ' ASP . 35.3 tt0 -151.38 133.52 15.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 54.45 111.066 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 m -118.69 120.22 36.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 61.01 109.984 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 185' ' ' ASN . 39.3 m-80 -116.82 121.95 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.806 -0.813 . . . . 62.22 108.806 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -139.8 155.48 47.25 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.567 -0.853 . . . . 61.25 111.797 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.574 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -144.81 152.71 40.74 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.616 -0.72 . . . . 75.0 110.23 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 42.9 t -130.21 151.63 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.613 -1.254 . . . . 54.32 107.613 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -158.04 111.03 0.47 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.029 -1.081 . . . . 72.54 112.197 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.458 ' CE2' HD22 ' A' ' 180' ' ' LEU . 39.2 p90 -113.39 138.36 50.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.428 0.632 . . . . 71.53 110.957 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -104.63 127.17 52.31 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.695 -1.139 . . . . 62.11 110.486 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 178' ' ' PHE . 33.5 m -127.12 162.54 25.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.555 -0.906 . . . . 74.42 108.555 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.61 -54.7 11.1 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.522 0.564 . . . . 50.22 112.522 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.28 -21.93 13.44 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.896 -0.322 . . . . 63.4 111.698 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.519 ' O ' ' HB ' ' A' ' 175' ' ' THR . 91.4 m-85 -124.69 142.84 51.1 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.805 0.336 . . . . 73.32 110.913 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 29.2 tt0 -135.23 122.9 22.22 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.206 -1.035 . . . . 72.21 108.206 172.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.502 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 8.8 tt -121.54 137.45 54.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.987 -0.685 . . . . 64.31 111.2 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 19.9 t-80 -127.3 114.8 18.07 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.248 -0.887 . . . . 65.1 110.573 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -81.51 148.31 29.25 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.804 -0.813 . . . . 62.04 108.804 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.403 ' HB2' ' CE1' ' A' ' 181' ' ' HIS . 25.0 t-20 -147.93 137.02 22.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.3 -0.56 . . . . 74.13 111.25 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.9 t -133.78 123.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.554 -0.748 . . . . 62.34 110.068 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 89.2 m-20 -117.08 112.44 20.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.641 -0.709 . . . . 74.42 109.529 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.548 ' HA ' ' HG3' ' A' ' 166' ' ' GLN . 21.0 t70 63.7 -173.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.418 -0.81 . . . . 71.53 109.072 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.9 -6.0 89.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.395 -0.907 . . . . 43.21 111.101 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.2 m -97.03 -26.95 14.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.0 0.741 . . . . 62.32 113.0 -171.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 16.7 mm-40 -116.5 111.15 19.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.523 0.601 . . . . 72.13 110.427 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -127.63 123.62 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 74.25 109.371 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -174.13 -144.87 4.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.802 -1.19 . . . . 65.41 113.33 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -166.23 -172.08 33.13 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.613 -0.804 . . . . 44.0 113.038 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 4.1 m -148.76 139.0 22.39 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.544 0.738 . . . . 72.41 109.12 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.1 mp -124.23 117.45 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 121.2 -0.2 . . . . 73.21 110.464 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.501 ' HD1' ' HB2' ' A' ' 205' ' ' ALA . 11.6 t80 -108.41 120.33 42.09 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.542 -0.54 . . . . 54.4 109.542 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -125.72 133.05 52.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.472 -0.331 . . . . 74.23 110.45 -175.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -101.15 114.41 28.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.477 -0.329 . . . . 73.43 110.378 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 199' ' ' ASN . 8.3 t -73.77 171.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.373 -0.603 . . . . 71.15 109.373 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.555 ' H ' HG12 ' A' ' 198' ' ' VAL . 12.9 m120 -66.11 -30.87 71.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.756 0.312 . . . . 44.13 111.31 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 4.7 mptp? -92.81 -164.51 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 55.42 110.846 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 200' ' ' LYS . 32.0 tptt -79.11 39.09 0.37 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 73.44 110.496 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.965 ' HG ' ' HB3' ' A' ' 225' ' ' TYR . 4.5 tt -120.92 122.01 39.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 73.44 109.661 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.86 130.54 53.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.98 -0.555 . . . . 71.31 109.658 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.0 t -121.64 153.75 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.863 0.363 . . . . 73.4 110.63 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.02 147.79 37.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.498 0.666 . . . . 60.03 111.55 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 221' ' ' ILE . 71.3 t -112.13 132.79 59.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.158 -0.928 . . . . 71.1 109.517 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.3 p-10 -114.2 127.3 55.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.934 -1.136 . . . . 71.52 107.934 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 tp -144.15 129.58 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.556 -0.458 . . . . 71.31 110.819 -169.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.453 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -150.57 129.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.534 . . . . 71.21 111.216 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.648 ' CZ2' ' HA ' ' A' ' 215' ' ' SER . 3.5 t-105 -95.1 125.33 39.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.281 -1.007 . . . . 62.15 108.281 174.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 t -101.56 123.02 44.9 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.495 0.664 . . . . 64.52 110.312 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.7 127.32 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 53.02 111.533 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 153.96 -70.51 0.29 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.875 -0.89 . . . . 70.45 110.875 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.9 -166.01 1.43 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.387 -0.597 . . . . 75.04 109.387 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.648 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . 64.6 m -95.57 24.8 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.094 0.474 . . . . 74.23 110.808 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.07 111.82 20.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 73.34 109.779 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.6 t -99.82 135.97 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.05 0.452 . . . . 72.24 110.007 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -96.5 115.12 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.459 -0.571 . . . . 74.21 109.459 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.627 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 47.6 p90 -119.64 154.95 33.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.846 0.355 . . . . 74.34 110.736 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.39 23.12 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.849 -0.691 . . . . 73.31 111.943 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.854 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -135.49 140.64 44.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 121.035 -0.266 . . . . 74.34 110.458 177.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.763 ' HB3' HG13 ' A' ' 17' ' ' VAL . . . -133.69 131.13 39.13 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.345 0.403 . . . . 63.1 110.706 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.56 125.14 53.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.393 -0.367 . . . . 72.53 110.186 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -112.02 114.08 26.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 53.3 109.218 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.965 ' HB3' ' HG ' ' A' ' 202' ' ' LEU . 7.9 p90 -127.03 124.63 39.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.435 0.636 . . . . 53.31 111.24 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -82.32 106.87 14.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.048 -0.978 . . . . 72.32 108.946 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.54 HG21 ' HE1' ' A' ' 233' ' ' PHE . 14.8 tt -70.11 -43.98 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.692 0.627 . . . . 64.41 112.692 -167.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.773 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 14.4 t70 -171.79 -63.56 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.311 0.486 . . . . 73.23 112.311 -175.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 78.4 Cg_endo -93.4 -127.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.281 1.987 . . . . 53.32 112.911 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.5 p-10 -92.35 12.63 21.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.708 -0.678 . . . . 73.11 110.829 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.24 133.1 55.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.456 0.646 . . . . 62.14 111.322 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -121.36 140.26 52.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.833 -1.076 . . . . 54.21 109.34 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.54 ' HE1' HG21 ' A' ' 227' ' ' ILE . 88.1 m-85 -106.45 126.74 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.123 -0.325 . . . . 72.4 110.123 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 15.0 m -120.59 117.63 28.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.484 . . . . 63.55 110.067 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -118.42 140.48 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.829 -0.434 . . . . 54.34 109.829 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.62 ' HB2' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -143.74 148.03 35.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 62.25 111.251 -177.448 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.523 HG12 HG12 ' A' ' 221' ' ' ILE . 7.0 p -122.58 148.57 26.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 116.32 -0.4 . . . . 64.25 110.113 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -110.45 150.04 29.43 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.254 0.972 . . . . 71.05 109.591 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.627 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 6.8 p30 -37.98 -36.39 0.2 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.61 1.564 . . . . 71.22 114.815 -172.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.699 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.1 m -81.83 21.19 0.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.772 0.32 . . . . 64.4 111.033 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.3 m 68.43 31.54 4.9 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.634 -0.712 . . . . 71.54 111.203 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.836 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.6 mp -96.86 129.53 44.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.566 -0.454 . . . . 71.4 111.536 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.575 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -111.49 116.52 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.3 0.572 . . . . 63.22 110.834 -172.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -116.28 133.72 10.95 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.739 -0.664 . . . . 73.22 111.867 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 245' ' ' LEU . 1.3 pp -119.9 146.51 45.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.42 . . . . 52.24 110.678 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -134.17 133.44 6.87 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.612 -0.722 . . . . 73.31 111.778 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.717 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 19.4 m-85 -102.86 114.48 28.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.666 -0.864 . . . . 73.54 108.666 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 22.1 m -116.84 114.95 24.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.811 0.339 . . . . 63.21 110.417 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -132.45 137.51 47.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.854 0.359 . . . . 74.22 110.676 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.9 m -112.37 95.71 5.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.001 -0.545 . . . . 60.34 110.159 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 43.7 tp -82.05 88.34 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.268 -0.642 . . . . 75.02 109.268 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 75.1 mmtt 67.93 163.82 0.13 Allowed Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.259 -0.882 . . . . 72.24 110.273 -175.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 40.8 Cg_endo -69.23 64.29 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.355 2.037 . . . . 31.24 112.3 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -158.68 -45.43 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.911 -0.586 . . . . 74.34 112.315 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.6 mt -124.08 121.44 62.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 64.15 111.652 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 280' ' ' GLU . 37.1 ttmt -117.47 115.44 25.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.367 -0.605 . . . . 64.0 109.367 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.5 tp -100.44 130.53 46.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.424 -0.353 . . . . 73.44 110.521 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 30.0 m -129.98 111.25 12.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.554 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.922 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.21 122.84 44.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.892 -1.151 . . . . 72.24 107.892 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.9 m -124.39 139.58 53.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.971 0.415 . . . . 63.34 110.854 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.4 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -143.92 127.77 17.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.99 -0.55 . . . . 42.22 110.248 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.754 HD11 HD23 ' A' ' 242' ' ' LEU . 2.7 tm? -101.62 118.04 36.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.361 -0.977 . . . . 74.12 108.361 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -97.7 110.95 23.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.605 -0.887 . . . . 64.41 108.605 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.836 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.9 m-20 -68.62 102.34 1.47 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.711 -0.848 . . . . 53.32 108.711 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -64.9 -10.06 43.65 Favored Glycine 0 C--N 1.321 -0.293 0 CA-C-N 115.64 -0.709 . . . . 71.3 111.844 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -90.59 -25.34 20.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.206 -0.497 . . . . 73.31 111.092 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -161.5 24.25 0.12 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.105 1.52 . . . . 74.43 115.105 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 264' ' ' ASP . 0.2 OUTLIER -64.18 -46.47 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 120.079 1.309 . . . . 73.42 112.878 176.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.43 -25.92 62.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.067 0.461 . . . . 61.53 110.594 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.87 2.37 32.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 52.51 111.067 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.63 -103.12 0.34 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.141 -1.028 . . . . 71.2 112.856 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -158.78 167.28 34.69 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.082 -1.056 . . . . 32.33 113.223 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -111.47 150.12 30.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.66 -0.77 . . . . 73.52 109.593 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.666 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 43.6 mttm -93.7 137.18 33.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.689 -0.856 . . . . 71.03 108.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.7 tm? -125.66 133.06 52.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.755 0.312 . . . . 72.21 110.294 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.469 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.24 122.39 2.18 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.062 -0.815 . . . . 61.35 111.062 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.922 HD23 HD22 ' A' ' 259' ' ' LEU . 2.2 tm? -115.82 125.32 52.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.644 -0.502 . . . . 64.33 109.644 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -134.9 138.43 10.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.429 -0.891 . . . . 70.14 112.895 -175.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.85 132.39 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.777 -0.453 . . . . 74.31 109.777 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.728 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 46.4 mt-10 -109.85 110.88 22.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.812 -0.81 . . . . 70.25 108.812 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.567 ' HD1' HD13 ' A' ' 31' ' ' LEU . 16.4 t80 -104.16 141.6 35.96 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.589 -0.893 . . . . 74.14 108.589 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -135.56 119.79 17.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.935 0.398 . . . . 52.01 110.639 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.22 108.43 19.05 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.156 -0.683 . . . . 53.04 109.156 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 34' ' ' LYS . 36.2 mt -121.13 -69.02 0.86 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.843 -0.799 . . . . 40.33 108.843 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 114.679 -1.146 . . . . 70.3 108.532 177.228 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.683 0.278 . . . . 54.23 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.745 ' HB ' ' HE2' ' A' ' 119' ' ' LYS . 60.5 t -67.43 125.99 91.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.037 -0.529 . . . . 72.11 110.332 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 46.7 Cg_exo -57.23 153.98 36.87 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.39 2.727 . . . . 52.13 113.279 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.03 64.34 6.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.114 2.543 . . . . 72.05 112.047 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.604 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.9 p -69.63 -37.74 76.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.466 -0.788 . . . . 52.22 111.096 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.742 ' HB3' HG21 ' A' ' 143' ' ' VAL . 3.5 p90 -64.12 -22.03 66.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 72.31 111.278 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.69 -19.79 44.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.066 -0.516 . . . . 54.4 110.367 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.49 11.91 37.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.032 0.92 . . . . 71.32 109.333 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.979 HD21 ' HA3' ' A' ' 152' ' ' GLY . 3.3 tp -76.53 -14.3 60.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.007 -0.997 . . . . 73.11 110.849 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.66 26.23 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.44 -0.886 . . . . 65.41 113.291 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -68.93 -50.17 51.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.151 0.476 . . . . 71.5 110.525 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -57.34 -38.86 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.836 -0.62 . . . . 72.52 111.027 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.65 72.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 72.32 111.402 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.77 -39.91 84.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.6 -0.273 . . . . 74.33 111.518 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 14.7 t70 -58.59 -49.83 76.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.642 -0.254 . . . . 73.12 111.353 -175.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -70.23 -31.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.015 0.436 . . . . 73.21 110.867 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -72.64 -32.19 65.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 74.03 110.71 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -81.87 -25.84 34.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 65.12 110.73 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.573 ' HD3' ' O ' ' A' ' 16' ' ' ASP . 1.9 mptm? -85.17 20.06 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 63.35 110.865 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.601 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -99.61 -19.47 20.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 53.43 113.286 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -87.16 138.28 31.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.267 0.556 . . . . 74.15 112.141 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -152.35 109.65 0.42 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.22 -0.9 . . . . 63.04 111.709 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -103.73 14.99 29.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.785 0.326 . . . . 74.42 111.005 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.33 14.61 53.52 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 109.226 -1.55 . . . . 72.42 109.226 -166.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 46' ' ' SER . 5.3 tt -99.47 145.6 27.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.944 -1.128 . . . . 64.43 110.688 -168.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 277' ' ' LEU . 28.3 mm -102.49 125.26 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.986 -1.006 . . . . 61.11 110.198 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -107.79 120.01 41.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.332 -0.618 . . . . 63.41 109.332 175.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 279' ' ' LEU . 22.5 tp -114.44 147.56 39.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.837 0.351 . . . . 73.1 110.554 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.6 t70 -150.82 131.65 14.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 55.14 109.768 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.942 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -126.84 123.59 37.67 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 97.1 mttt -132.65 124.97 29.29 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.839 -0.344 . . . . 63.34 110.988 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 41' ' ' PHE . 8.8 t -135.83 129.95 33.2 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.285 -0.635 . . . . 52.15 109.285 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.728 ' HB3' HH12 ' A' ' 63' ' ' ARG . 90.3 mttt -118.3 131.17 56.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.965 -0.562 . . . . 53.12 109.969 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -132.91 150.26 52.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.238 -0.437 . . . . 54.14 110.513 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.91 2.37 46.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.799 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -100.08 24.75 8.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 54.24 111.521 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.3 -5.89 82.64 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.328 -0.939 . . . . 64.42 113.451 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.42 127.78 46.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.179 0.99 . . . . 70.14 111.764 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.3 117.6 11.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.507 -0.923 . . . . 74.43 108.507 164.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' HB2' HG22 ' A' ' 33' ' ' THR . 96.0 m-85 -110.32 125.6 53.34 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.588 -0.445 . . . . 75.04 110.768 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 20.6 m -125.18 116.11 21.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 61.52 109.934 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 6.4 m -108.76 123.28 48.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.051 -0.722 . . . . 75.21 109.051 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -130.03 126.41 37.64 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.006 -0.368 . . . . 74.05 110.006 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.14 156.66 26.97 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.946 -1.121 . . . . 61.1 112.576 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.593 ' HB3' HD21 ' A' ' 26' ' ' LEU . 16.6 m -137.98 132.35 32.15 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.308 -0.627 . . . . 33.35 109.308 176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -144.32 130.04 19.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.862 0.363 . . . . 71.42 110.593 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 46.1 t30 -80.64 142.02 34.39 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.444 -0.576 . . . . 73.24 109.444 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -64.04 -19.37 65.16 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.968 0.413 . . . . 63.01 111.255 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -70.62 -13.6 62.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 64.14 110.442 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m 71.56 -3.52 2.12 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.726 -0.67 . . . . 70.51 111.726 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -73.06 -27.46 61.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.217 -0.447 . . . . 71.12 110.981 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.28 101.66 6.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 71.21 110.034 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -125.66 120.69 58.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.985 -0.552 . . . . 70.13 110.11 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -131.3 125.03 31.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.955 -0.387 . . . . 65.43 109.955 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.83 155.19 20.06 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.266 -0.969 . . . . 75.23 112.409 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 p -146.8 141.21 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.111 0.482 . . . . 74.53 110.441 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.38 122.54 42.03 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.926 -1.139 . . . . 73.25 107.926 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 28.0 mt-10 -116.98 119.96 36.91 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.956 -0.565 . . . . 73.1 109.82 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -109.78 120.99 44.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.724 -0.671 . . . . 70.15 109.841 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 42.9 tttp -117.08 132.51 56.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.067 -0.716 . . . . 65.3 109.067 176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 70' ' ' THR . 37.9 t80 -100.19 121.6 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.044 -1.095 . . . . 74.22 108.044 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.728 HH12 ' HB3' ' A' ' 34' ' ' LYS . 10.6 ttp180 -123.72 107.3 11.31 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.538 0.685 . . . . 73.05 111.094 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.4 ' HB2' ' HE2' ' A' ' 62' ' ' TYR . 63.3 t-105 -113.55 115.58 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.79 -1.096 . . . . 64.45 108.886 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m 70.93 139.13 0.04 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.961 0.788 . . . . 72.53 109.59 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 2.7 tp10 -65.58 101.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.692 -0.485 . . . . 71.53 109.692 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.24 68.92 0.59 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.378 -0.828 . . . . 72.14 110.684 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.04 -76.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.382 -1.087 . . . . 74.34 110.382 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -122.11 130.18 53.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.743 0.306 . . . . 61.13 110.247 173.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.797 HG23 ' HB ' ' A' ' 86' ' ' THR . 9.0 t -138.44 135.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.425 0.631 . . . . 75.41 112.089 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 85.2 m-85 -105.75 133.77 49.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.844 -0.798 . . . . 74.43 108.844 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.4 m -120.84 119.31 32.29 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.71 -0.396 . . . . 71.24 111.465 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 28.1 mt-10 -130.96 152.2 50.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.668 -0.697 . . . . 73.05 109.803 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -160.43 104.38 1.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 71.22 110.917 178.196 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.975 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 48.8 t90 -98.53 127.94 44.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.298 -0.41 . . . . 71.15 110.358 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.86 136.84 38.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.488 -0.93 . . . . 71.01 108.488 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -61.8 -25.83 67.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 72.22 111.862 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.7 -38.17 5.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.118 0.784 . . . . 72.12 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.27 -90.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.347 0.869 . . . . 55.31 113.347 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 m -85.22 123.6 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.811 0.671 . . . . 73.33 112.811 -166.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.975 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -108.48 119.07 38.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.624 -0.51 . . . . 64.24 109.624 168.301 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -115.53 156.61 15.54 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.643 -0.789 . . . . 41.11 112.776 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 9.8 t -172.88 148.72 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.681 -0.489 . . . . 74.42 109.681 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 100' ' ' ASP . 12.2 mm-40 165.58 -155.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.585 1.154 . . . . 73.4 110.491 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.495 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -131.58 138.97 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.49 0.552 . . . . 64.5 112.49 -165.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.797 ' HB ' HG23 ' A' ' 70' ' ' THR . 23.1 m -127.77 131.75 49.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.337 -0.392 . . . . 53.1 110.003 175.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 97' ' ' LEU . 3.9 p -129.95 129.8 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 64.41 111.672 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.56 117.87 30.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.278 -1.008 . . . . 73.44 108.278 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -87.28 140.18 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.26 -0.576 . . . . 71.42 111.642 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.84 -25.85 15.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.279 -0.873 . . . . 74.42 110.655 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.9 tp -67.13 -57.23 7.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.032 -0.729 . . . . 74.14 109.032 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.54 76.17 5.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.298 -1.001 . . . . 70.34 108.298 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.67 123.11 13.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.554 -0.748 . . . . 71.23 110.683 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . 100.6 -0.91 55.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.665 -0.698 . . . . 73.42 112.319 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.3 tp -91.41 131.1 37.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 51.13 110.201 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -121.68 111.24 16.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.328 -0.851 . . . . 72.34 109.85 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.437 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.9 mm? -100.79 126.34 47.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.083 -0.71 . . . . 72.35 109.083 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 23.6 m -128.87 118.34 22.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.119 0.485 . . . . 75.3 111.749 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.637 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 77.7 m-85 -111.06 116.22 30.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.85 -1.167 . . . . 72.23 107.85 170.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.649 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.5 p-10 -130.56 128.19 40.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.846 0.355 . . . . 73.44 110.575 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 t -119.57 148.81 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.732 0.301 . . . . 63.25 110.528 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 7.9 p -133.04 134.54 44.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.301 -0.409 . . . . 60.14 110.478 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.637 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 9.8 m-85 -111.21 138.94 47.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.207 -0.294 . . . . 75.03 110.207 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.2 p -122.47 107.85 34.05 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.834 0.35 . . . . 64.21 110.195 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.91 -1.13 9.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.986 2.457 . . . . 74.33 112.76 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -63.86 -61.59 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.38 0.609 . . . . 73.52 109.51 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.516 ' HB ' ' HG3' ' A' ' 109' ' ' LYS . 42.7 m -91.76 -27.27 18.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.283 -0.871 . . . . 54.3 109.958 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.5 9.4 60.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.666 -0.778 . . . . 54.31 111.843 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.587 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -94.16 148.94 21.69 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.802 0.334 . . . . 61.04 110.617 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.431 ' CB ' ' HD1' ' A' ' 103' ' ' PHE . 18.6 ptpt -114.23 152.74 30.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 44.33 110.796 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.587 ' OD1' ' HE2' ' A' ' 109' ' ' LYS . 2.8 m-20 -116.7 122.58 44.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.952 -0.758 . . . . 71.31 108.952 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.33 114.92 29.33 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.343 -0.614 . . . . 53.42 109.343 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.408 ' HD2' ' OD2' ' A' ' 130' ' ' ASP . 50.1 tttm -115.03 137.98 51.38 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.211 0.529 . . . . 74.23 110.606 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.53 HG23 ' HB3' ' A' ' 129' ' ' MET . 3.2 tp -127.3 126.0 66.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.431 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 24.4 ttpp -118.9 120.31 36.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.202 0.525 . . . . 72.02 110.208 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.8 p -107.34 116.89 32.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.604 -0.887 . . . . 73.53 108.604 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.37 135.78 8.19 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.985 -1.103 . . . . 42.32 112.106 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -126.78 124.81 40.56 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.442 -0.577 . . . . 73.1 109.442 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.745 ' HE2' ' HB ' ' A' ' 3' ' ' VAL . 15.9 ptmt -109.08 121.71 45.73 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.486 0.66 . . . . 72.44 109.921 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 120' ' ' ARG . 22.2 mmt180 -104.56 155.92 18.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.013 -1.106 . . . . 72.1 108.013 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -54.68 -28.57 48.52 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.416 0.447 . . . . 74.21 112.184 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.34 -15.38 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.548 -0.296 . . . . 74.43 111.692 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -146.35 135.56 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.601 -0.44 . . . . 72.42 111.74 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.739 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 43.8 t30 -122.63 120.86 34.99 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.764 -0.585 . . . . 72.24 111.737 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.4 127.03 53.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.696 0.284 . . . . 73.14 111.213 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.39 125.64 4.08 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.037 -0.601 . . . . 54.21 112.047 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 49.7 m -113.32 112.11 23.14 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.578 -0.366 . . . . 63.41 111.275 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 9.9 m-20 -96.2 147.46 23.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 73.44 109.994 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.53 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.5 ttt -139.77 120.41 14.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.627 -0.261 . . . . 75.44 110.543 173.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 113' ' ' LYS . 35.4 m-20 -90.72 117.45 29.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.762 -0.829 . . . . 73.44 108.762 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.18 97.53 9.26 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.079 0.466 . . . . 63.43 110.142 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.03 150.23 26.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.629 -0.714 . . . . 55.34 109.212 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.77 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -72.27 -19.9 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.98 0.363 . . . . 74.24 111.98 -175.437 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.56 -18.96 21.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 74.4 111.047 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 167.8 128.93 1.03 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.519 -0.848 . . . . 73.21 112.578 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.0 150.56 26.65 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.77 2.314 . . . . 61.22 112.657 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 m -126.8 134.01 50.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.566 . . . . 61.1 110.08 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 118.72 56.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.017 0.437 . . . . 72.2 109.87 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 12.1 ttp180 -111.24 130.18 55.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.622 -0.51 . . . . 71.44 109.622 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.19 132.49 10.94 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.993 -1.099 . . . . 73.33 111.406 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.84 115.47 23.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.361 -0.607 . . . . 61.44 109.361 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 123' ' ' ILE . 8.9 tp -121.0 124.31 44.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.989 -0.55 . . . . 70.24 110.383 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.742 HG21 ' HB3' ' A' ' 7' ' ' TYR . 77.3 t -110.92 131.78 61.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 52.1 109.809 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.5 mm? -108.22 137.6 45.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.347 -0.842 . . . . 75.13 108.93 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -125.86 117.38 2.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.582 -0.736 . . . . 41.32 111.537 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 90.0 m-85 -136.32 148.42 47.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.022 -0.733 . . . . 64.23 109.022 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.69 99.84 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 65.13 110.673 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.97 -30.87 9.53 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.564 -0.744 . . . . 74.32 111.866 -176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.727 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 85.5 m95 -105.95 122.06 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.221 0.534 . . . . 74.52 111.703 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.604 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.6 tm? -110.61 149.37 30.51 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.828 -1.545 . . . . 73.53 106.828 172.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -157.44 160.14 38.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.67 -0.812 . . . . 73.35 111.248 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.979 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -156.8 133.34 3.58 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.047 -0.979 . . . . 62.43 110.882 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.434 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 34.0 m-85 -130.75 117.81 19.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.087 0.47 . . . . 74.04 110.205 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 168' ' ' ASN . 39.7 mt-30 -113.77 129.06 56.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.639 -0.71 . . . . 74.04 109.976 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.4 133.59 34.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.534 -0.303 . . . . 73.42 110.2 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 6.7 t30 -113.67 119.43 37.4 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.753 -0.462 . . . . 73.54 109.753 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 83.5 t80 -105.4 124.06 48.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.107 -0.497 . . . . 74.3 110.249 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.436 ' OE1' ' HE2' ' A' ' 161' ' ' LYS . 35.3 tt0 -86.96 97.73 10.86 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.672 -0.862 . . . . 75.41 108.672 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.1 m -71.53 -21.88 61.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 113.673 -1.603 . . . . 72.31 111.188 173.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.41 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -57.88 -34.01 69.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.735 -0.839 . . . . 63.5 108.735 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.574 ' HG2' ' H ' ' A' ' 162' ' ' SER . 17.0 ttmm -112.9 -157.45 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.52 -1.289 . . . . 60.02 107.52 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.574 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 5.6 p -109.74 27.67 9.34 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 122.034 -0.416 . . . . 50.44 111.703 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -143.83 147.65 34.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 117.747 -1.581 . . . . 75.43 114.406 -161.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.636 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 69.4 t -73.75 124.26 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.265 -0.88 . . . . 51.43 109.456 171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.8 p -95.94 -31.97 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.629 -0.26 . . . . 74.03 111.581 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 64.2 mt-30 -127.31 131.71 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.743 0.306 . . . . 72.11 110.785 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 17.7 m -121.86 129.35 52.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.754 -0.461 . . . . 65.25 109.754 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 27.9 t-20 -136.87 121.33 18.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.766 -0.457 . . . . 70.13 109.766 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.645 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 46.4 m-85 -121.78 140.63 52.11 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.948 -0.301 . . . . 71.12 110.59 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.65 139.6 38.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.323 -0.399 . . . . 44.22 110.706 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 12.4 t -132.3 152.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.187 -0.672 . . . . 64.41 109.187 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.18 116.83 1.36 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.804 -0.712 . . . . 74.1 112.037 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -113.39 121.23 43.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.807 -0.812 . . . . 64.35 108.807 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 129.72 56.5 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.983 0.896 . . . . 74.15 111.892 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.9 m -110.13 161.8 15.21 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 106.591 -1.633 . . . . 75.53 106.591 166.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -57.51 -46.61 83.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.076 0.398 . . . . 73.43 111.9 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -106.18 -1.68 23.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.7 0.259 . . . . 71.01 111.7 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.2 117.42 14.52 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 110.489 -0.189 . . . . 70.24 110.489 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -118.86 124.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.145 -0.622 . . . . 74.52 110.987 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.8 tt -118.9 138.1 52.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.548 0.689 . . . . 74.23 111.652 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.812 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 64.2 m80 -114.72 150.51 35.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.124 -0.944 . . . . 74.21 108.98 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.572 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 27.8 m -123.33 138.68 54.56 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.265 -0.642 . . . . 72.41 109.265 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -134.27 140.97 46.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 65.0 111.322 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 47.0 t -133.47 115.55 22.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.283 -0.871 . . . . 72.4 110.019 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.782 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.0 t30 -103.62 99.46 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.384 0.611 . . . . 73.23 110.059 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 46.0 m-20 58.01 -161.48 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.886 -1.052 . . . . 73.41 110.804 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.52 -5.24 87.95 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.263 -0.881 . . . . 74.12 111.056 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 25.1 p -88.54 -24.65 22.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.039 0.755 . . . . 73.01 113.039 -173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 5.2 tm-20 -136.25 125.98 25.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.801 -0.36 . . . . 44.4 111.154 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.4 123.92 26.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 74.12 109.198 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.71 -146.2 4.82 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.238 -0.982 . . . . 61.24 113.003 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -172.82 -171.16 37.32 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.859 -0.686 . . . . 64.34 112.962 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.812 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 41.3 t -147.19 140.13 25.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.283 -0.636 . . . . 72.42 109.283 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.9 mp -120.13 118.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 110.07 -0.344 . . . . 75.25 110.07 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -108.91 120.42 42.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.301 0.572 . . . . 75.52 109.796 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 196' ' ' GLN . 11.1 mm100 -123.02 112.59 17.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.45 -0.795 . . . . 64.14 110.812 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -108.68 127.76 54.26 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.097 -0.705 . . . . 75.35 109.097 177.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 202' ' ' LEU . 1.1 m -111.57 151.79 13.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.091 0.472 . . . . 64.43 110.473 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -63.4 -20.19 65.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 64.32 111.829 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.79 47.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.363 0.505 . . . . 53.23 112.363 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 226' ' ' GLN . 48.9 mmtm 64.58 23.23 12.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 63.02 113.08 169.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 225' ' ' TYR . 7.2 tt -126.79 134.61 50.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 73.33 110.764 -174.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -126.28 134.96 51.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.144 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 223' ' ' ALA . 24.7 m -122.91 141.75 51.56 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.324 -0.251 . . . . 64.31 110.324 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.41 135.58 48.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.235 0.541 . . . . 54.11 110.412 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.742 HG22 HG22 ' A' ' 221' ' ' ILE . 93.2 t -114.6 132.87 62.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.62 -0.718 . . . . 73.22 110.036 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -113.61 126.98 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.181 -1.044 . . . . 73.35 108.181 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 218' ' ' ARG . 5.0 tp -140.8 128.77 21.94 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 110.133 -0.321 . . . . 63.31 110.133 -170.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.435 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.96 135.83 19.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.0 0.428 . . . . 75.11 111.696 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -111.23 124.16 51.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.812 -0.631 . . . . 74.02 109.633 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.8 p -95.66 112.92 24.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 73.45 110.901 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.39 143.79 52.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 73.45 110.437 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.99 -18.19 50.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.978 -0.849 . . . . 54.31 110.978 -173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -136.36 164.24 28.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.395 -0.403 . . . . 70.31 110.136 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.6 p -92.46 16.4 11.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.416 0.627 . . . . 74.55 109.483 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.02 111.01 17.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.285 -0.87 . . . . 72.24 111.637 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 25.1 m -96.17 122.67 39.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.204 -1.036 . . . . 54.14 108.204 168.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.405 ' O ' HD12 ' A' ' 208' ' ' LEU . 28.8 mmm180 -105.52 116.9 32.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.592 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 23.9 p90 -114.03 152.53 30.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.243 0.544 . . . . 74.54 110.387 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.67 140.38 7.63 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.921 -1.036 . . . . 72.55 110.724 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 206' ' ' VAL . 15.8 pt -131.74 134.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.729 0.265 . . . . 63.13 110.512 -177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -138.63 130.07 27.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.827 0.346 . . . . 62.03 110.583 174.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -120.85 125.66 48.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.53 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -107.24 114.96 29.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.509 0.671 . . . . 62.2 110.025 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.694 ' HB2' ' HG ' ' A' ' 202' ' ' LEU . 45.3 t80 -129.17 126.84 40.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.227 -0.897 . . . . 74.0 110.542 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.411 ' CG ' ' HB3' ' A' ' 201' ' ' LYS . 16.8 pt20 -77.14 123.75 26.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.373 -0.603 . . . . 70.25 109.373 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 233' ' ' PHE . 73.7 mt -70.14 -55.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.933 -0.576 . . . . 75.43 111.22 -172.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.637 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.2 t70 177.07 -54.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 123.66 0.6 . . . . 72.31 110.806 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 96.5 Cg_endo -83.75 -133.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.984 1.789 . . . . 74.3 112.051 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 9.8 m-20 -92.39 11.83 24.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 54.23 110.709 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.1 133.8 54.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.54 . . . . 75.02 111.082 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.89 142.14 47.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.182 -0.917 . . . . 61.05 109.43 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.489 ' HB2' HD11 ' A' ' 227' ' ' ILE . 70.9 t80 -106.78 132.38 52.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.183 0.516 . . . . 72.44 110.262 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 17.7 m -123.12 127.2 48.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.528 -0.76 . . . . 63.4 110.028 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -111.94 141.35 45.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.65 -0.5 . . . . 63.43 109.65 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 20.9 pttm -141.1 153.87 45.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.521 0.2 . . . . 70.25 110.868 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.625 HG12 HG12 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -147.47 155.15 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 74.42 110.187 175.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.764 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.1 t-20 -125.55 148.01 49.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.899 -0.778 . . . . 63.43 108.899 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.592 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 26.4 t-20 -41.29 -37.64 1.01 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.645 1.216 . . . . 64.23 113.36 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.1 m -78.49 27.45 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.752 -0.204 . . . . 61.32 111.285 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.7 p 57.93 40.83 25.36 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.956 0.902 . . . . 64.51 110.605 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.819 ' HB3' HD11 ' A' ' 262' ' ' LEU . 56.4 mt -97.75 117.09 31.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.802 -0.635 . . . . 72.11 109.744 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.571 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.9 mp -103.27 117.99 49.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 109.776 -0.453 . . . . 52.41 109.776 -174.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.52 148.25 17.58 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.358 -0.925 . . . . 43.33 113.122 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.72 150.62 38.78 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.675 -0.861 . . . . 74.13 108.675 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.33 123.17 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.533 -0.841 . . . . 61.2 111.591 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.37 116.27 19.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.235 0.54 . . . . 72.32 110.225 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.8 t -116.05 136.72 52.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.543 -0.753 . . . . 74.54 110.732 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -132.87 134.28 44.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 65.24 110.68 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.2 t -89.03 115.34 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.943 -0.762 . . . . 73.23 108.943 172.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 251' ' ' LEU . 5.6 mp -75.19 -59.24 2.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.585 0.707 . . . . 45.01 109.517 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -119.73 149.69 48.87 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 106.991 -1.485 . . . . 55.11 106.991 171.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.8 99.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.391 2.061 . . . . 61.04 112.181 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.19 -22.05 6.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.769 -0.65 . . . . 72.12 112.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 252' ' ' LYS . 3.4 mp -106.26 119.25 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.376 -0.485 . . . . 71.05 109.981 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -120.62 120.65 36.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.679 . . . . 74.31 111.473 -172.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.2 tp -100.95 128.57 46.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.101 -0.703 . . . . 52.34 109.101 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.4 t -126.16 113.99 17.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.518 0.675 . . . . 73.32 111.125 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.955 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -99.64 124.12 44.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.21 -1.033 . . . . 75.52 108.21 175.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 22.6 t -127.32 143.16 51.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.945 0.402 . . . . 74.15 110.079 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.48 154.52 45.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.804 -0.443 . . . . 62.1 109.804 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.9 tm? -130.84 118.59 20.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.341 -0.985 . . . . 72.21 108.341 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.646 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -97.4 106.69 19.05 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.343 -1.355 . . . . 72.34 107.343 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 5.2 m-20 -71.62 105.76 3.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.126 -0.694 . . . . 62.32 109.126 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.14 -13.89 10.28 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.256 -0.497 . . . . 65.22 112.885 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.47 -18.39 26.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.728 0.299 . . . . 63.24 110.946 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 4.2 m-20 -120.89 -41.31 2.56 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.72 0.637 . . . . 73.41 112.72 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -59.35 -25.81 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.429 0.529 . . . . 75.35 112.429 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -63.59 -30.36 71.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 72.03 110.431 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.34 -16.76 15.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 45.43 110.677 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.95 94.58 1.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.019 -0.537 . . . . 64.33 112.265 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 177.93 86.43 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.661 -0.78 . . . . 34.45 112.498 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -113.98 144.65 42.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.658 0.266 . . . . 65.24 110.639 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 25.6 mmtp -97.35 144.11 27.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.507 -0.315 . . . . 72.31 110.238 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 275' ' ' LEU . 1.7 tm? -134.85 126.28 28.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.835 0.35 . . . . 71.25 110.105 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 126.78 5.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 43.24 111.419 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.955 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -115.26 134.02 55.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.739 -0.467 . . . . 71.42 109.739 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -137.59 144.57 16.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.419 -0.896 . . . . 54.53 113.25 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.703 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.3 mm? -123.98 131.43 53.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.419 -0.585 . . . . 63.52 109.419 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.72 112.22 15.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.346 -0.613 . . . . 73.52 109.346 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.942 ' HB2' HD22 ' A' ' 31' ' ' LEU . 93.6 m-85 -106.9 106.38 16.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.112 -0.495 . . . . 70.12 110.308 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.556 ' HG2' HD23 ' A' ' 284' ' ' LEU . 29.7 tt0 -99.73 110.62 23.01 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.474 -0.565 . . . . 72.1 109.474 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -97.95 108.67 21.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.419 0.628 . . . . 63.31 110.967 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 282' ' ' GLN . 3.0 mm? -135.14 -38.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.837 -1.074 . . . . 72.11 108.779 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.825 -1.08 . . . . 74.14 109.519 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.178 -0.304 . . . . 75.41 110.178 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 119' ' ' LYS . 21.3 t 64.47 96.97 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.548 -0.751 . . . . 51.2 111.242 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.9 Cg_endo -69.42 142.23 48.84 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.794 2.329 . . . . 73.32 112.388 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 19.3 Cg_exo -66.39 90.96 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.807 2.338 . . . . 61.42 111.974 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.549 ' HB ' HD21 ' A' ' 150' ' ' LEU . 2.3 p -84.17 -2.57 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.443 0.639 . . . . 64.13 110.781 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -57.92 -24.63 58.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 72.23 109.753 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.98 -26.21 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.11 110.078 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.41 -4.53 48.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 71.33 110.574 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD23 ' CD1' ' A' ' 150' ' ' LEU . 66.3 mt -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 72.13 110.905 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.32 40.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.543 -1.313 . . . . 54.31 114.247 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 37.7 tttm -57.95 -54.57 45.47 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.462 0.631 . . . . 64.33 109.669 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 p -58.72 -39.33 80.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.568 -0.742 . . . . 62.11 111.676 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.39 70.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.532 -0.304 . . . . 72.32 111.195 -176.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -68.02 -36.23 79.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 73.13 110.588 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 9.9 t70 -68.43 -48.69 63.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.373 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.26 -39.33 78.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.445 -0.343 . . . . 71.53 111.213 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.8 -41.35 78.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.939 -0.393 . . . . 75.41 109.939 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m 70.78 94.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.378 -0.828 . . . . 62.22 111.998 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -110.76 -12.22 14.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 54.04 110.548 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.85 1.2 89.01 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.864 -0.684 . . . . 24.13 112.536 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.668 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 87.8 m-85 -133.84 144.17 48.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.344 -0.613 . . . . 73.1 109.344 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.94 34.0 0.4 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.182 -1.008 . . . . 51.2 112.796 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.2 -1.79 38.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.259 0.552 . . . . 75.32 109.973 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 83.78 12.95 76.44 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.254 -1.139 . . . . 43.04 110.254 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 48' ' ' ASN . 6.8 tp -131.24 179.22 6.14 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.664 0.745 . . . . 63.43 112.015 -169.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.916 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -110.26 147.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.815 -1.084 . . . . 75.45 109.492 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.562 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 14.6 ptpt -138.41 154.38 48.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 50.24 109.577 171.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.7 tt -140.09 145.09 37.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.695 0.284 . . . . 73.25 111.12 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -131.11 128.35 39.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.553 0.692 . . . . 73.44 109.901 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -108.43 124.5 50.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.267 -0.879 . . . . 71.34 108.879 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -125.56 123.33 38.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.798 0.332 . . . . 63.23 110.122 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.9 m -137.95 121.56 17.37 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.643 -0.873 . . . . 63.44 108.643 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -137.07 143.82 42.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.551 0.691 . . . . 74.45 112.276 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -139.1 137.49 36.22 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.949 -1.13 . . . . 50.42 107.949 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.75 49.32 1.32 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.846 0.832 . . . . 72.44 110.756 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -122.46 22.64 9.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.677 -1.147 . . . . 71.02 109.099 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.695 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 91.14 -8.24 79.79 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 119.4 -0.667 . . . . 54.55 113.751 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.69 127.38 48.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.514 1.157 . . . . 73.42 112.643 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.677 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 22.9 mt-10 -139.54 118.85 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.891 -0.411 . . . . 63.52 109.891 165.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.95 121.31 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.79 0.329 . . . . 72.23 110.271 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.859 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.4 m -126.95 132.37 50.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 73.24 111.18 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 m -125.36 140.45 52.8 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.39 -0.596 . . . . 51.14 109.39 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.8 m -147.57 126.11 12.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.785 0.326 . . . . 51.42 110.479 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.681 ' HA3' ' HA2' ' A' ' 56' ' ' GLY . . . -164.17 -167.14 24.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 73.2 112.25 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 39.0 m -127.59 158.54 37.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 55.14 110.505 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -135.08 135.58 41.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 75.22 110.328 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.67 ' HA ' HD11 ' A' ' 26' ' ' LEU . 24.4 t-20 -76.23 138.06 40.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.977 -0.556 . . . . 44.3 109.648 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.499 ' HA ' HD13 ' A' ' 27' ' ' ILE . 1.9 m -46.63 138.95 5.54 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.14 0.9 . . . . 72.4 111.983 -176.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 72.05 29.74 2.3 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.899 0.749 . . . . 72.03 110.321 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p 49.95 37.73 14.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.651 0.781 . . . . 73.21 112.037 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -72.61 -35.14 67.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.268 -0.423 . . . . 62.2 111.39 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -160.5 118.73 2.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.935 -0.395 . . . . 54.22 109.935 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -117.01 120.97 66.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.844 0.354 . . . . 71.5 110.282 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.8 m -136.79 129.55 30.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.272 -0.422 . . . . 74.22 110.359 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.681 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -138.94 153.94 22.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.244 -0.979 . . . . 54.32 113.092 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.603 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 14.1 p -101.54 163.54 12.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.431 -0.581 . . . . 64.33 109.431 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tp -121.03 150.19 41.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.515 0.674 . . . . 61.11 112.044 -170.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.859 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 61.8 mt-10 -126.94 120.07 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.981 -1.009 . . . . 70.4 108.832 174.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -103.52 118.82 37.63 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 34.1 mtmm -117.23 144.02 45.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.149 0.5 . . . . 74.31 110.322 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 32.9 m-85 -116.19 120.15 38.06 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.775 -0.824 . . . . 72.14 108.775 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.536 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 20.5 ttm-85 -106.72 107.27 18.21 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.56 0.695 . . . . 73.21 111.084 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 68.4 t-105 -114.35 107.62 15.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.375 -1.284 . . . . 74.02 110.12 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -94.28 66.78 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.322 0.582 . . . . 75.33 111.93 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -85.19 -37.36 20.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.791 -1.188 . . . . 70.43 107.791 166.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' CB ' ' HA ' ' A' ' 90' ' ' GLN . 3.7 m-85 -157.34 -43.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.153 -1.385 . . . . 74.43 108.717 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.8 74.81 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.5 -0.773 . . . . 24.13 112.072 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -111.44 130.05 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 75.24 110.502 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 41.7 m -137.93 113.15 9.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.033 -0.531 . . . . 73.31 110.434 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 43.4 t80 -99.65 132.08 45.22 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.857 -0.794 . . . . 65.03 108.857 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 28.6 m -128.05 121.4 29.61 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.023 0.44 . . . . 70.03 111.661 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.63 120.54 42.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.715 -0.846 . . . . 71.12 108.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 26.1 ttpt -113.46 94.83 5.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.14 -0.482 . . . . 62.4 109.803 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.514 ' O ' ' HB2' ' A' ' 57' ' ' SER . 3.9 t90 -100.15 127.08 46.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.259 -0.428 . . . . 75.24 109.878 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.603 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 92.7 m-20 -105.46 166.99 10.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 75.13 110.477 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 p -67.5 -16.53 64.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.133 0.492 . . . . 54.53 111.593 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 13.4 m-20 -78.72 -2.53 39.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.642 . . . . 73.31 110.559 175.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 54.5 m-80 77.81 14.63 1.63 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.479 -0.782 . . . . 75.41 111.935 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -89.13 141.25 28.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.599 -0.519 . . . . 64.1 109.599 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.04 119.35 34.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.376 -0.375 . . . . 71.12 110.488 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.86 105.99 3.35 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.787 -0.925 . . . . 63.12 110.787 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -94.74 104.94 16.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.034 0.445 . . . . 73.35 110.501 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.738 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 40.7 mt-10 -110.84 125.46 53.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.627 -0.715 . . . . 63.21 110.363 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -113.95 120.94 65.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.653 -0.869 . . . . 62.33 108.653 171.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.1 m -120.92 123.61 42.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.851 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.77 120.45 50.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 50.21 109.971 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' ' HB2' ' A' ' 96' ' ' LYS . 43.9 mt-10 -125.24 136.14 53.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.499 -0.318 . . . . 75.12 110.66 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 m-20 63.68 23.66 13.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.765 -0.652 . . . . 73.42 112.046 168.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 67' ' ' TYR . 56.5 tt0 -63.98 -79.31 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 73.34 111.227 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.93 -73.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 64.23 109.604 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.32 96.46 9.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.609 -0.515 . . . . 51.13 109.609 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 29.1 ptt180 -57.24 137.17 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 75.12 110.744 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.655 ' HA2' ' HB2' ' A' ' 119' ' ' LYS . . . 103.02 -24.45 30.5 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.032 -0.985 . . . . 33.42 111.432 -169.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.34 -0.506 . . . . 64.44 109.711 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HG2' ' HA3' ' A' ' 117' ' ' GLY . 10.2 ptpp? -121.33 131.76 54.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 65.43 109.809 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 96' ' ' LYS . 2.1 mm? -124.53 126.34 45.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.566 -0.531 . . . . 62.04 109.566 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.8 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 18.5 m -130.19 119.02 22.29 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.519 -0.31 . . . . 75.32 110.346 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.578 ' HB3' HG22 ' A' ' 85' ' ' ILE . 86.6 t80 -109.72 114.93 28.93 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.624 -0.51 . . . . 71.24 109.624 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.738 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 4.1 t70 -110.86 122.62 48.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.576 -0.738 . . . . 71.41 109.55 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 8.9 t -126.31 120.41 29.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.81 -0.441 . . . . 74.51 109.81 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 18.5 m -95.8 122.16 38.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.317 -0.623 . . . . 64.4 109.317 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -120.79 119.28 32.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 64.23 110.328 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 t -120.02 103.15 45.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.31 -0.626 . . . . 64.31 109.31 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.44 -37.54 38.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.093 2.529 . . . . 54.43 112.873 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -60.25 -40.7 91.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 62.51 111.879 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 p -96.26 -29.2 14.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.867 0.365 . . . . 63.43 111.338 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.3 59.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.113 -0.795 . . . . 73.42 111.113 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 137.05 33.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.849 0.356 . . . . 70.41 110.726 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' SER . 60.1 pttt -144.8 129.47 18.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.844 -0.616 . . . . 71.01 109.99 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 101' ' ' SER . 19.0 m120 -119.97 149.84 41.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 72.03 109.385 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.83 122.49 17.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.352 -0.24 . . . . 74.45 110.352 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.738 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 14.0 pttp -128.37 147.56 50.64 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.26 -0.274 . . . . 74.23 110.26 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.41 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -126.61 126.36 68.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.777 0.799 . . . . 75.34 110.263 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HD3' ' HB2' ' A' ' 128' ' ' ASP . 2.8 tppp? -99.61 120.73 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.843 -1.071 . . . . 64.43 109.442 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.461 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 8.5 m -118.54 118.94 33.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.393 -0.595 . . . . 73.23 109.393 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.611 ' HA3' ' HG2' ' A' ' 96' ' ' LYS . . . -129.53 148.14 18.19 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.754 -1.213 . . . . 41.55 113.966 -173.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -125.57 121.73 34.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.021 -0.589 . . . . 71.51 109.496 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 9.7 mtmp? -117.84 121.66 41.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.317 0.579 . . . . 73.32 111.977 -177.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.616 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 22.3 tpp180 -108.6 164.22 12.55 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.532 -1.284 . . . . 64.11 107.532 165.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -55.55 -30.41 60.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.194 0.452 . . . . 74.43 112.167 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -116.76 8.07 13.6 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.901 -0.32 . . . . 72.22 111.365 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 2.1 mm -138.61 124.97 25.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.94 0.4 . . . . 72.23 111.708 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.775 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 52.3 t30 -123.45 116.16 22.77 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.344 -0.542 . . . . 73.14 110.572 175.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.454 ' CD2' HD13 ' A' ' 142' ' ' LEU . 3.6 mm? -109.88 137.26 47.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 61.43 110.298 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.49 114.66 0.69 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.77 -0.729 . . . . 63.21 112.169 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 116' ' ' THR . 22.3 p -112.59 116.8 30.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.095 0.448 . . . . 63.44 110.655 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.834 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 21.1 t70 -113.76 122.28 46.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 71.3 109.995 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 21.6 ptp -115.24 118.84 34.44 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.19 -0.3 . . . . 74.25 110.19 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.507 ' HA ' ' CB ' ' A' ' 113' ' ' LYS . 3.9 p30 -106.77 127.21 53.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.488 0.661 . . . . 74.22 111.267 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HD2' ' HG3' ' A' ' 136' ' ' PRO . 85.1 t80 -78.05 103.69 8.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.696 . . . . 74.11 110.074 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 22.0 t70 -92.09 161.64 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.51 -0.922 . . . . 51.12 108.51 172.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 133' ' ' ILE . 2.5 mp -66.3 -28.76 44.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 70.42 110.125 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.07 54.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 71.53 110.625 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' ASP . . . 145.1 154.98 6.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 51.0 112.624 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.521 ' HG3' ' HD2' ' A' ' 131' ' ' PHE . 14.9 Cg_exo -69.11 113.72 3.36 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.193 2.595 . . . . 61.44 112.86 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.7 t -82.23 141.5 32.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.957 -0.565 . . . . 72.1 109.561 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.837 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 40.9 mm -107.21 116.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.564 -0.455 . . . . 64.41 110.126 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -115.31 111.39 20.82 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.922 0.392 . . . . 72.53 109.994 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.35 132.78 11.1 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.867 -1.159 . . . . 44.02 112.311 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -128.99 115.92 18.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.223 0.535 . . . . 52.5 110.261 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 143' ' ' VAL . 6.8 tp -116.85 123.89 48.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.674 -0.694 . . . . 74.12 110.245 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.775 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 88.8 t -110.64 131.37 61.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.956 -0.565 . . . . 75.54 110.061 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.74 137.24 46.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.242 -0.651 . . . . 74.34 109.242 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.8 121.01 5.43 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.707 -0.679 . . . . 74.2 112.337 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.894 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 79.0 m-85 -127.36 149.73 49.93 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.574 -0.528 . . . . 73.32 109.574 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -49.81 96.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.812 0.339 . . . . 73.2 111.051 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 174' ' ' LYS . . . 88.55 -26.1 8.59 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.194 -0.457 . . . . 73.23 112.706 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.894 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 4.1 m0 -104.54 146.29 29.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.28 0.562 . . . . 74.42 110.96 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 144' ' ' LEU . 2.6 tm? -134.18 145.21 49.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.727 -0.842 . . . . 73.44 108.727 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -144.13 161.4 38.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.579 -0.7 . . . . 45.04 111.373 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -155.99 133.78 3.84 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.317 -0.401 . . . . 52.11 112.562 -176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.541 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 98.3 m-85 -125.1 119.21 27.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.476 -0.564 . . . . 75.51 109.476 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 30.1 tt0 -128.56 122.25 30.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.018 0.437 . . . . 63.4 110.327 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 16.9 ptp -135.32 142.5 45.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.002 0.43 . . . . 73.11 111.027 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.446 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 16.5 m-80 -113.13 117.66 32.58 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.034 -0.728 . . . . 74.45 109.034 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.918 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 71.1 t80 -94.13 121.85 36.06 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 123.642 0.777 . . . . 75.15 110.95 -176.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.6 tp10 -89.28 108.87 19.87 Favored 'General case' 0 C--O 1.264 1.82 0 CA-C-N 115.557 -0.747 . . . . 71.52 109.877 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -71.52 -17.02 62.35 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 112.923 -1.944 . . . . 73.41 111.974 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.85 67.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.819 0.819 . . . . 62.42 109.112 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 162' ' ' SER . 13.6 mptt -118.05 -156.09 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.363 -1.29 . . . . 73.23 108.022 167.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 161' ' ' LYS . 50.1 m -105.9 30.13 6.09 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.299 -0.63 . . . . 73.24 109.299 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 15.6 mmm180 -136.65 141.51 43.18 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.446 -0.902 . . . . 73.52 112.159 -161.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.918 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 4.6 m -73.66 136.19 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.235 -0.654 . . . . 73.32 109.235 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 3.0 t -91.64 -22.68 20.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.157 0.503 . . . . 71.11 110.143 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.74 132.27 20.93 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 72.53 109.577 172.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.6 p -121.18 105.97 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.135 0.493 . . . . 74.5 109.946 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 20.5 m120 -107.16 135.52 48.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.544 0.687 . . . . 64.45 110.889 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' HD1' ' HD2' ' A' ' 153' ' ' TYR . 60.2 m-85 -121.78 143.89 49.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.832 -0.622 . . . . 75.43 109.927 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.75 132.89 33.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.46 -0.336 . . . . 72.04 110.537 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 43.1 t -129.87 126.48 62.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.001 -0.37 . . . . 64.34 110.001 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.21 100.36 1.21 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.692 -0.963 . . . . 34.53 110.692 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.634 ' HB3' ' CD2' ' A' ' 180' ' ' LEU . 75.3 t80 -109.46 120.44 42.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.559 -0.904 . . . . 71.41 108.559 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 148' ' ' GLY . 13.0 ttmm -127.72 126.1 41.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.731 -1.122 . . . . 73.01 111.327 -167.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 39.8 m -132.96 110.39 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.795 -1.187 . . . . 62.41 107.795 160.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 25.37 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.023 1.49 . . . . 71.42 115.023 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -89.18 -7.84 54.82 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.852 0.686 . . . . 63.14 112.852 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -123.32 115.66 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 75.42 111.06 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -136.94 143.29 42.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 63.03 111.043 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.634 ' CD2' ' HB3' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -123.92 141.94 51.58 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-O 122.522 1.153 . . . . 62.34 111.495 163.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 36.2 m80 -104.75 112.47 25.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.369 -2.196 . . . . 72.12 106.551 165.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 38.4 m -96.17 135.93 37.32 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.215 -0.661 . . . . 63.1 109.215 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.8 p30 -133.86 138.86 45.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.415 0.626 . . . . 71.31 110.124 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 54.2 t -127.56 125.62 65.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.34 -0.845 . . . . 62.2 109.837 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.865 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 63.1 t30 -103.92 90.01 3.48 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.048 -0.723 . . . . 72.24 109.048 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.97 -173.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.704 -1.134 . . . . 75.04 110.136 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.0 -7.42 70.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.365 -0.921 . . . . 72.12 112.335 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.8 p -95.47 -24.32 16.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.023 0.749 . . . . 72.0 113.023 -174.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.865 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 65.9 tt0 -129.48 125.23 35.92 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.89 -0.724 . . . . 62.42 111.125 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -134.88 140.25 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.638 0.256 . . . . 75.02 110.397 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.91 -163.32 21.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.457 -0.878 . . . . 63.21 112.895 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -164.85 -174.3 34.43 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.696 -0.562 . . . . 53.12 111.696 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 41.0 m -148.76 136.95 20.99 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.617 -0.882 . . . . 63.44 108.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.3 mm -117.61 117.67 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.343 -0.543 . . . . 64.34 110.621 -171.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -107.53 119.42 39.36 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -125.0 131.16 53.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.53 -0.544 . . . . 71.44 109.53 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -107.56 114.97 29.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.42 -0.355 . . . . 61.33 111.582 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 202' ' ' LEU . 58.8 t -88.76 132.39 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.625 -0.879 . . . . 74.24 108.625 171.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.4 -25.9 62.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.948 0.351 . . . . 63.33 111.948 -173.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.482 ' H ' HG12 ' A' ' 198' ' ' VAL . 58.9 mtmt -84.6 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 73.23 111.653 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.05 24.43 14.5 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.625 0.77 . . . . 75.53 112.69 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 225' ' ' TYR . 4.7 tt -110.58 108.99 19.12 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.163 -0.68 . . . . 63.15 109.163 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.731 ' HB2' ' HG3' ' A' ' 224' ' ' LYS . 39.5 mt-10 -106.65 137.04 45.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.522 -0.548 . . . . 75.23 109.522 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.6 m -122.74 142.55 50.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.655 0.265 . . . . 72.42 110.596 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.54 136.58 49.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.986 -0.552 . . . . 64.03 109.863 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.879 HG22 HG22 ' A' ' 221' ' ' ILE . 39.6 t -111.83 137.07 45.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.004 -0.544 . . . . 70.43 109.62 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -112.75 127.55 56.18 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.557 -0.905 . . . . 63.25 108.557 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 219' ' ' PHE . 3.1 tp -142.64 129.89 20.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.612 -171.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.413 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -154.58 139.11 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 73.21 111.192 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -128.87 132.7 47.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.985 -0.746 . . . . 74.13 108.985 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 m -95.04 107.21 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.918 0.389 . . . . 63.02 110.034 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.75 135.86 55.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.629 -0.714 . . . . 72.43 111.252 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.85 -2.43 66.58 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.163 -0.775 . . . . 72.12 111.163 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -131.01 167.61 18.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.236 -0.482 . . . . 70.31 109.767 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -102.51 -14.23 16.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.969 -0.752 . . . . 64.2 108.969 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.66 110.89 1.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.498 -0.773 . . . . 73.21 110.769 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 15.9 m -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 61.11 109.432 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.566 ' HA ' ' HE ' ' A' ' 218' ' ' ARG . 0.2 OUTLIER -114.63 116.06 28.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.579 -0.448 . . . . 73.31 109.866 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.452 ' HB3' HD13 ' A' ' 208' ' ' LEU . 53.3 p90 -134.14 146.91 50.66 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.972 -0.381 . . . . 72.3 109.972 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.61 160.88 32.27 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.49 -0.862 . . . . 51.14 112.123 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.879 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.259 0.552 . . . . 72.35 110.62 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.593 ' HB2' ' HG3' ' A' ' 236' ' ' LYS . . . -117.84 141.43 48.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.169 -0.923 . . . . 70.5 109.911 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -118.12 140.82 49.21 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.399 -0.364 . . . . 72.53 110.429 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.731 ' HG3' ' HB2' ' A' ' 203' ' ' GLU . 14.8 ptmt -125.47 114.66 19.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.836 -0.62 . . . . 72.44 109.5 174.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.551 ' HD2' ' HG ' ' A' ' 202' ' ' LEU . 17.2 t80 -119.22 117.23 28.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.503 -0.772 . . . . 75.13 109.426 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.59 105.9 18.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.176 0.512 . . . . 64.33 109.857 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 227' ' ' ILE . 13.4 pt -81.69 -33.5 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.506 -0.77 . . . . 64.24 111.067 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.41 162.15 28.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 72.53 109.017 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 -19.14 17.41 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.064 2.51 . . . . 70.03 114.323 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -112.2 7.94 19.67 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.049 -0.26 . . . . 73.21 111.659 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.04 123.64 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.289 0.566 . . . . 64.51 112.21 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -124.09 127.44 47.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 51.25 108.957 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -98.04 133.38 42.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.931 0.396 . . . . 74.33 110.654 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 48.4 t -115.9 138.06 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.844 -0.617 . . . . 44.44 109.994 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -133.12 141.73 48.32 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.467 -0.568 . . . . 51.05 109.467 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.593 ' HG3' ' HB2' ' A' ' 222' ' ' ALA . 3.3 mppt? -133.39 141.42 47.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.771 0.32 . . . . 72.32 110.791 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.584 HG12 HG12 ' A' ' 221' ' ' ILE . 3.7 p -140.49 136.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.218 -0.66 . . . . 71.35 109.218 170.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 88.2 m-20 -115.67 152.93 32.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.164 -0.471 . . . . 73.05 110.993 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 241' ' ' SER . 1.1 t-20 -35.12 -42.49 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.967 1.417 . . . . 64.54 114.052 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.462 ' OG ' HD13 ' A' ' 242' ' ' LEU . 2.3 p -78.56 24.58 0.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.839 0.352 . . . . 62.11 111.448 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 239' ' ' ASN . 18.6 t 61.7 37.83 15.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.586 -0.734 . . . . 53.24 109.817 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.971 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 4.6 mp -92.23 140.12 29.94 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.851 -0.613 . . . . 53.05 110.51 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -122.88 118.74 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.012 -0.54 . . . . 72.05 110.898 -172.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -126.08 155.56 19.3 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.751 -0.738 . . . . 61.2 112.417 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -138.18 160.65 38.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.065 0.46 . . . . 53.32 110.79 177.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -151.43 141.03 8.24 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.752 -0.658 . . . . 51.24 111.559 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -129.08 115.27 17.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 110.131 -0.322 . . . . 60.14 110.131 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.3 m -109.34 115.7 30.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.326 -0.397 . . . . 74.35 110.015 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.78 145.01 50.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.946 0.403 . . . . 72.21 111.024 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.3 m -108.11 124.47 50.28 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.873 -0.603 . . . . 75.31 110.631 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 2.8 mm? -117.17 147.28 42.6 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.835 -1.172 . . . . 70.1 107.835 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.924 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 32.9 mmtp 61.84 -174.97 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 117.742 0.246 . . . . 64.45 110.439 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.924 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 67.6 Cg_endo -75.69 -2.91 13.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.618 1.546 . . . . 64.21 113.657 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.43 0.25 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.188 -1.482 . . . . 74.44 114.794 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.627 HG12 ' HB2' ' A' ' 252' ' ' LYS . 45.4 mm -112.24 120.67 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 117.759 0.78 . . . . 73.31 109.6 174.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 280' ' ' GLU . 0.0 OUTLIER -115.61 118.04 31.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.999 0.428 . . . . 54.14 110.413 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.94 124.31 45.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.994 -0.548 . . . . 64.34 109.776 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.2 m -118.56 110.26 17.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.082 0.468 . . . . 73.45 110.562 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 1.014 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.56 125.5 49.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.786 -1.19 . . . . 74.02 107.786 174.186 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.6 t -138.56 139.43 38.65 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.435 -0.506 . . . . 63.31 109.864 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 135.74 13.65 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.602 -0.518 . . . . 74.32 109.602 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.769 HD21 HD23 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -124.27 131.63 53.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.394 -0.595 . . . . 75.1 109.394 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.806 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -106.43 111.19 23.66 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.78 -1.193 . . . . 74.23 107.78 179.063 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.971 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.7 m-20 -71.54 106.96 4.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.871 -0.604 . . . . 72.44 109.418 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.06 -16.79 14.5 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 116.019 -0.537 . . . . 51.51 112.877 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 266' ' ' LYS . 1.6 tmtp? -91.15 -26.95 18.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.879 0.371 . . . . 64.22 110.783 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 10.3 m120 -106.44 -34.66 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.644 0.609 . . . . 75.15 112.644 -172.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.806 HG11 ' HB3' ' A' ' 263' ' ' LEU . 35.1 m -62.28 -17.49 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.537 0.208 . . . . 70.1 111.558 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.09 -44.65 83.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 75.41 110.722 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.59 -16.74 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.493 . . . . 71.31 110.828 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 123.66 90.52 0.93 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.321 -0.712 . . . . 64.54 111.321 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.637 ' HA3' ' HB3' ' A' ' 267' ' ' ASN . . . -164.7 69.72 0.2 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 65.52 112.358 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.619 ' HB2' HD12 ' A' ' 263' ' ' LEU . 24.0 p-80 -113.17 145.48 40.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.367 -0.605 . . . . 75.23 109.367 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.68 136.85 49.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.477 -0.489 . . . . 54.33 110.131 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -120.58 136.85 54.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.563 -0.744 . . . . 72.12 109.839 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.668 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -138.68 110.54 0.73 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.655 -0.783 . . . . 74.1 111.591 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 1.014 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -112.79 128.19 56.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.745 -0.835 . . . . 75.21 108.745 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.6 ' HA3' ' HE2' ' A' ' 22' ' ' TYR . . . -140.12 131.87 5.27 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.258 -0.973 . . . . 50.13 112.284 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.684 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.4 mm? -103.45 130.14 50.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.233 -0.654 . . . . 75.35 109.233 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 0.6 OUTLIER -113.73 109.71 19.01 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.881 -1.155 . . . . 72.14 107.881 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.647 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 2.4 t80 -106.39 124.41 49.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.717 -0.674 . . . . 62.1 109.891 -172.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -127.5 109.63 11.93 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.647 ' HB2' ' HE1' ' A' ' 281' ' ' PHE . . . -110.1 111.84 23.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 65.31 111.346 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.61 -70.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 75.45 108.926 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.991 -0.549 . . . . 75.45 109.585 172.691 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.946 0.403 . . . . 54.3 110.252 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.851 HG22 ' HA ' ' A' ' 121' ' ' GLU . 13.7 t -120.48 112.16 34.38 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.488 -0.56 . . . . 74.12 109.488 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.9 161.04 19.73 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.035 2.49 . . . . 75.31 112.62 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.68 86.61 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.796 2.331 . . . . 53.21 111.189 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.021 ' HB ' HG11 ' A' ' 143' ' ' VAL . 9.2 p -70.18 -53.5 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.358 -0.837 . . . . 64.14 112.826 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' H ' ' HG1' ' A' ' 6' ' ' THR . 11.6 p90 -69.07 -23.92 64.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.243 0.544 . . . . 63.41 111.313 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.31 -20.71 36.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.62 . . . . 63.43 111.533 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -91.05 -11.5 38.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 71.53 110.896 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 152' ' ' GLY . 45.9 mt -58.29 -34.97 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.328 0.492 . . . . 71.24 112.328 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.47 50.87 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.586 -1.292 . . . . 75.24 114.694 168.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -40.24 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.167 -1.049 . . . . 71.23 108.167 171.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -60.97 -35.48 76.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.726 -1.125 . . . . 63.35 110.751 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.07 73.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.12 -0.491 . . . . 62.11 111.883 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -69.61 -31.09 69.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.47 . . . . 71.31 110.51 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.17 -47.39 85.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.69 -0.686 . . . . 75.0 111.804 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.31 -31.4 52.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.95 0.405 . . . . 70.03 110.797 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.665 ' HE2' ' HA3' ' A' ' 220' ' ' GLY . 82.6 t80 -73.03 -41.82 63.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.681 -0.69 . . . . 70.22 111.331 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -83.44 -28.07 29.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.146 -0.479 . . . . 75.14 112.209 -173.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -66.78 91.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.527 . . . . 75.53 110.433 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.42 -23.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.916 -0.874 . . . . 75.35 110.916 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.85 76.16 1.62 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 74.24 110.386 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.94 119.1 4.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.72 -0.753 . . . . 41.11 111.3 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -80.34 8.04 8.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.065 0.459 . . . . 75.32 111.035 -175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.53 13.22 54.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.982 -0.847 . . . . 53.34 110.982 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 2.7 pp -107.45 177.97 4.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.946 0.879 . . . . 41.11 112.749 -173.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG13 HD12 ' A' ' 277' ' ' LEU . 1.7 mp -103.0 132.53 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.293 -1.321 . . . . 72.25 110.224 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 26.0 tptp -102.84 118.66 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.965 -1.016 . . . . 75.13 109.193 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.71 128.23 56.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.623 -0.51 . . . . 70.43 109.623 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 43' ' ' SER . 30.6 m-20 -133.28 134.14 43.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.104 0.478 . . . . 45.43 110.373 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.759 HD22 ' HB2' ' A' ' 281' ' ' PHE . 1.2 tm? -123.72 126.01 45.77 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.157 -1.053 . . . . 61.3 108.157 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.9 mtpp -132.29 129.7 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.858 0.361 . . . . 73.42 110.59 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.8 m -136.27 131.64 34.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.134 -0.484 . . . . 71.01 109.839 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -104.98 136.77 43.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 71.25 110.209 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.3 m -139.59 169.27 18.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.002 -0.545 . . . . 61.14 110.168 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.22 178.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 75.32 110.771 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 t30 65.21 24.43 12.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.578 0.704 . . . . 53.51 109.537 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.32 19.81 79.74 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 120.618 -0.801 . . . . 60.15 111.988 175.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 62' ' ' TYR . 10.2 mt -85.55 137.3 32.97 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.222 1.011 . . . . 61.3 113.266 -171.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.736 ' HB2' HH12 ' A' ' 63' ' ' ARG . 43.4 tt0 -139.51 118.56 12.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.24 -1.8 . . . . 65.43 108.828 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 90.9 m-85 -103.6 120.09 40.2 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.695 -0.483 . . . . 75.33 109.695 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 25.9 m -126.05 126.07 43.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.234 -0.439 . . . . 75.35 110.397 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 22.8 t -119.66 123.25 43.37 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.858 -0.793 . . . . 74.53 108.858 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -123.78 124.88 43.67 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.081 -0.34 . . . . 75.22 110.081 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.06 153.61 24.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.463 -0.875 . . . . 75.4 111.857 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -137.52 133.92 35.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.919 -0.771 . . . . 75.2 108.919 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -148.92 129.26 13.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.969 0.414 . . . . 34.03 111.426 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.61 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 16.4 t-20 -102.02 113.93 27.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.403 -0.962 . . . . 63.42 108.403 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 m -47.27 103.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.066 0.854 . . . . 74.34 113.069 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.47 17.08 10.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.209 -0.905 . . . . 72.33 112.296 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 48' ' ' ASN . 11.0 m -97.81 8.86 43.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 71.44 110.062 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m 62.91 31.47 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.338 -0.847 . . . . 75.53 111.305 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 54.7 mmtt -130.5 83.52 2.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.29 0.566 . . . . 51.44 110.112 175.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 47' ' ' ALA . 48.0 t -125.35 120.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.991 -1.004 . . . . 71.33 109.652 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.6 t -133.43 143.4 48.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.14 -0.318 . . . . 70.11 110.14 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.82 141.26 12.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.928 -0.653 . . . . 73.23 112.823 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -132.83 135.06 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.083 0.553 . . . . 73.05 109.663 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -121.74 125.63 47.02 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.239 -0.652 . . . . 62.22 109.239 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.764 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 22.2 tt0 -117.68 120.36 37.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.395 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 3.3 m -113.45 118.37 34.31 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.873 -1.158 . . . . 73.43 107.873 168.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -116.82 120.64 39.15 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.01 -0.676 . . . . 61.42 110.242 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 1.4 m-85 -107.0 125.56 51.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 70.24 109.699 -175.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.736 HH12 ' HB2' ' A' ' 40' ' ' GLU . 1.6 mpp_? -129.51 106.49 8.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.328 -0.949 . . . . 72.34 111.807 169.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 49.0 t-105 -88.79 91.82 8.97 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.234 -1.024 . . . . 75.42 108.234 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 67' ' ' TYR . 9.4 m 67.8 141.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.614 -1.176 . . . . 44.42 110.486 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.93 -8.54 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.432 0.634 . . . . 71.44 110.289 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.704 ' H ' HG22 ' A' ' 65' ' ' THR . 81.8 t80 -126.36 86.53 2.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.113 -0.949 . . . . 75.53 108.573 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 88' ' ' GLU . . . 170.91 -101.72 0.17 Allowed Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.705 -0.76 . . . . 73.3 112.383 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.8 mm? -113.65 138.24 50.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.482 0.658 . . . . 45.2 111.77 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.1 m -135.74 111.31 9.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.191 -0.913 . . . . 53.14 109.469 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.703 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 12.2 t80 -119.77 125.75 49.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.811 0.338 . . . . 74.52 110.422 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 84' ' ' GLU . 28.2 m -110.85 117.65 33.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.937 0.399 . . . . 52.43 110.353 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 34.7 tt0 -111.94 123.85 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.698 -0.683 . . . . 75.02 109.911 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.8 ptmm? -127.26 133.22 50.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.22 0.533 . . . . 73.02 110.188 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.622 ' CD1' HD22 ' A' ' 81' ' ' LEU . 32.6 t90 -134.04 128.27 33.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.559 -0.534 . . . . 72.41 109.559 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -116.41 133.21 56.28 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.842 -0.743 . . . . 72.33 110.791 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -73.9 -25.71 60.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.739 0.78 . . . . 72.53 110.09 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -96.14 -16.2 21.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.501 -1.227 . . . . 61.24 111.779 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.8 -98.05 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.354 0.872 . . . . 64.51 113.354 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 p -115.85 144.72 43.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.869 1.063 . . . . 71.13 113.869 -166.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.622 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -87.94 157.05 19.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.326 -1.361 . . . . 74.14 107.326 165.113 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 101' ' ' SER . . . -171.01 147.69 10.62 Favored Glycine 0 C--N 1.322 -0.205 0 C-N-CA 119.79 -1.195 . . . . 35.11 113.173 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -148.98 128.52 13.12 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.254 0.222 . . . . 74.44 111.165 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.9 pt-20 -126.41 125.98 43.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 74.33 110.023 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.24 128.3 68.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 73.13 110.439 -176.155 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.592 ' CG2' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m -118.17 123.91 46.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.113 -0.494 . . . . 73.24 111.248 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.33 137.88 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.126 -0.488 . . . . 75.03 109.828 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 1.1 pp20? -89.52 161.95 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.986 -0.686 . . . . 61.4 110.879 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -95.67 124.73 39.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.813 -0.44 . . . . 71.42 109.813 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.4 -25.82 65.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 72.41 111.546 -175.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.74 -45.74 5.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.867 0.365 . . . . 73.21 110.248 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -92.01 77.17 5.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.36 -0.607 . . . . 63.43 109.36 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.455 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 56.2 mtt180 -64.1 134.65 55.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.349 -0.841 . . . . 71.4 111.623 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 102.14 -12.2 57.27 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.016 -0.993 . . . . 72.54 111.681 -174.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -85.02 121.3 27.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.604 0.24 . . . . 75.31 110.402 178.14 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.592 ' HE3' ' CG2' ' A' ' 86' ' ' THR . 29.9 mmmt -121.96 112.05 17.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 64.53 109.443 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 86' ' ' THR . 1.9 mm? -94.85 128.2 41.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.47 . . . . 55.01 109.779 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 1.118 ' HB ' ' HG3' ' A' ' 115' ' ' LYS . 3.3 m -128.45 132.89 48.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.077 0.465 . . . . 75.13 111.534 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 76.7 t80 -117.8 120.63 38.51 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.375 -0.602 . . . . 74.04 109.375 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 113' ' ' LYS . 6.9 t70 -111.62 143.07 43.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.401 . . . . 75.0 110.475 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.438 ' O ' ' HA2' ' A' ' 82' ' ' GLY . 72.9 m -142.86 122.19 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.835 0.35 . . . . 72.43 110.876 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 t -108.04 133.16 52.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.762 -0.829 . . . . 65.22 108.762 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 110' ' ' LYS . 35.6 t80 -122.87 125.13 44.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.819 0.342 . . . . 72.31 110.722 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.7 t -87.38 106.19 10.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.695 -0.854 . . . . 62.42 108.695 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.45 -39.92 79.38 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.04 2.493 . . . . 72.0 112.699 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.48 -49.9 24.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.592 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 m -66.06 -40.67 91.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 64.44 111.304 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.6 -5.7 80.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.89 -0.671 . . . . 71.1 111.791 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -94.62 148.16 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 60.53 110.355 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -126.42 151.33 47.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 74.22 111.019 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -119.25 121.01 38.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.566 -0.743 . . . . 75.42 109.01 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.56 28.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.871 0.367 . . . . 73.22 110.99 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 130' ' ' ASP . 17.3 mmtm -124.22 141.46 52.04 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.174 -0.676 . . . . 64.44 109.174 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.92 117.74 56.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.126 -1.065 . . . . 72.45 108.126 169.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 1.118 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 8.0 ptmt -129.16 119.86 24.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.231 -0.895 . . . . 64.45 110.818 -171.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.0 p -109.23 117.75 34.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.354 -0.839 . . . . 71.41 109.531 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.456 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -128.82 114.23 1.73 Allowed Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.303 -0.951 . . . . 5.3 111.961 -174.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.791 ' HB3' HD22 ' A' ' 95' ' ' LEU . 12.9 p90 -118.77 131.81 56.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.167 0.508 . . . . 72.53 110.458 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.713 ' HE3' ' HB ' ' A' ' 3' ' ' VAL . 8.7 ptmt -109.11 121.32 44.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.576 -0.738 . . . . 74.15 110.213 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 120' ' ' ARG . 9.3 tpt180 -106.72 157.02 18.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.851 ' HA ' HG22 ' A' ' 3' ' ' VAL . 3.8 pm0 -53.22 -28.9 29.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.966 0.728 . . . . 71.24 112.966 -169.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -114.54 -16.03 11.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.884 -0.327 . . . . 63.44 111.542 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 142' ' ' LEU . 10.9 tp -145.03 130.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.298 -0.561 . . . . 75.41 111.809 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.438 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 38.1 t-20 -117.95 117.31 28.89 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.058 -0.401 . . . . 63.43 110.637 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 125' ' ' LEU . 3.9 mm? -113.01 128.73 56.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.681 0.277 . . . . 75.23 111.145 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.456 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.43 123.53 3.08 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.528 -0.629 . . . . 72.13 111.528 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 60.3 m -113.78 108.28 16.88 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.678 -0.307 . . . . 54.15 111.091 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.831 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 3.2 m-20 -100.81 117.52 35.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.482 -0.562 . . . . 65.43 109.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.2 ptm -98.0 118.64 35.05 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.458 -0.897 . . . . 72.03 109.531 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 8.9 t70 -94.52 117.66 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 73.12 109.967 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -97.16 102.68 14.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.071 0.462 . . . . 64.1 111.465 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -105.29 146.72 28.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.171 -1.048 . . . . 74.41 108.171 167.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.601 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -62.68 -22.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.845 0.313 . . . . 70.3 111.845 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.2 -6.67 47.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.572 0.225 . . . . 75.22 111.602 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.457 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 160.82 121.47 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.339 -0.934 . . . . 75.34 112.921 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 2.9 Cg_exo -74.55 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 52.21 111.802 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -81.99 153.29 26.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.21 -0.45 . . . . 75.02 110.053 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.665 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 3.5 mp -107.11 117.43 52.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.945 -0.702 . . . . 73.4 109.94 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.831 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 59.8 ttt-85 -104.68 130.12 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.706 -0.479 . . . . 73.45 109.706 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -116.91 132.14 9.89 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.961 -1.114 . . . . 63.31 111.553 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.73 115.74 21.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.478 -0.564 . . . . 74.43 109.478 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 123' ' ' ILE . 11.6 tp -128.02 122.56 32.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.259 -0.428 . . . . 62.12 110.131 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 1.021 HG11 ' HB ' ' A' ' 6' ' ' THR . 21.8 t -119.59 130.51 73.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.075 0.464 . . . . 72.3 109.851 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 144' ' ' LEU . 5.1 mp -109.35 138.29 45.92 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 73.02 109.538 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.73 123.43 5.82 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.714 -0.755 . . . . 63.23 112.774 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.812 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 56.0 m-85 -125.9 148.32 49.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.007 -0.738 . . . . 72.32 109.007 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -53.44 102.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.952 0.406 . . . . 65.44 110.413 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.56 -31.1 7.45 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.746 -0.661 . . . . 62.43 112.492 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.5 m0 -105.89 134.56 48.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 75.33 110.837 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 6' ' ' THR . 3.2 tm? -139.41 134.59 32.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.237 -0.653 . . . . 63.24 109.237 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 171' ' ' VAL . . . -148.97 141.12 23.95 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.821 -0.352 . . . . 74.1 111.664 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -140.33 141.0 11.05 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.965 -0.454 . . . . 63.02 111.965 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.435 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 43.1 m-85 -124.08 121.26 34.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.182 -0.303 . . . . 73.21 110.182 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 28.6 mp0 -114.19 122.15 45.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 74.44 109.284 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.19 145.46 51.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.808 0.337 . . . . 73.1 111.002 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 166' ' ' GLN . 6.0 m-20 -112.55 118.34 34.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.845 -0.798 . . . . 72.22 108.845 175.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.665 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 76.7 t80 -95.64 121.87 37.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.479 -0.782 . . . . 54.31 111.007 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.8 tp10 -79.24 99.34 7.01 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 114.386 -1.279 . . . . 74.14 109.129 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -70.9 -23.83 62.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.442 -1.708 . . . . 71.54 112.212 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.7 -32.18 71.43 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.916 0.865 . . . . 71.21 109.165 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -114.6 -157.5 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.199 -1.364 . . . . 62.44 108.205 170.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.9 p -107.56 30.72 6.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.407 -0.59 . . . . 50.32 109.407 172.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.553 ' HA ' ' HE ' ' A' ' 163' ' ' ARG . 3.7 mmp_? -119.55 171.8 8.11 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 119.689 -0.804 . . . . 74.43 112.871 -159.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.61 127.09 59.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.166 -0.679 . . . . 44.35 109.166 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.3 t -95.86 -24.13 16.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.887 0.375 . . . . 50.15 110.935 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.591 ' HB3' ' HB2' ' A' ' 156' ' ' ASN . 32.8 tt0 -145.83 133.04 20.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 53.13 110.645 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 169' ' ' PHE . 17.0 p -122.54 106.43 11.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.109 -0.496 . . . . 63.22 110.617 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 5.3 t30 -108.37 121.56 45.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.264 -0.643 . . . . 72.23 109.264 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 167' ' ' SER . 29.5 m-85 -123.86 156.83 35.49 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.386 -0.526 . . . . 65.32 111.027 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -150.75 128.25 11.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.963 -0.562 . . . . 33.51 109.796 171.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 151' ' ' ALA . 27.2 t -143.98 130.44 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.301 -0.629 . . . . 72.32 109.301 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.11 174.74 35.38 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.041 -1.552 . . . . 63.52 114.111 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -134.36 138.05 44.59 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -109.71 127.41 54.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.731 -0.668 . . . . 73.25 111.985 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 29.8 m -131.94 143.14 49.91 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.39 -1.337 . . . . 72.31 107.39 164.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.09 -1.98 6.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.138 0.792 . . . . 64.24 113.138 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.548 ' HG3' ' HD1' ' A' ' 178' ' ' PHE . 9.0 pt-20 -116.64 -26.08 7.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.537 -0.465 . . . . 65.41 111.478 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.548 ' HD1' ' HG3' ' A' ' 177' ' ' GLU . 41.3 p90 -140.87 127.93 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.705 0.288 . . . . 70.32 110.303 173.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.86 124.38 35.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.185 -0.302 . . . . 64.54 110.185 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.618 HD12 HG13 ' A' ' 194' ' ' ILE . 3.9 tt -110.86 128.26 55.72 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.062 -0.655 . . . . 73.44 110.031 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -131.81 115.83 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.906 -0.588 . . . . 65.42 109.769 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 84.8 m -99.51 123.16 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.127 -0.488 . . . . 72.11 110.213 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.3 p30 -119.86 141.49 49.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.142 0.496 . . . . 73.1 110.719 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 79.1 t -119.6 130.02 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.898 -0.592 . . . . 63.11 110.193 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 36.2 m-80 -113.24 106.96 15.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.838 -0.619 . . . . 65.43 109.34 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.01 -165.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.047 -0.979 . . . . 43.42 110.282 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.98 -6.99 89.09 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.385 -0.912 . . . . 73.31 111.947 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.2 p -102.23 -25.2 13.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.98 1.104 . . . . 71.42 113.98 -170.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 39.2 tt0 -120.41 112.74 19.36 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.17 -1.012 . . . . 72.44 112.19 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -106.26 124.88 50.27 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.393 -0.966 . . . . 70.0 108.393 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -136.6 131.6 5.71 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.037 -1.077 . . . . 34.41 113.677 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -114.79 121.76 5.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.115 -0.794 . . . . 71.41 111.115 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m -115.07 137.13 52.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.294 0.547 . . . . 72.14 110.931 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.618 HG13 HD12 ' A' ' 180' ' ' LEU . 4.3 mp -121.87 132.29 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.926 -0.579 . . . . 74.3 109.724 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -108.28 120.1 41.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.787 -0.82 . . . . 64.42 108.787 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -118.08 130.05 55.92 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.862 -0.608 . . . . 74.42 110.845 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -98.72 109.62 22.35 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 74.44 108.34 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.454 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 44.0 t -83.3 -40.22 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.538 0.685 . . . . 72.31 109.774 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 54.3 t30 -155.72 161.64 40.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.792 -1.188 . . . . 70.33 107.792 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.63 126.46 27.71 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt 82.17 -1.01 1.46 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.077 0.86 . . . . 75.33 111.325 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 199' ' ' ASN . 39.9 tp -125.32 99.92 6.28 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.603 0.716 . . . . 72.53 111.015 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -106.43 158.57 16.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.062 -0.972 . . . . 75.31 109.892 -176.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.6 m -152.91 142.87 22.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.18 -0.304 . . . . 73.44 110.18 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -132.11 136.49 47.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.877 0.37 . . . . 34.13 110.94 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.42 131.65 71.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.85 -0.614 . . . . 74.11 110.105 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 27.3 t-20 -119.16 133.26 55.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.935 0.398 . . . . 74.31 110.998 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.477 ' O ' ' HA2' ' A' ' 191' ' ' GLY . 4.1 mm? -118.74 130.24 55.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 71.54 108.715 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.36 129.18 35.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.047 0.451 . . . . 63.31 110.85 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -120.06 129.71 54.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.874 -0.603 . . . . 73.14 109.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.514 ' HB ' ' OD1' ' A' ' 216' ' ' ASN . 29.1 m -95.39 106.8 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.117 0.484 . . . . 70.22 110.007 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.63 136.99 50.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.849 . . . . 74.53 111.393 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -33.77 5.66 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.055 -0.818 . . . . 54.42 111.055 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -125.83 -178.57 4.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.768 -0.456 . . . . 72.05 109.768 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.5 t -109.96 27.11 9.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.408 . . . . 72.24 110.641 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 211' ' ' THR . 23.6 p-10 -81.85 110.82 17.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.793 0.806 . . . . 75.0 110.271 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.8 p -107.87 123.49 48.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.067 -0.97 . . . . 70.33 110.108 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -106.59 116.44 31.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.99 -0.55 . . . . 75.43 109.751 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 37.0 p90 -115.05 146.83 40.88 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.544 -0.462 . . . . 65.0 110.101 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.665 ' HA3' ' HE2' ' A' ' 18' ' ' PHE . . . -146.57 139.87 8.34 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.992 -0.843 . . . . 71.1 110.992 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.2 mp -123.84 128.87 74.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.65 -0.5 . . . . 71.41 109.65 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -122.84 130.34 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.344 0.403 . . . . 73.55 110.407 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.25 126.04 54.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.229 -0.442 . . . . 70.42 109.981 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -113.48 113.3 24.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 73.33 109.904 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -130.89 128.32 40.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.915 0.388 . . . . 74.34 110.553 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 36.5 tt0 -78.72 98.45 6.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 74.41 108.922 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.4 tt -79.22 -24.86 12.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.276 0.56 . . . . 74.55 110.656 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.431 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 3.1 t70 -143.72 148.54 43.33 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.106 -1.072 . . . . 72.44 108.106 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 52.6 Cg_exo -38.2 -40.35 1.15 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.846 3.031 . . . . 65.42 115.211 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' ' 250' ' ' THR . 6.8 m-20 -117.01 11.37 14.26 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.849 0.315 . . . . 73.14 111.849 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -129.73 123.17 30.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 70.13 111.415 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -122.51 127.35 49.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.971 -0.559 . . . . 73.5 110.639 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.853 ' HD1' ' HB3' ' A' ' 247' ' ' TYR . 63.0 t80 -107.58 133.86 51.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.636 -0.711 . . . . 73.32 110.828 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.7 p -122.17 120.77 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 52.51 110.853 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.82 141.32 42.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.366 -0.605 . . . . 71.24 109.366 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 10.8 ptpt -148.19 149.24 31.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.041 0.448 . . . . 70.05 111.694 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 7.7 p -137.22 148.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.443 -0.344 . . . . 71.01 110.353 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.827 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 7.1 m-20 -114.69 150.06 35.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.836 -0.62 . . . . 73.44 110.123 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 241' ' ' SER . 25.2 t30 -44.72 -36.11 3.0 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.476 1.11 . . . . 74.02 113.016 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 17.8 m -78.94 25.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.714 0.292 . . . . 65.35 111.036 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.9 m 64.93 36.83 7.37 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.616 -0.72 . . . . 71.22 110.238 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 238' ' ' ASN . 26.3 mt -98.69 115.93 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.11 109.879 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.26 117.38 48.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 120.539 -0.465 . . . . 74.53 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -119.91 134.02 10.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.831 -0.699 . . . . 70.43 112.491 177.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 260' ' ' SER . 3.0 pp -128.91 141.74 51.17 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.805 -0.443 . . . . 54.52 109.805 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -155.95 121.58 1.11 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.542 -0.837 . . . . 73.34 111.988 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.853 ' HB3' ' HD1' ' A' ' 233' ' ' PHE . 36.2 p90 -114.45 130.85 56.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.255 0.55 . . . . 63.51 110.955 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.708 HG22 ' HB ' ' A' ' 258' ' ' THR . 18.2 p -100.19 115.08 29.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.96 -1.018 . . . . 73.0 109.557 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -123.87 123.24 40.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.269 -0.423 . . . . 54.34 110.53 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 230' ' ' ASP . 9.5 m -69.51 111.62 5.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.371 -0.603 . . . . 74.44 109.371 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.49 -47.42 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 64.35 109.479 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.951 ' HB2' HD11 ' A' ' 255' ' ' ILE . 68.0 mttm -142.53 155.94 63.67 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.623 -1.251 . . . . 74.24 107.623 173.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.99 98.44 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.401 2.067 . . . . 74.35 111.79 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.46 -30.07 3.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.961 -0.638 . . . . 43.3 112.197 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.951 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -124.42 121.87 62.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.707 0.765 . . . . 70.52 111.747 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.91 125.39 52.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.271 -0.877 . . . . 72.23 109.707 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.2 tp -99.89 125.26 45.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.95 -0.568 . . . . 74.21 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.708 ' HB ' HG22 ' A' ' 248' ' ' THR . 6.8 t -117.77 121.42 40.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.486 0.66 . . . . 72.12 110.478 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.666 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -107.31 123.98 49.12 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.885 -1.154 . . . . 72.44 107.885 176.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 23.5 m -134.18 152.38 51.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.8 0.333 . . . . 72.2 110.482 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.448 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -156.86 131.56 8.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.311 -0.404 . . . . 45.22 110.601 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.791 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -108.34 114.57 28.53 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.934 -1.136 . . . . 74.42 107.934 174.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.943 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -101.97 105.21 15.96 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.11 -1.441 . . . . 64.12 107.11 174.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.705 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 4.8 p-10 -76.01 98.49 4.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.233 -1.025 . . . . 72.14 108.233 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.35 -9.16 3.02 Favored Glycine 0 C--N 1.321 -0.28 0 CA-C-N 114.106 -1.407 . . . . 54.21 114.371 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -88.04 -20.23 26.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.034 0.445 . . . . 73.3 110.243 -173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.0 -33.9 0.9 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.778 0.799 . . . . 71.3 109.083 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.943 HG11 ' HB3' ' A' ' 263' ' ' LEU . 1.8 t -54.09 -29.65 19.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 113.8 -1.546 . . . . 72.31 112.529 176.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.24 -37.15 84.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.596 . . . . 54.55 111.251 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.43 -16.27 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.067 0.395 . . . . 72.23 112.067 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.79 3.85 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.805 -0.712 . . . . 64.11 112.86 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -105.61 149.08 16.65 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 121.164 -0.541 . . . . 74.23 112.716 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.909 ' HB2' HD12 ' A' ' 263' ' ' LEU . 5.5 p-80 -103.83 149.15 25.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.844 -0.678 . . . . 62.44 110.208 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -96.27 138.62 33.61 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.084 -0.646 . . . . 71.31 110.764 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.0 tm? -120.77 144.72 48.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.676 -0.693 . . . . 70.13 110.443 -169.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.59 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -133.0 118.49 2.17 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.364 -0.694 . . . . 71.32 111.364 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -114.41 123.84 50.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.915 -0.772 . . . . 71.2 108.915 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -136.27 147.04 19.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.739 -1.219 . . . . 73.52 113.588 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.68 131.45 51.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.016 -0.735 . . . . 44.24 109.016 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -115.66 111.77 21.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.35 -0.611 . . . . 72.02 109.35 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.759 ' HB2' HD22 ' A' ' 31' ' ' LEU . 13.0 m-85 -95.32 101.85 13.61 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.686 -0.688 . . . . 72.51 109.22 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -103.73 110.93 23.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.966 -0.561 . . . . 64.13 110.031 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.37 110.06 21.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.857 -0.61 . . . . 73.41 109.712 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 61.5 mt -125.79 179.16 5.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.682 -0.69 . . . . 52.43 109.818 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.186 -0.672 . . . . 71.11 109.186 176.893 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.754 -0.461 . . . . 62.55 109.754 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.652 HG11 ' HB2' ' A' ' 119' ' ' LYS . 6.2 t -110.66 102.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 74.35 110.523 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 159.27 37.63 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.628 2.219 . . . . 52.44 112.076 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.89 85.6 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.653 2.236 . . . . 72.12 111.626 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.9 p -75.16 -29.17 60.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.042 -0.526 . . . . 63.4 111.303 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.439 ' HB2' HG21 ' A' ' 143' ' ' VAL . 73.2 t80 -57.45 -40.09 77.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.23 0.538 . . . . 73.21 110.796 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.3 -24.05 34.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 71.13 110.4 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.21 8.32 33.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.701 . . . . 72.35 110.505 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.16 -14.89 61.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 74.25 110.422 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . 140.31 64.72 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 121.1 -0.571 . . . . 72.53 112.396 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -65.96 -43.1 88.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.988 0.394 . . . . 74.04 109.972 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -59.44 -38.75 81.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 75.05 110.489 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.09 74.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 70.31 111.032 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 48.3 mtp85 -64.73 -29.84 70.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 53.45 111.161 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.19 -37.55 72.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.292 0.567 . . . . 63.32 110.425 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.555 ' HA ' ' HE2' ' A' ' 236' ' ' LYS . 13.6 t -83.26 -36.38 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 74.2 111.035 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.53 -41.82 65.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.659 . . . . 73.24 112.327 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 15' ' ' ARG . 3.5 t -95.45 172.69 7.93 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.972 -0.291 . . . . 64.3 110.504 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -79.99 73.6 6.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.626 0.726 . . . . 74.02 110.977 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.48 36.27 3.96 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.579 -0.737 . . . . 63.02 111.496 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.618 ' HA ' ' OG ' ' A' ' 260' ' ' SER . 15.4 p90 -147.9 136.06 21.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.287 . . . . 73.24 110.788 -176.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.31 64.92 3.39 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.034 -0.53 . . . . 42.11 113.235 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.61 -3.74 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 75.53 110.842 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.22 -1.87 78.89 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.011 -0.54 . . . . 74.52 112.898 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -147.98 -179.6 7.03 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.088 0.947 . . . . 71.31 113.441 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.621 HG23 HD12 ' A' ' 277' ' ' LEU . 36.8 mm -102.82 122.94 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.693 -1.594 . . . . 72.22 108.717 174.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -118.22 124.99 49.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.324 0.583 . . . . 71.31 110.432 178.163 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tp -124.19 144.12 50.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.0 -0.546 . . . . 64.23 110.057 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.8 p30 -144.66 140.03 28.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.116 0.484 . . . . 64.34 110.028 171.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.77 HD13 ' HD1' ' A' ' 281' ' ' PHE . 16.0 tp -119.07 123.32 44.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.351 -0.84 . . . . 44.32 109.494 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 4.1 ptpp? -116.64 124.41 49.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.476 -0.783 . . . . 71.4 109.841 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 283' ' ' ALA . 45.4 m -123.16 121.57 36.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.692 -0.686 . . . . 63.32 110.089 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.56 123.41 47.31 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.413 -0.515 . . . . 74.34 109.954 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 48.0 t -141.81 146.99 36.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 55.13 109.615 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.91 -148.09 0.49 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.421 0.451 . . . . 65.12 111.247 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.71 136.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.036 -0.529 . . . . 70.23 110.281 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.751 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.51 -9.24 36.36 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 118.799 -1.001 . . . . 53.21 115.243 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -100.57 127.47 46.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.465 1.633 . . . . 70.3 112.547 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.13 118.11 11.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.762 -0.829 . . . . 65.04 108.762 162.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -100.64 120.79 40.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.63 -0.508 . . . . 74.33 109.63 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.963 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 10.5 m -125.91 116.89 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.882 0.372 . . . . 61.12 110.848 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 10.6 t -111.61 122.47 47.89 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.635 -0.876 . . . . 73.21 108.635 174.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -129.71 126.75 38.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.928 0.394 . . . . 41.34 110.301 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.47 16.08 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.757 -0.735 . . . . 71.43 111.773 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.4 m -125.02 134.32 52.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.49 -0.559 . . . . 74.51 109.49 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -137.02 128.56 28.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.005 0.431 . . . . 74.51 110.725 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 18.4 m120 -75.4 113.06 12.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.32 -0.622 . . . . 64.14 109.32 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.431 ' HB ' HG12 ' A' ' 27' ' ' ILE . 8.8 t -63.71 132.41 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 73.21 111.0 -174.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 60.48 15.07 5.27 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.165 -0.925 . . . . 71.23 111.05 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.479 ' HB ' ' CB ' ' A' ' 48' ' ' ASN . 5.1 m -119.84 -10.13 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.43 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p 52.94 34.81 17.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.574 0.75 . . . . 42.34 112.679 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 35.3 mmtp -113.19 102.05 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.053 -0.721 . . . . 42.44 109.053 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 47' ' ' ALA . 13.7 t -123.78 123.42 67.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.123 -0.489 . . . . 74.11 111.661 -170.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -111.03 125.69 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 73.33 109.243 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.07 136.96 11.56 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.609 -0.805 . . . . 64.12 112.396 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 p -137.04 153.75 50.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.917 0.389 . . . . 73.41 110.56 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -127.27 124.79 39.66 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.142 -0.688 . . . . 75.54 109.142 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.963 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 87.0 mt-10 -108.41 119.97 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.298 -0.41 . . . . 53.11 110.386 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 73' ' ' GLU . 20.5 p -99.19 117.7 34.24 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.007 -1.109 . . . . 74.53 108.007 168.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.6 ttmp? -119.93 131.3 55.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.571 -0.529 . . . . 74.24 109.571 -174.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 25.8 m-85 -108.27 121.43 44.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.902 -0.59 . . . . 74.43 109.989 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.588 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 tmm_? -103.9 104.66 14.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.732 -0.84 . . . . 71.3 108.732 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 7.3 t-105 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.158 -0.928 . . . . 74.14 111.657 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 67' ' ' TYR . 25.1 m 69.84 144.99 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.93 0.769 . . . . 61.42 112.151 173.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -82.21 12.02 4.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.505 . . . . 54.13 111.145 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.453 ' H ' HG22 ' A' ' 65' ' ' THR . 54.3 m-85 -102.4 -46.8 4.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.481 -0.327 . . . . 72.12 110.424 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' HD12 ' A' ' 69' ' ' LEU . . . 144.95 71.86 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.125 -1.035 . . . . 70.31 113.393 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.688 ' HG ' ' HA ' ' A' ' 87' ' ' VAL . 8.3 mp -112.44 134.81 53.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.094 -0.651 . . . . 61.03 110.453 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -136.64 112.07 9.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.774 -0.648 . . . . 61.11 110.24 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 32.4 t80 -106.11 122.12 45.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.399 -0.593 . . . . 74.41 109.399 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 14.8 m -117.15 117.36 29.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.798 0.332 . . . . 74.33 111.275 -175.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HB2' ' OG1' ' A' ' 60' ' ' THR . 43.3 mt-10 -103.14 120.42 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 53.23 108.452 168.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.928 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 3.4 tmtp? -114.53 98.04 6.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.95 -0.568 . . . . 62.43 109.592 -174.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.587 ' HE1' ' HA ' ' A' ' 79' ' ' ASN . 2.1 t90 -99.51 129.02 45.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.212 -0.449 . . . . 72.12 110.422 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 39.5 t30 -97.78 154.24 17.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.221 -0.659 . . . . 45.25 109.221 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -65.31 -17.51 64.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.93 0.395 . . . . 73.02 111.348 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 12.8 m-20 -80.58 -1.28 41.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.054 -0.521 . . . . 72.04 110.371 174.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.587 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 4.1 m-20 77.7 35.16 0.31 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.979 0.912 . . . . 64.23 110.959 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 11.2 m -85.42 117.68 24.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.604 -0.725 . . . . 52.23 109.601 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.4 124.23 39.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.992 0.425 . . . . 72.14 111.352 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.85 109.31 2.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.745 -0.942 . . . . 43.34 110.745 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 m -104.62 99.64 9.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.918 0.359 . . . . 65.3 110.958 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.677 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 28.4 tt0 -111.73 132.26 54.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 72.42 110.209 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.8 tt -129.4 126.14 63.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 70.35 111.077 173.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 25.6 m -116.14 123.73 48.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.009 -0.541 . . . . 60.14 109.827 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 2.7 p -128.54 121.88 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.371 -0.233 . . . . 72.12 110.371 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 mt-10 -99.0 137.52 37.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 75.12 110.798 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.77 151.82 27.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 45.43 111.274 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.01 -38.94 14.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 73.52 111.545 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.74 -45.69 13.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.57 0.7 . . . . 74.32 109.477 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -87.17 66.56 9.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.324 -0.853 . . . . 74.41 108.83 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.755 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -53.4 124.7 15.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 73.41 110.378 -177.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.48 -3.82 56.53 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.429 -0.891 . . . . 43.42 112.57 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.6 HD22 ' HD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -81.81 117.34 22.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.493 -0.558 . . . . 73.34 109.493 175.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HG2' ' HG2' ' A' ' 88' ' ' GLU . 26.6 mtpp -116.35 110.65 18.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 71.31 109.083 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.504 ' HB2' HG13 ' A' ' 87' ' ' VAL . 2.0 mm? -99.93 126.29 46.06 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.37 -0.604 . . . . 71.4 109.37 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 28.4 m -130.16 119.17 22.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.95 0.405 . . . . 74.33 110.61 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -115.32 113.26 23.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.516 -0.92 . . . . 70.44 108.516 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.518 ' OD1' ' HD2' ' A' ' 113' ' ' LYS . 9.8 p-10 -120.77 134.39 55.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.317 0.579 . . . . 75.1 110.109 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 14.9 m -131.2 134.32 46.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.777 -0.647 . . . . 74.52 111.289 -175.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.3 t -95.27 122.0 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.082 -1.081 . . . . 61.3 108.082 172.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HD1' ' HB3' ' A' ' 110' ' ' LYS . 82.1 t80 -127.51 129.52 47.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.217 0.532 . . . . 73.13 110.642 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.8 m -120.45 103.2 44.48 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.787 -0.642 . . . . 75.22 109.737 176.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.97 -16.42 55.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.023 2.482 . . . . 64.23 112.978 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -66.35 -45.15 81.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.966 0.412 . . . . 74.54 110.607 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.3 p -105.16 -13.54 15.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.89 -0.595 . . . . 72.24 111.571 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.95 85.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 73.53 111.531 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 87.0 tttt -74.2 137.9 43.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 75.23 111.123 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.91 132.81 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 64.5 110.706 177.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.635 HD22 ' HA ' ' A' ' 132' ' ' ASP . 16.3 m120 -120.33 122.93 41.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 64.32 109.494 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.94 126.86 52.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.136 0.493 . . . . 40.12 111.419 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.518 ' HD2' ' OD1' ' A' ' 100' ' ' ASP . 57.0 mttm -121.14 138.44 54.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.424 -0.584 . . . . 70.21 109.424 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mm -119.75 117.79 54.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.101 0.476 . . . . 73.3 110.524 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.805 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 40.3 mttp -115.02 119.81 37.73 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.8 -0.636 . . . . 64.45 109.729 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.489 HG22 HD12 ' A' ' 97' ' ' LEU . 27.8 p -116.36 117.61 30.44 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.078 -0.51 . . . . 73.25 110.125 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.83 130.27 9.42 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.55 -0.833 . . . . 72.31 112.034 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.6 ' HD1' HD22 ' A' ' 95' ' ' LEU . 71.4 t80 -123.14 115.26 21.5 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.027 -0.731 . . . . 63.22 109.027 174.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB2' HG11 ' A' ' 3' ' ' VAL . 22.0 pttm -111.69 122.64 48.34 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.605 -0.838 . . . . 64.03 110.962 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HB3' HG22 ' A' ' 123' ' ' ILE . 37.6 ttm180 -106.29 169.13 8.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.757 -1.201 . . . . 65.01 107.757 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 3' ' ' VAL . 41.5 tp10 -53.28 -34.1 55.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 73.42 112.219 -167.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.435 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 92.9 m-70 -119.96 3.85 10.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 113.189 0.811 . . . . 75.32 113.189 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 120' ' ' ARG . 18.8 tt -144.82 147.89 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.248 -0.981 . . . . 61.13 112.235 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.506 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.1 m-20 -123.6 124.33 42.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.032 0.444 . . . . 63.12 110.8 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.457 ' CD1' HD13 ' A' ' 142' ' ' LEU . 4.2 mm? -111.06 139.89 46.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.129 -0.487 . . . . 75.25 109.975 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.17 116.83 0.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.598 -0.81 . . . . 63.45 112.14 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 60.9 m -112.1 115.28 28.61 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.545 -0.385 . . . . 73.53 110.377 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.96 116.84 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 75.25 110.472 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 44.9 mtt -103.59 117.59 34.77 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.686 -0.857 . . . . 73.14 108.686 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.17 114.8 29.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.431 -0.507 . . . . 75.12 109.928 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.447 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 53.0 t80 -99.29 97.56 8.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.954 0.406 . . . . 72.41 110.419 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.635 ' HA ' HD22 ' A' ' 111' ' ' ASN . 12.6 t70 -101.18 144.22 30.32 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.113 -1.069 . . . . 43.23 108.113 170.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -65.64 -25.74 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.78 -0.452 . . . . 73.21 109.78 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.05 -1.42 57.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 62.14 111.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.19 108.19 0.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.368 -0.92 . . . . 32.12 113.024 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 2.3 Cg_endo -82.58 126.76 4.78 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.352 2.701 . . . . 70.24 112.096 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 p -126.49 162.94 24.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.812 0.339 . . . . 74.32 111.227 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 49.4 mm -108.9 123.58 64.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.479 -0.328 . . . . 74.54 110.65 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.06 113.23 21.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.931 0.396 . . . . 71.41 109.945 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.83 11.18 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.069 -1.062 . . . . 75.12 111.817 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.15 116.83 26.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.036 0.446 . . . . 71.12 110.015 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -116.51 123.83 48.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.142 -0.481 . . . . 64.23 110.289 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 93.8 t -111.94 129.4 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 55.12 109.975 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.796 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.32 138.45 43.5 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.002 -0.74 . . . . 61.44 109.002 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 122' ' ' HIS . . . -117.78 118.55 4.12 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.439 -0.886 . . . . 53.31 112.641 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.564 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 25.0 t80 -131.66 146.42 52.17 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.483 -1.303 . . . . 73.31 107.483 175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.1 101.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.099 0.476 . . . . 72.53 111.403 -176.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.72 -31.2 8.11 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.378 -0.828 . . . . 63.3 112.512 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 33.3 m0 -105.12 122.81 46.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.62 0.248 . . . . 75.1 111.471 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.55 137.65 46.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 70.13 110.105 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.796 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -129.96 158.18 40.26 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.852 -0.425 . . . . 51.4 109.852 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -157.46 132.86 3.33 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.395 -0.682 . . . . 63.22 111.395 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.573 ' CD1' ' HD1' ' A' ' 169' ' ' PHE . 21.7 m-85 -127.13 118.96 25.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 117.271 0.535 . . . . 72.44 109.841 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.839 ' HG3' ' HB3' ' A' ' 168' ' ' ASN . 26.8 pt20 -105.55 122.86 46.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.655 0.741 . . . . 71.41 109.771 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 ptm -126.67 140.49 52.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 70.01 110.666 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 22.0 t-20 -113.2 117.66 32.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.712 -0.477 . . . . 71.44 109.712 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 87.9 t80 -100.86 129.12 46.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.687 -0.688 . . . . 74.32 109.822 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.828 ' HG3' ' H ' ' A' ' 161' ' ' LYS . 9.0 tp10 -99.81 103.31 14.92 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 115.851 -0.613 . . . . 74.15 109.803 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 m -70.89 -27.01 63.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.548 -1.66 . . . . 73.03 111.327 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.05 75.05 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.777 0.799 . . . . 75.11 108.909 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.828 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 48.1 mmtm -95.28 -162.61 0.96 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.681 -1.229 . . . . 71.31 107.681 167.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -109.48 22.12 16.17 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.91 -0.494 . . . . 73.53 110.836 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -166.28 165.66 17.23 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 118.56 -1.256 . . . . 74.45 113.411 -163.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.855 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -77.7 136.39 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.66 -0.7 . . . . 64.32 110.096 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.1 m -94.63 -21.59 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 74.32 110.516 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 156' ' ' ASN . 22.0 tt0 -133.47 132.28 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 61.12 111.14 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -122.79 105.95 10.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.546 -0.752 . . . . 62.23 109.539 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.839 ' HB3' ' HG3' ' A' ' 154' ' ' GLN . 11.8 t-20 -117.09 128.84 55.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.928 -0.397 . . . . 73.14 109.928 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.573 ' HD1' ' CD1' ' A' ' 153' ' ' TYR . 47.4 m-85 -121.8 149.82 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.61 -0.268 . . . . 74.22 110.751 -173.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -151.84 137.76 18.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.65 -0.25 . . . . 23.35 110.908 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.653 ' HB ' HG22 ' A' ' 182' ' ' THR . 63.7 t -135.03 127.07 47.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.439 -0.578 . . . . 50.12 109.439 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.37 108.46 0.88 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.103 -0.799 . . . . 62.41 111.103 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.544 ' CZ ' HD21 ' A' ' 180' ' ' LEU . 28.7 p90 -127.63 151.51 48.85 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.52 -0.872 . . . . 74.33 111.936 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.666 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 95.9 mttt -118.34 138.19 52.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.116 -1.402 . . . . 75.31 110.498 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -131.78 113.44 13.52 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.66 -0.867 . . . . 55.54 108.66 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.47 -95.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.823 0.702 . . . . 33.03 112.402 -172.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 197' ' ' LYS . 11.8 mm-40 -108.39 4.79 24.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.793 0.33 . . . . 75.12 111.235 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.84 122.5 47.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.42 -0.215 . . . . 61.21 110.42 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.666 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 31.6 mt-30 -135.9 123.17 21.79 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 119.48 -0.295 . . . . 62.41 110.606 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.574 ' O ' ' HA2' ' A' ' 172' ' ' GLY 0.262 0.0 OUTLIER -127.86 144.13 51.1 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.264 1.03 . . . . 61.32 113.728 171.396 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.575 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 22.0 t60 -108.38 114.29 28.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.117 -1.856 . . . . 72.22 108.587 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.653 HG22 ' HB ' ' A' ' 171' ' ' VAL . 14.0 t -96.83 157.94 15.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.153 -1.055 . . . . 42.2 108.153 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -147.95 149.71 32.7 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.722 -0.391 . . . . 75.41 110.157 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -131.41 116.03 30.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.509 -0.552 . . . . 65.05 109.509 170.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.786 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 57.7 t30 -94.33 97.02 9.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.591 -0.731 . . . . 73.23 109.812 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.23 -165.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.053 -0.976 . . . . 63.11 110.787 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.87 89.48 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.85 -0.691 . . . . 74.15 112.104 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -102.09 -25.72 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.157 0.799 . . . . 61.21 113.157 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.786 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 38.3 tt0 -129.82 139.92 51.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 119.698 -0.801 . . . . 74.51 113.066 -170.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.36 153.91 21.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.342 -0.844 . . . . 75.32 108.82 172.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -149.64 162.92 29.22 Favored Glycine 0 C--N 1.314 -0.654 0 C-N-CA 120.669 -0.776 . . . . 70.22 112.629 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -159.1 154.82 25.9 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.609 -0.596 . . . . 61.44 111.609 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.0 m -148.73 135.18 19.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.93 -0.767 . . . . 70.31 108.93 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.0 mp -123.15 124.51 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 71.33 110.15 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.791 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -112.61 119.86 39.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 73.41 109.932 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.494 ' HB3' ' CG2' ' A' ' 204' ' ' THR . 5.5 tp-100 -108.82 111.92 23.9 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.112 -0.699 . . . . 72.41 109.112 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.607 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 8.7 tmtm? -97.28 108.62 21.38 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.534 -0.913 . . . . 63.53 108.534 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.82 ' HB ' ' HB3' ' A' ' 201' ' ' LYS . 15.0 t -77.94 123.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.181 -1.044 . . . . 65.4 108.181 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -38.95 -60.57 0.84 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.445 1.09 . . . . 62.53 112.234 -170.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -123.42 83.87 2.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.967 0.413 . . . . 71.1 109.913 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.82 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 20.2 tptm -167.99 -90.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 74.05 109.654 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.807 ' HB3' ' HD1' ' A' ' 225' ' ' TYR . 0.0 OUTLIER -163.18 -176.18 4.69 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.654 0.264 . . . . 71.05 110.525 173.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.791 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 3.2 mp0 -108.18 131.86 54.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 73.41 109.741 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.494 ' CG2' ' HB3' ' A' ' 196' ' ' GLN . 15.0 t -122.15 150.0 42.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.234 -0.654 . . . . 71.05 109.234 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -129.79 159.38 36.7 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.489 0.661 . . . . 74.54 111.408 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 221' ' ' ILE . 2.3 t -132.58 124.86 52.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.382 -1.281 . . . . 65.2 108.428 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -114.64 131.07 56.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 70.33 109.197 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.621 HD13 ' HD1' ' A' ' 219' ' ' PHE . 5.0 tp -147.06 136.28 22.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.023 -0.535 . . . . 71.32 110.448 -171.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.474 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -154.97 132.03 10.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.665 0.269 . . . . 44.31 110.693 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -130.96 118.45 20.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.1 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 1.4 m -94.76 108.7 20.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.069 -0.514 . . . . 75.32 109.918 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.06 130.37 43.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 61.15 110.683 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.46 1.42 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.384 -0.686 . . . . 63.11 111.384 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.36 88.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.234 0.54 . . . . 73.54 111.39 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 62.5 m -144.32 167.03 23.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.574 . . . . 71.33 110.134 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.87 124.1 22.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 63.25 110.25 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 23.5 p -77.73 123.29 26.5 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.097 0.475 . . . . 71.45 110.024 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.534 ' O ' HD12 ' A' ' 208' ' ' LEU . 63.7 mtt85 -89.6 113.02 24.4 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.408 -0.59 . . . . 61.34 109.408 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.621 ' HD1' HD13 ' A' ' 208' ' ' LEU . 93.4 t80 -126.62 136.39 52.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.981 -0.748 . . . . 71.01 108.981 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.38 162.78 33.57 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.033 -1.079 . . . . 54.45 112.474 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.63 HG12 HG12 ' A' ' 237' ' ' VAL . 0.1 OUTLIER -137.72 147.55 26.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.008 0.432 . . . . 52.14 109.969 176.603 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 205' ' ' ALA . . . -136.99 157.75 46.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.656 -0.702 . . . . 71.31 110.564 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -141.57 126.27 17.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.685 0.278 . . . . 24.01 111.016 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 69.2 mttm -108.02 112.98 25.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.771 -0.826 . . . . 61.24 108.771 172.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.807 ' HD1' ' HB3' ' A' ' 202' ' ' LEU . 30.0 t80 -114.15 119.0 35.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.725 . . . . 72.33 111.471 -172.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -76.45 104.42 6.96 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.861 -1.163 . . . . 73.01 107.861 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.13 -56.69 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.142 -0.481 . . . . 72.03 111.513 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.627 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 35.8 t70 178.32 -54.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 74.25 111.145 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 89.5 Cg_endo -83.16 -142.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.936 1.757 . . . . 74.44 112.586 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 14.7 p-10 -91.97 10.98 26.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 72.13 110.324 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 132.78 54.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.712 -0.676 . . . . 71.45 110.533 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.471 ' SG ' ' HB ' ' A' ' 248' ' ' THR . 11.9 p -122.23 142.6 50.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.45 -0.795 . . . . 64.04 109.813 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -101.94 132.89 47.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 62.42 110.008 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 52.0 p -122.95 120.74 34.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.952 0.406 . . . . 64.31 110.448 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.14 152.8 24.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.507 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 60.2 mttp -139.89 142.43 36.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.093 -0.706 . . . . 62.23 109.093 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.63 HG12 HG12 ' A' ' 221' ' ' ILE . 3.6 p -140.85 137.74 34.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.369 -0.532 . . . . 73.15 109.995 174.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.694 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 83.8 m-20 -109.01 149.57 29.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.511 . . . . 71.22 110.045 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 241' ' ' SER . 3.9 p-10 -55.02 -24.18 23.23 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.257 0.973 . . . . 63.45 112.525 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.691 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.5 m -79.59 20.5 0.57 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 70.45 110.165 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.486 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 40.7 m 65.97 36.99 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.352 -0.84 . . . . 44.1 110.771 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.3 mp -97.44 138.26 35.15 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.458 -0.497 . . . . 70.13 111.223 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 243' ' ' ILE . 3.0 mp -113.3 117.9 56.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.588 -0.733 . . . . 75.03 109.993 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.13 138.1 12.33 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.595 -0.812 . . . . 74.31 111.886 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.53 139.48 42.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 73.12 110.159 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.28 146.23 17.29 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.844 -0.693 . . . . 54.01 112.204 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.72 126.83 55.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.066 -0.346 . . . . 74.2 110.066 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.471 ' HB ' ' SG ' ' A' ' 232' ' ' CYS . 11.7 m -120.92 114.71 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 74.31 109.699 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 257' ' ' LEU . 48.1 tt0 -125.28 138.9 54.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.364 -0.38 . . . . 75.32 110.535 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 2.5 t -121.98 92.84 3.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.503 0.668 . . . . 75.34 110.032 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.812 ' HB3' HG23 ' A' ' 255' ' ' ILE . 53.6 tp -88.81 66.12 7.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.883 -0.599 . . . . 62.34 109.431 -175.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' A' ' 253' ' ' PRO . 40.9 ttmt 69.38 150.86 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.115 -0.948 . . . . 60.31 109.908 -174.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 252' ' ' LYS . 51.4 Cg_exo -54.44 84.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.324 2.016 . . . . 73.03 111.642 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 282' ' ' GLN . . . -178.6 -35.21 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.112 -0.949 . . . . 53.15 110.793 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.812 HG23 ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -149.08 122.3 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.75 0.786 . . . . 64.43 110.82 176.282 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 99.2 mttt -116.99 131.65 56.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.056 -0.975 . . . . 74.45 109.827 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.679 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 28.8 tp -102.93 122.12 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.723 -0.473 . . . . 74.44 109.723 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.2 t -135.22 109.98 8.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 55.11 110.512 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.631 ' HB3' HD23 ' A' ' 277' ' ' LEU . 1.6 pp -135.08 158.38 44.5 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.085 -0.646 . . . . 72.53 110.54 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 22' ' ' TYR . 20.1 p -148.99 143.39 26.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.827 -0.624 . . . . 74.43 110.262 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.446 ' HB2' HD22 ' A' ' 275' ' ' LEU . . . -139.55 130.2 25.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.221 -0.659 . . . . 71.12 109.221 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.838 HD21 HD23 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -119.91 127.34 52.6 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.633 0.73 . . . . 64.42 110.084 179.518 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.867 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -101.74 109.68 21.51 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.23 -1.396 . . . . 54.13 107.23 176.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.872 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 10.5 t0 -72.25 106.87 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.405 -0.961 . . . . 64.51 108.405 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.48 -21.43 27.5 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.367 -0.444 . . . . 72.11 113.115 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -90.95 -20.16 22.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.741 0.305 . . . . 64.14 110.786 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 29.3 t-20 -110.5 -29.06 8.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.914 0.388 . . . . 62.45 111.942 -173.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 263' ' ' LEU . 23.0 m -63.27 -16.55 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.063 -0.398 . . . . 73.44 111.804 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -53.93 -35.93 62.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.928 -0.397 . . . . 75.45 109.928 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -96.89 -16.78 20.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 61.23 110.53 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 117.62 7.21 12.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.8 -0.714 . . . . 54.32 113.176 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -70.2 85.71 0.32 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 44.43 113.041 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.552 ' HB2' HD12 ' A' ' 263' ' ' LEU . 55.8 p-80 -113.96 138.89 49.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.098 -0.334 . . . . 74.45 110.098 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 9.5 mmpt? -105.76 137.44 43.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.276 -0.268 . . . . 74.51 110.276 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -129.26 132.54 47.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.57 -0.286 . . . . 50.03 110.275 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.505 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.89 118.95 1.65 Allowed Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.541 -0.624 . . . . 55.21 111.541 174.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 259' ' ' LEU . 1.7 tm? -118.57 124.59 47.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.903 0.352 . . . . 73.12 110.09 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -132.56 141.0 12.31 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.547 -0.835 . . . . 62.3 113.442 -177.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.913 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.4 mm? -122.7 132.4 54.23 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.523 0.201 . . . . 65.55 110.908 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 16.2 mt-10 -105.43 111.54 24.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 64.12 109.169 167.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.77 ' HD1' HD13 ' A' ' 31' ' ' LEU . 5.6 t80 -107.64 133.68 51.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.436 -0.95 . . . . 75.22 108.436 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 pt20 -137.4 125.49 22.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.288 0.566 . . . . 74.42 111.758 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.438 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -106.36 112.4 25.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.514 -0.766 . . . . 61.32 109.493 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 74.9 mt -115.42 156.87 24.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.921 -0.581 . . . . 75.4 110.134 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 109.127 -0.694 . . . . 72.4 109.127 178.287 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.365 0.602 . . . . 62.44 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.022 HG12 ' HB3' ' A' ' 119' ' ' LYS . 9.9 p -88.09 142.81 32.2 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.191 -0.913 . . . . 72.42 110.087 -174.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 85.0 Cg_exo -48.47 146.66 10.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.167 2.578 . . . . 73.52 112.926 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 7.6 Cg_exo -72.08 91.58 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.97 2.447 . . . . 70.31 112.49 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -76.36 -20.22 57.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.504 . . . . 70.1 110.134 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' HA ' HG21 ' A' ' 143' ' ' VAL . 63.7 t80 -56.64 -38.36 72.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 63.41 110.081 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.56 -28.26 28.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.771 -0.649 . . . . 70.45 110.573 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.67 6.37 35.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.794 -0.639 . . . . 74.15 110.708 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 143' ' ' VAL . 89.3 mt -60.78 -15.93 35.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.39 0.614 . . . . 61.34 109.823 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.705 ' HA3' ' HB2' ' A' ' 181' ' ' HIS . . . 164.72 57.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.099 -1.201 . . . . 75.11 110.099 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 14.2 tmtt? -56.16 -54.32 46.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.875 0.47 . . . . 64.11 111.54 -170.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -65.19 -42.15 93.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.091 0.472 . . . . 60.14 111.485 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 -36.5 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 62.52 112.423 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.461 ' O ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.23 -31.45 70.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 64.21 111.574 -173.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 2.3 m-20 -65.75 -41.85 91.61 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 121.248 -0.181 . . . . 62.31 111.343 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.81 -38.97 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.329 0.585 . . . . 54.24 110.113 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -72.91 -41.39 64.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.442 -0.799 . . . . 72.43 112.186 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 20' ' ' LYS . 14.4 t -94.66 -6.6 42.98 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.321 0.489 . . . . 54.42 112.321 -173.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.511 ' HD2' HG23 ' A' ' 19' ' ' THR . 13.7 mptt -101.41 28.34 5.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 63.11 110.405 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.04 134.14 36.98 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.903 -0.665 . . . . 73.34 112.117 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.904 ' HB3' ' HD2' ' A' ' 274' ' ' LYS . 96.3 m-85 72.01 -57.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.498 0.719 . . . . 70.32 111.771 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.14 155.53 12.78 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.498 -1.041 . . . . 42.53 110.498 -173.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -83.18 -4.46 58.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.232 0.516 . . . . 73.14 111.174 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.99 4.0 84.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.945 -0.645 . . . . 62.55 113.377 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.5 pp -148.91 -177.83 6.02 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 122.199 1.0 . . . . 73.33 113.013 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.829 HG23 HD23 ' A' ' 277' ' ' LEU . 25.6 mm -90.97 129.06 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 113.858 -1.519 . . . . 74.43 109.637 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 87.5 tttt -118.18 133.23 56.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.786 0.327 . . . . 54.14 110.372 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 279' ' ' LEU . 35.7 tp -117.52 149.65 40.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.855 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 11.5 t70 -142.37 139.78 31.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.282 -0.872 . . . . 71.33 108.88 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.757 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -134.74 127.67 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.845 -0.428 . . . . 73.21 109.845 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -123.51 125.67 45.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.964 -0.754 . . . . 64.53 108.964 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.899 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 19.2 m -137.71 141.7 41.04 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.146 -0.222 . . . . 74.41 111.205 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -103.03 140.01 37.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.801 -0.444 . . . . 74.1 109.801 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 53.5 m -139.56 174.38 10.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.561 -0.533 . . . . 74.24 109.561 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -30.54 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 72.32 111.836 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -44.77 130.02 7.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.41 0.624 . . . . 61.44 111.929 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 89.19 -10.65 72.25 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.196 -0.911 . . . . 70.11 113.555 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 35' ' ' SER . 3.1 mm? -105.14 129.01 53.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.659 1.23 . . . . 64.24 111.488 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.963 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 34.2 tt0 -139.57 146.8 40.3 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.572 -0.899 . . . . 75.04 108.572 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.899 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 59.4 t80 -121.42 121.31 37.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.686 0.279 . . . . 75.34 110.776 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.882 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.0 m -126.08 132.39 51.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 64.13 110.322 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 19.4 m -132.28 143.25 49.76 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.975 -0.453 . . . . 75.22 110.799 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -143.27 125.95 15.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.029 -0.36 . . . . 75.12 110.029 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.8 152.46 20.31 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.428 -0.891 . . . . 55.2 111.914 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -128.45 133.27 48.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.19 -0.67 . . . . 61.23 109.19 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -138.1 130.94 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.922 0.391 . . . . 62.13 111.533 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.58 142.93 42.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.881 -0.6 . . . . 64.22 109.42 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 t -75.36 141.75 43.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.727 0.298 . . . . 71.32 110.956 -176.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 mp0 73.12 -74.38 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.481 0.712 . . . . 74.14 111.93 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.38 139.0 45.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.399 . . . . 64.4 111.468 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 m -74.74 80.25 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.2 0.524 . . . . 61.4 111.916 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 24.2 mmmt -126.3 93.93 3.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.362 -0.607 . . . . 75.0 109.362 172.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 62.22 110.458 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 m -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 61.44 108.876 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.96 125.08 6.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.518 -0.849 . . . . 51.11 112.763 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 m -109.31 134.02 52.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.265 -0.642 . . . . 72.12 109.265 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.11 124.68 46.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.834 -0.802 . . . . 73.51 108.834 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.882 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -107.96 117.35 33.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.536 0.684 . . . . 64.44 110.285 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 m -93.54 118.89 31.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.027 -1.101 . . . . 72.15 108.027 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 13.6 tptm -112.34 135.31 53.18 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.572 -0.451 . . . . 74.11 109.878 -173.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.849 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 81.0 m-85 -118.91 120.69 38.05 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.906 -0.776 . . . . 73.32 108.906 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.1 ttm-85 -122.91 109.27 13.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 70.22 111.533 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 69' ' ' LEU . 70.6 m95 -106.65 93.59 4.66 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.993 -1.003 . . . . 74.23 108.943 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -67.73 -38.29 83.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.058 . . . . 73.12 112.516 -170.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 tp10 -86.42 61.62 6.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.38 0.609 . . . . 64.24 111.235 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.588 ' HD1' HD23 ' A' ' 69' ' ' LEU . 47.9 t80 172.38 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.409 -1.269 . . . . 73.52 108.456 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.07 49.75 0.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.465 -0.789 . . . . 74.03 111.927 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.588 HD23 ' HD1' ' A' ' 67' ' ' TYR . 1.5 mm? -114.67 131.83 56.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.076 0.465 . . . . 75.32 111.228 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.2 m -134.43 112.73 11.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.669 -0.696 . . . . 73.21 110.28 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.849 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 16.0 t80 -109.46 125.4 52.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.942 -0.572 . . . . 73.44 109.572 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 5.0 m -121.42 117.1 26.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.742 0.305 . . . . 75.23 110.655 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.721 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.4 tt0 -101.76 119.87 39.46 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.002 -0.74 . . . . 64.45 109.002 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 15.8 ttmm -107.99 86.67 2.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.421 -0.585 . . . . 43.44 109.421 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.728 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 11.9 t90 -101.06 129.42 46.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.127 -0.488 . . . . 75.12 111.088 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -108.07 164.1 12.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.551 . . . . 73.44 109.825 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -68.89 -18.23 64.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.278 0.561 . . . . 72.42 110.51 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 25.0 t70 -74.28 -4.4 35.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 64.25 109.94 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 93.5 m-20 74.76 9.52 4.11 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.969 -1.014 . . . . 72.03 110.644 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 117.37 21.83 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 72.01 109.518 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.728 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.9 pt? -123.02 136.98 55.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 63.01 111.374 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.61 106.28 2.28 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.251 -0.886 . . . . 70.43 111.237 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 32.0 m -85.78 100.06 11.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.861 0.362 . . . . 64.55 110.664 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 35.2 mt-10 -99.11 108.04 20.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 41.42 109.722 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.4 pp -112.18 137.92 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.518 -0.473 . . . . 42.12 110.584 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.1 m -129.21 128.55 43.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.581 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.01 125.72 74.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.968 0.413 . . . . 71.44 110.316 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -90.28 127.91 36.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 73.12 109.295 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 t70 -82.92 144.05 30.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.885 -0.413 . . . . 73.4 109.885 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.63 -21.56 15.22 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.076 -0.25 . . . . 75.24 111.367 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.0 tp -71.49 -45.52 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 74.01 109.302 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.32 75.31 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.786 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 35.6 ttm180 -61.46 135.36 57.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.19 0.519 . . . . 73.0 110.25 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.9 55.76 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.606 -0.998 . . . . 74.3 110.606 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.54 112.78 25.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.491 -1.3 . . . . 64.12 107.491 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 138.75 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.128 0.49 . . . . 71.25 110.054 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.34 127.27 51.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.497 -0.927 . . . . 74.42 108.497 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 1.061 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -125.96 130.37 51.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.178 0.513 . . . . 74.42 110.064 -176.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' HB1' ' A' ' 112' ' ' ALA . 31.4 t80 -123.63 123.04 39.68 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.942 -0.762 . . . . 73.33 108.942 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.507 ' HB2' ' HD2' ' A' ' 113' ' ' LYS . 81.4 m-20 -108.54 121.25 44.59 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.372 -0.603 . . . . 72.14 109.372 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 20.2 m -111.51 120.79 43.33 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.816 -0.354 . . . . 72.25 110.152 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.5 m -101.54 120.05 39.71 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.624 -0.88 . . . . 64.33 108.624 175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.669 ' HD2' ' HB3' ' A' ' 110' ' ' LYS . 49.2 t80 -134.91 137.97 43.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.037 0.446 . . . . 72.52 110.652 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 m -127.96 102.49 21.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.853 -0.612 . . . . 75.04 109.734 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 36.5 Cg_exo -59.32 -34.25 97.79 Favored 'Trans proline' 0 N--CA 1.466 -0.09 0 C-N-CA 122.454 2.103 . . . . 73.33 111.417 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.69 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 73.55 111.175 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.3 m -76.9 -23.25 52.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.698 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.42 2.27 73.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.668 -0.777 . . . . 74.41 112.976 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.72 148.36 22.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 54.32 111.858 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.669 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 19.1 ptmt -145.88 124.98 12.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 74.2 110.612 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.57 140.27 51.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.509 -0.552 . . . . 74.22 109.509 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.446 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -119.51 130.67 55.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.056 0.455 . . . . 64.34 111.365 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.607 ' HG2' ' OD1' ' A' ' 130' ' ' ASP . 42.6 mttm -114.37 136.44 52.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.664 -0.495 . . . . 65.34 109.664 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 tp -120.6 117.93 54.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.433 0.635 . . . . 65.44 109.585 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 1.061 ' HB2' HG23 ' A' ' 98' ' ' THR . 21.4 mtpt -122.93 134.83 54.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.698 -0.683 . . . . 71.14 110.7 -170.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -112.17 127.91 56.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.276 -0.638 . . . . 74.31 109.276 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.91 126.04 4.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.105 -1.045 . . . . 62.52 112.748 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.99 133.86 47.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.099 -0.334 . . . . 65.41 110.099 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 1.022 ' HB3' HG12 ' A' ' 3' ' ' VAL . 76.5 mttt -122.01 122.72 39.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.775 0.797 . . . . 61.43 111.464 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.874 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 18.9 tpt180 -110.26 162.18 14.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.517 -1.22 . . . . 74.0 108.089 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 3' ' ' VAL . 1.2 pm0 -58.48 -27.9 64.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.54 0.609 . . . . 73.42 110.932 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -107.97 3.16 23.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.177 -0.465 . . . . 72.35 111.526 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.874 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 15.5 mm -139.15 131.54 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.765 0.654 . . . . 74.44 112.765 -169.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.417 HD21 HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -117.92 111.95 19.68 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.818 -1.179 . . . . 74.44 107.818 163.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 142' ' ' LEU . 4.8 tp -128.32 124.6 36.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.996 0.427 . . . . 73.22 111.389 -175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.72 115.39 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.944 -0.646 . . . . 74.02 111.975 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 63.2 m -114.43 116.4 28.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.82 -0.223 . . . . 71.44 110.467 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.654 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 3.3 p30 -105.76 122.74 46.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.431 0.634 . . . . 73.03 110.643 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 67.4 mtm -104.41 117.67 34.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 72.42 109.5 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.607 ' OD1' ' HG2' ' A' ' 113' ' ' LYS . 15.7 t0 -106.1 120.48 41.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.237 -0.438 . . . . 74.03 111.25 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -93.89 97.25 10.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.303 0.573 . . . . 74.53 109.708 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.25 143.88 32.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.469 -0.787 . . . . 60.52 109.242 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.94 -12.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 63.12 112.513 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.95 -9.43 37.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 33.13 110.981 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.48 120.75 1.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.92 -0.657 . . . . 75.42 112.231 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 29.2 Cg_exo -61.94 131.19 33.87 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.851 2.367 . . . . 72.43 112.37 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.4 m -126.55 129.95 49.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.942 -0.572 . . . . 33.11 110.182 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.707 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.2 mp -107.57 124.95 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.015 -0.365 . . . . 65.32 110.015 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.89 112.97 24.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.445 -0.576 . . . . 64.53 109.445 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 127' ' ' CYS . . . -111.69 131.93 10.55 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.722 -1.228 . . . . 73.14 111.757 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.88 116.8 23.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 62.54 110.26 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 125' ' ' LEU . 12.2 tp -122.57 123.64 41.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 62.42 110.344 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 7' ' ' TYR . 86.1 t -122.49 124.96 71.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.352 -0.84 . . . . 71.21 109.692 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.15 137.69 46.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 73.13 108.711 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.544 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -129.43 132.71 7.21 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.868 -1.158 . . . . 75.14 114.177 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.454 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 73.8 t80 -136.16 147.27 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.34 -0.985 . . . . 75.44 108.34 171.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -39.28 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.497 0.925 . . . . 71.34 113.497 -174.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.92 -35.19 4.92 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.205 -0.907 . . . . 43.42 113.668 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.454 ' CE2' ' HB3' ' A' ' 146' ' ' TYR . 55.9 p-90 -110.57 138.83 46.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.082 0.941 . . . . 72.23 112.014 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.544 HD23 ' HA2' ' A' ' 145' ' ' GLY . 12.9 mt -127.19 137.25 52.89 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 74.33 110.186 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.66 124.41 23.89 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.847 -0.427 . . . . 71.23 109.847 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 143' ' ' VAL . . . -141.83 151.21 22.62 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.439 -0.886 . . . . 65.2 111.937 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -145.31 133.31 21.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.252 0.549 . . . . 71.54 111.867 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.25 123.75 44.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.301 -0.863 . . . . 74.4 109.417 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 45.9 ttm -119.46 134.26 55.3 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.987 -0.375 . . . . 75.25 109.987 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -111.59 119.0 37.26 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.24 0.543 . . . . 75.3 110.373 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.707 ' HB2' ' HB ' ' A' ' 138' ' ' ILE . 69.1 m-85 -98.56 127.0 44.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.121 -0.945 . . . . 74.03 110.47 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.608 ' HB2' ' OG1' ' A' ' 165' ' ' THR . 81.7 tt0 -99.7 98.99 9.77 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 109.513 -0.551 . . . . 75.14 109.513 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.5 m -72.25 -17.56 61.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 113.949 -1.478 . . . . 70.24 111.278 171.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.03 -27.0 65.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.697 -0.853 . . . . 63.52 108.697 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.86 -153.51 0.57 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.214 -1.357 . . . . 71.04 108.095 168.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.7 p -109.79 28.0 9.01 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.93 -0.481 . . . . 74.25 112.098 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -140.87 171.54 13.93 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 118.035 -1.466 . . . . 64.35 114.433 -160.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -93.81 127.76 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.661 -1.154 . . . . 70.11 108.813 170.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.608 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 1.7 m -96.06 -36.24 11.08 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.227 -0.589 . . . . 54.34 111.196 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.13 133.19 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.065 -0.516 . . . . 74.4 110.307 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -119.42 107.0 12.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.111 -0.7 . . . . 73.22 109.111 173.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -105.95 133.1 51.22 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.655 -0.498 . . . . 73.32 109.655 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.8 m-85 -121.99 146.98 46.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.396 -0.365 . . . . 70.41 110.468 -176.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -140.1 128.96 23.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.126 0.488 . . . . 73.44 109.998 176.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.65 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 39.6 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.506 -0.553 . . . . 74.44 109.506 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -121.95 135.57 10.47 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.376 -0.916 . . . . 52.33 112.597 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.574 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 68.4 t80 -117.12 120.32 37.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.561 -1.274 . . . . 72.5 107.561 171.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -115.41 121.64 43.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.032 0.92 . . . . 73.23 112.099 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.711 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 42.6 m -136.33 163.21 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.469 -1.678 . . . . 72.24 106.469 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.491 ' HB2' ' OE2' ' A' ' 177' ' ' GLU . 6.3 m-20 -63.28 -43.38 98.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.414 1.006 . . . . 72.55 110.363 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 176' ' ' ASP . 2.2 mp0 -85.96 -21.81 27.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 74.53 111.251 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.711 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 54.3 m-85 -119.22 115.35 24.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.524 -0.307 . . . . 74.22 111.359 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 1.5 mp0 -118.7 121.46 40.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.934 -0.765 . . . . 62.4 108.934 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.845 HD12 HG13 ' A' ' 194' ' ' ILE . 2.3 tt -124.11 131.9 53.59 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.574 -0.451 . . . . 54.55 110.553 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.705 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 19.5 t-80 -129.13 114.52 16.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.181 -0.463 . . . . 64.22 110.543 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.65 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 57.3 m -95.58 137.59 34.43 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.327 -0.99 . . . . 71.34 108.327 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -132.67 138.64 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.585 -0.446 . . . . 62.4 110.477 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 74.7 t -133.05 131.39 58.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.962 -0.563 . . . . 72.31 110.625 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 8.0 t30 -117.19 96.82 5.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.682 -0.859 . . . . 70.43 108.682 174.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 9.6 t70 59.4 -162.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.169 -0.923 . . . . 61.4 109.656 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -80.26 -7.01 88.94 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 52.44 112.53 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 211' ' ' THR . 13.2 m -95.63 -26.94 15.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 mp0 -119.48 114.77 22.8 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.84 -0.538 . . . . 64.24 111.286 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.484 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 28.1 p90 -135.67 129.14 32.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.782 0.325 . . . . 75.12 110.192 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.9 175.38 36.73 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.398 -0.906 . . . . 74.41 112.462 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -147.78 141.25 9.06 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.97 -0.633 . . . . 52.13 112.061 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 8.7 t -122.29 138.28 54.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.87 -0.418 . . . . 73.2 109.87 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.845 HG13 HD12 ' A' ' 180' ' ' LEU . 4.5 mp -120.21 122.72 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.918 -0.583 . . . . 63.34 109.953 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.551 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 59.5 t80 -108.09 120.42 42.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.851 -0.796 . . . . 73.51 108.851 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -121.29 116.52 25.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.9 -0.591 . . . . 72.12 111.136 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.97 116.72 24.37 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.346 -0.983 . . . . 71.31 108.346 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 199' ' ' ASN . 21.4 t -76.32 168.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.631 -0.507 . . . . 75.32 109.631 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.49 ' N ' HG12 ' A' ' 198' ' ' VAL . 16.6 t-20 -59.84 -37.1 78.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.109 0.48 . . . . 64.52 110.234 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.99 171.19 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.216 -0.661 . . . . 72.34 109.216 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 201' ' ' LYS . 36.7 mmtm -80.11 61.8 4.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.79 0.805 . . . . 74.41 111.464 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 203' ' ' GLU . 5.6 tt -137.02 132.37 34.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.322 -1.308 . . . . 73.24 107.753 175.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.451 ' N ' HD23 ' A' ' 202' ' ' LEU . 31.2 mt-10 -119.08 145.65 45.75 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.503 -0.555 . . . . 70.31 109.503 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.7 t -133.71 152.56 51.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.603 -0.439 . . . . 73.13 110.5 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB2' ' HD2' ' A' ' 195' ' ' TYR . . . -130.19 135.21 47.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.212 0.529 . . . . 63.13 110.153 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 193' ' ' SER . 33.9 t -121.87 125.63 73.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.484 -0.78 . . . . 74.13 109.603 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.79 127.68 54.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.74 0.305 . . . . 73.24 110.926 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.6 mm? -119.13 130.48 55.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 73.15 109.725 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 218' ' ' ARG . . . -132.71 129.68 39.05 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.627 -0.508 . . . . 31.23 109.627 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -127.04 121.52 31.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.478 -0.564 . . . . 73.31 109.478 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 215' ' ' SER . 5.4 t -106.24 117.87 35.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.616 0.722 . . . . 61.01 109.578 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.484 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.33 150.33 39.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.989 -1.005 . . . . 63.02 111.932 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 118.39 24.11 3.28 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.635 -0.711 . . . . 74.14 111.831 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.9 29.59 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.341 0.591 . . . . 60.41 110.471 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.663 ' HB2' HG23 ' A' ' 211' ' ' THR . 9.9 m -83.46 -170.34 3.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.48 -0.782 . . . . 75.44 110.537 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.61 149.62 38.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.376 -0.374 . . . . 70.21 110.6 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 38.7 m -95.91 123.0 39.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.681 -0.859 . . . . 64.11 108.681 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 43.7 ttt180 -101.2 117.62 35.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.392 -0.367 . . . . 74.43 110.808 -171.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.671 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 40.7 p90 -114.87 154.1 29.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.067 -0.515 . . . . 71.04 110.194 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.0 140.31 7.67 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.194 -0.762 . . . . 74.41 111.194 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.86 128.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.711 -0.477 . . . . 73.14 109.711 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 236' ' ' LYS . . . -122.23 133.05 54.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.363 0.414 . . . . 72.24 110.555 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.0 124.91 53.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.787 -0.449 . . . . 52.12 109.787 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.115 -0.493 . . . . 75.52 109.922 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -128.03 133.07 49.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.113 0.482 . . . . 74.22 110.537 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.71 97.68 9.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.697 -0.683 . . . . 63.2 109.266 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.8 tt -71.78 -23.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.043 0.925 . . . . 75.44 108.529 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.72 137.91 13.45 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.199 -1.364 . . . . 72.34 107.525 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.18 -15.91 11.73 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 122.902 2.401 . . . . 72.41 113.814 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.39 -22.3 19.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.813 0.339 . . . . 74.11 111.256 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.51 128.76 36.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.152 0.501 . . . . 52.05 111.83 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.3 m -104.85 119.71 39.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 63.43 110.429 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -100.55 133.51 44.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 72.43 110.651 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 38.8 t -131.16 117.81 19.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 75.51 111.515 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.93 40.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.914 -0.772 . . . . 70.24 108.914 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 222' ' ' ALA . 9.8 pttm -152.66 159.52 43.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 74.31 112.231 -171.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 5.0 p -143.5 154.25 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 60.33 109.438 176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 20.0 t-20 -130.75 153.82 48.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.683 -0.235 . . . . 71.43 110.87 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.671 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 32.5 t30 -38.05 -41.83 0.6 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.972 1.309 . . . . 73.4 113.661 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.4 t -78.17 24.37 0.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 73.2 111.051 -173.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.9 m 65.32 36.47 6.92 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 64.12 109.725 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.98 ' HB3' HD11 ' A' ' 262' ' ' LEU . 25.4 mt -93.6 115.39 27.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 51.13 110.098 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.5 mp -100.29 116.55 43.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.928 -0.767 . . . . 73.53 108.928 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -128.18 140.28 11.68 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.059 -1.067 . . . . 73.21 113.571 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.536 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -122.13 148.34 45.03 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.386 -0.598 . . . . 61.13 109.386 172.67 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -162.92 122.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.573 -0.822 . . . . 42.25 112.241 -177.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -118.47 133.07 56.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.274 0.559 . . . . 75.44 110.758 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.1 m -110.9 120.04 41.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.068 -0.969 . . . . 72.52 109.896 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -114.24 130.28 56.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.861 0.363 . . . . 65.21 110.136 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.5 p -104.79 107.7 18.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.819 -0.628 . . . . 74.2 109.909 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.63 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 4.1 mm? -71.18 173.87 7.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.854 0.359 . . . . 43.04 110.909 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -47.87 57.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.046 -0.524 . . . . 75.4 110.65 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 13.5 Cg_exo -70.96 -177.62 2.36 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.619 1.546 . . . . 72.24 110.68 169.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -76.84 50.3 2.95 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.556 -0.831 . . . . 45.22 112.791 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.63 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 48.5 mt -108.75 121.42 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.408 -0.466 . . . . 75.11 110.338 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 280' ' ' GLU . 68.7 tttt -110.53 119.2 38.39 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.247 -0.433 . . . . 55.31 109.895 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 15.3 tp -101.66 126.78 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.437 -0.801 . . . . 74.13 109.983 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.451 ' O ' HD12 ' A' ' 277' ' ' LEU . 19.5 m -132.05 109.77 10.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.867 0.365 . . . . 74.1 110.376 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.648 ' CD2' HD13 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -112.77 125.14 54.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.768 -0.826 . . . . 65.35 108.768 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.408 ' N ' HD13 ' A' ' 259' ' ' LEU . 51.4 m -138.99 148.81 43.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.782 0.325 . . . . 63.14 110.532 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.4 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -145.06 128.69 17.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.69 -0.485 . . . . 41.25 109.69 176.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.98 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -111.44 118.31 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.205 -0.665 . . . . 73.02 109.205 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.694 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -98.05 107.43 19.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.797 -1.186 . . . . 71.02 107.797 174.394 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.749 ' OD1' ' HG2' ' A' ' 266' ' ' LYS . 19.0 t0 -71.53 104.41 3.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.53 -0.915 . . . . 64.23 108.53 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.39 -27.1 39.52 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 115.709 -0.678 . . . . 64.31 114.159 -171.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.749 ' HG2' ' OD1' ' A' ' 264' ' ' ASP . 23.7 pttm -91.98 -13.55 30.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.078 0.439 . . . . 64.31 111.123 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.702 ' OD1' ' HA3' ' A' ' 272' ' ' GLY . 10.9 t-20 -116.22 -26.81 7.07 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.001 0.371 . . . . 71.45 112.001 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.694 HG11 ' HB3' ' A' ' 263' ' ' LEU . 24.1 m -62.07 -17.86 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 O-C-N 122.166 -0.334 . . . . 34.33 110.917 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -59.29 -29.37 67.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.773 -0.649 . . . . 75.21 109.999 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -100.04 -16.98 17.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 64.45 110.637 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.19 13.82 6.83 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.933 -0.651 . . . . 23.44 113.064 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.702 ' HA3' ' OD1' ' A' ' 267' ' ' ASN . . . -85.83 79.52 1.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.663 -0.78 . . . . 73.43 113.125 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.422 ' HB2' HD12 ' A' ' 263' ' ' LEU . 8.2 p80 -114.22 142.09 46.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.52 -0.548 . . . . 75.34 109.52 175.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.904 ' HD2' ' HB3' ' A' ' 22' ' ' TYR . 80.2 mttt -110.61 143.1 41.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.399 -0.52 . . . . 71.45 111.49 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.5 tm? -115.5 137.97 51.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.884 . . . . 64.11 108.866 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.496 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -134.51 104.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.507 -0.854 . . . . 73.12 111.521 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.829 HD23 HG23 ' A' ' 27' ' ' ILE . 40.1 tp -114.12 145.46 41.6 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.33 -0.548 . . . . 73.14 110.677 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.669 ' H ' HD12 ' A' ' 277' ' ' LEU . . . -150.33 124.1 1.68 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.197 -0.911 . . . . 53.41 111.479 178.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.404 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.2 mm? -118.33 131.89 56.3 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.748 -0.834 . . . . 73.31 108.748 174.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.652 ' CG ' ' HB3' ' A' ' 256' ' ' LYS . 8.7 pt-20 -125.22 115.18 20.0 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.861 -0.736 . . . . 61.45 110.369 171.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.757 ' HB3' HD22 ' A' ' 31' ' ' LEU . 57.3 t80 -99.83 106.19 18.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.948 -1.024 . . . . 74.45 109.812 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -102.56 111.95 24.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.893 -0.594 . . . . 52.33 110.043 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -111.94 126.2 54.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.958 -0.564 . . . . 72.24 110.459 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.44 0.34 16.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.367 0.603 . . . . 73.24 110.243 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.585 -0.734 . . . . 71.24 109.731 179.398 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.743 -0.466 . . . . 71.4 109.743 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 120' ' ' ARG . 9.1 p -163.33 137.06 4.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.409 -0.589 . . . . 73.33 109.409 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.4 Cg_exo -63.56 131.92 33.49 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.888 2.392 . . . . 63.42 113.397 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 6.5 Cg_exo -73.57 99.84 1.18 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.917 2.411 . . . . 63.23 111.565 175.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.543 ' HB ' HD11 ' A' ' 150' ' ' LEU . 5.2 p -94.82 -2.75 50.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.351 -0.386 . . . . 73.42 111.865 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.694 ' HB3' HG21 ' A' ' 143' ' ' VAL . 6.1 p90 -62.25 -21.32 65.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.66 0.743 . . . . 74.42 109.973 170.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.25 54.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.135 -0.939 . . . . 72.22 110.143 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 51.4 m-20 -91.58 -1.9 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 71.21 109.943 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.111 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -76.39 -34.04 58.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.173 -0.921 . . . . 73.12 111.67 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.23 -36.07 0.51 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.08 -1.057 . . . . 74.51 113.892 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.77 -41.73 78.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.967 0.383 . . . . 62.14 111.981 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 m -58.15 -46.38 85.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.034 0.445 . . . . 74.43 111.244 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -35.03 72.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.934 -0.575 . . . . 54.25 111.4 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -58.55 -35.91 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 72.33 112.79 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.37 -49.87 75.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.978 0.418 . . . . 72.33 111.387 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HB ' ' HB2' ' A' ' 207' ' ' ASN . 2.8 t -85.21 -31.5 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 73.24 111.149 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -66.91 -38.24 85.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.189 -0.459 . . . . 75.23 112.001 -174.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -57.24 150.85 16.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 74.43 111.191 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -116.59 -13.52 10.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.213 0.53 . . . . 62.4 110.224 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.77 51.76 4.48 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.607 -0.724 . . . . 63.42 111.755 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.6 -36.94 74.82 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.408 0.623 . . . . 74.15 109.582 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.05 101.58 0.44 Allowed Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.014 -0.994 . . . . 52.44 111.05 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -81.28 -3.81 53.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 75.11 110.14 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.89 7.33 78.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.815 -0.629 . . . . 71.21 112.643 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mp -123.34 168.36 12.6 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.966 0.889 . . . . 61.44 112.435 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.804 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.9 mp -108.27 124.14 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.047 -1.433 . . . . 64.11 108.925 174.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -105.61 136.31 45.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.963 0.411 . . . . 74.32 111.03 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.76 129.04 56.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.21 -1.033 . . . . 74.41 108.21 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.56 133.93 48.5 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.807 -0.812 . . . . 55.0 108.807 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.63 HD13 ' HD2' ' A' ' 281' ' ' PHE . 16.9 tp -138.41 126.02 22.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.21 111.78 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -114.86 127.25 55.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.55 109.6 172.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 41' ' ' PHE . 7.6 t -137.21 150.96 48.23 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.535 -0.466 . . . . 63.54 110.386 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HE2' HD11 ' A' ' 284' ' ' LEU . 18.3 ttmm -133.08 148.71 52.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.376 -0.374 . . . . 73.22 110.016 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -140.13 136.62 33.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.769 -0.196 . . . . 54.44 110.509 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 39.84 -97.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.294 1.038 . . . . 65.13 113.254 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -154.76 141.24 18.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.854 -0.795 . . . . 72.32 108.854 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 88.51 -9.08 77.12 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.586 -0.34 . . . . 52.22 112.71 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.21 128.03 48.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.658 0.729 . . . . 74.22 111.803 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.959 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 3.5 tp10 -141.03 118.9 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.911 -1.144 . . . . 75.3 107.911 165.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.773 ' HB3' HG22 ' A' ' 33' ' ' THR . 59.3 t80 -116.96 124.86 50.41 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.25 -0.906 . . . . 74.0 111.107 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.7 m -126.84 117.73 23.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 65.15 110.911 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -116.25 127.23 54.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.607 -0.27 . . . . 75.31 110.297 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -125.9 126.06 43.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 61.33 109.933 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.45 138.17 8.01 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.224 -0.989 . . . . 74.1 111.858 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -121.01 133.18 55.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.889 -0.411 . . . . 70.44 109.889 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 135.31 45.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.133 0.492 . . . . 73.13 111.161 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.834 ' HB3' ' HB3' ' A' ' 53' ' ' LYS . 39.1 t30 -77.27 147.19 36.43 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.347 -0.842 . . . . 74.1 109.41 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -44.93 -37.66 4.12 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.987 0.423 . . . . 75.42 111.02 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.93 123.58 27.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.212 -0.662 . . . . 73.24 109.212 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -68.72 -5.3 19.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.241 0.544 . . . . 71.14 111.826 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -83.59 5.33 24.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.117 0.484 . . . . 73.41 110.85 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.834 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 31.2 tptt -137.64 84.38 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 63.22 110.346 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.81 132.56 70.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.696 0.284 . . . . 73.43 110.785 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -125.16 142.69 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.22 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.19 155.72 22.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.102 -1.047 . . . . 52.24 113.206 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 m -146.31 127.33 14.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.343 -0.614 . . . . 42.14 109.343 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 74' ' ' LYS . 2.0 tm? -121.46 127.14 50.79 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.164 -0.31 . . . . 74.35 110.164 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 45.5 mt-10 -116.7 118.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.752 -0.658 . . . . 60.45 110.14 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.6 m -100.42 118.73 37.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.24 -1.022 . . . . 64.41 108.24 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.959 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 66.0 mttm -113.68 133.51 55.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.21 0.529 . . . . 71.54 110.543 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.75 ' HD2' ' HB2' ' A' ' 71' ' ' PHE . 38.4 m-85 -101.13 119.65 39.06 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.794 -1.187 . . . . 53.11 107.794 172.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 9.9 ttm180 -115.57 106.0 13.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.606 0.717 . . . . 75.34 109.971 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -113.7 104.14 11.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.516 -1.22 . . . . 75.54 109.335 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.7 p 60.57 126.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.692 1.245 . . . . 52.32 112.326 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.4 pm0 -60.72 130.31 45.86 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.11 -0.7 . . . . 74.21 109.11 174.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 62.12 75.67 0.4 Allowed 'General case' 0 C--N 1.332 -0.183 0 O-C-N 123.825 0.703 . . . . 71.01 109.598 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.95 -101.63 0.15 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.31 -0.859 . . . . 44.4 111.777 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.498 ' CD1' ' HB ' ' A' ' 87' ' ' VAL . 4.0 mm? -121.34 131.96 54.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.137 0.494 . . . . 54.43 112.325 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.608 HG23 ' HB ' ' A' ' 86' ' ' THR . 4.1 t -137.3 119.01 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 74.0 110.033 171.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.75 ' HB2' ' HD2' ' A' ' 62' ' ' TYR . 34.5 m-85 -114.81 121.58 43.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.671 -0.241 . . . . 72.34 110.435 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 83' ' ' THR . 57.6 m -109.96 115.56 30.01 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.997 -0.281 . . . . 55.4 110.585 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.91 143.69 47.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.681 -0.408 . . . . 75.45 111.619 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HG3' HD12 ' A' ' 58' ' ' LEU . 20.5 mmtt 159.41 -119.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.65 1.219 . . . . 72.04 111.479 162.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.783 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 15.5 t90 -135.18 140.31 45.25 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.588 -0.445 . . . . 75.44 112.081 -164.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -110.18 164.14 12.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 73.44 110.836 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 t -69.9 -7.37 39.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 51.44 111.328 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 14.1 m-20 -80.0 -2.27 43.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.856 -0.611 . . . . 40.41 110.39 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 78' ' ' ASP . 28.5 t-20 81.71 -8.53 1.32 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.96 0.788 . . . . 72.32 109.936 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.4 m -85.25 140.15 31.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.344 -0.844 . . . . 71.42 110.398 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.783 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -92.52 126.56 37.66 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.337 -0.616 . . . . 74.22 109.337 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.35 13.67 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.172 -1.013 . . . . 64.53 113.044 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.1 t -136.16 104.41 5.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.743 0.782 . . . . 71.53 110.736 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 43.9 tt0 -106.78 115.66 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.194 -0.912 . . . . 74.43 109.448 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -111.77 137.98 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 44.21 110.62 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.672 HG23 ' HB ' ' A' ' 98' ' ' THR . 16.9 m -129.17 129.92 45.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.899 0.38 . . . . 70.0 111.246 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.498 ' HB ' ' CD1' ' A' ' 69' ' ' LEU . 2.8 p -129.24 124.89 61.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.724 -0.671 . . . . 74.04 110.23 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -113.53 122.68 48.0 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.405 -0.591 . . . . 71.22 109.405 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.37 151.84 19.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.191 0.519 . . . . 52.13 111.85 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -102.21 -24.1 13.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.731 -0.668 . . . . 73.23 110.661 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.46 -56.88 8.83 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.449 -1.315 . . . . 73.35 107.449 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.45 61.2 6.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.27 -1.011 . . . . 53.23 108.27 167.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -53.03 124.4 14.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.061 -0.972 . . . . 74.24 112.612 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 100.98 -16.45 57.31 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.083 -0.962 . . . . 65.01 112.093 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' A' ' 118' ' ' TYR . 3.1 tm? -92.5 123.82 36.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.606 -0.516 . . . . 64.21 109.606 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.76 51.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.74 -0.664 . . . . 72.01 109.668 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -116.24 125.71 52.59 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.114 -0.699 . . . . 73.32 109.114 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 86' ' ' THR . 0.5 OUTLIER -130.49 119.91 23.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.195 0.521 . . . . 61.32 110.279 176.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.453 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 91.9 t80 -123.91 125.43 44.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.535 -0.757 . . . . 75.13 110.372 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 4.5 t70 -109.72 131.99 54.55 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.024 -0.534 . . . . 74.14 109.714 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.8 t -126.0 120.86 31.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.38 -0.6 . . . . 62.12 109.38 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.0 m -109.99 122.14 46.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.959 -0.564 . . . . 73.15 110.048 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.87 119.85 39.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.006 0.431 . . . . 74.21 110.714 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.477 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 8.2 t -99.77 139.77 21.06 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 108.506 -0.924 . . . . 71.24 108.506 176.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 31.3 Cg_exo -62.12 41.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 124.127 3.218 . . . . 71.32 114.832 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -123.86 150.02 45.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 60.12 108.822 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.0 m -66.55 105.19 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.099 0.475 . . . . 63.22 111.292 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.42 68.56 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.994 -0.622 . . . . 61.23 112.869 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -94.97 111.64 23.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.072 0.463 . . . . 64.24 109.945 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.47 143.57 26.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.869 -0.605 . . . . 74.33 110.618 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.37 122.47 40.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.049 -0.523 . . . . 75.03 109.705 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -129.13 141.8 51.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.976 -0.289 . . . . 74.43 111.389 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -124.68 137.38 54.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.947 -0.761 . . . . 62.25 108.947 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 5.0 tp -124.75 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.188 0.518 . . . . 74.13 110.218 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -116.45 120.96 40.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.837 -0.62 . . . . 74.23 110.467 -178.118 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -107.19 116.89 32.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.599 -0.728 . . . . 74.43 109.083 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.556 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -133.74 125.71 4.04 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.694 -1.241 . . . . 72.34 113.145 -172.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.719 ' HB3' HD23 ' A' ' 95' ' ' LEU . 6.3 p90 -117.01 136.64 52.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.192 0.52 . . . . 74.2 110.032 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 43.6 pttt -119.74 124.66 46.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.866 0.841 . . . . 74.13 111.58 -175.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.514 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.3 mmt180 -100.32 166.37 11.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.256 -1.338 . . . . 74.21 109.06 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.11 -27.25 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.762 0.825 . . . . 75.44 112.813 -172.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -118.36 -12.1 9.93 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.699 0.629 . . . . 74.11 112.699 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 144' ' ' LEU . 19.5 pt -142.76 145.72 22.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.612 -0.835 . . . . 71.2 111.815 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.636 HD22 ' N ' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -129.02 115.82 18.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.759 -0.46 . . . . 64.23 109.759 178.77 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.534 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -130.52 143.07 50.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.331 -0.547 . . . . 70.32 111.634 -175.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.556 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -141.57 138.75 8.91 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 61.01 112.621 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 67.9 m -108.66 112.38 24.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.013 -0.365 . . . . 71.33 110.013 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 9.6 t70 -104.47 148.17 26.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.046 -0.525 . . . . 55.44 110.088 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.1 mtm -131.38 118.31 20.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.312 -0.625 . . . . 62.32 109.312 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 10.5 t70 -89.78 115.74 27.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.945 -0.761 . . . . 75.41 108.945 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -97.12 99.71 11.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.956 -0.565 . . . . 75.21 110.962 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.55 145.69 37.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.983 -1.117 . . . . 74.25 107.983 169.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.862 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -64.68 -21.67 29.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.613 0.244 . . . . 72.15 111.536 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.53 -18.83 34.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.542 0.21 . . . . 64.43 111.101 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.5 105.66 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.868 -0.682 . . . . 74.1 112.799 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 3.1 Cg_exo -76.2 109.45 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.092 2.528 . . . . 61.52 111.366 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -99.09 160.55 14.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.522 -0.308 . . . . 55.14 110.946 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mp -107.38 118.38 55.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.672 -0.411 . . . . 63.42 110.036 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 33.8 ttp180 -115.2 111.15 20.54 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.076 0.465 . . . . 54.04 110.102 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.95 144.29 17.3 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.955 -1.117 . . . . 54.22 112.382 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -137.6 114.71 10.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.127 0.489 . . . . 73.3 110.184 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' A' ' 125' ' ' LEU . 4.2 tp -117.68 123.16 45.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.968 -0.56 . . . . 61.02 109.701 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.694 HG21 ' HB3' ' A' ' 7' ' ' TYR . 5.2 t -119.24 121.51 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.494 . . . . 75.05 110.293 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 123' ' ' ILE . 5.0 mp -108.08 138.64 44.0 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.425 -0.583 . . . . 60.22 109.425 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.45 119.31 4.24 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.607 -0.724 . . . . 61.12 111.358 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.661 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 56.4 t80 -118.16 148.97 41.82 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.299 -1.0 . . . . 63.44 108.299 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -52.79 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.344 0.592 . . . . 74.44 110.973 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.04 -32.74 7.21 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.144 -0.935 . . . . 73.24 112.493 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 90.9 m95 -106.52 146.39 30.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.285 0.846 . . . . 74.4 113.285 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.543 HD11 ' HB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -128.91 142.62 50.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.775 -1.194 . . . . 73.22 107.775 168.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -155.65 123.87 5.83 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.443 -0.577 . . . . 61.45 109.443 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.111 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -142.16 142.14 11.5 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.945 -1.121 . . . . 71.35 111.872 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 36.1 m-85 -123.47 117.17 24.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.032 -0.359 . . . . 75.32 110.032 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.28 122.58 43.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.525 -0.546 . . . . 63.21 109.525 166.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.752 ' HB2' HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -137.2 143.69 42.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.682 0.277 . . . . 72.12 110.485 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 t30 -118.62 118.88 32.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 65.02 110.471 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.943 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 93.1 m-85 -91.85 121.25 33.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.109 -0.951 . . . . 75.12 110.192 -175.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.37 109.89 14.14 Favored 'General case' 0 C--O 1.254 1.325 0 CA-C-N 114.449 -1.251 . . . . 75.1 109.172 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -71.72 -21.51 61.76 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 125.354 1.659 . . . . 73.21 111.775 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.31 -31.8 71.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.392 -0.966 . . . . 55.5 108.392 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -107.92 -161.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.979 -1.464 . . . . 70.41 107.984 168.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.9 m -111.04 26.76 10.37 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 121.89 -0.506 . . . . 52.41 110.476 171.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -149.31 150.31 32.3 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.99 1.108 . . . . 72.4 113.99 -159.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.943 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 p -73.16 128.91 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.537 -0.756 . . . . 72.44 110.231 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 3.9 p -102.49 -33.9 9.34 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.638 -0.71 . . . . 55.2 111.526 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -112.67 129.21 56.48 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.626 -0.43 . . . . 54.2 110.175 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.3 m -124.34 115.33 20.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.033 -0.531 . . . . 72.53 110.665 173.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 7.8 t30 -125.97 120.25 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.96 -0.756 . . . . 64.14 108.96 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -138.34 165.21 27.33 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.741 -0.784 . . . . 70.35 111.921 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.19 133.31 35.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.326 -0.852 . . . . 54.53 110.767 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.51 127.09 64.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.007 -0.738 . . . . 62.01 109.007 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.58 166.79 26.07 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 119.735 -1.221 . . . . 45.54 112.831 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.62 ' CE1' HD22 ' A' ' 180' ' ' LEU . 37.4 p90 -138.55 140.4 39.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.168 0.509 . . . . 73.3 110.649 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -103.4 132.62 49.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.132 -0.94 . . . . 74.22 109.935 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 m -131.37 163.2 28.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.782 -0.821 . . . . 74.34 108.782 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -51.75 -50.29 60.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.7 0.285 . . . . 53.35 111.541 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.722 ' HA ' ' HE3' ' A' ' 197' ' ' LYS . 27.0 mm-40 -101.41 -22.51 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.184 0.438 . . . . 72.43 112.184 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 194' ' ' ILE . 72.7 t80 -124.29 144.89 49.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.666 0.27 . . . . 75.03 111.681 -170.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 5.1 tp-100 -135.61 122.4 21.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.947 -0.39 . . . . 75.15 109.947 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.676 HD12 HG13 ' A' ' 194' ' ' ILE . 3.8 tt -125.88 138.15 53.78 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.261 -0.575 . . . . 70.4 111.786 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.643 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 12.4 m170 -128.31 114.17 16.56 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.889 -0.782 . . . . 53.21 108.889 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 95.0 m -90.86 141.42 28.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.856 -0.424 . . . . 72.31 109.856 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -129.83 141.22 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.992 0.425 . . . . 73.21 110.737 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 5.4 t -130.95 128.36 62.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.296 -0.411 . . . . 64.2 111.042 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 37.0 t-20 -109.14 90.85 3.42 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.645 -0.872 . . . . 65.4 108.645 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 60.65 -169.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 71.45 111.718 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.83 -5.59 86.65 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.42 -0.809 . . . . 45.5 111.981 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 24.2 m -94.32 -27.1 16.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.64 0.607 . . . . 74.21 112.64 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 51.5 mt-10 -135.02 129.6 34.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.931 -0.708 . . . . 74.34 112.223 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.445 ' HD2' HG22 ' A' ' 184' ' ' VAL . 44.3 m-85 -127.23 143.84 51.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.619 -0.718 . . . . 72.11 109.713 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . 179.74 -138.24 3.36 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.778 -0.725 . . . . 74.54 112.101 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 182' ' ' THR . . . 152.6 -155.61 26.23 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.168 -1.015 . . . . 71.45 113.037 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.1 p -142.09 138.55 31.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.291 0.567 . . . . 64.21 110.817 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.817 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.1 mp -119.8 118.76 58.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.645 -0.707 . . . . 72.15 109.612 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.438 ' HB3' ' HB3' ' A' ' 179' ' ' GLN . 44.8 t80 -108.71 119.69 40.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.108 0.48 . . . . 65.53 110.025 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.57 131.54 52.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.743 -0.662 . . . . 75.15 109.776 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.722 ' HE3' ' HA ' ' A' ' 177' ' ' GLU . 18.1 pttp -107.55 127.36 53.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 64.2 110.943 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 202' ' ' LEU . 47.6 t -82.99 155.74 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 45.45 109.446 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -61.77 -45.04 95.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.893 0.378 . . . . 61.32 110.083 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.66 148.35 48.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.722 -1.214 . . . . 72.32 107.722 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -63.41 86.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.562 0.696 . . . . 74.51 112.457 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 225' ' ' TYR . 36.2 mt -144.24 115.16 7.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.57 -1.195 . . . . 60.43 108.551 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.46 128.94 52.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.776 -0.824 . . . . 42.43 108.776 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -123.46 138.33 54.61 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.702 -0.399 . . . . 43.44 111.212 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.39 135.5 48.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.024 -0.535 . . . . 75.43 110.177 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 221' ' ' ILE . 87.9 t -114.58 136.22 51.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.663 -0.699 . . . . 74.41 109.612 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.774 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 8.7 t30 -114.71 132.34 56.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.802 0.334 . . . . 72.15 110.402 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.486 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -122.58 136.49 54.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.651 -0.704 . . . . 74.5 110.443 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.97 127.13 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.005 -0.543 . . . . 65.24 109.63 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.686 ' HB2' HG23 ' A' ' 217' ' ' THR . 28.4 t90 -130.72 126.11 35.62 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.529 -0.305 . . . . 64.42 110.472 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.585 HG23 ' HB2' ' A' ' 215' ' ' SER . 3.5 t -101.29 116.39 32.68 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 73.42 109.823 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.48 141.26 56.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.335 -0.848 . . . . 63.24 111.158 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 128.36 31.49 0.67 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.864 -0.684 . . . . 71.25 111.655 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 67.36 12.16 8.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.875 0.47 . . . . 63.1 111.826 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 211' ' ' THR . 17.8 m -80.45 160.84 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 70.21 109.777 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -77.66 153.37 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.379 . . . . 74.24 111.122 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 210' ' ' TRP . 26.4 m -84.54 131.23 34.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.555 . . . . 74.31 109.744 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -88.54 116.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.947 -0.76 . . . . 75.12 108.947 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 54.5 p90 -123.44 141.34 52.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -144.83 141.53 10.07 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.226 -0.75 . . . . 74.22 111.226 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.89 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -119.53 130.54 73.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.879 0.371 . . . . 72.25 110.426 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -129.82 129.48 44.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.605 -0.725 . . . . 72.15 109.954 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.672 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -117.97 129.15 55.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.288 -0.415 . . . . 63.33 110.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -115.66 115.83 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.021 -0.733 . . . . 71.23 109.021 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 233' ' ' PHE . 3.9 p90 -132.78 119.25 20.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.248 0.547 . . . . 64.44 111.77 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 35.4 tt0 -89.54 97.94 11.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 71.31 109.075 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -97.15 -24.62 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 73.32 109.668 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 4.6 t70 -114.63 137.22 22.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.653 -0.869 . . . . 72.15 108.653 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -34.97 -51.89 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.381 3.388 . . . . 65.13 115.214 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -107.23 4.78 27.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.902 0.334 . . . . 75.32 111.902 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -124.73 122.58 37.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.453 0.644 . . . . 50.24 111.958 -175.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 50.7 t -113.18 119.09 36.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 75.2 108.84 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.517 ' HB2' ' CE2' ' A' ' 225' ' ' TYR . 57.6 m-85 -100.2 132.13 45.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.434 -0.348 . . . . 51.44 110.272 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 21.1 t -121.75 140.91 51.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.046 0.45 . . . . 32.1 110.349 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -127.16 140.8 52.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.095 -0.705 . . . . 74.33 109.095 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -135.6 141.4 45.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.693 -0.484 . . . . 55.23 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.588 HG12 HG12 ' A' ' 221' ' ' ILE . 5.4 p -140.6 140.13 34.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.488 -0.485 . . . . 70.31 110.028 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.589 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -107.27 150.36 26.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.573 -0.74 . . . . 44.42 110.381 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 241' ' ' SER . 28.3 p-10 -43.9 -33.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.95 1.406 . . . . 74.51 114.064 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.497 ' HB3' HD13 ' A' ' 242' ' ' LEU . 17.9 t -82.08 21.95 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 61.54 110.024 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.531 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 50.1 m 68.5 36.33 2.95 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 115.232 -0.894 . . . . 64.02 111.265 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.817 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.2 mp -95.68 125.45 40.28 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.309 -0.556 . . . . 74.43 111.316 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -112.52 116.57 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.659 -0.701 . . . . 73.43 110.022 -170.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -126.35 145.76 15.9 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.55 -0.833 . . . . 43.33 112.654 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -118.39 148.91 42.05 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.062 0.458 . . . . 52.34 110.247 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.94 121.79 2.42 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.604 -0.726 . . . . 52.3 111.544 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -108.13 118.84 37.8 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.963 -0.384 . . . . 72.54 109.963 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.644 HG22 HG22 ' A' ' 258' ' ' THR . 14.1 p -113.6 112.86 24.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 72.33 109.895 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 257' ' ' LEU . 22.4 mp0 -118.97 124.83 47.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.937 -0.574 . . . . 72.35 110.168 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 26.0 m -95.91 88.53 4.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.92 -0.77 . . . . 75.52 108.92 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 44.8 tp -82.04 78.25 8.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.733 . . . . 74.43 109.511 -175.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 0.5 OUTLIER 68.1 152.71 0.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.058 -0.974 . . . . 73.44 109.901 -172.272 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.17 74.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.481 2.12 . . . . 62.51 112.059 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.64 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.34 -0.845 . . . . 72.51 111.441 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.2 122.0 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 54.12 110.695 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 30.8 tttp -117.87 122.01 42.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.532 -0.544 . . . . 64.44 109.532 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 249' ' ' GLN . 52.3 tp -100.26 131.22 46.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.309 -0.405 . . . . 73.22 110.009 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.644 HG22 HG22 ' A' ' 248' ' ' THR . 18.5 p -128.91 110.87 12.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.326 0.584 . . . . 64.4 110.558 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.877 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -108.9 125.54 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.453 -0.943 . . . . 71.32 108.453 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.2 m -135.38 138.86 43.73 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.61 -0.436 . . . . 64.01 110.359 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.448 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -148.05 128.07 13.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.111 -0.495 . . . . 72.11 109.766 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.785 HD11 HD23 ' A' ' 242' ' ' LEU . 2.4 tm? -111.44 115.22 28.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.474 -0.936 . . . . 75.01 108.474 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.607 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -92.24 108.49 19.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.54 -1.282 . . . . 72.44 107.54 174.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.817 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -69.79 105.06 2.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.888 -0.782 . . . . 71.31 108.888 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -59.84 -15.72 35.91 Favored Glycine 0 C--N 1.32 -0.31 0 C-N-CA 121.222 -0.513 . . . . 72.33 112.638 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -90.16 -25.83 20.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.747 0.308 . . . . 70.21 110.767 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 19.5 m120 -115.81 -27.96 6.86 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.362 0.875 . . . . 75.24 113.362 -170.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.607 HG11 ' HB3' ' A' ' 263' ' ' LEU . 27.8 m -62.62 -19.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 117.965 0.348 . . . . 73.3 111.522 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.72 -40.73 84.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.996 -0.547 . . . . 74.53 110.574 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.94 -16.38 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 72.22 110.96 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.15 79.39 0.87 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.913 -0.66 . . . . 71.44 112.238 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.568 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -159.27 87.34 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.865 -0.683 . . . . 61.12 112.235 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.08 147.07 39.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.373 -0.232 . . . . 72.2 110.373 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.5 mmtm -96.19 137.9 34.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.592 -0.522 . . . . 65.32 109.592 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -130.03 126.74 38.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.002 0.429 . . . . 72.22 110.245 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.41 117.74 2.21 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.892 -0.671 . . . . 71.23 111.473 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.877 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -115.12 135.85 53.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.181 -0.674 . . . . 72.52 109.181 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.35 137.91 6.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.107 -1.044 . . . . 74.43 112.984 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.78 131.38 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.6 -0.889 . . . . 54.24 108.6 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 26.5 tt0 -114.95 111.31 20.97 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.59 -0.893 . . . . 72.1 108.59 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.63 ' HD2' HD13 ' A' ' 31' ' ' LEU . 26.3 t80 -112.83 145.86 39.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.799 -0.637 . . . . 73.53 109.805 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -138.04 142.89 40.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.86 0.362 . . . . 71.23 110.295 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.526 ' O ' HD22 ' A' ' 284' ' ' LEU . . . -122.83 107.29 11.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.463 -0.569 . . . . 73.23 109.463 172.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 283' ' ' ALA . 1.7 mm? -138.62 -0.57 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.229 -0.896 . . . . 53.42 109.676 -176.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.942 -1.026 . . . . 74.24 109.759 -172.566 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.973 -0.38 . . . . 65.12 109.973 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 14.9 p -100.52 131.96 23.07 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.965 -0.383 . . . . 71.23 109.965 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.75 143.51 99.62 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 40.12 111.836 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.93 89.66 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.582 2.188 . . . . 51.24 112.14 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.3 p -70.78 -30.91 67.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.684 -0.689 . . . . 52.22 110.724 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.785 ' HB3' HG21 ' A' ' 143' ' ' VAL . 30.5 p90 -61.05 -26.37 67.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.567 . . . . 64.15 110.892 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.4 -19.46 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.107 -0.497 . . . . 64.14 110.751 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.916 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 14.5 t70 -93.99 -13.77 26.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.383 . . . . 74.21 110.318 -177.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.624 HD11 HG22 ' A' ' 143' ' ' VAL . 86.8 mt -57.62 -36.09 71.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.22 0.533 . . . . 73.21 110.001 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.9 30.68 4.32 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.298 -0.864 . . . . 54.01 111.523 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.916 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 5.0 tppp? -61.84 -57.89 10.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.458 . . . . 73.34 110.191 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -67.02 -39.11 86.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.542 -0.754 . . . . 73.33 110.258 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.76 93.47 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.071 -0.968 . . . . 42.33 112.633 -171.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -60.68 -39.93 90.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.665 0.211 . . . . 75.34 111.405 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 38.5 t70 -68.16 -36.65 79.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 65.41 111.036 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 207' ' ' ASN . 26.9 t -84.03 -46.62 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.202 0.445 . . . . 52.55 112.202 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -72.38 -43.47 63.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.814 0.34 . . . . 71.15 110.906 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.6 p -111.97 71.94 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.141 0.972 . . . . 72.55 108.48 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 18.8 pttm -85.86 173.11 10.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.925 -1.489 . . . . 74.25 112.563 -166.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.58 97.11 0.2 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.517 -1.033 . . . . 53.41 110.517 170.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' HE2' ' HG ' ' A' ' 262' ' ' LEU . 56.2 t80 -115.81 146.03 42.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.827 0.346 . . . . 74.32 110.305 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -72.23 90.12 0.52 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.763 -0.732 . . . . 43.52 111.918 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -80.68 -3.81 52.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.153 0.501 . . . . 64.34 110.308 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.93 58.19 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.627 -0.797 . . . . 73.5 113.57 174.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 pp -140.66 171.79 13.62 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.553 1.168 . . . . 74.23 113.862 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.921 HG23 HD12 ' A' ' 277' ' ' LEU . 33.3 mm -105.75 122.07 58.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 113.121 -1.854 . . . . 71.41 108.945 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.675 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 11.2 pttp -126.65 154.31 44.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.186 0.517 . . . . 71.44 110.644 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -148.03 149.86 32.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.753 -0.832 . . . . 63.45 108.753 169.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' SER . 3.4 p-10 -139.49 131.02 27.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.786 0.803 . . . . 65.44 111.419 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.6 OUTLIER -94.16 124.85 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.577 -1.192 . . . . 71.23 108.487 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HG3' ' HA ' ' A' ' 282' ' ' GLN . 0.2 OUTLIER -126.4 124.48 40.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 73.31 110.554 178.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 283' ' ' ALA . 88.3 m -137.07 120.96 17.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.535 -0.757 . . . . 71.21 109.121 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -136.78 126.12 24.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.107 0.48 . . . . 73.33 110.366 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.0 m -137.07 138.51 40.47 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.923 -0.769 . . . . 72.2 108.923 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.3 mt-10 -77.76 61.68 2.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.959 0.885 . . . . 64.54 110.194 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -137.61 18.92 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.149 -1.387 . . . . 75.13 108.341 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.8 -8.55 79.64 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.21 -0.904 . . . . 63.12 113.943 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.4 126.02 48.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.777 1.288 . . . . 64.42 111.986 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.97 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 19.8 tt0 -142.68 126.48 17.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.381 -0.6 . . . . 75.01 109.381 166.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.5 127.82 38.08 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.031 -0.418 . . . . 75.01 111.56 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.8 m -127.38 116.78 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 54.22 110.344 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.4 t -118.01 122.88 44.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.59 -0.522 . . . . 64.34 109.59 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 m -120.72 126.76 50.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.669 0.271 . . . . 74.21 110.912 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.98 134.94 8.09 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.719 -0.753 . . . . 72.43 111.96 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -121.57 135.37 55.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.73 -0.47 . . . . 53.22 109.73 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.98 129.32 29.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.278 0.561 . . . . 72.03 111.614 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.799 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 33.5 m-80 -93.7 124.27 37.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.368 -0.833 . . . . 54.31 109.399 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 p -82.5 19.36 1.28 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.263 0.468 . . . . 75.41 112.263 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.05 -42.17 76.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.172 0.511 . . . . 73.21 109.799 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 52' ' ' THR . 1.6 t -160.15 -73.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 60.31 109.647 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.746 ' H ' HG23 ' A' ' 51' ' ' THR . 37.8 m -156.41 86.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.737 -0.468 . . . . 62.25 109.737 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.799 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 46.7 tptt -128.9 91.71 3.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.65 -0.5 . . . . 74.24 109.65 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.3 121.09 63.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.204 -0.453 . . . . 53.25 111.178 -174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 p -110.36 140.31 44.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.77 -0.65 . . . . 74.14 109.984 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.39 19.46 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.316 -0.945 . . . . 75.24 112.753 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -141.88 133.06 26.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.864 -0.791 . . . . 64.21 108.864 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.79 124.53 44.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.757 -0.461 . . . . 74.34 109.757 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -113.72 118.37 34.13 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.102 -0.499 . . . . 70.42 109.659 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -110.77 122.82 48.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.913 -0.773 . . . . 74.33 108.913 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.97 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 72.1 mttt -129.4 134.78 48.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.298 0.57 . . . . 72.12 111.337 -172.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 49.4 t80 -106.81 119.51 39.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.485 -0.931 . . . . 71.42 108.485 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.495 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 63.6 ttm-85 -118.55 110.18 17.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.356 0.598 . . . . 75.02 111.654 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.632 ' HD1' ' HE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.58 125.17 35.54 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 114.948 -1.024 . . . . 74.33 109.811 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -81.0 -178.71 7.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 125.047 1.467 . . . . 72.13 111.915 -172.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 65' ' ' THR . 49.4 mt-10 71.99 -50.27 0.69 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.662 0.785 . . . . 73.41 110.937 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -95.06 -139.94 0.24 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.682 -1.229 . . . . 72.15 107.682 169.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.8 67.8 0.42 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.115 -0.794 . . . . 61.31 111.115 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -100.42 129.53 46.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.806 -0.757 . . . . 64.21 110.609 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.5 m -138.31 111.99 8.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.404 -0.362 . . . . 65.21 110.886 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -104.49 119.17 38.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.43 -0.952 . . . . 70.1 108.43 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 61' ' ' LYS . 11.9 p -128.53 138.08 52.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.953 0.406 . . . . 53.14 111.87 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 43.1 mt-10 -117.54 120.63 38.65 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.809 -0.811 . . . . 72.13 108.809 166.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 7.0 pttp -110.83 105.4 14.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.355 0.598 . . . . 55.43 109.948 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -98.51 133.18 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.142 -0.936 . . . . 75.01 111.161 -174.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -110.47 143.55 40.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.937 -0.764 . . . . 70.52 108.937 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.8 t -56.4 -18.43 11.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.028 0.531 . . . . 71.12 112.149 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 24.7 t70 -67.21 -6.64 18.98 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.797 0.332 . . . . 72.35 110.738 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 51.7 m-80 79.79 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.155 0.982 . . . . 71.31 110.058 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -114.84 117.79 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.377 -0.829 . . . . 73.33 110.301 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.79 119.59 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.101 -0.333 . . . . 72.41 110.101 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -107.24 88.1 0.52 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.609 -0.805 . . . . 64.42 111.775 175.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.585 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 35.8 m -84.32 101.17 11.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.208 0.527 . . . . 75.22 110.275 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 3.7 tm-20 -114.75 128.25 56.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.604 -0.726 . . . . 75.51 109.683 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.98 121.74 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.297 0.57 . . . . 74.0 110.571 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.7 m -107.32 129.02 54.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 72.14 109.93 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.16 119.55 49.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.265 0.555 . . . . 73.54 110.842 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.57 118.98 36.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.629 -1.249 . . . . 71.14 107.629 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.71 169.34 11.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.681 0.753 . . . . 61.2 112.341 -166.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -111.91 -2.03 15.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.998 -1.001 . . . . 71.22 110.229 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 89' ' ' ASP . 53.2 tp -85.08 -55.43 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 74.12 110.026 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -118.81 79.63 1.42 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.978 -0.749 . . . . 75.33 108.978 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -47.39 129.08 12.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.475 -0.784 . . . . 74.31 112.435 -171.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.45 -4.25 47.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.205 -0.907 . . . . 70.52 111.973 -173.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -88.02 114.76 24.95 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.825 -0.435 . . . . 65.22 109.825 175.362 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.07 121.03 36.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 72.24 110.119 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.5 mm? -109.46 127.66 54.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.457 -0.792 . . . . 52.5 109.245 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.911 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.2 t -129.13 128.92 44.44 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 73.32 109.984 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.752 ' HD2' HG12 ' A' ' 114' ' ' ILE . 80.4 t80 -121.38 125.84 47.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.842 -0.617 . . . . 73.45 110.242 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 2.1 m-20 -108.23 121.72 45.46 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.765 -0.458 . . . . 65.12 109.765 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.585 ' OG ' ' HB ' ' A' ' 83' ' ' THR . 8.5 p -115.67 120.18 38.53 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.533 -0.543 . . . . 71.53 109.533 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.3 m -101.34 121.43 41.89 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.858 -0.61 . . . . 65.34 109.528 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -128.46 119.76 25.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.075 -0.512 . . . . 75.44 109.737 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -113.71 103.44 55.33 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.252 -0.431 . . . . 74.3 111.085 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.63 -14.31 34.97 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.209 2.606 . . . . 74.33 112.938 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 104' ' ' SER . 24.9 p30 -72.07 -21.0 61.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 72.12 110.924 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 p -126.54 -37.54 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.992 -0.549 . . . . 72.15 111.016 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.24 50.02 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.021 -0.609 . . . . 71.03 112.471 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -87.59 145.82 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 75.45 110.811 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.31 125.52 46.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.142 -0.688 . . . . 64.32 109.142 171.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -118.84 126.22 51.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.72 -0.474 . . . . 73.3 109.72 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.31 124.49 49.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.907 -0.588 . . . . 62.21 111.367 -173.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 54.8 mttp -111.55 136.24 51.01 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.101 -1.074 . . . . 73.21 108.101 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 129' ' ' MET . 0.4 OUTLIER -125.28 130.95 72.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.325 -0.62 . . . . 62.44 109.325 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.911 ' HB2' HG23 ' A' ' 98' ' ' THR . 3.1 mptp? -123.42 120.73 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.605 -0.517 . . . . 75.21 109.605 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.412 HG23 ' HB2' ' A' ' 127' ' ' CYS . 4.5 t -114.21 116.31 28.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.628 -0.879 . . . . 72.45 108.628 173.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -130.08 121.66 3.44 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 119.541 -1.314 . . . . 32.41 112.574 -174.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.416 ' HB3' HD22 ' A' ' 95' ' ' LEU . 25.0 p90 -111.96 117.6 33.15 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.971 -0.751 . . . . 72.33 108.971 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -109.93 122.19 46.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.694 -0.684 . . . . 74.54 109.284 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -106.65 157.01 18.02 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.401 -0.592 . . . . 74.11 109.401 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.651 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 7.7 pt-20 -51.68 -27.03 10.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.634 0.774 . . . . 73.43 112.784 -172.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.435 ' ND1' ' HG3' ' A' ' 121' ' ' GLU . 74.3 m80 -106.22 -24.09 12.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.212 0.449 . . . . 72.13 112.212 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.73 HD11 HD11 ' A' ' 142' ' ' LEU . 17.7 tt -147.25 141.61 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 120.324 -0.55 . . . . 64.11 111.992 -173.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.66 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 6.1 m-20 -110.59 117.78 34.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.735 0.302 . . . . 65.22 111.717 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 142' ' ' LEU . 4.3 mm? -111.7 137.49 49.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.821 0.343 . . . . 55.52 111.104 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -146.25 131.03 3.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.88 -0.676 . . . . 52.32 112.692 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.412 ' HB2' HG23 ' A' ' 116' ' ' THR . 58.1 m -113.35 119.7 38.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.966 0.412 . . . . 51.01 110.851 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.846 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -105.29 136.39 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.898 -0.592 . . . . 62.21 110.289 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.769 ' HB2' HG22 ' A' ' 114' ' ' ILE . 64.9 mtt -133.86 121.49 21.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.954 -0.388 . . . . 65.52 109.954 174.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.41 120.13 41.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.038 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -93.35 105.73 17.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.277 0.56 . . . . 72.45 111.069 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.53 172.87 7.65 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.767 -0.827 . . . . 64.44 108.767 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 133' ' ' ILE . 3.5 mp -67.07 -33.12 61.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.309 -0.626 . . . . 70.23 109.309 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.47 -15.29 59.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.545 -0.752 . . . . 75.42 110.951 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.55 178.9 17.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.4 -0.905 . . . . 45.31 112.692 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -87.93 128.81 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.91 2.406 . . . . 75.43 112.812 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 t -99.36 140.75 33.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 62.4 108.757 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.82 118.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.551 -0.459 . . . . 73.3 111.071 -171.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.846 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 40.9 mtp180 -110.12 125.46 53.02 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.885 -0.783 . . . . 65.3 108.885 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.58 10.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 119.709 -1.234 . . . . 65.4 111.444 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.54 116.02 19.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.13 0.491 . . . . 63.42 110.926 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.73 HD11 HD11 ' A' ' 123' ' ' ILE . 6.6 tp -121.81 124.64 44.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 75.01 110.642 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' A' ' 7' ' ' TYR . 86.1 t -112.37 129.56 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.302 -0.863 . . . . 73.43 109.87 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.896 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.4 mm? -108.28 138.61 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.53 -0.759 . . . . 62.15 109.896 -170.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.22 118.53 5.59 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.561 -0.745 . . . . 42.3 112.058 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.834 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 86.5 m-85 -127.87 148.4 50.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 75.3 109.723 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.71 98.42 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.481 -0.327 . . . . 72.54 111.054 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.13 -21.51 20.05 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 116.29 -0.414 . . . . 62.24 112.756 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 24.8 m95 -105.54 131.82 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 75.2 111.209 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.4 mt -112.12 136.51 51.4 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.385 -0.598 . . . . 55.22 109.385 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -131.77 153.25 50.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.285 -0.416 . . . . 41.11 110.038 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -158.46 133.99 3.66 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.937 -0.865 . . . . 44.34 110.937 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -142.43 121.82 13.17 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.712 -0.795 . . . . 71.15 110.184 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.728 ' HG2' ' HB3' ' A' ' 168' ' ' ASN . 1.3 pm0 -117.72 120.19 37.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.956 0.884 . . . . 71.13 110.102 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.451 ' C ' HD22 ' A' ' 156' ' ' ASN . 15.1 ptt? -117.72 133.46 55.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.153 -0.93 . . . . 74.31 109.304 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -110.54 116.53 31.52 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.781 -0.822 . . . . 74.53 108.781 -173.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 45.4 m-85 -94.36 118.38 31.52 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 123.577 0.548 . . . . 64.51 110.105 -176.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.981 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.3 tp10 -91.21 102.17 14.9 Favored 'General case' 0 C--O 1.262 1.752 0 CA-C-N 115.831 -0.622 . . . . 71.53 109.596 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 m -70.52 -25.2 63.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 112.893 -1.958 . . . . 71.32 110.93 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.87 71.84 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.01 -0.737 . . . . 43.13 109.01 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.666 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 69.6 mmtt -104.72 -163.41 0.96 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.844 -1.169 . . . . 73.1 107.844 170.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.3 t -108.35 26.37 10.54 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 121.838 -0.539 . . . . 74.13 110.294 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -166.3 172.2 11.33 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 118.89 -1.124 . . . . 73.52 111.542 -166.03 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.11 135.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 64.44 110.168 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.981 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.4 t -94.41 -21.48 18.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.946 -0.57 . . . . 71.41 110.815 -174.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 165' ' ' THR . 46.2 mt-30 -143.58 134.66 25.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.854 0.359 . . . . 70.2 110.314 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -117.74 106.75 13.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.211 -0.45 . . . . 75.35 109.984 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.728 ' HB3' ' HG2' ' A' ' 154' ' ' GLN . 2.7 t-20 -115.94 122.58 45.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.69 -0.485 . . . . 74.22 109.69 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 90.1 m-85 -122.05 156.74 32.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.53 -0.305 . . . . 74.2 110.518 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -152.0 129.0 11.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.041 0.448 . . . . 34.23 110.888 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.89 125.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.637 -0.875 . . . . 70.11 108.637 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -142.11 109.16 0.56 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.934 -1.126 . . . . 74.23 112.507 -176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.722 ' CZ ' HD21 ' A' ' 180' ' ' LEU . 11.4 p90 -114.16 133.34 55.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.036 -0.728 . . . . 61.24 109.036 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -132.55 130.86 40.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.963 -1.017 . . . . 74.13 113.066 -162.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 m -121.01 155.51 34.17 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.111 -1.44 . . . . 71.42 107.111 166.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -49.75 -46.45 50.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 75.11 112.417 -170.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.45 -22.98 20.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.665 0.617 . . . . 72.05 112.665 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.73 119.72 15.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.325 0.583 . . . . 74.41 111.895 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -135.28 143.01 46.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.739 -0.664 . . . . 62.42 109.984 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.948 ' HB3' HG13 ' A' ' 194' ' ' ILE 0.256 0.0 OUTLIER -127.45 139.0 53.1 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.382 1.087 . . . . 73.2 111.503 159.274 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 45.3 m-70 -124.05 115.59 21.42 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.707 -2.042 . . . . 73.25 107.228 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 23.8 m -111.93 134.79 53.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.479 -0.328 . . . . 72.35 110.489 -173.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -118.75 140.21 50.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.34 -0.615 . . . . 72.02 109.34 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 25.5 t -121.56 118.61 56.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.239 -0.437 . . . . 41.22 110.959 -176.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 80.5 m-20 -97.68 91.09 5.23 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.079 -0.964 . . . . 72.11 108.96 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 58.42 -168.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.754 -1.112 . . . . 73.51 110.214 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.83 86.9 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.275 -0.964 . . . . 71.33 111.216 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 211' ' ' THR . 3.5 m -89.38 -26.75 20.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.566 0.58 . . . . 65.41 112.566 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 40.4 tt0 -139.14 117.61 12.08 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 119.779 -0.768 . . . . 63.35 112.255 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -109.18 126.21 53.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 73.32 109.374 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -129.23 109.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.844 -0.693 . . . . 55.44 112.503 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' A' ' 182' ' ' THR . . . -105.63 131.77 10.8 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.735 -0.745 . . . . 52.23 111.725 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 20.6 t -119.06 137.8 53.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.895 -0.409 . . . . 73.34 109.895 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 1.049 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.5 mp -118.91 132.56 68.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.445 . . . . 75.31 109.894 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.76 119.9 40.18 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.352 -0.981 . . . . 74.14 108.352 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 204' ' ' THR . 0.3 OUTLIER -122.39 112.43 18.07 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.184 -0.673 . . . . 70.51 109.184 -176.201 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -98.19 113.37 25.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.848 -0.615 . . . . 64.22 109.688 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 200' ' ' LYS . 47.9 t -80.63 150.16 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 54.11 109.129 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -61.13 -22.21 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 54.12 111.368 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 4.4 mptp? -91.27 -165.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.567 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.99 46.16 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.839 0.352 . . . . 74.53 110.665 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.572 ' HG ' ' HD1' ' A' ' 225' ' ' TYR . 3.7 tt -132.51 119.81 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.109 0.48 . . . . 52.15 110.248 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 49.0 mt-10 -111.53 138.41 48.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.113 -0.699 . . . . 54.04 109.113 171.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 196' ' ' GLN . 35.1 m -122.13 139.73 53.39 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.464 -0.569 . . . . 73.54 109.464 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 17' ' ' VAL . . . -129.74 136.95 50.25 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.942 0.401 . . . . 63.42 110.16 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 1.049 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 10.3 t -115.32 137.06 50.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.323 -176.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.519 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 27.1 t-20 -120.77 127.41 51.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.034 0.445 . . . . 65.45 110.965 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.5 mm? -122.78 129.75 52.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.363 -0.835 . . . . 63.21 109.57 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -132.75 126.22 31.95 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.618 -0.433 . . . . 72.01 109.865 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -131.68 124.22 29.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.03 0.443 . . . . 74.22 110.69 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.896 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 1.1 p -104.46 103.58 13.3 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.676 -0.693 . . . . 70.0 110.523 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.34 127.8 33.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.846 -0.615 . . . . 64.54 110.553 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.2 27.11 73.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.066 -0.587 . . . . 71.25 112.178 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.896 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 10.7 t-20 -138.77 -147.36 0.23 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.533 -0.914 . . . . 72.32 108.533 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 51.5 m -77.58 178.72 7.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.176 0.512 . . . . 72.01 112.329 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.65 154.74 24.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.178 -0.919 . . . . 73.03 111.786 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.2 t -78.4 139.82 38.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 71.1 110.406 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.41 135.16 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.188 -0.46 . . . . 72.11 109.981 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -130.74 135.57 47.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.137 -0.483 . . . . 71.03 109.77 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.22 171.66 32.8 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.845 -0.693 . . . . 75.11 111.716 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -138.37 147.56 25.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.958 0.409 . . . . 53.41 111.333 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -128.93 130.42 46.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.485 -0.779 . . . . 70.24 109.933 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -115.76 128.53 55.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.63 0.252 . . . . 72.22 111.128 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 2.4 ttmp? -109.04 116.06 31.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 75.34 109.377 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.572 ' HD1' ' HG ' ' A' ' 202' ' ' LEU . 10.8 t80 -119.0 131.96 56.03 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.957 0.408 . . . . 63.25 110.389 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -96.73 99.62 11.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 62.35 110.132 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.85 HD13 ' H ' ' A' ' 227' ' ' ILE . 0.2 OUTLIER -94.38 -28.87 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.267 -0.424 . . . . 72.13 111.133 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.6 141.13 19.72 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.642 -0.503 . . . . 62.53 109.642 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.3 -30.62 20.37 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.158 2.572 . . . . 74.22 113.524 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.06 -9.46 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.111 0.412 . . . . 71.31 112.111 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.63 136.63 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.978 0.362 . . . . 63.14 111.978 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -131.26 142.42 50.14 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.32 -0.4 . . . . 53.31 110.538 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.11 134.15 52.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 70.23 111.052 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 46.5 p -130.97 118.36 20.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.993 -0.549 . . . . 42.34 110.622 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -109.12 141.5 41.23 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.743 -0.466 . . . . 73.34 109.743 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -142.34 140.92 32.28 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.868 -0.333 . . . . 75.21 110.787 -177.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.55 146.53 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.513 -0.312 . . . . 72.42 110.284 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -115.92 150.05 37.74 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.65 -0.704 . . . . 71.33 109.664 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 241' ' ' SER . 27.2 p-10 -53.82 -18.55 3.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.952 0.783 . . . . 73.33 112.83 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.463 ' HB3' ' HG ' ' A' ' 242' ' ' LEU . 34.4 t -78.85 21.37 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.713 0.292 . . . . 72.35 110.54 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 239' ' ' ASN . 46.1 t 64.31 32.24 12.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.198 0.523 . . . . 65.43 109.746 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 262' ' ' LEU . 58.5 mt -99.07 114.71 27.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.436 -0.506 . . . . 71.12 109.981 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.774 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -109.68 117.96 55.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.929 0.395 . . . . 73.0 110.57 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -116.92 139.71 15.33 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.935 -0.65 . . . . 35.15 113.126 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.16 127.81 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.819 -0.808 . . . . 71.44 108.819 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -139.85 132.36 5.54 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.942 -1.123 . . . . 70.2 112.641 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -129.17 133.61 47.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.087 0.47 . . . . 73.5 110.16 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 13.5 t -123.21 136.15 54.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.013 -0.539 . . . . 73.45 109.776 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -142.69 149.12 38.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.295 -0.411 . . . . 70.23 110.665 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 13.8 m -98.89 121.71 41.19 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.466 ' CB ' HG23 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.38 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.286 0.366 . . . . 72.51 110.817 -173.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.747 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 63.3 mttm -150.37 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.58 -0.282 . . . . 73.12 111.558 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 3.0 Cg_exo -75.0 -76.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.91 1.74 . . . . 71.53 112.767 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -152.63 28.72 0.85 Allowed Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.85 -0.691 . . . . 71.32 112.038 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.504 HD12 ' CE2' ' A' ' 281' ' ' PHE . 1.0 OUTLIER -106.99 122.42 61.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.104 0.478 . . . . 63.21 110.485 -178.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -104.04 130.73 51.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.682 -0.69 . . . . 71.13 109.839 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.4 tp -98.39 124.37 43.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.213 -0.662 . . . . 64.43 109.213 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.8 m -116.11 110.33 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.933 -0.576 . . . . 73.44 109.907 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.845 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -114.23 124.82 52.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.919 -0.771 . . . . 75.45 108.919 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 62.8 m -138.65 139.95 38.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.812 0.339 . . . . 64.14 110.282 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.07 127.83 20.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.801 -0.444 . . . . 73.44 109.801 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.1 tm? -107.61 121.8 45.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.43 -0.952 . . . . 73.5 108.43 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.774 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.1 mm? -98.78 106.16 18.4 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.847 -1.168 . . . . 61.25 107.847 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.568 ' HA ' HD22 ' A' ' 242' ' ' LEU . 4.8 m-20 -72.54 106.26 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.614 -0.884 . . . . 75.13 108.614 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.52 -22.56 24.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.991 -0.623 . . . . 61.24 113.121 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -90.88 -3.38 57.39 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.996 0.427 . . . . 74.34 111.193 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 47.4 t-20 -123.79 -44.67 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.816 0.341 . . . . 60.04 110.969 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.626 HG11 ' HB3' ' A' ' 263' ' ' LEU . 26.5 m -61.24 -18.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.259 0.466 . . . . 71.33 112.259 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.02 -38.98 88.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.795 0.331 . . . . 72.43 110.443 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.49 29.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.539 . . . . 61.43 110.915 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.02 100.83 2.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.715 -0.755 . . . . 64.41 112.071 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.59 77.17 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.775 -0.726 . . . . 65.11 112.082 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -87.39 144.23 26.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 74.33 109.819 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 65.2 mttm -97.38 137.02 37.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.522 . . . . 74.11 109.887 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.8 tm? -125.77 131.7 52.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.805 -0.634 . . . . 71.31 110.044 -173.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.435 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -125.2 113.07 1.84 Allowed Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.505 -1.038 . . . . 72.04 110.505 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.921 HD12 HG23 ' A' ' 27' ' ' ILE . 3.4 tm? -114.38 134.87 54.67 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 72.44 109.668 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.675 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -148.58 125.89 2.16 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.095 -1.05 . . . . 41.1 113.172 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 2.5 mm? -102.29 131.92 48.58 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.166 -0.679 . . . . 74.22 109.166 171.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.426 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 51.9 mt-10 -115.57 110.87 19.85 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.571 -0.529 . . . . 63.52 109.571 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.755 ' HB2' HD22 ' A' ' 31' ' ' LEU . 89.4 m-85 -101.26 100.98 11.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.933 -0.576 . . . . 72.31 110.483 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.538 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 52.9 tt0 -92.07 111.96 23.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.264 -0.643 . . . . 63.03 109.264 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 33' ' ' THR . . . -107.77 111.25 23.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.095 0.474 . . . . 73.05 110.985 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.12 133.75 55.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.709 -0.678 . . . . 73.42 109.322 173.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.43 -0.795 . . . . 72.13 110.7 -174.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HA ' ' HB3' ' A' ' 121' ' ' GLU . 61.1 mtt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.966 0.413 . . . . 44.05 110.877 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.5 88.56 2.76 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.878 -0.786 . . . . 73.14 108.878 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.815 HG22 ' HA ' ' A' ' 121' ' ' GLU . 2.2 t -107.59 109.0 62.32 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 74.44 110.898 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 5.3 Cg_exo -77.4 164.77 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.251 2.634 . . . . 74.44 111.633 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.59 70.09 2.05 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.839 2.359 . . . . 74.32 111.825 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.738 ' HB ' HD21 ' A' ' 150' ' ' LEU . 20.6 p -70.13 -42.29 72.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 61.1 111.056 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.602 ' HB3' HG21 ' A' ' 143' ' ' VAL . 29.6 p90 -54.92 -30.58 58.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 71.12 111.538 174.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.83 46.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.524 . . . . 75.01 110.61 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.94 -9.63 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 71.43 109.834 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 150' ' ' LEU . 81.3 mt -70.69 -34.51 72.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.781 -0.645 . . . . 75.11 110.983 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . -129.05 0.03 6.03 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.593 -1.289 . . . . 72.21 114.83 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.572 ' HG3' ' N ' ' A' ' 13' ' ' SER . 4.8 pttm -62.43 -46.22 89.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.781 1.29 . . . . 74.51 110.505 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.572 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 5.0 p -66.54 -49.46 66.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.345 0.593 . . . . 71.33 111.168 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.72 69.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.308 -0.86 . . . . 71.23 112.438 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -59.86 -38.9 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.883 0.327 . . . . 71.23 111.883 -171.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.95 -47.44 71.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.873 0.368 . . . . 73.45 110.959 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 222' ' ' ALA . 25.1 m -82.74 -27.53 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.435 0.532 . . . . 72.31 112.435 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.15 -31.31 65.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.627 0.251 . . . . 74.0 111.462 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.9 m -59.78 135.44 57.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.389 -0.369 . . . . 73.45 110.704 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.51 -53.98 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 63.34 111.249 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.88 46.86 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.759 -0.734 . . . . 52.41 111.617 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.45 93.47 6.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.617 0.722 . . . . 55.33 111.031 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.01 124.83 7.73 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.789 -0.719 . . . . 73.32 111.84 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -84.25 10.96 9.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.6 0.238 . . . . 71.25 111.596 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.92 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 92.7 13.85 56.15 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.363 -0.923 . . . . 72.23 111.608 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 46' ' ' SER . 1.5 pp -101.94 179.42 4.33 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.572 0.701 . . . . 72.1 112.747 -171.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 277' ' ' LEU . 35.1 mm -102.06 130.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.785 -1.098 . . . . 64.14 110.407 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.601 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 1.0 OUTLIER -103.81 134.63 46.79 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.455 -0.943 . . . . 75.33 108.455 176.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.538 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 16.5 tp -121.56 147.83 45.29 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.677 -0.409 . . . . 71.43 110.853 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.812 ' HB3' ' HG2' ' A' ' 280' ' ' GLU . 12.3 t70 -153.72 127.9 9.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.294 -0.866 . . . . 73.31 108.919 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.734 HD13 ' HB3' ' A' ' 281' ' ' PHE . 8.9 tp -137.46 125.02 22.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.346 -0.612 . . . . 72.11 109.346 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 23.3 ttmt -133.12 124.69 28.01 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.46 . . . . 73.41 110.683 -175.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.717 HG22 ' HB3' ' A' ' 283' ' ' ALA . 80.6 p -120.64 123.61 43.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.631 . . . . 72.32 109.705 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HB2' HD13 ' A' ' 284' ' ' LEU . 91.0 mttt -112.17 139.46 47.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.273 0.559 . . . . 61.41 112.14 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 43.1 t -139.17 137.18 35.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.835 -1.172 . . . . 75.4 107.835 168.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -82.12 34.97 0.42 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.616 0.722 . . . . 71.2 109.902 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 35' ' ' SER . 5.4 m-20 -120.5 18.71 12.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.477 -0.783 . . . . 71.32 111.424 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 97.76 -3.4 60.81 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.194 -1.162 . . . . 61.52 110.194 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 3.4 tm? -99.65 127.22 45.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.762 -0.375 . . . . 73.31 111.717 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.758 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 22.0 tt0 -141.6 129.22 21.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.969 -0.752 . . . . 75.2 108.969 163.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.456 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 74.5 t80 -124.78 127.05 46.61 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.267 -0.896 . . . . 65.13 110.872 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.903 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.5 m -128.58 131.53 48.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.092 0.473 . . . . 74.22 111.682 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 17.1 m -120.3 123.02 42.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.854 . . . . 75.02 108.693 171.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.3 p -139.65 157.65 45.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.378 -0.529 . . . . 65.34 111.093 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 158.83 -175.22 35.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.539 -1.315 . . . . 52.23 113.567 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 26' ' ' LEU . 12.1 p -137.03 138.5 40.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.617 -0.292 . . . . 74.32 110.249 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HB1' HG22 ' A' ' 54' ' ' VAL . . . -135.27 129.12 33.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.781 0.324 . . . . 71.24 110.709 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' A' ' 53' ' ' LYS . 8.3 t-20 -90.67 113.72 25.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 50.5 109.153 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -84.84 7.33 21.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.181 0.808 . . . . 70.21 113.181 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -74.13 -46.26 43.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.71 -0.396 . . . . 70.14 110.405 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -126.36 -81.33 0.61 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.749 -0.463 . . . . 71.22 109.749 171.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -172.69 84.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.949 0.88 . . . . 65.12 110.296 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 16.6 tppt? -126.25 86.53 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 73.24 109.449 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG22 ' HB1' ' A' ' 47' ' ' ALA . 25.9 t -109.22 120.04 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.017 -0.538 . . . . 63.32 110.821 -175.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -137.67 124.6 21.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.893 -0.594 . . . . 62.1 109.56 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 45' ' ' GLY . . . -155.57 -155.43 7.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.539 -0.838 . . . . 72.35 111.958 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -148.03 150.99 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.185 0.517 . . . . 72.31 110.177 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -119.96 125.06 47.48 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.65 -0.87 . . . . 65.14 108.65 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.903 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 3.4 mp0 -109.04 118.87 37.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.454 -0.793 . . . . 71.24 110.93 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -99.55 117.72 34.56 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.794 -1.558 . . . . 74.04 106.794 164.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.758 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 74.3 tttt -127.37 150.28 49.68 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.363 0.602 . . . . 74.45 110.311 -171.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.86 ' HB2' ' HB2' ' A' ' 71' ' ' PHE . 99.6 m-85 -126.72 121.42 31.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.879 -0.601 . . . . 74.11 110.155 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.3 ptm85 -121.27 106.1 11.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.789 0.804 . . . . 54.23 111.376 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 t90 -117.02 104.64 11.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.869 -1.06 . . . . 75.21 109.583 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 m 73.55 132.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.615 0.572 . . . . 64.05 110.508 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.9 mp0 -50.95 -59.98 3.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.858 -0.61 . . . . 71.03 110.911 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.03 67.37 0.7 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.702 -0.681 . . . . 71.41 109.383 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 -85.58 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.608 -0.806 . . . . 35.1 112.847 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.98 130.53 52.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 74.44 111.807 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.8 m -137.72 112.36 8.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 72.25 110.561 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 8.9 m-85 -102.73 122.4 44.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.609 -0.515 . . . . 61.31 109.609 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 m -119.93 117.29 27.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.64 -0.424 . . . . 73.31 111.76 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.6 123.65 45.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 75.21 109.099 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 59' ' ' GLU . 10.3 ptmm? -142.86 140.18 31.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.288 -0.565 . . . . 62.13 110.969 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.412 ' CD1' ' HG ' ' A' ' 81' ' ' LEU . 31.5 t90 -129.85 130.08 44.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.092 -0.504 . . . . 73.12 110.132 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -93.46 150.92 20.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 63.13 110.756 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -63.82 -20.43 65.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 73.02 109.553 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.77 -4.13 29.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.092 -0.958 . . . . 75.0 110.344 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.7 t30 82.31 4.64 1.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.015 0.926 . . . . 63.53 111.113 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 103' ' ' PHE . 18.9 p -80.76 143.86 32.57 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 116.129 -0.487 . . . . 65.42 109.803 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 103' ' ' PHE . 3.3 mp -122.88 113.59 19.34 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.761 -1.176 . . . . 75.22 113.872 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.62 131.12 10.08 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 119.771 -1.204 . . . . 73.41 113.686 -170.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.902 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 91.0 m -136.25 140.17 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.641 0.258 . . . . 34.34 110.745 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.87 108.83 3.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.503 HG13 ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -116.59 120.65 65.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.005 0.431 . . . . 35.12 109.987 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.6 m -110.53 135.8 50.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.996 -0.547 . . . . 70.13 111.772 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.2 125.33 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.178 -0.919 . . . . 74.11 109.738 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.53 130.03 35.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.546 -0.539 . . . . 75.15 109.546 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.55 133.16 36.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.785 -0.45 . . . . 75.32 109.785 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -91.53 -21.69 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.33 -0.396 . . . . 62.04 111.47 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.97 -51.08 11.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.964 -0.754 . . . . 70.21 108.964 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.06 7.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 42.32 109.823 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.778 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -62.49 124.63 21.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 71.25 110.514 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . 100.12 1.62 55.91 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.705 -0.76 . . . . 74.15 112.322 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.712 HD23 ' HD1' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -98.86 124.35 43.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 64.43 109.871 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.23 123.19 40.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 63.31 110.53 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.475 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.7 mm? -112.97 125.61 54.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.619 -0.512 . . . . 73.1 109.619 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.921 HG23 ' HB3' ' A' ' 115' ' ' LYS . 1.1 t -132.52 136.24 46.51 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.232 0.539 . . . . 64.21 110.637 173.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -104.78 120.67 41.94 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.88 -0.785 . . . . 74.1 108.88 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.51 151.9 26.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.561 -0.745 . . . . 72.3 110.976 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.902 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 22.3 m -128.11 131.92 49.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.5 -0.773 . . . . 74.41 109.251 172.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -91.64 141.94 28.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.392 -0.822 . . . . 63.34 108.859 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.69 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 2.3 p90 -95.51 98.01 10.21 Favored 'General case' 0 C--O 1.188 -2.171 0 N-CA-C 114.824 1.416 . . . . 74.11 114.824 -161.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.502 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 60.7 p -76.89 124.15 87.5 Favored Pre-proline 0 N--CA 1.465 0.31 0 O-C-N 121.091 -1.006 . . . . 55.25 112.974 -164.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 33.9 Cg_exo -61.72 -54.97 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.205 2.603 . . . . 72.35 113.16 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -106.14 -30.78 9.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 53.13 111.28 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -62.64 -48.72 78.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.369 . . . . 35.21 111.686 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.24 -14.95 59.53 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.037 -0.601 . . . . 63.33 111.841 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -97.22 130.69 44.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.205 -0.665 . . . . 75.34 109.205 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.61 150.27 36.46 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.056 -0.658 . . . . 64.23 109.54 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 101' ' ' SER . 66.0 t30 -116.51 156.17 27.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 65.41 109.957 -174.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.43 126.54 49.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.909 0.861 . . . . 72.44 112.347 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.518 ' HZ3' ' CG ' ' A' ' 128' ' ' ASP . 28.0 ttpp -128.38 140.61 51.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.537 -1.211 . . . . 72.03 108.656 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.506 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -112.48 124.23 68.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.002 -0.74 . . . . 73.23 109.002 -178.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.921 ' HB3' HG23 ' A' ' 98' ' ' THR . 84.4 tttt -120.08 119.67 34.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.508 -0.769 . . . . 54.35 109.752 -171.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.9 m -122.67 137.08 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.335 -0.393 . . . . 63.04 110.951 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.22 122.62 3.35 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.819 -0.705 . . . . 71.14 112.421 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.712 ' HD1' HD23 ' A' ' 95' ' ' LEU . 81.8 t80 -117.59 128.49 55.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.238 -0.653 . . . . 45.31 109.238 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.73 ' HB3' HG11 ' A' ' 3' ' ' VAL . 26.3 mtmm -109.13 123.16 48.75 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.894 -0.722 . . . . 75.04 110.54 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -104.69 147.83 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.3 -1.37 . . . . 64.24 107.3 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.815 ' HA ' HG22 ' A' ' 3' ' ' VAL . 10.5 pt-20 -52.37 -28.48 19.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.489 0.551 . . . . 71.14 112.489 -167.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -100.84 -31.94 10.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.468 0.544 . . . . 71.01 112.468 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.987 HG22 ' H ' ' A' ' 145' ' ' GLY . 16.6 pt -142.89 154.23 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 118.594 0.634 . . . . 74.04 112.254 -170.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.748 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 3.5 t-20 -110.14 128.9 55.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.698 -0.683 . . . . 72.43 111.231 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 142' ' ' LEU . 4.6 mm? -110.84 135.73 50.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.515 -0.311 . . . . 73.32 110.174 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.4 125.8 3.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.529 -0.843 . . . . 73.22 112.511 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.8 m -113.45 117.81 32.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.763 -0.458 . . . . 73.32 109.763 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.518 ' CG ' ' HZ3' ' A' ' 113' ' ' LYS . 38.9 t0 -126.09 117.57 23.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.955 0.407 . . . . 73.02 110.1 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.701 ' HG3' HG13 ' A' ' 138' ' ' ILE . 60.8 ttp -119.67 118.15 30.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.919 0.39 . . . . 75.11 111.563 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.21 120.18 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.366 -0.605 . . . . 70.33 109.366 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 85.5 t80 -95.03 104.66 16.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.065 0.46 . . . . 63.33 111.674 -172.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.486 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 20.3 t70 -97.99 149.4 22.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 74.2 108.904 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.405 ' C ' HD13 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -68.6 -35.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.734 -0.212 . . . . 72.41 111.101 -174.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.52 -20.13 20.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 52.21 111.403 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.86 98.71 0.12 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.366 -0.921 . . . . 73.14 112.662 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 37.9 Cg_endo -67.19 150.79 81.88 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.577 2.185 . . . . 74.12 112.43 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -115.13 128.84 56.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.442 -0.577 . . . . 51.31 109.442 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.701 HG13 ' HG3' ' A' ' 129' ' ' MET . 3.9 mp -109.73 118.34 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.354 -0.609 . . . . 63.33 109.354 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -112.19 132.49 54.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.337 0.589 . . . . 75.24 110.308 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.63 132.66 10.99 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.389 -0.823 . . . . 62.3 111.343 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.11 134.76 55.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.961 -0.385 . . . . 71.31 109.961 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.766 HD11 HD12 ' A' ' 123' ' ' ILE . 6.3 tp -137.97 122.33 18.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.207 0.527 . . . . 74.35 110.164 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.748 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 97.8 t -107.89 130.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.23 -0.895 . . . . 65.23 108.937 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.6 mm? -108.14 137.24 46.46 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.258 -0.645 . . . . 74.32 109.258 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.987 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -130.49 119.36 2.73 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 115.527 -0.76 . . . . 61.3 111.46 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 149' ' ' TRP . 1.8 p90 -142.28 147.78 36.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.523 . . . . 73.01 109.589 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 7.0 mp0 -35.24 102.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.575 0.954 . . . . 70.03 113.575 -169.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.31 -33.92 5.31 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.0 -1.0 . . . . 63.21 113.7 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.499 ' HB2' ' CE1' ' A' ' 146' ' ' TYR . 78.1 m95 -106.01 143.28 34.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.63 0.728 . . . . 73.33 112.193 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.738 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.9 tm? -124.75 136.68 54.07 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 72.23 107.985 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.87 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -139.02 162.15 35.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.682 0.277 . . . . 65.54 110.692 -175.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -159.88 145.49 11.37 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.373 -0.691 . . . . 72.13 111.373 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.526 ' OH ' HD23 ' A' ' 142' ' ' LEU . 39.8 p90 -146.72 127.39 14.26 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.694 0.747 . . . . 74.03 111.673 165.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 0.9 OUTLIER -115.72 121.64 43.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.421 -0.809 . . . . 72.2 109.163 177.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 94.8 mmm -121.6 140.15 52.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.176 -0.305 . . . . 71.54 110.176 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.474 ' HB2' ' H ' ' A' ' 166' ' ' GLN . 3.8 m-20 -110.3 119.14 38.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.763 -0.458 . . . . 63.33 109.763 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.23 117.27 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.568 -0.53 . . . . 52.33 109.568 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.468 ' HG2' ' HB3' ' A' ' 160' ' ' ALA . 15.0 tt0 -98.54 105.55 17.71 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-O 121.094 0.473 . . . . 71.13 110.107 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.3 m -70.42 -20.81 62.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.3 -1.773 . . . . 72.02 111.124 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 158' ' ' GLU . . . -59.7 -28.65 67.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.924 0.869 . . . . 72.31 109.155 173.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 158' ' ' GLU . 78.8 mttt -117.72 -157.77 0.68 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.311 -1.366 . . . . 71.45 107.311 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.7 p -109.29 26.74 10.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.85 -0.426 . . . . 62.54 109.85 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -141.97 154.32 44.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.24 -1.384 . . . . 70.41 114.591 -154.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 93.9 t -74.37 131.61 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 114.721 -1.127 . . . . 61.14 110.206 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 33.1 m -98.63 -34.22 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.627 -0.26 . . . . 60.43 111.488 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' ' 156' ' ' ASN . 81.1 mm-40 -138.59 134.68 34.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.183 -0.303 . . . . 73.4 110.183 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.7 p -120.84 109.46 15.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.198 0.523 . . . . 74.23 110.561 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 26.6 m-80 -109.31 138.45 45.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 5.7 t80 -138.68 149.35 45.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.421 -0.512 . . . . 74.24 110.419 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -149.9 136.8 19.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.178 0.513 . . . . 60.0 110.733 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 10.2 t -145.88 154.07 13.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 61.11 108.427 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 180' ' ' LEU . . . 166.02 -170.72 40.86 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 118.855 -1.641 . . . . 63.12 113.602 169.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.73 153.39 48.49 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.43 -0.385 . . . . 71.31 110.301 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -114.26 126.55 55.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.182 0.515 . . . . 73.31 110.414 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 m -126.29 163.27 23.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.545 -0.752 . . . . 73.34 109.142 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.44 -57.29 3.65 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.765 0.654 . . . . 73.32 112.765 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -109.2 -8.92 15.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 75.13 111.447 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.7 132.09 46.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.898 0.38 . . . . 71.1 111.451 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 83.4 mt-30 -125.98 124.06 39.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.146 -0.687 . . . . 64.11 109.146 173.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.624 HD12 HG13 ' A' ' 194' ' ' ILE . 3.6 tt -120.3 128.49 53.34 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.557 . . . . 72.24 110.948 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 77.6 m-70 -132.05 116.81 17.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.618 -0.719 . . . . 74.01 111.206 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.68 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 29.6 m -83.09 118.56 23.64 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.788 -0.819 . . . . 75.45 108.788 172.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.1 140.97 49.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.167 0.508 . . . . 64.03 111.12 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 190' ' ' PHE . 70.2 t -124.62 128.14 73.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.574 -0.739 . . . . 72.24 110.798 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -115.46 97.29 6.08 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.241 -0.891 . . . . 73.33 108.652 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 30.2 t70 62.49 178.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.919 -1.037 . . . . 71.03 109.573 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.93 58.43 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.958 -0.857 . . . . 54.43 110.958 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 211' ' ' THR . 56.4 m -87.52 -28.1 22.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 112.564 0.579 . . . . 75.24 112.564 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -141.07 119.42 12.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.402 -0.919 . . . . 74.32 112.443 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.518 ' CB ' HG22 ' A' ' 184' ' ' VAL . 19.1 p90 -134.89 126.09 28.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.446 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.767 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -158.84 -162.6 12.07 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 120.491 -0.861 . . . . 63.24 112.388 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -137.74 152.01 21.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.737 -0.744 . . . . 52.34 112.752 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 15.0 m -125.15 138.28 54.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.711 0.291 . . . . 63.44 110.603 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.624 HG13 HD12 ' A' ' 180' ' ' LEU . 4.4 mp -123.72 124.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.272 -0.422 . . . . 70.14 109.896 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 6.6 t80 -108.47 116.37 31.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.73 -0.841 . . . . 61.22 108.73 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -128.5 134.58 48.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.936 0.398 . . . . 73.53 111.011 -177.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.632 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 56.2 mtpt -108.02 127.52 53.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.428 -0.351 . . . . 71.52 110.549 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.44 110.61 27.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -49.8 111.79 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.398 -0.819 . . . . 71.53 112.349 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 200' ' ' LYS . 34.0 ttmt 72.84 1.39 4.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.329 -0.851 . . . . 62.45 112.257 170.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -103.73 -73.14 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 74.41 110.148 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 225' ' ' TYR . 3.2 pp -162.96 170.8 17.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.663 -0.699 . . . . 74.24 109.619 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.632 ' HG3' ' HG2' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -125.52 134.64 51.93 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.941 -0.392 . . . . 71.2 109.941 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.0 m -124.03 142.54 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.136 0.493 . . . . 72.44 111.44 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HB3' HG11 ' A' ' 17' ' ' VAL . . . -130.33 136.18 48.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.966 -0.561 . . . . 71.14 110.154 175.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 221' ' ' ILE . 75.6 t -112.41 134.47 54.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 73.32 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -133.74 126.31 30.42 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.452 -0.573 . . . . 54.31 109.452 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.3 pt? -147.14 135.09 21.36 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.617 -0.433 . . . . 65.11 110.69 174.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.767 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -134.58 149.57 50.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.645 . . . . 71.01 111.432 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -100.05 130.87 46.25 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.0 t -109.91 124.53 51.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.657 . . . . 73.45 110.894 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.57 58.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 73.02 111.442 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 129.95 -54.04 0.79 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.635 -0.986 . . . . 62.14 110.635 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.404 ' HB2' ' OD1' ' A' ' 216' ' ' ASN . 47.9 m-80 -139.04 172.41 12.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.219 -1.03 . . . . 75.32 108.219 172.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -81.57 67.66 7.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.973 0.416 . . . . 75.15 110.887 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.487 ' HB2' HG22 ' A' ' 211' ' ' THR . 15.1 m120 -102.78 129.21 49.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 74.23 110.727 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 m -108.63 123.51 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.334 -0.617 . . . . 74.5 109.334 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 41.7 ttm-85 -101.13 114.81 29.11 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.764 -0.828 . . . . 75.21 108.764 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.58 ' HB3' ' HB2' ' A' ' 239' ' ' ASN . 83.7 t80 -117.8 136.62 53.29 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.507 0.194 . . . . 74.04 110.761 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.67 140.45 7.43 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.792 -0.718 . . . . 64.53 111.825 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.941 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -131.1 136.86 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 71.44 110.799 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.634 ' HB3' HG12 ' A' ' 17' ' ' VAL . . . -128.81 139.78 52.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.01 -0.541 . . . . 62.44 110.23 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.1 126.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.591 0.234 . . . . 75.33 110.584 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 17.2 pttm -102.53 119.52 38.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.845 0.831 . . . . 42.43 110.314 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.561 ' HD2' ' HB3' ' A' ' 202' ' ' LEU . 37.5 t80 -112.3 116.54 30.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.274 -1.33 . . . . 63.21 110.156 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -111.48 121.27 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.188 0.518 . . . . 32.1 111.252 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.9 pt -110.26 -27.41 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.305 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 19.2 t70 -135.15 143.24 44.98 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.57 -0.53 . . . . 74.24 109.57 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.53 -29.22 58.96 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.573 2.182 . . . . 70.52 112.487 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -103.56 4.12 35.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.375 -0.375 . . . . 73.1 111.307 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -143.6 121.27 11.84 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.394 0.616 . . . . 71.5 111.872 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -139.87 128.65 23.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.781 -0.645 . . . . 72.02 109.539 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.07 125.14 50.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.002 -0.279 . . . . 71.33 110.543 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 224' ' ' LYS . 14.2 m -116.47 118.08 31.69 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 52.34 110.043 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -122.98 141.52 51.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.789 -0.364 . . . . 75.51 110.971 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.05 144.24 38.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.316 -0.402 . . . . 73.51 110.229 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 243' ' ' ILE . 9.1 p -131.56 142.61 42.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.751 -0.463 . . . . 54.42 109.751 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -107.42 150.57 26.61 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.068 -0.716 . . . . 73.45 109.068 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 219' ' ' PHE . 6.2 t30 -58.87 -11.78 3.69 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.782 0.676 . . . . 73.42 112.147 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.622 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m -78.66 15.36 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.54 -0.541 . . . . 75.41 109.54 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.4 m 68.45 28.27 6.08 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 115.137 -0.938 . . . . 64.31 110.554 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 240' ' ' SER . 42.7 mt -100.36 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.561 -0.456 . . . . 73.52 110.627 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 237' ' ' VAL . 1.7 mp -108.51 115.41 49.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 120.879 -0.329 . . . . 61.21 110.173 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -123.59 133.39 8.87 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.929 -0.653 . . . . 44.35 112.301 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -128.06 150.72 49.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.341 0.591 . . . . 63.55 111.593 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -132.32 121.65 3.06 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 114.991 -1.004 . . . . 61.12 110.777 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -103.59 115.66 30.92 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.921 -0.4 . . . . 63.34 109.921 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.6 m -98.31 115.51 28.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.842 0.353 . . . . 72.51 110.211 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -126.19 128.92 48.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.096 -0.502 . . . . 63.14 109.903 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.1 m -95.09 119.12 33.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.739 0.304 . . . . 44.14 110.33 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 3.0 mm? -108.1 86.04 2.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 51.1 109.793 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 251' ' ' LEU . 0.0 OUTLIER 71.55 156.06 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.445 -0.798 . . . . 72.43 110.546 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.0 95.81 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.703 2.269 . . . . 73.01 112.854 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 142.18 -19.43 2.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.486 -0.864 . . . . 72.34 112.865 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.49 122.02 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.077 0.465 . . . . 72.21 111.903 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 43.1 mtmt -112.07 126.27 54.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 73.34 109.975 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -100.93 124.01 45.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.507 -0.553 . . . . 73.11 109.507 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 36.9 m -120.34 111.02 17.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 72.54 110.54 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.913 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -97.73 123.59 41.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.212 -1.033 . . . . 74.23 108.212 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 21.8 m -130.21 140.6 50.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.647 0.26 . . . . 51.22 110.462 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.499 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -154.89 128.8 8.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.644 -0.253 . . . . 73.12 110.942 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 274' ' ' LYS . 2.3 tm? -101.68 117.07 34.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.46 -0.941 . . . . 63.4 108.46 173.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.476 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.6 mm? -100.02 109.95 22.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.781 -0.645 . . . . 74.21 109.547 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.456 ' HA ' HD22 ' A' ' 242' ' ' LEU . 2.9 m-20 -69.67 103.75 2.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.824 . . . . 75.51 109.522 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.65 -8.45 7.54 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.097 -0.956 . . . . 52.21 112.581 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 267' ' ' ASN . 48.3 tptt -64.99 -28.63 69.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.547 -0.538 . . . . 61.11 109.547 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 266' ' ' LYS . 44.5 t-20 157.38 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.604 1.19 . . . . 72.22 108.697 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -65.44 -45.15 93.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 112.918 0.71 . . . . 73.23 112.918 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.03 -44.87 91.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.676 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.96 -13.09 16.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.829 0.307 . . . . 44.23 111.829 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -103.34 -14.23 26.51 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.048 -1.072 . . . . 72.34 112.768 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 106.98 153.83 19.6 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.621 -0.799 . . . . 73.43 112.434 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -110.87 147.23 35.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.355 -0.98 . . . . 73.32 108.355 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.9 mmtm -94.0 134.96 35.85 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.335 -1.357 . . . . 64.31 107.335 173.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.92 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.5 tm? -135.29 136.12 41.37 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.255 0.55 . . . . 62.43 110.907 -170.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.461 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.59 117.16 1.23 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 110.52 -1.032 . . . . 65.12 110.52 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.913 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -112.21 122.3 47.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.926 -1.139 . . . . 72.21 107.926 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -129.36 137.34 9.51 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.148 -1.025 . . . . 72.3 112.995 -170.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -114.07 130.55 56.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.936 -0.764 . . . . 71.34 108.936 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.812 ' HG2' ' HB3' ' A' ' 30' ' ' ASP . 50.8 mt-10 -121.02 112.1 18.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.812 -0.44 . . . . 64.32 109.812 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.734 ' HB3' HD13 ' A' ' 31' ' ' LEU . 14.7 t80 -103.53 141.92 35.17 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.854 -0.795 . . . . 71.25 108.854 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.74 141.89 40.97 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.884 0.373 . . . . 51.5 111.348 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.717 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -123.6 110.4 14.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.55 . . . . 74.43 109.679 172.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 34' ' ' LYS . 4.2 mm? -124.09 -47.35 1.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.491 -0.777 . . . . 64.53 109.822 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.423 -0.799 . . . . 74.43 109.285 176.12 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtp . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.727 0.299 . . . . 73.41 111.525 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.49 79.65 1.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.45 -0.574 . . . . 71.24 109.45 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.825 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 4.5 p -110.68 135.85 20.71 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.797 -0.638 . . . . 71.0 111.12 -171.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.98 155.38 15.04 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.586 2.191 . . . . 74.1 110.973 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HA ' HD22 ' A' ' 124' ' ' ASN . 30.2 Cg_endo -65.99 101.16 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.925 1.75 . . . . 60.35 111.956 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.669 ' HB ' HD21 ' A' ' 150' ' ' LEU . 6.7 p -73.48 -19.3 60.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.64 . . . . 74.05 110.411 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.616 ' HB2' HG21 ' A' ' 143' ' ' VAL . 90.2 t80 -56.55 -24.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.999 -1.001 . . . . 75.51 110.441 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.22 -26.12 33.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 55.43 110.057 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.737 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 18.6 t70 -82.99 -14.8 53.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.856 -0.611 . . . . 71.54 109.447 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.023 HD21 ' HA3' ' A' ' 152' ' ' GLY . 2.3 tp -55.85 -34.39 65.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.802 -1.09 . . . . 74.22 110.637 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.565 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . -136.25 21.9 3.44 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 64.41 111.705 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.737 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 4.7 ttpm? -56.71 -56.08 25.99 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.418 . . . . 74.5 111.178 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.17 -38.1 89.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.65 -0.704 . . . . 73.35 110.681 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.27 80.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 64.41 112.417 -174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 98.7 mtt180 -57.88 -42.23 84.19 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.635 0.606 . . . . 74.14 112.635 -170.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.07 -37.89 86.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 74.45 110.507 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.83 -34.77 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 41.41 110.918 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -72.32 -42.6 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 72.43 111.814 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -126.9 57.68 1.45 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.994 0.902 . . . . 64.02 110.652 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 21' ' ' GLY . 45.3 tptt -75.16 177.31 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.501 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 20' ' ' LYS . . . -64.5 116.62 9.26 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.554 -0.832 . . . . 43.14 111.68 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.73 173.98 6.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 73.31 110.761 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.928 ' HA3' ' HB3' ' A' ' 274' ' ' LYS . . . -83.14 88.17 1.49 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.749 -0.738 . . . . 63.34 112.786 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -93.26 -4.33 52.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.033 -0.358 . . . . 74.52 110.033 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.5 79.36 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.933 -0.576 . . . . 71.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.31 155.15 39.18 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 122.162 0.982 . . . . 71.42 112.797 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.976 HG23 HD23 ' A' ' 277' ' ' LEU . 43.6 mm -94.03 121.25 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.704 -1.589 . . . . 63.45 107.809 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 6.5 mtpm? -114.83 139.44 49.75 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.852 -0.339 . . . . 63.04 110.71 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tt -142.84 142.66 31.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.081 173.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -144.66 128.05 16.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.61 0.719 . . . . 72.34 110.434 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 281' ' ' PHE . 11.8 tp -120.84 126.75 50.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.896 -1.047 . . . . 74.24 110.33 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 2.0 ptmm? -121.8 124.49 44.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.483 0.659 . . . . 62.42 110.514 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 3.6 t -110.68 121.86 46.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.084 -1.08 . . . . 62.1 108.084 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.562 ' HB3' ' HG3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -143.41 139.05 29.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.791 0.805 . . . . 73.41 112.706 -170.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 37' ' ' ASN . 23.1 t -139.32 137.93 36.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.944 -1.873 . . . . 62.23 105.944 168.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -79.62 44.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.044 0.926 . . . . 62.45 111.128 -171.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 35' ' ' SER . 1.4 m-20 -98.37 19.41 14.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.966 -1.47 . . . . 75.4 107.431 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 95.62 -7.05 68.09 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.495 -1.23 . . . . 74.32 113.253 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.4 mm? -102.77 128.41 49.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.252 1.026 . . . . 63.33 113.489 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 25.6 tt0 -140.56 117.84 11.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.898 -0.779 . . . . 65.04 108.898 160.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 87.9 t80 -108.16 120.54 42.62 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.955 -0.466 . . . . 74.34 109.812 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 34.0 m -120.85 115.95 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 72.23 110.48 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -114.41 123.54 49.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.547 -0.538 . . . . 61.41 109.547 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 20.1 m -117.69 133.89 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 63.44 110.378 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.63 125.33 2.71 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.832 -0.699 . . . . 73.31 111.606 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.6 m -119.69 133.99 55.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 72.1 109.037 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -137.43 146.46 44.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.158 0.504 . . . . 35.53 111.858 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -68.87 142.91 54.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.503 -0.771 . . . . 64.34 109.157 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -57.88 -21.76 44.75 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.209 0.528 . . . . 74.22 111.271 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.75 7.46 33.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 64.24 110.632 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.9 p 50.05 25.66 1.78 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.383 1.073 . . . . 64.3 113.318 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 p -99.72 -18.44 17.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 70.52 111.712 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -134.93 108.64 8.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.183 -0.673 . . . . 72.15 109.183 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 47' ' ' ALA . 23.6 t -125.3 120.77 58.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.026 0.441 . . . . 74.03 110.742 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -111.22 126.49 54.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.146 0.498 . . . . 64.41 110.359 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.26 155.49 16.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.855 -0.688 . . . . 73.11 112.425 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.9 m -143.65 126.78 16.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.438 -0.949 . . . . 71.42 108.438 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.9 tm? -121.3 124.61 45.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.38 -0.528 . . . . 75.0 110.479 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 44.2 mt-10 -114.82 118.71 34.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.92 -0.582 . . . . 73.03 110.122 174.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 m -97.7 117.2 31.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.472 -1.307 . . . . 73.31 107.472 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 24.3 mtpp -121.93 139.38 53.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.325 0.583 . . . . 70.44 110.554 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 76.5 m-85 -109.67 120.82 43.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.416 -0.811 . . . . 73.11 109.082 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -118.04 109.16 16.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.258 0.551 . . . . 53.15 111.304 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 20.0 t90 -112.9 92.46 4.02 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.201 -0.909 . . . . 74.21 109.514 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 67' ' ' TYR . 10.8 m 71.63 151.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.134 0.896 . . . . 55.03 111.393 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.44 -38.21 63.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.561 0.696 . . . . 61.01 110.08 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.483 ' H ' HG22 ' A' ' 65' ' ' THR . 14.0 p90 -121.43 103.04 8.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 74.14 109.121 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.39 -102.07 0.17 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.225 -0.988 . . . . 72.32 112.141 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.7 mm? -117.51 136.55 53.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.322 0.582 . . . . 55.01 112.293 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -135.39 112.23 10.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.198 -0.91 . . . . 61.01 109.327 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 56.2 t80 -117.32 132.5 56.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.789 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 58.7 m -128.67 117.65 21.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.777 -0.192 . . . . 55.14 111.408 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -103.31 121.14 42.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.879 -1.156 . . . . 65.1 107.879 167.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -123.36 102.37 7.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.967 -0.56 . . . . 73.05 110.856 -168.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.849 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 67.9 t90 -96.67 132.84 41.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 74.25 109.889 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -119.76 165.82 14.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.852 -0.425 . . . . 63.41 109.852 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.7 t -64.84 -6.3 7.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.02 0.438 . . . . 74.53 111.932 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -79.82 -3.28 47.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.57 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 89.9 m-20 73.97 18.64 3.22 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.92 0.763 . . . . 74.1 110.028 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.6 m -102.93 135.92 43.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 72.35 110.487 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.849 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 4.8 mp -112.79 119.71 38.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.246 -0.434 . . . . 71.14 110.412 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 130.55 10.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.74 -0.743 . . . . 60.14 111.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.3 m -112.78 107.48 16.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.011 0.434 . . . . 60.35 111.144 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.789 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 21.7 tt0 -105.39 127.8 53.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.588 -0.733 . . . . 63.15 109.885 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.59 ' CG2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -130.02 120.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.364 -0.606 . . . . 64.12 109.364 169.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 24.6 m -126.36 129.24 48.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.685 -0.689 . . . . 52.5 110.229 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.02 134.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 70.12 111.253 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' OE2' ' HG3' ' A' ' 96' ' ' LYS . 67.8 mm-40 -96.46 118.86 33.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.55 -0.908 . . . . 62.13 108.55 172.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.27 122.9 28.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 73.12 109.822 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -85.56 -27.58 25.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.235 -0.438 . . . . 71.41 110.99 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.37 -44.8 42.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.295 -0.631 . . . . 53.31 109.295 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -99.61 67.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.516 -0.92 . . . . 62.45 108.516 170.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -49.95 131.23 22.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 52.12 111.759 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA2' ' HD2' ' A' ' 119' ' ' LYS . . . 102.85 -15.16 55.78 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.11 -0.95 . . . . 71.12 112.444 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.696 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -78.96 121.07 24.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.15 0.475 . . . . 64.02 111.126 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.478 ' HG3' ' OE2' ' A' ' 88' ' ' GLU . 48.9 tttp -118.06 111.78 19.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.571 -0.741 . . . . 74.43 109.574 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.632 HD12 HG22 ' A' ' 116' ' ' THR . 1.9 mm? -103.53 128.53 50.74 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.875 -0.417 . . . . 73.51 109.875 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.726 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 10.5 m -128.82 122.65 30.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.458 -0.337 . . . . 71.44 111.375 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.607 ' CE2' HD13 ' A' ' 114' ' ' ILE . 47.4 m-85 -119.55 115.67 24.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.477 -0.564 . . . . 75.02 109.477 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.1 t70 -115.42 122.05 44.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.55 -0.537 . . . . 73.15 109.55 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -134.83 121.69 20.99 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.061 0.457 . . . . 64.42 110.455 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 m -99.29 121.93 41.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.01 -0.541 . . . . 62.04 109.915 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.35 119.37 39.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 72.31 109.716 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 m -115.16 102.37 54.67 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.894 -0.41 . . . . 22.23 109.894 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.73 -33.04 28.71 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.559 2.173 . . . . 65.53 111.51 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -83.67 -46.11 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.643 -0.708 . . . . 75.24 111.102 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -70.25 -36.26 74.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.877 0.37 . . . . 75.23 110.806 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.26 -18.34 57.57 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.033 -0.603 . . . . 72.12 112.487 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.62 123.89 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.138 0.495 . . . . 62.14 110.568 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.22 116.56 28.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.92 -0.77 . . . . 70.13 108.92 173.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 132' ' ' ASP . 10.2 m120 -120.1 144.37 47.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.417 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.85 141.0 36.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.376 -0.375 . . . . 75.03 110.597 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.609 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -128.82 142.56 50.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.908 -0.404 . . . . 73.3 109.908 175.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.607 HD13 ' CE2' ' A' ' 99' ' ' PHE . 2.2 tp -118.07 117.68 55.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.885 -0.598 . . . . 74.02 110.08 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.726 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 27.9 ttpp -115.19 119.76 37.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.049 -0.523 . . . . 62.21 110.029 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.632 HG22 HD12 ' A' ' 97' ' ' LEU . 17.6 p -113.04 116.95 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.327 -0.62 . . . . 75.45 109.327 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.47 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -136.09 116.65 1.5 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.86 -1.162 . . . . 64.23 112.728 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.696 ' HB3' HD22 ' A' ' 95' ' ' LEU . 21.4 p90 -108.1 122.67 47.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.583 -0.525 . . . . 73.52 109.583 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -109.29 123.59 49.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.547 0.689 . . . . 71.44 110.965 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -106.25 165.02 11.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.741 -1.118 . . . . 64.34 109.256 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.825 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 10.4 pt-20 -52.65 -29.81 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.273 0.842 . . . . 51.32 113.273 -167.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -120.42 -6.1 9.81 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.924 -0.71 . . . . 63.15 112.502 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.37 126.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.424 -0.91 . . . . 64.15 113.011 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.818 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.0 m-20 -100.94 121.57 41.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.725 -0.671 . . . . 63.43 110.783 175.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 142' ' ' LEU . 3.9 mm? -112.05 126.69 55.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.229 0.212 . . . . 55.35 110.577 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.47 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.1 118.64 1.96 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.574 -0.822 . . . . 52.21 112.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 63.0 m -112.3 109.25 18.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.369 . . . . 63.03 110.51 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.63 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 4.3 t70 -108.82 146.01 34.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.832 -0.622 . . . . 71.41 110.125 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.484 ' HG3' HD13 ' A' ' 138' ' ' ILE . 22.2 ttt -135.96 117.21 14.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.045 -0.354 . . . . 72.44 110.045 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -100.22 117.35 34.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.512 -0.551 . . . . 73.53 109.512 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -98.18 122.98 42.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.121 0.486 . . . . 62.12 112.17 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.419 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 28.3 t70 -117.29 148.26 41.84 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.295 -1.002 . . . . 75.15 108.295 166.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -65.78 -19.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.108 0.41 . . . . 71.11 112.108 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.65 -12.26 29.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.32 . . . . 42.34 111.21 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.89 122.8 0.63 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 52.23 112.394 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.509 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 5.8 Cg_endo -87.3 145.78 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.602 2.868 . . . . 72.54 112.923 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 p -117.82 148.33 42.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.87 -0.605 . . . . 72.02 110.385 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 41.6 mm -107.55 118.39 55.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 110.265 -0.272 . . . . 64.04 110.265 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 155' ' ' MET . 70.6 mtm180 -105.7 116.9 32.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.127 0.489 . . . . 73.4 109.969 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.02 134.07 11.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.102 -1.046 . . . . 74.11 111.982 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.22 127.66 40.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.404 . . . . 61.34 110.557 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 125' ' ' LEU . 13.0 tp -132.51 124.23 28.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 64.15 110.12 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.818 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 36.1 t -123.79 120.78 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.486 . . . . 75.33 110.539 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' A' ' 142' ' ' LEU . 4.9 mp -110.62 140.7 44.7 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.388 -0.369 . . . . 75.1 110.214 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.88 119.17 4.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.949 -0.643 . . . . 65.24 112.857 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 78.3 m-85 -128.21 148.23 50.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.867 -0.79 . . . . 71.22 108.867 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -53.48 103.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 72.13 110.781 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.06 -32.94 6.71 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.247 -0.888 . . . . 74.52 112.497 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 93.4 m95 -108.06 123.45 48.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.721 0.638 . . . . 72.33 112.721 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.669 HD21 ' HB ' ' A' ' 6' ' ' THR . 2.0 tm? -113.99 137.35 51.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.31 -1.737 . . . . 52.45 106.31 170.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -135.73 132.83 37.34 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.954 -0.699 . . . . 64.12 110.813 -167.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.023 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -132.57 132.77 6.76 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.369 -0.919 . . . . 74.41 112.045 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.449 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 53.4 m-85 -132.49 118.2 18.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.636 -0.505 . . . . 74.31 109.636 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 27.5 mp0 -120.35 144.27 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.0 -0.546 . . . . 71.44 109.989 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.418 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 23.5 ptp -145.3 147.47 32.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.66 0.266 . . . . 64.51 110.578 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.579 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 8.3 t30 -113.95 117.37 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.219 -0.659 . . . . 74.43 109.219 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.86 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 69.7 t80 -94.59 125.18 39.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.61 -0.723 . . . . 72.53 111.062 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 161' ' ' LYS . 44.8 tt0 -91.29 103.98 16.58 Favored 'General case' 0 C--O 1.266 1.929 0 CA-C-N 115.104 -0.953 . . . . 71.41 109.384 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.28 -18.61 63.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.774 -2.012 . . . . 71.23 111.646 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.92 75.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.879 0.847 . . . . 63.21 108.907 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.516 ' HD3' ' OE2' ' A' ' 158' ' ' GLU . 2.0 mptm? -111.55 -159.37 0.68 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 73.41 107.996 168.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.3 m -107.9 28.67 8.0 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 122.252 -0.28 . . . . 62.1 110.287 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 158' ' ' GLU . 28.9 mtm180 -132.15 171.69 13.33 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 118.94 -1.104 . . . . 64.43 111.797 -163.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.6 m -103.06 133.01 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.389 -0.967 . . . . 71.42 108.389 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 p -99.89 1.38 42.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.067 0.46 . . . . 72.2 111.501 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.605 ' HG3' ' HB2' ' A' ' 186' ' ' ASP . 35.7 tt0 -150.87 130.82 13.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 71.31 109.687 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 m -121.78 112.87 18.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.857 -0.611 . . . . 65.11 109.936 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 84.0 m-20 -107.32 127.97 54.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.432 -0.581 . . . . 75.12 109.432 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.619 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.6 m-85 -121.39 153.01 38.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.286 -0.566 . . . . 74.52 111.065 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -148.67 128.53 13.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.504 -0.771 . . . . 71.41 109.833 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.1 t -125.81 126.17 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.501 -0.555 . . . . 70.14 109.501 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -117.32 130.58 8.94 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.624 -0.798 . . . . 63.11 112.713 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -113.03 120.2 40.53 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.557 -1.275 . . . . 73.35 107.557 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HG3' HE21 ' A' ' 179' ' ' GLN . 83.6 tttt -118.02 126.86 53.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.693 0.759 . . . . 74.41 112.797 -167.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 178' ' ' PHE . 23.8 m -131.89 162.56 30.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.31 -1.367 . . . . 64.24 107.31 169.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -46.76 -50.65 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.537 0.569 . . . . 61.24 112.537 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 7.9 pt-20 -116.16 10.95 15.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.094 0.473 . . . . 63.22 111.544 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.744 ' HD1' ' HG2' ' A' ' 196' ' ' GLN . 61.2 t80 -137.13 121.28 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.193 -0.458 . . . . 64.53 110.526 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.435 HE21 ' HG3' ' A' ' 174' ' ' LYS . 87.5 mt-30 -133.61 122.75 23.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.208 0.528 . . . . 71.24 110.605 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.744 HD12 HG13 ' A' ' 194' ' ' ILE . 3.2 tt -111.91 131.98 55.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.388 -0.597 . . . . 74.14 109.388 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -129.85 115.16 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.195 0.521 . . . . 73.24 109.982 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 27.4 m -86.25 135.41 33.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.397 -0.819 . . . . 73.4 109.088 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -128.66 138.1 51.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.227 0.536 . . . . 73.11 111.087 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 53.6 t -132.13 128.42 59.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 64.34 110.133 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -115.17 95.63 5.29 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.896 -0.779 . . . . 75.22 108.896 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.605 ' HB2' ' HG3' ' A' ' 166' ' ' GLN . 29.8 t0 58.46 -174.0 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.842 -1.072 . . . . 75.35 109.793 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -75.69 -6.73 82.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.617 -0.801 . . . . 72.01 111.783 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 186' ' ' ASP . 7.2 t -89.59 -27.42 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.455 0.539 . . . . 64.22 112.455 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.45 114.26 15.33 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 119.911 -0.716 . . . . 52.25 111.023 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -133.83 132.85 40.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.783 0.325 . . . . 72.3 110.583 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -166.34 -159.31 11.98 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.785 -0.721 . . . . 63.12 112.088 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.19 153.78 24.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.889 -0.672 . . . . 64.11 111.979 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.0 m -126.8 139.34 53.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.087 0.47 . . . . 62.41 110.255 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.744 HG13 HD12 ' A' ' 180' ' ' LEU . 4.5 mp -119.47 129.72 74.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.874 -0.603 . . . . 75.35 109.724 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -125.19 119.13 27.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.395 -0.594 . . . . 74.33 109.395 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.744 ' HG2' ' HD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -125.56 120.04 29.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.156 -0.475 . . . . 71.03 110.405 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.916 ' HG3' ' HG2' ' A' ' 203' ' ' GLU . 58.1 tttm -106.11 116.03 31.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.295 -0.631 . . . . 73.53 109.295 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 200' ' ' LYS . 16.1 t -86.33 143.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.714 -0.846 . . . . 72.53 108.714 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -73.36 6.33 3.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.61 0.719 . . . . 73.41 110.508 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.59 ' H ' HG12 ' A' ' 198' ' ' VAL . 49.0 tptt -98.19 37.71 1.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.062 -0.972 . . . . 73.23 108.911 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 200' ' ' LYS . 34.6 mmtp 75.95 -55.54 0.6 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.992 -1.004 . . . . 63.14 112.884 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.14 132.62 53.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.768 0.794 . . . . 73.2 112.752 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.916 ' HG2' ' HG3' ' A' ' 197' ' ' LYS . 31.3 mt-10 -110.7 142.97 41.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.611 -1.177 . . . . 75.43 109.303 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.9 m -131.68 138.99 48.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.661 -0.245 . . . . 52.24 110.58 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -131.01 148.94 52.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.655 -0.248 . . . . 51.33 110.657 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.81 HG22 HG22 ' A' ' 221' ' ' ILE . 92.1 t -135.11 140.45 45.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.998 -0.371 . . . . 65.23 109.998 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -124.76 127.07 46.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.76 0.314 . . . . 71.12 110.513 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.3 mm? -123.01 136.57 54.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.619 . . . . 61.4 110.016 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.416 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.21 129.58 14.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.371 -0.377 . . . . 52.51 110.22 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -114.66 126.78 55.28 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.989 -0.745 . . . . 74.24 108.989 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 188' ' ' THR . 6.4 t -101.82 112.99 25.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.441 0.639 . . . . 60.21 109.638 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.24 126.42 27.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.303 -0.862 . . . . 75.4 110.922 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 156.44 -78.55 0.19 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.789 . . . . 31.32 112.484 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.76 50.52 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.43 . . . . 71.04 111.367 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.0 m 58.54 18.88 6.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.955 0.724 . . . . 70.12 112.955 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.455 ' HB3' ' CG2' ' A' ' 211' ' ' THR . 48.1 t-20 -75.94 114.31 14.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 60.43 110.053 -176.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.5 m -113.34 130.87 56.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.778 -0.646 . . . . 72.05 110.862 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -106.04 125.89 51.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 74.21 110.121 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 239' ' ' ASN . 9.5 t80 -130.44 141.52 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.233 -0.894 . . . . 64.33 109.25 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.27 147.78 15.66 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.445 -0.883 . . . . 73.44 112.0 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.81 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -128.24 144.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.725 0.298 . . . . 75.31 110.213 177.036 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -130.51 142.25 50.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.979 -0.555 . . . . 64.32 110.851 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -116.42 135.16 54.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.798 -0.637 . . . . 62.2 109.627 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 64.6 tttt -129.63 117.32 20.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.283 -0.417 . . . . 64.43 110.285 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -132.78 125.85 31.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.042 0.448 . . . . 54.31 111.005 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -91.92 100.77 13.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.042 -0.725 . . . . 74.23 109.042 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 17.4 tt -71.03 -30.2 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 71.22 111.061 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.715 ' HB2' ' HD2' ' A' ' 229' ' ' PRO . 3.4 p30 -156.22 164.07 22.7 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.722 -0.844 . . . . 71.4 108.722 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 228' ' ' ASP . 13.6 Cg_endo -56.26 -20.42 31.78 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.865 2.377 . . . . 70.24 114.53 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -104.62 -19.42 13.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.904 -0.318 . . . . 62.31 111.58 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -124.3 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.322 0.582 . . . . 63.33 112.312 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.4 m -125.09 133.34 52.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.637 -0.711 . . . . 64.42 110.262 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -114.42 133.15 55.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.88 0.371 . . . . 72.33 110.159 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 11.3 p -137.97 149.33 46.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.123 -0.489 . . . . 72.14 110.42 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -144.55 155.99 43.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.867 -0.42 . . . . 74.44 109.867 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -144.87 149.64 35.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.441 . . . . 61.52 111.067 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 1.2 t -127.28 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.774 -0.648 . . . . 72.35 110.017 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.7 m120 -106.06 150.16 26.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.106 -0.497 . . . . 55.13 109.956 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 219' ' ' PHE . 22.5 p-10 -45.07 -32.24 1.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.807 1.317 . . . . 75.12 113.692 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.659 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 19.7 m -82.23 25.64 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.873 0.368 . . . . 73.5 110.748 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.405 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 22.2 m 69.84 31.1 3.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.591 -0.731 . . . . 63.41 110.863 174.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 262' ' ' LEU . 5.2 mp -88.17 126.95 35.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 120.686 -0.406 . . . . 73.13 110.618 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.71 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.88 116.65 53.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 123.884 0.74 . . . . 73.14 109.859 -177.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 262' ' ' LEU . . . -129.84 151.87 19.46 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.157 -1.021 . . . . 63.13 112.929 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.499 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -136.7 154.22 50.67 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.431 . . . . 72.11 110.952 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.71 120.76 1.32 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.253 -0.739 . . . . 60.22 111.253 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -112.36 119.07 37.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.992 -0.373 . . . . 73.24 109.992 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -119.73 121.93 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.471 0.653 . . . . 71.35 110.661 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 24.7 tt0 -123.9 131.07 53.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.854 -0.612 . . . . 73.22 109.802 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.0 m -87.21 114.37 23.76 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.435 -0.348 . . . . 73.43 110.456 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.796 ' HG ' ' HD2' ' A' ' 253' ' ' PRO . 19.2 tp -75.71 139.7 42.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.555 -0.906 . . . . 71.25 108.555 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -55.94 -43.94 99.46 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.787 1.032 . . . . 73.04 113.787 -168.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.796 ' HD2' ' HG ' ' A' ' 251' ' ' LEU . 72.4 Cg_exo -43.8 -64.33 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 75.23 113.703 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 163.95 38.65 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 120.721 -0.752 . . . . 15.43 111.696 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 279' ' ' LEU . 1.8 tp -143.46 122.2 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.821 -0.437 . . . . 71.01 109.821 -174.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.533 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 12.7 ptmm? -106.63 133.19 51.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.455 0.645 . . . . 74.24 110.534 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.7 tp -99.91 124.14 44.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.755 -1.111 . . . . 63.13 110.025 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.7 t -125.45 112.54 16.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.645 0.736 . . . . 64.32 110.671 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -100.17 124.78 45.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.893 -1.151 . . . . 74.03 107.893 175.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 p -129.94 139.55 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.981 0.42 . . . . 73.43 111.006 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.5 128.64 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 75.5 110.2 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -110.25 121.69 45.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.98 . . . . 64.3 108.353 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.944 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -102.28 109.47 21.15 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.991 -0.744 . . . . 52.23 108.991 176.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.006 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 1.7 m-20 -68.64 106.09 2.49 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.69 -1.226 . . . . 65.32 107.69 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -53.49 -24.85 25.54 Favored Glycine 0 C--N 1.32 -0.355 0 O-C-N 123.517 0.511 . . . . 54.53 113.48 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.12 -26.48 19.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.672 0.272 . . . . 74.03 111.039 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 1.006 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 7.2 m-20 -96.69 -30.8 13.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.463 -0.335 . . . . 74.11 111.882 -173.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.944 HG11 ' HB3' ' A' ' 263' ' ' LEU . 21.7 m -62.95 -18.68 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 71.51 111.216 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -62.19 -31.08 71.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 63.24 109.783 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.27 9.99 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 74.21 110.63 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.17 15.94 63.73 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.969 -0.56 . . . . 71.34 112.985 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.69 96.12 2.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 61.13 112.479 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -110.18 142.82 41.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.082 -0.34 . . . . 74.1 110.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.928 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 58.4 mttm -101.06 134.48 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.006 -0.739 . . . . 75.51 109.006 170.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.31 132.42 37.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.795 -0.446 . . . . 72.44 109.795 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.49 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -148.07 132.69 4.32 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.872 -0.68 . . . . 43.32 111.611 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.976 HD23 HG23 ' A' ' 27' ' ' ILE . 45.4 tp -114.77 145.65 41.86 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 64.22 110.722 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.579 ' H ' HD12 ' A' ' 277' ' ' LEU . . . -142.32 125.47 2.67 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 63.41 112.006 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 255' ' ' ILE . 2.9 mm? -109.23 129.25 55.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.112 -0.699 . . . . 73.31 109.112 170.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.533 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 20.9 mt-10 -113.91 110.69 20.49 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.089 -0.708 . . . . 74.35 109.089 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.561 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -116.77 135.16 53.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.096 0.475 . . . . 73.33 110.155 -173.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -130.96 112.67 13.16 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.899 -0.778 . . . . 74.52 108.899 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.718 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -83.03 107.55 15.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 35.51 109.833 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 283' ' ' ALA . 3.4 mm? -137.9 -61.11 0.63 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.988 -1.006 . . . . 63.45 109.071 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.991 -0.528 . . . . 61.0 109.8 177.102 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.657 0.265 . . . . 63.05 111.274 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.32 148.68 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.316 . . . . 74.21 110.893 -175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.941 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 3.8 t -116.02 114.77 41.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.978 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.88 175.07 11.85 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.702 2.268 . . . . 74.31 111.993 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 13.2 Cg_exo -70.79 85.13 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.443 2.095 . . . . 75.15 111.298 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 p -69.38 -34.35 74.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 42.43 111.54 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.598 ' HB3' HG21 ' A' ' 143' ' ' VAL . 10.9 p90 -61.24 -28.71 69.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.139 0.495 . . . . 74.21 110.983 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -84.86 -20.78 30.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 64.34 110.892 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -102.43 -0.12 32.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.177 0.989 . . . . 53.04 108.48 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.857 HD21 ' HA3' ' A' ' 152' ' ' GLY . 8.6 tp -58.04 -24.12 57.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.618 -1.628 . . . . 71.33 110.519 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.64 51.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.619 -0.719 . . . . 52.04 111.916 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 13.8 ptmm? -62.38 -44.04 97.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.653 0.264 . . . . 72.23 111.504 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -65.23 -38.95 91.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.182 0.515 . . . . 74.31 110.971 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 193' ' ' SER . . . -70.08 -43.79 70.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 44.24 111.95 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.67 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 5.4 ptm180 -61.2 -28.38 69.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.477 -0.329 . . . . 73.41 111.104 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.89 -42.48 84.73 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.375 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -82.68 -31.46 9.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 70.44 110.794 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 94.6 t80 -71.47 -22.64 61.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 73.53 112.323 -174.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -29.86 117.04 0.13 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.213 0.946 . . . . 74.34 113.352 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -80.42 -9.47 59.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.075 -0.966 . . . . 74.13 110.235 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.94 91.28 1.22 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.045 -0.822 . . . . 61.42 111.045 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -84.13 169.83 14.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.884 0.373 . . . . 72.32 111.055 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.4 112.39 3.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.097 -0.573 . . . . 63.11 112.656 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.432 ' HB2' HD13 ' A' ' 26' ' ' LEU . 45.7 m-85 -92.99 14.46 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.696 0.284 . . . . 71.1 110.905 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.7 13.57 53.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 54.34 112.065 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD13 ' HB2' ' A' ' 24' ' ' PHE . 10.7 mp -100.05 160.05 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.025 0.917 . . . . 63.45 112.376 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.715 HG13 HD23 ' A' ' 277' ' ' LEU . 1.7 mp -104.28 127.55 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.071 -1.422 . . . . 61.34 108.789 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -106.87 142.21 36.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.681 0.277 . . . . 71.43 110.47 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.68 148.17 46.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.298 -0.41 . . . . 51.43 110.031 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 13.8 t70 -155.16 134.62 12.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 74.45 109.95 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.871 -0.418 . . . . 73.33 109.871 -178.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -126.05 125.35 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.916 0.389 . . . . 73.5 110.087 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -137.68 120.04 15.85 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.025 -0.732 . . . . 63.03 109.025 170.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HE3' HD22 ' A' ' 284' ' ' LEU . 17.9 ptpt -133.41 144.58 49.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.546 . . . . 64.43 111.93 -176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 39' ' ' LEU . 18.8 m -141.21 164.83 29.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 72.24 109.297 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -80.03 26.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.968 0.413 . . . . 72.44 110.995 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 7.6 t-20 -107.28 21.08 18.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.116 0.484 . . . . 53.24 110.286 -173.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 77.11 -6.73 40.69 Favored Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.745 -0.74 . . . . 72.33 113.176 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 39' ' ' LEU . 2.0 pp -102.44 132.94 48.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.837 0.68 . . . . 72.24 112.837 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.066 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 39.3 mt-10 -137.2 124.88 22.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 54.51 109.124 165.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -107.06 120.13 41.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.1 -0.333 . . . . 74.33 110.1 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.861 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 29.5 m -128.77 132.16 47.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 62.24 111.125 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.0 t -125.04 135.28 52.58 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.749 -0.834 . . . . 75.34 108.749 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -148.56 125.76 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.007 -0.277 . . . . 73.13 110.708 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.89 168.22 40.99 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.951 -1.119 . . . . 32.42 113.001 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -137.48 135.53 36.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.448 -0.575 . . . . 74.35 109.448 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -149.94 150.62 32.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.266 0.555 . . . . 75.44 111.973 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -71.68 139.53 49.24 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.245 -1.02 . . . . 74.3 108.245 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -67.99 -8.55 38.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.41 0.624 . . . . 42.12 111.144 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -82.34 -3.25 55.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.75 -0.659 . . . . 71.03 109.968 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.9 p 54.48 21.01 3.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.181 0.992 . . . . 51.2 112.651 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 p -91.92 -26.65 18.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 74.51 110.976 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.41 95.99 4.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.502 -0.555 . . . . 74.21 109.502 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 47' ' ' ALA . 44.8 t -125.61 124.15 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.917 -0.583 . . . . 61.55 110.773 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 126.0 25.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.369 -0.604 . . . . 75.22 109.369 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.92 -178.01 37.9 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.263 -0.97 . . . . 63.55 112.786 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 5.0 p -138.4 153.23 48.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.169 0.509 . . . . 50.31 111.057 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.72 124.02 45.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.264 -1.384 . . . . 74.12 107.264 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.861 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 46.0 mt-10 -110.16 118.06 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.965 -0.561 . . . . 55.52 110.302 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -103.52 120.16 40.31 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.021 -1.103 . . . . 62.45 108.021 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 1.066 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 59.7 mttm -118.41 147.18 43.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.117 -0.492 . . . . 70.1 109.772 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.766 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 67.2 m-85 -118.12 120.18 36.98 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.959 -0.564 . . . . 63.4 109.634 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.606 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 14.6 ttm180 -114.09 106.84 14.86 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.505 0.669 . . . . 73.13 111.606 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -115.2 91.86 3.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.739 -1.119 . . . . 71.52 109.003 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 93.2 m 69.33 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.903 0.752 . . . . 70.5 111.286 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.04 129.03 39.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 73.54 110.5 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HD2' ' HG3' ' A' ' 88' ' ' GLU . 32.2 m-85 62.57 35.05 14.66 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.613 -0.722 . . . . 75.32 110.587 -173.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.03 -90.52 0.97 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.655 -1.378 . . . . 32.25 109.655 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 69' ' ' LEU . 2.1 mm? -122.75 129.42 51.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.313 0.578 . . . . 74.24 111.199 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.6 p -137.78 121.4 17.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.261 -0.881 . . . . 60.52 110.371 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -122.39 123.48 41.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.534 -0.543 . . . . 74.34 109.534 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.71 ' HB ' ' HG2' ' A' ' 61' ' ' LYS . 7.4 p -128.3 130.63 48.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.853 -0.739 . . . . 71.33 111.123 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 35.7 tt0 -109.88 121.67 45.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.448 -0.575 . . . . 75.42 109.448 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -109.65 94.21 4.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.74 -0.467 . . . . 73.04 109.74 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.953 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 32.2 t90 -96.7 128.17 43.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.487 -0.324 . . . . 73.34 110.416 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 1.9 m-20 -106.61 134.21 50.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.862 -0.792 . . . . 71.23 108.862 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.8 m -72.11 -27.56 62.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.716 0.769 . . . . 71.11 109.764 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.54 -24.32 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.813 -1.085 . . . . 74.24 111.836 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.437 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 13.4 t-20 -131.16 -108.71 0.26 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.408 -0.517 . . . . 73.01 112.181 -171.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 104' ' ' SER . 16.4 p -115.46 144.58 43.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.006 0.743 . . . . 75.14 113.006 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.953 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -98.8 119.76 38.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.867 -0.79 . . . . 70.32 108.867 166.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.42 120.95 4.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.423 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -104.4 114.0 27.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.682 0.277 . . . . 72.43 110.576 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 13.6 pt-20 -120.06 132.71 55.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.073 0.463 . . . . 64.11 110.495 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.26 121.77 65.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.837 -0.619 . . . . 63.43 109.357 177.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -117.88 123.04 44.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.657 -0.702 . . . . 74.54 110.805 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -129.45 132.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 74.33 110.354 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.622 ' HG3' ' HD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -91.91 118.73 31.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.164 -1.421 . . . . 71.21 107.164 172.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.522 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 8.5 t70 -56.05 124.05 16.47 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.503 0.502 . . . . 71.35 111.081 -168.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -67.21 -23.31 65.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.874 -0.603 . . . . 74.24 111.222 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.99 -51.58 4.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.711 -0.478 . . . . 73.43 109.711 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.32 77.8 3.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.244 -0.435 . . . . 61.43 110.52 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 89' ' ' ASP . 30.0 mmm180 -63.26 128.45 35.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.961 -0.563 . . . . 75.14 110.031 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.57 44.03 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.24 -0.744 . . . . 74.43 111.24 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 118' ' ' TYR . 20.8 tp -123.19 120.24 32.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.213 -0.662 . . . . 63.33 109.213 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -118.01 121.0 39.51 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.989 -0.55 . . . . 71.31 109.764 -173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -104.64 127.09 52.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.709 . . . . 63.5 109.991 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 93.5 m -129.2 118.62 22.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.256 -0.429 . . . . 73.4 110.552 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -111.32 115.8 29.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.267 -0.642 . . . . 74.5 109.267 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 3.0 p30 -117.47 151.03 37.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.297 0.57 . . . . 71.01 110.613 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.508 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 50.4 m -142.13 121.49 13.15 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 71.0 110.033 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -102.93 122.23 44.16 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.872 -0.603 . . . . 35.21 109.546 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.553 ' HD2' HD21 ' A' ' 81' ' ' LEU . 82.4 t80 -110.24 130.54 55.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.718 -0.475 . . . . 61.04 109.718 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.437 ' HB2' HG22 ' A' ' 80' ' ' THR . 35.5 t -106.99 106.94 59.65 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 74.24 109.9 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 37.2 Cg_endo -66.58 -16.09 49.69 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.7 2.267 . . . . 62.11 111.992 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -74.52 -38.46 62.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 75.35 110.874 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.652 HG23 ' H ' ' A' ' 109' ' ' LYS . 3.0 t -108.31 -27.96 9.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.351 . . . . 63.34 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 2.89 67.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.748 -0.739 . . . . 54.32 112.227 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.652 ' H ' HG23 ' A' ' 107' ' ' THR . 51.2 mtmt -89.08 148.4 23.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 53.24 110.956 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.508 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 61.7 tttm -123.08 136.94 55.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 73.42 109.939 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 101' ' ' SER . 14.4 t-20 -119.6 122.81 42.41 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.891 -0.411 . . . . 74.21 109.891 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.83 129.72 56.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.249 -0.432 . . . . 61.2 110.6 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.801 ' HG2' ' HA ' ' A' ' 130' ' ' ASP . 35.9 mtmm -127.85 138.47 52.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.207 -0.451 . . . . 63.44 110.336 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.8 tp -116.56 117.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.479 0.657 . . . . 53.21 110.166 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 46.0 mttp -107.32 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.223 -0.899 . . . . 72.23 110.959 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -123.73 117.62 25.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.902 -0.777 . . . . 61.4 108.902 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.08 114.99 2.19 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.201 -1.0 . . . . 73.34 112.731 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.446 ' HB3' HD13 ' A' ' 95' ' ' LEU . 5.1 p90 -109.79 122.65 47.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.367 0.603 . . . . 65.24 109.753 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.941 ' HD3' ' HB ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.538 -0.756 . . . . 65.02 112.186 -173.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 46.1 mmt-85 -106.45 152.93 22.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.668 -1.234 . . . . 74.34 107.668 165.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -29.57 59.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.955 0.724 . . . . 73.41 112.955 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.4 -5.94 15.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.001 0.371 . . . . 75.21 112.001 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 120' ' ' ARG . 9.0 tp -145.61 123.51 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.248 0.547 . . . . 63.5 111.48 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.636 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 4.1 t30 -119.97 117.05 27.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.2 -0.312 . . . . 74.5 110.53 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.0 mm? -112.97 127.1 56.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.909 0.385 . . . . 62.22 110.923 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -130.84 118.31 2.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.909 -0.587 . . . . 53.04 111.773 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.9 m -105.21 120.72 42.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.767 0.318 . . . . 73.1 110.678 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -114.85 117.4 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 72.14 110.162 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 77.6 mmm -99.02 117.07 32.71 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.441 -0.577 . . . . 64.14 109.441 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.801 ' HA ' ' HG2' ' A' ' 113' ' ' LYS . 11.0 t70 -102.81 118.5 36.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 72.23 110.696 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -97.84 97.85 9.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.436 -0.347 . . . . 72.51 110.844 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -105.1 144.38 31.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.972 -0.751 . . . . 63.52 108.972 170.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.02 -34.67 53.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.108 0.48 . . . . 71.32 111.977 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.22 -18.0 59.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.181 -0.463 . . . . 62.04 111.546 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.17 118.61 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.871 -0.681 . . . . 74.22 112.148 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.26 126.75 21.76 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.797 2.331 . . . . 62.03 112.04 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.9 m -107.63 150.82 26.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.275 -0.421 . . . . 64.0 110.363 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 33.4 mm -107.02 116.9 51.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.481 -0.562 . . . . 72.13 109.481 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -111.54 123.18 49.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.403 0.621 . . . . 72.4 110.348 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.34 132.93 11.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.307 -0.949 . . . . 73.31 111.959 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.27 23.76 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.197 -0.668 . . . . 64.41 109.197 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 143' ' ' VAL . 14.9 tp -124.16 131.67 53.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.107 -0.497 . . . . 61.55 110.608 -175.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 34.1 t -131.38 129.66 62.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.196 -0.456 . . . . 71.34 110.037 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 6.2 mp -109.48 138.66 45.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.117 -0.697 . . . . 64.04 109.117 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.553 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -119.55 119.32 4.23 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 121.04 -0.6 . . . . 75.11 112.888 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 63.4 t80 -126.99 149.07 50.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.684 -1.228 . . . . 74.33 107.684 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -49.31 101.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 74.52 111.55 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.48 -30.78 7.39 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.822 -0.626 . . . . 72.41 112.744 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 39.0 m95 -104.7 126.8 52.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 73.54 111.523 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.773 ' HB3' HD12 ' A' ' 10' ' ' LEU . 20.1 mt -120.32 146.98 45.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.022 0.439 . . . . 74.04 110.285 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -137.1 127.37 26.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.014 -0.736 . . . . 62.44 109.014 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.857 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -131.51 142.46 13.85 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.375 -0.917 . . . . 63.5 111.717 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.674 ' HD2' ' HD2' ' A' ' 169' ' ' PHE . 64.3 m-85 -136.0 121.76 19.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.743 0.306 . . . . 73.32 110.375 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.822 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 23.5 mp0 -106.05 122.58 46.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.961 -0.755 . . . . 65.4 108.961 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 49.1 ttm -127.96 141.87 51.41 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.735 -0.386 . . . . 73.53 110.464 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 51.5 t-20 -130.74 117.41 19.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.406 -0.59 . . . . 61.13 109.406 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.799 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 63.4 t80 -95.16 120.77 35.96 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.491 0.494 . . . . 72.01 110.053 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 43.4 tt0 -99.03 99.59 10.64 Favored 'General case' 0 C--O 1.26 1.649 0 CA-C-O 121.548 0.689 . . . . 73.31 110.678 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -70.59 -22.23 62.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 113.542 -1.663 . . . . 75.44 110.794 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.12 69.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.793 0.806 . . . . 54.43 109.119 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.653 ' HG3' ' H ' ' A' ' 162' ' ' SER . 21.5 tptp -113.41 -158.56 0.66 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.437 -1.32 . . . . 51.22 107.437 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.653 ' H ' ' HG3' ' A' ' 161' ' ' LYS . 17.2 m -108.72 28.08 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.918 -0.488 . . . . 44.22 110.813 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 163' ' ' ARG . 2.4 ptm180 -157.01 160.77 39.32 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.053 -1.059 . . . . 75.11 111.954 -164.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.6 m -74.0 133.4 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.165 -1.05 . . . . 75.13 108.165 169.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.7 t -93.39 -14.83 26.34 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.951 -0.3 . . . . 75.05 110.273 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.71 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 19.6 mt-30 -142.21 132.74 25.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.399 0.618 . . . . 72.42 111.796 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -123.0 105.98 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.058 -0.974 . . . . 74.42 109.388 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.822 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 80.7 m-20 -114.42 136.06 53.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 64.35 110.176 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.674 ' HD2' ' HD2' ' A' ' 153' ' ' TYR . 36.5 m-85 -130.42 140.71 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 75.12 110.053 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -142.69 129.03 19.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.832 0.348 . . . . 73.5 110.282 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 45.8 t -124.54 127.13 72.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.004 -0.739 . . . . 60.33 109.004 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -140.49 115.39 1.05 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.85 -1.167 . . . . 74.23 112.293 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.49 ' CE2' HD22 ' A' ' 180' ' ' LEU . 54.2 p90 -115.47 134.48 55.05 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.422 -0.511 . . . . 64.11 110.241 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -119.25 124.95 47.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.311 -0.859 . . . . 62.11 110.225 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 51.1 m -134.78 112.69 10.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.893 -0.323 . . . . 74.32 110.301 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.6 t70 43.12 -87.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.35 1.031 . . . . 73.33 113.752 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 10.2 pt-20 -101.86 -12.13 18.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.213 0.449 . . . . 74.3 112.213 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.47 ' HD2' ' HG2' ' A' ' 196' ' ' GLN . 74.6 t80 -119.18 117.19 28.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 74.52 111.247 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -123.84 124.36 42.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 72.45 109.584 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.629 HD12 HG13 ' A' ' 194' ' ' ILE . 3.1 tt -119.49 135.41 54.78 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.512 -0.475 . . . . 74.35 110.677 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.58 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 47.7 t60 -129.75 115.11 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.373 -0.83 . . . . 75.42 110.225 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.0 m -92.48 142.8 27.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.492 -0.929 . . . . 75.35 108.492 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.15 139.83 33.98 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 63.53 110.754 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.35 121.06 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.714 -0.675 . . . . 61.21 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 75.2 m-20 -103.62 94.24 5.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.374 -0.83 . . . . 61.2 109.276 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.71 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 12.1 m-20 65.83 -169.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.836 -1.074 . . . . 71.22 110.907 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 212' ' ' ALA . . . -76.49 -6.5 84.32 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.425 -0.893 . . . . 72.12 111.714 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.2 m -96.8 -25.56 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.616 0.598 . . . . 74.24 112.616 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.4 tt0 -129.72 113.98 15.41 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.062 -0.655 . . . . 74.01 111.54 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -121.86 124.74 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.933 -0.765 . . . . 73.04 108.933 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.45 -160.75 11.36 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.788 -1.196 . . . . 72.33 112.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.66 175.8 44.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.539 -0.838 . . . . 75.15 112.389 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.641 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 26.2 m -148.68 138.09 21.87 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.391 -0.596 . . . . 61.43 109.391 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.76 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.6 mp -121.2 137.18 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.532 -0.544 . . . . 71.44 109.532 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -121.6 119.92 33.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.787 -0.82 . . . . 72.34 108.787 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.47 ' HG2' ' HD2' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -124.97 111.07 14.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.714 -0.847 . . . . 75.04 108.714 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 60.1 tttp -97.23 119.48 35.82 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.811 -0.631 . . . . 74.0 109.745 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.84 146.0 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.467 -1.308 . . . . 74.42 107.467 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -74.54 56.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.769 0.795 . . . . 74.12 110.997 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.461 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 67.8 mttm -152.85 -146.78 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.848 -1.524 . . . . 74.32 108.028 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.801 ' HB3' ' HB3' ' A' ' 226' ' ' GLN . 1.2 mptm? -103.01 26.16 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.315 0.578 . . . . 75.51 109.587 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.55 110.32 19.06 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.464 -0.789 . . . . 75.23 110.269 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.947 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 12.8 mm-40 -107.01 134.39 50.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 52.45 109.795 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.5 m -123.38 143.11 50.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 64.2 109.919 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -142.32 158.58 43.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 65.15 111.114 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.76 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 71.5 t -132.45 141.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.533 -0.543 . . . . 55.31 109.533 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.46 125.4 16.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.038 -0.727 . . . . 64.32 109.038 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.662 HD13 ' HD1' ' A' ' 219' ' ' PHE . 2.5 pt? -146.6 150.65 35.9 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.415 -0.514 . . . . 73.14 111.036 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.38 130.88 22.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 72.02 110.194 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.671 ' HB2' HG23 ' A' ' 217' ' ' THR . 9.4 t90 -125.28 135.11 52.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.606 -0.724 . . . . 70.01 109.489 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.909 HG23 ' HB3' ' A' ' 214' ' ' ASN . 3.9 t -95.27 113.95 25.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.355 0.598 . . . . 72.34 110.457 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -64.94 144.71 57.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 72.35 110.846 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.58 -2.72 86.33 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.675 -0.97 . . . . 52.5 110.675 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.909 ' HB3' HG23 ' A' ' 211' ' ' THR . 37.2 t-20 -138.28 159.18 42.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.332 -0.988 . . . . 54.31 108.332 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.1 t -93.41 -9.29 39.12 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.174 -0.329 . . . . 73.14 110.542 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.97 108.92 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.213 0.53 . . . . 70.14 110.951 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 210' ' ' TRP . 28.1 m -117.13 135.07 54.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.281 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -126.1 117.5 23.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.899 -0.32 . . . . 72.45 110.255 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.662 ' HD1' HD13 ' A' ' 208' ' ' LEU . 74.5 t80 -113.27 138.42 50.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.567 -0.742 . . . . 74.41 109.241 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.82 157.21 26.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.527 -0.844 . . . . 42.41 112.705 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.65 136.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 64.31 109.649 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 205' ' ' ALA . . . -114.51 152.66 31.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.783 -0.451 . . . . 53.11 109.783 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.78 140.2 34.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.397 -0.365 . . . . 75.32 110.498 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.947 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 28.9 ttmt -123.1 113.84 19.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.128 -0.693 . . . . 63.13 109.128 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -105.2 116.47 32.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.48 -0.327 . . . . 71.51 110.535 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.801 ' HB3' ' HB3' ' A' ' 201' ' ' LYS . 63.1 tt0 -91.99 104.17 16.61 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.461 -0.94 . . . . 72.43 108.461 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.83 -49.06 60.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.472 -0.785 . . . . 73.35 110.991 -172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.747 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.1 t70 -164.78 -59.64 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 74.42 111.491 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 72.1 Cg_endo -89.38 -139.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.023 1.815 . . . . 63.35 113.443 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 1.8 m-20 -92.13 13.38 19.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.815 -1.084 . . . . 71.13 110.37 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.09 124.93 45.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 63.25 110.154 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.644 ' HB2' HG23 ' A' ' 248' ' ' THR . 59.6 m -113.09 145.09 41.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.191 -0.913 . . . . 74.44 110.173 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.24 125.98 39.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.962 -1.125 . . . . 75.11 107.962 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.8 t -106.45 144.56 32.95 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.166 -0.47 . . . . 72.15 110.013 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -148.57 147.69 29.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.34 -0.391 . . . . 61.1 110.431 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -148.01 138.53 22.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.132 -0.692 . . . . 63.53 109.132 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.33 152.92 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 242' ' ' LEU . 11.7 p30 -133.4 152.43 51.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.965 -0.694 . . . . 74.02 110.777 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.58 5.02 0.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.539 -1.209 . . . . 64.33 112.982 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.601 ' HB3' HD13 ' A' ' 242' ' ' LEU . 32.3 t -89.01 13.83 12.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.506 -0.924 . . . . 52.21 108.506 170.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 49.9 m 69.26 31.72 3.83 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 114.626 -1.17 . . . . 70.32 111.357 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.999 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 10.2 mp -99.75 142.62 31.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.287 -0.565 . . . . 74.23 111.202 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -125.59 118.0 51.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.695 -0.684 . . . . 63.21 110.317 -169.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.07 143.57 16.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.739 -0.743 . . . . 74.23 112.436 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.37 156.72 43.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.845 0.355 . . . . 71.14 110.153 176.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.92 -177.73 36.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.435 -0.888 . . . . 42.24 113.049 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.15 115.93 26.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.603 -0.517 . . . . 71.12 109.603 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 232' ' ' CYS . 6.3 t -111.06 113.93 26.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.075 -0.713 . . . . 74.44 109.075 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -132.82 150.4 52.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.222 -0.444 . . . . 65.31 111.463 -168.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 8.9 t -124.78 132.83 53.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.117 -1.068 . . . . 71.23 108.117 167.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.636 HD23 HD12 ' A' ' 255' ' ' ILE . 36.8 tp -72.27 -65.15 0.81 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.5 -0.48 . . . . 60.12 109.851 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.654 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 0.5 OUTLIER 174.72 -57.91 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.466 -0.788 . . . . 62.12 110.137 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 83.5 Cg_endo -80.4 52.35 4.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.308 2.005 . . . . 64.42 113.403 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.96 64.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.666 -0.778 . . . . 75.44 112.596 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.636 HD12 HD23 ' A' ' 251' ' ' LEU . 61.7 mt -107.27 122.25 61.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 122.733 -0.275 . . . . 70.14 110.262 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.673 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 17.2 tptm -121.17 122.64 40.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.645 . . . . 74.04 110.75 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.76 124.08 51.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.136 -0.938 . . . . 73.42 109.815 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 277' ' ' LEU . 38.0 m -119.75 110.22 16.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.177 0.513 . . . . 74.22 110.743 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -111.13 125.77 54.13 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.86 -1.163 . . . . 72.24 107.86 173.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.9 p -139.08 141.01 38.18 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.762 -0.375 . . . . 41.32 110.742 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.42 127.62 19.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.325 -0.62 . . . . 63.21 109.325 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.729 HD21 HD23 ' A' ' 242' ' ' LEU . 0.4 OUTLIER -108.75 128.91 55.29 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.445 0.641 . . . . 74.3 109.466 177.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.895 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.4 mm? -102.1 106.96 17.91 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.252 -0.885 . . . . 70.05 108.957 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.999 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 6.3 t70 -73.48 98.99 2.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.754 -1.112 . . . . 62.43 108.329 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.83 -9.36 3.67 Favored Glycine 0 C--N 1.314 -0.673 0 CA-C-N 115.725 -0.671 . . . . 74.35 113.38 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -92.46 -21.84 19.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.867 -0.166 . . . . 65.2 111.025 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.89 -23.74 0.92 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.441 1.115 . . . . 73.41 110.831 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 273' ' ' HIS . 1.0 OUTLIER -63.21 -26.7 41.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 113.748 -1.569 . . . . 61.55 112.844 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.48 -26.32 68.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.055 -0.52 . . . . 73.25 110.274 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -88.29 -16.5 32.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.196 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.63 -1.2 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.521 -0.847 . . . . 43.2 113.637 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.86 51.79 4.36 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.561 -0.828 . . . . 75.33 113.046 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.921 ' HA ' HG22 ' A' ' 268' ' ' VAL . 4.4 p-80 -78.31 144.44 36.09 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.767 0.318 . . . . 72.3 111.389 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.51 138.18 38.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 60.34 110.878 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.575 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -128.32 144.13 51.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 62.0 109.699 -174.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -146.32 119.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.933 -0.651 . . . . 55.43 111.821 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.715 HD23 HG13 ' A' ' 27' ' ' ILE . 54.0 tp -114.68 146.93 40.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 70.45 110.874 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.77 124.47 1.67 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.893 -0.594 . . . . 70.22 111.693 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.434 HD21 HD21 ' A' ' 277' ' ' LEU . 2.8 mm? -111.04 130.28 55.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.065 -0.717 . . . . 63.4 109.065 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.673 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 16.9 pt-20 -137.1 122.73 19.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.467 0.651 . . . . 72.02 110.459 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.681 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.2 m-85 -114.43 110.48 19.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.863 -0.791 . . . . 71.13 108.863 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.54 111.0 19.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.103 0.477 . . . . 63.41 111.497 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -104.19 109.75 21.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.453 -0.943 . . . . 73.32 108.453 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.485 HD22 ' HE3' ' A' ' 34' ' ' LYS . 56.9 mt -120.34 -98.42 0.45 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.381 -0.372 . . . . 71.31 111.535 -171.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.492 -0.766 . . . . 74.21 109.981 -176.562 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.193 0.521 . . . . 74.21 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.72 94.92 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.523 -0.547 . . . . 53.34 109.523 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.777 ' HB ' ' HD2' ' A' ' 119' ' ' LYS . 16.3 t -117.89 117.09 35.82 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.924 -0.58 . . . . 74.42 110.705 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.43 161.9 14.88 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.539 2.159 . . . . 73.31 111.433 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 102.75 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.354 2.036 . . . . 54.04 111.63 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.539 ' HB ' HG11 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -70.09 -42.67 72.41 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.943 -0.571 . . . . 54.02 111.01 -176.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.918 ' HA ' ' HB3' ' A' ' 10' ' ' LEU . 64.4 t80 -50.15 -25.82 3.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.467 0.707 . . . . 74.52 111.68 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.683 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -76.65 -17.61 59.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.929 -0.578 . . . . 51.02 110.487 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -105.89 -31.36 8.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.547 -1.279 . . . . 61.35 107.547 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.918 ' HB3' ' HA ' ' A' ' 7' ' ' TYR . 2.5 tt -58.4 -36.09 73.02 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.351 -2.204 . . . . 73.24 110.738 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.12 -21.89 0.14 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 119.181 -1.485 . . . . 74.45 115.753 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.683 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 16.8 ttmm -57.15 -52.59 64.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.448 1.124 . . . . 74.33 112.358 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -56.62 -38.81 72.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.114 0.483 . . . . 72.4 111.073 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 181' ' ' HIS . . . -70.3 -42.65 71.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.563 -0.744 . . . . 42.15 111.156 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 5.2 tmm_? -59.66 -34.59 73.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.125 -0.488 . . . . 62.14 111.385 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -47.15 84.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 73.31 111.635 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.521 ' HA ' ' HE1' ' A' ' 22' ' ' TYR . 78.9 t -82.7 -32.03 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.922 0.391 . . . . 51.33 110.966 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 86.8 t80 -60.54 -35.36 75.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 73.23 112.171 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -79.43 131.0 35.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 60.02 111.464 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.974 ' H ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -69.87 151.05 46.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.009 -0.996 . . . . 64.14 110.236 175.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.75 78.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.853 -0.689 . . . . 55.43 112.291 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.521 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 72.1 m-85 -70.28 -23.36 62.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.609 0.242 . . . . 74.33 111.454 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -123.72 133.25 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.798 -0.715 . . . . 73.33 111.756 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -104.21 2.12 31.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.085 0.469 . . . . 72.12 110.687 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.95 12.57 57.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.919 -0.658 . . . . 63.44 112.172 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.56 158.65 17.05 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 122.592 1.187 . . . . 75.34 113.656 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.803 HG23 HD12 ' A' ' 277' ' ' LEU . 46.2 mm -105.63 121.82 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 113.016 -1.902 . . . . 65.14 108.924 173.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 25.2 ttpp -109.64 129.07 55.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 75.42 110.65 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tm? -128.43 127.39 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.338 -0.986 . . . . 74.31 108.338 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.0 p30 -142.94 140.92 31.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.223 0.535 . . . . 73.14 110.989 175.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' THR . 7.2 tp -127.06 124.38 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.13 -0.941 . . . . 73.41 109.87 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 ptmm? -127.35 125.78 41.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.756 . . . . 63.34 110.385 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 9.9 t -131.73 132.21 43.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.8 -0.636 . . . . 75.13 110.221 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 28.9 mtpp -111.77 132.04 54.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.206 -0.664 . . . . 73.21 109.206 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 17.6 m -133.6 169.21 17.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 72.11 110.446 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -86.5 158.74 19.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.052 -0.522 . . . . 73.32 109.704 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.29 55.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.607 0.567 . . . . 71.54 111.991 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 85.16 -5.16 84.05 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 116.108 1.203 . . . . 73.24 116.108 168.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 2.7 mm? -100.31 124.75 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.024 1.912 . . . . 62.45 112.769 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.867 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 35.9 mt-10 -142.35 139.87 31.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 64.03 108.542 159.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' HB3' ' CG2' ' A' ' 33' ' ' THR . 90.3 t80 -131.51 121.84 25.14 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 122.061 -0.399 . . . . 71.14 110.547 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.769 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 18.2 m -127.33 131.38 50.43 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.991 0.424 . . . . 73.43 110.488 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -126.51 126.19 43.31 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.06 -0.718 . . . . 53.14 109.06 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 p -126.54 126.22 43.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 63.12 111.159 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.04 139.7 9.16 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 53.24 112.36 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 p -132.21 136.59 47.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.058 0.456 . . . . 72.22 110.67 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.8 51.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.793 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -84.83 137.89 32.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.542 -0.54 . . . . 73.35 109.542 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.3 m -80.33 -27.5 38.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.005 0.431 . . . . 62.42 110.991 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.13 -71.37 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 74.23 110.52 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 p -93.24 159.82 15.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.249 -0.432 . . . . 52.31 110.603 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -79.81 88.48 5.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.468 0.652 . . . . 75.01 110.34 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -138.0 104.46 5.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 73.34 109.518 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.31 119.6 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.145 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -114.05 126.24 54.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.839 -0.619 . . . . 75.25 109.777 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.73 123.84 3.63 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.476 -0.869 . . . . 52.13 112.415 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 p -114.1 142.65 45.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.68 -0.489 . . . . 64.22 109.68 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -121.31 123.33 41.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.955 -0.757 . . . . 60.22 108.955 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.769 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 2.1 pm0 -114.16 118.97 35.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.076 0.941 . . . . 73.33 111.226 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -99.25 120.94 40.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.597 -1.183 . . . . 65.31 108.947 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 43.6 mtpt -112.56 126.92 55.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.219 0.533 . . . . 64.11 110.814 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 84.4 m-85 -103.3 120.28 40.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.55 -0.907 . . . . 75.25 108.55 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 36.0 ttt180 -110.71 108.2 18.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 73.23 110.742 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.501 ' HE3' ' HB3' ' A' ' 69' ' ' LEU . 5.3 m-90 -107.09 99.35 8.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.791 -0.64 . . . . 74.2 110.577 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 m 70.59 133.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.512 -0.767 . . . . 64.33 111.084 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.6 pm0 -64.73 124.58 22.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 62.14 110.559 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 63.4 35.49 12.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.433 -0.803 . . . . 73.41 111.077 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.37 -77.77 0.38 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.207 -0.757 . . . . 74.22 111.207 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.8 mm? -124.86 132.63 53.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.095 0.474 . . . . 71.43 111.378 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.34 112.59 11.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.83 -0.623 . . . . 61.22 110.248 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.565 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 58.5 t80 -111.6 120.26 41.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.007 -0.542 . . . . 70.12 109.745 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 t -124.27 117.29 24.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.308 0.575 . . . . 75.3 110.93 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 34.5 tt0 -102.76 120.62 40.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 63.12 109.697 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -107.19 113.98 27.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 63.24 110.336 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.848 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 70.4 t90 -103.1 134.89 45.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.776 -0.453 . . . . 70.01 109.776 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -110.22 156.19 21.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 73.13 109.481 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -61.35 -16.0 41.69 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.832 0.678 . . . . 61.45 112.832 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.6 -1.47 57.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.828 -0.169 . . . . 54.43 111.333 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 87.81 11.51 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.241 1.016 . . . . 72.14 112.432 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -81.83 126.38 31.8 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.775 -0.37 . . . . 44.45 110.099 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.848 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -105.63 119.48 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.33 -0.395 . . . . 60.2 110.155 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.83 98.65 0.92 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.352 -1.099 . . . . 65.15 110.352 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' HG3' ' A' ' 73' ' ' GLU . 9.7 t -106.63 120.86 43.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.516 0.674 . . . . 73.34 111.641 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 40.5 tt0 -109.3 123.47 49.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.376 -0.829 . . . . 52.31 110.169 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.565 ' HB ' ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -112.58 124.13 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 63.35 109.496 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 m -111.4 130.04 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 63.53 111.17 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 5.9 t -110.45 120.28 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.556 -0.747 . . . . 74.31 109.51 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.88 116.98 34.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.243 -0.28 . . . . 63.51 110.243 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 52.19 62.99 2.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.596 -0.729 . . . . 73.4 111.326 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.681 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 23.7 tp60 -62.42 -74.7 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.606 . . . . 75.11 111.24 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.681 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 88.5 mt -115.61 -31.93 5.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 64.44 110.111 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.92 125.64 51.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 64.04 110.268 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -63.64 135.38 56.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.124 0.488 . . . . 74.54 110.822 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.72 -15.23 58.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.556 -0.747 . . . . 72.15 112.257 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.2 131.4 36.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.501 . . . . 73.15 111.442 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -119.25 111.08 17.77 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.613 -0.884 . . . . 74.2 108.613 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -103.65 127.47 51.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.493 -0.558 . . . . 64.35 109.493 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.894 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 21.9 m -127.84 119.25 25.25 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.642 0.258 . . . . 74.13 110.579 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 82.5 m-85 -117.46 114.95 24.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.593 . . . . 70.35 109.4 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.961 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.9 t70 -111.14 122.65 48.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.183 -0.673 . . . . 75.04 109.183 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -118.2 120.47 37.8 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.016 0.436 . . . . 65.13 110.01 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 111' ' ' ASN . 53.7 m -109.55 121.48 45.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.138 -0.483 . . . . 64.31 109.922 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -123.66 125.07 44.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.968 -0.56 . . . . 75.33 110.186 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 t -114.03 101.75 54.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 109.683 -0.488 . . . . 73.12 109.683 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.05 -9.16 19.25 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.932 2.421 . . . . 75.04 110.577 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -72.03 -55.48 7.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.887 -1.051 . . . . 61.23 109.89 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.5 t -103.92 -19.77 14.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 63.54 111.556 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.16 22.79 18.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.691 -0.766 . . . . 52.1 112.604 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HE3' ' OD1' ' A' ' 111' ' ' ASN . 60.6 tttp -95.35 146.49 24.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.537 0.208 . . . . 75.31 110.774 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 140.66 45.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.873 0.368 . . . . 75.33 110.023 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.2 m120 -128.81 132.57 47.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.3 110.376 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -111.0 114.76 28.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.047 -0.524 . . . . 70.22 110.106 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.961 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 56.8 tttp -113.25 135.39 53.88 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.485 -0.561 . . . . 64.44 109.485 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.529 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -136.37 135.66 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 74.52 110.053 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.6 ttpm? -131.2 121.36 24.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.187 0.518 . . . . 75.43 110.582 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 p -112.63 121.17 44.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.437 -0.801 . . . . 73.51 109.278 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.46 154.52 21.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.004 -1.093 . . . . 63.44 112.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.38 116.64 21.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.454 -0.943 . . . . 74.31 108.454 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.777 ' HD2' ' HB ' ' A' ' 3' ' ' VAL . 24.4 pttm -110.18 121.94 46.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.42 0.628 . . . . 75.32 111.252 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.6 mpt_? -107.48 148.63 28.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.954 -1.128 . . . . 63.14 107.954 168.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.34 -27.9 50.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.986 0.422 . . . . 64.35 110.972 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -93.08 -31.2 14.92 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.272 0.471 . . . . 73.41 112.272 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 ' HB2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -144.21 132.32 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.822 -0.751 . . . . 63.31 110.974 -167.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.73 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 7.4 t30 -120.92 125.65 48.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.366 0.506 . . . . 72.51 112.366 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.94 131.64 55.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.936 -0.574 . . . . 63.24 110.049 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -141.38 117.07 1.17 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.331 -0.938 . . . . 43.31 112.626 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 42.0 t -109.78 108.57 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.323 . . . . 31.15 110.483 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.719 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 10.7 t70 -108.29 138.55 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 55.11 109.592 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.543 ' HG2' HG13 ' A' ' 138' ' ' ILE . 73.7 mtm -138.14 128.04 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.819 -0.551 . . . . 62.12 111.241 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -97.73 117.27 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.187 -0.672 . . . . 64.12 109.187 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 84.6 t80 -97.02 114.87 26.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.174 0.511 . . . . 74.24 111.048 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.3 153.9 45.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.595 -0.891 . . . . 72.51 108.595 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.435 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.8 pp -69.62 -17.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 73.25 111.1 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.56 -10.38 57.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.781 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.87 125.25 1.79 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.775 -0.726 . . . . 65.33 112.374 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 6.3 Cg_exo -80.03 122.07 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.23 2.62 . . . . 72.52 111.921 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 m -97.2 135.73 38.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.014 -0.365 . . . . 70.53 110.014 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.543 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -106.1 119.27 55.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.133 0.492 . . . . 64.35 110.026 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -117.62 111.73 19.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.945 -0.571 . . . . 75.14 109.98 -174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.46 132.99 11.3 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.907 -1.14 . . . . 73.4 112.096 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 116.36 24.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.186 0.517 . . . . 75.1 109.946 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.476 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.1 tp -116.87 123.58 47.4 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 73.35 109.889 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 53.0 t -117.01 128.76 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.196 -0.456 . . . . 61.52 110.415 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -107.78 137.9 44.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.259 -1.015 . . . . 74.14 108.259 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.37 121.05 2.33 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.312 -0.947 . . . . 54.32 113.529 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.14 149.36 41.41 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.072 -1.084 . . . . 74.32 108.072 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.47 105.15 0.08 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.655 0.741 . . . . 73.4 111.718 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.39 -32.18 7.85 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.273 -0.876 . . . . 64.12 112.441 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -105.35 122.47 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.777 0.322 . . . . 53.14 111.602 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 150' ' ' LEU . 6.6 mt -115.05 136.32 53.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.684 -1.228 . . . . 55.42 107.684 163.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.657 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -136.28 152.72 51.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.55 ' HA3' HD11 ' A' ' 10' ' ' LEU . . . -157.21 133.18 3.47 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.193 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.664 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 67.8 m-85 -124.02 114.68 20.07 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.429 -0.582 . . . . 74.44 109.429 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -105.45 120.88 42.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.697 -0.683 . . . . 73.22 109.71 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.415 ' SD ' HG11 ' A' ' 164' ' ' VAL . 58.4 ttp -132.48 129.0 38.62 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.42 -0.355 . . . . 74.44 110.444 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.461 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 73.6 m-20 -111.16 115.87 30.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.941 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.5 t80 -97.28 127.1 42.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.993 -1.003 . . . . 75.12 110.273 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 6.6 tp10 -94.39 100.23 12.29 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-N 115.858 -0.61 . . . . 61.42 109.593 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 -19.95 62.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.769 -1.56 . . . . 74.05 111.008 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.72 77.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.613 -0.884 . . . . 24.25 108.613 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -102.77 -160.45 0.78 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.296 -1.32 . . . . 65.14 108.026 167.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.1 m -109.48 27.07 9.92 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.047 -0.408 . . . . 74.53 110.929 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -163.24 161.64 24.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 118.912 -1.115 . . . . 72.22 111.596 -165.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.941 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -72.95 136.1 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.137 0.494 . . . . 74.0 109.865 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 5.1 t -93.61 -23.45 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.897 -0.592 . . . . 75.14 110.317 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -140.1 132.88 29.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.61 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 p -121.07 109.31 14.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.805 -0.634 . . . . 70.13 110.274 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -111.69 127.56 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.387 0.613 . . . . 44.12 110.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.664 ' HD2' ' HD1' ' A' ' 153' ' ' TYR . 80.0 m-85 -121.03 144.29 48.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.701 -0.481 . . . . 74.34 109.701 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -147.26 137.25 23.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.524 0.678 . . . . 42.04 111.091 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.994 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 99.5 t -133.44 152.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.267 -1.012 . . . . 72.12 108.267 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 181' ' ' HIS . . . -147.88 123.16 1.66 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.101 -1.047 . . . . 61.12 112.271 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.07 120.59 42.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.171 -0.677 . . . . 73.44 109.171 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.04 126.86 53.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.793 0.806 . . . . 74.22 111.867 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -116.94 163.26 16.47 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.78 -1.563 . . . . 62.3 106.78 168.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -53.64 -42.08 67.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.239 0.459 . . . . 41.3 112.239 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -107.3 -14.02 14.98 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.288 0.477 . . . . 72.24 112.288 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -132.11 120.85 22.89 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.125 -0.359 . . . . 64.12 110.941 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -135.19 124.08 24.03 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.785 -0.366 . . . . 64.02 110.683 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.785 ' HB2' ' HA ' ' A' ' 194' ' ' ILE . 0.0 OUTLIER -124.53 138.43 54.33 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.775 -0.578 . . . . 65.14 110.472 175.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 95.3 m-70 -115.46 117.85 31.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 74.44 110.385 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.994 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 90.0 m -78.79 122.84 26.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 71.25 109.685 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.35 139.66 53.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.369 0.604 . . . . 72.42 111.432 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 90.3 t -131.2 117.1 35.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.594 -0.73 . . . . 74.15 110.146 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.28 105.67 15.81 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.9 -0.778 . . . . 72.14 108.9 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.8 t70 63.36 -172.4 0.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.539 -0.755 . . . . 73.3 108.968 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.52 -6.76 88.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 64.42 110.842 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 211' ' ' THR . 1.2 p -88.68 -24.49 22.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.416 0.895 . . . . 63.35 113.416 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.26 110.67 11.28 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.876 0.762 . . . . 71.25 111.111 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -121.48 124.63 44.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.005 -0.543 . . . . 74.22 109.999 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -176.42 -149.75 7.78 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.545 -1.312 . . . . 60.12 113.672 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.54 175.07 35.68 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.291 -0.723 . . . . 70.01 111.291 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.496 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 55.9 m -148.3 138.42 22.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.095 0.448 . . . . 74.43 110.032 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 1.012 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.1 mp -117.88 129.73 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.833 0.349 . . . . 74.33 110.681 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -108.18 120.04 41.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.388 -0.967 . . . . 75.24 108.388 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.662 ' HB2' ' HB ' ' A' ' 204' ' ' THR . 13.1 mm-40 -120.48 132.18 55.09 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.085 0.402 . . . . 71.43 112.085 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -103.51 108.79 20.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.166 -0.679 . . . . 73.14 109.166 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.872 ' HB ' HD12 ' A' ' 202' ' ' LEU . 59.5 t -95.23 -26.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.39 0.614 . . . . 62.04 109.762 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -158.47 -179.92 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.236 -1.024 . . . . 64.25 108.236 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.36 -40.83 75.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.455 0.539 . . . . 72.3 112.455 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.91 ' HB2' ' HB3' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -126.78 13.53 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.014 0.435 . . . . 71.21 111.072 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.872 HD12 ' HB ' ' A' ' 198' ' ' VAL . 2.3 tm? -107.12 103.03 12.33 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 75.51 108.664 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -117.6 153.92 32.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.784 -0.644 . . . . 54.51 110.159 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 196' ' ' GLN . 16.6 m -130.06 149.6 51.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.988 -0.551 . . . . 51.33 109.92 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.54 136.15 50.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 53.32 109.672 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 1.012 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -119.82 136.87 55.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.646 -0.706 . . . . 62.44 111.005 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -114.31 127.66 55.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 62.51 110.436 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 208' ' ' LEU . 1.7 mm? -130.94 129.71 42.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.18 -0.674 . . . . 74.51 109.18 171.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.455 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -156.49 149.01 23.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.13 0.49 . . . . 74.31 111.193 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -131.19 124.92 31.67 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.154 -0.684 . . . . 71.21 109.154 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.7 t -101.83 117.88 35.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.397 0.618 . . . . 74.54 110.132 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.76 130.85 47.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.597 -0.729 . . . . 75.25 110.835 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -15.84 27.5 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.919 -0.657 . . . . 43.02 111.789 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -138.86 150.16 45.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.148 -0.316 . . . . 72.05 110.148 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.8 m -86.28 -16.47 37.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.408 -0.36 . . . . 65.43 111.067 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -67.79 111.21 4.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.0 0.429 . . . . 73.32 110.825 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.0 t -87.99 138.43 31.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.536 -0.913 . . . . 63.33 108.536 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 30.0 mtt-85 -88.28 116.67 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.292 -0.633 . . . . 74.04 109.292 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -115.17 129.37 56.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.864 -1.162 . . . . 71.02 107.864 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -141.11 150.85 22.12 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.895 -1.145 . . . . 54.35 112.46 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.933 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 3.5 mp -132.58 132.35 59.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.017 -1.105 . . . . 71.43 108.017 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.829 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . . . -124.93 130.23 51.94 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.328 1.018 . . . . 71.1 109.837 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.598 ' H ' ' HB2' ' A' ' 236' ' ' LYS . . . -113.87 126.34 55.07 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.117 -0.633 . . . . 74.31 111.187 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 62.23 110.71 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.63 ' HD1' HD13 ' A' ' 227' ' ' ILE . 90.6 t80 -120.81 127.85 52.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 71.12 110.077 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.91 ' HB3' ' HB2' ' A' ' 201' ' ' LYS . 34.7 tt0 -79.92 100.88 8.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.962 -0.563 . . . . 74.22 109.537 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.63 HD13 ' HD1' ' A' ' 225' ' ' TYR . 26.2 mm -68.82 -42.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.869 0.842 . . . . 73.11 109.297 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -137.05 146.77 56.09 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.533 -1.284 . . . . 71.13 107.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -44.97 -25.63 1.73 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.88 2.387 . . . . 60.42 114.185 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.87 -3.32 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.348 0.499 . . . . 75.12 112.348 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.76 123.42 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 70.54 112.002 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 35.7 m -120.76 122.64 40.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 74.24 110.399 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.734 ' HD2' ' HB3' ' A' ' 247' ' ' TYR . 87.6 t80 -104.7 133.13 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.06 -0.348 . . . . 73.24 110.06 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 12.5 p -131.0 140.62 50.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 64.45 111.487 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -156.66 136.71 12.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 70.13 109.127 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.933 ' HB3' ' O ' ' A' ' 221' ' ' ILE . 2.7 mmtm -173.29 179.0 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.865 0.466 . . . . 74.05 110.908 166.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.8 152.03 27.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.129 0.49 . . . . 63.11 111.674 -160.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -109.01 150.74 27.32 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.889 -0.596 . . . . 71.24 110.324 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 241' ' ' SER . 4.4 t-20 -39.46 -33.54 0.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.477 1.511 . . . . 72.42 114.03 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 13.5 m -77.52 24.55 0.2 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.562 0.22 . . . . 62.24 110.651 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.3 p 58.0 29.54 17.86 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.563 1.145 . . . . 73.33 110.937 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 1.056 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.1 mp -99.39 128.98 45.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 116.221 -0.445 . . . . 73.03 111.926 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.887 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.42 116.35 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.699 -0.682 . . . . 65.03 110.525 -171.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.58 133.46 11.59 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.743 -0.742 . . . . 74.24 112.419 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.8 pp -134.23 149.06 50.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 62.15 109.98 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.72 145.86 11.14 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.885 -0.674 . . . . 40.32 111.776 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.734 ' HB3' ' HD2' ' A' ' 233' ' ' PHE . 22.1 p90 -124.61 122.34 37.26 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.297 0.57 . . . . 74.1 110.097 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 10.0 t -111.62 124.25 51.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.341 -0.845 . . . . 64.43 109.445 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -135.77 124.26 23.52 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.58 -0.737 . . . . 73.42 110.487 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 2.3 t -78.64 103.86 8.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.818 -1.178 . . . . 74.41 107.818 171.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.92 -54.5 44.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.511 -0.768 . . . . 72.42 109.654 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.605 ' HB2' HD11 ' A' ' 255' ' ' ILE . 96.8 mttt -145.17 152.16 50.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 106.93 -1.508 . . . . 74.43 106.93 174.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.61 98.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.51 2.14 . . . . 51.22 112.566 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.32 -24.44 2.94 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.889 -0.596 . . . . 64.21 112.662 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -134.34 122.08 39.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.394 0.616 . . . . 62.31 112.002 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.859 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 14.8 ptpt -114.13 133.28 55.68 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 72.42 110.299 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.71 126.89 52.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.25 -0.886 . . . . 72.15 109.713 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.8 t -127.51 111.0 13.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.556 0.693 . . . . 72.45 110.423 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.816 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.68 123.22 45.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 175.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 26.4 t -131.95 140.86 49.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.894 0.378 . . . . 53.15 110.039 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.72 128.48 20.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.914 -0.584 . . . . 71.53 110.433 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.755 HD11 HD23 ' A' ' 242' ' ' LEU . 2.3 tm? -102.48 117.67 35.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.511 -1.292 . . . . 65.11 107.511 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.887 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.3 mm? -92.72 107.71 19.42 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.559 -1.274 . . . . 73.14 107.559 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.056 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.1 m-20 -70.46 104.02 2.62 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.356 -0.979 . . . . 53.32 108.356 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.28 -19.1 38.31 Favored Glycine 0 C--O 1.229 -0.166 0 CA-C-N 115.94 -0.573 . . . . 75.33 112.497 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.36 -24.19 20.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.368 . . . . 73.35 111.016 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 93.8 m-20 -113.34 -30.54 6.87 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.645 0.98 . . . . 72.21 113.645 -170.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.449 HG11 ' HB3' ' A' ' 263' ' ' LEU . 30.8 m -62.62 -26.41 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.041 0.756 . . . . 63.14 113.041 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -70.31 -23.72 62.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.961 0.41 . . . . 54.24 110.369 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.81 6.02 36.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 72.52 110.123 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.65 102.54 0.79 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.752 -0.658 . . . . 54.35 111.831 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 165.15 78.68 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.258 -0.972 . . . . 62.21 112.519 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -113.48 146.68 39.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.504 -0.554 . . . . 75.14 109.504 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 74.2 mmtt -95.39 137.69 34.09 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.586 -0.446 . . . . 62.2 110.231 -175.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.4 tm? -117.7 134.5 54.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.179 -0.464 . . . . 65.35 109.91 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.478 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -135.17 104.27 0.5 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.959 -0.856 . . . . 74.13 110.959 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.816 HD23 HD22 ' A' ' 259' ' ' LEU . 2.4 tm? -114.76 130.95 56.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.51 -0.552 . . . . 63.34 109.51 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.506 ' N ' HD22 ' A' ' 277' ' ' LEU . . . -143.24 136.75 7.19 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.175 -1.012 . . . . 35.42 112.888 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.602 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.6 mm? -114.91 131.08 56.99 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.325 -0.62 . . . . 75.34 109.325 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.859 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 52.6 mt-10 -111.82 112.12 23.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.418 -0.586 . . . . 74.12 109.418 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -99.2 125.15 44.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.809 -1.182 . . . . 70.21 107.809 177.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 75.4 mt-30 -132.53 116.87 17.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.127 0.489 . . . . 42.12 109.985 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -115.61 131.97 56.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.809 -0.632 . . . . 45.15 110.471 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 285' ' ' GLU . 65.9 mt -122.09 -45.17 2.25 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.062 -0.718 . . . . 74.21 109.062 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 284' ' ' LEU . 42.5 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.633 -1.167 . . . . 63.51 109.395 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 4' ' ' PRO . 22.3 ptp . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.762 0.315 . . . . 74.23 110.35 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.01 -35.11 43.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.045 0.45 . . . . 64.33 110.521 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 121' ' ' GLU . 21.3 t -118.58 101.98 50.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 54.34 109.735 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 4.4 Cg_exo -77.54 138.63 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.006 2.471 . . . . 72.01 112.075 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 35.2 Cg_exo -61.94 91.15 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.814 2.343 . . . . 74.13 111.683 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p -81.24 -15.99 54.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.684 -0.689 . . . . 74.13 111.321 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.853 ' HB3' HG21 ' A' ' 143' ' ' VAL . 45.8 p90 -62.75 -24.78 67.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.538 0.685 . . . . 74.11 109.677 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 12' ' ' LYS . . . -75.79 -30.0 58.93 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.157 -0.929 . . . . 74.05 110.855 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -104.26 9.34 36.05 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 119.978 -0.689 . . . . 62.35 111.717 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.531 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 94.8 mt -56.78 -35.68 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.377 . . . . 71.01 111.721 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.32 39.8 0.7 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.705 -1.236 . . . . 50.22 114.162 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 9.1 mtmp? -69.17 -48.68 61.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.896 0.848 . . . . 75.4 109.7 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -64.36 -38.37 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 71.24 110.971 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.17 -35.55 74.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 70.41 111.987 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -58.11 -38.07 75.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 60.02 112.177 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.85 -42.9 80.64 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.912 0.338 . . . . 74.25 111.912 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 t -84.47 -32.41 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.297 0.48 . . . . 43.14 112.297 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.96 -21.69 63.23 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.623 0.601 . . . . 70.12 112.623 -171.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 p -57.84 152.61 15.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 62.11 112.493 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 2.8 mptp? -86.37 -21.29 27.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.577 -0.738 . . . . 74.43 109.185 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.73 113.29 1.74 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.016 -0.993 . . . . 55.31 111.132 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' HB2' HD23 ' A' ' 262' ' ' LEU . 81.7 m-85 -85.79 -14.36 45.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.098 0.475 . . . . 71.42 110.688 -176.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.48 118.58 4.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.042 -0.823 . . . . 65.24 111.042 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -80.21 -4.67 54.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.94 0.37 . . . . 74.14 111.341 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.94 -3.57 69.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.273 -0.489 . . . . 64.24 113.262 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.7 pp -149.07 -178.12 6.2 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.707 0.765 . . . . 74.3 112.555 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -99.88 133.13 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.529 -1.214 . . . . 62.01 109.689 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.587 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.0 ttpp -124.87 146.26 49.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.768 -0.456 . . . . 72.2 109.768 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.695 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tm? -131.9 128.33 38.35 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.71 -0.478 . . . . 65.1 109.71 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.665 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 11.1 m-20 -134.32 120.37 19.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.11 -0.7 . . . . 75.02 109.11 171.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 tp -140.88 128.23 21.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 65.4 110.477 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 15.3 ptpt -118.14 127.29 53.63 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.972 0.415 . . . . 72.24 111.103 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 283' ' ' ALA . 38.7 p -89.7 121.69 32.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.338 -0.986 . . . . 63.03 108.338 168.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -105.04 132.04 51.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.325 0.583 . . . . 73.34 111.784 -169.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 28.8 t -138.97 141.05 38.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.293 -0.867 . . . . 64.45 108.851 172.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.9 13.96 21.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.47 0.653 . . . . 75.53 109.586 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.92 37.18 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.364 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.47 -9.64 76.94 Favored Glycine 0 C--O 1.221 -0.694 0 CA-C-O 119.008 -0.884 . . . . 60.31 114.976 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -103.9 127.57 51.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 119.279 1.54 . . . . 73.3 112.84 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 37.6 tt0 -141.74 117.59 10.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.48 -0.934 . . . . 72.33 108.48 158.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 93.4 m-85 -107.08 120.36 41.87 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.225 -0.59 . . . . 72.51 110.296 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 68.4 m -112.85 117.32 31.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.116 0.484 . . . . 74.42 110.665 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 p -105.03 124.28 49.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.826 -0.624 . . . . 75.31 109.502 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.0 t -133.86 125.99 29.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.827 -0.434 . . . . 72.12 109.827 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 159.09 27.92 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.375 -0.917 . . . . 41.22 112.411 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -129.32 134.77 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.746 -0.464 . . . . 52.14 109.746 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.621 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -129.81 127.68 40.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.136 0.493 . . . . 62.52 111.018 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 50' ' ' GLU . 45.9 m-80 -90.92 144.86 25.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.387 -0.824 . . . . 72.54 109.885 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -70.19 18.87 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.315 0.579 . . . . 44.41 111.921 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 48' ' ' ASN . 21.7 mm-40 -89.25 -167.24 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 73.22 110.075 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -68.13 90.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.64 -0.254 . . . . 74.34 111.54 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p 48.21 45.71 19.9 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.117 0.567 . . . . 75.43 112.246 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 29.1 mmmt -91.12 75.78 6.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 70.23 109.61 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 47' ' ' ALA . 13.3 t -120.54 123.51 70.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.162 -0.926 . . . . 64.23 110.859 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.7 p -109.44 137.04 47.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.085 -0.507 . . . . 52.34 109.669 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.94 136.41 8.82 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.464 -0.874 . . . . 71.0 112.773 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 p -127.63 145.18 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.878 -0.416 . . . . 65.3 109.878 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.3 tm? -120.68 124.97 46.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.708 -0.479 . . . . 72.55 109.708 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.7 tt0 -107.01 118.19 36.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.076 -0.712 . . . . 51.33 109.076 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.2 m -100.45 119.85 39.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.195 -0.668 . . . . 71.22 109.195 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 42.3 mtpt -121.66 127.58 50.95 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.057 0.456 . . . . 72.01 110.408 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.72 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 94.6 m-85 -106.89 120.79 43.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.897 -0.592 . . . . 73.21 109.653 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 17.5 tpt180 -111.8 106.99 15.89 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.534 0.683 . . . . 70.1 110.643 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 40.0 t-105 -105.59 108.16 19.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.574 -1.194 . . . . 75.14 109.876 -174.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -58.6 -36.24 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.221 -0.899 . . . . 71.42 111.943 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 14.3 mm-40 -66.25 120.46 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.437 -0.347 . . . . 75.43 110.324 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 74.57 -44.55 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.015 0.822 . . . . 72.12 111.384 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.95 64.45 0.46 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.904 -0.665 . . . . 42.13 111.899 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.02 134.72 53.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.867 0.365 . . . . 71.5 110.839 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 29.6 m -136.19 112.66 9.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.384 . . . . 73.43 110.647 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 77.6 t80 -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.683 -0.488 . . . . 71.13 109.683 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 84' ' ' GLU . 60.9 p -125.66 116.03 21.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.853 0.359 . . . . 54.22 111.011 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 40.7 tt0 -123.93 122.42 37.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.106 -0.331 . . . . 74.21 110.106 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 55.8 tttm -113.21 116.76 30.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 71.04 111.122 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -103.6 131.78 50.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 65.12 110.395 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.424 ' HB2' HG22 ' A' ' 80' ' ' THR . 7.4 m-20 -101.69 161.8 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 73.14 111.063 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.5 m -62.29 -22.21 65.84 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.584 0.707 . . . . 72.4 110.215 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -72.23 -4.0 26.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.22 -0.9 . . . . 71.01 111.177 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 10.4 m-80 69.64 40.95 1.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.493 0.663 . . . . 74.45 110.677 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 76' ' ' ASN . 9.9 t -114.35 135.47 54.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.373 -0.83 . . . . 74.35 109.613 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.1 mm? -99.59 135.87 40.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.609 -0.723 . . . . 71.42 110.872 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -117.22 89.93 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.504 -1.039 . . . . 52.21 110.504 171.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -95.48 105.43 17.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.862 0.363 . . . . 63.44 111.773 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 26.2 mt-10 -110.07 131.6 54.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.18 -0.464 . . . . 70.02 109.895 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -119.36 121.78 67.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.005 -0.739 . . . . 74.14 109.005 173.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.0 m -112.0 124.31 52.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.296 0.569 . . . . 74.33 111.664 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 66.6 t -111.03 121.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.136 -0.938 . . . . 75.25 109.663 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.32 142.67 28.18 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.77 -0.826 . . . . 32.11 108.77 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 94' ' ' GLY . 5.1 p-10 -49.69 143.89 6.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.216 0.821 . . . . 70.25 113.216 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -126.99 -56.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.814 -1.084 . . . . 73.51 108.974 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.45 -67.05 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.661 -0.7 . . . . 71.14 109.582 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 86.77 5.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 73.0 110.187 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.447 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -52.92 135.43 36.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.443 -0.798 . . . . 74.4 111.702 -177.23 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . 102.9 -22.91 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.577 -0.738 . . . . 63.14 113.726 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 35.8 tp -80.69 131.56 35.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.329 1.065 . . . . 65.24 112.18 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -123.73 120.63 33.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.917 -0.583 . . . . 64.42 109.72 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.753 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -109.89 129.8 55.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.689 0.281 . . . . 74.21 110.434 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.932 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.2 m -131.27 119.89 22.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.661 0.267 . . . . 72.23 110.456 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.538 ' HB2' HG22 ' A' ' 85' ' ' ILE . 80.6 m-85 -111.19 115.41 29.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.759 -0.46 . . . . 75.5 109.759 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 2.3 t70 -109.39 136.01 49.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.48 . . . . 74.4 110.343 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.0 m -144.08 122.74 12.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.022 0.439 . . . . 63.23 110.881 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 22.8 t -95.97 125.55 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.401 -0.592 . . . . 70.22 109.401 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 98.6 m-85 -111.48 123.56 50.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.818 -0.628 . . . . 74.23 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -115.58 103.14 54.19 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 70.31 109.465 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.53 -19.15 63.52 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.354 2.703 . . . . 65.52 113.007 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -57.12 -48.11 79.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 64.51 110.811 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.6 m -109.28 -21.71 12.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.314 0.578 . . . . 64.13 111.011 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.03 23.84 43.55 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.848 -0.901 . . . . 73.31 110.848 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.76 148.1 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 73.21 111.852 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.27 116.47 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.167 -0.924 . . . . 72.02 109.165 172.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -118.41 121.16 39.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.876 -1.157 . . . . 73.53 107.876 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.19 149.67 46.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.65 0.611 . . . . 73.22 112.65 -165.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 54.0 mttp -115.23 138.01 51.4 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.149 -1.056 . . . . 65.51 108.149 169.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.905 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -114.96 119.39 61.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.565 -0.902 . . . . 62.31 108.565 174.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.932 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 22.9 tttp -115.11 119.5 36.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.631 -0.713 . . . . 63.44 109.631 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.5 m -127.94 116.83 20.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.438 -0.578 . . . . 64.41 109.438 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -137.1 122.94 2.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.94 -1.124 . . . . 63.33 112.009 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 125' ' ' LEU . 10.5 p90 -107.4 135.41 48.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.316 0.579 . . . . 74.52 110.349 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.417 ' HB3' HG11 ' A' ' 3' ' ' VAL . 19.3 mtmm -109.31 120.43 42.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.925 -1.034 . . . . 74.41 110.142 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.584 ' HB3' HG22 ' A' ' 123' ' ' ILE . 8.3 tpt180 -108.52 157.73 18.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.939 -1.134 . . . . 61.42 107.939 169.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.641 ' HA ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -54.32 -29.27 47.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.723 0.638 . . . . 73.05 112.723 -170.54 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -112.37 -12.19 13.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 64.43 112.381 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 142' ' ' LEU . 9.8 tp -143.45 132.8 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.821 -0.752 . . . . 62.3 112.47 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.442 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 35.4 t-20 -118.76 119.16 33.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.811 -0.44 . . . . 70.3 109.811 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 142' ' ' LEU . 3.9 mm? -111.87 119.96 40.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.229 -0.441 . . . . 73.25 110.277 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.88 127.51 5.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.673 -0.775 . . . . 64.44 112.872 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.0 m -111.08 121.61 45.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.619 -0.511 . . . . 74.41 109.619 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 t70 -124.23 117.69 25.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.169 -0.678 . . . . 65.11 109.169 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.905 ' HB3' HG22 ' A' ' 114' ' ' ILE . 36.1 ttm -118.33 130.38 55.99 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.854 -0.529 . . . . 72.22 111.668 -172.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.35 118.78 31.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.725 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.641 ' HE2' ' HB ' ' A' ' 114' ' ' ILE . 92.6 m-85 -96.26 96.53 8.84 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.855 -1.165 . . . . 72.42 107.855 167.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -136.72 155.44 49.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.271 -0.422 . . . . 63.42 110.587 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -30.0 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 63.34 110.97 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.08 -14.08 60.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.049 0.452 . . . . 75.44 110.859 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.67 128.49 2.18 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.626 -0.797 . . . . 73.13 112.731 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.81 118.56 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.604 2.203 . . . . 70.42 110.653 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -125.96 144.77 50.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.866 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.05 118.15 54.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.324 0.583 . . . . 55.12 109.842 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 21.5 ttp-105 -106.94 129.8 54.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.618 -0.719 . . . . 62.42 109.799 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.33 133.23 11.38 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.312 -0.947 . . . . 73.32 111.875 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -126.07 116.47 21.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.758 -0.46 . . . . 61.14 109.758 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 123' ' ' ILE . 8.8 tp -120.62 123.94 44.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.666 -0.494 . . . . 74.3 109.666 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.853 HG21 ' HB3' ' A' ' 7' ' ' TYR . 94.0 t -127.41 129.41 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.312 -0.404 . . . . 72.35 110.715 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.632 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.54 136.72 48.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.973 -0.751 . . . . 63.32 108.973 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.67 118.93 4.18 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.598 -0.81 . . . . 55.21 112.07 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -141.58 147.35 37.53 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 75.33 109.475 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.64 101.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 70.42 111.703 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 174' ' ' LYS . . . 88.22 -32.35 4.43 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.098 -0.955 . . . . 74.34 112.692 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -105.92 122.37 45.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 73.43 111.175 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 151' ' ' ALA . 5.3 tp -138.42 135.1 34.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.359 -0.608 . . . . 74.23 109.359 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -136.73 132.54 34.97 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.843 -0.343 . . . . 72.03 111.227 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.531 ' HA3' ' CD1' ' A' ' 10' ' ' LEU . . . -132.98 133.82 7.22 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.971 -0.633 . . . . 44.31 112.034 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.535 ' HA ' ' HD2' ' A' ' 169' ' ' PHE . 22.6 m-85 -122.8 119.7 31.36 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.421 -0.585 . . . . 71.22 109.421 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -118.63 130.22 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 75.34 110.077 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 21.8 ptp -143.73 143.74 31.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.162 -0.472 . . . . 53.15 110.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -112.36 118.41 35.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.231 -1.026 . . . . 71.23 108.231 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -107.23 118.36 36.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.74 -0.467 . . . . 54.53 109.74 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -86.83 95.35 9.83 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.589 -0.893 . . . . 74.34 108.589 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 m -72.57 -25.16 61.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 113.532 -1.667 . . . . 70.52 111.435 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.55 -31.16 69.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.719 0.771 . . . . 54.44 109.083 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -109.9 -159.79 0.69 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.378 -1.283 . . . . 72.21 108.112 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.0 p -109.47 26.77 10.26 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.132 -0.355 . . . . 72.53 111.111 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 mtp85 -133.66 171.25 14.38 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 114.828 1.418 . . . . 71.21 114.828 -160.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.1 t -104.37 132.22 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.286 -1.325 . . . . 73.52 108.651 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -94.38 -33.91 12.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 45.33 111.245 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -151.87 132.74 14.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.435 -0.348 . . . . 73.05 110.102 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.9 t -124.34 106.94 10.64 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.417 -0.586 . . . . 73.41 109.417 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.91 135.17 55.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.306 0.574 . . . . 75.31 110.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 153' ' ' TYR . 57.5 m-85 -125.83 155.9 40.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.242 -0.436 . . . . 72.41 110.555 -176.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . . . -150.65 127.96 11.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.158 -0.473 . . . . 73.53 109.795 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 63.7 t -129.77 127.59 64.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.918 0.39 . . . . 75.24 110.491 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.02 111.25 4.19 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.05 -0.82 . . . . 61.54 111.05 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -112.06 120.44 41.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.794 -0.817 . . . . 71.34 108.794 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 11.5 tmtt? -103.23 126.5 50.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.373 0.606 . . . . 74.34 109.89 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 3.9 m -116.91 164.08 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.913 -1.04 . . . . 70.3 108.398 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -34.13 -66.82 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.177 0.806 . . . . 54.24 113.177 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.89 13.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.898 -0.321 . . . . 72.14 111.694 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.497 ' HD1' ' NE2' ' A' ' 196' ' ' GLN . 10.3 m-85 -126.5 137.97 53.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.577 -0.283 . . . . 73.42 110.269 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -122.11 122.73 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.832 -0.747 . . . . 73.2 109.81 170.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 194' ' ' ILE . 4.9 tt -123.77 139.19 54.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.737 -0.665 . . . . 72.31 111.068 -172.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.84 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 96.9 m-70 -116.45 117.13 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.36 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.6 m -96.02 110.83 23.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.228 -0.656 . . . . 71.05 109.228 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -124.42 160.63 27.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 41.11 110.919 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.504 HG22 ' HD1' ' A' ' 190' ' ' PHE . 16.6 t -131.72 124.4 53.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.872 -0.604 . . . . 73.15 109.764 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 30.2 t30 -99.89 95.45 6.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.622 -0.717 . . . . 53.44 109.705 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.63 178.82 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.282 -0.872 . . . . 44.23 109.381 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.21 -7.14 71.09 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.075 -1.06 . . . . 72.21 111.404 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.9 m -95.01 -25.71 16.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.762 0.653 . . . . 71.52 112.762 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 43.2 tt0 -132.38 145.05 50.95 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.467 -0.771 . . . . 61.41 111.957 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.504 ' HD1' HG22 ' A' ' 184' ' ' VAL . 22.9 m-85 -117.17 150.27 39.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.459 -0.941 . . . . 65.41 108.459 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.32 155.81 24.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.176 -1.012 . . . . 62.14 113.491 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -141.14 126.0 2.95 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.271 -0.732 . . . . 52.15 111.271 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.84 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 46.8 t -112.1 136.6 51.26 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.895 0.379 . . . . 51.42 110.075 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.75 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.6 mm -120.53 124.3 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.868 -0.606 . . . . 63.51 109.542 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.457 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 0.3 OUTLIER -118.23 121.47 40.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.425 -0.583 . . . . 75.42 109.425 173.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.497 ' NE2' ' HD1' ' A' ' 178' ' ' PHE . 14.5 mm100 -124.45 132.04 53.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 63.4 111.635 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -86.53 122.57 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.216 -0.661 . . . . 74.02 109.216 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.5 m -136.22 173.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.317 -0.401 . . . . 71.22 110.896 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -97.51 -41.92 7.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 45.11 110.098 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -69.93 -33.19 71.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 73.12 112.345 -177.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.437 ' HB3' ' HB1' ' A' ' 223' ' ' ALA . 94.1 mttt -123.54 11.77 9.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.264 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 -85.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.787 0.679 . . . . 60.43 110.892 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.835 ' HG3' ' HB3' ' A' ' 224' ' ' LYS . 9.5 pt-20 -127.1 128.75 46.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.171 -0.678 . . . . 74.33 109.171 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 196' ' ' GLN . 15.4 t -123.44 148.82 45.78 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.374 -0.53 . . . . 75.44 110.419 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.45 136.59 49.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.67 -0.696 . . . . 63.31 110.964 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.83 HG22 HG22 ' A' ' 221' ' ' ILE . 61.1 t -118.8 137.96 51.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.447 -0.797 . . . . 53.43 109.159 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.416 ' OD1' ' HA3' ' A' ' 220' ' ' GLY . 2.9 p-10 -124.6 134.19 53.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 71.21 110.715 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.46 141.36 49.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.054 -0.976 . . . . 75.54 109.397 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -142.21 130.61 22.38 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.182 -0.463 . . . . 31.21 110.036 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.9 122.37 37.18 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.906 -0.405 . . . . 74.44 109.906 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 216' ' ' ASN . 27.0 m -95.21 107.96 20.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.584 -0.524 . . . . 74.25 109.584 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.16 146.21 48.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.723 -0.671 . . . . 55.54 111.162 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.95 -46.42 3.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.134 -0.555 . . . . 30.2 112.261 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 216' ' ' ASN . 21.1 t-20 -86.59 -21.2 26.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.896 0.379 . . . . 75.32 110.271 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.5 m 66.74 17.42 10.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.577 -0.738 . . . . 61.44 110.758 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.432 ' HB2' ' OD1' ' A' ' 214' ' ' ASN . 53.7 t-20 -69.48 121.18 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 73.41 109.526 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.3 m -113.71 122.56 47.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.069 0.461 . . . . 73.22 110.031 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.747 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 37.4 mmt180 -105.31 125.0 50.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.959 -0.564 . . . . 74.43 109.924 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.755 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 46.9 m-85 -113.9 133.6 55.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.909 -0.775 . . . . 65.13 108.909 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.416 ' HA3' ' OD1' ' A' ' 207' ' ' ASN . . . -145.03 141.15 9.66 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.31 -0.948 . . . . 52.43 112.044 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.83 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -132.36 133.3 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 64.13 110.857 178.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -132.51 138.37 47.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.875 -0.602 . . . . 55.04 111.062 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.65 125.56 54.28 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.84 -0.43 . . . . 53.04 109.84 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.835 ' HB3' ' HG3' ' A' ' 203' ' ' GLU . 4.3 ttpp -113.34 113.32 25.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.252 0.549 . . . . 63.44 109.691 -177.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -131.9 116.54 17.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 74.32 110.144 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.686 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 12.0 pt20 -85.07 103.1 13.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.382 0.61 . . . . 61.21 109.987 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.3 -29.33 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.487 -0.779 . . . . 40.43 110.561 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.723 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 23.2 m-20 -123.47 163.29 35.28 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.625 . . . . 72.41 109.542 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.21 -29.73 64.52 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.172 1.915 . . . . 71.23 111.916 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -109.81 -2.27 17.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 64.14 111.607 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -134.7 124.53 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.476 . . . . 72.41 111.891 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 43.3 t -123.43 135.41 54.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 63.41 109.668 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -115.79 133.61 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.126 0.489 . . . . 62.13 110.534 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.3 p -125.26 123.85 40.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.912 -0.585 . . . . 63.34 110.325 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -107.6 140.01 41.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.323 -0.991 . . . . 54.41 108.323 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -148.88 150.07 32.34 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.828 -0.349 . . . . 74.23 110.745 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 10.0 p -145.64 142.91 21.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 72.13 109.943 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 15.4 t-20 -105.31 149.45 26.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.475 -0.784 . . . . 73.22 109.11 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.755 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 20.8 t-20 -57.04 -21.59 32.35 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.996 0.81 . . . . 43.11 112.251 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.5 p -79.24 21.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.958 0.409 . . . . 54.12 110.842 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 239' ' ' ASN . 25.9 t 68.59 31.28 4.79 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.461 -0.79 . . . . 63.02 110.641 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.892 ' HB3' HD11 ' A' ' 262' ' ' LEU . 36.1 mt -99.73 116.01 30.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.344 -0.542 . . . . 71.04 110.468 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 243' ' ' ILE . 3.4 mp -99.76 117.83 45.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 N-CA-C 109.896 -0.409 . . . . 74.14 109.896 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.41 141.46 16.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.013 -0.613 . . . . 61.01 113.21 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 260' ' ' SER . 8.0 mt -116.18 137.95 51.69 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -141.4 120.71 1.73 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.32 -0.943 . . . . 33.3 111.875 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.5 115.42 18.11 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.847 -0.427 . . . . 73.12 109.847 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -114.74 130.57 56.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.15 0.5 . . . . 63.22 110.351 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 58.1 tt0 -143.66 131.65 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.938 -0.574 . . . . 75.12 110.289 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 23.2 p -78.67 129.1 34.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.591 0.234 . . . . 55.12 110.89 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 251' ' ' LEU . 1.6 pp -140.8 145.23 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.864 -0.421 . . . . 75.41 109.864 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 92.3 mttt 67.74 156.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 123.619 0.574 . . . . 74.01 110.51 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 36.3 Cg_endo -66.71 86.7 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.21 1.94 . . . . 71.05 113.366 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.759 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 105.46 29.54 5.03 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.904 -0.665 . . . . 74.1 113.926 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 251' ' ' LEU . 64.7 mt -132.76 133.95 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 117.384 0.592 . . . . 74.3 110.72 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.14 133.63 53.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.76 0.314 . . . . 43.33 110.323 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.3 tp -98.06 132.57 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 73.14 109.765 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 15.3 m -126.06 111.15 14.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.347 -0.388 . . . . 72.02 110.201 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.977 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.09 124.58 47.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.664 -0.865 . . . . 64.01 108.664 176.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 45.0 m -133.63 140.41 47.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.907 0.384 . . . . 64.35 110.435 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.013 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.892 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -106.87 115.91 31.01 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.082 -0.71 . . . . 64.14 109.082 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.588 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -95.0 106.25 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.48 -1.304 . . . . 54.54 107.48 175.141 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.607 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 42.7 m-20 -71.95 104.77 3.62 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.759 -0.83 . . . . 73.42 108.759 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.62 -20.66 25.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.246 -0.502 . . . . 34.12 112.996 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -90.8 -3.51 57.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.811 0.338 . . . . 70.24 110.936 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.607 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 62.9 t30 -133.03 -35.53 1.05 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.754 0.65 . . . . 73.35 112.754 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' ' 263' ' ' LEU . 29.4 m -62.46 -18.41 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.747 0.647 . . . . 72.14 112.747 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -68.38 -25.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 65.11 110.324 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.33 -5.98 24.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.431 0.634 . . . . 63.25 110.005 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 91.95 103.48 1.42 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.608 -0.724 . . . . 72.02 111.809 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 173.81 85.62 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.54 -0.838 . . . . 72.31 112.17 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -113.47 147.18 38.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.881 -0.414 . . . . 73.45 109.881 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 7.1 mmpt? -95.15 137.08 34.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.062 -0.718 . . . . 64.23 109.062 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.75 127.61 54.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.82 -0.437 . . . . 73.51 109.82 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.55 104.96 0.83 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.56 -1.016 . . . . 34.14 110.56 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.977 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -113.76 125.35 54.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.905 -0.776 . . . . 72.33 108.905 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -145.68 133.64 5.1 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.6 -1.286 . . . . 54.2 112.98 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.695 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.3 mm? -108.7 128.01 54.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.248 -1.019 . . . . 64.33 108.248 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 10.5 pt-20 -140.86 137.92 33.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 119.328 -0.368 . . . . 55.11 110.594 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.759 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.6 OUTLIER 166.56 -148.96 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.124 0.89 . . . . 75.52 111.213 168.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 22.3 pt20 -137.68 119.11 14.76 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.208 -0.451 . . . . 61.12 110.776 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.664 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -82.58 109.98 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.169 0.509 . . . . 60.11 110.004 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 284' ' ' LEU . 3.8 mm? -125.29 164.04 21.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.768 -0.651 . . . . 71.33 110.542 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.551 -0.907 . . . . 74.11 108.551 178.302 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.96 -0.385 . . . . 73.25 109.96 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.14 116.08 8.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.44 . . . . 75.21 111.448 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 76.5 t -123.18 124.63 26.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 54.41 109.948 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 31.2 Cg_exo -59.42 143.83 99.59 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.097 2.531 . . . . 62.5 112.835 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 4.9 Cg_exo -77.17 69.17 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.198 2.599 . . . . 74.35 111.283 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -68.46 -29.61 68.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.802 -0.636 . . . . 72.32 112.075 -173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.89 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.9 p90 -64.56 -26.72 68.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.924 0.392 . . . . 73.23 111.089 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.64 35.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.052 0.453 . . . . 63.14 110.033 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -94.9 4.03 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.949 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 ' HA3' ' A' ' 152' ' ' GLY . 92.4 mt -63.94 -33.2 75.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.401 . . . . 73.22 110.216 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 61.91 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.012 -0.613 . . . . 63.21 112.143 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.12 -39.08 79.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 70.45 110.239 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 m -59.24 -36.47 75.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.226 -0.897 . . . . 72.43 111.836 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.47 69.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.324 -0.398 . . . . 52.45 112.052 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -62.33 -31.53 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 72.25 110.934 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 62.2 111.392 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 222' ' ' ALA . 40.0 t -78.59 -46.18 24.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.966 -0.294 . . . . 62.32 110.797 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 218' ' ' ARG . 90.9 t80 -64.79 -42.6 94.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.17 0.509 . . . . 74.31 110.807 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 20' ' ' LYS . 1.8 m -108.55 -142.98 0.38 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.237 -1.023 . . . . 74.33 108.237 174.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.577 ' H ' HG22 ' A' ' 19' ' ' THR . 43.2 mmtm -141.59 106.02 4.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.909 -0.404 . . . . 73.45 109.909 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.73 -44.02 21.53 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.67 -0.972 . . . . 62.42 110.67 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 28' ' ' LYS . 30.0 m-85 -135.15 -179.24 5.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.402 -0.592 . . . . 72.11 109.402 173.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 51.91 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.487 -0.863 . . . . 51.22 112.215 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -103.55 11.01 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.919 0.39 . . . . 71.32 110.819 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.667 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 93.52 13.75 54.81 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.444 -0.884 . . . . 72.12 111.854 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.6 pp -126.89 179.16 5.53 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-O 122.239 1.019 . . . . 75.53 113.317 -170.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.696 HD12 HD12 ' A' ' 277' ' ' LEU . 29.9 mm -98.58 142.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.888 -1.505 . . . . 62.43 109.855 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.595 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 3.9 tmtm? -122.47 135.82 54.75 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 74.34 109.424 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.0 tp -123.78 148.5 46.6 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.727 -0.389 . . . . 74.32 110.507 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 43' ' ' SER . 10.4 t70 -145.22 127.66 15.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.306 -0.861 . . . . 74.2 108.886 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.4 OUTLIER -126.65 124.61 40.26 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.839 -0.8 . . . . 62.13 108.839 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -125.61 138.16 53.92 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.706 -0.479 . . . . 73.01 109.706 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 33.4 m -136.34 128.71 30.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.697 0.284 . . . . 65.25 110.374 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -104.59 141.84 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 70.45 110.798 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.925 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 31.1 m -134.03 170.02 16.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.099 -0.704 . . . . 73.15 109.099 172.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.98 -62.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.258 0.836 . . . . 73.23 113.258 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -144.23 126.86 16.07 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.177 -0.609 . . . . 70.41 111.654 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 86.84 -10.5 67.71 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 119.084 -0.842 . . . . 74.11 114.806 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.925 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 3.0 mm? -103.03 129.38 49.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.782 1.291 . . . . 74.3 112.41 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.872 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 38.4 tt0 -139.77 118.08 12.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.242 -0.651 . . . . 75.31 109.242 165.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.78 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 66.7 t80 -104.9 121.33 43.47 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.798 -0.361 . . . . 75.04 110.325 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 87.2 m -127.3 128.22 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 72.3 111.385 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.7 t -122.48 132.33 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.824 -0.806 . . . . 70.32 108.824 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 p -134.33 125.61 27.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.104 -0.332 . . . . 71.54 110.104 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.67 151.27 23.19 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.803 -1.189 . . . . 65.34 113.04 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 27.3 m -138.12 134.23 34.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.766 -0.828 . . . . 62.44 108.766 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.573 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -144.39 131.98 21.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.581 -0.448 . . . . 70.32 111.914 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.9 143.85 55.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.633 -0.712 . . . . 74.44 109.164 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 m -54.69 -27.12 38.02 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.451 0.537 . . . . 63.53 112.451 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -88.52 6.56 37.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.152 0.501 . . . . 63.43 110.529 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.5 p 52.41 24.98 3.22 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.812 0.845 . . . . 70.23 112.507 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 p -85.06 -50.81 7.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.192 0.52 . . . . 42.33 111.101 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.61 100.22 9.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.745 -0.835 . . . . 75.32 108.745 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 47' ' ' ALA . 15.1 t -125.31 132.65 70.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.466 -0.788 . . . . 54.51 110.798 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 124.7 52.09 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 42.45 108.98 173.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.16 103.84 0.54 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.885 -0.674 . . . . 64.11 111.725 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 t -111.15 139.28 46.66 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.11 0.481 . . . . 73.41 110.177 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.38 124.59 46.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.936 -1.135 . . . . 53.4 107.936 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 56.5 mt-10 -120.24 119.11 32.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.328 0.585 . . . . 73.11 110.331 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' ' 73' ' ' GLU . 5.0 t -110.83 120.59 42.89 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.153 -0.684 . . . . 73.14 109.153 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.872 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 2.7 mptp? -110.21 137.67 47.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 64.11 109.496 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 18.2 m-85 -115.23 118.86 34.5 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.079 -1.082 . . . . 74.03 108.079 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.537 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ptt180 -131.57 108.41 9.52 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.388 -0.925 . . . . 64.12 111.879 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -95.7 100.74 12.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.124 -1.398 . . . . 74.54 108.745 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m 72.8 124.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.348 1.03 . . . . 65.23 111.556 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.84 130.58 46.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.048 -0.723 . . . . 63.11 109.048 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 63.34 66.15 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.289 -0.634 . . . . 72.14 109.289 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.55 -107.26 0.21 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.972 -0.632 . . . . 73.31 111.578 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.582 ' CD1' HG12 ' A' ' 87' ' ' VAL . 2.0 mm? -117.51 132.75 56.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.236 0.458 . . . . 61.41 112.236 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 60.0 m -136.34 119.18 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.28 0.562 . . . . 62.32 111.204 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 59.0 m-85 -109.87 133.36 53.25 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.972 -0.751 . . . . 73.24 108.972 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -125.14 132.66 53.04 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.509 -0.476 . . . . 54.13 111.573 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 37.3 mt-10 -125.34 123.25 38.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 73.21 109.439 171.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.44 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 63.0 tttp -122.76 109.66 14.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.288 -0.264 . . . . 62.43 110.288 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -107.29 134.3 50.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.959 -0.386 . . . . 71.53 109.959 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -120.1 155.13 33.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 73.34 110.529 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -58.24 -22.88 54.01 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.226 0.536 . . . . 74.41 111.38 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HB3' HG23 ' A' ' 107' ' ' THR . 46.6 m-20 -71.51 -1.39 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.569 -0.741 . . . . 71.34 111.829 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 20.5 m120 78.98 21.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.543 0.737 . . . . 71.13 109.925 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.861 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 3.6 m -90.72 118.99 30.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.559 -0.746 . . . . 64.53 110.757 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.2 mm? -101.13 118.14 36.41 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.411 -0.359 . . . . 71.3 110.556 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -116.78 96.14 0.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.606 -0.997 . . . . 41.24 110.606 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -143.59 156.1 44.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.088 0.403 . . . . 72.33 112.088 -169.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 mm-40 159.52 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 125.207 1.567 . . . . 64.32 110.047 167.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.501 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.55 137.71 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.644 0.609 . . . . 62.21 112.644 -161.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 98' ' ' THR . 12.8 t -129.38 140.39 51.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.977 0.418 . . . . 53.21 110.946 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 97' ' ' LEU . 6.2 m -117.88 138.44 48.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.11 -0.496 . . . . 72.34 109.834 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -114.42 116.57 29.11 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.507 -0.477 . . . . 74.32 110.827 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.589 ' HB3' ' H ' ' A' ' 94' ' ' GLY . 7.3 p-10 39.71 31.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.679 1.191 . . . . 72.22 113.612 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -75.2 -47.84 26.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 61.21 109.957 176.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -70.07 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.197 -0.668 . . . . 74.22 109.197 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -99.2 122.72 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.219 -0.446 . . . . 63.11 110.2 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 10.1 tpp85 -63.66 124.87 22.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.289 -0.414 . . . . 73.02 110.559 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.589 ' H ' ' HB3' ' A' ' 89' ' ' ASP . . . 97.0 -22.74 39.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.058 -0.591 . . . . 45.53 112.093 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.6 tp -89.92 136.93 32.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.009 0.433 . . . . 74.13 110.244 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.95 ' HE3' ' HD2' ' A' ' 119' ' ' LYS . 63.8 mmtt -121.66 116.5 24.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.186 -0.672 . . . . 73.03 109.186 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.4 mm? -108.0 127.52 53.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.937 -0.394 . . . . 72.02 109.937 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.916 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.3 m -129.35 119.55 24.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 72.12 111.42 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 87.4 m-85 -104.82 121.09 42.93 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.983 -1.118 . . . . 64.43 107.983 171.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 9.4 t70 -130.45 127.54 39.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.83 0.706 . . . . 72.12 109.35 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 p -140.24 130.68 25.39 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.275 -0.97 . . . . 75.31 112.156 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 45.1 t -113.32 122.27 46.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.57 -0.741 . . . . 43.4 109.448 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.689 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 36.5 p90 -138.03 119.24 14.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.877 0.846 . . . . 71.35 112.162 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.861 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 43.3 t -132.24 137.02 29.08 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.592 -1.186 . . . . 61.11 109.244 166.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 3.4 Cg_exo -81.89 -1.85 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.626 2.217 . . . . 42.42 111.183 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -110.2 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.676 -0.693 . . . . 73.24 110.173 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.589 HG23 ' HB3' ' A' ' 78' ' ' ASP . 3.3 t -146.89 133.86 20.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.433 -0.951 . . . . 71.14 108.433 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' HG23 ' A' ' 80' ' ' THR . . . 100.07 36.03 4.31 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 118.33 -1.891 . . . . 50.21 111.2 -164.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 104' ' ' SER . 11.7 mptt -55.61 155.95 5.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.481 0.658 . . . . 72.34 112.143 -168.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 103' ' ' PHE . 52.7 tttp -71.03 115.06 9.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.856 -1.065 . . . . 72.55 111.869 -159.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -133.44 132.8 41.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.455 -1.248 . . . . 65.31 109.167 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.58 127.9 54.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.032 -0.531 . . . . 62.42 110.593 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 30.6 mmtp -111.82 137.29 49.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.01 -0.541 . . . . 74.42 110.126 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.428 HG23 ' CG ' ' A' ' 129' ' ' MET . 3.4 tp -120.58 116.9 51.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.878 -0.786 . . . . 63.35 108.878 171.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.916 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.1 ttmp? -114.79 121.26 42.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.251 -0.886 . . . . 63.32 110.048 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.4 t -116.61 118.15 31.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.344 0.593 . . . . 61.02 109.448 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.95 151.5 17.02 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.749 -0.739 . . . . 60.21 112.087 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -132.87 127.68 34.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.316 -0.624 . . . . 73.43 109.316 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.95 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 68.3 mttm -110.77 120.26 41.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.139 -0.624 . . . . 71.24 111.465 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.646 ' HB2' HG22 ' A' ' 123' ' ' ILE . 80.5 mtp180 -109.58 162.56 14.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.079 -0.964 . . . . 75.23 108.612 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.54 -38.87 60.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.404 0.52 . . . . 65.32 112.404 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -120.86 8.27 10.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.569 -0.287 . . . . 63.24 111.737 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.755 HD11 ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -139.58 131.39 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.178 0.514 . . . . 74.04 111.234 -173.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.4 t30 -122.15 119.4 31.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.044 -0.526 . . . . 63.4 110.764 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.684 HD13 HD13 ' A' ' 142' ' ' LEU . 4.5 mm? -110.66 134.26 52.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 72.13 109.368 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.77 116.01 0.83 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.338 -0.934 . . . . 75.31 112.217 176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 73.5 m -110.33 107.45 17.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.999 0.428 . . . . 72.4 110.54 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 27.3 t70 -111.91 118.35 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.685 -0.689 . . . . 72.54 109.313 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.428 ' CG ' HG23 ' A' ' 114' ' ' ILE . 23.8 ptp -129.25 147.97 51.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.673 -0.811 . . . . 65.32 112.061 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 3.1 m-20 -76.04 119.72 20.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.535 -1.283 . . . . 75.45 107.535 174.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -86.53 109.41 19.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.265 0.839 . . . . 73.23 113.265 -163.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 136' ' ' PRO . 20.1 t70 43.34 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.87 1.433 . . . . 74.54 114.87 161.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -60.95 -26.15 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.663 0.616 . . . . 74.11 112.663 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -93.21 -5.18 50.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.048 0.452 . . . . 75.5 110.57 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.05 109.79 3.31 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.042 -0.823 . . . . 70.14 111.042 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.542 ' HG3' ' HA ' ' A' ' 132' ' ' ASP . 27.4 Cg_exo -61.38 100.62 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.802 2.335 . . . . 62.42 112.553 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 45.0 t -126.87 128.77 47.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 74.42 108.943 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.98 117.12 52.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.184 -0.606 . . . . 72.34 110.868 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 156' ' ' ASN . 24.1 mtt180 -108.08 121.64 45.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.021 -0.733 . . . . 73.31 109.021 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.68 131.55 10.45 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.791 -1.195 . . . . 73.15 111.603 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -122.24 116.24 23.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.764 -0.458 . . . . 71.12 109.764 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.684 HD13 HD13 ' A' ' 125' ' ' LEU . 12.9 tp -122.24 124.53 44.01 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.262 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.89 HG21 ' HB3' ' A' ' 7' ' ' TYR . 57.3 t -122.38 121.86 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 74.42 109.983 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.755 ' HG ' HD11 ' A' ' 123' ' ' ILE . 4.3 mp -109.11 137.21 47.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.091 -0.707 . . . . 73.21 109.091 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.537 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -122.38 119.0 3.82 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.617 -0.801 . . . . 75.52 112.847 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.425 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 47.5 m-85 -129.71 147.56 51.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.402 -1.333 . . . . 74.51 107.402 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -56.45 101.2 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.452 0.644 . . . . 75.25 111.059 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.758 ' HA2' ' HB3' ' A' ' 174' ' ' LYS . . . 104.09 -33.49 6.53 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.984 -1.007 . . . . 52.32 112.107 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 2.2 m-90 -107.01 120.26 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.212 -0.581 . . . . 73.5 111.898 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.537 HD23 ' HA2' ' A' ' 145' ' ' GLY . 7.6 mt -123.2 138.17 54.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.274 -0.421 . . . . 73.2 109.892 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -143.06 124.38 14.65 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.875 -0.33 . . . . 61.41 110.174 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.8 131.71 4.42 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.503 -0.856 . . . . 71.12 111.405 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 37.9 p90 -142.65 144.66 32.87 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.095 -0.642 . . . . 74.42 111.952 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 77.2 mt-30 -111.87 121.74 45.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.052 -0.976 . . . . 74.3 109.303 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 87.8 mtp -118.94 129.84 55.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.874 -0.787 . . . . 64.5 108.874 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.582 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 2.5 m-20 -109.99 114.56 28.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.969 -0.752 . . . . 74.54 108.969 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 25.1 m-85 -94.34 118.49 31.7 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 74.45 110.355 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 161' ' ' LYS . 38.0 tt0 -86.71 100.68 12.65 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 108.967 -0.753 . . . . 73.52 108.967 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 m -70.56 -17.46 62.92 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.334 -1.757 . . . . 71.31 111.355 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.85 92.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.341 -0.985 . . . . 64.33 108.341 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 158' ' ' GLU . 61.4 mttp -99.95 -159.5 0.74 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.538 -1.21 . . . . 73.54 108.299 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 p -109.15 28.44 8.5 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.221 -0.3 . . . . 55.11 110.528 172.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -151.7 150.58 30.38 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 119.086 -1.045 . . . . 74.13 112.249 -161.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.3 m -74.3 134.95 28.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.079 0.466 . . . . 73.13 110.325 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 9.4 t -95.45 -23.12 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.999 -0.546 . . . . 53.13 111.03 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -139.72 132.63 29.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 75.52 110.617 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 14.4 m -122.34 129.91 52.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.492 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.94 121.41 21.63 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.964 -0.384 . . . . 73.42 109.964 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.682 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 91.2 m-85 -121.01 140.48 51.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.827 0.346 . . . . 70.24 110.964 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.91 128.58 24.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.132 0.491 . . . . 64.42 110.077 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.669 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -127.19 150.15 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.495 -0.557 . . . . 55.22 109.495 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.46 120.06 2.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.114 -0.565 . . . . 55.23 111.868 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -113.29 120.73 42.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.861 0.362 . . . . 74.02 110.085 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.758 ' HB3' ' HA2' ' A' ' 148' ' ' GLY . 29.7 ttmt -104.68 123.9 48.42 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.433 -0.58 . . . . 63.42 109.433 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.9 m -134.42 114.09 12.54 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.513 -0.551 . . . . 64.24 109.513 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 47.66 -93.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.816 0.673 . . . . 73.43 112.816 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -111.48 6.41 20.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.02 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -113.34 127.37 56.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.503 -0.317 . . . . 72.21 110.794 -173.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.92 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.1 mm-40 -112.06 124.61 52.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.667 -0.864 . . . . 73.13 108.667 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.409 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 5.6 tt -122.22 134.09 54.71 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.725 -0.609 . . . . 73.51 110.577 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 41.0 t60 -119.97 116.7 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.876 -0.602 . . . . 71.13 110.575 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.669 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 12.3 m -90.46 141.01 29.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.988 -0.745 . . . . 74.34 108.988 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -142.4 138.77 31.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.358 -0.537 . . . . 72.22 111.187 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 61.0 t -132.39 125.8 54.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.41 -0.814 . . . . 52.12 110.067 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.61 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 26.2 t-20 -117.06 107.76 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.249 -0.648 . . . . 71.22 109.249 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.5 t70 62.93 -171.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.919 -0.771 . . . . 74.21 108.919 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.93 -6.33 89.16 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.452 -0.88 . . . . 73.02 111.356 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.5 m -97.83 -25.68 14.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.836 0.68 . . . . 73.42 112.836 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 3.7 tp10 -118.21 113.68 21.89 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.603 -0.686 . . . . 72.3 110.751 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 42.4 p90 -135.56 132.1 36.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.775 -0.37 . . . . 74.3 110.735 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -169.83 -158.91 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.238 -0.982 . . . . 64.0 113.404 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.14 178.43 23.85 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.527 -0.368 . . . . 25.44 112.528 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 181' ' ' HIS . 18.8 m -149.84 147.43 27.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.654 -0.499 . . . . 70.11 109.654 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.6 mp -128.79 124.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.659 0.266 . . . . 75.41 110.942 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.92 ' HB2' ' HB2' ' A' ' 179' ' ' GLN . 43.8 m-85 -108.19 123.66 49.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.667 -0.494 . . . . 75.35 109.667 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.49 ' HA ' ' OE1' ' A' ' 196' ' ' GLN . 14.9 mm-40 -120.7 124.67 45.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.313 -0.403 . . . . 71.33 111.763 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 203' ' ' GLU . 11.6 mmtp -96.0 107.51 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 52.43 109.532 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.89 92.43 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.911 -0.586 . . . . 63.13 110.642 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.7 26.5 11.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.255 -0.884 . . . . 52.3 111.553 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 68.41 5.12 4.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.345 -0.843 . . . . 71.41 112.539 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.42 -38.87 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 63.45 111.117 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.56 151.99 40.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.411 . . . . 73.2 110.759 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 41.6 tt0 -117.11 132.21 56.72 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.814 -0.81 . . . . 53.54 108.814 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -123.06 143.16 50.14 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.211 -0.292 . . . . 75.34 110.211 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -129.66 136.39 49.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.123 0.487 . . . . 75.45 110.848 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 193' ' ' SER . 39.3 t -112.89 130.91 65.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.652 . . . . 75.14 109.538 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 18' ' ' PHE . 14.2 m120 -114.52 128.95 56.6 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.277 -0.638 . . . . 73.23 109.277 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.707 HD13 ' HD2' ' A' ' 219' ' ' PHE . 5.5 tp -146.92 134.29 20.73 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.409 -0.359 . . . . 52.24 110.357 -170.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.7 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -157.74 150.44 22.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.849 0.357 . . . . 54.41 111.466 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.552 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 29.4 t-105 -115.79 133.03 56.44 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.985 -0.746 . . . . 70.24 108.985 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.854 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 20.9 m -95.54 108.23 20.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.709 -0.478 . . . . 74.35 109.709 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.589 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.62 147.5 49.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.79 . . . . 63.13 111.706 -174.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.03 -74.74 0.21 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.717 -0.674 . . . . 62.54 111.677 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -173.8 85.07 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 74.05 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.854 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 49.0 m -156.7 165.85 35.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.716 . . . . 64.3 109.415 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.05 160.01 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.921 -0.4 . . . . 43.34 109.921 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.552 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 9.2 t -78.7 134.46 37.1 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.591 -0.522 . . . . 62.41 109.591 174.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.473 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 20.5 mtt180 -92.21 117.72 30.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.881 -0.415 . . . . 73.33 109.881 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.707 ' HD2' HD13 ' A' ' 208' ' ' LEU . 33.9 t80 -114.13 148.82 36.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.564 -0.532 . . . . 73.2 109.564 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.58 152.35 23.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.459 -0.877 . . . . 74.32 112.578 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.506 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.3 mp -135.92 130.23 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.816 -0.439 . . . . 72.01 109.816 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.597 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -120.99 154.29 36.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.835 -0.432 . . . . 65.35 109.835 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -138.44 124.31 19.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.906 0.384 . . . . 62.52 110.313 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -111.26 113.68 26.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.559 -0.904 . . . . 62.41 108.559 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -113.51 114.07 26.01 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.044 0.45 . . . . 74.45 110.037 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.07 117.26 29.45 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.761 -0.829 . . . . 54.54 108.761 173.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 228' ' ' ASP . 3.2 mp -69.17 -53.28 26.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 64.52 109.546 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 227' ' ' ILE . 22.4 t70 172.66 -48.96 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 O-C-N 124.006 0.816 . . . . 71.4 110.929 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 86.1 Cg_endo -78.42 -144.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.337 2.024 . . . . 72.44 113.331 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 4.1 t0 -93.39 16.41 13.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 64.02 110.463 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.38 123.89 44.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.545 -0.752 . . . . 53.14 110.237 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.8 143.45 50.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 72.43 110.308 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -97.03 129.84 44.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.053 -0.521 . . . . 71.13 109.696 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -121.15 119.27 31.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.013 0.435 . . . . 63.25 110.135 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -123.5 152.14 42.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.078 -0.51 . . . . 43.54 110.012 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 19.9 ptpt -153.26 140.67 19.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.922 -0.399 . . . . 73.53 109.922 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 9.9 p -132.91 141.16 45.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.073 0.463 . . . . 55.11 109.959 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.645 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 20.7 m120 -108.46 150.22 27.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.126 -0.488 . . . . 62.24 109.796 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 241' ' ' SER . 9.0 p30 -50.51 -27.39 6.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.252 0.97 . . . . 74.45 113.241 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.625 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 6.0 m -82.03 24.51 0.63 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.581 . . . . 73.12 109.938 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.467 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 57.6 m 66.05 39.33 4.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.926 -1.034 . . . . 75.03 111.297 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.7 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.5 mp -91.76 121.72 33.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 120.545 -0.462 . . . . 61.13 111.141 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 243' ' ' ILE . 2.3 mp -105.54 115.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 O-C-N 123.62 0.575 . . . . 53.13 110.024 -171.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.83 133.54 9.46 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.55 -0.833 . . . . 50.32 113.082 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.521 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -140.92 141.36 34.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.969 0.414 . . . . 73.04 110.201 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 260' ' ' SER . . . -162.97 165.51 36.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.358 -0.925 . . . . 64.11 112.547 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -129.87 129.95 44.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.055 0.455 . . . . 75.11 110.462 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.57 HG22 HG23 ' A' ' 258' ' ' THR . 19.8 p -113.46 115.61 28.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.702 . . . . 55.12 109.725 177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -133.3 132.88 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 64.13 111.617 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 17.5 m -77.81 120.45 22.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.976 -0.556 . . . . 54.21 109.591 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 255' ' ' ILE . 16.1 tp -81.27 -55.28 4.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.582 0.706 . . . . 61.11 109.213 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.556 ' HB2' HG22 ' A' ' 255' ' ' ILE . 5.9 mtpm? -136.66 158.08 73.84 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.894 -1.15 . . . . 53.3 107.894 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.05 90.4 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.701 1.601 . . . . 74.45 110.422 171.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 282' ' ' GLN . . . 137.39 -9.51 3.78 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.848 -0.692 . . . . 62.23 111.786 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.556 HG22 ' HB2' ' A' ' 252' ' ' LYS . 6.5 tp -148.51 122.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.575 0.702 . . . . 73.01 111.464 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.56 135.25 53.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.591 -0.731 . . . . 73.23 110.527 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.65 126.76 45.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.465 -0.789 . . . . 44.54 110.419 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.57 HG23 HG22 ' A' ' 248' ' ' THR . 86.5 m -118.15 111.45 18.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 63.2 110.808 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.955 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -115.4 129.19 56.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.576 -0.898 . . . . 73.3 108.576 175.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.65 ' O ' ' HB2' ' A' ' 275' ' ' LEU . 11.0 t -151.11 146.25 26.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.51 . . . . 60.1 109.624 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.563 ' HA ' ' CB ' ' A' ' 275' ' ' LEU . . . -139.72 127.51 21.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.636 0.255 . . . . 74.21 110.511 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.683 HD11 HD23 ' A' ' 242' ' ' LEU . 2.2 tm? -112.92 118.31 34.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.593 -0.891 . . . . 75.42 108.593 176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.695 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -101.45 110.07 22.0 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.603 -0.888 . . . . 64.23 108.603 176.324 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.745 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 1.9 m-20 -68.65 104.34 1.95 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.85 -1.167 . . . . 71.41 107.85 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.3 -27.37 46.79 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.908 -0.587 . . . . 70.2 113.298 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -90.84 -20.14 22.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.718 0.294 . . . . 73.23 110.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.745 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 66.2 t30 -101.89 -36.1 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.654 -0.248 . . . . 44.03 111.398 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.7 m -63.18 -18.72 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.722 0.267 . . . . 65.12 111.722 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.65 -44.75 85.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.14 110.796 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.59 10.23 37.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.943 0.401 . . . . 74.42 110.837 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.63 97.88 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.023 -0.608 . . . . 50.14 111.979 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.435 ' HA3' ' ND2' ' A' ' 267' ' ' ASN . . . -175.99 75.63 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.824 -0.703 . . . . 71.3 112.143 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -113.73 145.96 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 122.413 0.285 . . . . 74.31 110.269 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.59 131.18 48.13 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.117 -0.697 . . . . 71.21 109.117 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.667 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -140.68 158.12 44.43 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 65.23 113.974 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.56 117.19 3.53 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 114.552 -1.204 . . . . 45.2 111.317 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.955 HD23 HD22 ' A' ' 259' ' ' LEU . 2.2 tm? -114.36 121.87 44.95 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.909 -1.145 . . . . 75.11 107.909 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -142.46 137.28 7.71 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.89 -1.148 . . . . 44.52 113.309 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.39 130.51 55.67 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.306 -0.627 . . . . 71.12 109.306 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.32 111.18 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.627 -0.509 . . . . 52.12 109.627 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.72 ' HB3' HD22 ' A' ' 31' ' ' LEU . 42.3 t80 -112.99 110.33 20.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 71.14 109.812 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.525 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 7.7 tt0 -114.49 110.21 19.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.677 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -92.34 110.91 22.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.241 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.7 mt -108.69 97.66 7.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 75.14 110.41 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.594 -0.717 . . . . 75.22 109.127 176.828 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.682 ' HA ' ' HG3' ' A' ' 93' ' ' ARG . 72.5 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.337 0.113 . . . . 64.31 110.769 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.13 106.08 17.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.774 0.321 . . . . 71.13 110.491 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 121' ' ' GLU . 11.5 t -116.61 112.91 40.69 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 60.42 109.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.66 166.95 22.38 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.231 2.621 . . . . 41.01 112.786 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 81.95 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.924 2.416 . . . . 74.12 111.789 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.0 p -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.484 -0.78 . . . . 64.1 111.386 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -60.48 -29.87 69.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.914 -0.584 . . . . 63.12 111.572 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.53 -19.57 38.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 52.51 110.965 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.98 13.68 33.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.41 0.624 . . . . 73.3 110.008 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 150' ' ' LEU . 72.4 mt -66.09 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.911 -0.586 . . . . 73.32 110.578 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.89 75.12 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.083 -0.58 . . . . 70.44 112.05 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -44.89 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.933 -0.395 . . . . 72.22 109.933 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p -56.4 -36.91 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.64 -0.709 . . . . 51.4 111.541 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.72 -37.6 73.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 74.53 111.376 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -63.26 -37.94 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.612 0.244 . . . . 62.13 111.147 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.09 -49.1 63.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.598 . . . . 64.3 110.69 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.628 HG21 ' CB ' ' A' ' 205' ' ' ALA . 79.0 t -84.58 -47.77 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.695 0.998 . . . . 71.33 113.695 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.17 -28.08 67.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.589 0.589 . . . . 71.54 112.589 -166.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -73.88 -16.79 61.11 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.819 -0.352 . . . . 75.43 110.96 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 0.1 OUTLIER 64.51 -82.61 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.262 -0.644 . . . . 75.14 109.262 -170.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.19 165.43 12.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.819 -1.312 . . . . 35.42 109.819 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.923 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 2.0 t80 -57.12 -44.94 83.76 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.904 -0.776 . . . . 74.44 108.904 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.72 28.45 56.88 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.219 -0.9 . . . . 63.24 114.422 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.558 ' HD2' ' HB2' ' A' ' 26' ' ' LEU . 56.3 t80 -87.78 -4.97 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.415 0.626 . . . . 74.03 109.455 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' C ' HD12 ' A' ' 26' ' ' LEU . . . 75.31 0.99 63.19 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.378 -0.828 . . . . 53.54 112.41 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 mp -134.55 178.76 6.74 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.262 1.029 . . . . 72.22 112.358 -172.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 277' ' ' LEU . 12.5 mm -103.69 122.43 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.579 -1.646 . . . . 73.15 107.988 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 34.9 mtmt -120.73 126.93 51.42 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.07 -0.652 . . . . 72.23 110.97 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tt -120.47 143.48 48.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.784 -0.644 . . . . 55.34 110.554 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.3 p30 -138.84 140.26 38.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.147 0.499 . . . . 73.31 109.844 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD13 ' HB3' ' A' ' 281' ' ' PHE . 14.5 tp -125.43 123.56 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.595 -0.729 . . . . 72.44 109.338 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -117.1 123.77 47.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 74.53 110.032 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 2.1 t -137.88 122.4 18.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.695 -0.684 . . . . 54.43 110.19 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -104.45 158.21 16.63 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.616 -0.434 . . . . 64.42 110.316 177.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -134.24 135.95 43.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.286 -0.635 . . . . 71.32 109.286 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 39.64 -99.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.357 1.035 . . . . 73.42 112.333 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.601 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 9.4 p30 -147.57 149.13 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.144 -0.687 . . . . 75.41 109.144 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 75.64 -11.02 10.88 Favored Glycine 0 C--O 1.213 -1.199 0 CA-C-O 119.236 -0.758 . . . . 74.32 114.187 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.52 127.25 52.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 119.457 1.629 . . . . 71.34 112.158 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.861 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 27.5 tt0 -142.53 118.85 10.84 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.98 -0.378 . . . . 72.13 109.98 162.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.549 ' HB3' HG23 ' A' ' 33' ' ' THR . 67.3 t80 -97.31 121.45 39.21 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.183 -0.673 . . . . 62.43 109.183 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.6 m -120.79 115.91 24.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.228 0.537 . . . . 73.52 110.772 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 34.6 t -107.88 134.46 50.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 64.11 109.43 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 43.2 m -135.05 126.94 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 71.22 110.331 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 130.26 5.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.453 -0.879 . . . . 64.43 111.846 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.2 m -111.42 133.46 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.474 -0.565 . . . . 44.43 109.474 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.71 135.0 37.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.729 -0.214 . . . . 72.22 110.578 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.766 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 54.2 t30 -69.28 143.07 53.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.783 -0.451 . . . . 74.11 109.783 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -64.62 124.32 21.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.486 . . . . 75.32 111.24 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 73.23 -65.41 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.313 -0.858 . . . . 74.14 111.11 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 3.1 m -78.5 113.13 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.213 -0.662 . . . . 65.24 109.213 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.0 p -75.44 93.08 2.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.068 0.766 . . . . 74.23 113.068 -168.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -113.78 99.6 7.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.868 -1.16 . . . . 75.13 107.868 165.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' SER . 13.9 t -114.21 120.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.818 -0.628 . . . . 71.21 111.115 -171.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -109.74 142.77 40.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.628 -0.715 . . . . 74.53 109.25 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.71 128.39 8.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.802 -0.713 . . . . 74.24 112.773 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.8 m -116.05 127.06 54.58 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.688 -0.856 . . . . 73.24 108.688 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.5 tm? -120.84 123.84 43.57 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.42 -0.585 . . . . 71.03 109.42 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.752 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 43.0 mt-10 -110.36 118.53 36.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.843 -0.617 . . . . 54.01 109.691 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 73' ' ' GLU . 9.1 t -98.75 119.94 38.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.624 -1.25 . . . . 44.11 107.624 172.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 28.0 ttmt -125.27 138.74 54.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.36 0.6 . . . . 74.24 111.261 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 98.9 m-85 -104.28 120.73 41.83 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.287 -0.87 . . . . 74.54 108.913 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.861 ' HG3' ' HB2' ' A' ' 40' ' ' GLU . 12.4 mtp85 -83.85 133.07 34.76 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.722 0.772 . . . . 72.44 111.304 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.747 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 8.8 p-90 -80.33 74.85 7.17 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 112.807 -1.997 . . . . 73.11 115.674 -161.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 37' ' ' ASN . 2.7 m -124.83 -17.8 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.655 -0.702 . . . . 74.14 111.03 -172.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.28 -36.12 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 62.02 109.881 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 69' ' ' LEU . 15.1 t80 -162.14 18.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 74.43 109.278 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.566 ' O ' HD12 ' A' ' 69' ' ' LEU . . . 80.81 56.59 3.06 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.072 -0.811 . . . . 53.43 111.072 -172.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 5.7 mp -139.59 127.98 22.79 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 113.749 1.018 . . . . 73.23 113.749 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.471 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 3.8 m -117.09 132.98 56.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.92 -0.488 . . . . 75.01 110.944 -173.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.572 ' HB3' ' HD2' ' A' ' 62' ' ' TYR . 44.7 t80 -123.19 120.36 32.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.981 -0.748 . . . . 54.43 108.981 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -126.7 117.29 22.42 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.813 -0.355 . . . . 74.41 110.915 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.5 tt0 -104.44 120.63 41.67 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.836 -0.802 . . . . 63.1 108.836 172.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -106.46 92.86 4.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.834 -0.621 . . . . 62.43 109.777 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.836 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 60.8 t90 -95.78 131.37 42.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.863 -0.335 . . . . 74.44 110.549 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.23 142.87 35.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.804 -0.813 . . . . 73.2 108.804 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.5 t -59.2 -9.82 2.42 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.618 0.97 . . . . 74.31 113.618 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 5.5 m-20 -71.24 -41.13 70.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.107 -0.237 . . . . 64.35 110.773 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 28.8 t-20 149.55 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.439 1.087 . . . . 61.24 109.745 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -80.7 132.19 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.645 . . . . 75.43 111.467 -173.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.836 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.8 pt? -124.28 146.5 48.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 62.12 110.681 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.57 117.05 4.08 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.517 -0.633 . . . . 71.33 111.517 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' ASP . 29.2 m -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.601 0.239 . . . . 71.32 110.734 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -125.13 108.37 11.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 63.2 110.118 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.04 129.66 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 74.12 110.699 -178.316 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 70' ' ' THR . 44.8 p -118.37 134.39 55.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 53.12 110.741 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.705 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 m -116.66 131.67 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.631 -0.507 . . . . 72.42 109.631 172.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 122.86 48.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 175.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 93' ' ' ARG . 35.6 t0 70.01 85.15 0.14 Allowed 'General case' 0 C--O 1.223 -0.323 0 O-C-N 124.029 0.831 . . . . 73.12 109.983 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 6.6 tp60 -102.98 5.16 38.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.457 -0.942 . . . . 75.3 108.457 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.5 tp 178.6 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.354 -1.294 . . . . 74.24 108.89 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.6 126.07 16.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.076 -0.965 . . . . 62.53 109.796 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.682 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -64.03 135.85 56.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 72.13 111.076 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.23 -14.78 54.95 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.003 -0.839 . . . . 44.31 111.003 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.24 126.22 38.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 73.23 109.293 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.3 ttpp -122.05 111.16 16.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.694 -0.685 . . . . 75.52 110.319 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.1 mm? -101.23 127.64 47.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.221 -0.659 . . . . 54.41 109.221 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 31.9 m -129.46 124.92 35.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.94 0.4 . . . . 62.33 111.437 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.28 116.05 31.29 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.234 -0.654 . . . . 73.51 109.234 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.716 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.2 t70 -111.68 133.51 53.87 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.003 -0.74 . . . . 75.03 109.003 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 24.4 m -141.44 121.87 14.07 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.941 0.4 . . . . 74.54 110.734 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.76 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 22.8 t -96.07 121.55 37.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.749 -1.204 . . . . 64.34 107.749 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.6 131.27 27.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.236 0.541 . . . . 73.22 111.22 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 16.5 m -119.8 103.43 45.89 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.542 -0.754 . . . . 74.45 109.293 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.423 ' HD2' ' OD1' ' A' ' 79' ' ' ASN . 47.6 Cg_exo -56.89 -33.91 95.92 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.972 2.448 . . . . 73.14 112.908 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -84.47 -40.47 17.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 52.55 111.01 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 104' ' ' SER . 5.8 m -81.99 -32.86 30.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.227 -0.442 . . . . 52.22 112.126 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 1.93 68.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.59 -0.814 . . . . 63.1 111.855 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.96 129.07 38.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.601 0.239 . . . . 71.02 110.426 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -139.39 122.27 16.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 73.52 110.464 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.76 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 8.5 m120 -121.54 123.51 42.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.924 -0.58 . . . . 74.55 109.812 172.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.91 113.8 27.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.067 -0.515 . . . . 71.52 109.68 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.716 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 4.8 ttmp? -122.67 138.1 54.71 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.05 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 tp -129.3 117.4 43.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.203 0.525 . . . . 64.31 110.16 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 1.7 mtpp -105.72 118.75 37.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 64.0 109.009 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 t -114.47 118.48 33.91 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.18 0.514 . . . . 63.41 109.739 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.93 118.24 2.96 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.466 -0.874 . . . . 71.11 112.184 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -106.76 117.59 34.45 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.018 -0.734 . . . . 72.42 109.018 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HB3' HG11 ' A' ' 3' ' ' VAL . 42.5 mtmt -109.22 122.11 46.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.31 0.576 . . . . 73.32 110.383 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -106.39 146.55 30.33 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.604 -1.628 . . . . 71.23 106.604 165.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HG3' HG22 ' A' ' 3' ' ' VAL . 2.2 mt-10 -55.23 -27.46 46.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.861 0.362 . . . . 75.21 111.758 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -88.99 -35.67 16.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 65.44 111.679 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 142' ' ' LEU . 8.7 tp -145.36 127.52 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 121.015 -0.274 . . . . 72.45 111.623 -167.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.523 HD21 ' HB ' ' A' ' 143' ' ' VAL . 3.6 p-10 -122.53 128.44 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.694 0.759 . . . . 65.31 111.807 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 142' ' ' LEU . 4.5 mm? -112.52 131.36 55.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.86 -1.064 . . . . 75.22 110.062 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.62 117.07 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.555 -0.831 . . . . 73.34 112.3 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.9 t -112.29 109.12 18.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.088 0.47 . . . . 70.32 110.135 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 115' ' ' LYS . 17.1 t70 -104.02 117.89 35.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.004 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.44 ' HG2' HG13 ' A' ' 138' ' ' ILE . 58.8 mtm -118.12 117.84 30.26 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.838 -0.345 . . . . 50.11 110.903 -176.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.451 ' HB2' ' HE3' ' A' ' 113' ' ' LYS . 30.4 t70 -107.87 120.42 42.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 63.11 110.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -94.47 109.68 21.53 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.26 -0.427 . . . . 73.42 110.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -116.24 156.39 26.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 71.23 109.501 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.8 pp -71.88 -17.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 111.961 0.356 . . . . 73.21 111.961 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.11 -17.37 32.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.117 0.484 . . . . 52.42 110.337 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.73 123.55 1.39 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.919 -0.657 . . . . 72.42 111.902 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.3 136.09 49.64 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.629 2.219 . . . . 61.01 112.135 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -117.12 137.57 52.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.54 . . . . 63.32 109.963 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.5 mp -107.46 117.98 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 70.33 110.158 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HD2' ' OD2' ' A' ' 128' ' ' ASP . 71.6 mtt180 -105.93 111.61 24.33 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.929 -0.767 . . . . 75.13 108.929 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.62 133.36 11.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.094 -1.05 . . . . 72.44 112.108 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.41 116.63 20.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.225 0.536 . . . . 63.5 110.275 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 123' ' ' ILE . 8.6 tp -116.04 127.07 54.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.711 -0.677 . . . . 63.51 109.979 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 56.6 t -128.03 134.47 65.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.065 0.46 . . . . 74.31 110.625 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.0 mp -109.41 137.04 47.87 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.648 -0.871 . . . . 74.4 108.648 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.405 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -115.75 121.03 5.12 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 123.819 0.699 . . . . 53.53 113.59 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 1.055 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 92.2 m-85 -133.92 149.93 51.3 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.373 -0.973 . . . . 71.43 108.373 173.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.79 93.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.04 0.448 . . . . 75.51 111.339 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.09 47.72 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.999 -0.546 . . . . 35.2 112.336 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 1.055 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 18.8 m95 -105.83 122.38 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.348 -0.241 . . . . 72.33 110.348 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.468 ' HB3' HD23 ' A' ' 10' ' ' LEU . 19.9 mt -128.51 136.96 51.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.865 0.364 . . . . 72.44 111.142 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -127.63 128.61 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 55.24 110.253 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -132.97 133.04 6.82 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.437 -0.887 . . . . 71.51 113.373 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.2 119.29 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.744 -0.465 . . . . 75.11 109.744 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 77.9 mt-30 -113.07 121.62 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.22 0.533 . . . . 73.25 109.569 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 90.4 mtp -133.92 135.82 43.84 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.623 -0.51 . . . . 72.43 109.623 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 166' ' ' GLN . 4.6 m-20 -111.56 117.54 33.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.566 -0.531 . . . . 73.04 109.566 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 14.1 m-85 -94.18 130.57 40.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.203 -0.908 . . . . 74.31 110.276 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 163' ' ' ARG . 11.9 pt-20 -96.52 124.78 40.62 Favored 'General case' 0 C--O 1.264 1.839 0 CA-C-O 121.307 0.575 . . . . 74.22 109.843 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -70.64 -16.67 62.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 113.258 -1.792 . . . . 73.44 111.511 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.25 -43.71 98.44 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.657 -0.868 . . . . 74.11 108.657 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -98.86 -159.58 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.546 -1.279 . . . . 74.42 107.546 165.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.6 m -109.52 27.31 9.69 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.825 -0.547 . . . . 71.3 109.552 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 35.8 ttm180 -151.77 160.16 43.68 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 118.513 -1.275 . . . . 65.11 112.915 -155.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.864 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -78.95 135.91 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.29 0.567 . . . . 52.4 111.369 -177.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -33.68 12.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 74.35 109.684 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 49.4 mt-30 -108.26 133.0 53.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.686 -0.688 . . . . 72.23 110.715 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.4 m -121.2 109.95 15.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 32.41 109.263 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 69.0 m-20 -113.8 126.82 55.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.885 -0.783 . . . . 72.44 108.885 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 94.0 m-85 -121.51 142.68 49.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.004 -0.678 . . . . 71.15 111.149 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -143.29 127.38 17.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.912 -0.585 . . . . 42.12 110.247 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 67.3 t -125.38 134.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.067 -0.346 . . . . 74.11 110.067 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -112.35 102.62 1.37 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.288 -0.725 . . . . 63.51 111.288 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -112.79 119.42 37.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.799 -0.815 . . . . 72.44 108.799 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 174' ' ' LYS . 1.4 tmmt? -112.37 125.94 54.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 64.52 111.422 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.2 m -120.84 154.48 35.73 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.379 -1.341 . . . . 63.13 107.379 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.23 -45.13 53.68 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.37 0.507 . . . . 71.43 112.37 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -113.61 0.26 14.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.02 -0.272 . . . . 64.33 111.401 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -136.75 114.86 11.54 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.497 -0.319 . . . . 64.25 110.769 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.71 123.49 49.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.33 -0.619 . . . . 75.31 109.33 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.799 HD12 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -117.74 131.07 56.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.171 0.51 . . . . 65.25 111.132 -176.345 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 72.3 t60 -115.58 115.12 25.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.622 -0.717 . . . . 60.52 109.483 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.646 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 8.6 m -82.78 139.94 33.28 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.903 -1.147 . . . . 73.31 107.903 173.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 12.0 t-20 -146.05 138.98 25.74 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.935 -0.706 . . . . 72.12 111.887 -173.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 59.4 t -131.55 120.94 46.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.482 -0.781 . . . . 62.52 109.962 172.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -112.03 111.15 21.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.59 -0.732 . . . . 73.01 110.154 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.0 t70 63.4 -168.58 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.817 -1.083 . . . . 71.03 109.29 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.64 -6.93 89.06 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.589 -0.815 . . . . 63.33 112.218 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 211' ' ' THR . 19.0 p -102.39 -28.35 12.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.786 1.032 . . . . 52.12 113.786 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.14 115.41 28.81 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.582 -0.847 . . . . 61.11 112.185 -172.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -120.77 126.3 49.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.06 -0.973 . . . . 71.42 109.665 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.76 -122.51 0.87 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.544 -0.836 . . . . 74.1 112.262 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 158.17 -160.67 31.03 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.617 -0.801 . . . . 74.13 112.587 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.9 t -148.05 139.15 23.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.699 -0.482 . . . . 50.53 109.699 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.799 HG13 HD12 ' A' ' 180' ' ' LEU . 4.2 mp -119.9 135.49 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.123 -0.325 . . . . 61.01 110.123 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.778 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 38.8 t80 -122.3 118.35 28.3 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 61.55 109.836 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.34 134.58 49.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.642 -0.503 . . . . 70.43 109.642 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -99.73 127.12 45.86 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 71.24 110.569 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.5 HG12 ' HD3' ' A' ' 200' ' ' LYS . 10.8 t -102.53 139.38 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.707 -0.849 . . . . 70.23 108.707 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.24 34.28 0.25 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.424 0.631 . . . . 64.3 112.621 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.5 ' HD3' HG12 ' A' ' 198' ' ' VAL . 2.5 mptp? -96.83 14.51 24.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.125 -1.065 . . . . 72.43 108.125 164.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 65.84 20.79 11.44 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.028 -0.987 . . . . 60.32 109.89 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.13 129.8 48.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.073 -0.967 . . . . 60.43 110.197 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.778 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 28.9 mt-10 -104.92 129.83 53.22 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.961 -1.126 . . . . 73.23 107.961 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -122.14 138.17 54.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.821 -0.352 . . . . 74.55 110.632 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.628 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -134.81 149.83 50.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.243 -0.435 . . . . 72.03 111.044 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.647 HG22 HG22 ' A' ' 221' ' ' ILE . 83.2 t -131.13 143.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.656 -0.702 . . . . 75.52 110.357 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -114.61 132.41 56.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.004 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 208' ' ' LEU . 2.1 mm? -125.17 129.48 50.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.219 -0.446 . . . . 72.24 110.21 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.01 127.71 12.47 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.078 -0.341 . . . . 61.34 110.078 171.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.506 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 2.3 t90 -118.75 133.34 55.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.999 -0.741 . . . . 74.44 108.999 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 188' ' ' THR . 31.6 m -93.89 103.02 15.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.184 0.516 . . . . 60.31 109.767 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.71 127.11 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.397 -0.82 . . . . 74.22 110.612 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.4 43.68 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.21 -0.756 . . . . 61.03 111.21 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -126.8 155.84 42.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.008 -0.738 . . . . 41.54 109.008 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.0 m -95.4 -9.8 31.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.155 0.428 . . . . 61.53 112.155 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -91.54 131.53 36.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.889 0.376 . . . . 71.44 110.613 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.506 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 7.9 t -107.19 139.13 42.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.288 0.566 . . . . 75.13 110.19 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -89.06 127.27 35.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.633 . . . . 74.32 109.997 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.636 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 93.9 m-85 -112.35 150.9 30.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.704 -0.68 . . . . 64.12 109.823 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.95 143.17 10.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.749 -0.94 . . . . 73.35 110.749 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.647 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -137.78 134.07 45.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 117.316 0.558 . . . . 71.15 110.583 177.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.528 ' CB ' ' HG2' ' A' ' 236' ' ' LYS . . . -126.29 142.17 51.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.885 -0.598 . . . . 65.22 111.388 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.09 124.06 51.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.74 -0.664 . . . . 74.53 109.456 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 21.3 tptp -113.93 114.02 25.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.328 -0.851 . . . . 74.51 109.425 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.56 121.14 32.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.045 0.45 . . . . 62.04 110.738 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 7.5 pt20 -91.36 99.28 12.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.712 -0.677 . . . . 75.4 109.756 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.6 -35.41 7.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.939 -0.573 . . . . 71.13 111.416 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.454 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -140.21 154.76 70.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 75.31 109.295 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 10.1 Cg_endo -52.52 -26.39 28.59 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.113 2.542 . . . . 42.31 113.309 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -107.97 -15.39 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.613 0.227 . . . . 71.34 111.613 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.26 123.68 40.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.015 0.436 . . . . 71.44 111.84 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.9 t -133.75 121.85 22.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 70.12 109.832 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -101.23 134.35 44.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.655 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 24.3 p -132.01 121.31 23.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.341 -0.391 . . . . 74.23 110.889 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.6 140.16 43.75 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.495 -0.557 . . . . 62.05 109.495 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 222' ' ' ALA . 71.6 mttt -137.92 150.68 47.28 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.044 -0.354 . . . . 63.31 110.044 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.513 HG12 HG12 ' A' ' 221' ' ' ILE . 8.7 p -144.69 143.88 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.119 0.485 . . . . 51.54 110.873 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 25.7 t-20 -105.03 148.9 26.26 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.433 -0.803 . . . . 75.3 109.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.636 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 64.4 t30 -46.65 -31.22 2.74 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.849 1.343 . . . . 61.15 113.378 -174.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.619 ' HB2' HD13 ' A' ' 242' ' ' LEU . 19.3 m -80.01 19.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.979 0.419 . . . . 61.31 110.603 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 56.0 m 68.67 34.2 3.54 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.467 -0.788 . . . . 62.1 111.19 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.2 mp -98.84 131.81 44.67 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 120.389 -0.524 . . . . 74.55 111.605 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 243' ' ' ILE . 2.3 mp -109.66 116.95 53.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.837 -0.62 . . . . 64.41 110.264 -169.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -112.85 133.55 11.4 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.617 -0.801 . . . . 45.1 111.947 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.708 ' H ' HD23 ' A' ' 245' ' ' LEU . 2.3 pt? -118.66 134.39 55.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.817 -0.438 . . . . 55.31 109.817 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.1 121.39 2.71 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.796 -0.716 . . . . 35.31 112.14 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.407 ' HE2' HD12 ' A' ' 245' ' ' LEU . 90.4 m-85 -108.87 115.79 30.76 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.453 -0.573 . . . . 73.23 109.453 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.0 m -109.05 112.85 25.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.176 0.513 . . . . 62.45 110.205 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.91 134.11 55.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 73.33 110.189 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 15.6 m -122.54 98.25 5.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.084 -0.507 . . . . 75.15 109.706 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.767 ' HB2' HG23 ' A' ' 255' ' ' ILE . 3.2 mm? -88.97 77.37 7.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.345 -0.613 . . . . 70.54 109.345 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.618 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 30.7 mmtp 68.37 166.63 0.12 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.343 -0.844 . . . . 73.02 110.136 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 55.7 Cg_endo -70.9 57.68 2.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.359 2.04 . . . . 55.03 112.178 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -147.94 -45.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.834 -0.621 . . . . 45.25 112.097 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.767 HG23 ' HB2' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -132.26 124.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.78 0.8 . . . . 73.32 110.67 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 57.2 tttt -119.61 131.9 55.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.99 -1.004 . . . . 74.24 110.092 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.02 125.54 49.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.839 -0.618 . . . . 63.02 110.466 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.2 t -128.87 111.59 13.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.627 0.727 . . . . 70.51 110.46 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.741 HD22 ' HG ' ' A' ' 277' ' ' LEU . 0.1 OUTLIER -106.3 124.49 49.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.41 -0.959 . . . . 72.33 108.41 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 46.8 p -140.79 140.73 34.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.198 -0.601 . . . . 74.11 110.999 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' A' ' 245' ' ' LEU . . . -144.89 146.69 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.985 -0.552 . . . . 75.32 110.088 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 242' ' ' LEU . 2.0 tm? -114.6 116.58 28.98 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.653 -0.869 . . . . 64.42 108.653 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.47 HD21 HD22 ' A' ' 245' ' ' LEU . 1.0 OUTLIER -92.13 107.35 19.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.911 -1.144 . . . . 52.53 107.911 173.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.85 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -70.79 104.92 3.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.259 -1.015 . . . . 73.23 108.259 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.7 -22.92 34.77 Favored Glycine 0 N--CA 1.459 0.211 0 C-N-CA 121.16 -0.543 . . . . 52.4 112.2 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -90.68 -15.73 29.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.257 -0.471 . . . . 65.44 111.798 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 17.5 t-20 -117.41 -38.37 3.34 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.227 0.455 . . . . 70.11 112.227 -174.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 264' ' ' ASP . 30.7 m -61.87 -17.79 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.103 0.408 . . . . 63.32 112.103 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -59.81 -32.67 70.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.053 0.454 . . . . 72.52 110.314 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.99 -16.57 15.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 44.45 110.277 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.32 119.52 3.28 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.81 -0.632 . . . . 50.31 111.827 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 149.73 82.7 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.462 -0.875 . . . . 50.31 112.413 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -113.61 150.13 33.57 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.698 -0.482 . . . . 55.14 109.698 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.1 mptt -91.73 137.11 32.63 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.682 -0.859 . . . . 74.23 108.682 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -120.53 137.72 54.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.151 -0.477 . . . . 55.33 109.845 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.923 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -144.15 112.68 0.69 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 111.045 -0.822 . . . . 64.43 111.045 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.741 ' HG ' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -113.96 143.51 44.6 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.29 -0.564 . . . . 70.41 109.512 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.563 ' H ' HD23 ' A' ' 277' ' ' LEU . . . -140.56 124.43 2.61 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.387 -0.824 . . . . 55.43 111.362 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.511 ' HB2' HD12 ' A' ' 29' ' ' LEU . 3.0 mm? -113.41 131.2 56.09 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.624 -0.88 . . . . 72.13 108.624 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 69.3 tt0 -125.42 116.14 21.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.133 0.492 . . . . 63.53 110.038 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.589 ' HB3' HD13 ' A' ' 31' ' ' LEU . 50.1 m-85 -105.33 138.57 41.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.678 -0.692 . . . . 65.24 109.782 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.498 ' HB3' HD23 ' A' ' 284' ' ' LEU . 75.8 mt-30 -130.85 114.03 14.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.451 -0.795 . . . . 74.22 110.209 -176.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.752 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -104.8 107.45 18.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.209 -0.664 . . . . 61.34 109.209 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.547 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.3 mm? -139.27 -3.27 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.421 -0.808 . . . . 62.12 110.171 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.59 -0.719 . . . . 72.23 109.885 -178.205 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.932 -0.396 . . . . 73.13 109.932 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.27 125.73 44.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.095 0.474 . . . . 75.31 110.915 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.634 ' CG1' ' HB3' ' A' ' 119' ' ' LYS . 7.9 p -147.81 134.86 10.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.17 -0.678 . . . . 73.1 109.17 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 9.6 Cg_endo -52.65 133.85 51.35 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.282 2.655 . . . . 74.12 113.664 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 13.0 Cg_exo -71.13 75.32 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.142 2.561 . . . . 61.12 110.893 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -76.4 -11.85 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.565 -0.743 . . . . 75.44 111.928 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.69 ' HB3' HG21 ' A' ' 143' ' ' VAL . 21.7 p90 -60.15 -22.12 62.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.314 0.578 . . . . 70.34 110.039 171.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -27.25 61.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.709 -0.678 . . . . 73.34 109.747 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -84.74 -14.12 49.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.056 -0.52 . . . . 72.2 110.091 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 170' ' ' ALA . 61.0 mt -76.89 -35.56 57.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.385 -0.825 . . . . 73.14 110.575 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 -61.45 0.23 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.386 -0.911 . . . . 74.5 114.025 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.75 -43.87 81.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.922 0.361 . . . . 71.45 111.338 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.1 t -62.09 -46.37 89.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.862 -0.608 . . . . 65.02 110.961 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.91 73.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.071 -0.513 . . . . 64.2 111.776 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -59.32 -30.11 68.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.12 112.243 -173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.59 -44.5 85.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.935 0.398 . . . . 75.14 110.452 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.41 -35.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.939 -0.573 . . . . 72.44 110.962 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -68.84 -23.05 64.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.946 -0.57 . . . . 74.44 111.533 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.8 p -76.03 93.05 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.313 0.578 . . . . 71.14 111.085 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.32 79.13 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.761 . . . . 74.44 112.214 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.4 63.92 3.11 Favored Glycine 0 C--N 1.335 0.479 0 O-C-N 123.984 0.803 . . . . 64.4 114.692 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -88.88 83.09 6.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.184 0.516 . . . . 74.34 110.732 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.3 121.84 5.77 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.531 -0.759 . . . . 53.12 111.465 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.81 5.61 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.645 0.239 . . . . 72.22 111.645 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.91 59.51 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.771 -0.728 . . . . 41.21 112.691 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 46' ' ' SER . 1.5 pp -129.04 -179.34 5.06 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.59 0.959 . . . . 74.34 113.59 -170.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.705 HG23 HD22 ' A' ' 277' ' ' LEU . 40.7 mm -99.1 132.79 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.061 -1.427 . . . . 75.21 109.802 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 17.9 ptpt -118.55 153.52 34.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.022 0.439 . . . . 72.14 109.906 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.804 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.3 tp -141.13 143.86 34.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.289 -0.414 . . . . 70.41 111.442 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 8.1 t70 -137.38 124.28 21.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.617 -1.253 . . . . 71.44 107.617 168.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.3 tm? -136.72 124.16 22.08 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.388 -0.597 . . . . 71.41 109.388 -175.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 29.6 mtmm -116.77 124.51 49.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 72.23 110.572 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -121.22 125.36 46.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.897 -0.592 . . . . 75.14 109.538 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -113.35 145.55 40.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.794 0.331 . . . . 71.13 110.335 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 21.7 m -139.21 138.19 36.65 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.48 -0.563 . . . . 71.04 109.48 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 49.21 -120.12 1.34 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.802 0.689 . . . . 73.24 110.572 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -136.27 152.24 50.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.725 -0.472 . . . . 50.55 109.725 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.757 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 79.29 -9.3 41.5 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 119.335 -0.703 . . . . 51.03 113.648 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -101.64 128.55 47.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.613 1.207 . . . . 63.33 112.043 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.822 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 29.0 tt0 -141.02 117.12 10.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 74.1 109.66 164.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 92.1 t80 -99.05 121.93 41.63 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.546 -0.538 . . . . 65.54 109.546 176.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 6.8 m -125.5 125.21 42.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.083 0.468 . . . . 74.43 111.521 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -112.43 123.84 51.17 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.775 -0.824 . . . . 62.04 108.775 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 22.1 m -137.85 125.66 22.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.203 -0.295 . . . . 62.11 110.203 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 178.9 42.33 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.328 -1.415 . . . . 55.53 113.442 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 26' ' ' LEU . 21.9 m -138.01 134.82 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.687 -0.486 . . . . 64.23 109.687 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -139.8 132.8 29.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.918 0.39 . . . . 50.53 111.25 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.06 120.96 37.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.894 -0.593 . . . . 64.21 109.409 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 m -84.52 -33.42 23.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 62.24 110.751 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -63.61 -59.4 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 75.35 110.027 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 m -112.52 111.31 22.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.228 -0.656 . . . . 72.41 109.228 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p -55.92 95.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.156 0.799 . . . . 55.24 113.156 -171.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -145.58 117.36 8.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.36 -0.978 . . . . 72.33 108.36 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' HB2' ' A' ' 47' ' ' ALA . 32.1 t -121.97 125.32 72.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.934 0.397 . . . . 71.34 110.821 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.6 m -109.54 125.08 52.14 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.493 -0.929 . . . . 73.02 108.493 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.56 5.33 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.947 -1.12 . . . . 73.24 113.267 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 75' ' ' TRP . 19.3 m -118.96 134.07 55.42 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.068 -0.715 . . . . 61.41 109.068 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -119.74 123.24 43.28 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.519 -0.919 . . . . 74.42 108.519 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.821 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 mt-10 -110.83 119.31 38.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.9 -0.591 . . . . 71.21 110.217 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -98.59 117.76 33.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.733 -1.21 . . . . 74.01 107.733 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.822 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 38.2 mttp -116.56 139.87 50.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.256 0.551 . . . . 62.44 110.75 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.757 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 96.6 m-85 -115.34 120.09 38.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.249 -0.887 . . . . 73.1 108.887 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.6 ptp180 -119.03 106.39 12.37 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 121.755 0.788 . . . . 72.43 111.224 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -116.11 92.67 3.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.919 -1.037 . . . . 74.12 109.994 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -81.22 1.22 33.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.748 -0.66 . . . . 70.4 111.448 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.43 14.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.524 0.678 . . . . 64.54 109.986 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -159.02 -49.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.875 -1.057 . . . . 62.33 108.578 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.366 -0.834 . . . . 72.1 111.306 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' CD1' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -106.93 131.86 53.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.796 0.331 . . . . 75.13 111.147 -174.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.9 m -129.99 111.93 13.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.002 -0.545 . . . . 74.05 109.993 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 33.4 t80 -112.88 123.76 51.05 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.547 -0.538 . . . . 71.45 109.547 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 61' ' ' LYS . 88.4 m -128.63 116.77 20.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.808 0.337 . . . . 74.32 111.018 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.38 121.52 45.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.892 -0.781 . . . . 71.54 108.892 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.711 ' HB3' ' HG2' ' A' ' 59' ' ' GLU . 17.4 ptmt -128.01 114.39 17.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.92 0.39 . . . . 54.45 111.442 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.662 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 78.6 t90 -99.9 139.23 35.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.524 -0.547 . . . . 72.4 109.524 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -119.7 160.86 21.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.422 -0.354 . . . . 51.55 110.276 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 p -62.41 -14.12 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.062 0.458 . . . . 72.32 111.95 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.683 ' HB3' HG22 ' A' ' 80' ' ' THR . 35.4 t70 -71.23 -4.75 27.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 71.04 110.108 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 3.7 m-20 77.85 -3.3 2.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.122 -0.944 . . . . 60.1 110.019 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.683 HG22 ' HB3' ' A' ' 78' ' ' ASP . 13.4 t -83.68 133.37 34.81 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.938 -0.574 . . . . 71.23 109.891 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.662 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 2.2 pt? -123.0 142.88 50.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.047 -0.524 . . . . 74.44 110.104 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.58 123.92 5.64 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.965 -0.636 . . . . 73.13 112.333 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 23.5 m -97.34 90.1 4.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.284 0.564 . . . . 71.44 109.679 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -91.57 110.0 21.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.123 -0.944 . . . . 71.43 109.482 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 85' ' ' ILE . 13.0 pt -124.36 134.84 65.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.734 0.778 . . . . 74.13 110.867 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -123.5 122.27 37.79 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.192 -0.913 . . . . 74.31 108.746 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.59 HG22 ' HB2' ' A' ' 97' ' ' LEU . 8.0 m -113.69 120.77 64.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.079 -0.51 . . . . 72.42 110.106 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -107.77 131.57 54.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.549 -0.908 . . . . 74.14 108.549 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -76.6 134.65 39.3 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.362 -0.535 . . . . 53.04 111.355 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.419 -0.809 . . . . 65.32 111.077 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.27 -53.22 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.687 -0.486 . . . . 63.12 109.687 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 71.87 10.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.34 110.719 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -63.37 133.35 53.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 73.5 110.219 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.5 -9.43 58.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.544 -0.836 . . . . 61.12 111.317 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -105.4 111.21 23.85 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.1 -0.704 . . . . 71.31 109.1 176.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.696 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -126.23 130.25 50.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.132 0.491 . . . . 73.43 110.404 177.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.724 HD12 HG22 ' A' ' 116' ' ' THR . 1.3 mm? -101.63 131.06 48.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.019 -0.537 . . . . 72.23 109.626 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -106.4 117.76 34.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.08 0.466 . . . . 62.24 110.494 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.785 ' HD1' ' HB ' ' A' ' 114' ' ' ILE . 82.3 t80 -126.21 115.95 20.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.279 -0.873 . . . . 75.54 110.295 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.691 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 1.3 t70 -112.18 138.6 48.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.765 -0.652 . . . . 64.53 110.768 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 33.2 m -126.93 120.74 29.89 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.951 -0.759 . . . . 54.14 108.951 169.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 4.7 t -127.49 121.89 31.94 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.918 -0.401 . . . . 72.24 109.918 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' THR . 69.6 m-85 -125.45 120.51 31.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.557 -0.292 . . . . 74.31 110.285 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.2 t -123.05 103.14 36.71 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.29 -0.414 . . . . 61.41 109.961 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.74 -25.32 46.4 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.972 2.448 . . . . 62.11 111.387 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -67.06 -37.44 84.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 63.14 110.329 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.764 ' HB ' ' HG2' ' A' ' 109' ' ' LYS . 5.2 m -88.18 -28.25 21.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.148 0.499 . . . . 75.01 110.104 175.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.67 4.19 83.02 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.229 -0.748 . . . . 70.14 111.229 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.764 ' HG2' ' HB ' ' A' ' 107' ' ' THR . 21.3 pttm -94.96 148.63 22.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.154 0.502 . . . . 54.03 111.472 -175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 122.74 37.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.316 -0.856 . . . . 53.13 109.236 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 17.8 m120 -119.61 137.79 53.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 75.5 110.521 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -140.15 123.3 16.78 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.616 -0.513 . . . . 53.55 109.616 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.691 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -117.58 131.92 56.6 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.539 -0.864 . . . . 74.23 109.204 176.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.785 ' HB ' ' HD1' ' A' ' 99' ' ' PHE . 4.0 tp -140.09 114.66 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.635 -0.506 . . . . 74.43 109.635 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.947 ' HB3' ' O ' ' A' ' 127' ' ' CYS 0.461 13.1 tttt -154.41 170.12 22.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 116.128 1.899 . . . . 51.32 116.128 160.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.724 HG22 HD12 ' A' ' 97' ' ' LEU . 77.1 p -101.18 130.16 47.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.311 -1.313 . . . . 64.31 110.956 -163.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.89 123.81 5.87 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.534 -0.841 . . . . 52.33 112.238 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.444 ' C ' ' HD2' ' A' ' 119' ' ' LYS . 35.5 p90 -124.9 128.09 48.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.62 0.724 . . . . 72.4 110.282 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.696 ' HD3' ' HD3' ' A' ' 96' ' ' LYS . 3.8 mptp? -111.38 122.7 48.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.672 -0.695 . . . . 73.51 110.929 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 31.0 mtp180 -108.36 158.02 17.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.798 -0.637 . . . . 73.4 110.694 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.68 -32.8 44.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.39 0.885 . . . . 70.31 113.39 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -119.15 -6.33 10.42 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.73 -0.388 . . . . 74.42 111.297 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -144.4 123.3 6.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.52 0.676 . . . . 42.53 110.6 -173.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.787 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.9 t-20 -104.64 115.45 30.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.03 -0.532 . . . . 64.34 109.582 -175.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.05 130.06 56.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.516 0.674 . . . . 64.13 111.761 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.47 115.9 1.61 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.316 -0.856 . . . . 42.23 111.37 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.947 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 59.4 m -112.66 126.1 55.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.824 -0.806 . . . . 65.31 108.824 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.765 ' HA ' ' CB ' ' A' ' 115' ' ' LYS . 1.1 m-20 -128.92 133.22 47.79 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.843 1.339 . . . . 62.41 111.364 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.855 ' H ' ' HB2' ' A' ' 115' ' ' LYS . 60.1 ttp -107.39 118.39 36.59 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 119.413 -0.915 . . . . 73.43 109.791 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 9.2 t70 -106.2 115.3 29.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.739 -0.467 . . . . 73.11 109.739 -175.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 92.3 t80 -97.87 117.78 32.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.839 -0.344 . . . . 75.22 111.125 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 22.5 t70 -115.02 157.03 24.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.872 -0.788 . . . . 75.21 108.872 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.47 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.6 pp -69.19 -17.19 21.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 111.705 0.261 . . . . 50.04 111.705 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.23 -19.34 24.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 71.31 111.073 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.482 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 168.93 148.45 5.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.528 -0.844 . . . . 74.3 112.527 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 2.8 Cg_endo -85.67 114.51 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.571 2.847 . . . . 65.12 111.749 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 m -104.0 144.44 31.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.018 -0.537 . . . . 74.54 110.612 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.35 118.52 55.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.41 -0.589 . . . . 71.21 109.41 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 139' ' ' ARG . 39.3 ttp-105 -103.57 126.31 50.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.773 -0.649 . . . . 70.33 110.23 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.14 132.02 10.1 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.181 -1.009 . . . . 74.31 111.643 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.09 116.09 23.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.713 -0.477 . . . . 53.3 109.713 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 123' ' ' ILE . 15.2 tp -124.26 124.53 42.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.356 -0.384 . . . . 74.02 110.621 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 46.5 t -125.1 128.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 72.31 109.821 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.2 mp -109.51 138.69 45.5 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.728 -0.841 . . . . 73.4 108.728 176.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.9 117.55 1.58 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.109 -1.043 . . . . 72.33 111.778 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.31 123.28 18.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.883 -0.327 . . . . 74.52 111.056 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 40.34 39.02 0.62 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.058 1.132 . . . . 73.14 114.058 171.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.09 6.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.26 -0.971 . . . . 71.33 113.512 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -98.66 137.01 37.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.904 0.852 . . . . 74.53 111.416 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 mt -115.59 140.17 49.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.442 -1.254 . . . . 74.41 110.56 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -127.17 125.88 41.88 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.275 -0.639 . . . . 61.3 109.275 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.63 134.02 7.59 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.26 -0.972 . . . . 52.54 112.572 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.472 ' HD2' ' CD2' ' A' ' 169' ' ' PHE . 13.7 m-85 -134.68 120.54 19.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.387 -0.407 . . . . 72.41 109.973 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.421 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . 73.1 mt-30 -119.92 123.12 42.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.426 0.631 . . . . 62.31 110.01 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -130.58 136.13 48.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.863 -0.608 . . . . 73.42 110.288 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -114.75 118.88 34.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.702 -0.481 . . . . 74.51 109.702 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 86.3 t80 -107.15 123.33 48.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.811 -0.631 . . . . 73.42 110.798 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -94.98 126.35 40.26 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.479 -0.563 . . . . 74.34 109.479 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 41.8 p -73.71 -48.24 33.47 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.083 -0.962 . . . . 63.35 112.993 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -65.58 -44.57 86.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.237 0.541 . . . . 62.35 110.189 -172.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 38.7 ttpt -101.64 112.91 25.63 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.941 -1.874 . . . . 73.23 105.941 160.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.4 p -75.5 38.07 0.14 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.355 1.243 . . . . 61.12 114.355 -152.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.567 ' HG2' ' N ' ' A' ' 164' ' ' VAL . 26.0 ttm180 -139.92 157.88 44.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.916 0.389 . . . . 71.23 111.085 -166.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 85.7 t -72.51 122.13 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.448 -0.945 . . . . 73.23 108.448 170.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.6 m -93.81 -31.08 14.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.354 -0.385 . . . . 63.12 110.826 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -132.94 129.7 38.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 64.5 110.321 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.5 m -124.75 106.67 10.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.562 -0.744 . . . . 74.51 109.632 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 154' ' ' GLN . 10.0 p30 -118.14 146.79 43.91 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.459 -0.496 . . . . 43.51 109.886 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' HD2' ' A' ' 153' ' ' TYR . 69.1 m-85 -135.21 162.1 33.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.45 -0.341 . . . . 75.22 110.648 -173.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 71.0 110.616 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.806 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 98.5 t -138.45 136.95 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.415 . . . . 73.23 109.878 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.73 111.28 1.9 Allowed Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.614 -0.803 . . . . 60.12 111.317 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.574 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 19.5 t80 -113.28 128.85 56.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.252 0.526 . . . . 62.31 109.976 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -102.15 130.82 48.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.981 0.896 . . . . 74.21 112.564 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 7.8 m -131.1 145.54 52.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 42.41 105.765 164.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.95 -30.25 67.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.328 0.513 . . . . 73.44 112.303 -168.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.08 -0.23 12.79 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.292 -0.255 . . . . 73.5 111.567 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.608 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 53.4 m-85 -136.84 119.93 16.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 73.35 110.57 -174.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -110.91 123.65 50.55 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.018 -0.426 . . . . 63.52 110.162 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 173' ' ' TYR . 2.0 tp -102.68 126.9 49.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.998 0.428 . . . . 50.21 110.077 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -118.55 114.83 23.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.627 -0.879 . . . . 75.31 108.627 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.806 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 26.6 m -99.94 137.57 38.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.406 -0.59 . . . . 40.41 109.406 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -136.97 139.05 41.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.137 0.494 . . . . 64.23 110.995 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 190' ' ' PHE . 84.2 t -128.04 111.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 63.5 109.546 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -96.54 103.8 15.73 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 108.672 -0.862 . . . . 54.34 108.672 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.435 ' HB3' HG22 ' A' ' 188' ' ' THR . 23.1 t70 64.82 172.61 0.2 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.03 -0.987 . . . . 70.02 109.64 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.8 56.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.435 -0.888 . . . . 34.42 111.785 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 186' ' ' ASP . 14.4 t -97.41 -24.14 15.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 113.14 0.792 . . . . 72.02 113.14 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.29 117.47 19.85 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.423 1.01 . . . . 62.42 111.33 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 184' ' ' VAL . 41.8 p90 -134.03 138.47 45.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.593 -0.276 . . . . 72.35 110.766 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . -163.45 -163.88 17.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.788 -0.72 . . . . 61.32 112.369 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.88 176.73 30.9 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 120.78 -0.724 . . . . 74.23 112.095 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 34.8 t -147.29 142.59 27.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.046 0.423 . . . . 75.21 110.881 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 194' ' ' ILE . 4.1 mp -119.31 118.4 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.194 -0.669 . . . . 70.51 109.194 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 9.2 t80 -108.24 121.07 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.588 -0.523 . . . . 72.5 109.588 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -116.96 126.69 53.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.424 -0.584 . . . . 73.34 109.424 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.647 ' HG2' ' HG2' ' A' ' 203' ' ' GLU . 2.9 tmtp? -108.69 114.17 27.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.982 -0.554 . . . . 51.15 110.24 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.461 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 43.6 t -73.89 159.75 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.462 -0.335 . . . . 73.4 110.319 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.405 ' N ' HG12 ' A' ' 198' ' ' VAL . 5.9 m-20 -57.62 -45.53 85.25 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.527 0.203 . . . . 63.13 111.041 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 172.47 13.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.906 -0.776 . . . . 55.05 108.906 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -78.08 70.1 4.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.756 0.788 . . . . 72.22 111.423 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.744 HD13 ' HD2' ' A' ' 225' ' ' TYR . 58.5 tp -133.58 113.01 11.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.465 -1.243 . . . . 75.0 108.759 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.647 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.6 mt-10 -117.12 129.09 55.74 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.512 -0.551 . . . . 55.21 109.512 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -124.36 139.41 53.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.725 0.298 . . . . 65.23 110.968 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.425 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -130.97 136.4 48.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.349 -0.387 . . . . 64.13 110.677 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 193' ' ' SER . 54.6 t -113.71 126.08 71.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.471 -0.566 . . . . 72.22 109.471 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.1 136.17 53.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.507 0.67 . . . . 74.45 111.004 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -119.55 141.1 49.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.029 -0.987 . . . . 62.5 109.325 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.11 130.37 25.18 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.283 -0.417 . . . . 64.2 110.872 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -116.48 132.84 56.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.981 -0.748 . . . . 71.31 108.981 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 10.1 t -114.2 122.72 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 63.11 110.691 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.64 135.62 57.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 74.44 111.14 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.38 -28.94 5.63 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.622 -0.717 . . . . 65.11 111.474 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.06 149.26 30.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.094 -0.706 . . . . 61.02 109.094 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.6 m -79.15 42.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.079 0.466 . . . . 64.34 110.667 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.57 120.88 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.573 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.6 t -105.8 136.89 44.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.14 0.495 . . . . 74.31 109.943 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.4 mmm-85 -102.0 138.19 39.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.445 -0.576 . . . . 75.22 109.445 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 66.0 m-85 -114.7 146.9 40.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.982 -0.377 . . . . 73.21 109.982 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.88 146.23 15.21 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.34 -0.704 . . . . 62.44 111.34 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.6 mp -132.14 129.5 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.94 0.37 . . . . 71.22 110.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -118.57 138.9 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.117 -0.327 . . . . 72.33 110.117 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.97 125.8 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.922 0.391 . . . . 60.13 110.813 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -115.44 114.34 24.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.74 -0.664 . . . . 73.24 109.909 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.744 ' HD2' HD13 ' A' ' 202' ' ' LEU . 36.6 t80 -117.7 120.05 36.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.477 -0.564 . . . . 73.43 109.477 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 229' ' ' PRO . 52.7 tt0 -112.25 112.22 23.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.952 0.406 . . . . 70.33 110.652 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 227' ' ' ILE . 3.7 mp -86.82 -55.51 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 62.33 109.711 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -106.1 153.86 39.96 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 73.53 109.606 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.639 ' HA ' HE21 ' A' ' 226' ' ' GLN . 21.0 Cg_endo -60.33 -23.82 75.63 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.549 2.166 . . . . 74.31 112.79 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -102.61 -9.27 20.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.587 -0.279 . . . . 75.23 111.342 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.85 122.67 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 73.32 111.348 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.47 142.32 51.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.878 -0.601 . . . . 71.32 110.651 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -108.43 125.77 52.14 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.251 -0.648 . . . . 71.1 109.251 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.5 t -126.45 117.15 22.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.818 -0.438 . . . . 53.14 109.818 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -124.74 155.86 38.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.367 -0.379 . . . . 62.54 110.324 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 0.0 OUTLIER -154.25 139.84 17.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.478 . . . . 63.44 109.857 175.07 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 243' ' ' ILE . 7.9 p -128.64 144.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 63.13 110.406 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -108.46 148.79 29.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.066 -0.516 . . . . 73.42 109.96 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 8.0 t30 -65.22 -3.78 4.35 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.182 0.808 . . . . 63.02 113.182 -170.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.667 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.6 m -85.76 17.06 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.946 -0.761 . . . . 73.34 108.946 172.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.594 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 51.0 m 69.77 30.45 3.82 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.691 -1.14 . . . . 74.21 111.585 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.848 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.7 mp -99.08 125.47 44.6 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 120.683 -0.407 . . . . 75.42 111.735 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.561 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.8 mp -113.2 115.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.721 -0.672 . . . . 74.23 110.506 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -111.08 133.78 11.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.74 -0.743 . . . . 23.43 111.748 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.56 151.71 50.57 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.687 -0.302 . . . . 75.13 110.527 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -146.45 137.8 7.03 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.63 -0.795 . . . . 63.0 113.026 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -103.63 120.19 40.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.742 -0.836 . . . . 64.45 108.742 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 2.0 m -121.93 115.76 23.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.737 0.303 . . . . 74.24 111.035 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -134.74 141.84 46.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.58 -0.282 . . . . 72.02 110.707 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.0 m -76.32 124.82 28.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.609 -0.515 . . . . 63.33 109.609 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.595 ' HG ' ' H ' ' A' ' 252' ' ' LYS . 17.9 tp -105.92 172.65 6.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.108 0.48 . . . . 72.35 111.804 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.595 ' H ' ' HG ' ' A' ' 251' ' ' LEU . 44.2 tptt -49.53 -54.54 29.73 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.998 1.11 . . . . 64.21 113.998 -172.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 13.1 Cg_exo -70.73 9.07 0.82 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.611 2.207 . . . . 61.22 114.295 -171.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 82.86 29.36 35.1 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.386 -0.911 . . . . 41.4 111.824 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 2.7 pp -121.94 146.02 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.447 -0.377 . . . . 70.43 110.35 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.581 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 73.7 tttt -91.64 126.17 36.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 74.52 108.864 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.6 tp -97.8 123.58 41.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.927 -0.398 . . . . 60.34 109.927 -176.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.4 m -124.75 111.5 15.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.789 -0.641 . . . . 65.44 110.543 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.638 ' CD2' HD12 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -98.92 122.8 42.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.553 -1.277 . . . . 74.21 107.553 170.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.8 m -131.47 143.91 50.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.932 0.396 . . . . 63.23 111.16 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.409 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -146.44 132.36 19.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 74.0 110.732 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.772 HD11 HD23 ' A' ' 242' ' ' LEU . 2.7 tm? -104.35 113.12 26.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.25 -1.018 . . . . 54.3 108.25 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.697 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.2 mm? -91.66 108.92 20.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.92 -1.141 . . . . 71.22 107.92 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.848 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 9.9 t0 -71.48 105.07 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.586 -1.265 . . . . 70.13 107.586 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.82 -25.03 43.4 Favored Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.907 -0.588 . . . . 44.31 113.497 -170.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 266' ' ' LYS . 46.0 mtpt -91.85 -26.63 18.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.627 0.251 . . . . 61.33 111.201 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 63.2 t30 -98.69 -28.57 13.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 61.25 112.357 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.738 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 26.9 m -62.51 -17.82 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.665 0.269 . . . . 74.25 111.315 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -55.57 -37.79 68.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.271 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.57 9.75 37.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 62.31 110.838 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.44 74.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.004 -0.617 . . . . 72.51 112.598 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.738 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -142.57 86.52 0.19 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.937 -0.649 . . . . 42.23 111.919 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -113.23 143.52 44.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.444 0.164 . . . . 72.42 110.642 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 65.5 mttm -97.47 137.91 35.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.252 -0.647 . . . . 75.33 109.252 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -121.94 142.55 50.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.814 -0.439 . . . . 74.33 109.814 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -157.37 123.81 1.33 Allowed Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.54 -0.838 . . . . 52.14 111.504 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.705 HD22 HG23 ' A' ' 27' ' ' ILE . 7.4 tt -114.05 145.2 41.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.005 -0.739 . . . . 74.45 109.005 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -149.4 125.37 1.99 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.944 -1.122 . . . . 75.53 113.012 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.804 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.1 mm? -99.18 128.0 45.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.418 -0.956 . . . . 70.5 108.418 168.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 13.8 pt-20 -140.05 125.07 18.55 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.045 -0.354 . . . . 64.41 110.045 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.688 ' HB3' ' HA ' ' A' ' 255' ' ' ILE . 1.3 t80 172.72 -142.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 71.34 111.547 170.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.506 ' HB3' HD23 ' A' ' 284' ' ' LEU . 74.9 mt-30 -136.32 122.07 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.28 -0.418 . . . . 72.31 111.396 -166.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.93 109.02 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.942 -0.762 . . . . 65.44 108.942 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 282' ' ' GLN . 2.9 mm? -131.75 158.92 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.12 -0.491 . . . . 73.15 110.709 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.938 -0.764 . . . . 72.21 108.938 176.298 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.973 -0.38 . . . . 71.23 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.642 ' HB1' ' HA2' ' A' ' 94' ' ' GLY . . . -88.89 -87.63 0.16 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.094 0.473 . . . . 32.55 112.096 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 119' ' ' LYS . 23.1 t -125.46 127.58 24.89 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 55.52 110.178 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.98 123.23 9.54 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.494 2.796 . . . . 65.22 112.599 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.41 85.4 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.699 2.266 . . . . 73.52 112.564 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 5.5 p -72.0 -13.27 61.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 74.3 110.208 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.551 ' HE1' HE21 ' A' ' 154' ' ' GLN . 51.8 t80 -53.74 -34.98 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.995 -1.002 . . . . 72.2 110.126 169.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.22 -27.18 30.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 74.32 110.673 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' THR . 2.2 m-20 -85.22 0.98 50.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.589 -0.732 . . . . 75.5 111.196 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.67 -34.48 77.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 75.23 110.386 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.52 59.81 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.544 -0.836 . . . . 64.32 112.699 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -59.26 -53.28 60.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 62.34 110.839 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -55.53 -36.48 66.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.634 -0.712 . . . . 62.55 112.132 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.57 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 72.13 112.205 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -67.79 -40.1 83.98 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 71.21 110.682 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -68.73 -44.43 73.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.675 -0.693 . . . . 64.11 110.979 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 p -68.98 -26.67 32.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.128 0.49 . . . . 74.02 110.435 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.99 -39.91 83.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.944 -0.571 . . . . 54.33 109.727 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 58.26 39.36 25.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.78 -0.646 . . . . 65.35 111.248 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 67.82 4.39 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.954 -0.567 . . . . 55.3 111.451 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.09 -78.27 0.68 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.164 -0.541 . . . . 44.32 112.695 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -122.09 170.08 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.812 0.339 . . . . 72.02 111.03 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 122.54 6.79 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.826 -0.702 . . . . 73.11 111.621 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' HD1' HD13 ' A' ' 26' ' ' LEU . 22.2 t80 -89.35 2.91 53.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.127 0.489 . . . . 64.3 110.894 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.01 59.25 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.579 -0.82 . . . . 50.44 112.72 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.621 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 9.3 mp -102.0 156.07 17.77 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.625 0.726 . . . . 74.31 112.288 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.687 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -104.71 122.04 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.402 -1.272 . . . . 75.22 108.74 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.7 mtpp -102.74 127.78 49.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.877 -0.601 . . . . 75.15 110.59 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.31 126.65 53.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.337 -0.986 . . . . 73.11 108.337 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.584 ' HB3' ' HD1' ' A' ' 281' ' ' PHE . 4.5 t0 -142.49 133.08 25.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.303 -0.999 . . . . 74.14 108.303 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.013 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -139.12 123.98 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.755 0.252 . . . . 53.21 110.575 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 32.1 ttpt -121.15 122.56 40.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.221 0.534 . . . . 75.53 110.28 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -138.82 120.66 15.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.308 -0.86 . . . . 74.02 109.381 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HB2' ' HG2' ' A' ' 40' ' ' GLU . 3.5 pttp -144.28 155.16 43.72 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.856 -0.738 . . . . 64.12 111.684 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -133.68 169.54 16.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.805 . . . . 61.33 109.782 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -89.07 13.79 12.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.056 0.391 . . . . 74.33 112.056 -172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.07 52.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.685 0.254 . . . . 61.13 111.685 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.94 -7.59 50.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 118.896 -0.947 . . . . 63.14 115.232 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.9 126.65 47.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.307 1.553 . . . . 63.22 112.186 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 23.9 mt-10 -139.36 118.49 12.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.308 -0.627 . . . . 74.44 109.308 165.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.98 126.07 53.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 74.23 111.244 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.9 m -126.17 117.11 22.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 63.43 110.655 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -116.63 133.54 55.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.714 -0.476 . . . . 73.35 109.714 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 31.7 m -139.96 149.93 43.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.911 0.386 . . . . 73.24 110.805 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.7 129.41 2.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.105 -0.569 . . . . 55.31 111.847 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -112.89 133.84 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.758 -0.83 . . . . 60.14 108.758 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.72 129.91 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.04 0.448 . . . . 71.42 111.208 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.621 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 37.7 t-20 -91.11 143.73 26.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.55 -0.908 . . . . 62.24 108.55 177.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -65.12 -6.34 8.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.877 0.325 . . . . 75.1 111.877 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.15 168.12 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.428 -0.582 . . . . 74.51 109.428 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -52.65 -69.25 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.322 0.86 . . . . 65.3 113.322 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.8 m -122.3 92.18 3.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.314 0.578 . . . . 55.1 111.72 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 9.3 tmtm? -154.67 78.83 1.07 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.204 -1.035 . . . . 75.35 108.204 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.72 120.5 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.216 -0.902 . . . . 73.14 109.479 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -110.31 124.57 51.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.33 -0.395 . . . . 62.11 109.97 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.3 154.37 16.87 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.716 -0.754 . . . . 63.1 112.206 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 20.1 m -146.19 126.52 13.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.65 -0.5 . . . . 70.13 109.65 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -125.34 125.86 44.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.525 -0.546 . . . . 71.2 109.525 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 38.1 tt0 -129.53 126.19 38.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.035 0.445 . . . . 74.31 110.628 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 73' ' ' GLU . 3.9 m -120.1 129.45 54.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.851 -0.613 . . . . 64.5 109.758 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 68.6 mttm -117.52 133.99 55.36 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.856 -0.424 . . . . 61.53 109.856 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 50.1 m-85 -101.89 119.78 39.33 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.406 -0.961 . . . . 73.22 108.406 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.6 ttm180 -121.08 110.77 16.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 119.943 -0.703 . . . . 70.43 112.741 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -91.9 136.14 33.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.724 -1.125 . . . . 64.21 109.443 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -75.46 -11.57 60.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 72.13 112.695 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.84 106.27 2.63 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.081 -0.34 . . . . 75.1 110.081 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 66.87 -68.07 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.019 0.824 . . . . 73.42 110.476 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' HA3' ' HG2' ' A' ' 88' ' ' GLU . . . 154.66 72.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.672 -0.971 . . . . 61.23 110.672 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 63' ' ' ARG . 4.1 mm? -101.12 131.39 47.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.213 -0.292 . . . . 62.3 110.213 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 23.0 m -136.19 118.55 15.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.442 -0.344 . . . . 65.23 111.352 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.416 ' HB3' ' HD1' ' A' ' 62' ' ' TYR . 69.8 t80 -96.63 121.93 39.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.668 -0.864 . . . . 74.32 108.668 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 83' ' ' THR . 96.3 m -113.46 126.54 55.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.172 0.51 . . . . 73.24 112.158 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' CG ' ' HB ' ' A' ' 60' ' ' THR . 3.1 pt-20 -118.82 139.23 51.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.078 -0.964 . . . . 55.14 109.006 169.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.0 ttpp -142.01 142.41 32.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.917 -0.771 . . . . 74.22 108.917 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 129.73 35.82 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.088 -0.645 . . . . 75.01 111.69 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -116.18 135.96 53.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.65 -0.87 . . . . 71.33 108.65 165.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -35.77 74.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.133 0.492 . . . . 71.04 111.221 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.57 -34.83 10.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.775 -0.648 . . . . 65.42 111.723 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -104.71 -104.17 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.663 -0.415 . . . . 74.13 111.814 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -116.43 145.33 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.544 0.687 . . . . 73.43 112.777 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -106.19 131.59 53.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.224 -1.028 . . . . 73.22 108.224 168.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.86 148.28 17.97 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.652 -0.785 . . . . 31.14 112.77 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 72' ' ' THR . 88.0 m -156.45 143.98 19.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.099 -0.704 . . . . 50.12 109.099 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.642 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 4.7 mm-40 165.36 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.19 0.931 . . . . 62.12 110.632 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.476 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.54 138.29 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 74.24 112.231 -162.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 70' ' ' THR . 25.7 m -122.85 123.46 41.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.134 -0.484 . . . . 73.1 109.906 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.16 137.44 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 73.24 111.336 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HG2' ' HA3' ' A' ' 68' ' ' GLY . 12.8 pt-20 -125.79 151.31 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.12 -0.232 . . . . 70.51 111.458 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.5 ' OD2' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER 66.92 1.19 2.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.809 1.04 . . . . 73.51 113.809 171.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.88 -58.85 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.172 -0.211 . . . . 70.13 111.412 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' HB3' HD23 ' A' ' 95' ' ' LEU . 58.9 tp -74.62 -49.26 22.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.001 0.429 . . . . 75.4 110.519 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.879 -0.6 . . . . 65.35 110.033 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 7.3 mpt_? -63.82 127.71 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 65.23 110.411 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.642 ' HA2' ' HB1' ' A' ' 2' ' ' ALA . . . 101.23 -7.47 56.67 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.668 -0.777 . . . . 71.04 112.436 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 91' ' ' LEU . 50.7 tp -94.56 129.78 41.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.18 0.514 . . . . 71.52 110.957 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -122.25 111.99 17.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.391 -0.822 . . . . 74.02 109.872 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -104.98 126.78 52.4 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.149 -0.686 . . . . 74.12 109.149 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.858 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 19.8 m -125.67 119.26 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.013 0.435 . . . . 63.53 110.851 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.642 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 56.1 m-85 -113.42 119.53 37.94 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.608 -0.886 . . . . 74.14 108.608 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 12.1 m-20 -125.32 122.79 37.86 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.729 0.643 . . . . 51.43 109.383 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -115.11 122.56 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.157 -0.617 . . . . 72.11 110.112 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.3 m -111.43 122.77 48.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 73.54 110.423 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.456 ' HD2' ' HG2' ' A' ' 110' ' ' LYS . 74.7 t80 -110.21 129.7 55.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.448 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 45.4 t -104.42 128.16 27.58 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.205 -0.665 . . . . 54.41 109.205 175.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 36.0 Cg_exo -60.58 -20.32 64.02 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.652 2.234 . . . . 71.2 111.786 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -78.7 116.69 19.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.538 -0.755 . . . . 63.11 110.611 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.4 p 56.01 12.39 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.266 1.026 . . . . 74.12 113.664 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.48 74.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.553 -0.832 . . . . 70.12 112.393 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 104' ' ' SER . 57.3 tttp -65.2 123.93 20.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.32 111.247 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' A' ' 103' ' ' PHE . 97.1 mttt -112.13 136.32 51.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 54.35 110.71 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.4 121.61 38.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.694 -0.854 . . . . 73.2 108.694 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.27 133.53 55.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.278 . . . . 50.11 111.264 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 8.6 mtpm? -117.0 136.98 52.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.859 0.361 . . . . 74.4 110.72 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.661 HG23 ' HB3' ' A' ' 129' ' ' MET . 2.8 tp -134.18 116.01 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.706 -0.679 . . . . 73.42 109.602 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 35.7 ttmt -114.58 121.75 44.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.675 -0.693 . . . . 64.31 110.524 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.5 t -114.54 117.18 30.2 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.055 -0.72 . . . . 60.33 109.055 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.07 123.31 4.78 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.456 -0.878 . . . . 63.02 112.549 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.07 117.3 33.71 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.25 -0.648 . . . . 75.54 109.25 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 1.01 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -110.19 119.13 38.27 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.404 0.621 . . . . 73.52 109.878 177.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.637 ' HB2' HG23 ' A' ' 123' ' ' ILE . 17.7 mmm-85 -108.36 163.67 12.99 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.031 -0.986 . . . . 71.22 108.943 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -53.09 -34.19 55.53 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.551 0.532 . . . . 74.43 112.186 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.01 -0.77 10.52 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.4 0.519 . . . . 65.02 112.4 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 120' ' ' ARG . 3.6 tp -145.49 120.72 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.937 -0.705 . . . . 65.15 111.463 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 1.01 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 7.2 p30 -129.44 116.12 18.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 63.1 111.136 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -129.65 144.42 51.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.106 0.479 . . . . 64.0 111.112 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.589 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -142.42 131.15 4.55 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.538 -0.755 . . . . 61.24 112.243 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.7 m -110.1 114.75 28.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.825 0.345 . . . . 62.32 110.54 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 32.4 t70 -106.63 116.14 31.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.265 -0.642 . . . . 74.13 109.265 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.661 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.7 ttt -97.67 122.78 41.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 75.33 110.615 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.88 116.74 31.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.353 -0.61 . . . . 62.12 109.353 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -97.3 115.07 26.98 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.918 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.83 149.8 36.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.919 -0.771 . . . . 74.52 108.919 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -32.33 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.679 0.276 . . . . 72.24 110.625 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.08 -18.33 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 75.5 111.1 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.58 116.6 0.37 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.754 . . . . 74.31 112.517 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.16 144.83 34.08 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.026 2.484 . . . . 72.33 111.883 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 m -124.13 146.62 48.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.492 -0.322 . . . . 55.32 110.474 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 30.9 mm -107.53 116.13 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.766 -0.457 . . . . 73.1 109.766 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -110.16 110.33 21.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.974 0.416 . . . . 72.41 110.223 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.94 133.58 11.52 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.209 -0.996 . . . . 74.15 112.318 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.93 113.77 18.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.201 0.524 . . . . 64.2 109.905 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 125' ' ' LEU . 7.3 tp -115.67 123.74 49.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.611 -0.722 . . . . 73.34 110.351 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 7' ' ' TYR . 59.5 t -123.0 124.02 69.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.104 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.54 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.17 138.2 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.029 -0.73 . . . . 75.31 109.029 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -119.47 119.16 4.19 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.747 -0.74 . . . . 75.54 113.039 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.797 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 55.3 m-85 -112.75 150.44 31.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.2 -1.407 . . . . 74.44 107.2 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -49.08 94.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.154 0.434 . . . . 71.35 111.386 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.55 -30.87 9.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.912 -0.585 . . . . 71.13 112.786 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 59.1 m95 -101.88 144.7 30.19 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.42 -0.459 . . . . 73.41 111.038 -173.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.458 HD23 ' HA2' ' A' ' 145' ' ' GLY . 16.3 mt -136.33 142.62 43.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.76 0.314 . . . . 73.23 111.424 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.26 126.13 24.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 51.25 109.943 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -131.9 133.54 7.21 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.655 -0.783 . . . . 70.25 112.157 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.557 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 92.1 m-85 -127.71 119.33 25.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.771 0.32 . . . . 73.55 110.723 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.551 HE21 ' HE1' ' A' ' 7' ' ' TYR . 85.8 mt-30 -106.52 123.04 47.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.215 -0.661 . . . . 74.1 109.215 173.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -137.44 129.8 29.56 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.549 -0.296 . . . . 65.31 110.255 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.404 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 48.3 t30 -112.57 118.98 36.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.502 -0.555 . . . . 61.13 109.502 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.888 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 27.7 m-85 -91.87 129.49 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 75.41 110.52 -173.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 23.8 tt0 -97.49 110.5 23.04 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 109.277 -0.638 . . . . 72.34 109.277 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -70.28 -16.04 62.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 112.777 -2.01 . . . . 71.21 111.822 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.86 66.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.871 0.843 . . . . 71.24 109.088 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.554 ' HG3' ' HB2' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -122.83 -153.97 0.58 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.36 -1.348 . . . . 74.42 107.36 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 p -107.31 28.3 8.23 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.916 -0.49 . . . . 71.3 110.452 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.554 ' HB2' ' HG3' ' A' ' 161' ' ' LYS . 14.4 mmt180 -139.75 149.11 43.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.051 -1.06 . . . . 72.1 112.355 -161.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.888 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.21 136.58 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.569 -0.53 . . . . 72.5 109.569 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 6.6 t -93.43 -23.52 18.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.903 -0.59 . . . . 71.21 110.41 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -141.14 133.19 27.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 64.25 110.599 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 2.7 m -121.89 115.91 23.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.574 -0.739 . . . . 63.14 109.759 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 51.7 t30 -118.77 120.46 37.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.881 -0.785 . . . . 73.43 108.881 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 24.8 m-85 -120.87 140.86 51.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.403 -0.519 . . . . 75.44 110.298 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -143.09 127.19 17.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.185 -0.461 . . . . 45.54 110.49 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' A' ' 182' ' ' THR . 49.0 t -126.39 136.97 59.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.866 -0.42 . . . . 74.25 109.866 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.55 124.81 7.0 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.22 -0.514 . . . . 52.31 112.111 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.57 125.6 54.44 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.327 -0.62 . . . . 63.14 109.327 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -102.94 125.63 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.379 0.609 . . . . 74.51 111.255 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 19.7 p -131.19 164.92 24.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.076 -0.965 . . . . 71.2 108.41 171.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.41 -46.93 76.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.248 0.462 . . . . 63.14 112.248 -170.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -102.45 -22.79 14.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.691 -0.404 . . . . 74.05 111.778 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.556 ' HB2' ' OG1' ' A' ' 175' ' ' THR . 47.5 m-85 -113.51 135.82 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.101 0.477 . . . . 75.42 111.604 -172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -111.07 122.68 48.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.732 -1.21 . . . . 75.11 107.732 165.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.69 136.94 53.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.32 0.581 . . . . 62.42 111.174 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.531 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 13.3 t60 -126.68 113.72 17.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.227 -0.897 . . . . 72.04 109.061 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.718 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 7.3 t -93.66 141.45 28.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.329 -0.989 . . . . 73.21 108.329 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -133.6 140.1 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 72.41 109.991 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 41.5 t -126.87 120.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.065 -0.516 . . . . 64.3 111.013 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.2 t30 -99.32 90.0 4.4 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.6 0.714 . . . . 74.24 109.092 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 3.1 t70 55.73 -161.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.002 -1.454 . . . . 65.33 110.944 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.598 -0.81 . . . . 64.23 112.157 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.7 m -93.52 -25.56 17.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.627 0.603 . . . . 73.3 112.627 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 32.8 tt0 -134.49 124.42 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.601 -0.84 . . . . 65.14 112.364 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -121.18 126.2 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.188 -0.914 . . . . 71.2 108.545 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.24 -172.56 19.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.773 -1.204 . . . . 71.31 113.395 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.23 172.94 31.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.716 -0.554 . . . . 74.33 111.716 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 33.1 m -148.27 142.29 25.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.238 -0.282 . . . . 44.12 110.238 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.584 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 10.6 mm -119.52 118.82 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 73.11 109.4 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -108.24 120.98 43.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.417 -0.586 . . . . 63.14 109.417 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 199' ' ' ASN . 1.7 mm-40 -121.78 111.69 17.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.787 -0.642 . . . . 71.31 111.41 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.601 ' HD2' ' O ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -89.85 130.8 36.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.485 -0.931 . . . . 73.33 108.485 169.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 197' ' ' LYS . 10.3 m 58.95 36.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.923 0.868 . . . . 75.34 110.95 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 196' ' ' GLN . 14.5 t30 -52.54 -50.35 63.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.68 -1.145 . . . . 63.2 108.827 170.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 200' ' ' LYS . 13.6 tppt? -144.31 71.19 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.73 -1.123 . . . . 75.43 107.981 169.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 70.25 -41.74 0.5 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.005 -0.998 . . . . 54.21 112.427 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.806 HD12 ' H ' ' A' ' 226' ' ' GLN . 2.5 mm? -92.74 -161.05 0.8 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.925 0.393 . . . . 75.45 111.089 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 224' ' ' LYS . 45.3 mt-10 -111.82 153.33 26.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.527 -0.306 . . . . 74.34 110.565 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -147.68 143.84 27.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.495 -0.321 . . . . 74.41 110.279 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -134.61 136.76 43.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.83 0.347 . . . . 70.2 110.407 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 45.1 t -123.25 145.42 30.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.074 -0.512 . . . . 74.54 110.088 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -131.98 136.28 47.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.876 0.37 . . . . 72.51 110.481 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.32 140.98 51.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 63.42 109.629 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -140.5 128.91 22.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.966 0.412 . . . . 41.2 111.399 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -115.39 132.88 56.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.737 -0.838 . . . . 74.31 108.737 174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 12.3 t -116.5 132.54 56.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.801 -0.444 . . . . 71.25 109.801 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.04 150.37 25.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.765 . . . . 70.02 111.457 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.01 15.07 13.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.464 -0.874 . . . . 52.04 112.392 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.26 87.34 0.11 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.268 0.556 . . . . 70.32 111.328 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.0 t -146.49 171.95 14.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 52.11 109.862 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.76 159.63 23.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.736 -0.468 . . . . 71.32 109.736 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.4 m -77.29 135.79 38.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.745 0.307 . . . . 61.23 110.329 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 55.2 mtm180 -88.96 136.39 33.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.923 -0.399 . . . . 73.34 109.923 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.647 ' HB2' ' HB3' ' A' ' 239' ' ' ASN . 79.7 m-85 -114.52 138.96 49.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.658 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.49 139.67 10.21 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.612 -0.995 . . . . 73.4 110.612 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.5 ' HB ' HG12 ' A' ' 237' ' ' VAL . 5.0 mp -136.14 130.48 48.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.2 0.5 . . . . 61.23 110.504 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.1 129.41 50.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.796 -0.446 . . . . 64.33 109.796 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.25 139.71 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.601 0.239 . . . . 62.34 110.59 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 203' ' ' GLU . 43.9 mtmt -117.28 114.75 24.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.465 ' HA ' ' HG ' ' A' ' 202' ' ' LEU . 47.4 m-85 -100.76 115.34 30.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.211 -0.662 . . . . 62.25 109.211 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.806 ' H ' HD12 ' A' ' 202' ' ' LEU . 35.7 tt0 -86.7 99.62 11.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.161 -0.472 . . . . 72.25 110.029 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.82 -37.31 12.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.499 0.666 . . . . 72.52 109.685 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.74 145.52 19.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.106 -0.952 . . . . 74.42 109.18 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.51 -30.73 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.955 2.437 . . . . 75.12 113.454 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.46 -18.62 21.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.085 0.402 . . . . 73.1 112.085 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.71 122.75 20.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.237 0.541 . . . . 50.33 111.797 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 52.0 t -124.49 136.44 54.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.21 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -99.99 128.82 46.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.743 -0.466 . . . . 74.32 109.743 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.9 m -113.95 152.79 30.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.844 0.354 . . . . 63.32 110.503 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -140.66 141.21 35.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.357 -0.609 . . . . 73.15 109.357 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 54.9 mtmt -134.46 154.51 51.37 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.309 -0.256 . . . . 75.42 110.309 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.1 p -149.98 147.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.966 0.413 . . . . 64.45 110.663 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.7 t-20 -117.63 149.55 40.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.655 -0.868 . . . . 61.32 108.655 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . 0.1 OUTLIER -56.63 -17.61 9.28 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.88 0.696 . . . . 65.42 112.88 -172.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 49.2 m -83.22 23.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.455 0.169 . . . . 71.04 111.021 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 50.1 m 64.9 39.66 5.8 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.299 0.571 . . . . 73.12 110.449 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.94 ' HB3' HD11 ' A' ' 262' ' ' LEU . 46.1 mt -98.15 115.61 28.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.748 -0.66 . . . . 73.21 109.5 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.9 OUTLIER -105.34 117.62 51.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 109.841 -0.429 . . . . 72.13 109.841 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -120.4 162.12 14.45 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.825 -0.702 . . . . 73.41 112.723 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 2.6 pp -142.01 160.39 40.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.032 -0.358 . . . . 72.25 110.032 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -150.54 150.86 22.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.751 -0.738 . . . . 71.44 112.905 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 258' ' ' THR . 81.7 m-85 -123.16 115.96 22.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.561 -0.533 . . . . 63.22 109.561 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 20.0 m -113.0 114.0 26.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.739 -0.467 . . . . 74.0 109.739 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -135.45 127.62 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 65.52 110.548 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 32.1 m -88.53 128.55 35.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.551 0.215 . . . . 74.04 110.468 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.463 HD23 ' HG3' ' A' ' 252' ' ' LYS . 3.3 tt -122.24 88.92 3.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.215 -0.661 . . . . 74.35 109.215 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.463 ' HG3' HD23 ' A' ' 251' ' ' LEU . 94.1 mttt 68.99 166.06 0.13 Allowed Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 115.545 -0.752 . . . . 74.21 111.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.09 71.77 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.64 2.227 . . . . 61.21 112.351 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.32 -59.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.062 -0.589 . . . . 64.14 111.885 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 279' ' ' LEU . 0.0 OUTLIER -119.24 122.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 71.44 111.992 -171.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 1.062 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 66.4 mttm -92.28 135.45 34.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.209 -1.034 . . . . 53.32 108.209 163.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.82 123.41 41.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.25 -0.648 . . . . 74.31 109.25 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 48.6 m -122.47 111.12 16.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.454 0.645 . . . . 73.35 110.462 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.728 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -100.21 125.62 46.4 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.664 -1.235 . . . . 64.13 107.664 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 60.1 m -131.44 140.02 49.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 73.44 110.927 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.77 139.83 26.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.817 -0.438 . . . . 73.33 109.817 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.94 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -118.4 121.99 41.7 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.816 -0.809 . . . . 65.32 108.816 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.626 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -103.08 106.72 17.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.605 -0.887 . . . . 74.53 108.605 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.953 ' H ' HG21 ' A' ' 268' ' ' VAL . 5.3 t70 -72.92 98.0 2.39 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.318 -0.993 . . . . 62.15 108.318 172.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.45 -8.46 2.66 Favored Glycine 0 C--N 1.307 -1.076 0 CA-C-N 115.078 -0.965 . . . . 54.14 114.044 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.42 -15.83 25.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.444 0.164 . . . . 60.41 110.981 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -152.84 -28.63 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.657 0.741 . . . . 74.45 110.906 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.953 HG21 ' H ' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -54.12 -22.25 7.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.595 -1.184 . . . . 63.43 113.021 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -55.9 -20.57 16.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.666 -0.697 . . . . 53.34 111.459 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.56 -16.58 59.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 63.42 111.43 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.35 -0.53 14.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 65.14 113.168 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -93.09 63.93 2.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 72.33 112.3 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.545 ' HB2' ' CD1' ' A' ' 263' ' ' LEU . 4.0 p-80 -79.27 147.92 32.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.68 -0.118 . . . . 74.45 110.68 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -95.3 138.02 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.533 -0.467 . . . . 71.43 109.759 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -132.84 140.57 48.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 75.31 110.631 -170.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.54 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -142.07 131.53 4.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.549 -0.62 . . . . 73.14 111.549 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.728 HD23 HD22 ' A' ' 259' ' ' LEU . 3.4 tm? -115.75 137.57 51.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.967 -0.753 . . . . 72.4 108.967 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.423 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -150.96 140.51 7.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.075 -1.059 . . . . 72.4 113.144 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.504 HD12 HD11 ' A' ' 255' ' ' ILE . 2.4 mm? -110.85 129.98 55.71 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.625 -0.88 . . . . 75.34 108.625 172.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 1.062 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 21.7 mm-40 -101.84 112.04 24.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.312 1.053 . . . . 72.3 112.997 -168.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 1.013 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 34.4 p90 -29.21 44.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 119.971 3.323 . . . . 43.2 119.971 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.858 ' HG2' ' HG3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -113.9 104.91 12.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 122.424 2.375 . . . . 74.1 112.332 -175.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.62 106.26 8.61 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.554 -0.906 . . . . 75.02 108.554 163.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -155.12 -166.06 2.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.383 -0.826 . . . . 61.43 109.122 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.778 -0.63 . . . . 74.33 109.739 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttm . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.084 0.469 . . . . 73.4 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.35 93.52 5.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.083 -0.508 . . . . 74.01 110.614 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.737 HG11 ' HB2' ' A' ' 119' ' ' LYS . 7.9 t -80.31 119.67 77.13 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.67 -0.695 . . . . 74.22 109.678 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.68 162.34 42.43 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.902 2.401 . . . . 71.53 112.824 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.63 79.85 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.764 2.31 . . . . 74.33 111.003 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.554 ' HB ' ' CG1' ' A' ' 143' ' ' VAL . 26.7 p -69.84 -46.95 64.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.434 -0.803 . . . . 73.31 111.995 -172.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -58.37 -28.4 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.058 -0.519 . . . . 71.3 111.41 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.26 -22.99 35.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.094 0.473 . . . . 74.41 110.839 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.27 -15.66 45.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.843 -0.617 . . . . 71.23 109.737 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.61 HD21 HG13 ' A' ' 143' ' ' VAL . 75.1 mt -63.72 -29.23 70.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.65 -0.705 . . . . 55.33 110.263 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.49 62.96 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.73 -0.668 . . . . 42.33 112.263 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 64.0 tttp -63.87 -49.4 72.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 65.23 110.183 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 m -64.55 -38.32 90.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.296 0.569 . . . . 72.41 110.529 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.439 -0.801 . . . . 75.44 112.254 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.638 ' HG3' ' N ' ' A' ' 16' ' ' ASP . 1.7 ptt180 -59.7 -36.99 77.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.563 0.22 . . . . 71.2 111.171 -175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.638 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 69.7 m-20 -68.47 -37.0 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 72.11 110.677 -175.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -72.43 -40.42 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 70.15 110.809 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -70.71 -33.75 71.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.812 -0.631 . . . . 71.21 110.983 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 m -70.04 133.72 47.51 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.71 -0.478 . . . . 73.31 109.71 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -69.53 79.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.72 0.772 . . . . 64.1 111.632 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.98 70.42 2.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.28 -0.728 . . . . 55.35 111.28 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' A' ' 274' ' ' LYS . 17.7 p90 -85.04 -53.62 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.568 0.223 . . . . 72.43 110.884 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.56 129.39 4.17 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.661 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -104.33 5.64 34.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.297 0.57 . . . . 71.32 110.463 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 89.39 12.6 62.8 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.543 -1.023 . . . . 72.34 110.543 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 46' ' ' SER . 0.5 OUTLIER -102.78 153.5 20.1 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.943 -0.628 . . . . 62.54 111.423 -169.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.783 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.8 mp -106.9 124.46 62.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.002 -0.999 . . . . 71.33 110.545 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.8 tptm -102.06 119.47 38.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.484 -0.562 . . . . 65.41 109.484 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -113.84 128.63 56.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.005 0.431 . . . . 75.01 110.132 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -120.76 136.35 54.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.735 . . . . 71.22 109.066 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.909 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -133.39 123.84 26.07 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.197 -0.668 . . . . 62.32 109.197 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 14.3 pttm -137.08 125.58 23.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.203 0.525 . . . . 75.54 111.498 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.758 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 18.9 m -109.71 121.27 44.84 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.512 -0.922 . . . . 61.4 108.512 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -109.82 124.45 51.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.933 -0.307 . . . . 74.25 111.165 -170.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.82 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 12.2 t -140.41 169.66 17.26 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.277 -1.008 . . . . 45.24 108.277 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.21 179.83 4.25 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.091 -0.707 . . . . 72.42 109.091 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.59 43.63 7.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.14 0.495 . . . . 75.41 111.27 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 94.49 -4.84 70.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 116.984 1.554 . . . . 73.43 116.984 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.82 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -100.2 124.13 45.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 120.971 2.385 . . . . 73.21 112.141 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.893 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.9 tt0 -143.08 118.02 9.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.987 -0.746 . . . . 52.24 108.987 162.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 97.4 m-85 -108.34 121.78 45.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.546 -0.462 . . . . 73.55 110.473 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 33.0 m -125.19 132.65 52.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.104 0.478 . . . . 72.35 111.062 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.685 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 44.3 t -125.32 143.11 51.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.729 -0.841 . . . . 75.15 108.729 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m -135.67 126.55 27.56 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.04 -0.356 . . . . 51.22 110.04 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' HA2' ' HA2' ' A' ' 56' ' ' GLY . . . -141.78 157.13 26.21 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.171 -1.014 . . . . 65.4 112.47 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB3' HD21 ' A' ' 26' ' ' LEU . 39.8 m -131.82 139.27 48.81 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.978 -0.749 . . . . 73.42 108.978 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -119.46 129.08 54.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.224 0.535 . . . . 63.14 110.574 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.83 145.93 24.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.043 -0.98 . . . . 60.43 108.852 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.06 76.19 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.371 0.605 . . . . 54.55 111.457 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -167.22 154.14 8.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.915 -1.143 . . . . 73.14 107.915 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.7 m -56.22 -45.94 79.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.097 0.777 . . . . 74.23 113.097 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.3 p -129.29 47.31 2.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 72.13 112.496 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.33 73.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.384 0.612 . . . . 71.14 110.991 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.57 120.57 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.47 -0.787 . . . . 72.13 109.633 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -109.2 126.53 53.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.709 -0.478 . . . . 71.35 109.709 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HA2' ' A' ' 45' ' ' GLY . . . -132.74 170.72 21.94 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.343 -0.932 . . . . 74.2 113.07 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.5 m -147.56 157.66 43.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.421 -0.585 . . . . 74.54 109.421 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 58' ' ' LEU . 1.2 tm? -120.22 125.02 47.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 74.04 109.371 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.8 tt0 -118.82 119.25 33.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.582 -0.736 . . . . 61.42 109.504 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 m -110.23 120.02 41.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.431 -0.349 . . . . 73.34 110.527 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.893 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mptt -106.61 131.45 53.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.224 0.535 . . . . 64.13 110.359 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.5 m-85 -103.21 118.48 36.87 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.305 -1.369 . . . . 74.23 107.305 170.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.447 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 33.3 ttm-85 -113.46 109.69 19.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.424 0.631 . . . . 75.33 111.876 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.21 91.2 8.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.161 -0.927 . . . . 71.54 109.254 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -16.42 61.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.299 -0.864 . . . . 71.21 110.679 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.89 -41.31 87.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.193 -0.912 . . . . 74.41 111.031 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.489 ' HB2' ' HG ' ' A' ' 69' ' ' LEU . 67.6 m-85 -108.14 -33.94 7.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.33 111.186 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.624 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 101.95 44.44 1.91 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.947 -0.861 . . . . 53.41 110.947 -173.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 87' ' ' VAL . 13.4 mt -126.91 147.21 50.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.804 -0.443 . . . . 75.44 109.804 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -136.57 135.3 38.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.691 0.281 . . . . 75.53 111.13 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 70.1 t80 -115.17 120.73 40.72 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.429 -0.582 . . . . 74.25 109.429 173.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 17.7 m -109.57 117.74 34.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.236 -0.438 . . . . 52.33 110.305 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 42.8 tt0 -109.15 120.34 42.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.355 -0.609 . . . . 72.31 109.355 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -107.81 97.6 7.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.095 -0.502 . . . . 71.0 109.7 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.585 ' HD1' HD13 ' A' ' 81' ' ' LEU . 46.4 t90 -100.35 131.84 46.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.345 0.593 . . . . 71.52 111.279 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.38 154.11 35.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.521 -0.763 . . . . 43.23 109.861 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 m -57.6 -18.4 19.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.016 0.436 . . . . 61.12 111.9 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 20.2 t70 -67.57 -3.86 10.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.095 -0.502 . . . . 73.44 110.906 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 77.6 m-20 79.66 22.84 0.51 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.876 0.87 . . . . 70.11 110.02 -175.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 25.7 m -88.83 118.14 28.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.54 -0.754 . . . . 61.31 111.015 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.585 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.8 mm? -97.19 118.37 33.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 63.41 109.213 172.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.68 92.83 0.85 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.512 -0.851 . . . . 43.24 111.21 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 p -91.39 103.5 16.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.986 0.422 . . . . 73.21 111.414 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 25.4 tt0 -106.73 111.63 24.25 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.456 -0.793 . . . . 70.25 109.565 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.9 121.52 64.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.437 -0.579 . . . . 74.34 109.437 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 98' ' ' THR . 14.3 t -128.2 129.66 46.81 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.54 0.686 . . . . 73.22 111.537 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.678 ' HA ' HD22 ' A' ' 69' ' ' LEU . 32.5 m -111.01 129.89 65.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.417 -0.81 . . . . 74.24 109.631 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.28 118.71 36.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 71.11 112.131 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 47.27 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.319 1.012 . . . . 73.24 112.804 171.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.511 ' HB2' ' H ' ' A' ' 91' ' ' LEU . 1.5 mp0 -116.97 -92.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.317 -0.401 . . . . 74.34 110.09 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' H ' ' HB2' ' A' ' 90' ' ' GLN . 8.1 mp -95.2 -44.72 7.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.982 -0.747 . . . . 71.51 108.982 175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.65 103.71 5.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 63.05 109.376 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.83 124.26 21.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.693 -0.685 . . . . 74.3 110.756 -173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.77 5.73 87.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.869 -0.681 . . . . 61.35 113.085 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 128.16 38.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.238 0.519 . . . . 71.32 111.638 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -118.28 111.39 18.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.61 -0.885 . . . . 64.21 108.61 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.633 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.2 mm? -102.52 124.78 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.514 -0.551 . . . . 54.51 109.514 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 7.8 m -131.21 119.69 22.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.54 -0.3 . . . . 71.04 111.015 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 72.5 t80 -111.2 115.32 29.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.473 -0.566 . . . . 72.13 109.473 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -112.02 122.63 48.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.189 -0.459 . . . . 62.4 109.775 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.4 t -138.16 123.83 19.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.43 -0.508 . . . . 71.54 111.004 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 13.0 m -104.17 122.69 45.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.064 -0.516 . . . . 51.31 110.264 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.81 124.87 48.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.556 -0.293 . . . . 64.25 110.786 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.9 t -127.6 102.42 22.97 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.437 -0.579 . . . . 54.01 109.437 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.23 -9.13 22.93 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.074 2.516 . . . . 74.15 112.755 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -78.52 -40.12 36.1 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.034 -0.358 . . . . 64.22 110.034 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 p -100.22 -25.61 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 73.0 111.171 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.936 -0.575 . . . . 74.23 111.897 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -79.12 123.93 27.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 71.42 111.275 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -132.66 124.63 28.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.934 -0.575 . . . . 73.43 109.495 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 101' ' ' SER . 7.4 m120 -120.45 128.37 53.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.825 -0.625 . . . . 65.12 110.353 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -114.07 114.79 26.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.259 -0.428 . . . . 64.11 110.366 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -111.13 136.95 49.43 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.158 -0.682 . . . . 74.13 109.158 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -119.47 117.62 54.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 72.03 109.833 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.2 tttp -115.26 119.13 35.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.495 -0.775 . . . . 72.44 109.285 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -127.2 118.59 24.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.679 -0.489 . . . . 63.13 109.679 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -127.13 122.84 4.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.333 -0.937 . . . . 63.53 112.577 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -110.0 121.03 44.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.375 0.607 . . . . 74.24 109.501 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.737 ' HB2' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.6 124.23 51.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.649 -0.705 . . . . 64.11 110.673 179.231 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 120' ' ' ARG . 10.0 tpp180 -104.96 167.68 9.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.559 -1.274 . . . . 75.41 107.559 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 120' ' ' ARG . 37.7 tt0 -53.16 -33.33 52.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.475 0.546 . . . . 63.15 112.475 -167.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -120.25 0.32 10.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.801 0.667 . . . . 71.41 112.801 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.926 HG13 HD21 ' A' ' 142' ' ' LEU . 7.7 tt -145.25 136.01 19.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 O-C-N 121.74 -0.6 . . . . 74.14 111.985 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.774 ' O ' HD23 ' A' ' 142' ' ' LEU . 5.4 t30 -129.19 109.84 11.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.088 -0.645 . . . . 62.45 111.308 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.049 ' HG ' ' HG ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -112.89 142.48 45.51 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.449 0.642 . . . . 64.52 111.719 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -143.33 127.06 2.97 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.78 -1.1 . . . . 51.42 112.737 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.22 111.85 24.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.952 -0.388 . . . . 73.32 109.952 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -113.52 118.23 33.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.495 -0.557 . . . . 73.0 109.495 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.635 ' HG2' HG13 ' A' ' 138' ' ' ILE . 59.3 mtt -120.94 119.37 32.39 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.747 -0.381 . . . . 53.43 111.391 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 15.3 m-20 -90.65 118.39 30.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 109.811 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 74.3 t80 -96.87 104.55 16.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.966 0.412 . . . . 65.22 110.014 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.26 157.27 30.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.865 -0.607 . . . . 70.31 109.717 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.2 pp -73.85 -15.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.209 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.441 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -88.88 -17.59 29.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.013 0.435 . . . . 74.14 110.714 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.44 117.54 0.67 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.926 -0.654 . . . . 73.12 112.08 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 56.1 Cg_endo -72.01 134.36 23.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.463 2.109 . . . . 72.0 111.781 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -119.37 144.14 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.458 -0.337 . . . . 75.41 110.397 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -107.29 117.12 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.459 -0.571 . . . . 75.44 109.459 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -114.63 113.85 24.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.745 -0.661 . . . . 74.5 109.532 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.71 129.57 9.35 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.375 -1.393 . . . . 71.14 111.365 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . . . -124.7 118.72 27.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.651 0.263 . . . . 65.03 110.704 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.049 ' HG ' ' HG ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -117.08 144.76 44.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.332 -0.394 . . . . 55.45 110.624 175.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.628 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 45.4 t -128.5 115.43 37.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.52 -1.289 . . . . 74.32 107.52 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -120.93 137.27 54.69 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.547 -1.206 . . . . 74.14 110.117 -169.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.54 135.7 13.06 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 120.604 -0.808 . . . . 50.12 113.2 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -143.8 125.36 14.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.011 0.434 . . . . 73.31 111.4 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 59.22 23.35 11.68 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.987 0.736 . . . . 64.22 112.987 168.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.69 -18.18 51.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.378 -0.915 . . . . 63.41 113.062 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -105.17 146.65 28.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.891 -0.411 . . . . 72.11 109.891 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.541 HD22 HG12 ' A' ' 143' ' ' VAL . 5.0 mt -108.9 148.39 30.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 72.11 110.637 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 144' ' ' LEU . . . -141.85 124.26 15.72 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.73 -1.211 . . . . 54.44 107.73 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -156.05 131.82 3.15 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.58 -0.819 . . . . 74.23 111.965 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.983 ' CB ' ' HA ' ' A' ' 169' ' ' PHE 0.423 0.1 OUTLIER -165.06 171.76 13.48 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 116.209 1.929 . . . . 74.11 116.209 167.326 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 26.4 pt20 -106.85 134.37 50.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.416 -1.72 . . . . 64.35 111.498 -166.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.8 ttp -110.84 141.53 44.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 51.34 109.576 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.53 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 43.4 m-80 -114.51 117.92 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.024 -0.27 . . . . 71.02 110.351 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.851 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 74.1 t80 -102.08 122.27 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.684 -0.689 . . . . 74.12 110.759 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 163' ' ' ARG . 32.4 tt0 -88.78 99.93 12.75 Favored 'General case' 0 C--O 1.259 1.574 0 CA-C-N 115.567 -0.742 . . . . 64.45 109.044 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.46 HG23 ' HE1' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -70.29 -19.98 63.06 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 113.446 -1.706 . . . . 71.12 111.664 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.18 -26.65 64.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.047 0.927 . . . . 62.13 108.732 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -122.39 -157.5 0.74 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.136 -1.393 . . . . 70.43 107.839 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -107.64 27.76 8.84 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.32 -0.622 . . . . 52.53 109.32 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -133.64 129.36 36.77 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.64 -0.824 . . . . 62.51 112.857 -159.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.851 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.8 m -73.54 136.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 168.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 2.0 m -90.01 -34.53 15.94 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.518 -0.473 . . . . 63.54 110.371 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -149.89 133.29 16.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 73.33 110.017 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.7 m -103.14 111.76 24.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.557 -0.905 . . . . 62.5 108.557 172.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.932 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 46.5 m-20 -106.4 121.67 44.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.863 -0.791 . . . . 73.22 108.863 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.983 ' HA ' ' CB ' ' A' ' 153' ' ' TYR . 51.4 p90 -131.17 138.94 49.65 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.057 0.848 . . . . 74.12 111.31 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.779 ' H ' ' HB2' ' A' ' 153' ' ' TYR . . . -130.25 145.84 51.8 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 120.883 0.373 . . . . 71.41 110.547 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 151' ' ' ALA . 48.8 t -127.56 131.28 70.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.276 -0.42 . . . . 75.14 110.635 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.3 95.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.655 -0.978 . . . . 72.3 110.655 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -110.92 119.62 39.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.853 -0.795 . . . . 72.25 108.853 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 34.0 mtmm -114.84 127.92 56.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.331 -0.395 . . . . 73.13 111.46 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 56.7 m -132.09 113.44 13.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.137 -0.483 . . . . 75.01 110.347 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 40.4 -93.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.266 1.21 . . . . 75.51 114.266 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.1 -11.85 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.672 0.619 . . . . 74.3 112.672 -170.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 175' ' ' THR . 48.4 p90 -129.97 135.94 48.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.622 0.725 . . . . 74.5 111.615 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.405 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 75.8 mt-30 -114.46 123.18 48.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.231 -0.895 . . . . 63.42 108.924 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.24 137.55 33.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.281 0.562 . . . . 64.02 111.081 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -123.8 115.67 21.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.052 -0.976 . . . . 74.13 108.689 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 43.8 m -124.54 115.46 20.9 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.658 -0.417 . . . . 74.25 110.086 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.43 140.62 50.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.371 0.605 . . . . 71.44 109.852 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 6.4 t -126.31 130.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.521 -0.763 . . . . 73.14 110.757 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.852 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 11.9 m-20 -105.51 93.69 4.8 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.383 -0.969 . . . . 70.43 108.383 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.0 t70 61.47 -179.53 0.12 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.633 -0.506 . . . . 74.41 109.633 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.48 -6.35 61.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.795 -0.717 . . . . 50.32 112.174 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.8 p -96.4 -26.17 15.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.055 0.761 . . . . 65.23 113.055 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.852 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 24.8 mt-10 -118.45 124.99 48.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 119.697 -0.801 . . . . 63.03 112.23 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.8 125.52 53.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.398 -0.819 . . . . 75.52 109.745 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.18 113.52 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.899 -0.667 . . . . 73.32 112.089 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.99 139.28 15.02 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.934 -0.65 . . . . 64.44 111.883 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 14.5 m -140.52 138.39 34.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.914 0.388 . . . . 62.41 110.03 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.3 mp -124.56 128.33 73.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.666 -0.494 . . . . 62.52 109.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 42.9 t80 -106.67 119.75 40.14 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.622 -0.881 . . . . 75.3 108.622 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -122.51 131.1 53.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.414 -0.587 . . . . 74.54 109.414 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 197' ' ' LYS . 24.9 ttpp -103.29 109.05 20.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.786 -0.643 . . . . 73.34 109.678 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 202' ' ' LEU . 0.0 OUTLIER -93.2 -17.36 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-O 121.555 0.693 . . . . 75.02 109.82 -176.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 14.2 t-20 -163.86 158.17 19.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.917 -1.038 . . . . 72.13 108.324 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -63.67 -13.24 41.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.014 0.435 . . . . 50.13 111.071 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 226' ' ' GLN . 19.0 tttp -116.05 3.98 13.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.001 -0.545 . . . . 54.41 110.642 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.541 ' HG ' HG23 ' A' ' 198' ' ' VAL . 47.8 tp -140.29 108.98 5.92 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.766 0.793 . . . . 62.22 111.307 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.554 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 24.7 mt-10 -115.32 137.84 51.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.953 -1.021 . . . . 63.31 110.192 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 p -123.68 151.17 43.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.122 -0.325 . . . . 71.41 110.122 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -140.11 139.03 35.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.015 0.436 . . . . 73.14 111.306 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 193' ' ' SER . 53.3 t -112.11 137.43 44.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.313 -0.625 . . . . 51.01 109.313 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -132.84 128.34 36.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.263 -0.643 . . . . 65.23 109.263 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.6 pt? -147.89 130.61 16.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.412 0.625 . . . . 74.44 111.082 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.2 132.87 55.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.33 -0.85 . . . . 75.2 110.363 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.779 ' HB2' HG23 ' A' ' 217' ' ' THR . 19.3 t90 -130.7 131.7 44.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.569 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 11.9 m -104.7 113.49 27.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.763 -0.653 . . . . 65.54 109.649 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.81 127.54 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.903 -0.406 . . . . 42.33 109.903 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.93 17.65 57.54 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 31.31 111.537 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 12.0 t-20 -129.93 -153.86 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.772 -0.825 . . . . 64.43 108.772 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 214' ' ' ASN . 17.2 m -85.95 -154.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.066 0.46 . . . . 71.44 111.747 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.72 163.47 7.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.497 -0.774 . . . . 72.1 112.553 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.779 HG23 ' HB2' ' A' ' 210' ' ' TRP . 32.7 m -76.39 134.55 39.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.605 -0.725 . . . . 63.0 109.18 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 69.3 mtt85 -101.05 116.12 32.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.723 -0.473 . . . . 71.44 109.723 -173.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.489 ' HD2' HD13 ' A' ' 208' ' ' LEU . 65.8 t80 -113.5 149.67 34.01 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.608 0.568 . . . . 74.04 110.493 -172.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -158.93 150.6 21.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.211 -0.519 . . . . 23.04 112.2 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.4 130.53 72.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.902 -0.407 . . . . 71.14 109.902 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -119.5 154.52 33.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.811 0.339 . . . . 54.23 110.303 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.67 125.71 18.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.174 -0.467 . . . . 42.1 110.23 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -112.38 114.06 26.58 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.62 -0.511 . . . . 73.55 109.62 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.45 ' HD2' HD13 ' A' ' 202' ' ' LEU . 74.8 t80 -113.73 116.29 29.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.448 -0.575 . . . . 74.12 109.448 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 3.6 pt20 -95.94 99.58 11.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.716 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.4 tt -69.44 -24.92 28.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.527 0.68 . . . . 60.44 109.521 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 230' ' ' ASP . 18.9 t70 -166.6 146.31 4.93 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.199 -1.037 . . . . 75.01 108.199 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 228' ' ' ASP . 27.8 Cg_exo -64.1 12.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.793 2.329 . . . . 73.4 113.399 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 228' ' ' ASP . 23.3 t70 -104.92 -29.34 10.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.44 110.067 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.33 125.86 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 73.13 110.831 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 56.1 m -124.04 142.23 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.129 0.49 . . . . 73.43 110.755 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -108.86 127.33 53.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.213 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 5.5 p -129.39 117.21 20.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 53.42 110.965 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.43 158.67 23.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.111 -0.329 . . . . 75.12 110.111 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 26.2 pttm -152.94 141.86 21.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.019 0.438 . . . . 70.33 110.849 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.8 p -128.66 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 71.41 109.814 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.8 m120 -107.91 150.56 26.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.752 -0.462 . . . . 73.02 109.752 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.73 -8.79 16.13 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.672 0.607 . . . . 75.34 111.534 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.468 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 13.3 m -80.82 14.67 2.07 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.824 -0.436 . . . . 75.54 109.824 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 17.4 m 68.31 36.83 2.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.256 -0.883 . . . . 62.23 110.702 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 262' ' ' LEU . 40.5 mt -99.29 115.61 29.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 63.43 109.697 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.645 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -112.29 116.7 53.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.65 -0.42 . . . . 63.33 110.503 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -135.61 152.21 20.87 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.123 -1.036 . . . . 74.21 113.526 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -127.96 156.12 43.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 71.33 110.737 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -143.42 143.59 12.59 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.993 -0.622 . . . . 74.32 112.157 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 258' ' ' THR . 63.8 m-85 -114.47 115.6 27.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.784 -0.451 . . . . 72.44 109.784 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 17.9 m -109.91 114.38 27.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.504 -0.554 . . . . 75.01 109.504 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -135.53 143.18 45.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.757 0.313 . . . . 62.22 110.801 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.8 t -107.54 116.18 31.49 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.051 -0.722 . . . . 60.44 109.051 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.512 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 3.8 mm? -70.34 173.57 6.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.861 -0.609 . . . . 63.23 110.518 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.614 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 20.8 mtpp -67.63 -44.97 45.56 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.25 -0.432 . . . . 75.3 110.852 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 16.8 Cg_exo -70.37 -174.49 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.887 1.725 . . . . 40.45 111.025 165.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -81.35 69.6 3.25 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.701 -0.762 . . . . 53.22 112.393 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.493 HG12 ' CD2' ' A' ' 281' ' ' PHE . 37.6 mt -136.81 124.78 33.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 122.652 -0.322 . . . . 54.41 111.02 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 280' ' ' GLU . 51.3 mttp -109.99 113.37 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.273 -0.64 . . . . 41.12 109.273 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.91 130.57 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.264 -0.426 . . . . 71.15 110.665 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 25.3 m -125.17 111.43 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 74.2 110.147 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.92 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -105.03 125.39 50.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.022 -1.103 . . . . 62.44 108.022 176.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 53.2 m -134.17 140.8 46.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.972 0.415 . . . . 70.55 111.406 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.67 128.01 19.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.92 -0.582 . . . . 61.3 109.648 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 242' ' ' LEU . 3.0 tm? -110.03 113.35 25.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.932 -0.766 . . . . 63.55 108.932 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.592 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.089 -1.078 . . . . 65.33 108.089 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.563 ' HA ' HD22 ' A' ' 242' ' ' LEU . 10.7 t70 -72.49 103.61 3.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.242 -0.89 . . . . 75.11 108.937 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.6 38.24 Favored Glycine 0 N--CA 1.458 0.118 0 O-C-N 123.395 0.434 . . . . 64.22 113.617 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -91.03 -26.99 18.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.568 0.223 . . . . 72.11 111.304 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.442 ' ND2' ' HA3' ' A' ' 272' ' ' GLY . 64.1 t30 -115.19 -22.83 9.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.813 0.671 . . . . 72.21 112.813 -171.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.531 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 29.4 m -62.17 -18.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.977 -0.452 . . . . 63.51 111.499 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -58.46 -39.73 80.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.123 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.51 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 41.3 110.862 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.57 89.29 1.69 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.826 -0.702 . . . . 41.14 111.673 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.531 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -157.92 38.83 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.812 -0.708 . . . . 52.21 112.137 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -80.05 145.7 32.33 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.221 -0.288 . . . . 74.3 110.221 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.723 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.3 mptt -96.72 138.07 34.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.173 -0.677 . . . . 74.22 109.173 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.453 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 tm? -125.93 131.14 52.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.961 -0.385 . . . . 54.44 109.961 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.437 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -137.08 125.21 3.31 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.473 -0.87 . . . . 40.3 112.092 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.92 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -114.96 138.1 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.771 -0.825 . . . . 73.42 108.771 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -158.18 122.21 1.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.349 -0.929 . . . . 74.45 111.13 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.477 HD13 HD11 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -144.91 138.87 27.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.015 0.436 . . . . 72.32 112.04 -175.077 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.558 ' CG ' ' HB2' ' A' ' 256' ' ' LYS . 6.8 pt-20 -110.71 120.66 43.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 62.35 110.502 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.909 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.7 t80 -98.78 118.7 36.1 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.991 -0.744 . . . . 75.33 108.991 175.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 4.1 pt20 -111.65 111.67 22.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.456 0.646 . . . . 71.42 110.447 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.65 111.59 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 73.11 109.592 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.99 135.91 53.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.942 -0.572 . . . . 63.41 109.771 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.106 -0.473 . . . . 61.32 110.757 -179.659 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 25.1 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.346 -0.242 . . . . 71.43 110.346 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -49.49 130.67 20.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.072 0.463 . . . . 44.53 111.917 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 15.9 t -68.16 125.63 91.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.222 -0.899 . . . . 73.41 111.369 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 28.3 Cg_exo -63.65 165.01 19.27 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.383 2.722 . . . . 65.42 112.565 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.84 71.33 4.15 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.204 2.603 . . . . 71.4 112.407 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.803 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.4 p -70.36 -48.84 54.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 74.41 111.606 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' HB2' HG21 ' A' ' 143' ' ' VAL . 70.9 t80 -60.84 -26.08 67.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.901 -0.59 . . . . 54.53 110.866 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -82.08 -10.76 59.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 54.43 111.351 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.31 -22.3 19.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.01 0.433 . . . . 74.12 111.136 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.99 -35.34 71.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.716 0.636 . . . . 72.32 112.716 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.53 15.65 8.56 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 119.917 -1.135 . . . . 53.21 114.114 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 8' ' ' ALA . 33.5 mmtm -63.98 -54.77 29.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.347 0.574 . . . . 74.24 111.713 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -63.36 -38.72 92.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 65.34 110.949 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.13 68.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 65.04 111.825 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -69.05 -35.72 76.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 64.0 111.297 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.11 -45.26 81.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.905 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.36 -25.34 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.461 . . . . 44.23 110.991 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -59.87 -39.82 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 74.43 110.806 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -89.34 36.16 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.295 0.569 . . . . 51.44 110.282 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -52.47 114.48 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.27 -0.877 . . . . 74.02 111.84 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.74 96.97 1.45 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.651 -0.704 . . . . 72.42 112.362 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -133.0 -166.49 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.475 -0.565 . . . . 72.42 109.475 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.13 89.08 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.701 -0.761 . . . . 62.42 111.731 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -100.26 -3.77 30.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.492 . . . . 74.03 110.076 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.59 61.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.977 -0.63 . . . . 71.22 113.07 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.739 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 3.5 pp -147.8 179.76 7.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 113.459 0.911 . . . . 61.24 113.459 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 277' ' ' LEU . 28.7 mm -100.91 122.93 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.876 -1.511 . . . . 63.44 109.061 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.4 ttmm -120.76 121.25 37.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 72.13 110.517 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.6 tt -113.59 142.05 46.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.563 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -135.46 128.37 31.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.381 -0.827 . . . . 52.32 109.466 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 18.3 tp -122.07 123.73 42.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 74.1 110.551 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 63.9 mttp -108.14 125.07 51.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.69 . . . . 55.53 109.406 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.772 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 39.4 m -128.45 121.82 29.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.589 0.233 . . . . 71.33 110.988 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 53.2 mtmt -137.39 123.74 20.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 70.04 110.531 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.603 ' H ' HD11 ' A' ' 39' ' ' LEU . 50.4 m -143.09 155.8 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 55.05 109.855 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 49.53 -131.28 1.86 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.593 0.558 . . . . 73.13 111.589 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.23 134.91 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.519 0.676 . . . . 63.4 111.493 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 93.15 -11.46 71.84 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.044 -0.98 . . . . 70.4 114.449 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.603 HD11 ' H ' ' A' ' 35' ' ' SER . 3.4 pp -103.96 133.86 48.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 118.646 1.223 . . . . 63.32 111.985 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.921 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 39.8 tt0 -138.5 128.71 25.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.886 . . . . 71.12 108.609 161.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.772 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 84.1 m-85 -118.28 121.73 41.16 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.877 -0.515 . . . . 45.5 110.828 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.957 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 21.2 m -117.11 115.81 26.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 71.42 109.814 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 27.5 t -112.65 123.67 50.82 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.358 . . . . 71.44 110.035 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 51.1 m -119.43 125.95 50.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.119 0.485 . . . . 72.31 110.312 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.5 117.48 2.26 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.613 -0.803 . . . . 75.34 111.475 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.6 m -112.67 133.94 54.45 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.733 -0.387 . . . . 44.34 109.983 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -135.55 126.66 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.44 -0.578 . . . . 72.31 109.44 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.739 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 7.4 t-20 -78.28 134.89 37.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.396 -173.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -96.36 -19.31 19.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.092 0.472 . . . . 61.21 110.97 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.91 -53.79 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.283 0.563 . . . . 51.41 109.751 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.563 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 35.1 m -122.2 105.6 10.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.226 -0.657 . . . . 53.44 109.226 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -52.6 102.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.937 0.718 . . . . 62.21 112.937 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -154.76 135.67 13.73 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.025 -1.102 . . . . 72.41 108.025 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.26 132.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.01 0.434 . . . . 54.25 111.222 -174.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -123.97 126.15 45.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 75.24 110.096 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.25 135.24 12.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.843 -0.694 . . . . 60.41 112.565 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 16.9 m -125.65 125.92 43.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.623 -0.88 . . . . 64.12 108.623 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.96 124.51 45.08 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.685 -0.487 . . . . 51.05 109.685 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.957 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 41.7 tt0 -106.77 117.87 35.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.155 0.502 . . . . 71.02 109.77 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 15.6 m -93.27 119.31 32.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.043 -1.095 . . . . 75.11 108.043 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.921 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.8 tptm -122.85 138.01 54.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.142 0.496 . . . . 74.22 109.763 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.763 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 86.5 m-85 -116.69 120.76 39.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.864 -0.791 . . . . 75.31 108.864 172.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.49 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.0 ptm85 -115.73 105.86 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.124 -0.63 . . . . 53.21 110.586 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.875 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 76.0 t90 -112.43 106.06 14.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 64.2 110.088 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 m 66.46 153.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.58 1.175 . . . . 75.43 111.273 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -64.04 102.82 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.27 -0.423 . . . . 75.13 109.927 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 t80 63.73 81.47 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 72.41 110.875 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.47 -75.09 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.369 -1.092 . . . . 44.21 110.369 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 2.0 mm? -113.09 131.42 55.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.854 0.359 . . . . 71.21 110.794 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' HB ' ' A' ' 86' ' ' THR . 6.3 p -135.19 112.66 10.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.716 . . . . 62.11 110.337 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.763 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 21.7 t80 -109.68 121.34 44.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.503 -0.554 . . . . 75.4 109.503 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 m -116.69 127.71 54.66 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.2 0.313 . . . . 74.32 110.753 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 28.1 tt0 -130.66 121.29 25.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.511 -0.551 . . . . 65.34 109.511 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -111.22 97.83 7.06 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.037 -0.727 . . . . 73.05 109.037 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.93 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 41.5 t90 -108.8 129.71 55.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.176 -0.466 . . . . 63.33 111.466 -174.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -105.95 139.28 40.74 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.981 -0.748 . . . . 72.05 108.981 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -60.05 -36.67 77.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.639 0.607 . . . . 43.11 112.639 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -111.07 -23.82 10.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 64.11 112.066 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.573 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 66.6 t30 -104.0 -106.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.265 -0.574 . . . . 75.04 112.427 -169.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 p -116.43 144.64 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.765 0.654 . . . . 75.55 112.765 -170.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.93 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -111.69 123.28 49.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.718 -0.475 . . . . 65.02 109.718 166.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.41 121.99 5.23 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.597 -0.729 . . . . 40.32 111.487 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 101' ' ' SER . 23.2 m -109.11 142.91 39.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.828 0.346 . . . . 62.32 111.059 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.54 113.73 7.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.808 -0.633 . . . . 54.01 109.406 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -112.27 136.41 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.801 -0.444 . . . . 71.44 109.801 179.03 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.403 ' HB ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m -128.54 124.03 34.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 61.05 110.292 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 2.7 p -125.83 120.54 57.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.38 0.61 . . . . 61.4 111.051 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.26 118.54 35.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.157 -1.423 . . . . 65.2 107.157 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 11.6 t70 -55.91 133.35 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.515 -0.474 . . . . 73.23 110.681 -173.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.499 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 19.7 pt20 -68.95 -25.35 64.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 64.33 111.75 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 85.6 mt -108.83 -52.2 2.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.128 0.49 . . . . 53.02 109.908 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.13 10.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 51.12 110.235 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 89' ' ' ASP . 36.3 mmt180 -59.72 135.14 57.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 73.32 109.899 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA2' ' HG3' ' A' ' 119' ' ' LYS . . . 102.49 7.18 46.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.633 -0.794 . . . . 74.43 111.492 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.48 114.75 22.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.629 -0.878 . . . . 75.23 108.629 173.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -122.49 111.8 17.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.934 -0.575 . . . . 61.52 110.705 -174.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.513 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.8 mm? -97.55 130.85 44.57 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.819 -0.808 . . . . 70.44 108.819 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -130.46 133.7 46.51 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.32 -0.4 . . . . 54.52 110.986 -177.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.56 ' H ' HG13 ' A' ' 85' ' ' ILE . 76.8 t80 -124.52 129.62 50.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.396 -0.366 . . . . 73.31 110.232 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 113' ' ' LYS . 6.3 m-20 -115.83 133.81 55.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.132 -0.485 . . . . 72.42 109.891 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.705 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 30.1 t -130.21 137.29 49.99 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.949 -0.389 . . . . 72.32 109.949 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -135.06 121.63 20.65 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.976 -0.379 . . . . 73.22 109.976 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' HD1' HD21 ' A' ' 81' ' ' LEU . 75.4 t80 -134.52 137.14 43.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 61.11 110.608 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 5.1 m -114.29 103.74 54.93 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.944 -0.571 . . . . 75.31 110.017 176.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 32.8 Cg_endo -65.46 152.14 82.82 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.533 2.155 . . . . 73.45 111.477 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.61 25.34 14.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.666 0.746 . . . . 73.13 109.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 m -140.3 -55.12 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.757 -0.656 . . . . 74.51 110.341 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.9 4.1 57.9 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 61.53 112.714 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -87.91 122.75 31.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.311 -0.625 . . . . 71.42 109.311 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 21.6 ptmt -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.101 0.477 . . . . 75.25 110.714 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -121.6 122.64 40.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.427 -0.806 . . . . 75.41 109.559 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 114.77 29.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.052 -0.522 . . . . 73.33 109.621 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.87 ' HG3' ' HB3' ' A' ' 130' ' ' ASP . 28.1 ttmt -118.38 135.4 54.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.234 0.54 . . . . 52.11 110.665 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.853 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 4.2 tp -129.99 132.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 107.739 -1.208 . . . . 73.44 107.739 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 16.6 ttpt -132.28 119.16 20.4 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 124.987 1.43 . . . . 64.4 110.662 -169.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.912 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 69.9 m -116.99 120.02 37.09 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 119.313 0.96 . . . . 60.25 111.251 -175.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.791 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -131.5 138.93 10.53 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.647 -1.263 . . . . 73.54 113.172 -174.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -115.27 130.65 56.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.435 -0.95 . . . . 75.14 108.435 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -110.58 122.29 47.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.616 0.722 . . . . 75.14 111.039 -175.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -105.65 153.17 22.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.358 -1.292 . . . . 64.54 107.825 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.44 -29.97 51.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.239 0.459 . . . . 74.04 112.239 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -108.95 -17.1 14.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.509 -0.314 . . . . 64.53 111.394 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -144.87 124.66 6.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.043 0.386 . . . . 74.54 112.043 -170.403 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.943 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 3.6 m-20 -112.79 116.66 30.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.197 -0.314 . . . . 74.44 110.523 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 142' ' ' LEU . 3.0 mm? -119.48 124.45 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.54 0.21 . . . . 73.4 111.04 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.791 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -136.57 114.16 1.13 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.943 -1.123 . . . . 51.44 113.029 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.1 t -116.97 122.98 45.81 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.941 -0.392 . . . . 50.34 109.941 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.912 ' HB2' ' H ' ' A' ' 116' ' ' THR 0.319 0.9 OUTLIER -154.15 169.91 22.47 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.659 -1.276 . . . . 75.22 112.924 159.588 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.0 mtt -101.79 140.09 36.54 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.781 0.324 . . . . 73.41 111.115 -162.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.87 ' HB3' ' HG3' ' A' ' 113' ' ' LYS . 9.9 p-10 -119.54 125.8 49.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 74.12 111.022 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.23 96.55 9.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.606 -0.516 . . . . 73.24 109.606 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.529 ' OD2' HG13 ' A' ' 133' ' ' ILE . 7.8 t70 -99.73 -165.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.789 -0.819 . . . . 73.44 108.789 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.529 HG13 ' OD2' ' A' ' 132' ' ' ASP . 2.9 pp -72.94 -13.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 70.32 110.421 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.62 4.69 52.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 73.53 110.569 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.47 -155.13 20.86 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.05 -0.595 . . . . 74.44 111.925 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.57 96.55 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.023 2.482 . . . . 51.41 112.094 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.438 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 16.0 m -92.96 162.89 13.88 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.992 -0.549 . . . . 55.45 109.636 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 36.2 mm -107.99 117.48 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.931 -0.396 . . . . 72.03 109.931 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.7 tpt180 -106.0 111.34 23.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.34 0.59 . . . . 75.22 110.338 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.16 10.09 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.987 -1.101 . . . . 75.22 111.524 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.25 116.84 23.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.974 0.416 . . . . 51.04 110.402 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -117.18 125.36 51.08 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.577 . . . . 75.24 110.637 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.943 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 77.4 t -117.45 133.89 62.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.11 0.481 . . . . 63.32 110.277 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -108.42 138.38 44.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.791 -0.818 . . . . 64.23 108.791 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.08 118.24 2.37 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.51 -0.852 . . . . 25.33 113.146 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 75.9 t80 -145.0 148.99 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.066 -0.346 . . . . 75.24 110.066 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -45.01 105.52 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.986 0.422 . . . . 74.32 111.866 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.13 -31.38 6.02 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.81 -0.632 . . . . 71.12 112.726 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 72.3 m95 -104.84 120.93 42.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 74.44 111.118 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.803 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -124.58 136.91 54.35 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.628 -1.249 . . . . 72.14 107.628 173.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HB3' HD23 ' A' ' 144' ' ' LEU . . . -143.1 160.79 39.74 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.628 -0.429 . . . . 72.05 110.877 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.58 137.2 5.46 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.833 -0.621 . . . . 60.53 111.566 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -143.83 118.35 9.73 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 122.539 -0.389 . . . . 75.31 110.229 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.801 ' HG3' ' HB2' ' A' ' 168' ' ' ASN . 12.2 pt20 -119.13 125.89 50.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.454 0.645 . . . . 75.44 111.02 176.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 81.7 mtp -118.3 142.68 47.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.822 -0.626 . . . . 52.23 109.998 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 50.8 t-20 -113.38 118.46 34.61 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.996 -0.742 . . . . 72.04 108.996 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.757 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.6 m-85 -94.4 120.39 34.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.665 -0.698 . . . . 74.2 111.029 -175.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 57.7 tt0 -87.34 103.2 15.25 Favored 'General case' 0 C--O 1.26 1.639 0 CA-C-O 121.469 0.652 . . . . 74.04 109.284 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 t -70.24 -14.51 62.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 113.127 -1.851 . . . . 71.32 111.904 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.8 68.23 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.559 0.695 . . . . 74.43 109.157 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.63 -147.68 0.4 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.532 -1.285 . . . . 75.23 107.532 162.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.7 m -107.94 28.18 8.49 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.46 -0.775 . . . . 60.34 111.155 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 163' ' ' ARG . 1.1 ptm180 -132.39 145.49 51.27 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.419 -1.313 . . . . 70.54 111.562 -163.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.64 134.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.092 0.473 . . . . 64.13 109.804 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 7.5 t -95.44 -9.79 31.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.126 -0.488 . . . . 75.12 111.016 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 39.3 mm-40 -149.94 132.25 15.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.869 0.366 . . . . 73.1 110.841 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.8 m -121.9 105.79 10.66 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.743 -0.662 . . . . 70.24 109.507 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.801 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 84.7 m-20 -110.33 123.91 50.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 54.34 109.844 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.78 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 45.9 t80 -120.4 149.99 41.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.224 -0.443 . . . . 72.44 109.867 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -144.33 142.31 30.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.069 0.461 . . . . 72.43 110.858 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -131.12 136.9 56.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.157 -0.474 . . . . 74.2 110.193 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.04 96.1 0.33 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.007 -0.837 . . . . 63.1 111.007 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -109.67 121.68 45.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.399 -0.593 . . . . 63.32 109.399 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.41 127.64 48.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.486 -0.779 . . . . 73.21 110.547 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 42.0 m -131.73 111.49 11.7 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.292 -0.632 . . . . 74.34 109.292 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.58 -87.42 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.379 1.049 . . . . 74.12 113.678 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.87 3.48 22.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.252 0.549 . . . . 52.33 111.416 -172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -112.86 126.57 55.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 73.43 110.134 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 55.0 mm-40 -121.16 123.68 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.173 -0.306 . . . . 64.4 110.173 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.9 tp -118.66 134.85 54.81 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.15 -0.344 . . . . 74.22 111.035 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -130.6 117.3 19.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 60.4 110.414 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 19.9 m -112.47 143.52 43.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.962 -0.385 . . . . 63.0 109.962 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -141.52 139.95 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 74.1 110.383 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.78 ' HB ' ' HB3' ' A' ' 169' ' ' PHE . 56.0 t -126.36 131.27 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.163 -0.471 . . . . 62.34 111.606 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 9.1 t30 -110.94 96.01 5.9 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.35 -0.841 . . . . 71.24 109.565 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.7 t70 62.09 -166.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.9 -1.046 . . . . 74.03 110.345 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.62 -6.67 89.21 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.05 -0.595 . . . . 64.41 111.839 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.7 p -94.13 -27.23 16.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.981 0.734 . . . . 73.03 112.981 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 38.8 mt-10 -134.48 125.04 26.59 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.934 -0.706 . . . . 71.12 111.201 -175.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.735 ' HB2' HG22 ' A' ' 184' ' ' VAL . 25.9 p90 -133.87 133.1 41.12 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.188 -0.605 . . . . 71.34 109.443 171.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -135.79 159.21 24.15 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.566 -0.826 . . . . 45.13 112.522 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -136.63 164.76 25.15 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.424 -0.67 . . . . 73.11 111.424 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 26.9 t -143.56 136.91 28.02 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.0 -0.741 . . . . 72.33 109.0 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 3.4 mp -120.31 117.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 75.55 109.743 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.751 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 84.2 t80 -108.04 120.76 43.25 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.513 0.673 . . . . 71.12 110.428 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -115.61 111.91 21.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.925 -1.034 . . . . 74.03 108.992 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 195' ' ' TYR . 84.1 tttt -103.93 107.19 17.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.141 -0.482 . . . . 70.13 109.973 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.47 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.183 -0.673 . . . . 72.45 109.183 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -76.24 10.08 2.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.301 0.572 . . . . 64.01 110.879 -173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -109.3 -10.37 14.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.776 -0.647 . . . . 71.25 109.361 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.435 ' HG3' HD22 ' A' ' 202' ' ' LEU . 15.6 tppt? -134.93 -68.55 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 74.2 110.528 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 201' ' ' LYS . 2.0 pt? -167.99 165.94 13.42 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.92 0.39 . . . . 72.32 110.484 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.435 ' HG3' ' HG3' ' A' ' 197' ' ' LYS . 23.6 mp0 -109.75 128.2 55.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.797 -0.816 . . . . 72.23 108.797 173.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 t -138.57 155.02 48.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.064 0.459 . . . . 72.32 111.377 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.85 148.05 36.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.723 -0.671 . . . . 75.3 110.61 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 193' ' ' SER . 55.7 t -110.86 138.23 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.033 -0.53 . . . . 55.33 109.617 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -113.9 127.8 56.13 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.284 -1.006 . . . . 60.13 108.284 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 219' ' ' PHE . 7.3 tp -144.56 140.88 29.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.558 -0.292 . . . . 64.32 110.3 -168.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.584 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -157.23 142.34 17.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.825 0.345 . . . . 65.24 111.223 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.507 ' HE3' ' HZ ' ' A' ' 190' ' ' PHE . 16.6 t90 -130.83 135.3 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.125 0.488 . . . . 74.31 110.071 173.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 53.2 m -94.47 105.31 17.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.43 -0.805 . . . . 65.23 109.971 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.76 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 70.53 111.127 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.24 -87.72 0.4 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.164 -0.774 . . . . 73.22 111.164 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -149.12 104.3 3.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.024 0.44 . . . . 73.2 110.484 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.9 t -176.4 149.0 0.79 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.08 159.34 29.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.226 -0.657 . . . . 75.02 109.226 173.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 8.8 t -77.58 123.24 26.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.076 -0.713 . . . . 75.43 109.076 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 218' ' ' ARG . 1.1 tpp180 -94.18 115.06 27.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.589 -0.732 . . . . 75.33 109.262 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.746 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 52.1 p90 -120.42 160.33 23.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 61.22 111.49 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.39 157.49 28.86 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.298 -0.864 . . . . 50.13 111.355 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.651 ' HB ' HG12 ' A' ' 237' ' ' VAL . 55.9 mt -132.25 135.15 58.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.964 0.382 . . . . 74.32 110.298 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -128.47 129.84 46.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.918 -0.401 . . . . 52.42 109.918 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -128.24 133.05 48.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.747 0.308 . . . . 61.14 111.061 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.3 114.53 26.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.62 . . . . 75.31 109.629 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -128.9 119.36 24.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 72.21 110.726 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -76.59 124.61 27.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.71 -0.478 . . . . 75.41 109.71 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 63.4 mt -70.48 -55.79 13.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.388 -0.369 . . . . 72.52 110.306 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.849 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 34.0 t70 -172.45 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.019 -0.537 . . . . 54.52 111.771 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 56.7 Cg_endo -95.05 -101.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.372 2.048 . . . . 70.21 113.524 -172.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.93 3.92 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 51.32 111.227 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -123.07 131.98 53.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.238 0.542 . . . . 75.35 111.748 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.58 142.16 50.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 60.4 109.264 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -104.31 131.41 51.68 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.837 -0.431 . . . . 73.2 109.837 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 57.8 p -116.6 120.96 40.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.051 0.453 . . . . 74.44 110.087 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.88 42.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.218 -0.66 . . . . 71.32 109.218 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 44.4 mttp -144.22 141.57 29.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.664 -0.495 . . . . 71.32 109.664 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.651 HG12 ' HB ' ' A' ' 221' ' ' ILE . 4.4 p -137.24 158.65 35.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.357 -0.609 . . . . 73.23 109.357 174.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 14.3 t30 -135.5 150.57 49.81 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.196 -0.457 . . . . 72.35 110.087 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.746 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 2.8 p-10 -46.44 -32.51 3.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.957 1.095 . . . . 72.33 113.957 -173.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.536 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 5.6 m -78.92 23.37 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.596 0.236 . . . . 55.15 111.097 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.4 m 64.53 36.27 8.76 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 121.371 0.605 . . . . 61.52 109.849 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 1.052 ' HB3' HD11 ' A' ' 262' ' ' LEU . 22.9 mt -98.04 116.71 30.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.729 -0.669 . . . . 63.12 110.075 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 243' ' ' ILE . 2.1 mp -106.69 116.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 62.22 110.007 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.12 133.47 9.64 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.576 -0.821 . . . . 75.21 112.685 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.467 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -119.37 154.25 33.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.376 -0.231 . . . . 71.43 110.376 178.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -149.24 134.32 4.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.444 -0.884 . . . . 64.32 112.675 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 258' ' ' THR . 59.1 m-85 -103.59 116.99 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.564 -0.532 . . . . 75.1 109.564 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.934 HG23 ' HB ' ' A' ' 258' ' ' THR . 3.2 m -117.36 115.25 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.121 -0.49 . . . . 74.42 110.31 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.99 150.73 44.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 73.24 111.83 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 19.6 m -83.37 128.41 34.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.864 -0.607 . . . . 61.33 110.155 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.803 HD23 HG12 ' A' ' 255' ' ' ILE . 3.3 mm? -73.73 -82.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.133 0.42 . . . . 64.23 112.133 -173.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 1.027 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 35.3 tttp -140.97 -62.67 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.948 -0.389 . . . . 74.35 109.948 -175.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 1.027 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 3.6 Cg_exo -79.45 -161.52 0.15 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.858 1.705 . . . . 71.14 110.861 166.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -80.82 62.21 4.43 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.663 -0.78 . . . . 73.53 113.162 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.803 HG12 HD23 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -136.49 142.26 38.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.084 0.468 . . . . 74.41 109.762 173.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.545 ' HG2' HG22 ' A' ' 248' ' ' THR . 36.0 ttpt -121.96 127.28 50.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.761 -0.654 . . . . 64.54 110.261 -176.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.609 ' HB2' HD21 ' A' ' 251' ' ' LEU . 28.6 tp -100.55 132.69 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 73.24 110.106 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.934 ' HB ' HG23 ' A' ' 248' ' ' THR . 7.7 t -129.52 112.48 13.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.615 0.722 . . . . 75.42 111.01 176.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.973 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -98.1 123.61 42.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.131 -1.063 . . . . 71.21 108.131 176.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 21.8 p -131.6 148.73 52.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.193 0.52 . . . . 62.34 111.454 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.436 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -140.89 133.15 28.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.732 -0.667 . . . . 65.31 109.907 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.052 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -102.88 121.28 42.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 70.5 109.133 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.596 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.4 mm? -104.1 108.01 19.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.431 -0.952 . . . . 74.4 108.431 175.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 268' ' ' VAL . 2.9 m-20 -71.59 103.87 3.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.906 -0.775 . . . . 72.53 108.906 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.77 -22.25 32.67 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.12 -0.562 . . . . 72.13 113.03 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -85.92 -23.47 26.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.671 0.272 . . . . 74.01 111.262 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 3.8 m-20 -115.61 -28.26 6.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.78 0.659 . . . . 50.41 112.78 -172.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 263' ' ' LEU . 24.6 m -62.82 -18.78 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.901 0.334 . . . . 64.31 111.901 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.6 -33.06 70.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 73.21 109.808 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.32 8.56 38.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.517 -0.765 . . . . 63.53 110.955 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.84 89.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.088 -0.577 . . . . 74.42 112.067 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.19 88.01 0.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.323 -0.942 . . . . 75.44 112.701 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -109.16 145.52 35.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.185 -0.302 . . . . 74.2 110.185 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 274' ' ' LYS . 30.6 tptt -103.85 137.89 41.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.009 -0.737 . . . . 72.5 109.009 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.3 tm? -110.11 137.9 47.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.647 0.261 . . . . 53.01 110.328 -174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.52 126.23 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.42 -0.672 . . . . 75.03 111.42 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.973 HD23 HD22 ' A' ' 259' ' ' LEU . 2.7 tm? -120.77 129.28 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.814 -0.439 . . . . 73.42 109.814 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -131.95 145.87 17.55 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.479 -0.867 . . . . 73.54 112.975 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.459 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.2 mm? -123.71 132.3 53.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.46 -0.57 . . . . 74.42 109.46 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -112.87 111.91 23.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.439 -0.578 . . . . 64.12 109.439 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.51 ' HB3' HD13 ' A' ' 31' ' ' LEU . 5.2 m-85 -102.32 141.48 35.09 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.115 -0.698 . . . . 73.5 109.115 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 284' ' ' LEU . 46.2 mt-30 -135.75 121.4 19.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.848 0.356 . . . . 55.4 110.566 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -105.35 109.26 21.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.206 -0.664 . . . . 65.45 109.206 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 282' ' ' GLN . 3.5 mm? -130.6 176.77 7.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.698 -0.683 . . . . 70.1 110.366 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.708 -0.678 . . . . 74.2 109.827 178.623 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.741 0.305 . . . . 75.24 110.486 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.74 -0.22 54.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.967 0.413 . . . . 75.43 110.314 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.841 HG11 ' HB3' ' A' ' 119' ' ' LYS . 2.2 t -82.15 115.19 56.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.688 -0.687 . . . . 70.24 109.643 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 6.6 Cg_endo -87.41 157.14 8.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.299 2.666 . . . . 74.33 113.157 -174.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 3.6 Cg_exo -75.92 64.62 6.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.135 2.556 . . . . 70.41 111.324 173.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.839 ' HB ' HD21 ' A' ' 150' ' ' LEU . 4.8 p -78.19 -18.97 54.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 53.01 111.548 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' HE2' HE21 ' A' ' 154' ' ' GLN . 81.0 t80 -56.11 -22.76 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 74.0 110.326 170.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.51 -25.62 54.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.456 -0.793 . . . . 73.5 109.569 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -85.86 -10.94 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.99 -0.745 . . . . 64.02 108.99 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.844 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -77.1 -34.86 56.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.766 -1.106 . . . . 63.14 110.857 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.24 -47.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.934 -1.127 . . . . 55.15 113.701 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -55.43 -53.91 50.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.674 0.62 . . . . 64.31 112.674 -170.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 t -63.95 -48.47 76.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 71.3 111.474 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.78 60.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 72.41 111.794 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 1.049 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 99.2 mtt180 -60.37 -24.82 65.4 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.708 0.633 . . . . 73.22 112.708 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.36 -41.51 76.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 61.24 110.752 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.512 ' HB ' ' ND2' ' A' ' 207' ' ' ASN . 66.8 t -83.73 -37.41 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.164 0.507 . . . . 42.34 110.315 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.049 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 89.6 t80 -63.56 -24.51 67.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.123 -0.944 . . . . 72.14 112.497 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -65.42 156.08 33.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 43.44 111.613 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.788 ' HD2' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.95 25.46 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.674 -0.693 . . . . 63.35 110.397 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.94 95.67 0.49 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.686 -0.688 . . . . 63.53 112.278 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -104.07 -162.4 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.797 -0.816 . . . . 74.42 108.797 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.55 108.18 2.38 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.142 -1.027 . . . . 23.44 111.131 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -80.7 -2.98 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.797 0.299 . . . . 75.12 111.573 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 12.79 83.81 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.458 -0.877 . . . . 54.15 112.434 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -142.35 179.97 6.62 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.866 0.841 . . . . 73.12 112.632 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.689 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -106.91 129.52 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.148 -1.387 . . . . 71.33 109.859 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 8.9 ttpt -102.78 135.99 43.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.407 -0.59 . . . . 74.5 109.407 174.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.9 tp -133.5 139.7 46.81 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.872 -0.331 . . . . 53.1 110.169 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.3 p30 -151.3 135.01 16.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 61.34 109.951 173.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.4 tp -128.31 124.14 35.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.509 -0.769 . . . . 73.11 109.679 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' N ' HD12 ' A' ' 31' ' ' LEU . 68.9 tttt -120.92 124.69 45.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.276 -0.874 . . . . 60.14 109.37 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 34.2 m -128.6 120.6 26.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.635 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -144.6 155.88 43.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.811 -0.756 . . . . 74.22 112.597 -176.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.4 t -139.92 154.31 47.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.523 -1.217 . . . . 74.04 107.991 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.27 20.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.991 0.424 . . . . 62.13 111.262 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 35' ' ' SER . 66.0 t30 -110.65 30.08 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.544 0.688 . . . . 75.33 110.212 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 96.39 1.17 60.83 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.864 -0.607 . . . . 45.51 112.513 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.0 tp -100.68 125.9 47.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.699 0.629 . . . . 64.24 112.699 -173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.857 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 28.0 mt-10 -142.32 118.17 10.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.962 -0.384 . . . . 65.34 109.962 160.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 50.4 m-85 -111.87 124.87 53.29 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.871 -0.518 . . . . 74.2 110.308 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.978 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 19.0 m -126.85 118.61 24.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.741 0.305 . . . . 73.4 111.383 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 29.0 t -120.35 123.6 43.5 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.273 -0.64 . . . . 73.23 109.273 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -134.73 130.44 36.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 43.21 111.468 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.43 148.02 19.38 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.507 -0.854 . . . . 64.33 112.541 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 m -119.83 134.17 55.33 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.821 -0.807 . . . . 72.41 108.821 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.7 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -154.85 141.29 18.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.984 0.421 . . . . 55.33 111.804 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 145.96 51.53 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.184 -0.672 . . . . 72.43 109.184 172.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -43.82 -39.74 4.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.538 0.524 . . . . 73.44 111.95 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -103.41 165.87 10.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.342 -0.614 . . . . 54.13 109.342 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -70.55 61.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.342 0.591 . . . . 70.1 112.052 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -97.84 -39.93 8.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 73.3 110.352 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -165.42 116.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 62.42 109.918 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.7 HG13 ' HB2' ' A' ' 47' ' ' ALA . 39.6 t -125.63 119.62 55.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.93 -0.577 . . . . 72.15 109.938 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -120.47 126.54 50.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.845 -0.428 . . . . 73.3 109.845 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 148.16 18.84 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.198 -1.001 . . . . 74.12 113.258 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 6.6 p -146.31 147.2 31.12 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.792 -0.447 . . . . 55.42 109.792 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 59' ' ' GLU . 1.8 tp -122.09 149.33 43.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.176 0.512 . . . . 72.42 111.196 -176.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.978 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 37.7 mt-10 -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.257 -0.883 . . . . 75.23 109.421 172.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.9 m -95.62 118.31 32.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.889 -1.152 . . . . 63.23 107.889 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.652 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 26.5 mttp -126.07 145.68 50.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.411 0.624 . . . . 75.14 110.911 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 70' ' ' THR . 74.3 m-85 -120.7 120.33 35.38 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.476 -0.935 . . . . 63.41 108.476 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.857 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 8.8 tpt180 -114.73 108.26 16.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 74.24 111.136 -173.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -113.51 102.69 10.54 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.434 -0.803 . . . . 75.55 110.754 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m 63.81 72.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.941 -1.027 . . . . 72.34 112.409 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.816 ' HG3' ' H ' ' A' ' 67' ' ' TYR . 9.7 pt-20 30.3 -92.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.449 1.1 . . . . 74.03 113.764 173.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.816 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 93.9 m-85 -87.11 86.87 7.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.224 -0.658 . . . . 73.03 109.224 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.81 -94.1 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.353 -0.699 . . . . 71.43 111.353 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 87' ' ' VAL . 3.5 mm? -125.4 131.59 52.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.038 0.447 . . . . 63.51 111.488 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.696 HG23 ' HB ' ' A' ' 86' ' ' THR . 4.8 t -136.97 113.19 9.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.796 -0.638 . . . . 73.35 109.781 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 72.3 m-85 -98.2 132.26 43.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 73.11 109.527 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 84' ' ' GLU . 96.9 m -127.91 136.57 51.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.923 0.392 . . . . 75.51 111.757 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.69 121.13 24.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.949 -0.759 . . . . 73.54 108.949 165.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -106.88 109.73 21.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.771 -0.65 . . . . 72.01 109.581 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.632 ' HD1' HD13 ' A' ' 81' ' ' LEU . 77.1 t90 -109.7 133.92 52.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.425 -0.352 . . . . 74.22 110.492 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.481 ' HB3' ' OG1' ' A' ' 80' ' ' THR . 8.5 t30 -114.72 152.88 31.27 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.582 -0.525 . . . . 53.2 109.582 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 m -54.28 -22.15 11.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.116 0.484 . . . . 73.51 112.301 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.5 m-20 -68.69 -2.67 9.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.117 -0.492 . . . . 74.12 111.986 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.528 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 92.1 m-20 77.8 27.69 0.58 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.461 0.704 . . . . 73.15 110.125 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 104' ' ' SER . 1.8 p -93.19 124.52 37.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.599 -0.728 . . . . 74.35 110.987 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.9 mm? -101.56 119.2 38.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.307 -0.86 . . . . 74.23 110.3 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.54 91.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.552 -0.832 . . . . 75.41 111.512 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 t -90.65 123.04 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 73.41 110.448 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 40.5 tt0 -135.3 118.69 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.983 -0.553 . . . . 74.35 110.027 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -112.03 138.68 39.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.709 0.29 . . . . 74.12 110.368 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.696 ' HB ' HG23 ' A' ' 70' ' ' THR . 25.8 m -122.73 123.63 41.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.297 0.57 . . . . 60.33 111.353 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 HD11 ' A' ' 69' ' ' LEU . 34.1 t -111.89 123.89 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.09 -0.959 . . . . 73.41 109.036 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -110.21 142.17 42.14 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.765 -0.457 . . . . 63.11 109.765 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 81.47 -66.5 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.95 0.781 . . . . 72.31 109.952 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.31 -78.11 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.29 0.636 . . . . 71.1 111.206 175.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -130.88 -58.73 1.01 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 74.31 109.624 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.23 27.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.857 -0.611 . . . . 72.43 109.399 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 5.8 ppt_? -52.97 132.67 37.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.467 0.651 . . . . 73.5 111.832 -175.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 119' ' ' LYS . . . 101.54 -12.43 58.19 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.593 -0.73 . . . . 70.24 112.08 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.646 HD23 ' HD1' ' A' ' 118' ' ' TYR . 1.0 OUTLIER -86.92 119.9 27.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.83 -0.804 . . . . 74.23 108.83 176.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' HD13 ' A' ' 97' ' ' LEU . 54.7 pttt -123.06 144.47 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 74.44 110.658 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -122.38 126.87 48.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.551 -0.75 . . . . 71.21 109.286 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.857 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 15.2 m -130.0 118.28 21.34 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.682 -0.407 . . . . 72.4 109.982 176.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 50.4 t80 -120.33 115.56 23.8 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.777 -0.369 . . . . 74.12 110.442 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 10.4 t70 -115.0 137.85 51.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.668 -0.696 . . . . 71.12 109.373 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -142.2 121.81 13.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.963 0.411 . . . . 72.03 110.06 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 41.4 m -103.04 121.71 43.14 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.715 -0.675 . . . . 63.42 109.803 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -120.88 128.82 53.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 73.55 109.523 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB3' HG22 ' A' ' 80' ' ' THR . 47.6 p -119.86 103.14 46.12 Favored Pre-proline 0 C--N 1.315 -0.919 0 C-N-CA 120.828 -0.349 . . . . 61.15 110.551 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 21.0 Cg_exo -67.11 -22.89 46.64 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.452 2.102 . . . . 60.14 111.256 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -85.48 -49.12 8.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 73.11 110.992 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -81.88 -36.73 27.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.392 . . . . 63.32 111.296 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.44 -3.44 61.43 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.139 -0.553 . . . . 42.2 113.191 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.76 148.69 22.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.165 0.507 . . . . 61.54 111.628 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -123.82 148.58 46.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.805 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -144.07 122.49 12.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.967 -0.383 . . . . 62.13 109.967 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . . . -110.08 129.89 55.62 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.798 -0.445 . . . . 63.02 109.798 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 129' ' ' MET . 7.9 ttmm -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.694 -0.484 . . . . 63.12 109.694 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.3 tp -132.32 129.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.108 0.48 . . . . 62.42 111.07 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 50.1 mttp -111.19 121.66 45.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.35 -0.841 . . . . 63.41 109.706 176.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -116.27 117.95 31.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.57 -0.9 . . . . 75.43 108.57 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.81 135.45 11.47 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.39 -0.909 . . . . 51.42 112.473 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.646 ' HD1' HD23 ' A' ' 95' ' ' LEU . 76.9 t80 -121.65 118.43 29.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.844 -0.799 . . . . 75.41 108.844 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.841 ' HB3' HG11 ' A' ' 3' ' ' VAL . 37.5 mtmm -108.07 122.93 47.88 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.041 -0.663 . . . . 63.55 110.642 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -105.38 154.91 19.65 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.556 -1.276 . . . . 75.24 107.556 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.0 tp10 -52.74 -29.84 29.24 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.674 0.62 . . . . 72.33 112.674 -165.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -102.39 -26.14 13.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.105 0.78 . . . . 64.32 113.105 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.791 HG22 ' H ' ' A' ' 145' ' ' GLY . 19.2 pt -142.22 153.35 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.927 -0.709 . . . . 71.24 112.242 -171.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.633 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 1.7 m-20 -112.3 128.94 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.263 -0.88 . . . . 70.31 111.457 -172.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 118' ' ' TYR . 4.5 mm? -111.37 137.69 48.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.608 0.242 . . . . 73.14 110.616 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.38 121.17 1.34 Allowed Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.959 -0.639 . . . . 65.11 112.493 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.4 m -113.35 116.44 29.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.894 0.347 . . . . 73.3 111.815 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.733 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -97.81 143.16 28.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.804 -0.634 . . . . 72.33 110.128 175.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.521 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 65.3 mtt -133.74 118.4 18.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.168 -0.308 . . . . 74.12 110.168 174.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.691 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 1.9 m-20 -99.38 119.26 37.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 72.14 110.067 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 96.7 m-85 -95.9 97.94 10.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.479 176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -120.58 156.99 30.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 55.23 108.988 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.898 ' H ' HD12 ' A' ' 133' ' ' ILE . 1.1 mp -75.08 -30.25 23.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.133 0.492 . . . . 73.44 109.986 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.0 -9.93 59.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 43.12 111.042 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 155.15 133.09 1.67 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.534 -0.841 . . . . 74.45 112.666 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 7.8 Cg_exo -74.23 119.1 5.65 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.122 2.548 . . . . 74.44 111.651 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.691 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 9.3 t -103.46 131.07 50.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.164 -0.471 . . . . 54.44 110.091 -177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mp -115.77 118.51 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.55 -0.46 . . . . 65.3 110.09 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 24.7 mtt180 -107.42 115.19 29.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.859 -0.423 . . . . 73.05 109.859 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.36 131.67 10.64 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.505 -1.331 . . . . 61.34 111.083 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.54 115.7 19.94 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.079 0.466 . . . . 72.33 109.977 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD11 HD12 ' A' ' 123' ' ' ILE . 5.9 tp -117.66 122.9 44.79 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.761 -0.654 . . . . 72.13 109.813 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.814 HG22 HD22 ' A' ' 10' ' ' LEU . 54.5 t -108.55 130.28 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.853 -0.612 . . . . 73.11 109.743 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.962 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.3 mm? -108.14 136.48 47.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.957 -0.757 . . . . 74.41 108.957 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.791 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -115.96 119.2 4.47 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.275 -0.875 . . . . 52.41 112.743 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.947 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 34.0 m-85 -123.46 149.64 44.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.304 -0.999 . . . . 74.05 108.304 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.78 100.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.96 0.41 . . . . 62.21 110.96 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 174' ' ' LYS . . . 90.84 -24.12 19.63 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.974 -0.557 . . . . 60.35 112.372 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.947 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.6 m0 -105.37 131.81 52.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.107 0.48 . . . . 64.23 110.783 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.839 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.4 tm? -117.33 149.07 41.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.736 -0.839 . . . . 63.22 108.736 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -151.28 154.53 36.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.646 -0.421 . . . . 74.35 110.058 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.844 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -158.41 135.66 4.38 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.744 -0.662 . . . . 44.45 111.576 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.4 115.18 21.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.44 -0.578 . . . . 71.1 109.44 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.94 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 87.7 mt-30 -99.42 121.86 41.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.728 -0.471 . . . . 72.25 109.728 166.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.9 ttm -127.17 128.58 46.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.698 -0.482 . . . . 74.32 109.698 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 24.7 m-80 -112.65 119.13 37.05 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.548 -0.538 . . . . 75.14 109.548 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.9 m-85 -94.35 127.05 39.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.095 -0.502 . . . . 75.41 110.805 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.794 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.9 tp10 -97.42 98.48 9.99 Favored 'General case' 0 C--O 1.26 1.631 0 N-CA-C 109.269 -0.641 . . . . 63.34 109.269 174.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -72.59 -17.59 61.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.641 -1.618 . . . . 63.45 111.209 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -63.1 -29.08 70.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.732 -0.84 . . . . 75.55 108.732 173.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 13.8 mmmm -111.17 -160.26 0.71 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.16 -1.382 . . . . 70.24 107.839 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 p -108.45 28.76 8.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.551 -0.536 . . . . 53.24 109.551 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 25.0 tpt180 -142.95 145.78 33.33 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 119.812 -0.755 . . . . 75.31 111.378 -160.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.5 m -73.22 136.7 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.777 -0.823 . . . . 54.23 108.777 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.794 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 8.8 t -92.2 -24.36 19.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.869 -171.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.572 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 93.4 mt-30 -144.8 133.16 21.81 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.616 0.246 . . . . 55.1 110.711 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.2 m -114.54 106.27 14.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.532 -0.544 . . . . 75.24 109.532 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.94 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 54.5 m-20 -106.99 129.93 54.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.46 . . . . 73.14 109.926 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.36 144.52 48.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.474 -0.33 . . . . 65.13 110.445 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -142.43 128.65 19.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.862 0.363 . . . . 33.45 110.169 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.58 128.54 60.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 73.3 109.409 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.81 109.17 1.69 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.804 -0.712 . . . . 73.25 112.05 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.75 119.95 39.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.064 -1.087 . . . . 74.34 108.064 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.819 ' HB2' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -136.21 144.83 45.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.182 0.991 . . . . 52.51 113.557 -171.083 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.433 ' HB ' ' OE2' ' A' ' 177' ' ' GLU . 3.7 m -109.9 163.88 13.12 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.582 -1.636 . . . . 75.34 106.582 167.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -27.4 60.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.849 0.685 . . . . 72.15 112.849 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -108.16 -20.51 13.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.569 0.581 . . . . 72.14 112.569 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -130.83 119.02 21.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.799 0.333 . . . . 72.34 111.074 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.819 ' HG2' ' HB2' ' A' ' 174' ' ' LYS . 45.1 mt-30 -116.35 124.31 49.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.496 -0.32 . . . . 71.42 110.418 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -107.9 132.24 53.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.063 0.458 . . . . 74.03 110.234 174.304 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -125.03 116.81 22.72 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.252 -0.647 . . . . 74.42 109.252 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 28.7 m -99.39 123.0 43.29 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.717 -0.475 . . . . 74.3 109.717 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -121.24 139.73 52.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.01 0.433 . . . . 71.5 109.963 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 78.2 t -131.12 124.79 56.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.762 -0.654 . . . . 53.42 109.591 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 92.4 m-20 -106.88 106.42 16.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 61.41 109.36 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 28.0 t70 59.64 -168.76 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.914 -1.039 . . . . 72.31 109.424 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -79.54 -6.35 89.01 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.542 -0.837 . . . . 71.43 112.128 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 211' ' ' THR . 26.9 p -101.28 -27.02 13.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.639 0.977 . . . . 73.21 113.639 -172.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.6 tt0 -113.1 115.15 27.85 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 119.274 -0.97 . . . . 71.54 111.909 -174.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.58 131.06 57.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 75.14 109.64 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -174.25 -139.82 3.08 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.552 -0.833 . . . . 64.33 112.107 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.86 -150.61 22.9 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.23 -0.986 . . . . 63.0 112.865 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 28.5 t -142.78 144.54 32.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.147 0.498 . . . . 71.22 110.97 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.718 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 17.3 mm -118.9 115.77 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.856 -0.794 . . . . 73.23 108.856 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.677 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 26.1 t80 -111.6 119.7 39.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.612 0.244 . . . . 71.25 110.652 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.681 ' CG ' ' HB2' ' A' ' 199' ' ' ASN . 5.0 tp-100 -127.81 128.49 45.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.505 -0.316 . . . . 73.33 110.34 176.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 198' ' ' VAL . 19.0 ptpt -103.1 132.41 49.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.674 -0.239 . . . . 73.12 110.933 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 197' ' ' LYS . 3.9 m 64.85 23.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.495 1.518 . . . . 75.44 112.423 176.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.681 ' HB2' ' CG ' ' A' ' 196' ' ' GLN . 24.9 t-20 -65.31 -48.62 72.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 64.51 110.764 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.414 ' HG3' ' OD1' ' A' ' 199' ' ' ASN . 98.7 mttt -125.18 -84.47 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.491 -0.322 . . . . 72.3 111.05 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -86.83 -66.18 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.461 -0.336 . . . . 74.15 110.449 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.2 tp -145.73 -84.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 64.02 110.164 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 224' ' ' LYS . 2.6 tp10 -107.25 142.03 37.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 13.5 t -143.38 138.67 29.57 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.19 -0.604 . . . . 73.42 110.775 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -138.61 137.29 36.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.778 -0.646 . . . . 54.34 110.678 -178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.718 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 70.5 t -111.32 140.65 29.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.116 -0.698 . . . . 71.31 109.116 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' HB ' ' A' ' 17' ' ' VAL . 18.5 m-80 -138.27 131.51 30.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.674 -0.491 . . . . 75.12 109.674 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.87 151.7 37.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.824 0.345 . . . . 62.55 111.789 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.536 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -141.07 134.54 29.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 71.25 110.334 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 217' ' ' THR . 24.1 t90 -128.71 123.41 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 64.11 110.384 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 188' ' ' THR . 1.0 OUTLIER -99.89 103.56 15.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.369 0.604 . . . . 70.35 110.473 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.29 136.69 56.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.07 -0.968 . . . . 35.1 111.8 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.24 -28.12 15.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.932 -0.651 . . . . 72.34 113.207 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -132.79 -47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.87 0.692 . . . . 45.55 112.87 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.8 t -110.67 -179.04 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.375 0.607 . . . . 70.33 111.861 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -102.94 166.12 10.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.957 -1.02 . . . . 73.4 109.983 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 210' ' ' TRP . 25.7 m -74.91 123.17 24.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.422 -0.584 . . . . 65.01 109.422 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 218' ' ' ARG . 43.2 mtp180 -114.16 117.15 30.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.394 -0.595 . . . . 71.11 109.394 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -124.24 145.74 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.386 0.612 . . . . 63.32 111.306 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.36 13.8 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.898 -1.046 . . . . 62.44 111.229 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.3 mp -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.941 -0.392 . . . . 72.15 109.941 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -116.41 145.15 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.946 0.403 . . . . 44.01 110.855 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -129.04 126.54 39.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.933 -0.576 . . . . 62.34 109.792 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.511 ' HG2' ' SG ' ' A' ' 232' ' ' CYS . 22.8 ttmm -118.17 112.41 20.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 63.34 109.427 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 233' ' ' PHE . 5.7 p90 -135.09 118.8 17.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 74.23 112.389 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 0.2 OUTLIER -88.01 112.36 22.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.805 -1.183 . . . . 72.22 107.805 172.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.22 -55.36 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.375 0.88 . . . . 65.23 113.375 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.733 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 13.5 t70 -138.73 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 75.24 112.953 -164.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 62.4 Cg_endo -90.96 -139.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.161 1.908 . . . . 71.4 112.834 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.453 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.3 p-10 -92.56 12.22 23.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.213 -0.903 . . . . 74.32 109.498 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.519 ' CB ' ' HG2' ' A' ' 249' ' ' GLN . . . -121.46 123.69 42.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.634 0.73 . . . . 73.31 111.65 -169.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.511 ' SG ' ' HG2' ' A' ' 224' ' ' LYS . 44.8 t -97.29 128.17 43.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.634 -1.166 . . . . 64.12 108.318 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.486 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 53.0 m-85 -96.18 126.45 41.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.779 -0.452 . . . . 75.53 109.779 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 19.6 m -126.38 117.15 22.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 70.32 109.93 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -122.76 141.63 51.6 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.956 -0.387 . . . . 60.21 109.956 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 62.6 pttt -137.9 140.22 40.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.035 0.445 . . . . 75.34 110.401 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 243' ' ' ILE . 5.5 p -122.98 140.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.569 -0.53 . . . . 74.0 109.569 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -105.21 148.03 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.085 -0.709 . . . . 75.15 109.085 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.97 2.58 2.56 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.48 0.548 . . . . 74.22 112.48 -172.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.646 ' HB2' HD13 ' A' ' 242' ' ' LEU . 14.7 m -82.81 12.74 4.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.902 -0.777 . . . . 52.21 108.902 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 17.5 m 69.89 28.79 4.17 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.955 -1.021 . . . . 73.34 110.948 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.844 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.9 mp -101.15 129.39 47.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.902 0.334 . . . . 71.55 111.902 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.508 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -118.61 116.49 51.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.706 -0.679 . . . . 72.33 110.099 -169.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -127.99 133.81 7.94 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.276 -0.964 . . . . 53.04 113.12 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 0.0 OUTLIER -123.94 156.54 36.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.693 0.282 . . . . 65.41 110.483 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.67 149.46 20.95 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.543 -0.836 . . . . 73.33 113.158 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.835 ' HD1' ' HB3' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -106.63 118.1 35.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.107 -0.701 . . . . 74.43 109.107 177.623 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 28.9 m -104.49 115.14 29.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.439 -0.578 . . . . 75.41 109.439 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.519 ' HG2' ' CB ' ' A' ' 231' ' ' ALA . 10.9 mt-30 -112.41 133.16 54.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.003 0.43 . . . . 70.32 111.013 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 11.7 m -104.16 102.51 12.23 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.884 -0.784 . . . . 71.14 108.884 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.86 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 8.9 mp -75.24 179.3 5.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.857 0.36 . . . . 44.12 110.855 -174.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 1.4 tppp? -60.68 -52.52 71.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 54.33 111.09 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.598 ' HG2' HG12 ' A' ' 255' ' ' ILE . 72.3 Cg_endo -80.2 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.811 1.674 . . . . 73.43 111.617 172.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -75.94 64.58 2.68 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.915 -0.659 . . . . 74.33 112.553 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.86 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mm -123.74 123.97 68.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.537 0.208 . . . . 54.42 110.869 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.798 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 26.6 ttmt -115.46 114.17 24.69 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.299 -0.63 . . . . 73.5 109.299 171.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 279' ' ' LEU . 13.9 tp -100.33 124.55 45.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.623 -0.717 . . . . 62.41 109.959 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.4 m -122.22 110.21 15.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.152 0.501 . . . . 75.14 110.793 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.989 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -106.85 123.58 48.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.464 -1.31 . . . . 75.51 107.464 173.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.7 p -137.72 150.62 47.45 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.64 -0.424 . . . . 71.21 111.228 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.408 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -145.55 128.68 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.35 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.725 HD11 HD23 ' A' ' 242' ' ' LEU . 2.6 tm? -104.81 115.89 31.07 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.354 -0.98 . . . . 71.33 108.354 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.822 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.3 mm? -92.27 108.77 20.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.353 -0.98 . . . . 73.21 108.353 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.844 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m-20 -70.45 111.02 5.69 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.4 -0.963 . . . . 71.34 108.4 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.23 -27.68 40.17 Favored Glycine 0 C--N 1.319 -0.397 0 C-N-CA 121.207 -0.521 . . . . 41.4 112.995 -173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -91.79 -27.48 17.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.679 0.276 . . . . 75.41 111.19 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.832 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 14.4 m120 -92.46 -35.33 13.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.201 0.445 . . . . 70.23 112.201 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -63.04 -18.24 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.681 0.277 . . . . 60.34 111.649 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.71 -29.89 71.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.334 0.587 . . . . 53.12 109.653 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.22 0.18 31.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.541 -0.754 . . . . 64.15 110.594 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.34 8.06 57.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 74.41 113.066 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.33 86.92 1.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 42.44 112.567 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.444 ' HB3' HG12 ' A' ' 268' ' ' VAL . 31.6 p-80 -114.39 144.9 42.55 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.76 -0.259 . . . . 61.54 110.537 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -99.24 138.02 36.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 63.22 111.179 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.2 tm? -113.05 139.4 48.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.818 -0.438 . . . . 74.14 109.818 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.546 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.06 117.8 1.53 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.883 -0.675 . . . . 64.53 111.631 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.989 HD23 HD22 ' A' ' 259' ' ' LEU . 3.0 tm? -115.51 141.97 47.35 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.418 -0.586 . . . . 71.53 109.418 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.571 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -153.31 129.37 2.68 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.381 -0.914 . . . . 75.42 113.11 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.798 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.7 mm? -112.49 131.52 55.54 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.874 -0.417 . . . . 44.34 109.874 172.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.798 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -124.06 112.01 16.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.736 0.779 . . . . 74.44 109.897 173.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.601 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -98.19 135.91 39.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.433 -1.258 . . . . 71.03 108.76 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.492 ' N ' ' HD2' ' A' ' 281' ' ' PHE . 7.4 tp60 -133.47 112.13 11.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 73.4 109.818 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.98 114.19 25.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.037 -0.529 . . . . 61.04 110.021 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.7 mt -120.53 115.97 24.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 55.03 110.598 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.379 -0.82 . . . . 72.13 109.868 178.103 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.668 -0.493 . . . . 55.24 109.668 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.528 ' CA ' ' HA2' ' A' ' 94' ' ' GLY . . . -74.8 121.16 21.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.706 0.288 . . . . 53.22 111.325 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.079 HG22 ' HB3' ' A' ' 119' ' ' LYS . 27.7 m -94.88 145.2 29.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.174 -0.466 . . . . 53.22 111.135 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 32.5 Cg_exo -58.88 161.69 14.9 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.481 2.121 . . . . 64.52 110.361 172.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.95 92.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.313 2.009 . . . . 65.21 112.385 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 p -67.02 -25.84 66.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.284 -0.416 . . . . 50.11 111.854 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.784 ' HB3' HG21 ' A' ' 143' ' ' VAL . 16.6 p90 -65.13 -29.25 70.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 71.45 110.922 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.72 -12.64 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.484 0.659 . . . . 55.12 109.986 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -104.26 -7.14 20.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.559 -0.904 . . . . 64.45 108.559 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.706 HD12 ' HB3' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -57.79 -33.78 68.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.786 -1.552 . . . . 74.53 110.83 178.389 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.72 63.61 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.082 -0.58 . . . . 50.52 112.175 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -62.05 -39.86 93.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.667 0.387 . . . . 75.43 111.753 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 m -61.0 -36.71 80.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 62.42 112.188 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.8 82.37 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.749 0.648 . . . . 73.24 112.749 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -67.74 -33.83 75.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.88 -0.328 . . . . 44.54 111.463 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 26.3 t70 -65.91 -47.99 72.93 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.5 -0.555 . . . . 70.11 109.5 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 222' ' ' ALA . 11.3 t -58.22 -33.49 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.956 -0.566 . . . . 71.44 111.566 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HD2' ' HB2' ' A' ' 207' ' ' ASN . 66.9 t80 -60.69 -39.52 88.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 64.25 111.695 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 18' ' ' PHE . 1.1 p -131.42 12.19 4.97 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.335 0.865 . . . . 73.41 113.335 -172.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 34.4 tttp -65.38 -38.7 90.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.166 0.507 . . . . 75.44 110.65 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.34 45.79 1.27 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.852 -0.69 . . . . 23.22 111.765 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.29 130.29 42.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.81 113.63 3.69 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.79 -0.719 . . . . 62.25 112.548 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -84.46 -3.67 58.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.792 0.33 . . . . 75.43 111.063 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.51 85.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.14 -0.552 . . . . 61.2 113.344 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 46' ' ' SER . 2.1 pp -147.21 179.89 7.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.047 0.758 . . . . 70.12 113.047 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.664 HD12 HD12 ' A' ' 277' ' ' LEU . 37.6 mm -100.59 124.47 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.368 -1.287 . . . . 72.43 109.55 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 33.3 ttpt -107.53 121.82 45.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.97 -0.382 . . . . 75.33 109.97 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.47 128.04 56.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.417 -0.586 . . . . 65.33 109.417 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.8 136.67 51.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.039 -0.726 . . . . 72.01 109.039 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.567 HD13 ' HD1' ' A' ' 281' ' ' PHE . 12.1 tp -137.04 124.62 22.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.931 0.396 . . . . 62.43 110.341 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' N ' HD12 ' A' ' 31' ' ' LEU . 39.8 tttp -116.97 125.44 51.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.449 -0.574 . . . . 71.04 109.449 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 25.4 m -126.06 149.51 48.83 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.335 -0.393 . . . . 63.33 110.5 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' HD3' HD22 ' A' ' 284' ' ' LEU . 55.0 mtpt -125.15 144.41 50.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.754 0.311 . . . . 63.13 110.878 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 52.3 m -140.75 158.28 44.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.31 -0.405 . . . . 60.44 110.995 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.626 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 28.3 tt0 -76.46 99.1 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.45 111.91 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.745 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t30 160.44 26.59 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.631 1.172 . . . . 52.13 107.861 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.718 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.65 18.05 79.35 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.273 -0.876 . . . . 72.24 110.991 -172.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 37' ' ' ASN . 3.1 mt -86.74 134.33 33.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.758 0.79 . . . . 55.34 112.916 -167.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.65 130.61 30.27 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.012 -1.449 . . . . 71.32 109.173 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 93.7 m-85 -115.65 121.54 42.86 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.854 -0.425 . . . . 74.12 109.854 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.896 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 23.7 m -115.94 116.48 28.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.091 0.472 . . . . 44.51 110.058 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 25.2 t -113.15 131.31 55.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.708 -0.678 . . . . 75.15 109.726 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -130.97 135.63 47.81 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.686 -0.487 . . . . 34.35 109.686 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.62 110.13 0.43 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.611 -0.804 . . . . 73.02 112.067 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.457 ' HB3' HD13 ' A' ' 26' ' ' LEU . 15.2 m -108.39 133.18 52.94 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.67 -0.863 . . . . 71.2 108.67 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.495 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -151.57 136.7 17.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.235 0.54 . . . . 72.02 111.24 -174.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -80.87 129.27 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 74.23 108.748 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.8 m -62.46 -20.9 65.01 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.973 0.416 . . . . 64.1 111.675 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -84.46 6.05 24.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.156 0.503 . . . . 72.14 110.204 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 p 49.24 72.0 0.34 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.68 0.792 . . . . 75.5 112.098 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -126.74 -30.87 2.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.253 -0.885 . . . . 63.3 110.172 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -149.13 113.85 5.36 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.101 -0.703 . . . . 71.11 109.101 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 47' ' ' ALA . 25.7 t -125.99 127.47 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 72.13 109.843 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -134.18 137.61 44.57 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.958 -0.386 . . . . 64.24 109.958 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -142.49 154.82 25.39 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.29 -0.957 . . . . 72.24 112.884 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.765 ' HB2' HG23 ' A' ' 77' ' ' THR . 26.7 t -146.73 148.68 32.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.226 -0.657 . . . . 72.3 109.226 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 74' ' ' LYS . 1.7 tm? -146.57 125.47 12.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.896 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 11.7 pt-20 -125.84 131.36 52.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.266 0.555 . . . . 63.11 110.195 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.419 HG23 ' CE1' ' A' ' 41' ' ' PHE . 48.3 m -107.62 119.4 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.813 -0.81 . . . . 75.31 108.813 172.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 19.9 mtpp -112.07 126.94 55.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 75.21 110.586 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.9 m-85 -110.77 120.97 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.36 -0.607 . . . . 54.34 109.36 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.718 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 39.5 mtp180 -114.61 110.9 20.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.809 0.814 . . . . 75.42 110.696 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -111.02 117.2 32.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.077 -1.42 . . . . 72.33 109.062 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m 73.64 122.85 0.04 OUTLIER 'General case' 0 C--O 1.231 0.108 0 O-C-N 124.021 0.826 . . . . 65.52 109.734 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.9 mp0 -63.01 106.47 0.84 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.037 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 87.2 m-85 68.0 84.77 0.15 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.207 -0.906 . . . . 71.44 109.37 -170.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.81 -83.05 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.309 -0.86 . . . . 71.14 111.443 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.8 mm? -121.26 131.71 54.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.985 0.421 . . . . 71.12 111.151 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 42.1 m -136.77 119.11 15.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.731 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 7.9 m-85 -107.98 133.38 52.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.239 -0.437 . . . . 74.21 110.115 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -128.35 119.44 25.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.074 0.397 . . . . 71.24 110.816 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 8.0 pt-20 -131.63 170.46 14.73 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.2 0.444 . . . . 64.01 112.2 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.625 ' HG3' HD12 ' A' ' 58' ' ' LEU . 72.5 mmtt 118.73 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.057 1.743 . . . . 64.23 113.452 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.535 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 13.2 t90 -135.0 143.57 46.89 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.484 0.55 . . . . 70.21 112.484 -163.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -119.38 159.23 24.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.951 -0.568 . . . . 72.21 111.112 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.765 HG23 ' HB2' ' A' ' 57' ' ' SER . 17.9 p -61.67 -17.99 57.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.296 0.85 . . . . 72.1 113.296 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.65 -1.61 35.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.658 -0.246 . . . . 74.22 110.89 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 78.9 13.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.762 0.825 . . . . 44.11 109.687 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -86.7 134.89 33.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.306 -0.861 . . . . 74.22 110.058 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.1 mp -107.72 161.09 15.2 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.375 -0.972 . . . . 74.42 108.375 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 102' ' ' SER . . . 148.23 -167.68 28.99 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.277 -1.439 . . . . 61.11 113.141 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 2.3 t -157.9 152.29 24.67 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.637 -0.282 . . . . 71.42 110.494 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.941 ' HA ' ' HB3' ' A' ' 100' ' ' ASP . 10.4 pt-20 -127.45 136.28 51.59 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 125.166 1.541 . . . . 71.22 109.678 171.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 99' ' ' PHE . 1.7 pp -111.4 133.11 58.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 118.658 -1.217 . . . . 71.35 110.815 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.93 ' HB ' ' HE3' ' A' ' 96' ' ' LYS . 21.1 p -114.8 137.52 51.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.727 -0.67 . . . . 64.44 110.783 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.75 135.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.32 -0.4 . . . . 73.34 110.672 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.05 127.33 36.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.378 -0.601 . . . . 74.13 109.378 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 27.1 t70 -69.94 156.64 38.8 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.248 0.547 . . . . 74.2 111.601 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -95.56 -37.31 10.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.5 -0.773 . . . . 72.4 110.831 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.64 -55.07 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 74.24 111.018 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.8 64.32 5.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.772 -0.825 . . . . 72.33 108.772 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -48.88 126.53 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 74.23 111.221 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.528 ' HA2' ' CA ' ' A' ' 2' ' ' ALA . . . 104.1 -4.25 44.94 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.69 -0.687 . . . . 52.31 112.204 -173.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 89' ' ' ASP . 52.7 tp -79.72 130.43 35.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.686 . . . . 75.43 109.146 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.93 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 55.9 tptt -121.72 111.15 16.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.658 -0.701 . . . . 70.4 109.732 -174.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 116' ' ' THR . 1.1 mm? -112.77 125.71 54.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.365 -0.605 . . . . 43.05 109.365 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.862 ' HB ' HG22 ' A' ' 86' ' ' THR . 1.8 t -131.92 118.98 20.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.306 -0.558 . . . . 73.44 112.219 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.935 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 88.1 t80 -127.39 114.23 17.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 75.42 109.407 174.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.941 ' HB3' ' HA ' ' A' ' 84' ' ' GLU 0.355 1.2 t70 -153.82 172.95 16.55 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 120.845 -1.159 . . . . 64.24 112.804 159.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.749 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 23.3 t -116.78 147.79 41.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.931 0.396 . . . . 52.32 110.687 -165.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.679 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 33.4 t -114.8 134.81 54.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 75.31 110.368 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -95.52 124.9 39.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.059 0.457 . . . . 72.22 110.252 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 31.3 m -109.61 115.2 56.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 74.43 110.75 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 19.3 Cg_exo -66.22 -7.81 18.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.184 2.589 . . . . 63.0 112.326 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -55.92 -50.81 69.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.743 -0.662 . . . . 75.32 111.01 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 p -129.36 -2.67 4.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.854 0.359 . . . . 71.3 111.65 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.92 11.68 81.02 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.664 -0.779 . . . . 64.31 111.734 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.843 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -94.35 149.08 21.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.693 -0.254 . . . . 71.43 110.567 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -106.94 135.98 47.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.04 0.448 . . . . 74.12 110.405 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -119.54 122.9 42.66 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.443 -0.947 . . . . 75.21 108.443 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.749 ' HA ' ' HA ' ' A' ' 101' ' ' SER . . . -104.45 147.16 27.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.942 0.401 . . . . 64.24 111.596 -168.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -121.65 137.56 54.7 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.473 0.654 . . . . 74.52 110.433 177.649 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.935 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 2.5 tp -127.77 115.86 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.385 -1.279 . . . . 63.31 109.359 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.779 ' HB3' HG23 ' A' ' 98' ' ' THR . 4.4 ttmp? -113.65 121.27 43.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.725 -0.67 . . . . 54.43 110.579 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.68 HG22 HD12 ' A' ' 97' ' ' LEU . 21.7 p -112.68 117.29 31.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.367 -0.605 . . . . 61.52 109.367 175.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.82 134.93 5.34 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.052 -1.07 . . . . 44.54 112.885 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -107.51 125.36 51.18 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.616 -0.512 . . . . 65.53 109.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 1.079 ' HB3' HG22 ' A' ' 3' ' ' VAL . 41.7 mttp -110.26 121.78 46.09 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 121.182 0.515 . . . . 75.23 110.852 -173.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 120' ' ' ARG . 6.4 mmt180 -108.89 152.5 24.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.202 -0.908 . . . . 74.44 109.317 169.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.869 ' HA ' HG11 ' A' ' 3' ' ' VAL . 8.8 tm-20 -50.88 -27.93 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.907 0.883 . . . . 75.33 111.317 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -110.9 -15.4 13.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.091 -0.504 . . . . 74.33 112.143 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 144' ' ' LEU . 16.6 tt -149.29 122.12 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 118.813 -1.155 . . . . 70.14 113.482 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 1.6 t30 -102.83 119.01 38.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.445 -0.798 . . . . 64.21 110.793 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 142' ' ' LEU . 3.1 mm? -112.43 111.9 23.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.166 -0.679 . . . . 73.31 109.166 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.11 118.58 2.44 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.991 -1.1 . . . . 54.33 113.103 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.8 t -110.66 111.22 22.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.935 0.398 . . . . 70.43 110.204 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 13.6 t70 -100.7 134.74 43.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 75.14 109.728 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.83 117.78 24.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.838 0.352 . . . . 73.14 110.119 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.32 119.22 37.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -82.45 96.9 8.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.903 0.382 . . . . 74.34 111.007 -171.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.593 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 13.0 t70 -96.82 145.31 25.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 65.31 109.638 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -29.17 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.544 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.72 58.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.944 0.402 . . . . 70.22 110.923 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.56 108.3 0.51 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.583 -0.607 . . . . 72.3 111.583 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.593 ' HA ' ' H ' ' A' ' 132' ' ' ASP . 77.0 Cg_exo -48.24 123.51 9.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.268 2.645 . . . . 70.14 112.755 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 t -84.68 136.67 33.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.251 -0.648 . . . . 63.34 109.251 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 45.5 mm -105.57 117.04 50.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 62.42 109.467 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -116.19 109.64 17.72 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.28 -0.637 . . . . 72.24 109.28 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.0 133.54 11.61 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.907 -1.139 . . . . 51.04 112.157 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.21 114.08 21.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.418 0.628 . . . . 75.02 109.491 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 144' ' ' LEU . 18.1 tp -116.47 122.94 46.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.362 -0.836 . . . . 72.54 109.569 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' A' ' 7' ' ' TYR . 48.3 t -133.9 120.26 35.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.958 -0.386 . . . . 74.32 109.958 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.665 HD12 HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -126.78 139.29 53.23 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.532 -0.867 . . . . 74.2 110.718 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -120.86 128.41 7.41 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 114.674 -1.148 . . . . 73.31 111.837 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -112.59 149.16 33.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.396 -1.705 . . . . 74.21 106.396 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -47.7 95.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 55.53 112.243 -171.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.3 -33.09 5.73 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.133 -0.94 . . . . 43.32 112.867 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.433 ' HD1' ' HB2' ' A' ' 173' ' ' TYR . 2.5 m0 -106.47 146.88 30.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.847 0.323 . . . . 74.34 111.463 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.706 ' HB3' HD12 ' A' ' 10' ' ' LEU . 7.5 mt -130.81 136.56 48.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.815 -0.809 . . . . 62.35 108.815 167.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.513 ' HB3' ' CD2' ' A' ' 144' ' ' LEU . . . -130.52 127.4 39.07 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.861 -0.422 . . . . 72.35 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.539 ' N ' HD21 ' A' ' 10' ' ' LEU . . . -131.85 133.54 7.21 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.986 -0.626 . . . . 75.11 111.791 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -129.36 118.72 22.68 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.212 -0.494 . . . . 75.34 110.538 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -111.6 121.83 46.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 45.23 109.508 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -135.48 146.69 48.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.065 -0.346 . . . . 74.2 110.065 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 2.0 p-10 -124.35 119.01 28.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.645 0.736 . . . . 71.12 110.966 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.856 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.8 t80 -97.03 123.1 40.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.527 -1.215 . . . . 71.42 109.298 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.708 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 25.0 tt0 -94.04 105.25 17.26 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.747 -0.464 . . . . 71.43 109.747 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.78 -22.09 62.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 113.687 -1.597 . . . . 53.25 111.149 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.23 77.83 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.595 -0.891 . . . . 70.34 108.595 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.708 ' H ' ' HG2' ' A' ' 158' ' ' GLU . 17.6 ttmm -98.89 -164.91 1.18 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.92 -1.511 . . . . 72.41 106.92 169.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 15.5 m -110.38 25.52 11.69 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.223 -0.923 . . . . 71.14 110.509 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -155.31 151.28 27.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 119.398 -0.921 . . . . 74.33 112.727 -160.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.856 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -74.77 135.72 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.105 -1.072 . . . . 71.1 108.105 168.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -93.99 -32.84 13.68 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.421 -0.512 . . . . 74.51 110.929 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 186' ' ' ASP . 35.3 tt0 -151.38 133.52 15.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 54.45 111.066 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 m -118.69 120.22 36.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 61.01 109.984 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 185' ' ' ASN . 39.3 m-80 -116.82 121.95 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.806 -0.813 . . . . 62.22 108.806 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -139.8 155.48 47.25 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.567 -0.853 . . . . 61.25 111.797 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.574 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -144.81 152.71 40.74 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.616 -0.72 . . . . 75.0 110.23 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 42.9 t -130.21 151.63 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.613 -1.254 . . . . 54.32 107.613 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -158.04 111.03 0.47 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.029 -1.081 . . . . 72.54 112.197 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.458 ' CE2' HD22 ' A' ' 180' ' ' LEU . 39.2 p90 -113.39 138.36 50.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.428 0.632 . . . . 71.53 110.957 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -104.63 127.17 52.31 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.695 -1.139 . . . . 62.11 110.486 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 178' ' ' PHE . 33.5 m -127.12 162.54 25.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.555 -0.906 . . . . 74.42 108.555 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.61 -54.7 11.1 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.522 0.564 . . . . 50.22 112.522 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.28 -21.93 13.44 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.896 -0.322 . . . . 63.4 111.698 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.519 ' O ' ' HB ' ' A' ' 175' ' ' THR . 91.4 m-85 -124.69 142.84 51.1 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.805 0.336 . . . . 73.32 110.913 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 29.2 tt0 -135.23 122.9 22.22 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.206 -1.035 . . . . 72.21 108.206 172.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.502 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 8.8 tt -121.54 137.45 54.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.987 -0.685 . . . . 64.31 111.2 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 19.9 t-80 -127.3 114.8 18.07 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.248 -0.887 . . . . 65.1 110.573 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -81.51 148.31 29.25 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.804 -0.813 . . . . 62.04 108.804 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.403 ' HB2' ' CE1' ' A' ' 181' ' ' HIS . 25.0 t-20 -147.93 137.02 22.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.3 -0.56 . . . . 74.13 111.25 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.9 t -133.78 123.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.554 -0.748 . . . . 62.34 110.068 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 89.2 m-20 -117.08 112.44 20.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.641 -0.709 . . . . 74.42 109.529 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.548 ' HA ' ' HG3' ' A' ' 166' ' ' GLN . 21.0 t70 63.7 -173.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.418 -0.81 . . . . 71.53 109.072 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.9 -6.0 89.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.395 -0.907 . . . . 43.21 111.101 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.2 m -97.03 -26.95 14.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.0 0.741 . . . . 62.32 113.0 -171.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 16.7 mm-40 -116.5 111.15 19.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.523 0.601 . . . . 72.13 110.427 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -127.63 123.62 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 74.25 109.371 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -174.13 -144.87 4.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.802 -1.19 . . . . 65.41 113.33 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -166.23 -172.08 33.13 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.613 -0.804 . . . . 44.0 113.038 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 4.1 m -148.76 139.0 22.39 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.544 0.738 . . . . 72.41 109.12 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.1 mp -124.23 117.45 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 121.2 -0.2 . . . . 73.21 110.464 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.501 ' HD1' ' HB2' ' A' ' 205' ' ' ALA . 11.6 t80 -108.41 120.33 42.09 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.542 -0.54 . . . . 54.4 109.542 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -125.72 133.05 52.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.472 -0.331 . . . . 74.23 110.45 -175.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -101.15 114.41 28.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.477 -0.329 . . . . 73.43 110.378 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 199' ' ' ASN . 8.3 t -73.77 171.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.373 -0.603 . . . . 71.15 109.373 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.555 ' H ' HG12 ' A' ' 198' ' ' VAL . 12.9 m120 -66.11 -30.87 71.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.756 0.312 . . . . 44.13 111.31 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 4.7 mptp? -92.81 -164.51 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 55.42 110.846 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 200' ' ' LYS . 32.0 tptt -79.11 39.09 0.37 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 73.44 110.496 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.965 ' HG ' ' HB3' ' A' ' 225' ' ' TYR . 4.5 tt -120.92 122.01 39.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 73.44 109.661 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.86 130.54 53.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.98 -0.555 . . . . 71.31 109.658 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.0 t -121.64 153.75 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.863 0.363 . . . . 73.4 110.63 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.02 147.79 37.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.498 0.666 . . . . 60.03 111.55 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 221' ' ' ILE . 71.3 t -112.13 132.79 59.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.158 -0.928 . . . . 71.1 109.517 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.3 p-10 -114.2 127.3 55.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.934 -1.136 . . . . 71.52 107.934 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 tp -144.15 129.58 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.556 -0.458 . . . . 71.31 110.819 -169.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.453 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -150.57 129.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.534 . . . . 71.21 111.216 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.648 ' CZ2' ' HA ' ' A' ' 215' ' ' SER . 3.5 t-105 -95.1 125.33 39.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.281 -1.007 . . . . 62.15 108.281 174.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 t -101.56 123.02 44.9 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.495 0.664 . . . . 64.52 110.312 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.7 127.32 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 53.02 111.533 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 153.96 -70.51 0.29 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.875 -0.89 . . . . 70.45 110.875 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.9 -166.01 1.43 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.387 -0.597 . . . . 75.04 109.387 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.648 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . 64.6 m -95.57 24.8 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.094 0.474 . . . . 74.23 110.808 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.07 111.82 20.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 73.34 109.779 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.6 t -99.82 135.97 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.05 0.452 . . . . 72.24 110.007 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -96.5 115.12 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.459 -0.571 . . . . 74.21 109.459 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.627 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 47.6 p90 -119.64 154.95 33.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.846 0.355 . . . . 74.34 110.736 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.39 23.12 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.849 -0.691 . . . . 73.31 111.943 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.854 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -135.49 140.64 44.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 121.035 -0.266 . . . . 74.34 110.458 177.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.763 ' HB3' HG13 ' A' ' 17' ' ' VAL . . . -133.69 131.13 39.13 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.345 0.403 . . . . 63.1 110.706 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.56 125.14 53.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.393 -0.367 . . . . 72.53 110.186 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -112.02 114.08 26.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 53.3 109.218 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.965 ' HB3' ' HG ' ' A' ' 202' ' ' LEU . 7.9 p90 -127.03 124.63 39.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.435 0.636 . . . . 53.31 111.24 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -82.32 106.87 14.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.048 -0.978 . . . . 72.32 108.946 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.54 HG21 ' HE1' ' A' ' 233' ' ' PHE . 14.8 tt -70.11 -43.98 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.692 0.627 . . . . 64.41 112.692 -167.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.773 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 14.4 t70 -171.79 -63.56 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.311 0.486 . . . . 73.23 112.311 -175.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 78.4 Cg_endo -93.4 -127.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.281 1.987 . . . . 53.32 112.911 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.5 p-10 -92.35 12.63 21.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.708 -0.678 . . . . 73.11 110.829 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.24 133.1 55.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.456 0.646 . . . . 62.14 111.322 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -121.36 140.26 52.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.833 -1.076 . . . . 54.21 109.34 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.54 ' HE1' HG21 ' A' ' 227' ' ' ILE . 88.1 m-85 -106.45 126.74 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.123 -0.325 . . . . 72.4 110.123 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 15.0 m -120.59 117.63 28.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.484 . . . . 63.55 110.067 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -118.42 140.48 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.829 -0.434 . . . . 54.34 109.829 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.62 ' HB2' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -143.74 148.03 35.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 62.25 111.251 -177.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.523 HG12 HG12 ' A' ' 221' ' ' ILE . 7.0 p -122.58 148.57 26.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 116.32 -0.4 . . . . 64.25 110.113 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -110.45 150.04 29.43 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.254 0.972 . . . . 71.05 109.591 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.627 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 6.8 p30 -37.98 -36.39 0.2 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.61 1.564 . . . . 71.22 114.815 -172.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.699 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.1 m -81.83 21.19 0.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.772 0.32 . . . . 64.4 111.033 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.3 m 68.43 31.54 4.9 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.634 -0.712 . . . . 71.54 111.203 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.836 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.6 mp -96.86 129.53 44.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.566 -0.454 . . . . 71.4 111.536 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.575 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -111.49 116.52 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.3 0.572 . . . . 63.22 110.834 -172.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -116.28 133.72 10.95 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.739 -0.664 . . . . 73.22 111.867 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 245' ' ' LEU . 1.3 pp -119.9 146.51 45.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.42 . . . . 52.24 110.678 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -134.17 133.44 6.87 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.612 -0.722 . . . . 73.31 111.778 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.717 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 19.4 m-85 -102.86 114.48 28.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.666 -0.864 . . . . 73.54 108.666 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 22.1 m -116.84 114.95 24.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.811 0.339 . . . . 63.21 110.417 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -132.45 137.51 47.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.854 0.359 . . . . 74.22 110.676 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.9 m -112.37 95.71 5.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.001 -0.545 . . . . 60.34 110.159 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 43.7 tp -82.05 88.34 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.268 -0.642 . . . . 75.02 109.268 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 75.1 mmtt 67.93 163.82 0.13 Allowed Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.259 -0.882 . . . . 72.24 110.273 -175.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 40.8 Cg_endo -69.23 64.29 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.355 2.037 . . . . 31.24 112.3 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -158.68 -45.43 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.911 -0.586 . . . . 74.34 112.315 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.6 mt -124.08 121.44 62.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 64.15 111.652 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 280' ' ' GLU . 37.1 ttmt -117.47 115.44 25.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.367 -0.605 . . . . 64.0 109.367 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.5 tp -100.44 130.53 46.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.424 -0.353 . . . . 73.44 110.521 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 30.0 m -129.98 111.25 12.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.554 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.922 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.21 122.84 44.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.892 -1.151 . . . . 72.24 107.892 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.9 m -124.39 139.58 53.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.971 0.415 . . . . 63.34 110.854 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.4 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -143.92 127.77 17.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.99 -0.55 . . . . 42.22 110.248 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.754 HD11 HD23 ' A' ' 242' ' ' LEU . 2.7 tm? -101.62 118.04 36.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.361 -0.977 . . . . 74.12 108.361 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -97.7 110.95 23.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.605 -0.887 . . . . 64.41 108.605 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.836 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.9 m-20 -68.62 102.34 1.47 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.711 -0.848 . . . . 53.32 108.711 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -64.9 -10.06 43.65 Favored Glycine 0 C--N 1.321 -0.293 0 CA-C-N 115.64 -0.709 . . . . 71.3 111.844 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -90.59 -25.34 20.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.206 -0.497 . . . . 73.31 111.092 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -161.5 24.25 0.12 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.105 1.52 . . . . 74.43 115.105 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 264' ' ' ASP . 0.2 OUTLIER -64.18 -46.47 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 120.079 1.309 . . . . 73.42 112.878 176.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.43 -25.92 62.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.067 0.461 . . . . 61.53 110.594 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.87 2.37 32.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 52.51 111.067 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.63 -103.12 0.34 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.141 -1.028 . . . . 71.2 112.856 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -158.78 167.28 34.69 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.082 -1.056 . . . . 32.33 113.223 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -111.47 150.12 30.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.66 -0.77 . . . . 73.52 109.593 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.666 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 43.6 mttm -93.7 137.18 33.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.689 -0.856 . . . . 71.03 108.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.7 tm? -125.66 133.06 52.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.755 0.312 . . . . 72.21 110.294 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.469 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.24 122.39 2.18 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.062 -0.815 . . . . 61.35 111.062 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.922 HD23 HD22 ' A' ' 259' ' ' LEU . 2.2 tm? -115.82 125.32 52.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.644 -0.502 . . . . 64.33 109.644 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -134.9 138.43 10.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.429 -0.891 . . . . 70.14 112.895 -175.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.85 132.39 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.777 -0.453 . . . . 74.31 109.777 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.728 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 46.4 mt-10 -109.85 110.88 22.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.812 -0.81 . . . . 70.25 108.812 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.567 ' HD1' HD13 ' A' ' 31' ' ' LEU . 16.4 t80 -104.16 141.6 35.96 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.589 -0.893 . . . . 74.14 108.589 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -135.56 119.79 17.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.935 0.398 . . . . 52.01 110.639 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.22 108.43 19.05 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.156 -0.683 . . . . 53.04 109.156 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 34' ' ' LYS . 36.2 mt -121.13 -69.02 0.86 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.843 -0.799 . . . . 40.33 108.843 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 114.679 -1.146 . . . . 70.3 108.532 177.228 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.347 0.118 . . . . 74.31 111.034 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.58 145.43 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.683 0.278 . . . . 54.23 110.69 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.745 ' HB ' ' HE2' ' A' ' 119' ' ' LYS . 60.5 t -67.43 125.99 91.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.037 -0.529 . . . . 72.11 110.332 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 46.7 Cg_exo -57.23 153.98 36.87 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.39 2.727 . . . . 52.13 113.279 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.03 64.34 6.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.114 2.543 . . . . 72.05 112.047 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.604 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.9 p -69.63 -37.74 76.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.466 -0.788 . . . . 52.22 111.096 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.742 ' HB3' HG21 ' A' ' 143' ' ' VAL . 3.5 p90 -64.12 -22.03 66.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 72.31 111.278 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.69 -19.79 44.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.066 -0.516 . . . . 54.4 110.367 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.49 11.91 37.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.032 0.92 . . . . 71.32 109.333 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.979 HD21 ' HA3' ' A' ' 152' ' ' GLY . 3.3 tp -76.53 -14.3 60.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.007 -0.997 . . . . 73.11 110.849 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.66 26.23 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.44 -0.886 . . . . 65.41 113.291 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -68.93 -50.17 51.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.151 0.476 . . . . 71.5 110.525 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -57.34 -38.86 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.836 -0.62 . . . . 72.52 111.027 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.65 72.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 72.32 111.402 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.77 -39.91 84.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.6 -0.273 . . . . 74.33 111.518 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 14.7 t70 -58.59 -49.83 76.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.642 -0.254 . . . . 73.12 111.353 -175.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -70.23 -31.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.015 0.436 . . . . 73.21 110.867 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -72.64 -32.19 65.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 74.03 110.71 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -81.87 -25.84 34.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 65.12 110.73 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' HD3' ' O ' ' A' ' 16' ' ' ASP . 1.9 mptm? -85.17 20.06 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 63.35 110.865 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.601 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -99.61 -19.47 20.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 53.43 113.286 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -87.16 138.28 31.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.267 0.556 . . . . 74.15 112.141 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -152.35 109.65 0.42 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.22 -0.9 . . . . 63.04 111.709 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -103.73 14.99 29.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.785 0.326 . . . . 74.42 111.005 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.33 14.61 53.52 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 109.226 -1.55 . . . . 72.42 109.226 -166.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 46' ' ' SER . 5.3 tt -99.47 145.6 27.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.944 -1.128 . . . . 64.43 110.688 -168.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 277' ' ' LEU . 28.3 mm -102.49 125.26 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.986 -1.006 . . . . 61.11 110.198 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -107.79 120.01 41.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.332 -0.618 . . . . 63.41 109.332 175.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 279' ' ' LEU . 22.5 tp -114.44 147.56 39.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.837 0.351 . . . . 73.1 110.554 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.6 t70 -150.82 131.65 14.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 55.14 109.768 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.942 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -126.84 123.59 37.67 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 97.1 mttt -132.65 124.97 29.29 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.839 -0.344 . . . . 63.34 110.988 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 41' ' ' PHE . 8.8 t -135.83 129.95 33.2 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.285 -0.635 . . . . 52.15 109.285 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.728 ' HB3' HH12 ' A' ' 63' ' ' ARG . 90.3 mttt -118.3 131.17 56.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.965 -0.562 . . . . 53.12 109.969 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -132.91 150.26 52.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.238 -0.437 . . . . 54.14 110.513 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.91 2.37 46.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.799 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -100.08 24.75 8.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 54.24 111.521 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.3 -5.89 82.64 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.328 -0.939 . . . . 64.42 113.451 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.42 127.78 46.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.179 0.99 . . . . 70.14 111.764 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.3 117.6 11.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.507 -0.923 . . . . 74.43 108.507 164.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' HB2' HG22 ' A' ' 33' ' ' THR . 96.0 m-85 -110.32 125.6 53.34 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.588 -0.445 . . . . 75.04 110.768 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 20.6 m -125.18 116.11 21.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 61.52 109.934 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 6.4 m -108.76 123.28 48.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.051 -0.722 . . . . 75.21 109.051 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -130.03 126.41 37.64 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.006 -0.368 . . . . 74.05 110.006 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.14 156.66 26.97 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.946 -1.121 . . . . 61.1 112.576 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.593 ' HB3' HD21 ' A' ' 26' ' ' LEU . 16.6 m -137.98 132.35 32.15 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.308 -0.627 . . . . 33.35 109.308 176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -144.32 130.04 19.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.862 0.363 . . . . 71.42 110.593 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 46.1 t30 -80.64 142.02 34.39 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.444 -0.576 . . . . 73.24 109.444 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -64.04 -19.37 65.16 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.968 0.413 . . . . 63.01 111.255 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -70.62 -13.6 62.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 64.14 110.442 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m 71.56 -3.52 2.12 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.726 -0.67 . . . . 70.51 111.726 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -73.06 -27.46 61.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.217 -0.447 . . . . 71.12 110.981 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.28 101.66 6.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 71.21 110.034 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -125.66 120.69 58.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.985 -0.552 . . . . 70.13 110.11 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -131.3 125.03 31.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.955 -0.387 . . . . 65.43 109.955 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.83 155.19 20.06 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.266 -0.969 . . . . 75.23 112.409 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 p -146.8 141.21 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.111 0.482 . . . . 74.53 110.441 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.38 122.54 42.03 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.926 -1.139 . . . . 73.25 107.926 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 28.0 mt-10 -116.98 119.96 36.91 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.956 -0.565 . . . . 73.1 109.82 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -109.78 120.99 44.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.724 -0.671 . . . . 70.15 109.841 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 42.9 tttp -117.08 132.51 56.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.067 -0.716 . . . . 65.3 109.067 176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 70' ' ' THR . 37.9 t80 -100.19 121.6 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.044 -1.095 . . . . 74.22 108.044 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.728 HH12 ' HB3' ' A' ' 34' ' ' LYS . 10.6 ttp180 -123.72 107.3 11.31 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.538 0.685 . . . . 73.05 111.094 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.4 ' HB2' ' HE2' ' A' ' 62' ' ' TYR . 63.3 t-105 -113.55 115.58 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.79 -1.096 . . . . 64.45 108.886 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m 70.93 139.13 0.04 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.961 0.788 . . . . 72.53 109.59 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 2.7 tp10 -65.58 101.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.692 -0.485 . . . . 71.53 109.692 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.24 68.92 0.59 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.378 -0.828 . . . . 72.14 110.684 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.04 -76.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.382 -1.087 . . . . 74.34 110.382 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -122.11 130.18 53.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.743 0.306 . . . . 61.13 110.247 173.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.797 HG23 ' HB ' ' A' ' 86' ' ' THR . 9.0 t -138.44 135.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.425 0.631 . . . . 75.41 112.089 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 85.2 m-85 -105.75 133.77 49.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.844 -0.798 . . . . 74.43 108.844 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.4 m -120.84 119.31 32.29 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.71 -0.396 . . . . 71.24 111.465 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 28.1 mt-10 -130.96 152.2 50.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.668 -0.697 . . . . 73.05 109.803 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -160.43 104.38 1.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 71.22 110.917 178.196 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.975 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 48.8 t90 -98.53 127.94 44.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.298 -0.41 . . . . 71.15 110.358 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.86 136.84 38.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.488 -0.93 . . . . 71.01 108.488 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -61.8 -25.83 67.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 72.22 111.862 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.7 -38.17 5.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.118 0.784 . . . . 72.12 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.27 -90.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.347 0.869 . . . . 55.31 113.347 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 m -85.22 123.6 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.811 0.671 . . . . 73.33 112.811 -166.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.975 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -108.48 119.07 38.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.624 -0.51 . . . . 64.24 109.624 168.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -115.53 156.61 15.54 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.643 -0.789 . . . . 41.11 112.776 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 9.8 t -172.88 148.72 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.681 -0.489 . . . . 74.42 109.681 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 100' ' ' ASP . 12.2 mm-40 165.58 -155.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.585 1.154 . . . . 73.4 110.491 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.495 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -131.58 138.97 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.49 0.552 . . . . 64.5 112.49 -165.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.797 ' HB ' HG23 ' A' ' 70' ' ' THR . 23.1 m -127.77 131.75 49.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.337 -0.392 . . . . 53.1 110.003 175.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 97' ' ' LEU . 3.9 p -129.95 129.8 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 64.41 111.672 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.56 117.87 30.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.278 -1.008 . . . . 73.44 108.278 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -87.28 140.18 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.26 -0.576 . . . . 71.42 111.642 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.84 -25.85 15.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.279 -0.873 . . . . 74.42 110.655 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.9 tp -67.13 -57.23 7.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.032 -0.729 . . . . 74.14 109.032 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.54 76.17 5.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.298 -1.001 . . . . 70.34 108.298 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.67 123.11 13.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.554 -0.748 . . . . 71.23 110.683 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . 100.6 -0.91 55.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.665 -0.698 . . . . 73.42 112.319 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.3 tp -91.41 131.1 37.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 51.13 110.201 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -121.68 111.24 16.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.328 -0.851 . . . . 72.34 109.85 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.437 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.9 mm? -100.79 126.34 47.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.083 -0.71 . . . . 72.35 109.083 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 23.6 m -128.87 118.34 22.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.119 0.485 . . . . 75.3 111.749 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.637 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 77.7 m-85 -111.06 116.22 30.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.85 -1.167 . . . . 72.23 107.85 170.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.649 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.5 p-10 -130.56 128.19 40.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.846 0.355 . . . . 73.44 110.575 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 t -119.57 148.81 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.732 0.301 . . . . 63.25 110.528 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 7.9 p -133.04 134.54 44.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.301 -0.409 . . . . 60.14 110.478 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.637 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 9.8 m-85 -111.21 138.94 47.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.207 -0.294 . . . . 75.03 110.207 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.2 p -122.47 107.85 34.05 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.834 0.35 . . . . 64.21 110.195 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.91 -1.13 9.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.986 2.457 . . . . 74.33 112.76 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -63.86 -61.59 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.38 0.609 . . . . 73.52 109.51 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.516 ' HB ' ' HG3' ' A' ' 109' ' ' LYS . 42.7 m -91.76 -27.27 18.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.283 -0.871 . . . . 54.3 109.958 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.5 9.4 60.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.666 -0.778 . . . . 54.31 111.843 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.587 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -94.16 148.94 21.69 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.802 0.334 . . . . 61.04 110.617 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' CB ' ' HD1' ' A' ' 103' ' ' PHE . 18.6 ptpt -114.23 152.74 30.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 44.33 110.796 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.587 ' OD1' ' HE2' ' A' ' 109' ' ' LYS . 2.8 m-20 -116.7 122.58 44.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.952 -0.758 . . . . 71.31 108.952 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.33 114.92 29.33 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.343 -0.614 . . . . 53.42 109.343 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.408 ' HD2' ' OD2' ' A' ' 130' ' ' ASP . 50.1 tttm -115.03 137.98 51.38 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.211 0.529 . . . . 74.23 110.606 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.53 HG23 ' HB3' ' A' ' 129' ' ' MET . 3.2 tp -127.3 126.0 66.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.431 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 24.4 ttpp -118.9 120.31 36.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.202 0.525 . . . . 72.02 110.208 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.8 p -107.34 116.89 32.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.604 -0.887 . . . . 73.53 108.604 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.37 135.78 8.19 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.985 -1.103 . . . . 42.32 112.106 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -126.78 124.81 40.56 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.442 -0.577 . . . . 73.1 109.442 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.745 ' HE2' ' HB ' ' A' ' 3' ' ' VAL . 15.9 ptmt -109.08 121.71 45.73 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.486 0.66 . . . . 72.44 109.921 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 120' ' ' ARG . 22.2 mmt180 -104.56 155.92 18.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.013 -1.106 . . . . 72.1 108.013 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -54.68 -28.57 48.52 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.416 0.447 . . . . 74.21 112.184 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.34 -15.38 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.548 -0.296 . . . . 74.43 111.692 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -146.35 135.56 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.601 -0.44 . . . . 72.42 111.74 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.739 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 43.8 t30 -122.63 120.86 34.99 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.764 -0.585 . . . . 72.24 111.737 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.4 127.03 53.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.696 0.284 . . . . 73.14 111.213 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.39 125.64 4.08 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.037 -0.601 . . . . 54.21 112.047 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 49.7 m -113.32 112.11 23.14 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.578 -0.366 . . . . 63.41 111.275 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 9.9 m-20 -96.2 147.46 23.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 73.44 109.994 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.53 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.5 ttt -139.77 120.41 14.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.627 -0.261 . . . . 75.44 110.543 173.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 113' ' ' LYS . 35.4 m-20 -90.72 117.45 29.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.762 -0.829 . . . . 73.44 108.762 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.18 97.53 9.26 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.079 0.466 . . . . 63.43 110.142 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.03 150.23 26.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.629 -0.714 . . . . 55.34 109.212 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.77 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -72.27 -19.9 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.98 0.363 . . . . 74.24 111.98 -175.437 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.56 -18.96 21.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 74.4 111.047 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 167.8 128.93 1.03 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.519 -0.848 . . . . 73.21 112.578 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.0 150.56 26.65 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.77 2.314 . . . . 61.22 112.657 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 m -126.8 134.01 50.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.566 . . . . 61.1 110.08 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 118.72 56.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.017 0.437 . . . . 72.2 109.87 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 12.1 ttp180 -111.24 130.18 55.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.622 -0.51 . . . . 71.44 109.622 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.19 132.49 10.94 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.993 -1.099 . . . . 73.33 111.406 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.84 115.47 23.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.361 -0.607 . . . . 61.44 109.361 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 123' ' ' ILE . 8.9 tp -121.0 124.31 44.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.989 -0.55 . . . . 70.24 110.383 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.742 HG21 ' HB3' ' A' ' 7' ' ' TYR . 77.3 t -110.92 131.78 61.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 52.1 109.809 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.5 mm? -108.22 137.6 45.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.347 -0.842 . . . . 75.13 108.93 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -125.86 117.38 2.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.582 -0.736 . . . . 41.32 111.537 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 90.0 m-85 -136.32 148.42 47.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.022 -0.733 . . . . 64.23 109.022 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.69 99.84 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 65.13 110.673 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.97 -30.87 9.53 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.564 -0.744 . . . . 74.32 111.866 -176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.727 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 85.5 m95 -105.95 122.06 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.221 0.534 . . . . 74.52 111.703 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.604 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.6 tm? -110.61 149.37 30.51 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.828 -1.545 . . . . 73.53 106.828 172.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -157.44 160.14 38.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.67 -0.812 . . . . 73.35 111.248 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.979 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -156.8 133.34 3.58 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.047 -0.979 . . . . 62.43 110.882 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.434 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 34.0 m-85 -130.75 117.81 19.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.087 0.47 . . . . 74.04 110.205 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 168' ' ' ASN . 39.7 mt-30 -113.77 129.06 56.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.639 -0.71 . . . . 74.04 109.976 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.4 133.59 34.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.534 -0.303 . . . . 73.42 110.2 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 6.7 t30 -113.67 119.43 37.4 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.753 -0.462 . . . . 73.54 109.753 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 83.5 t80 -105.4 124.06 48.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.107 -0.497 . . . . 74.3 110.249 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.436 ' OE1' ' HE2' ' A' ' 161' ' ' LYS . 35.3 tt0 -86.96 97.73 10.86 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.672 -0.862 . . . . 75.41 108.672 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.1 m -71.53 -21.88 61.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 113.673 -1.603 . . . . 72.31 111.188 173.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.41 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -57.88 -34.01 69.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.735 -0.839 . . . . 63.5 108.735 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.574 ' HG2' ' H ' ' A' ' 162' ' ' SER . 17.0 ttmm -112.9 -157.45 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.52 -1.289 . . . . 60.02 107.52 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.574 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 5.6 p -109.74 27.67 9.34 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 122.034 -0.416 . . . . 50.44 111.703 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -143.83 147.65 34.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 117.747 -1.581 . . . . 75.43 114.406 -161.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.636 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 69.4 t -73.75 124.26 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.265 -0.88 . . . . 51.43 109.456 171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.8 p -95.94 -31.97 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.629 -0.26 . . . . 74.03 111.581 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 64.2 mt-30 -127.31 131.71 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.743 0.306 . . . . 72.11 110.785 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 17.7 m -121.86 129.35 52.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.754 -0.461 . . . . 65.25 109.754 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 27.9 t-20 -136.87 121.33 18.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.766 -0.457 . . . . 70.13 109.766 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.645 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 46.4 m-85 -121.78 140.63 52.11 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.948 -0.301 . . . . 71.12 110.59 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.65 139.6 38.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.323 -0.399 . . . . 44.22 110.706 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 12.4 t -132.3 152.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.187 -0.672 . . . . 64.41 109.187 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.18 116.83 1.36 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.804 -0.712 . . . . 74.1 112.037 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -113.39 121.23 43.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.807 -0.812 . . . . 64.35 108.807 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 129.72 56.5 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.983 0.896 . . . . 74.15 111.892 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.9 m -110.13 161.8 15.21 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 106.591 -1.633 . . . . 75.53 106.591 166.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -57.51 -46.61 83.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.076 0.398 . . . . 73.43 111.9 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -106.18 -1.68 23.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.7 0.259 . . . . 71.01 111.7 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.2 117.42 14.52 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 110.489 -0.189 . . . . 70.24 110.489 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -118.86 124.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.145 -0.622 . . . . 74.52 110.987 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.8 tt -118.9 138.1 52.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.548 0.689 . . . . 74.23 111.652 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.812 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 64.2 m80 -114.72 150.51 35.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.124 -0.944 . . . . 74.21 108.98 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.572 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 27.8 m -123.33 138.68 54.56 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.265 -0.642 . . . . 72.41 109.265 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -134.27 140.97 46.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 65.0 111.322 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 47.0 t -133.47 115.55 22.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.283 -0.871 . . . . 72.4 110.019 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.782 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.0 t30 -103.62 99.46 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.384 0.611 . . . . 73.23 110.059 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 46.0 m-20 58.01 -161.48 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.886 -1.052 . . . . 73.41 110.804 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.52 -5.24 87.95 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.263 -0.881 . . . . 74.12 111.056 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 25.1 p -88.54 -24.65 22.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.039 0.755 . . . . 73.01 113.039 -173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 5.2 tm-20 -136.25 125.98 25.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.801 -0.36 . . . . 44.4 111.154 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.4 123.92 26.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 74.12 109.198 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.71 -146.2 4.82 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.238 -0.982 . . . . 61.24 113.003 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -172.82 -171.16 37.32 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.859 -0.686 . . . . 64.34 112.962 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.812 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 41.3 t -147.19 140.13 25.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.283 -0.636 . . . . 72.42 109.283 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.9 mp -120.13 118.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 110.07 -0.344 . . . . 75.25 110.07 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -108.91 120.42 42.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.301 0.572 . . . . 75.52 109.796 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 196' ' ' GLN . 11.1 mm100 -123.02 112.59 17.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.45 -0.795 . . . . 64.14 110.812 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -108.68 127.76 54.26 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.097 -0.705 . . . . 75.35 109.097 177.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 202' ' ' LEU . 1.1 m -111.57 151.79 13.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.091 0.472 . . . . 64.43 110.473 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -63.4 -20.19 65.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 64.32 111.829 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.79 47.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.363 0.505 . . . . 53.23 112.363 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 226' ' ' GLN . 48.9 mmtm 64.58 23.23 12.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 63.02 113.08 169.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 225' ' ' TYR . 7.2 tt -126.79 134.61 50.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 73.33 110.764 -174.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -126.28 134.96 51.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.144 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 223' ' ' ALA . 24.7 m -122.91 141.75 51.56 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.324 -0.251 . . . . 64.31 110.324 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.41 135.58 48.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.235 0.541 . . . . 54.11 110.412 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.742 HG22 HG22 ' A' ' 221' ' ' ILE . 93.2 t -114.6 132.87 62.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.62 -0.718 . . . . 73.22 110.036 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -113.61 126.98 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.181 -1.044 . . . . 73.35 108.181 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 218' ' ' ARG . 5.0 tp -140.8 128.77 21.94 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 110.133 -0.321 . . . . 63.31 110.133 -170.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.435 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.96 135.83 19.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.0 0.428 . . . . 75.11 111.696 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -111.23 124.16 51.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.812 -0.631 . . . . 74.02 109.633 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.8 p -95.66 112.92 24.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 73.45 110.901 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.39 143.79 52.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 73.45 110.437 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.99 -18.19 50.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.978 -0.849 . . . . 54.31 110.978 -173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -136.36 164.24 28.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.395 -0.403 . . . . 70.31 110.136 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.6 p -92.46 16.4 11.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.416 0.627 . . . . 74.55 109.483 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.02 111.01 17.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.285 -0.87 . . . . 72.24 111.637 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 25.1 m -96.17 122.67 39.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.204 -1.036 . . . . 54.14 108.204 168.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.405 ' O ' HD12 ' A' ' 208' ' ' LEU . 28.8 mmm180 -105.52 116.9 32.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.592 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 23.9 p90 -114.03 152.53 30.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.243 0.544 . . . . 74.54 110.387 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.67 140.38 7.63 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.921 -1.036 . . . . 72.55 110.724 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 206' ' ' VAL . 15.8 pt -131.74 134.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.729 0.265 . . . . 63.13 110.512 -177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -138.63 130.07 27.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.827 0.346 . . . . 62.03 110.583 174.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -120.85 125.66 48.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.53 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -107.24 114.96 29.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.509 0.671 . . . . 62.2 110.025 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.694 ' HB2' ' HG ' ' A' ' 202' ' ' LEU . 45.3 t80 -129.17 126.84 40.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.227 -0.897 . . . . 74.0 110.542 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.411 ' CG ' ' HB3' ' A' ' 201' ' ' LYS . 16.8 pt20 -77.14 123.75 26.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.373 -0.603 . . . . 70.25 109.373 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 233' ' ' PHE . 73.7 mt -70.14 -55.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.933 -0.576 . . . . 75.43 111.22 -172.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.637 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.2 t70 177.07 -54.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 123.66 0.6 . . . . 72.31 110.806 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 96.5 Cg_endo -83.75 -133.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.984 1.789 . . . . 74.3 112.051 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 9.8 m-20 -92.39 11.83 24.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 54.23 110.709 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.1 133.8 54.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.54 . . . . 75.02 111.082 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.89 142.14 47.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.182 -0.917 . . . . 61.05 109.43 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.489 ' HB2' HD11 ' A' ' 227' ' ' ILE . 70.9 t80 -106.78 132.38 52.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.183 0.516 . . . . 72.44 110.262 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 17.7 m -123.12 127.2 48.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.528 -0.76 . . . . 63.4 110.028 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -111.94 141.35 45.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.65 -0.5 . . . . 63.43 109.65 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 20.9 pttm -141.1 153.87 45.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.521 0.2 . . . . 70.25 110.868 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.625 HG12 HG12 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -147.47 155.15 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 74.42 110.187 175.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.764 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.1 t-20 -125.55 148.01 49.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.899 -0.778 . . . . 63.43 108.899 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.592 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 26.4 t-20 -41.29 -37.64 1.01 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.645 1.216 . . . . 64.23 113.36 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.1 m -78.49 27.45 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.752 -0.204 . . . . 61.32 111.285 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.7 p 57.93 40.83 25.36 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.956 0.902 . . . . 64.51 110.605 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.819 ' HB3' HD11 ' A' ' 262' ' ' LEU . 56.4 mt -97.75 117.09 31.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.802 -0.635 . . . . 72.11 109.744 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.571 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.9 mp -103.27 117.99 49.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 109.776 -0.453 . . . . 52.41 109.776 -174.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.52 148.25 17.58 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.358 -0.925 . . . . 43.33 113.122 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.72 150.62 38.78 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.675 -0.861 . . . . 74.13 108.675 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.33 123.17 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.533 -0.841 . . . . 61.2 111.591 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.37 116.27 19.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.235 0.54 . . . . 72.32 110.225 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.8 t -116.05 136.72 52.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.543 -0.753 . . . . 74.54 110.732 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -132.87 134.28 44.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 65.24 110.68 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.2 t -89.03 115.34 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.943 -0.762 . . . . 73.23 108.943 172.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 251' ' ' LEU . 5.6 mp -75.19 -59.24 2.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.585 0.707 . . . . 45.01 109.517 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -119.73 149.69 48.87 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 106.991 -1.485 . . . . 55.11 106.991 171.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.8 99.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.391 2.061 . . . . 61.04 112.181 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.19 -22.05 6.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.769 -0.65 . . . . 72.12 112.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 252' ' ' LYS . 3.4 mp -106.26 119.25 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.376 -0.485 . . . . 71.05 109.981 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -120.62 120.65 36.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.679 . . . . 74.31 111.473 -172.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.2 tp -100.95 128.57 46.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.101 -0.703 . . . . 52.34 109.101 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.4 t -126.16 113.99 17.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.518 0.675 . . . . 73.32 111.125 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.955 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -99.64 124.12 44.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.21 -1.033 . . . . 75.52 108.21 175.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 22.6 t -127.32 143.16 51.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.945 0.402 . . . . 74.15 110.079 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.48 154.52 45.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.804 -0.443 . . . . 62.1 109.804 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.9 tm? -130.84 118.59 20.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.341 -0.985 . . . . 72.21 108.341 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.646 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -97.4 106.69 19.05 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.343 -1.355 . . . . 72.34 107.343 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 5.2 m-20 -71.62 105.76 3.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.126 -0.694 . . . . 62.32 109.126 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.14 -13.89 10.28 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.256 -0.497 . . . . 65.22 112.885 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.47 -18.39 26.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.728 0.299 . . . . 63.24 110.946 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 4.2 m-20 -120.89 -41.31 2.56 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.72 0.637 . . . . 73.41 112.72 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -59.35 -25.81 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.429 0.529 . . . . 75.35 112.429 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -63.59 -30.36 71.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 72.03 110.431 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.34 -16.76 15.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 45.43 110.677 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.95 94.58 1.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.019 -0.537 . . . . 64.33 112.265 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 177.93 86.43 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.661 -0.78 . . . . 34.45 112.498 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -113.98 144.65 42.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.658 0.266 . . . . 65.24 110.639 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 25.6 mmtp -97.35 144.11 27.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.507 -0.315 . . . . 72.31 110.238 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 275' ' ' LEU . 1.7 tm? -134.85 126.28 28.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.835 0.35 . . . . 71.25 110.105 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 126.78 5.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 43.24 111.419 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.955 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -115.26 134.02 55.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.739 -0.467 . . . . 71.42 109.739 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -137.59 144.57 16.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.419 -0.896 . . . . 54.53 113.25 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.703 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.3 mm? -123.98 131.43 53.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.419 -0.585 . . . . 63.52 109.419 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.72 112.22 15.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.346 -0.613 . . . . 73.52 109.346 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.942 ' HB2' HD22 ' A' ' 31' ' ' LEU . 93.6 m-85 -106.9 106.38 16.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.112 -0.495 . . . . 70.12 110.308 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.556 ' HG2' HD23 ' A' ' 284' ' ' LEU . 29.7 tt0 -99.73 110.62 23.01 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.474 -0.565 . . . . 72.1 109.474 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -97.95 108.67 21.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.419 0.628 . . . . 63.31 110.967 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 282' ' ' GLN . 3.0 mm? -135.14 -38.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.837 -1.074 . . . . 72.11 108.779 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.825 -1.08 . . . . 74.14 109.519 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.743 0.306 . . . . 71.33 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.6 -44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.359 . . . . 75.41 110.178 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 119' ' ' LYS . 21.3 t 64.47 96.97 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.548 -0.751 . . . . 51.2 111.242 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.9 Cg_endo -69.42 142.23 48.84 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.794 2.329 . . . . 73.32 112.388 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 19.3 Cg_exo -66.39 90.96 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.807 2.338 . . . . 61.42 111.974 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.549 ' HB ' HD21 ' A' ' 150' ' ' LEU . 2.3 p -84.17 -2.57 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.443 0.639 . . . . 64.13 110.781 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -57.92 -24.63 58.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 72.23 109.753 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.98 -26.21 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.11 110.078 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.41 -4.53 48.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 71.33 110.574 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD23 ' CD1' ' A' ' 150' ' ' LEU . 66.3 mt -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 72.13 110.905 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.32 40.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.543 -1.313 . . . . 54.31 114.247 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 37.7 tttm -57.95 -54.57 45.47 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.462 0.631 . . . . 64.33 109.669 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 p -58.72 -39.33 80.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.568 -0.742 . . . . 62.11 111.676 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.39 70.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.532 -0.304 . . . . 72.32 111.195 -176.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -68.02 -36.23 79.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 73.13 110.588 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 9.9 t70 -68.43 -48.69 63.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.373 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.26 -39.33 78.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.445 -0.343 . . . . 71.53 111.213 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.8 -41.35 78.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.939 -0.393 . . . . 75.41 109.939 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m 70.78 94.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.378 -0.828 . . . . 62.22 111.998 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -110.76 -12.22 14.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 54.04 110.548 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.85 1.2 89.01 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.864 -0.684 . . . . 24.13 112.536 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.668 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 87.8 m-85 -133.84 144.17 48.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.344 -0.613 . . . . 73.1 109.344 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.94 34.0 0.4 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.182 -1.008 . . . . 51.2 112.796 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.2 -1.79 38.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.259 0.552 . . . . 75.32 109.973 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 83.78 12.95 76.44 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.254 -1.139 . . . . 43.04 110.254 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 48' ' ' ASN . 6.8 tp -131.24 179.22 6.14 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.664 0.745 . . . . 63.43 112.015 -169.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.916 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -110.26 147.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.815 -1.084 . . . . 75.45 109.492 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.562 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 14.6 ptpt -138.41 154.38 48.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 50.24 109.577 171.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.7 tt -140.09 145.09 37.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.695 0.284 . . . . 73.25 111.12 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -131.11 128.35 39.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.553 0.692 . . . . 73.44 109.901 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -108.43 124.5 50.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.267 -0.879 . . . . 71.34 108.879 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -125.56 123.33 38.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.798 0.332 . . . . 63.23 110.122 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.9 m -137.95 121.56 17.37 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.643 -0.873 . . . . 63.44 108.643 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -137.07 143.82 42.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.551 0.691 . . . . 74.45 112.276 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -139.1 137.49 36.22 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.949 -1.13 . . . . 50.42 107.949 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.75 49.32 1.32 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.846 0.832 . . . . 72.44 110.756 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -122.46 22.64 9.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.677 -1.147 . . . . 71.02 109.099 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.695 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 91.14 -8.24 79.79 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 119.4 -0.667 . . . . 54.55 113.751 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.69 127.38 48.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.514 1.157 . . . . 73.42 112.643 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.677 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 22.9 mt-10 -139.54 118.85 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.891 -0.411 . . . . 63.52 109.891 165.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.95 121.31 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.79 0.329 . . . . 72.23 110.271 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.859 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.4 m -126.95 132.37 50.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 73.24 111.18 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 m -125.36 140.45 52.8 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.39 -0.596 . . . . 51.14 109.39 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.8 m -147.57 126.11 12.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.785 0.326 . . . . 51.42 110.479 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.681 ' HA3' ' HA2' ' A' ' 56' ' ' GLY . . . -164.17 -167.14 24.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 73.2 112.25 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 39.0 m -127.59 158.54 37.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 55.14 110.505 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -135.08 135.58 41.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 75.22 110.328 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.67 ' HA ' HD11 ' A' ' 26' ' ' LEU . 24.4 t-20 -76.23 138.06 40.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.977 -0.556 . . . . 44.3 109.648 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.499 ' HA ' HD13 ' A' ' 27' ' ' ILE . 1.9 m -46.63 138.95 5.54 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.14 0.9 . . . . 72.4 111.983 -176.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 72.05 29.74 2.3 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.899 0.749 . . . . 72.03 110.321 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p 49.95 37.73 14.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.651 0.781 . . . . 73.21 112.037 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -72.61 -35.14 67.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.268 -0.423 . . . . 62.2 111.39 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -160.5 118.73 2.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.935 -0.395 . . . . 54.22 109.935 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -117.01 120.97 66.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.844 0.354 . . . . 71.5 110.282 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.8 m -136.79 129.55 30.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.272 -0.422 . . . . 74.22 110.359 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.681 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -138.94 153.94 22.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.244 -0.979 . . . . 54.32 113.092 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.603 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 14.1 p -101.54 163.54 12.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.431 -0.581 . . . . 64.33 109.431 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tp -121.03 150.19 41.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.515 0.674 . . . . 61.11 112.044 -170.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.859 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 61.8 mt-10 -126.94 120.07 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.981 -1.009 . . . . 70.4 108.832 174.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -103.52 118.82 37.63 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 34.1 mtmm -117.23 144.02 45.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.149 0.5 . . . . 74.31 110.322 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 32.9 m-85 -116.19 120.15 38.06 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.775 -0.824 . . . . 72.14 108.775 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.536 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 20.5 ttm-85 -106.72 107.27 18.21 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.56 0.695 . . . . 73.21 111.084 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 68.4 t-105 -114.35 107.62 15.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.375 -1.284 . . . . 74.02 110.12 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -94.28 66.78 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.322 0.582 . . . . 75.33 111.93 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -85.19 -37.36 20.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.791 -1.188 . . . . 70.43 107.791 166.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' CB ' ' HA ' ' A' ' 90' ' ' GLN . 3.7 m-85 -157.34 -43.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.153 -1.385 . . . . 74.43 108.717 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.8 74.81 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.5 -0.773 . . . . 24.13 112.072 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -111.44 130.05 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 75.24 110.502 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 41.7 m -137.93 113.15 9.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.033 -0.531 . . . . 73.31 110.434 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 43.4 t80 -99.65 132.08 45.22 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.857 -0.794 . . . . 65.03 108.857 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 28.6 m -128.05 121.4 29.61 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.023 0.44 . . . . 70.03 111.661 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.63 120.54 42.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.715 -0.846 . . . . 71.12 108.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 26.1 ttpt -113.46 94.83 5.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.14 -0.482 . . . . 62.4 109.803 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.514 ' O ' ' HB2' ' A' ' 57' ' ' SER . 3.9 t90 -100.15 127.08 46.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.259 -0.428 . . . . 75.24 109.878 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.603 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 92.7 m-20 -105.46 166.99 10.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 75.13 110.477 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 p -67.5 -16.53 64.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.133 0.492 . . . . 54.53 111.593 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 13.4 m-20 -78.72 -2.53 39.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.642 . . . . 73.31 110.559 175.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 54.5 m-80 77.81 14.63 1.63 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.479 -0.782 . . . . 75.41 111.935 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -89.13 141.25 28.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.599 -0.519 . . . . 64.1 109.599 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.04 119.35 34.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.376 -0.375 . . . . 71.12 110.488 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.86 105.99 3.35 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.787 -0.925 . . . . 63.12 110.787 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -94.74 104.94 16.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.034 0.445 . . . . 73.35 110.501 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.738 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 40.7 mt-10 -110.84 125.46 53.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.627 -0.715 . . . . 63.21 110.363 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -113.95 120.94 65.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.653 -0.869 . . . . 62.33 108.653 171.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.1 m -120.92 123.61 42.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.851 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.77 120.45 50.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 50.21 109.971 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' ' HB2' ' A' ' 96' ' ' LYS . 43.9 mt-10 -125.24 136.14 53.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.499 -0.318 . . . . 75.12 110.66 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 m-20 63.68 23.66 13.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.765 -0.652 . . . . 73.42 112.046 168.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 67' ' ' TYR . 56.5 tt0 -63.98 -79.31 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 73.34 111.227 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.93 -73.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 64.23 109.604 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.32 96.46 9.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.609 -0.515 . . . . 51.13 109.609 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 29.1 ptt180 -57.24 137.17 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 75.12 110.744 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.655 ' HA2' ' HB2' ' A' ' 119' ' ' LYS . . . 103.02 -24.45 30.5 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.032 -0.985 . . . . 33.42 111.432 -169.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.34 -0.506 . . . . 64.44 109.711 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HG2' ' HA3' ' A' ' 117' ' ' GLY . 10.2 ptpp? -121.33 131.76 54.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 65.43 109.809 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 96' ' ' LYS . 2.1 mm? -124.53 126.34 45.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.566 -0.531 . . . . 62.04 109.566 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.8 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 18.5 m -130.19 119.02 22.29 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.519 -0.31 . . . . 75.32 110.346 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.578 ' HB3' HG22 ' A' ' 85' ' ' ILE . 86.6 t80 -109.72 114.93 28.93 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.624 -0.51 . . . . 71.24 109.624 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.738 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 4.1 t70 -110.86 122.62 48.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.576 -0.738 . . . . 71.41 109.55 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 8.9 t -126.31 120.41 29.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.81 -0.441 . . . . 74.51 109.81 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 18.5 m -95.8 122.16 38.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.317 -0.623 . . . . 64.4 109.317 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -120.79 119.28 32.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 64.23 110.328 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 t -120.02 103.15 45.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.31 -0.626 . . . . 64.31 109.31 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.44 -37.54 38.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.093 2.529 . . . . 54.43 112.873 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -60.25 -40.7 91.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 62.51 111.879 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 p -96.26 -29.2 14.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.867 0.365 . . . . 63.43 111.338 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.3 59.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.113 -0.795 . . . . 73.42 111.113 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 137.05 33.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.849 0.356 . . . . 70.41 110.726 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' SER . 60.1 pttt -144.8 129.47 18.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.844 -0.616 . . . . 71.01 109.99 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 101' ' ' SER . 19.0 m120 -119.97 149.84 41.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 72.03 109.385 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.83 122.49 17.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.352 -0.24 . . . . 74.45 110.352 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.738 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 14.0 pttp -128.37 147.56 50.64 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.26 -0.274 . . . . 74.23 110.26 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.41 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -126.61 126.36 68.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.777 0.799 . . . . 75.34 110.263 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HD3' ' HB2' ' A' ' 128' ' ' ASP . 2.8 tppp? -99.61 120.73 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.843 -1.071 . . . . 64.43 109.442 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.461 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 8.5 m -118.54 118.94 33.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.393 -0.595 . . . . 73.23 109.393 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.611 ' HA3' ' HG2' ' A' ' 96' ' ' LYS . . . -129.53 148.14 18.19 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.754 -1.213 . . . . 41.55 113.966 -173.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -125.57 121.73 34.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.021 -0.589 . . . . 71.51 109.496 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 9.7 mtmp? -117.84 121.66 41.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.317 0.579 . . . . 73.32 111.977 -177.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.616 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 22.3 tpp180 -108.6 164.22 12.55 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.532 -1.284 . . . . 64.11 107.532 165.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -55.55 -30.41 60.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.194 0.452 . . . . 74.43 112.167 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -116.76 8.07 13.6 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.901 -0.32 . . . . 72.22 111.365 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 2.1 mm -138.61 124.97 25.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.94 0.4 . . . . 72.23 111.708 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.775 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 52.3 t30 -123.45 116.16 22.77 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.344 -0.542 . . . . 73.14 110.572 175.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.454 ' CD2' HD13 ' A' ' 142' ' ' LEU . 3.6 mm? -109.88 137.26 47.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 61.43 110.298 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.49 114.66 0.69 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.77 -0.729 . . . . 63.21 112.169 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 116' ' ' THR . 22.3 p -112.59 116.8 30.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.095 0.448 . . . . 63.44 110.655 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.834 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 21.1 t70 -113.76 122.28 46.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 71.3 109.995 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 21.6 ptp -115.24 118.84 34.44 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.19 -0.3 . . . . 74.25 110.19 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' HA ' ' CB ' ' A' ' 113' ' ' LYS . 3.9 p30 -106.77 127.21 53.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.488 0.661 . . . . 74.22 111.267 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HD2' ' HG3' ' A' ' 136' ' ' PRO . 85.1 t80 -78.05 103.69 8.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.696 . . . . 74.11 110.074 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 22.0 t70 -92.09 161.64 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.51 -0.922 . . . . 51.12 108.51 172.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 133' ' ' ILE . 2.5 mp -66.3 -28.76 44.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 70.42 110.125 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.07 54.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 71.53 110.625 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' ASP . . . 145.1 154.98 6.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 51.0 112.624 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.521 ' HG3' ' HD2' ' A' ' 131' ' ' PHE . 14.9 Cg_exo -69.11 113.72 3.36 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.193 2.595 . . . . 61.44 112.86 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.7 t -82.23 141.5 32.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.957 -0.565 . . . . 72.1 109.561 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.837 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 40.9 mm -107.21 116.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.564 -0.455 . . . . 64.41 110.126 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -115.31 111.39 20.82 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.922 0.392 . . . . 72.53 109.994 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.35 132.78 11.1 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.867 -1.159 . . . . 44.02 112.311 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -128.99 115.92 18.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.223 0.535 . . . . 52.5 110.261 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 143' ' ' VAL . 6.8 tp -116.85 123.89 48.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.674 -0.694 . . . . 74.12 110.245 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.775 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 88.8 t -110.64 131.37 61.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.956 -0.565 . . . . 75.54 110.061 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.74 137.24 46.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.242 -0.651 . . . . 74.34 109.242 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.8 121.01 5.43 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.707 -0.679 . . . . 74.2 112.337 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.894 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 79.0 m-85 -127.36 149.73 49.93 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.574 -0.528 . . . . 73.32 109.574 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -49.81 96.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.812 0.339 . . . . 73.2 111.051 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 174' ' ' LYS . . . 88.55 -26.1 8.59 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.194 -0.457 . . . . 73.23 112.706 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.894 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 4.1 m0 -104.54 146.29 29.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.28 0.562 . . . . 74.42 110.96 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 144' ' ' LEU . 2.6 tm? -134.18 145.21 49.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.727 -0.842 . . . . 73.44 108.727 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -144.13 161.4 38.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.579 -0.7 . . . . 45.04 111.373 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -155.99 133.78 3.84 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.317 -0.401 . . . . 52.11 112.562 -176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.541 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 98.3 m-85 -125.1 119.21 27.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.476 -0.564 . . . . 75.51 109.476 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 30.1 tt0 -128.56 122.25 30.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.018 0.437 . . . . 63.4 110.327 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 16.9 ptp -135.32 142.5 45.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.002 0.43 . . . . 73.11 111.027 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.446 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 16.5 m-80 -113.13 117.66 32.58 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.034 -0.728 . . . . 74.45 109.034 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.918 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 71.1 t80 -94.13 121.85 36.06 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 123.642 0.777 . . . . 75.15 110.95 -176.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.6 tp10 -89.28 108.87 19.87 Favored 'General case' 0 C--O 1.264 1.82 0 CA-C-N 115.557 -0.747 . . . . 71.52 109.877 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -71.52 -17.02 62.35 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 112.923 -1.944 . . . . 73.41 111.974 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.85 67.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.819 0.819 . . . . 62.42 109.112 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 162' ' ' SER . 13.6 mptt -118.05 -156.09 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.363 -1.29 . . . . 73.23 108.022 167.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 161' ' ' LYS . 50.1 m -105.9 30.13 6.09 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.299 -0.63 . . . . 73.24 109.299 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 15.6 mmm180 -136.65 141.51 43.18 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.446 -0.902 . . . . 73.52 112.159 -161.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.918 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 4.6 m -73.66 136.19 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.235 -0.654 . . . . 73.32 109.235 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 3.0 t -91.64 -22.68 20.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.157 0.503 . . . . 71.11 110.143 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.74 132.27 20.93 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 72.53 109.577 172.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.6 p -121.18 105.97 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.135 0.493 . . . . 74.5 109.946 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 20.5 m120 -107.16 135.52 48.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.544 0.687 . . . . 64.45 110.889 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' HD1' ' HD2' ' A' ' 153' ' ' TYR . 60.2 m-85 -121.78 143.89 49.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.832 -0.622 . . . . 75.43 109.927 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.75 132.89 33.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.46 -0.336 . . . . 72.04 110.537 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 43.1 t -129.87 126.48 62.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.001 -0.37 . . . . 64.34 110.001 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.21 100.36 1.21 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.692 -0.963 . . . . 34.53 110.692 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.634 ' HB3' ' CD2' ' A' ' 180' ' ' LEU . 75.3 t80 -109.46 120.44 42.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.559 -0.904 . . . . 71.41 108.559 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 148' ' ' GLY . 13.0 ttmm -127.72 126.1 41.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.731 -1.122 . . . . 73.01 111.327 -167.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 39.8 m -132.96 110.39 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.795 -1.187 . . . . 62.41 107.795 160.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 25.37 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.023 1.49 . . . . 71.42 115.023 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -89.18 -7.84 54.82 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.852 0.686 . . . . 63.14 112.852 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -123.32 115.66 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 75.42 111.06 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -136.94 143.29 42.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 63.03 111.043 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.634 ' CD2' ' HB3' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -123.92 141.94 51.58 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-O 122.522 1.153 . . . . 62.34 111.495 163.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 36.2 m80 -104.75 112.47 25.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.369 -2.196 . . . . 72.12 106.551 165.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 38.4 m -96.17 135.93 37.32 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.215 -0.661 . . . . 63.1 109.215 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.8 p30 -133.86 138.86 45.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.415 0.626 . . . . 71.31 110.124 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 54.2 t -127.56 125.62 65.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.34 -0.845 . . . . 62.2 109.837 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.865 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 63.1 t30 -103.92 90.01 3.48 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.048 -0.723 . . . . 72.24 109.048 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.97 -173.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.704 -1.134 . . . . 75.04 110.136 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.0 -7.42 70.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.365 -0.921 . . . . 72.12 112.335 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.8 p -95.47 -24.32 16.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.023 0.749 . . . . 72.0 113.023 -174.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.865 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 65.9 tt0 -129.48 125.23 35.92 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.89 -0.724 . . . . 62.42 111.125 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -134.88 140.25 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.638 0.256 . . . . 75.02 110.397 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.91 -163.32 21.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.457 -0.878 . . . . 63.21 112.895 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -164.85 -174.3 34.43 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.696 -0.562 . . . . 53.12 111.696 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 41.0 m -148.76 136.95 20.99 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.617 -0.882 . . . . 63.44 108.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.3 mm -117.61 117.67 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.343 -0.543 . . . . 64.34 110.621 -171.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -107.53 119.42 39.36 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -125.0 131.16 53.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.53 -0.544 . . . . 71.44 109.53 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -107.56 114.97 29.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.42 -0.355 . . . . 61.33 111.582 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 202' ' ' LEU . 58.8 t -88.76 132.39 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.625 -0.879 . . . . 74.24 108.625 171.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.4 -25.9 62.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.948 0.351 . . . . 63.33 111.948 -173.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.482 ' H ' HG12 ' A' ' 198' ' ' VAL . 58.9 mtmt -84.6 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 73.23 111.653 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.05 24.43 14.5 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.625 0.77 . . . . 75.53 112.69 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 225' ' ' TYR . 4.7 tt -110.58 108.99 19.12 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.163 -0.68 . . . . 63.15 109.163 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.731 ' HB2' ' HG3' ' A' ' 224' ' ' LYS . 39.5 mt-10 -106.65 137.04 45.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.522 -0.548 . . . . 75.23 109.522 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.6 m -122.74 142.55 50.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.655 0.265 . . . . 72.42 110.596 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.54 136.58 49.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.986 -0.552 . . . . 64.03 109.863 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.879 HG22 HG22 ' A' ' 221' ' ' ILE . 39.6 t -111.83 137.07 45.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.004 -0.544 . . . . 70.43 109.62 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -112.75 127.55 56.18 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.557 -0.905 . . . . 63.25 108.557 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 219' ' ' PHE . 3.1 tp -142.64 129.89 20.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.612 -171.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.413 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -154.58 139.11 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 73.21 111.192 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -128.87 132.7 47.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.985 -0.746 . . . . 74.13 108.985 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 m -95.04 107.21 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.918 0.389 . . . . 63.02 110.034 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.75 135.86 55.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.629 -0.714 . . . . 72.43 111.252 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.85 -2.43 66.58 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.163 -0.775 . . . . 72.12 111.163 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -131.01 167.61 18.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.236 -0.482 . . . . 70.31 109.767 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -102.51 -14.23 16.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.969 -0.752 . . . . 64.2 108.969 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.66 110.89 1.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.498 -0.773 . . . . 73.21 110.769 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 15.9 m -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 61.11 109.432 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.566 ' HA ' ' HE ' ' A' ' 218' ' ' ARG . 0.2 OUTLIER -114.63 116.06 28.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.579 -0.448 . . . . 73.31 109.866 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.452 ' HB3' HD13 ' A' ' 208' ' ' LEU . 53.3 p90 -134.14 146.91 50.66 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.972 -0.381 . . . . 72.3 109.972 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.61 160.88 32.27 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.49 -0.862 . . . . 51.14 112.123 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.879 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.259 0.552 . . . . 72.35 110.62 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.593 ' HB2' ' HG3' ' A' ' 236' ' ' LYS . . . -117.84 141.43 48.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.169 -0.923 . . . . 70.5 109.911 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -118.12 140.82 49.21 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.399 -0.364 . . . . 72.53 110.429 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.731 ' HG3' ' HB2' ' A' ' 203' ' ' GLU . 14.8 ptmt -125.47 114.66 19.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.836 -0.62 . . . . 72.44 109.5 174.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.551 ' HD2' ' HG ' ' A' ' 202' ' ' LEU . 17.2 t80 -119.22 117.23 28.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.503 -0.772 . . . . 75.13 109.426 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.59 105.9 18.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.176 0.512 . . . . 64.33 109.857 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 227' ' ' ILE . 13.4 pt -81.69 -33.5 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.506 -0.77 . . . . 64.24 111.067 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.41 162.15 28.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 72.53 109.017 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 -19.14 17.41 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.064 2.51 . . . . 70.03 114.323 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -112.2 7.94 19.67 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.049 -0.26 . . . . 73.21 111.659 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.04 123.64 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.289 0.566 . . . . 64.51 112.21 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -124.09 127.44 47.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 51.25 108.957 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -98.04 133.38 42.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.931 0.396 . . . . 74.33 110.654 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 48.4 t -115.9 138.06 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.844 -0.617 . . . . 44.44 109.994 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -133.12 141.73 48.32 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.467 -0.568 . . . . 51.05 109.467 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.593 ' HG3' ' HB2' ' A' ' 222' ' ' ALA . 3.3 mppt? -133.39 141.42 47.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.771 0.32 . . . . 72.32 110.791 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.584 HG12 HG12 ' A' ' 221' ' ' ILE . 3.7 p -140.49 136.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.218 -0.66 . . . . 71.35 109.218 170.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 88.2 m-20 -115.67 152.93 32.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.164 -0.471 . . . . 73.05 110.993 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 241' ' ' SER . 1.1 t-20 -35.12 -42.49 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.967 1.417 . . . . 64.54 114.052 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.462 ' OG ' HD13 ' A' ' 242' ' ' LEU . 2.3 p -78.56 24.58 0.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.839 0.352 . . . . 62.11 111.448 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 239' ' ' ASN . 18.6 t 61.7 37.83 15.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.586 -0.734 . . . . 53.24 109.817 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.971 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 4.6 mp -92.23 140.12 29.94 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.851 -0.613 . . . . 53.05 110.51 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -122.88 118.74 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.012 -0.54 . . . . 72.05 110.898 -172.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -126.08 155.56 19.3 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.751 -0.738 . . . . 61.2 112.417 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -138.18 160.65 38.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.065 0.46 . . . . 53.32 110.79 177.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -151.43 141.03 8.24 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.752 -0.658 . . . . 51.24 111.559 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -129.08 115.27 17.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 110.131 -0.322 . . . . 60.14 110.131 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.3 m -109.34 115.7 30.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.326 -0.397 . . . . 74.35 110.015 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.78 145.01 50.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.946 0.403 . . . . 72.21 111.024 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.3 m -108.11 124.47 50.28 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.873 -0.603 . . . . 75.31 110.631 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 2.8 mm? -117.17 147.28 42.6 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.835 -1.172 . . . . 70.1 107.835 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.924 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 32.9 mmtp 61.84 -174.97 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 117.742 0.246 . . . . 64.45 110.439 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.924 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 67.6 Cg_endo -75.69 -2.91 13.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.618 1.546 . . . . 64.21 113.657 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.43 0.25 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.188 -1.482 . . . . 74.44 114.794 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.627 HG12 ' HB2' ' A' ' 252' ' ' LYS . 45.4 mm -112.24 120.67 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 117.759 0.78 . . . . 73.31 109.6 174.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 280' ' ' GLU . 0.0 OUTLIER -115.61 118.04 31.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.999 0.428 . . . . 54.14 110.413 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.94 124.31 45.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.994 -0.548 . . . . 64.34 109.776 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.2 m -118.56 110.26 17.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.082 0.468 . . . . 73.45 110.562 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 1.014 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.56 125.5 49.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.786 -1.19 . . . . 74.02 107.786 174.186 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.6 t -138.56 139.43 38.65 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.435 -0.506 . . . . 63.31 109.864 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 135.74 13.65 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.602 -0.518 . . . . 74.32 109.602 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.769 HD21 HD23 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -124.27 131.63 53.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.394 -0.595 . . . . 75.1 109.394 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.806 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -106.43 111.19 23.66 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.78 -1.193 . . . . 74.23 107.78 179.063 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.971 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.7 m-20 -71.54 106.96 4.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.871 -0.604 . . . . 72.44 109.418 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.06 -16.79 14.5 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 116.019 -0.537 . . . . 51.51 112.877 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 266' ' ' LYS . 1.6 tmtp? -91.15 -26.95 18.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.879 0.371 . . . . 64.22 110.783 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 10.3 m120 -106.44 -34.66 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.644 0.609 . . . . 75.15 112.644 -172.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.806 HG11 ' HB3' ' A' ' 263' ' ' LEU . 35.1 m -62.28 -17.49 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.537 0.208 . . . . 70.1 111.558 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.09 -44.65 83.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 75.41 110.722 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.59 -16.74 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.493 . . . . 71.31 110.828 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 123.66 90.52 0.93 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.321 -0.712 . . . . 64.54 111.321 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.637 ' HA3' ' HB3' ' A' ' 267' ' ' ASN . . . -164.7 69.72 0.2 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 65.52 112.358 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.619 ' HB2' HD12 ' A' ' 263' ' ' LEU . 24.0 p-80 -113.17 145.48 40.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.367 -0.605 . . . . 75.23 109.367 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.68 136.85 49.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.477 -0.489 . . . . 54.33 110.131 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -120.58 136.85 54.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.563 -0.744 . . . . 72.12 109.839 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.668 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -138.68 110.54 0.73 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.655 -0.783 . . . . 74.1 111.591 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 1.014 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -112.79 128.19 56.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.745 -0.835 . . . . 75.21 108.745 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.6 ' HA3' ' HE2' ' A' ' 22' ' ' TYR . . . -140.12 131.87 5.27 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.258 -0.973 . . . . 50.13 112.284 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.684 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.4 mm? -103.45 130.14 50.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.233 -0.654 . . . . 75.35 109.233 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 0.6 OUTLIER -113.73 109.71 19.01 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.881 -1.155 . . . . 72.14 107.881 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.647 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 2.4 t80 -106.39 124.41 49.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.717 -0.674 . . . . 62.1 109.891 -172.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -127.5 109.63 11.93 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.647 ' HB2' ' HE1' ' A' ' 281' ' ' PHE . . . -110.1 111.84 23.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 65.31 111.346 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.61 -70.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 75.45 108.926 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.991 -0.549 . . . . 75.45 109.585 172.691 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.763 0.316 . . . . 71.23 110.386 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.29 -64.44 1.22 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.185 -0.461 . . . . 54.3 110.252 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.851 HG22 ' HA ' ' A' ' 121' ' ' GLU . 13.7 t -120.48 112.16 34.38 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.488 -0.56 . . . . 74.12 109.488 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.9 161.04 19.73 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.035 2.49 . . . . 75.31 112.62 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.68 86.61 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.796 2.331 . . . . 53.21 111.189 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.021 ' HB ' HG11 ' A' ' 143' ' ' VAL . 9.2 p -70.18 -53.5 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.358 -0.837 . . . . 64.14 112.826 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' H ' ' HG1' ' A' ' 6' ' ' THR . 11.6 p90 -69.07 -23.92 64.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.243 0.544 . . . . 63.41 111.313 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.31 -20.71 36.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.62 . . . . 63.43 111.533 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -91.05 -11.5 38.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 71.53 110.896 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 152' ' ' GLY . 45.9 mt -58.29 -34.97 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.328 0.492 . . . . 71.24 112.328 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.47 50.87 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.586 -1.292 . . . . 75.24 114.694 168.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -40.24 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.167 -1.049 . . . . 71.23 108.167 171.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -60.97 -35.48 76.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.726 -1.125 . . . . 63.35 110.751 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.07 73.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.12 -0.491 . . . . 62.11 111.883 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -69.61 -31.09 69.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.47 . . . . 71.31 110.51 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.17 -47.39 85.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.69 -0.686 . . . . 75.0 111.804 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.31 -31.4 52.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.95 0.405 . . . . 70.03 110.797 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.665 ' HE2' ' HA3' ' A' ' 220' ' ' GLY . 82.6 t80 -73.03 -41.82 63.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.681 -0.69 . . . . 70.22 111.331 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -83.44 -28.07 29.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.146 -0.479 . . . . 75.14 112.209 -173.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -66.78 91.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.527 . . . . 75.53 110.433 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.42 -23.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.916 -0.874 . . . . 75.35 110.916 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.85 76.16 1.62 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 74.24 110.386 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.94 119.1 4.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.72 -0.753 . . . . 41.11 111.3 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -80.34 8.04 8.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.065 0.459 . . . . 75.32 111.035 -175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.53 13.22 54.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.982 -0.847 . . . . 53.34 110.982 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 2.7 pp -107.45 177.97 4.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.946 0.879 . . . . 41.11 112.749 -173.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG13 HD12 ' A' ' 277' ' ' LEU . 1.7 mp -103.0 132.53 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.293 -1.321 . . . . 72.25 110.224 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 26.0 tptp -102.84 118.66 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.965 -1.016 . . . . 75.13 109.193 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.71 128.23 56.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.623 -0.51 . . . . 70.43 109.623 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 43' ' ' SER . 30.6 m-20 -133.28 134.14 43.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.104 0.478 . . . . 45.43 110.373 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.759 HD22 ' HB2' ' A' ' 281' ' ' PHE . 1.2 tm? -123.72 126.01 45.77 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.157 -1.053 . . . . 61.3 108.157 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.9 mtpp -132.29 129.7 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.858 0.361 . . . . 73.42 110.59 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.8 m -136.27 131.64 34.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.134 -0.484 . . . . 71.01 109.839 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -104.98 136.77 43.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 71.25 110.209 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.3 m -139.59 169.27 18.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.002 -0.545 . . . . 61.14 110.168 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.22 178.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 75.32 110.771 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 t30 65.21 24.43 12.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.578 0.704 . . . . 53.51 109.537 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.32 19.81 79.74 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 120.618 -0.801 . . . . 60.15 111.988 175.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 62' ' ' TYR . 10.2 mt -85.55 137.3 32.97 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.222 1.011 . . . . 61.3 113.266 -171.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.736 ' HB2' HH12 ' A' ' 63' ' ' ARG . 43.4 tt0 -139.51 118.56 12.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.24 -1.8 . . . . 65.43 108.828 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 90.9 m-85 -103.6 120.09 40.2 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.695 -0.483 . . . . 75.33 109.695 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 25.9 m -126.05 126.07 43.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.234 -0.439 . . . . 75.35 110.397 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 22.8 t -119.66 123.25 43.37 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.858 -0.793 . . . . 74.53 108.858 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -123.78 124.88 43.67 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.081 -0.34 . . . . 75.22 110.081 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.06 153.61 24.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.463 -0.875 . . . . 75.4 111.857 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -137.52 133.92 35.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.919 -0.771 . . . . 75.2 108.919 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -148.92 129.26 13.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.969 0.414 . . . . 34.03 111.426 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.61 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 16.4 t-20 -102.02 113.93 27.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.403 -0.962 . . . . 63.42 108.403 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 m -47.27 103.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.066 0.854 . . . . 74.34 113.069 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.47 17.08 10.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.209 -0.905 . . . . 72.33 112.296 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 48' ' ' ASN . 11.0 m -97.81 8.86 43.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 71.44 110.062 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m 62.91 31.47 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.338 -0.847 . . . . 75.53 111.305 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 54.7 mmtt -130.5 83.52 2.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.29 0.566 . . . . 51.44 110.112 175.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 47' ' ' ALA . 48.0 t -125.35 120.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.991 -1.004 . . . . 71.33 109.652 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.6 t -133.43 143.4 48.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.14 -0.318 . . . . 70.11 110.14 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.82 141.26 12.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.928 -0.653 . . . . 73.23 112.823 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -132.83 135.06 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.083 0.553 . . . . 73.05 109.663 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -121.74 125.63 47.02 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.239 -0.652 . . . . 62.22 109.239 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.764 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 22.2 tt0 -117.68 120.36 37.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.395 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 3.3 m -113.45 118.37 34.31 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.873 -1.158 . . . . 73.43 107.873 168.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -116.82 120.64 39.15 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.01 -0.676 . . . . 61.42 110.242 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 1.4 m-85 -107.0 125.56 51.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 70.24 109.699 -175.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.736 HH12 ' HB2' ' A' ' 40' ' ' GLU . 1.6 mpp_? -129.51 106.49 8.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.328 -0.949 . . . . 72.34 111.807 169.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 49.0 t-105 -88.79 91.82 8.97 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.234 -1.024 . . . . 75.42 108.234 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 67' ' ' TYR . 9.4 m 67.8 141.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.614 -1.176 . . . . 44.42 110.486 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.93 -8.54 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.432 0.634 . . . . 71.44 110.289 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.704 ' H ' HG22 ' A' ' 65' ' ' THR . 81.8 t80 -126.36 86.53 2.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.113 -0.949 . . . . 75.53 108.573 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 88' ' ' GLU . . . 170.91 -101.72 0.17 Allowed Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.705 -0.76 . . . . 73.3 112.383 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.8 mm? -113.65 138.24 50.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.482 0.658 . . . . 45.2 111.77 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.1 m -135.74 111.31 9.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.191 -0.913 . . . . 53.14 109.469 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.703 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 12.2 t80 -119.77 125.75 49.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.811 0.338 . . . . 74.52 110.422 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 84' ' ' GLU . 28.2 m -110.85 117.65 33.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.937 0.399 . . . . 52.43 110.353 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 34.7 tt0 -111.94 123.85 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.698 -0.683 . . . . 75.02 109.911 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.8 ptmm? -127.26 133.22 50.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.22 0.533 . . . . 73.02 110.188 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.622 ' CD1' HD22 ' A' ' 81' ' ' LEU . 32.6 t90 -134.04 128.27 33.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.559 -0.534 . . . . 72.41 109.559 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -116.41 133.21 56.28 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.842 -0.743 . . . . 72.33 110.791 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -73.9 -25.71 60.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.739 0.78 . . . . 72.53 110.09 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -96.14 -16.2 21.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.501 -1.227 . . . . 61.24 111.779 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.8 -98.05 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.354 0.872 . . . . 64.51 113.354 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 p -115.85 144.72 43.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.869 1.063 . . . . 71.13 113.869 -166.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.622 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -87.94 157.05 19.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.326 -1.361 . . . . 74.14 107.326 165.113 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 101' ' ' SER . . . -171.01 147.69 10.62 Favored Glycine 0 C--N 1.322 -0.205 0 C-N-CA 119.79 -1.195 . . . . 35.11 113.173 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -148.98 128.52 13.12 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.254 0.222 . . . . 74.44 111.165 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.9 pt-20 -126.41 125.98 43.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 74.33 110.023 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.24 128.3 68.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 73.13 110.439 -176.155 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.592 ' CG2' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m -118.17 123.91 46.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.113 -0.494 . . . . 73.24 111.248 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.33 137.88 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.126 -0.488 . . . . 75.03 109.828 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 1.1 pp20? -89.52 161.95 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.986 -0.686 . . . . 61.4 110.879 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -95.67 124.73 39.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.813 -0.44 . . . . 71.42 109.813 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.4 -25.82 65.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 72.41 111.546 -175.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.74 -45.74 5.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.867 0.365 . . . . 73.21 110.248 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -92.01 77.17 5.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.36 -0.607 . . . . 63.43 109.36 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.455 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 56.2 mtt180 -64.1 134.65 55.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.349 -0.841 . . . . 71.4 111.623 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 102.14 -12.2 57.27 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.016 -0.993 . . . . 72.54 111.681 -174.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -85.02 121.3 27.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.604 0.24 . . . . 75.31 110.402 178.14 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.592 ' HE3' ' CG2' ' A' ' 86' ' ' THR . 29.9 mmmt -121.96 112.05 17.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 64.53 109.443 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 86' ' ' THR . 1.9 mm? -94.85 128.2 41.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.47 . . . . 55.01 109.779 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 1.118 ' HB ' ' HG3' ' A' ' 115' ' ' LYS . 3.3 m -128.45 132.89 48.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.077 0.465 . . . . 75.13 111.534 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 76.7 t80 -117.8 120.63 38.51 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.375 -0.602 . . . . 74.04 109.375 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 113' ' ' LYS . 6.9 t70 -111.62 143.07 43.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.401 . . . . 75.0 110.475 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.438 ' O ' ' HA2' ' A' ' 82' ' ' GLY . 72.9 m -142.86 122.19 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.835 0.35 . . . . 72.43 110.876 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 t -108.04 133.16 52.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.762 -0.829 . . . . 65.22 108.762 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 110' ' ' LYS . 35.6 t80 -122.87 125.13 44.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.819 0.342 . . . . 72.31 110.722 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.7 t -87.38 106.19 10.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.695 -0.854 . . . . 62.42 108.695 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.45 -39.92 79.38 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.04 2.493 . . . . 72.0 112.699 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.48 -49.9 24.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.592 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 m -66.06 -40.67 91.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 64.44 111.304 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.6 -5.7 80.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.89 -0.671 . . . . 71.1 111.791 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -94.62 148.16 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 60.53 110.355 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -126.42 151.33 47.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 74.22 111.019 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -119.25 121.01 38.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.566 -0.743 . . . . 75.42 109.01 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.56 28.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.871 0.367 . . . . 73.22 110.99 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 130' ' ' ASP . 17.3 mmtm -124.22 141.46 52.04 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.174 -0.676 . . . . 64.44 109.174 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.92 117.74 56.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.126 -1.065 . . . . 72.45 108.126 169.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 1.118 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 8.0 ptmt -129.16 119.86 24.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.231 -0.895 . . . . 64.45 110.818 -171.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.0 p -109.23 117.75 34.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.354 -0.839 . . . . 71.41 109.531 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.456 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -128.82 114.23 1.73 Allowed Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.303 -0.951 . . . . 5.3 111.961 -174.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.791 ' HB3' HD22 ' A' ' 95' ' ' LEU . 12.9 p90 -118.77 131.81 56.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.167 0.508 . . . . 72.53 110.458 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.713 ' HE3' ' HB ' ' A' ' 3' ' ' VAL . 8.7 ptmt -109.11 121.32 44.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.576 -0.738 . . . . 74.15 110.213 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 120' ' ' ARG . 9.3 tpt180 -106.72 157.02 18.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.851 ' HA ' HG22 ' A' ' 3' ' ' VAL . 3.8 pm0 -53.22 -28.9 29.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.966 0.728 . . . . 71.24 112.966 -169.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -114.54 -16.03 11.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.884 -0.327 . . . . 63.44 111.542 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 142' ' ' LEU . 10.9 tp -145.03 130.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.298 -0.561 . . . . 75.41 111.809 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.438 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 38.1 t-20 -117.95 117.31 28.89 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.058 -0.401 . . . . 63.43 110.637 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 125' ' ' LEU . 3.9 mm? -113.01 128.73 56.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.681 0.277 . . . . 75.23 111.145 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.456 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.43 123.53 3.08 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.528 -0.629 . . . . 72.13 111.528 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 60.3 m -113.78 108.28 16.88 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.678 -0.307 . . . . 54.15 111.091 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.831 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 3.2 m-20 -100.81 117.52 35.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.482 -0.562 . . . . 65.43 109.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.2 ptm -98.0 118.64 35.05 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.458 -0.897 . . . . 72.03 109.531 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 8.9 t70 -94.52 117.66 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 73.12 109.967 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -97.16 102.68 14.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.071 0.462 . . . . 64.1 111.465 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -105.29 146.72 28.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.171 -1.048 . . . . 74.41 108.171 167.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.601 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -62.68 -22.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.845 0.313 . . . . 70.3 111.845 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.2 -6.67 47.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.572 0.225 . . . . 75.22 111.602 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.457 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 160.82 121.47 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.339 -0.934 . . . . 75.34 112.921 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 2.9 Cg_exo -74.55 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 52.21 111.802 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -81.99 153.29 26.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.21 -0.45 . . . . 75.02 110.053 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.665 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 3.5 mp -107.11 117.43 52.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.945 -0.702 . . . . 73.4 109.94 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.831 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 59.8 ttt-85 -104.68 130.12 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.706 -0.479 . . . . 73.45 109.706 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -116.91 132.14 9.89 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.961 -1.114 . . . . 63.31 111.553 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.73 115.74 21.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.478 -0.564 . . . . 74.43 109.478 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 123' ' ' ILE . 11.6 tp -128.02 122.56 32.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.259 -0.428 . . . . 62.12 110.131 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 1.021 HG11 ' HB ' ' A' ' 6' ' ' THR . 21.8 t -119.59 130.51 73.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.075 0.464 . . . . 72.3 109.851 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 144' ' ' LEU . 5.1 mp -109.35 138.29 45.92 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 73.02 109.538 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.73 123.43 5.82 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.714 -0.755 . . . . 63.23 112.774 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.812 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 56.0 m-85 -125.9 148.32 49.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.007 -0.738 . . . . 72.32 109.007 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -53.44 102.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.952 0.406 . . . . 65.44 110.413 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.56 -31.1 7.45 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.746 -0.661 . . . . 62.43 112.492 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.5 m0 -105.89 134.56 48.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 75.33 110.837 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 6' ' ' THR . 3.2 tm? -139.41 134.59 32.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.237 -0.653 . . . . 63.24 109.237 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 171' ' ' VAL . . . -148.97 141.12 23.95 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.821 -0.352 . . . . 74.1 111.664 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -140.33 141.0 11.05 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.965 -0.454 . . . . 63.02 111.965 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.435 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 43.1 m-85 -124.08 121.26 34.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.182 -0.303 . . . . 73.21 110.182 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 28.6 mp0 -114.19 122.15 45.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 74.44 109.284 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.19 145.46 51.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.808 0.337 . . . . 73.1 111.002 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 166' ' ' GLN . 6.0 m-20 -112.55 118.34 34.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.845 -0.798 . . . . 72.22 108.845 175.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.665 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 76.7 t80 -95.64 121.87 37.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.479 -0.782 . . . . 54.31 111.007 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.8 tp10 -79.24 99.34 7.01 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 114.386 -1.279 . . . . 74.14 109.129 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -70.9 -23.83 62.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.442 -1.708 . . . . 71.54 112.212 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.7 -32.18 71.43 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.916 0.865 . . . . 71.21 109.165 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -114.6 -157.5 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.199 -1.364 . . . . 62.44 108.205 170.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.9 p -107.56 30.72 6.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.407 -0.59 . . . . 50.32 109.407 172.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.553 ' HA ' ' HE ' ' A' ' 163' ' ' ARG . 3.7 mmp_? -119.55 171.8 8.11 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 119.689 -0.804 . . . . 74.43 112.871 -159.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.61 127.09 59.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.166 -0.679 . . . . 44.35 109.166 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.3 t -95.86 -24.13 16.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.887 0.375 . . . . 50.15 110.935 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.591 ' HB3' ' HB2' ' A' ' 156' ' ' ASN . 32.8 tt0 -145.83 133.04 20.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 53.13 110.645 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 169' ' ' PHE . 17.0 p -122.54 106.43 11.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.109 -0.496 . . . . 63.22 110.617 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 5.3 t30 -108.37 121.56 45.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.264 -0.643 . . . . 72.23 109.264 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 167' ' ' SER . 29.5 m-85 -123.86 156.83 35.49 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.386 -0.526 . . . . 65.32 111.027 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -150.75 128.25 11.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.963 -0.562 . . . . 33.51 109.796 171.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 151' ' ' ALA . 27.2 t -143.98 130.44 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.301 -0.629 . . . . 72.32 109.301 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.11 174.74 35.38 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.041 -1.552 . . . . 63.52 114.111 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -134.36 138.05 44.59 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -109.71 127.41 54.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.731 -0.668 . . . . 73.25 111.985 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 29.8 m -131.94 143.14 49.91 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.39 -1.337 . . . . 72.31 107.39 164.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.09 -1.98 6.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.138 0.792 . . . . 64.24 113.138 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.548 ' HG3' ' HD1' ' A' ' 178' ' ' PHE . 9.0 pt-20 -116.64 -26.08 7.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.537 -0.465 . . . . 65.41 111.478 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.548 ' HD1' ' HG3' ' A' ' 177' ' ' GLU . 41.3 p90 -140.87 127.93 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.705 0.288 . . . . 70.32 110.303 173.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.86 124.38 35.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.185 -0.302 . . . . 64.54 110.185 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.618 HD12 HG13 ' A' ' 194' ' ' ILE . 3.9 tt -110.86 128.26 55.72 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.062 -0.655 . . . . 73.44 110.031 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -131.81 115.83 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.906 -0.588 . . . . 65.42 109.769 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 84.8 m -99.51 123.16 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.127 -0.488 . . . . 72.11 110.213 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.3 p30 -119.86 141.49 49.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.142 0.496 . . . . 73.1 110.719 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 79.1 t -119.6 130.02 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.898 -0.592 . . . . 63.11 110.193 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 36.2 m-80 -113.24 106.96 15.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.838 -0.619 . . . . 65.43 109.34 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.01 -165.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.047 -0.979 . . . . 43.42 110.282 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.98 -6.99 89.09 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.385 -0.912 . . . . 73.31 111.947 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.2 p -102.23 -25.2 13.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.98 1.104 . . . . 71.42 113.98 -170.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 39.2 tt0 -120.41 112.74 19.36 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.17 -1.012 . . . . 72.44 112.19 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -106.26 124.88 50.27 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.393 -0.966 . . . . 70.0 108.393 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -136.6 131.6 5.71 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.037 -1.077 . . . . 34.41 113.677 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -114.79 121.76 5.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.115 -0.794 . . . . 71.41 111.115 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m -115.07 137.13 52.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.294 0.547 . . . . 72.14 110.931 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.618 HG13 HD12 ' A' ' 180' ' ' LEU . 4.3 mp -121.87 132.29 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.926 -0.579 . . . . 74.3 109.724 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -108.28 120.1 41.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.787 -0.82 . . . . 64.42 108.787 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -118.08 130.05 55.92 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.862 -0.608 . . . . 74.42 110.845 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -98.72 109.62 22.35 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 74.44 108.34 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.454 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 44.0 t -83.3 -40.22 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.538 0.685 . . . . 72.31 109.774 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 54.3 t30 -155.72 161.64 40.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.792 -1.188 . . . . 70.33 107.792 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.63 126.46 27.71 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt 82.17 -1.01 1.46 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.077 0.86 . . . . 75.33 111.325 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 199' ' ' ASN . 39.9 tp -125.32 99.92 6.28 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.603 0.716 . . . . 72.53 111.015 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -106.43 158.57 16.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.062 -0.972 . . . . 75.31 109.892 -176.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.6 m -152.91 142.87 22.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.18 -0.304 . . . . 73.44 110.18 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -132.11 136.49 47.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.877 0.37 . . . . 34.13 110.94 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.42 131.65 71.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.85 -0.614 . . . . 74.11 110.105 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 27.3 t-20 -119.16 133.26 55.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.935 0.398 . . . . 74.31 110.998 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.477 ' O ' ' HA2' ' A' ' 191' ' ' GLY . 4.1 mm? -118.74 130.24 55.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 71.54 108.715 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.36 129.18 35.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.047 0.451 . . . . 63.31 110.85 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -120.06 129.71 54.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.874 -0.603 . . . . 73.14 109.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.514 ' HB ' ' OD1' ' A' ' 216' ' ' ASN . 29.1 m -95.39 106.8 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.117 0.484 . . . . 70.22 110.007 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.63 136.99 50.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.849 . . . . 74.53 111.393 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -33.77 5.66 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.055 -0.818 . . . . 54.42 111.055 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -125.83 -178.57 4.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.768 -0.456 . . . . 72.05 109.768 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.5 t -109.96 27.11 9.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.408 . . . . 72.24 110.641 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 211' ' ' THR . 23.6 p-10 -81.85 110.82 17.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.793 0.806 . . . . 75.0 110.271 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.8 p -107.87 123.49 48.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.067 -0.97 . . . . 70.33 110.108 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -106.59 116.44 31.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.99 -0.55 . . . . 75.43 109.751 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 37.0 p90 -115.05 146.83 40.88 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.544 -0.462 . . . . 65.0 110.101 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.665 ' HA3' ' HE2' ' A' ' 18' ' ' PHE . . . -146.57 139.87 8.34 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.992 -0.843 . . . . 71.1 110.992 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.2 mp -123.84 128.87 74.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.65 -0.5 . . . . 71.41 109.65 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -122.84 130.34 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.344 0.403 . . . . 73.55 110.407 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.25 126.04 54.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.229 -0.442 . . . . 70.42 109.981 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -113.48 113.3 24.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 73.33 109.904 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -130.89 128.32 40.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.915 0.388 . . . . 74.34 110.553 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 36.5 tt0 -78.72 98.45 6.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 74.41 108.922 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.4 tt -79.22 -24.86 12.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.276 0.56 . . . . 74.55 110.656 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.431 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 3.1 t70 -143.72 148.54 43.33 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.106 -1.072 . . . . 72.44 108.106 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 52.6 Cg_exo -38.2 -40.35 1.15 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.846 3.031 . . . . 65.42 115.211 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' ' 250' ' ' THR . 6.8 m-20 -117.01 11.37 14.26 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.849 0.315 . . . . 73.14 111.849 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -129.73 123.17 30.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 70.13 111.415 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -122.51 127.35 49.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.971 -0.559 . . . . 73.5 110.639 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.853 ' HD1' ' HB3' ' A' ' 247' ' ' TYR . 63.0 t80 -107.58 133.86 51.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.636 -0.711 . . . . 73.32 110.828 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.7 p -122.17 120.77 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 52.51 110.853 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.82 141.32 42.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.366 -0.605 . . . . 71.24 109.366 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 10.8 ptpt -148.19 149.24 31.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.041 0.448 . . . . 70.05 111.694 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 7.7 p -137.22 148.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.443 -0.344 . . . . 71.01 110.353 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.827 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 7.1 m-20 -114.69 150.06 35.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.836 -0.62 . . . . 73.44 110.123 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 241' ' ' SER . 25.2 t30 -44.72 -36.11 3.0 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.476 1.11 . . . . 74.02 113.016 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 17.8 m -78.94 25.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.714 0.292 . . . . 65.35 111.036 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.9 m 64.93 36.83 7.37 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.616 -0.72 . . . . 71.22 110.238 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 238' ' ' ASN . 26.3 mt -98.69 115.93 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.11 109.879 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.26 117.38 48.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 120.539 -0.465 . . . . 74.53 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -119.91 134.02 10.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.831 -0.699 . . . . 70.43 112.491 177.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 260' ' ' SER . 3.0 pp -128.91 141.74 51.17 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.805 -0.443 . . . . 54.52 109.805 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -155.95 121.58 1.11 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.542 -0.837 . . . . 73.34 111.988 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.853 ' HB3' ' HD1' ' A' ' 233' ' ' PHE . 36.2 p90 -114.45 130.85 56.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.255 0.55 . . . . 63.51 110.955 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.708 HG22 ' HB ' ' A' ' 258' ' ' THR . 18.2 p -100.19 115.08 29.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.96 -1.018 . . . . 73.0 109.557 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -123.87 123.24 40.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.269 -0.423 . . . . 54.34 110.53 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 230' ' ' ASP . 9.5 m -69.51 111.62 5.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.371 -0.603 . . . . 74.44 109.371 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.49 -47.42 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 64.35 109.479 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.951 ' HB2' HD11 ' A' ' 255' ' ' ILE . 68.0 mttm -142.53 155.94 63.67 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.623 -1.251 . . . . 74.24 107.623 173.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.99 98.44 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.401 2.067 . . . . 74.35 111.79 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.46 -30.07 3.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.961 -0.638 . . . . 43.3 112.197 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.951 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -124.42 121.87 62.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.707 0.765 . . . . 70.52 111.747 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.91 125.39 52.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.271 -0.877 . . . . 72.23 109.707 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.2 tp -99.89 125.26 45.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.95 -0.568 . . . . 74.21 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.708 ' HB ' HG22 ' A' ' 248' ' ' THR . 6.8 t -117.77 121.42 40.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.486 0.66 . . . . 72.12 110.478 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.666 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -107.31 123.98 49.12 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.885 -1.154 . . . . 72.44 107.885 176.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 23.5 m -134.18 152.38 51.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.8 0.333 . . . . 72.2 110.482 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.448 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -156.86 131.56 8.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.311 -0.404 . . . . 45.22 110.601 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.791 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -108.34 114.57 28.53 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.934 -1.136 . . . . 74.42 107.934 174.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.943 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -101.97 105.21 15.96 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.11 -1.441 . . . . 64.12 107.11 174.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.705 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 4.8 p-10 -76.01 98.49 4.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.233 -1.025 . . . . 72.14 108.233 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.35 -9.16 3.02 Favored Glycine 0 C--N 1.321 -0.28 0 CA-C-N 114.106 -1.407 . . . . 54.21 114.371 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -88.04 -20.23 26.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.034 0.445 . . . . 73.3 110.243 -173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.0 -33.9 0.9 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.778 0.799 . . . . 71.3 109.083 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.943 HG11 ' HB3' ' A' ' 263' ' ' LEU . 1.8 t -54.09 -29.65 19.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 113.8 -1.546 . . . . 72.31 112.529 176.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.24 -37.15 84.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.596 . . . . 54.55 111.251 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.43 -16.27 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.067 0.395 . . . . 72.23 112.067 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.79 3.85 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.805 -0.712 . . . . 64.11 112.86 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -105.61 149.08 16.65 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 121.164 -0.541 . . . . 74.23 112.716 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.909 ' HB2' HD12 ' A' ' 263' ' ' LEU . 5.5 p-80 -103.83 149.15 25.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.844 -0.678 . . . . 62.44 110.208 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -96.27 138.62 33.61 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.084 -0.646 . . . . 71.31 110.764 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.0 tm? -120.77 144.72 48.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.676 -0.693 . . . . 70.13 110.443 -169.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.59 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -133.0 118.49 2.17 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.364 -0.694 . . . . 71.32 111.364 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -114.41 123.84 50.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.915 -0.772 . . . . 71.2 108.915 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -136.27 147.04 19.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.739 -1.219 . . . . 73.52 113.588 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.68 131.45 51.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.016 -0.735 . . . . 44.24 109.016 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -115.66 111.77 21.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.35 -0.611 . . . . 72.02 109.35 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.759 ' HB2' HD22 ' A' ' 31' ' ' LEU . 13.0 m-85 -95.32 101.85 13.61 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.686 -0.688 . . . . 72.51 109.22 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -103.73 110.93 23.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.966 -0.561 . . . . 64.13 110.031 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.37 110.06 21.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.857 -0.61 . . . . 73.41 109.712 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 61.5 mt -125.79 179.16 5.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.682 -0.69 . . . . 52.43 109.818 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.186 -0.672 . . . . 71.11 109.186 176.893 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.861 0.362 . . . . 75.34 110.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 85.25 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.754 -0.461 . . . . 62.55 109.754 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.652 HG11 ' HB2' ' A' ' 119' ' ' LYS . 6.2 t -110.66 102.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 74.35 110.523 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 159.27 37.63 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.628 2.219 . . . . 52.44 112.076 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.89 85.6 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.653 2.236 . . . . 72.12 111.626 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.9 p -75.16 -29.17 60.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.042 -0.526 . . . . 63.4 111.303 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.439 ' HB2' HG21 ' A' ' 143' ' ' VAL . 73.2 t80 -57.45 -40.09 77.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.23 0.538 . . . . 73.21 110.796 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.3 -24.05 34.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 71.13 110.4 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.21 8.32 33.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.701 . . . . 72.35 110.505 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.16 -14.89 61.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 74.25 110.422 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . 140.31 64.72 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 121.1 -0.571 . . . . 72.53 112.396 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -65.96 -43.1 88.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.988 0.394 . . . . 74.04 109.972 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -59.44 -38.75 81.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 75.05 110.489 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.09 74.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 70.31 111.032 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 48.3 mtp85 -64.73 -29.84 70.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 53.45 111.161 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.19 -37.55 72.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.292 0.567 . . . . 63.32 110.425 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.555 ' HA ' ' HE2' ' A' ' 236' ' ' LYS . 13.6 t -83.26 -36.38 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 74.2 111.035 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.53 -41.82 65.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.659 . . . . 73.24 112.327 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 15' ' ' ARG . 3.5 t -95.45 172.69 7.93 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.972 -0.291 . . . . 64.3 110.504 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -79.99 73.6 6.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.626 0.726 . . . . 74.02 110.977 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.48 36.27 3.96 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.579 -0.737 . . . . 63.02 111.496 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.618 ' HA ' ' OG ' ' A' ' 260' ' ' SER . 15.4 p90 -147.9 136.06 21.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.287 . . . . 73.24 110.788 -176.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.31 64.92 3.39 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.034 -0.53 . . . . 42.11 113.235 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.61 -3.74 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 75.53 110.842 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.22 -1.87 78.89 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.011 -0.54 . . . . 74.52 112.898 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -147.98 -179.6 7.03 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.088 0.947 . . . . 71.31 113.441 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.621 HG23 HD12 ' A' ' 277' ' ' LEU . 36.8 mm -102.82 122.94 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.693 -1.594 . . . . 72.22 108.717 174.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -118.22 124.99 49.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.324 0.583 . . . . 71.31 110.432 178.163 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tp -124.19 144.12 50.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.0 -0.546 . . . . 64.23 110.057 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.8 p30 -144.66 140.03 28.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.116 0.484 . . . . 64.34 110.028 171.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.77 HD13 ' HD1' ' A' ' 281' ' ' PHE . 16.0 tp -119.07 123.32 44.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.351 -0.84 . . . . 44.32 109.494 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 4.1 ptpp? -116.64 124.41 49.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.476 -0.783 . . . . 71.4 109.841 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 283' ' ' ALA . 45.4 m -123.16 121.57 36.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.692 -0.686 . . . . 63.32 110.089 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.56 123.41 47.31 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.413 -0.515 . . . . 74.34 109.954 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 48.0 t -141.81 146.99 36.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 55.13 109.615 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.91 -148.09 0.49 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.421 0.451 . . . . 65.12 111.247 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.71 136.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.036 -0.529 . . . . 70.23 110.281 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.751 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.51 -9.24 36.36 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 118.799 -1.001 . . . . 53.21 115.243 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -100.57 127.47 46.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.465 1.633 . . . . 70.3 112.547 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.13 118.11 11.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.762 -0.829 . . . . 65.04 108.762 162.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -100.64 120.79 40.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.63 -0.508 . . . . 74.33 109.63 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.963 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 10.5 m -125.91 116.89 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.882 0.372 . . . . 61.12 110.848 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 10.6 t -111.61 122.47 47.89 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.635 -0.876 . . . . 73.21 108.635 174.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -129.71 126.75 38.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.928 0.394 . . . . 41.34 110.301 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.47 16.08 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.757 -0.735 . . . . 71.43 111.773 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.4 m -125.02 134.32 52.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.49 -0.559 . . . . 74.51 109.49 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -137.02 128.56 28.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.005 0.431 . . . . 74.51 110.725 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 18.4 m120 -75.4 113.06 12.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.32 -0.622 . . . . 64.14 109.32 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.431 ' HB ' HG12 ' A' ' 27' ' ' ILE . 8.8 t -63.71 132.41 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 73.21 111.0 -174.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 60.48 15.07 5.27 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.165 -0.925 . . . . 71.23 111.05 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.479 ' HB ' ' CB ' ' A' ' 48' ' ' ASN . 5.1 m -119.84 -10.13 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.43 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p 52.94 34.81 17.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.574 0.75 . . . . 42.34 112.679 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 35.3 mmtp -113.19 102.05 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.053 -0.721 . . . . 42.44 109.053 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 47' ' ' ALA . 13.7 t -123.78 123.42 67.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.123 -0.489 . . . . 74.11 111.661 -170.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -111.03 125.69 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 73.33 109.243 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.07 136.96 11.56 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.609 -0.805 . . . . 64.12 112.396 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 p -137.04 153.75 50.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.917 0.389 . . . . 73.41 110.56 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -127.27 124.79 39.66 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.142 -0.688 . . . . 75.54 109.142 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.963 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 87.0 mt-10 -108.41 119.97 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.298 -0.41 . . . . 53.11 110.386 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 73' ' ' GLU . 20.5 p -99.19 117.7 34.24 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.007 -1.109 . . . . 74.53 108.007 168.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.6 ttmp? -119.93 131.3 55.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.571 -0.529 . . . . 74.24 109.571 -174.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 25.8 m-85 -108.27 121.43 44.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.902 -0.59 . . . . 74.43 109.989 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.588 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 tmm_? -103.9 104.66 14.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.732 -0.84 . . . . 71.3 108.732 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 7.3 t-105 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.158 -0.928 . . . . 74.14 111.657 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 67' ' ' TYR . 25.1 m 69.84 144.99 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.93 0.769 . . . . 61.42 112.151 173.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -82.21 12.02 4.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.505 . . . . 54.13 111.145 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.453 ' H ' HG22 ' A' ' 65' ' ' THR . 54.3 m-85 -102.4 -46.8 4.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.481 -0.327 . . . . 72.12 110.424 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' HD12 ' A' ' 69' ' ' LEU . . . 144.95 71.86 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.125 -1.035 . . . . 70.31 113.393 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.688 ' HG ' ' HA ' ' A' ' 87' ' ' VAL . 8.3 mp -112.44 134.81 53.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.094 -0.651 . . . . 61.03 110.453 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -136.64 112.07 9.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.774 -0.648 . . . . 61.11 110.24 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 32.4 t80 -106.11 122.12 45.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.399 -0.593 . . . . 74.41 109.399 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 14.8 m -117.15 117.36 29.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.798 0.332 . . . . 74.33 111.275 -175.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HB2' ' OG1' ' A' ' 60' ' ' THR . 43.3 mt-10 -103.14 120.42 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 53.23 108.452 168.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.928 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 3.4 tmtp? -114.53 98.04 6.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.95 -0.568 . . . . 62.43 109.592 -174.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.587 ' HE1' ' HA ' ' A' ' 79' ' ' ASN . 2.1 t90 -99.51 129.02 45.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.212 -0.449 . . . . 72.12 110.422 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 39.5 t30 -97.78 154.24 17.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.221 -0.659 . . . . 45.25 109.221 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -65.31 -17.51 64.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.93 0.395 . . . . 73.02 111.348 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 12.8 m-20 -80.58 -1.28 41.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.054 -0.521 . . . . 72.04 110.371 174.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.587 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 4.1 m-20 77.7 35.16 0.31 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.979 0.912 . . . . 64.23 110.959 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 11.2 m -85.42 117.68 24.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.604 -0.725 . . . . 52.23 109.601 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.4 124.23 39.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.992 0.425 . . . . 72.14 111.352 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.85 109.31 2.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.745 -0.942 . . . . 43.34 110.745 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 m -104.62 99.64 9.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.918 0.359 . . . . 65.3 110.958 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.677 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 28.4 tt0 -111.73 132.26 54.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 72.42 110.209 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.8 tt -129.4 126.14 63.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 70.35 111.077 173.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 25.6 m -116.14 123.73 48.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.009 -0.541 . . . . 60.14 109.827 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 2.7 p -128.54 121.88 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.371 -0.233 . . . . 72.12 110.371 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 mt-10 -99.0 137.52 37.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 75.12 110.798 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.77 151.82 27.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 45.43 111.274 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.01 -38.94 14.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 73.52 111.545 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.74 -45.69 13.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.57 0.7 . . . . 74.32 109.477 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -87.17 66.56 9.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.324 -0.853 . . . . 74.41 108.83 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.755 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -53.4 124.7 15.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 73.41 110.378 -177.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.48 -3.82 56.53 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.429 -0.891 . . . . 43.42 112.57 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.6 HD22 ' HD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -81.81 117.34 22.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.493 -0.558 . . . . 73.34 109.493 175.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HG2' ' HG2' ' A' ' 88' ' ' GLU . 26.6 mtpp -116.35 110.65 18.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 71.31 109.083 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.504 ' HB2' HG13 ' A' ' 87' ' ' VAL . 2.0 mm? -99.93 126.29 46.06 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.37 -0.604 . . . . 71.4 109.37 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 28.4 m -130.16 119.17 22.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.95 0.405 . . . . 74.33 110.61 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -115.32 113.26 23.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.516 -0.92 . . . . 70.44 108.516 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.518 ' OD1' ' HD2' ' A' ' 113' ' ' LYS . 9.8 p-10 -120.77 134.39 55.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.317 0.579 . . . . 75.1 110.109 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 14.9 m -131.2 134.32 46.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.777 -0.647 . . . . 74.52 111.289 -175.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.3 t -95.27 122.0 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.082 -1.081 . . . . 61.3 108.082 172.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HD1' ' HB3' ' A' ' 110' ' ' LYS . 82.1 t80 -127.51 129.52 47.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.217 0.532 . . . . 73.13 110.642 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.8 m -120.45 103.2 44.48 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.787 -0.642 . . . . 75.22 109.737 176.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.97 -16.42 55.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.023 2.482 . . . . 64.23 112.978 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -66.35 -45.15 81.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.966 0.412 . . . . 74.54 110.607 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.3 p -105.16 -13.54 15.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.89 -0.595 . . . . 72.24 111.571 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.95 85.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 73.53 111.531 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 87.0 tttt -74.2 137.9 43.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 75.23 111.123 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.91 132.81 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 64.5 110.706 177.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.635 HD22 ' HA ' ' A' ' 132' ' ' ASP . 16.3 m120 -120.33 122.93 41.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 64.32 109.494 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.94 126.86 52.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.136 0.493 . . . . 40.12 111.419 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.518 ' HD2' ' OD1' ' A' ' 100' ' ' ASP . 57.0 mttm -121.14 138.44 54.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.424 -0.584 . . . . 70.21 109.424 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mm -119.75 117.79 54.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.101 0.476 . . . . 73.3 110.524 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.805 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 40.3 mttp -115.02 119.81 37.73 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.8 -0.636 . . . . 64.45 109.729 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.489 HG22 HD12 ' A' ' 97' ' ' LEU . 27.8 p -116.36 117.61 30.44 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.078 -0.51 . . . . 73.25 110.125 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.83 130.27 9.42 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.55 -0.833 . . . . 72.31 112.034 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.6 ' HD1' HD22 ' A' ' 95' ' ' LEU . 71.4 t80 -123.14 115.26 21.5 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.027 -0.731 . . . . 63.22 109.027 174.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB2' HG11 ' A' ' 3' ' ' VAL . 22.0 pttm -111.69 122.64 48.34 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.605 -0.838 . . . . 64.03 110.962 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HB3' HG22 ' A' ' 123' ' ' ILE . 37.6 ttm180 -106.29 169.13 8.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.757 -1.201 . . . . 65.01 107.757 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 3' ' ' VAL . 41.5 tp10 -53.28 -34.1 55.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 73.42 112.219 -167.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.435 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 92.9 m-70 -119.96 3.85 10.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 113.189 0.811 . . . . 75.32 113.189 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 120' ' ' ARG . 18.8 tt -144.82 147.89 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.248 -0.981 . . . . 61.13 112.235 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.506 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.1 m-20 -123.6 124.33 42.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.032 0.444 . . . . 63.12 110.8 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.457 ' CD1' HD13 ' A' ' 142' ' ' LEU . 4.2 mm? -111.06 139.89 46.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.129 -0.487 . . . . 75.25 109.975 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.17 116.83 0.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.598 -0.81 . . . . 63.45 112.14 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 60.9 m -112.1 115.28 28.61 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.545 -0.385 . . . . 73.53 110.377 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.96 116.84 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 75.25 110.472 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 44.9 mtt -103.59 117.59 34.77 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.686 -0.857 . . . . 73.14 108.686 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.17 114.8 29.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.431 -0.507 . . . . 75.12 109.928 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.447 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 53.0 t80 -99.29 97.56 8.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.954 0.406 . . . . 72.41 110.419 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.635 ' HA ' HD22 ' A' ' 111' ' ' ASN . 12.6 t70 -101.18 144.22 30.32 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.113 -1.069 . . . . 43.23 108.113 170.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -65.64 -25.74 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.78 -0.452 . . . . 73.21 109.78 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.05 -1.42 57.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 62.14 111.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.19 108.19 0.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.368 -0.92 . . . . 32.12 113.024 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 2.3 Cg_endo -82.58 126.76 4.78 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.352 2.701 . . . . 70.24 112.096 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 p -126.49 162.94 24.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.812 0.339 . . . . 74.32 111.227 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 49.4 mm -108.9 123.58 64.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.479 -0.328 . . . . 74.54 110.65 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.06 113.23 21.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.931 0.396 . . . . 71.41 109.945 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.83 11.18 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.069 -1.062 . . . . 75.12 111.817 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.15 116.83 26.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.036 0.446 . . . . 71.12 110.015 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -116.51 123.83 48.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.142 -0.481 . . . . 64.23 110.289 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 93.8 t -111.94 129.4 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 55.12 109.975 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.796 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.32 138.45 43.5 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.002 -0.74 . . . . 61.44 109.002 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 122' ' ' HIS . . . -117.78 118.55 4.12 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.439 -0.886 . . . . 53.31 112.641 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.564 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 25.0 t80 -131.66 146.42 52.17 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.483 -1.303 . . . . 73.31 107.483 175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.1 101.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.099 0.476 . . . . 72.53 111.403 -176.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.72 -31.2 8.11 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.378 -0.828 . . . . 63.3 112.512 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 33.3 m0 -105.12 122.81 46.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.62 0.248 . . . . 75.1 111.471 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.55 137.65 46.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 70.13 110.105 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.796 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -129.96 158.18 40.26 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.852 -0.425 . . . . 51.4 109.852 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -157.46 132.86 3.33 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.395 -0.682 . . . . 63.22 111.395 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.573 ' CD1' ' HD1' ' A' ' 169' ' ' PHE . 21.7 m-85 -127.13 118.96 25.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 117.271 0.535 . . . . 72.44 109.841 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.839 ' HG3' ' HB3' ' A' ' 168' ' ' ASN . 26.8 pt20 -105.55 122.86 46.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.655 0.741 . . . . 71.41 109.771 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 ptm -126.67 140.49 52.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 70.01 110.666 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 22.0 t-20 -113.2 117.66 32.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.712 -0.477 . . . . 71.44 109.712 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 87.9 t80 -100.86 129.12 46.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.687 -0.688 . . . . 74.32 109.822 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.828 ' HG3' ' H ' ' A' ' 161' ' ' LYS . 9.0 tp10 -99.81 103.31 14.92 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 115.851 -0.613 . . . . 74.15 109.803 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 m -70.89 -27.01 63.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.548 -1.66 . . . . 73.03 111.327 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.05 75.05 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.777 0.799 . . . . 75.11 108.909 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.828 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 48.1 mmtm -95.28 -162.61 0.96 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.681 -1.229 . . . . 71.31 107.681 167.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -109.48 22.12 16.17 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.91 -0.494 . . . . 73.53 110.836 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -166.28 165.66 17.23 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 118.56 -1.256 . . . . 74.45 113.411 -163.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.855 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -77.7 136.39 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.66 -0.7 . . . . 64.32 110.096 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.1 m -94.63 -21.59 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 74.32 110.516 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 156' ' ' ASN . 22.0 tt0 -133.47 132.28 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 61.12 111.14 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -122.79 105.95 10.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.546 -0.752 . . . . 62.23 109.539 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.839 ' HB3' ' HG3' ' A' ' 154' ' ' GLN . 11.8 t-20 -117.09 128.84 55.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.928 -0.397 . . . . 73.14 109.928 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.573 ' HD1' ' CD1' ' A' ' 153' ' ' TYR . 47.4 m-85 -121.8 149.82 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.61 -0.268 . . . . 74.22 110.751 -173.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -151.84 137.76 18.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.65 -0.25 . . . . 23.35 110.908 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.653 ' HB ' HG22 ' A' ' 182' ' ' THR . 63.7 t -135.03 127.07 47.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.439 -0.578 . . . . 50.12 109.439 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.37 108.46 0.88 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.103 -0.799 . . . . 62.41 111.103 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.544 ' CZ ' HD21 ' A' ' 180' ' ' LEU . 28.7 p90 -127.63 151.51 48.85 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.52 -0.872 . . . . 74.33 111.936 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.666 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 95.9 mttt -118.34 138.19 52.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.116 -1.402 . . . . 75.31 110.498 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -131.78 113.44 13.52 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.66 -0.867 . . . . 55.54 108.66 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.47 -95.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.823 0.702 . . . . 33.03 112.402 -172.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 197' ' ' LYS . 11.8 mm-40 -108.39 4.79 24.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.793 0.33 . . . . 75.12 111.235 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.84 122.5 47.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.42 -0.215 . . . . 61.21 110.42 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.666 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 31.6 mt-30 -135.9 123.17 21.79 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 119.48 -0.295 . . . . 62.41 110.606 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.574 ' O ' ' HA2' ' A' ' 172' ' ' GLY 0.262 0.0 OUTLIER -127.86 144.13 51.1 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.264 1.03 . . . . 61.32 113.728 171.396 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.575 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 22.0 t60 -108.38 114.29 28.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.117 -1.856 . . . . 72.22 108.587 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.653 HG22 ' HB ' ' A' ' 171' ' ' VAL . 14.0 t -96.83 157.94 15.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.153 -1.055 . . . . 42.2 108.153 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -147.95 149.71 32.7 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.722 -0.391 . . . . 75.41 110.157 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -131.41 116.03 30.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.509 -0.552 . . . . 65.05 109.509 170.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.786 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 57.7 t30 -94.33 97.02 9.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.591 -0.731 . . . . 73.23 109.812 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.23 -165.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.053 -0.976 . . . . 63.11 110.787 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.87 89.48 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.85 -0.691 . . . . 74.15 112.104 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -102.09 -25.72 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.157 0.799 . . . . 61.21 113.157 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.786 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 38.3 tt0 -129.82 139.92 51.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 119.698 -0.801 . . . . 74.51 113.066 -170.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.36 153.91 21.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.342 -0.844 . . . . 75.32 108.82 172.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -149.64 162.92 29.22 Favored Glycine 0 C--N 1.314 -0.654 0 C-N-CA 120.669 -0.776 . . . . 70.22 112.629 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -159.1 154.82 25.9 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.609 -0.596 . . . . 61.44 111.609 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.0 m -148.73 135.18 19.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.93 -0.767 . . . . 70.31 108.93 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.0 mp -123.15 124.51 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 71.33 110.15 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.791 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -112.61 119.86 39.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 73.41 109.932 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.494 ' HB3' ' CG2' ' A' ' 204' ' ' THR . 5.5 tp-100 -108.82 111.92 23.9 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.112 -0.699 . . . . 72.41 109.112 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.607 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 8.7 tmtm? -97.28 108.62 21.38 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.534 -0.913 . . . . 63.53 108.534 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.82 ' HB ' ' HB3' ' A' ' 201' ' ' LYS . 15.0 t -77.94 123.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.181 -1.044 . . . . 65.4 108.181 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -38.95 -60.57 0.84 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.445 1.09 . . . . 62.53 112.234 -170.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -123.42 83.87 2.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.967 0.413 . . . . 71.1 109.913 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.82 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 20.2 tptm -167.99 -90.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 74.05 109.654 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.807 ' HB3' ' HD1' ' A' ' 225' ' ' TYR . 0.0 OUTLIER -163.18 -176.18 4.69 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.654 0.264 . . . . 71.05 110.525 173.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.791 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 3.2 mp0 -108.18 131.86 54.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 73.41 109.741 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.494 ' CG2' ' HB3' ' A' ' 196' ' ' GLN . 15.0 t -122.15 150.0 42.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.234 -0.654 . . . . 71.05 109.234 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -129.79 159.38 36.7 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.489 0.661 . . . . 74.54 111.408 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 221' ' ' ILE . 2.3 t -132.58 124.86 52.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.382 -1.281 . . . . 65.2 108.428 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -114.64 131.07 56.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 70.33 109.197 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.621 HD13 ' HD1' ' A' ' 219' ' ' PHE . 5.0 tp -147.06 136.28 22.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.023 -0.535 . . . . 71.32 110.448 -171.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.474 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -154.97 132.03 10.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.665 0.269 . . . . 44.31 110.693 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -130.96 118.45 20.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.1 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 1.4 m -94.76 108.7 20.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.069 -0.514 . . . . 75.32 109.918 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.06 130.37 43.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 61.15 110.683 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.46 1.42 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.384 -0.686 . . . . 63.11 111.384 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.36 88.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.234 0.54 . . . . 73.54 111.39 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 62.5 m -144.32 167.03 23.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.574 . . . . 71.33 110.134 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.87 124.1 22.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 63.25 110.25 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 23.5 p -77.73 123.29 26.5 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.097 0.475 . . . . 71.45 110.024 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.534 ' O ' HD12 ' A' ' 208' ' ' LEU . 63.7 mtt85 -89.6 113.02 24.4 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.408 -0.59 . . . . 61.34 109.408 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.621 ' HD1' HD13 ' A' ' 208' ' ' LEU . 93.4 t80 -126.62 136.39 52.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.981 -0.748 . . . . 71.01 108.981 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.38 162.78 33.57 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.033 -1.079 . . . . 54.45 112.474 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.63 HG12 HG12 ' A' ' 237' ' ' VAL . 0.1 OUTLIER -137.72 147.55 26.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.008 0.432 . . . . 52.14 109.969 176.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 205' ' ' ALA . . . -136.99 157.75 46.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.656 -0.702 . . . . 71.31 110.564 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -141.57 126.27 17.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.685 0.278 . . . . 24.01 111.016 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 69.2 mttm -108.02 112.98 25.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.771 -0.826 . . . . 61.24 108.771 172.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.807 ' HD1' ' HB3' ' A' ' 202' ' ' LEU . 30.0 t80 -114.15 119.0 35.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.725 . . . . 72.33 111.471 -172.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -76.45 104.42 6.96 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.861 -1.163 . . . . 73.01 107.861 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.13 -56.69 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.142 -0.481 . . . . 72.03 111.513 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.627 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 35.8 t70 178.32 -54.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 74.25 111.145 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 89.5 Cg_endo -83.16 -142.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.936 1.757 . . . . 74.44 112.586 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 14.7 p-10 -91.97 10.98 26.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 72.13 110.324 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 132.78 54.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.712 -0.676 . . . . 71.45 110.533 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.471 ' SG ' ' HB ' ' A' ' 248' ' ' THR . 11.9 p -122.23 142.6 50.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.45 -0.795 . . . . 64.04 109.813 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -101.94 132.89 47.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 62.42 110.008 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 52.0 p -122.95 120.74 34.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.952 0.406 . . . . 64.31 110.448 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.14 152.8 24.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.507 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 60.2 mttp -139.89 142.43 36.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.093 -0.706 . . . . 62.23 109.093 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.63 HG12 HG12 ' A' ' 221' ' ' ILE . 3.6 p -140.85 137.74 34.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.369 -0.532 . . . . 73.15 109.995 174.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.694 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 83.8 m-20 -109.01 149.57 29.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.511 . . . . 71.22 110.045 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 241' ' ' SER . 3.9 p-10 -55.02 -24.18 23.23 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.257 0.973 . . . . 63.45 112.525 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.691 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.5 m -79.59 20.5 0.57 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 70.45 110.165 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.486 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 40.7 m 65.97 36.99 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.352 -0.84 . . . . 44.1 110.771 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.3 mp -97.44 138.26 35.15 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.458 -0.497 . . . . 70.13 111.223 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 243' ' ' ILE . 3.0 mp -113.3 117.9 56.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.588 -0.733 . . . . 75.03 109.993 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.13 138.1 12.33 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.595 -0.812 . . . . 74.31 111.886 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.53 139.48 42.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 73.12 110.159 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.28 146.23 17.29 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.844 -0.693 . . . . 54.01 112.204 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.72 126.83 55.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.066 -0.346 . . . . 74.2 110.066 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.471 ' HB ' ' SG ' ' A' ' 232' ' ' CYS . 11.7 m -120.92 114.71 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 74.31 109.699 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 257' ' ' LEU . 48.1 tt0 -125.28 138.9 54.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.364 -0.38 . . . . 75.32 110.535 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 2.5 t -121.98 92.84 3.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.503 0.668 . . . . 75.34 110.032 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.812 ' HB3' HG23 ' A' ' 255' ' ' ILE . 53.6 tp -88.81 66.12 7.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.883 -0.599 . . . . 62.34 109.431 -175.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' A' ' 253' ' ' PRO . 40.9 ttmt 69.38 150.86 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.115 -0.948 . . . . 60.31 109.908 -174.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 252' ' ' LYS . 51.4 Cg_exo -54.44 84.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.324 2.016 . . . . 73.03 111.642 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 282' ' ' GLN . . . -178.6 -35.21 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.112 -0.949 . . . . 53.15 110.793 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.812 HG23 ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -149.08 122.3 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.75 0.786 . . . . 64.43 110.82 176.282 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 99.2 mttt -116.99 131.65 56.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.056 -0.975 . . . . 74.45 109.827 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.679 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 28.8 tp -102.93 122.12 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.723 -0.473 . . . . 74.44 109.723 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.2 t -135.22 109.98 8.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 55.11 110.512 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.631 ' HB3' HD23 ' A' ' 277' ' ' LEU . 1.6 pp -135.08 158.38 44.5 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.085 -0.646 . . . . 72.53 110.54 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 22' ' ' TYR . 20.1 p -148.99 143.39 26.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.827 -0.624 . . . . 74.43 110.262 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.446 ' HB2' HD22 ' A' ' 275' ' ' LEU . . . -139.55 130.2 25.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.221 -0.659 . . . . 71.12 109.221 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.838 HD21 HD23 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -119.91 127.34 52.6 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.633 0.73 . . . . 64.42 110.084 179.518 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.867 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -101.74 109.68 21.51 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.23 -1.396 . . . . 54.13 107.23 176.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.872 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 10.5 t0 -72.25 106.87 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.405 -0.961 . . . . 64.51 108.405 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.48 -21.43 27.5 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.367 -0.444 . . . . 72.11 113.115 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -90.95 -20.16 22.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.741 0.305 . . . . 64.14 110.786 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 29.3 t-20 -110.5 -29.06 8.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.914 0.388 . . . . 62.45 111.942 -173.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 263' ' ' LEU . 23.0 m -63.27 -16.55 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.063 -0.398 . . . . 73.44 111.804 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -53.93 -35.93 62.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.928 -0.397 . . . . 75.45 109.928 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -96.89 -16.78 20.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 61.23 110.53 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 117.62 7.21 12.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.8 -0.714 . . . . 54.32 113.176 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -70.2 85.71 0.32 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 44.43 113.041 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.552 ' HB2' HD12 ' A' ' 263' ' ' LEU . 55.8 p-80 -113.96 138.89 49.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.098 -0.334 . . . . 74.45 110.098 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 9.5 mmpt? -105.76 137.44 43.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.276 -0.268 . . . . 74.51 110.276 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -129.26 132.54 47.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.57 -0.286 . . . . 50.03 110.275 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.505 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.89 118.95 1.65 Allowed Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.541 -0.624 . . . . 55.21 111.541 174.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 259' ' ' LEU . 1.7 tm? -118.57 124.59 47.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.903 0.352 . . . . 73.12 110.09 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -132.56 141.0 12.31 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.547 -0.835 . . . . 62.3 113.442 -177.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.913 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.4 mm? -122.7 132.4 54.23 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.523 0.201 . . . . 65.55 110.908 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 16.2 mt-10 -105.43 111.54 24.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 64.12 109.169 167.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.77 ' HD1' HD13 ' A' ' 31' ' ' LEU . 5.6 t80 -107.64 133.68 51.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.436 -0.95 . . . . 75.22 108.436 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 pt20 -137.4 125.49 22.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.288 0.566 . . . . 74.42 111.758 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.438 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -106.36 112.4 25.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.514 -0.766 . . . . 61.32 109.493 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 74.9 mt -115.42 156.87 24.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.921 -0.581 . . . . 75.4 110.134 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 109.127 -0.694 . . . . 72.4 109.127 178.287 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.26 -0.274 . . . . 71.44 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.18 73.57 8.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.365 0.602 . . . . 62.44 109.457 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.022 HG12 ' HB3' ' A' ' 119' ' ' LYS . 9.9 p -88.09 142.81 32.2 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.191 -0.913 . . . . 72.42 110.087 -174.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 85.0 Cg_exo -48.47 146.66 10.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.167 2.578 . . . . 73.52 112.926 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 7.6 Cg_exo -72.08 91.58 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.97 2.447 . . . . 70.31 112.49 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -76.36 -20.22 57.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.504 . . . . 70.1 110.134 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' HA ' HG21 ' A' ' 143' ' ' VAL . 63.7 t80 -56.64 -38.36 72.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 63.41 110.081 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.56 -28.26 28.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.771 -0.649 . . . . 70.45 110.573 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.67 6.37 35.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.794 -0.639 . . . . 74.15 110.708 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 143' ' ' VAL . 89.3 mt -60.78 -15.93 35.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.39 0.614 . . . . 61.34 109.823 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.705 ' HA3' ' HB2' ' A' ' 181' ' ' HIS . . . 164.72 57.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.099 -1.201 . . . . 75.11 110.099 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 14.2 tmtt? -56.16 -54.32 46.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.875 0.47 . . . . 64.11 111.54 -170.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -65.19 -42.15 93.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.091 0.472 . . . . 60.14 111.485 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 -36.5 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 62.52 112.423 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.461 ' O ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.23 -31.45 70.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 64.21 111.574 -173.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 2.3 m-20 -65.75 -41.85 91.61 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 121.248 -0.181 . . . . 62.31 111.343 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.81 -38.97 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.329 0.585 . . . . 54.24 110.113 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -72.91 -41.39 64.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.442 -0.799 . . . . 72.43 112.186 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 20' ' ' LYS . 14.4 t -94.66 -6.6 42.98 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.321 0.489 . . . . 54.42 112.321 -173.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.511 ' HD2' HG23 ' A' ' 19' ' ' THR . 13.7 mptt -101.41 28.34 5.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 63.11 110.405 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.04 134.14 36.98 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.903 -0.665 . . . . 73.34 112.117 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.904 ' HB3' ' HD2' ' A' ' 274' ' ' LYS . 96.3 m-85 72.01 -57.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.498 0.719 . . . . 70.32 111.771 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.14 155.53 12.78 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.498 -1.041 . . . . 42.53 110.498 -173.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -83.18 -4.46 58.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.232 0.516 . . . . 73.14 111.174 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.99 4.0 84.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.945 -0.645 . . . . 62.55 113.377 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.5 pp -148.91 -177.83 6.02 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 122.199 1.0 . . . . 73.33 113.013 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.829 HG23 HD23 ' A' ' 277' ' ' LEU . 25.6 mm -90.97 129.06 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 113.858 -1.519 . . . . 74.43 109.637 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 87.5 tttt -118.18 133.23 56.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.786 0.327 . . . . 54.14 110.372 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 279' ' ' LEU . 35.7 tp -117.52 149.65 40.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.855 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 11.5 t70 -142.37 139.78 31.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.282 -0.872 . . . . 71.33 108.88 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.757 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -134.74 127.67 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.845 -0.428 . . . . 73.21 109.845 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -123.51 125.67 45.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.964 -0.754 . . . . 64.53 108.964 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.899 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 19.2 m -137.71 141.7 41.04 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.146 -0.222 . . . . 74.41 111.205 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -103.03 140.01 37.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.801 -0.444 . . . . 74.1 109.801 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 53.5 m -139.56 174.38 10.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.561 -0.533 . . . . 74.24 109.561 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -30.54 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 72.32 111.836 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -44.77 130.02 7.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.41 0.624 . . . . 61.44 111.929 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 89.19 -10.65 72.25 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.196 -0.911 . . . . 70.11 113.555 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 35' ' ' SER . 3.1 mm? -105.14 129.01 53.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.659 1.23 . . . . 64.24 111.488 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.963 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 34.2 tt0 -139.57 146.8 40.3 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.572 -0.899 . . . . 75.04 108.572 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.899 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 59.4 t80 -121.42 121.31 37.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.686 0.279 . . . . 75.34 110.776 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.882 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.0 m -126.08 132.39 51.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 64.13 110.322 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 19.4 m -132.28 143.25 49.76 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.975 -0.453 . . . . 75.22 110.799 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -143.27 125.95 15.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.029 -0.36 . . . . 75.12 110.029 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.8 152.46 20.31 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.428 -0.891 . . . . 55.2 111.914 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -128.45 133.27 48.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.19 -0.67 . . . . 61.23 109.19 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -138.1 130.94 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.922 0.391 . . . . 62.13 111.533 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.58 142.93 42.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.881 -0.6 . . . . 64.22 109.42 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 t -75.36 141.75 43.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.727 0.298 . . . . 71.32 110.956 -176.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 mp0 73.12 -74.38 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.481 0.712 . . . . 74.14 111.93 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.38 139.0 45.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.399 . . . . 64.4 111.468 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 m -74.74 80.25 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.2 0.524 . . . . 61.4 111.916 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 24.2 mmmt -126.3 93.93 3.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.362 -0.607 . . . . 75.0 109.362 172.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 62.22 110.458 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 m -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 61.44 108.876 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.96 125.08 6.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.518 -0.849 . . . . 51.11 112.763 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 m -109.31 134.02 52.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.265 -0.642 . . . . 72.12 109.265 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.11 124.68 46.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.834 -0.802 . . . . 73.51 108.834 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.882 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -107.96 117.35 33.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.536 0.684 . . . . 64.44 110.285 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 m -93.54 118.89 31.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.027 -1.101 . . . . 72.15 108.027 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 13.6 tptm -112.34 135.31 53.18 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.572 -0.451 . . . . 74.11 109.878 -173.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.849 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 81.0 m-85 -118.91 120.69 38.05 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.906 -0.776 . . . . 73.32 108.906 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.1 ttm-85 -122.91 109.27 13.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 70.22 111.533 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 69' ' ' LEU . 70.6 m95 -106.65 93.59 4.66 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.993 -1.003 . . . . 74.23 108.943 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -67.73 -38.29 83.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.058 . . . . 73.12 112.516 -170.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 tp10 -86.42 61.62 6.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.38 0.609 . . . . 64.24 111.235 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.588 ' HD1' HD23 ' A' ' 69' ' ' LEU . 47.9 t80 172.38 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.409 -1.269 . . . . 73.52 108.456 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.07 49.75 0.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.465 -0.789 . . . . 74.03 111.927 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.588 HD23 ' HD1' ' A' ' 67' ' ' TYR . 1.5 mm? -114.67 131.83 56.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.076 0.465 . . . . 75.32 111.228 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.2 m -134.43 112.73 11.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.669 -0.696 . . . . 73.21 110.28 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.849 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 16.0 t80 -109.46 125.4 52.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.942 -0.572 . . . . 73.44 109.572 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 5.0 m -121.42 117.1 26.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.742 0.305 . . . . 75.23 110.655 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.721 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.4 tt0 -101.76 119.87 39.46 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.002 -0.74 . . . . 64.45 109.002 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 15.8 ttmm -107.99 86.67 2.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.421 -0.585 . . . . 43.44 109.421 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.728 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 11.9 t90 -101.06 129.42 46.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.127 -0.488 . . . . 75.12 111.088 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -108.07 164.1 12.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.551 . . . . 73.44 109.825 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -68.89 -18.23 64.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.278 0.561 . . . . 72.42 110.51 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 25.0 t70 -74.28 -4.4 35.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 64.25 109.94 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 93.5 m-20 74.76 9.52 4.11 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.969 -1.014 . . . . 72.03 110.644 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 117.37 21.83 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 72.01 109.518 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.728 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.9 pt? -123.02 136.98 55.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 63.01 111.374 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.61 106.28 2.28 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.251 -0.886 . . . . 70.43 111.237 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 32.0 m -85.78 100.06 11.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.861 0.362 . . . . 64.55 110.664 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 35.2 mt-10 -99.11 108.04 20.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 41.42 109.722 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.4 pp -112.18 137.92 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.518 -0.473 . . . . 42.12 110.584 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.1 m -129.21 128.55 43.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.581 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.01 125.72 74.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.968 0.413 . . . . 71.44 110.316 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -90.28 127.91 36.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 73.12 109.295 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 t70 -82.92 144.05 30.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.885 -0.413 . . . . 73.4 109.885 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.63 -21.56 15.22 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.076 -0.25 . . . . 75.24 111.367 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.0 tp -71.49 -45.52 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 74.01 109.302 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.32 75.31 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.786 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 35.6 ttm180 -61.46 135.36 57.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.19 0.519 . . . . 73.0 110.25 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.9 55.76 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.606 -0.998 . . . . 74.3 110.606 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.54 112.78 25.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.491 -1.3 . . . . 64.12 107.491 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 138.75 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.128 0.49 . . . . 71.25 110.054 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.34 127.27 51.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.497 -0.927 . . . . 74.42 108.497 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 1.061 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -125.96 130.37 51.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.178 0.513 . . . . 74.42 110.064 -176.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' HB1' ' A' ' 112' ' ' ALA . 31.4 t80 -123.63 123.04 39.68 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.942 -0.762 . . . . 73.33 108.942 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.507 ' HB2' ' HD2' ' A' ' 113' ' ' LYS . 81.4 m-20 -108.54 121.25 44.59 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.372 -0.603 . . . . 72.14 109.372 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 20.2 m -111.51 120.79 43.33 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.816 -0.354 . . . . 72.25 110.152 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.5 m -101.54 120.05 39.71 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.624 -0.88 . . . . 64.33 108.624 175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.669 ' HD2' ' HB3' ' A' ' 110' ' ' LYS . 49.2 t80 -134.91 137.97 43.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.037 0.446 . . . . 72.52 110.652 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 m -127.96 102.49 21.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.853 -0.612 . . . . 75.04 109.734 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 36.5 Cg_exo -59.32 -34.25 97.79 Favored 'Trans proline' 0 N--CA 1.466 -0.09 0 C-N-CA 122.454 2.103 . . . . 73.33 111.417 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.69 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 73.55 111.175 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.3 m -76.9 -23.25 52.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.698 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.42 2.27 73.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.668 -0.777 . . . . 74.41 112.976 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.72 148.36 22.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 54.32 111.858 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.669 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 19.1 ptmt -145.88 124.98 12.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 74.2 110.612 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.57 140.27 51.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.509 -0.552 . . . . 74.22 109.509 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.446 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -119.51 130.67 55.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.056 0.455 . . . . 64.34 111.365 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.607 ' HG2' ' OD1' ' A' ' 130' ' ' ASP . 42.6 mttm -114.37 136.44 52.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.664 -0.495 . . . . 65.34 109.664 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 tp -120.6 117.93 54.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.433 0.635 . . . . 65.44 109.585 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 1.061 ' HB2' HG23 ' A' ' 98' ' ' THR . 21.4 mtpt -122.93 134.83 54.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.698 -0.683 . . . . 71.14 110.7 -170.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -112.17 127.91 56.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.276 -0.638 . . . . 74.31 109.276 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.91 126.04 4.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.105 -1.045 . . . . 62.52 112.748 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.99 133.86 47.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.099 -0.334 . . . . 65.41 110.099 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 1.022 ' HB3' HG12 ' A' ' 3' ' ' VAL . 76.5 mttt -122.01 122.72 39.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.775 0.797 . . . . 61.43 111.464 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.874 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 18.9 tpt180 -110.26 162.18 14.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.517 -1.22 . . . . 74.0 108.089 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 3' ' ' VAL . 1.2 pm0 -58.48 -27.9 64.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.54 0.609 . . . . 73.42 110.932 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -107.97 3.16 23.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.177 -0.465 . . . . 72.35 111.526 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.874 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 15.5 mm -139.15 131.54 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.765 0.654 . . . . 74.44 112.765 -169.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.417 HD21 HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -117.92 111.95 19.68 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.818 -1.179 . . . . 74.44 107.818 163.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 142' ' ' LEU . 4.8 tp -128.32 124.6 36.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.996 0.427 . . . . 73.22 111.389 -175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.72 115.39 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.944 -0.646 . . . . 74.02 111.975 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 63.2 m -114.43 116.4 28.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.82 -0.223 . . . . 71.44 110.467 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.654 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 3.3 p30 -105.76 122.74 46.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.431 0.634 . . . . 73.03 110.643 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 67.4 mtm -104.41 117.67 34.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 72.42 109.5 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.607 ' OD1' ' HG2' ' A' ' 113' ' ' LYS . 15.7 t0 -106.1 120.48 41.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.237 -0.438 . . . . 74.03 111.25 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -93.89 97.25 10.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.303 0.573 . . . . 74.53 109.708 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.25 143.88 32.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.469 -0.787 . . . . 60.52 109.242 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.94 -12.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 63.12 112.513 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.95 -9.43 37.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 33.13 110.981 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.48 120.75 1.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.92 -0.657 . . . . 75.42 112.231 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 29.2 Cg_exo -61.94 131.19 33.87 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.851 2.367 . . . . 72.43 112.37 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.4 m -126.55 129.95 49.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.942 -0.572 . . . . 33.11 110.182 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.707 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.2 mp -107.57 124.95 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.015 -0.365 . . . . 65.32 110.015 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.89 112.97 24.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.445 -0.576 . . . . 64.53 109.445 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 127' ' ' CYS . . . -111.69 131.93 10.55 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.722 -1.228 . . . . 73.14 111.757 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.88 116.8 23.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 62.54 110.26 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 125' ' ' LEU . 12.2 tp -122.57 123.64 41.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 62.42 110.344 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 7' ' ' TYR . 86.1 t -122.49 124.96 71.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.352 -0.84 . . . . 71.21 109.692 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.15 137.69 46.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 73.13 108.711 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.544 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -129.43 132.71 7.21 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.868 -1.158 . . . . 75.14 114.177 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.454 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 73.8 t80 -136.16 147.27 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.34 -0.985 . . . . 75.44 108.34 171.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -39.28 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.497 0.925 . . . . 71.34 113.497 -174.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.92 -35.19 4.92 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.205 -0.907 . . . . 43.42 113.668 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.454 ' CE2' ' HB3' ' A' ' 146' ' ' TYR . 55.9 p-90 -110.57 138.83 46.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.082 0.941 . . . . 72.23 112.014 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.544 HD23 ' HA2' ' A' ' 145' ' ' GLY . 12.9 mt -127.19 137.25 52.89 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 74.33 110.186 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.66 124.41 23.89 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.847 -0.427 . . . . 71.23 109.847 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 143' ' ' VAL . . . -141.83 151.21 22.62 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.439 -0.886 . . . . 65.2 111.937 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -145.31 133.31 21.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.252 0.549 . . . . 71.54 111.867 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.25 123.75 44.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.301 -0.863 . . . . 74.4 109.417 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 45.9 ttm -119.46 134.26 55.3 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.987 -0.375 . . . . 75.25 109.987 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -111.59 119.0 37.26 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.24 0.543 . . . . 75.3 110.373 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.707 ' HB2' ' HB ' ' A' ' 138' ' ' ILE . 69.1 m-85 -98.56 127.0 44.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.121 -0.945 . . . . 74.03 110.47 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.608 ' HB2' ' OG1' ' A' ' 165' ' ' THR . 81.7 tt0 -99.7 98.99 9.77 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 109.513 -0.551 . . . . 75.14 109.513 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.5 m -72.25 -17.56 61.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 113.949 -1.478 . . . . 70.24 111.278 171.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.03 -27.0 65.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.697 -0.853 . . . . 63.52 108.697 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.86 -153.51 0.57 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.214 -1.357 . . . . 71.04 108.095 168.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.7 p -109.79 28.0 9.01 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.93 -0.481 . . . . 74.25 112.098 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -140.87 171.54 13.93 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 118.035 -1.466 . . . . 64.35 114.433 -160.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -93.81 127.76 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.661 -1.154 . . . . 70.11 108.813 170.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.608 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 1.7 m -96.06 -36.24 11.08 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.227 -0.589 . . . . 54.34 111.196 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.13 133.19 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.065 -0.516 . . . . 74.4 110.307 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -119.42 107.0 12.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.111 -0.7 . . . . 73.22 109.111 173.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -105.95 133.1 51.22 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.655 -0.498 . . . . 73.32 109.655 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.8 m-85 -121.99 146.98 46.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.396 -0.365 . . . . 70.41 110.468 -176.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -140.1 128.96 23.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.126 0.488 . . . . 73.44 109.998 176.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.65 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 39.6 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.506 -0.553 . . . . 74.44 109.506 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -121.95 135.57 10.47 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.376 -0.916 . . . . 52.33 112.597 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.574 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 68.4 t80 -117.12 120.32 37.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.561 -1.274 . . . . 72.5 107.561 171.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -115.41 121.64 43.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.032 0.92 . . . . 73.23 112.099 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.711 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 42.6 m -136.33 163.21 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.469 -1.678 . . . . 72.24 106.469 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.491 ' HB2' ' OE2' ' A' ' 177' ' ' GLU . 6.3 m-20 -63.28 -43.38 98.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.414 1.006 . . . . 72.55 110.363 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 176' ' ' ASP . 2.2 mp0 -85.96 -21.81 27.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 74.53 111.251 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.711 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 54.3 m-85 -119.22 115.35 24.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.524 -0.307 . . . . 74.22 111.359 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 1.5 mp0 -118.7 121.46 40.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.934 -0.765 . . . . 62.4 108.934 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.845 HD12 HG13 ' A' ' 194' ' ' ILE . 2.3 tt -124.11 131.9 53.59 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.574 -0.451 . . . . 54.55 110.553 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.705 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 19.5 t-80 -129.13 114.52 16.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.181 -0.463 . . . . 64.22 110.543 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.65 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 57.3 m -95.58 137.59 34.43 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.327 -0.99 . . . . 71.34 108.327 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -132.67 138.64 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.585 -0.446 . . . . 62.4 110.477 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 74.7 t -133.05 131.39 58.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.962 -0.563 . . . . 72.31 110.625 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 8.0 t30 -117.19 96.82 5.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.682 -0.859 . . . . 70.43 108.682 174.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 9.6 t70 59.4 -162.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.169 -0.923 . . . . 61.4 109.656 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -80.26 -7.01 88.94 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 52.44 112.53 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 211' ' ' THR . 13.2 m -95.63 -26.94 15.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 mp0 -119.48 114.77 22.8 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.84 -0.538 . . . . 64.24 111.286 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.484 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 28.1 p90 -135.67 129.14 32.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.782 0.325 . . . . 75.12 110.192 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.9 175.38 36.73 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.398 -0.906 . . . . 74.41 112.462 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -147.78 141.25 9.06 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.97 -0.633 . . . . 52.13 112.061 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 8.7 t -122.29 138.28 54.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.87 -0.418 . . . . 73.2 109.87 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.845 HG13 HD12 ' A' ' 180' ' ' LEU . 4.5 mp -120.21 122.72 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.918 -0.583 . . . . 63.34 109.953 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.551 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 59.5 t80 -108.09 120.42 42.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.851 -0.796 . . . . 73.51 108.851 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -121.29 116.52 25.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.9 -0.591 . . . . 72.12 111.136 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.97 116.72 24.37 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.346 -0.983 . . . . 71.31 108.346 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 199' ' ' ASN . 21.4 t -76.32 168.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.631 -0.507 . . . . 75.32 109.631 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.49 ' N ' HG12 ' A' ' 198' ' ' VAL . 16.6 t-20 -59.84 -37.1 78.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.109 0.48 . . . . 64.52 110.234 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.99 171.19 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.216 -0.661 . . . . 72.34 109.216 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 201' ' ' LYS . 36.7 mmtm -80.11 61.8 4.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.79 0.805 . . . . 74.41 111.464 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 203' ' ' GLU . 5.6 tt -137.02 132.37 34.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.322 -1.308 . . . . 73.24 107.753 175.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.451 ' N ' HD23 ' A' ' 202' ' ' LEU . 31.2 mt-10 -119.08 145.65 45.75 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.503 -0.555 . . . . 70.31 109.503 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.7 t -133.71 152.56 51.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.603 -0.439 . . . . 73.13 110.5 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB2' ' HD2' ' A' ' 195' ' ' TYR . . . -130.19 135.21 47.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.212 0.529 . . . . 63.13 110.153 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 193' ' ' SER . 33.9 t -121.87 125.63 73.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.484 -0.78 . . . . 74.13 109.603 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.79 127.68 54.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.74 0.305 . . . . 73.24 110.926 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.6 mm? -119.13 130.48 55.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 73.15 109.725 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 218' ' ' ARG . . . -132.71 129.68 39.05 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.627 -0.508 . . . . 31.23 109.627 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -127.04 121.52 31.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.478 -0.564 . . . . 73.31 109.478 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 215' ' ' SER . 5.4 t -106.24 117.87 35.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.616 0.722 . . . . 61.01 109.578 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.484 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.33 150.33 39.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.989 -1.005 . . . . 63.02 111.932 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 118.39 24.11 3.28 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.635 -0.711 . . . . 74.14 111.831 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.9 29.59 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.341 0.591 . . . . 60.41 110.471 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.663 ' HB2' HG23 ' A' ' 211' ' ' THR . 9.9 m -83.46 -170.34 3.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.48 -0.782 . . . . 75.44 110.537 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.61 149.62 38.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.376 -0.374 . . . . 70.21 110.6 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 38.7 m -95.91 123.0 39.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.681 -0.859 . . . . 64.11 108.681 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 43.7 ttt180 -101.2 117.62 35.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.392 -0.367 . . . . 74.43 110.808 -171.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.671 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 40.7 p90 -114.87 154.1 29.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.067 -0.515 . . . . 71.04 110.194 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.0 140.31 7.67 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.194 -0.762 . . . . 74.41 111.194 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.86 128.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.711 -0.477 . . . . 73.14 109.711 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 236' ' ' LYS . . . -122.23 133.05 54.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.363 0.414 . . . . 72.24 110.555 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.0 124.91 53.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.787 -0.449 . . . . 52.12 109.787 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.115 -0.493 . . . . 75.52 109.922 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -128.03 133.07 49.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.113 0.482 . . . . 74.22 110.537 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.71 97.68 9.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.697 -0.683 . . . . 63.2 109.266 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.8 tt -71.78 -23.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.043 0.925 . . . . 75.44 108.529 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.72 137.91 13.45 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.199 -1.364 . . . . 72.34 107.525 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.18 -15.91 11.73 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 122.902 2.401 . . . . 72.41 113.814 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.39 -22.3 19.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.813 0.339 . . . . 74.11 111.256 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.51 128.76 36.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.152 0.501 . . . . 52.05 111.83 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.3 m -104.85 119.71 39.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 63.43 110.429 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -100.55 133.51 44.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 72.43 110.651 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 38.8 t -131.16 117.81 19.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 75.51 111.515 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.93 40.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.914 -0.772 . . . . 70.24 108.914 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 222' ' ' ALA . 9.8 pttm -152.66 159.52 43.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 74.31 112.231 -171.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 5.0 p -143.5 154.25 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 60.33 109.438 176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 20.0 t-20 -130.75 153.82 48.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.683 -0.235 . . . . 71.43 110.87 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.671 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 32.5 t30 -38.05 -41.83 0.6 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.972 1.309 . . . . 73.4 113.661 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.4 t -78.17 24.37 0.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 73.2 111.051 -173.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.9 m 65.32 36.47 6.92 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 64.12 109.725 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.98 ' HB3' HD11 ' A' ' 262' ' ' LEU . 25.4 mt -93.6 115.39 27.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 51.13 110.098 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.5 mp -100.29 116.55 43.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.928 -0.767 . . . . 73.53 108.928 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -128.18 140.28 11.68 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.059 -1.067 . . . . 73.21 113.571 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.536 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -122.13 148.34 45.03 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.386 -0.598 . . . . 61.13 109.386 172.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -162.92 122.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.573 -0.822 . . . . 42.25 112.241 -177.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -118.47 133.07 56.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.274 0.559 . . . . 75.44 110.758 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.1 m -110.9 120.04 41.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.068 -0.969 . . . . 72.52 109.896 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -114.24 130.28 56.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.861 0.363 . . . . 65.21 110.136 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.5 p -104.79 107.7 18.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.819 -0.628 . . . . 74.2 109.909 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.63 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 4.1 mm? -71.18 173.87 7.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.854 0.359 . . . . 43.04 110.909 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -47.87 57.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.046 -0.524 . . . . 75.4 110.65 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 13.5 Cg_exo -70.96 -177.62 2.36 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.619 1.546 . . . . 72.24 110.68 169.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -76.84 50.3 2.95 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.556 -0.831 . . . . 45.22 112.791 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.63 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 48.5 mt -108.75 121.42 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.408 -0.466 . . . . 75.11 110.338 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 280' ' ' GLU . 68.7 tttt -110.53 119.2 38.39 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.247 -0.433 . . . . 55.31 109.895 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 15.3 tp -101.66 126.78 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.437 -0.801 . . . . 74.13 109.983 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.451 ' O ' HD12 ' A' ' 277' ' ' LEU . 19.5 m -132.05 109.77 10.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.867 0.365 . . . . 74.1 110.376 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.648 ' CD2' HD13 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -112.77 125.14 54.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.768 -0.826 . . . . 65.35 108.768 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.408 ' N ' HD13 ' A' ' 259' ' ' LEU . 51.4 m -138.99 148.81 43.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.782 0.325 . . . . 63.14 110.532 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.4 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -145.06 128.69 17.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.69 -0.485 . . . . 41.25 109.69 176.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.98 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -111.44 118.31 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.205 -0.665 . . . . 73.02 109.205 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.694 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -98.05 107.43 19.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.797 -1.186 . . . . 71.02 107.797 174.394 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.749 ' OD1' ' HG2' ' A' ' 266' ' ' LYS . 19.0 t0 -71.53 104.41 3.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.53 -0.915 . . . . 64.23 108.53 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.39 -27.1 39.52 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 115.709 -0.678 . . . . 64.31 114.159 -171.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.749 ' HG2' ' OD1' ' A' ' 264' ' ' ASP . 23.7 pttm -91.98 -13.55 30.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.078 0.439 . . . . 64.31 111.123 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.702 ' OD1' ' HA3' ' A' ' 272' ' ' GLY . 10.9 t-20 -116.22 -26.81 7.07 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.001 0.371 . . . . 71.45 112.001 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.694 HG11 ' HB3' ' A' ' 263' ' ' LEU . 24.1 m -62.07 -17.86 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 O-C-N 122.166 -0.334 . . . . 34.33 110.917 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -59.29 -29.37 67.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.773 -0.649 . . . . 75.21 109.999 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -100.04 -16.98 17.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 64.45 110.637 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.19 13.82 6.83 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.933 -0.651 . . . . 23.44 113.064 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.702 ' HA3' ' OD1' ' A' ' 267' ' ' ASN . . . -85.83 79.52 1.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.663 -0.78 . . . . 73.43 113.125 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.422 ' HB2' HD12 ' A' ' 263' ' ' LEU . 8.2 p80 -114.22 142.09 46.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.52 -0.548 . . . . 75.34 109.52 175.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.904 ' HD2' ' HB3' ' A' ' 22' ' ' TYR . 80.2 mttt -110.61 143.1 41.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.399 -0.52 . . . . 71.45 111.49 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.5 tm? -115.5 137.97 51.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.884 . . . . 64.11 108.866 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.496 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -134.51 104.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.507 -0.854 . . . . 73.12 111.521 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.829 HD23 HG23 ' A' ' 27' ' ' ILE . 40.1 tp -114.12 145.46 41.6 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.33 -0.548 . . . . 73.14 110.677 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.669 ' H ' HD12 ' A' ' 277' ' ' LEU . . . -150.33 124.1 1.68 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.197 -0.911 . . . . 53.41 111.479 178.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.404 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.2 mm? -118.33 131.89 56.3 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.748 -0.834 . . . . 73.31 108.748 174.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.652 ' CG ' ' HB3' ' A' ' 256' ' ' LYS . 8.7 pt-20 -125.22 115.18 20.0 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.861 -0.736 . . . . 61.45 110.369 171.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.757 ' HB3' HD22 ' A' ' 31' ' ' LEU . 57.3 t80 -99.83 106.19 18.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.948 -1.024 . . . . 74.45 109.812 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -102.56 111.95 24.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.893 -0.594 . . . . 52.33 110.043 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -111.94 126.2 54.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.958 -0.564 . . . . 72.24 110.459 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.44 0.34 16.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.367 0.603 . . . . 73.24 110.243 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.585 -0.734 . . . . 71.24 109.731 179.398 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG3' ' HB2' ' A' ' 93' ' ' ARG . 26.3 ttt . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.573 0.225 . . . . 44.2 110.451 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.83 104.77 16.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.743 -0.466 . . . . 71.4 109.743 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 120' ' ' ARG . 9.1 p -163.33 137.06 4.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.409 -0.589 . . . . 73.33 109.409 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.4 Cg_exo -63.56 131.92 33.49 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.888 2.392 . . . . 63.42 113.397 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 6.5 Cg_exo -73.57 99.84 1.18 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.917 2.411 . . . . 63.23 111.565 175.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.543 ' HB ' HD11 ' A' ' 150' ' ' LEU . 5.2 p -94.82 -2.75 50.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.351 -0.386 . . . . 73.42 111.865 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.694 ' HB3' HG21 ' A' ' 143' ' ' VAL . 6.1 p90 -62.25 -21.32 65.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.66 0.743 . . . . 74.42 109.973 170.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.25 54.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.135 -0.939 . . . . 72.22 110.143 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 51.4 m-20 -91.58 -1.9 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 71.21 109.943 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.111 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -76.39 -34.04 58.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.173 -0.921 . . . . 73.12 111.67 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.23 -36.07 0.51 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.08 -1.057 . . . . 74.51 113.892 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.77 -41.73 78.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.967 0.383 . . . . 62.14 111.981 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 m -58.15 -46.38 85.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.034 0.445 . . . . 74.43 111.244 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -35.03 72.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.934 -0.575 . . . . 54.25 111.4 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -58.55 -35.91 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 72.33 112.79 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.37 -49.87 75.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.978 0.418 . . . . 72.33 111.387 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HB ' ' HB2' ' A' ' 207' ' ' ASN . 2.8 t -85.21 -31.5 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 73.24 111.149 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -66.91 -38.24 85.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.189 -0.459 . . . . 75.23 112.001 -174.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -57.24 150.85 16.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 74.43 111.191 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -116.59 -13.52 10.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.213 0.53 . . . . 62.4 110.224 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.77 51.76 4.48 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.607 -0.724 . . . . 63.42 111.755 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.6 -36.94 74.82 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.408 0.623 . . . . 74.15 109.582 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.05 101.58 0.44 Allowed Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.014 -0.994 . . . . 52.44 111.05 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -81.28 -3.81 53.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 75.11 110.14 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.89 7.33 78.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.815 -0.629 . . . . 71.21 112.643 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mp -123.34 168.36 12.6 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.966 0.889 . . . . 61.44 112.435 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.804 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.9 mp -108.27 124.14 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.047 -1.433 . . . . 64.11 108.925 174.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -105.61 136.31 45.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.963 0.411 . . . . 74.32 111.03 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.76 129.04 56.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.21 -1.033 . . . . 74.41 108.21 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.56 133.93 48.5 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.807 -0.812 . . . . 55.0 108.807 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.63 HD13 ' HD2' ' A' ' 281' ' ' PHE . 16.9 tp -138.41 126.02 22.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.21 111.78 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -114.86 127.25 55.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.55 109.6 172.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 41' ' ' PHE . 7.6 t -137.21 150.96 48.23 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.535 -0.466 . . . . 63.54 110.386 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HE2' HD11 ' A' ' 284' ' ' LEU . 18.3 ttmm -133.08 148.71 52.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.376 -0.374 . . . . 73.22 110.016 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -140.13 136.62 33.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.769 -0.196 . . . . 54.44 110.509 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 39.84 -97.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.294 1.038 . . . . 65.13 113.254 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -154.76 141.24 18.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.854 -0.795 . . . . 72.32 108.854 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 88.51 -9.08 77.12 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.586 -0.34 . . . . 52.22 112.71 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.21 128.03 48.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.658 0.729 . . . . 74.22 111.803 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.959 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 3.5 tp10 -141.03 118.9 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.911 -1.144 . . . . 75.3 107.911 165.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.773 ' HB3' HG22 ' A' ' 33' ' ' THR . 59.3 t80 -116.96 124.86 50.41 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.25 -0.906 . . . . 74.0 111.107 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.7 m -126.84 117.73 23.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 65.15 110.911 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -116.25 127.23 54.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.607 -0.27 . . . . 75.31 110.297 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -125.9 126.06 43.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 61.33 109.933 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.45 138.17 8.01 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.224 -0.989 . . . . 74.1 111.858 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -121.01 133.18 55.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.889 -0.411 . . . . 70.44 109.889 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 135.31 45.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.133 0.492 . . . . 73.13 111.161 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.834 ' HB3' ' HB3' ' A' ' 53' ' ' LYS . 39.1 t30 -77.27 147.19 36.43 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.347 -0.842 . . . . 74.1 109.41 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -44.93 -37.66 4.12 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.987 0.423 . . . . 75.42 111.02 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.93 123.58 27.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.212 -0.662 . . . . 73.24 109.212 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -68.72 -5.3 19.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.241 0.544 . . . . 71.14 111.826 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -83.59 5.33 24.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.117 0.484 . . . . 73.41 110.85 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.834 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 31.2 tptt -137.64 84.38 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 63.22 110.346 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.81 132.56 70.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.696 0.284 . . . . 73.43 110.785 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -125.16 142.69 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.22 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.19 155.72 22.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.102 -1.047 . . . . 52.24 113.206 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 m -146.31 127.33 14.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.343 -0.614 . . . . 42.14 109.343 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 74' ' ' LYS . 2.0 tm? -121.46 127.14 50.79 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.164 -0.31 . . . . 74.35 110.164 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 45.5 mt-10 -116.7 118.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.752 -0.658 . . . . 60.45 110.14 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.6 m -100.42 118.73 37.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.24 -1.022 . . . . 64.41 108.24 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.959 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 66.0 mttm -113.68 133.51 55.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.21 0.529 . . . . 71.54 110.543 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.75 ' HD2' ' HB2' ' A' ' 71' ' ' PHE . 38.4 m-85 -101.13 119.65 39.06 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.794 -1.187 . . . . 53.11 107.794 172.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 9.9 ttm180 -115.57 106.0 13.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.606 0.717 . . . . 75.34 109.971 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -113.7 104.14 11.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.516 -1.22 . . . . 75.54 109.335 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.7 p 60.57 126.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.692 1.245 . . . . 52.32 112.326 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.4 pm0 -60.72 130.31 45.86 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.11 -0.7 . . . . 74.21 109.11 174.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 62.12 75.67 0.4 Allowed 'General case' 0 C--N 1.332 -0.183 0 O-C-N 123.825 0.703 . . . . 71.01 109.598 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.95 -101.63 0.15 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.31 -0.859 . . . . 44.4 111.777 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.498 ' CD1' ' HB ' ' A' ' 87' ' ' VAL . 4.0 mm? -121.34 131.96 54.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.137 0.494 . . . . 54.43 112.325 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.608 HG23 ' HB ' ' A' ' 86' ' ' THR . 4.1 t -137.3 119.01 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 74.0 110.033 171.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.75 ' HB2' ' HD2' ' A' ' 62' ' ' TYR . 34.5 m-85 -114.81 121.58 43.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.671 -0.241 . . . . 72.34 110.435 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 83' ' ' THR . 57.6 m -109.96 115.56 30.01 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.997 -0.281 . . . . 55.4 110.585 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.91 143.69 47.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.681 -0.408 . . . . 75.45 111.619 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HG3' HD12 ' A' ' 58' ' ' LEU . 20.5 mmtt 159.41 -119.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.65 1.219 . . . . 72.04 111.479 162.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.783 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 15.5 t90 -135.18 140.31 45.25 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.588 -0.445 . . . . 75.44 112.081 -164.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -110.18 164.14 12.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 73.44 110.836 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 t -69.9 -7.37 39.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 51.44 111.328 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 14.1 m-20 -80.0 -2.27 43.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.856 -0.611 . . . . 40.41 110.39 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 78' ' ' ASP . 28.5 t-20 81.71 -8.53 1.32 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.96 0.788 . . . . 72.32 109.936 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.4 m -85.25 140.15 31.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.344 -0.844 . . . . 71.42 110.398 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.783 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -92.52 126.56 37.66 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.337 -0.616 . . . . 74.22 109.337 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.35 13.67 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.172 -1.013 . . . . 64.53 113.044 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.1 t -136.16 104.41 5.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.743 0.782 . . . . 71.53 110.736 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 43.9 tt0 -106.78 115.66 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.194 -0.912 . . . . 74.43 109.448 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -111.77 137.98 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 44.21 110.62 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.672 HG23 ' HB ' ' A' ' 98' ' ' THR . 16.9 m -129.17 129.92 45.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.899 0.38 . . . . 70.0 111.246 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.498 ' HB ' ' CD1' ' A' ' 69' ' ' LEU . 2.8 p -129.24 124.89 61.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.724 -0.671 . . . . 74.04 110.23 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -113.53 122.68 48.0 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.405 -0.591 . . . . 71.22 109.405 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.37 151.84 19.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.191 0.519 . . . . 52.13 111.85 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -102.21 -24.1 13.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.731 -0.668 . . . . 73.23 110.661 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.46 -56.88 8.83 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.449 -1.315 . . . . 73.35 107.449 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.45 61.2 6.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.27 -1.011 . . . . 53.23 108.27 167.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.417 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 14.5 ptp180 -53.03 124.4 14.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.061 -0.972 . . . . 74.24 112.612 -171.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 100.98 -16.45 57.31 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.083 -0.962 . . . . 65.01 112.093 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' A' ' 118' ' ' TYR . 3.1 tm? -92.5 123.82 36.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.606 -0.516 . . . . 64.21 109.606 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.76 51.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.74 -0.664 . . . . 72.01 109.668 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -116.24 125.71 52.59 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.114 -0.699 . . . . 73.32 109.114 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 86' ' ' THR . 0.5 OUTLIER -130.49 119.91 23.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.195 0.521 . . . . 61.32 110.279 176.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.453 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 91.9 t80 -123.91 125.43 44.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.535 -0.757 . . . . 75.13 110.372 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 4.5 t70 -109.72 131.99 54.55 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.024 -0.534 . . . . 74.14 109.714 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.8 t -126.0 120.86 31.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.38 -0.6 . . . . 62.12 109.38 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.0 m -109.99 122.14 46.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.959 -0.564 . . . . 73.15 110.048 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.87 119.85 39.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.006 0.431 . . . . 74.21 110.714 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.477 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 8.2 t -99.77 139.77 21.06 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 108.506 -0.924 . . . . 71.24 108.506 176.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 31.3 Cg_exo -62.12 41.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 124.127 3.218 . . . . 71.32 114.832 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -123.86 150.02 45.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 60.12 108.822 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.0 m -66.55 105.19 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.099 0.475 . . . . 63.22 111.292 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.42 68.56 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.994 -0.622 . . . . 61.23 112.869 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -94.97 111.64 23.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.072 0.463 . . . . 64.24 109.945 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.47 143.57 26.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.869 -0.605 . . . . 74.33 110.618 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.37 122.47 40.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.049 -0.523 . . . . 75.03 109.705 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -129.13 141.8 51.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.976 -0.289 . . . . 74.43 111.389 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -124.68 137.38 54.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.947 -0.761 . . . . 62.25 108.947 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 5.0 tp -124.75 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.188 0.518 . . . . 74.13 110.218 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -116.45 120.96 40.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.837 -0.62 . . . . 74.23 110.467 -178.118 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -107.19 116.89 32.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.599 -0.728 . . . . 74.43 109.083 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.556 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -133.74 125.71 4.04 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.694 -1.241 . . . . 72.34 113.145 -172.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.719 ' HB3' HD23 ' A' ' 95' ' ' LEU . 6.3 p90 -117.01 136.64 52.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.192 0.52 . . . . 74.2 110.032 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 43.6 pttt -119.74 124.66 46.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.866 0.841 . . . . 74.13 111.58 -175.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.514 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.3 mmt180 -100.32 166.37 11.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.256 -1.338 . . . . 74.21 109.06 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.11 -27.25 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.762 0.825 . . . . 75.44 112.813 -172.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -118.36 -12.1 9.93 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.699 0.629 . . . . 74.11 112.699 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 144' ' ' LEU . 19.5 pt -142.76 145.72 22.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.612 -0.835 . . . . 71.2 111.815 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.636 HD22 ' N ' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -129.02 115.82 18.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.759 -0.46 . . . . 64.23 109.759 178.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.534 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -130.52 143.07 50.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.331 -0.547 . . . . 70.32 111.634 -175.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.556 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -141.57 138.75 8.91 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 61.01 112.621 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 67.9 m -108.66 112.38 24.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.013 -0.365 . . . . 71.33 110.013 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 9.6 t70 -104.47 148.17 26.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.046 -0.525 . . . . 55.44 110.088 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.1 mtm -131.38 118.31 20.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.312 -0.625 . . . . 62.32 109.312 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 10.5 t70 -89.78 115.74 27.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.945 -0.761 . . . . 75.41 108.945 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -97.12 99.71 11.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.956 -0.565 . . . . 75.21 110.962 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.55 145.69 37.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.983 -1.117 . . . . 74.25 107.983 169.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.862 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -64.68 -21.67 29.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.613 0.244 . . . . 72.15 111.536 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.53 -18.83 34.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.542 0.21 . . . . 64.43 111.101 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.5 105.66 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.868 -0.682 . . . . 74.1 112.799 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 3.1 Cg_exo -76.2 109.45 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.092 2.528 . . . . 61.52 111.366 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -99.09 160.55 14.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.522 -0.308 . . . . 55.14 110.946 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mp -107.38 118.38 55.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.672 -0.411 . . . . 63.42 110.036 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 33.8 ttp180 -115.2 111.15 20.54 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.076 0.465 . . . . 54.04 110.102 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.95 144.29 17.3 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.955 -1.117 . . . . 54.22 112.382 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -137.6 114.71 10.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.127 0.489 . . . . 73.3 110.184 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' A' ' 125' ' ' LEU . 4.2 tp -117.68 123.16 45.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.968 -0.56 . . . . 61.02 109.701 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.694 HG21 ' HB3' ' A' ' 7' ' ' TYR . 5.2 t -119.24 121.51 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.494 . . . . 75.05 110.293 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 123' ' ' ILE . 5.0 mp -108.08 138.64 44.0 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.425 -0.583 . . . . 60.22 109.425 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.45 119.31 4.24 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.607 -0.724 . . . . 61.12 111.358 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.661 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 56.4 t80 -118.16 148.97 41.82 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.299 -1.0 . . . . 63.44 108.299 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -52.79 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.344 0.592 . . . . 74.44 110.973 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.04 -32.74 7.21 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.144 -0.935 . . . . 73.24 112.493 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 90.9 m95 -106.52 146.39 30.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.285 0.846 . . . . 74.4 113.285 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.543 HD11 ' HB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -128.91 142.62 50.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.775 -1.194 . . . . 73.22 107.775 168.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -155.65 123.87 5.83 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.443 -0.577 . . . . 61.45 109.443 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.111 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -142.16 142.14 11.5 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.945 -1.121 . . . . 71.35 111.872 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 36.1 m-85 -123.47 117.17 24.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.032 -0.359 . . . . 75.32 110.032 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.28 122.58 43.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.525 -0.546 . . . . 63.21 109.525 166.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.752 ' HB2' HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -137.2 143.69 42.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.682 0.277 . . . . 72.12 110.485 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 t30 -118.62 118.88 32.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 65.02 110.471 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.943 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 93.1 m-85 -91.85 121.25 33.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.109 -0.951 . . . . 75.12 110.192 -175.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.37 109.89 14.14 Favored 'General case' 0 C--O 1.254 1.325 0 CA-C-N 114.449 -1.251 . . . . 75.1 109.172 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -71.72 -21.51 61.76 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 125.354 1.659 . . . . 73.21 111.775 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.31 -31.8 71.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.392 -0.966 . . . . 55.5 108.392 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -107.92 -161.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.979 -1.464 . . . . 70.41 107.984 168.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.9 m -111.04 26.76 10.37 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 121.89 -0.506 . . . . 52.41 110.476 171.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -149.31 150.31 32.3 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.99 1.108 . . . . 72.4 113.99 -159.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.943 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 p -73.16 128.91 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.537 -0.756 . . . . 72.44 110.231 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 3.9 p -102.49 -33.9 9.34 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.638 -0.71 . . . . 55.2 111.526 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -112.67 129.21 56.48 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.626 -0.43 . . . . 54.2 110.175 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.3 m -124.34 115.33 20.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.033 -0.531 . . . . 72.53 110.665 173.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 7.8 t30 -125.97 120.25 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.96 -0.756 . . . . 64.14 108.96 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -138.34 165.21 27.33 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.741 -0.784 . . . . 70.35 111.921 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.19 133.31 35.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.326 -0.852 . . . . 54.53 110.767 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.51 127.09 64.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.007 -0.738 . . . . 62.01 109.007 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.58 166.79 26.07 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 119.735 -1.221 . . . . 45.54 112.831 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.62 ' CE1' HD22 ' A' ' 180' ' ' LEU . 37.4 p90 -138.55 140.4 39.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.168 0.509 . . . . 73.3 110.649 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -103.4 132.62 49.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.132 -0.94 . . . . 74.22 109.935 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 m -131.37 163.2 28.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.782 -0.821 . . . . 74.34 108.782 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -51.75 -50.29 60.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.7 0.285 . . . . 53.35 111.541 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.722 ' HA ' ' HE3' ' A' ' 197' ' ' LYS . 27.0 mm-40 -101.41 -22.51 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.184 0.438 . . . . 72.43 112.184 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 194' ' ' ILE . 72.7 t80 -124.29 144.89 49.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.666 0.27 . . . . 75.03 111.681 -170.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 5.1 tp-100 -135.61 122.4 21.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.947 -0.39 . . . . 75.15 109.947 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.676 HD12 HG13 ' A' ' 194' ' ' ILE . 3.8 tt -125.88 138.15 53.78 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.261 -0.575 . . . . 70.4 111.786 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.643 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 12.4 m170 -128.31 114.17 16.56 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.889 -0.782 . . . . 53.21 108.889 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 95.0 m -90.86 141.42 28.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.856 -0.424 . . . . 72.31 109.856 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -129.83 141.22 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.992 0.425 . . . . 73.21 110.737 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 5.4 t -130.95 128.36 62.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.296 -0.411 . . . . 64.2 111.042 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 37.0 t-20 -109.14 90.85 3.42 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.645 -0.872 . . . . 65.4 108.645 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 60.65 -169.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 71.45 111.718 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.83 -5.59 86.65 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.42 -0.809 . . . . 45.5 111.981 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 24.2 m -94.32 -27.1 16.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.64 0.607 . . . . 74.21 112.64 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 51.5 mt-10 -135.02 129.6 34.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.931 -0.708 . . . . 74.34 112.223 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.445 ' HD2' HG22 ' A' ' 184' ' ' VAL . 44.3 m-85 -127.23 143.84 51.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.619 -0.718 . . . . 72.11 109.713 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . 179.74 -138.24 3.36 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.778 -0.725 . . . . 74.54 112.101 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 182' ' ' THR . . . 152.6 -155.61 26.23 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.168 -1.015 . . . . 71.45 113.037 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.1 p -142.09 138.55 31.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.291 0.567 . . . . 64.21 110.817 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.817 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.1 mp -119.8 118.76 58.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.645 -0.707 . . . . 72.15 109.612 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.438 ' HB3' ' HB3' ' A' ' 179' ' ' GLN . 44.8 t80 -108.71 119.69 40.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.108 0.48 . . . . 65.53 110.025 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.57 131.54 52.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.743 -0.662 . . . . 75.15 109.776 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.722 ' HE3' ' HA ' ' A' ' 177' ' ' GLU . 18.1 pttp -107.55 127.36 53.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 64.2 110.943 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 202' ' ' LEU . 47.6 t -82.99 155.74 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 45.45 109.446 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -61.77 -45.04 95.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.893 0.378 . . . . 61.32 110.083 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.66 148.35 48.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.722 -1.214 . . . . 72.32 107.722 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -63.41 86.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.562 0.696 . . . . 74.51 112.457 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 225' ' ' TYR . 36.2 mt -144.24 115.16 7.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.57 -1.195 . . . . 60.43 108.551 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.46 128.94 52.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.776 -0.824 . . . . 42.43 108.776 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -123.46 138.33 54.61 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.702 -0.399 . . . . 43.44 111.212 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.39 135.5 48.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.024 -0.535 . . . . 75.43 110.177 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 221' ' ' ILE . 87.9 t -114.58 136.22 51.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.663 -0.699 . . . . 74.41 109.612 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.774 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 8.7 t30 -114.71 132.34 56.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.802 0.334 . . . . 72.15 110.402 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.486 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -122.58 136.49 54.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.651 -0.704 . . . . 74.5 110.443 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.97 127.13 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.005 -0.543 . . . . 65.24 109.63 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.686 ' HB2' HG23 ' A' ' 217' ' ' THR . 28.4 t90 -130.72 126.11 35.62 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.529 -0.305 . . . . 64.42 110.472 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.585 HG23 ' HB2' ' A' ' 215' ' ' SER . 3.5 t -101.29 116.39 32.68 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 73.42 109.823 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.48 141.26 56.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.335 -0.848 . . . . 63.24 111.158 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 128.36 31.49 0.67 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.864 -0.684 . . . . 71.25 111.655 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 67.36 12.16 8.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.875 0.47 . . . . 63.1 111.826 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 211' ' ' THR . 17.8 m -80.45 160.84 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 70.21 109.777 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -77.66 153.37 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.379 . . . . 74.24 111.122 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 210' ' ' TRP . 26.4 m -84.54 131.23 34.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.555 . . . . 74.31 109.744 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -88.54 116.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.947 -0.76 . . . . 75.12 108.947 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 54.5 p90 -123.44 141.34 52.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -144.83 141.53 10.07 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.226 -0.75 . . . . 74.22 111.226 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.89 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -119.53 130.54 73.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.879 0.371 . . . . 72.25 110.426 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -129.82 129.48 44.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.605 -0.725 . . . . 72.15 109.954 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.672 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -117.97 129.15 55.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.288 -0.415 . . . . 63.33 110.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -115.66 115.83 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.021 -0.733 . . . . 71.23 109.021 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 233' ' ' PHE . 3.9 p90 -132.78 119.25 20.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.248 0.547 . . . . 64.44 111.77 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 35.4 tt0 -89.54 97.94 11.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 71.31 109.075 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -97.15 -24.62 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 73.32 109.668 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 4.6 t70 -114.63 137.22 22.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.653 -0.869 . . . . 72.15 108.653 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -34.97 -51.89 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.381 3.388 . . . . 65.13 115.214 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -107.23 4.78 27.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.902 0.334 . . . . 75.32 111.902 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -124.73 122.58 37.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.453 0.644 . . . . 50.24 111.958 -175.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 50.7 t -113.18 119.09 36.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 75.2 108.84 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.517 ' HB2' ' CE2' ' A' ' 225' ' ' TYR . 57.6 m-85 -100.2 132.13 45.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.434 -0.348 . . . . 51.44 110.272 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 21.1 t -121.75 140.91 51.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.046 0.45 . . . . 32.1 110.349 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -127.16 140.8 52.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.095 -0.705 . . . . 74.33 109.095 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -135.6 141.4 45.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.693 -0.484 . . . . 55.23 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.588 HG12 HG12 ' A' ' 221' ' ' ILE . 5.4 p -140.6 140.13 34.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.488 -0.485 . . . . 70.31 110.028 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.589 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -107.27 150.36 26.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.573 -0.74 . . . . 44.42 110.381 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 241' ' ' SER . 28.3 p-10 -43.9 -33.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.95 1.406 . . . . 74.51 114.064 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.497 ' HB3' HD13 ' A' ' 242' ' ' LEU . 17.9 t -82.08 21.95 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 61.54 110.024 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.531 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 50.1 m 68.5 36.33 2.95 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 115.232 -0.894 . . . . 64.02 111.265 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.817 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.2 mp -95.68 125.45 40.28 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.309 -0.556 . . . . 74.43 111.316 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -112.52 116.57 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.659 -0.701 . . . . 73.43 110.022 -170.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -126.35 145.76 15.9 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.55 -0.833 . . . . 43.33 112.654 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -118.39 148.91 42.05 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.062 0.458 . . . . 52.34 110.247 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.94 121.79 2.42 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.604 -0.726 . . . . 52.3 111.544 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -108.13 118.84 37.8 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.963 -0.384 . . . . 72.54 109.963 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.644 HG22 HG22 ' A' ' 258' ' ' THR . 14.1 p -113.6 112.86 24.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 72.33 109.895 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 257' ' ' LEU . 22.4 mp0 -118.97 124.83 47.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.937 -0.574 . . . . 72.35 110.168 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 26.0 m -95.91 88.53 4.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.92 -0.77 . . . . 75.52 108.92 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 44.8 tp -82.04 78.25 8.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.733 . . . . 74.43 109.511 -175.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 0.5 OUTLIER 68.1 152.71 0.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.058 -0.974 . . . . 73.44 109.901 -172.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.17 74.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.481 2.12 . . . . 62.51 112.059 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.64 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.34 -0.845 . . . . 72.51 111.441 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.2 122.0 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 54.12 110.695 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 30.8 tttp -117.87 122.01 42.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.532 -0.544 . . . . 64.44 109.532 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 249' ' ' GLN . 52.3 tp -100.26 131.22 46.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.309 -0.405 . . . . 73.22 110.009 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.644 HG22 HG22 ' A' ' 248' ' ' THR . 18.5 p -128.91 110.87 12.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.326 0.584 . . . . 64.4 110.558 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.877 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -108.9 125.54 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.453 -0.943 . . . . 71.32 108.453 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.2 m -135.38 138.86 43.73 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.61 -0.436 . . . . 64.01 110.359 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.448 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -148.05 128.07 13.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.111 -0.495 . . . . 72.11 109.766 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.785 HD11 HD23 ' A' ' 242' ' ' LEU . 2.4 tm? -111.44 115.22 28.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.474 -0.936 . . . . 75.01 108.474 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.607 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -92.24 108.49 19.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.54 -1.282 . . . . 72.44 107.54 174.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.817 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -69.79 105.06 2.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.888 -0.782 . . . . 71.31 108.888 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -59.84 -15.72 35.91 Favored Glycine 0 C--N 1.32 -0.31 0 C-N-CA 121.222 -0.513 . . . . 72.33 112.638 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -90.16 -25.83 20.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.747 0.308 . . . . 70.21 110.767 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 19.5 m120 -115.81 -27.96 6.86 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.362 0.875 . . . . 75.24 113.362 -170.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.607 HG11 ' HB3' ' A' ' 263' ' ' LEU . 27.8 m -62.62 -19.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 117.965 0.348 . . . . 73.3 111.522 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.72 -40.73 84.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.996 -0.547 . . . . 74.53 110.574 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.94 -16.38 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 72.22 110.96 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.15 79.39 0.87 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.913 -0.66 . . . . 71.44 112.238 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.568 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -159.27 87.34 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.865 -0.683 . . . . 61.12 112.235 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.08 147.07 39.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.373 -0.232 . . . . 72.2 110.373 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.5 mmtm -96.19 137.9 34.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.592 -0.522 . . . . 65.32 109.592 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -130.03 126.74 38.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.002 0.429 . . . . 72.22 110.245 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.41 117.74 2.21 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.892 -0.671 . . . . 71.23 111.473 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.877 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -115.12 135.85 53.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.181 -0.674 . . . . 72.52 109.181 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.35 137.91 6.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.107 -1.044 . . . . 74.43 112.984 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.78 131.38 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.6 -0.889 . . . . 54.24 108.6 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 26.5 tt0 -114.95 111.31 20.97 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.59 -0.893 . . . . 72.1 108.59 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.63 ' HD2' HD13 ' A' ' 31' ' ' LEU . 26.3 t80 -112.83 145.86 39.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.799 -0.637 . . . . 73.53 109.805 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -138.04 142.89 40.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.86 0.362 . . . . 71.23 110.295 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.526 ' O ' HD22 ' A' ' 284' ' ' LEU . . . -122.83 107.29 11.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.463 -0.569 . . . . 73.23 109.463 172.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 283' ' ' ALA . 1.7 mm? -138.62 -0.57 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.229 -0.896 . . . . 53.42 109.676 -176.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.942 -1.026 . . . . 74.24 109.759 -172.566 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 tpp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.011 0.434 . . . . 74.24 110.36 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.84 178.49 4.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 65.12 109.973 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 14.9 p -100.52 131.96 23.07 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.965 -0.383 . . . . 71.23 109.965 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.75 143.51 99.62 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 40.12 111.836 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.93 89.66 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.582 2.188 . . . . 51.24 112.14 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.3 p -70.78 -30.91 67.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.684 -0.689 . . . . 52.22 110.724 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.785 ' HB3' HG21 ' A' ' 143' ' ' VAL . 30.5 p90 -61.05 -26.37 67.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.567 . . . . 64.15 110.892 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.4 -19.46 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.107 -0.497 . . . . 64.14 110.751 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.916 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 14.5 t70 -93.99 -13.77 26.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.383 . . . . 74.21 110.318 -177.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.624 HD11 HG22 ' A' ' 143' ' ' VAL . 86.8 mt -57.62 -36.09 71.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.22 0.533 . . . . 73.21 110.001 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.9 30.68 4.32 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.298 -0.864 . . . . 54.01 111.523 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.916 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 5.0 tppp? -61.84 -57.89 10.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.458 . . . . 73.34 110.191 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -67.02 -39.11 86.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.542 -0.754 . . . . 73.33 110.258 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.76 93.47 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.071 -0.968 . . . . 42.33 112.633 -171.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -60.68 -39.93 90.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.665 0.211 . . . . 75.34 111.405 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 38.5 t70 -68.16 -36.65 79.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 65.41 111.036 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 207' ' ' ASN . 26.9 t -84.03 -46.62 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.202 0.445 . . . . 52.55 112.202 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -72.38 -43.47 63.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.814 0.34 . . . . 71.15 110.906 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.6 p -111.97 71.94 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.141 0.972 . . . . 72.55 108.48 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 18.8 pttm -85.86 173.11 10.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.925 -1.489 . . . . 74.25 112.563 -166.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.58 97.11 0.2 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.517 -1.033 . . . . 53.41 110.517 170.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' HE2' ' HG ' ' A' ' 262' ' ' LEU . 56.2 t80 -115.81 146.03 42.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.827 0.346 . . . . 74.32 110.305 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -72.23 90.12 0.52 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.763 -0.732 . . . . 43.52 111.918 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -80.68 -3.81 52.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.153 0.501 . . . . 64.34 110.308 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.93 58.19 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.627 -0.797 . . . . 73.5 113.57 174.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 pp -140.66 171.79 13.62 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.553 1.168 . . . . 74.23 113.862 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.921 HG23 HD12 ' A' ' 277' ' ' LEU . 33.3 mm -105.75 122.07 58.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 113.121 -1.854 . . . . 71.41 108.945 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.675 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 11.2 pttp -126.65 154.31 44.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.186 0.517 . . . . 71.44 110.644 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -148.03 149.86 32.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.753 -0.832 . . . . 63.45 108.753 169.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' SER . 3.4 p-10 -139.49 131.02 27.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.786 0.803 . . . . 65.44 111.419 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.6 OUTLIER -94.16 124.85 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.577 -1.192 . . . . 71.23 108.487 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HG3' ' HA ' ' A' ' 282' ' ' GLN . 0.2 OUTLIER -126.4 124.48 40.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 73.31 110.554 178.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 283' ' ' ALA . 88.3 m -137.07 120.96 17.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.535 -0.757 . . . . 71.21 109.121 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -136.78 126.12 24.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.107 0.48 . . . . 73.33 110.366 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.0 m -137.07 138.51 40.47 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.923 -0.769 . . . . 72.2 108.923 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.3 mt-10 -77.76 61.68 2.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.959 0.885 . . . . 64.54 110.194 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -137.61 18.92 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.149 -1.387 . . . . 75.13 108.341 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.8 -8.55 79.64 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.21 -0.904 . . . . 63.12 113.943 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.4 126.02 48.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.777 1.288 . . . . 64.42 111.986 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.97 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 19.8 tt0 -142.68 126.48 17.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.381 -0.6 . . . . 75.01 109.381 166.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.5 127.82 38.08 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.031 -0.418 . . . . 75.01 111.56 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.8 m -127.38 116.78 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 54.22 110.344 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.4 t -118.01 122.88 44.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.59 -0.522 . . . . 64.34 109.59 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 m -120.72 126.76 50.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.669 0.271 . . . . 74.21 110.912 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.98 134.94 8.09 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.719 -0.753 . . . . 72.43 111.96 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -121.57 135.37 55.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.73 -0.47 . . . . 53.22 109.73 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.98 129.32 29.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.278 0.561 . . . . 72.03 111.614 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.799 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 33.5 m-80 -93.7 124.27 37.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.368 -0.833 . . . . 54.31 109.399 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 p -82.5 19.36 1.28 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.263 0.468 . . . . 75.41 112.263 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.05 -42.17 76.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.172 0.511 . . . . 73.21 109.799 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 52' ' ' THR . 1.6 t -160.15 -73.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 60.31 109.647 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.746 ' H ' HG23 ' A' ' 51' ' ' THR . 37.8 m -156.41 86.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.737 -0.468 . . . . 62.25 109.737 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.799 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 46.7 tptt -128.9 91.71 3.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.65 -0.5 . . . . 74.24 109.65 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.3 121.09 63.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.204 -0.453 . . . . 53.25 111.178 -174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 p -110.36 140.31 44.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.77 -0.65 . . . . 74.14 109.984 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.39 19.46 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.316 -0.945 . . . . 75.24 112.753 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -141.88 133.06 26.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.864 -0.791 . . . . 64.21 108.864 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.79 124.53 44.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.757 -0.461 . . . . 74.34 109.757 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -113.72 118.37 34.13 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.102 -0.499 . . . . 70.42 109.659 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -110.77 122.82 48.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.913 -0.773 . . . . 74.33 108.913 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.97 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 72.1 mttt -129.4 134.78 48.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.298 0.57 . . . . 72.12 111.337 -172.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 49.4 t80 -106.81 119.51 39.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.485 -0.931 . . . . 71.42 108.485 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.495 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 63.6 ttm-85 -118.55 110.18 17.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.356 0.598 . . . . 75.02 111.654 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.632 ' HD1' ' HE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.58 125.17 35.54 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 114.948 -1.024 . . . . 74.33 109.811 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -81.0 -178.71 7.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 125.047 1.467 . . . . 72.13 111.915 -172.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 65' ' ' THR . 49.4 mt-10 71.99 -50.27 0.69 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.662 0.785 . . . . 73.41 110.937 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -95.06 -139.94 0.24 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.682 -1.229 . . . . 72.15 107.682 169.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.8 67.8 0.42 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.115 -0.794 . . . . 61.31 111.115 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -100.42 129.53 46.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.806 -0.757 . . . . 64.21 110.609 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.5 m -138.31 111.99 8.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.404 -0.362 . . . . 65.21 110.886 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -104.49 119.17 38.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.43 -0.952 . . . . 70.1 108.43 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 61' ' ' LYS . 11.9 p -128.53 138.08 52.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.953 0.406 . . . . 53.14 111.87 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 43.1 mt-10 -117.54 120.63 38.65 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.809 -0.811 . . . . 72.13 108.809 166.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 7.0 pttp -110.83 105.4 14.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.355 0.598 . . . . 55.43 109.948 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -98.51 133.18 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.142 -0.936 . . . . 75.01 111.161 -174.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -110.47 143.55 40.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.937 -0.764 . . . . 70.52 108.937 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.8 t -56.4 -18.43 11.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.028 0.531 . . . . 71.12 112.149 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 24.7 t70 -67.21 -6.64 18.98 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.797 0.332 . . . . 72.35 110.738 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 51.7 m-80 79.79 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.155 0.982 . . . . 71.31 110.058 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -114.84 117.79 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.377 -0.829 . . . . 73.33 110.301 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.79 119.59 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.101 -0.333 . . . . 72.41 110.101 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -107.24 88.1 0.52 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.609 -0.805 . . . . 64.42 111.775 175.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.585 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 35.8 m -84.32 101.17 11.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.208 0.527 . . . . 75.22 110.275 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 3.7 tm-20 -114.75 128.25 56.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.604 -0.726 . . . . 75.51 109.683 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.98 121.74 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.297 0.57 . . . . 74.0 110.571 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.7 m -107.32 129.02 54.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 72.14 109.93 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.16 119.55 49.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.265 0.555 . . . . 73.54 110.842 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.57 118.98 36.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.629 -1.249 . . . . 71.14 107.629 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.71 169.34 11.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.681 0.753 . . . . 61.2 112.341 -166.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -111.91 -2.03 15.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.998 -1.001 . . . . 71.22 110.229 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 89' ' ' ASP . 53.2 tp -85.08 -55.43 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 74.12 110.026 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -118.81 79.63 1.42 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.978 -0.749 . . . . 75.33 108.978 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -47.39 129.08 12.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.475 -0.784 . . . . 74.31 112.435 -171.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.45 -4.25 47.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.205 -0.907 . . . . 70.52 111.973 -173.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -88.02 114.76 24.95 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.825 -0.435 . . . . 65.22 109.825 175.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.07 121.03 36.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 72.24 110.119 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.5 mm? -109.46 127.66 54.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.457 -0.792 . . . . 52.5 109.245 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.911 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.2 t -129.13 128.92 44.44 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 73.32 109.984 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.752 ' HD2' HG12 ' A' ' 114' ' ' ILE . 80.4 t80 -121.38 125.84 47.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.842 -0.617 . . . . 73.45 110.242 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 2.1 m-20 -108.23 121.72 45.46 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.765 -0.458 . . . . 65.12 109.765 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.585 ' OG ' ' HB ' ' A' ' 83' ' ' THR . 8.5 p -115.67 120.18 38.53 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.533 -0.543 . . . . 71.53 109.533 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.3 m -101.34 121.43 41.89 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.858 -0.61 . . . . 65.34 109.528 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -128.46 119.76 25.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.075 -0.512 . . . . 75.44 109.737 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -113.71 103.44 55.33 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.252 -0.431 . . . . 74.3 111.085 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.63 -14.31 34.97 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.209 2.606 . . . . 74.33 112.938 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 104' ' ' SER . 24.9 p30 -72.07 -21.0 61.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 72.12 110.924 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 p -126.54 -37.54 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.992 -0.549 . . . . 72.15 111.016 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.24 50.02 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.021 -0.609 . . . . 71.03 112.471 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -87.59 145.82 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 75.45 110.811 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.31 125.52 46.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.142 -0.688 . . . . 64.32 109.142 171.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -118.84 126.22 51.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.72 -0.474 . . . . 73.3 109.72 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.31 124.49 49.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.907 -0.588 . . . . 62.21 111.367 -173.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 54.8 mttp -111.55 136.24 51.01 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.101 -1.074 . . . . 73.21 108.101 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 129' ' ' MET . 0.4 OUTLIER -125.28 130.95 72.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.325 -0.62 . . . . 62.44 109.325 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.911 ' HB2' HG23 ' A' ' 98' ' ' THR . 3.1 mptp? -123.42 120.73 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.605 -0.517 . . . . 75.21 109.605 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.412 HG23 ' HB2' ' A' ' 127' ' ' CYS . 4.5 t -114.21 116.31 28.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.628 -0.879 . . . . 72.45 108.628 173.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -130.08 121.66 3.44 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 119.541 -1.314 . . . . 32.41 112.574 -174.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.416 ' HB3' HD22 ' A' ' 95' ' ' LEU . 25.0 p90 -111.96 117.6 33.15 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.971 -0.751 . . . . 72.33 108.971 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -109.93 122.19 46.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.694 -0.684 . . . . 74.54 109.284 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -106.65 157.01 18.02 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.401 -0.592 . . . . 74.11 109.401 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.651 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 7.7 pt-20 -51.68 -27.03 10.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.634 0.774 . . . . 73.43 112.784 -172.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.435 ' ND1' ' HG3' ' A' ' 121' ' ' GLU . 74.3 m80 -106.22 -24.09 12.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.212 0.449 . . . . 72.13 112.212 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.73 HD11 HD11 ' A' ' 142' ' ' LEU . 17.7 tt -147.25 141.61 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 120.324 -0.55 . . . . 64.11 111.992 -173.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.66 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 6.1 m-20 -110.59 117.78 34.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.735 0.302 . . . . 65.22 111.717 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 142' ' ' LEU . 4.3 mm? -111.7 137.49 49.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.821 0.343 . . . . 55.52 111.104 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -146.25 131.03 3.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.88 -0.676 . . . . 52.32 112.692 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.412 ' HB2' HG23 ' A' ' 116' ' ' THR . 58.1 m -113.35 119.7 38.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.966 0.412 . . . . 51.01 110.851 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.846 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -105.29 136.39 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.898 -0.592 . . . . 62.21 110.289 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.769 ' HB2' HG22 ' A' ' 114' ' ' ILE . 64.9 mtt -133.86 121.49 21.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.954 -0.388 . . . . 65.52 109.954 174.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.41 120.13 41.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.038 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -93.35 105.73 17.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.277 0.56 . . . . 72.45 111.069 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.53 172.87 7.65 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.767 -0.827 . . . . 64.44 108.767 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 133' ' ' ILE . 3.5 mp -67.07 -33.12 61.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.309 -0.626 . . . . 70.23 109.309 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.47 -15.29 59.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.545 -0.752 . . . . 75.42 110.951 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.55 178.9 17.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.4 -0.905 . . . . 45.31 112.692 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -87.93 128.81 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.91 2.406 . . . . 75.43 112.812 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 t -99.36 140.75 33.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 62.4 108.757 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.82 118.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.551 -0.459 . . . . 73.3 111.071 -171.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.846 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 40.9 mtp180 -110.12 125.46 53.02 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.885 -0.783 . . . . 65.3 108.885 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.58 10.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 119.709 -1.234 . . . . 65.4 111.444 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.54 116.02 19.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.13 0.491 . . . . 63.42 110.926 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.73 HD11 HD11 ' A' ' 123' ' ' ILE . 6.6 tp -121.81 124.64 44.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 75.01 110.642 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' A' ' 7' ' ' TYR . 86.1 t -112.37 129.56 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.302 -0.863 . . . . 73.43 109.87 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.896 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.4 mm? -108.28 138.61 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.53 -0.759 . . . . 62.15 109.896 -170.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.22 118.53 5.59 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.561 -0.745 . . . . 42.3 112.058 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.834 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 86.5 m-85 -127.87 148.4 50.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 75.3 109.723 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.71 98.42 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.481 -0.327 . . . . 72.54 111.054 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.13 -21.51 20.05 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 116.29 -0.414 . . . . 62.24 112.756 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 24.8 m95 -105.54 131.82 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 75.2 111.209 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.4 mt -112.12 136.51 51.4 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.385 -0.598 . . . . 55.22 109.385 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -131.77 153.25 50.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.285 -0.416 . . . . 41.11 110.038 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -158.46 133.99 3.66 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.937 -0.865 . . . . 44.34 110.937 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -142.43 121.82 13.17 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.712 -0.795 . . . . 71.15 110.184 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.728 ' HG2' ' HB3' ' A' ' 168' ' ' ASN . 1.3 pm0 -117.72 120.19 37.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.956 0.884 . . . . 71.13 110.102 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.451 ' C ' HD22 ' A' ' 156' ' ' ASN . 15.1 ptt? -117.72 133.46 55.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.153 -0.93 . . . . 74.31 109.304 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -110.54 116.53 31.52 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.781 -0.822 . . . . 74.53 108.781 -173.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 45.4 m-85 -94.36 118.38 31.52 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 123.577 0.548 . . . . 64.51 110.105 -176.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.981 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.3 tp10 -91.21 102.17 14.9 Favored 'General case' 0 C--O 1.262 1.752 0 CA-C-N 115.831 -0.622 . . . . 71.53 109.596 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 m -70.52 -25.2 63.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 112.893 -1.958 . . . . 71.32 110.93 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.87 71.84 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.01 -0.737 . . . . 43.13 109.01 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.666 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 69.6 mmtt -104.72 -163.41 0.96 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.844 -1.169 . . . . 73.1 107.844 170.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.3 t -108.35 26.37 10.54 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 121.838 -0.539 . . . . 74.13 110.294 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -166.3 172.2 11.33 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 118.89 -1.124 . . . . 73.52 111.542 -166.03 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.11 135.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 64.44 110.168 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.981 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.4 t -94.41 -21.48 18.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.946 -0.57 . . . . 71.41 110.815 -174.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 165' ' ' THR . 46.2 mt-30 -143.58 134.66 25.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.854 0.359 . . . . 70.2 110.314 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -117.74 106.75 13.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.211 -0.45 . . . . 75.35 109.984 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.728 ' HB3' ' HG2' ' A' ' 154' ' ' GLN . 2.7 t-20 -115.94 122.58 45.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.69 -0.485 . . . . 74.22 109.69 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 90.1 m-85 -122.05 156.74 32.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.53 -0.305 . . . . 74.2 110.518 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -152.0 129.0 11.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.041 0.448 . . . . 34.23 110.888 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.89 125.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.637 -0.875 . . . . 70.11 108.637 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -142.11 109.16 0.56 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.934 -1.126 . . . . 74.23 112.507 -176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.722 ' CZ ' HD21 ' A' ' 180' ' ' LEU . 11.4 p90 -114.16 133.34 55.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.036 -0.728 . . . . 61.24 109.036 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -132.55 130.86 40.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.963 -1.017 . . . . 74.13 113.066 -162.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 m -121.01 155.51 34.17 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.111 -1.44 . . . . 71.42 107.111 166.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -49.75 -46.45 50.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 75.11 112.417 -170.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.45 -22.98 20.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.665 0.617 . . . . 72.05 112.665 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.73 119.72 15.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.325 0.583 . . . . 74.41 111.895 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -135.28 143.01 46.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.739 -0.664 . . . . 62.42 109.984 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.948 ' HB3' HG13 ' A' ' 194' ' ' ILE 0.256 0.0 OUTLIER -127.45 139.0 53.1 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.382 1.087 . . . . 73.2 111.503 159.274 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 45.3 m-70 -124.05 115.59 21.42 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.707 -2.042 . . . . 73.25 107.228 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 23.8 m -111.93 134.79 53.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.479 -0.328 . . . . 72.35 110.489 -173.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -118.75 140.21 50.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.34 -0.615 . . . . 72.02 109.34 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 25.5 t -121.56 118.61 56.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.239 -0.437 . . . . 41.22 110.959 -176.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 80.5 m-20 -97.68 91.09 5.23 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.079 -0.964 . . . . 72.11 108.96 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 58.42 -168.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.754 -1.112 . . . . 73.51 110.214 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.83 86.9 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.275 -0.964 . . . . 71.33 111.216 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 211' ' ' THR . 3.5 m -89.38 -26.75 20.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.566 0.58 . . . . 65.41 112.566 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 40.4 tt0 -139.14 117.61 12.08 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 119.779 -0.768 . . . . 63.35 112.255 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -109.18 126.21 53.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 73.32 109.374 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -129.23 109.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.844 -0.693 . . . . 55.44 112.503 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' A' ' 182' ' ' THR . . . -105.63 131.77 10.8 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.735 -0.745 . . . . 52.23 111.725 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 20.6 t -119.06 137.8 53.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.895 -0.409 . . . . 73.34 109.895 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 1.049 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.5 mp -118.91 132.56 68.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.445 . . . . 75.31 109.894 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.76 119.9 40.18 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.352 -0.981 . . . . 74.14 108.352 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 204' ' ' THR . 0.3 OUTLIER -122.39 112.43 18.07 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.184 -0.673 . . . . 70.51 109.184 -176.201 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -98.19 113.37 25.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.848 -0.615 . . . . 64.22 109.688 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 200' ' ' LYS . 47.9 t -80.63 150.16 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 54.11 109.129 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -61.13 -22.21 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 54.12 111.368 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 4.4 mptp? -91.27 -165.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.567 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.99 46.16 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.839 0.352 . . . . 74.53 110.665 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.572 ' HG ' ' HD1' ' A' ' 225' ' ' TYR . 3.7 tt -132.51 119.81 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.109 0.48 . . . . 52.15 110.248 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 49.0 mt-10 -111.53 138.41 48.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.113 -0.699 . . . . 54.04 109.113 171.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 196' ' ' GLN . 35.1 m -122.13 139.73 53.39 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.464 -0.569 . . . . 73.54 109.464 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 17' ' ' VAL . . . -129.74 136.95 50.25 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.942 0.401 . . . . 63.42 110.16 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 1.049 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 10.3 t -115.32 137.06 50.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.323 -176.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.519 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 27.1 t-20 -120.77 127.41 51.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.034 0.445 . . . . 65.45 110.965 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.5 mm? -122.78 129.75 52.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.363 -0.835 . . . . 63.21 109.57 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -132.75 126.22 31.95 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.618 -0.433 . . . . 72.01 109.865 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -131.68 124.22 29.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.03 0.443 . . . . 74.22 110.69 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.896 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 1.1 p -104.46 103.58 13.3 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.676 -0.693 . . . . 70.0 110.523 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.34 127.8 33.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.846 -0.615 . . . . 64.54 110.553 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.2 27.11 73.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.066 -0.587 . . . . 71.25 112.178 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.896 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 10.7 t-20 -138.77 -147.36 0.23 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.533 -0.914 . . . . 72.32 108.533 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 51.5 m -77.58 178.72 7.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.176 0.512 . . . . 72.01 112.329 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.65 154.74 24.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.178 -0.919 . . . . 73.03 111.786 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.2 t -78.4 139.82 38.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 71.1 110.406 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.41 135.16 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.188 -0.46 . . . . 72.11 109.981 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -130.74 135.57 47.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.137 -0.483 . . . . 71.03 109.77 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.22 171.66 32.8 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.845 -0.693 . . . . 75.11 111.716 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -138.37 147.56 25.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.958 0.409 . . . . 53.41 111.333 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -128.93 130.42 46.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.485 -0.779 . . . . 70.24 109.933 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -115.76 128.53 55.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.63 0.252 . . . . 72.22 111.128 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 2.4 ttmp? -109.04 116.06 31.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 75.34 109.377 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.572 ' HD1' ' HG ' ' A' ' 202' ' ' LEU . 10.8 t80 -119.0 131.96 56.03 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.957 0.408 . . . . 63.25 110.389 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -96.73 99.62 11.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 62.35 110.132 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.85 HD13 ' H ' ' A' ' 227' ' ' ILE . 0.2 OUTLIER -94.38 -28.87 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.267 -0.424 . . . . 72.13 111.133 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.6 141.13 19.72 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.642 -0.503 . . . . 62.53 109.642 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.3 -30.62 20.37 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.158 2.572 . . . . 74.22 113.524 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.06 -9.46 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.111 0.412 . . . . 71.31 112.111 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.63 136.63 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.978 0.362 . . . . 63.14 111.978 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -131.26 142.42 50.14 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.32 -0.4 . . . . 53.31 110.538 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.11 134.15 52.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 70.23 111.052 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 46.5 p -130.97 118.36 20.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.993 -0.549 . . . . 42.34 110.622 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -109.12 141.5 41.23 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.743 -0.466 . . . . 73.34 109.743 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -142.34 140.92 32.28 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.868 -0.333 . . . . 75.21 110.787 -177.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.55 146.53 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.513 -0.312 . . . . 72.42 110.284 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -115.92 150.05 37.74 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.65 -0.704 . . . . 71.33 109.664 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 241' ' ' SER . 27.2 p-10 -53.82 -18.55 3.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.952 0.783 . . . . 73.33 112.83 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.463 ' HB3' ' HG ' ' A' ' 242' ' ' LEU . 34.4 t -78.85 21.37 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.713 0.292 . . . . 72.35 110.54 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 239' ' ' ASN . 46.1 t 64.31 32.24 12.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.198 0.523 . . . . 65.43 109.746 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 262' ' ' LEU . 58.5 mt -99.07 114.71 27.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.436 -0.506 . . . . 71.12 109.981 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.774 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -109.68 117.96 55.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.929 0.395 . . . . 73.0 110.57 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -116.92 139.71 15.33 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.935 -0.65 . . . . 35.15 113.126 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.16 127.81 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.819 -0.808 . . . . 71.44 108.819 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -139.85 132.36 5.54 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.942 -1.123 . . . . 70.2 112.641 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -129.17 133.61 47.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.087 0.47 . . . . 73.5 110.16 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 13.5 t -123.21 136.15 54.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.013 -0.539 . . . . 73.45 109.776 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -142.69 149.12 38.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.295 -0.411 . . . . 70.23 110.665 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 13.8 m -98.89 121.71 41.19 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.466 ' CB ' HG23 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.38 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.286 0.366 . . . . 72.51 110.817 -173.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.747 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 63.3 mttm -150.37 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.58 -0.282 . . . . 73.12 111.558 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 3.0 Cg_exo -75.0 -76.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.91 1.74 . . . . 71.53 112.767 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -152.63 28.72 0.85 Allowed Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.85 -0.691 . . . . 71.32 112.038 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.504 HD12 ' CE2' ' A' ' 281' ' ' PHE . 1.0 OUTLIER -106.99 122.42 61.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.104 0.478 . . . . 63.21 110.485 -178.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -104.04 130.73 51.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.682 -0.69 . . . . 71.13 109.839 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.4 tp -98.39 124.37 43.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.213 -0.662 . . . . 64.43 109.213 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.8 m -116.11 110.33 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.933 -0.576 . . . . 73.44 109.907 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.845 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -114.23 124.82 52.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.919 -0.771 . . . . 75.45 108.919 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 62.8 m -138.65 139.95 38.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.812 0.339 . . . . 64.14 110.282 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.07 127.83 20.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.801 -0.444 . . . . 73.44 109.801 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.1 tm? -107.61 121.8 45.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.43 -0.952 . . . . 73.5 108.43 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.774 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.1 mm? -98.78 106.16 18.4 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.847 -1.168 . . . . 61.25 107.847 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.568 ' HA ' HD22 ' A' ' 242' ' ' LEU . 4.8 m-20 -72.54 106.26 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.614 -0.884 . . . . 75.13 108.614 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.52 -22.56 24.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.991 -0.623 . . . . 61.24 113.121 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -90.88 -3.38 57.39 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.996 0.427 . . . . 74.34 111.193 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 47.4 t-20 -123.79 -44.67 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.816 0.341 . . . . 60.04 110.969 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.626 HG11 ' HB3' ' A' ' 263' ' ' LEU . 26.5 m -61.24 -18.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.259 0.466 . . . . 71.33 112.259 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.02 -38.98 88.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.795 0.331 . . . . 72.43 110.443 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.49 29.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.539 . . . . 61.43 110.915 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.02 100.83 2.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.715 -0.755 . . . . 64.41 112.071 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.59 77.17 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.775 -0.726 . . . . 65.11 112.082 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -87.39 144.23 26.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 74.33 109.819 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 65.2 mttm -97.38 137.02 37.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.522 . . . . 74.11 109.887 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.8 tm? -125.77 131.7 52.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.805 -0.634 . . . . 71.31 110.044 -173.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.435 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -125.2 113.07 1.84 Allowed Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.505 -1.038 . . . . 72.04 110.505 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.921 HD12 HG23 ' A' ' 27' ' ' ILE . 3.4 tm? -114.38 134.87 54.67 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 72.44 109.668 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.675 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -148.58 125.89 2.16 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.095 -1.05 . . . . 41.1 113.172 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 2.5 mm? -102.29 131.92 48.58 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.166 -0.679 . . . . 74.22 109.166 171.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.426 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 51.9 mt-10 -115.57 110.87 19.85 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.571 -0.529 . . . . 63.52 109.571 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.755 ' HB2' HD22 ' A' ' 31' ' ' LEU . 89.4 m-85 -101.26 100.98 11.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.933 -0.576 . . . . 72.31 110.483 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.538 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 52.9 tt0 -92.07 111.96 23.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.264 -0.643 . . . . 63.03 109.264 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 33' ' ' THR . . . -107.77 111.25 23.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.095 0.474 . . . . 73.05 110.985 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.12 133.75 55.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.709 -0.678 . . . . 73.42 109.322 173.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.43 -0.795 . . . . 72.13 110.7 -174.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.878 -0.786 . . . . 73.14 108.878 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.815 HG22 ' HA ' ' A' ' 121' ' ' GLU . 2.2 t -107.59 109.0 62.32 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 74.44 110.898 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 5.3 Cg_exo -77.4 164.77 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.251 2.634 . . . . 74.44 111.633 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.59 70.09 2.05 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.839 2.359 . . . . 74.32 111.825 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.738 ' HB ' HD21 ' A' ' 150' ' ' LEU . 20.6 p -70.13 -42.29 72.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 61.1 111.056 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.602 ' HB3' HG21 ' A' ' 143' ' ' VAL . 29.6 p90 -54.92 -30.58 58.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 71.12 111.538 174.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.83 46.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.524 . . . . 75.01 110.61 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.94 -9.63 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 71.43 109.834 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 150' ' ' LEU . 81.3 mt -70.69 -34.51 72.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.781 -0.645 . . . . 75.11 110.983 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . -129.05 0.03 6.03 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.593 -1.289 . . . . 72.21 114.83 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.572 ' HG3' ' N ' ' A' ' 13' ' ' SER . 4.8 pttm -62.43 -46.22 89.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.781 1.29 . . . . 74.51 110.505 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.572 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 5.0 p -66.54 -49.46 66.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.345 0.593 . . . . 71.33 111.168 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.72 69.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.308 -0.86 . . . . 71.23 112.438 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -59.86 -38.9 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.883 0.327 . . . . 71.23 111.883 -171.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.95 -47.44 71.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.873 0.368 . . . . 73.45 110.959 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 222' ' ' ALA . 25.1 m -82.74 -27.53 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.435 0.532 . . . . 72.31 112.435 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.15 -31.31 65.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.627 0.251 . . . . 74.0 111.462 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.9 m -59.78 135.44 57.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.389 -0.369 . . . . 73.45 110.704 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.51 -53.98 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 63.34 111.249 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.88 46.86 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.759 -0.734 . . . . 52.41 111.617 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.45 93.47 6.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.617 0.722 . . . . 55.33 111.031 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.01 124.83 7.73 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.789 -0.719 . . . . 73.32 111.84 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -84.25 10.96 9.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.6 0.238 . . . . 71.25 111.596 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.92 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 92.7 13.85 56.15 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.363 -0.923 . . . . 72.23 111.608 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 46' ' ' SER . 1.5 pp -101.94 179.42 4.33 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.572 0.701 . . . . 72.1 112.747 -171.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 277' ' ' LEU . 35.1 mm -102.06 130.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.785 -1.098 . . . . 64.14 110.407 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.601 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 1.0 OUTLIER -103.81 134.63 46.79 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.455 -0.943 . . . . 75.33 108.455 176.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.538 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 16.5 tp -121.56 147.83 45.29 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.677 -0.409 . . . . 71.43 110.853 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.812 ' HB3' ' HG2' ' A' ' 280' ' ' GLU . 12.3 t70 -153.72 127.9 9.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.294 -0.866 . . . . 73.31 108.919 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.734 HD13 ' HB3' ' A' ' 281' ' ' PHE . 8.9 tp -137.46 125.02 22.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.346 -0.612 . . . . 72.11 109.346 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 23.3 ttmt -133.12 124.69 28.01 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.46 . . . . 73.41 110.683 -175.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.717 HG22 ' HB3' ' A' ' 283' ' ' ALA . 80.6 p -120.64 123.61 43.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.631 . . . . 72.32 109.705 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HB2' HD13 ' A' ' 284' ' ' LEU . 91.0 mttt -112.17 139.46 47.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.273 0.559 . . . . 61.41 112.14 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 43.1 t -139.17 137.18 35.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.835 -1.172 . . . . 75.4 107.835 168.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -82.12 34.97 0.42 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.616 0.722 . . . . 71.2 109.902 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.7 OUTLIER -120.5 18.71 12.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.477 -0.783 . . . . 71.32 111.424 -177.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 97.76 -3.4 60.81 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.194 -1.162 . . . . 61.52 110.194 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 3.4 tm? -99.65 127.22 45.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.762 -0.375 . . . . 73.31 111.717 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.758 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 22.0 tt0 -141.6 129.22 21.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.969 -0.752 . . . . 75.2 108.969 163.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.456 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 74.5 t80 -124.78 127.05 46.61 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.267 -0.896 . . . . 65.13 110.872 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.903 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.5 m -128.58 131.53 48.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.092 0.473 . . . . 74.22 111.682 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 17.1 m -120.3 123.02 42.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.854 . . . . 75.02 108.693 171.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.3 p -139.65 157.65 45.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.378 -0.529 . . . . 65.34 111.093 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 158.83 -175.22 35.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.539 -1.315 . . . . 52.23 113.567 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 26' ' ' LEU . 12.1 p -137.03 138.5 40.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.617 -0.292 . . . . 74.32 110.249 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HB1' HG22 ' A' ' 54' ' ' VAL . . . -135.27 129.12 33.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.781 0.324 . . . . 71.24 110.709 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -90.67 113.72 25.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 50.5 109.153 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -84.84 7.33 21.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.181 0.808 . . . . 70.21 113.181 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -74.13 -46.26 43.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.71 -0.396 . . . . 70.14 110.405 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -126.36 -81.33 0.61 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.749 -0.463 . . . . 71.22 109.749 171.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -172.69 84.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.949 0.88 . . . . 65.12 110.296 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 16.6 tppt? -126.25 86.53 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 73.24 109.449 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG22 ' HB1' ' A' ' 47' ' ' ALA . 25.9 t -109.22 120.04 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.017 -0.538 . . . . 63.32 110.821 -175.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -137.67 124.6 21.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.893 -0.594 . . . . 62.1 109.56 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 45' ' ' GLY . . . -155.57 -155.43 7.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.539 -0.838 . . . . 72.35 111.958 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.447 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 33.4 t -148.03 150.99 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.185 0.517 . . . . 72.31 110.177 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -119.96 125.06 47.48 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.65 -0.87 . . . . 65.14 108.65 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.903 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 3.4 mp0 -109.04 118.87 37.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.454 -0.793 . . . . 71.24 110.93 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -99.55 117.72 34.56 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.794 -1.558 . . . . 74.04 106.794 164.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.758 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 74.3 tttt -127.37 150.28 49.68 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.363 0.602 . . . . 74.45 110.311 -171.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.86 ' HB2' ' HB2' ' A' ' 71' ' ' PHE . 99.6 m-85 -126.72 121.42 31.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.879 -0.601 . . . . 74.11 110.155 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.3 ptm85 -121.27 106.1 11.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.789 0.804 . . . . 54.23 111.376 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 t90 -117.02 104.64 11.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.869 -1.06 . . . . 75.21 109.583 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 m 73.55 132.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.615 0.572 . . . . 64.05 110.508 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.9 mp0 -50.95 -59.98 3.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.858 -0.61 . . . . 71.03 110.911 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.03 67.37 0.7 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.702 -0.681 . . . . 71.41 109.383 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 -85.58 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.608 -0.806 . . . . 35.1 112.847 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.98 130.53 52.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 74.44 111.807 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.8 m -137.72 112.36 8.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 72.25 110.561 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 8.9 m-85 -102.73 122.4 44.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.609 -0.515 . . . . 61.31 109.609 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 m -119.93 117.29 27.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.64 -0.424 . . . . 73.31 111.76 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.6 123.65 45.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 75.21 109.099 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 59' ' ' GLU . 10.3 ptmm? -142.86 140.18 31.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.288 -0.565 . . . . 62.13 110.969 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.412 ' CD1' ' HG ' ' A' ' 81' ' ' LEU . 31.5 t90 -129.85 130.08 44.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.092 -0.504 . . . . 73.12 110.132 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.447 ' ND2' ' HB2' ' A' ' 57' ' ' SER . 15.8 m120 -93.46 150.92 20.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 63.13 110.756 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -63.82 -20.43 65.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 73.02 109.553 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.77 -4.13 29.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.092 -0.958 . . . . 75.0 110.344 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.7 t30 82.31 4.64 1.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.015 0.926 . . . . 63.53 111.113 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 103' ' ' PHE . 18.9 p -80.76 143.86 32.57 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 116.129 -0.487 . . . . 65.42 109.803 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 103' ' ' PHE . 3.3 mp -122.88 113.59 19.34 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.761 -1.176 . . . . 75.22 113.872 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.62 131.12 10.08 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 119.771 -1.204 . . . . 73.41 113.686 -170.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.902 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 91.0 m -136.25 140.17 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.641 0.258 . . . . 34.34 110.745 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.87 108.83 3.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.503 HG13 ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -116.59 120.65 65.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.005 0.431 . . . . 35.12 109.987 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.6 m -110.53 135.8 50.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.996 -0.547 . . . . 70.13 111.772 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.2 125.33 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.178 -0.919 . . . . 74.11 109.738 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.53 130.03 35.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.546 -0.539 . . . . 75.15 109.546 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.55 133.16 36.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.785 -0.45 . . . . 75.32 109.785 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -91.53 -21.69 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.33 -0.396 . . . . 62.04 111.47 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.97 -51.08 11.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.964 -0.754 . . . . 70.21 108.964 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.06 7.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 42.32 109.823 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.778 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -62.49 124.63 21.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 71.25 110.514 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . 100.12 1.62 55.91 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.705 -0.76 . . . . 74.15 112.322 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.712 HD23 ' HD1' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -98.86 124.35 43.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 64.43 109.871 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.23 123.19 40.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 63.31 110.53 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.475 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.7 mm? -112.97 125.61 54.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.619 -0.512 . . . . 73.1 109.619 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.921 HG23 ' HB3' ' A' ' 115' ' ' LYS . 1.1 t -132.52 136.24 46.51 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.232 0.539 . . . . 64.21 110.637 173.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -104.78 120.67 41.94 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.88 -0.785 . . . . 74.1 108.88 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.51 151.9 26.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.561 -0.745 . . . . 72.3 110.976 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.902 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 22.3 m -128.11 131.92 49.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.5 -0.773 . . . . 74.41 109.251 172.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -91.64 141.94 28.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.392 -0.822 . . . . 63.34 108.859 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.69 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 2.3 p90 -95.51 98.01 10.21 Favored 'General case' 0 C--O 1.188 -2.171 0 N-CA-C 114.824 1.416 . . . . 74.11 114.824 -161.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.502 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 60.7 p -76.89 124.15 87.5 Favored Pre-proline 0 N--CA 1.465 0.31 0 O-C-N 121.091 -1.006 . . . . 55.25 112.974 -164.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 33.9 Cg_exo -61.72 -54.97 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.205 2.603 . . . . 72.35 113.16 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -106.14 -30.78 9.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 53.13 111.28 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -62.64 -48.72 78.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.369 . . . . 35.21 111.686 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.24 -14.95 59.53 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.037 -0.601 . . . . 63.33 111.841 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -97.22 130.69 44.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.205 -0.665 . . . . 75.34 109.205 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.61 150.27 36.46 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.056 -0.658 . . . . 64.23 109.54 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 101' ' ' SER . 66.0 t30 -116.51 156.17 27.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 65.41 109.957 -174.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.43 126.54 49.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.909 0.861 . . . . 72.44 112.347 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.518 ' HZ3' ' CG ' ' A' ' 128' ' ' ASP . 28.0 ttpp -128.38 140.61 51.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.537 -1.211 . . . . 72.03 108.656 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.506 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -112.48 124.23 68.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.002 -0.74 . . . . 73.23 109.002 -178.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.921 ' HB3' HG23 ' A' ' 98' ' ' THR . 84.4 tttt -120.08 119.67 34.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.508 -0.769 . . . . 54.35 109.752 -171.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.9 m -122.67 137.08 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.335 -0.393 . . . . 63.04 110.951 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.22 122.62 3.35 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.819 -0.705 . . . . 71.14 112.421 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.712 ' HD1' HD23 ' A' ' 95' ' ' LEU . 81.8 t80 -117.59 128.49 55.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.238 -0.653 . . . . 45.31 109.238 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.73 ' HB3' HG11 ' A' ' 3' ' ' VAL . 26.3 mtmm -109.13 123.16 48.75 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.894 -0.722 . . . . 75.04 110.54 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -104.69 147.83 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.3 -1.37 . . . . 64.24 107.3 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.815 ' HA ' HG22 ' A' ' 3' ' ' VAL . 10.5 pt-20 -52.37 -28.48 19.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.489 0.551 . . . . 71.14 112.489 -167.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -100.84 -31.94 10.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.468 0.544 . . . . 71.01 112.468 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.987 HG22 ' H ' ' A' ' 145' ' ' GLY . 16.6 pt -142.89 154.23 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 118.594 0.634 . . . . 74.04 112.254 -170.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.748 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 3.5 t-20 -110.14 128.9 55.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.698 -0.683 . . . . 72.43 111.231 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 142' ' ' LEU . 4.6 mm? -110.84 135.73 50.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.515 -0.311 . . . . 73.32 110.174 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.4 125.8 3.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.529 -0.843 . . . . 73.22 112.511 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.8 m -113.45 117.81 32.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.763 -0.458 . . . . 73.32 109.763 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.518 ' CG ' ' HZ3' ' A' ' 113' ' ' LYS . 38.9 t0 -126.09 117.57 23.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.955 0.407 . . . . 73.02 110.1 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.701 ' HG3' HG13 ' A' ' 138' ' ' ILE . 60.8 ttp -119.67 118.15 30.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.919 0.39 . . . . 75.11 111.563 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.21 120.18 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.366 -0.605 . . . . 70.33 109.366 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 85.5 t80 -95.03 104.66 16.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.065 0.46 . . . . 63.33 111.674 -172.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.486 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 20.3 t70 -97.99 149.4 22.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 74.2 108.904 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.405 ' C ' HD13 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -68.6 -35.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.734 -0.212 . . . . 72.41 111.101 -174.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.52 -20.13 20.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 52.21 111.403 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.86 98.71 0.12 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.366 -0.921 . . . . 73.14 112.662 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 37.9 Cg_endo -67.19 150.79 81.88 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.577 2.185 . . . . 74.12 112.43 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -115.13 128.84 56.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.442 -0.577 . . . . 51.31 109.442 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.701 HG13 ' HG3' ' A' ' 129' ' ' MET . 3.9 mp -109.73 118.34 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.354 -0.609 . . . . 63.33 109.354 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -112.19 132.49 54.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.337 0.589 . . . . 75.24 110.308 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.63 132.66 10.99 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.389 -0.823 . . . . 62.3 111.343 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.11 134.76 55.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.961 -0.385 . . . . 71.31 109.961 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.766 HD11 HD12 ' A' ' 123' ' ' ILE . 6.3 tp -137.97 122.33 18.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.207 0.527 . . . . 74.35 110.164 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.748 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 97.8 t -107.89 130.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.23 -0.895 . . . . 65.23 108.937 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.6 mm? -108.14 137.24 46.46 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.258 -0.645 . . . . 74.32 109.258 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.987 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -130.49 119.36 2.73 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 115.527 -0.76 . . . . 61.3 111.46 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 149' ' ' TRP . 1.8 p90 -142.28 147.78 36.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.523 . . . . 73.01 109.589 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 7.0 mp0 -35.24 102.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.575 0.954 . . . . 70.03 113.575 -169.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.31 -33.92 5.31 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.0 -1.0 . . . . 63.21 113.7 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.499 ' HB2' ' CE1' ' A' ' 146' ' ' TYR . 78.1 m95 -106.01 143.28 34.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.63 0.728 . . . . 73.33 112.193 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.738 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.9 tm? -124.75 136.68 54.07 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 72.23 107.985 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.87 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -139.02 162.15 35.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.682 0.277 . . . . 65.54 110.692 -175.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -159.88 145.49 11.37 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.373 -0.691 . . . . 72.13 111.373 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.526 ' OH ' HD23 ' A' ' 142' ' ' LEU . 39.8 p90 -146.72 127.39 14.26 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.694 0.747 . . . . 74.03 111.673 165.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 0.9 OUTLIER -115.72 121.64 43.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.421 -0.809 . . . . 72.2 109.163 177.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 94.8 mmm -121.6 140.15 52.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.176 -0.305 . . . . 71.54 110.176 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.474 ' HB2' ' H ' ' A' ' 166' ' ' GLN . 3.8 m-20 -110.3 119.14 38.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.763 -0.458 . . . . 63.33 109.763 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.23 117.27 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.568 -0.53 . . . . 52.33 109.568 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.468 ' HG2' ' HB3' ' A' ' 160' ' ' ALA . 15.0 tt0 -98.54 105.55 17.71 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-O 121.094 0.473 . . . . 71.13 110.107 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.3 m -70.42 -20.81 62.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.3 -1.773 . . . . 72.02 111.124 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 158' ' ' GLU . . . -59.7 -28.65 67.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.924 0.869 . . . . 72.31 109.155 173.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 158' ' ' GLU . 78.8 mttt -117.72 -157.77 0.68 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.311 -1.366 . . . . 71.45 107.311 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.7 p -109.29 26.74 10.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.85 -0.426 . . . . 62.54 109.85 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -141.97 154.32 44.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.24 -1.384 . . . . 70.41 114.591 -154.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 93.9 t -74.37 131.61 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 114.721 -1.127 . . . . 61.14 110.206 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 33.1 m -98.63 -34.22 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.627 -0.26 . . . . 60.43 111.488 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' ' 156' ' ' ASN . 14.1 mm100 -138.59 134.68 34.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.183 -0.303 . . . . 73.4 110.183 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.7 p -120.84 109.46 15.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.198 0.523 . . . . 74.23 110.561 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 26.6 m-80 -109.31 138.45 45.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 5.7 t80 -138.68 149.35 45.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.421 -0.512 . . . . 74.24 110.419 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -149.9 136.8 19.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.178 0.513 . . . . 60.0 110.733 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 10.2 t -145.88 154.07 13.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 61.11 108.427 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 180' ' ' LEU . . . 166.02 -170.72 40.86 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 118.855 -1.641 . . . . 63.12 113.602 169.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.73 153.39 48.49 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.43 -0.385 . . . . 71.31 110.301 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -114.26 126.55 55.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.182 0.515 . . . . 73.31 110.414 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 m -126.29 163.27 23.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.545 -0.752 . . . . 73.34 109.142 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.44 -57.29 3.65 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.765 0.654 . . . . 73.32 112.765 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -109.2 -8.92 15.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 75.13 111.447 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.7 132.09 46.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.898 0.38 . . . . 71.1 111.451 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 83.4 mt-30 -125.98 124.06 39.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.146 -0.687 . . . . 64.11 109.146 173.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.624 HD12 HG13 ' A' ' 194' ' ' ILE . 3.6 tt -120.3 128.49 53.34 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.557 . . . . 72.24 110.948 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 77.6 m-70 -132.05 116.81 17.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.618 -0.719 . . . . 74.01 111.206 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.68 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 29.6 m -83.09 118.56 23.64 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.788 -0.819 . . . . 75.45 108.788 172.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.1 140.97 49.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.167 0.508 . . . . 64.03 111.12 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 190' ' ' PHE . 70.2 t -124.62 128.14 73.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.574 -0.739 . . . . 72.24 110.798 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -115.46 97.29 6.08 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.241 -0.891 . . . . 73.33 108.652 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 30.2 t70 62.49 178.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.919 -1.037 . . . . 71.03 109.573 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.93 58.43 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.958 -0.857 . . . . 54.43 110.958 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 211' ' ' THR . 56.4 m -87.52 -28.1 22.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 112.564 0.579 . . . . 75.24 112.564 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -141.07 119.42 12.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.402 -0.919 . . . . 74.32 112.443 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.518 ' CB ' HG22 ' A' ' 184' ' ' VAL . 19.1 p90 -134.89 126.09 28.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.446 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.767 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -158.84 -162.6 12.07 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 120.491 -0.861 . . . . 63.24 112.388 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -137.74 152.01 21.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.737 -0.744 . . . . 52.34 112.752 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 15.0 m -125.15 138.28 54.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.711 0.291 . . . . 63.44 110.603 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.624 HG13 HD12 ' A' ' 180' ' ' LEU . 4.4 mp -123.72 124.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.272 -0.422 . . . . 70.14 109.896 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 6.6 t80 -108.47 116.37 31.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.73 -0.841 . . . . 61.22 108.73 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -128.5 134.58 48.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.936 0.398 . . . . 73.53 111.011 -177.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.632 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 56.2 mtpt -108.02 127.52 53.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.428 -0.351 . . . . 71.52 110.549 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.44 110.61 27.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -49.8 111.79 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.398 -0.819 . . . . 71.53 112.349 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 200' ' ' LYS . 34.0 ttmt 72.84 1.39 4.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.329 -0.851 . . . . 62.45 112.257 170.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -103.73 -73.14 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 74.41 110.148 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 225' ' ' TYR . 3.2 pp -162.96 170.8 17.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.663 -0.699 . . . . 74.24 109.619 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.632 ' HG3' ' HG2' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -125.52 134.64 51.93 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.941 -0.392 . . . . 71.2 109.941 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.0 m -124.03 142.54 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.136 0.493 . . . . 72.44 111.44 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HB3' HG11 ' A' ' 17' ' ' VAL . . . -130.33 136.18 48.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.966 -0.561 . . . . 71.14 110.154 175.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 221' ' ' ILE . 75.6 t -112.41 134.47 54.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 73.32 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -133.74 126.31 30.42 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.452 -0.573 . . . . 54.31 109.452 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.3 pt? -147.14 135.09 21.36 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.617 -0.433 . . . . 65.11 110.69 174.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.767 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -134.58 149.57 50.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.645 . . . . 71.01 111.432 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -100.05 130.87 46.25 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.0 t -109.91 124.53 51.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.657 . . . . 73.45 110.894 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.57 58.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 73.02 111.442 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 129.95 -54.04 0.79 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.635 -0.986 . . . . 62.14 110.635 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.733 ' HB2' HD21 ' A' ' 216' ' ' ASN . 47.9 m-80 -139.04 172.41 12.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.219 -1.03 . . . . 75.32 108.219 172.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -81.57 67.66 7.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.973 0.416 . . . . 75.15 110.887 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.733 HD21 ' HB2' ' A' ' 214' ' ' ASN . 25.2 m-80 -102.78 129.21 49.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 74.23 110.727 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 m -108.63 123.51 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.334 -0.617 . . . . 74.5 109.334 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 41.7 ttm-85 -101.13 114.81 29.11 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.764 -0.828 . . . . 75.21 108.764 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.58 ' HB3' ' HB2' ' A' ' 239' ' ' ASN . 83.7 t80 -117.8 136.62 53.29 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.507 0.194 . . . . 74.04 110.761 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.67 140.45 7.43 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.792 -0.718 . . . . 64.53 111.825 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.941 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -131.1 136.86 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 71.44 110.799 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.634 ' HB3' HG12 ' A' ' 17' ' ' VAL . . . -128.81 139.78 52.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.01 -0.541 . . . . 62.44 110.23 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.1 126.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.591 0.234 . . . . 75.33 110.584 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 17.2 pttm -102.53 119.52 38.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.845 0.831 . . . . 42.43 110.314 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.561 ' HD2' ' HB3' ' A' ' 202' ' ' LEU . 37.5 t80 -112.3 116.54 30.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.274 -1.33 . . . . 63.21 110.156 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -111.48 121.27 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.188 0.518 . . . . 32.1 111.252 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.9 pt -110.26 -27.41 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.305 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 19.2 t70 -135.15 143.24 44.98 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.57 -0.53 . . . . 74.24 109.57 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.53 -29.22 58.96 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.573 2.182 . . . . 70.52 112.487 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -103.56 4.12 35.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.375 -0.375 . . . . 73.1 111.307 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -143.6 121.27 11.84 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.394 0.616 . . . . 71.5 111.872 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -139.87 128.65 23.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.781 -0.645 . . . . 72.02 109.539 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.07 125.14 50.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.002 -0.279 . . . . 71.33 110.543 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 224' ' ' LYS . 14.2 m -116.47 118.08 31.69 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 52.34 110.043 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -122.98 141.52 51.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.789 -0.364 . . . . 75.51 110.971 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.05 144.24 38.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.316 -0.402 . . . . 73.51 110.229 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 243' ' ' ILE . 9.1 p -131.56 142.61 42.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.751 -0.463 . . . . 54.42 109.751 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -107.42 150.57 26.61 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.068 -0.716 . . . . 73.45 109.068 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 219' ' ' PHE . 6.2 t30 -58.87 -11.78 3.69 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.782 0.676 . . . . 73.42 112.147 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.622 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m -78.66 15.36 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.54 -0.541 . . . . 75.41 109.54 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.4 m 68.45 28.27 6.08 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 115.137 -0.938 . . . . 64.31 110.554 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 240' ' ' SER . 42.7 mt -100.36 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.561 -0.456 . . . . 73.52 110.627 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 237' ' ' VAL . 1.7 mp -108.51 115.41 49.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 120.879 -0.329 . . . . 61.21 110.173 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -123.59 133.39 8.87 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.929 -0.653 . . . . 44.35 112.301 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -128.06 150.72 49.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.341 0.591 . . . . 63.55 111.593 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -132.32 121.65 3.06 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 114.991 -1.004 . . . . 61.12 110.777 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -103.59 115.66 30.92 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.921 -0.4 . . . . 63.34 109.921 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.6 m -98.31 115.51 28.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.842 0.353 . . . . 72.51 110.211 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -126.19 128.92 48.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.096 -0.502 . . . . 63.14 109.903 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.1 m -95.09 119.12 33.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.739 0.304 . . . . 44.14 110.33 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 3.0 mm? -108.1 86.04 2.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 51.1 109.793 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 251' ' ' LEU . 0.0 OUTLIER 71.55 156.06 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.445 -0.798 . . . . 72.43 110.546 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.0 95.81 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.703 2.269 . . . . 73.01 112.854 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 142.18 -19.43 2.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.486 -0.864 . . . . 72.34 112.865 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.49 122.02 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.077 0.465 . . . . 72.21 111.903 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 43.1 mtmt -112.07 126.27 54.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 73.34 109.975 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -100.93 124.01 45.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.507 -0.553 . . . . 73.11 109.507 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 36.9 m -120.34 111.02 17.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 72.54 110.54 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.913 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -97.73 123.59 41.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.212 -1.033 . . . . 74.23 108.212 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 21.8 m -130.21 140.6 50.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.647 0.26 . . . . 51.22 110.462 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.499 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -154.89 128.8 8.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.644 -0.253 . . . . 73.12 110.942 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 274' ' ' LYS . 2.3 tm? -101.68 117.07 34.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.46 -0.941 . . . . 63.4 108.46 173.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.476 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.6 mm? -100.02 109.95 22.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.781 -0.645 . . . . 74.21 109.547 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.456 ' HA ' HD22 ' A' ' 242' ' ' LEU . 2.9 m-20 -69.67 103.75 2.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.824 . . . . 75.51 109.522 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.65 -8.45 7.54 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.097 -0.956 . . . . 52.21 112.581 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 267' ' ' ASN . 48.3 tptt -64.99 -28.63 69.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.547 -0.538 . . . . 61.11 109.547 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 266' ' ' LYS . 44.5 t-20 157.38 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.604 1.19 . . . . 72.22 108.697 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -65.44 -45.15 93.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 112.918 0.71 . . . . 73.23 112.918 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.03 -44.87 91.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.676 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.96 -13.09 16.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.829 0.307 . . . . 44.23 111.829 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -103.34 -14.23 26.51 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.048 -1.072 . . . . 72.34 112.768 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 106.98 153.83 19.6 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.621 -0.799 . . . . 73.43 112.434 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -110.87 147.23 35.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.355 -0.98 . . . . 73.32 108.355 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.9 mmtm -94.0 134.96 35.85 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.335 -1.357 . . . . 64.31 107.335 173.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.92 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.5 tm? -135.29 136.12 41.37 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.255 0.55 . . . . 62.43 110.907 -170.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.461 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.59 117.16 1.23 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 110.52 -1.032 . . . . 65.12 110.52 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.913 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -112.21 122.3 47.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.926 -1.139 . . . . 72.21 107.926 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -129.36 137.34 9.51 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.148 -1.025 . . . . 72.3 112.995 -170.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -114.07 130.55 56.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.936 -0.764 . . . . 71.34 108.936 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.812 ' HG2' ' HB3' ' A' ' 30' ' ' ASP . 50.8 mt-10 -121.02 112.1 18.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.812 -0.44 . . . . 64.32 109.812 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.734 ' HB3' HD13 ' A' ' 31' ' ' LEU . 14.7 t80 -103.53 141.92 35.17 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.854 -0.795 . . . . 71.25 108.854 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.74 141.89 40.97 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.884 0.373 . . . . 51.5 111.348 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.717 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -123.6 110.4 14.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.55 . . . . 74.43 109.679 172.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 34' ' ' LYS . 4.2 mm? -124.09 -47.35 1.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.491 -0.777 . . . . 64.53 109.822 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.423 -0.799 . . . . 74.43 109.285 176.12 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.45 -0.574 . . . . 71.24 109.45 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.825 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 4.5 p -110.68 135.85 20.71 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.797 -0.638 . . . . 71.0 111.12 -171.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.98 155.38 15.04 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.586 2.191 . . . . 74.1 110.973 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.99 101.16 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.925 1.75 . . . . 60.35 111.956 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.669 ' HB ' HD21 ' A' ' 150' ' ' LEU . 6.7 p -73.48 -19.3 60.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.64 . . . . 74.05 110.411 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.616 ' HB2' HG21 ' A' ' 143' ' ' VAL . 90.2 t80 -56.55 -24.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.999 -1.001 . . . . 75.51 110.441 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.22 -26.12 33.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 55.43 110.057 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.737 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 18.6 t70 -82.99 -14.8 53.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.856 -0.611 . . . . 71.54 109.447 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.023 HD21 ' HA3' ' A' ' 152' ' ' GLY . 2.3 tp -55.85 -34.39 65.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.802 -1.09 . . . . 74.22 110.637 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.565 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . -136.25 21.9 3.44 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 64.41 111.705 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.737 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 4.7 ttpm? -56.71 -56.08 25.99 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.418 . . . . 74.5 111.178 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.17 -38.1 89.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.65 -0.704 . . . . 73.35 110.681 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.27 80.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 64.41 112.417 -174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 98.7 mtt180 -57.88 -42.23 84.19 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.635 0.606 . . . . 74.14 112.635 -170.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.07 -37.89 86.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 74.45 110.507 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.83 -34.77 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 41.41 110.918 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -72.32 -42.6 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 72.43 111.814 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -126.9 57.68 1.45 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.994 0.902 . . . . 64.02 110.652 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 21' ' ' GLY . 45.3 tptt -75.16 177.31 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.501 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 20' ' ' LYS . . . -64.5 116.62 9.26 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.554 -0.832 . . . . 43.14 111.68 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.73 173.98 6.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 73.31 110.761 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.928 ' HA3' ' HB3' ' A' ' 274' ' ' LYS . . . -83.14 88.17 1.49 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.749 -0.738 . . . . 63.34 112.786 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -93.26 -4.33 52.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.033 -0.358 . . . . 74.52 110.033 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.5 79.36 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.933 -0.576 . . . . 71.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.31 155.15 39.18 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 122.162 0.982 . . . . 71.42 112.797 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.976 HG23 HD23 ' A' ' 277' ' ' LEU . 43.6 mm -94.03 121.25 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.704 -1.589 . . . . 63.45 107.809 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 6.5 mtpm? -114.83 139.44 49.75 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.852 -0.339 . . . . 63.04 110.71 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tt -142.84 142.66 31.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.081 173.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -144.66 128.05 16.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.61 0.719 . . . . 72.34 110.434 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 281' ' ' PHE . 11.8 tp -120.84 126.75 50.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.896 -1.047 . . . . 74.24 110.33 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 2.0 ptmm? -121.8 124.49 44.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.483 0.659 . . . . 62.42 110.514 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 3.6 t -110.68 121.86 46.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.084 -1.08 . . . . 62.1 108.084 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.562 ' HB3' ' HG3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -143.41 139.05 29.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.791 0.805 . . . . 73.41 112.706 -170.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 37' ' ' ASN . 23.1 t -139.32 137.93 36.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.944 -1.873 . . . . 62.23 105.944 168.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -79.62 44.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.044 0.926 . . . . 62.45 111.128 -171.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 35' ' ' SER . 1.4 m-20 -98.37 19.41 14.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.966 -1.47 . . . . 75.4 107.431 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 95.62 -7.05 68.09 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.495 -1.23 . . . . 74.32 113.253 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.4 mm? -102.77 128.41 49.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.252 1.026 . . . . 63.33 113.489 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 25.6 tt0 -140.56 117.84 11.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.898 -0.779 . . . . 65.04 108.898 160.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 87.9 t80 -108.16 120.54 42.62 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.955 -0.466 . . . . 74.34 109.812 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 34.0 m -120.85 115.95 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 72.23 110.48 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -114.41 123.54 49.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.547 -0.538 . . . . 61.41 109.547 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 20.1 m -117.69 133.89 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 63.44 110.378 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.63 125.33 2.71 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.832 -0.699 . . . . 73.31 111.606 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.6 m -119.69 133.99 55.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 72.1 109.037 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -137.43 146.46 44.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.158 0.504 . . . . 35.53 111.858 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -68.87 142.91 54.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.503 -0.771 . . . . 64.34 109.157 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -57.88 -21.76 44.75 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.209 0.528 . . . . 74.22 111.271 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.75 7.46 33.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 64.24 110.632 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.9 p 50.05 25.66 1.78 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.383 1.073 . . . . 64.3 113.318 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 p -99.72 -18.44 17.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 70.52 111.712 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -134.93 108.64 8.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.183 -0.673 . . . . 72.15 109.183 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 47' ' ' ALA . 23.6 t -125.3 120.77 58.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.026 0.441 . . . . 74.03 110.742 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -111.22 126.49 54.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.146 0.498 . . . . 64.41 110.359 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.26 155.49 16.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.855 -0.688 . . . . 73.11 112.425 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.9 m -143.65 126.78 16.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.438 -0.949 . . . . 71.42 108.438 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.9 tm? -121.3 124.61 45.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.38 -0.528 . . . . 75.0 110.479 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 44.2 mt-10 -114.82 118.71 34.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.92 -0.582 . . . . 73.03 110.122 174.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 m -97.7 117.2 31.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.472 -1.307 . . . . 73.31 107.472 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 24.3 mtpp -121.93 139.38 53.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.325 0.583 . . . . 70.44 110.554 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 76.5 m-85 -109.67 120.82 43.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.416 -0.811 . . . . 73.11 109.082 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -118.04 109.16 16.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.258 0.551 . . . . 53.15 111.304 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 20.0 t90 -112.9 92.46 4.02 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.201 -0.909 . . . . 74.21 109.514 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 67' ' ' TYR . 10.8 m 71.63 151.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.134 0.896 . . . . 55.03 111.393 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.44 -38.21 63.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.561 0.696 . . . . 61.01 110.08 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.483 ' H ' HG22 ' A' ' 65' ' ' THR . 14.0 p90 -121.43 103.04 8.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 74.14 109.121 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.39 -102.07 0.17 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.225 -0.988 . . . . 72.32 112.141 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.7 mm? -117.51 136.55 53.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.322 0.582 . . . . 55.01 112.293 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -135.39 112.23 10.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.198 -0.91 . . . . 61.01 109.327 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 56.2 t80 -117.32 132.5 56.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.789 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 58.7 m -128.67 117.65 21.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.777 -0.192 . . . . 55.14 111.408 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -103.31 121.14 42.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.879 -1.156 . . . . 65.1 107.879 167.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -123.36 102.37 7.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.967 -0.56 . . . . 73.05 110.856 -168.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.849 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 67.9 t90 -96.67 132.84 41.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 74.25 109.889 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -119.76 165.82 14.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.852 -0.425 . . . . 63.41 109.852 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.7 t -64.84 -6.3 7.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.02 0.438 . . . . 74.53 111.932 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -79.82 -3.28 47.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.57 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 14.7 m120 73.97 18.64 3.22 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.92 0.763 . . . . 74.1 110.028 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.6 m -102.93 135.92 43.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 72.35 110.487 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.849 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 4.8 mp -112.79 119.71 38.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.246 -0.434 . . . . 71.14 110.412 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 130.55 10.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.74 -0.743 . . . . 60.14 111.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.3 m -112.78 107.48 16.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.011 0.434 . . . . 60.35 111.144 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.789 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 21.7 tt0 -105.39 127.8 53.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.588 -0.733 . . . . 63.15 109.885 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.59 ' CG2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -130.02 120.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.364 -0.606 . . . . 64.12 109.364 169.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 24.6 m -126.36 129.24 48.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.685 -0.689 . . . . 52.5 110.229 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.02 134.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 70.12 111.253 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' OE2' ' HG3' ' A' ' 96' ' ' LYS . 67.8 mm-40 -96.46 118.86 33.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.55 -0.908 . . . . 62.13 108.55 172.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.27 122.9 28.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 73.12 109.822 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -85.56 -27.58 25.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.235 -0.438 . . . . 71.41 110.99 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.37 -44.8 42.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.295 -0.631 . . . . 53.31 109.295 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -99.61 67.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.516 -0.92 . . . . 62.45 108.516 170.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -49.95 131.23 22.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 52.12 111.759 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA2' ' HD2' ' A' ' 119' ' ' LYS . . . 102.85 -15.16 55.78 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.11 -0.95 . . . . 71.12 112.444 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.696 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -78.96 121.07 24.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.15 0.475 . . . . 64.02 111.126 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.478 ' HG3' ' OE2' ' A' ' 88' ' ' GLU . 48.9 tttp -118.06 111.78 19.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.571 -0.741 . . . . 74.43 109.574 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.632 HD12 HG22 ' A' ' 116' ' ' THR . 1.9 mm? -103.53 128.53 50.74 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.875 -0.417 . . . . 73.51 109.875 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.726 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 10.5 m -128.82 122.65 30.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.458 -0.337 . . . . 71.44 111.375 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.607 ' CE2' HD13 ' A' ' 114' ' ' ILE . 47.4 m-85 -119.55 115.67 24.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.477 -0.564 . . . . 75.02 109.477 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.1 t70 -115.42 122.05 44.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.55 -0.537 . . . . 73.15 109.55 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -134.83 121.69 20.99 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.061 0.457 . . . . 64.42 110.455 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 m -99.29 121.93 41.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.01 -0.541 . . . . 62.04 109.915 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.35 119.37 39.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 72.31 109.716 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 m -115.16 102.37 54.67 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.894 -0.41 . . . . 22.23 109.894 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.73 -33.04 28.71 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.559 2.173 . . . . 65.53 111.51 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -83.67 -46.11 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.643 -0.708 . . . . 75.24 111.102 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -70.25 -36.26 74.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.877 0.37 . . . . 75.23 110.806 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.26 -18.34 57.57 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.033 -0.603 . . . . 72.12 112.487 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.62 123.89 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.138 0.495 . . . . 62.14 110.568 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.22 116.56 28.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.92 -0.77 . . . . 70.13 108.92 173.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 132' ' ' ASP . 10.2 m120 -120.1 144.37 47.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.417 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.85 141.0 36.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.376 -0.375 . . . . 75.03 110.597 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.609 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -128.82 142.56 50.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.908 -0.404 . . . . 73.3 109.908 175.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.607 HD13 ' CE2' ' A' ' 99' ' ' PHE . 2.2 tp -118.07 117.68 55.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.885 -0.598 . . . . 74.02 110.08 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.726 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 27.9 ttpp -115.19 119.76 37.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.049 -0.523 . . . . 62.21 110.029 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.632 HG22 HD12 ' A' ' 97' ' ' LEU . 17.6 p -113.04 116.95 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.327 -0.62 . . . . 75.45 109.327 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.47 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -136.09 116.65 1.5 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.86 -1.162 . . . . 64.23 112.728 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.696 ' HB3' HD22 ' A' ' 95' ' ' LEU . 21.4 p90 -108.1 122.67 47.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.583 -0.525 . . . . 73.52 109.583 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -109.29 123.59 49.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.547 0.689 . . . . 71.44 110.965 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -106.25 165.02 11.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.741 -1.118 . . . . 64.34 109.256 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.825 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 10.4 pt-20 -52.65 -29.81 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.273 0.842 . . . . 51.32 113.273 -167.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -120.42 -6.1 9.81 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.924 -0.71 . . . . 63.15 112.502 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.37 126.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.424 -0.91 . . . . 64.15 113.011 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.818 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.8 OUTLIER -100.94 121.57 41.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.725 -0.671 . . . . 63.43 110.783 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 142' ' ' LEU . 3.9 mm? -112.05 126.69 55.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.229 0.212 . . . . 55.35 110.577 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.47 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.1 118.64 1.96 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.574 -0.822 . . . . 52.21 112.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 63.0 m -112.3 109.25 18.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.369 . . . . 63.03 110.51 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.63 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 4.3 t70 -108.82 146.01 34.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.832 -0.622 . . . . 71.41 110.125 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.484 ' HG3' HD13 ' A' ' 138' ' ' ILE . 22.2 ttt -135.96 117.21 14.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.045 -0.354 . . . . 72.44 110.045 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -100.22 117.35 34.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.512 -0.551 . . . . 73.53 109.512 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -98.18 122.98 42.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.121 0.486 . . . . 62.12 112.17 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.419 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 28.3 t70 -117.29 148.26 41.84 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.295 -1.002 . . . . 75.15 108.295 166.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -65.78 -19.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.108 0.41 . . . . 71.11 112.108 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.65 -12.26 29.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.32 . . . . 42.34 111.21 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.89 122.8 0.63 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 52.23 112.394 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.509 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 5.8 Cg_endo -87.3 145.78 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.602 2.868 . . . . 72.54 112.923 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 p -117.82 148.33 42.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.87 -0.605 . . . . 72.02 110.385 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 41.6 mm -107.55 118.39 55.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 110.265 -0.272 . . . . 64.04 110.265 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 155' ' ' MET . 70.6 mtm180 -105.7 116.9 32.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.127 0.489 . . . . 73.4 109.969 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.02 134.07 11.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.102 -1.046 . . . . 74.11 111.982 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.22 127.66 40.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.404 . . . . 61.34 110.557 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 125' ' ' LEU . 13.0 tp -132.51 124.23 28.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 64.15 110.12 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.818 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 36.1 t -123.79 120.78 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.486 . . . . 75.33 110.539 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' A' ' 142' ' ' LEU . 4.9 mp -110.62 140.7 44.7 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.388 -0.369 . . . . 75.1 110.214 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.88 119.17 4.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.949 -0.643 . . . . 65.24 112.857 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 78.3 m-85 -128.21 148.23 50.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.867 -0.79 . . . . 71.22 108.867 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -53.48 103.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 72.13 110.781 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.06 -32.94 6.71 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.247 -0.888 . . . . 74.52 112.497 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 93.4 m95 -108.06 123.45 48.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.721 0.638 . . . . 72.33 112.721 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.669 HD21 ' HB ' ' A' ' 6' ' ' THR . 2.0 tm? -113.99 137.35 51.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.31 -1.737 . . . . 52.45 106.31 170.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -135.73 132.83 37.34 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.954 -0.699 . . . . 64.12 110.813 -167.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.023 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -132.57 132.77 6.76 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.369 -0.919 . . . . 74.41 112.045 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.449 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 53.4 m-85 -132.49 118.2 18.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.636 -0.505 . . . . 74.31 109.636 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 1.9 mp0 -120.35 144.27 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.0 -0.546 . . . . 71.44 109.989 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.418 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 23.5 ptp -145.3 147.47 32.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.66 0.266 . . . . 64.51 110.578 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.579 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 8.3 t30 -113.95 117.37 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.219 -0.659 . . . . 74.43 109.219 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.86 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 69.7 t80 -94.59 125.18 39.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.61 -0.723 . . . . 72.53 111.062 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 161' ' ' LYS . 44.8 tt0 -91.29 103.98 16.58 Favored 'General case' 0 C--O 1.266 1.929 0 CA-C-N 115.104 -0.953 . . . . 71.41 109.384 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.28 -18.61 63.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.774 -2.012 . . . . 71.23 111.646 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.92 75.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.879 0.847 . . . . 63.21 108.907 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.516 ' HD3' ' OE2' ' A' ' 158' ' ' GLU . 2.0 mptm? -111.55 -159.37 0.68 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 73.41 107.996 168.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.3 m -107.9 28.67 8.0 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 122.252 -0.28 . . . . 62.1 110.287 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 158' ' ' GLU . 28.9 mtm180 -132.15 171.69 13.33 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 118.94 -1.104 . . . . 64.43 111.797 -163.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.6 m -103.06 133.01 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.389 -0.967 . . . . 71.42 108.389 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 p -99.89 1.38 42.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.067 0.46 . . . . 72.2 111.501 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.605 ' HG3' ' HB2' ' A' ' 186' ' ' ASP . 35.7 tt0 -150.87 130.82 13.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 71.31 109.687 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 m -121.78 112.87 18.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.857 -0.611 . . . . 65.11 109.936 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 84.0 m-20 -107.32 127.97 54.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.432 -0.581 . . . . 75.12 109.432 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.619 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.6 m-85 -121.39 153.01 38.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.286 -0.566 . . . . 74.52 111.065 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -148.67 128.53 13.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.504 -0.771 . . . . 71.41 109.833 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.1 t -125.81 126.17 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.501 -0.555 . . . . 70.14 109.501 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -117.32 130.58 8.94 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.624 -0.798 . . . . 63.11 112.713 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -113.03 120.2 40.53 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.557 -1.275 . . . . 73.35 107.557 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HG3' HE21 ' A' ' 179' ' ' GLN . 83.6 tttt -118.02 126.86 53.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.693 0.759 . . . . 74.41 112.797 -167.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 178' ' ' PHE . 23.8 m -131.89 162.56 30.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.31 -1.367 . . . . 64.24 107.31 169.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -46.76 -50.65 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.537 0.569 . . . . 61.24 112.537 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 7.9 pt-20 -116.16 10.95 15.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.094 0.473 . . . . 63.22 111.544 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.744 ' HD1' ' HG2' ' A' ' 196' ' ' GLN . 61.2 t80 -137.13 121.28 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.193 -0.458 . . . . 64.53 110.526 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.435 HE21 ' HG3' ' A' ' 174' ' ' LYS . 87.5 mt-30 -133.61 122.75 23.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.208 0.528 . . . . 71.24 110.605 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.744 HD12 HG13 ' A' ' 194' ' ' ILE . 3.2 tt -111.91 131.98 55.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.388 -0.597 . . . . 74.14 109.388 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -129.85 115.16 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.195 0.521 . . . . 73.24 109.982 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 27.4 m -86.25 135.41 33.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.397 -0.819 . . . . 73.4 109.088 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -128.66 138.1 51.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.227 0.536 . . . . 73.11 111.087 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 53.6 t -132.13 128.42 59.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 64.34 110.133 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -115.17 95.63 5.29 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.896 -0.779 . . . . 75.22 108.896 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.605 ' HB2' ' HG3' ' A' ' 166' ' ' GLN . 29.8 t0 58.46 -174.0 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.842 -1.072 . . . . 75.35 109.793 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -75.69 -6.73 82.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.617 -0.801 . . . . 72.01 111.783 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 186' ' ' ASP . 7.2 t -89.59 -27.42 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.455 0.539 . . . . 64.22 112.455 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.45 114.26 15.33 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 119.911 -0.716 . . . . 52.25 111.023 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -133.83 132.85 40.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.783 0.325 . . . . 72.3 110.583 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -166.34 -159.31 11.98 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.785 -0.721 . . . . 63.12 112.088 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.19 153.78 24.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.889 -0.672 . . . . 64.11 111.979 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.0 m -126.8 139.34 53.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.087 0.47 . . . . 62.41 110.255 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.744 HG13 HD12 ' A' ' 180' ' ' LEU . 4.5 mp -119.47 129.72 74.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.874 -0.603 . . . . 75.35 109.724 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -125.19 119.13 27.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.395 -0.594 . . . . 74.33 109.395 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.744 ' HG2' ' HD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -125.56 120.04 29.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.156 -0.475 . . . . 71.03 110.405 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.916 ' HG3' ' HG2' ' A' ' 203' ' ' GLU . 58.1 tttm -106.11 116.03 31.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.295 -0.631 . . . . 73.53 109.295 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 200' ' ' LYS . 16.1 t -86.33 143.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.714 -0.846 . . . . 72.53 108.714 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -73.36 6.33 3.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.61 0.719 . . . . 73.41 110.508 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.59 ' H ' HG12 ' A' ' 198' ' ' VAL . 49.0 tptt -98.19 37.71 1.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.062 -0.972 . . . . 73.23 108.911 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 200' ' ' LYS . 34.6 mmtp 75.95 -55.54 0.6 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.992 -1.004 . . . . 63.14 112.884 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.14 132.62 53.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.768 0.794 . . . . 73.2 112.752 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.916 ' HG2' ' HG3' ' A' ' 197' ' ' LYS . 31.3 mt-10 -110.7 142.97 41.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.611 -1.177 . . . . 75.43 109.303 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.9 m -131.68 138.99 48.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.661 -0.245 . . . . 52.24 110.58 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -131.01 148.94 52.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.655 -0.248 . . . . 51.33 110.657 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.81 HG22 HG22 ' A' ' 221' ' ' ILE . 92.1 t -135.11 140.45 45.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.998 -0.371 . . . . 65.23 109.998 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -124.76 127.07 46.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.76 0.314 . . . . 71.12 110.513 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.3 mm? -123.01 136.57 54.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.619 . . . . 61.4 110.016 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.416 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.21 129.58 14.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.371 -0.377 . . . . 52.51 110.22 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -114.66 126.78 55.28 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.989 -0.745 . . . . 74.24 108.989 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 188' ' ' THR . 6.4 t -101.82 112.99 25.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.441 0.639 . . . . 60.21 109.638 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.24 126.42 27.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.303 -0.862 . . . . 75.4 110.922 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 156.44 -78.55 0.19 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.789 . . . . 31.32 112.484 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.76 50.52 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.43 . . . . 71.04 111.367 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.0 m 58.54 18.88 6.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.955 0.724 . . . . 70.12 112.955 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.455 ' HB3' ' CG2' ' A' ' 211' ' ' THR . 48.1 t-20 -75.94 114.31 14.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 60.43 110.053 -176.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.5 m -113.34 130.87 56.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.778 -0.646 . . . . 72.05 110.862 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -106.04 125.89 51.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 74.21 110.121 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 239' ' ' ASN . 9.5 t80 -130.44 141.52 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.233 -0.894 . . . . 64.33 109.25 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.27 147.78 15.66 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.445 -0.883 . . . . 73.44 112.0 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.81 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -128.24 144.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.725 0.298 . . . . 75.31 110.213 177.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -130.51 142.25 50.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.979 -0.555 . . . . 64.32 110.851 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -116.42 135.16 54.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.798 -0.637 . . . . 62.2 109.627 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 64.6 tttt -129.63 117.32 20.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.283 -0.417 . . . . 64.43 110.285 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -132.78 125.85 31.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.042 0.448 . . . . 54.31 111.005 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -91.92 100.77 13.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.042 -0.725 . . . . 74.23 109.042 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 17.4 tt -71.03 -30.2 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 71.22 111.061 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.715 ' HB2' ' HD2' ' A' ' 229' ' ' PRO . 3.4 p30 -156.22 164.07 22.7 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.722 -0.844 . . . . 71.4 108.722 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 228' ' ' ASP . 13.6 Cg_endo -56.26 -20.42 31.78 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.865 2.377 . . . . 70.24 114.53 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -104.62 -19.42 13.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.904 -0.318 . . . . 62.31 111.58 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -124.3 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.322 0.582 . . . . 63.33 112.312 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.4 m -125.09 133.34 52.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.637 -0.711 . . . . 64.42 110.262 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -114.42 133.15 55.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.88 0.371 . . . . 72.33 110.159 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 11.3 p -137.97 149.33 46.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.123 -0.489 . . . . 72.14 110.42 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -144.55 155.99 43.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.867 -0.42 . . . . 74.44 109.867 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -144.87 149.64 35.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.441 . . . . 61.52 111.067 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 1.2 t -127.28 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.774 -0.648 . . . . 72.35 110.017 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.7 m120 -106.06 150.16 26.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.106 -0.497 . . . . 55.13 109.956 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 219' ' ' PHE . 22.5 p-10 -45.07 -32.24 1.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.807 1.317 . . . . 75.12 113.692 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.659 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 19.7 m -82.23 25.64 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.873 0.368 . . . . 73.5 110.748 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.405 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 22.2 m 69.84 31.1 3.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.591 -0.731 . . . . 63.41 110.863 174.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 262' ' ' LEU . 5.2 mp -88.17 126.95 35.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 120.686 -0.406 . . . . 73.13 110.618 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.71 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.88 116.65 53.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 123.884 0.74 . . . . 73.14 109.859 -177.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 262' ' ' LEU . . . -129.84 151.87 19.46 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.157 -1.021 . . . . 63.13 112.929 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.499 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -136.7 154.22 50.67 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.431 . . . . 72.11 110.952 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.71 120.76 1.32 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.253 -0.739 . . . . 60.22 111.253 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -112.36 119.07 37.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.992 -0.373 . . . . 73.24 109.992 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -119.73 121.93 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.471 0.653 . . . . 71.35 110.661 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 24.7 tt0 -123.9 131.07 53.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.854 -0.612 . . . . 73.22 109.802 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.0 m -87.21 114.37 23.76 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.435 -0.348 . . . . 73.43 110.456 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.796 ' HG ' ' HD2' ' A' ' 253' ' ' PRO . 19.2 tp -75.71 139.7 42.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.555 -0.906 . . . . 71.25 108.555 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -55.94 -43.94 99.46 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.787 1.032 . . . . 73.04 113.787 -168.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.796 ' HD2' ' HG ' ' A' ' 251' ' ' LEU . 72.4 Cg_exo -43.8 -64.33 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 75.23 113.703 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 163.95 38.65 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 120.721 -0.752 . . . . 15.43 111.696 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 279' ' ' LEU . 1.8 tp -143.46 122.2 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.821 -0.437 . . . . 71.01 109.821 -174.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.533 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 12.7 ptmm? -106.63 133.19 51.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.455 0.645 . . . . 74.24 110.534 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.7 tp -99.91 124.14 44.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.755 -1.111 . . . . 63.13 110.025 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.7 t -125.45 112.54 16.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.645 0.736 . . . . 64.32 110.671 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -100.17 124.78 45.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.893 -1.151 . . . . 74.03 107.893 175.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 p -129.94 139.55 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.981 0.42 . . . . 73.43 111.006 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.5 128.64 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 75.5 110.2 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -110.25 121.69 45.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.98 . . . . 64.3 108.353 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.944 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -102.28 109.47 21.15 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.991 -0.744 . . . . 52.23 108.991 176.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.006 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 1.7 m-20 -68.64 106.09 2.49 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.69 -1.226 . . . . 65.32 107.69 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -53.49 -24.85 25.54 Favored Glycine 0 C--N 1.32 -0.355 0 O-C-N 123.517 0.511 . . . . 54.53 113.48 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.12 -26.48 19.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.672 0.272 . . . . 74.03 111.039 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 1.006 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 7.2 m-20 -96.69 -30.8 13.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.463 -0.335 . . . . 74.11 111.882 -173.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.944 HG11 ' HB3' ' A' ' 263' ' ' LEU . 21.7 m -62.95 -18.68 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 71.51 111.216 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -62.19 -31.08 71.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 63.24 109.783 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.27 9.99 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 74.21 110.63 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.17 15.94 63.73 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.969 -0.56 . . . . 71.34 112.985 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.69 96.12 2.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 61.13 112.479 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -110.18 142.82 41.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.082 -0.34 . . . . 74.1 110.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.928 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 58.4 mttm -101.06 134.48 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.006 -0.739 . . . . 75.51 109.006 170.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.31 132.42 37.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.795 -0.446 . . . . 72.44 109.795 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.49 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -148.07 132.69 4.32 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.872 -0.68 . . . . 43.32 111.611 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.976 HD23 HG23 ' A' ' 27' ' ' ILE . 45.4 tp -114.77 145.65 41.86 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 64.22 110.722 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.579 ' H ' HD12 ' A' ' 277' ' ' LEU . . . -142.32 125.47 2.67 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 63.41 112.006 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 255' ' ' ILE . 2.9 mm? -109.23 129.25 55.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.112 -0.699 . . . . 73.31 109.112 170.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.533 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 20.9 mt-10 -113.91 110.69 20.49 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.089 -0.708 . . . . 74.35 109.089 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.561 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -116.77 135.16 53.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.096 0.475 . . . . 73.33 110.155 -173.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -130.96 112.67 13.16 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.899 -0.778 . . . . 74.52 108.899 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.718 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -83.03 107.55 15.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 35.51 109.833 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 283' ' ' ALA . 3.4 mm? -137.9 -61.11 0.63 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.988 -1.006 . . . . 63.45 109.071 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.991 -0.528 . . . . 61.0 109.8 177.102 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.713 0.292 . . . . 74.21 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.941 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 3.8 t -116.02 114.77 41.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.978 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.88 175.07 11.85 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.702 2.268 . . . . 74.31 111.993 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 13.2 Cg_exo -70.79 85.13 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.443 2.095 . . . . 75.15 111.298 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 p -69.38 -34.35 74.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 42.43 111.54 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.598 ' HB3' HG21 ' A' ' 143' ' ' VAL . 10.9 p90 -61.24 -28.71 69.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.139 0.495 . . . . 74.21 110.983 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -84.86 -20.78 30.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 64.34 110.892 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -102.43 -0.12 32.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.177 0.989 . . . . 53.04 108.48 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.857 HD21 ' HA3' ' A' ' 152' ' ' GLY . 8.6 tp -58.04 -24.12 57.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.618 -1.628 . . . . 71.33 110.519 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.64 51.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.619 -0.719 . . . . 52.04 111.916 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 13.8 ptmm? -62.38 -44.04 97.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.653 0.264 . . . . 72.23 111.504 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -65.23 -38.95 91.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.182 0.515 . . . . 74.31 110.971 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 193' ' ' SER . . . -70.08 -43.79 70.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 44.24 111.95 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.67 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 5.4 ptm180 -61.2 -28.38 69.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.477 -0.329 . . . . 73.41 111.104 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.89 -42.48 84.73 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.375 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -82.68 -31.46 9.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 70.44 110.794 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 94.6 t80 -71.47 -22.64 61.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 73.53 112.323 -174.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -29.86 117.04 0.13 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.213 0.946 . . . . 74.34 113.352 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -80.42 -9.47 59.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.075 -0.966 . . . . 74.13 110.235 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.94 91.28 1.22 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.045 -0.822 . . . . 61.42 111.045 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -84.13 169.83 14.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.884 0.373 . . . . 72.32 111.055 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.4 112.39 3.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.097 -0.573 . . . . 63.11 112.656 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.432 ' HB2' HD13 ' A' ' 26' ' ' LEU . 45.7 m-85 -92.99 14.46 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.696 0.284 . . . . 71.1 110.905 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.7 13.57 53.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 54.34 112.065 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD13 ' HB2' ' A' ' 24' ' ' PHE . 10.7 mp -100.05 160.05 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.025 0.917 . . . . 63.45 112.376 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.715 HG13 HD23 ' A' ' 277' ' ' LEU . 1.7 mp -104.28 127.55 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.071 -1.422 . . . . 61.34 108.789 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -106.87 142.21 36.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.681 0.277 . . . . 71.43 110.47 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.68 148.17 46.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.298 -0.41 . . . . 51.43 110.031 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 13.8 t70 -155.16 134.62 12.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 74.45 109.95 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.871 -0.418 . . . . 73.33 109.871 -178.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -126.05 125.35 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.916 0.389 . . . . 73.5 110.087 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -137.68 120.04 15.85 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.025 -0.732 . . . . 63.03 109.025 170.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HE3' HD22 ' A' ' 284' ' ' LEU . 17.9 ptpt -133.41 144.58 49.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.546 . . . . 64.43 111.93 -176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 39' ' ' LEU . 18.8 m -141.21 164.83 29.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 72.24 109.297 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -80.03 26.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.968 0.413 . . . . 72.44 110.995 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 7.6 t-20 -107.28 21.08 18.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.116 0.484 . . . . 53.24 110.286 -173.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 77.11 -6.73 40.69 Favored Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.745 -0.74 . . . . 72.33 113.176 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 39' ' ' LEU . 2.0 pp -102.44 132.94 48.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.837 0.68 . . . . 72.24 112.837 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.066 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 39.3 mt-10 -137.2 124.88 22.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 54.51 109.124 165.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -107.06 120.13 41.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.1 -0.333 . . . . 74.33 110.1 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.861 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 29.5 m -128.77 132.16 47.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 62.24 111.125 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.0 t -125.04 135.28 52.58 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.749 -0.834 . . . . 75.34 108.749 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -148.56 125.76 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.007 -0.277 . . . . 73.13 110.708 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.89 168.22 40.99 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.951 -1.119 . . . . 32.42 113.001 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -137.48 135.53 36.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.448 -0.575 . . . . 74.35 109.448 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -149.94 150.62 32.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.266 0.555 . . . . 75.44 111.973 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -71.68 139.53 49.24 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.245 -1.02 . . . . 74.3 108.245 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -67.99 -8.55 38.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.41 0.624 . . . . 42.12 111.144 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -82.34 -3.25 55.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.75 -0.659 . . . . 71.03 109.968 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.9 p 54.48 21.01 3.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.181 0.992 . . . . 51.2 112.651 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 p -91.92 -26.65 18.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 74.51 110.976 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.41 95.99 4.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.502 -0.555 . . . . 74.21 109.502 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 47' ' ' ALA . 44.8 t -125.61 124.15 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.917 -0.583 . . . . 61.55 110.773 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 126.0 25.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.369 -0.604 . . . . 75.22 109.369 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.92 -178.01 37.9 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.263 -0.97 . . . . 63.55 112.786 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 5.0 p -138.4 153.23 48.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.169 0.509 . . . . 50.31 111.057 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.72 124.02 45.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.264 -1.384 . . . . 74.12 107.264 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.861 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 46.0 mt-10 -110.16 118.06 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.965 -0.561 . . . . 55.52 110.302 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -103.52 120.16 40.31 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.021 -1.103 . . . . 62.45 108.021 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 1.066 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 59.7 mttm -118.41 147.18 43.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.117 -0.492 . . . . 70.1 109.772 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.766 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 67.2 m-85 -118.12 120.18 36.98 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.959 -0.564 . . . . 63.4 109.634 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.606 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 14.6 ttm180 -114.09 106.84 14.86 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.505 0.669 . . . . 73.13 111.606 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -115.2 91.86 3.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.739 -1.119 . . . . 71.52 109.003 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 93.2 m 69.33 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.903 0.752 . . . . 70.5 111.286 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.04 129.03 39.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 73.54 110.5 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HD2' ' HG3' ' A' ' 88' ' ' GLU . 32.2 m-85 62.57 35.05 14.66 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.613 -0.722 . . . . 75.32 110.587 -173.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.03 -90.52 0.97 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.655 -1.378 . . . . 32.25 109.655 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 69' ' ' LEU . 2.1 mm? -122.75 129.42 51.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.313 0.578 . . . . 74.24 111.199 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.6 p -137.78 121.4 17.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.261 -0.881 . . . . 60.52 110.371 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -122.39 123.48 41.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.534 -0.543 . . . . 74.34 109.534 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.71 ' HB ' ' HG2' ' A' ' 61' ' ' LYS . 7.4 p -128.3 130.63 48.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.853 -0.739 . . . . 71.33 111.123 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 35.7 tt0 -109.88 121.67 45.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.448 -0.575 . . . . 75.42 109.448 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -109.65 94.21 4.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.74 -0.467 . . . . 73.04 109.74 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.953 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 32.2 t90 -96.7 128.17 43.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.487 -0.324 . . . . 73.34 110.416 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 1.9 m-20 -106.61 134.21 50.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.862 -0.792 . . . . 71.23 108.862 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.8 m -72.11 -27.56 62.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.716 0.769 . . . . 71.11 109.764 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.54 -24.32 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.813 -1.085 . . . . 74.24 111.836 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.437 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 13.4 t-20 -131.16 -108.71 0.26 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.408 -0.517 . . . . 73.01 112.181 -171.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 104' ' ' SER . 16.4 p -115.46 144.58 43.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.006 0.743 . . . . 75.14 113.006 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.953 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -98.8 119.76 38.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.867 -0.79 . . . . 70.32 108.867 166.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.42 120.95 4.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.423 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -104.4 114.0 27.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.682 0.277 . . . . 72.43 110.576 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 13.6 pt-20 -120.06 132.71 55.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.073 0.463 . . . . 64.11 110.495 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.26 121.77 65.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.837 -0.619 . . . . 63.43 109.357 177.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -117.88 123.04 44.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.657 -0.702 . . . . 74.54 110.805 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -129.45 132.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 74.33 110.354 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.622 ' HG3' ' HD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -91.91 118.73 31.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.164 -1.421 . . . . 71.21 107.164 172.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.522 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 8.5 t70 -56.05 124.05 16.47 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.503 0.502 . . . . 71.35 111.081 -168.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -67.21 -23.31 65.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.874 -0.603 . . . . 74.24 111.222 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.99 -51.58 4.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.711 -0.478 . . . . 73.43 109.711 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.32 77.8 3.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.244 -0.435 . . . . 61.43 110.52 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 89' ' ' ASP . 30.0 mmm180 -63.26 128.45 35.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.961 -0.563 . . . . 75.14 110.031 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.57 44.03 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.24 -0.744 . . . . 74.43 111.24 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 118' ' ' TYR . 20.8 tp -123.19 120.24 32.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.213 -0.662 . . . . 63.33 109.213 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -118.01 121.0 39.51 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.989 -0.55 . . . . 71.31 109.764 -173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -104.64 127.09 52.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.709 . . . . 63.5 109.991 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 93.5 m -129.2 118.62 22.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.256 -0.429 . . . . 73.4 110.552 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -111.32 115.8 29.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.267 -0.642 . . . . 74.5 109.267 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 3.0 p30 -117.47 151.03 37.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.297 0.57 . . . . 71.01 110.613 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.508 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 50.4 m -142.13 121.49 13.15 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 71.0 110.033 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -102.93 122.23 44.16 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.872 -0.603 . . . . 35.21 109.546 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.553 ' HD2' HD21 ' A' ' 81' ' ' LEU . 82.4 t80 -110.24 130.54 55.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.718 -0.475 . . . . 61.04 109.718 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.437 ' HB2' HG22 ' A' ' 80' ' ' THR . 35.5 t -106.99 106.94 59.65 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 74.24 109.9 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 37.2 Cg_endo -66.58 -16.09 49.69 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.7 2.267 . . . . 62.11 111.992 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -74.52 -38.46 62.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 75.35 110.874 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.652 HG23 ' H ' ' A' ' 109' ' ' LYS . 3.0 t -108.31 -27.96 9.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.351 . . . . 63.34 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 2.89 67.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.748 -0.739 . . . . 54.32 112.227 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.652 ' H ' HG23 ' A' ' 107' ' ' THR . 51.2 mtmt -89.08 148.4 23.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 53.24 110.956 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.508 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 61.7 tttm -123.08 136.94 55.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 73.42 109.939 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 101' ' ' SER . 14.4 t-20 -119.6 122.81 42.41 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.891 -0.411 . . . . 74.21 109.891 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.83 129.72 56.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.249 -0.432 . . . . 61.2 110.6 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.801 ' HG2' ' HA ' ' A' ' 130' ' ' ASP . 35.9 mtmm -127.85 138.47 52.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.207 -0.451 . . . . 63.44 110.336 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.8 tp -116.56 117.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.479 0.657 . . . . 53.21 110.166 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 46.0 mttp -107.32 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.223 -0.899 . . . . 72.23 110.959 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -123.73 117.62 25.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.902 -0.777 . . . . 61.4 108.902 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.08 114.99 2.19 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.201 -1.0 . . . . 73.34 112.731 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.446 ' HB3' HD13 ' A' ' 95' ' ' LEU . 5.1 p90 -109.79 122.65 47.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.367 0.603 . . . . 65.24 109.753 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.941 ' HD3' ' HB ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.538 -0.756 . . . . 65.02 112.186 -173.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 46.1 mmt-85 -106.45 152.93 22.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.668 -1.234 . . . . 74.34 107.668 165.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -29.57 59.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.955 0.724 . . . . 73.41 112.955 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.4 -5.94 15.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.001 0.371 . . . . 75.21 112.001 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 120' ' ' ARG . 9.0 tp -145.61 123.51 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.248 0.547 . . . . 63.5 111.48 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.636 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 4.1 t30 -119.97 117.05 27.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.2 -0.312 . . . . 74.5 110.53 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.0 mm? -112.97 127.1 56.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.909 0.385 . . . . 62.22 110.923 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -130.84 118.31 2.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.909 -0.587 . . . . 53.04 111.773 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.9 m -105.21 120.72 42.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.767 0.318 . . . . 73.1 110.678 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -114.85 117.4 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 72.14 110.162 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 77.6 mmm -99.02 117.07 32.71 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.441 -0.577 . . . . 64.14 109.441 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.801 ' HA ' ' HG2' ' A' ' 113' ' ' LYS . 11.0 t70 -102.81 118.5 36.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 72.23 110.696 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -97.84 97.85 9.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.436 -0.347 . . . . 72.51 110.844 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -105.1 144.38 31.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.972 -0.751 . . . . 63.52 108.972 170.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.02 -34.67 53.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.108 0.48 . . . . 71.32 111.977 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.22 -18.0 59.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.181 -0.463 . . . . 62.04 111.546 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.17 118.61 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.871 -0.681 . . . . 74.22 112.148 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.26 126.75 21.76 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.797 2.331 . . . . 62.03 112.04 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.9 m -107.63 150.82 26.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.275 -0.421 . . . . 64.0 110.363 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 33.4 mm -107.02 116.9 51.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.481 -0.562 . . . . 72.13 109.481 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -111.54 123.18 49.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.403 0.621 . . . . 72.4 110.348 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.34 132.93 11.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.307 -0.949 . . . . 73.31 111.959 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.27 23.76 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.197 -0.668 . . . . 64.41 109.197 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 143' ' ' VAL . 14.9 tp -124.16 131.67 53.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.107 -0.497 . . . . 61.55 110.608 -175.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 34.1 t -131.38 129.66 62.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.196 -0.456 . . . . 71.34 110.037 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 6.2 mp -109.48 138.66 45.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.117 -0.697 . . . . 64.04 109.117 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.553 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -119.55 119.32 4.23 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 121.04 -0.6 . . . . 75.11 112.888 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 63.4 t80 -126.99 149.07 50.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.684 -1.228 . . . . 74.33 107.684 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -49.31 101.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 74.52 111.55 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.48 -30.78 7.39 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.822 -0.626 . . . . 72.41 112.744 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 39.0 m95 -104.7 126.8 52.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 73.54 111.523 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.773 ' HB3' HD12 ' A' ' 10' ' ' LEU . 20.1 mt -120.32 146.98 45.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.022 0.439 . . . . 74.04 110.285 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -137.1 127.37 26.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.014 -0.736 . . . . 62.44 109.014 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.857 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -131.51 142.46 13.85 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.375 -0.917 . . . . 63.5 111.717 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.674 ' HD2' ' HD2' ' A' ' 169' ' ' PHE . 64.3 m-85 -136.0 121.76 19.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.743 0.306 . . . . 73.32 110.375 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.822 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 23.5 mp0 -106.05 122.58 46.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.961 -0.755 . . . . 65.4 108.961 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 49.1 ttm -127.96 141.87 51.41 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.735 -0.386 . . . . 73.53 110.464 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 51.5 t-20 -130.74 117.41 19.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.406 -0.59 . . . . 61.13 109.406 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.799 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 63.4 t80 -95.16 120.77 35.96 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.491 0.494 . . . . 72.01 110.053 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 43.4 tt0 -99.03 99.59 10.64 Favored 'General case' 0 C--O 1.26 1.649 0 CA-C-O 121.548 0.689 . . . . 73.31 110.678 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -70.59 -22.23 62.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 113.542 -1.663 . . . . 75.44 110.794 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.12 69.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.793 0.806 . . . . 54.43 109.119 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.653 ' HG3' ' H ' ' A' ' 162' ' ' SER . 21.5 tptp -113.41 -158.56 0.66 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.437 -1.32 . . . . 51.22 107.437 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.653 ' H ' ' HG3' ' A' ' 161' ' ' LYS . 17.2 m -108.72 28.08 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.918 -0.488 . . . . 44.22 110.813 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 163' ' ' ARG . 2.4 ptm180 -157.01 160.77 39.32 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.053 -1.059 . . . . 75.11 111.954 -164.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.6 m -74.0 133.4 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.165 -1.05 . . . . 75.13 108.165 169.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.7 t -93.39 -14.83 26.34 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.951 -0.3 . . . . 75.05 110.273 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.71 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 19.6 mt-30 -142.21 132.74 25.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.399 0.618 . . . . 72.42 111.796 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -123.0 105.98 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.058 -0.974 . . . . 74.42 109.388 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.822 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 13.7 m120 -114.42 136.06 53.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 64.35 110.176 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.674 ' HD2' ' HD2' ' A' ' 153' ' ' TYR . 36.5 m-85 -130.42 140.71 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 75.12 110.053 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -142.69 129.03 19.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.832 0.348 . . . . 73.5 110.282 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 45.8 t -124.54 127.13 72.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.004 -0.739 . . . . 60.33 109.004 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -140.49 115.39 1.05 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.85 -1.167 . . . . 74.23 112.293 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.49 ' CE2' HD22 ' A' ' 180' ' ' LEU . 54.2 p90 -115.47 134.48 55.05 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.422 -0.511 . . . . 64.11 110.241 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -119.25 124.95 47.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.311 -0.859 . . . . 62.11 110.225 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 51.1 m -134.78 112.69 10.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.893 -0.323 . . . . 74.32 110.301 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.6 t70 43.12 -87.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.35 1.031 . . . . 73.33 113.752 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 10.2 pt-20 -101.86 -12.13 18.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.213 0.449 . . . . 74.3 112.213 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.47 ' HD2' ' HG2' ' A' ' 196' ' ' GLN . 74.6 t80 -119.18 117.19 28.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 74.52 111.247 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -123.84 124.36 42.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 72.45 109.584 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.629 HD12 HG13 ' A' ' 194' ' ' ILE . 3.1 tt -119.49 135.41 54.78 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.512 -0.475 . . . . 74.35 110.677 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.58 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 47.7 t60 -129.75 115.11 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.373 -0.83 . . . . 75.42 110.225 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.0 m -92.48 142.8 27.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.492 -0.929 . . . . 75.35 108.492 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.15 139.83 33.98 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 63.53 110.754 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.35 121.06 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.714 -0.675 . . . . 61.21 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 75.2 m-20 -103.62 94.24 5.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.374 -0.83 . . . . 61.2 109.276 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.71 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 12.1 m-20 65.83 -169.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.836 -1.074 . . . . 71.22 110.907 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 212' ' ' ALA . . . -76.49 -6.5 84.32 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.425 -0.893 . . . . 72.12 111.714 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.2 m -96.8 -25.56 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.616 0.598 . . . . 74.24 112.616 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.4 tt0 -129.72 113.98 15.41 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.062 -0.655 . . . . 74.01 111.54 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -121.86 124.74 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.933 -0.765 . . . . 73.04 108.933 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.45 -160.75 11.36 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.788 -1.196 . . . . 72.33 112.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.66 175.8 44.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.539 -0.838 . . . . 75.15 112.389 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.641 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 26.2 m -148.68 138.09 21.87 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.391 -0.596 . . . . 61.43 109.391 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.76 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.6 mp -121.2 137.18 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.532 -0.544 . . . . 71.44 109.532 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -121.6 119.92 33.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.787 -0.82 . . . . 72.34 108.787 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.47 ' HG2' ' HD2' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -124.97 111.07 14.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.714 -0.847 . . . . 75.04 108.714 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 60.1 tttp -97.23 119.48 35.82 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.811 -0.631 . . . . 74.0 109.745 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.84 146.0 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.467 -1.308 . . . . 74.42 107.467 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -74.54 56.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.769 0.795 . . . . 74.12 110.997 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.461 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 67.8 mttm -152.85 -146.78 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.848 -1.524 . . . . 74.32 108.028 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.801 ' HB3' ' HB3' ' A' ' 226' ' ' GLN . 1.2 mptm? -103.01 26.16 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.315 0.578 . . . . 75.51 109.587 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.55 110.32 19.06 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.464 -0.789 . . . . 75.23 110.269 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.947 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 12.8 mm-40 -107.01 134.39 50.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 52.45 109.795 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.5 m -123.38 143.11 50.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 64.2 109.919 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -142.32 158.58 43.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 65.15 111.114 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.76 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 71.5 t -132.45 141.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.533 -0.543 . . . . 55.31 109.533 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.46 125.4 16.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.038 -0.727 . . . . 64.32 109.038 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.662 HD13 ' HD1' ' A' ' 219' ' ' PHE . 2.5 pt? -146.6 150.65 35.9 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.415 -0.514 . . . . 73.14 111.036 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.38 130.88 22.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 72.02 110.194 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.671 ' HB2' HG23 ' A' ' 217' ' ' THR . 9.4 t90 -125.28 135.11 52.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.606 -0.724 . . . . 70.01 109.489 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.909 HG23 ' HB3' ' A' ' 214' ' ' ASN . 3.9 t -95.27 113.95 25.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.355 0.598 . . . . 72.34 110.457 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -64.94 144.71 57.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 72.35 110.846 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.58 -2.72 86.33 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.675 -0.97 . . . . 52.5 110.675 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.909 ' HB3' HG23 ' A' ' 211' ' ' THR . 37.2 t-20 -138.28 159.18 42.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.332 -0.988 . . . . 54.31 108.332 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.1 t -93.41 -9.29 39.12 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.174 -0.329 . . . . 73.14 110.542 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.97 108.92 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.213 0.53 . . . . 70.14 110.951 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 210' ' ' TRP . 28.1 m -117.13 135.07 54.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.281 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -126.1 117.5 23.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.899 -0.32 . . . . 72.45 110.255 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.662 ' HD1' HD13 ' A' ' 208' ' ' LEU . 74.5 t80 -113.27 138.42 50.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.567 -0.742 . . . . 74.41 109.241 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.82 157.21 26.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.527 -0.844 . . . . 42.41 112.705 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.65 136.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 64.31 109.649 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 205' ' ' ALA . . . -114.51 152.66 31.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.783 -0.451 . . . . 53.11 109.783 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.78 140.2 34.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.397 -0.365 . . . . 75.32 110.498 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.947 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 28.9 ttmt -123.1 113.84 19.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.128 -0.693 . . . . 63.13 109.128 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -105.2 116.47 32.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.48 -0.327 . . . . 71.51 110.535 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.801 ' HB3' ' HB3' ' A' ' 201' ' ' LYS . 63.1 tt0 -91.99 104.17 16.61 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.461 -0.94 . . . . 72.43 108.461 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.83 -49.06 60.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.472 -0.785 . . . . 73.35 110.991 -172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.747 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.1 t70 -164.78 -59.64 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 74.42 111.491 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 72.1 Cg_endo -89.38 -139.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.023 1.815 . . . . 63.35 113.443 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 1.8 m-20 -92.13 13.38 19.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.815 -1.084 . . . . 71.13 110.37 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.09 124.93 45.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 63.25 110.154 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.644 ' HB2' HG23 ' A' ' 248' ' ' THR . 59.6 m -113.09 145.09 41.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.191 -0.913 . . . . 74.44 110.173 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.24 125.98 39.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.962 -1.125 . . . . 75.11 107.962 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.8 t -106.45 144.56 32.95 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.166 -0.47 . . . . 72.15 110.013 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -148.57 147.69 29.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.34 -0.391 . . . . 61.1 110.431 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -148.01 138.53 22.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.132 -0.692 . . . . 63.53 109.132 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.33 152.92 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 242' ' ' LEU . 11.7 p30 -133.4 152.43 51.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.965 -0.694 . . . . 74.02 110.777 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.58 5.02 0.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.539 -1.209 . . . . 64.33 112.982 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.601 ' HB3' HD13 ' A' ' 242' ' ' LEU . 32.3 t -89.01 13.83 12.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.506 -0.924 . . . . 52.21 108.506 170.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 49.9 m 69.26 31.72 3.83 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 114.626 -1.17 . . . . 70.32 111.357 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.999 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 10.2 mp -99.75 142.62 31.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.287 -0.565 . . . . 74.23 111.202 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -125.59 118.0 51.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.695 -0.684 . . . . 63.21 110.317 -169.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.07 143.57 16.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.739 -0.743 . . . . 74.23 112.436 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.37 156.72 43.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.845 0.355 . . . . 71.14 110.153 176.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.92 -177.73 36.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.435 -0.888 . . . . 42.24 113.049 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.711 ' HB3' HE21 ' A' ' 249' ' ' GLN . 87.6 m-85 -117.15 115.93 26.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.603 -0.517 . . . . 71.12 109.603 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 232' ' ' CYS . 6.3 t -111.06 113.93 26.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.075 -0.713 . . . . 74.44 109.075 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.711 HE21 ' HB3' ' A' ' 247' ' ' TYR . 53.2 mt-30 -132.82 150.4 52.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.222 -0.444 . . . . 65.31 111.463 -168.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 8.9 t -124.78 132.83 53.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.117 -1.068 . . . . 71.23 108.117 167.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.636 HD23 HD12 ' A' ' 255' ' ' ILE . 36.8 tp -72.27 -65.15 0.81 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.5 -0.48 . . . . 60.12 109.851 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.654 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 0.5 OUTLIER 174.72 -57.91 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.466 -0.788 . . . . 62.12 110.137 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 83.5 Cg_endo -80.4 52.35 4.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.308 2.005 . . . . 64.42 113.403 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.96 64.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.666 -0.778 . . . . 75.44 112.596 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.636 HD12 HD23 ' A' ' 251' ' ' LEU . 61.7 mt -107.27 122.25 61.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 122.733 -0.275 . . . . 70.14 110.262 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.673 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 17.2 tptm -121.17 122.64 40.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.645 . . . . 74.04 110.75 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.76 124.08 51.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.136 -0.938 . . . . 73.42 109.815 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 277' ' ' LEU . 38.0 m -119.75 110.22 16.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.177 0.513 . . . . 74.22 110.743 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -111.13 125.77 54.13 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.86 -1.163 . . . . 72.24 107.86 173.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.9 p -139.08 141.01 38.18 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.762 -0.375 . . . . 41.32 110.742 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.42 127.62 19.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.325 -0.62 . . . . 63.21 109.325 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.729 HD21 HD23 ' A' ' 242' ' ' LEU . 0.4 OUTLIER -108.75 128.91 55.29 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.445 0.641 . . . . 74.3 109.466 177.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.895 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.4 mm? -102.1 106.96 17.91 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.252 -0.885 . . . . 70.05 108.957 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.999 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 6.3 t70 -73.48 98.99 2.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.754 -1.112 . . . . 62.43 108.329 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.83 -9.36 3.67 Favored Glycine 0 C--N 1.314 -0.673 0 CA-C-N 115.725 -0.671 . . . . 74.35 113.38 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -92.46 -21.84 19.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.867 -0.166 . . . . 65.2 111.025 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.89 -23.74 0.92 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.441 1.115 . . . . 73.41 110.831 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 273' ' ' HIS . 1.0 OUTLIER -63.21 -26.7 41.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 113.748 -1.569 . . . . 61.55 112.844 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.48 -26.32 68.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.055 -0.52 . . . . 73.25 110.274 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -88.29 -16.5 32.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.196 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.63 -1.2 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.521 -0.847 . . . . 43.2 113.637 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.86 51.79 4.36 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.561 -0.828 . . . . 75.33 113.046 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.921 ' HA ' HG22 ' A' ' 268' ' ' VAL . 0.6 OUTLIER -78.31 144.44 36.09 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.767 0.318 . . . . 72.3 111.389 -175.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.51 138.18 38.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 60.34 110.878 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.575 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -128.32 144.13 51.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 62.0 109.699 -174.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -146.32 119.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.933 -0.651 . . . . 55.43 111.821 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.715 HD23 HG13 ' A' ' 27' ' ' ILE . 54.0 tp -114.68 146.93 40.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 70.45 110.874 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.77 124.47 1.67 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.893 -0.594 . . . . 70.22 111.693 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.434 HD21 HD21 ' A' ' 277' ' ' LEU . 2.8 mm? -111.04 130.28 55.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.065 -0.717 . . . . 63.4 109.065 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.673 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 16.9 pt-20 -137.1 122.73 19.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.467 0.651 . . . . 72.02 110.459 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.681 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.2 m-85 -114.43 110.48 19.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.863 -0.791 . . . . 71.13 108.863 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.54 111.0 19.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.103 0.477 . . . . 63.41 111.497 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -104.19 109.75 21.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.453 -0.943 . . . . 73.32 108.453 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.485 HD22 ' HE3' ' A' ' 34' ' ' LYS . 56.9 mt -120.34 -98.42 0.45 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.381 -0.372 . . . . 71.31 111.535 -171.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.492 -0.766 . . . . 74.21 109.981 -176.562 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.523 -0.547 . . . . 53.34 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.777 ' HB ' ' HD2' ' A' ' 119' ' ' LYS . 16.3 t -117.89 117.09 35.82 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.924 -0.58 . . . . 74.42 110.705 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.43 161.9 14.88 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.539 2.159 . . . . 73.31 111.433 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 102.75 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.354 2.036 . . . . 54.04 111.63 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.539 ' HB ' HG11 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -70.09 -42.67 72.41 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.943 -0.571 . . . . 54.02 111.01 -176.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.918 ' HA ' ' HB3' ' A' ' 10' ' ' LEU . 64.4 t80 -50.15 -25.82 3.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.467 0.707 . . . . 74.52 111.68 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.683 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -76.65 -17.61 59.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.929 -0.578 . . . . 51.02 110.487 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -105.89 -31.36 8.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.547 -1.279 . . . . 61.35 107.547 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.918 ' HB3' ' HA ' ' A' ' 7' ' ' TYR . 2.5 tt -58.4 -36.09 73.02 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.351 -2.204 . . . . 73.24 110.738 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.12 -21.89 0.14 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 119.181 -1.485 . . . . 74.45 115.753 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.683 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 16.8 ttmm -57.15 -52.59 64.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.448 1.124 . . . . 74.33 112.358 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -56.62 -38.81 72.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.114 0.483 . . . . 72.4 111.073 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 181' ' ' HIS . . . -70.3 -42.65 71.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.563 -0.744 . . . . 42.15 111.156 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 5.2 tmm_? -59.66 -34.59 73.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.125 -0.488 . . . . 62.14 111.385 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -47.15 84.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 73.31 111.635 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.521 ' HA ' ' HE1' ' A' ' 22' ' ' TYR . 78.9 t -82.7 -32.03 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.922 0.391 . . . . 51.33 110.966 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.485 ' HA ' HD22 ' A' ' 207' ' ' ASN . 86.8 t80 -60.54 -35.36 75.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 73.23 112.171 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -79.43 131.0 35.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 60.02 111.464 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.974 ' H ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -69.87 151.05 46.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.009 -0.996 . . . . 64.14 110.236 175.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.75 78.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.853 -0.689 . . . . 55.43 112.291 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.521 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 72.1 m-85 -70.28 -23.36 62.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.609 0.242 . . . . 74.33 111.454 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -123.72 133.25 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.798 -0.715 . . . . 73.33 111.756 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -104.21 2.12 31.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.085 0.469 . . . . 72.12 110.687 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.95 12.57 57.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.919 -0.658 . . . . 63.44 112.172 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.56 158.65 17.05 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 122.592 1.187 . . . . 75.34 113.656 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.803 HG23 HD12 ' A' ' 277' ' ' LEU . 46.2 mm -105.63 121.82 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 113.016 -1.902 . . . . 65.14 108.924 173.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 25.2 ttpp -109.64 129.07 55.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 75.42 110.65 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tm? -128.43 127.39 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.338 -0.986 . . . . 74.31 108.338 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.0 p30 -142.94 140.92 31.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.223 0.535 . . . . 73.14 110.989 175.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' THR . 7.2 tp -127.06 124.38 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.13 -0.941 . . . . 73.41 109.87 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 ptmm? -127.35 125.78 41.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.756 . . . . 63.34 110.385 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 9.9 t -131.73 132.21 43.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.8 -0.636 . . . . 75.13 110.221 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 28.9 mtpp -111.77 132.04 54.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.206 -0.664 . . . . 73.21 109.206 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 17.6 m -133.6 169.21 17.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 72.11 110.446 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -86.5 158.74 19.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.052 -0.522 . . . . 73.32 109.704 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.29 55.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.607 0.567 . . . . 71.54 111.991 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 85.16 -5.16 84.05 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 116.108 1.203 . . . . 73.24 116.108 168.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 2.7 mm? -100.31 124.75 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.024 1.912 . . . . 62.45 112.769 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.867 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 35.9 mt-10 -142.35 139.87 31.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 64.03 108.542 159.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.498 ' HB3' ' CG2' ' A' ' 33' ' ' THR . 90.3 t80 -131.51 121.84 25.14 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 122.061 -0.399 . . . . 71.14 110.547 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.769 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 18.2 m -127.33 131.38 50.43 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.991 0.424 . . . . 73.43 110.488 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -126.51 126.19 43.31 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.06 -0.718 . . . . 53.14 109.06 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 p -126.54 126.22 43.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 63.12 111.159 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.04 139.7 9.16 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 53.24 112.36 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 p -132.21 136.59 47.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.058 0.456 . . . . 72.22 110.67 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.8 51.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.793 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -84.83 137.89 32.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.542 -0.54 . . . . 73.35 109.542 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.3 m -80.33 -27.5 38.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.005 0.431 . . . . 62.42 110.991 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.13 -71.37 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 74.23 110.52 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 p -93.24 159.82 15.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.249 -0.432 . . . . 52.31 110.603 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -79.81 88.48 5.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.468 0.652 . . . . 75.01 110.34 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -138.0 104.46 5.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 73.34 109.518 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.31 119.6 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.145 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -114.05 126.24 54.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.839 -0.619 . . . . 75.25 109.777 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.73 123.84 3.63 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.476 -0.869 . . . . 52.13 112.415 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 p -114.1 142.65 45.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.68 -0.489 . . . . 64.22 109.68 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -121.31 123.33 41.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.955 -0.757 . . . . 60.22 108.955 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.769 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 2.1 pm0 -114.16 118.97 35.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.076 0.941 . . . . 73.33 111.226 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -99.25 120.94 40.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.597 -1.183 . . . . 65.31 108.947 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 43.6 mtpt -112.56 126.92 55.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.219 0.533 . . . . 64.11 110.814 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 84.4 m-85 -103.3 120.28 40.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.55 -0.907 . . . . 75.25 108.55 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 36.0 ttt180 -110.71 108.2 18.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 73.23 110.742 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.501 ' HE3' ' HB3' ' A' ' 69' ' ' LEU . 5.3 m-90 -107.09 99.35 8.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.791 -0.64 . . . . 74.2 110.577 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 m 70.59 133.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.512 -0.767 . . . . 64.33 111.084 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.6 pm0 -64.73 124.58 22.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 62.14 110.559 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 63.4 35.49 12.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.433 -0.803 . . . . 73.41 111.077 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.37 -77.77 0.38 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.207 -0.757 . . . . 74.22 111.207 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.8 mm? -124.86 132.63 53.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.095 0.474 . . . . 71.43 111.378 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.34 112.59 11.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.83 -0.623 . . . . 61.22 110.248 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.565 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 58.5 t80 -111.6 120.26 41.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.007 -0.542 . . . . 70.12 109.745 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 t -124.27 117.29 24.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.308 0.575 . . . . 75.3 110.93 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 34.5 tt0 -102.76 120.62 40.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 63.12 109.697 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -107.19 113.98 27.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 63.24 110.336 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.848 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 70.4 t90 -103.1 134.89 45.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.776 -0.453 . . . . 70.01 109.776 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -110.22 156.19 21.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 73.13 109.481 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -61.35 -16.0 41.69 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.832 0.678 . . . . 61.45 112.832 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.6 -1.47 57.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.828 -0.169 . . . . 54.43 111.333 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 87.81 11.51 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.241 1.016 . . . . 72.14 112.432 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -81.83 126.38 31.8 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.775 -0.37 . . . . 44.45 110.099 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.848 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -105.63 119.48 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.33 -0.395 . . . . 60.2 110.155 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.83 98.65 0.92 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.352 -1.099 . . . . 65.15 110.352 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' HG3' ' A' ' 73' ' ' GLU . 9.7 t -106.63 120.86 43.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.516 0.674 . . . . 73.34 111.641 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 40.5 tt0 -109.3 123.47 49.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.376 -0.829 . . . . 52.31 110.169 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.565 ' HB ' ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -112.58 124.13 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 63.35 109.496 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 m -111.4 130.04 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 63.53 111.17 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 5.9 t -110.45 120.28 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.556 -0.747 . . . . 74.31 109.51 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.88 116.98 34.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.243 -0.28 . . . . 63.51 110.243 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 52.19 62.99 2.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.596 -0.729 . . . . 73.4 111.326 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.681 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 23.7 tp60 -62.42 -74.7 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.606 . . . . 75.11 111.24 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.681 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 88.5 mt -115.61 -31.93 5.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 64.44 110.111 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.92 125.64 51.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 64.04 110.268 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -63.64 135.38 56.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.124 0.488 . . . . 74.54 110.822 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.72 -15.23 58.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.556 -0.747 . . . . 72.15 112.257 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.2 131.4 36.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.501 . . . . 73.15 111.442 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -119.25 111.08 17.77 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.613 -0.884 . . . . 74.2 108.613 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -103.65 127.47 51.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.493 -0.558 . . . . 64.35 109.493 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.894 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 21.9 m -127.84 119.25 25.25 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.642 0.258 . . . . 74.13 110.579 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 82.5 m-85 -117.46 114.95 24.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.593 . . . . 70.35 109.4 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.961 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.9 t70 -111.14 122.65 48.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.183 -0.673 . . . . 75.04 109.183 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -118.2 120.47 37.8 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.016 0.436 . . . . 65.13 110.01 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 111' ' ' ASN . 53.7 m -109.55 121.48 45.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.138 -0.483 . . . . 64.31 109.922 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -123.66 125.07 44.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.968 -0.56 . . . . 75.33 110.186 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 t -114.03 101.75 54.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 109.683 -0.488 . . . . 73.12 109.683 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.05 -9.16 19.25 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.932 2.421 . . . . 75.04 110.577 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -72.03 -55.48 7.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.887 -1.051 . . . . 61.23 109.89 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.5 t -103.92 -19.77 14.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 63.54 111.556 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.16 22.79 18.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.691 -0.766 . . . . 52.1 112.604 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HE3' ' OD1' ' A' ' 111' ' ' ASN . 60.6 tttp -95.35 146.49 24.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.537 0.208 . . . . 75.31 110.774 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 140.66 45.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.873 0.368 . . . . 75.33 110.023 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.2 m120 -128.81 132.57 47.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.3 110.376 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -111.0 114.76 28.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.047 -0.524 . . . . 70.22 110.106 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.961 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 56.8 tttp -113.25 135.39 53.88 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.485 -0.561 . . . . 64.44 109.485 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.529 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -136.37 135.66 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 74.52 110.053 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.6 ttpm? -131.2 121.36 24.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.187 0.518 . . . . 75.43 110.582 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 p -112.63 121.17 44.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.437 -0.801 . . . . 73.51 109.278 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.46 154.52 21.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.004 -1.093 . . . . 63.44 112.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.38 116.64 21.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.454 -0.943 . . . . 74.31 108.454 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.777 ' HD2' ' HB ' ' A' ' 3' ' ' VAL . 24.4 pttm -110.18 121.94 46.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.42 0.628 . . . . 75.32 111.252 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.6 mpt_? -107.48 148.63 28.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.954 -1.128 . . . . 63.14 107.954 168.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.34 -27.9 50.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.986 0.422 . . . . 64.35 110.972 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -93.08 -31.2 14.92 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.272 0.471 . . . . 73.41 112.272 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 ' HB2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -144.21 132.32 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.822 -0.751 . . . . 63.31 110.974 -167.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.73 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 7.4 t30 -120.92 125.65 48.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.366 0.506 . . . . 72.51 112.366 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.94 131.64 55.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.936 -0.574 . . . . 63.24 110.049 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -141.38 117.07 1.17 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.331 -0.938 . . . . 43.31 112.626 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 42.0 t -109.78 108.57 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.323 . . . . 31.15 110.483 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.719 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 10.7 t70 -108.29 138.55 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 55.11 109.592 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.543 ' HG2' HG13 ' A' ' 138' ' ' ILE . 73.7 mtm -138.14 128.04 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.819 -0.551 . . . . 62.12 111.241 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -97.73 117.27 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.187 -0.672 . . . . 64.12 109.187 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 84.6 t80 -97.02 114.87 26.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.174 0.511 . . . . 74.24 111.048 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.3 153.9 45.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.595 -0.891 . . . . 72.51 108.595 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.435 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.8 pp -69.62 -17.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 73.25 111.1 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.56 -10.38 57.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.781 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.87 125.25 1.79 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.775 -0.726 . . . . 65.33 112.374 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 6.3 Cg_exo -80.03 122.07 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.23 2.62 . . . . 72.52 111.921 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 m -97.2 135.73 38.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.014 -0.365 . . . . 70.53 110.014 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.543 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -106.1 119.27 55.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.133 0.492 . . . . 64.35 110.026 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -117.62 111.73 19.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.945 -0.571 . . . . 75.14 109.98 -174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.46 132.99 11.3 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.907 -1.14 . . . . 73.4 112.096 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 116.36 24.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.186 0.517 . . . . 75.1 109.946 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.476 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.1 tp -116.87 123.58 47.4 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 73.35 109.889 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 53.0 t -117.01 128.76 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.196 -0.456 . . . . 61.52 110.415 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -107.78 137.9 44.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.259 -1.015 . . . . 74.14 108.259 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.37 121.05 2.33 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.312 -0.947 . . . . 54.32 113.529 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.14 149.36 41.41 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.072 -1.084 . . . . 74.32 108.072 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.47 105.15 0.08 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.655 0.741 . . . . 73.4 111.718 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.39 -32.18 7.85 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.273 -0.876 . . . . 64.12 112.441 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -105.35 122.47 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.777 0.322 . . . . 53.14 111.602 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 150' ' ' LEU . 6.6 mt -115.05 136.32 53.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.684 -1.228 . . . . 55.42 107.684 163.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.657 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -136.28 152.72 51.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.55 ' HA3' HD11 ' A' ' 10' ' ' LEU . . . -157.21 133.18 3.47 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.193 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.664 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 67.8 m-85 -124.02 114.68 20.07 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.429 -0.582 . . . . 74.44 109.429 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -105.45 120.88 42.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.697 -0.683 . . . . 73.22 109.71 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.415 ' SD ' HG11 ' A' ' 164' ' ' VAL . 58.4 ttp -132.48 129.0 38.62 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.42 -0.355 . . . . 74.44 110.444 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.461 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 73.6 m-20 -111.16 115.87 30.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.941 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.5 t80 -97.28 127.1 42.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.993 -1.003 . . . . 75.12 110.273 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 6.6 tp10 -94.39 100.23 12.29 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-N 115.858 -0.61 . . . . 61.42 109.593 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 -19.95 62.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.769 -1.56 . . . . 74.05 111.008 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.72 77.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.613 -0.884 . . . . 24.25 108.613 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -102.77 -160.45 0.78 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.296 -1.32 . . . . 65.14 108.026 167.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.1 m -109.48 27.07 9.92 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.047 -0.408 . . . . 74.53 110.929 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -163.24 161.64 24.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 118.912 -1.115 . . . . 72.22 111.596 -165.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.941 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -72.95 136.1 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.137 0.494 . . . . 74.0 109.865 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 5.1 t -93.61 -23.45 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.897 -0.592 . . . . 75.14 110.317 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -140.1 132.88 29.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.61 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 p -121.07 109.31 14.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.805 -0.634 . . . . 70.13 110.274 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -111.69 127.56 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.387 0.613 . . . . 44.12 110.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.664 ' HD2' ' HD1' ' A' ' 153' ' ' TYR . 80.0 m-85 -121.03 144.29 48.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.701 -0.481 . . . . 74.34 109.701 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -147.26 137.25 23.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.524 0.678 . . . . 42.04 111.091 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.994 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 99.5 t -133.44 152.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.267 -1.012 . . . . 72.12 108.267 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 181' ' ' HIS . . . -147.88 123.16 1.66 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.101 -1.047 . . . . 61.12 112.271 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.07 120.59 42.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.171 -0.677 . . . . 73.44 109.171 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.04 126.86 53.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.793 0.806 . . . . 74.22 111.867 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -116.94 163.26 16.47 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.78 -1.563 . . . . 62.3 106.78 168.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -53.64 -42.08 67.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.239 0.459 . . . . 41.3 112.239 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -107.3 -14.02 14.98 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.288 0.477 . . . . 72.24 112.288 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.471 ' HD2' ' NE2' ' A' ' 196' ' ' GLN . 7.5 m-85 -132.11 120.85 22.89 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.125 -0.359 . . . . 64.12 110.941 -173.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -135.19 124.08 24.03 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.785 -0.366 . . . . 64.02 110.683 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.785 ' HB2' ' HA ' ' A' ' 194' ' ' ILE . 0.0 OUTLIER -124.53 138.43 54.33 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.775 -0.578 . . . . 65.14 110.472 175.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 95.3 m-70 -115.46 117.85 31.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 74.44 110.385 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.994 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 90.0 m -78.79 122.84 26.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 71.25 109.685 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.35 139.66 53.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.369 0.604 . . . . 72.42 111.432 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 90.3 t -131.2 117.1 35.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.594 -0.73 . . . . 74.15 110.146 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.28 105.67 15.81 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.9 -0.778 . . . . 72.14 108.9 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.8 t70 63.36 -172.4 0.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.539 -0.755 . . . . 73.3 108.968 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.52 -6.76 88.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 64.42 110.842 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 211' ' ' THR . 1.2 p -88.68 -24.49 22.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.416 0.895 . . . . 63.35 113.416 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.26 110.67 11.28 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.876 0.762 . . . . 71.25 111.111 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -121.48 124.63 44.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.005 -0.543 . . . . 74.22 109.999 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -176.42 -149.75 7.78 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.545 -1.312 . . . . 60.12 113.672 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.54 175.07 35.68 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.291 -0.723 . . . . 70.01 111.291 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.496 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 55.9 m -148.3 138.42 22.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.095 0.448 . . . . 74.43 110.032 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 1.012 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.1 mp -117.88 129.73 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.833 0.349 . . . . 74.33 110.681 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -108.18 120.04 41.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.388 -0.967 . . . . 75.24 108.388 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 1.05 HE21 ' HA ' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -120.48 132.18 55.09 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.085 0.402 . . . . 71.43 112.085 -172.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -103.51 108.79 20.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.166 -0.679 . . . . 73.14 109.166 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.872 ' HB ' HD12 ' A' ' 202' ' ' LEU . 59.5 t -95.23 -26.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.39 0.614 . . . . 62.04 109.762 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -158.47 -179.92 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.236 -1.024 . . . . 64.25 108.236 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.36 -40.83 75.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.455 0.539 . . . . 72.3 112.455 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.91 ' HB2' ' HB3' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -126.78 13.53 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.014 0.435 . . . . 71.21 111.072 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.872 HD12 ' HB ' ' A' ' 198' ' ' VAL . 2.3 tm? -107.12 103.03 12.33 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 75.51 108.664 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -117.6 153.92 32.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.784 -0.644 . . . . 54.51 110.159 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 196' ' ' GLN . 16.6 m -130.06 149.6 51.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.988 -0.551 . . . . 51.33 109.92 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.54 136.15 50.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 53.32 109.672 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 1.012 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -119.82 136.87 55.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.646 -0.706 . . . . 62.44 111.005 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.485 HD22 ' HA ' ' A' ' 18' ' ' PHE . 20.1 t-20 -114.31 127.66 55.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 62.51 110.436 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 208' ' ' LEU . 1.7 mm? -130.94 129.71 42.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.18 -0.674 . . . . 74.51 109.18 171.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.455 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -156.49 149.01 23.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.13 0.49 . . . . 74.31 111.193 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -131.19 124.92 31.67 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.154 -0.684 . . . . 71.21 109.154 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.7 t -101.83 117.88 35.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.397 0.618 . . . . 74.54 110.132 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.76 130.85 47.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.597 -0.729 . . . . 75.25 110.835 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -15.84 27.5 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.919 -0.657 . . . . 43.02 111.789 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -138.86 150.16 45.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.148 -0.316 . . . . 72.05 110.148 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.8 m -86.28 -16.47 37.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.408 -0.36 . . . . 65.43 111.067 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -67.79 111.21 4.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.0 0.429 . . . . 73.32 110.825 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.0 t -87.99 138.43 31.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.536 -0.913 . . . . 63.33 108.536 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 30.0 mtt-85 -88.28 116.67 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.292 -0.633 . . . . 74.04 109.292 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -115.17 129.37 56.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.864 -1.162 . . . . 71.02 107.864 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -141.11 150.85 22.12 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.895 -1.145 . . . . 54.35 112.46 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.933 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 3.5 mp -132.58 132.35 59.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.017 -1.105 . . . . 71.43 108.017 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.829 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . . . -124.93 130.23 51.94 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.328 1.018 . . . . 71.1 109.837 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.598 ' H ' ' HB2' ' A' ' 236' ' ' LYS . . . -113.87 126.34 55.07 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.117 -0.633 . . . . 74.31 111.187 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 62.23 110.71 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.63 ' HD1' HD13 ' A' ' 227' ' ' ILE . 90.6 t80 -120.81 127.85 52.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 71.12 110.077 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.91 ' HB3' ' HB2' ' A' ' 201' ' ' LYS . 29.2 tt0 -79.92 100.88 8.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.962 -0.563 . . . . 74.22 109.537 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.63 HD13 ' HD1' ' A' ' 225' ' ' TYR . 26.2 mm -68.82 -42.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.869 0.842 . . . . 73.11 109.297 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -137.05 146.77 56.09 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.533 -1.284 . . . . 71.13 107.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -44.97 -25.63 1.73 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.88 2.387 . . . . 60.42 114.185 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.87 -3.32 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.348 0.499 . . . . 75.12 112.348 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.76 123.42 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 70.54 112.002 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 35.7 m -120.76 122.64 40.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 74.24 110.399 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.734 ' HD2' ' HB3' ' A' ' 247' ' ' TYR . 87.6 t80 -104.7 133.13 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.06 -0.348 . . . . 73.24 110.06 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 12.5 p -131.0 140.62 50.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 64.45 111.487 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -156.66 136.71 12.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 70.13 109.127 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.933 ' HB3' ' O ' ' A' ' 221' ' ' ILE . 2.7 mmtm -173.29 179.0 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.865 0.466 . . . . 74.05 110.908 166.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.8 152.03 27.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.129 0.49 . . . . 63.11 111.674 -160.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -109.01 150.74 27.32 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.889 -0.596 . . . . 71.24 110.324 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 241' ' ' SER . 4.4 t-20 -39.46 -33.54 0.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.477 1.511 . . . . 72.42 114.03 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 13.5 m -77.52 24.55 0.2 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.562 0.22 . . . . 62.24 110.651 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.3 p 58.0 29.54 17.86 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.563 1.145 . . . . 73.33 110.937 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 1.056 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.1 mp -99.39 128.98 45.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 116.221 -0.445 . . . . 73.03 111.926 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.887 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.42 116.35 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.699 -0.682 . . . . 65.03 110.525 -171.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.58 133.46 11.59 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.743 -0.742 . . . . 74.24 112.419 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.8 pp -134.23 149.06 50.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 62.15 109.98 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.72 145.86 11.14 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.885 -0.674 . . . . 40.32 111.776 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.734 ' HB3' ' HD2' ' A' ' 233' ' ' PHE . 22.1 p90 -124.61 122.34 37.26 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.297 0.57 . . . . 74.1 110.097 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 10.0 t -111.62 124.25 51.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.341 -0.845 . . . . 64.43 109.445 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -135.77 124.26 23.52 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.58 -0.737 . . . . 73.42 110.487 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 2.3 t -78.64 103.86 8.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.818 -1.178 . . . . 74.41 107.818 171.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.92 -54.5 44.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.511 -0.768 . . . . 72.42 109.654 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.605 ' HB2' HD11 ' A' ' 255' ' ' ILE . 96.8 mttt -145.17 152.16 50.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 106.93 -1.508 . . . . 74.43 106.93 174.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.61 98.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.51 2.14 . . . . 51.22 112.566 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.32 -24.44 2.94 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.889 -0.596 . . . . 64.21 112.662 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -134.34 122.08 39.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.394 0.616 . . . . 62.31 112.002 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.859 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 14.8 ptpt -114.13 133.28 55.68 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 72.42 110.299 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.71 126.89 52.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.25 -0.886 . . . . 72.15 109.713 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.8 t -127.51 111.0 13.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.556 0.693 . . . . 72.45 110.423 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.816 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.68 123.22 45.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 175.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 26.4 t -131.95 140.86 49.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.894 0.378 . . . . 53.15 110.039 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.72 128.48 20.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.914 -0.584 . . . . 71.53 110.433 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.755 HD11 HD23 ' A' ' 242' ' ' LEU . 2.3 tm? -102.48 117.67 35.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.511 -1.292 . . . . 65.11 107.511 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.887 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.3 mm? -92.72 107.71 19.42 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.559 -1.274 . . . . 73.14 107.559 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.056 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.1 m-20 -70.46 104.02 2.62 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.356 -0.979 . . . . 53.32 108.356 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.28 -19.1 38.31 Favored Glycine 0 C--O 1.229 -0.166 0 CA-C-N 115.94 -0.573 . . . . 75.33 112.497 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.36 -24.19 20.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.368 . . . . 73.35 111.016 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 93.8 m-20 -113.34 -30.54 6.87 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.645 0.98 . . . . 72.21 113.645 -170.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.449 HG11 ' HB3' ' A' ' 263' ' ' LEU . 30.8 m -62.62 -26.41 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.041 0.756 . . . . 63.14 113.041 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -70.31 -23.72 62.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.961 0.41 . . . . 54.24 110.369 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.81 6.02 36.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 72.52 110.123 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.65 102.54 0.79 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.752 -0.658 . . . . 54.35 111.831 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 165.15 78.68 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.258 -0.972 . . . . 62.21 112.519 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -113.48 146.68 39.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.504 -0.554 . . . . 75.14 109.504 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 74.2 mmtt -95.39 137.69 34.09 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.586 -0.446 . . . . 62.2 110.231 -175.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.4 tm? -117.7 134.5 54.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.179 -0.464 . . . . 65.35 109.91 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.478 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -135.17 104.27 0.5 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.959 -0.856 . . . . 74.13 110.959 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.816 HD23 HD22 ' A' ' 259' ' ' LEU . 2.4 tm? -114.76 130.95 56.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.51 -0.552 . . . . 63.34 109.51 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.506 ' N ' HD22 ' A' ' 277' ' ' LEU . . . -143.24 136.75 7.19 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.175 -1.012 . . . . 35.42 112.888 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.602 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.6 mm? -114.91 131.08 56.99 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.325 -0.62 . . . . 75.34 109.325 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.859 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 52.6 mt-10 -111.82 112.12 23.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.418 -0.586 . . . . 74.12 109.418 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -99.2 125.15 44.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.809 -1.182 . . . . 70.21 107.809 177.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 75.4 mt-30 -132.53 116.87 17.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.127 0.489 . . . . 42.12 109.985 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -115.61 131.97 56.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.809 -0.632 . . . . 45.15 110.471 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 285' ' ' GLU . 65.9 mt -122.09 -45.17 2.25 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.062 -0.718 . . . . 74.21 109.062 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 284' ' ' LEU . 42.5 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.633 -1.167 . . . . 63.51 109.395 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.045 0.45 . . . . 64.33 110.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 121' ' ' GLU . 21.3 t -118.58 101.98 50.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 54.34 109.735 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 4.4 Cg_exo -77.54 138.63 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.006 2.471 . . . . 72.01 112.075 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 35.2 Cg_exo -61.94 91.15 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.814 2.343 . . . . 74.13 111.683 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p -81.24 -15.99 54.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.684 -0.689 . . . . 74.13 111.321 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.853 ' HB3' HG21 ' A' ' 143' ' ' VAL . 45.8 p90 -62.75 -24.78 67.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.538 0.685 . . . . 74.11 109.677 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 12' ' ' LYS . . . -75.79 -30.0 58.93 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.157 -0.929 . . . . 74.05 110.855 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -104.26 9.34 36.05 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 119.978 -0.689 . . . . 62.35 111.717 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.531 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 94.8 mt -56.78 -35.68 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.377 . . . . 71.01 111.721 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.32 39.8 0.7 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.705 -1.236 . . . . 50.22 114.162 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 9.1 mtmp? -69.17 -48.68 61.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.896 0.848 . . . . 75.4 109.7 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -64.36 -38.37 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 71.24 110.971 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.17 -35.55 74.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 70.41 111.987 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -58.11 -38.07 75.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 60.02 112.177 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.85 -42.9 80.64 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.912 0.338 . . . . 74.25 111.912 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 t -84.47 -32.41 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.297 0.48 . . . . 43.14 112.297 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.96 -21.69 63.23 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.623 0.601 . . . . 70.12 112.623 -171.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 p -57.84 152.61 15.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 62.11 112.493 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 2.8 mptp? -86.37 -21.29 27.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.577 -0.738 . . . . 74.43 109.185 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.73 113.29 1.74 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.016 -0.993 . . . . 55.31 111.132 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.442 ' HB2' HD23 ' A' ' 262' ' ' LEU . 81.7 m-85 -85.79 -14.36 45.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.098 0.475 . . . . 71.42 110.688 -176.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.48 118.58 4.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.042 -0.823 . . . . 65.24 111.042 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -80.21 -4.67 54.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.94 0.37 . . . . 74.14 111.341 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.94 -3.57 69.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.273 -0.489 . . . . 64.24 113.262 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.7 pp -149.07 -178.12 6.2 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.707 0.765 . . . . 74.3 112.555 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -99.88 133.13 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.529 -1.214 . . . . 62.01 109.689 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.587 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.0 ttpp -124.87 146.26 49.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.768 -0.456 . . . . 72.2 109.768 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.695 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tm? -131.9 128.33 38.35 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.71 -0.478 . . . . 65.1 109.71 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.665 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 11.1 m-20 -134.32 120.37 19.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.11 -0.7 . . . . 75.02 109.11 171.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 tp -140.88 128.23 21.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 65.4 110.477 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 15.3 ptpt -118.14 127.29 53.63 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.972 0.415 . . . . 72.24 111.103 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 283' ' ' ALA . 38.7 p -89.7 121.69 32.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.338 -0.986 . . . . 63.03 108.338 168.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -105.04 132.04 51.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.325 0.583 . . . . 73.34 111.784 -169.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 28.8 t -138.97 141.05 38.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.293 -0.867 . . . . 64.45 108.851 172.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.9 13.96 21.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.47 0.653 . . . . 75.53 109.586 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.92 37.18 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.364 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.47 -9.64 76.94 Favored Glycine 0 C--O 1.221 -0.694 0 CA-C-O 119.008 -0.884 . . . . 60.31 114.976 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -103.9 127.57 51.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 119.279 1.54 . . . . 73.3 112.84 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 37.6 tt0 -141.74 117.59 10.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.48 -0.934 . . . . 72.33 108.48 158.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 93.4 m-85 -107.08 120.36 41.87 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.225 -0.59 . . . . 72.51 110.296 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 68.4 m -112.85 117.32 31.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.116 0.484 . . . . 74.42 110.665 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 p -105.03 124.28 49.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.826 -0.624 . . . . 75.31 109.502 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.0 t -133.86 125.99 29.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.827 -0.434 . . . . 72.12 109.827 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 159.09 27.92 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.375 -0.917 . . . . 41.22 112.411 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -129.32 134.77 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.746 -0.464 . . . . 52.14 109.746 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.621 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -129.81 127.68 40.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.136 0.493 . . . . 62.52 111.018 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 50' ' ' GLU . 45.9 m-80 -90.92 144.86 25.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.387 -0.824 . . . . 72.54 109.885 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -70.19 18.87 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.315 0.579 . . . . 44.41 111.921 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 48' ' ' ASN . 21.7 mm-40 -89.25 -167.24 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 73.22 110.075 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -68.13 90.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.64 -0.254 . . . . 74.34 111.54 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p 48.21 45.71 19.9 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.117 0.567 . . . . 75.43 112.246 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 29.1 mmmt -91.12 75.78 6.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 70.23 109.61 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 47' ' ' ALA . 13.3 t -120.54 123.51 70.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.162 -0.926 . . . . 64.23 110.859 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.7 p -109.44 137.04 47.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.085 -0.507 . . . . 52.34 109.669 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.94 136.41 8.82 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.464 -0.874 . . . . 71.0 112.773 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 p -127.63 145.18 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.878 -0.416 . . . . 65.3 109.878 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.3 tm? -120.68 124.97 46.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.708 -0.479 . . . . 72.55 109.708 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.7 tt0 -107.01 118.19 36.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.076 -0.712 . . . . 51.33 109.076 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.2 m -100.45 119.85 39.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.195 -0.668 . . . . 71.22 109.195 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 42.3 mtpt -121.66 127.58 50.95 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.057 0.456 . . . . 72.01 110.408 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.72 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 94.6 m-85 -106.89 120.79 43.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.897 -0.592 . . . . 73.21 109.653 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 17.5 tpt180 -111.8 106.99 15.89 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.534 0.683 . . . . 70.1 110.643 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 40.0 t-105 -105.59 108.16 19.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.574 -1.194 . . . . 75.14 109.876 -174.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -58.6 -36.24 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.221 -0.899 . . . . 71.42 111.943 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 14.3 mm-40 -66.25 120.46 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.437 -0.347 . . . . 75.43 110.324 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 74.57 -44.55 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.015 0.822 . . . . 72.12 111.384 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.95 64.45 0.46 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.904 -0.665 . . . . 42.13 111.899 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.02 134.72 53.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.867 0.365 . . . . 71.5 110.839 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 29.6 m -136.19 112.66 9.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.384 . . . . 73.43 110.647 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 77.6 t80 -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.683 -0.488 . . . . 71.13 109.683 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 84' ' ' GLU . 60.9 p -125.66 116.03 21.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.853 0.359 . . . . 54.22 111.011 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 40.7 tt0 -123.93 122.42 37.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.106 -0.331 . . . . 74.21 110.106 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 55.8 tttm -113.21 116.76 30.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 71.04 111.122 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -103.6 131.78 50.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 65.12 110.395 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.424 ' HB2' HG22 ' A' ' 80' ' ' THR . 7.4 m-20 -101.69 161.8 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 73.14 111.063 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.5 m -62.29 -22.21 65.84 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.584 0.707 . . . . 72.4 110.215 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -72.23 -4.0 26.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.22 -0.9 . . . . 71.01 111.177 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 10.4 m-80 69.64 40.95 1.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.493 0.663 . . . . 74.45 110.677 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 76' ' ' ASN . 9.9 t -114.35 135.47 54.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.373 -0.83 . . . . 74.35 109.613 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.1 mm? -99.59 135.87 40.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.609 -0.723 . . . . 71.42 110.872 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -117.22 89.93 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.504 -1.039 . . . . 52.21 110.504 171.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -95.48 105.43 17.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.862 0.363 . . . . 63.44 111.773 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.56 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 26.2 mt-10 -110.07 131.6 54.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.18 -0.464 . . . . 70.02 109.895 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -119.36 121.78 67.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.005 -0.739 . . . . 74.14 109.005 173.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.0 m -112.0 124.31 52.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.296 0.569 . . . . 74.33 111.664 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 66.6 t -111.03 121.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.136 -0.938 . . . . 75.25 109.663 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.32 142.67 28.18 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.77 -0.826 . . . . 32.11 108.77 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 94' ' ' GLY . 5.1 p-10 -49.69 143.89 6.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.216 0.821 . . . . 70.25 113.216 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -126.99 -56.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.814 -1.084 . . . . 73.51 108.974 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.45 -67.05 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.661 -0.7 . . . . 71.14 109.582 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 86.77 5.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 73.0 110.187 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.447 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -52.92 135.43 36.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.443 -0.798 . . . . 74.4 111.702 -177.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . 102.9 -22.91 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.577 -0.738 . . . . 63.14 113.726 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 35.8 tp -80.69 131.56 35.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.329 1.065 . . . . 65.24 112.18 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -123.73 120.63 33.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.917 -0.583 . . . . 64.42 109.72 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.753 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -109.89 129.8 55.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.689 0.281 . . . . 74.21 110.434 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.932 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.2 m -131.27 119.89 22.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.661 0.267 . . . . 72.23 110.456 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.538 ' HB2' HG22 ' A' ' 85' ' ' ILE . 80.6 m-85 -111.19 115.41 29.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.759 -0.46 . . . . 75.5 109.759 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 2.3 t70 -109.39 136.01 49.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.48 . . . . 74.4 110.343 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.0 m -144.08 122.74 12.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.022 0.439 . . . . 63.23 110.881 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 22.8 t -95.97 125.55 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.401 -0.592 . . . . 70.22 109.401 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 98.6 m-85 -111.48 123.56 50.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.818 -0.628 . . . . 74.23 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -115.58 103.14 54.19 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 70.31 109.465 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.53 -19.15 63.52 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.354 2.703 . . . . 65.52 113.007 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -57.12 -48.11 79.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 64.51 110.811 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.6 m -109.28 -21.71 12.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.314 0.578 . . . . 64.13 111.011 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.03 23.84 43.55 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.848 -0.901 . . . . 73.31 110.848 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.76 148.1 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 73.21 111.852 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.27 116.47 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.167 -0.924 . . . . 72.02 109.165 172.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -118.41 121.16 39.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.876 -1.157 . . . . 73.53 107.876 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.19 149.67 46.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.65 0.611 . . . . 73.22 112.65 -165.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 54.0 mttp -115.23 138.01 51.4 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.149 -1.056 . . . . 65.51 108.149 169.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.905 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -114.96 119.39 61.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.565 -0.902 . . . . 62.31 108.565 174.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.932 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 22.9 tttp -115.11 119.5 36.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.631 -0.713 . . . . 63.44 109.631 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.5 m -127.94 116.83 20.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.438 -0.578 . . . . 64.41 109.438 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -137.1 122.94 2.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.94 -1.124 . . . . 63.33 112.009 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 125' ' ' LEU . 10.5 p90 -107.4 135.41 48.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.316 0.579 . . . . 74.52 110.349 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.417 ' HB3' HG11 ' A' ' 3' ' ' VAL . 19.3 mtmm -109.31 120.43 42.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.925 -1.034 . . . . 74.41 110.142 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.584 ' HB3' HG22 ' A' ' 123' ' ' ILE . 8.3 tpt180 -108.52 157.73 18.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.939 -1.134 . . . . 61.42 107.939 169.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.641 ' HA ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -54.32 -29.27 47.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.723 0.638 . . . . 73.05 112.723 -170.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -112.37 -12.19 13.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 64.43 112.381 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 142' ' ' LEU . 9.8 tp -143.45 132.8 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.821 -0.752 . . . . 62.3 112.47 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -118.76 119.16 33.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.811 -0.44 . . . . 70.3 109.811 179.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 124' ' ' ASN . 3.9 mm? -111.87 119.96 40.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.229 -0.441 . . . . 73.25 110.277 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.88 127.51 5.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.673 -0.775 . . . . 64.44 112.872 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.0 m -111.08 121.61 45.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.619 -0.511 . . . . 74.41 109.619 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 t70 -124.23 117.69 25.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.169 -0.678 . . . . 65.11 109.169 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.905 ' HB3' HG22 ' A' ' 114' ' ' ILE . 36.1 ttm -118.33 130.38 55.99 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.854 -0.529 . . . . 72.22 111.668 -172.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.35 118.78 31.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.725 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.641 ' HE2' ' HB ' ' A' ' 114' ' ' ILE . 92.6 m-85 -96.26 96.53 8.84 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.855 -1.165 . . . . 72.42 107.855 167.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -136.72 155.44 49.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.271 -0.422 . . . . 63.42 110.587 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -30.0 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 63.34 110.97 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.08 -14.08 60.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.049 0.452 . . . . 75.44 110.859 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.67 128.49 2.18 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.626 -0.797 . . . . 73.13 112.731 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.81 118.56 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.604 2.203 . . . . 70.42 110.653 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -125.96 144.77 50.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.866 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.05 118.15 54.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.324 0.583 . . . . 55.12 109.842 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 21.5 ttp-105 -106.94 129.8 54.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.618 -0.719 . . . . 62.42 109.799 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.33 133.23 11.38 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.312 -0.947 . . . . 73.32 111.875 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -126.07 116.47 21.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.758 -0.46 . . . . 61.14 109.758 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 123' ' ' ILE . 8.8 tp -120.62 123.94 44.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.666 -0.494 . . . . 74.3 109.666 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.853 HG21 ' HB3' ' A' ' 7' ' ' TYR . 94.0 t -127.41 129.41 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.312 -0.404 . . . . 72.35 110.715 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.632 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.54 136.72 48.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.973 -0.751 . . . . 63.32 108.973 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.67 118.93 4.18 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.598 -0.81 . . . . 55.21 112.07 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -141.58 147.35 37.53 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 75.33 109.475 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.64 101.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 70.42 111.703 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 174' ' ' LYS . . . 88.22 -32.35 4.43 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.098 -0.955 . . . . 74.34 112.692 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -105.92 122.37 45.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 73.43 111.175 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 151' ' ' ALA . 5.3 tp -138.42 135.1 34.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.359 -0.608 . . . . 74.23 109.359 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -136.73 132.54 34.97 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.843 -0.343 . . . . 72.03 111.227 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.531 ' HA3' ' CD1' ' A' ' 10' ' ' LEU . . . -132.98 133.82 7.22 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.971 -0.633 . . . . 44.31 112.034 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.535 ' HA ' ' HD2' ' A' ' 169' ' ' PHE . 22.6 m-85 -122.8 119.7 31.36 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.421 -0.585 . . . . 71.22 109.421 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -118.63 130.22 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 75.34 110.077 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 21.8 ptp -143.73 143.74 31.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.162 -0.472 . . . . 53.15 110.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -112.36 118.41 35.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.231 -1.026 . . . . 71.23 108.231 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -107.23 118.36 36.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.74 -0.467 . . . . 54.53 109.74 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -86.83 95.35 9.83 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.589 -0.893 . . . . 74.34 108.589 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 m -72.57 -25.16 61.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 113.532 -1.667 . . . . 70.52 111.435 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.55 -31.16 69.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.719 0.771 . . . . 54.44 109.083 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -109.9 -159.79 0.69 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.378 -1.283 . . . . 72.21 108.112 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.0 p -109.47 26.77 10.26 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.132 -0.355 . . . . 72.53 111.111 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 mtp85 -133.66 171.25 14.38 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 114.828 1.418 . . . . 71.21 114.828 -160.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.1 t -104.37 132.22 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.286 -1.325 . . . . 73.52 108.651 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -94.38 -33.91 12.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 45.33 111.245 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -151.87 132.74 14.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.435 -0.348 . . . . 73.05 110.102 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.9 t -124.34 106.94 10.64 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.417 -0.586 . . . . 73.41 109.417 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.91 135.17 55.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.306 0.574 . . . . 75.31 110.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 153' ' ' TYR . 57.5 m-85 -125.83 155.9 40.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.242 -0.436 . . . . 72.41 110.555 -176.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . . . -150.65 127.96 11.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.158 -0.473 . . . . 73.53 109.795 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 63.7 t -129.77 127.59 64.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.918 0.39 . . . . 75.24 110.491 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.02 111.25 4.19 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.05 -0.82 . . . . 61.54 111.05 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -112.06 120.44 41.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.794 -0.817 . . . . 71.34 108.794 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 11.5 tmtt? -103.23 126.5 50.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.373 0.606 . . . . 74.34 109.89 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 3.9 m -116.91 164.08 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.913 -1.04 . . . . 70.3 108.398 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -34.13 -66.82 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.177 0.806 . . . . 54.24 113.177 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.89 13.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.898 -0.321 . . . . 72.14 111.694 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.497 ' HD1' ' NE2' ' A' ' 196' ' ' GLN . 10.3 m-85 -126.5 137.97 53.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.577 -0.283 . . . . 73.42 110.269 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -122.11 122.73 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.832 -0.747 . . . . 73.2 109.81 170.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 194' ' ' ILE . 4.9 tt -123.77 139.19 54.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.737 -0.665 . . . . 72.31 111.068 -172.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.84 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 58.4 m80 -116.45 117.13 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.36 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.6 m -96.02 110.83 23.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.228 -0.656 . . . . 71.05 109.228 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -124.42 160.63 27.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 41.11 110.919 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.504 HG22 ' HD1' ' A' ' 190' ' ' PHE . 16.6 t -131.72 124.4 53.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.872 -0.604 . . . . 73.15 109.764 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 30.2 t30 -99.89 95.45 6.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.622 -0.717 . . . . 53.44 109.705 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.63 178.82 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.282 -0.872 . . . . 44.23 109.381 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.21 -7.14 71.09 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.075 -1.06 . . . . 72.21 111.404 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.9 m -95.01 -25.71 16.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.762 0.653 . . . . 71.52 112.762 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 43.2 tt0 -132.38 145.05 50.95 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.467 -0.771 . . . . 61.41 111.957 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.504 ' HD1' HG22 ' A' ' 184' ' ' VAL . 22.9 m-85 -117.17 150.27 39.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.459 -0.941 . . . . 65.41 108.459 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.32 155.81 24.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.176 -1.012 . . . . 62.14 113.491 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -141.14 126.0 2.95 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.271 -0.732 . . . . 52.15 111.271 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.84 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 46.8 t -112.1 136.6 51.26 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.895 0.379 . . . . 51.42 110.075 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.75 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.6 mm -120.53 124.3 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.868 -0.606 . . . . 63.51 109.542 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.457 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 0.3 OUTLIER -118.23 121.47 40.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.425 -0.583 . . . . 75.42 109.425 173.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.497 ' NE2' ' HD1' ' A' ' 178' ' ' PHE . 14.5 mm100 -124.45 132.04 53.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 63.4 111.635 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -86.53 122.57 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.216 -0.661 . . . . 74.02 109.216 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.5 m -136.22 173.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.317 -0.401 . . . . 71.22 110.896 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -97.51 -41.92 7.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 45.11 110.098 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -69.93 -33.19 71.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 73.12 112.345 -177.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.437 ' HB3' ' HB1' ' A' ' 223' ' ' ALA . 94.1 mttt -123.54 11.77 9.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.264 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 -85.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.787 0.679 . . . . 60.43 110.892 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.835 ' HG3' ' HB3' ' A' ' 224' ' ' LYS . 9.5 pt-20 -127.1 128.75 46.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.171 -0.678 . . . . 74.33 109.171 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 196' ' ' GLN . 15.4 t -123.44 148.82 45.78 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.374 -0.53 . . . . 75.44 110.419 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.45 136.59 49.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.67 -0.696 . . . . 63.31 110.964 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.83 HG22 HG22 ' A' ' 221' ' ' ILE . 61.1 t -118.8 137.96 51.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.447 -0.797 . . . . 53.43 109.159 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.416 ' OD1' ' HA3' ' A' ' 220' ' ' GLY . 2.9 p-10 -124.6 134.19 53.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 71.21 110.715 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.46 141.36 49.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.054 -0.976 . . . . 75.54 109.397 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -142.21 130.61 22.38 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.182 -0.463 . . . . 31.21 110.036 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.9 122.37 37.18 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.906 -0.405 . . . . 74.44 109.906 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 216' ' ' ASN . 27.0 m -95.21 107.96 20.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.584 -0.524 . . . . 74.25 109.584 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.16 146.21 48.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.723 -0.671 . . . . 55.54 111.162 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.95 -46.42 3.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.134 -0.555 . . . . 30.2 112.261 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 216' ' ' ASN . 21.1 t-20 -86.59 -21.2 26.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.896 0.379 . . . . 75.32 110.271 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.5 m 66.74 17.42 10.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.577 -0.738 . . . . 61.44 110.758 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.432 ' HB2' ' OD1' ' A' ' 214' ' ' ASN . 53.7 t-20 -69.48 121.18 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 73.41 109.526 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.3 m -113.71 122.56 47.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.069 0.461 . . . . 73.22 110.031 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.747 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 37.4 mmt180 -105.31 125.0 50.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.959 -0.564 . . . . 74.43 109.924 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.755 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 46.9 m-85 -113.9 133.6 55.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.909 -0.775 . . . . 65.13 108.909 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.416 ' HA3' ' OD1' ' A' ' 207' ' ' ASN . . . -145.03 141.15 9.66 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.31 -0.948 . . . . 52.43 112.044 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.83 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -132.36 133.3 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 64.13 110.857 178.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -132.51 138.37 47.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.875 -0.602 . . . . 55.04 111.062 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.65 125.56 54.28 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.84 -0.43 . . . . 53.04 109.84 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.835 ' HB3' ' HG3' ' A' ' 203' ' ' GLU . 4.3 ttpp -113.34 113.32 25.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.252 0.549 . . . . 63.44 109.691 -177.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -131.9 116.54 17.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 74.32 110.144 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.686 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 12.0 pt20 -85.07 103.1 13.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.382 0.61 . . . . 61.21 109.987 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.3 -29.33 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.487 -0.779 . . . . 40.43 110.561 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.723 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 23.2 m-20 -123.47 163.29 35.28 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.625 . . . . 72.41 109.542 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.21 -29.73 64.52 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.172 1.915 . . . . 71.23 111.916 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -109.81 -2.27 17.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 64.14 111.607 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -134.7 124.53 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.476 . . . . 72.41 111.891 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 43.3 t -123.43 135.41 54.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 63.41 109.668 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -115.79 133.61 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.126 0.489 . . . . 62.13 110.534 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.3 p -125.26 123.85 40.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.912 -0.585 . . . . 63.34 110.325 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -107.6 140.01 41.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.323 -0.991 . . . . 54.41 108.323 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -148.88 150.07 32.34 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.828 -0.349 . . . . 74.23 110.745 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 10.0 p -145.64 142.91 21.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 72.13 109.943 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 15.4 t-20 -105.31 149.45 26.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.475 -0.784 . . . . 73.22 109.11 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.755 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 20.8 t-20 -57.04 -21.59 32.35 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.996 0.81 . . . . 43.11 112.251 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.5 p -79.24 21.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.958 0.409 . . . . 54.12 110.842 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 239' ' ' ASN . 25.9 t 68.59 31.28 4.79 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.461 -0.79 . . . . 63.02 110.641 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.892 ' HB3' HD11 ' A' ' 262' ' ' LEU . 36.1 mt -99.73 116.01 30.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.344 -0.542 . . . . 71.04 110.468 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 243' ' ' ILE . 3.4 mp -99.76 117.83 45.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 N-CA-C 109.896 -0.409 . . . . 74.14 109.896 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.41 141.46 16.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.013 -0.613 . . . . 61.01 113.21 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 260' ' ' SER . 8.0 mt -116.18 137.95 51.69 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -141.4 120.71 1.73 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.32 -0.943 . . . . 33.3 111.875 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.5 115.42 18.11 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.847 -0.427 . . . . 73.12 109.847 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -114.74 130.57 56.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.15 0.5 . . . . 63.22 110.351 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 58.1 tt0 -143.66 131.65 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.938 -0.574 . . . . 75.12 110.289 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 23.2 p -78.67 129.1 34.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.591 0.234 . . . . 55.12 110.89 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 251' ' ' LEU . 1.6 pp -140.8 145.23 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.864 -0.421 . . . . 75.41 109.864 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 92.3 mttt 67.74 156.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 123.619 0.574 . . . . 74.01 110.51 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 36.3 Cg_endo -66.71 86.7 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.21 1.94 . . . . 71.05 113.366 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.759 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 105.46 29.54 5.03 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.904 -0.665 . . . . 74.1 113.926 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 251' ' ' LEU . 64.7 mt -132.76 133.95 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 117.384 0.592 . . . . 74.3 110.72 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.14 133.63 53.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.76 0.314 . . . . 43.33 110.323 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.3 tp -98.06 132.57 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 73.14 109.765 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 15.3 m -126.06 111.15 14.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.347 -0.388 . . . . 72.02 110.201 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.977 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.09 124.58 47.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.664 -0.865 . . . . 64.01 108.664 176.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 45.0 m -133.63 140.41 47.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.907 0.384 . . . . 64.35 110.435 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.013 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.892 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -106.87 115.91 31.01 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.082 -0.71 . . . . 64.14 109.082 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.588 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -95.0 106.25 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.48 -1.304 . . . . 54.54 107.48 175.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.607 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 42.7 m-20 -71.95 104.77 3.62 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.759 -0.83 . . . . 73.42 108.759 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.62 -20.66 25.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.246 -0.502 . . . . 34.12 112.996 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -90.8 -3.51 57.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.811 0.338 . . . . 70.24 110.936 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.607 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 62.9 t30 -133.03 -35.53 1.05 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.754 0.65 . . . . 73.35 112.754 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' ' 263' ' ' LEU . 29.4 m -62.46 -18.41 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.747 0.647 . . . . 72.14 112.747 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -68.38 -25.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 65.11 110.324 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.33 -5.98 24.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.431 0.634 . . . . 63.25 110.005 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 91.95 103.48 1.42 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.608 -0.724 . . . . 72.02 111.809 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 173.81 85.62 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.54 -0.838 . . . . 72.31 112.17 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -113.47 147.18 38.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.881 -0.414 . . . . 73.45 109.881 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 7.1 mmpt? -95.15 137.08 34.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.062 -0.718 . . . . 64.23 109.062 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.75 127.61 54.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.82 -0.437 . . . . 73.51 109.82 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.55 104.96 0.83 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.56 -1.016 . . . . 34.14 110.56 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.977 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -113.76 125.35 54.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.905 -0.776 . . . . 72.33 108.905 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -145.68 133.64 5.1 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.6 -1.286 . . . . 54.2 112.98 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.695 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.3 mm? -108.7 128.01 54.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.248 -1.019 . . . . 64.33 108.248 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 10.5 pt-20 -140.86 137.92 33.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 119.328 -0.368 . . . . 55.11 110.594 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.759 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.6 OUTLIER 166.56 -148.96 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.124 0.89 . . . . 75.52 111.213 168.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 22.3 pt20 -137.68 119.11 14.76 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.208 -0.451 . . . . 61.12 110.776 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.664 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -82.58 109.98 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.169 0.509 . . . . 60.11 110.004 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 284' ' ' LEU . 3.8 mm? -125.29 164.04 21.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.768 -0.651 . . . . 71.33 110.542 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.551 -0.907 . . . . 74.11 108.551 178.302 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.849 0.356 . . . . 75.21 111.448 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 76.5 t -123.18 124.63 26.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 54.41 109.948 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 31.2 Cg_exo -59.42 143.83 99.59 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.097 2.531 . . . . 62.5 112.835 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 4.9 Cg_exo -77.17 69.17 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.198 2.599 . . . . 74.35 111.283 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -68.46 -29.61 68.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.802 -0.636 . . . . 72.32 112.075 -173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.89 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.9 p90 -64.56 -26.72 68.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.924 0.392 . . . . 73.23 111.089 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.64 35.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.052 0.453 . . . . 63.14 110.033 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -94.9 4.03 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.949 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 ' HA3' ' A' ' 152' ' ' GLY . 92.4 mt -63.94 -33.2 75.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.401 . . . . 73.22 110.216 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 61.91 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.012 -0.613 . . . . 63.21 112.143 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.12 -39.08 79.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 70.45 110.239 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 m -59.24 -36.47 75.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.226 -0.897 . . . . 72.43 111.836 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.47 69.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.324 -0.398 . . . . 52.45 112.052 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -62.33 -31.53 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 72.25 110.934 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 62.2 111.392 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 222' ' ' ALA . 40.0 t -78.59 -46.18 24.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.966 -0.294 . . . . 62.32 110.797 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 218' ' ' ARG . 90.9 t80 -64.79 -42.6 94.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.17 0.509 . . . . 74.31 110.807 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 20' ' ' LYS . 1.8 m -108.55 -142.98 0.38 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.237 -1.023 . . . . 74.33 108.237 174.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.577 ' H ' HG22 ' A' ' 19' ' ' THR . 43.2 mmtm -141.59 106.02 4.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.909 -0.404 . . . . 73.45 109.909 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.73 -44.02 21.53 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.67 -0.972 . . . . 62.42 110.67 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 28' ' ' LYS . 30.0 m-85 -135.15 -179.24 5.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.402 -0.592 . . . . 72.11 109.402 173.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 51.91 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.487 -0.863 . . . . 51.22 112.215 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -103.55 11.01 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.919 0.39 . . . . 71.32 110.819 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.667 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 93.52 13.75 54.81 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.444 -0.884 . . . . 72.12 111.854 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.6 pp -126.89 179.16 5.53 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-O 122.239 1.019 . . . . 75.53 113.317 -170.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.696 HD12 HD12 ' A' ' 277' ' ' LEU . 29.9 mm -98.58 142.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.888 -1.505 . . . . 62.43 109.855 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.595 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 3.9 tmtm? -122.47 135.82 54.75 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 74.34 109.424 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.0 tp -123.78 148.5 46.6 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.727 -0.389 . . . . 74.32 110.507 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 43' ' ' SER . 10.4 t70 -145.22 127.66 15.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.306 -0.861 . . . . 74.2 108.886 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.4 OUTLIER -126.65 124.61 40.26 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.839 -0.8 . . . . 62.13 108.839 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -125.61 138.16 53.92 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.706 -0.479 . . . . 73.01 109.706 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 33.4 m -136.34 128.71 30.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.697 0.284 . . . . 65.25 110.374 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -104.59 141.84 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 70.45 110.798 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.925 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 31.1 m -134.03 170.02 16.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.099 -0.704 . . . . 73.15 109.099 172.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.98 -62.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.258 0.836 . . . . 73.23 113.258 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -144.23 126.86 16.07 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.177 -0.609 . . . . 70.41 111.654 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 86.84 -10.5 67.71 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 119.084 -0.842 . . . . 74.11 114.806 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.925 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 3.0 mm? -103.03 129.38 49.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.782 1.291 . . . . 74.3 112.41 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.872 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 38.4 tt0 -139.77 118.08 12.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.242 -0.651 . . . . 75.31 109.242 165.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.78 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 66.7 t80 -104.9 121.33 43.47 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.798 -0.361 . . . . 75.04 110.325 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 87.2 m -127.3 128.22 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 72.3 111.385 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.7 t -122.48 132.33 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.824 -0.806 . . . . 70.32 108.824 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 p -134.33 125.61 27.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.104 -0.332 . . . . 71.54 110.104 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.67 151.27 23.19 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.803 -1.189 . . . . 65.34 113.04 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 27.3 m -138.12 134.23 34.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.766 -0.828 . . . . 62.44 108.766 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.573 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -144.39 131.98 21.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.581 -0.448 . . . . 70.32 111.914 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.9 143.85 55.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.633 -0.712 . . . . 74.44 109.164 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 m -54.69 -27.12 38.02 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.451 0.537 . . . . 63.53 112.451 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -88.52 6.56 37.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.152 0.501 . . . . 63.43 110.529 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.5 p 52.41 24.98 3.22 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.812 0.845 . . . . 70.23 112.507 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 p -85.06 -50.81 7.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.192 0.52 . . . . 42.33 111.101 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.61 100.22 9.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.745 -0.835 . . . . 75.32 108.745 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 47' ' ' ALA . 15.1 t -125.31 132.65 70.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.466 -0.788 . . . . 54.51 110.798 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 124.7 52.09 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 42.45 108.98 173.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.16 103.84 0.54 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.885 -0.674 . . . . 64.11 111.725 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 t -111.15 139.28 46.66 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.11 0.481 . . . . 73.41 110.177 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.38 124.59 46.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.936 -1.135 . . . . 53.4 107.936 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 56.5 mt-10 -120.24 119.11 32.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.328 0.585 . . . . 73.11 110.331 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' ' 73' ' ' GLU . 5.0 t -110.83 120.59 42.89 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.153 -0.684 . . . . 73.14 109.153 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.872 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 2.7 mptp? -110.21 137.67 47.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 64.11 109.496 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 18.2 m-85 -115.23 118.86 34.5 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.079 -1.082 . . . . 74.03 108.079 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.537 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ptt180 -131.57 108.41 9.52 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.388 -0.925 . . . . 64.12 111.879 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -95.7 100.74 12.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.124 -1.398 . . . . 74.54 108.745 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m 72.8 124.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.348 1.03 . . . . 65.23 111.556 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.84 130.58 46.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.048 -0.723 . . . . 63.11 109.048 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 63.34 66.15 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.289 -0.634 . . . . 72.14 109.289 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.55 -107.26 0.21 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.972 -0.632 . . . . 73.31 111.578 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.582 ' CD1' HG12 ' A' ' 87' ' ' VAL . 2.0 mm? -117.51 132.75 56.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.236 0.458 . . . . 61.41 112.236 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 60.0 m -136.34 119.18 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.28 0.562 . . . . 62.32 111.204 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 59.0 m-85 -109.87 133.36 53.25 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.972 -0.751 . . . . 73.24 108.972 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -125.14 132.66 53.04 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.509 -0.476 . . . . 54.13 111.573 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 37.3 mt-10 -125.34 123.25 38.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 73.21 109.439 171.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.44 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 63.0 tttp -122.76 109.66 14.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.288 -0.264 . . . . 62.43 110.288 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -107.29 134.3 50.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.959 -0.386 . . . . 71.53 109.959 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -120.1 155.13 33.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 73.34 110.529 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -58.24 -22.88 54.01 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.226 0.536 . . . . 74.41 111.38 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HB3' HG23 ' A' ' 107' ' ' THR . 46.6 m-20 -71.51 -1.39 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.569 -0.741 . . . . 71.34 111.829 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 20.5 m120 78.98 21.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.543 0.737 . . . . 71.13 109.925 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.861 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 3.6 m -90.72 118.99 30.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.559 -0.746 . . . . 64.53 110.757 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.2 mm? -101.13 118.14 36.41 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.411 -0.359 . . . . 71.3 110.556 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -116.78 96.14 0.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.606 -0.997 . . . . 41.24 110.606 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -143.59 156.1 44.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.088 0.403 . . . . 72.33 112.088 -169.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 mm-40 159.52 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 125.207 1.567 . . . . 64.32 110.047 167.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.501 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.55 137.71 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.644 0.609 . . . . 62.21 112.644 -161.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 98' ' ' THR . 12.8 t -129.38 140.39 51.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.977 0.418 . . . . 53.21 110.946 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 97' ' ' LEU . 6.2 m -117.88 138.44 48.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.11 -0.496 . . . . 72.34 109.834 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -114.42 116.57 29.11 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.507 -0.477 . . . . 74.32 110.827 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.589 ' HB3' ' H ' ' A' ' 94' ' ' GLY . 7.3 p-10 39.71 31.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.679 1.191 . . . . 72.22 113.612 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -75.2 -47.84 26.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 61.21 109.957 176.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -70.07 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.197 -0.668 . . . . 74.22 109.197 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -99.2 122.72 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.219 -0.446 . . . . 63.11 110.2 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 10.1 tpp85 -63.66 124.87 22.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.289 -0.414 . . . . 73.02 110.559 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.589 ' H ' ' HB3' ' A' ' 89' ' ' ASP . . . 97.0 -22.74 39.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.058 -0.591 . . . . 45.53 112.093 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.6 tp -89.92 136.93 32.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.009 0.433 . . . . 74.13 110.244 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.95 ' HE3' ' HD2' ' A' ' 119' ' ' LYS . 63.8 mmtt -121.66 116.5 24.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.186 -0.672 . . . . 73.03 109.186 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.4 mm? -108.0 127.52 53.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.937 -0.394 . . . . 72.02 109.937 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.916 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.3 m -129.35 119.55 24.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 72.12 111.42 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 87.4 m-85 -104.82 121.09 42.93 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.983 -1.118 . . . . 64.43 107.983 171.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 9.4 t70 -130.45 127.54 39.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.83 0.706 . . . . 72.12 109.35 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 p -140.24 130.68 25.39 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.275 -0.97 . . . . 75.31 112.156 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 45.1 t -113.32 122.27 46.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.57 -0.741 . . . . 43.4 109.448 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.689 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 36.5 p90 -138.03 119.24 14.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.877 0.846 . . . . 71.35 112.162 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.861 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 43.3 t -132.24 137.02 29.08 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.592 -1.186 . . . . 61.11 109.244 166.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 3.4 Cg_exo -81.89 -1.85 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.626 2.217 . . . . 42.42 111.183 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -110.2 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.676 -0.693 . . . . 73.24 110.173 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.589 HG23 ' HB3' ' A' ' 78' ' ' ASP . 3.3 t -146.89 133.86 20.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.433 -0.951 . . . . 71.14 108.433 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' HG23 ' A' ' 80' ' ' THR . . . 100.07 36.03 4.31 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 118.33 -1.891 . . . . 50.21 111.2 -164.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 104' ' ' SER . 11.7 mptt -55.61 155.95 5.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.481 0.658 . . . . 72.34 112.143 -168.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 103' ' ' PHE . 52.7 tttp -71.03 115.06 9.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.856 -1.065 . . . . 72.55 111.869 -159.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -133.44 132.8 41.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.455 -1.248 . . . . 65.31 109.167 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.58 127.9 54.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.032 -0.531 . . . . 62.42 110.593 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 30.6 mmtp -111.82 137.29 49.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.01 -0.541 . . . . 74.42 110.126 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.428 HG23 ' CG ' ' A' ' 129' ' ' MET . 3.4 tp -120.58 116.9 51.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.878 -0.786 . . . . 63.35 108.878 171.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.916 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.1 ttmp? -114.79 121.26 42.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.251 -0.886 . . . . 63.32 110.048 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.4 t -116.61 118.15 31.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.344 0.593 . . . . 61.02 109.448 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.95 151.5 17.02 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.749 -0.739 . . . . 60.21 112.087 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -132.87 127.68 34.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.316 -0.624 . . . . 73.43 109.316 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.95 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 68.3 mttm -110.77 120.26 41.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.139 -0.624 . . . . 71.24 111.465 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.646 ' HB2' HG22 ' A' ' 123' ' ' ILE . 80.5 mtp180 -109.58 162.56 14.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.079 -0.964 . . . . 75.23 108.612 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.54 -38.87 60.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.404 0.52 . . . . 65.32 112.404 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -120.86 8.27 10.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.569 -0.287 . . . . 63.24 111.737 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.755 HD11 ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -139.58 131.39 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.178 0.514 . . . . 74.04 111.234 -173.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.4 t30 -122.15 119.4 31.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.044 -0.526 . . . . 63.4 110.764 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.684 HD13 HD13 ' A' ' 142' ' ' LEU . 4.5 mm? -110.66 134.26 52.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 72.13 109.368 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.77 116.01 0.83 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.338 -0.934 . . . . 75.31 112.217 176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 73.5 m -110.33 107.45 17.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.999 0.428 . . . . 72.4 110.54 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 27.3 t70 -111.91 118.35 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.685 -0.689 . . . . 72.54 109.313 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.428 ' CG ' HG23 ' A' ' 114' ' ' ILE . 23.8 ptp -129.25 147.97 51.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.673 -0.811 . . . . 65.32 112.061 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 3.1 m-20 -76.04 119.72 20.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.535 -1.283 . . . . 75.45 107.535 174.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -86.53 109.41 19.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.265 0.839 . . . . 73.23 113.265 -163.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 136' ' ' PRO . 20.1 t70 43.34 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.87 1.433 . . . . 74.54 114.87 161.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -60.95 -26.15 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.663 0.616 . . . . 74.11 112.663 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -93.21 -5.18 50.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.048 0.452 . . . . 75.5 110.57 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.05 109.79 3.31 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.042 -0.823 . . . . 70.14 111.042 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.542 ' HG3' ' HA ' ' A' ' 132' ' ' ASP . 27.4 Cg_exo -61.38 100.62 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.802 2.335 . . . . 62.42 112.553 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 45.0 t -126.87 128.77 47.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 74.42 108.943 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.98 117.12 52.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.184 -0.606 . . . . 72.34 110.868 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 156' ' ' ASN . 24.1 mtt180 -108.08 121.64 45.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.021 -0.733 . . . . 73.31 109.021 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.68 131.55 10.45 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.791 -1.195 . . . . 73.15 111.603 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -122.24 116.24 23.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.764 -0.458 . . . . 71.12 109.764 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.684 HD13 HD13 ' A' ' 125' ' ' LEU . 12.9 tp -122.24 124.53 44.01 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.262 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.89 HG21 ' HB3' ' A' ' 7' ' ' TYR . 57.3 t -122.38 121.86 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 74.42 109.983 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.755 ' HG ' HD11 ' A' ' 123' ' ' ILE . 4.3 mp -109.11 137.21 47.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.091 -0.707 . . . . 73.21 109.091 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.537 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -122.38 119.0 3.82 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.617 -0.801 . . . . 75.52 112.847 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.425 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 47.5 m-85 -129.71 147.56 51.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.402 -1.333 . . . . 74.51 107.402 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -56.45 101.2 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.452 0.644 . . . . 75.25 111.059 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.758 ' HA2' ' HB3' ' A' ' 174' ' ' LYS . . . 104.09 -33.49 6.53 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.984 -1.007 . . . . 52.32 112.107 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 2.2 m-90 -107.01 120.26 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.212 -0.581 . . . . 73.5 111.898 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.537 HD23 ' HA2' ' A' ' 145' ' ' GLY . 7.6 mt -123.2 138.17 54.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.274 -0.421 . . . . 73.2 109.892 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -143.06 124.38 14.65 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.875 -0.33 . . . . 61.41 110.174 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.8 131.71 4.42 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.503 -0.856 . . . . 71.12 111.405 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 37.9 p90 -142.65 144.66 32.87 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.095 -0.642 . . . . 74.42 111.952 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 77.2 mt-30 -111.87 121.74 45.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.052 -0.976 . . . . 74.3 109.303 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.4 ' C ' HD22 ' A' ' 156' ' ' ASN . 87.8 mtp -118.94 129.84 55.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.874 -0.787 . . . . 64.5 108.874 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -109.99 114.56 28.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.969 -0.752 . . . . 74.54 108.969 -177.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 25.1 m-85 -94.34 118.49 31.7 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 74.45 110.355 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 161' ' ' LYS . 38.0 tt0 -86.71 100.68 12.65 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 108.967 -0.753 . . . . 73.52 108.967 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 m -70.56 -17.46 62.92 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.334 -1.757 . . . . 71.31 111.355 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.85 92.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.341 -0.985 . . . . 64.33 108.341 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 158' ' ' GLU . 61.4 mttp -99.95 -159.5 0.74 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.538 -1.21 . . . . 73.54 108.299 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 p -109.15 28.44 8.5 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.221 -0.3 . . . . 55.11 110.528 172.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -151.7 150.58 30.38 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 119.086 -1.045 . . . . 74.13 112.249 -161.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.3 m -74.3 134.95 28.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.079 0.466 . . . . 73.13 110.325 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 9.4 t -95.45 -23.12 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.999 -0.546 . . . . 53.13 111.03 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -139.72 132.63 29.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 75.52 110.617 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.431 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 14.4 m -122.34 129.91 52.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.492 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.94 121.41 21.63 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.964 -0.384 . . . . 73.42 109.964 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.682 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 91.2 m-85 -121.01 140.48 51.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.827 0.346 . . . . 70.24 110.964 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.91 128.58 24.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.132 0.491 . . . . 64.42 110.077 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.669 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -127.19 150.15 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.495 -0.557 . . . . 55.22 109.495 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.46 120.06 2.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.114 -0.565 . . . . 55.23 111.868 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -113.29 120.73 42.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.861 0.362 . . . . 74.02 110.085 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.758 ' HB3' ' HA2' ' A' ' 148' ' ' GLY . 29.7 ttmt -104.68 123.9 48.42 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.433 -0.58 . . . . 63.42 109.433 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.9 m -134.42 114.09 12.54 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.513 -0.551 . . . . 64.24 109.513 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 47.66 -93.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.816 0.673 . . . . 73.43 112.816 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -111.48 6.41 20.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.02 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.83 ' HD2' HE22 ' A' ' 196' ' ' GLN . 7.2 m-85 -113.34 127.37 56.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.503 -0.317 . . . . 72.21 110.794 -173.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.92 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.1 mm-40 -112.06 124.61 52.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.667 -0.864 . . . . 73.13 108.667 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.409 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 5.6 tt -122.22 134.09 54.71 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.725 -0.609 . . . . 73.51 110.577 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 41.0 t60 -119.97 116.7 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.876 -0.602 . . . . 71.13 110.575 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.669 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 12.3 m -90.46 141.01 29.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.988 -0.745 . . . . 74.34 108.988 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -142.4 138.77 31.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.358 -0.537 . . . . 72.22 111.187 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 61.0 t -132.39 125.8 54.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.41 -0.814 . . . . 52.12 110.067 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.61 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 26.2 t-20 -117.06 107.76 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.249 -0.648 . . . . 71.22 109.249 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.5 t70 62.93 -171.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.919 -0.771 . . . . 74.21 108.919 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.93 -6.33 89.16 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.452 -0.88 . . . . 73.02 111.356 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.5 m -97.83 -25.68 14.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.836 0.68 . . . . 73.42 112.836 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 3.7 tp10 -118.21 113.68 21.89 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.603 -0.686 . . . . 72.3 110.751 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 42.4 p90 -135.56 132.1 36.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.775 -0.37 . . . . 74.3 110.735 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -169.83 -158.91 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.238 -0.982 . . . . 64.0 113.404 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.14 178.43 23.85 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.527 -0.368 . . . . 25.44 112.528 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 181' ' ' HIS . 18.8 m -149.84 147.43 27.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.654 -0.499 . . . . 70.11 109.654 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.6 mp -128.79 124.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.659 0.266 . . . . 75.41 110.942 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.92 ' HB2' ' HB2' ' A' ' 179' ' ' GLN . 43.8 m-85 -108.19 123.66 49.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.667 -0.494 . . . . 75.35 109.667 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 1.024 HE21 ' HA ' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -120.7 124.67 45.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.313 -0.403 . . . . 71.33 111.763 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 203' ' ' GLU . 11.6 mmtp -96.0 107.51 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 52.43 109.532 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.89 92.43 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.911 -0.586 . . . . 63.13 110.642 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.7 26.5 11.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.255 -0.884 . . . . 52.3 111.553 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 68.41 5.12 4.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.345 -0.843 . . . . 71.41 112.539 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.42 -38.87 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 63.45 111.117 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.56 151.99 40.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.411 . . . . 73.2 110.759 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 41.6 tt0 -117.11 132.21 56.72 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.814 -0.81 . . . . 53.54 108.814 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -123.06 143.16 50.14 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.211 -0.292 . . . . 75.34 110.211 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -129.66 136.39 49.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.123 0.487 . . . . 75.45 110.848 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 193' ' ' SER . 39.3 t -112.89 130.91 65.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.652 . . . . 75.14 109.538 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 18' ' ' PHE . 14.2 m120 -114.52 128.95 56.6 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.277 -0.638 . . . . 73.23 109.277 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.707 HD13 ' HD2' ' A' ' 219' ' ' PHE . 5.5 tp -146.92 134.29 20.73 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.409 -0.359 . . . . 52.24 110.357 -170.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.7 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -157.74 150.44 22.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.849 0.357 . . . . 54.41 111.466 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.552 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 29.4 t-105 -115.79 133.03 56.44 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.985 -0.746 . . . . 70.24 108.985 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.854 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 20.9 m -95.54 108.23 20.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.709 -0.478 . . . . 74.35 109.709 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.589 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.62 147.5 49.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.79 . . . . 63.13 111.706 -174.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.03 -74.74 0.21 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.717 -0.674 . . . . 62.54 111.677 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -173.8 85.07 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 74.05 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.854 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 49.0 m -156.7 165.85 35.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.716 . . . . 64.3 109.415 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.05 160.01 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.921 -0.4 . . . . 43.34 109.921 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.552 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 9.2 t -78.7 134.46 37.1 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.591 -0.522 . . . . 62.41 109.591 174.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.473 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 20.5 mtt180 -92.21 117.72 30.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.881 -0.415 . . . . 73.33 109.881 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.707 ' HD2' HD13 ' A' ' 208' ' ' LEU . 33.9 t80 -114.13 148.82 36.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.564 -0.532 . . . . 73.2 109.564 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.58 152.35 23.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.459 -0.877 . . . . 74.32 112.578 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.506 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.3 mp -135.92 130.23 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.816 -0.439 . . . . 72.01 109.816 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.597 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -120.99 154.29 36.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.835 -0.432 . . . . 65.35 109.835 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -138.44 124.31 19.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.906 0.384 . . . . 62.52 110.313 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -111.26 113.68 26.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.559 -0.904 . . . . 62.41 108.559 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -113.51 114.07 26.01 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.044 0.45 . . . . 74.45 110.037 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.72 ' H ' ' NE2' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -91.07 117.26 29.45 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.761 -0.829 . . . . 54.54 108.761 173.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 228' ' ' ASP . 3.2 mp -69.17 -53.28 26.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 64.52 109.546 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 227' ' ' ILE . 22.4 t70 172.66 -48.96 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 O-C-N 124.006 0.816 . . . . 71.4 110.929 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 86.1 Cg_endo -78.42 -144.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.337 2.024 . . . . 72.44 113.331 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 4.1 t0 -93.39 16.41 13.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 64.02 110.463 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.38 123.89 44.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.545 -0.752 . . . . 53.14 110.237 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.8 143.45 50.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 72.43 110.308 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -97.03 129.84 44.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.053 -0.521 . . . . 71.13 109.696 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -121.15 119.27 31.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.013 0.435 . . . . 63.25 110.135 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -123.5 152.14 42.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.078 -0.51 . . . . 43.54 110.012 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 19.9 ptpt -153.26 140.67 19.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.922 -0.399 . . . . 73.53 109.922 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 9.9 p -132.91 141.16 45.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.073 0.463 . . . . 55.11 109.959 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.645 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 20.7 m120 -108.46 150.22 27.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.126 -0.488 . . . . 62.24 109.796 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 241' ' ' SER . 9.0 p30 -50.51 -27.39 6.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.252 0.97 . . . . 74.45 113.241 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.625 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 6.0 m -82.03 24.51 0.63 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.581 . . . . 73.12 109.938 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.467 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 57.6 m 66.05 39.33 4.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.926 -1.034 . . . . 75.03 111.297 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.7 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.5 mp -91.76 121.72 33.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 120.545 -0.462 . . . . 61.13 111.141 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 243' ' ' ILE . 2.3 mp -105.54 115.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 O-C-N 123.62 0.575 . . . . 53.13 110.024 -171.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.83 133.54 9.46 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.55 -0.833 . . . . 50.32 113.082 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.521 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -140.92 141.36 34.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.969 0.414 . . . . 73.04 110.201 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 260' ' ' SER . . . -162.97 165.51 36.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.358 -0.925 . . . . 64.11 112.547 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -129.87 129.95 44.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.055 0.455 . . . . 75.11 110.462 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.57 HG22 HG23 ' A' ' 258' ' ' THR . 19.8 p -113.46 115.61 28.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.702 . . . . 55.12 109.725 177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.3 132.88 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 64.13 111.617 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 17.5 m -77.81 120.45 22.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.976 -0.556 . . . . 54.21 109.591 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 255' ' ' ILE . 16.1 tp -81.27 -55.28 4.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.582 0.706 . . . . 61.11 109.213 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.556 ' HB2' HG22 ' A' ' 255' ' ' ILE . 5.9 mtpm? -136.66 158.08 73.84 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.894 -1.15 . . . . 53.3 107.894 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.05 90.4 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.701 1.601 . . . . 74.45 110.422 171.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 282' ' ' GLN . . . 137.39 -9.51 3.78 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.848 -0.692 . . . . 62.23 111.786 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.556 HG22 ' HB2' ' A' ' 252' ' ' LYS . 6.5 tp -148.51 122.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.575 0.702 . . . . 73.01 111.464 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.56 135.25 53.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.591 -0.731 . . . . 73.23 110.527 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.65 126.76 45.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.465 -0.789 . . . . 44.54 110.419 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.57 HG23 HG22 ' A' ' 248' ' ' THR . 86.5 m -118.15 111.45 18.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 63.2 110.808 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.955 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -115.4 129.19 56.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.576 -0.898 . . . . 73.3 108.576 175.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.65 ' O ' ' HB2' ' A' ' 275' ' ' LEU . 11.0 t -151.11 146.25 26.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.51 . . . . 60.1 109.624 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.563 ' HA ' ' CB ' ' A' ' 275' ' ' LEU . . . -139.72 127.51 21.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.636 0.255 . . . . 74.21 110.511 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.683 HD11 HD23 ' A' ' 242' ' ' LEU . 2.2 tm? -112.92 118.31 34.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.593 -0.891 . . . . 75.42 108.593 176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.695 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -101.45 110.07 22.0 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.603 -0.888 . . . . 64.23 108.603 176.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.745 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 1.9 m-20 -68.65 104.34 1.95 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.85 -1.167 . . . . 71.41 107.85 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.3 -27.37 46.79 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.908 -0.587 . . . . 70.2 113.298 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -90.84 -20.14 22.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.718 0.294 . . . . 73.23 110.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.745 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 66.2 t30 -101.89 -36.1 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.654 -0.248 . . . . 44.03 111.398 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.7 m -63.18 -18.72 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.722 0.267 . . . . 65.12 111.722 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.65 -44.75 85.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.14 110.796 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.59 10.23 37.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.943 0.401 . . . . 74.42 110.837 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.63 97.88 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.023 -0.608 . . . . 50.14 111.979 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.435 ' HA3' ' ND2' ' A' ' 267' ' ' ASN . . . -175.99 75.63 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.824 -0.703 . . . . 71.3 112.143 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -113.73 145.96 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 122.413 0.285 . . . . 74.31 110.269 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.59 131.18 48.13 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.117 -0.697 . . . . 71.21 109.117 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.667 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -140.68 158.12 44.43 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 65.23 113.974 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.56 117.19 3.53 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 114.552 -1.204 . . . . 45.2 111.317 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.955 HD23 HD22 ' A' ' 259' ' ' LEU . 2.2 tm? -114.36 121.87 44.95 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.909 -1.145 . . . . 75.11 107.909 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -142.46 137.28 7.71 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.89 -1.148 . . . . 44.52 113.309 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.39 130.51 55.67 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.306 -0.627 . . . . 71.12 109.306 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.32 111.18 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.627 -0.509 . . . . 52.12 109.627 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.72 ' HB3' HD22 ' A' ' 31' ' ' LEU . 42.3 t80 -112.99 110.33 20.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 71.14 109.812 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.775 HE21 HD21 ' A' ' 284' ' ' LEU . 49.9 tt0 -114.49 110.21 19.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.677 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -92.34 110.91 22.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.241 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.775 HD21 HE21 ' A' ' 282' ' ' GLN . 55.7 mt -108.69 97.66 7.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 75.14 110.41 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.594 -0.717 . . . . 75.22 109.127 176.828 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.774 0.321 . . . . 71.13 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 121' ' ' GLU . 11.5 t -116.61 112.91 40.69 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 60.42 109.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.66 166.95 22.38 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.231 2.621 . . . . 41.01 112.786 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 81.95 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.924 2.416 . . . . 74.12 111.789 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.0 p -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.484 -0.78 . . . . 64.1 111.386 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -60.48 -29.87 69.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.914 -0.584 . . . . 63.12 111.572 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.53 -19.57 38.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 52.51 110.965 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.98 13.68 33.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.41 0.624 . . . . 73.3 110.008 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 150' ' ' LEU . 72.4 mt -66.09 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.911 -0.586 . . . . 73.32 110.578 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.89 75.12 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.083 -0.58 . . . . 70.44 112.05 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -44.89 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.933 -0.395 . . . . 72.22 109.933 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p -56.4 -36.91 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.64 -0.709 . . . . 51.4 111.541 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.72 -37.6 73.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 74.53 111.376 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -63.26 -37.94 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.612 0.244 . . . . 62.13 111.147 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.09 -49.1 63.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.598 . . . . 64.3 110.69 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.628 HG21 ' CB ' ' A' ' 205' ' ' ALA . 79.0 t -84.58 -47.77 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.695 0.998 . . . . 71.33 113.695 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.17 -28.08 67.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.589 0.589 . . . . 71.54 112.589 -166.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -73.88 -16.79 61.11 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.819 -0.352 . . . . 75.43 110.96 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 0.1 OUTLIER 64.51 -82.61 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.262 -0.644 . . . . 75.14 109.262 -170.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.19 165.43 12.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.819 -1.312 . . . . 35.42 109.819 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.923 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 2.0 t80 -57.12 -44.94 83.76 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.904 -0.776 . . . . 74.44 108.904 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.72 28.45 56.88 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.219 -0.9 . . . . 63.24 114.422 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.558 ' HD2' ' HB2' ' A' ' 26' ' ' LEU . 56.3 t80 -87.78 -4.97 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.415 0.626 . . . . 74.03 109.455 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' C ' HD12 ' A' ' 26' ' ' LEU . . . 75.31 0.99 63.19 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.378 -0.828 . . . . 53.54 112.41 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 mp -134.55 178.76 6.74 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.262 1.029 . . . . 72.22 112.358 -172.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 277' ' ' LEU . 12.5 mm -103.69 122.43 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.579 -1.646 . . . . 73.15 107.988 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 34.9 mtmt -120.73 126.93 51.42 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.07 -0.652 . . . . 72.23 110.97 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tt -120.47 143.48 48.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.784 -0.644 . . . . 55.34 110.554 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.3 p30 -138.84 140.26 38.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.147 0.499 . . . . 73.31 109.844 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD13 ' HB3' ' A' ' 281' ' ' PHE . 14.5 tp -125.43 123.56 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.595 -0.729 . . . . 72.44 109.338 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -117.1 123.77 47.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 74.53 110.032 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 2.1 t -137.88 122.4 18.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.695 -0.684 . . . . 54.43 110.19 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.471 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -104.45 158.21 16.63 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.616 -0.434 . . . . 64.42 110.316 177.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -134.24 135.95 43.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.286 -0.635 . . . . 71.32 109.286 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 39.64 -99.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.357 1.035 . . . . 73.42 112.333 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.601 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 9.4 p30 -147.57 149.13 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.144 -0.687 . . . . 75.41 109.144 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 75.64 -11.02 10.88 Favored Glycine 0 C--O 1.213 -1.199 0 CA-C-O 119.236 -0.758 . . . . 74.32 114.187 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.52 127.25 52.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 119.457 1.629 . . . . 71.34 112.158 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.861 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 27.5 tt0 -142.53 118.85 10.84 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.98 -0.378 . . . . 72.13 109.98 162.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.549 ' HB3' HG23 ' A' ' 33' ' ' THR . 67.3 t80 -97.31 121.45 39.21 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.183 -0.673 . . . . 62.43 109.183 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.6 m -120.79 115.91 24.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.228 0.537 . . . . 73.52 110.772 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 34.6 t -107.88 134.46 50.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 64.11 109.43 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 43.2 m -135.05 126.94 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 71.22 110.331 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 130.26 5.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.453 -0.879 . . . . 64.43 111.846 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.2 m -111.42 133.46 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.474 -0.565 . . . . 44.43 109.474 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.71 135.0 37.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.729 -0.214 . . . . 72.22 110.578 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.766 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 54.2 t30 -69.28 143.07 53.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.783 -0.451 . . . . 74.11 109.783 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -64.62 124.32 21.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.486 . . . . 75.32 111.24 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 73.23 -65.41 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.313 -0.858 . . . . 74.14 111.11 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 3.1 m -78.5 113.13 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.213 -0.662 . . . . 65.24 109.213 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.0 p -75.44 93.08 2.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.068 0.766 . . . . 74.23 113.068 -168.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -113.78 99.6 7.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.868 -1.16 . . . . 75.13 107.868 165.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' SER . 13.9 t -114.21 120.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.818 -0.628 . . . . 71.21 111.115 -171.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -109.74 142.77 40.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.628 -0.715 . . . . 74.53 109.25 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.71 128.39 8.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.802 -0.713 . . . . 74.24 112.773 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.8 m -116.05 127.06 54.58 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.688 -0.856 . . . . 73.24 108.688 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.5 tm? -120.84 123.84 43.57 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.42 -0.585 . . . . 71.03 109.42 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.752 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 43.0 mt-10 -110.36 118.53 36.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.843 -0.617 . . . . 54.01 109.691 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 73' ' ' GLU . 9.1 t -98.75 119.94 38.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.624 -1.25 . . . . 44.11 107.624 172.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 28.0 ttmt -125.27 138.74 54.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.36 0.6 . . . . 74.24 111.261 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 98.9 m-85 -104.28 120.73 41.83 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.287 -0.87 . . . . 74.54 108.913 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.861 ' HG3' ' HB2' ' A' ' 40' ' ' GLU . 12.4 mtp85 -83.85 133.07 34.76 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.722 0.772 . . . . 72.44 111.304 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.747 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 8.8 p-90 -80.33 74.85 7.17 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 112.807 -1.997 . . . . 73.11 115.674 -161.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 37' ' ' ASN . 2.7 m -124.83 -17.8 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.655 -0.702 . . . . 74.14 111.03 -172.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.28 -36.12 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 62.02 109.881 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 69' ' ' LEU . 15.1 t80 -162.14 18.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 74.43 109.278 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.566 ' O ' HD12 ' A' ' 69' ' ' LEU . . . 80.81 56.59 3.06 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.072 -0.811 . . . . 53.43 111.072 -172.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 5.7 mp -139.59 127.98 22.79 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 113.749 1.018 . . . . 73.23 113.749 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.471 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 3.8 m -117.09 132.98 56.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.92 -0.488 . . . . 75.01 110.944 -173.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.572 ' HB3' ' HD2' ' A' ' 62' ' ' TYR . 44.7 t80 -123.19 120.36 32.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.981 -0.748 . . . . 54.43 108.981 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -126.7 117.29 22.42 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.813 -0.355 . . . . 74.41 110.915 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.5 tt0 -104.44 120.63 41.67 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.836 -0.802 . . . . 63.1 108.836 172.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -106.46 92.86 4.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.834 -0.621 . . . . 62.43 109.777 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.836 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 60.8 t90 -95.78 131.37 42.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.863 -0.335 . . . . 74.44 110.549 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.23 142.87 35.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.804 -0.813 . . . . 73.2 108.804 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.5 t -59.2 -9.82 2.42 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.618 0.97 . . . . 74.31 113.618 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 5.5 m-20 -71.24 -41.13 70.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.107 -0.237 . . . . 64.35 110.773 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 28.8 t-20 149.55 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.439 1.087 . . . . 61.24 109.745 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -80.7 132.19 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.645 . . . . 75.43 111.467 -173.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.836 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.8 pt? -124.28 146.5 48.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 62.12 110.681 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.57 117.05 4.08 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.517 -0.633 . . . . 71.33 111.517 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' ASP . 29.2 m -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.601 0.239 . . . . 71.32 110.734 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -125.13 108.37 11.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 63.2 110.118 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.04 129.66 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 74.12 110.699 -178.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 70' ' ' THR . 44.8 p -118.37 134.39 55.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 53.12 110.741 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.705 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 m -116.66 131.67 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.631 -0.507 . . . . 72.42 109.631 172.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 122.86 48.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 175.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 93' ' ' ARG . 35.6 t0 70.01 85.15 0.14 Allowed 'General case' 0 C--O 1.223 -0.323 0 O-C-N 124.029 0.831 . . . . 73.12 109.983 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 6.6 tp60 -102.98 5.16 38.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.457 -0.942 . . . . 75.3 108.457 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.5 tp 178.6 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.354 -1.294 . . . . 74.24 108.89 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.6 126.07 16.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.076 -0.965 . . . . 62.53 109.796 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -64.03 135.85 56.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 72.13 111.076 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.23 -14.78 54.95 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.003 -0.839 . . . . 44.31 111.003 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.24 126.22 38.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 73.23 109.293 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.3 ttpp -122.05 111.16 16.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.694 -0.685 . . . . 75.52 110.319 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.1 mm? -101.23 127.64 47.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.221 -0.659 . . . . 54.41 109.221 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 31.9 m -129.46 124.92 35.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.94 0.4 . . . . 62.33 111.437 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.28 116.05 31.29 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.234 -0.654 . . . . 73.51 109.234 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.716 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.2 t70 -111.68 133.51 53.87 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.003 -0.74 . . . . 75.03 109.003 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 24.4 m -141.44 121.87 14.07 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.941 0.4 . . . . 74.54 110.734 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.76 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 22.8 t -96.07 121.55 37.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.749 -1.204 . . . . 64.34 107.749 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.6 131.27 27.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.236 0.541 . . . . 73.22 111.22 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 16.5 m -119.8 103.43 45.89 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.542 -0.754 . . . . 74.45 109.293 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.423 ' HD2' ' OD1' ' A' ' 79' ' ' ASN . 47.6 Cg_exo -56.89 -33.91 95.92 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.972 2.448 . . . . 73.14 112.908 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -84.47 -40.47 17.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 52.55 111.01 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 104' ' ' SER . 5.8 m -81.99 -32.86 30.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.227 -0.442 . . . . 52.22 112.126 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 1.93 68.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.59 -0.814 . . . . 63.1 111.855 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.96 129.07 38.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.601 0.239 . . . . 71.02 110.426 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -139.39 122.27 16.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 73.52 110.464 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.76 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 8.5 m120 -121.54 123.51 42.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.924 -0.58 . . . . 74.55 109.812 172.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.91 113.8 27.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.067 -0.515 . . . . 71.52 109.68 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.716 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 4.8 ttmp? -122.67 138.1 54.71 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.05 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 tp -129.3 117.4 43.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.203 0.525 . . . . 64.31 110.16 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 1.7 mtpp -105.72 118.75 37.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 64.0 109.009 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 t -114.47 118.48 33.91 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.18 0.514 . . . . 63.41 109.739 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.93 118.24 2.96 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.466 -0.874 . . . . 71.11 112.184 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -106.76 117.59 34.45 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.018 -0.734 . . . . 72.42 109.018 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HB3' HG11 ' A' ' 3' ' ' VAL . 42.5 mtmt -109.22 122.11 46.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.31 0.576 . . . . 73.32 110.383 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -106.39 146.55 30.33 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.604 -1.628 . . . . 71.23 106.604 165.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HG3' HG22 ' A' ' 3' ' ' VAL . 2.2 mt-10 -55.23 -27.46 46.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.861 0.362 . . . . 75.21 111.758 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -88.99 -35.67 16.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 65.44 111.679 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 142' ' ' LEU . 8.7 tp -145.36 127.52 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 121.015 -0.274 . . . . 72.45 111.623 -167.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.523 HD21 ' HB ' ' A' ' 143' ' ' VAL . 3.6 p-10 -122.53 128.44 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.694 0.759 . . . . 65.31 111.807 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 142' ' ' LEU . 4.5 mm? -112.52 131.36 55.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.86 -1.064 . . . . 75.22 110.062 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.62 117.07 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.555 -0.831 . . . . 73.34 112.3 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.9 t -112.29 109.12 18.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.088 0.47 . . . . 70.32 110.135 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 115' ' ' LYS . 17.1 t70 -104.02 117.89 35.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.004 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.44 ' HG2' HG13 ' A' ' 138' ' ' ILE . 58.8 mtm -118.12 117.84 30.26 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.838 -0.345 . . . . 50.11 110.903 -176.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.451 ' HB2' ' HE3' ' A' ' 113' ' ' LYS . 30.4 t70 -107.87 120.42 42.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 63.11 110.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -94.47 109.68 21.53 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.26 -0.427 . . . . 73.42 110.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -116.24 156.39 26.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 71.23 109.501 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.8 pp -71.88 -17.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 111.961 0.356 . . . . 73.21 111.961 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.11 -17.37 32.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.117 0.484 . . . . 52.42 110.337 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.73 123.55 1.39 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.919 -0.657 . . . . 72.42 111.902 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.3 136.09 49.64 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.629 2.219 . . . . 61.01 112.135 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -117.12 137.57 52.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.54 . . . . 63.32 109.963 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.5 mp -107.46 117.98 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 70.33 110.158 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HD2' ' OD2' ' A' ' 128' ' ' ASP . 71.6 mtt180 -105.93 111.61 24.33 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.929 -0.767 . . . . 75.13 108.929 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.62 133.36 11.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.094 -1.05 . . . . 72.44 112.108 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.41 116.63 20.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.225 0.536 . . . . 63.5 110.275 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 123' ' ' ILE . 8.6 tp -116.04 127.07 54.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.711 -0.677 . . . . 63.51 109.979 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 56.6 t -128.03 134.47 65.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.065 0.46 . . . . 74.31 110.625 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.0 mp -109.41 137.04 47.87 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.648 -0.871 . . . . 74.4 108.648 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.405 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -115.75 121.03 5.12 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 123.819 0.699 . . . . 53.53 113.59 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 1.055 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 92.2 m-85 -133.92 149.93 51.3 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.373 -0.973 . . . . 71.43 108.373 173.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.79 93.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.04 0.448 . . . . 75.51 111.339 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.09 47.72 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.999 -0.546 . . . . 35.2 112.336 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 1.055 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 18.8 m95 -105.83 122.38 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.348 -0.241 . . . . 72.33 110.348 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.468 ' HB3' HD23 ' A' ' 10' ' ' LEU . 19.9 mt -128.51 136.96 51.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.865 0.364 . . . . 72.44 111.142 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -127.63 128.61 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 55.24 110.253 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -132.97 133.04 6.82 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.437 -0.887 . . . . 71.51 113.373 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.2 119.29 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.744 -0.465 . . . . 75.11 109.744 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 77.9 mt-30 -113.07 121.62 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.22 0.533 . . . . 73.25 109.569 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 90.4 mtp -133.92 135.82 43.84 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.623 -0.51 . . . . 72.43 109.623 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 166' ' ' GLN . 0.9 OUTLIER -111.56 117.54 33.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.566 -0.531 . . . . 73.04 109.566 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 14.1 m-85 -94.18 130.57 40.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.203 -0.908 . . . . 74.31 110.276 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 163' ' ' ARG . 11.9 pt-20 -96.52 124.78 40.62 Favored 'General case' 0 C--O 1.264 1.839 0 CA-C-O 121.307 0.575 . . . . 74.22 109.843 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -70.64 -16.67 62.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 113.258 -1.792 . . . . 73.44 111.511 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.25 -43.71 98.44 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.657 -0.868 . . . . 74.11 108.657 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -98.86 -159.58 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.546 -1.279 . . . . 74.42 107.546 165.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.6 m -109.52 27.31 9.69 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.825 -0.547 . . . . 71.3 109.552 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 35.8 ttm180 -151.77 160.16 43.68 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 118.513 -1.275 . . . . 65.11 112.915 -155.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.864 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -78.95 135.91 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.29 0.567 . . . . 52.4 111.369 -177.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -33.68 12.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 74.35 109.684 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 49.4 mt-30 -108.26 133.0 53.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.686 -0.688 . . . . 72.23 110.715 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.4 m -121.2 109.95 15.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 32.41 109.263 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 10.7 m120 -113.8 126.82 55.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.885 -0.783 . . . . 72.44 108.885 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 94.0 m-85 -121.51 142.68 49.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.004 -0.678 . . . . 71.15 111.149 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -143.29 127.38 17.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.912 -0.585 . . . . 42.12 110.247 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 67.3 t -125.38 134.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.067 -0.346 . . . . 74.11 110.067 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -112.35 102.62 1.37 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.288 -0.725 . . . . 63.51 111.288 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -112.79 119.42 37.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.799 -0.815 . . . . 72.44 108.799 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 174' ' ' LYS . 1.4 tmmt? -112.37 125.94 54.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 64.52 111.422 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.2 m -120.84 154.48 35.73 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.379 -1.341 . . . . 63.13 107.379 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.23 -45.13 53.68 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.37 0.507 . . . . 71.43 112.37 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -113.61 0.26 14.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.02 -0.272 . . . . 64.33 111.401 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -136.75 114.86 11.54 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.497 -0.319 . . . . 64.25 110.769 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.71 123.49 49.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.33 -0.619 . . . . 75.31 109.33 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.799 HD12 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -117.74 131.07 56.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.171 0.51 . . . . 65.25 111.132 -176.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 72.3 t60 -115.58 115.12 25.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.622 -0.717 . . . . 60.52 109.483 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.646 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 8.6 m -82.78 139.94 33.28 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.903 -1.147 . . . . 73.31 107.903 173.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.9 t30 -146.05 138.98 25.74 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.935 -0.706 . . . . 72.12 111.887 -173.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 59.4 t -131.55 120.94 46.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.482 -0.781 . . . . 62.52 109.962 172.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.03 111.15 21.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.59 -0.732 . . . . 73.01 110.154 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.584 ' H ' ' ND2' ' A' ' 168' ' ' ASN . 5.0 t70 63.4 -168.58 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.817 -1.083 . . . . 71.03 109.29 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.64 -6.93 89.06 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.589 -0.815 . . . . 63.33 112.218 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 211' ' ' THR . 19.0 p -102.39 -28.35 12.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.786 1.032 . . . . 52.12 113.786 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.14 115.41 28.81 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.582 -0.847 . . . . 61.11 112.185 -172.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -120.77 126.3 49.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.06 -0.973 . . . . 71.42 109.665 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.76 -122.51 0.87 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.544 -0.836 . . . . 74.1 112.262 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 158.17 -160.67 31.03 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.617 -0.801 . . . . 74.13 112.587 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.9 t -148.05 139.15 23.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.699 -0.482 . . . . 50.53 109.699 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.799 HG13 HD12 ' A' ' 180' ' ' LEU . 4.2 mp -119.9 135.49 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.123 -0.325 . . . . 61.01 110.123 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.778 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 38.8 t80 -122.3 118.35 28.3 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 61.55 109.836 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.34 134.58 49.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.642 -0.503 . . . . 70.43 109.642 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -99.73 127.12 45.86 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 71.24 110.569 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.5 HG12 ' HD3' ' A' ' 200' ' ' LYS . 10.8 t -102.53 139.38 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.707 -0.849 . . . . 70.23 108.707 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.24 34.28 0.25 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.424 0.631 . . . . 64.3 112.621 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.5 ' HD3' HG12 ' A' ' 198' ' ' VAL . 2.5 mptp? -96.83 14.51 24.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.125 -1.065 . . . . 72.43 108.125 164.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 65.84 20.79 11.44 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.028 -0.987 . . . . 60.32 109.89 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.13 129.8 48.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.073 -0.967 . . . . 60.43 110.197 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.778 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 28.9 mt-10 -104.92 129.83 53.22 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.961 -1.126 . . . . 73.23 107.961 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -122.14 138.17 54.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.821 -0.352 . . . . 74.55 110.632 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.628 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -134.81 149.83 50.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.243 -0.435 . . . . 72.03 111.044 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.647 HG22 HG22 ' A' ' 221' ' ' ILE . 83.2 t -131.13 143.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.656 -0.702 . . . . 75.52 110.357 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -114.61 132.41 56.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.004 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 208' ' ' LEU . 2.1 mm? -125.17 129.48 50.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.219 -0.446 . . . . 72.24 110.21 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.01 127.71 12.47 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.078 -0.341 . . . . 61.34 110.078 171.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.506 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 2.3 t90 -118.75 133.34 55.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.999 -0.741 . . . . 74.44 108.999 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 188' ' ' THR . 31.6 m -93.89 103.02 15.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.184 0.516 . . . . 60.31 109.767 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.71 127.11 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.397 -0.82 . . . . 74.22 110.612 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.4 43.68 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.21 -0.756 . . . . 61.03 111.21 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -126.8 155.84 42.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.008 -0.738 . . . . 41.54 109.008 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.0 m -95.4 -9.8 31.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.155 0.428 . . . . 61.53 112.155 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -91.54 131.53 36.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.889 0.376 . . . . 71.44 110.613 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.506 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 7.9 t -107.19 139.13 42.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.288 0.566 . . . . 75.13 110.19 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -89.06 127.27 35.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.633 . . . . 74.32 109.997 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.636 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 93.9 m-85 -112.35 150.9 30.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.704 -0.68 . . . . 64.12 109.823 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.95 143.17 10.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.749 -0.94 . . . . 73.35 110.749 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.647 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -137.78 134.07 45.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 117.316 0.558 . . . . 71.15 110.583 177.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.528 ' CB ' ' HG2' ' A' ' 236' ' ' LYS . . . -126.29 142.17 51.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.885 -0.598 . . . . 65.22 111.388 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.09 124.06 51.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.74 -0.664 . . . . 74.53 109.456 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 21.3 tptp -113.93 114.02 25.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.328 -0.851 . . . . 74.51 109.425 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.56 121.14 32.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.045 0.45 . . . . 62.04 110.738 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 7.5 pt20 -91.36 99.28 12.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.712 -0.677 . . . . 75.4 109.756 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.6 -35.41 7.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.939 -0.573 . . . . 71.13 111.416 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.454 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -140.21 154.76 70.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 75.31 109.295 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 10.1 Cg_endo -52.52 -26.39 28.59 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.113 2.542 . . . . 42.31 113.309 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -107.97 -15.39 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.613 0.227 . . . . 71.34 111.613 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.26 123.68 40.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.015 0.436 . . . . 71.44 111.84 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.9 t -133.75 121.85 22.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 70.12 109.832 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -101.23 134.35 44.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.655 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 24.3 p -132.01 121.31 23.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.341 -0.391 . . . . 74.23 110.889 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.6 140.16 43.75 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.495 -0.557 . . . . 62.05 109.495 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 222' ' ' ALA . 71.6 mttt -137.92 150.68 47.28 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.044 -0.354 . . . . 63.31 110.044 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.513 HG12 HG12 ' A' ' 221' ' ' ILE . 8.7 p -144.69 143.88 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.119 0.485 . . . . 51.54 110.873 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 25.7 t-20 -105.03 148.9 26.26 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.433 -0.803 . . . . 75.3 109.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.636 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 64.4 t30 -46.65 -31.22 2.74 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.849 1.343 . . . . 61.15 113.378 -174.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.619 ' HB2' HD13 ' A' ' 242' ' ' LEU . 19.3 m -80.01 19.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.979 0.419 . . . . 61.31 110.603 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 56.0 m 68.67 34.2 3.54 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.467 -0.788 . . . . 62.1 111.19 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.2 mp -98.84 131.81 44.67 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 120.389 -0.524 . . . . 74.55 111.605 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 243' ' ' ILE . 2.3 mp -109.66 116.95 53.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.837 -0.62 . . . . 64.41 110.264 -169.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -112.85 133.55 11.4 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.617 -0.801 . . . . 45.1 111.947 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.708 ' H ' HD23 ' A' ' 245' ' ' LEU . 2.3 pt? -118.66 134.39 55.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.817 -0.438 . . . . 55.31 109.817 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.1 121.39 2.71 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.796 -0.716 . . . . 35.31 112.14 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.407 ' HE2' HD12 ' A' ' 245' ' ' LEU . 90.4 m-85 -108.87 115.79 30.76 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.453 -0.573 . . . . 73.23 109.453 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.0 m -109.05 112.85 25.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.176 0.513 . . . . 62.45 110.205 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.91 134.11 55.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 73.33 110.189 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 15.6 m -122.54 98.25 5.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.084 -0.507 . . . . 75.15 109.706 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.767 ' HB2' HG23 ' A' ' 255' ' ' ILE . 3.2 mm? -88.97 77.37 7.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.345 -0.613 . . . . 70.54 109.345 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.618 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 30.7 mmtp 68.37 166.63 0.12 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.343 -0.844 . . . . 73.02 110.136 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 55.7 Cg_endo -70.9 57.68 2.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.359 2.04 . . . . 55.03 112.178 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -147.94 -45.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.834 -0.621 . . . . 45.25 112.097 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.767 HG23 ' HB2' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -132.26 124.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.78 0.8 . . . . 73.32 110.67 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 57.2 tttt -119.61 131.9 55.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.99 -1.004 . . . . 74.24 110.092 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.02 125.54 49.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.839 -0.618 . . . . 63.02 110.466 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.2 t -128.87 111.59 13.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.627 0.727 . . . . 70.51 110.46 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.741 HD22 ' HG ' ' A' ' 277' ' ' LEU . 0.1 OUTLIER -106.3 124.49 49.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.41 -0.959 . . . . 72.33 108.41 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 46.8 p -140.79 140.73 34.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.198 -0.601 . . . . 74.11 110.999 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' A' ' 245' ' ' LEU . . . -144.89 146.69 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.985 -0.552 . . . . 75.32 110.088 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 242' ' ' LEU . 2.0 tm? -114.6 116.58 28.98 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.653 -0.869 . . . . 64.42 108.653 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.47 HD21 HD22 ' A' ' 245' ' ' LEU . 1.0 OUTLIER -92.13 107.35 19.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.911 -1.144 . . . . 52.53 107.911 173.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.85 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -70.79 104.92 3.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.259 -1.015 . . . . 73.23 108.259 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.7 -22.92 34.77 Favored Glycine 0 N--CA 1.459 0.211 0 C-N-CA 121.16 -0.543 . . . . 52.4 112.2 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -90.68 -15.73 29.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.257 -0.471 . . . . 65.44 111.798 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 17.5 t-20 -117.41 -38.37 3.34 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.227 0.455 . . . . 70.11 112.227 -174.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 264' ' ' ASP . 30.7 m -61.87 -17.79 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.103 0.408 . . . . 63.32 112.103 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -59.81 -32.67 70.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.053 0.454 . . . . 72.52 110.314 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.99 -16.57 15.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 44.45 110.277 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.32 119.52 3.28 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.81 -0.632 . . . . 50.31 111.827 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 149.73 82.7 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.462 -0.875 . . . . 50.31 112.413 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -113.61 150.13 33.57 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.698 -0.482 . . . . 55.14 109.698 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.1 mptt -91.73 137.11 32.63 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.682 -0.859 . . . . 74.23 108.682 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -120.53 137.72 54.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.151 -0.477 . . . . 55.33 109.845 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.923 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -144.15 112.68 0.69 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 111.045 -0.822 . . . . 64.43 111.045 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.741 ' HG ' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -113.96 143.51 44.6 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.29 -0.564 . . . . 70.41 109.512 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.563 ' H ' HD23 ' A' ' 277' ' ' LEU . . . -140.56 124.43 2.61 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.387 -0.824 . . . . 55.43 111.362 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.511 ' HB2' HD12 ' A' ' 29' ' ' LEU . 3.0 mm? -113.41 131.2 56.09 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.624 -0.88 . . . . 72.13 108.624 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 69.3 tt0 -125.42 116.14 21.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.133 0.492 . . . . 63.53 110.038 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.589 ' HB3' HD13 ' A' ' 31' ' ' LEU . 50.1 m-85 -105.33 138.57 41.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.678 -0.692 . . . . 65.24 109.782 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.498 ' HB3' HD23 ' A' ' 284' ' ' LEU . 75.8 mt-30 -130.85 114.03 14.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.451 -0.795 . . . . 74.22 110.209 -176.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.752 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -104.8 107.45 18.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.209 -0.664 . . . . 61.34 109.209 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.547 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.3 mm? -139.27 -3.27 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.421 -0.808 . . . . 62.12 110.171 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.59 -0.719 . . . . 72.23 109.885 -178.205 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.095 0.474 . . . . 75.31 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.634 ' CG1' ' HB3' ' A' ' 119' ' ' LYS . 7.9 p -147.81 134.86 10.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.17 -0.678 . . . . 73.1 109.17 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 9.6 Cg_endo -52.65 133.85 51.35 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.282 2.655 . . . . 74.12 113.664 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 13.0 Cg_exo -71.13 75.32 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.142 2.561 . . . . 61.12 110.893 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -76.4 -11.85 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.565 -0.743 . . . . 75.44 111.928 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.69 ' HB3' HG21 ' A' ' 143' ' ' VAL . 21.7 p90 -60.15 -22.12 62.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.314 0.578 . . . . 70.34 110.039 171.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -27.25 61.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.709 -0.678 . . . . 73.34 109.747 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -84.74 -14.12 49.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.056 -0.52 . . . . 72.2 110.091 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 170' ' ' ALA . 61.0 mt -76.89 -35.56 57.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.385 -0.825 . . . . 73.14 110.575 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 -61.45 0.23 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.386 -0.911 . . . . 74.5 114.025 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.75 -43.87 81.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.922 0.361 . . . . 71.45 111.338 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.1 t -62.09 -46.37 89.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.862 -0.608 . . . . 65.02 110.961 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.91 73.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.071 -0.513 . . . . 64.2 111.776 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -59.32 -30.11 68.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.12 112.243 -173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.59 -44.5 85.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.935 0.398 . . . . 75.14 110.452 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.41 -35.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.939 -0.573 . . . . 72.44 110.962 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -68.84 -23.05 64.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.946 -0.57 . . . . 74.44 111.533 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.8 p -76.03 93.05 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.313 0.578 . . . . 71.14 111.085 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.32 79.13 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.761 . . . . 74.44 112.214 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.4 63.92 3.11 Favored Glycine 0 C--N 1.335 0.479 0 O-C-N 123.984 0.803 . . . . 64.4 114.692 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -88.88 83.09 6.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.184 0.516 . . . . 74.34 110.732 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.3 121.84 5.77 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.531 -0.759 . . . . 53.12 111.465 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.81 5.61 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.645 0.239 . . . . 72.22 111.645 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.91 59.51 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.771 -0.728 . . . . 41.21 112.691 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 46' ' ' SER . 1.5 pp -129.04 -179.34 5.06 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.59 0.959 . . . . 74.34 113.59 -170.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.705 HG23 HD22 ' A' ' 277' ' ' LEU . 40.7 mm -99.1 132.79 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.061 -1.427 . . . . 75.21 109.802 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 17.9 ptpt -118.55 153.52 34.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.022 0.439 . . . . 72.14 109.906 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.804 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.3 tp -141.13 143.86 34.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.289 -0.414 . . . . 70.41 111.442 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 8.1 t70 -137.38 124.28 21.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.617 -1.253 . . . . 71.44 107.617 168.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.3 tm? -136.72 124.16 22.08 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.388 -0.597 . . . . 71.41 109.388 -175.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 29.6 mtmm -116.77 124.51 49.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 72.23 110.572 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -121.22 125.36 46.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.897 -0.592 . . . . 75.14 109.538 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -113.35 145.55 40.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.794 0.331 . . . . 71.13 110.335 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 21.7 m -139.21 138.19 36.65 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.48 -0.563 . . . . 71.04 109.48 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 49.21 -120.12 1.34 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.802 0.689 . . . . 73.24 110.572 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -136.27 152.24 50.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.725 -0.472 . . . . 50.55 109.725 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.757 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 79.29 -9.3 41.5 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 119.335 -0.703 . . . . 51.03 113.648 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -101.64 128.55 47.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.613 1.207 . . . . 63.33 112.043 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.822 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 29.0 tt0 -141.02 117.12 10.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 74.1 109.66 164.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 92.1 t80 -99.05 121.93 41.63 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.546 -0.538 . . . . 65.54 109.546 176.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 6.8 m -125.5 125.21 42.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.083 0.468 . . . . 74.43 111.521 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -112.43 123.84 51.17 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.775 -0.824 . . . . 62.04 108.775 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 22.1 m -137.85 125.66 22.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.203 -0.295 . . . . 62.11 110.203 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 178.9 42.33 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.328 -1.415 . . . . 55.53 113.442 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 26' ' ' LEU . 21.9 m -138.01 134.82 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.687 -0.486 . . . . 64.23 109.687 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -139.8 132.8 29.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.918 0.39 . . . . 50.53 111.25 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.06 120.96 37.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.894 -0.593 . . . . 64.21 109.409 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 m -84.52 -33.42 23.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 62.24 110.751 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -63.61 -59.4 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 75.35 110.027 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 m -112.52 111.31 22.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.228 -0.656 . . . . 72.41 109.228 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p -55.92 95.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.156 0.799 . . . . 55.24 113.156 -171.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -145.58 117.36 8.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.36 -0.978 . . . . 72.33 108.36 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' HB2' ' A' ' 47' ' ' ALA . 32.1 t -121.97 125.32 72.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.934 0.397 . . . . 71.34 110.821 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.6 m -109.54 125.08 52.14 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.493 -0.929 . . . . 73.02 108.493 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.56 5.33 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.947 -1.12 . . . . 73.24 113.267 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 75' ' ' TRP . 19.3 m -118.96 134.07 55.42 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.068 -0.715 . . . . 61.41 109.068 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -119.74 123.24 43.28 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.519 -0.919 . . . . 74.42 108.519 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.821 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 mt-10 -110.83 119.31 38.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.9 -0.591 . . . . 71.21 110.217 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -98.59 117.76 33.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.733 -1.21 . . . . 74.01 107.733 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.822 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 38.2 mttp -116.56 139.87 50.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.256 0.551 . . . . 62.44 110.75 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.757 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 96.6 m-85 -115.34 120.09 38.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.249 -0.887 . . . . 73.1 108.887 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.6 ptp180 -119.03 106.39 12.37 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 121.755 0.788 . . . . 72.43 111.224 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -116.11 92.67 3.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.919 -1.037 . . . . 74.12 109.994 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -81.22 1.22 33.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.748 -0.66 . . . . 70.4 111.448 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.43 14.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.524 0.678 . . . . 64.54 109.986 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -159.02 -49.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.875 -1.057 . . . . 62.33 108.578 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.366 -0.834 . . . . 72.1 111.306 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' CD1' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -106.93 131.86 53.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.796 0.331 . . . . 75.13 111.147 -174.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.9 m -129.99 111.93 13.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.002 -0.545 . . . . 74.05 109.993 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 33.4 t80 -112.88 123.76 51.05 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.547 -0.538 . . . . 71.45 109.547 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 61' ' ' LYS . 88.4 m -128.63 116.77 20.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.808 0.337 . . . . 74.32 111.018 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.38 121.52 45.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.892 -0.781 . . . . 71.54 108.892 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.711 ' HB3' ' HG2' ' A' ' 59' ' ' GLU . 17.4 ptmt -128.01 114.39 17.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.92 0.39 . . . . 54.45 111.442 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.662 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 78.6 t90 -99.9 139.23 35.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.524 -0.547 . . . . 72.4 109.524 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -119.7 160.86 21.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.422 -0.354 . . . . 51.55 110.276 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 p -62.41 -14.12 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.062 0.458 . . . . 72.32 111.95 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.683 ' HB3' HG22 ' A' ' 80' ' ' THR . 35.4 t70 -71.23 -4.75 27.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 71.04 110.108 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER 77.85 -3.3 2.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.122 -0.944 . . . . 60.1 110.019 -176.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.683 HG22 ' HB3' ' A' ' 78' ' ' ASP . 13.4 t -83.68 133.37 34.81 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.938 -0.574 . . . . 71.23 109.891 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.662 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 2.2 pt? -123.0 142.88 50.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.047 -0.524 . . . . 74.44 110.104 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.58 123.92 5.64 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.965 -0.636 . . . . 73.13 112.333 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 23.5 m -97.34 90.1 4.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.284 0.564 . . . . 71.44 109.679 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -91.57 110.0 21.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.123 -0.944 . . . . 71.43 109.482 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 85' ' ' ILE . 13.0 pt -124.36 134.84 65.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.734 0.778 . . . . 74.13 110.867 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -123.5 122.27 37.79 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.192 -0.913 . . . . 74.31 108.746 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.59 HG22 ' HB2' ' A' ' 97' ' ' LEU . 8.0 m -113.69 120.77 64.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.079 -0.51 . . . . 72.42 110.106 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -107.77 131.57 54.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.549 -0.908 . . . . 74.14 108.549 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -76.6 134.65 39.3 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.362 -0.535 . . . . 53.04 111.355 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.419 -0.809 . . . . 65.32 111.077 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.27 -53.22 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.687 -0.486 . . . . 63.12 109.687 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 71.87 10.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.34 110.719 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -63.37 133.35 53.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 73.5 110.219 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.5 -9.43 58.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.544 -0.836 . . . . 61.12 111.317 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -105.4 111.21 23.85 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.1 -0.704 . . . . 71.31 109.1 176.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.696 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -126.23 130.25 50.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.132 0.491 . . . . 73.43 110.404 177.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.724 HD12 HG22 ' A' ' 116' ' ' THR . 1.3 mm? -101.63 131.06 48.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.019 -0.537 . . . . 72.23 109.626 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -106.4 117.76 34.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.08 0.466 . . . . 62.24 110.494 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.785 ' HD1' ' HB ' ' A' ' 114' ' ' ILE . 82.3 t80 -126.21 115.95 20.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.279 -0.873 . . . . 75.54 110.295 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.691 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 1.3 t70 -112.18 138.6 48.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.765 -0.652 . . . . 64.53 110.768 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 33.2 m -126.93 120.74 29.89 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.951 -0.759 . . . . 54.14 108.951 169.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 4.7 t -127.49 121.89 31.94 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.918 -0.401 . . . . 72.24 109.918 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' THR . 69.6 m-85 -125.45 120.51 31.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.557 -0.292 . . . . 74.31 110.285 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.2 t -123.05 103.14 36.71 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.29 -0.414 . . . . 61.41 109.961 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.74 -25.32 46.4 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.972 2.448 . . . . 62.11 111.387 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -67.06 -37.44 84.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 63.14 110.329 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.764 ' HB ' ' HG2' ' A' ' 109' ' ' LYS . 5.2 m -88.18 -28.25 21.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.148 0.499 . . . . 75.01 110.104 175.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.67 4.19 83.02 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.229 -0.748 . . . . 70.14 111.229 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.764 ' HG2' ' HB ' ' A' ' 107' ' ' THR . 21.3 pttm -94.96 148.63 22.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.154 0.502 . . . . 54.03 111.472 -175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 122.74 37.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.316 -0.856 . . . . 53.13 109.236 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 17.8 m120 -119.61 137.79 53.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 75.5 110.521 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -140.15 123.3 16.78 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.616 -0.513 . . . . 53.55 109.616 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.691 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -117.58 131.92 56.6 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.539 -0.864 . . . . 74.23 109.204 176.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.785 ' HB ' ' HD1' ' A' ' 99' ' ' PHE . 4.0 tp -140.09 114.66 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.635 -0.506 . . . . 74.43 109.635 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.947 ' HB3' ' O ' ' A' ' 127' ' ' CYS 0.461 13.1 tttt -154.41 170.12 22.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 116.128 1.899 . . . . 51.32 116.128 160.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.724 HG22 HD12 ' A' ' 97' ' ' LEU . 77.1 p -101.18 130.16 47.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.311 -1.313 . . . . 64.31 110.956 -163.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.89 123.81 5.87 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.534 -0.841 . . . . 52.33 112.238 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.444 ' C ' ' HD2' ' A' ' 119' ' ' LYS . 35.5 p90 -124.9 128.09 48.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.62 0.724 . . . . 72.4 110.282 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.696 ' HD3' ' HD3' ' A' ' 96' ' ' LYS . 3.8 mptp? -111.38 122.7 48.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.672 -0.695 . . . . 73.51 110.929 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 31.0 mtp180 -108.36 158.02 17.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.798 -0.637 . . . . 73.4 110.694 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.68 -32.8 44.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.39 0.885 . . . . 70.31 113.39 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -119.15 -6.33 10.42 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.73 -0.388 . . . . 74.42 111.297 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -144.4 123.3 6.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.52 0.676 . . . . 42.53 110.6 -173.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.787 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.9 t-20 -104.64 115.45 30.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.03 -0.532 . . . . 64.34 109.582 -175.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.05 130.06 56.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.516 0.674 . . . . 64.13 111.761 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.47 115.9 1.61 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.316 -0.856 . . . . 42.23 111.37 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.947 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 59.4 m -112.66 126.1 55.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.824 -0.806 . . . . 65.31 108.824 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.765 ' HA ' ' CB ' ' A' ' 115' ' ' LYS . 1.1 m-20 -128.92 133.22 47.79 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.843 1.339 . . . . 62.41 111.364 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.855 ' H ' ' HB2' ' A' ' 115' ' ' LYS . 60.1 ttp -107.39 118.39 36.59 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 119.413 -0.915 . . . . 73.43 109.791 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 9.2 t70 -106.2 115.3 29.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.739 -0.467 . . . . 73.11 109.739 -175.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 92.3 t80 -97.87 117.78 32.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.839 -0.344 . . . . 75.22 111.125 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 22.5 t70 -115.02 157.03 24.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.872 -0.788 . . . . 75.21 108.872 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.47 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.6 pp -69.19 -17.19 21.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 111.705 0.261 . . . . 50.04 111.705 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.23 -19.34 24.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 71.31 111.073 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.482 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 168.93 148.45 5.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.528 -0.844 . . . . 74.3 112.527 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 2.8 Cg_endo -85.67 114.51 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.571 2.847 . . . . 65.12 111.749 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 m -104.0 144.44 31.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.018 -0.537 . . . . 74.54 110.612 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.35 118.52 55.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.41 -0.589 . . . . 71.21 109.41 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 139' ' ' ARG . 39.3 ttp-105 -103.57 126.31 50.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.773 -0.649 . . . . 70.33 110.23 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.14 132.02 10.1 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.181 -1.009 . . . . 74.31 111.643 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.09 116.09 23.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.713 -0.477 . . . . 53.3 109.713 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 123' ' ' ILE . 15.2 tp -124.26 124.53 42.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.356 -0.384 . . . . 74.02 110.621 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 46.5 t -125.1 128.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 72.31 109.821 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.2 mp -109.51 138.69 45.5 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.728 -0.841 . . . . 73.4 108.728 176.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.9 117.55 1.58 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.109 -1.043 . . . . 72.33 111.778 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.31 123.28 18.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.883 -0.327 . . . . 74.52 111.056 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 40.34 39.02 0.62 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.058 1.132 . . . . 73.14 114.058 171.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.09 6.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.26 -0.971 . . . . 71.33 113.512 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -98.66 137.01 37.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.904 0.852 . . . . 74.53 111.416 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 mt -115.59 140.17 49.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.442 -1.254 . . . . 74.41 110.56 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -127.17 125.88 41.88 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.275 -0.639 . . . . 61.3 109.275 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.63 134.02 7.59 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.26 -0.972 . . . . 52.54 112.572 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.472 ' HD2' ' CD2' ' A' ' 169' ' ' PHE . 13.7 m-85 -134.68 120.54 19.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.387 -0.407 . . . . 72.41 109.973 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.421 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . 73.1 mt-30 -119.92 123.12 42.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.426 0.631 . . . . 62.31 110.01 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -130.58 136.13 48.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.863 -0.608 . . . . 73.42 110.288 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -114.75 118.88 34.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.702 -0.481 . . . . 74.51 109.702 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 86.3 t80 -107.15 123.33 48.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.811 -0.631 . . . . 73.42 110.798 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -94.98 126.35 40.26 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.479 -0.563 . . . . 74.34 109.479 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 41.8 p -73.71 -48.24 33.47 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.083 -0.962 . . . . 63.35 112.993 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -65.58 -44.57 86.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.237 0.541 . . . . 62.35 110.189 -172.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 38.7 ttpt -101.64 112.91 25.63 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.941 -1.874 . . . . 73.23 105.941 160.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.4 p -75.5 38.07 0.14 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.355 1.243 . . . . 61.12 114.355 -152.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.567 ' HG2' ' N ' ' A' ' 164' ' ' VAL . 26.0 ttm180 -139.92 157.88 44.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.916 0.389 . . . . 71.23 111.085 -166.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 85.7 t -72.51 122.13 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.448 -0.945 . . . . 73.23 108.448 170.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.6 m -93.81 -31.08 14.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.354 -0.385 . . . . 63.12 110.826 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -132.94 129.7 38.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 64.5 110.321 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.5 m -124.75 106.67 10.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.562 -0.744 . . . . 74.51 109.632 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 154' ' ' GLN . 10.0 p30 -118.14 146.79 43.91 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.459 -0.496 . . . . 43.51 109.886 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' HD2' ' A' ' 153' ' ' TYR . 69.1 m-85 -135.21 162.1 33.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.45 -0.341 . . . . 75.22 110.648 -173.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 71.0 110.616 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.806 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 98.5 t -138.45 136.95 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.415 . . . . 73.23 109.878 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.73 111.28 1.9 Allowed Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.614 -0.803 . . . . 60.12 111.317 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.574 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 19.5 t80 -113.28 128.85 56.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.252 0.526 . . . . 62.31 109.976 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -102.15 130.82 48.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.981 0.896 . . . . 74.21 112.564 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 7.8 m -131.1 145.54 52.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 42.41 105.765 164.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.95 -30.25 67.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.328 0.513 . . . . 73.44 112.303 -168.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.08 -0.23 12.79 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.292 -0.255 . . . . 73.5 111.567 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.608 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 53.4 m-85 -136.84 119.93 16.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 73.35 110.57 -174.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -110.91 123.65 50.55 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.018 -0.426 . . . . 63.52 110.162 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 173' ' ' TYR . 2.0 tp -102.68 126.9 49.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.998 0.428 . . . . 50.21 110.077 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -118.55 114.83 23.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.627 -0.879 . . . . 75.31 108.627 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.806 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 26.6 m -99.94 137.57 38.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.406 -0.59 . . . . 40.41 109.406 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -136.97 139.05 41.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.137 0.494 . . . . 64.23 110.995 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 190' ' ' PHE . 84.2 t -128.04 111.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 63.5 109.546 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -96.54 103.8 15.73 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 108.672 -0.862 . . . . 54.34 108.672 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.435 ' HB3' HG22 ' A' ' 188' ' ' THR . 23.1 t70 64.82 172.61 0.2 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.03 -0.987 . . . . 70.02 109.64 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.8 56.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.435 -0.888 . . . . 34.42 111.785 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 186' ' ' ASP . 14.4 t -97.41 -24.14 15.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 113.14 0.792 . . . . 72.02 113.14 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.29 117.47 19.85 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.423 1.01 . . . . 62.42 111.33 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 184' ' ' VAL . 41.8 p90 -134.03 138.47 45.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.593 -0.276 . . . . 72.35 110.766 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . -163.45 -163.88 17.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.788 -0.72 . . . . 61.32 112.369 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.88 176.73 30.9 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 120.78 -0.724 . . . . 74.23 112.095 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 34.8 t -147.29 142.59 27.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.046 0.423 . . . . 75.21 110.881 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 194' ' ' ILE . 4.1 mp -119.31 118.4 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.194 -0.669 . . . . 70.51 109.194 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 9.2 t80 -108.24 121.07 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.588 -0.523 . . . . 72.5 109.588 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -116.96 126.69 53.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.424 -0.584 . . . . 73.34 109.424 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.647 ' HG2' ' HG2' ' A' ' 203' ' ' GLU . 2.9 tmtp? -108.69 114.17 27.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.982 -0.554 . . . . 51.15 110.24 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.461 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 43.6 t -73.89 159.75 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.462 -0.335 . . . . 73.4 110.319 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.405 ' N ' HG12 ' A' ' 198' ' ' VAL . 0.9 OUTLIER -57.62 -45.53 85.25 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.527 0.203 . . . . 63.13 111.041 178.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 172.47 13.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.906 -0.776 . . . . 55.05 108.906 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -78.08 70.1 4.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.756 0.788 . . . . 72.22 111.423 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.744 HD13 ' HD2' ' A' ' 225' ' ' TYR . 58.5 tp -133.58 113.01 11.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.465 -1.243 . . . . 75.0 108.759 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.647 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.6 mt-10 -117.12 129.09 55.74 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.512 -0.551 . . . . 55.21 109.512 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -124.36 139.41 53.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.725 0.298 . . . . 65.23 110.968 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.425 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -130.97 136.4 48.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.349 -0.387 . . . . 64.13 110.677 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 193' ' ' SER . 54.6 t -113.71 126.08 71.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.471 -0.566 . . . . 72.22 109.471 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.1 136.17 53.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.507 0.67 . . . . 74.45 111.004 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -119.55 141.1 49.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.029 -0.987 . . . . 62.5 109.325 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.11 130.37 25.18 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.283 -0.417 . . . . 64.2 110.872 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -116.48 132.84 56.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.981 -0.748 . . . . 71.31 108.981 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 10.1 t -114.2 122.72 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 63.11 110.691 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.64 135.62 57.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 74.44 111.14 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.38 -28.94 5.63 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.622 -0.717 . . . . 65.11 111.474 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.06 149.26 30.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.094 -0.706 . . . . 61.02 109.094 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.6 m -79.15 42.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.079 0.466 . . . . 64.34 110.667 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.57 120.88 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.573 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.6 t -105.8 136.89 44.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.14 0.495 . . . . 74.31 109.943 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.4 mmm-85 -102.0 138.19 39.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.445 -0.576 . . . . 75.22 109.445 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 66.0 m-85 -114.7 146.9 40.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.982 -0.377 . . . . 73.21 109.982 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.88 146.23 15.21 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.34 -0.704 . . . . 62.44 111.34 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.6 mp -132.14 129.5 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.94 0.37 . . . . 71.22 110.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -118.57 138.9 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.117 -0.327 . . . . 72.33 110.117 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.97 125.8 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.922 0.391 . . . . 60.13 110.813 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -115.44 114.34 24.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.74 -0.664 . . . . 73.24 109.909 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.744 ' HD2' HD13 ' A' ' 202' ' ' LEU . 36.6 t80 -117.7 120.05 36.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.477 -0.564 . . . . 73.43 109.477 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 229' ' ' PRO . 52.7 tt0 -112.25 112.22 23.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.952 0.406 . . . . 70.33 110.652 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 227' ' ' ILE . 3.7 mp -86.82 -55.51 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 62.33 109.711 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -106.1 153.86 39.96 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 73.53 109.606 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.639 ' HA ' HE21 ' A' ' 226' ' ' GLN . 21.0 Cg_endo -60.33 -23.82 75.63 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.549 2.166 . . . . 74.31 112.79 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -102.61 -9.27 20.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.587 -0.279 . . . . 75.23 111.342 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.85 122.67 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 73.32 111.348 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.47 142.32 51.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.878 -0.601 . . . . 71.32 110.651 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -108.43 125.77 52.14 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.251 -0.648 . . . . 71.1 109.251 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.5 t -126.45 117.15 22.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.818 -0.438 . . . . 53.14 109.818 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -124.74 155.86 38.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.367 -0.379 . . . . 62.54 110.324 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 0.0 OUTLIER -154.25 139.84 17.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.478 . . . . 63.44 109.857 175.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 243' ' ' ILE . 7.9 p -128.64 144.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 63.13 110.406 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 240' ' ' SER . 9.2 t30 -108.46 148.79 29.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.066 -0.516 . . . . 73.42 109.96 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 8.0 t30 -65.22 -3.78 4.35 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.182 0.808 . . . . 63.02 113.182 -170.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.667 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.6 m -85.76 17.06 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.946 -0.761 . . . . 73.34 108.946 172.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.594 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 51.0 m 69.77 30.45 3.82 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.691 -1.14 . . . . 74.21 111.585 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.848 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.7 mp -99.08 125.47 44.6 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 120.683 -0.407 . . . . 75.42 111.735 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.561 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.8 mp -113.2 115.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.721 -0.672 . . . . 74.23 110.506 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -111.08 133.78 11.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.74 -0.743 . . . . 23.43 111.748 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.56 151.71 50.57 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.687 -0.302 . . . . 75.13 110.527 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -146.45 137.8 7.03 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.63 -0.795 . . . . 63.0 113.026 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -103.63 120.19 40.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.742 -0.836 . . . . 64.45 108.742 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 2.0 m -121.93 115.76 23.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.737 0.303 . . . . 74.24 111.035 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -134.74 141.84 46.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.58 -0.282 . . . . 72.02 110.707 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.0 m -76.32 124.82 28.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.609 -0.515 . . . . 63.33 109.609 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.595 ' HG ' ' H ' ' A' ' 252' ' ' LYS . 17.9 tp -105.92 172.65 6.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.108 0.48 . . . . 72.35 111.804 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.595 ' H ' ' HG ' ' A' ' 251' ' ' LEU . 44.2 tptt -49.53 -54.54 29.73 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.998 1.11 . . . . 64.21 113.998 -172.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 13.1 Cg_exo -70.73 9.07 0.82 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.611 2.207 . . . . 61.22 114.295 -171.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 82.86 29.36 35.1 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.386 -0.911 . . . . 41.4 111.824 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 2.7 pp -121.94 146.02 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.447 -0.377 . . . . 70.43 110.35 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.581 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 73.7 tttt -91.64 126.17 36.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 74.52 108.864 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.6 tp -97.8 123.58 41.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.927 -0.398 . . . . 60.34 109.927 -176.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.4 m -124.75 111.5 15.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.789 -0.641 . . . . 65.44 110.543 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.638 ' CD2' HD12 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -98.92 122.8 42.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.553 -1.277 . . . . 74.21 107.553 170.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.8 m -131.47 143.91 50.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.932 0.396 . . . . 63.23 111.16 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.409 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -146.44 132.36 19.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 74.0 110.732 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.772 HD11 HD23 ' A' ' 242' ' ' LEU . 2.7 tm? -104.35 113.12 26.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.25 -1.018 . . . . 54.3 108.25 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.697 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.2 mm? -91.66 108.92 20.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.92 -1.141 . . . . 71.22 107.92 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.848 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 9.9 t0 -71.48 105.07 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.586 -1.265 . . . . 70.13 107.586 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.82 -25.03 43.4 Favored Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.907 -0.588 . . . . 44.31 113.497 -170.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 266' ' ' LYS . 46.0 mtpt -91.85 -26.63 18.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.627 0.251 . . . . 61.33 111.201 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 63.2 t30 -98.69 -28.57 13.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 61.25 112.357 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.738 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 26.9 m -62.51 -17.82 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.665 0.269 . . . . 74.25 111.315 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -55.57 -37.79 68.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.271 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.57 9.75 37.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 62.31 110.838 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.44 74.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.004 -0.617 . . . . 72.51 112.598 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.738 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -142.57 86.52 0.19 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.937 -0.649 . . . . 42.23 111.919 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -113.23 143.52 44.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.444 0.164 . . . . 72.42 110.642 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 65.5 mttm -97.47 137.91 35.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.252 -0.647 . . . . 75.33 109.252 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -121.94 142.55 50.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.814 -0.439 . . . . 74.33 109.814 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -157.37 123.81 1.33 Allowed Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.54 -0.838 . . . . 52.14 111.504 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.705 HD22 HG23 ' A' ' 27' ' ' ILE . 7.4 tt -114.05 145.2 41.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.005 -0.739 . . . . 74.45 109.005 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -149.4 125.37 1.99 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.944 -1.122 . . . . 75.53 113.012 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.804 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.1 mm? -99.18 128.0 45.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.418 -0.956 . . . . 70.5 108.418 168.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 13.8 pt-20 -140.05 125.07 18.55 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.045 -0.354 . . . . 64.41 110.045 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.688 ' HB3' ' HA ' ' A' ' 255' ' ' ILE . 1.3 t80 172.72 -142.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 71.34 111.547 170.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.506 ' HB3' HD23 ' A' ' 284' ' ' LEU . 74.9 mt-30 -136.32 122.07 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.28 -0.418 . . . . 72.31 111.396 -166.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.93 109.02 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.942 -0.762 . . . . 65.44 108.942 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 282' ' ' GLN . 2.9 mm? -131.75 158.92 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.12 -0.491 . . . . 73.15 110.709 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.938 -0.764 . . . . 72.21 108.938 176.298 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.642 ' HB1' ' HA2' ' A' ' 94' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.094 0.473 . . . . 32.55 112.096 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 119' ' ' LYS . 23.1 t -125.46 127.58 24.89 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 55.52 110.178 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.98 123.23 9.54 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.494 2.796 . . . . 65.22 112.599 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.41 85.4 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.699 2.266 . . . . 73.52 112.564 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 5.5 p -72.0 -13.27 61.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 74.3 110.208 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.551 ' HE1' HE21 ' A' ' 154' ' ' GLN . 51.8 t80 -53.74 -34.98 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.995 -1.002 . . . . 72.2 110.126 169.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.22 -27.18 30.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 74.32 110.673 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' THR . 2.2 m-20 -85.22 0.98 50.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.589 -0.732 . . . . 75.5 111.196 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.67 -34.48 77.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 75.23 110.386 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.52 59.81 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.544 -0.836 . . . . 64.32 112.699 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -59.26 -53.28 60.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 62.34 110.839 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -55.53 -36.48 66.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.634 -0.712 . . . . 62.55 112.132 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.57 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 72.13 112.205 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -67.79 -40.1 83.98 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 71.21 110.682 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -68.73 -44.43 73.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.675 -0.693 . . . . 64.11 110.979 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 p -68.98 -26.67 32.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.128 0.49 . . . . 74.02 110.435 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.99 -39.91 83.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.944 -0.571 . . . . 54.33 109.727 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 58.26 39.36 25.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.78 -0.646 . . . . 65.35 111.248 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 67.82 4.39 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.954 -0.567 . . . . 55.3 111.451 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.09 -78.27 0.68 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.164 -0.541 . . . . 44.32 112.695 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -122.09 170.08 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.812 0.339 . . . . 72.02 111.03 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 122.54 6.79 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.826 -0.702 . . . . 73.11 111.621 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' HD1' HD13 ' A' ' 26' ' ' LEU . 22.2 t80 -89.35 2.91 53.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.127 0.489 . . . . 64.3 110.894 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.01 59.25 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.579 -0.82 . . . . 50.44 112.72 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.621 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 9.3 mp -102.0 156.07 17.77 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.625 0.726 . . . . 74.31 112.288 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.687 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -104.71 122.04 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.402 -1.272 . . . . 75.22 108.74 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.7 mtpp -102.74 127.78 49.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.877 -0.601 . . . . 75.15 110.59 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.31 126.65 53.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.337 -0.986 . . . . 73.11 108.337 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.584 ' HB3' ' HD1' ' A' ' 281' ' ' PHE . 4.5 t0 -142.49 133.08 25.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.303 -0.999 . . . . 74.14 108.303 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.013 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -139.12 123.98 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.755 0.252 . . . . 53.21 110.575 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 32.1 ttpt -121.15 122.56 40.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.221 0.534 . . . . 75.53 110.28 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -138.82 120.66 15.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.308 -0.86 . . . . 74.02 109.381 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HB2' ' HG2' ' A' ' 40' ' ' GLU . 3.5 pttp -144.28 155.16 43.72 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.856 -0.738 . . . . 64.12 111.684 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -133.68 169.54 16.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.805 . . . . 61.33 109.782 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -89.07 13.79 12.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.056 0.391 . . . . 74.33 112.056 -172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.07 52.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.685 0.254 . . . . 61.13 111.685 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.94 -7.59 50.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 118.896 -0.947 . . . . 63.14 115.232 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.9 126.65 47.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.307 1.553 . . . . 63.22 112.186 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 23.9 mt-10 -139.36 118.49 12.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.308 -0.627 . . . . 74.44 109.308 165.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.98 126.07 53.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 74.23 111.244 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.9 m -126.17 117.11 22.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 63.43 110.655 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -116.63 133.54 55.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.714 -0.476 . . . . 73.35 109.714 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 31.7 m -139.96 149.93 43.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.911 0.386 . . . . 73.24 110.805 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.7 129.41 2.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.105 -0.569 . . . . 55.31 111.847 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -112.89 133.84 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.758 -0.83 . . . . 60.14 108.758 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.72 129.91 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.04 0.448 . . . . 71.42 111.208 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.621 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 37.7 t-20 -91.11 143.73 26.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.55 -0.908 . . . . 62.24 108.55 177.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -65.12 -6.34 8.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.877 0.325 . . . . 75.1 111.877 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.15 168.12 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.428 -0.582 . . . . 74.51 109.428 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -52.65 -69.25 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.322 0.86 . . . . 65.3 113.322 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.8 m -122.3 92.18 3.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.314 0.578 . . . . 55.1 111.72 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 9.3 tmtm? -154.67 78.83 1.07 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.204 -1.035 . . . . 75.35 108.204 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.72 120.5 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.216 -0.902 . . . . 73.14 109.479 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -110.31 124.57 51.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.33 -0.395 . . . . 62.11 109.97 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.3 154.37 16.87 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.716 -0.754 . . . . 63.1 112.206 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 20.1 m -146.19 126.52 13.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.65 -0.5 . . . . 70.13 109.65 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -125.34 125.86 44.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.525 -0.546 . . . . 71.2 109.525 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 38.1 tt0 -129.53 126.19 38.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.035 0.445 . . . . 74.31 110.628 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 73' ' ' GLU . 3.9 m -120.1 129.45 54.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.851 -0.613 . . . . 64.5 109.758 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 68.6 mttm -117.52 133.99 55.36 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.856 -0.424 . . . . 61.53 109.856 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 50.1 m-85 -101.89 119.78 39.33 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.406 -0.961 . . . . 73.22 108.406 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.6 ttm180 -121.08 110.77 16.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 119.943 -0.703 . . . . 70.43 112.741 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -91.9 136.14 33.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.724 -1.125 . . . . 64.21 109.443 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -75.46 -11.57 60.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 72.13 112.695 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.84 106.27 2.63 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.081 -0.34 . . . . 75.1 110.081 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 66.87 -68.07 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.019 0.824 . . . . 73.42 110.476 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' HA3' ' HG2' ' A' ' 88' ' ' GLU . . . 154.66 72.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.672 -0.971 . . . . 61.23 110.672 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 63' ' ' ARG . 4.1 mm? -101.12 131.39 47.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.213 -0.292 . . . . 62.3 110.213 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 23.0 m -136.19 118.55 15.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.442 -0.344 . . . . 65.23 111.352 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.416 ' HB3' ' HD1' ' A' ' 62' ' ' TYR . 69.8 t80 -96.63 121.93 39.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.668 -0.864 . . . . 74.32 108.668 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 83' ' ' THR . 96.3 m -113.46 126.54 55.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.172 0.51 . . . . 73.24 112.158 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' CG ' ' HB ' ' A' ' 60' ' ' THR . 3.1 pt-20 -118.82 139.23 51.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.078 -0.964 . . . . 55.14 109.006 169.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.0 ttpp -142.01 142.41 32.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.917 -0.771 . . . . 74.22 108.917 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 129.73 35.82 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.088 -0.645 . . . . 75.01 111.69 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -116.18 135.96 53.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.65 -0.87 . . . . 71.33 108.65 165.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -35.77 74.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.133 0.492 . . . . 71.04 111.221 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.57 -34.83 10.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.775 -0.648 . . . . 65.42 111.723 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -104.71 -104.17 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.663 -0.415 . . . . 74.13 111.814 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -116.43 145.33 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.544 0.687 . . . . 73.43 112.777 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -106.19 131.59 53.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.224 -1.028 . . . . 73.22 108.224 168.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.86 148.28 17.97 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.652 -0.785 . . . . 31.14 112.77 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 72' ' ' THR . 88.0 m -156.45 143.98 19.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.099 -0.704 . . . . 50.12 109.099 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.642 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 4.7 mm-40 165.36 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.19 0.931 . . . . 62.12 110.632 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.476 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.54 138.29 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 74.24 112.231 -162.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 70' ' ' THR . 25.7 m -122.85 123.46 41.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.134 -0.484 . . . . 73.1 109.906 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.16 137.44 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 73.24 111.336 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HG2' ' HA3' ' A' ' 68' ' ' GLY . 12.8 pt-20 -125.79 151.31 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.12 -0.232 . . . . 70.51 111.458 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.5 ' OD2' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER 66.92 1.19 2.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.809 1.04 . . . . 73.51 113.809 171.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.88 -58.85 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.172 -0.211 . . . . 70.13 111.412 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.453 ' HB3' HD23 ' A' ' 95' ' ' LEU . 58.9 tp -74.62 -49.26 22.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.001 0.429 . . . . 75.4 110.519 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.879 -0.6 . . . . 65.35 110.033 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 7.3 mpt_? -63.82 127.71 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 65.23 110.411 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.642 ' HA2' ' HB1' ' A' ' 2' ' ' ALA . . . 101.23 -7.47 56.67 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.668 -0.777 . . . . 71.04 112.436 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 91' ' ' LEU . 50.7 tp -94.56 129.78 41.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.18 0.514 . . . . 71.52 110.957 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -122.25 111.99 17.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.391 -0.822 . . . . 74.02 109.872 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -104.98 126.78 52.4 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.149 -0.686 . . . . 74.12 109.149 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.858 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 19.8 m -125.67 119.26 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.013 0.435 . . . . 63.53 110.851 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.642 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 56.1 m-85 -113.42 119.53 37.94 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.608 -0.886 . . . . 74.14 108.608 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 12.1 m-20 -125.32 122.79 37.86 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.729 0.643 . . . . 51.43 109.383 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -115.11 122.56 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.157 -0.617 . . . . 72.11 110.112 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.3 m -111.43 122.77 48.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 73.54 110.423 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.456 ' HD2' ' HG2' ' A' ' 110' ' ' LYS . 74.7 t80 -110.21 129.7 55.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.448 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 45.4 t -104.42 128.16 27.58 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.205 -0.665 . . . . 54.41 109.205 175.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 36.0 Cg_exo -60.58 -20.32 64.02 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.652 2.234 . . . . 71.2 111.786 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -78.7 116.69 19.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.538 -0.755 . . . . 63.11 110.611 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.4 p 56.01 12.39 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.266 1.026 . . . . 74.12 113.664 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.48 74.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.553 -0.832 . . . . 70.12 112.393 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 104' ' ' SER . 57.3 tttp -65.2 123.93 20.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.32 111.247 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' A' ' 103' ' ' PHE . 97.1 mttt -112.13 136.32 51.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 54.35 110.71 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.4 121.61 38.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.694 -0.854 . . . . 73.2 108.694 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.27 133.53 55.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.278 . . . . 50.11 111.264 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 8.6 mtpm? -117.0 136.98 52.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.859 0.361 . . . . 74.4 110.72 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.661 HG23 ' HB3' ' A' ' 129' ' ' MET . 2.8 tp -134.18 116.01 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.706 -0.679 . . . . 73.42 109.602 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 35.7 ttmt -114.58 121.75 44.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.675 -0.693 . . . . 64.31 110.524 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.5 t -114.54 117.18 30.2 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.055 -0.72 . . . . 60.33 109.055 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.07 123.31 4.78 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.456 -0.878 . . . . 63.02 112.549 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.07 117.3 33.71 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.25 -0.648 . . . . 75.54 109.25 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 1.01 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -110.19 119.13 38.27 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.404 0.621 . . . . 73.52 109.878 177.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.637 ' HB2' HG23 ' A' ' 123' ' ' ILE . 17.7 mmm-85 -108.36 163.67 12.99 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.031 -0.986 . . . . 71.22 108.943 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -53.09 -34.19 55.53 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.551 0.532 . . . . 74.43 112.186 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.01 -0.77 10.52 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.4 0.519 . . . . 65.02 112.4 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 120' ' ' ARG . 3.6 tp -145.49 120.72 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.937 -0.705 . . . . 65.15 111.463 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 1.01 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 7.2 p30 -129.44 116.12 18.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 63.1 111.136 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -129.65 144.42 51.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.106 0.479 . . . . 64.0 111.112 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.589 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -142.42 131.15 4.55 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.538 -0.755 . . . . 61.24 112.243 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.7 m -110.1 114.75 28.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.825 0.345 . . . . 62.32 110.54 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 32.4 t70 -106.63 116.14 31.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.265 -0.642 . . . . 74.13 109.265 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.661 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.7 ttt -97.67 122.78 41.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 75.33 110.615 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.88 116.74 31.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.353 -0.61 . . . . 62.12 109.353 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -97.3 115.07 26.98 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.918 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.83 149.8 36.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.919 -0.771 . . . . 74.52 108.919 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -32.33 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.679 0.276 . . . . 72.24 110.625 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.08 -18.33 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 75.5 111.1 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.58 116.6 0.37 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.754 . . . . 74.31 112.517 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.16 144.83 34.08 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.026 2.484 . . . . 72.33 111.883 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 m -124.13 146.62 48.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.492 -0.322 . . . . 55.32 110.474 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 30.9 mm -107.53 116.13 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.766 -0.457 . . . . 73.1 109.766 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -110.16 110.33 21.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.974 0.416 . . . . 72.41 110.223 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.94 133.58 11.52 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.209 -0.996 . . . . 74.15 112.318 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.93 113.77 18.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.201 0.524 . . . . 64.2 109.905 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 125' ' ' LEU . 7.3 tp -115.67 123.74 49.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.611 -0.722 . . . . 73.34 110.351 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 7' ' ' TYR . 59.5 t -123.0 124.02 69.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.104 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.54 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.17 138.2 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.029 -0.73 . . . . 75.31 109.029 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -119.47 119.16 4.19 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.747 -0.74 . . . . 75.54 113.039 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.797 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 55.3 m-85 -112.75 150.44 31.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.2 -1.407 . . . . 74.44 107.2 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -49.08 94.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.154 0.434 . . . . 71.35 111.386 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.55 -30.87 9.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.912 -0.585 . . . . 71.13 112.786 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 59.1 m95 -101.88 144.7 30.19 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.42 -0.459 . . . . 73.41 111.038 -173.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.458 HD23 ' HA2' ' A' ' 145' ' ' GLY . 16.3 mt -136.33 142.62 43.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.76 0.314 . . . . 73.23 111.424 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.26 126.13 24.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 51.25 109.943 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -131.9 133.54 7.21 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.655 -0.783 . . . . 70.25 112.157 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.557 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 92.1 m-85 -127.71 119.33 25.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.771 0.32 . . . . 73.55 110.723 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.551 HE21 ' HE1' ' A' ' 7' ' ' TYR . 85.8 mt-30 -106.52 123.04 47.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.215 -0.661 . . . . 74.1 109.215 173.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -137.44 129.8 29.56 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.549 -0.296 . . . . 65.31 110.255 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.404 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 48.3 t30 -112.57 118.98 36.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.502 -0.555 . . . . 61.13 109.502 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.888 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 27.7 m-85 -91.87 129.49 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 75.41 110.52 -173.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 23.8 tt0 -97.49 110.5 23.04 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 109.277 -0.638 . . . . 72.34 109.277 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -70.28 -16.04 62.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 112.777 -2.01 . . . . 71.21 111.822 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.86 66.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.871 0.843 . . . . 71.24 109.088 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.554 ' HG3' ' HB2' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -122.83 -153.97 0.58 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.36 -1.348 . . . . 74.42 107.36 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 p -107.31 28.3 8.23 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.916 -0.49 . . . . 71.3 110.452 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.554 ' HB2' ' HG3' ' A' ' 161' ' ' LYS . 14.4 mmt180 -139.75 149.11 43.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.051 -1.06 . . . . 72.1 112.355 -161.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.888 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.21 136.58 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.569 -0.53 . . . . 72.5 109.569 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 6.6 t -93.43 -23.52 18.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.903 -0.59 . . . . 71.21 110.41 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -141.14 133.19 27.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 64.25 110.599 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 2.7 m -121.89 115.91 23.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.574 -0.739 . . . . 63.14 109.759 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 51.7 t30 -118.77 120.46 37.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.881 -0.785 . . . . 73.43 108.881 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 24.8 m-85 -120.87 140.86 51.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.403 -0.519 . . . . 75.44 110.298 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -143.09 127.19 17.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.185 -0.461 . . . . 45.54 110.49 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' A' ' 182' ' ' THR . 49.0 t -126.39 136.97 59.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.866 -0.42 . . . . 74.25 109.866 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.55 124.81 7.0 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.22 -0.514 . . . . 52.31 112.111 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.57 125.6 54.44 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.327 -0.62 . . . . 63.14 109.327 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -102.94 125.63 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.379 0.609 . . . . 74.51 111.255 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 19.7 p -131.19 164.92 24.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.076 -0.965 . . . . 71.2 108.41 171.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.41 -46.93 76.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.248 0.462 . . . . 63.14 112.248 -170.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.444 ' HG3' HE22 ' A' ' 196' ' ' GLN . 3.7 tp10 -102.45 -22.79 14.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.691 -0.404 . . . . 74.05 111.778 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.556 ' HB2' ' OG1' ' A' ' 175' ' ' THR . 47.5 m-85 -113.51 135.82 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.101 0.477 . . . . 75.42 111.604 -172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -111.07 122.68 48.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.732 -1.21 . . . . 75.11 107.732 165.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.69 136.94 53.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.32 0.581 . . . . 62.42 111.174 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.531 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 13.3 t60 -126.68 113.72 17.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.227 -0.897 . . . . 72.04 109.061 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.718 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 7.3 t -93.66 141.45 28.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.329 -0.989 . . . . 73.21 108.329 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -133.6 140.1 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 72.41 109.991 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 41.5 t -126.87 120.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.065 -0.516 . . . . 64.3 111.013 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.2 t30 -99.32 90.0 4.4 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.6 0.714 . . . . 74.24 109.092 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 3.1 t70 55.73 -161.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.002 -1.454 . . . . 65.33 110.944 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.598 -0.81 . . . . 64.23 112.157 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.7 m -93.52 -25.56 17.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.627 0.603 . . . . 73.3 112.627 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 32.8 tt0 -134.49 124.42 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.601 -0.84 . . . . 65.14 112.364 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -121.18 126.2 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.188 -0.914 . . . . 71.2 108.545 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.24 -172.56 19.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.773 -1.204 . . . . 71.31 113.395 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.23 172.94 31.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.716 -0.554 . . . . 74.33 111.716 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 33.1 m -148.27 142.29 25.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.238 -0.282 . . . . 44.12 110.238 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.584 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 10.6 mm -119.52 118.82 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 73.11 109.4 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -108.24 120.98 43.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.417 -0.586 . . . . 63.14 109.417 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 199' ' ' ASN . 0.0 OUTLIER -121.78 111.69 17.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.787 -0.642 . . . . 71.31 111.41 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.601 ' HD2' ' O ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -89.85 130.8 36.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.485 -0.931 . . . . 73.33 108.485 169.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 197' ' ' LYS . 10.3 m 58.95 36.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.923 0.868 . . . . 75.34 110.95 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 196' ' ' GLN . 14.5 t30 -52.54 -50.35 63.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.68 -1.145 . . . . 63.2 108.827 170.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 200' ' ' LYS . 13.6 tppt? -144.31 71.19 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.73 -1.123 . . . . 75.43 107.981 169.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 70.25 -41.74 0.5 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.005 -0.998 . . . . 54.21 112.427 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.806 HD12 ' H ' ' A' ' 226' ' ' GLN . 2.5 mm? -92.74 -161.05 0.8 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.925 0.393 . . . . 75.45 111.089 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 224' ' ' LYS . 45.3 mt-10 -111.82 153.33 26.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.527 -0.306 . . . . 74.34 110.565 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -147.68 143.84 27.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.495 -0.321 . . . . 74.41 110.279 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -134.61 136.76 43.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.83 0.347 . . . . 70.2 110.407 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 45.1 t -123.25 145.42 30.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.074 -0.512 . . . . 74.54 110.088 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -131.98 136.28 47.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.876 0.37 . . . . 72.51 110.481 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.32 140.98 51.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 63.42 109.629 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -140.5 128.91 22.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.966 0.412 . . . . 41.2 111.399 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -115.39 132.88 56.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.737 -0.838 . . . . 74.31 108.737 174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 12.3 t -116.5 132.54 56.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.801 -0.444 . . . . 71.25 109.801 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.04 150.37 25.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.765 . . . . 70.02 111.457 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.01 15.07 13.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.464 -0.874 . . . . 52.04 112.392 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.26 87.34 0.11 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.268 0.556 . . . . 70.32 111.328 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.0 t -146.49 171.95 14.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 52.11 109.862 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.76 159.63 23.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.736 -0.468 . . . . 71.32 109.736 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.4 m -77.29 135.79 38.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.745 0.307 . . . . 61.23 110.329 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 55.2 mtm180 -88.96 136.39 33.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.923 -0.399 . . . . 73.34 109.923 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.647 ' HB2' ' HB3' ' A' ' 239' ' ' ASN . 79.7 m-85 -114.52 138.96 49.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.658 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.49 139.67 10.21 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.612 -0.995 . . . . 73.4 110.612 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.5 ' HB ' HG12 ' A' ' 237' ' ' VAL . 5.0 mp -136.14 130.48 48.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.2 0.5 . . . . 61.23 110.504 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.1 129.41 50.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.796 -0.446 . . . . 64.33 109.796 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.25 139.71 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.601 0.239 . . . . 62.34 110.59 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 203' ' ' GLU . 43.9 mtmt -117.28 114.75 24.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.465 ' HA ' ' HG ' ' A' ' 202' ' ' LEU . 47.4 m-85 -100.76 115.34 30.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.211 -0.662 . . . . 62.25 109.211 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.806 ' H ' HD12 ' A' ' 202' ' ' LEU . 35.7 tt0 -86.7 99.62 11.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.161 -0.472 . . . . 72.25 110.029 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.82 -37.31 12.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.499 0.666 . . . . 72.52 109.685 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.74 145.52 19.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.106 -0.952 . . . . 74.42 109.18 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.51 -30.73 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.955 2.437 . . . . 75.12 113.454 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.46 -18.62 21.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.085 0.402 . . . . 73.1 112.085 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.71 122.75 20.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.237 0.541 . . . . 50.33 111.797 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 52.0 t -124.49 136.44 54.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.21 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -99.99 128.82 46.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.743 -0.466 . . . . 74.32 109.743 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.9 m -113.95 152.79 30.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.844 0.354 . . . . 63.32 110.503 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -140.66 141.21 35.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.357 -0.609 . . . . 73.15 109.357 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 54.9 mtmt -134.46 154.51 51.37 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.309 -0.256 . . . . 75.42 110.309 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.1 p -149.98 147.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.966 0.413 . . . . 64.45 110.663 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.7 t-20 -117.63 149.55 40.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.655 -0.868 . . . . 61.32 108.655 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . 0.1 OUTLIER -56.63 -17.61 9.28 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.88 0.696 . . . . 65.42 112.88 -172.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 49.2 m -83.22 23.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.455 0.169 . . . . 71.04 111.021 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 50.1 m 64.9 39.66 5.8 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.299 0.571 . . . . 73.12 110.449 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.94 ' HB3' HD11 ' A' ' 262' ' ' LEU . 46.1 mt -98.15 115.61 28.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.748 -0.66 . . . . 73.21 109.5 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.9 OUTLIER -105.34 117.62 51.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 109.841 -0.429 . . . . 72.13 109.841 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -120.4 162.12 14.45 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.825 -0.702 . . . . 73.41 112.723 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 2.6 pp -142.01 160.39 40.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.032 -0.358 . . . . 72.25 110.032 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -150.54 150.86 22.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.751 -0.738 . . . . 71.44 112.905 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 258' ' ' THR . 81.7 m-85 -123.16 115.96 22.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.561 -0.533 . . . . 63.22 109.561 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 20.0 m -113.0 114.0 26.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.739 -0.467 . . . . 74.0 109.739 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -135.45 127.62 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 65.52 110.548 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 32.1 m -88.53 128.55 35.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.551 0.215 . . . . 74.04 110.468 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.463 HD23 ' HG3' ' A' ' 252' ' ' LYS . 3.3 tt -122.24 88.92 3.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.215 -0.661 . . . . 74.35 109.215 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.463 ' HG3' HD23 ' A' ' 251' ' ' LEU . 94.1 mttt 68.99 166.06 0.13 Allowed Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 115.545 -0.752 . . . . 74.21 111.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.09 71.77 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.64 2.227 . . . . 61.21 112.351 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.32 -59.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.062 -0.589 . . . . 64.14 111.885 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 279' ' ' LEU . 0.0 OUTLIER -119.24 122.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 71.44 111.992 -171.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 1.062 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 66.4 mttm -92.28 135.45 34.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.209 -1.034 . . . . 53.32 108.209 163.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.82 123.41 41.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.25 -0.648 . . . . 74.31 109.25 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 48.6 m -122.47 111.12 16.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.454 0.645 . . . . 73.35 110.462 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.728 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -100.21 125.62 46.4 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.664 -1.235 . . . . 64.13 107.664 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 60.1 m -131.44 140.02 49.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 73.44 110.927 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.77 139.83 26.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.817 -0.438 . . . . 73.33 109.817 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.94 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -118.4 121.99 41.7 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.816 -0.809 . . . . 65.32 108.816 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.626 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -103.08 106.72 17.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.605 -0.887 . . . . 74.53 108.605 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.953 ' H ' HG21 ' A' ' 268' ' ' VAL . 5.3 t70 -72.92 98.0 2.39 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.318 -0.993 . . . . 62.15 108.318 172.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.45 -8.46 2.66 Favored Glycine 0 C--N 1.307 -1.076 0 CA-C-N 115.078 -0.965 . . . . 54.14 114.044 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.42 -15.83 25.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.444 0.164 . . . . 60.41 110.981 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -152.84 -28.63 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.657 0.741 . . . . 74.45 110.906 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.953 HG21 ' H ' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -54.12 -22.25 7.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.595 -1.184 . . . . 63.43 113.021 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -55.9 -20.57 16.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.666 -0.697 . . . . 53.34 111.459 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.56 -16.58 59.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 63.42 111.43 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.35 -0.53 14.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 65.14 113.168 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -93.09 63.93 2.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 72.33 112.3 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.545 ' HB2' ' CD1' ' A' ' 263' ' ' LEU . 4.0 p-80 -79.27 147.92 32.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.68 -0.118 . . . . 74.45 110.68 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -95.3 138.02 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.533 -0.467 . . . . 71.43 109.759 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -132.84 140.57 48.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 75.31 110.631 -170.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.54 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -142.07 131.53 4.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.549 -0.62 . . . . 73.14 111.549 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.728 HD23 HD22 ' A' ' 259' ' ' LEU . 3.4 tm? -115.75 137.57 51.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.967 -0.753 . . . . 72.4 108.967 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.423 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -150.96 140.51 7.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.075 -1.059 . . . . 72.4 113.144 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.504 HD12 HD11 ' A' ' 255' ' ' ILE . 2.4 mm? -110.85 129.98 55.71 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.625 -0.88 . . . . 75.34 108.625 172.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 1.062 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 21.7 mm-40 -101.84 112.04 24.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.312 1.053 . . . . 72.3 112.997 -168.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 1.013 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 34.4 p90 -29.21 44.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 119.971 3.323 . . . . 43.2 119.971 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.858 ' HG2' ' HG3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -113.9 104.91 12.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 122.424 2.375 . . . . 74.1 112.332 -175.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.62 106.26 8.61 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.554 -0.906 . . . . 75.02 108.554 163.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -155.12 -166.06 2.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.383 -0.826 . . . . 61.43 109.122 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.778 -0.63 . . . . 74.33 109.739 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.994 0.426 . . . . 74.01 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.737 HG11 ' HB2' ' A' ' 119' ' ' LYS . 7.9 t -80.31 119.67 77.13 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.67 -0.695 . . . . 74.22 109.678 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.68 162.34 42.43 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.902 2.401 . . . . 71.53 112.824 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.63 79.85 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.764 2.31 . . . . 74.33 111.003 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.554 ' HB ' ' CG1' ' A' ' 143' ' ' VAL . 26.7 p -69.84 -46.95 64.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.434 -0.803 . . . . 73.31 111.995 -172.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -58.37 -28.4 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.058 -0.519 . . . . 71.3 111.41 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.26 -22.99 35.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.094 0.473 . . . . 74.41 110.839 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.27 -15.66 45.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.843 -0.617 . . . . 71.23 109.737 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.61 HD21 HG13 ' A' ' 143' ' ' VAL . 75.1 mt -63.72 -29.23 70.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.65 -0.705 . . . . 55.33 110.263 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.49 62.96 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.73 -0.668 . . . . 42.33 112.263 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 64.0 tttp -63.87 -49.4 72.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 65.23 110.183 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 m -64.55 -38.32 90.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.296 0.569 . . . . 72.41 110.529 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.439 -0.801 . . . . 75.44 112.254 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.638 ' HG3' ' N ' ' A' ' 16' ' ' ASP . 1.7 ptt180 -59.7 -36.99 77.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.563 0.22 . . . . 71.2 111.171 -175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.638 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 69.7 m-20 -68.47 -37.0 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 72.11 110.677 -175.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -72.43 -40.42 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 70.15 110.809 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -70.71 -33.75 71.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.812 -0.631 . . . . 71.21 110.983 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 m -70.04 133.72 47.51 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.71 -0.478 . . . . 73.31 109.71 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -69.53 79.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.72 0.772 . . . . 64.1 111.632 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.98 70.42 2.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.28 -0.728 . . . . 55.35 111.28 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' A' ' 274' ' ' LYS . 17.7 p90 -85.04 -53.62 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.568 0.223 . . . . 72.43 110.884 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.56 129.39 4.17 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.661 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -104.33 5.64 34.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.297 0.57 . . . . 71.32 110.463 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 89.39 12.6 62.8 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.543 -1.023 . . . . 72.34 110.543 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 46' ' ' SER . 0.5 OUTLIER -102.78 153.5 20.1 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.943 -0.628 . . . . 62.54 111.423 -169.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.783 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.8 mp -106.9 124.46 62.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.002 -0.999 . . . . 71.33 110.545 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.8 tptm -102.06 119.47 38.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.484 -0.562 . . . . 65.41 109.484 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -113.84 128.63 56.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.005 0.431 . . . . 75.01 110.132 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -120.76 136.35 54.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.735 . . . . 71.22 109.066 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.909 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -133.39 123.84 26.07 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.197 -0.668 . . . . 62.32 109.197 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 14.3 pttm -137.08 125.58 23.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.203 0.525 . . . . 75.54 111.498 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.758 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 18.9 m -109.71 121.27 44.84 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.512 -0.922 . . . . 61.4 108.512 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -109.82 124.45 51.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.933 -0.307 . . . . 74.25 111.165 -170.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.82 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 12.2 t -140.41 169.66 17.26 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.277 -1.008 . . . . 45.24 108.277 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.21 179.83 4.25 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.091 -0.707 . . . . 72.42 109.091 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.59 43.63 7.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.14 0.495 . . . . 75.41 111.27 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 94.49 -4.84 70.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 116.984 1.554 . . . . 73.43 116.984 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.82 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -100.2 124.13 45.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 120.971 2.385 . . . . 73.21 112.141 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.893 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.9 tt0 -143.08 118.02 9.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.987 -0.746 . . . . 52.24 108.987 162.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 97.4 m-85 -108.34 121.78 45.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.546 -0.462 . . . . 73.55 110.473 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 33.0 m -125.19 132.65 52.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.104 0.478 . . . . 72.35 111.062 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.685 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 44.3 t -125.32 143.11 51.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.729 -0.841 . . . . 75.15 108.729 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m -135.67 126.55 27.56 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.04 -0.356 . . . . 51.22 110.04 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.452 ' HA2' ' HA2' ' A' ' 56' ' ' GLY . . . -141.78 157.13 26.21 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.171 -1.014 . . . . 65.4 112.47 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB3' HD21 ' A' ' 26' ' ' LEU . 39.8 m -131.82 139.27 48.81 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.978 -0.749 . . . . 73.42 108.978 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -119.46 129.08 54.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.224 0.535 . . . . 63.14 110.574 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.83 145.93 24.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.043 -0.98 . . . . 60.43 108.852 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.06 76.19 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.371 0.605 . . . . 54.55 111.457 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -167.22 154.14 8.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.915 -1.143 . . . . 73.14 107.915 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.7 m -56.22 -45.94 79.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.097 0.777 . . . . 74.23 113.097 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.3 p -129.29 47.31 2.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 72.13 112.496 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.33 73.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.384 0.612 . . . . 71.14 110.991 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.57 120.57 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.47 -0.787 . . . . 72.13 109.633 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -109.2 126.53 53.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.709 -0.478 . . . . 71.35 109.709 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HA2' ' A' ' 45' ' ' GLY . . . -132.74 170.72 21.94 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.343 -0.932 . . . . 74.2 113.07 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.5 m -147.56 157.66 43.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.421 -0.585 . . . . 74.54 109.421 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 58' ' ' LEU . 1.2 tm? -120.22 125.02 47.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 74.04 109.371 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.8 tt0 -118.82 119.25 33.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.582 -0.736 . . . . 61.42 109.504 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 m -110.23 120.02 41.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.431 -0.349 . . . . 73.34 110.527 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.893 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mptt -106.61 131.45 53.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.224 0.535 . . . . 64.13 110.359 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.5 m-85 -103.21 118.48 36.87 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.305 -1.369 . . . . 74.23 107.305 170.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.447 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 33.3 ttm-85 -113.46 109.69 19.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.424 0.631 . . . . 75.33 111.876 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.21 91.2 8.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.161 -0.927 . . . . 71.54 109.254 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -16.42 61.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.299 -0.864 . . . . 71.21 110.679 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.89 -41.31 87.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.193 -0.912 . . . . 74.41 111.031 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.489 ' HB2' ' HG ' ' A' ' 69' ' ' LEU . 67.6 m-85 -108.14 -33.94 7.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.33 111.186 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.624 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 101.95 44.44 1.91 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.947 -0.861 . . . . 53.41 110.947 -173.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 87' ' ' VAL . 13.4 mt -126.91 147.21 50.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.804 -0.443 . . . . 75.44 109.804 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -136.57 135.3 38.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.691 0.281 . . . . 75.53 111.13 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 70.1 t80 -115.17 120.73 40.72 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.429 -0.582 . . . . 74.25 109.429 173.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 17.7 m -109.57 117.74 34.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.236 -0.438 . . . . 52.33 110.305 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 42.8 tt0 -109.15 120.34 42.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.355 -0.609 . . . . 72.31 109.355 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -107.81 97.6 7.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.095 -0.502 . . . . 71.0 109.7 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.585 ' HD1' HD13 ' A' ' 81' ' ' LEU . 46.4 t90 -100.35 131.84 46.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.345 0.593 . . . . 71.52 111.279 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.38 154.11 35.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.521 -0.763 . . . . 43.23 109.861 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 m -57.6 -18.4 19.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.016 0.436 . . . . 61.12 111.9 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 20.2 t70 -67.57 -3.86 10.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.095 -0.502 . . . . 73.44 110.906 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 8.1 m120 79.66 22.84 0.51 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.876 0.87 . . . . 70.11 110.02 -175.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 25.7 m -88.83 118.14 28.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.54 -0.754 . . . . 61.31 111.015 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.585 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.8 mm? -97.19 118.37 33.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 63.41 109.213 172.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.68 92.83 0.85 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.512 -0.851 . . . . 43.24 111.21 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 p -91.39 103.5 16.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.986 0.422 . . . . 73.21 111.414 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 25.4 tt0 -106.73 111.63 24.25 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.456 -0.793 . . . . 70.25 109.565 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.9 121.52 64.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.437 -0.579 . . . . 74.34 109.437 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 98' ' ' THR . 14.3 t -128.2 129.66 46.81 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.54 0.686 . . . . 73.22 111.537 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.678 ' HA ' HD22 ' A' ' 69' ' ' LEU . 32.5 m -111.01 129.89 65.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.417 -0.81 . . . . 74.24 109.631 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.28 118.71 36.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 71.11 112.131 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 47.27 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.319 1.012 . . . . 73.24 112.804 171.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.511 ' HB2' ' H ' ' A' ' 91' ' ' LEU . 1.5 mp0 -116.97 -92.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.317 -0.401 . . . . 74.34 110.09 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.511 ' H ' ' HB2' ' A' ' 90' ' ' GLN . 8.1 mp -95.2 -44.72 7.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.982 -0.747 . . . . 71.51 108.982 175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.65 103.71 5.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 63.05 109.376 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.83 124.26 21.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.693 -0.685 . . . . 74.3 110.756 -173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.77 5.73 87.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.869 -0.681 . . . . 61.35 113.085 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 128.16 38.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.238 0.519 . . . . 71.32 111.638 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -118.28 111.39 18.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.61 -0.885 . . . . 64.21 108.61 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.633 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.2 mm? -102.52 124.78 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.514 -0.551 . . . . 54.51 109.514 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 7.8 m -131.21 119.69 22.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.54 -0.3 . . . . 71.04 111.015 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 72.5 t80 -111.2 115.32 29.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.473 -0.566 . . . . 72.13 109.473 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -112.02 122.63 48.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.189 -0.459 . . . . 62.4 109.775 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.4 t -138.16 123.83 19.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.43 -0.508 . . . . 71.54 111.004 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 13.0 m -104.17 122.69 45.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.064 -0.516 . . . . 51.31 110.264 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.81 124.87 48.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.556 -0.293 . . . . 64.25 110.786 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.9 t -127.6 102.42 22.97 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.437 -0.579 . . . . 54.01 109.437 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.23 -9.13 22.93 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.074 2.516 . . . . 74.15 112.755 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -78.52 -40.12 36.1 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.034 -0.358 . . . . 64.22 110.034 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 p -100.22 -25.61 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 73.0 111.171 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.936 -0.575 . . . . 74.23 111.897 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -79.12 123.93 27.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 71.42 111.275 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -132.66 124.63 28.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.934 -0.575 . . . . 73.43 109.495 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 101' ' ' SER . 7.4 m120 -120.45 128.37 53.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.825 -0.625 . . . . 65.12 110.353 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -114.07 114.79 26.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.259 -0.428 . . . . 64.11 110.366 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -111.13 136.95 49.43 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.158 -0.682 . . . . 74.13 109.158 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -119.47 117.62 54.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 72.03 109.833 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.2 tttp -115.26 119.13 35.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.495 -0.775 . . . . 72.44 109.285 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -127.2 118.59 24.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.679 -0.489 . . . . 63.13 109.679 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -127.13 122.84 4.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.333 -0.937 . . . . 63.53 112.577 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -110.0 121.03 44.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.375 0.607 . . . . 74.24 109.501 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.737 ' HB2' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.6 124.23 51.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.649 -0.705 . . . . 64.11 110.673 179.231 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 120' ' ' ARG . 10.0 tpp180 -104.96 167.68 9.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.559 -1.274 . . . . 75.41 107.559 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 120' ' ' ARG . 37.7 tt0 -53.16 -33.33 52.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.475 0.546 . . . . 63.15 112.475 -167.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -120.25 0.32 10.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.801 0.667 . . . . 71.41 112.801 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.926 HG13 HD21 ' A' ' 142' ' ' LEU . 7.7 tt -145.25 136.01 19.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 O-C-N 121.74 -0.6 . . . . 74.14 111.985 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.774 ' O ' HD23 ' A' ' 142' ' ' LEU . 5.4 t30 -129.19 109.84 11.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.088 -0.645 . . . . 62.45 111.308 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.049 ' HG ' ' HG ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -112.89 142.48 45.51 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.449 0.642 . . . . 64.52 111.719 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -143.33 127.06 2.97 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.78 -1.1 . . . . 51.42 112.737 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.22 111.85 24.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.952 -0.388 . . . . 73.32 109.952 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -113.52 118.23 33.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.495 -0.557 . . . . 73.0 109.495 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.635 ' HG2' HG13 ' A' ' 138' ' ' ILE . 59.3 mtt -120.94 119.37 32.39 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.747 -0.381 . . . . 53.43 111.391 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 15.3 m-20 -90.65 118.39 30.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 109.811 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 74.3 t80 -96.87 104.55 16.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.966 0.412 . . . . 65.22 110.014 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.26 157.27 30.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.865 -0.607 . . . . 70.31 109.717 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.2 pp -73.85 -15.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.209 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.441 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -88.88 -17.59 29.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.013 0.435 . . . . 74.14 110.714 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.44 117.54 0.67 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.926 -0.654 . . . . 73.12 112.08 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 56.1 Cg_endo -72.01 134.36 23.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.463 2.109 . . . . 72.0 111.781 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -119.37 144.14 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.458 -0.337 . . . . 75.41 110.397 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -107.29 117.12 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.459 -0.571 . . . . 75.44 109.459 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -114.63 113.85 24.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.745 -0.661 . . . . 74.5 109.532 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.71 129.57 9.35 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.375 -1.393 . . . . 71.14 111.365 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . . . -124.7 118.72 27.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.651 0.263 . . . . 65.03 110.704 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.049 ' HG ' ' HG ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -117.08 144.76 44.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.332 -0.394 . . . . 55.45 110.624 175.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.628 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 45.4 t -128.5 115.43 37.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.52 -1.289 . . . . 74.32 107.52 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -120.93 137.27 54.69 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.547 -1.206 . . . . 74.14 110.117 -169.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.54 135.7 13.06 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 120.604 -0.808 . . . . 50.12 113.2 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -143.8 125.36 14.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.011 0.434 . . . . 73.31 111.4 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 59.22 23.35 11.68 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.987 0.736 . . . . 64.22 112.987 168.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.69 -18.18 51.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.378 -0.915 . . . . 63.41 113.062 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -105.17 146.65 28.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.891 -0.411 . . . . 72.11 109.891 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.541 HD22 HG12 ' A' ' 143' ' ' VAL . 5.0 mt -108.9 148.39 30.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 72.11 110.637 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 144' ' ' LEU . . . -141.85 124.26 15.72 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.73 -1.211 . . . . 54.44 107.73 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -156.05 131.82 3.15 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.58 -0.819 . . . . 74.23 111.965 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.983 ' CB ' ' HA ' ' A' ' 169' ' ' PHE 0.423 0.1 OUTLIER -165.06 171.76 13.48 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 116.209 1.929 . . . . 74.11 116.209 167.326 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 26.4 pt20 -106.85 134.37 50.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.416 -1.72 . . . . 64.35 111.498 -166.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.8 ttp -110.84 141.53 44.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 51.34 109.576 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.53 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 43.4 m-80 -114.51 117.92 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.024 -0.27 . . . . 71.02 110.351 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.851 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 74.1 t80 -102.08 122.27 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.684 -0.689 . . . . 74.12 110.759 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 163' ' ' ARG . 32.4 tt0 -88.78 99.93 12.75 Favored 'General case' 0 C--O 1.259 1.574 0 CA-C-N 115.567 -0.742 . . . . 64.45 109.044 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.46 HG23 ' HE1' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -70.29 -19.98 63.06 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 113.446 -1.706 . . . . 71.12 111.664 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.18 -26.65 64.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.047 0.927 . . . . 62.13 108.732 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -122.39 -157.5 0.74 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.136 -1.393 . . . . 70.43 107.839 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -107.64 27.76 8.84 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.32 -0.622 . . . . 52.53 109.32 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -133.64 129.36 36.77 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.64 -0.824 . . . . 62.51 112.857 -159.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.851 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.8 m -73.54 136.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 168.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 2.0 m -90.01 -34.53 15.94 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.518 -0.473 . . . . 63.54 110.371 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -149.89 133.29 16.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 73.33 110.017 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.7 m -103.14 111.76 24.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.557 -0.905 . . . . 62.5 108.557 172.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.932 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 46.5 m-20 -106.4 121.67 44.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.863 -0.791 . . . . 73.22 108.863 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.983 ' HA ' ' CB ' ' A' ' 153' ' ' TYR . 51.4 p90 -131.17 138.94 49.65 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.057 0.848 . . . . 74.12 111.31 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.779 ' H ' ' HB2' ' A' ' 153' ' ' TYR . . . -130.25 145.84 51.8 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 120.883 0.373 . . . . 71.41 110.547 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 151' ' ' ALA . 48.8 t -127.56 131.28 70.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.276 -0.42 . . . . 75.14 110.635 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.3 95.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.655 -0.978 . . . . 72.3 110.655 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -110.92 119.62 39.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.853 -0.795 . . . . 72.25 108.853 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 34.0 mtmm -114.84 127.92 56.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.331 -0.395 . . . . 73.13 111.46 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 56.7 m -132.09 113.44 13.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.137 -0.483 . . . . 75.01 110.347 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 40.4 -93.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.266 1.21 . . . . 75.51 114.266 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.1 -11.85 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.672 0.619 . . . . 74.3 112.672 -170.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 175' ' ' THR . 48.4 p90 -129.97 135.94 48.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.622 0.725 . . . . 74.5 111.615 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.405 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 75.8 mt-30 -114.46 123.18 48.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.231 -0.895 . . . . 63.42 108.924 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.24 137.55 33.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.281 0.562 . . . . 64.02 111.081 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -123.8 115.67 21.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.052 -0.976 . . . . 74.13 108.689 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 43.8 m -124.54 115.46 20.9 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.658 -0.417 . . . . 74.25 110.086 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.43 140.62 50.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.371 0.605 . . . . 71.44 109.852 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 6.4 t -126.31 130.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.521 -0.763 . . . . 73.14 110.757 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.852 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 11.9 m-20 -105.51 93.69 4.8 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.383 -0.969 . . . . 70.43 108.383 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.0 t70 61.47 -179.53 0.12 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.633 -0.506 . . . . 74.41 109.633 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.48 -6.35 61.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.795 -0.717 . . . . 50.32 112.174 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.8 p -96.4 -26.17 15.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.055 0.761 . . . . 65.23 113.055 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.852 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 24.8 mt-10 -118.45 124.99 48.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 119.697 -0.801 . . . . 63.03 112.23 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.8 125.52 53.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.398 -0.819 . . . . 75.52 109.745 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.18 113.52 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.899 -0.667 . . . . 73.32 112.089 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.99 139.28 15.02 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.934 -0.65 . . . . 64.44 111.883 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 14.5 m -140.52 138.39 34.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.914 0.388 . . . . 62.41 110.03 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.3 mp -124.56 128.33 73.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.666 -0.494 . . . . 62.52 109.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 42.9 t80 -106.67 119.75 40.14 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.622 -0.881 . . . . 75.3 108.622 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -122.51 131.1 53.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.414 -0.587 . . . . 74.54 109.414 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 197' ' ' LYS . 24.9 ttpp -103.29 109.05 20.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.786 -0.643 . . . . 73.34 109.678 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 202' ' ' LEU . 0.0 OUTLIER -93.2 -17.36 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-O 121.555 0.693 . . . . 75.02 109.82 -176.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 14.2 t-20 -163.86 158.17 19.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.917 -1.038 . . . . 72.13 108.324 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -63.67 -13.24 41.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.014 0.435 . . . . 50.13 111.071 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 226' ' ' GLN . 19.0 tttp -116.05 3.98 13.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.001 -0.545 . . . . 54.41 110.642 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.541 ' HG ' HG23 ' A' ' 198' ' ' VAL . 47.8 tp -140.29 108.98 5.92 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.766 0.793 . . . . 62.22 111.307 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.554 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 24.7 mt-10 -115.32 137.84 51.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.953 -1.021 . . . . 63.31 110.192 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 p -123.68 151.17 43.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.122 -0.325 . . . . 71.41 110.122 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -140.11 139.03 35.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.015 0.436 . . . . 73.14 111.306 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 193' ' ' SER . 53.3 t -112.11 137.43 44.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.313 -0.625 . . . . 51.01 109.313 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -132.84 128.34 36.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.263 -0.643 . . . . 65.23 109.263 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.6 pt? -147.89 130.61 16.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.412 0.625 . . . . 74.44 111.082 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.2 132.87 55.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.33 -0.85 . . . . 75.2 110.363 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.779 ' HB2' HG23 ' A' ' 217' ' ' THR . 19.3 t90 -130.7 131.7 44.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.569 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 11.9 m -104.7 113.49 27.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.763 -0.653 . . . . 65.54 109.649 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.81 127.54 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.903 -0.406 . . . . 42.33 109.903 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.93 17.65 57.54 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 31.31 111.537 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 12.0 t-20 -129.93 -153.86 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.772 -0.825 . . . . 64.43 108.772 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 214' ' ' ASN . 17.2 m -85.95 -154.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.066 0.46 . . . . 71.44 111.747 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.72 163.47 7.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.497 -0.774 . . . . 72.1 112.553 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.779 HG23 ' HB2' ' A' ' 210' ' ' TRP . 32.7 m -76.39 134.55 39.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.605 -0.725 . . . . 63.0 109.18 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 69.3 mtt85 -101.05 116.12 32.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.723 -0.473 . . . . 71.44 109.723 -173.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.489 ' HD2' HD13 ' A' ' 208' ' ' LEU . 65.8 t80 -113.5 149.67 34.01 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.608 0.568 . . . . 74.04 110.493 -172.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -158.93 150.6 21.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.211 -0.519 . . . . 23.04 112.2 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.4 130.53 72.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.902 -0.407 . . . . 71.14 109.902 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -119.5 154.52 33.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.811 0.339 . . . . 54.23 110.303 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.67 125.71 18.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.174 -0.467 . . . . 42.1 110.23 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -112.38 114.06 26.58 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.62 -0.511 . . . . 73.55 109.62 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.45 ' HD2' HD13 ' A' ' 202' ' ' LEU . 74.8 t80 -113.73 116.29 29.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.448 -0.575 . . . . 74.12 109.448 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 3.6 pt20 -95.94 99.58 11.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.716 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.4 tt -69.44 -24.92 28.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.527 0.68 . . . . 60.44 109.521 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 230' ' ' ASP . 18.9 t70 -166.6 146.31 4.93 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.199 -1.037 . . . . 75.01 108.199 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 228' ' ' ASP . 27.8 Cg_exo -64.1 12.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.793 2.329 . . . . 73.4 113.399 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 228' ' ' ASP . 23.3 t70 -104.92 -29.34 10.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.44 110.067 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.33 125.86 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 73.13 110.831 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 56.1 m -124.04 142.23 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.129 0.49 . . . . 73.43 110.755 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -108.86 127.33 53.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.213 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 5.5 p -129.39 117.21 20.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 53.42 110.965 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.43 158.67 23.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.111 -0.329 . . . . 75.12 110.111 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 26.2 pttm -152.94 141.86 21.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.019 0.438 . . . . 70.33 110.849 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.8 p -128.66 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 71.41 109.814 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.8 m120 -107.91 150.56 26.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.752 -0.462 . . . . 73.02 109.752 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.73 -8.79 16.13 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.672 0.607 . . . . 75.34 111.534 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.468 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 13.3 m -80.82 14.67 2.07 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.824 -0.436 . . . . 75.54 109.824 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 17.4 m 68.31 36.83 2.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.256 -0.883 . . . . 62.23 110.702 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 262' ' ' LEU . 40.5 mt -99.29 115.61 29.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 63.43 109.697 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.645 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -112.29 116.7 53.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.65 -0.42 . . . . 63.33 110.503 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -135.61 152.21 20.87 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.123 -1.036 . . . . 74.21 113.526 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -127.96 156.12 43.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 71.33 110.737 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -143.42 143.59 12.59 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.993 -0.622 . . . . 74.32 112.157 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 258' ' ' THR . 63.8 m-85 -114.47 115.6 27.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.784 -0.451 . . . . 72.44 109.784 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 17.9 m -109.91 114.38 27.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.504 -0.554 . . . . 75.01 109.504 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -135.53 143.18 45.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.757 0.313 . . . . 62.22 110.801 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.8 t -107.54 116.18 31.49 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.051 -0.722 . . . . 60.44 109.051 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.512 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 3.8 mm? -70.34 173.57 6.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.861 -0.609 . . . . 63.23 110.518 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.614 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 20.8 mtpp -67.63 -44.97 45.56 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.25 -0.432 . . . . 75.3 110.852 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 16.8 Cg_exo -70.37 -174.49 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.887 1.725 . . . . 40.45 111.025 165.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -81.35 69.6 3.25 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.701 -0.762 . . . . 53.22 112.393 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.493 HG12 ' CD2' ' A' ' 281' ' ' PHE . 37.6 mt -136.81 124.78 33.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 122.652 -0.322 . . . . 54.41 111.02 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 280' ' ' GLU . 51.3 mttp -109.99 113.37 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.273 -0.64 . . . . 41.12 109.273 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.91 130.57 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.264 -0.426 . . . . 71.15 110.665 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 25.3 m -125.17 111.43 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 74.2 110.147 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.92 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -105.03 125.39 50.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.022 -1.103 . . . . 62.44 108.022 176.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 53.2 m -134.17 140.8 46.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.972 0.415 . . . . 70.55 111.406 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.67 128.01 19.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.92 -0.582 . . . . 61.3 109.648 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 242' ' ' LEU . 3.0 tm? -110.03 113.35 25.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.932 -0.766 . . . . 63.55 108.932 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.592 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.089 -1.078 . . . . 65.33 108.089 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.563 ' HA ' HD22 ' A' ' 242' ' ' LEU . 10.7 t70 -72.49 103.61 3.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.242 -0.89 . . . . 75.11 108.937 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.6 38.24 Favored Glycine 0 N--CA 1.458 0.118 0 O-C-N 123.395 0.434 . . . . 64.22 113.617 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -91.03 -26.99 18.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.568 0.223 . . . . 72.11 111.304 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.442 ' ND2' ' HA3' ' A' ' 272' ' ' GLY . 64.1 t30 -115.19 -22.83 9.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.813 0.671 . . . . 72.21 112.813 -171.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.531 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 29.4 m -62.17 -18.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.977 -0.452 . . . . 63.51 111.499 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.46 -39.73 80.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.123 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.51 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 41.3 110.862 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.57 89.29 1.69 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.826 -0.702 . . . . 41.14 111.673 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.531 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -157.92 38.83 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.812 -0.708 . . . . 52.21 112.137 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -80.05 145.7 32.33 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.221 -0.288 . . . . 74.3 110.221 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.723 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.3 mptt -96.72 138.07 34.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.173 -0.677 . . . . 74.22 109.173 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.453 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 tm? -125.93 131.14 52.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.961 -0.385 . . . . 54.44 109.961 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.437 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -137.08 125.21 3.31 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.473 -0.87 . . . . 40.3 112.092 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.92 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -114.96 138.1 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.771 -0.825 . . . . 73.42 108.771 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -158.18 122.21 1.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.349 -0.929 . . . . 74.45 111.13 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.477 HD13 HD11 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -144.91 138.87 27.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.015 0.436 . . . . 72.32 112.04 -175.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.558 ' CG ' ' HB2' ' A' ' 256' ' ' LYS . 6.8 pt-20 -110.71 120.66 43.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 62.35 110.502 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.909 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.7 t80 -98.78 118.7 36.1 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.991 -0.744 . . . . 75.33 108.991 175.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 4.1 pt20 -111.65 111.67 22.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.456 0.646 . . . . 71.42 110.447 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.65 111.59 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 73.11 109.592 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.99 135.91 53.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.942 -0.572 . . . . 63.41 109.771 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.106 -0.473 . . . . 61.32 110.757 -179.659 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.072 0.463 . . . . 44.53 111.917 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 15.9 t -68.16 125.63 91.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.222 -0.899 . . . . 73.41 111.369 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 28.3 Cg_exo -63.65 165.01 19.27 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.383 2.722 . . . . 65.42 112.565 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.84 71.33 4.15 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.204 2.603 . . . . 71.4 112.407 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.803 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.4 p -70.36 -48.84 54.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 74.41 111.606 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' HB2' HG21 ' A' ' 143' ' ' VAL . 70.9 t80 -60.84 -26.08 67.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.901 -0.59 . . . . 54.53 110.866 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -82.08 -10.76 59.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 54.43 111.351 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.31 -22.3 19.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.01 0.433 . . . . 74.12 111.136 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.99 -35.34 71.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.716 0.636 . . . . 72.32 112.716 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.53 15.65 8.56 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 119.917 -1.135 . . . . 53.21 114.114 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 8' ' ' ALA . 33.5 mmtm -63.98 -54.77 29.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.347 0.574 . . . . 74.24 111.713 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -63.36 -38.72 92.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 65.34 110.949 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.13 68.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 65.04 111.825 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -69.05 -35.72 76.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 64.0 111.297 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.11 -45.26 81.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.905 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.36 -25.34 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.461 . . . . 44.23 110.991 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -59.87 -39.82 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 74.43 110.806 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -89.34 36.16 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.295 0.569 . . . . 51.44 110.282 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -52.47 114.48 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.27 -0.877 . . . . 74.02 111.84 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.74 96.97 1.45 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.651 -0.704 . . . . 72.42 112.362 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -133.0 -166.49 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.475 -0.565 . . . . 72.42 109.475 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.13 89.08 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.701 -0.761 . . . . 62.42 111.731 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -100.26 -3.77 30.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.492 . . . . 74.03 110.076 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.59 61.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.977 -0.63 . . . . 71.22 113.07 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.739 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 3.5 pp -147.8 179.76 7.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 113.459 0.911 . . . . 61.24 113.459 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 277' ' ' LEU . 28.7 mm -100.91 122.93 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.876 -1.511 . . . . 63.44 109.061 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.4 ttmm -120.76 121.25 37.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 72.13 110.517 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.6 tt -113.59 142.05 46.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.563 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -135.46 128.37 31.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.381 -0.827 . . . . 52.32 109.466 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 18.3 tp -122.07 123.73 42.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 74.1 110.551 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 63.9 mttp -108.14 125.07 51.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.69 . . . . 55.53 109.406 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.772 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 39.4 m -128.45 121.82 29.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.589 0.233 . . . . 71.33 110.988 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 53.2 mtmt -137.39 123.74 20.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 70.04 110.531 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.603 ' H ' HD11 ' A' ' 39' ' ' LEU . 50.4 m -143.09 155.8 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 55.05 109.855 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 49.53 -131.28 1.86 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.593 0.558 . . . . 73.13 111.589 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.23 134.91 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.519 0.676 . . . . 63.4 111.493 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 93.15 -11.46 71.84 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.044 -0.98 . . . . 70.4 114.449 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.603 HD11 ' H ' ' A' ' 35' ' ' SER . 3.4 pp -103.96 133.86 48.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 118.646 1.223 . . . . 63.32 111.985 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.921 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 39.8 tt0 -138.5 128.71 25.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.886 . . . . 71.12 108.609 161.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.772 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 84.1 m-85 -118.28 121.73 41.16 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.877 -0.515 . . . . 45.5 110.828 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.957 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 21.2 m -117.11 115.81 26.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 71.42 109.814 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 27.5 t -112.65 123.67 50.82 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.358 . . . . 71.44 110.035 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 51.1 m -119.43 125.95 50.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.119 0.485 . . . . 72.31 110.312 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.5 117.48 2.26 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.613 -0.803 . . . . 75.34 111.475 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.6 m -112.67 133.94 54.45 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.733 -0.387 . . . . 44.34 109.983 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -135.55 126.66 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.44 -0.578 . . . . 72.31 109.44 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.739 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 7.4 t-20 -78.28 134.89 37.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.396 -173.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -96.36 -19.31 19.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.092 0.472 . . . . 61.21 110.97 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.91 -53.79 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.283 0.563 . . . . 51.41 109.751 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.563 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 35.1 m -122.2 105.6 10.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.226 -0.657 . . . . 53.44 109.226 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -52.6 102.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.937 0.718 . . . . 62.21 112.937 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -154.76 135.67 13.73 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.025 -1.102 . . . . 72.41 108.025 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.26 132.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.01 0.434 . . . . 54.25 111.222 -174.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -123.97 126.15 45.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 75.24 110.096 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.25 135.24 12.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.843 -0.694 . . . . 60.41 112.565 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 16.9 m -125.65 125.92 43.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.623 -0.88 . . . . 64.12 108.623 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.96 124.51 45.08 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.685 -0.487 . . . . 51.05 109.685 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.957 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 41.7 tt0 -106.77 117.87 35.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.155 0.502 . . . . 71.02 109.77 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 15.6 m -93.27 119.31 32.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.043 -1.095 . . . . 75.11 108.043 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.921 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.8 tptm -122.85 138.01 54.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.142 0.496 . . . . 74.22 109.763 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.763 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 86.5 m-85 -116.69 120.76 39.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.864 -0.791 . . . . 75.31 108.864 172.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.49 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.0 ptm85 -115.73 105.86 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.124 -0.63 . . . . 53.21 110.586 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.875 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 76.0 t90 -112.43 106.06 14.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 64.2 110.088 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 m 66.46 153.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.58 1.175 . . . . 75.43 111.273 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -64.04 102.82 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.27 -0.423 . . . . 75.13 109.927 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 t80 63.73 81.47 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 72.41 110.875 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.47 -75.09 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.369 -1.092 . . . . 44.21 110.369 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 2.0 mm? -113.09 131.42 55.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.854 0.359 . . . . 71.21 110.794 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' HB ' ' A' ' 86' ' ' THR . 6.3 p -135.19 112.66 10.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.716 . . . . 62.11 110.337 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.763 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 21.7 t80 -109.68 121.34 44.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.503 -0.554 . . . . 75.4 109.503 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 m -116.69 127.71 54.66 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.2 0.313 . . . . 74.32 110.753 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 28.1 tt0 -130.66 121.29 25.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.511 -0.551 . . . . 65.34 109.511 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -111.22 97.83 7.06 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.037 -0.727 . . . . 73.05 109.037 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.93 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 41.5 t90 -108.8 129.71 55.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.176 -0.466 . . . . 63.33 111.466 -174.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -105.95 139.28 40.74 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.981 -0.748 . . . . 72.05 108.981 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -60.05 -36.67 77.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.639 0.607 . . . . 43.11 112.639 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -111.07 -23.82 10.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 64.11 112.066 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.573 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 2.5 t-20 -104.0 -106.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.265 -0.574 . . . . 75.04 112.427 -169.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 p -116.43 144.64 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.765 0.654 . . . . 75.55 112.765 -170.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.93 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -111.69 123.28 49.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.718 -0.475 . . . . 65.02 109.718 166.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.41 121.99 5.23 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.597 -0.729 . . . . 40.32 111.487 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 101' ' ' SER . 23.2 m -109.11 142.91 39.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.828 0.346 . . . . 62.32 111.059 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.54 113.73 7.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.808 -0.633 . . . . 54.01 109.406 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -112.27 136.41 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.801 -0.444 . . . . 71.44 109.801 179.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.403 ' HB ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m -128.54 124.03 34.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 61.05 110.292 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 2.7 p -125.83 120.54 57.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.38 0.61 . . . . 61.4 111.051 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.26 118.54 35.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.157 -1.423 . . . . 65.2 107.157 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 11.6 t70 -55.91 133.35 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.515 -0.474 . . . . 73.23 110.681 -173.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.499 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 19.7 pt20 -68.95 -25.35 64.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 64.33 111.75 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 85.6 mt -108.83 -52.2 2.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.128 0.49 . . . . 53.02 109.908 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.13 10.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 51.12 110.235 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 89' ' ' ASP . 36.3 mmt180 -59.72 135.14 57.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 73.32 109.899 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA2' ' HG3' ' A' ' 119' ' ' LYS . . . 102.49 7.18 46.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.633 -0.794 . . . . 74.43 111.492 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.48 114.75 22.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.629 -0.878 . . . . 75.23 108.629 173.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -122.49 111.8 17.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.934 -0.575 . . . . 61.52 110.705 -174.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.513 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.8 mm? -97.55 130.85 44.57 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.819 -0.808 . . . . 70.44 108.819 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -130.46 133.7 46.51 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.32 -0.4 . . . . 54.52 110.986 -177.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.56 ' H ' HG13 ' A' ' 85' ' ' ILE . 76.8 t80 -124.52 129.62 50.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.396 -0.366 . . . . 73.31 110.232 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 113' ' ' LYS . 6.3 m-20 -115.83 133.81 55.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.132 -0.485 . . . . 72.42 109.891 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.705 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 30.1 t -130.21 137.29 49.99 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.949 -0.389 . . . . 72.32 109.949 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -135.06 121.63 20.65 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.976 -0.379 . . . . 73.22 109.976 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' HD1' HD21 ' A' ' 81' ' ' LEU . 75.4 t80 -134.52 137.14 43.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 61.11 110.608 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 5.1 m -114.29 103.74 54.93 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.944 -0.571 . . . . 75.31 110.017 176.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 32.8 Cg_endo -65.46 152.14 82.82 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.533 2.155 . . . . 73.45 111.477 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.61 25.34 14.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.666 0.746 . . . . 73.13 109.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 m -140.3 -55.12 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.757 -0.656 . . . . 74.51 110.341 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.9 4.1 57.9 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 61.53 112.714 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -87.91 122.75 31.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.311 -0.625 . . . . 71.42 109.311 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 21.6 ptmt -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.101 0.477 . . . . 75.25 110.714 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -121.6 122.64 40.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.427 -0.806 . . . . 75.41 109.559 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 114.77 29.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.052 -0.522 . . . . 73.33 109.621 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.87 ' HG3' ' HB3' ' A' ' 130' ' ' ASP . 28.1 ttmt -118.38 135.4 54.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.234 0.54 . . . . 52.11 110.665 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.853 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 4.2 tp -129.99 132.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 107.739 -1.208 . . . . 73.44 107.739 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 16.6 ttpt -132.28 119.16 20.4 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 124.987 1.43 . . . . 64.4 110.662 -169.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.912 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 69.9 m -116.99 120.02 37.09 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 119.313 0.96 . . . . 60.25 111.251 -175.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.791 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -131.5 138.93 10.53 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.647 -1.263 . . . . 73.54 113.172 -174.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -115.27 130.65 56.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.435 -0.95 . . . . 75.14 108.435 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -110.58 122.29 47.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.616 0.722 . . . . 75.14 111.039 -175.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -105.65 153.17 22.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.358 -1.292 . . . . 64.54 107.825 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.44 -29.97 51.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.239 0.459 . . . . 74.04 112.239 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -108.95 -17.1 14.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.509 -0.314 . . . . 64.53 111.394 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -144.87 124.66 6.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.043 0.386 . . . . 74.54 112.043 -170.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.943 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.8 OUTLIER -112.79 116.66 30.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.197 -0.314 . . . . 74.44 110.523 176.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 142' ' ' LEU . 3.0 mm? -119.48 124.45 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.54 0.21 . . . . 73.4 111.04 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.791 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -136.57 114.16 1.13 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.943 -1.123 . . . . 51.44 113.029 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.1 t -116.97 122.98 45.81 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.941 -0.392 . . . . 50.34 109.941 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.912 ' HB2' ' H ' ' A' ' 116' ' ' THR 0.319 0.9 OUTLIER -154.15 169.91 22.47 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.659 -1.276 . . . . 75.22 112.924 159.588 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.0 mtt -101.79 140.09 36.54 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.781 0.324 . . . . 73.41 111.115 -162.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.87 ' HB3' ' HG3' ' A' ' 113' ' ' LYS . 9.9 p-10 -119.54 125.8 49.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 74.12 111.022 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.23 96.55 9.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.606 -0.516 . . . . 73.24 109.606 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.529 ' OD2' HG13 ' A' ' 133' ' ' ILE . 7.8 t70 -99.73 -165.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.789 -0.819 . . . . 73.44 108.789 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.529 HG13 ' OD2' ' A' ' 132' ' ' ASP . 2.9 pp -72.94 -13.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 70.32 110.421 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.62 4.69 52.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 73.53 110.569 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.47 -155.13 20.86 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.05 -0.595 . . . . 74.44 111.925 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.57 96.55 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.023 2.482 . . . . 51.41 112.094 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.438 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 16.0 m -92.96 162.89 13.88 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.992 -0.549 . . . . 55.45 109.636 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 36.2 mm -107.99 117.48 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.931 -0.396 . . . . 72.03 109.931 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.7 tpt180 -106.0 111.34 23.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.34 0.59 . . . . 75.22 110.338 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.16 10.09 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.987 -1.101 . . . . 75.22 111.524 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.25 116.84 23.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.974 0.416 . . . . 51.04 110.402 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -117.18 125.36 51.08 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.577 . . . . 75.24 110.637 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.943 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 77.4 t -117.45 133.89 62.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.11 0.481 . . . . 63.32 110.277 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -108.42 138.38 44.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.791 -0.818 . . . . 64.23 108.791 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.08 118.24 2.37 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.51 -0.852 . . . . 25.33 113.146 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 75.9 t80 -145.0 148.99 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.066 -0.346 . . . . 75.24 110.066 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -45.01 105.52 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.986 0.422 . . . . 74.32 111.866 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.13 -31.38 6.02 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.81 -0.632 . . . . 71.12 112.726 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 72.3 m95 -104.84 120.93 42.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 74.44 111.118 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.803 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -124.58 136.91 54.35 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.628 -1.249 . . . . 72.14 107.628 173.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HB3' HD23 ' A' ' 144' ' ' LEU . . . -143.1 160.79 39.74 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.628 -0.429 . . . . 72.05 110.877 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.58 137.2 5.46 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.833 -0.621 . . . . 60.53 111.566 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -143.83 118.35 9.73 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 122.539 -0.389 . . . . 75.31 110.229 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.801 ' HG3' ' HB2' ' A' ' 168' ' ' ASN . 12.2 pt20 -119.13 125.89 50.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.454 0.645 . . . . 75.44 111.02 176.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 81.7 mtp -118.3 142.68 47.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.822 -0.626 . . . . 52.23 109.998 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 50.8 t-20 -113.38 118.46 34.61 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.996 -0.742 . . . . 72.04 108.996 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.757 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.6 m-85 -94.4 120.39 34.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.665 -0.698 . . . . 74.2 111.029 -175.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 57.7 tt0 -87.34 103.2 15.25 Favored 'General case' 0 C--O 1.26 1.639 0 CA-C-O 121.469 0.652 . . . . 74.04 109.284 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 t -70.24 -14.51 62.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 113.127 -1.851 . . . . 71.32 111.904 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.8 68.23 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.559 0.695 . . . . 74.43 109.157 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.63 -147.68 0.4 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.532 -1.285 . . . . 75.23 107.532 162.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.7 m -107.94 28.18 8.49 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.46 -0.775 . . . . 60.34 111.155 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 163' ' ' ARG . 1.1 ptm180 -132.39 145.49 51.27 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.419 -1.313 . . . . 70.54 111.562 -163.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.64 134.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.092 0.473 . . . . 64.13 109.804 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 7.5 t -95.44 -9.79 31.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.126 -0.488 . . . . 75.12 111.016 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 39.3 mm-40 -149.94 132.25 15.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.869 0.366 . . . . 73.1 110.841 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.8 m -121.9 105.79 10.66 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.743 -0.662 . . . . 70.24 109.507 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.801 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 13.9 m120 -110.33 123.91 50.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 54.34 109.844 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.78 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 45.9 t80 -120.4 149.99 41.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.224 -0.443 . . . . 72.44 109.867 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -144.33 142.31 30.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.069 0.461 . . . . 72.43 110.858 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -131.12 136.9 56.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.157 -0.474 . . . . 74.2 110.193 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.04 96.1 0.33 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.007 -0.837 . . . . 63.1 111.007 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -109.67 121.68 45.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.399 -0.593 . . . . 63.32 109.399 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.41 127.64 48.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.486 -0.779 . . . . 73.21 110.547 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 42.0 m -131.73 111.49 11.7 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.292 -0.632 . . . . 74.34 109.292 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.58 -87.42 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.379 1.049 . . . . 74.12 113.678 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.87 3.48 22.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.252 0.549 . . . . 52.33 111.416 -172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -112.86 126.57 55.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 73.43 110.134 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 55.0 mm-40 -121.16 123.68 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.173 -0.306 . . . . 64.4 110.173 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.9 tp -118.66 134.85 54.81 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.15 -0.344 . . . . 74.22 111.035 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -130.6 117.3 19.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 60.4 110.414 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 19.9 m -112.47 143.52 43.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.962 -0.385 . . . . 63.0 109.962 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -141.52 139.95 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 74.1 110.383 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.78 ' HB ' ' HB3' ' A' ' 169' ' ' PHE . 56.0 t -126.36 131.27 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.163 -0.471 . . . . 62.34 111.606 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 9.1 t30 -110.94 96.01 5.9 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.35 -0.841 . . . . 71.24 109.565 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.7 t70 62.09 -166.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.9 -1.046 . . . . 74.03 110.345 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.62 -6.67 89.21 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.05 -0.595 . . . . 64.41 111.839 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.7 p -94.13 -27.23 16.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.981 0.734 . . . . 73.03 112.981 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 38.8 mt-10 -134.48 125.04 26.59 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.934 -0.706 . . . . 71.12 111.201 -175.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.735 ' HB2' HG22 ' A' ' 184' ' ' VAL . 25.9 p90 -133.87 133.1 41.12 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.188 -0.605 . . . . 71.34 109.443 171.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -135.79 159.21 24.15 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.566 -0.826 . . . . 45.13 112.522 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -136.63 164.76 25.15 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.424 -0.67 . . . . 73.11 111.424 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 26.9 t -143.56 136.91 28.02 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.0 -0.741 . . . . 72.33 109.0 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 3.4 mp -120.31 117.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 75.55 109.743 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.751 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 84.2 t80 -108.04 120.76 43.25 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.513 0.673 . . . . 71.12 110.428 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -115.61 111.91 21.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.925 -1.034 . . . . 74.03 108.992 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 195' ' ' TYR . 84.1 tttt -103.93 107.19 17.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.141 -0.482 . . . . 70.13 109.973 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.47 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.183 -0.673 . . . . 72.45 109.183 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 199' ' ' ASN . 2.0 t-20 -76.24 10.08 2.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.301 0.572 . . . . 64.01 110.879 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -109.3 -10.37 14.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.776 -0.647 . . . . 71.25 109.361 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.435 ' HG3' HD22 ' A' ' 202' ' ' LEU . 15.6 tppt? -134.93 -68.55 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 74.2 110.528 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 201' ' ' LYS . 2.0 pt? -167.99 165.94 13.42 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.92 0.39 . . . . 72.32 110.484 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.435 ' HG3' ' HG3' ' A' ' 197' ' ' LYS . 23.6 mp0 -109.75 128.2 55.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.797 -0.816 . . . . 72.23 108.797 173.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 t -138.57 155.02 48.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.064 0.459 . . . . 72.32 111.377 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.85 148.05 36.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.723 -0.671 . . . . 75.3 110.61 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 193' ' ' SER . 55.7 t -110.86 138.23 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.033 -0.53 . . . . 55.33 109.617 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -113.9 127.8 56.13 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.284 -1.006 . . . . 60.13 108.284 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 219' ' ' PHE . 7.3 tp -144.56 140.88 29.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.558 -0.292 . . . . 64.32 110.3 -168.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.584 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -157.23 142.34 17.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.825 0.345 . . . . 65.24 111.223 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.507 ' HE3' ' HZ ' ' A' ' 190' ' ' PHE . 16.6 t90 -130.83 135.3 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.125 0.488 . . . . 74.31 110.071 173.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 53.2 m -94.47 105.31 17.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.43 -0.805 . . . . 65.23 109.971 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.76 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 70.53 111.127 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.24 -87.72 0.4 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.164 -0.774 . . . . 73.22 111.164 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -149.12 104.3 3.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.024 0.44 . . . . 73.2 110.484 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.9 t -176.4 149.0 0.79 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.08 159.34 29.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.226 -0.657 . . . . 75.02 109.226 173.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 8.8 t -77.58 123.24 26.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.076 -0.713 . . . . 75.43 109.076 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.442 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 1.1 tpp180 -94.18 115.06 27.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.589 -0.732 . . . . 75.33 109.262 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.746 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 52.1 p90 -120.42 160.33 23.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 61.22 111.49 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.39 157.49 28.86 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.298 -0.864 . . . . 50.13 111.355 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.651 ' HB ' HG12 ' A' ' 237' ' ' VAL . 55.9 mt -132.25 135.15 58.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.964 0.382 . . . . 74.32 110.298 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -128.47 129.84 46.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.918 -0.401 . . . . 52.42 109.918 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -128.24 133.05 48.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.747 0.308 . . . . 61.14 111.061 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.3 114.53 26.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.62 . . . . 75.31 109.629 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -128.9 119.36 24.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 72.21 110.726 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -76.59 124.61 27.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.71 -0.478 . . . . 75.41 109.71 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 63.4 mt -70.48 -55.79 13.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.388 -0.369 . . . . 72.52 110.306 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.849 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 34.0 t70 -172.45 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.019 -0.537 . . . . 54.52 111.771 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 56.7 Cg_endo -95.05 -101.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.372 2.048 . . . . 70.21 113.524 -172.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.93 3.92 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 51.32 111.227 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -123.07 131.98 53.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.238 0.542 . . . . 75.35 111.748 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.58 142.16 50.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 60.4 109.264 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -104.31 131.41 51.68 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.837 -0.431 . . . . 73.2 109.837 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 57.8 p -116.6 120.96 40.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.051 0.453 . . . . 74.44 110.087 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.88 42.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.218 -0.66 . . . . 71.32 109.218 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 44.4 mttp -144.22 141.57 29.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.664 -0.495 . . . . 71.32 109.664 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.651 HG12 ' HB ' ' A' ' 221' ' ' ILE . 4.4 p -137.24 158.65 35.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.357 -0.609 . . . . 73.23 109.357 174.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 14.3 t30 -135.5 150.57 49.81 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.196 -0.457 . . . . 72.35 110.087 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.746 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 5.8 p30 -46.44 -32.51 3.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.957 1.095 . . . . 72.33 113.957 -173.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.536 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 5.6 m -78.92 23.37 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.596 0.236 . . . . 55.15 111.097 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.4 m 64.53 36.27 8.76 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 121.371 0.605 . . . . 61.52 109.849 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 1.052 ' HB3' HD11 ' A' ' 262' ' ' LEU . 22.9 mt -98.04 116.71 30.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.729 -0.669 . . . . 63.12 110.075 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 243' ' ' ILE . 2.1 mp -106.69 116.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 62.22 110.007 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.12 133.47 9.64 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.576 -0.821 . . . . 75.21 112.685 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.467 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -119.37 154.25 33.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.376 -0.231 . . . . 71.43 110.376 178.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -149.24 134.32 4.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.444 -0.884 . . . . 64.32 112.675 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 258' ' ' THR . 59.1 m-85 -103.59 116.99 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.564 -0.532 . . . . 75.1 109.564 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.934 HG23 ' HB ' ' A' ' 258' ' ' THR . 3.2 m -117.36 115.25 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.121 -0.49 . . . . 74.42 110.31 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.99 150.73 44.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 73.24 111.83 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 19.6 m -83.37 128.41 34.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.864 -0.607 . . . . 61.33 110.155 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.803 HD23 HG12 ' A' ' 255' ' ' ILE . 3.3 mm? -73.73 -82.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.133 0.42 . . . . 64.23 112.133 -173.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 1.027 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 35.3 tttp -140.97 -62.67 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.948 -0.389 . . . . 74.35 109.948 -175.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 1.027 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 3.6 Cg_exo -79.45 -161.52 0.15 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.858 1.705 . . . . 71.14 110.861 166.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -80.82 62.21 4.43 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.663 -0.78 . . . . 73.53 113.162 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.803 HG12 HD23 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -136.49 142.26 38.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.084 0.468 . . . . 74.41 109.762 173.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.545 ' HG2' HG22 ' A' ' 248' ' ' THR . 36.0 ttpt -121.96 127.28 50.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.761 -0.654 . . . . 64.54 110.261 -176.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.609 ' HB2' HD21 ' A' ' 251' ' ' LEU . 28.6 tp -100.55 132.69 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 73.24 110.106 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.934 ' HB ' HG23 ' A' ' 248' ' ' THR . 7.7 t -129.52 112.48 13.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.615 0.722 . . . . 75.42 111.01 176.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.973 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -98.1 123.61 42.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.131 -1.063 . . . . 71.21 108.131 176.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 21.8 p -131.6 148.73 52.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.193 0.52 . . . . 62.34 111.454 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.436 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -140.89 133.15 28.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.732 -0.667 . . . . 65.31 109.907 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.052 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -102.88 121.28 42.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 70.5 109.133 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.596 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.4 mm? -104.1 108.01 19.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.431 -0.952 . . . . 74.4 108.431 175.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 268' ' ' VAL . 2.9 m-20 -71.59 103.87 3.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.906 -0.775 . . . . 72.53 108.906 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.77 -22.25 32.67 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.12 -0.562 . . . . 72.13 113.03 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -85.92 -23.47 26.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.671 0.272 . . . . 74.01 111.262 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 3.8 m-20 -115.61 -28.26 6.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.78 0.659 . . . . 50.41 112.78 -172.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 263' ' ' LEU . 24.6 m -62.82 -18.78 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.901 0.334 . . . . 64.31 111.901 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.6 -33.06 70.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 73.21 109.808 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.32 8.56 38.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.517 -0.765 . . . . 63.53 110.955 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.84 89.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.088 -0.577 . . . . 74.42 112.067 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.19 88.01 0.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.323 -0.942 . . . . 75.44 112.701 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -109.16 145.52 35.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.185 -0.302 . . . . 74.2 110.185 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 274' ' ' LYS . 30.6 tptt -103.85 137.89 41.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.009 -0.737 . . . . 72.5 109.009 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.3 tm? -110.11 137.9 47.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.647 0.261 . . . . 53.01 110.328 -174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.52 126.23 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.42 -0.672 . . . . 75.03 111.42 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.973 HD23 HD22 ' A' ' 259' ' ' LEU . 2.7 tm? -120.77 129.28 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.814 -0.439 . . . . 73.42 109.814 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -131.95 145.87 17.55 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.479 -0.867 . . . . 73.54 112.975 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.459 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.2 mm? -123.71 132.3 53.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.46 -0.57 . . . . 74.42 109.46 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -112.87 111.91 23.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.439 -0.578 . . . . 64.12 109.439 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.51 ' HB3' HD13 ' A' ' 31' ' ' LEU . 5.2 m-85 -102.32 141.48 35.09 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.115 -0.698 . . . . 73.5 109.115 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 284' ' ' LEU . 46.2 mt-30 -135.75 121.4 19.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.848 0.356 . . . . 55.4 110.566 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -105.35 109.26 21.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.206 -0.664 . . . . 65.45 109.206 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 282' ' ' GLN . 3.5 mm? -130.6 176.77 7.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.698 -0.683 . . . . 70.1 110.366 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.708 -0.678 . . . . 74.2 109.827 178.623 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 75.43 110.314 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.841 HG11 ' HB3' ' A' ' 119' ' ' LYS . 2.2 t -82.15 115.19 56.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.688 -0.687 . . . . 70.24 109.643 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 6.6 Cg_endo -87.41 157.14 8.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.299 2.666 . . . . 74.33 113.157 -174.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 3.6 Cg_exo -75.92 64.62 6.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.135 2.556 . . . . 70.41 111.324 173.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.839 ' HB ' HD21 ' A' ' 150' ' ' LEU . 4.8 p -78.19 -18.97 54.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 53.01 111.548 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' HE2' HE21 ' A' ' 154' ' ' GLN . 81.0 t80 -56.11 -22.76 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 74.0 110.326 170.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.51 -25.62 54.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.456 -0.793 . . . . 73.5 109.569 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.636 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 39.5 m-20 -85.86 -10.94 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.99 -0.745 . . . . 64.02 108.99 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.844 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -77.1 -34.86 56.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.766 -1.106 . . . . 63.14 110.857 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.24 -47.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.934 -1.127 . . . . 55.15 113.701 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -55.43 -53.91 50.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.674 0.62 . . . . 64.31 112.674 -170.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 t -63.95 -48.47 76.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 71.3 111.474 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.78 60.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 72.41 111.794 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 1.049 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 99.2 mtt180 -60.37 -24.82 65.4 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.708 0.633 . . . . 73.22 112.708 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.36 -41.51 76.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 61.24 110.752 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.512 ' HB ' ' ND2' ' A' ' 207' ' ' ASN . 66.8 t -83.73 -37.41 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.164 0.507 . . . . 42.34 110.315 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.049 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 89.6 t80 -63.56 -24.51 67.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.123 -0.944 . . . . 72.14 112.497 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -65.42 156.08 33.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 43.44 111.613 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.788 ' HD2' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.95 25.46 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.674 -0.693 . . . . 63.35 110.397 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.94 95.67 0.49 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.686 -0.688 . . . . 63.53 112.278 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -104.07 -162.4 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.797 -0.816 . . . . 74.42 108.797 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.55 108.18 2.38 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.142 -1.027 . . . . 23.44 111.131 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -80.7 -2.98 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.797 0.299 . . . . 75.12 111.573 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 12.79 83.81 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.458 -0.877 . . . . 54.15 112.434 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -142.35 179.97 6.62 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.866 0.841 . . . . 73.12 112.632 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.689 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -106.91 129.52 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.148 -1.387 . . . . 71.33 109.859 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 8.9 ttpt -102.78 135.99 43.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.407 -0.59 . . . . 74.5 109.407 174.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.9 tp -133.5 139.7 46.81 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.872 -0.331 . . . . 53.1 110.169 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.3 p30 -151.3 135.01 16.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 61.34 109.951 173.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.4 tp -128.31 124.14 35.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.509 -0.769 . . . . 73.11 109.679 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' N ' HD12 ' A' ' 31' ' ' LEU . 68.9 tttt -120.92 124.69 45.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.276 -0.874 . . . . 60.14 109.37 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 34.2 m -128.6 120.6 26.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.635 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -144.6 155.88 43.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.811 -0.756 . . . . 74.22 112.597 -176.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.4 t -139.92 154.31 47.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.523 -1.217 . . . . 74.04 107.991 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.27 20.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.991 0.424 . . . . 62.13 111.262 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 35' ' ' SER . 66.0 t30 -110.65 30.08 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.544 0.688 . . . . 75.33 110.212 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 96.39 1.17 60.83 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.864 -0.607 . . . . 45.51 112.513 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.0 tp -100.68 125.9 47.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.699 0.629 . . . . 64.24 112.699 -173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.857 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 28.0 mt-10 -142.32 118.17 10.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.962 -0.384 . . . . 65.34 109.962 160.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 50.4 m-85 -111.87 124.87 53.29 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.871 -0.518 . . . . 74.2 110.308 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.978 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 19.0 m -126.85 118.61 24.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.741 0.305 . . . . 73.4 111.383 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 29.0 t -120.35 123.6 43.5 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.273 -0.64 . . . . 73.23 109.273 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -134.73 130.44 36.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 43.21 111.468 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.43 148.02 19.38 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.507 -0.854 . . . . 64.33 112.541 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 m -119.83 134.17 55.33 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.821 -0.807 . . . . 72.41 108.821 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.7 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -154.85 141.29 18.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.984 0.421 . . . . 55.33 111.804 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 145.96 51.53 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.184 -0.672 . . . . 72.43 109.184 172.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -43.82 -39.74 4.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.538 0.524 . . . . 73.44 111.95 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -103.41 165.87 10.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.342 -0.614 . . . . 54.13 109.342 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -70.55 61.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.342 0.591 . . . . 70.1 112.052 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -97.84 -39.93 8.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 73.3 110.352 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -165.42 116.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 62.42 109.918 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.7 HG13 ' HB2' ' A' ' 47' ' ' ALA . 39.6 t -125.63 119.62 55.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.93 -0.577 . . . . 72.15 109.938 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -120.47 126.54 50.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.845 -0.428 . . . . 73.3 109.845 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 148.16 18.84 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.198 -1.001 . . . . 74.12 113.258 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 6.6 p -146.31 147.2 31.12 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.792 -0.447 . . . . 55.42 109.792 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 59' ' ' GLU . 1.8 tp -122.09 149.33 43.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.176 0.512 . . . . 72.42 111.196 -176.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.978 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 37.7 mt-10 -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.257 -0.883 . . . . 75.23 109.421 172.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.9 m -95.62 118.31 32.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.889 -1.152 . . . . 63.23 107.889 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.652 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 26.5 mttp -126.07 145.68 50.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.411 0.624 . . . . 75.14 110.911 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 70' ' ' THR . 74.3 m-85 -120.7 120.33 35.38 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.476 -0.935 . . . . 63.41 108.476 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.857 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 8.8 tpt180 -114.73 108.26 16.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 74.24 111.136 -173.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -113.51 102.69 10.54 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.434 -0.803 . . . . 75.55 110.754 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m 63.81 72.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.941 -1.027 . . . . 72.34 112.409 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.816 ' HG3' ' H ' ' A' ' 67' ' ' TYR . 9.7 pt-20 30.3 -92.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.449 1.1 . . . . 74.03 113.764 173.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.816 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 93.9 m-85 -87.11 86.87 7.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.224 -0.658 . . . . 73.03 109.224 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.81 -94.1 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.353 -0.699 . . . . 71.43 111.353 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 87' ' ' VAL . 3.5 mm? -125.4 131.59 52.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.038 0.447 . . . . 63.51 111.488 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.696 HG23 ' HB ' ' A' ' 86' ' ' THR . 4.8 t -136.97 113.19 9.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.796 -0.638 . . . . 73.35 109.781 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 72.3 m-85 -98.2 132.26 43.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 73.11 109.527 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 84' ' ' GLU . 96.9 m -127.91 136.57 51.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.923 0.392 . . . . 75.51 111.757 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.69 121.13 24.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.949 -0.759 . . . . 73.54 108.949 165.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -106.88 109.73 21.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.771 -0.65 . . . . 72.01 109.581 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.632 ' HD1' HD13 ' A' ' 81' ' ' LEU . 77.1 t90 -109.7 133.92 52.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.425 -0.352 . . . . 74.22 110.492 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.481 ' HB3' ' OG1' ' A' ' 80' ' ' THR . 8.5 t30 -114.72 152.88 31.27 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.582 -0.525 . . . . 53.2 109.582 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 m -54.28 -22.15 11.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.116 0.484 . . . . 73.51 112.301 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.5 m-20 -68.69 -2.67 9.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.117 -0.492 . . . . 74.12 111.986 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.528 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 12.2 m120 77.8 27.69 0.58 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.461 0.704 . . . . 73.15 110.125 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 104' ' ' SER . 1.8 p -93.19 124.52 37.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.599 -0.728 . . . . 74.35 110.987 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.9 mm? -101.56 119.2 38.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.307 -0.86 . . . . 74.23 110.3 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.54 91.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.552 -0.832 . . . . 75.41 111.512 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 t -90.65 123.04 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 73.41 110.448 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 40.5 tt0 -135.3 118.69 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.983 -0.553 . . . . 74.35 110.027 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -112.03 138.68 39.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.709 0.29 . . . . 74.12 110.368 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.696 ' HB ' HG23 ' A' ' 70' ' ' THR . 25.8 m -122.73 123.63 41.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.297 0.57 . . . . 60.33 111.353 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 HD11 ' A' ' 69' ' ' LEU . 34.1 t -111.89 123.89 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.09 -0.959 . . . . 73.41 109.036 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -110.21 142.17 42.14 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.765 -0.457 . . . . 63.11 109.765 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 81.47 -66.5 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.95 0.781 . . . . 72.31 109.952 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.31 -78.11 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.29 0.636 . . . . 71.1 111.206 175.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -130.88 -58.73 1.01 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 74.31 109.624 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.23 27.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.857 -0.611 . . . . 72.43 109.399 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 5.8 ppt_? -52.97 132.67 37.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.467 0.651 . . . . 73.5 111.832 -175.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 119' ' ' LYS . . . 101.54 -12.43 58.19 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.593 -0.73 . . . . 70.24 112.08 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.646 HD23 ' HD1' ' A' ' 118' ' ' TYR . 1.0 OUTLIER -86.92 119.9 27.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.83 -0.804 . . . . 74.23 108.83 176.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' HD13 ' A' ' 97' ' ' LEU . 54.7 pttt -123.06 144.47 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 74.44 110.658 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -122.38 126.87 48.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.551 -0.75 . . . . 71.21 109.286 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.857 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 15.2 m -130.0 118.28 21.34 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.682 -0.407 . . . . 72.4 109.982 176.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 50.4 t80 -120.33 115.56 23.8 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.777 -0.369 . . . . 74.12 110.442 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 10.4 t70 -115.0 137.85 51.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.668 -0.696 . . . . 71.12 109.373 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -142.2 121.81 13.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.963 0.411 . . . . 72.03 110.06 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 41.4 m -103.04 121.71 43.14 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.715 -0.675 . . . . 63.42 109.803 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -120.88 128.82 53.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 73.55 109.523 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB3' HG22 ' A' ' 80' ' ' THR . 47.6 p -119.86 103.14 46.12 Favored Pre-proline 0 C--N 1.315 -0.919 0 C-N-CA 120.828 -0.349 . . . . 61.15 110.551 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 21.0 Cg_exo -67.11 -22.89 46.64 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.452 2.102 . . . . 60.14 111.256 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -85.48 -49.12 8.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 73.11 110.992 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -81.88 -36.73 27.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.392 . . . . 63.32 111.296 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.44 -3.44 61.43 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.139 -0.553 . . . . 42.2 113.191 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.76 148.69 22.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.165 0.507 . . . . 61.54 111.628 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -123.82 148.58 46.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.805 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -144.07 122.49 12.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.967 -0.383 . . . . 62.13 109.967 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . . . -110.08 129.89 55.62 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.798 -0.445 . . . . 63.02 109.798 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 129' ' ' MET . 7.9 ttmm -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.694 -0.484 . . . . 63.12 109.694 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.3 tp -132.32 129.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.108 0.48 . . . . 62.42 111.07 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 50.1 mttp -111.19 121.66 45.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.35 -0.841 . . . . 63.41 109.706 176.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -116.27 117.95 31.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.57 -0.9 . . . . 75.43 108.57 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.81 135.45 11.47 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.39 -0.909 . . . . 51.42 112.473 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.646 ' HD1' HD23 ' A' ' 95' ' ' LEU . 76.9 t80 -121.65 118.43 29.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.844 -0.799 . . . . 75.41 108.844 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.841 ' HB3' HG11 ' A' ' 3' ' ' VAL . 37.5 mtmm -108.07 122.93 47.88 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.041 -0.663 . . . . 63.55 110.642 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -105.38 154.91 19.65 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.556 -1.276 . . . . 75.24 107.556 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.0 tp10 -52.74 -29.84 29.24 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.674 0.62 . . . . 72.33 112.674 -165.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -102.39 -26.14 13.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.105 0.78 . . . . 64.32 113.105 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.791 HG22 ' H ' ' A' ' 145' ' ' GLY . 19.2 pt -142.22 153.35 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.927 -0.709 . . . . 71.24 112.242 -171.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.633 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 1.7 m-20 -112.3 128.94 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.263 -0.88 . . . . 70.31 111.457 -172.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 118' ' ' TYR . 4.5 mm? -111.37 137.69 48.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.608 0.242 . . . . 73.14 110.616 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.38 121.17 1.34 Allowed Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.959 -0.639 . . . . 65.11 112.493 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.4 m -113.35 116.44 29.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.894 0.347 . . . . 73.3 111.815 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.733 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -97.81 143.16 28.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.804 -0.634 . . . . 72.33 110.128 175.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.521 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 65.3 mtt -133.74 118.4 18.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.168 -0.308 . . . . 74.12 110.168 174.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.691 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 1.9 m-20 -99.38 119.26 37.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 72.14 110.067 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 96.7 m-85 -95.9 97.94 10.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.479 176.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -120.58 156.99 30.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 55.23 108.988 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.898 ' H ' HD12 ' A' ' 133' ' ' ILE . 1.1 mp -75.08 -30.25 23.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.133 0.492 . . . . 73.44 109.986 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.0 -9.93 59.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 43.12 111.042 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 155.15 133.09 1.67 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.534 -0.841 . . . . 74.45 112.666 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 7.8 Cg_exo -74.23 119.1 5.65 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.122 2.548 . . . . 74.44 111.651 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.691 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 9.3 t -103.46 131.07 50.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.164 -0.471 . . . . 54.44 110.091 -177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mp -115.77 118.51 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.55 -0.46 . . . . 65.3 110.09 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 24.7 mtt180 -107.42 115.19 29.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.859 -0.423 . . . . 73.05 109.859 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.36 131.67 10.64 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.505 -1.331 . . . . 61.34 111.083 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.54 115.7 19.94 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.079 0.466 . . . . 72.33 109.977 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.578 HD11 HD12 ' A' ' 123' ' ' ILE . 5.9 tp -117.66 122.9 44.79 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.761 -0.654 . . . . 72.13 109.813 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.814 HG22 HD22 ' A' ' 10' ' ' LEU . 54.5 t -108.55 130.28 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.853 -0.612 . . . . 73.11 109.743 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.962 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.3 mm? -108.14 136.48 47.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.957 -0.757 . . . . 74.41 108.957 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.791 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -115.96 119.2 4.47 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.275 -0.875 . . . . 52.41 112.743 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.947 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 34.0 m-85 -123.46 149.64 44.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.304 -0.999 . . . . 74.05 108.304 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.78 100.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.96 0.41 . . . . 62.21 110.96 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 174' ' ' LYS . . . 90.84 -24.12 19.63 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.974 -0.557 . . . . 60.35 112.372 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.947 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.6 m0 -105.37 131.81 52.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.107 0.48 . . . . 64.23 110.783 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.839 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.4 tm? -117.33 149.07 41.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.736 -0.839 . . . . 63.22 108.736 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -151.28 154.53 36.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.646 -0.421 . . . . 74.35 110.058 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.844 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -158.41 135.66 4.38 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.744 -0.662 . . . . 44.45 111.576 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.4 115.18 21.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.44 -0.578 . . . . 71.1 109.44 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.94 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 87.7 mt-30 -99.42 121.86 41.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.728 -0.471 . . . . 72.25 109.728 166.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.9 ttm -127.17 128.58 46.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.698 -0.482 . . . . 74.32 109.698 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 24.7 m-80 -112.65 119.13 37.05 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.548 -0.538 . . . . 75.14 109.548 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.9 m-85 -94.35 127.05 39.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.095 -0.502 . . . . 75.41 110.805 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.794 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.9 tp10 -97.42 98.48 9.99 Favored 'General case' 0 C--O 1.26 1.631 0 N-CA-C 109.269 -0.641 . . . . 63.34 109.269 174.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -72.59 -17.59 61.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.641 -1.618 . . . . 63.45 111.209 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -63.1 -29.08 70.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.732 -0.84 . . . . 75.55 108.732 173.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 13.8 mmmm -111.17 -160.26 0.71 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.16 -1.382 . . . . 70.24 107.839 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 p -108.45 28.76 8.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.551 -0.536 . . . . 53.24 109.551 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 25.0 tpt180 -142.95 145.78 33.33 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 119.812 -0.755 . . . . 75.31 111.378 -160.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.5 m -73.22 136.7 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.777 -0.823 . . . . 54.23 108.777 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.794 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 8.8 t -92.2 -24.36 19.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.869 -171.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.572 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 93.4 mt-30 -144.8 133.16 21.81 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.616 0.246 . . . . 55.1 110.711 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.2 m -114.54 106.27 14.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.532 -0.544 . . . . 75.24 109.532 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.94 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 54.5 m-20 -106.99 129.93 54.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.46 . . . . 73.14 109.926 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.36 144.52 48.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.474 -0.33 . . . . 65.13 110.445 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -142.43 128.65 19.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.862 0.363 . . . . 33.45 110.169 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.58 128.54 60.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 73.3 109.409 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.81 109.17 1.69 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.804 -0.712 . . . . 73.25 112.05 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.75 119.95 39.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.064 -1.087 . . . . 74.34 108.064 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.819 ' HB2' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -136.21 144.83 45.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.182 0.991 . . . . 52.51 113.557 -171.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.433 ' HB ' ' OE2' ' A' ' 177' ' ' GLU . 3.7 m -109.9 163.88 13.12 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.582 -1.636 . . . . 75.34 106.582 167.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -27.4 60.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.849 0.685 . . . . 72.15 112.849 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -108.16 -20.51 13.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.569 0.581 . . . . 72.14 112.569 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -130.83 119.02 21.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.799 0.333 . . . . 72.34 111.074 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.819 ' HG2' ' HB2' ' A' ' 174' ' ' LYS . 45.1 mt-30 -116.35 124.31 49.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.496 -0.32 . . . . 71.42 110.418 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -107.9 132.24 53.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.063 0.458 . . . . 74.03 110.234 174.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.636 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 41.6 m-70 -125.03 116.81 22.72 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.252 -0.647 . . . . 74.42 109.252 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 28.7 m -99.39 123.0 43.29 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.717 -0.475 . . . . 74.3 109.717 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -121.24 139.73 52.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.01 0.433 . . . . 71.5 109.963 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 78.2 t -131.12 124.79 56.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.762 -0.654 . . . . 53.42 109.591 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 92.4 m-20 -106.88 106.42 16.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 61.41 109.36 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 28.0 t70 59.64 -168.76 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.914 -1.039 . . . . 72.31 109.424 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -79.54 -6.35 89.01 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.542 -0.837 . . . . 71.43 112.128 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 211' ' ' THR . 26.9 p -101.28 -27.02 13.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.639 0.977 . . . . 73.21 113.639 -172.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.6 tt0 -113.1 115.15 27.85 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 119.274 -0.97 . . . . 71.54 111.909 -174.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.58 131.06 57.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 75.14 109.64 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -174.25 -139.82 3.08 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.552 -0.833 . . . . 64.33 112.107 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.86 -150.61 22.9 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.23 -0.986 . . . . 63.0 112.865 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 28.5 t -142.78 144.54 32.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.147 0.498 . . . . 71.22 110.97 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.718 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 17.3 mm -118.9 115.77 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.856 -0.794 . . . . 73.23 108.856 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.677 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 26.1 t80 -111.6 119.7 39.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.612 0.244 . . . . 71.25 110.652 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.681 ' CG ' ' HB2' ' A' ' 199' ' ' ASN . 23.0 tp60 -127.81 128.49 45.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.505 -0.316 . . . . 73.33 110.34 176.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 198' ' ' VAL . 19.0 ptpt -103.1 132.41 49.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.674 -0.239 . . . . 73.12 110.933 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 197' ' ' LYS . 3.9 m 64.85 23.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.495 1.518 . . . . 75.44 112.423 176.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.867 HD22 ' HG3' ' A' ' 200' ' ' LYS . 9.1 t30 -65.31 -48.62 72.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 64.51 110.764 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.867 ' HG3' HD22 ' A' ' 199' ' ' ASN . 98.7 mttt -125.18 -84.47 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.491 -0.322 . . . . 72.3 111.05 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -86.83 -66.18 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.461 -0.336 . . . . 74.15 110.449 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.2 tp -145.73 -84.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 64.02 110.164 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 224' ' ' LYS . 2.6 tp10 -107.25 142.03 37.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 13.5 t -143.38 138.67 29.57 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.19 -0.604 . . . . 73.42 110.775 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -138.61 137.29 36.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.778 -0.646 . . . . 54.34 110.678 -178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.718 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 70.5 t -111.32 140.65 29.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.116 -0.698 . . . . 71.31 109.116 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' HB ' ' A' ' 17' ' ' VAL . 18.5 m-80 -138.27 131.51 30.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.674 -0.491 . . . . 75.12 109.674 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.87 151.7 37.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.824 0.345 . . . . 62.55 111.789 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.536 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -141.07 134.54 29.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 71.25 110.334 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 217' ' ' THR . 24.1 t90 -128.71 123.41 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 64.11 110.384 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 188' ' ' THR . 1.0 OUTLIER -99.89 103.56 15.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.369 0.604 . . . . 70.35 110.473 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.29 136.69 56.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.07 -0.968 . . . . 35.1 111.8 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.24 -28.12 15.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.932 -0.651 . . . . 72.34 113.207 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -132.79 -47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.87 0.692 . . . . 45.55 112.87 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.8 t -110.67 -179.04 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.375 0.607 . . . . 70.33 111.861 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -102.94 166.12 10.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.957 -1.02 . . . . 73.4 109.983 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 210' ' ' TRP . 25.7 m -74.91 123.17 24.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.422 -0.584 . . . . 65.01 109.422 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 218' ' ' ARG . 43.2 mtp180 -114.16 117.15 30.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.394 -0.595 . . . . 71.11 109.394 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -124.24 145.74 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.386 0.612 . . . . 63.32 111.306 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.36 13.8 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.898 -1.046 . . . . 62.44 111.229 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.3 mp -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.941 -0.392 . . . . 72.15 109.941 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -116.41 145.15 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.946 0.403 . . . . 44.01 110.855 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -129.04 126.54 39.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.933 -0.576 . . . . 62.34 109.792 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.511 ' HG2' ' SG ' ' A' ' 232' ' ' CYS . 22.8 ttmm -118.17 112.41 20.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 63.34 109.427 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 233' ' ' PHE . 5.7 p90 -135.09 118.8 17.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 74.23 112.389 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 0.2 OUTLIER -88.01 112.36 22.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.805 -1.183 . . . . 72.22 107.805 172.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.22 -55.36 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.375 0.88 . . . . 65.23 113.375 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.733 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 13.5 t70 -138.73 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 75.24 112.953 -164.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 62.4 Cg_endo -90.96 -139.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.161 1.908 . . . . 71.4 112.834 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.453 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.3 p-10 -92.56 12.22 23.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.213 -0.903 . . . . 74.32 109.498 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.519 ' CB ' ' HG2' ' A' ' 249' ' ' GLN . . . -121.46 123.69 42.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.634 0.73 . . . . 73.31 111.65 -169.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.511 ' SG ' ' HG2' ' A' ' 224' ' ' LYS . 44.8 t -97.29 128.17 43.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.634 -1.166 . . . . 64.12 108.318 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.486 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 53.0 m-85 -96.18 126.45 41.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.779 -0.452 . . . . 75.53 109.779 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 19.6 m -126.38 117.15 22.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 70.32 109.93 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -122.76 141.63 51.6 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.956 -0.387 . . . . 60.21 109.956 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 62.6 pttt -137.9 140.22 40.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.035 0.445 . . . . 75.34 110.401 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 243' ' ' ILE . 5.5 p -122.98 140.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.569 -0.53 . . . . 74.0 109.569 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -105.21 148.03 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.085 -0.709 . . . . 75.15 109.085 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.97 2.58 2.56 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.48 0.548 . . . . 74.22 112.48 -172.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.646 ' HB2' HD13 ' A' ' 242' ' ' LEU . 14.7 m -82.81 12.74 4.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.902 -0.777 . . . . 52.21 108.902 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 17.5 m 69.89 28.79 4.17 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.955 -1.021 . . . . 73.34 110.948 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.844 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.9 mp -101.15 129.39 47.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.902 0.334 . . . . 71.55 111.902 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.508 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -118.61 116.49 51.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.706 -0.679 . . . . 72.33 110.099 -169.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -127.99 133.81 7.94 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.276 -0.964 . . . . 53.04 113.12 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 0.0 OUTLIER -123.94 156.54 36.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.693 0.282 . . . . 65.41 110.483 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.67 149.46 20.95 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.543 -0.836 . . . . 73.33 113.158 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.835 ' HD1' ' HB3' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -106.63 118.1 35.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.107 -0.701 . . . . 74.43 109.107 177.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 28.9 m -104.49 115.14 29.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.439 -0.578 . . . . 75.41 109.439 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.519 ' HG2' ' CB ' ' A' ' 231' ' ' ALA . 10.9 mt-30 -112.41 133.16 54.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.003 0.43 . . . . 70.32 111.013 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 11.7 m -104.16 102.51 12.23 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.884 -0.784 . . . . 71.14 108.884 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.86 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 8.9 mp -75.24 179.3 5.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.857 0.36 . . . . 44.12 110.855 -174.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 1.4 tppp? -60.68 -52.52 71.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 54.33 111.09 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.598 ' HG2' HG12 ' A' ' 255' ' ' ILE . 72.3 Cg_endo -80.2 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.811 1.674 . . . . 73.43 111.617 172.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -75.94 64.58 2.68 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.915 -0.659 . . . . 74.33 112.553 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.86 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mm -123.74 123.97 68.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.537 0.208 . . . . 54.42 110.869 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.798 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 26.6 ttmt -115.46 114.17 24.69 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.299 -0.63 . . . . 73.5 109.299 171.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 279' ' ' LEU . 13.9 tp -100.33 124.55 45.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.623 -0.717 . . . . 62.41 109.959 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.4 m -122.22 110.21 15.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.152 0.501 . . . . 75.14 110.793 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.989 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -106.85 123.58 48.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.464 -1.31 . . . . 75.51 107.464 173.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.7 p -137.72 150.62 47.45 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.64 -0.424 . . . . 71.21 111.228 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.408 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -145.55 128.68 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.35 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.725 HD11 HD23 ' A' ' 242' ' ' LEU . 2.6 tm? -104.81 115.89 31.07 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.354 -0.98 . . . . 71.33 108.354 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.822 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.3 mm? -92.27 108.77 20.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.353 -0.98 . . . . 73.21 108.353 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.844 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m-20 -70.45 111.02 5.69 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.4 -0.963 . . . . 71.34 108.4 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.23 -27.68 40.17 Favored Glycine 0 C--N 1.319 -0.397 0 C-N-CA 121.207 -0.521 . . . . 41.4 112.995 -173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -91.79 -27.48 17.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.679 0.276 . . . . 75.41 111.19 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.832 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 14.4 m120 -92.46 -35.33 13.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.201 0.445 . . . . 70.23 112.201 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -63.04 -18.24 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.681 0.277 . . . . 60.34 111.649 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.71 -29.89 71.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.334 0.587 . . . . 53.12 109.653 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.22 0.18 31.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.541 -0.754 . . . . 64.15 110.594 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.34 8.06 57.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 74.41 113.066 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.33 86.92 1.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 42.44 112.567 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.444 ' HB3' HG12 ' A' ' 268' ' ' VAL . 6.6 p80 -114.39 144.9 42.55 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.76 -0.259 . . . . 61.54 110.537 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -99.24 138.02 36.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 63.22 111.179 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.2 tm? -113.05 139.4 48.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.818 -0.438 . . . . 74.14 109.818 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.546 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.06 117.8 1.53 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.883 -0.675 . . . . 64.53 111.631 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.989 HD23 HD22 ' A' ' 259' ' ' LEU . 3.0 tm? -115.51 141.97 47.35 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.418 -0.586 . . . . 71.53 109.418 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.571 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -153.31 129.37 2.68 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.381 -0.914 . . . . 75.42 113.11 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.798 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.7 mm? -112.49 131.52 55.54 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.874 -0.417 . . . . 44.34 109.874 172.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.798 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -124.06 112.01 16.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.736 0.779 . . . . 74.44 109.897 173.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.601 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -98.19 135.91 39.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.433 -1.258 . . . . 71.03 108.76 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.492 ' N ' ' HD2' ' A' ' 281' ' ' PHE . 7.4 tp60 -133.47 112.13 11.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 73.4 109.818 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.98 114.19 25.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.037 -0.529 . . . . 61.04 110.021 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.7 mt -120.53 115.97 24.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 55.03 110.598 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.379 -0.82 . . . . 72.13 109.868 178.103 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.528 ' CA ' ' HA2' ' A' ' 94' ' ' GLY . . . . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 120.706 0.288 . . . . 53.22 111.325 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.079 HG22 ' HB3' ' A' ' 119' ' ' LYS . 27.7 m -94.88 145.2 29.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.174 -0.466 . . . . 53.22 111.135 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 32.5 Cg_exo -58.88 161.69 14.9 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.481 2.121 . . . . 64.52 110.361 172.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.95 92.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.313 2.009 . . . . 65.21 112.385 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 p -67.02 -25.84 66.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.284 -0.416 . . . . 50.11 111.854 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.784 ' HB3' HG21 ' A' ' 143' ' ' VAL . 16.6 p90 -65.13 -29.25 70.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 71.45 110.922 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.72 -12.64 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.484 0.659 . . . . 55.12 109.986 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -104.26 -7.14 20.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.559 -0.904 . . . . 64.45 108.559 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.706 HD12 ' HB3' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -57.79 -33.78 68.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.786 -1.552 . . . . 74.53 110.83 178.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.72 63.61 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.082 -0.58 . . . . 50.52 112.175 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -62.05 -39.86 93.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.667 0.387 . . . . 75.43 111.753 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 m -61.0 -36.71 80.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 62.42 112.188 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.8 82.37 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.749 0.648 . . . . 73.24 112.749 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -67.74 -33.83 75.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.88 -0.328 . . . . 44.54 111.463 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 26.3 t70 -65.91 -47.99 72.93 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.5 -0.555 . . . . 70.11 109.5 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 222' ' ' ALA . 11.3 t -58.22 -33.49 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.956 -0.566 . . . . 71.44 111.566 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HD2' ' HB2' ' A' ' 207' ' ' ASN . 66.9 t80 -60.69 -39.52 88.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 64.25 111.695 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 18' ' ' PHE . 1.1 p -131.42 12.19 4.97 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.335 0.865 . . . . 73.41 113.335 -172.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 34.4 tttp -65.38 -38.7 90.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.166 0.507 . . . . 75.44 110.65 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.34 45.79 1.27 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.852 -0.69 . . . . 23.22 111.765 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.29 130.29 42.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.81 113.63 3.69 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.79 -0.719 . . . . 62.25 112.548 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -84.46 -3.67 58.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.792 0.33 . . . . 75.43 111.063 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.51 85.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.14 -0.552 . . . . 61.2 113.344 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 46' ' ' SER . 2.1 pp -147.21 179.89 7.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.047 0.758 . . . . 70.12 113.047 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.664 HD12 HD12 ' A' ' 277' ' ' LEU . 37.6 mm -100.59 124.47 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.368 -1.287 . . . . 72.43 109.55 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 33.3 ttpt -107.53 121.82 45.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.97 -0.382 . . . . 75.33 109.97 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.47 128.04 56.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.417 -0.586 . . . . 65.33 109.417 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.8 136.67 51.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.039 -0.726 . . . . 72.01 109.039 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.567 HD13 ' HD1' ' A' ' 281' ' ' PHE . 12.1 tp -137.04 124.62 22.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.931 0.396 . . . . 62.43 110.341 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' N ' HD12 ' A' ' 31' ' ' LEU . 39.8 tttp -116.97 125.44 51.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.449 -0.574 . . . . 71.04 109.449 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 25.4 m -126.06 149.51 48.83 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.335 -0.393 . . . . 63.33 110.5 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' HD3' HD22 ' A' ' 284' ' ' LEU . 55.0 mtpt -125.15 144.41 50.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.754 0.311 . . . . 63.13 110.878 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 52.3 m -140.75 158.28 44.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.31 -0.405 . . . . 60.44 110.995 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.626 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 28.3 tt0 -76.46 99.1 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.45 111.91 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.745 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t30 160.44 26.59 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.631 1.172 . . . . 52.13 107.861 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.718 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.65 18.05 79.35 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.273 -0.876 . . . . 72.24 110.991 -172.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 37' ' ' ASN . 3.1 mt -86.74 134.33 33.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.758 0.79 . . . . 55.34 112.916 -167.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.65 130.61 30.27 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.012 -1.449 . . . . 71.32 109.173 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 93.7 m-85 -115.65 121.54 42.86 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.854 -0.425 . . . . 74.12 109.854 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.896 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 23.7 m -115.94 116.48 28.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.091 0.472 . . . . 44.51 110.058 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 25.2 t -113.15 131.31 55.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.708 -0.678 . . . . 75.15 109.726 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -130.97 135.63 47.81 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.686 -0.487 . . . . 34.35 109.686 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.62 110.13 0.43 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.611 -0.804 . . . . 73.02 112.067 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.457 ' HB3' HD13 ' A' ' 26' ' ' LEU . 15.2 m -108.39 133.18 52.94 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.67 -0.863 . . . . 71.2 108.67 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.495 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -151.57 136.7 17.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.235 0.54 . . . . 72.02 111.24 -174.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -80.87 129.27 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 74.23 108.748 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.8 m -62.46 -20.9 65.01 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.973 0.416 . . . . 64.1 111.675 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -84.46 6.05 24.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.156 0.503 . . . . 72.14 110.204 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 p 49.24 72.0 0.34 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.68 0.792 . . . . 75.5 112.098 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -126.74 -30.87 2.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.253 -0.885 . . . . 63.3 110.172 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -149.13 113.85 5.36 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.101 -0.703 . . . . 71.11 109.101 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 47' ' ' ALA . 25.7 t -125.99 127.47 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 72.13 109.843 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -134.18 137.61 44.57 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.958 -0.386 . . . . 64.24 109.958 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -142.49 154.82 25.39 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.29 -0.957 . . . . 72.24 112.884 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.765 ' HB2' HG23 ' A' ' 77' ' ' THR . 26.7 t -146.73 148.68 32.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.226 -0.657 . . . . 72.3 109.226 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 74' ' ' LYS . 1.7 tm? -146.57 125.47 12.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.896 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 11.7 pt-20 -125.84 131.36 52.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.266 0.555 . . . . 63.11 110.195 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.419 HG23 ' CE1' ' A' ' 41' ' ' PHE . 48.3 m -107.62 119.4 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.813 -0.81 . . . . 75.31 108.813 172.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 19.9 mtpp -112.07 126.94 55.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 75.21 110.586 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.9 m-85 -110.77 120.97 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.36 -0.607 . . . . 54.34 109.36 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.718 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 39.5 mtp180 -114.61 110.9 20.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.809 0.814 . . . . 75.42 110.696 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -111.02 117.2 32.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.077 -1.42 . . . . 72.33 109.062 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m 73.64 122.85 0.04 OUTLIER 'General case' 0 C--O 1.231 0.108 0 O-C-N 124.021 0.826 . . . . 65.52 109.734 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.9 mp0 -63.01 106.47 0.84 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.037 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 87.2 m-85 68.0 84.77 0.15 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.207 -0.906 . . . . 71.44 109.37 -170.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.81 -83.05 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.309 -0.86 . . . . 71.14 111.443 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.8 mm? -121.26 131.71 54.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.985 0.421 . . . . 71.12 111.151 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 42.1 m -136.77 119.11 15.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.731 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 7.9 m-85 -107.98 133.38 52.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.239 -0.437 . . . . 74.21 110.115 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -128.35 119.44 25.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.074 0.397 . . . . 71.24 110.816 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 8.0 pt-20 -131.63 170.46 14.73 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.2 0.444 . . . . 64.01 112.2 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.625 ' HG3' HD12 ' A' ' 58' ' ' LEU . 72.5 mmtt 118.73 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.057 1.743 . . . . 64.23 113.452 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.535 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 13.2 t90 -135.0 143.57 46.89 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.484 0.55 . . . . 70.21 112.484 -163.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.501 ' ND2' ' H ' ' A' ' 78' ' ' ASP . 4.9 t30 -119.38 159.23 24.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.951 -0.568 . . . . 72.21 111.112 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.765 HG23 ' HB2' ' A' ' 57' ' ' SER . 17.9 p -61.67 -17.99 57.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.296 0.85 . . . . 72.1 113.296 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 5.5 m-20 -78.65 -1.61 35.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.658 -0.246 . . . . 74.22 110.89 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 78.9 13.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.762 0.825 . . . . 44.11 109.687 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -86.7 134.89 33.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.306 -0.861 . . . . 74.22 110.058 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.1 mp -107.72 161.09 15.2 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.375 -0.972 . . . . 74.42 108.375 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 102' ' ' SER . . . 148.23 -167.68 28.99 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.277 -1.439 . . . . 61.11 113.141 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 2.3 t -157.9 152.29 24.67 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.637 -0.282 . . . . 71.42 110.494 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.941 ' HA ' ' HB3' ' A' ' 100' ' ' ASP . 10.4 pt-20 -127.45 136.28 51.59 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 125.166 1.541 . . . . 71.22 109.678 171.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 99' ' ' PHE . 1.7 pp -111.4 133.11 58.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 118.658 -1.217 . . . . 71.35 110.815 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.93 ' HB ' ' HE3' ' A' ' 96' ' ' LYS . 21.1 p -114.8 137.52 51.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.727 -0.67 . . . . 64.44 110.783 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.75 135.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.32 -0.4 . . . . 73.34 110.672 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.05 127.33 36.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.378 -0.601 . . . . 74.13 109.378 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 27.1 t70 -69.94 156.64 38.8 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.248 0.547 . . . . 74.2 111.601 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -95.56 -37.31 10.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.5 -0.773 . . . . 72.4 110.831 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.64 -55.07 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 74.24 111.018 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.8 64.32 5.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.772 -0.825 . . . . 72.33 108.772 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -48.88 126.53 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 74.23 111.221 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.528 ' HA2' ' CA ' ' A' ' 2' ' ' ALA . . . 104.1 -4.25 44.94 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.69 -0.687 . . . . 52.31 112.204 -173.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 89' ' ' ASP . 52.7 tp -79.72 130.43 35.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.686 . . . . 75.43 109.146 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.93 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 55.9 tptt -121.72 111.15 16.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.658 -0.701 . . . . 70.4 109.732 -174.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 116' ' ' THR . 1.1 mm? -112.77 125.71 54.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.365 -0.605 . . . . 43.05 109.365 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.862 ' HB ' HG22 ' A' ' 86' ' ' THR . 1.8 t -131.92 118.98 20.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.306 -0.558 . . . . 73.44 112.219 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.935 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 88.1 t80 -127.39 114.23 17.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 75.42 109.407 174.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.941 ' HB3' ' HA ' ' A' ' 84' ' ' GLU 0.355 1.2 t70 -153.82 172.95 16.55 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 120.845 -1.159 . . . . 64.24 112.804 159.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.749 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 23.3 t -116.78 147.79 41.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.931 0.396 . . . . 52.32 110.687 -165.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.679 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 33.4 t -114.8 134.81 54.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 75.31 110.368 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -95.52 124.9 39.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.059 0.457 . . . . 72.22 110.252 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 31.3 m -109.61 115.2 56.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 74.43 110.75 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 19.3 Cg_exo -66.22 -7.81 18.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.184 2.589 . . . . 63.0 112.326 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -55.92 -50.81 69.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.743 -0.662 . . . . 75.32 111.01 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 p -129.36 -2.67 4.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.854 0.359 . . . . 71.3 111.65 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.92 11.68 81.02 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.664 -0.779 . . . . 64.31 111.734 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.843 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -94.35 149.08 21.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.693 -0.254 . . . . 71.43 110.567 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -106.94 135.98 47.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.04 0.448 . . . . 74.12 110.405 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -119.54 122.9 42.66 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.443 -0.947 . . . . 75.21 108.443 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.749 ' HA ' ' HA ' ' A' ' 101' ' ' SER . . . -104.45 147.16 27.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.942 0.401 . . . . 64.24 111.596 -168.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -121.65 137.56 54.7 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.473 0.654 . . . . 74.52 110.433 177.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.935 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 2.5 tp -127.77 115.86 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.385 -1.279 . . . . 63.31 109.359 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.779 ' HB3' HG23 ' A' ' 98' ' ' THR . 4.4 ttmp? -113.65 121.27 43.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.725 -0.67 . . . . 54.43 110.579 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.68 HG22 HD12 ' A' ' 97' ' ' LEU . 21.7 p -112.68 117.29 31.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.367 -0.605 . . . . 61.52 109.367 175.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.82 134.93 5.34 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.052 -1.07 . . . . 44.54 112.885 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -107.51 125.36 51.18 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.616 -0.512 . . . . 65.53 109.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 1.079 ' HB3' HG22 ' A' ' 3' ' ' VAL . 41.7 mttp -110.26 121.78 46.09 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 121.182 0.515 . . . . 75.23 110.852 -173.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 120' ' ' ARG . 6.4 mmt180 -108.89 152.5 24.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.202 -0.908 . . . . 74.44 109.317 169.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.869 ' HA ' HG11 ' A' ' 3' ' ' VAL . 8.8 tm-20 -50.88 -27.93 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.907 0.883 . . . . 75.33 111.317 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -110.9 -15.4 13.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.091 -0.504 . . . . 74.33 112.143 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 144' ' ' LEU . 16.6 tt -149.29 122.12 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 118.813 -1.155 . . . . 70.14 113.482 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 1.6 t30 -102.83 119.01 38.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.445 -0.798 . . . . 64.21 110.793 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 142' ' ' LEU . 3.1 mm? -112.43 111.9 23.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.166 -0.679 . . . . 73.31 109.166 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.11 118.58 2.44 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.991 -1.1 . . . . 54.33 113.103 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.8 t -110.66 111.22 22.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.935 0.398 . . . . 70.43 110.204 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 13.6 t70 -100.7 134.74 43.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 75.14 109.728 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.83 117.78 24.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.838 0.352 . . . . 73.14 110.119 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.32 119.22 37.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -82.45 96.9 8.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.903 0.382 . . . . 74.34 111.007 -171.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.593 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 13.0 t70 -96.82 145.31 25.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 65.31 109.638 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -29.17 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.544 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.72 58.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.944 0.402 . . . . 70.22 110.923 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.56 108.3 0.51 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.583 -0.607 . . . . 72.3 111.583 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.593 ' HA ' ' H ' ' A' ' 132' ' ' ASP . 77.0 Cg_exo -48.24 123.51 9.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.268 2.645 . . . . 70.14 112.755 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 t -84.68 136.67 33.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.251 -0.648 . . . . 63.34 109.251 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 45.5 mm -105.57 117.04 50.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 62.42 109.467 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -116.19 109.64 17.72 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.28 -0.637 . . . . 72.24 109.28 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.0 133.54 11.61 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.907 -1.139 . . . . 51.04 112.157 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.21 114.08 21.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.418 0.628 . . . . 75.02 109.491 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 144' ' ' LEU . 18.1 tp -116.47 122.94 46.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.362 -0.836 . . . . 72.54 109.569 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' A' ' 7' ' ' TYR . 48.3 t -133.9 120.26 35.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.958 -0.386 . . . . 74.32 109.958 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.665 HD12 HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -126.78 139.29 53.23 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.532 -0.867 . . . . 74.2 110.718 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -120.86 128.41 7.41 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 114.674 -1.148 . . . . 73.31 111.837 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -112.59 149.16 33.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.396 -1.705 . . . . 74.21 106.396 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -47.7 95.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 55.53 112.243 -171.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.3 -33.09 5.73 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.133 -0.94 . . . . 43.32 112.867 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.433 ' HD1' ' HB2' ' A' ' 173' ' ' TYR . 2.5 m0 -106.47 146.88 30.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.847 0.323 . . . . 74.34 111.463 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.706 ' HB3' HD12 ' A' ' 10' ' ' LEU . 7.5 mt -130.81 136.56 48.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.815 -0.809 . . . . 62.35 108.815 167.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.513 ' HB3' ' CD2' ' A' ' 144' ' ' LEU . . . -130.52 127.4 39.07 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.861 -0.422 . . . . 72.35 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.539 ' N ' HD21 ' A' ' 10' ' ' LEU . . . -131.85 133.54 7.21 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.986 -0.626 . . . . 75.11 111.791 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -129.36 118.72 22.68 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.212 -0.494 . . . . 75.34 110.538 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -111.6 121.83 46.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 45.23 109.508 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -135.48 146.69 48.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.065 -0.346 . . . . 74.2 110.065 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 166' ' ' GLN . 7.3 p30 -124.35 119.01 28.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.645 0.736 . . . . 71.12 110.966 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.856 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.8 t80 -97.03 123.1 40.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.527 -1.215 . . . . 71.42 109.298 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.708 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 25.0 tt0 -94.04 105.25 17.26 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.747 -0.464 . . . . 71.43 109.747 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.78 -22.09 62.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 113.687 -1.597 . . . . 53.25 111.149 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.23 77.83 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.595 -0.891 . . . . 70.34 108.595 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.708 ' H ' ' HG2' ' A' ' 158' ' ' GLU . 17.6 ttmm -98.89 -164.91 1.18 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.92 -1.511 . . . . 72.41 106.92 169.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 15.5 m -110.38 25.52 11.69 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.223 -0.923 . . . . 71.14 110.509 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -155.31 151.28 27.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 119.398 -0.921 . . . . 74.33 112.727 -160.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.856 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -74.77 135.72 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.105 -1.072 . . . . 71.1 108.105 168.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -93.99 -32.84 13.68 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.421 -0.512 . . . . 74.51 110.929 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.695 ' HB3' HD21 ' A' ' 156' ' ' ASN . 35.3 tt0 -151.38 133.52 15.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 54.45 111.066 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 m -118.69 120.22 36.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 61.01 109.984 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 185' ' ' ASN . 39.3 m-80 -116.82 121.95 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.806 -0.813 . . . . 62.22 108.806 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -139.8 155.48 47.25 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.567 -0.853 . . . . 61.25 111.797 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.574 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -144.81 152.71 40.74 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.616 -0.72 . . . . 75.0 110.23 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 42.9 t -130.21 151.63 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.613 -1.254 . . . . 54.32 107.613 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -158.04 111.03 0.47 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.029 -1.081 . . . . 72.54 112.197 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.458 ' CE2' HD22 ' A' ' 180' ' ' LEU . 39.2 p90 -113.39 138.36 50.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.428 0.632 . . . . 71.53 110.957 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -104.63 127.17 52.31 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.695 -1.139 . . . . 62.11 110.486 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 178' ' ' PHE . 33.5 m -127.12 162.54 25.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.555 -0.906 . . . . 74.42 108.555 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.61 -54.7 11.1 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.522 0.564 . . . . 50.22 112.522 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.28 -21.93 13.44 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.896 -0.322 . . . . 63.4 111.698 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.519 ' O ' ' HB ' ' A' ' 175' ' ' THR . 91.4 m-85 -124.69 142.84 51.1 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.805 0.336 . . . . 73.32 110.913 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 29.2 tt0 -135.23 122.9 22.22 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.206 -1.035 . . . . 72.21 108.206 172.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.502 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 8.8 tt -121.54 137.45 54.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.987 -0.685 . . . . 64.31 111.2 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 19.9 t-80 -127.3 114.8 18.07 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.248 -0.887 . . . . 65.1 110.573 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -81.51 148.31 29.25 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.804 -0.813 . . . . 62.04 108.804 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.403 ' HB2' ' CE1' ' A' ' 181' ' ' HIS . 8.3 t30 -147.93 137.02 22.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.3 -0.56 . . . . 74.13 111.25 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.9 t -133.78 123.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.554 -0.748 . . . . 62.34 110.068 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 11.7 m120 -117.08 112.44 20.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.641 -0.709 . . . . 74.42 109.529 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.548 ' HA ' ' HG3' ' A' ' 166' ' ' GLN . 21.0 t70 63.7 -173.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.418 -0.81 . . . . 71.53 109.072 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.9 -6.0 89.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.395 -0.907 . . . . 43.21 111.101 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.2 m -97.03 -26.95 14.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.0 0.741 . . . . 62.32 113.0 -171.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 16.7 mm-40 -116.5 111.15 19.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.523 0.601 . . . . 72.13 110.427 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -127.63 123.62 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 74.25 109.371 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -174.13 -144.87 4.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.802 -1.19 . . . . 65.41 113.33 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -166.23 -172.08 33.13 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.613 -0.804 . . . . 44.0 113.038 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 4.1 m -148.76 139.0 22.39 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.544 0.738 . . . . 72.41 109.12 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.1 mp -124.23 117.45 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 121.2 -0.2 . . . . 73.21 110.464 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.501 ' HD1' ' HB2' ' A' ' 205' ' ' ALA . 11.6 t80 -108.41 120.33 42.09 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.542 -0.54 . . . . 54.4 109.542 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -125.72 133.05 52.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.472 -0.331 . . . . 74.23 110.45 -175.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -101.15 114.41 28.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.477 -0.329 . . . . 73.43 110.378 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 199' ' ' ASN . 8.3 t -73.77 171.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.373 -0.603 . . . . 71.15 109.373 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.555 ' H ' HG12 ' A' ' 198' ' ' VAL . 12.9 m120 -66.11 -30.87 71.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.756 0.312 . . . . 44.13 111.31 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 4.7 mptp? -92.81 -164.51 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 55.42 110.846 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 200' ' ' LYS . 32.0 tptt -79.11 39.09 0.37 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 73.44 110.496 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.965 ' HG ' ' HB3' ' A' ' 225' ' ' TYR . 4.5 tt -120.92 122.01 39.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 73.44 109.661 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.86 130.54 53.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.98 -0.555 . . . . 71.31 109.658 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.0 t -121.64 153.75 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.863 0.363 . . . . 73.4 110.63 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.02 147.79 37.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.498 0.666 . . . . 60.03 111.55 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 221' ' ' ILE . 71.3 t -112.13 132.79 59.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.158 -0.928 . . . . 71.1 109.517 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.3 p-10 -114.2 127.3 55.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.934 -1.136 . . . . 71.52 107.934 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 tp -144.15 129.58 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.556 -0.458 . . . . 71.31 110.819 -169.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.453 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -150.57 129.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.534 . . . . 71.21 111.216 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.648 ' CZ2' ' HA ' ' A' ' 215' ' ' SER . 3.5 t-105 -95.1 125.33 39.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.281 -1.007 . . . . 62.15 108.281 174.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 t -101.56 123.02 44.9 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.495 0.664 . . . . 64.52 110.312 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.7 127.32 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 53.02 111.533 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 153.96 -70.51 0.29 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.875 -0.89 . . . . 70.45 110.875 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.9 -166.01 1.43 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.387 -0.597 . . . . 75.04 109.387 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.648 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . 64.6 m -95.57 24.8 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.094 0.474 . . . . 74.23 110.808 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.07 111.82 20.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 73.34 109.779 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.6 t -99.82 135.97 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.05 0.452 . . . . 72.24 110.007 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -96.5 115.12 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.459 -0.571 . . . . 74.21 109.459 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.627 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 47.6 p90 -119.64 154.95 33.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.846 0.355 . . . . 74.34 110.736 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.39 23.12 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.849 -0.691 . . . . 73.31 111.943 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.854 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -135.49 140.64 44.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 121.035 -0.266 . . . . 74.34 110.458 177.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.763 ' HB3' HG13 ' A' ' 17' ' ' VAL . . . -133.69 131.13 39.13 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.345 0.403 . . . . 63.1 110.706 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.56 125.14 53.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.393 -0.367 . . . . 72.53 110.186 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -112.02 114.08 26.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 53.3 109.218 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.965 ' HB3' ' HG ' ' A' ' 202' ' ' LEU . 7.9 p90 -127.03 124.63 39.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.435 0.636 . . . . 53.31 111.24 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -82.32 106.87 14.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.048 -0.978 . . . . 72.32 108.946 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.54 HG21 ' HE1' ' A' ' 233' ' ' PHE . 14.8 tt -70.11 -43.98 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.692 0.627 . . . . 64.41 112.692 -167.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.773 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 14.4 t70 -171.79 -63.56 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.311 0.486 . . . . 73.23 112.311 -175.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 78.4 Cg_endo -93.4 -127.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.281 1.987 . . . . 53.32 112.911 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.5 p-10 -92.35 12.63 21.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.708 -0.678 . . . . 73.11 110.829 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.24 133.1 55.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.456 0.646 . . . . 62.14 111.322 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -121.36 140.26 52.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.833 -1.076 . . . . 54.21 109.34 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.54 ' HE1' HG21 ' A' ' 227' ' ' ILE . 88.1 m-85 -106.45 126.74 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.123 -0.325 . . . . 72.4 110.123 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 15.0 m -120.59 117.63 28.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.484 . . . . 63.55 110.067 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -118.42 140.48 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.829 -0.434 . . . . 54.34 109.829 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.62 ' HB2' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -143.74 148.03 35.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 62.25 111.251 -177.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.523 HG12 HG12 ' A' ' 221' ' ' ILE . 7.0 p -122.58 148.57 26.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 116.32 -0.4 . . . . 64.25 110.113 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -110.45 150.04 29.43 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.254 0.972 . . . . 71.05 109.591 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.627 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 6.8 p30 -37.98 -36.39 0.2 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.61 1.564 . . . . 71.22 114.815 -172.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.699 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.1 m -81.83 21.19 0.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.772 0.32 . . . . 64.4 111.033 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.3 m 68.43 31.54 4.9 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.634 -0.712 . . . . 71.54 111.203 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.836 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.6 mp -96.86 129.53 44.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.566 -0.454 . . . . 71.4 111.536 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.575 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -111.49 116.52 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.3 0.572 . . . . 63.22 110.834 -172.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -116.28 133.72 10.95 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.739 -0.664 . . . . 73.22 111.867 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 245' ' ' LEU . 1.3 pp -119.9 146.51 45.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.42 . . . . 52.24 110.678 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -134.17 133.44 6.87 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.612 -0.722 . . . . 73.31 111.778 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.717 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 19.4 m-85 -102.86 114.48 28.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.666 -0.864 . . . . 73.54 108.666 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 22.1 m -116.84 114.95 24.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.811 0.339 . . . . 63.21 110.417 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -132.45 137.51 47.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.854 0.359 . . . . 74.22 110.676 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.9 m -112.37 95.71 5.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.001 -0.545 . . . . 60.34 110.159 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 43.7 tp -82.05 88.34 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.268 -0.642 . . . . 75.02 109.268 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 75.1 mmtt 67.93 163.82 0.13 Allowed Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.259 -0.882 . . . . 72.24 110.273 -175.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 40.8 Cg_endo -69.23 64.29 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.355 2.037 . . . . 31.24 112.3 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -158.68 -45.43 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.911 -0.586 . . . . 74.34 112.315 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.6 mt -124.08 121.44 62.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 64.15 111.652 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 280' ' ' GLU . 37.1 ttmt -117.47 115.44 25.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.367 -0.605 . . . . 64.0 109.367 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.5 tp -100.44 130.53 46.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.424 -0.353 . . . . 73.44 110.521 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 30.0 m -129.98 111.25 12.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.554 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.922 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.21 122.84 44.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.892 -1.151 . . . . 72.24 107.892 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.9 m -124.39 139.58 53.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.971 0.415 . . . . 63.34 110.854 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.4 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -143.92 127.77 17.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.99 -0.55 . . . . 42.22 110.248 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.754 HD11 HD23 ' A' ' 242' ' ' LEU . 2.7 tm? -101.62 118.04 36.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.361 -0.977 . . . . 74.12 108.361 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -97.7 110.95 23.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.605 -0.887 . . . . 64.41 108.605 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.836 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.9 m-20 -68.62 102.34 1.47 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.711 -0.848 . . . . 53.32 108.711 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -64.9 -10.06 43.65 Favored Glycine 0 C--N 1.321 -0.293 0 CA-C-N 115.64 -0.709 . . . . 71.3 111.844 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -90.59 -25.34 20.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.206 -0.497 . . . . 73.31 111.092 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -161.5 24.25 0.12 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.105 1.52 . . . . 74.43 115.105 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 264' ' ' ASP . 0.2 OUTLIER -64.18 -46.47 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 120.079 1.309 . . . . 73.42 112.878 176.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.43 -25.92 62.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.067 0.461 . . . . 61.53 110.594 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.87 2.37 32.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 52.51 111.067 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.63 -103.12 0.34 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.141 -1.028 . . . . 71.2 112.856 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -158.78 167.28 34.69 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.082 -1.056 . . . . 32.33 113.223 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -111.47 150.12 30.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.66 -0.77 . . . . 73.52 109.593 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.666 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 43.6 mttm -93.7 137.18 33.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.689 -0.856 . . . . 71.03 108.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.7 tm? -125.66 133.06 52.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.755 0.312 . . . . 72.21 110.294 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.469 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.24 122.39 2.18 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.062 -0.815 . . . . 61.35 111.062 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.922 HD23 HD22 ' A' ' 259' ' ' LEU . 2.2 tm? -115.82 125.32 52.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.644 -0.502 . . . . 64.33 109.644 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -134.9 138.43 10.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.429 -0.891 . . . . 70.14 112.895 -175.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.85 132.39 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.777 -0.453 . . . . 74.31 109.777 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.728 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 46.4 mt-10 -109.85 110.88 22.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.812 -0.81 . . . . 70.25 108.812 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.567 ' HD1' HD13 ' A' ' 31' ' ' LEU . 16.4 t80 -104.16 141.6 35.96 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.589 -0.893 . . . . 74.14 108.589 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -135.56 119.79 17.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.935 0.398 . . . . 52.01 110.639 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.22 108.43 19.05 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.156 -0.683 . . . . 53.04 109.156 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 34' ' ' LYS . 36.2 mt -121.13 -69.02 0.86 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.843 -0.799 . . . . 40.33 108.843 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 114.679 -1.146 . . . . 70.3 108.532 177.228 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.683 0.278 . . . . 54.23 110.69 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.745 ' HB ' ' HE2' ' A' ' 119' ' ' LYS . 60.5 t -67.43 125.99 91.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.037 -0.529 . . . . 72.11 110.332 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 46.7 Cg_exo -57.23 153.98 36.87 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.39 2.727 . . . . 52.13 113.279 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.03 64.34 6.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.114 2.543 . . . . 72.05 112.047 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.604 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.9 p -69.63 -37.74 76.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.466 -0.788 . . . . 52.22 111.096 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.742 ' HB3' HG21 ' A' ' 143' ' ' VAL . 3.5 p90 -64.12 -22.03 66.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 72.31 111.278 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.69 -19.79 44.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.066 -0.516 . . . . 54.4 110.367 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.49 11.91 37.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.032 0.92 . . . . 71.32 109.333 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.979 HD21 ' HA3' ' A' ' 152' ' ' GLY . 3.3 tp -76.53 -14.3 60.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.007 -0.997 . . . . 73.11 110.849 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.66 26.23 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.44 -0.886 . . . . 65.41 113.291 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -68.93 -50.17 51.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.151 0.476 . . . . 71.5 110.525 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -57.34 -38.86 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.836 -0.62 . . . . 72.52 111.027 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.65 72.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 72.32 111.402 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.77 -39.91 84.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.6 -0.273 . . . . 74.33 111.518 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 14.7 t70 -58.59 -49.83 76.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.642 -0.254 . . . . 73.12 111.353 -175.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -70.23 -31.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.015 0.436 . . . . 73.21 110.867 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -72.64 -32.19 65.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 74.03 110.71 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -81.87 -25.84 34.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 65.12 110.73 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.573 ' HD3' ' O ' ' A' ' 16' ' ' ASP . 1.9 mptm? -85.17 20.06 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 63.35 110.865 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.601 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -99.61 -19.47 20.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 53.43 113.286 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -87.16 138.28 31.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.267 0.556 . . . . 74.15 112.141 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -152.35 109.65 0.42 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.22 -0.9 . . . . 63.04 111.709 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -103.73 14.99 29.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.785 0.326 . . . . 74.42 111.005 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.33 14.61 53.52 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 109.226 -1.55 . . . . 72.42 109.226 -166.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 46' ' ' SER . 5.3 tt -99.47 145.6 27.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.944 -1.128 . . . . 64.43 110.688 -168.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 277' ' ' LEU . 28.3 mm -102.49 125.26 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.986 -1.006 . . . . 61.11 110.198 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -107.79 120.01 41.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.332 -0.618 . . . . 63.41 109.332 175.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 279' ' ' LEU . 22.5 tp -114.44 147.56 39.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.837 0.351 . . . . 73.1 110.554 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.6 t70 -150.82 131.65 14.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 55.14 109.768 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.942 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -126.84 123.59 37.67 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 97.1 mttt -132.65 124.97 29.29 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.839 -0.344 . . . . 63.34 110.988 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 41' ' ' PHE . 8.8 t -135.83 129.95 33.2 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.285 -0.635 . . . . 52.15 109.285 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.728 ' HB3' HH12 ' A' ' 63' ' ' ARG . 90.3 mttt -118.3 131.17 56.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.965 -0.562 . . . . 53.12 109.969 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -132.91 150.26 52.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.238 -0.437 . . . . 54.14 110.513 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.91 2.37 46.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.799 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -100.08 24.75 8.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 54.24 111.521 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.3 -5.89 82.64 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.328 -0.939 . . . . 64.42 113.451 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.42 127.78 46.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.179 0.99 . . . . 70.14 111.764 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.3 117.6 11.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.507 -0.923 . . . . 74.43 108.507 164.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' HB2' HG22 ' A' ' 33' ' ' THR . 96.0 m-85 -110.32 125.6 53.34 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.588 -0.445 . . . . 75.04 110.768 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 20.6 m -125.18 116.11 21.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 61.52 109.934 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 6.4 m -108.76 123.28 48.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.051 -0.722 . . . . 75.21 109.051 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -130.03 126.41 37.64 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.006 -0.368 . . . . 74.05 110.006 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.14 156.66 26.97 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.946 -1.121 . . . . 61.1 112.576 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.593 ' HB3' HD21 ' A' ' 26' ' ' LEU . 16.6 m -137.98 132.35 32.15 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.308 -0.627 . . . . 33.35 109.308 176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -144.32 130.04 19.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.862 0.363 . . . . 71.42 110.593 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 46.1 t30 -80.64 142.02 34.39 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.444 -0.576 . . . . 73.24 109.444 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -64.04 -19.37 65.16 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.968 0.413 . . . . 63.01 111.255 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -70.62 -13.6 62.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 64.14 110.442 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m 71.56 -3.52 2.12 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.726 -0.67 . . . . 70.51 111.726 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -73.06 -27.46 61.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.217 -0.447 . . . . 71.12 110.981 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.28 101.66 6.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 71.21 110.034 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -125.66 120.69 58.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.985 -0.552 . . . . 70.13 110.11 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -131.3 125.03 31.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.955 -0.387 . . . . 65.43 109.955 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.83 155.19 20.06 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.266 -0.969 . . . . 75.23 112.409 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 p -146.8 141.21 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.111 0.482 . . . . 74.53 110.441 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.38 122.54 42.03 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.926 -1.139 . . . . 73.25 107.926 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 28.0 mt-10 -116.98 119.96 36.91 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.956 -0.565 . . . . 73.1 109.82 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -109.78 120.99 44.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.724 -0.671 . . . . 70.15 109.841 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 42.9 tttp -117.08 132.51 56.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.067 -0.716 . . . . 65.3 109.067 176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 70' ' ' THR . 37.9 t80 -100.19 121.6 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.044 -1.095 . . . . 74.22 108.044 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.728 HH12 ' HB3' ' A' ' 34' ' ' LYS . 10.6 ttp180 -123.72 107.3 11.31 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.538 0.685 . . . . 73.05 111.094 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.4 ' HB2' ' HE2' ' A' ' 62' ' ' TYR . 63.3 t-105 -113.55 115.58 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.79 -1.096 . . . . 64.45 108.886 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m 70.93 139.13 0.04 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.961 0.788 . . . . 72.53 109.59 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 2.7 tp10 -65.58 101.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.692 -0.485 . . . . 71.53 109.692 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.24 68.92 0.59 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.378 -0.828 . . . . 72.14 110.684 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.04 -76.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.382 -1.087 . . . . 74.34 110.382 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -122.11 130.18 53.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.743 0.306 . . . . 61.13 110.247 173.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.797 HG23 ' HB ' ' A' ' 86' ' ' THR . 9.0 t -138.44 135.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.425 0.631 . . . . 75.41 112.089 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 85.2 m-85 -105.75 133.77 49.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.844 -0.798 . . . . 74.43 108.844 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.4 m -120.84 119.31 32.29 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.71 -0.396 . . . . 71.24 111.465 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 28.1 mt-10 -130.96 152.2 50.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.668 -0.697 . . . . 73.05 109.803 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -160.43 104.38 1.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 71.22 110.917 178.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.975 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 48.8 t90 -98.53 127.94 44.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.298 -0.41 . . . . 71.15 110.358 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.86 136.84 38.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.488 -0.93 . . . . 71.01 108.488 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -61.8 -25.83 67.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 72.22 111.862 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.7 -38.17 5.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.118 0.784 . . . . 72.12 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.27 -90.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.347 0.869 . . . . 55.31 113.347 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 m -85.22 123.6 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.811 0.671 . . . . 73.33 112.811 -166.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.975 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -108.48 119.07 38.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.624 -0.51 . . . . 64.24 109.624 168.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -115.53 156.61 15.54 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.643 -0.789 . . . . 41.11 112.776 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 9.8 t -172.88 148.72 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.681 -0.489 . . . . 74.42 109.681 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 100' ' ' ASP . 12.2 mm-40 165.58 -155.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.585 1.154 . . . . 73.4 110.491 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.495 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -131.58 138.97 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.49 0.552 . . . . 64.5 112.49 -165.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.797 ' HB ' HG23 ' A' ' 70' ' ' THR . 23.1 m -127.77 131.75 49.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.337 -0.392 . . . . 53.1 110.003 175.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 97' ' ' LEU . 3.9 p -129.95 129.8 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 64.41 111.672 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.56 117.87 30.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.278 -1.008 . . . . 73.44 108.278 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -87.28 140.18 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.26 -0.576 . . . . 71.42 111.642 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.84 -25.85 15.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.279 -0.873 . . . . 74.42 110.655 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.9 tp -67.13 -57.23 7.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.032 -0.729 . . . . 74.14 109.032 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.54 76.17 5.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.298 -1.001 . . . . 70.34 108.298 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.67 123.11 13.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.554 -0.748 . . . . 71.23 110.683 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . 100.6 -0.91 55.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.665 -0.698 . . . . 73.42 112.319 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.3 tp -91.41 131.1 37.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 51.13 110.201 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -121.68 111.24 16.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.328 -0.851 . . . . 72.34 109.85 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.437 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.9 mm? -100.79 126.34 47.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.083 -0.71 . . . . 72.35 109.083 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 23.6 m -128.87 118.34 22.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.119 0.485 . . . . 75.3 111.749 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.637 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 77.7 m-85 -111.06 116.22 30.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.85 -1.167 . . . . 72.23 107.85 170.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.649 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.5 p-10 -130.56 128.19 40.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.846 0.355 . . . . 73.44 110.575 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 t -119.57 148.81 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.732 0.301 . . . . 63.25 110.528 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 7.9 p -133.04 134.54 44.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.301 -0.409 . . . . 60.14 110.478 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.637 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 9.8 m-85 -111.21 138.94 47.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.207 -0.294 . . . . 75.03 110.207 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.2 p -122.47 107.85 34.05 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.834 0.35 . . . . 64.21 110.195 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.91 -1.13 9.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.986 2.457 . . . . 74.33 112.76 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -63.86 -61.59 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.38 0.609 . . . . 73.52 109.51 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.516 ' HB ' ' HG3' ' A' ' 109' ' ' LYS . 42.7 m -91.76 -27.27 18.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.283 -0.871 . . . . 54.3 109.958 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.5 9.4 60.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.666 -0.778 . . . . 54.31 111.843 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.587 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -94.16 148.94 21.69 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.802 0.334 . . . . 61.04 110.617 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.431 ' CB ' ' HD1' ' A' ' 103' ' ' PHE . 18.6 ptpt -114.23 152.74 30.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 44.33 110.796 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.587 ' OD1' ' HE2' ' A' ' 109' ' ' LYS . 2.8 m-20 -116.7 122.58 44.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.952 -0.758 . . . . 71.31 108.952 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.33 114.92 29.33 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.343 -0.614 . . . . 53.42 109.343 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.408 ' HD2' ' OD2' ' A' ' 130' ' ' ASP . 50.1 tttm -115.03 137.98 51.38 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.211 0.529 . . . . 74.23 110.606 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.53 HG23 ' HB3' ' A' ' 129' ' ' MET . 3.2 tp -127.3 126.0 66.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.431 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 24.4 ttpp -118.9 120.31 36.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.202 0.525 . . . . 72.02 110.208 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.8 p -107.34 116.89 32.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.604 -0.887 . . . . 73.53 108.604 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.37 135.78 8.19 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.985 -1.103 . . . . 42.32 112.106 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -126.78 124.81 40.56 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.442 -0.577 . . . . 73.1 109.442 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.745 ' HE2' ' HB ' ' A' ' 3' ' ' VAL . 15.9 ptmt -109.08 121.71 45.73 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.486 0.66 . . . . 72.44 109.921 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 120' ' ' ARG . 22.2 mmt180 -104.56 155.92 18.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.013 -1.106 . . . . 72.1 108.013 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -54.68 -28.57 48.52 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.416 0.447 . . . . 74.21 112.184 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.34 -15.38 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.548 -0.296 . . . . 74.43 111.692 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -146.35 135.56 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.601 -0.44 . . . . 72.42 111.74 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.739 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 43.8 t30 -122.63 120.86 34.99 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.764 -0.585 . . . . 72.24 111.737 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.4 127.03 53.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.696 0.284 . . . . 73.14 111.213 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.39 125.64 4.08 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.037 -0.601 . . . . 54.21 112.047 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 49.7 m -113.32 112.11 23.14 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.578 -0.366 . . . . 63.41 111.275 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 9.9 m-20 -96.2 147.46 23.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 73.44 109.994 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.53 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.5 ttt -139.77 120.41 14.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.627 -0.261 . . . . 75.44 110.543 173.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 113' ' ' LYS . 35.4 m-20 -90.72 117.45 29.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.762 -0.829 . . . . 73.44 108.762 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.18 97.53 9.26 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.079 0.466 . . . . 63.43 110.142 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.03 150.23 26.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.629 -0.714 . . . . 55.34 109.212 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.77 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -72.27 -19.9 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.98 0.363 . . . . 74.24 111.98 -175.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.56 -18.96 21.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 74.4 111.047 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 167.8 128.93 1.03 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.519 -0.848 . . . . 73.21 112.578 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.0 150.56 26.65 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.77 2.314 . . . . 61.22 112.657 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 m -126.8 134.01 50.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.566 . . . . 61.1 110.08 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 118.72 56.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.017 0.437 . . . . 72.2 109.87 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 12.1 ttp180 -111.24 130.18 55.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.622 -0.51 . . . . 71.44 109.622 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.19 132.49 10.94 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.993 -1.099 . . . . 73.33 111.406 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.84 115.47 23.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.361 -0.607 . . . . 61.44 109.361 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 123' ' ' ILE . 8.9 tp -121.0 124.31 44.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.989 -0.55 . . . . 70.24 110.383 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.742 HG21 ' HB3' ' A' ' 7' ' ' TYR . 77.3 t -110.92 131.78 61.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 52.1 109.809 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.5 mm? -108.22 137.6 45.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.347 -0.842 . . . . 75.13 108.93 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -125.86 117.38 2.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.582 -0.736 . . . . 41.32 111.537 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 90.0 m-85 -136.32 148.42 47.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.022 -0.733 . . . . 64.23 109.022 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.69 99.84 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 65.13 110.673 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.97 -30.87 9.53 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.564 -0.744 . . . . 74.32 111.866 -176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.727 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 85.5 m95 -105.95 122.06 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.221 0.534 . . . . 74.52 111.703 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.604 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.6 tm? -110.61 149.37 30.51 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.828 -1.545 . . . . 73.53 106.828 172.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -157.44 160.14 38.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.67 -0.812 . . . . 73.35 111.248 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.979 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -156.8 133.34 3.58 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.047 -0.979 . . . . 62.43 110.882 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.434 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 34.0 m-85 -130.75 117.81 19.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.087 0.47 . . . . 74.04 110.205 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 168' ' ' ASN . 39.7 mt-30 -113.77 129.06 56.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.639 -0.71 . . . . 74.04 109.976 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.4 133.59 34.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.534 -0.303 . . . . 73.42 110.2 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 6.7 t30 -113.67 119.43 37.4 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.753 -0.462 . . . . 73.54 109.753 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 83.5 t80 -105.4 124.06 48.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.107 -0.497 . . . . 74.3 110.249 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.436 ' OE1' ' HE2' ' A' ' 161' ' ' LYS . 35.3 tt0 -86.96 97.73 10.86 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.672 -0.862 . . . . 75.41 108.672 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.1 m -71.53 -21.88 61.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 113.673 -1.603 . . . . 72.31 111.188 173.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.41 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -57.88 -34.01 69.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.735 -0.839 . . . . 63.5 108.735 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.574 ' HG2' ' H ' ' A' ' 162' ' ' SER . 17.0 ttmm -112.9 -157.45 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.52 -1.289 . . . . 60.02 107.52 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.574 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 5.6 p -109.74 27.67 9.34 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 122.034 -0.416 . . . . 50.44 111.703 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -143.83 147.65 34.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 117.747 -1.581 . . . . 75.43 114.406 -161.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.636 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 69.4 t -73.75 124.26 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.265 -0.88 . . . . 51.43 109.456 171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.8 p -95.94 -31.97 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.629 -0.26 . . . . 74.03 111.581 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 64.2 mt-30 -127.31 131.71 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.743 0.306 . . . . 72.11 110.785 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 17.7 m -121.86 129.35 52.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.754 -0.461 . . . . 65.25 109.754 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 27.9 t-20 -136.87 121.33 18.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.766 -0.457 . . . . 70.13 109.766 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.645 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 46.4 m-85 -121.78 140.63 52.11 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.948 -0.301 . . . . 71.12 110.59 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.65 139.6 38.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.323 -0.399 . . . . 44.22 110.706 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 12.4 t -132.3 152.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.187 -0.672 . . . . 64.41 109.187 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.18 116.83 1.36 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.804 -0.712 . . . . 74.1 112.037 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -113.39 121.23 43.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.807 -0.812 . . . . 64.35 108.807 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 129.72 56.5 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.983 0.896 . . . . 74.15 111.892 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.9 m -110.13 161.8 15.21 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 106.591 -1.633 . . . . 75.53 106.591 166.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -57.51 -46.61 83.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.076 0.398 . . . . 73.43 111.9 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -106.18 -1.68 23.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.7 0.259 . . . . 71.01 111.7 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.2 117.42 14.52 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 110.489 -0.189 . . . . 70.24 110.489 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -118.86 124.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.145 -0.622 . . . . 74.52 110.987 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.8 tt -118.9 138.1 52.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.548 0.689 . . . . 74.23 111.652 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.812 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 64.2 m80 -114.72 150.51 35.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.124 -0.944 . . . . 74.21 108.98 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.572 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 27.8 m -123.33 138.68 54.56 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.265 -0.642 . . . . 72.41 109.265 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -134.27 140.97 46.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 65.0 111.322 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 47.0 t -133.47 115.55 22.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.283 -0.871 . . . . 72.4 110.019 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.782 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.0 t30 -103.62 99.46 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.384 0.611 . . . . 73.23 110.059 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 46.0 m-20 58.01 -161.48 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.886 -1.052 . . . . 73.41 110.804 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.52 -5.24 87.95 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.263 -0.881 . . . . 74.12 111.056 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 25.1 p -88.54 -24.65 22.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.039 0.755 . . . . 73.01 113.039 -173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 5.2 tm-20 -136.25 125.98 25.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.801 -0.36 . . . . 44.4 111.154 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.4 123.92 26.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 74.12 109.198 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.71 -146.2 4.82 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.238 -0.982 . . . . 61.24 113.003 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -172.82 -171.16 37.32 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.859 -0.686 . . . . 64.34 112.962 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.812 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 41.3 t -147.19 140.13 25.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.283 -0.636 . . . . 72.42 109.283 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.9 mp -120.13 118.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 110.07 -0.344 . . . . 75.25 110.07 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -108.91 120.42 42.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.301 0.572 . . . . 75.52 109.796 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 196' ' ' GLN . 11.1 mm100 -123.02 112.59 17.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.45 -0.795 . . . . 64.14 110.812 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -108.68 127.76 54.26 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.097 -0.705 . . . . 75.35 109.097 177.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 202' ' ' LEU . 1.1 m -111.57 151.79 13.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.091 0.472 . . . . 64.43 110.473 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -63.4 -20.19 65.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 64.32 111.829 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.79 47.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.363 0.505 . . . . 53.23 112.363 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 226' ' ' GLN . 48.9 mmtm 64.58 23.23 12.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 63.02 113.08 169.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 225' ' ' TYR . 7.2 tt -126.79 134.61 50.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 73.33 110.764 -174.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -126.28 134.96 51.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.144 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 223' ' ' ALA . 24.7 m -122.91 141.75 51.56 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.324 -0.251 . . . . 64.31 110.324 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.41 135.58 48.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.235 0.541 . . . . 54.11 110.412 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.742 HG22 HG22 ' A' ' 221' ' ' ILE . 93.2 t -114.6 132.87 62.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.62 -0.718 . . . . 73.22 110.036 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -113.61 126.98 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.181 -1.044 . . . . 73.35 108.181 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 218' ' ' ARG . 5.0 tp -140.8 128.77 21.94 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 110.133 -0.321 . . . . 63.31 110.133 -170.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.435 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.96 135.83 19.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.0 0.428 . . . . 75.11 111.696 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -111.23 124.16 51.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.812 -0.631 . . . . 74.02 109.633 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.8 p -95.66 112.92 24.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 73.45 110.901 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.39 143.79 52.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 73.45 110.437 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.99 -18.19 50.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.978 -0.849 . . . . 54.31 110.978 -173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -136.36 164.24 28.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.395 -0.403 . . . . 70.31 110.136 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.6 p -92.46 16.4 11.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.416 0.627 . . . . 74.55 109.483 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.02 111.01 17.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.285 -0.87 . . . . 72.24 111.637 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 25.1 m -96.17 122.67 39.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.204 -1.036 . . . . 54.14 108.204 168.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.405 ' O ' HD12 ' A' ' 208' ' ' LEU . 28.8 mmm180 -105.52 116.9 32.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.592 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 23.9 p90 -114.03 152.53 30.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.243 0.544 . . . . 74.54 110.387 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.67 140.38 7.63 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.921 -1.036 . . . . 72.55 110.724 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 206' ' ' VAL . 15.8 pt -131.74 134.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.729 0.265 . . . . 63.13 110.512 -177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -138.63 130.07 27.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.827 0.346 . . . . 62.03 110.583 174.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -120.85 125.66 48.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.53 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -107.24 114.96 29.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.509 0.671 . . . . 62.2 110.025 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.694 ' HB2' ' HG ' ' A' ' 202' ' ' LEU . 45.3 t80 -129.17 126.84 40.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.227 -0.897 . . . . 74.0 110.542 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.411 ' CG ' ' HB3' ' A' ' 201' ' ' LYS . 16.8 pt20 -77.14 123.75 26.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.373 -0.603 . . . . 70.25 109.373 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 233' ' ' PHE . 73.7 mt -70.14 -55.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.933 -0.576 . . . . 75.43 111.22 -172.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.637 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.2 t70 177.07 -54.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 123.66 0.6 . . . . 72.31 110.806 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 96.5 Cg_endo -83.75 -133.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.984 1.789 . . . . 74.3 112.051 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 9.8 m-20 -92.39 11.83 24.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 54.23 110.709 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.1 133.8 54.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.54 . . . . 75.02 111.082 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.89 142.14 47.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.182 -0.917 . . . . 61.05 109.43 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.489 ' HB2' HD11 ' A' ' 227' ' ' ILE . 70.9 t80 -106.78 132.38 52.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.183 0.516 . . . . 72.44 110.262 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 17.7 m -123.12 127.2 48.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.528 -0.76 . . . . 63.4 110.028 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -111.94 141.35 45.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.65 -0.5 . . . . 63.43 109.65 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 20.9 pttm -141.1 153.87 45.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.521 0.2 . . . . 70.25 110.868 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.625 HG12 HG12 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -147.47 155.15 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 74.42 110.187 175.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.764 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.1 t-20 -125.55 148.01 49.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.899 -0.778 . . . . 63.43 108.899 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.592 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 7.6 t30 -41.29 -37.64 1.01 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.645 1.216 . . . . 64.23 113.36 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.1 m -78.49 27.45 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.752 -0.204 . . . . 61.32 111.285 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.7 p 57.93 40.83 25.36 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.956 0.902 . . . . 64.51 110.605 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.819 ' HB3' HD11 ' A' ' 262' ' ' LEU . 56.4 mt -97.75 117.09 31.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.802 -0.635 . . . . 72.11 109.744 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.571 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.9 mp -103.27 117.99 49.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 109.776 -0.453 . . . . 52.41 109.776 -174.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.52 148.25 17.58 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.358 -0.925 . . . . 43.33 113.122 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.72 150.62 38.78 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.675 -0.861 . . . . 74.13 108.675 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.33 123.17 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.533 -0.841 . . . . 61.2 111.591 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.37 116.27 19.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.235 0.54 . . . . 72.32 110.225 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.8 t -116.05 136.72 52.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.543 -0.753 . . . . 74.54 110.732 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -132.87 134.28 44.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 65.24 110.68 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.2 t -89.03 115.34 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.943 -0.762 . . . . 73.23 108.943 172.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 251' ' ' LEU . 5.6 mp -75.19 -59.24 2.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.585 0.707 . . . . 45.01 109.517 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -119.73 149.69 48.87 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 106.991 -1.485 . . . . 55.11 106.991 171.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.8 99.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.391 2.061 . . . . 61.04 112.181 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.19 -22.05 6.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.769 -0.65 . . . . 72.12 112.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 252' ' ' LYS . 3.4 mp -106.26 119.25 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.376 -0.485 . . . . 71.05 109.981 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -120.62 120.65 36.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.679 . . . . 74.31 111.473 -172.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.2 tp -100.95 128.57 46.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.101 -0.703 . . . . 52.34 109.101 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.4 t -126.16 113.99 17.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.518 0.675 . . . . 73.32 111.125 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.955 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -99.64 124.12 44.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.21 -1.033 . . . . 75.52 108.21 175.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 22.6 t -127.32 143.16 51.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.945 0.402 . . . . 74.15 110.079 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.48 154.52 45.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.804 -0.443 . . . . 62.1 109.804 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.9 tm? -130.84 118.59 20.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.341 -0.985 . . . . 72.21 108.341 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.646 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -97.4 106.69 19.05 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.343 -1.355 . . . . 72.34 107.343 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 5.2 m-20 -71.62 105.76 3.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.126 -0.694 . . . . 62.32 109.126 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.14 -13.89 10.28 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.256 -0.497 . . . . 65.22 112.885 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.47 -18.39 26.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.728 0.299 . . . . 63.24 110.946 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 4.2 m-20 -120.89 -41.31 2.56 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.72 0.637 . . . . 73.41 112.72 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -59.35 -25.81 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.429 0.529 . . . . 75.35 112.429 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 269' ' ' ASN . 2.4 t-20 -63.59 -30.36 71.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 72.03 110.431 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.34 -16.76 15.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 45.43 110.677 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.95 94.58 1.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.019 -0.537 . . . . 64.33 112.265 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 177.93 86.43 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.661 -0.78 . . . . 34.45 112.498 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -113.98 144.65 42.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.658 0.266 . . . . 65.24 110.639 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 25.6 mmtp -97.35 144.11 27.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.507 -0.315 . . . . 72.31 110.238 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 275' ' ' LEU . 1.7 tm? -134.85 126.28 28.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.835 0.35 . . . . 71.25 110.105 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 126.78 5.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 43.24 111.419 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.955 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -115.26 134.02 55.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.739 -0.467 . . . . 71.42 109.739 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -137.59 144.57 16.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.419 -0.896 . . . . 54.53 113.25 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.703 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.3 mm? -123.98 131.43 53.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.419 -0.585 . . . . 63.52 109.419 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.72 112.22 15.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.346 -0.613 . . . . 73.52 109.346 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.942 ' HB2' HD22 ' A' ' 31' ' ' LEU . 93.6 m-85 -106.9 106.38 16.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.112 -0.495 . . . . 70.12 110.308 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.556 ' HG2' HD23 ' A' ' 284' ' ' LEU . 29.7 tt0 -99.73 110.62 23.01 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.474 -0.565 . . . . 72.1 109.474 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -97.95 108.67 21.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.419 0.628 . . . . 63.31 110.967 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 282' ' ' GLN . 3.0 mm? -135.14 -38.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.837 -1.074 . . . . 72.11 108.779 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.825 -1.08 . . . . 74.14 109.519 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.178 -0.304 . . . . 75.41 110.178 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 119' ' ' LYS . 21.3 t 64.47 96.97 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.548 -0.751 . . . . 51.2 111.242 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.9 Cg_endo -69.42 142.23 48.84 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.794 2.329 . . . . 73.32 112.388 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 19.3 Cg_exo -66.39 90.96 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.807 2.338 . . . . 61.42 111.974 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.549 ' HB ' HD21 ' A' ' 150' ' ' LEU . 2.3 p -84.17 -2.57 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.443 0.639 . . . . 64.13 110.781 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -57.92 -24.63 58.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 72.23 109.753 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.98 -26.21 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.11 110.078 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.41 -4.53 48.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 71.33 110.574 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD23 ' CD1' ' A' ' 150' ' ' LEU . 66.3 mt -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 72.13 110.905 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.32 40.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.543 -1.313 . . . . 54.31 114.247 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 37.7 tttm -57.95 -54.57 45.47 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.462 0.631 . . . . 64.33 109.669 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 p -58.72 -39.33 80.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.568 -0.742 . . . . 62.11 111.676 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.39 70.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.532 -0.304 . . . . 72.32 111.195 -176.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -68.02 -36.23 79.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 73.13 110.588 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 9.9 t70 -68.43 -48.69 63.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.373 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.26 -39.33 78.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.445 -0.343 . . . . 71.53 111.213 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.8 -41.35 78.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.939 -0.393 . . . . 75.41 109.939 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m 70.78 94.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.378 -0.828 . . . . 62.22 111.998 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -110.76 -12.22 14.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 54.04 110.548 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.85 1.2 89.01 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.864 -0.684 . . . . 24.13 112.536 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.668 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 87.8 m-85 -133.84 144.17 48.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.344 -0.613 . . . . 73.1 109.344 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.94 34.0 0.4 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.182 -1.008 . . . . 51.2 112.796 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.2 -1.79 38.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.259 0.552 . . . . 75.32 109.973 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 83.78 12.95 76.44 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.254 -1.139 . . . . 43.04 110.254 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 48' ' ' ASN . 6.8 tp -131.24 179.22 6.14 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.664 0.745 . . . . 63.43 112.015 -169.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.916 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -110.26 147.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.815 -1.084 . . . . 75.45 109.492 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.562 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 14.6 ptpt -138.41 154.38 48.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 50.24 109.577 171.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.7 tt -140.09 145.09 37.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.695 0.284 . . . . 73.25 111.12 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -131.11 128.35 39.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.553 0.692 . . . . 73.44 109.901 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -108.43 124.5 50.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.267 -0.879 . . . . 71.34 108.879 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -125.56 123.33 38.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.798 0.332 . . . . 63.23 110.122 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.9 m -137.95 121.56 17.37 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.643 -0.873 . . . . 63.44 108.643 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -137.07 143.82 42.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.551 0.691 . . . . 74.45 112.276 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -139.1 137.49 36.22 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.949 -1.13 . . . . 50.42 107.949 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.75 49.32 1.32 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.846 0.832 . . . . 72.44 110.756 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -122.46 22.64 9.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.677 -1.147 . . . . 71.02 109.099 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.695 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 91.14 -8.24 79.79 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 119.4 -0.667 . . . . 54.55 113.751 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.69 127.38 48.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.514 1.157 . . . . 73.42 112.643 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.677 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 22.9 mt-10 -139.54 118.85 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.891 -0.411 . . . . 63.52 109.891 165.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.95 121.31 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.79 0.329 . . . . 72.23 110.271 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.859 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.4 m -126.95 132.37 50.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 73.24 111.18 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 m -125.36 140.45 52.8 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.39 -0.596 . . . . 51.14 109.39 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.8 m -147.57 126.11 12.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.785 0.326 . . . . 51.42 110.479 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.681 ' HA3' ' HA2' ' A' ' 56' ' ' GLY . . . -164.17 -167.14 24.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 73.2 112.25 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 39.0 m -127.59 158.54 37.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 55.14 110.505 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -135.08 135.58 41.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 75.22 110.328 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.67 ' HA ' HD11 ' A' ' 26' ' ' LEU . 24.4 t-20 -76.23 138.06 40.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.977 -0.556 . . . . 44.3 109.648 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.499 ' HA ' HD13 ' A' ' 27' ' ' ILE . 1.9 m -46.63 138.95 5.54 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.14 0.9 . . . . 72.4 111.983 -176.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 72.05 29.74 2.3 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.899 0.749 . . . . 72.03 110.321 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p 49.95 37.73 14.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.651 0.781 . . . . 73.21 112.037 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -72.61 -35.14 67.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.268 -0.423 . . . . 62.2 111.39 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -160.5 118.73 2.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.935 -0.395 . . . . 54.22 109.935 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -117.01 120.97 66.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.844 0.354 . . . . 71.5 110.282 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.8 m -136.79 129.55 30.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.272 -0.422 . . . . 74.22 110.359 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.681 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -138.94 153.94 22.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.244 -0.979 . . . . 54.32 113.092 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.603 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 14.1 p -101.54 163.54 12.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.431 -0.581 . . . . 64.33 109.431 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tp -121.03 150.19 41.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.515 0.674 . . . . 61.11 112.044 -170.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.859 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 61.8 mt-10 -126.94 120.07 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.981 -1.009 . . . . 70.4 108.832 174.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -103.52 118.82 37.63 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 34.1 mtmm -117.23 144.02 45.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.149 0.5 . . . . 74.31 110.322 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 32.9 m-85 -116.19 120.15 38.06 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.775 -0.824 . . . . 72.14 108.775 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.536 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 20.5 ttm-85 -106.72 107.27 18.21 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.56 0.695 . . . . 73.21 111.084 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 68.4 t-105 -114.35 107.62 15.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.375 -1.284 . . . . 74.02 110.12 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -94.28 66.78 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.322 0.582 . . . . 75.33 111.93 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -85.19 -37.36 20.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.791 -1.188 . . . . 70.43 107.791 166.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' CB ' ' HA ' ' A' ' 90' ' ' GLN . 3.7 m-85 -157.34 -43.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.153 -1.385 . . . . 74.43 108.717 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.8 74.81 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.5 -0.773 . . . . 24.13 112.072 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -111.44 130.05 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 75.24 110.502 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 41.7 m -137.93 113.15 9.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.033 -0.531 . . . . 73.31 110.434 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 43.4 t80 -99.65 132.08 45.22 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.857 -0.794 . . . . 65.03 108.857 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 28.6 m -128.05 121.4 29.61 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.023 0.44 . . . . 70.03 111.661 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.63 120.54 42.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.715 -0.846 . . . . 71.12 108.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 26.1 ttpt -113.46 94.83 5.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.14 -0.482 . . . . 62.4 109.803 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.514 ' O ' ' HB2' ' A' ' 57' ' ' SER . 3.9 t90 -100.15 127.08 46.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.259 -0.428 . . . . 75.24 109.878 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.603 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 15.3 m120 -105.46 166.99 10.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 75.13 110.477 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 p -67.5 -16.53 64.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.133 0.492 . . . . 54.53 111.593 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 13.4 m-20 -78.72 -2.53 39.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.642 . . . . 73.31 110.559 175.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 54.5 m-80 77.81 14.63 1.63 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.479 -0.782 . . . . 75.41 111.935 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -89.13 141.25 28.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.599 -0.519 . . . . 64.1 109.599 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.04 119.35 34.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.376 -0.375 . . . . 71.12 110.488 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.86 105.99 3.35 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.787 -0.925 . . . . 63.12 110.787 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -94.74 104.94 16.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.034 0.445 . . . . 73.35 110.501 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.738 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 40.7 mt-10 -110.84 125.46 53.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.627 -0.715 . . . . 63.21 110.363 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -113.95 120.94 65.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.653 -0.869 . . . . 62.33 108.653 171.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.1 m -120.92 123.61 42.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.851 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.77 120.45 50.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 50.21 109.971 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' ' HB2' ' A' ' 96' ' ' LYS . 43.9 mt-10 -125.24 136.14 53.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.499 -0.318 . . . . 75.12 110.66 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 m-20 63.68 23.66 13.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.765 -0.652 . . . . 73.42 112.046 168.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 67' ' ' TYR . 56.5 tt0 -63.98 -79.31 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 73.34 111.227 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.93 -73.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 64.23 109.604 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.32 96.46 9.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.609 -0.515 . . . . 51.13 109.609 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 29.1 ptt180 -57.24 137.17 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 75.12 110.744 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.655 ' HA2' ' HB2' ' A' ' 119' ' ' LYS . . . 103.02 -24.45 30.5 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.032 -0.985 . . . . 33.42 111.432 -169.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.34 -0.506 . . . . 64.44 109.711 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HG2' ' HA3' ' A' ' 117' ' ' GLY . 10.2 ptpp? -121.33 131.76 54.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 65.43 109.809 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 96' ' ' LYS . 2.1 mm? -124.53 126.34 45.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.566 -0.531 . . . . 62.04 109.566 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.8 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 18.5 m -130.19 119.02 22.29 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.519 -0.31 . . . . 75.32 110.346 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.578 ' HB3' HG22 ' A' ' 85' ' ' ILE . 86.6 t80 -109.72 114.93 28.93 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.624 -0.51 . . . . 71.24 109.624 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.738 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 4.1 t70 -110.86 122.62 48.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.576 -0.738 . . . . 71.41 109.55 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 8.9 t -126.31 120.41 29.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.81 -0.441 . . . . 74.51 109.81 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 18.5 m -95.8 122.16 38.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.317 -0.623 . . . . 64.4 109.317 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -120.79 119.28 32.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 64.23 110.328 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 t -120.02 103.15 45.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.31 -0.626 . . . . 64.31 109.31 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.44 -37.54 38.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.093 2.529 . . . . 54.43 112.873 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -60.25 -40.7 91.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 62.51 111.879 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 p -96.26 -29.2 14.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.867 0.365 . . . . 63.43 111.338 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.3 59.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.113 -0.795 . . . . 73.42 111.113 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 137.05 33.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.849 0.356 . . . . 70.41 110.726 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' SER . 60.1 pttt -144.8 129.47 18.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.844 -0.616 . . . . 71.01 109.99 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 101' ' ' SER . 19.0 m120 -119.97 149.84 41.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 72.03 109.385 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.83 122.49 17.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.352 -0.24 . . . . 74.45 110.352 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.738 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 14.0 pttp -128.37 147.56 50.64 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.26 -0.274 . . . . 74.23 110.26 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.41 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -126.61 126.36 68.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.777 0.799 . . . . 75.34 110.263 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HD3' ' HB2' ' A' ' 128' ' ' ASP . 2.8 tppp? -99.61 120.73 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.843 -1.071 . . . . 64.43 109.442 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.461 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 8.5 m -118.54 118.94 33.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.393 -0.595 . . . . 73.23 109.393 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.611 ' HA3' ' HG2' ' A' ' 96' ' ' LYS . . . -129.53 148.14 18.19 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.754 -1.213 . . . . 41.55 113.966 -173.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -125.57 121.73 34.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.021 -0.589 . . . . 71.51 109.496 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 9.7 mtmp? -117.84 121.66 41.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.317 0.579 . . . . 73.32 111.977 -177.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.616 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 22.3 tpp180 -108.6 164.22 12.55 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.532 -1.284 . . . . 64.11 107.532 165.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -55.55 -30.41 60.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.194 0.452 . . . . 74.43 112.167 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -116.76 8.07 13.6 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.901 -0.32 . . . . 72.22 111.365 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 2.1 mm -138.61 124.97 25.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.94 0.4 . . . . 72.23 111.708 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.775 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 52.3 t30 -123.45 116.16 22.77 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.344 -0.542 . . . . 73.14 110.572 175.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.454 ' CD2' HD13 ' A' ' 142' ' ' LEU . 3.6 mm? -109.88 137.26 47.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 61.43 110.298 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.49 114.66 0.69 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.77 -0.729 . . . . 63.21 112.169 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 116' ' ' THR . 22.3 p -112.59 116.8 30.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.095 0.448 . . . . 63.44 110.655 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.834 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 21.1 t70 -113.76 122.28 46.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 71.3 109.995 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 21.6 ptp -115.24 118.84 34.44 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.19 -0.3 . . . . 74.25 110.19 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.507 ' HA ' ' CB ' ' A' ' 113' ' ' LYS . 3.9 p30 -106.77 127.21 53.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.488 0.661 . . . . 74.22 111.267 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HD2' ' HG3' ' A' ' 136' ' ' PRO . 85.1 t80 -78.05 103.69 8.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.696 . . . . 74.11 110.074 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 22.0 t70 -92.09 161.64 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.51 -0.922 . . . . 51.12 108.51 172.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 133' ' ' ILE . 2.5 mp -66.3 -28.76 44.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 70.42 110.125 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.07 54.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 71.53 110.625 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' ASP . . . 145.1 154.98 6.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 51.0 112.624 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.521 ' HG3' ' HD2' ' A' ' 131' ' ' PHE . 14.9 Cg_exo -69.11 113.72 3.36 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.193 2.595 . . . . 61.44 112.86 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.7 t -82.23 141.5 32.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.957 -0.565 . . . . 72.1 109.561 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.837 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 40.9 mm -107.21 116.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.564 -0.455 . . . . 64.41 110.126 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -115.31 111.39 20.82 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.922 0.392 . . . . 72.53 109.994 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.35 132.78 11.1 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.867 -1.159 . . . . 44.02 112.311 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.477 ' HB2' HE21 ' A' ' 154' ' ' GLN . . . -128.99 115.92 18.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.223 0.535 . . . . 52.5 110.261 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 143' ' ' VAL . 6.8 tp -116.85 123.89 48.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.674 -0.694 . . . . 74.12 110.245 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.775 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 88.8 t -110.64 131.37 61.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.956 -0.565 . . . . 75.54 110.061 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.74 137.24 46.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.242 -0.651 . . . . 74.34 109.242 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.8 121.01 5.43 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.707 -0.679 . . . . 74.2 112.337 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.894 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 79.0 m-85 -127.36 149.73 49.93 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.574 -0.528 . . . . 73.32 109.574 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -49.81 96.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.812 0.339 . . . . 73.2 111.051 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 174' ' ' LYS . . . 88.55 -26.1 8.59 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.194 -0.457 . . . . 73.23 112.706 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.894 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 4.1 m0 -104.54 146.29 29.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.28 0.562 . . . . 74.42 110.96 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 144' ' ' LEU . 2.6 tm? -134.18 145.21 49.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.727 -0.842 . . . . 73.44 108.727 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -144.13 161.4 38.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.579 -0.7 . . . . 45.04 111.373 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -155.99 133.78 3.84 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.317 -0.401 . . . . 52.11 112.562 -176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.541 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 98.3 m-85 -125.1 119.21 27.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.476 -0.564 . . . . 75.51 109.476 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 35.5 tt0 -128.56 122.25 30.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.018 0.437 . . . . 63.4 110.327 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 16.9 ptp -135.32 142.5 45.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.002 0.43 . . . . 73.11 111.027 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.446 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 16.5 m-80 -113.13 117.66 32.58 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.034 -0.728 . . . . 74.45 109.034 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.918 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 71.1 t80 -94.13 121.85 36.06 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 123.642 0.777 . . . . 75.15 110.95 -176.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.6 tp10 -89.28 108.87 19.87 Favored 'General case' 0 C--O 1.264 1.82 0 CA-C-N 115.557 -0.747 . . . . 71.52 109.877 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -71.52 -17.02 62.35 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 112.923 -1.944 . . . . 73.41 111.974 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.85 67.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.819 0.819 . . . . 62.42 109.112 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 162' ' ' SER . 13.6 mptt -118.05 -156.09 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.363 -1.29 . . . . 73.23 108.022 167.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 161' ' ' LYS . 50.1 m -105.9 30.13 6.09 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.299 -0.63 . . . . 73.24 109.299 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 15.6 mmm180 -136.65 141.51 43.18 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.446 -0.902 . . . . 73.52 112.159 -161.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.918 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 4.6 m -73.66 136.19 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.235 -0.654 . . . . 73.32 109.235 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 3.0 t -91.64 -22.68 20.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.157 0.503 . . . . 71.11 110.143 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.74 132.27 20.93 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 72.53 109.577 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.6 p -121.18 105.97 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.135 0.493 . . . . 74.5 109.946 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 20.5 m120 -107.16 135.52 48.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.544 0.687 . . . . 64.45 110.889 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' HD1' ' HD2' ' A' ' 153' ' ' TYR . 60.2 m-85 -121.78 143.89 49.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.832 -0.622 . . . . 75.43 109.927 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.75 132.89 33.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.46 -0.336 . . . . 72.04 110.537 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 43.1 t -129.87 126.48 62.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.001 -0.37 . . . . 64.34 110.001 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.21 100.36 1.21 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.692 -0.963 . . . . 34.53 110.692 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.634 ' HB3' ' CD2' ' A' ' 180' ' ' LEU . 75.3 t80 -109.46 120.44 42.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.559 -0.904 . . . . 71.41 108.559 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 148' ' ' GLY . 13.0 ttmm -127.72 126.1 41.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.731 -1.122 . . . . 73.01 111.327 -167.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 39.8 m -132.96 110.39 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.795 -1.187 . . . . 62.41 107.795 160.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 25.37 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.023 1.49 . . . . 71.42 115.023 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -89.18 -7.84 54.82 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.852 0.686 . . . . 63.14 112.852 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -123.32 115.66 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 75.42 111.06 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -136.94 143.29 42.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 63.03 111.043 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.634 ' CD2' ' HB3' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -123.92 141.94 51.58 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-O 122.522 1.153 . . . . 62.34 111.495 163.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 36.2 m80 -104.75 112.47 25.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.369 -2.196 . . . . 72.12 106.551 165.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 38.4 m -96.17 135.93 37.32 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.215 -0.661 . . . . 63.1 109.215 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.8 p30 -133.86 138.86 45.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.415 0.626 . . . . 71.31 110.124 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 54.2 t -127.56 125.62 65.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.34 -0.845 . . . . 62.2 109.837 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.865 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 63.1 t30 -103.92 90.01 3.48 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.048 -0.723 . . . . 72.24 109.048 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.97 -173.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.704 -1.134 . . . . 75.04 110.136 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.0 -7.42 70.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.365 -0.921 . . . . 72.12 112.335 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.8 p -95.47 -24.32 16.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.023 0.749 . . . . 72.0 113.023 -174.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.865 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 65.9 tt0 -129.48 125.23 35.92 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.89 -0.724 . . . . 62.42 111.125 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -134.88 140.25 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.638 0.256 . . . . 75.02 110.397 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.91 -163.32 21.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.457 -0.878 . . . . 63.21 112.895 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -164.85 -174.3 34.43 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.696 -0.562 . . . . 53.12 111.696 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 41.0 m -148.76 136.95 20.99 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.617 -0.882 . . . . 63.44 108.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.3 mm -117.61 117.67 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.343 -0.543 . . . . 64.34 110.621 -171.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -107.53 119.42 39.36 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -125.0 131.16 53.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.53 -0.544 . . . . 71.44 109.53 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -107.56 114.97 29.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.42 -0.355 . . . . 61.33 111.582 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 202' ' ' LEU . 58.8 t -88.76 132.39 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.625 -0.879 . . . . 74.24 108.625 171.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.4 -25.9 62.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.948 0.351 . . . . 63.33 111.948 -173.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.482 ' H ' HG12 ' A' ' 198' ' ' VAL . 58.9 mtmt -84.6 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 73.23 111.653 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.05 24.43 14.5 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.625 0.77 . . . . 75.53 112.69 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 225' ' ' TYR . 4.7 tt -110.58 108.99 19.12 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.163 -0.68 . . . . 63.15 109.163 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.731 ' HB2' ' HG3' ' A' ' 224' ' ' LYS . 39.5 mt-10 -106.65 137.04 45.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.522 -0.548 . . . . 75.23 109.522 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.6 m -122.74 142.55 50.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.655 0.265 . . . . 72.42 110.596 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.54 136.58 49.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.986 -0.552 . . . . 64.03 109.863 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.879 HG22 HG22 ' A' ' 221' ' ' ILE . 39.6 t -111.83 137.07 45.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.004 -0.544 . . . . 70.43 109.62 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -112.75 127.55 56.18 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.557 -0.905 . . . . 63.25 108.557 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 219' ' ' PHE . 3.1 tp -142.64 129.89 20.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.612 -171.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.413 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -154.58 139.11 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 73.21 111.192 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -128.87 132.7 47.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.985 -0.746 . . . . 74.13 108.985 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 m -95.04 107.21 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.918 0.389 . . . . 63.02 110.034 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.75 135.86 55.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.629 -0.714 . . . . 72.43 111.252 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.85 -2.43 66.58 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.163 -0.775 . . . . 72.12 111.163 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -131.01 167.61 18.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.236 -0.482 . . . . 70.31 109.767 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -102.51 -14.23 16.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.969 -0.752 . . . . 64.2 108.969 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.66 110.89 1.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.498 -0.773 . . . . 73.21 110.769 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 15.9 m -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 61.11 109.432 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.566 ' HA ' ' HE ' ' A' ' 218' ' ' ARG . 0.2 OUTLIER -114.63 116.06 28.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.579 -0.448 . . . . 73.31 109.866 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.452 ' HB3' HD13 ' A' ' 208' ' ' LEU . 53.3 p90 -134.14 146.91 50.66 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.972 -0.381 . . . . 72.3 109.972 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.61 160.88 32.27 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.49 -0.862 . . . . 51.14 112.123 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.879 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.259 0.552 . . . . 72.35 110.62 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.593 ' HB2' ' HG3' ' A' ' 236' ' ' LYS . . . -117.84 141.43 48.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.169 -0.923 . . . . 70.5 109.911 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -118.12 140.82 49.21 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.399 -0.364 . . . . 72.53 110.429 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.731 ' HG3' ' HB2' ' A' ' 203' ' ' GLU . 14.8 ptmt -125.47 114.66 19.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.836 -0.62 . . . . 72.44 109.5 174.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.551 ' HD2' ' HG ' ' A' ' 202' ' ' LEU . 17.2 t80 -119.22 117.23 28.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.503 -0.772 . . . . 75.13 109.426 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.59 105.9 18.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.176 0.512 . . . . 64.33 109.857 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 227' ' ' ILE . 13.4 pt -81.69 -33.5 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.506 -0.77 . . . . 64.24 111.067 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.41 162.15 28.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 72.53 109.017 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 -19.14 17.41 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.064 2.51 . . . . 70.03 114.323 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -112.2 7.94 19.67 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.049 -0.26 . . . . 73.21 111.659 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.04 123.64 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.289 0.566 . . . . 64.51 112.21 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -124.09 127.44 47.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 51.25 108.957 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -98.04 133.38 42.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.931 0.396 . . . . 74.33 110.654 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 48.4 t -115.9 138.06 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.844 -0.617 . . . . 44.44 109.994 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -133.12 141.73 48.32 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.467 -0.568 . . . . 51.05 109.467 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.593 ' HG3' ' HB2' ' A' ' 222' ' ' ALA . 3.3 mppt? -133.39 141.42 47.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.771 0.32 . . . . 72.32 110.791 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.584 HG12 HG12 ' A' ' 221' ' ' ILE . 3.7 p -140.49 136.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.218 -0.66 . . . . 71.35 109.218 170.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 13.1 m120 -115.67 152.93 32.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.164 -0.471 . . . . 73.05 110.993 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 241' ' ' SER . 1.1 t-20 -35.12 -42.49 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.967 1.417 . . . . 64.54 114.052 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.462 ' OG ' HD13 ' A' ' 242' ' ' LEU . 2.3 p -78.56 24.58 0.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.839 0.352 . . . . 62.11 111.448 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 239' ' ' ASN . 18.6 t 61.7 37.83 15.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.586 -0.734 . . . . 53.24 109.817 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.971 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 4.6 mp -92.23 140.12 29.94 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.851 -0.613 . . . . 53.05 110.51 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -122.88 118.74 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.012 -0.54 . . . . 72.05 110.898 -172.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -126.08 155.56 19.3 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.751 -0.738 . . . . 61.2 112.417 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -138.18 160.65 38.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.065 0.46 . . . . 53.32 110.79 177.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -151.43 141.03 8.24 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.752 -0.658 . . . . 51.24 111.559 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -129.08 115.27 17.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 110.131 -0.322 . . . . 60.14 110.131 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.3 m -109.34 115.7 30.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.326 -0.397 . . . . 74.35 110.015 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.78 145.01 50.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.946 0.403 . . . . 72.21 111.024 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.3 m -108.11 124.47 50.28 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.873 -0.603 . . . . 75.31 110.631 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 2.8 mm? -117.17 147.28 42.6 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.835 -1.172 . . . . 70.1 107.835 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.924 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 32.9 mmtp 61.84 -174.97 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 117.742 0.246 . . . . 64.45 110.439 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.924 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 67.6 Cg_endo -75.69 -2.91 13.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.618 1.546 . . . . 64.21 113.657 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.43 0.25 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.188 -1.482 . . . . 74.44 114.794 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.627 HG12 ' HB2' ' A' ' 252' ' ' LYS . 45.4 mm -112.24 120.67 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 117.759 0.78 . . . . 73.31 109.6 174.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 280' ' ' GLU . 0.0 OUTLIER -115.61 118.04 31.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.999 0.428 . . . . 54.14 110.413 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.94 124.31 45.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.994 -0.548 . . . . 64.34 109.776 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.2 m -118.56 110.26 17.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.082 0.468 . . . . 73.45 110.562 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 1.014 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.56 125.5 49.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.786 -1.19 . . . . 74.02 107.786 174.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.6 t -138.56 139.43 38.65 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.435 -0.506 . . . . 63.31 109.864 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 135.74 13.65 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.602 -0.518 . . . . 74.32 109.602 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.769 HD21 HD23 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -124.27 131.63 53.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.394 -0.595 . . . . 75.1 109.394 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.806 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -106.43 111.19 23.66 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.78 -1.193 . . . . 74.23 107.78 179.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.971 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.7 m-20 -71.54 106.96 4.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.871 -0.604 . . . . 72.44 109.418 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.06 -16.79 14.5 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 116.019 -0.537 . . . . 51.51 112.877 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 266' ' ' LYS . 1.6 tmtp? -91.15 -26.95 18.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.879 0.371 . . . . 64.22 110.783 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 10.3 m120 -106.44 -34.66 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.644 0.609 . . . . 75.15 112.644 -172.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.806 HG11 ' HB3' ' A' ' 263' ' ' LEU . 35.1 m -62.28 -17.49 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.537 0.208 . . . . 70.1 111.558 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.09 -44.65 83.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 75.41 110.722 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.59 -16.74 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.493 . . . . 71.31 110.828 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 123.66 90.52 0.93 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.321 -0.712 . . . . 64.54 111.321 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.637 ' HA3' ' HB3' ' A' ' 267' ' ' ASN . . . -164.7 69.72 0.2 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 65.52 112.358 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.619 ' HB2' HD12 ' A' ' 263' ' ' LEU . 24.0 p-80 -113.17 145.48 40.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.367 -0.605 . . . . 75.23 109.367 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.68 136.85 49.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.477 -0.489 . . . . 54.33 110.131 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -120.58 136.85 54.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.563 -0.744 . . . . 72.12 109.839 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.668 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -138.68 110.54 0.73 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.655 -0.783 . . . . 74.1 111.591 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 1.014 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -112.79 128.19 56.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.745 -0.835 . . . . 75.21 108.745 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.6 ' HA3' ' HE2' ' A' ' 22' ' ' TYR . . . -140.12 131.87 5.27 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.258 -0.973 . . . . 50.13 112.284 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.684 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.4 mm? -103.45 130.14 50.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.233 -0.654 . . . . 75.35 109.233 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 0.6 OUTLIER -113.73 109.71 19.01 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.881 -1.155 . . . . 72.14 107.881 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.647 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 2.4 t80 -106.39 124.41 49.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.717 -0.674 . . . . 62.1 109.891 -172.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -127.5 109.63 11.93 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.647 ' HB2' ' HE1' ' A' ' 281' ' ' PHE . . . -110.1 111.84 23.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 65.31 111.346 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.61 -70.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 75.45 108.926 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.991 -0.549 . . . . 75.45 109.585 172.691 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.946 0.403 . . . . 54.3 110.252 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.851 HG22 ' HA ' ' A' ' 121' ' ' GLU . 13.7 t -120.48 112.16 34.38 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.488 -0.56 . . . . 74.12 109.488 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.9 161.04 19.73 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.035 2.49 . . . . 75.31 112.62 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.68 86.61 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.796 2.331 . . . . 53.21 111.189 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.021 ' HB ' HG11 ' A' ' 143' ' ' VAL . 9.2 p -70.18 -53.5 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.358 -0.837 . . . . 64.14 112.826 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -69.07 -23.92 64.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.243 0.544 . . . . 63.41 111.313 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.31 -20.71 36.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.62 . . . . 63.43 111.533 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -91.05 -11.5 38.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 71.53 110.896 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 152' ' ' GLY . 45.9 mt -58.29 -34.97 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.328 0.492 . . . . 71.24 112.328 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.47 50.87 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.586 -1.292 . . . . 75.24 114.694 168.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -40.24 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.167 -1.049 . . . . 71.23 108.167 171.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -60.97 -35.48 76.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.726 -1.125 . . . . 63.35 110.751 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.07 73.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.12 -0.491 . . . . 62.11 111.883 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -69.61 -31.09 69.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.47 . . . . 71.31 110.51 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.17 -47.39 85.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.69 -0.686 . . . . 75.0 111.804 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.31 -31.4 52.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.95 0.405 . . . . 70.03 110.797 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.665 ' HE2' ' HA3' ' A' ' 220' ' ' GLY . 82.6 t80 -73.03 -41.82 63.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.681 -0.69 . . . . 70.22 111.331 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -83.44 -28.07 29.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.146 -0.479 . . . . 75.14 112.209 -173.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -66.78 91.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.527 . . . . 75.53 110.433 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.42 -23.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.916 -0.874 . . . . 75.35 110.916 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.85 76.16 1.62 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 74.24 110.386 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.94 119.1 4.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.72 -0.753 . . . . 41.11 111.3 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -80.34 8.04 8.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.065 0.459 . . . . 75.32 111.035 -175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.53 13.22 54.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.982 -0.847 . . . . 53.34 110.982 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 2.7 pp -107.45 177.97 4.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.946 0.879 . . . . 41.11 112.749 -173.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG13 HD12 ' A' ' 277' ' ' LEU . 1.7 mp -103.0 132.53 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.293 -1.321 . . . . 72.25 110.224 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 26.0 tptp -102.84 118.66 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.965 -1.016 . . . . 75.13 109.193 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.71 128.23 56.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.623 -0.51 . . . . 70.43 109.623 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 43' ' ' SER . 30.6 m-20 -133.28 134.14 43.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.104 0.478 . . . . 45.43 110.373 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.759 HD22 ' HB2' ' A' ' 281' ' ' PHE . 1.2 tm? -123.72 126.01 45.77 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.157 -1.053 . . . . 61.3 108.157 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.9 mtpp -132.29 129.7 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.858 0.361 . . . . 73.42 110.59 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.8 m -136.27 131.64 34.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.134 -0.484 . . . . 71.01 109.839 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -104.98 136.77 43.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 71.25 110.209 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.3 m -139.59 169.27 18.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.002 -0.545 . . . . 61.14 110.168 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.22 178.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 75.32 110.771 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 t30 65.21 24.43 12.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.578 0.704 . . . . 53.51 109.537 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.32 19.81 79.74 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 120.618 -0.801 . . . . 60.15 111.988 175.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 62' ' ' TYR . 10.2 mt -85.55 137.3 32.97 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.222 1.011 . . . . 61.3 113.266 -171.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.736 ' HB2' HH12 ' A' ' 63' ' ' ARG . 43.4 tt0 -139.51 118.56 12.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.24 -1.8 . . . . 65.43 108.828 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 90.9 m-85 -103.6 120.09 40.2 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.695 -0.483 . . . . 75.33 109.695 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 25.9 m -126.05 126.07 43.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.234 -0.439 . . . . 75.35 110.397 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 22.8 t -119.66 123.25 43.37 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.858 -0.793 . . . . 74.53 108.858 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -123.78 124.88 43.67 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.081 -0.34 . . . . 75.22 110.081 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.06 153.61 24.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.463 -0.875 . . . . 75.4 111.857 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -137.52 133.92 35.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.919 -0.771 . . . . 75.2 108.919 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -148.92 129.26 13.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.969 0.414 . . . . 34.03 111.426 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.61 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -102.02 113.93 27.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.403 -0.962 . . . . 63.42 108.403 173.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 m -47.27 103.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.066 0.854 . . . . 74.34 113.069 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.47 17.08 10.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.209 -0.905 . . . . 72.33 112.296 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 48' ' ' ASN . 11.0 m -97.81 8.86 43.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 71.44 110.062 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m 62.91 31.47 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.338 -0.847 . . . . 75.53 111.305 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 54.7 mmtt -130.5 83.52 2.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.29 0.566 . . . . 51.44 110.112 175.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 47' ' ' ALA . 48.0 t -125.35 120.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.991 -1.004 . . . . 71.33 109.652 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.6 t -133.43 143.4 48.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.14 -0.318 . . . . 70.11 110.14 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.82 141.26 12.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.928 -0.653 . . . . 73.23 112.823 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -132.83 135.06 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.083 0.553 . . . . 73.05 109.663 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -121.74 125.63 47.02 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.239 -0.652 . . . . 62.22 109.239 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.764 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 22.2 tt0 -117.68 120.36 37.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.395 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 3.3 m -113.45 118.37 34.31 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.873 -1.158 . . . . 73.43 107.873 168.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -116.82 120.64 39.15 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.01 -0.676 . . . . 61.42 110.242 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 1.4 m-85 -107.0 125.56 51.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 70.24 109.699 -175.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.736 HH12 ' HB2' ' A' ' 40' ' ' GLU . 1.6 mpp_? -129.51 106.49 8.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.328 -0.949 . . . . 72.34 111.807 169.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 49.0 t-105 -88.79 91.82 8.97 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.234 -1.024 . . . . 75.42 108.234 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 67' ' ' TYR . 9.4 m 67.8 141.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.614 -1.176 . . . . 44.42 110.486 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.93 -8.54 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.432 0.634 . . . . 71.44 110.289 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.704 ' H ' HG22 ' A' ' 65' ' ' THR . 81.8 t80 -126.36 86.53 2.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.113 -0.949 . . . . 75.53 108.573 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 88' ' ' GLU . . . 170.91 -101.72 0.17 Allowed Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.705 -0.76 . . . . 73.3 112.383 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.8 mm? -113.65 138.24 50.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.482 0.658 . . . . 45.2 111.77 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.1 m -135.74 111.31 9.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.191 -0.913 . . . . 53.14 109.469 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.703 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 12.2 t80 -119.77 125.75 49.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.811 0.338 . . . . 74.52 110.422 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 84' ' ' GLU . 28.2 m -110.85 117.65 33.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.937 0.399 . . . . 52.43 110.353 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 34.7 tt0 -111.94 123.85 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.698 -0.683 . . . . 75.02 109.911 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.8 ptmm? -127.26 133.22 50.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.22 0.533 . . . . 73.02 110.188 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.622 ' CD1' HD22 ' A' ' 81' ' ' LEU . 32.6 t90 -134.04 128.27 33.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.559 -0.534 . . . . 72.41 109.559 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -116.41 133.21 56.28 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.842 -0.743 . . . . 72.33 110.791 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -73.9 -25.71 60.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.739 0.78 . . . . 72.53 110.09 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -96.14 -16.2 21.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.501 -1.227 . . . . 61.24 111.779 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.8 -98.05 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.354 0.872 . . . . 64.51 113.354 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 p -115.85 144.72 43.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.869 1.063 . . . . 71.13 113.869 -166.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.622 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -87.94 157.05 19.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.326 -1.361 . . . . 74.14 107.326 165.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 101' ' ' SER . . . -171.01 147.69 10.62 Favored Glycine 0 C--N 1.322 -0.205 0 C-N-CA 119.79 -1.195 . . . . 35.11 113.173 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -148.98 128.52 13.12 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.254 0.222 . . . . 74.44 111.165 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.9 pt-20 -126.41 125.98 43.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 74.33 110.023 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.24 128.3 68.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 73.13 110.439 -176.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.592 ' CG2' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m -118.17 123.91 46.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.113 -0.494 . . . . 73.24 111.248 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.33 137.88 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.126 -0.488 . . . . 75.03 109.828 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 1.1 pp20? -89.52 161.95 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.986 -0.686 . . . . 61.4 110.879 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -95.67 124.73 39.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.813 -0.44 . . . . 71.42 109.813 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -68.4 -25.82 65.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 72.41 111.546 -175.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.74 -45.74 5.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.867 0.365 . . . . 73.21 110.248 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -92.01 77.17 5.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.36 -0.607 . . . . 63.43 109.36 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.455 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 56.2 mtt180 -64.1 134.65 55.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.349 -0.841 . . . . 71.4 111.623 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 102.14 -12.2 57.27 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.016 -0.993 . . . . 72.54 111.681 -174.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -85.02 121.3 27.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.604 0.24 . . . . 75.31 110.402 178.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.592 ' HE3' ' CG2' ' A' ' 86' ' ' THR . 29.9 mmmt -121.96 112.05 17.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 64.53 109.443 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 86' ' ' THR . 1.9 mm? -94.85 128.2 41.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.47 . . . . 55.01 109.779 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 1.118 ' HB ' ' HG3' ' A' ' 115' ' ' LYS . 3.3 m -128.45 132.89 48.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.077 0.465 . . . . 75.13 111.534 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 76.7 t80 -117.8 120.63 38.51 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.375 -0.602 . . . . 74.04 109.375 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 113' ' ' LYS . 6.9 t70 -111.62 143.07 43.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.401 . . . . 75.0 110.475 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.438 ' O ' ' HA2' ' A' ' 82' ' ' GLY . 72.9 m -142.86 122.19 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.835 0.35 . . . . 72.43 110.876 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 t -108.04 133.16 52.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.762 -0.829 . . . . 65.22 108.762 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 110' ' ' LYS . 35.6 t80 -122.87 125.13 44.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.819 0.342 . . . . 72.31 110.722 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.7 t -87.38 106.19 10.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.695 -0.854 . . . . 62.42 108.695 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.45 -39.92 79.38 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.04 2.493 . . . . 72.0 112.699 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.48 -49.9 24.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.592 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 m -66.06 -40.67 91.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 64.44 111.304 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.6 -5.7 80.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.89 -0.671 . . . . 71.1 111.791 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -94.62 148.16 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 60.53 110.355 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -126.42 151.33 47.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 74.22 111.019 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -119.25 121.01 38.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.566 -0.743 . . . . 75.42 109.01 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.56 28.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.871 0.367 . . . . 73.22 110.99 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 130' ' ' ASP . 17.3 mmtm -124.22 141.46 52.04 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.174 -0.676 . . . . 64.44 109.174 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.92 117.74 56.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.126 -1.065 . . . . 72.45 108.126 169.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 1.118 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 8.0 ptmt -129.16 119.86 24.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.231 -0.895 . . . . 64.45 110.818 -171.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.0 p -109.23 117.75 34.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.354 -0.839 . . . . 71.41 109.531 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.456 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -128.82 114.23 1.73 Allowed Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.303 -0.951 . . . . 5.3 111.961 -174.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.791 ' HB3' HD22 ' A' ' 95' ' ' LEU . 12.9 p90 -118.77 131.81 56.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.167 0.508 . . . . 72.53 110.458 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.713 ' HE3' ' HB ' ' A' ' 3' ' ' VAL . 8.7 ptmt -109.11 121.32 44.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.576 -0.738 . . . . 74.15 110.213 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 120' ' ' ARG . 9.3 tpt180 -106.72 157.02 18.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.851 ' HA ' HG22 ' A' ' 3' ' ' VAL . 3.8 pm0 -53.22 -28.9 29.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.966 0.728 . . . . 71.24 112.966 -169.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -114.54 -16.03 11.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.884 -0.327 . . . . 63.44 111.542 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 142' ' ' LEU . 10.9 tp -145.03 130.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.298 -0.561 . . . . 75.41 111.809 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -117.95 117.31 28.89 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.058 -0.401 . . . . 63.43 110.637 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 124' ' ' ASN . 3.9 mm? -113.01 128.73 56.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.681 0.277 . . . . 75.23 111.145 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.456 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.43 123.53 3.08 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.528 -0.629 . . . . 72.13 111.528 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 60.3 m -113.78 108.28 16.88 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.678 -0.307 . . . . 54.15 111.091 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.831 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 3.2 m-20 -100.81 117.52 35.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.482 -0.562 . . . . 65.43 109.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.2 ptm -98.0 118.64 35.05 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.458 -0.897 . . . . 72.03 109.531 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 8.9 t70 -94.52 117.66 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 73.12 109.967 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -97.16 102.68 14.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.071 0.462 . . . . 64.1 111.465 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -105.29 146.72 28.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.171 -1.048 . . . . 74.41 108.171 167.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.601 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -62.68 -22.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.845 0.313 . . . . 70.3 111.845 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.2 -6.67 47.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.572 0.225 . . . . 75.22 111.602 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.457 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 160.82 121.47 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.339 -0.934 . . . . 75.34 112.921 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 2.9 Cg_exo -74.55 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 52.21 111.802 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -81.99 153.29 26.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.21 -0.45 . . . . 75.02 110.053 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.665 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 3.5 mp -107.11 117.43 52.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.945 -0.702 . . . . 73.4 109.94 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.831 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 59.8 ttt-85 -104.68 130.12 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.706 -0.479 . . . . 73.45 109.706 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -116.91 132.14 9.89 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.961 -1.114 . . . . 63.31 111.553 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.73 115.74 21.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.478 -0.564 . . . . 74.43 109.478 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 123' ' ' ILE . 11.6 tp -128.02 122.56 32.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.259 -0.428 . . . . 62.12 110.131 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 1.021 HG11 ' HB ' ' A' ' 6' ' ' THR . 21.8 t -119.59 130.51 73.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.075 0.464 . . . . 72.3 109.851 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 144' ' ' LEU . 5.1 mp -109.35 138.29 45.92 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 73.02 109.538 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.73 123.43 5.82 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.714 -0.755 . . . . 63.23 112.774 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.812 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 56.0 m-85 -125.9 148.32 49.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.007 -0.738 . . . . 72.32 109.007 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -53.44 102.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.952 0.406 . . . . 65.44 110.413 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.56 -31.1 7.45 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.746 -0.661 . . . . 62.43 112.492 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.5 m0 -105.89 134.56 48.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 75.33 110.837 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 6' ' ' THR . 3.2 tm? -139.41 134.59 32.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.237 -0.653 . . . . 63.24 109.237 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 171' ' ' VAL . . . -148.97 141.12 23.95 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.821 -0.352 . . . . 74.1 111.664 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -140.33 141.0 11.05 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.965 -0.454 . . . . 63.02 111.965 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.435 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 43.1 m-85 -124.08 121.26 34.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.182 -0.303 . . . . 73.21 110.182 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 2.1 mp0 -114.19 122.15 45.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 74.44 109.284 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.19 145.46 51.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.808 0.337 . . . . 73.1 111.002 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 166' ' ' GLN . 6.0 m-20 -112.55 118.34 34.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.845 -0.798 . . . . 72.22 108.845 175.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.665 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 76.7 t80 -95.64 121.87 37.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.479 -0.782 . . . . 54.31 111.007 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.8 tp10 -79.24 99.34 7.01 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 114.386 -1.279 . . . . 74.14 109.129 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -70.9 -23.83 62.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.442 -1.708 . . . . 71.54 112.212 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.7 -32.18 71.43 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.916 0.865 . . . . 71.21 109.165 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -114.6 -157.5 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.199 -1.364 . . . . 62.44 108.205 170.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.9 p -107.56 30.72 6.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.407 -0.59 . . . . 50.32 109.407 172.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.553 ' HA ' ' HE ' ' A' ' 163' ' ' ARG . 3.7 mmp_? -119.55 171.8 8.11 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 119.689 -0.804 . . . . 74.43 112.871 -159.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.61 127.09 59.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.166 -0.679 . . . . 44.35 109.166 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.3 t -95.86 -24.13 16.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.887 0.375 . . . . 50.15 110.935 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.591 ' HB3' ' HB2' ' A' ' 156' ' ' ASN . 32.8 tt0 -145.83 133.04 20.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 53.13 110.645 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 169' ' ' PHE . 17.0 p -122.54 106.43 11.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.109 -0.496 . . . . 63.22 110.617 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 26.0 t-20 -108.37 121.56 45.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.264 -0.643 . . . . 72.23 109.264 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 167' ' ' SER . 29.5 m-85 -123.86 156.83 35.49 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.386 -0.526 . . . . 65.32 111.027 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -150.75 128.25 11.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.963 -0.562 . . . . 33.51 109.796 171.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 151' ' ' ALA . 27.2 t -143.98 130.44 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.301 -0.629 . . . . 72.32 109.301 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.11 174.74 35.38 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.041 -1.552 . . . . 63.52 114.111 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -134.36 138.05 44.59 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -109.71 127.41 54.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.731 -0.668 . . . . 73.25 111.985 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 29.8 m -131.94 143.14 49.91 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.39 -1.337 . . . . 72.31 107.39 164.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.09 -1.98 6.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.138 0.792 . . . . 64.24 113.138 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.548 ' HG3' ' HD1' ' A' ' 178' ' ' PHE . 9.0 pt-20 -116.64 -26.08 7.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.537 -0.465 . . . . 65.41 111.478 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.548 ' HD1' ' HG3' ' A' ' 177' ' ' GLU . 41.3 p90 -140.87 127.93 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.705 0.288 . . . . 70.32 110.303 173.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.86 124.38 35.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.185 -0.302 . . . . 64.54 110.185 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.618 HD12 HG13 ' A' ' 194' ' ' ILE . 3.9 tt -110.86 128.26 55.72 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.062 -0.655 . . . . 73.44 110.031 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -131.81 115.83 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.906 -0.588 . . . . 65.42 109.769 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 84.8 m -99.51 123.16 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.127 -0.488 . . . . 72.11 110.213 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.3 p30 -119.86 141.49 49.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.142 0.496 . . . . 73.1 110.719 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 79.1 t -119.6 130.02 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.898 -0.592 . . . . 63.11 110.193 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 36.2 m-80 -113.24 106.96 15.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.838 -0.619 . . . . 65.43 109.34 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.01 -165.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.047 -0.979 . . . . 43.42 110.282 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.98 -6.99 89.09 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.385 -0.912 . . . . 73.31 111.947 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.2 p -102.23 -25.2 13.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.98 1.104 . . . . 71.42 113.98 -170.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 39.2 tt0 -120.41 112.74 19.36 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.17 -1.012 . . . . 72.44 112.19 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -106.26 124.88 50.27 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.393 -0.966 . . . . 70.0 108.393 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -136.6 131.6 5.71 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.037 -1.077 . . . . 34.41 113.677 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -114.79 121.76 5.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.115 -0.794 . . . . 71.41 111.115 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m -115.07 137.13 52.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.294 0.547 . . . . 72.14 110.931 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.618 HG13 HD12 ' A' ' 180' ' ' LEU . 4.3 mp -121.87 132.29 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.926 -0.579 . . . . 74.3 109.724 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -108.28 120.1 41.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.787 -0.82 . . . . 64.42 108.787 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -118.08 130.05 55.92 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.862 -0.608 . . . . 74.42 110.845 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -98.72 109.62 22.35 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 74.44 108.34 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.454 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 44.0 t -83.3 -40.22 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.538 0.685 . . . . 72.31 109.774 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 54.3 t30 -155.72 161.64 40.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.792 -1.188 . . . . 70.33 107.792 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.63 126.46 27.71 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt 82.17 -1.01 1.46 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.077 0.86 . . . . 75.33 111.325 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 199' ' ' ASN . 39.9 tp -125.32 99.92 6.28 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.603 0.716 . . . . 72.53 111.015 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -106.43 158.57 16.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.062 -0.972 . . . . 75.31 109.892 -176.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.6 m -152.91 142.87 22.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.18 -0.304 . . . . 73.44 110.18 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -132.11 136.49 47.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.877 0.37 . . . . 34.13 110.94 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.42 131.65 71.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.85 -0.614 . . . . 74.11 110.105 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 27.3 t-20 -119.16 133.26 55.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.935 0.398 . . . . 74.31 110.998 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.477 ' O ' ' HA2' ' A' ' 191' ' ' GLY . 4.1 mm? -118.74 130.24 55.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 71.54 108.715 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.36 129.18 35.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.047 0.451 . . . . 63.31 110.85 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -120.06 129.71 54.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.874 -0.603 . . . . 73.14 109.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.514 ' HB ' ' OD1' ' A' ' 216' ' ' ASN . 29.1 m -95.39 106.8 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.117 0.484 . . . . 70.22 110.007 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.63 136.99 50.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.849 . . . . 74.53 111.393 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -33.77 5.66 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.055 -0.818 . . . . 54.42 111.055 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -125.83 -178.57 4.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.768 -0.456 . . . . 72.05 109.768 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.5 t -109.96 27.11 9.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.408 . . . . 72.24 110.641 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 211' ' ' THR . 23.6 p-10 -81.85 110.82 17.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.793 0.806 . . . . 75.0 110.271 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.8 p -107.87 123.49 48.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.067 -0.97 . . . . 70.33 110.108 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -106.59 116.44 31.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.99 -0.55 . . . . 75.43 109.751 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 37.0 p90 -115.05 146.83 40.88 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.544 -0.462 . . . . 65.0 110.101 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.665 ' HA3' ' HE2' ' A' ' 18' ' ' PHE . . . -146.57 139.87 8.34 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.992 -0.843 . . . . 71.1 110.992 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.2 mp -123.84 128.87 74.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.65 -0.5 . . . . 71.41 109.65 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -122.84 130.34 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.344 0.403 . . . . 73.55 110.407 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.25 126.04 54.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.229 -0.442 . . . . 70.42 109.981 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -113.48 113.3 24.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 73.33 109.904 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -130.89 128.32 40.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.915 0.388 . . . . 74.34 110.553 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 36.5 tt0 -78.72 98.45 6.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 74.41 108.922 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.4 tt -79.22 -24.86 12.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.276 0.56 . . . . 74.55 110.656 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.431 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 3.1 t70 -143.72 148.54 43.33 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.106 -1.072 . . . . 72.44 108.106 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 52.6 Cg_exo -38.2 -40.35 1.15 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.846 3.031 . . . . 65.42 115.211 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' ' 250' ' ' THR . 6.8 m-20 -117.01 11.37 14.26 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.849 0.315 . . . . 73.14 111.849 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -129.73 123.17 30.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 70.13 111.415 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -122.51 127.35 49.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.971 -0.559 . . . . 73.5 110.639 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.853 ' HD1' ' HB3' ' A' ' 247' ' ' TYR . 63.0 t80 -107.58 133.86 51.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.636 -0.711 . . . . 73.32 110.828 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.7 p -122.17 120.77 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 52.51 110.853 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.82 141.32 42.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.366 -0.605 . . . . 71.24 109.366 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 10.8 ptpt -148.19 149.24 31.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.041 0.448 . . . . 70.05 111.694 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 7.7 p -137.22 148.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.443 -0.344 . . . . 71.01 110.353 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.827 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -114.69 150.06 35.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.836 -0.62 . . . . 73.44 110.123 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 241' ' ' SER . 25.2 t30 -44.72 -36.11 3.0 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.476 1.11 . . . . 74.02 113.016 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 17.8 m -78.94 25.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.714 0.292 . . . . 65.35 111.036 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.9 m 64.93 36.83 7.37 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.616 -0.72 . . . . 71.22 110.238 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 238' ' ' ASN . 26.3 mt -98.69 115.93 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.11 109.879 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.26 117.38 48.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 120.539 -0.465 . . . . 74.53 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -119.91 134.02 10.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.831 -0.699 . . . . 70.43 112.491 177.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 260' ' ' SER . 3.0 pp -128.91 141.74 51.17 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.805 -0.443 . . . . 54.52 109.805 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -155.95 121.58 1.11 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.542 -0.837 . . . . 73.34 111.988 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.853 ' HB3' ' HD1' ' A' ' 233' ' ' PHE . 36.2 p90 -114.45 130.85 56.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.255 0.55 . . . . 63.51 110.955 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.708 HG22 ' HB ' ' A' ' 258' ' ' THR . 18.2 p -100.19 115.08 29.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.96 -1.018 . . . . 73.0 109.557 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -123.87 123.24 40.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.269 -0.423 . . . . 54.34 110.53 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 230' ' ' ASP . 9.5 m -69.51 111.62 5.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.371 -0.603 . . . . 74.44 109.371 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.49 -47.42 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 64.35 109.479 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.951 ' HB2' HD11 ' A' ' 255' ' ' ILE . 68.0 mttm -142.53 155.94 63.67 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.623 -1.251 . . . . 74.24 107.623 173.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.99 98.44 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.401 2.067 . . . . 74.35 111.79 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.46 -30.07 3.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.961 -0.638 . . . . 43.3 112.197 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.951 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -124.42 121.87 62.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.707 0.765 . . . . 70.52 111.747 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.91 125.39 52.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.271 -0.877 . . . . 72.23 109.707 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.2 tp -99.89 125.26 45.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.95 -0.568 . . . . 74.21 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.708 ' HB ' HG22 ' A' ' 248' ' ' THR . 6.8 t -117.77 121.42 40.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.486 0.66 . . . . 72.12 110.478 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.666 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -107.31 123.98 49.12 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.885 -1.154 . . . . 72.44 107.885 176.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 23.5 m -134.18 152.38 51.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.8 0.333 . . . . 72.2 110.482 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.448 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -156.86 131.56 8.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.311 -0.404 . . . . 45.22 110.601 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.791 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -108.34 114.57 28.53 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.934 -1.136 . . . . 74.42 107.934 174.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.943 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -101.97 105.21 15.96 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.11 -1.441 . . . . 64.12 107.11 174.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.705 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 4.8 p-10 -76.01 98.49 4.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.233 -1.025 . . . . 72.14 108.233 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.35 -9.16 3.02 Favored Glycine 0 C--N 1.321 -0.28 0 CA-C-N 114.106 -1.407 . . . . 54.21 114.371 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -88.04 -20.23 26.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.034 0.445 . . . . 73.3 110.243 -173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.0 -33.9 0.9 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.778 0.799 . . . . 71.3 109.083 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.943 HG11 ' HB3' ' A' ' 263' ' ' LEU . 1.8 t -54.09 -29.65 19.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 113.8 -1.546 . . . . 72.31 112.529 176.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.24 -37.15 84.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.596 . . . . 54.55 111.251 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.43 -16.27 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.067 0.395 . . . . 72.23 112.067 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.79 3.85 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.805 -0.712 . . . . 64.11 112.86 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -105.61 149.08 16.65 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 121.164 -0.541 . . . . 74.23 112.716 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.909 ' HB2' HD12 ' A' ' 263' ' ' LEU . 5.5 p-80 -103.83 149.15 25.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.844 -0.678 . . . . 62.44 110.208 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -96.27 138.62 33.61 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.084 -0.646 . . . . 71.31 110.764 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.0 tm? -120.77 144.72 48.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.676 -0.693 . . . . 70.13 110.443 -169.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.59 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -133.0 118.49 2.17 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.364 -0.694 . . . . 71.32 111.364 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -114.41 123.84 50.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.915 -0.772 . . . . 71.2 108.915 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -136.27 147.04 19.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.739 -1.219 . . . . 73.52 113.588 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.68 131.45 51.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.016 -0.735 . . . . 44.24 109.016 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -115.66 111.77 21.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.35 -0.611 . . . . 72.02 109.35 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.759 ' HB2' HD22 ' A' ' 31' ' ' LEU . 13.0 m-85 -95.32 101.85 13.61 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.686 -0.688 . . . . 72.51 109.22 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -103.73 110.93 23.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.966 -0.561 . . . . 64.13 110.031 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.37 110.06 21.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.857 -0.61 . . . . 73.41 109.712 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 61.5 mt -125.79 179.16 5.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.682 -0.69 . . . . 52.43 109.818 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.186 -0.672 . . . . 71.11 109.186 176.893 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.754 -0.461 . . . . 62.55 109.754 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.652 HG11 ' HB2' ' A' ' 119' ' ' LYS . 6.2 t -110.66 102.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 74.35 110.523 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 159.27 37.63 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.628 2.219 . . . . 52.44 112.076 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.89 85.6 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.653 2.236 . . . . 72.12 111.626 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.9 p -75.16 -29.17 60.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.042 -0.526 . . . . 63.4 111.303 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.439 ' HB2' HG21 ' A' ' 143' ' ' VAL . 73.2 t80 -57.45 -40.09 77.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.23 0.538 . . . . 73.21 110.796 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.3 -24.05 34.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 71.13 110.4 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.21 8.32 33.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.701 . . . . 72.35 110.505 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.16 -14.89 61.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 74.25 110.422 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . 140.31 64.72 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 121.1 -0.571 . . . . 72.53 112.396 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -65.96 -43.1 88.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.988 0.394 . . . . 74.04 109.972 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -59.44 -38.75 81.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 75.05 110.489 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.09 74.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 70.31 111.032 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 48.3 mtp85 -64.73 -29.84 70.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 53.45 111.161 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.19 -37.55 72.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.292 0.567 . . . . 63.32 110.425 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.555 ' HA ' ' HE2' ' A' ' 236' ' ' LYS . 13.6 t -83.26 -36.38 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 74.2 111.035 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.53 -41.82 65.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.659 . . . . 73.24 112.327 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 15' ' ' ARG . 3.5 t -95.45 172.69 7.93 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.972 -0.291 . . . . 64.3 110.504 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -79.99 73.6 6.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.626 0.726 . . . . 74.02 110.977 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.48 36.27 3.96 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.579 -0.737 . . . . 63.02 111.496 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.618 ' HA ' ' OG ' ' A' ' 260' ' ' SER . 15.4 p90 -147.9 136.06 21.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.287 . . . . 73.24 110.788 -176.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.31 64.92 3.39 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.034 -0.53 . . . . 42.11 113.235 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.61 -3.74 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 75.53 110.842 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.22 -1.87 78.89 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.011 -0.54 . . . . 74.52 112.898 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -147.98 -179.6 7.03 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.088 0.947 . . . . 71.31 113.441 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.621 HG23 HD12 ' A' ' 277' ' ' LEU . 36.8 mm -102.82 122.94 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.693 -1.594 . . . . 72.22 108.717 174.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -118.22 124.99 49.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.324 0.583 . . . . 71.31 110.432 178.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tp -124.19 144.12 50.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.0 -0.546 . . . . 64.23 110.057 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.8 p30 -144.66 140.03 28.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.116 0.484 . . . . 64.34 110.028 171.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.77 HD13 ' HD1' ' A' ' 281' ' ' PHE . 16.0 tp -119.07 123.32 44.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.351 -0.84 . . . . 44.32 109.494 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 4.1 ptpp? -116.64 124.41 49.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.476 -0.783 . . . . 71.4 109.841 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 283' ' ' ALA . 45.4 m -123.16 121.57 36.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.692 -0.686 . . . . 63.32 110.089 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.56 123.41 47.31 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.413 -0.515 . . . . 74.34 109.954 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 48.0 t -141.81 146.99 36.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 55.13 109.615 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.91 -148.09 0.49 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.421 0.451 . . . . 65.12 111.247 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.71 136.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.036 -0.529 . . . . 70.23 110.281 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.751 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.51 -9.24 36.36 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 118.799 -1.001 . . . . 53.21 115.243 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -100.57 127.47 46.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.465 1.633 . . . . 70.3 112.547 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.13 118.11 11.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.762 -0.829 . . . . 65.04 108.762 162.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -100.64 120.79 40.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.63 -0.508 . . . . 74.33 109.63 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.963 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 10.5 m -125.91 116.89 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.882 0.372 . . . . 61.12 110.848 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 10.6 t -111.61 122.47 47.89 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.635 -0.876 . . . . 73.21 108.635 174.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -129.71 126.75 38.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.928 0.394 . . . . 41.34 110.301 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.47 16.08 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.757 -0.735 . . . . 71.43 111.773 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.4 m -125.02 134.32 52.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.49 -0.559 . . . . 74.51 109.49 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -137.02 128.56 28.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.005 0.431 . . . . 74.51 110.725 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 18.4 m120 -75.4 113.06 12.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.32 -0.622 . . . . 64.14 109.32 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.431 ' HB ' HG12 ' A' ' 27' ' ' ILE . 8.8 t -63.71 132.41 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 73.21 111.0 -174.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 60.48 15.07 5.27 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.165 -0.925 . . . . 71.23 111.05 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.479 ' HB ' ' CB ' ' A' ' 48' ' ' ASN . 5.1 m -119.84 -10.13 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.43 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p 52.94 34.81 17.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.574 0.75 . . . . 42.34 112.679 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 35.3 mmtp -113.19 102.05 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.053 -0.721 . . . . 42.44 109.053 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 47' ' ' ALA . 13.7 t -123.78 123.42 67.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.123 -0.489 . . . . 74.11 111.661 -170.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -111.03 125.69 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 73.33 109.243 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.07 136.96 11.56 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.609 -0.805 . . . . 64.12 112.396 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 p -137.04 153.75 50.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.917 0.389 . . . . 73.41 110.56 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -127.27 124.79 39.66 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.142 -0.688 . . . . 75.54 109.142 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.963 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 87.0 mt-10 -108.41 119.97 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.298 -0.41 . . . . 53.11 110.386 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 73' ' ' GLU . 20.5 p -99.19 117.7 34.24 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.007 -1.109 . . . . 74.53 108.007 168.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.6 ttmp? -119.93 131.3 55.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.571 -0.529 . . . . 74.24 109.571 -174.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 25.8 m-85 -108.27 121.43 44.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.902 -0.59 . . . . 74.43 109.989 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.588 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 tmm_? -103.9 104.66 14.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.732 -0.84 . . . . 71.3 108.732 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 7.3 t-105 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.158 -0.928 . . . . 74.14 111.657 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 67' ' ' TYR . 25.1 m 69.84 144.99 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.93 0.769 . . . . 61.42 112.151 173.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -82.21 12.02 4.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.505 . . . . 54.13 111.145 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.453 ' H ' HG22 ' A' ' 65' ' ' THR . 54.3 m-85 -102.4 -46.8 4.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.481 -0.327 . . . . 72.12 110.424 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' HD12 ' A' ' 69' ' ' LEU . . . 144.95 71.86 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.125 -1.035 . . . . 70.31 113.393 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.688 ' HG ' ' HA ' ' A' ' 87' ' ' VAL . 8.3 mp -112.44 134.81 53.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.094 -0.651 . . . . 61.03 110.453 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -136.64 112.07 9.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.774 -0.648 . . . . 61.11 110.24 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 32.4 t80 -106.11 122.12 45.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.399 -0.593 . . . . 74.41 109.399 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 14.8 m -117.15 117.36 29.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.798 0.332 . . . . 74.33 111.275 -175.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HB2' ' OG1' ' A' ' 60' ' ' THR . 43.3 mt-10 -103.14 120.42 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 53.23 108.452 168.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.928 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 3.4 tmtp? -114.53 98.04 6.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.95 -0.568 . . . . 62.43 109.592 -174.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.587 ' HE1' ' HA ' ' A' ' 79' ' ' ASN . 2.1 t90 -99.51 129.02 45.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.212 -0.449 . . . . 72.12 110.422 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 39.5 t30 -97.78 154.24 17.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.221 -0.659 . . . . 45.25 109.221 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -65.31 -17.51 64.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.93 0.395 . . . . 73.02 111.348 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 12.8 m-20 -80.58 -1.28 41.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.054 -0.521 . . . . 72.04 110.371 174.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.587 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 4.1 m-20 77.7 35.16 0.31 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.979 0.912 . . . . 64.23 110.959 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 11.2 m -85.42 117.68 24.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.604 -0.725 . . . . 52.23 109.601 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.4 124.23 39.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.992 0.425 . . . . 72.14 111.352 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.85 109.31 2.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.745 -0.942 . . . . 43.34 110.745 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 m -104.62 99.64 9.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.918 0.359 . . . . 65.3 110.958 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.677 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 28.4 tt0 -111.73 132.26 54.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 72.42 110.209 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.8 tt -129.4 126.14 63.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 70.35 111.077 173.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 25.6 m -116.14 123.73 48.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.009 -0.541 . . . . 60.14 109.827 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 2.7 p -128.54 121.88 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.371 -0.233 . . . . 72.12 110.371 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 mt-10 -99.0 137.52 37.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 75.12 110.798 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.77 151.82 27.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 45.43 111.274 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.01 -38.94 14.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 73.52 111.545 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.74 -45.69 13.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.57 0.7 . . . . 74.32 109.477 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -87.17 66.56 9.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.324 -0.853 . . . . 74.41 108.83 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.755 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -53.4 124.7 15.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 73.41 110.378 -177.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.48 -3.82 56.53 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.429 -0.891 . . . . 43.42 112.57 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.6 HD22 ' HD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -81.81 117.34 22.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.493 -0.558 . . . . 73.34 109.493 175.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HG2' ' HG2' ' A' ' 88' ' ' GLU . 26.6 mtpp -116.35 110.65 18.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 71.31 109.083 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.504 ' HB2' HG13 ' A' ' 87' ' ' VAL . 2.0 mm? -99.93 126.29 46.06 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.37 -0.604 . . . . 71.4 109.37 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 28.4 m -130.16 119.17 22.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.95 0.405 . . . . 74.33 110.61 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -115.32 113.26 23.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.516 -0.92 . . . . 70.44 108.516 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.518 ' OD1' ' HD2' ' A' ' 113' ' ' LYS . 9.8 p-10 -120.77 134.39 55.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.317 0.579 . . . . 75.1 110.109 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 14.9 m -131.2 134.32 46.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.777 -0.647 . . . . 74.52 111.289 -175.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.3 t -95.27 122.0 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.082 -1.081 . . . . 61.3 108.082 172.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HD1' ' HB3' ' A' ' 110' ' ' LYS . 82.1 t80 -127.51 129.52 47.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.217 0.532 . . . . 73.13 110.642 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.8 m -120.45 103.2 44.48 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.787 -0.642 . . . . 75.22 109.737 176.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.97 -16.42 55.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.023 2.482 . . . . 64.23 112.978 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -66.35 -45.15 81.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.966 0.412 . . . . 74.54 110.607 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.3 p -105.16 -13.54 15.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.89 -0.595 . . . . 72.24 111.571 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.95 85.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 73.53 111.531 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 87.0 tttt -74.2 137.9 43.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 75.23 111.123 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.91 132.81 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 64.5 110.706 177.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.635 HD22 ' HA ' ' A' ' 132' ' ' ASP . 16.3 m120 -120.33 122.93 41.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 64.32 109.494 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.94 126.86 52.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.136 0.493 . . . . 40.12 111.419 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.518 ' HD2' ' OD1' ' A' ' 100' ' ' ASP . 57.0 mttm -121.14 138.44 54.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.424 -0.584 . . . . 70.21 109.424 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mm -119.75 117.79 54.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.101 0.476 . . . . 73.3 110.524 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.805 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 40.3 mttp -115.02 119.81 37.73 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.8 -0.636 . . . . 64.45 109.729 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.489 HG22 HD12 ' A' ' 97' ' ' LEU . 27.8 p -116.36 117.61 30.44 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.078 -0.51 . . . . 73.25 110.125 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.83 130.27 9.42 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.55 -0.833 . . . . 72.31 112.034 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.6 ' HD1' HD22 ' A' ' 95' ' ' LEU . 71.4 t80 -123.14 115.26 21.5 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.027 -0.731 . . . . 63.22 109.027 174.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB2' HG11 ' A' ' 3' ' ' VAL . 22.0 pttm -111.69 122.64 48.34 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.605 -0.838 . . . . 64.03 110.962 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HB3' HG22 ' A' ' 123' ' ' ILE . 37.6 ttm180 -106.29 169.13 8.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.757 -1.201 . . . . 65.01 107.757 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 3' ' ' VAL . 41.5 tp10 -53.28 -34.1 55.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 73.42 112.219 -167.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.435 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 92.9 m-70 -119.96 3.85 10.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 113.189 0.811 . . . . 75.32 113.189 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 120' ' ' ARG . 18.8 tt -144.82 147.89 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.248 -0.981 . . . . 61.13 112.235 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.506 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -123.6 124.33 42.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.032 0.444 . . . . 63.12 110.8 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.457 ' CD1' HD13 ' A' ' 142' ' ' LEU . 4.2 mm? -111.06 139.89 46.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.129 -0.487 . . . . 75.25 109.975 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.17 116.83 0.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.598 -0.81 . . . . 63.45 112.14 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 60.9 m -112.1 115.28 28.61 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.545 -0.385 . . . . 73.53 110.377 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.96 116.84 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 75.25 110.472 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 44.9 mtt -103.59 117.59 34.77 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.686 -0.857 . . . . 73.14 108.686 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.17 114.8 29.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.431 -0.507 . . . . 75.12 109.928 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.447 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 53.0 t80 -99.29 97.56 8.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.954 0.406 . . . . 72.41 110.419 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.635 ' HA ' HD22 ' A' ' 111' ' ' ASN . 12.6 t70 -101.18 144.22 30.32 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.113 -1.069 . . . . 43.23 108.113 170.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -65.64 -25.74 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.78 -0.452 . . . . 73.21 109.78 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.05 -1.42 57.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 62.14 111.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.19 108.19 0.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.368 -0.92 . . . . 32.12 113.024 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 2.3 Cg_endo -82.58 126.76 4.78 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.352 2.701 . . . . 70.24 112.096 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 p -126.49 162.94 24.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.812 0.339 . . . . 74.32 111.227 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 49.4 mm -108.9 123.58 64.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.479 -0.328 . . . . 74.54 110.65 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.06 113.23 21.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.931 0.396 . . . . 71.41 109.945 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.83 11.18 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.069 -1.062 . . . . 75.12 111.817 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.15 116.83 26.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.036 0.446 . . . . 71.12 110.015 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -116.51 123.83 48.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.142 -0.481 . . . . 64.23 110.289 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 93.8 t -111.94 129.4 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 55.12 109.975 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.796 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.32 138.45 43.5 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.002 -0.74 . . . . 61.44 109.002 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 122' ' ' HIS . . . -117.78 118.55 4.12 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.439 -0.886 . . . . 53.31 112.641 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.564 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 25.0 t80 -131.66 146.42 52.17 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.483 -1.303 . . . . 73.31 107.483 175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.1 101.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.099 0.476 . . . . 72.53 111.403 -176.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.72 -31.2 8.11 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.378 -0.828 . . . . 63.3 112.512 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 33.3 m0 -105.12 122.81 46.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.62 0.248 . . . . 75.1 111.471 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.55 137.65 46.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 70.13 110.105 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.796 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -129.96 158.18 40.26 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.852 -0.425 . . . . 51.4 109.852 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -157.46 132.86 3.33 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.395 -0.682 . . . . 63.22 111.395 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.573 ' CD1' ' HD1' ' A' ' 169' ' ' PHE . 21.7 m-85 -127.13 118.96 25.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 117.271 0.535 . . . . 72.44 109.841 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.839 ' HG3' ' HB3' ' A' ' 168' ' ' ASN . 26.8 pt20 -105.55 122.86 46.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.655 0.741 . . . . 71.41 109.771 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 ptm -126.67 140.49 52.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 70.01 110.666 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 22.0 t-20 -113.2 117.66 32.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.712 -0.477 . . . . 71.44 109.712 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 87.9 t80 -100.86 129.12 46.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.687 -0.688 . . . . 74.32 109.822 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.828 ' HG3' ' H ' ' A' ' 161' ' ' LYS . 9.0 tp10 -99.81 103.31 14.92 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 115.851 -0.613 . . . . 74.15 109.803 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 m -70.89 -27.01 63.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.548 -1.66 . . . . 73.03 111.327 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.05 75.05 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.777 0.799 . . . . 75.11 108.909 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.828 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 48.1 mmtm -95.28 -162.61 0.96 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.681 -1.229 . . . . 71.31 107.681 167.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -109.48 22.12 16.17 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.91 -0.494 . . . . 73.53 110.836 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -166.28 165.66 17.23 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 118.56 -1.256 . . . . 74.45 113.411 -163.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.855 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -77.7 136.39 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.66 -0.7 . . . . 64.32 110.096 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.1 m -94.63 -21.59 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 74.32 110.516 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 156' ' ' ASN . 22.0 tt0 -133.47 132.28 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 61.12 111.14 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -122.79 105.95 10.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.546 -0.752 . . . . 62.23 109.539 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.839 ' HB3' ' HG3' ' A' ' 154' ' ' GLN . 11.8 t-20 -117.09 128.84 55.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.928 -0.397 . . . . 73.14 109.928 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.573 ' HD1' ' CD1' ' A' ' 153' ' ' TYR . 47.4 m-85 -121.8 149.82 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.61 -0.268 . . . . 74.22 110.751 -173.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -151.84 137.76 18.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.65 -0.25 . . . . 23.35 110.908 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.653 ' HB ' HG22 ' A' ' 182' ' ' THR . 63.7 t -135.03 127.07 47.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.439 -0.578 . . . . 50.12 109.439 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.37 108.46 0.88 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.103 -0.799 . . . . 62.41 111.103 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.544 ' CZ ' HD21 ' A' ' 180' ' ' LEU . 28.7 p90 -127.63 151.51 48.85 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.52 -0.872 . . . . 74.33 111.936 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.666 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 95.9 mttt -118.34 138.19 52.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.116 -1.402 . . . . 75.31 110.498 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -131.78 113.44 13.52 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.66 -0.867 . . . . 55.54 108.66 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.47 -95.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.823 0.702 . . . . 33.03 112.402 -172.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 197' ' ' LYS . 11.8 mm-40 -108.39 4.79 24.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.793 0.33 . . . . 75.12 111.235 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.84 122.5 47.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.42 -0.215 . . . . 61.21 110.42 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.666 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 3.8 mt-30 -135.9 123.17 21.79 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 119.48 -0.295 . . . . 62.41 110.606 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.574 ' O ' ' HA2' ' A' ' 172' ' ' GLY 0.262 0.0 OUTLIER -127.86 144.13 51.1 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.264 1.03 . . . . 61.32 113.728 171.396 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.575 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 22.0 t60 -108.38 114.29 28.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.117 -1.856 . . . . 72.22 108.587 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.653 HG22 ' HB ' ' A' ' 171' ' ' VAL . 14.0 t -96.83 157.94 15.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.153 -1.055 . . . . 42.2 108.153 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -147.95 149.71 32.7 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.722 -0.391 . . . . 75.41 110.157 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -131.41 116.03 30.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.509 -0.552 . . . . 65.05 109.509 170.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.786 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 57.7 t30 -94.33 97.02 9.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.591 -0.731 . . . . 73.23 109.812 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.23 -165.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.053 -0.976 . . . . 63.11 110.787 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.87 89.48 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.85 -0.691 . . . . 74.15 112.104 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -102.09 -25.72 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.157 0.799 . . . . 61.21 113.157 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.786 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 38.3 tt0 -129.82 139.92 51.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 119.698 -0.801 . . . . 74.51 113.066 -170.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.36 153.91 21.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.342 -0.844 . . . . 75.32 108.82 172.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -149.64 162.92 29.22 Favored Glycine 0 C--N 1.314 -0.654 0 C-N-CA 120.669 -0.776 . . . . 70.22 112.629 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -159.1 154.82 25.9 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.609 -0.596 . . . . 61.44 111.609 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.0 m -148.73 135.18 19.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.93 -0.767 . . . . 70.31 108.93 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.0 mp -123.15 124.51 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 71.33 110.15 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.791 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -112.61 119.86 39.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 73.41 109.932 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.494 ' HB3' ' CG2' ' A' ' 204' ' ' THR . 22.1 tp60 -108.82 111.92 23.9 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.112 -0.699 . . . . 72.41 109.112 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.607 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 8.7 tmtm? -97.28 108.62 21.38 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.534 -0.913 . . . . 63.53 108.534 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.82 ' HB ' ' HB3' ' A' ' 201' ' ' LYS . 15.0 t -77.94 123.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.181 -1.044 . . . . 65.4 108.181 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -38.95 -60.57 0.84 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.445 1.09 . . . . 62.53 112.234 -170.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -123.42 83.87 2.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.967 0.413 . . . . 71.1 109.913 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.82 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 20.2 tptm -167.99 -90.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 74.05 109.654 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.807 ' HB3' ' HD1' ' A' ' 225' ' ' TYR . 0.0 OUTLIER -163.18 -176.18 4.69 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.654 0.264 . . . . 71.05 110.525 173.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.791 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 3.2 mp0 -108.18 131.86 54.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 73.41 109.741 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.494 ' CG2' ' HB3' ' A' ' 196' ' ' GLN . 15.0 t -122.15 150.0 42.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.234 -0.654 . . . . 71.05 109.234 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -129.79 159.38 36.7 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.489 0.661 . . . . 74.54 111.408 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 221' ' ' ILE . 2.3 t -132.58 124.86 52.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.382 -1.281 . . . . 65.2 108.428 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -114.64 131.07 56.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 70.33 109.197 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.621 HD13 ' HD1' ' A' ' 219' ' ' PHE . 5.0 tp -147.06 136.28 22.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.023 -0.535 . . . . 71.32 110.448 -171.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.474 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -154.97 132.03 10.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.665 0.269 . . . . 44.31 110.693 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -130.96 118.45 20.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.1 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 1.4 m -94.76 108.7 20.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.069 -0.514 . . . . 75.32 109.918 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.06 130.37 43.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 61.15 110.683 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.46 1.42 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.384 -0.686 . . . . 63.11 111.384 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.36 88.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.234 0.54 . . . . 73.54 111.39 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 62.5 m -144.32 167.03 23.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.574 . . . . 71.33 110.134 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.87 124.1 22.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 63.25 110.25 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 23.5 p -77.73 123.29 26.5 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.097 0.475 . . . . 71.45 110.024 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.534 ' O ' HD12 ' A' ' 208' ' ' LEU . 63.7 mtt85 -89.6 113.02 24.4 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.408 -0.59 . . . . 61.34 109.408 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.621 ' HD1' HD13 ' A' ' 208' ' ' LEU . 93.4 t80 -126.62 136.39 52.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.981 -0.748 . . . . 71.01 108.981 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.38 162.78 33.57 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.033 -1.079 . . . . 54.45 112.474 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.63 HG12 HG12 ' A' ' 237' ' ' VAL . 0.1 OUTLIER -137.72 147.55 26.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.008 0.432 . . . . 52.14 109.969 176.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 205' ' ' ALA . . . -136.99 157.75 46.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.656 -0.702 . . . . 71.31 110.564 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -141.57 126.27 17.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.685 0.278 . . . . 24.01 111.016 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 69.2 mttm -108.02 112.98 25.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.771 -0.826 . . . . 61.24 108.771 172.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.807 ' HD1' ' HB3' ' A' ' 202' ' ' LEU . 30.0 t80 -114.15 119.0 35.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.725 . . . . 72.33 111.471 -172.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -76.45 104.42 6.96 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.861 -1.163 . . . . 73.01 107.861 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.13 -56.69 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.142 -0.481 . . . . 72.03 111.513 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.627 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 35.8 t70 178.32 -54.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 74.25 111.145 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 89.5 Cg_endo -83.16 -142.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.936 1.757 . . . . 74.44 112.586 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 14.7 p-10 -91.97 10.98 26.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 72.13 110.324 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 132.78 54.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.712 -0.676 . . . . 71.45 110.533 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.471 ' SG ' ' HB ' ' A' ' 248' ' ' THR . 11.9 p -122.23 142.6 50.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.45 -0.795 . . . . 64.04 109.813 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -101.94 132.89 47.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 62.42 110.008 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 52.0 p -122.95 120.74 34.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.952 0.406 . . . . 64.31 110.448 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.14 152.8 24.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.507 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 60.2 mttp -139.89 142.43 36.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.093 -0.706 . . . . 62.23 109.093 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.63 HG12 HG12 ' A' ' 221' ' ' ILE . 3.6 p -140.85 137.74 34.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.369 -0.532 . . . . 73.15 109.995 174.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.694 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 12.8 m120 -109.01 149.57 29.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.511 . . . . 71.22 110.045 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.59 ' ND2' ' H ' ' A' ' 219' ' ' PHE . 7.9 p30 -55.02 -24.18 23.23 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.257 0.973 . . . . 63.45 112.525 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.691 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.5 m -79.59 20.5 0.57 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 70.45 110.165 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.486 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 40.7 m 65.97 36.99 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.352 -0.84 . . . . 44.1 110.771 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.3 mp -97.44 138.26 35.15 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.458 -0.497 . . . . 70.13 111.223 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 243' ' ' ILE . 3.0 mp -113.3 117.9 56.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.588 -0.733 . . . . 75.03 109.993 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.13 138.1 12.33 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.595 -0.812 . . . . 74.31 111.886 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.53 139.48 42.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 73.12 110.159 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.28 146.23 17.29 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.844 -0.693 . . . . 54.01 112.204 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.72 126.83 55.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.066 -0.346 . . . . 74.2 110.066 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.471 ' HB ' ' SG ' ' A' ' 232' ' ' CYS . 11.7 m -120.92 114.71 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 74.31 109.699 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 257' ' ' LEU . 48.1 tt0 -125.28 138.9 54.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.364 -0.38 . . . . 75.32 110.535 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 2.5 t -121.98 92.84 3.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.503 0.668 . . . . 75.34 110.032 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.812 ' HB3' HG23 ' A' ' 255' ' ' ILE . 53.6 tp -88.81 66.12 7.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.883 -0.599 . . . . 62.34 109.431 -175.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' A' ' 253' ' ' PRO . 40.9 ttmt 69.38 150.86 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.115 -0.948 . . . . 60.31 109.908 -174.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 252' ' ' LYS . 51.4 Cg_exo -54.44 84.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.324 2.016 . . . . 73.03 111.642 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 282' ' ' GLN . . . -178.6 -35.21 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.112 -0.949 . . . . 53.15 110.793 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.812 HG23 ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -149.08 122.3 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.75 0.786 . . . . 64.43 110.82 176.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 99.2 mttt -116.99 131.65 56.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.056 -0.975 . . . . 74.45 109.827 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.679 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 28.8 tp -102.93 122.12 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.723 -0.473 . . . . 74.44 109.723 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.2 t -135.22 109.98 8.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 55.11 110.512 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.631 ' HB3' HD23 ' A' ' 277' ' ' LEU . 1.6 pp -135.08 158.38 44.5 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.085 -0.646 . . . . 72.53 110.54 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 22' ' ' TYR . 20.1 p -148.99 143.39 26.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.827 -0.624 . . . . 74.43 110.262 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.446 ' HB2' HD22 ' A' ' 275' ' ' LEU . . . -139.55 130.2 25.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.221 -0.659 . . . . 71.12 109.221 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.838 HD21 HD23 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -119.91 127.34 52.6 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.633 0.73 . . . . 64.42 110.084 179.518 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.867 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -101.74 109.68 21.51 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.23 -1.396 . . . . 54.13 107.23 176.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.872 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 10.5 t0 -72.25 106.87 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.405 -0.961 . . . . 64.51 108.405 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.48 -21.43 27.5 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.367 -0.444 . . . . 72.11 113.115 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -90.95 -20.16 22.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.741 0.305 . . . . 64.14 110.786 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 29.3 t-20 -110.5 -29.06 8.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.914 0.388 . . . . 62.45 111.942 -173.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 263' ' ' LEU . 23.0 m -63.27 -16.55 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.063 -0.398 . . . . 73.44 111.804 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -53.93 -35.93 62.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.928 -0.397 . . . . 75.45 109.928 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -96.89 -16.78 20.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 61.23 110.53 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 117.62 7.21 12.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.8 -0.714 . . . . 54.32 113.176 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -70.2 85.71 0.32 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 44.43 113.041 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.552 ' HB2' HD12 ' A' ' 263' ' ' LEU . 55.8 p-80 -113.96 138.89 49.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.098 -0.334 . . . . 74.45 110.098 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 9.5 mmpt? -105.76 137.44 43.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.276 -0.268 . . . . 74.51 110.276 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -129.26 132.54 47.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.57 -0.286 . . . . 50.03 110.275 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.505 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.89 118.95 1.65 Allowed Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.541 -0.624 . . . . 55.21 111.541 174.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 259' ' ' LEU . 1.7 tm? -118.57 124.59 47.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.903 0.352 . . . . 73.12 110.09 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -132.56 141.0 12.31 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.547 -0.835 . . . . 62.3 113.442 -177.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.913 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.4 mm? -122.7 132.4 54.23 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.523 0.201 . . . . 65.55 110.908 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 16.2 mt-10 -105.43 111.54 24.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 64.12 109.169 167.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.77 ' HD1' HD13 ' A' ' 31' ' ' LEU . 5.6 t80 -107.64 133.68 51.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.436 -0.95 . . . . 75.22 108.436 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 pt20 -137.4 125.49 22.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.288 0.566 . . . . 74.42 111.758 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.438 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -106.36 112.4 25.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.514 -0.766 . . . . 61.32 109.493 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 74.9 mt -115.42 156.87 24.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.921 -0.581 . . . . 75.4 110.134 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 109.127 -0.694 . . . . 72.4 109.127 178.287 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.365 0.602 . . . . 62.44 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.022 HG12 ' HB3' ' A' ' 119' ' ' LYS . 9.9 p -88.09 142.81 32.2 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.191 -0.913 . . . . 72.42 110.087 -174.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 85.0 Cg_exo -48.47 146.66 10.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.167 2.578 . . . . 73.52 112.926 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 7.6 Cg_exo -72.08 91.58 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.97 2.447 . . . . 70.31 112.49 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -76.36 -20.22 57.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.504 . . . . 70.1 110.134 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' HA ' HG21 ' A' ' 143' ' ' VAL . 63.7 t80 -56.64 -38.36 72.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 63.41 110.081 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.56 -28.26 28.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.771 -0.649 . . . . 70.45 110.573 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.67 6.37 35.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.794 -0.639 . . . . 74.15 110.708 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 143' ' ' VAL . 89.3 mt -60.78 -15.93 35.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.39 0.614 . . . . 61.34 109.823 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.705 ' HA3' ' HB2' ' A' ' 181' ' ' HIS . . . 164.72 57.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.099 -1.201 . . . . 75.11 110.099 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 14.2 tmtt? -56.16 -54.32 46.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.875 0.47 . . . . 64.11 111.54 -170.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -65.19 -42.15 93.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.091 0.472 . . . . 60.14 111.485 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 -36.5 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 62.52 112.423 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.461 ' O ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.23 -31.45 70.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 64.21 111.574 -173.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 2.3 m-20 -65.75 -41.85 91.61 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 121.248 -0.181 . . . . 62.31 111.343 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.81 -38.97 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.329 0.585 . . . . 54.24 110.113 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -72.91 -41.39 64.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.442 -0.799 . . . . 72.43 112.186 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 20' ' ' LYS . 14.4 t -94.66 -6.6 42.98 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.321 0.489 . . . . 54.42 112.321 -173.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.511 ' HD2' HG23 ' A' ' 19' ' ' THR . 13.7 mptt -101.41 28.34 5.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 63.11 110.405 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.04 134.14 36.98 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.903 -0.665 . . . . 73.34 112.117 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.904 ' HB3' ' HD2' ' A' ' 274' ' ' LYS . 96.3 m-85 72.01 -57.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.498 0.719 . . . . 70.32 111.771 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.14 155.53 12.78 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.498 -1.041 . . . . 42.53 110.498 -173.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -83.18 -4.46 58.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.232 0.516 . . . . 73.14 111.174 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.99 4.0 84.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.945 -0.645 . . . . 62.55 113.377 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.5 pp -148.91 -177.83 6.02 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 122.199 1.0 . . . . 73.33 113.013 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.829 HG23 HD23 ' A' ' 277' ' ' LEU . 25.6 mm -90.97 129.06 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 113.858 -1.519 . . . . 74.43 109.637 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 87.5 tttt -118.18 133.23 56.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.786 0.327 . . . . 54.14 110.372 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 279' ' ' LEU . 35.7 tp -117.52 149.65 40.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.855 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 11.5 t70 -142.37 139.78 31.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.282 -0.872 . . . . 71.33 108.88 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.757 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -134.74 127.67 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.845 -0.428 . . . . 73.21 109.845 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -123.51 125.67 45.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.964 -0.754 . . . . 64.53 108.964 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.899 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 19.2 m -137.71 141.7 41.04 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.146 -0.222 . . . . 74.41 111.205 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -103.03 140.01 37.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.801 -0.444 . . . . 74.1 109.801 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 53.5 m -139.56 174.38 10.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.561 -0.533 . . . . 74.24 109.561 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -30.54 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 72.32 111.836 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -44.77 130.02 7.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.41 0.624 . . . . 61.44 111.929 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 89.19 -10.65 72.25 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.196 -0.911 . . . . 70.11 113.555 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 35' ' ' SER . 3.1 mm? -105.14 129.01 53.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.659 1.23 . . . . 64.24 111.488 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.963 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 34.2 tt0 -139.57 146.8 40.3 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.572 -0.899 . . . . 75.04 108.572 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.899 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 59.4 t80 -121.42 121.31 37.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.686 0.279 . . . . 75.34 110.776 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.882 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.0 m -126.08 132.39 51.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 64.13 110.322 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 19.4 m -132.28 143.25 49.76 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.975 -0.453 . . . . 75.22 110.799 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -143.27 125.95 15.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.029 -0.36 . . . . 75.12 110.029 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.8 152.46 20.31 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.428 -0.891 . . . . 55.2 111.914 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -128.45 133.27 48.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.19 -0.67 . . . . 61.23 109.19 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -138.1 130.94 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.922 0.391 . . . . 62.13 111.533 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.58 142.93 42.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.881 -0.6 . . . . 64.22 109.42 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 t -75.36 141.75 43.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.727 0.298 . . . . 71.32 110.956 -176.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 mp0 73.12 -74.38 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.481 0.712 . . . . 74.14 111.93 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.38 139.0 45.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.399 . . . . 64.4 111.468 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 m -74.74 80.25 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.2 0.524 . . . . 61.4 111.916 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 24.2 mmmt -126.3 93.93 3.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.362 -0.607 . . . . 75.0 109.362 172.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 62.22 110.458 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 m -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 61.44 108.876 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.96 125.08 6.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.518 -0.849 . . . . 51.11 112.763 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 m -109.31 134.02 52.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.265 -0.642 . . . . 72.12 109.265 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.11 124.68 46.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.834 -0.802 . . . . 73.51 108.834 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.882 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -107.96 117.35 33.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.536 0.684 . . . . 64.44 110.285 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 m -93.54 118.89 31.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.027 -1.101 . . . . 72.15 108.027 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 13.6 tptm -112.34 135.31 53.18 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.572 -0.451 . . . . 74.11 109.878 -173.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.849 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 81.0 m-85 -118.91 120.69 38.05 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.906 -0.776 . . . . 73.32 108.906 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.1 ttm-85 -122.91 109.27 13.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 70.22 111.533 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 69' ' ' LEU . 70.6 m95 -106.65 93.59 4.66 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.993 -1.003 . . . . 74.23 108.943 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -67.73 -38.29 83.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.058 . . . . 73.12 112.516 -170.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 tp10 -86.42 61.62 6.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.38 0.609 . . . . 64.24 111.235 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.588 ' HD1' HD23 ' A' ' 69' ' ' LEU . 47.9 t80 172.38 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.409 -1.269 . . . . 73.52 108.456 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.07 49.75 0.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.465 -0.789 . . . . 74.03 111.927 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.588 HD23 ' HD1' ' A' ' 67' ' ' TYR . 1.5 mm? -114.67 131.83 56.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.076 0.465 . . . . 75.32 111.228 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.2 m -134.43 112.73 11.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.669 -0.696 . . . . 73.21 110.28 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.849 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 16.0 t80 -109.46 125.4 52.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.942 -0.572 . . . . 73.44 109.572 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 5.0 m -121.42 117.1 26.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.742 0.305 . . . . 75.23 110.655 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.721 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.4 tt0 -101.76 119.87 39.46 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.002 -0.74 . . . . 64.45 109.002 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 15.8 ttmm -107.99 86.67 2.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.421 -0.585 . . . . 43.44 109.421 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.728 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 11.9 t90 -101.06 129.42 46.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.127 -0.488 . . . . 75.12 111.088 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -108.07 164.1 12.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.551 . . . . 73.44 109.825 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -68.89 -18.23 64.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.278 0.561 . . . . 72.42 110.51 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 25.0 t70 -74.28 -4.4 35.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 64.25 109.94 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 10.8 m120 74.76 9.52 4.11 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.969 -1.014 . . . . 72.03 110.644 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 117.37 21.83 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 72.01 109.518 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.728 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.9 pt? -123.02 136.98 55.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 63.01 111.374 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.61 106.28 2.28 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.251 -0.886 . . . . 70.43 111.237 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 32.0 m -85.78 100.06 11.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.861 0.362 . . . . 64.55 110.664 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 35.2 mt-10 -99.11 108.04 20.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 41.42 109.722 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.4 pp -112.18 137.92 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.518 -0.473 . . . . 42.12 110.584 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.1 m -129.21 128.55 43.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.581 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.01 125.72 74.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.968 0.413 . . . . 71.44 110.316 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -90.28 127.91 36.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 73.12 109.295 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 t70 -82.92 144.05 30.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.885 -0.413 . . . . 73.4 109.885 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.63 -21.56 15.22 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.076 -0.25 . . . . 75.24 111.367 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.0 tp -71.49 -45.52 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 74.01 109.302 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.32 75.31 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.786 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 35.6 ttm180 -61.46 135.36 57.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.19 0.519 . . . . 73.0 110.25 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.9 55.76 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.606 -0.998 . . . . 74.3 110.606 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.54 112.78 25.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.491 -1.3 . . . . 64.12 107.491 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 138.75 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.128 0.49 . . . . 71.25 110.054 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.34 127.27 51.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.497 -0.927 . . . . 74.42 108.497 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 1.061 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -125.96 130.37 51.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.178 0.513 . . . . 74.42 110.064 -176.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' HB1' ' A' ' 112' ' ' ALA . 31.4 t80 -123.63 123.04 39.68 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.942 -0.762 . . . . 73.33 108.942 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.507 ' HB2' ' HD2' ' A' ' 113' ' ' LYS . 81.4 m-20 -108.54 121.25 44.59 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.372 -0.603 . . . . 72.14 109.372 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 20.2 m -111.51 120.79 43.33 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.816 -0.354 . . . . 72.25 110.152 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.5 m -101.54 120.05 39.71 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.624 -0.88 . . . . 64.33 108.624 175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.669 ' HD2' ' HB3' ' A' ' 110' ' ' LYS . 49.2 t80 -134.91 137.97 43.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.037 0.446 . . . . 72.52 110.652 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 m -127.96 102.49 21.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.853 -0.612 . . . . 75.04 109.734 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 36.5 Cg_exo -59.32 -34.25 97.79 Favored 'Trans proline' 0 N--CA 1.466 -0.09 0 C-N-CA 122.454 2.103 . . . . 73.33 111.417 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.69 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 73.55 111.175 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.3 m -76.9 -23.25 52.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.698 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.42 2.27 73.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.668 -0.777 . . . . 74.41 112.976 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.72 148.36 22.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 54.32 111.858 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.669 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 19.1 ptmt -145.88 124.98 12.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 74.2 110.612 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.57 140.27 51.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.509 -0.552 . . . . 74.22 109.509 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.446 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -119.51 130.67 55.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.056 0.455 . . . . 64.34 111.365 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.607 ' HG2' ' OD1' ' A' ' 130' ' ' ASP . 42.6 mttm -114.37 136.44 52.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.664 -0.495 . . . . 65.34 109.664 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 tp -120.6 117.93 54.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.433 0.635 . . . . 65.44 109.585 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 1.061 ' HB2' HG23 ' A' ' 98' ' ' THR . 21.4 mtpt -122.93 134.83 54.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.698 -0.683 . . . . 71.14 110.7 -170.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -112.17 127.91 56.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.276 -0.638 . . . . 74.31 109.276 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.91 126.04 4.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.105 -1.045 . . . . 62.52 112.748 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.99 133.86 47.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.099 -0.334 . . . . 65.41 110.099 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 1.022 ' HB3' HG12 ' A' ' 3' ' ' VAL . 76.5 mttt -122.01 122.72 39.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.775 0.797 . . . . 61.43 111.464 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.874 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 18.9 tpt180 -110.26 162.18 14.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.517 -1.22 . . . . 74.0 108.089 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 3' ' ' VAL . 1.2 pm0 -58.48 -27.9 64.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.54 0.609 . . . . 73.42 110.932 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -107.97 3.16 23.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.177 -0.465 . . . . 72.35 111.526 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.874 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 15.5 mm -139.15 131.54 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.765 0.654 . . . . 74.44 112.765 -169.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.417 HD21 HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -117.92 111.95 19.68 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.818 -1.179 . . . . 74.44 107.818 163.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 142' ' ' LEU . 4.8 tp -128.32 124.6 36.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.996 0.427 . . . . 73.22 111.389 -175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.72 115.39 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.944 -0.646 . . . . 74.02 111.975 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 63.2 m -114.43 116.4 28.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.82 -0.223 . . . . 71.44 110.467 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.654 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 3.3 p30 -105.76 122.74 46.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.431 0.634 . . . . 73.03 110.643 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 67.4 mtm -104.41 117.67 34.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 72.42 109.5 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.607 ' OD1' ' HG2' ' A' ' 113' ' ' LYS . 15.7 t0 -106.1 120.48 41.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.237 -0.438 . . . . 74.03 111.25 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -93.89 97.25 10.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.303 0.573 . . . . 74.53 109.708 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.25 143.88 32.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.469 -0.787 . . . . 60.52 109.242 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.94 -12.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 63.12 112.513 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.95 -9.43 37.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 33.13 110.981 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.48 120.75 1.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.92 -0.657 . . . . 75.42 112.231 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 29.2 Cg_exo -61.94 131.19 33.87 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.851 2.367 . . . . 72.43 112.37 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.4 m -126.55 129.95 49.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.942 -0.572 . . . . 33.11 110.182 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.707 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.2 mp -107.57 124.95 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.015 -0.365 . . . . 65.32 110.015 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.89 112.97 24.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.445 -0.576 . . . . 64.53 109.445 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 127' ' ' CYS . . . -111.69 131.93 10.55 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.722 -1.228 . . . . 73.14 111.757 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.88 116.8 23.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 62.54 110.26 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 125' ' ' LEU . 12.2 tp -122.57 123.64 41.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 62.42 110.344 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 7' ' ' TYR . 86.1 t -122.49 124.96 71.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.352 -0.84 . . . . 71.21 109.692 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.15 137.69 46.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 73.13 108.711 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.544 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -129.43 132.71 7.21 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.868 -1.158 . . . . 75.14 114.177 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.454 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 73.8 t80 -136.16 147.27 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.34 -0.985 . . . . 75.44 108.34 171.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -39.28 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.497 0.925 . . . . 71.34 113.497 -174.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.92 -35.19 4.92 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.205 -0.907 . . . . 43.42 113.668 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.454 ' CE2' ' HB3' ' A' ' 146' ' ' TYR . 55.9 p-90 -110.57 138.83 46.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.082 0.941 . . . . 72.23 112.014 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.544 HD23 ' HA2' ' A' ' 145' ' ' GLY . 12.9 mt -127.19 137.25 52.89 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 74.33 110.186 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.66 124.41 23.89 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.847 -0.427 . . . . 71.23 109.847 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 143' ' ' VAL . . . -141.83 151.21 22.62 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.439 -0.886 . . . . 65.2 111.937 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -145.31 133.31 21.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.252 0.549 . . . . 71.54 111.867 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.25 123.75 44.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.301 -0.863 . . . . 74.4 109.417 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 45.9 ttm -119.46 134.26 55.3 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.987 -0.375 . . . . 75.25 109.987 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -111.59 119.0 37.26 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.24 0.543 . . . . 75.3 110.373 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.707 ' HB2' ' HB ' ' A' ' 138' ' ' ILE . 69.1 m-85 -98.56 127.0 44.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.121 -0.945 . . . . 74.03 110.47 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.608 ' HB2' ' OG1' ' A' ' 165' ' ' THR . 81.7 tt0 -99.7 98.99 9.77 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 109.513 -0.551 . . . . 75.14 109.513 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.5 m -72.25 -17.56 61.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 113.949 -1.478 . . . . 70.24 111.278 171.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.03 -27.0 65.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.697 -0.853 . . . . 63.52 108.697 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.86 -153.51 0.57 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.214 -1.357 . . . . 71.04 108.095 168.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.7 p -109.79 28.0 9.01 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.93 -0.481 . . . . 74.25 112.098 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -140.87 171.54 13.93 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 118.035 -1.466 . . . . 64.35 114.433 -160.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -93.81 127.76 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.661 -1.154 . . . . 70.11 108.813 170.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.608 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 1.7 m -96.06 -36.24 11.08 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.227 -0.589 . . . . 54.34 111.196 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -130.13 133.19 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.065 -0.516 . . . . 74.4 110.307 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -119.42 107.0 12.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.111 -0.7 . . . . 73.22 109.111 173.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -105.95 133.1 51.22 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.655 -0.498 . . . . 73.32 109.655 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.8 m-85 -121.99 146.98 46.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.396 -0.365 . . . . 70.41 110.468 -176.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -140.1 128.96 23.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.126 0.488 . . . . 73.44 109.998 176.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.65 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 39.6 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.506 -0.553 . . . . 74.44 109.506 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -121.95 135.57 10.47 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.376 -0.916 . . . . 52.33 112.597 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.574 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 68.4 t80 -117.12 120.32 37.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.561 -1.274 . . . . 72.5 107.561 171.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -115.41 121.64 43.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.032 0.92 . . . . 73.23 112.099 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.711 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 42.6 m -136.33 163.21 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.469 -1.678 . . . . 72.24 106.469 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.491 ' HB2' ' OE2' ' A' ' 177' ' ' GLU . 6.3 m-20 -63.28 -43.38 98.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.414 1.006 . . . . 72.55 110.363 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 176' ' ' ASP . 2.2 mp0 -85.96 -21.81 27.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 74.53 111.251 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.711 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 54.3 m-85 -119.22 115.35 24.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.524 -0.307 . . . . 74.22 111.359 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 1.5 mp0 -118.7 121.46 40.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.934 -0.765 . . . . 62.4 108.934 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.845 HD12 HG13 ' A' ' 194' ' ' ILE . 2.3 tt -124.11 131.9 53.59 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.574 -0.451 . . . . 54.55 110.553 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.705 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 19.5 t-80 -129.13 114.52 16.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.181 -0.463 . . . . 64.22 110.543 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.65 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 57.3 m -95.58 137.59 34.43 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.327 -0.99 . . . . 71.34 108.327 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -132.67 138.64 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.585 -0.446 . . . . 62.4 110.477 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 74.7 t -133.05 131.39 58.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.962 -0.563 . . . . 72.31 110.625 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 8.0 t30 -117.19 96.82 5.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.682 -0.859 . . . . 70.43 108.682 174.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 9.6 t70 59.4 -162.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.169 -0.923 . . . . 61.4 109.656 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -80.26 -7.01 88.94 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 52.44 112.53 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 211' ' ' THR . 13.2 m -95.63 -26.94 15.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 mp0 -119.48 114.77 22.8 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.84 -0.538 . . . . 64.24 111.286 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.484 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 28.1 p90 -135.67 129.14 32.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.782 0.325 . . . . 75.12 110.192 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.9 175.38 36.73 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.398 -0.906 . . . . 74.41 112.462 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -147.78 141.25 9.06 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.97 -0.633 . . . . 52.13 112.061 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 8.7 t -122.29 138.28 54.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.87 -0.418 . . . . 73.2 109.87 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.845 HG13 HD12 ' A' ' 180' ' ' LEU . 4.5 mp -120.21 122.72 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.918 -0.583 . . . . 63.34 109.953 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.551 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 59.5 t80 -108.09 120.42 42.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.851 -0.796 . . . . 73.51 108.851 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -121.29 116.52 25.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.9 -0.591 . . . . 72.12 111.136 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.97 116.72 24.37 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.346 -0.983 . . . . 71.31 108.346 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 199' ' ' ASN . 21.4 t -76.32 168.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.631 -0.507 . . . . 75.32 109.631 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.49 ' N ' HG12 ' A' ' 198' ' ' VAL . 16.6 t-20 -59.84 -37.1 78.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.109 0.48 . . . . 64.52 110.234 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.99 171.19 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.216 -0.661 . . . . 72.34 109.216 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 201' ' ' LYS . 36.7 mmtm -80.11 61.8 4.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.79 0.805 . . . . 74.41 111.464 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 203' ' ' GLU . 5.6 tt -137.02 132.37 34.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.322 -1.308 . . . . 73.24 107.753 175.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.451 ' N ' HD23 ' A' ' 202' ' ' LEU . 31.2 mt-10 -119.08 145.65 45.75 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.503 -0.555 . . . . 70.31 109.503 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.7 t -133.71 152.56 51.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.603 -0.439 . . . . 73.13 110.5 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB2' ' HD2' ' A' ' 195' ' ' TYR . . . -130.19 135.21 47.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.212 0.529 . . . . 63.13 110.153 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 193' ' ' SER . 33.9 t -121.87 125.63 73.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.484 -0.78 . . . . 74.13 109.603 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.79 127.68 54.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.74 0.305 . . . . 73.24 110.926 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.6 mm? -119.13 130.48 55.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 73.15 109.725 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 218' ' ' ARG . . . -132.71 129.68 39.05 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.627 -0.508 . . . . 31.23 109.627 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -127.04 121.52 31.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.478 -0.564 . . . . 73.31 109.478 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 215' ' ' SER . 5.4 t -106.24 117.87 35.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.616 0.722 . . . . 61.01 109.578 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.484 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.33 150.33 39.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.989 -1.005 . . . . 63.02 111.932 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 118.39 24.11 3.28 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.635 -0.711 . . . . 74.14 111.831 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.9 29.59 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.341 0.591 . . . . 60.41 110.471 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.663 ' HB2' HG23 ' A' ' 211' ' ' THR . 9.9 m -83.46 -170.34 3.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.48 -0.782 . . . . 75.44 110.537 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.61 149.62 38.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.376 -0.374 . . . . 70.21 110.6 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 38.7 m -95.91 123.0 39.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.681 -0.859 . . . . 64.11 108.681 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 43.7 ttt180 -101.2 117.62 35.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.392 -0.367 . . . . 74.43 110.808 -171.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.671 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 40.7 p90 -114.87 154.1 29.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.067 -0.515 . . . . 71.04 110.194 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.0 140.31 7.67 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.194 -0.762 . . . . 74.41 111.194 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.86 128.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.711 -0.477 . . . . 73.14 109.711 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 236' ' ' LYS . . . -122.23 133.05 54.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.363 0.414 . . . . 72.24 110.555 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.0 124.91 53.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.787 -0.449 . . . . 52.12 109.787 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.115 -0.493 . . . . 75.52 109.922 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -128.03 133.07 49.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.113 0.482 . . . . 74.22 110.537 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.71 97.68 9.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.697 -0.683 . . . . 63.2 109.266 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.8 tt -71.78 -23.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.043 0.925 . . . . 75.44 108.529 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.72 137.91 13.45 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.199 -1.364 . . . . 72.34 107.525 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.18 -15.91 11.73 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 122.902 2.401 . . . . 72.41 113.814 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.39 -22.3 19.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.813 0.339 . . . . 74.11 111.256 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.51 128.76 36.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.152 0.501 . . . . 52.05 111.83 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.3 m -104.85 119.71 39.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 63.43 110.429 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -100.55 133.51 44.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 72.43 110.651 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 38.8 t -131.16 117.81 19.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 75.51 111.515 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.93 40.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.914 -0.772 . . . . 70.24 108.914 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 222' ' ' ALA . 9.8 pttm -152.66 159.52 43.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 74.31 112.231 -171.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 5.0 p -143.5 154.25 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 60.33 109.438 176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 20.0 t-20 -130.75 153.82 48.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.683 -0.235 . . . . 71.43 110.87 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.671 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 32.5 t30 -38.05 -41.83 0.6 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.972 1.309 . . . . 73.4 113.661 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.4 t -78.17 24.37 0.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 73.2 111.051 -173.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.9 m 65.32 36.47 6.92 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 64.12 109.725 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.98 ' HB3' HD11 ' A' ' 262' ' ' LEU . 25.4 mt -93.6 115.39 27.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 51.13 110.098 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.5 mp -100.29 116.55 43.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.928 -0.767 . . . . 73.53 108.928 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -128.18 140.28 11.68 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.059 -1.067 . . . . 73.21 113.571 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.536 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -122.13 148.34 45.03 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.386 -0.598 . . . . 61.13 109.386 172.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -162.92 122.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.573 -0.822 . . . . 42.25 112.241 -177.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -118.47 133.07 56.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.274 0.559 . . . . 75.44 110.758 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.1 m -110.9 120.04 41.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.068 -0.969 . . . . 72.52 109.896 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -114.24 130.28 56.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.861 0.363 . . . . 65.21 110.136 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.5 p -104.79 107.7 18.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.819 -0.628 . . . . 74.2 109.909 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.63 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 4.1 mm? -71.18 173.87 7.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.854 0.359 . . . . 43.04 110.909 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -47.87 57.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.046 -0.524 . . . . 75.4 110.65 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 13.5 Cg_exo -70.96 -177.62 2.36 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.619 1.546 . . . . 72.24 110.68 169.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -76.84 50.3 2.95 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.556 -0.831 . . . . 45.22 112.791 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.63 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 48.5 mt -108.75 121.42 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.408 -0.466 . . . . 75.11 110.338 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 280' ' ' GLU . 68.7 tttt -110.53 119.2 38.39 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.247 -0.433 . . . . 55.31 109.895 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 15.3 tp -101.66 126.78 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.437 -0.801 . . . . 74.13 109.983 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.451 ' O ' HD12 ' A' ' 277' ' ' LEU . 19.5 m -132.05 109.77 10.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.867 0.365 . . . . 74.1 110.376 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.648 ' CD2' HD13 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -112.77 125.14 54.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.768 -0.826 . . . . 65.35 108.768 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.408 ' N ' HD13 ' A' ' 259' ' ' LEU . 51.4 m -138.99 148.81 43.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.782 0.325 . . . . 63.14 110.532 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.4 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -145.06 128.69 17.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.69 -0.485 . . . . 41.25 109.69 176.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.98 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -111.44 118.31 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.205 -0.665 . . . . 73.02 109.205 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.694 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -98.05 107.43 19.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.797 -1.186 . . . . 71.02 107.797 174.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.749 ' OD1' ' HG2' ' A' ' 266' ' ' LYS . 19.0 t0 -71.53 104.41 3.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.53 -0.915 . . . . 64.23 108.53 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.39 -27.1 39.52 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 115.709 -0.678 . . . . 64.31 114.159 -171.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.749 ' HG2' ' OD1' ' A' ' 264' ' ' ASP . 23.7 pttm -91.98 -13.55 30.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.078 0.439 . . . . 64.31 111.123 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.702 ' OD1' ' HA3' ' A' ' 272' ' ' GLY . 10.9 t-20 -116.22 -26.81 7.07 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.001 0.371 . . . . 71.45 112.001 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.694 HG11 ' HB3' ' A' ' 263' ' ' LEU . 24.1 m -62.07 -17.86 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 O-C-N 122.166 -0.334 . . . . 34.33 110.917 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -59.29 -29.37 67.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.773 -0.649 . . . . 75.21 109.999 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -100.04 -16.98 17.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 64.45 110.637 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.19 13.82 6.83 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.933 -0.651 . . . . 23.44 113.064 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.702 ' HA3' ' OD1' ' A' ' 267' ' ' ASN . . . -85.83 79.52 1.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.663 -0.78 . . . . 73.43 113.125 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.422 ' HB2' HD12 ' A' ' 263' ' ' LEU . 8.2 p80 -114.22 142.09 46.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.52 -0.548 . . . . 75.34 109.52 175.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.904 ' HD2' ' HB3' ' A' ' 22' ' ' TYR . 80.2 mttt -110.61 143.1 41.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.399 -0.52 . . . . 71.45 111.49 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.5 tm? -115.5 137.97 51.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.884 . . . . 64.11 108.866 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.496 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -134.51 104.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.507 -0.854 . . . . 73.12 111.521 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.829 HD23 HG23 ' A' ' 27' ' ' ILE . 40.1 tp -114.12 145.46 41.6 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.33 -0.548 . . . . 73.14 110.677 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.669 ' H ' HD12 ' A' ' 277' ' ' LEU . . . -150.33 124.1 1.68 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.197 -0.911 . . . . 53.41 111.479 178.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.404 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.2 mm? -118.33 131.89 56.3 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.748 -0.834 . . . . 73.31 108.748 174.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.652 ' CG ' ' HB3' ' A' ' 256' ' ' LYS . 8.7 pt-20 -125.22 115.18 20.0 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.861 -0.736 . . . . 61.45 110.369 171.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.757 ' HB3' HD22 ' A' ' 31' ' ' LEU . 57.3 t80 -99.83 106.19 18.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.948 -1.024 . . . . 74.45 109.812 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -102.56 111.95 24.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.893 -0.594 . . . . 52.33 110.043 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -111.94 126.2 54.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.958 -0.564 . . . . 72.24 110.459 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.44 0.34 16.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.367 0.603 . . . . 73.24 110.243 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.585 -0.734 . . . . 71.24 109.731 179.398 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.743 -0.466 . . . . 71.4 109.743 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 120' ' ' ARG . 9.1 p -163.33 137.06 4.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.409 -0.589 . . . . 73.33 109.409 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.4 Cg_exo -63.56 131.92 33.49 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.888 2.392 . . . . 63.42 113.397 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 6.5 Cg_exo -73.57 99.84 1.18 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.917 2.411 . . . . 63.23 111.565 175.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.543 ' HB ' HD11 ' A' ' 150' ' ' LEU . 5.2 p -94.82 -2.75 50.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.351 -0.386 . . . . 73.42 111.865 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.694 ' HB3' HG21 ' A' ' 143' ' ' VAL . 6.1 p90 -62.25 -21.32 65.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.66 0.743 . . . . 74.42 109.973 170.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.25 54.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.135 -0.939 . . . . 72.22 110.143 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 51.4 m-20 -91.58 -1.9 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 71.21 109.943 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.111 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -76.39 -34.04 58.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.173 -0.921 . . . . 73.12 111.67 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.23 -36.07 0.51 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.08 -1.057 . . . . 74.51 113.892 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.77 -41.73 78.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.967 0.383 . . . . 62.14 111.981 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 m -58.15 -46.38 85.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.034 0.445 . . . . 74.43 111.244 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -35.03 72.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.934 -0.575 . . . . 54.25 111.4 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -58.55 -35.91 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 72.33 112.79 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.37 -49.87 75.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.978 0.418 . . . . 72.33 111.387 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HB ' ' HB2' ' A' ' 207' ' ' ASN . 2.8 t -85.21 -31.5 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 73.24 111.149 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.405 ' HB2' ' ND2' ' A' ' 207' ' ' ASN . 88.0 t80 -66.91 -38.24 85.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.189 -0.459 . . . . 75.23 112.001 -174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -57.24 150.85 16.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 74.43 111.191 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -116.59 -13.52 10.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.213 0.53 . . . . 62.4 110.224 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.77 51.76 4.48 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.607 -0.724 . . . . 63.42 111.755 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.6 -36.94 74.82 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.408 0.623 . . . . 74.15 109.582 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.05 101.58 0.44 Allowed Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.014 -0.994 . . . . 52.44 111.05 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -81.28 -3.81 53.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 75.11 110.14 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.89 7.33 78.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.815 -0.629 . . . . 71.21 112.643 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mp -123.34 168.36 12.6 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.966 0.889 . . . . 61.44 112.435 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.804 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.9 mp -108.27 124.14 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.047 -1.433 . . . . 64.11 108.925 174.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -105.61 136.31 45.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.963 0.411 . . . . 74.32 111.03 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.76 129.04 56.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.21 -1.033 . . . . 74.41 108.21 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.56 133.93 48.5 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.807 -0.812 . . . . 55.0 108.807 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.63 HD13 ' HD2' ' A' ' 281' ' ' PHE . 16.9 tp -138.41 126.02 22.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.21 111.78 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -114.86 127.25 55.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.55 109.6 172.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 41' ' ' PHE . 7.6 t -137.21 150.96 48.23 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.535 -0.466 . . . . 63.54 110.386 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HE2' HD11 ' A' ' 284' ' ' LEU . 18.3 ttmm -133.08 148.71 52.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.376 -0.374 . . . . 73.22 110.016 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -140.13 136.62 33.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.769 -0.196 . . . . 54.44 110.509 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 39.84 -97.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.294 1.038 . . . . 65.13 113.254 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -154.76 141.24 18.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.854 -0.795 . . . . 72.32 108.854 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 88.51 -9.08 77.12 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.586 -0.34 . . . . 52.22 112.71 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.21 128.03 48.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.658 0.729 . . . . 74.22 111.803 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.959 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 3.5 tp10 -141.03 118.9 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.911 -1.144 . . . . 75.3 107.911 165.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.773 ' HB3' HG22 ' A' ' 33' ' ' THR . 59.3 t80 -116.96 124.86 50.41 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.25 -0.906 . . . . 74.0 111.107 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.7 m -126.84 117.73 23.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 65.15 110.911 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -116.25 127.23 54.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.607 -0.27 . . . . 75.31 110.297 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -125.9 126.06 43.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 61.33 109.933 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.45 138.17 8.01 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.224 -0.989 . . . . 74.1 111.858 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -121.01 133.18 55.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.889 -0.411 . . . . 70.44 109.889 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 135.31 45.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.133 0.492 . . . . 73.13 111.161 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.834 ' HB3' ' HB3' ' A' ' 53' ' ' LYS . 39.1 t30 -77.27 147.19 36.43 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.347 -0.842 . . . . 74.1 109.41 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -44.93 -37.66 4.12 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.987 0.423 . . . . 75.42 111.02 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.93 123.58 27.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.212 -0.662 . . . . 73.24 109.212 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -68.72 -5.3 19.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.241 0.544 . . . . 71.14 111.826 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -83.59 5.33 24.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.117 0.484 . . . . 73.41 110.85 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.834 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 31.2 tptt -137.64 84.38 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 63.22 110.346 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.81 132.56 70.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.696 0.284 . . . . 73.43 110.785 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -125.16 142.69 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.22 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.19 155.72 22.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.102 -1.047 . . . . 52.24 113.206 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 m -146.31 127.33 14.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.343 -0.614 . . . . 42.14 109.343 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 74' ' ' LYS . 2.0 tm? -121.46 127.14 50.79 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.164 -0.31 . . . . 74.35 110.164 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 45.5 mt-10 -116.7 118.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.752 -0.658 . . . . 60.45 110.14 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.6 m -100.42 118.73 37.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.24 -1.022 . . . . 64.41 108.24 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.959 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 66.0 mttm -113.68 133.51 55.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.21 0.529 . . . . 71.54 110.543 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.75 ' HD2' ' HB2' ' A' ' 71' ' ' PHE . 38.4 m-85 -101.13 119.65 39.06 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.794 -1.187 . . . . 53.11 107.794 172.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 9.9 ttm180 -115.57 106.0 13.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.606 0.717 . . . . 75.34 109.971 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -113.7 104.14 11.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.516 -1.22 . . . . 75.54 109.335 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.7 p 60.57 126.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.692 1.245 . . . . 52.32 112.326 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.4 pm0 -60.72 130.31 45.86 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.11 -0.7 . . . . 74.21 109.11 174.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 62.12 75.67 0.4 Allowed 'General case' 0 C--N 1.332 -0.183 0 O-C-N 123.825 0.703 . . . . 71.01 109.598 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.95 -101.63 0.15 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.31 -0.859 . . . . 44.4 111.777 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.498 ' CD1' ' HB ' ' A' ' 87' ' ' VAL . 4.0 mm? -121.34 131.96 54.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.137 0.494 . . . . 54.43 112.325 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.608 HG23 ' HB ' ' A' ' 86' ' ' THR . 4.1 t -137.3 119.01 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 74.0 110.033 171.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.75 ' HB2' ' HD2' ' A' ' 62' ' ' TYR . 34.5 m-85 -114.81 121.58 43.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.671 -0.241 . . . . 72.34 110.435 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 83' ' ' THR . 57.6 m -109.96 115.56 30.01 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.997 -0.281 . . . . 55.4 110.585 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.91 143.69 47.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.681 -0.408 . . . . 75.45 111.619 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HG3' HD12 ' A' ' 58' ' ' LEU . 20.5 mmtt 159.41 -119.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.65 1.219 . . . . 72.04 111.479 162.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.783 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 15.5 t90 -135.18 140.31 45.25 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.588 -0.445 . . . . 75.44 112.081 -164.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -110.18 164.14 12.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 73.44 110.836 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 t -69.9 -7.37 39.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 51.44 111.328 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 14.1 m-20 -80.0 -2.27 43.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.856 -0.611 . . . . 40.41 110.39 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.543 HD21 ' HG2' ' A' ' 105' ' ' PRO . 9.0 t30 81.71 -8.53 1.32 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.96 0.788 . . . . 72.32 109.936 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.4 m -85.25 140.15 31.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.344 -0.844 . . . . 71.42 110.398 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.783 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -92.52 126.56 37.66 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.337 -0.616 . . . . 74.22 109.337 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.35 13.67 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.172 -1.013 . . . . 64.53 113.044 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.1 t -136.16 104.41 5.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.743 0.782 . . . . 71.53 110.736 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 43.9 tt0 -106.78 115.66 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.194 -0.912 . . . . 74.43 109.448 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -111.77 137.98 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 44.21 110.62 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.672 HG23 ' HB ' ' A' ' 98' ' ' THR . 16.9 m -129.17 129.92 45.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.899 0.38 . . . . 70.0 111.246 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.498 ' HB ' ' CD1' ' A' ' 69' ' ' LEU . 2.8 p -129.24 124.89 61.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.724 -0.671 . . . . 74.04 110.23 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -113.53 122.68 48.0 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.405 -0.591 . . . . 71.22 109.405 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.37 151.84 19.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.191 0.519 . . . . 52.13 111.85 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -102.21 -24.1 13.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.731 -0.668 . . . . 73.23 110.661 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.46 -56.88 8.83 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.449 -1.315 . . . . 73.35 107.449 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.45 61.2 6.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.27 -1.011 . . . . 53.23 108.27 167.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -53.03 124.4 14.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.061 -0.972 . . . . 74.24 112.612 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 100.98 -16.45 57.31 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.083 -0.962 . . . . 65.01 112.093 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' A' ' 118' ' ' TYR . 3.1 tm? -92.5 123.82 36.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.606 -0.516 . . . . 64.21 109.606 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.76 51.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.74 -0.664 . . . . 72.01 109.668 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -116.24 125.71 52.59 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.114 -0.699 . . . . 73.32 109.114 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 86' ' ' THR . 0.5 OUTLIER -130.49 119.91 23.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.195 0.521 . . . . 61.32 110.279 176.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.453 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 91.9 t80 -123.91 125.43 44.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.535 -0.757 . . . . 75.13 110.372 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 4.5 t70 -109.72 131.99 54.55 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.024 -0.534 . . . . 74.14 109.714 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.8 t -126.0 120.86 31.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.38 -0.6 . . . . 62.12 109.38 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.0 m -109.99 122.14 46.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.959 -0.564 . . . . 73.15 110.048 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.87 119.85 39.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.006 0.431 . . . . 74.21 110.714 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.477 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 8.2 t -99.77 139.77 21.06 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 108.506 -0.924 . . . . 71.24 108.506 176.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.543 ' HG2' HD21 ' A' ' 79' ' ' ASN . 31.3 Cg_exo -62.12 41.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 124.127 3.218 . . . . 71.32 114.832 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -123.86 150.02 45.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 60.12 108.822 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.0 m -66.55 105.19 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.099 0.475 . . . . 63.22 111.292 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.42 68.56 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.994 -0.622 . . . . 61.23 112.869 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -94.97 111.64 23.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.072 0.463 . . . . 64.24 109.945 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.47 143.57 26.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.869 -0.605 . . . . 74.33 110.618 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.37 122.47 40.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.049 -0.523 . . . . 75.03 109.705 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -129.13 141.8 51.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.976 -0.289 . . . . 74.43 111.389 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -124.68 137.38 54.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.947 -0.761 . . . . 62.25 108.947 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 5.0 tp -124.75 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.188 0.518 . . . . 74.13 110.218 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -116.45 120.96 40.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.837 -0.62 . . . . 74.23 110.467 -178.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -107.19 116.89 32.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.599 -0.728 . . . . 74.43 109.083 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.556 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -133.74 125.71 4.04 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.694 -1.241 . . . . 72.34 113.145 -172.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.719 ' HB3' HD23 ' A' ' 95' ' ' LEU . 6.3 p90 -117.01 136.64 52.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.192 0.52 . . . . 74.2 110.032 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 43.6 pttt -119.74 124.66 46.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.866 0.841 . . . . 74.13 111.58 -175.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.514 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.3 mmt180 -100.32 166.37 11.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.256 -1.338 . . . . 74.21 109.06 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.11 -27.25 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.762 0.825 . . . . 75.44 112.813 -172.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -118.36 -12.1 9.93 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.699 0.629 . . . . 74.11 112.699 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 144' ' ' LEU . 19.5 pt -142.76 145.72 22.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.612 -0.835 . . . . 71.2 111.815 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.636 HD22 ' N ' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -129.02 115.82 18.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.759 -0.46 . . . . 64.23 109.759 178.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.534 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -130.52 143.07 50.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.331 -0.547 . . . . 70.32 111.634 -175.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.556 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -141.57 138.75 8.91 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 61.01 112.621 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 67.9 m -108.66 112.38 24.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.013 -0.365 . . . . 71.33 110.013 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 9.6 t70 -104.47 148.17 26.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.046 -0.525 . . . . 55.44 110.088 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.1 mtm -131.38 118.31 20.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.312 -0.625 . . . . 62.32 109.312 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 10.5 t70 -89.78 115.74 27.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.945 -0.761 . . . . 75.41 108.945 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -97.12 99.71 11.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.956 -0.565 . . . . 75.21 110.962 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.55 145.69 37.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.983 -1.117 . . . . 74.25 107.983 169.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.862 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -64.68 -21.67 29.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.613 0.244 . . . . 72.15 111.536 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.53 -18.83 34.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.542 0.21 . . . . 64.43 111.101 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.5 105.66 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.868 -0.682 . . . . 74.1 112.799 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 3.1 Cg_exo -76.2 109.45 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.092 2.528 . . . . 61.52 111.366 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -99.09 160.55 14.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.522 -0.308 . . . . 55.14 110.946 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mp -107.38 118.38 55.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.672 -0.411 . . . . 63.42 110.036 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 33.8 ttp180 -115.2 111.15 20.54 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.076 0.465 . . . . 54.04 110.102 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.95 144.29 17.3 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.955 -1.117 . . . . 54.22 112.382 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -137.6 114.71 10.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.127 0.489 . . . . 73.3 110.184 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' A' ' 125' ' ' LEU . 4.2 tp -117.68 123.16 45.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.968 -0.56 . . . . 61.02 109.701 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.694 HG21 ' HB3' ' A' ' 7' ' ' TYR . 5.2 t -119.24 121.51 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.494 . . . . 75.05 110.293 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 123' ' ' ILE . 5.0 mp -108.08 138.64 44.0 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.425 -0.583 . . . . 60.22 109.425 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.45 119.31 4.24 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.607 -0.724 . . . . 61.12 111.358 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.661 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 56.4 t80 -118.16 148.97 41.82 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.299 -1.0 . . . . 63.44 108.299 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -52.79 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.344 0.592 . . . . 74.44 110.973 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.04 -32.74 7.21 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.144 -0.935 . . . . 73.24 112.493 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 90.9 m95 -106.52 146.39 30.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.285 0.846 . . . . 74.4 113.285 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.543 HD11 ' HB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -128.91 142.62 50.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.775 -1.194 . . . . 73.22 107.775 168.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -155.65 123.87 5.83 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.443 -0.577 . . . . 61.45 109.443 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.111 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -142.16 142.14 11.5 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.945 -1.121 . . . . 71.35 111.872 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 36.1 m-85 -123.47 117.17 24.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.032 -0.359 . . . . 75.32 110.032 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.28 122.58 43.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.525 -0.546 . . . . 63.21 109.525 166.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.752 ' HB2' HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -137.2 143.69 42.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.682 0.277 . . . . 72.12 110.485 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 t30 -118.62 118.88 32.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 65.02 110.471 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.943 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 93.1 m-85 -91.85 121.25 33.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.109 -0.951 . . . . 75.12 110.192 -175.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.37 109.89 14.14 Favored 'General case' 0 C--O 1.254 1.325 0 CA-C-N 114.449 -1.251 . . . . 75.1 109.172 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -71.72 -21.51 61.76 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 125.354 1.659 . . . . 73.21 111.775 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.31 -31.8 71.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.392 -0.966 . . . . 55.5 108.392 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -107.92 -161.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.979 -1.464 . . . . 70.41 107.984 168.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.9 m -111.04 26.76 10.37 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 121.89 -0.506 . . . . 52.41 110.476 171.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -149.31 150.31 32.3 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.99 1.108 . . . . 72.4 113.99 -159.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.943 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 p -73.16 128.91 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.537 -0.756 . . . . 72.44 110.231 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 3.9 p -102.49 -33.9 9.34 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.638 -0.71 . . . . 55.2 111.526 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -112.67 129.21 56.48 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.626 -0.43 . . . . 54.2 110.175 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.3 m -124.34 115.33 20.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.033 -0.531 . . . . 72.53 110.665 173.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 7.8 t30 -125.97 120.25 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.96 -0.756 . . . . 64.14 108.96 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -138.34 165.21 27.33 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.741 -0.784 . . . . 70.35 111.921 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.19 133.31 35.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.326 -0.852 . . . . 54.53 110.767 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.51 127.09 64.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.007 -0.738 . . . . 62.01 109.007 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.58 166.79 26.07 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 119.735 -1.221 . . . . 45.54 112.831 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.62 ' CE1' HD22 ' A' ' 180' ' ' LEU . 37.4 p90 -138.55 140.4 39.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.168 0.509 . . . . 73.3 110.649 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -103.4 132.62 49.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.132 -0.94 . . . . 74.22 109.935 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 m -131.37 163.2 28.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.782 -0.821 . . . . 74.34 108.782 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -51.75 -50.29 60.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.7 0.285 . . . . 53.35 111.541 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.722 ' HA ' ' HE3' ' A' ' 197' ' ' LYS . 27.0 mm-40 -101.41 -22.51 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.184 0.438 . . . . 72.43 112.184 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 194' ' ' ILE . 72.7 t80 -124.29 144.89 49.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.666 0.27 . . . . 75.03 111.681 -170.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 5.1 tp-100 -135.61 122.4 21.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.947 -0.39 . . . . 75.15 109.947 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.676 HD12 HG13 ' A' ' 194' ' ' ILE . 3.8 tt -125.88 138.15 53.78 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.261 -0.575 . . . . 70.4 111.786 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.643 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 12.4 m170 -128.31 114.17 16.56 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.889 -0.782 . . . . 53.21 108.889 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 95.0 m -90.86 141.42 28.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.856 -0.424 . . . . 72.31 109.856 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -129.83 141.22 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.992 0.425 . . . . 73.21 110.737 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 5.4 t -130.95 128.36 62.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.296 -0.411 . . . . 64.2 111.042 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 0.2 OUTLIER -109.14 90.85 3.42 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.645 -0.872 . . . . 65.4 108.645 176.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 60.65 -169.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 71.45 111.718 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.83 -5.59 86.65 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.42 -0.809 . . . . 45.5 111.981 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 24.2 m -94.32 -27.1 16.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.64 0.607 . . . . 74.21 112.64 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 51.5 mt-10 -135.02 129.6 34.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.931 -0.708 . . . . 74.34 112.223 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.445 ' HD2' HG22 ' A' ' 184' ' ' VAL . 44.3 m-85 -127.23 143.84 51.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.619 -0.718 . . . . 72.11 109.713 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . 179.74 -138.24 3.36 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.778 -0.725 . . . . 74.54 112.101 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 182' ' ' THR . . . 152.6 -155.61 26.23 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.168 -1.015 . . . . 71.45 113.037 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.1 p -142.09 138.55 31.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.291 0.567 . . . . 64.21 110.817 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.817 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.1 mp -119.8 118.76 58.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.645 -0.707 . . . . 72.15 109.612 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.438 ' HB3' ' HB3' ' A' ' 179' ' ' GLN . 44.8 t80 -108.71 119.69 40.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.108 0.48 . . . . 65.53 110.025 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.57 131.54 52.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.743 -0.662 . . . . 75.15 109.776 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.722 ' HE3' ' HA ' ' A' ' 177' ' ' GLU . 18.1 pttp -107.55 127.36 53.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 64.2 110.943 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 202' ' ' LEU . 47.6 t -82.99 155.74 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 45.45 109.446 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -61.77 -45.04 95.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.893 0.378 . . . . 61.32 110.083 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.66 148.35 48.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.722 -1.214 . . . . 72.32 107.722 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -63.41 86.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.562 0.696 . . . . 74.51 112.457 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 225' ' ' TYR . 36.2 mt -144.24 115.16 7.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.57 -1.195 . . . . 60.43 108.551 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.46 128.94 52.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.776 -0.824 . . . . 42.43 108.776 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -123.46 138.33 54.61 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.702 -0.399 . . . . 43.44 111.212 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.39 135.5 48.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.024 -0.535 . . . . 75.43 110.177 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 221' ' ' ILE . 87.9 t -114.58 136.22 51.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.663 -0.699 . . . . 74.41 109.612 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.774 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 28.7 t-20 -114.71 132.34 56.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.802 0.334 . . . . 72.15 110.402 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.486 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -122.58 136.49 54.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.651 -0.704 . . . . 74.5 110.443 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.97 127.13 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.005 -0.543 . . . . 65.24 109.63 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.686 ' HB2' HG23 ' A' ' 217' ' ' THR . 28.4 t90 -130.72 126.11 35.62 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.529 -0.305 . . . . 64.42 110.472 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.585 HG23 ' HB2' ' A' ' 215' ' ' SER . 3.5 t -101.29 116.39 32.68 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 73.42 109.823 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.48 141.26 56.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.335 -0.848 . . . . 63.24 111.158 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 128.36 31.49 0.67 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.864 -0.684 . . . . 71.25 111.655 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 67.36 12.16 8.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.875 0.47 . . . . 63.1 111.826 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 211' ' ' THR . 17.8 m -80.45 160.84 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 70.21 109.777 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -77.66 153.37 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.379 . . . . 74.24 111.122 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 210' ' ' TRP . 26.4 m -84.54 131.23 34.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.555 . . . . 74.31 109.744 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -88.54 116.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.947 -0.76 . . . . 75.12 108.947 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 54.5 p90 -123.44 141.34 52.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -144.83 141.53 10.07 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.226 -0.75 . . . . 74.22 111.226 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.89 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -119.53 130.54 73.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.879 0.371 . . . . 72.25 110.426 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -129.82 129.48 44.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.605 -0.725 . . . . 72.15 109.954 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.672 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -117.97 129.15 55.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.288 -0.415 . . . . 63.33 110.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -115.66 115.83 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.021 -0.733 . . . . 71.23 109.021 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 233' ' ' PHE . 3.9 p90 -132.78 119.25 20.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.248 0.547 . . . . 64.44 111.77 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 35.4 tt0 -89.54 97.94 11.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 71.31 109.075 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -97.15 -24.62 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 73.32 109.668 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 4.6 t70 -114.63 137.22 22.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.653 -0.869 . . . . 72.15 108.653 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -34.97 -51.89 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.381 3.388 . . . . 65.13 115.214 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -107.23 4.78 27.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.902 0.334 . . . . 75.32 111.902 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -124.73 122.58 37.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.453 0.644 . . . . 50.24 111.958 -175.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 50.7 t -113.18 119.09 36.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 75.2 108.84 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.517 ' HB2' ' CE2' ' A' ' 225' ' ' TYR . 57.6 m-85 -100.2 132.13 45.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.434 -0.348 . . . . 51.44 110.272 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 21.1 t -121.75 140.91 51.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.046 0.45 . . . . 32.1 110.349 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -127.16 140.8 52.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.095 -0.705 . . . . 74.33 109.095 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -135.6 141.4 45.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.693 -0.484 . . . . 55.23 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.588 HG12 HG12 ' A' ' 221' ' ' ILE . 5.4 p -140.6 140.13 34.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.488 -0.485 . . . . 70.31 110.028 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.589 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -107.27 150.36 26.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.573 -0.74 . . . . 44.42 110.381 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 241' ' ' SER . 28.3 p-10 -43.9 -33.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.95 1.406 . . . . 74.51 114.064 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.497 ' HB3' HD13 ' A' ' 242' ' ' LEU . 17.9 t -82.08 21.95 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 61.54 110.024 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.531 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 50.1 m 68.5 36.33 2.95 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 115.232 -0.894 . . . . 64.02 111.265 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.817 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.2 mp -95.68 125.45 40.28 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.309 -0.556 . . . . 74.43 111.316 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -112.52 116.57 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.659 -0.701 . . . . 73.43 110.022 -170.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -126.35 145.76 15.9 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.55 -0.833 . . . . 43.33 112.654 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -118.39 148.91 42.05 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.062 0.458 . . . . 52.34 110.247 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.94 121.79 2.42 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.604 -0.726 . . . . 52.3 111.544 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -108.13 118.84 37.8 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.963 -0.384 . . . . 72.54 109.963 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.644 HG22 HG22 ' A' ' 258' ' ' THR . 14.1 p -113.6 112.86 24.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 72.33 109.895 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 257' ' ' LEU . 22.4 mp0 -118.97 124.83 47.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.937 -0.574 . . . . 72.35 110.168 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 26.0 m -95.91 88.53 4.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.92 -0.77 . . . . 75.52 108.92 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 44.8 tp -82.04 78.25 8.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.733 . . . . 74.43 109.511 -175.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 0.5 OUTLIER 68.1 152.71 0.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.058 -0.974 . . . . 73.44 109.901 -172.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.17 74.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.481 2.12 . . . . 62.51 112.059 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.64 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.34 -0.845 . . . . 72.51 111.441 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.2 122.0 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 54.12 110.695 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 30.8 tttp -117.87 122.01 42.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.532 -0.544 . . . . 64.44 109.532 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 249' ' ' GLN . 52.3 tp -100.26 131.22 46.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.309 -0.405 . . . . 73.22 110.009 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.644 HG22 HG22 ' A' ' 248' ' ' THR . 18.5 p -128.91 110.87 12.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.326 0.584 . . . . 64.4 110.558 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.877 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -108.9 125.54 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.453 -0.943 . . . . 71.32 108.453 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.2 m -135.38 138.86 43.73 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.61 -0.436 . . . . 64.01 110.359 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.448 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -148.05 128.07 13.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.111 -0.495 . . . . 72.11 109.766 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.785 HD11 HD23 ' A' ' 242' ' ' LEU . 2.4 tm? -111.44 115.22 28.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.474 -0.936 . . . . 75.01 108.474 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.607 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -92.24 108.49 19.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.54 -1.282 . . . . 72.44 107.54 174.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.817 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -69.79 105.06 2.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.888 -0.782 . . . . 71.31 108.888 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -59.84 -15.72 35.91 Favored Glycine 0 C--N 1.32 -0.31 0 C-N-CA 121.222 -0.513 . . . . 72.33 112.638 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -90.16 -25.83 20.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.747 0.308 . . . . 70.21 110.767 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 19.5 m120 -115.81 -27.96 6.86 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.362 0.875 . . . . 75.24 113.362 -170.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.607 HG11 ' HB3' ' A' ' 263' ' ' LEU . 27.8 m -62.62 -19.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 117.965 0.348 . . . . 73.3 111.522 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.72 -40.73 84.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.996 -0.547 . . . . 74.53 110.574 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.94 -16.38 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 72.22 110.96 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.15 79.39 0.87 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.913 -0.66 . . . . 71.44 112.238 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.568 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -159.27 87.34 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.865 -0.683 . . . . 61.12 112.235 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.08 147.07 39.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.373 -0.232 . . . . 72.2 110.373 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.5 mmtm -96.19 137.9 34.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.592 -0.522 . . . . 65.32 109.592 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -130.03 126.74 38.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.002 0.429 . . . . 72.22 110.245 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.41 117.74 2.21 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.892 -0.671 . . . . 71.23 111.473 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.877 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -115.12 135.85 53.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.181 -0.674 . . . . 72.52 109.181 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.35 137.91 6.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.107 -1.044 . . . . 74.43 112.984 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.78 131.38 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.6 -0.889 . . . . 54.24 108.6 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 26.5 tt0 -114.95 111.31 20.97 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.59 -0.893 . . . . 72.1 108.59 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.63 ' HD2' HD13 ' A' ' 31' ' ' LEU . 26.3 t80 -112.83 145.86 39.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.799 -0.637 . . . . 73.53 109.805 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -138.04 142.89 40.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.86 0.362 . . . . 71.23 110.295 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.526 ' O ' HD22 ' A' ' 284' ' ' LEU . . . -122.83 107.29 11.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.463 -0.569 . . . . 73.23 109.463 172.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 283' ' ' ALA . 1.7 mm? -138.62 -0.57 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.229 -0.896 . . . . 53.42 109.676 -176.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.942 -1.026 . . . . 74.24 109.759 -172.566 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.973 -0.38 . . . . 65.12 109.973 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 14.9 p -100.52 131.96 23.07 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.965 -0.383 . . . . 71.23 109.965 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.75 143.51 99.62 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 40.12 111.836 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.93 89.66 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.582 2.188 . . . . 51.24 112.14 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.3 p -70.78 -30.91 67.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.684 -0.689 . . . . 52.22 110.724 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.785 ' HB3' HG21 ' A' ' 143' ' ' VAL . 30.5 p90 -61.05 -26.37 67.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.567 . . . . 64.15 110.892 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.4 -19.46 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.107 -0.497 . . . . 64.14 110.751 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.916 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 14.5 t70 -93.99 -13.77 26.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.383 . . . . 74.21 110.318 -177.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.624 HD11 HG22 ' A' ' 143' ' ' VAL . 86.8 mt -57.62 -36.09 71.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.22 0.533 . . . . 73.21 110.001 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.9 30.68 4.32 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.298 -0.864 . . . . 54.01 111.523 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.916 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 5.0 tppp? -61.84 -57.89 10.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.458 . . . . 73.34 110.191 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -67.02 -39.11 86.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.542 -0.754 . . . . 73.33 110.258 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.76 93.47 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.071 -0.968 . . . . 42.33 112.633 -171.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -60.68 -39.93 90.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.665 0.211 . . . . 75.34 111.405 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 38.5 t70 -68.16 -36.65 79.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 65.41 111.036 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 207' ' ' ASN . 26.9 t -84.03 -46.62 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.202 0.445 . . . . 52.55 112.202 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -72.38 -43.47 63.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.814 0.34 . . . . 71.15 110.906 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.6 p -111.97 71.94 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.141 0.972 . . . . 72.55 108.48 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 18.8 pttm -85.86 173.11 10.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.925 -1.489 . . . . 74.25 112.563 -166.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.58 97.11 0.2 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.517 -1.033 . . . . 53.41 110.517 170.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' HE2' ' HG ' ' A' ' 262' ' ' LEU . 56.2 t80 -115.81 146.03 42.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.827 0.346 . . . . 74.32 110.305 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -72.23 90.12 0.52 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.763 -0.732 . . . . 43.52 111.918 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -80.68 -3.81 52.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.153 0.501 . . . . 64.34 110.308 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.93 58.19 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.627 -0.797 . . . . 73.5 113.57 174.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 pp -140.66 171.79 13.62 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.553 1.168 . . . . 74.23 113.862 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.921 HG23 HD12 ' A' ' 277' ' ' LEU . 33.3 mm -105.75 122.07 58.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 113.121 -1.854 . . . . 71.41 108.945 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.675 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 11.2 pttp -126.65 154.31 44.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.186 0.517 . . . . 71.44 110.644 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -148.03 149.86 32.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.753 -0.832 . . . . 63.45 108.753 169.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' SER . 3.4 p-10 -139.49 131.02 27.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.786 0.803 . . . . 65.44 111.419 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.6 OUTLIER -94.16 124.85 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.577 -1.192 . . . . 71.23 108.487 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HG3' ' HA ' ' A' ' 282' ' ' GLN . 0.2 OUTLIER -126.4 124.48 40.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 73.31 110.554 178.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 283' ' ' ALA . 88.3 m -137.07 120.96 17.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.535 -0.757 . . . . 71.21 109.121 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -136.78 126.12 24.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.107 0.48 . . . . 73.33 110.366 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.0 m -137.07 138.51 40.47 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.923 -0.769 . . . . 72.2 108.923 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.3 mt-10 -77.76 61.68 2.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.959 0.885 . . . . 64.54 110.194 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -137.61 18.92 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.149 -1.387 . . . . 75.13 108.341 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.8 -8.55 79.64 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.21 -0.904 . . . . 63.12 113.943 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.4 126.02 48.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.777 1.288 . . . . 64.42 111.986 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.97 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 19.8 tt0 -142.68 126.48 17.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.381 -0.6 . . . . 75.01 109.381 166.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.5 127.82 38.08 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.031 -0.418 . . . . 75.01 111.56 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.8 m -127.38 116.78 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 54.22 110.344 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.4 t -118.01 122.88 44.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.59 -0.522 . . . . 64.34 109.59 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 m -120.72 126.76 50.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.669 0.271 . . . . 74.21 110.912 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.98 134.94 8.09 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.719 -0.753 . . . . 72.43 111.96 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -121.57 135.37 55.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.73 -0.47 . . . . 53.22 109.73 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.98 129.32 29.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.278 0.561 . . . . 72.03 111.614 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.799 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m120 -93.7 124.27 37.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.368 -0.833 . . . . 54.31 109.399 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 p -82.5 19.36 1.28 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.263 0.468 . . . . 75.41 112.263 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.05 -42.17 76.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.172 0.511 . . . . 73.21 109.799 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 52' ' ' THR . 1.6 t -160.15 -73.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 60.31 109.647 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.746 ' H ' HG23 ' A' ' 51' ' ' THR . 37.8 m -156.41 86.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.737 -0.468 . . . . 62.25 109.737 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.799 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 46.7 tptt -128.9 91.71 3.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.65 -0.5 . . . . 74.24 109.65 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.3 121.09 63.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.204 -0.453 . . . . 53.25 111.178 -174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 p -110.36 140.31 44.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.77 -0.65 . . . . 74.14 109.984 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.39 19.46 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.316 -0.945 . . . . 75.24 112.753 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -141.88 133.06 26.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.864 -0.791 . . . . 64.21 108.864 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.79 124.53 44.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.757 -0.461 . . . . 74.34 109.757 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -113.72 118.37 34.13 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.102 -0.499 . . . . 70.42 109.659 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -110.77 122.82 48.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.913 -0.773 . . . . 74.33 108.913 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.97 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 72.1 mttt -129.4 134.78 48.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.298 0.57 . . . . 72.12 111.337 -172.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 49.4 t80 -106.81 119.51 39.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.485 -0.931 . . . . 71.42 108.485 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.495 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 63.6 ttm-85 -118.55 110.18 17.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.356 0.598 . . . . 75.02 111.654 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.632 ' HD1' ' HE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.58 125.17 35.54 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 114.948 -1.024 . . . . 74.33 109.811 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -81.0 -178.71 7.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 125.047 1.467 . . . . 72.13 111.915 -172.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 65' ' ' THR . 49.4 mt-10 71.99 -50.27 0.69 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.662 0.785 . . . . 73.41 110.937 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -95.06 -139.94 0.24 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.682 -1.229 . . . . 72.15 107.682 169.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.8 67.8 0.42 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.115 -0.794 . . . . 61.31 111.115 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -100.42 129.53 46.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.806 -0.757 . . . . 64.21 110.609 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.5 m -138.31 111.99 8.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.404 -0.362 . . . . 65.21 110.886 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -104.49 119.17 38.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.43 -0.952 . . . . 70.1 108.43 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 61' ' ' LYS . 11.9 p -128.53 138.08 52.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.953 0.406 . . . . 53.14 111.87 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 43.1 mt-10 -117.54 120.63 38.65 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.809 -0.811 . . . . 72.13 108.809 166.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 7.0 pttp -110.83 105.4 14.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.355 0.598 . . . . 55.43 109.948 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -98.51 133.18 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.142 -0.936 . . . . 75.01 111.161 -174.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -110.47 143.55 40.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.937 -0.764 . . . . 70.52 108.937 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.8 t -56.4 -18.43 11.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.028 0.531 . . . . 71.12 112.149 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 24.7 t70 -67.21 -6.64 18.98 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.797 0.332 . . . . 72.35 110.738 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 51.7 m-80 79.79 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.155 0.982 . . . . 71.31 110.058 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -114.84 117.79 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.377 -0.829 . . . . 73.33 110.301 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.79 119.59 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.101 -0.333 . . . . 72.41 110.101 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -107.24 88.1 0.52 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.609 -0.805 . . . . 64.42 111.775 175.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.585 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 35.8 m -84.32 101.17 11.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.208 0.527 . . . . 75.22 110.275 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 3.7 tm-20 -114.75 128.25 56.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.604 -0.726 . . . . 75.51 109.683 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.98 121.74 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.297 0.57 . . . . 74.0 110.571 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.7 m -107.32 129.02 54.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 72.14 109.93 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.16 119.55 49.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.265 0.555 . . . . 73.54 110.842 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.57 118.98 36.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.629 -1.249 . . . . 71.14 107.629 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.71 169.34 11.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.681 0.753 . . . . 61.2 112.341 -166.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -111.91 -2.03 15.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.998 -1.001 . . . . 71.22 110.229 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 89' ' ' ASP . 53.2 tp -85.08 -55.43 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 74.12 110.026 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -118.81 79.63 1.42 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.978 -0.749 . . . . 75.33 108.978 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -47.39 129.08 12.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.475 -0.784 . . . . 74.31 112.435 -171.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.45 -4.25 47.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.205 -0.907 . . . . 70.52 111.973 -173.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -88.02 114.76 24.95 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.825 -0.435 . . . . 65.22 109.825 175.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.07 121.03 36.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 72.24 110.119 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.5 mm? -109.46 127.66 54.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.457 -0.792 . . . . 52.5 109.245 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.911 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.2 t -129.13 128.92 44.44 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 73.32 109.984 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.752 ' HD2' HG12 ' A' ' 114' ' ' ILE . 80.4 t80 -121.38 125.84 47.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.842 -0.617 . . . . 73.45 110.242 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 2.1 m-20 -108.23 121.72 45.46 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.765 -0.458 . . . . 65.12 109.765 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.585 ' OG ' ' HB ' ' A' ' 83' ' ' THR . 8.5 p -115.67 120.18 38.53 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.533 -0.543 . . . . 71.53 109.533 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.3 m -101.34 121.43 41.89 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.858 -0.61 . . . . 65.34 109.528 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -128.46 119.76 25.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.075 -0.512 . . . . 75.44 109.737 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -113.71 103.44 55.33 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.252 -0.431 . . . . 74.3 111.085 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.63 -14.31 34.97 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.209 2.606 . . . . 74.33 112.938 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 104' ' ' SER . 24.9 p30 -72.07 -21.0 61.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 72.12 110.924 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 p -126.54 -37.54 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.992 -0.549 . . . . 72.15 111.016 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.24 50.02 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.021 -0.609 . . . . 71.03 112.471 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -87.59 145.82 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 75.45 110.811 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.31 125.52 46.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.142 -0.688 . . . . 64.32 109.142 171.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -118.84 126.22 51.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.72 -0.474 . . . . 73.3 109.72 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.31 124.49 49.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.907 -0.588 . . . . 62.21 111.367 -173.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 54.8 mttp -111.55 136.24 51.01 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.101 -1.074 . . . . 73.21 108.101 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 129' ' ' MET . 0.4 OUTLIER -125.28 130.95 72.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.325 -0.62 . . . . 62.44 109.325 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.911 ' HB2' HG23 ' A' ' 98' ' ' THR . 3.1 mptp? -123.42 120.73 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.605 -0.517 . . . . 75.21 109.605 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.412 HG23 ' HB2' ' A' ' 127' ' ' CYS . 4.5 t -114.21 116.31 28.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.628 -0.879 . . . . 72.45 108.628 173.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -130.08 121.66 3.44 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 119.541 -1.314 . . . . 32.41 112.574 -174.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.416 ' HB3' HD22 ' A' ' 95' ' ' LEU . 25.0 p90 -111.96 117.6 33.15 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.971 -0.751 . . . . 72.33 108.971 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -109.93 122.19 46.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.694 -0.684 . . . . 74.54 109.284 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -106.65 157.01 18.02 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.401 -0.592 . . . . 74.11 109.401 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.724 ' HG3' ' HD2' ' A' ' 122' ' ' HIS . 7.7 pt-20 -51.68 -27.03 10.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.634 0.774 . . . . 73.43 112.784 -172.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.724 ' HD2' ' HG3' ' A' ' 121' ' ' GLU . 66.5 m-70 -106.22 -24.09 12.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.212 0.449 . . . . 72.13 112.212 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.73 HD11 HD11 ' A' ' 142' ' ' LEU . 17.7 tt -147.25 141.61 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 120.324 -0.55 . . . . 64.11 111.992 -173.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.66 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -110.59 117.78 34.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.735 0.302 . . . . 65.22 111.717 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 142' ' ' LEU . 4.3 mm? -111.7 137.49 49.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.821 0.343 . . . . 55.52 111.104 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -146.25 131.03 3.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.88 -0.676 . . . . 52.32 112.692 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.412 ' HB2' HG23 ' A' ' 116' ' ' THR . 58.1 m -113.35 119.7 38.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.966 0.412 . . . . 51.01 110.851 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.846 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -105.29 136.39 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.898 -0.592 . . . . 62.21 110.289 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.769 ' HB2' HG22 ' A' ' 114' ' ' ILE . 64.9 mtt -133.86 121.49 21.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.954 -0.388 . . . . 65.52 109.954 174.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.41 120.13 41.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.038 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -93.35 105.73 17.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.277 0.56 . . . . 72.45 111.069 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.53 172.87 7.65 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.767 -0.827 . . . . 64.44 108.767 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 133' ' ' ILE . 3.5 mp -67.07 -33.12 61.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.309 -0.626 . . . . 70.23 109.309 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.47 -15.29 59.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.545 -0.752 . . . . 75.42 110.951 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.55 178.9 17.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.4 -0.905 . . . . 45.31 112.692 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -87.93 128.81 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.91 2.406 . . . . 75.43 112.812 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 t -99.36 140.75 33.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 62.4 108.757 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.82 118.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.551 -0.459 . . . . 73.3 111.071 -171.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.846 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 40.9 mtp180 -110.12 125.46 53.02 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.885 -0.783 . . . . 65.3 108.885 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.58 10.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 119.709 -1.234 . . . . 65.4 111.444 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.54 116.02 19.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.13 0.491 . . . . 63.42 110.926 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.73 HD11 HD11 ' A' ' 123' ' ' ILE . 6.6 tp -121.81 124.64 44.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 75.01 110.642 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' A' ' 7' ' ' TYR . 86.1 t -112.37 129.56 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.302 -0.863 . . . . 73.43 109.87 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.896 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.4 mm? -108.28 138.61 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.53 -0.759 . . . . 62.15 109.896 -170.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.22 118.53 5.59 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.561 -0.745 . . . . 42.3 112.058 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.834 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 86.5 m-85 -127.87 148.4 50.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 75.3 109.723 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.71 98.42 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.481 -0.327 . . . . 72.54 111.054 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.13 -21.51 20.05 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 116.29 -0.414 . . . . 62.24 112.756 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 24.8 m95 -105.54 131.82 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 75.2 111.209 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.4 mt -112.12 136.51 51.4 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.385 -0.598 . . . . 55.22 109.385 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -131.77 153.25 50.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.285 -0.416 . . . . 41.11 110.038 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -158.46 133.99 3.66 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.937 -0.865 . . . . 44.34 110.937 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -142.43 121.82 13.17 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.712 -0.795 . . . . 71.15 110.184 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.728 ' HG2' ' HB3' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -117.72 120.19 37.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.956 0.884 . . . . 71.13 110.102 176.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.451 ' C ' HD22 ' A' ' 156' ' ' ASN . 15.1 ptt? -117.72 133.46 55.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.153 -0.93 . . . . 74.31 109.304 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -110.54 116.53 31.52 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.781 -0.822 . . . . 74.53 108.781 -173.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 45.4 m-85 -94.36 118.38 31.52 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 123.577 0.548 . . . . 64.51 110.105 -176.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.981 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.3 tp10 -91.21 102.17 14.9 Favored 'General case' 0 C--O 1.262 1.752 0 CA-C-N 115.831 -0.622 . . . . 71.53 109.596 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 m -70.52 -25.2 63.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 112.893 -1.958 . . . . 71.32 110.93 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.87 71.84 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.01 -0.737 . . . . 43.13 109.01 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.666 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 69.6 mmtt -104.72 -163.41 0.96 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.844 -1.169 . . . . 73.1 107.844 170.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.3 t -108.35 26.37 10.54 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 121.838 -0.539 . . . . 74.13 110.294 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -166.3 172.2 11.33 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 118.89 -1.124 . . . . 73.52 111.542 -166.03 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.11 135.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 64.44 110.168 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.981 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.4 t -94.41 -21.48 18.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.946 -0.57 . . . . 71.41 110.815 -174.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 165' ' ' THR . 46.2 mt-30 -143.58 134.66 25.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.854 0.359 . . . . 70.2 110.314 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -117.74 106.75 13.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.211 -0.45 . . . . 75.35 109.984 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.728 ' HB3' ' HG2' ' A' ' 154' ' ' GLN . 2.7 t-20 -115.94 122.58 45.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.69 -0.485 . . . . 74.22 109.69 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 90.1 m-85 -122.05 156.74 32.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.53 -0.305 . . . . 74.2 110.518 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -152.0 129.0 11.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.041 0.448 . . . . 34.23 110.888 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.89 125.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.637 -0.875 . . . . 70.11 108.637 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -142.11 109.16 0.56 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.934 -1.126 . . . . 74.23 112.507 -176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.722 ' CZ ' HD21 ' A' ' 180' ' ' LEU . 11.4 p90 -114.16 133.34 55.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.036 -0.728 . . . . 61.24 109.036 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -132.55 130.86 40.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.963 -1.017 . . . . 74.13 113.066 -162.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 m -121.01 155.51 34.17 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.111 -1.44 . . . . 71.42 107.111 166.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -49.75 -46.45 50.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 75.11 112.417 -170.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.45 -22.98 20.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.665 0.617 . . . . 72.05 112.665 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.73 119.72 15.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.325 0.583 . . . . 74.41 111.895 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -135.28 143.01 46.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.739 -0.664 . . . . 62.42 109.984 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.948 ' HB3' HG13 ' A' ' 194' ' ' ILE 0.256 0.0 OUTLIER -127.45 139.0 53.1 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.382 1.087 . . . . 73.2 111.503 159.274 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 45.3 m-70 -124.05 115.59 21.42 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.707 -2.042 . . . . 73.25 107.228 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 23.8 m -111.93 134.79 53.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.479 -0.328 . . . . 72.35 110.489 -173.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -118.75 140.21 50.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.34 -0.615 . . . . 72.02 109.34 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 25.5 t -121.56 118.61 56.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.239 -0.437 . . . . 41.22 110.959 -176.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 80.5 m-20 -97.68 91.09 5.23 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.079 -0.964 . . . . 72.11 108.96 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 58.42 -168.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.754 -1.112 . . . . 73.51 110.214 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.83 86.9 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.275 -0.964 . . . . 71.33 111.216 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 211' ' ' THR . 3.5 m -89.38 -26.75 20.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.566 0.58 . . . . 65.41 112.566 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 40.4 tt0 -139.14 117.61 12.08 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 119.779 -0.768 . . . . 63.35 112.255 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -109.18 126.21 53.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 73.32 109.374 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -129.23 109.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.844 -0.693 . . . . 55.44 112.503 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' A' ' 182' ' ' THR . . . -105.63 131.77 10.8 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.735 -0.745 . . . . 52.23 111.725 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 20.6 t -119.06 137.8 53.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.895 -0.409 . . . . 73.34 109.895 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 1.049 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.5 mp -118.91 132.56 68.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.445 . . . . 75.31 109.894 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.76 119.9 40.18 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.352 -0.981 . . . . 74.14 108.352 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 204' ' ' THR . 0.3 OUTLIER -122.39 112.43 18.07 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.184 -0.673 . . . . 70.51 109.184 -176.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -98.19 113.37 25.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.848 -0.615 . . . . 64.22 109.688 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 200' ' ' LYS . 47.9 t -80.63 150.16 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 54.11 109.129 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -61.13 -22.21 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 54.12 111.368 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 4.4 mptp? -91.27 -165.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.567 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.99 46.16 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.839 0.352 . . . . 74.53 110.665 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.572 ' HG ' ' HD1' ' A' ' 225' ' ' TYR . 3.7 tt -132.51 119.81 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.109 0.48 . . . . 52.15 110.248 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 49.0 mt-10 -111.53 138.41 48.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.113 -0.699 . . . . 54.04 109.113 171.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 196' ' ' GLN . 35.1 m -122.13 139.73 53.39 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.464 -0.569 . . . . 73.54 109.464 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 17' ' ' VAL . . . -129.74 136.95 50.25 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.942 0.401 . . . . 63.42 110.16 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 1.049 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 10.3 t -115.32 137.06 50.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.323 -176.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.519 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 27.1 t-20 -120.77 127.41 51.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.034 0.445 . . . . 65.45 110.965 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.5 mm? -122.78 129.75 52.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.363 -0.835 . . . . 63.21 109.57 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -132.75 126.22 31.95 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.618 -0.433 . . . . 72.01 109.865 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -131.68 124.22 29.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.03 0.443 . . . . 74.22 110.69 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.896 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 1.1 p -104.46 103.58 13.3 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.676 -0.693 . . . . 70.0 110.523 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.34 127.8 33.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.846 -0.615 . . . . 64.54 110.553 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.2 27.11 73.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.066 -0.587 . . . . 71.25 112.178 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.896 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 10.7 t-20 -138.77 -147.36 0.23 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.533 -0.914 . . . . 72.32 108.533 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 51.5 m -77.58 178.72 7.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.176 0.512 . . . . 72.01 112.329 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.65 154.74 24.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.178 -0.919 . . . . 73.03 111.786 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.2 t -78.4 139.82 38.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 71.1 110.406 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.41 135.16 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.188 -0.46 . . . . 72.11 109.981 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -130.74 135.57 47.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.137 -0.483 . . . . 71.03 109.77 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.22 171.66 32.8 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.845 -0.693 . . . . 75.11 111.716 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -138.37 147.56 25.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.958 0.409 . . . . 53.41 111.333 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -128.93 130.42 46.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.485 -0.779 . . . . 70.24 109.933 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -115.76 128.53 55.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.63 0.252 . . . . 72.22 111.128 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 2.4 ttmp? -109.04 116.06 31.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 75.34 109.377 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.572 ' HD1' ' HG ' ' A' ' 202' ' ' LEU . 10.8 t80 -119.0 131.96 56.03 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.957 0.408 . . . . 63.25 110.389 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -96.73 99.62 11.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 62.35 110.132 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.85 HD13 ' H ' ' A' ' 227' ' ' ILE . 0.2 OUTLIER -94.38 -28.87 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.267 -0.424 . . . . 72.13 111.133 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.6 141.13 19.72 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.642 -0.503 . . . . 62.53 109.642 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.3 -30.62 20.37 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.158 2.572 . . . . 74.22 113.524 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.06 -9.46 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.111 0.412 . . . . 71.31 112.111 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.63 136.63 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.978 0.362 . . . . 63.14 111.978 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -131.26 142.42 50.14 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.32 -0.4 . . . . 53.31 110.538 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.11 134.15 52.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 70.23 111.052 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 46.5 p -130.97 118.36 20.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.993 -0.549 . . . . 42.34 110.622 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -109.12 141.5 41.23 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.743 -0.466 . . . . 73.34 109.743 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -142.34 140.92 32.28 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.868 -0.333 . . . . 75.21 110.787 -177.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.55 146.53 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.513 -0.312 . . . . 72.42 110.284 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -115.92 150.05 37.74 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.65 -0.704 . . . . 71.33 109.664 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 241' ' ' SER . 27.2 p-10 -53.82 -18.55 3.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.952 0.783 . . . . 73.33 112.83 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.463 ' HB3' ' HG ' ' A' ' 242' ' ' LEU . 34.4 t -78.85 21.37 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.713 0.292 . . . . 72.35 110.54 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 239' ' ' ASN . 46.1 t 64.31 32.24 12.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.198 0.523 . . . . 65.43 109.746 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 262' ' ' LEU . 58.5 mt -99.07 114.71 27.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.436 -0.506 . . . . 71.12 109.981 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.774 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -109.68 117.96 55.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.929 0.395 . . . . 73.0 110.57 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -116.92 139.71 15.33 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.935 -0.65 . . . . 35.15 113.126 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.16 127.81 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.819 -0.808 . . . . 71.44 108.819 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -139.85 132.36 5.54 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.942 -1.123 . . . . 70.2 112.641 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -129.17 133.61 47.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.087 0.47 . . . . 73.5 110.16 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 13.5 t -123.21 136.15 54.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.013 -0.539 . . . . 73.45 109.776 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -142.69 149.12 38.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.295 -0.411 . . . . 70.23 110.665 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 13.8 m -98.89 121.71 41.19 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.466 ' CB ' HG23 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.38 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.286 0.366 . . . . 72.51 110.817 -173.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.747 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 63.3 mttm -150.37 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.58 -0.282 . . . . 73.12 111.558 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 3.0 Cg_exo -75.0 -76.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.91 1.74 . . . . 71.53 112.767 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -152.63 28.72 0.85 Allowed Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.85 -0.691 . . . . 71.32 112.038 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.504 HD12 ' CE2' ' A' ' 281' ' ' PHE . 1.0 OUTLIER -106.99 122.42 61.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.104 0.478 . . . . 63.21 110.485 -178.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -104.04 130.73 51.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.682 -0.69 . . . . 71.13 109.839 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.4 tp -98.39 124.37 43.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.213 -0.662 . . . . 64.43 109.213 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.8 m -116.11 110.33 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.933 -0.576 . . . . 73.44 109.907 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.845 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -114.23 124.82 52.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.919 -0.771 . . . . 75.45 108.919 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 62.8 m -138.65 139.95 38.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.812 0.339 . . . . 64.14 110.282 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.07 127.83 20.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.801 -0.444 . . . . 73.44 109.801 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.1 tm? -107.61 121.8 45.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.43 -0.952 . . . . 73.5 108.43 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.774 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.1 mm? -98.78 106.16 18.4 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.847 -1.168 . . . . 61.25 107.847 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.568 ' HA ' HD22 ' A' ' 242' ' ' LEU . 4.8 m-20 -72.54 106.26 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.614 -0.884 . . . . 75.13 108.614 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.52 -22.56 24.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.991 -0.623 . . . . 61.24 113.121 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -90.88 -3.38 57.39 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.996 0.427 . . . . 74.34 111.193 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 47.4 t-20 -123.79 -44.67 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.816 0.341 . . . . 60.04 110.969 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.626 HG11 ' HB3' ' A' ' 263' ' ' LEU . 26.5 m -61.24 -18.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.259 0.466 . . . . 71.33 112.259 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.02 -38.98 88.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.795 0.331 . . . . 72.43 110.443 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.49 29.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.539 . . . . 61.43 110.915 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.02 100.83 2.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.715 -0.755 . . . . 64.41 112.071 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.59 77.17 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.775 -0.726 . . . . 65.11 112.082 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -87.39 144.23 26.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 74.33 109.819 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 65.2 mttm -97.38 137.02 37.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.522 . . . . 74.11 109.887 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.8 tm? -125.77 131.7 52.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.805 -0.634 . . . . 71.31 110.044 -173.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.435 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -125.2 113.07 1.84 Allowed Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.505 -1.038 . . . . 72.04 110.505 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.921 HD12 HG23 ' A' ' 27' ' ' ILE . 3.4 tm? -114.38 134.87 54.67 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 72.44 109.668 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.675 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -148.58 125.89 2.16 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.095 -1.05 . . . . 41.1 113.172 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 2.5 mm? -102.29 131.92 48.58 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.166 -0.679 . . . . 74.22 109.166 171.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.426 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 51.9 mt-10 -115.57 110.87 19.85 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.571 -0.529 . . . . 63.52 109.571 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.755 ' HB2' HD22 ' A' ' 31' ' ' LEU . 89.4 m-85 -101.26 100.98 11.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.933 -0.576 . . . . 72.31 110.483 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.538 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 52.9 tt0 -92.07 111.96 23.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.264 -0.643 . . . . 63.03 109.264 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 33' ' ' THR . . . -107.77 111.25 23.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.095 0.474 . . . . 73.05 110.985 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.12 133.75 55.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.709 -0.678 . . . . 73.42 109.322 173.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.43 -0.795 . . . . 72.13 110.7 -174.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HA ' ' HB3' ' A' ' 121' ' ' GLU . 61.1 mtt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.966 0.413 . . . . 44.05 110.877 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.5 88.56 2.76 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.878 -0.786 . . . . 73.14 108.878 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.815 HG22 ' HA ' ' A' ' 121' ' ' GLU . 2.2 t -107.59 109.0 62.32 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 74.44 110.898 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 5.3 Cg_exo -77.4 164.77 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.251 2.634 . . . . 74.44 111.633 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.59 70.09 2.05 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.839 2.359 . . . . 74.32 111.825 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.738 ' HB ' HD21 ' A' ' 150' ' ' LEU . 20.6 p -70.13 -42.29 72.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 61.1 111.056 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.602 ' HB3' HG21 ' A' ' 143' ' ' VAL . 29.6 p90 -54.92 -30.58 58.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 71.12 111.538 174.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.83 46.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.524 . . . . 75.01 110.61 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.94 -9.63 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 71.43 109.834 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 150' ' ' LEU . 81.3 mt -70.69 -34.51 72.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.781 -0.645 . . . . 75.11 110.983 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . -129.05 0.03 6.03 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.593 -1.289 . . . . 72.21 114.83 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.572 ' HG3' ' N ' ' A' ' 13' ' ' SER . 4.8 pttm -62.43 -46.22 89.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.781 1.29 . . . . 74.51 110.505 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.572 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 5.0 p -66.54 -49.46 66.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.345 0.593 . . . . 71.33 111.168 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.72 69.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.308 -0.86 . . . . 71.23 112.438 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -59.86 -38.9 83.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.883 0.327 . . . . 71.23 111.883 -171.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.95 -47.44 71.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.873 0.368 . . . . 73.45 110.959 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 222' ' ' ALA . 25.1 m -82.74 -27.53 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.435 0.532 . . . . 72.31 112.435 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.15 -31.31 65.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.627 0.251 . . . . 74.0 111.462 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.9 m -59.78 135.44 57.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.389 -0.369 . . . . 73.45 110.704 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.51 -53.98 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 63.34 111.249 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.88 46.86 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.759 -0.734 . . . . 52.41 111.617 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.45 93.47 6.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.617 0.722 . . . . 55.33 111.031 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.01 124.83 7.73 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.789 -0.719 . . . . 73.32 111.84 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -84.25 10.96 9.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.6 0.238 . . . . 71.25 111.596 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.92 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 92.7 13.85 56.15 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.363 -0.923 . . . . 72.23 111.608 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 46' ' ' SER . 1.5 pp -101.94 179.42 4.33 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.572 0.701 . . . . 72.1 112.747 -171.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 277' ' ' LEU . 35.1 mm -102.06 130.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.785 -1.098 . . . . 64.14 110.407 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.601 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 1.0 OUTLIER -103.81 134.63 46.79 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.455 -0.943 . . . . 75.33 108.455 176.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.538 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 16.5 tp -121.56 147.83 45.29 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.677 -0.409 . . . . 71.43 110.853 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.812 ' HB3' ' HG2' ' A' ' 280' ' ' GLU . 12.3 t70 -153.72 127.9 9.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.294 -0.866 . . . . 73.31 108.919 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.734 HD13 ' HB3' ' A' ' 281' ' ' PHE . 8.9 tp -137.46 125.02 22.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.346 -0.612 . . . . 72.11 109.346 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 23.3 ttmt -133.12 124.69 28.01 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.46 . . . . 73.41 110.683 -175.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.717 HG22 ' HB3' ' A' ' 283' ' ' ALA . 80.6 p -120.64 123.61 43.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.631 . . . . 72.32 109.705 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HB2' HD13 ' A' ' 284' ' ' LEU . 91.0 mttt -112.17 139.46 47.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.273 0.559 . . . . 61.41 112.14 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 43.1 t -139.17 137.18 35.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.835 -1.172 . . . . 75.4 107.835 168.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -82.12 34.97 0.42 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.616 0.722 . . . . 71.2 109.902 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.7 OUTLIER -120.5 18.71 12.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.477 -0.783 . . . . 71.32 111.424 -177.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 97.76 -3.4 60.81 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.194 -1.162 . . . . 61.52 110.194 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 3.4 tm? -99.65 127.22 45.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.762 -0.375 . . . . 73.31 111.717 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.758 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 22.0 tt0 -141.6 129.22 21.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.969 -0.752 . . . . 75.2 108.969 163.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.456 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 74.5 t80 -124.78 127.05 46.61 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.267 -0.896 . . . . 65.13 110.872 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.903 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.5 m -128.58 131.53 48.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.092 0.473 . . . . 74.22 111.682 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 17.1 m -120.3 123.02 42.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.854 . . . . 75.02 108.693 171.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.3 p -139.65 157.65 45.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.378 -0.529 . . . . 65.34 111.093 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 158.83 -175.22 35.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.539 -1.315 . . . . 52.23 113.567 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 26' ' ' LEU . 12.1 p -137.03 138.5 40.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.617 -0.292 . . . . 74.32 110.249 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HB1' HG22 ' A' ' 54' ' ' VAL . . . -135.27 129.12 33.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.781 0.324 . . . . 71.24 110.709 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.435 ' CB ' ' HB3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -90.67 113.72 25.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 50.5 109.153 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 p -84.84 7.33 21.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.181 0.808 . . . . 70.21 113.181 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -74.13 -46.26 43.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.71 -0.396 . . . . 70.14 110.405 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -126.36 -81.33 0.61 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.749 -0.463 . . . . 71.22 109.749 171.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -172.69 84.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.949 0.88 . . . . 65.12 110.296 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 16.6 tppt? -126.25 86.53 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 73.24 109.449 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG22 ' HB1' ' A' ' 47' ' ' ALA . 25.9 t -109.22 120.04 59.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.017 -0.538 . . . . 63.32 110.821 -175.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 m -137.67 124.6 21.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.893 -0.594 . . . . 62.1 109.56 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 45' ' ' GLY . . . -155.57 -155.43 7.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.539 -0.838 . . . . 72.35 111.958 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.447 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 33.4 t -148.03 150.99 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.185 0.517 . . . . 72.31 110.177 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -119.96 125.06 47.48 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.65 -0.87 . . . . 65.14 108.65 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.903 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 3.4 mp0 -109.04 118.87 37.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.454 -0.793 . . . . 71.24 110.93 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -99.55 117.72 34.56 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.794 -1.558 . . . . 74.04 106.794 164.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.758 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 74.3 tttt -127.37 150.28 49.68 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.363 0.602 . . . . 74.45 110.311 -171.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.86 ' HB2' ' HB2' ' A' ' 71' ' ' PHE . 99.6 m-85 -126.72 121.42 31.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.879 -0.601 . . . . 74.11 110.155 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.3 ptm85 -121.27 106.1 11.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.789 0.804 . . . . 54.23 111.376 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 t90 -117.02 104.64 11.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.869 -1.06 . . . . 75.21 109.583 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 m 73.55 132.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.615 0.572 . . . . 64.05 110.508 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.9 mp0 -50.95 -59.98 3.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.858 -0.61 . . . . 71.03 110.911 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.03 67.37 0.7 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.702 -0.681 . . . . 71.41 109.383 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 -85.58 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.608 -0.806 . . . . 35.1 112.847 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.98 130.53 52.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 74.44 111.807 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.8 m -137.72 112.36 8.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 72.25 110.561 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 8.9 m-85 -102.73 122.4 44.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.609 -0.515 . . . . 61.31 109.609 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 m -119.93 117.29 27.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.64 -0.424 . . . . 73.31 111.76 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.6 123.65 45.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 75.21 109.099 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 59' ' ' GLU . 10.3 ptmm? -142.86 140.18 31.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.288 -0.565 . . . . 62.13 110.969 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.412 ' CD1' ' HG ' ' A' ' 81' ' ' LEU . 31.5 t90 -129.85 130.08 44.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.092 -0.504 . . . . 73.12 110.132 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.447 ' ND2' ' HB2' ' A' ' 57' ' ' SER . 15.8 m120 -93.46 150.92 20.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 63.13 110.756 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -63.82 -20.43 65.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 73.02 109.553 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.77 -4.13 29.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.092 -0.958 . . . . 75.0 110.344 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.7 t30 82.31 4.64 1.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.015 0.926 . . . . 63.53 111.113 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 103' ' ' PHE . 18.9 p -80.76 143.86 32.57 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 116.129 -0.487 . . . . 65.42 109.803 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 103' ' ' PHE . 3.3 mp -122.88 113.59 19.34 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 118.761 -1.176 . . . . 75.22 113.872 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.62 131.12 10.08 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 119.771 -1.204 . . . . 73.41 113.686 -170.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.902 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 91.0 m -136.25 140.17 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.641 0.258 . . . . 34.34 110.745 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.87 108.83 3.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.503 HG13 ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -116.59 120.65 65.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.005 0.431 . . . . 35.12 109.987 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.6 m -110.53 135.8 50.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.996 -0.547 . . . . 70.13 111.772 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.2 125.33 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.178 -0.919 . . . . 74.11 109.738 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.53 130.03 35.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.546 -0.539 . . . . 75.15 109.546 176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.55 133.16 36.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.785 -0.45 . . . . 75.32 109.785 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -91.53 -21.69 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.33 -0.396 . . . . 62.04 111.47 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.97 -51.08 11.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.964 -0.754 . . . . 70.21 108.964 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.06 7.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 42.32 109.823 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.778 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -62.49 124.63 21.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 71.25 110.514 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . 100.12 1.62 55.91 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.705 -0.76 . . . . 74.15 112.322 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.712 HD23 ' HD1' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -98.86 124.35 43.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 64.43 109.871 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.23 123.19 40.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 63.31 110.53 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.475 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.7 mm? -112.97 125.61 54.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.619 -0.512 . . . . 73.1 109.619 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.921 HG23 ' HB3' ' A' ' 115' ' ' LYS . 1.1 t -132.52 136.24 46.51 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.232 0.539 . . . . 64.21 110.637 173.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -104.78 120.67 41.94 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.88 -0.785 . . . . 74.1 108.88 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.51 151.9 26.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.561 -0.745 . . . . 72.3 110.976 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.902 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 22.3 m -128.11 131.92 49.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.5 -0.773 . . . . 74.41 109.251 172.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -91.64 141.94 28.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.392 -0.822 . . . . 63.34 108.859 -173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.69 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 2.3 p90 -95.51 98.01 10.21 Favored 'General case' 0 C--O 1.188 -2.171 0 N-CA-C 114.824 1.416 . . . . 74.11 114.824 -161.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.502 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 60.7 p -76.89 124.15 87.5 Favored Pre-proline 0 N--CA 1.465 0.31 0 O-C-N 121.091 -1.006 . . . . 55.25 112.974 -164.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 33.9 Cg_exo -61.72 -54.97 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.205 2.603 . . . . 72.35 113.16 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -106.14 -30.78 9.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 53.13 111.28 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -62.64 -48.72 78.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.369 . . . . 35.21 111.686 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.24 -14.95 59.53 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.037 -0.601 . . . . 63.33 111.841 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -97.22 130.69 44.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.205 -0.665 . . . . 75.34 109.205 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.61 150.27 36.46 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.056 -0.658 . . . . 64.23 109.54 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 101' ' ' SER . 66.0 t30 -116.51 156.17 27.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 65.41 109.957 -174.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.43 126.54 49.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.909 0.861 . . . . 72.44 112.347 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.518 ' HZ3' ' CG ' ' A' ' 128' ' ' ASP . 28.0 ttpp -128.38 140.61 51.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.537 -1.211 . . . . 72.03 108.656 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.506 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -112.48 124.23 68.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.002 -0.74 . . . . 73.23 109.002 -178.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.921 ' HB3' HG23 ' A' ' 98' ' ' THR . 84.4 tttt -120.08 119.67 34.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.508 -0.769 . . . . 54.35 109.752 -171.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.9 m -122.67 137.08 55.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.335 -0.393 . . . . 63.04 110.951 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.22 122.62 3.35 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.819 -0.705 . . . . 71.14 112.421 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.712 ' HD1' HD23 ' A' ' 95' ' ' LEU . 81.8 t80 -117.59 128.49 55.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.238 -0.653 . . . . 45.31 109.238 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.73 ' HB3' HG11 ' A' ' 3' ' ' VAL . 26.3 mtmm -109.13 123.16 48.75 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.894 -0.722 . . . . 75.04 110.54 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -104.69 147.83 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.3 -1.37 . . . . 64.24 107.3 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.815 ' HA ' HG22 ' A' ' 3' ' ' VAL . 10.5 pt-20 -52.37 -28.48 19.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.489 0.551 . . . . 71.14 112.489 -167.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -100.84 -31.94 10.92 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.468 0.544 . . . . 71.01 112.468 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.987 HG22 ' H ' ' A' ' 145' ' ' GLY . 16.6 pt -142.89 154.23 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 118.594 0.634 . . . . 74.04 112.254 -170.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.748 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 3.5 t-20 -110.14 128.9 55.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.698 -0.683 . . . . 72.43 111.231 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 142' ' ' LEU . 4.6 mm? -110.84 135.73 50.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.515 -0.311 . . . . 73.32 110.174 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.4 125.8 3.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.529 -0.843 . . . . 73.22 112.511 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.8 m -113.45 117.81 32.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.763 -0.458 . . . . 73.32 109.763 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.518 ' CG ' ' HZ3' ' A' ' 113' ' ' LYS . 38.9 t0 -126.09 117.57 23.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.955 0.407 . . . . 73.02 110.1 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.701 ' HG3' HG13 ' A' ' 138' ' ' ILE . 60.8 ttp -119.67 118.15 30.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.919 0.39 . . . . 75.11 111.563 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.21 120.18 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.366 -0.605 . . . . 70.33 109.366 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 85.5 t80 -95.03 104.66 16.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.065 0.46 . . . . 63.33 111.674 -172.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.486 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 20.3 t70 -97.99 149.4 22.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 74.2 108.904 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.405 ' C ' HD13 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -68.6 -35.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.734 -0.212 . . . . 72.41 111.101 -174.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.52 -20.13 20.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 52.21 111.403 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.86 98.71 0.12 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.366 -0.921 . . . . 73.14 112.662 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 37.9 Cg_endo -67.19 150.79 81.88 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.577 2.185 . . . . 74.12 112.43 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -115.13 128.84 56.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.442 -0.577 . . . . 51.31 109.442 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.701 HG13 ' HG3' ' A' ' 129' ' ' MET . 3.9 mp -109.73 118.34 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.354 -0.609 . . . . 63.33 109.354 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -112.19 132.49 54.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.337 0.589 . . . . 75.24 110.308 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.63 132.66 10.99 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.389 -0.823 . . . . 62.3 111.343 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.11 134.76 55.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.961 -0.385 . . . . 71.31 109.961 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.766 HD11 HD12 ' A' ' 123' ' ' ILE . 6.3 tp -137.97 122.33 18.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.207 0.527 . . . . 74.35 110.164 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.748 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 97.8 t -107.89 130.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.23 -0.895 . . . . 65.23 108.937 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.6 mm? -108.14 137.24 46.46 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.258 -0.645 . . . . 74.32 109.258 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.987 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -130.49 119.36 2.73 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 115.527 -0.76 . . . . 61.3 111.46 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 149' ' ' TRP . 1.8 p90 -142.28 147.78 36.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.523 . . . . 73.01 109.589 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 7.0 mp0 -35.24 102.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.575 0.954 . . . . 70.03 113.575 -169.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.31 -33.92 5.31 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.0 -1.0 . . . . 63.21 113.7 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.499 ' HB2' ' CE1' ' A' ' 146' ' ' TYR . 78.1 m95 -106.01 143.28 34.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.63 0.728 . . . . 73.33 112.193 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.738 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.9 tm? -124.75 136.68 54.07 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 72.23 107.985 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.87 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -139.02 162.15 35.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.682 0.277 . . . . 65.54 110.692 -175.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -159.88 145.49 11.37 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.373 -0.691 . . . . 72.13 111.373 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.526 ' OH ' HD23 ' A' ' 142' ' ' LEU . 39.8 p90 -146.72 127.39 14.26 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 117.694 0.747 . . . . 74.03 111.673 165.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 0.9 OUTLIER -115.72 121.64 43.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.421 -0.809 . . . . 72.2 109.163 177.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 94.8 mmm -121.6 140.15 52.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.176 -0.305 . . . . 71.54 110.176 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.474 ' HB2' ' H ' ' A' ' 166' ' ' GLN . 3.8 m-20 -110.3 119.14 38.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.763 -0.458 . . . . 63.33 109.763 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.23 117.27 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.568 -0.53 . . . . 52.33 109.568 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.468 ' HG2' ' HB3' ' A' ' 160' ' ' ALA . 15.0 tt0 -98.54 105.55 17.71 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-O 121.094 0.473 . . . . 71.13 110.107 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.3 m -70.42 -20.81 62.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.3 -1.773 . . . . 72.02 111.124 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 158' ' ' GLU . . . -59.7 -28.65 67.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.924 0.869 . . . . 72.31 109.155 173.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 158' ' ' GLU . 78.8 mttt -117.72 -157.77 0.68 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.311 -1.366 . . . . 71.45 107.311 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.7 p -109.29 26.74 10.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.85 -0.426 . . . . 62.54 109.85 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -141.97 154.32 44.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 118.24 -1.384 . . . . 70.41 114.591 -154.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 93.9 t -74.37 131.61 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 114.721 -1.127 . . . . 61.14 110.206 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 33.1 m -98.63 -34.22 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.627 -0.26 . . . . 60.43 111.488 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' ' 156' ' ' ASN . 14.1 mm100 -138.59 134.68 34.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.183 -0.303 . . . . 73.4 110.183 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.7 p -120.84 109.46 15.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.198 0.523 . . . . 74.23 110.561 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.699 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 26.6 m-80 -109.31 138.45 45.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 5.7 t80 -138.68 149.35 45.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.421 -0.512 . . . . 74.24 110.419 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -149.9 136.8 19.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.178 0.513 . . . . 60.0 110.733 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 10.2 t -145.88 154.07 13.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.427 -0.953 . . . . 61.11 108.427 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 180' ' ' LEU . . . 166.02 -170.72 40.86 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 118.855 -1.641 . . . . 63.12 113.602 169.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.73 153.39 48.49 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.43 -0.385 . . . . 71.31 110.301 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -114.26 126.55 55.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.182 0.515 . . . . 73.31 110.414 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 m -126.29 163.27 23.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.545 -0.752 . . . . 73.34 109.142 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.44 -57.29 3.65 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.765 0.654 . . . . 73.32 112.765 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -109.2 -8.92 15.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 75.13 111.447 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.7 132.09 46.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.898 0.38 . . . . 71.1 111.451 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 83.4 mt-30 -125.98 124.06 39.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.146 -0.687 . . . . 64.11 109.146 173.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.624 HD12 HG13 ' A' ' 194' ' ' ILE . 3.6 tt -120.3 128.49 53.34 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.557 . . . . 72.24 110.948 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 77.6 m-70 -132.05 116.81 17.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.618 -0.719 . . . . 74.01 111.206 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.68 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 29.6 m -83.09 118.56 23.64 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.788 -0.819 . . . . 75.45 108.788 172.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.1 140.97 49.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.167 0.508 . . . . 64.03 111.12 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 190' ' ' PHE . 70.2 t -124.62 128.14 73.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.574 -0.739 . . . . 72.24 110.798 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -115.46 97.29 6.08 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.241 -0.891 . . . . 73.33 108.652 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 30.2 t70 62.49 178.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.919 -1.037 . . . . 71.03 109.573 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.93 58.43 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.958 -0.857 . . . . 54.43 110.958 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 211' ' ' THR . 56.4 m -87.52 -28.1 22.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 112.564 0.579 . . . . 75.24 112.564 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -141.07 119.42 12.2 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.402 -0.919 . . . . 74.32 112.443 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.518 ' CB ' HG22 ' A' ' 184' ' ' VAL . 19.1 p90 -134.89 126.09 28.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.446 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.767 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -158.84 -162.6 12.07 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 120.491 -0.861 . . . . 63.24 112.388 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -137.74 152.01 21.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.737 -0.744 . . . . 52.34 112.752 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 15.0 m -125.15 138.28 54.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.711 0.291 . . . . 63.44 110.603 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.624 HG13 HD12 ' A' ' 180' ' ' LEU . 4.4 mp -123.72 124.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.272 -0.422 . . . . 70.14 109.896 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 6.6 t80 -108.47 116.37 31.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.73 -0.841 . . . . 61.22 108.73 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -128.5 134.58 48.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.936 0.398 . . . . 73.53 111.011 -177.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.632 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 56.2 mtpt -108.02 127.52 53.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.428 -0.351 . . . . 71.52 110.549 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.44 110.61 27.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -49.8 111.79 0.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.398 -0.819 . . . . 71.53 112.349 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 200' ' ' LYS . 34.0 ttmt 72.84 1.39 4.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.329 -0.851 . . . . 62.45 112.257 170.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -103.73 -73.14 0.68 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 74.41 110.148 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 225' ' ' TYR . 3.2 pp -162.96 170.8 17.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.663 -0.699 . . . . 74.24 109.619 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.632 ' HG3' ' HG2' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -125.52 134.64 51.93 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.941 -0.392 . . . . 71.2 109.941 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.0 m -124.03 142.54 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.136 0.493 . . . . 72.44 111.44 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HB3' HG11 ' A' ' 17' ' ' VAL . . . -130.33 136.18 48.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.966 -0.561 . . . . 71.14 110.154 175.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 221' ' ' ILE . 75.6 t -112.41 134.47 54.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 73.32 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -133.74 126.31 30.42 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.452 -0.573 . . . . 54.31 109.452 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.3 pt? -147.14 135.09 21.36 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.617 -0.433 . . . . 65.11 110.69 174.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.767 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -134.58 149.57 50.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.645 . . . . 71.01 111.432 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -100.05 130.87 46.25 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.0 t -109.91 124.53 51.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.657 . . . . 73.45 110.894 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.57 58.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.906 . . . . 73.02 111.442 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 129.95 -54.04 0.79 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.635 -0.986 . . . . 62.14 110.635 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.733 ' HB2' HD21 ' A' ' 216' ' ' ASN . 47.9 m-80 -139.04 172.41 12.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.219 -1.03 . . . . 75.32 108.219 172.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -81.57 67.66 7.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.973 0.416 . . . . 75.15 110.887 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.733 HD21 ' HB2' ' A' ' 214' ' ' ASN . 25.2 m-80 -102.78 129.21 49.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 74.23 110.727 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 m -108.63 123.51 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.334 -0.617 . . . . 74.5 109.334 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 41.7 ttm-85 -101.13 114.81 29.11 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.764 -0.828 . . . . 75.21 108.764 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.58 ' HB3' ' HB2' ' A' ' 239' ' ' ASN . 83.7 t80 -117.8 136.62 53.29 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.507 0.194 . . . . 74.04 110.761 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.67 140.45 7.43 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.792 -0.718 . . . . 64.53 111.825 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.941 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -131.1 136.86 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.791 0.329 . . . . 71.44 110.799 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.634 ' HB3' HG12 ' A' ' 17' ' ' VAL . . . -128.81 139.78 52.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.01 -0.541 . . . . 62.44 110.23 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.1 126.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.591 0.234 . . . . 75.33 110.584 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 17.2 pttm -102.53 119.52 38.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.845 0.831 . . . . 42.43 110.314 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.561 ' HD2' ' HB3' ' A' ' 202' ' ' LEU . 37.5 t80 -112.3 116.54 30.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.274 -1.33 . . . . 63.21 110.156 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -111.48 121.27 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.188 0.518 . . . . 32.1 111.252 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 9.9 pt -110.26 -27.41 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.305 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 19.2 t70 -135.15 143.24 44.98 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 109.57 -0.53 . . . . 74.24 109.57 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.53 -29.22 58.96 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.573 2.182 . . . . 70.52 112.487 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -103.56 4.12 35.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.375 -0.375 . . . . 73.1 111.307 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -143.6 121.27 11.84 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.394 0.616 . . . . 71.5 111.872 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -139.87 128.65 23.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.781 -0.645 . . . . 72.02 109.539 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.07 125.14 50.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.002 -0.279 . . . . 71.33 110.543 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 224' ' ' LYS . 14.2 m -116.47 118.08 31.69 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 52.34 110.043 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -122.98 141.52 51.85 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.789 -0.364 . . . . 75.51 110.971 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.05 144.24 38.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.316 -0.402 . . . . 73.51 110.229 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 243' ' ' ILE . 9.1 p -131.56 142.61 42.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.751 -0.463 . . . . 54.42 109.751 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -107.42 150.57 26.61 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.068 -0.716 . . . . 73.45 109.068 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 219' ' ' PHE . 6.2 t30 -58.87 -11.78 3.69 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.782 0.676 . . . . 73.42 112.147 -174.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.622 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m -78.66 15.36 1.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.54 -0.541 . . . . 75.41 109.54 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.4 m 68.45 28.27 6.08 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 115.137 -0.938 . . . . 64.31 110.554 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 240' ' ' SER . 42.7 mt -100.36 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.561 -0.456 . . . . 73.52 110.627 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 237' ' ' VAL . 1.7 mp -108.51 115.41 49.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 120.879 -0.329 . . . . 61.21 110.173 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -123.59 133.39 8.87 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.929 -0.653 . . . . 44.35 112.301 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -128.06 150.72 49.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.341 0.591 . . . . 63.55 111.593 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -132.32 121.65 3.06 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 114.991 -1.004 . . . . 61.12 110.777 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -103.59 115.66 30.92 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.921 -0.4 . . . . 63.34 109.921 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.6 m -98.31 115.51 28.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.842 0.353 . . . . 72.51 110.211 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -126.19 128.92 48.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.096 -0.502 . . . . 63.14 109.903 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.1 m -95.09 119.12 33.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.739 0.304 . . . . 44.14 110.33 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 3.0 mm? -108.1 86.04 2.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 51.1 109.793 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 251' ' ' LEU . 0.0 OUTLIER 71.55 156.06 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.445 -0.798 . . . . 72.43 110.546 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.0 95.81 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.703 2.269 . . . . 73.01 112.854 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 142.18 -19.43 2.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.486 -0.864 . . . . 72.34 112.865 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.49 122.02 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.077 0.465 . . . . 72.21 111.903 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 43.1 mtmt -112.07 126.27 54.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 73.34 109.975 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -100.93 124.01 45.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.507 -0.553 . . . . 73.11 109.507 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 36.9 m -120.34 111.02 17.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 72.54 110.54 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.913 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -97.73 123.59 41.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.212 -1.033 . . . . 74.23 108.212 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 21.8 m -130.21 140.6 50.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.647 0.26 . . . . 51.22 110.462 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.499 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -154.89 128.8 8.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.644 -0.253 . . . . 73.12 110.942 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 274' ' ' LYS . 2.3 tm? -101.68 117.07 34.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.46 -0.941 . . . . 63.4 108.46 173.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.476 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.6 mm? -100.02 109.95 22.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.781 -0.645 . . . . 74.21 109.547 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.456 ' HA ' HD22 ' A' ' 242' ' ' LEU . 2.9 m-20 -69.67 103.75 2.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.388 -0.824 . . . . 75.51 109.522 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.65 -8.45 7.54 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.097 -0.956 . . . . 52.21 112.581 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 267' ' ' ASN . 48.3 tptt -64.99 -28.63 69.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.547 -0.538 . . . . 61.11 109.547 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 266' ' ' LYS . 44.5 t-20 157.38 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.604 1.19 . . . . 72.22 108.697 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -65.44 -45.15 93.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 112.918 0.71 . . . . 73.23 112.918 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.03 -44.87 91.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.676 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.96 -13.09 16.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.829 0.307 . . . . 44.23 111.829 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -103.34 -14.23 26.51 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.048 -1.072 . . . . 72.34 112.768 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 106.98 153.83 19.6 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.621 -0.799 . . . . 73.43 112.434 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -110.87 147.23 35.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.355 -0.98 . . . . 73.32 108.355 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.9 mmtm -94.0 134.96 35.85 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.335 -1.357 . . . . 64.31 107.335 173.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.92 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.5 tm? -135.29 136.12 41.37 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.255 0.55 . . . . 62.43 110.907 -170.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.461 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.59 117.16 1.23 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 110.52 -1.032 . . . . 65.12 110.52 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.913 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -112.21 122.3 47.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.926 -1.139 . . . . 72.21 107.926 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -129.36 137.34 9.51 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.148 -1.025 . . . . 72.3 112.995 -170.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -114.07 130.55 56.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.936 -0.764 . . . . 71.34 108.936 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.812 ' HG2' ' HB3' ' A' ' 30' ' ' ASP . 50.8 mt-10 -121.02 112.1 18.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.812 -0.44 . . . . 64.32 109.812 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.734 ' HB3' HD13 ' A' ' 31' ' ' LEU . 14.7 t80 -103.53 141.92 35.17 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.854 -0.795 . . . . 71.25 108.854 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.74 141.89 40.97 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.884 0.373 . . . . 51.5 111.348 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.717 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -123.6 110.4 14.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.989 -0.55 . . . . 74.43 109.679 172.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 34' ' ' LYS . 4.2 mm? -124.09 -47.35 1.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.491 -0.777 . . . . 64.53 109.822 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.423 -0.799 . . . . 74.43 109.285 176.12 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtp . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.727 0.299 . . . . 73.41 111.525 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.49 79.65 1.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.45 -0.574 . . . . 71.24 109.45 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.825 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 4.5 p -110.68 135.85 20.71 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.797 -0.638 . . . . 71.0 111.12 -171.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.98 155.38 15.04 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.586 2.191 . . . . 74.1 110.973 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.99 101.16 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.925 1.75 . . . . 60.35 111.956 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.669 ' HB ' HD21 ' A' ' 150' ' ' LEU . 6.7 p -73.48 -19.3 60.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.64 . . . . 74.05 110.411 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.616 ' HB2' HG21 ' A' ' 143' ' ' VAL . 90.2 t80 -56.55 -24.15 44.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.999 -1.001 . . . . 75.51 110.441 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.22 -26.12 33.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.802 -0.635 . . . . 55.43 110.057 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.737 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 18.6 t70 -82.99 -14.8 53.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.856 -0.611 . . . . 71.54 109.447 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.023 HD21 ' HA3' ' A' ' 152' ' ' GLY . 2.3 tp -55.85 -34.39 65.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.802 -1.09 . . . . 74.22 110.637 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.565 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . -136.25 21.9 3.44 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 64.41 111.705 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.737 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 4.7 ttpm? -56.71 -56.08 25.99 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.418 . . . . 74.5 111.178 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.17 -38.1 89.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.65 -0.704 . . . . 73.35 110.681 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.27 80.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 64.41 112.417 -174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 98.7 mtt180 -57.88 -42.23 84.19 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.635 0.606 . . . . 74.14 112.635 -170.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.07 -37.89 86.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 74.45 110.507 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.83 -34.77 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 41.41 110.918 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -72.32 -42.6 65.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 72.43 111.814 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -126.9 57.68 1.45 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.994 0.902 . . . . 64.02 110.652 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 21' ' ' GLY . 45.3 tptt -75.16 177.31 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.501 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 20' ' ' LYS . . . -64.5 116.62 9.26 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.554 -0.832 . . . . 43.14 111.68 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.73 173.98 6.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 73.31 110.761 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.928 ' HA3' ' HB3' ' A' ' 274' ' ' LYS . . . -83.14 88.17 1.49 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.749 -0.738 . . . . 63.34 112.786 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -93.26 -4.33 52.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.033 -0.358 . . . . 74.52 110.033 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.19 11.5 79.36 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.933 -0.576 . . . . 71.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.31 155.15 39.18 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 122.162 0.982 . . . . 71.42 112.797 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.976 HG23 HD23 ' A' ' 277' ' ' LEU . 43.6 mm -94.03 121.25 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.704 -1.589 . . . . 63.45 107.809 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 6.5 mtpm? -114.83 139.44 49.75 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.852 -0.339 . . . . 63.04 110.71 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tt -142.84 142.66 31.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.081 173.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -144.66 128.05 16.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.61 0.719 . . . . 72.34 110.434 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 281' ' ' PHE . 11.8 tp -120.84 126.75 50.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.896 -1.047 . . . . 74.24 110.33 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 2.0 ptmm? -121.8 124.49 44.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.483 0.659 . . . . 62.42 110.514 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 3.6 t -110.68 121.86 46.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.084 -1.08 . . . . 62.1 108.084 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.562 ' HB3' ' HG3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -143.41 139.05 29.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.791 0.805 . . . . 73.41 112.706 -170.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 37' ' ' ASN . 23.1 t -139.32 137.93 36.24 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.944 -1.873 . . . . 62.23 105.944 168.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -79.62 44.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.044 0.926 . . . . 62.45 111.128 -171.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 35' ' ' SER . 1.4 m-20 -98.37 19.41 14.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.966 -1.47 . . . . 75.4 107.431 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 95.62 -7.05 68.09 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.495 -1.23 . . . . 74.32 113.253 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.4 mm? -102.77 128.41 49.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.252 1.026 . . . . 63.33 113.489 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 25.6 tt0 -140.56 117.84 11.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.898 -0.779 . . . . 65.04 108.898 160.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 87.9 t80 -108.16 120.54 42.62 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.955 -0.466 . . . . 74.34 109.812 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 34.0 m -120.85 115.95 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 72.23 110.48 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -114.41 123.54 49.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.547 -0.538 . . . . 61.41 109.547 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 20.1 m -117.69 133.89 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.237 -0.438 . . . . 63.44 110.378 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.63 125.33 2.71 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.832 -0.699 . . . . 73.31 111.606 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.6 m -119.69 133.99 55.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 72.1 109.037 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -137.43 146.46 44.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.158 0.504 . . . . 35.53 111.858 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -68.87 142.91 54.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.503 -0.771 . . . . 64.34 109.157 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -57.88 -21.76 44.75 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.209 0.528 . . . . 74.22 111.271 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.75 7.46 33.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 64.24 110.632 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.9 p 50.05 25.66 1.78 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.383 1.073 . . . . 64.3 113.318 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 p -99.72 -18.44 17.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 70.52 111.712 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -134.93 108.64 8.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.183 -0.673 . . . . 72.15 109.183 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 47' ' ' ALA . 23.6 t -125.3 120.77 58.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.026 0.441 . . . . 74.03 110.742 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -111.22 126.49 54.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.146 0.498 . . . . 64.41 110.359 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.26 155.49 16.06 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.855 -0.688 . . . . 73.11 112.425 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.9 m -143.65 126.78 16.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.438 -0.949 . . . . 71.42 108.438 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.9 tm? -121.3 124.61 45.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.38 -0.528 . . . . 75.0 110.479 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 44.2 mt-10 -114.82 118.71 34.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.92 -0.582 . . . . 73.03 110.122 174.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 m -97.7 117.2 31.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.472 -1.307 . . . . 73.31 107.472 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 24.3 mtpp -121.93 139.38 53.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.325 0.583 . . . . 70.44 110.554 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 76.5 m-85 -109.67 120.82 43.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.416 -0.811 . . . . 73.11 109.082 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -118.04 109.16 16.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.258 0.551 . . . . 53.15 111.304 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 20.0 t90 -112.9 92.46 4.02 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.201 -0.909 . . . . 74.21 109.514 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 67' ' ' TYR . 10.8 m 71.63 151.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.134 0.896 . . . . 55.03 111.393 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.44 -38.21 63.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.561 0.696 . . . . 61.01 110.08 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.483 ' H ' HG22 ' A' ' 65' ' ' THR . 14.0 p90 -121.43 103.04 8.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 74.14 109.121 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.39 -102.07 0.17 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.225 -0.988 . . . . 72.32 112.141 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.7 mm? -117.51 136.55 53.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.322 0.582 . . . . 55.01 112.293 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -135.39 112.23 10.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.198 -0.91 . . . . 61.01 109.327 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 56.2 t80 -117.32 132.5 56.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.789 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 58.7 m -128.67 117.65 21.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.777 -0.192 . . . . 55.14 111.408 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -103.31 121.14 42.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.879 -1.156 . . . . 65.1 107.879 167.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -123.36 102.37 7.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.967 -0.56 . . . . 73.05 110.856 -168.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.849 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 67.9 t90 -96.67 132.84 41.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 74.25 109.889 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -119.76 165.82 14.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.852 -0.425 . . . . 63.41 109.852 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.7 t -64.84 -6.3 7.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.02 0.438 . . . . 74.53 111.932 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -79.82 -3.28 47.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.033 -0.531 . . . . 72.43 110.57 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 14.7 m120 73.97 18.64 3.22 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.92 0.763 . . . . 74.1 110.028 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.6 m -102.93 135.92 43.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 72.35 110.487 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.849 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 4.8 mp -112.79 119.71 38.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.246 -0.434 . . . . 71.14 110.412 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 130.55 10.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.74 -0.743 . . . . 60.14 111.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.3 m -112.78 107.48 16.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.011 0.434 . . . . 60.35 111.144 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.789 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 21.7 tt0 -105.39 127.8 53.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.588 -0.733 . . . . 63.15 109.885 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.59 ' CG2' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -130.02 120.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.364 -0.606 . . . . 64.12 109.364 169.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 24.6 m -126.36 129.24 48.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.685 -0.689 . . . . 52.5 110.229 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.02 134.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 70.12 111.253 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' OE2' ' HG3' ' A' ' 96' ' ' LYS . 67.8 mm-40 -96.46 118.86 33.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.55 -0.908 . . . . 62.13 108.55 172.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.27 122.9 28.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.822 -0.436 . . . . 73.12 109.822 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -85.56 -27.58 25.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.235 -0.438 . . . . 71.41 110.99 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.37 -44.8 42.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.295 -0.631 . . . . 53.31 109.295 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -99.61 67.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.516 -0.92 . . . . 62.45 108.516 170.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -49.95 131.23 22.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 52.12 111.759 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA2' ' HD2' ' A' ' 119' ' ' LYS . . . 102.85 -15.16 55.78 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.11 -0.95 . . . . 71.12 112.444 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.696 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -78.96 121.07 24.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.15 0.475 . . . . 64.02 111.126 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.478 ' HG3' ' OE2' ' A' ' 88' ' ' GLU . 48.9 tttp -118.06 111.78 19.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.571 -0.741 . . . . 74.43 109.574 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.632 HD12 HG22 ' A' ' 116' ' ' THR . 1.9 mm? -103.53 128.53 50.74 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.875 -0.417 . . . . 73.51 109.875 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.726 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 10.5 m -128.82 122.65 30.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.458 -0.337 . . . . 71.44 111.375 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.607 ' CE2' HD13 ' A' ' 114' ' ' ILE . 47.4 m-85 -119.55 115.67 24.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.477 -0.564 . . . . 75.02 109.477 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.1 t70 -115.42 122.05 44.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.55 -0.537 . . . . 73.15 109.55 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -134.83 121.69 20.99 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.061 0.457 . . . . 64.42 110.455 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.3 m -99.29 121.93 41.76 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.01 -0.541 . . . . 62.04 109.915 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -106.35 119.37 39.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 72.31 109.716 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 m -115.16 102.37 54.67 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.894 -0.41 . . . . 22.23 109.894 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.73 -33.04 28.71 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.559 2.173 . . . . 65.53 111.51 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -83.67 -46.11 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.643 -0.708 . . . . 75.24 111.102 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -70.25 -36.26 74.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.877 0.37 . . . . 75.23 110.806 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.26 -18.34 57.57 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.033 -0.603 . . . . 72.12 112.487 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.62 123.89 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.138 0.495 . . . . 62.14 110.568 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.22 116.56 28.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.92 -0.77 . . . . 70.13 108.92 173.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 132' ' ' ASP . 10.2 m120 -120.1 144.37 47.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.417 -174.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.85 141.0 36.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.376 -0.375 . . . . 75.03 110.597 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.609 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -128.82 142.56 50.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.908 -0.404 . . . . 73.3 109.908 175.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.607 HD13 ' CE2' ' A' ' 99' ' ' PHE . 2.2 tp -118.07 117.68 55.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.885 -0.598 . . . . 74.02 110.08 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.726 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 27.9 ttpp -115.19 119.76 37.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.049 -0.523 . . . . 62.21 110.029 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.632 HG22 HD12 ' A' ' 97' ' ' LEU . 17.6 p -113.04 116.95 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.327 -0.62 . . . . 75.45 109.327 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.47 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -136.09 116.65 1.5 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.86 -1.162 . . . . 64.23 112.728 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.696 ' HB3' HD22 ' A' ' 95' ' ' LEU . 21.4 p90 -108.1 122.67 47.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.583 -0.525 . . . . 73.52 109.583 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -109.29 123.59 49.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.547 0.689 . . . . 71.44 110.965 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -106.25 165.02 11.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.741 -1.118 . . . . 64.34 109.256 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.825 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 10.4 pt-20 -52.65 -29.81 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.273 0.842 . . . . 51.32 113.273 -167.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -120.42 -6.1 9.81 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.924 -0.71 . . . . 63.15 112.502 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.37 126.27 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.424 -0.91 . . . . 64.15 113.011 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.818 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.8 OUTLIER -100.94 121.57 41.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.725 -0.671 . . . . 63.43 110.783 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 142' ' ' LEU . 3.9 mm? -112.05 126.69 55.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.229 0.212 . . . . 55.35 110.577 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.47 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.1 118.64 1.96 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.574 -0.822 . . . . 52.21 112.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 63.0 m -112.3 109.25 18.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.369 . . . . 63.03 110.51 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.63 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 4.3 t70 -108.82 146.01 34.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.832 -0.622 . . . . 71.41 110.125 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.484 ' HG3' HD13 ' A' ' 138' ' ' ILE . 22.2 ttt -135.96 117.21 14.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.045 -0.354 . . . . 72.44 110.045 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -100.22 117.35 34.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.512 -0.551 . . . . 73.53 109.512 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -98.18 122.98 42.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.121 0.486 . . . . 62.12 112.17 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.419 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 28.3 t70 -117.29 148.26 41.84 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.295 -1.002 . . . . 75.15 108.295 166.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -65.78 -19.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.108 0.41 . . . . 71.11 112.108 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.65 -12.26 29.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.32 . . . . 42.34 111.21 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.89 122.8 0.63 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 52.23 112.394 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.509 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 5.8 Cg_endo -87.3 145.78 7.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.602 2.868 . . . . 72.54 112.923 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 p -117.82 148.33 42.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.87 -0.605 . . . . 72.02 110.385 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 41.6 mm -107.55 118.39 55.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 110.265 -0.272 . . . . 64.04 110.265 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 155' ' ' MET . 70.6 mtm180 -105.7 116.9 32.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.127 0.489 . . . . 73.4 109.969 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.02 134.07 11.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.102 -1.046 . . . . 74.11 111.982 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.22 127.66 40.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.404 . . . . 61.34 110.557 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 125' ' ' LEU . 13.0 tp -132.51 124.23 28.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 64.15 110.12 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.818 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 36.1 t -123.79 120.78 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.486 . . . . 75.33 110.539 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' A' ' 142' ' ' LEU . 4.9 mp -110.62 140.7 44.7 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.388 -0.369 . . . . 75.1 110.214 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.88 119.17 4.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.949 -0.643 . . . . 65.24 112.857 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 78.3 m-85 -128.21 148.23 50.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.867 -0.79 . . . . 71.22 108.867 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -53.48 103.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 72.13 110.781 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.06 -32.94 6.71 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.247 -0.888 . . . . 74.52 112.497 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 93.4 m95 -108.06 123.45 48.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.721 0.638 . . . . 72.33 112.721 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.669 HD21 ' HB ' ' A' ' 6' ' ' THR . 2.0 tm? -113.99 137.35 51.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.31 -1.737 . . . . 52.45 106.31 170.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -135.73 132.83 37.34 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.954 -0.699 . . . . 64.12 110.813 -167.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.023 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -132.57 132.77 6.76 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.369 -0.919 . . . . 74.41 112.045 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.449 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 53.4 m-85 -132.49 118.2 18.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.636 -0.505 . . . . 74.31 109.636 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 1.9 mp0 -120.35 144.27 47.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.0 -0.546 . . . . 71.44 109.989 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.418 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 23.5 ptp -145.3 147.47 32.38 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.66 0.266 . . . . 64.51 110.578 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.579 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 8.3 t30 -113.95 117.37 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.219 -0.659 . . . . 74.43 109.219 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.86 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 69.7 t80 -94.59 125.18 39.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.61 -0.723 . . . . 72.53 111.062 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 161' ' ' LYS . 44.8 tt0 -91.29 103.98 16.58 Favored 'General case' 0 C--O 1.266 1.929 0 CA-C-N 115.104 -0.953 . . . . 71.41 109.384 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.28 -18.61 63.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 112.774 -2.012 . . . . 71.23 111.646 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.92 75.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.879 0.847 . . . . 63.21 108.907 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.516 ' HD3' ' OE2' ' A' ' 158' ' ' GLU . 2.0 mptm? -111.55 -159.37 0.68 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 73.41 107.996 168.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.3 m -107.9 28.67 8.0 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 122.252 -0.28 . . . . 62.1 110.287 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 158' ' ' GLU . 28.9 mtm180 -132.15 171.69 13.33 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 118.94 -1.104 . . . . 64.43 111.797 -163.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.6 m -103.06 133.01 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.389 -0.967 . . . . 71.42 108.389 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.0 p -99.89 1.38 42.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.067 0.46 . . . . 72.2 111.501 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.605 ' HG3' ' HB2' ' A' ' 186' ' ' ASP . 35.7 tt0 -150.87 130.82 13.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 71.31 109.687 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 m -121.78 112.87 18.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.857 -0.611 . . . . 65.11 109.936 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 84.0 m-20 -107.32 127.97 54.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.432 -0.581 . . . . 75.12 109.432 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.619 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.6 m-85 -121.39 153.01 38.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.286 -0.566 . . . . 74.52 111.065 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -148.67 128.53 13.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.504 -0.771 . . . . 71.41 109.833 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.1 t -125.81 126.17 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.501 -0.555 . . . . 70.14 109.501 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -117.32 130.58 8.94 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.624 -0.798 . . . . 63.11 112.713 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -113.03 120.2 40.53 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.557 -1.275 . . . . 73.35 107.557 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HG3' HE21 ' A' ' 179' ' ' GLN . 83.6 tttt -118.02 126.86 53.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.693 0.759 . . . . 74.41 112.797 -167.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 178' ' ' PHE . 23.8 m -131.89 162.56 30.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.31 -1.367 . . . . 64.24 107.31 169.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -46.76 -50.65 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.537 0.569 . . . . 61.24 112.537 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 7.9 pt-20 -116.16 10.95 15.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.094 0.473 . . . . 63.22 111.544 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.744 ' HD1' ' HG2' ' A' ' 196' ' ' GLN . 61.2 t80 -137.13 121.28 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.193 -0.458 . . . . 64.53 110.526 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.435 HE21 ' HG3' ' A' ' 174' ' ' LYS . 87.5 mt-30 -133.61 122.75 23.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.208 0.528 . . . . 71.24 110.605 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.744 HD12 HG13 ' A' ' 194' ' ' ILE . 3.2 tt -111.91 131.98 55.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.388 -0.597 . . . . 74.14 109.388 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -129.85 115.16 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.195 0.521 . . . . 73.24 109.982 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 27.4 m -86.25 135.41 33.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.397 -0.819 . . . . 73.4 109.088 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -128.66 138.1 51.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.227 0.536 . . . . 73.11 111.087 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 53.6 t -132.13 128.42 59.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 64.34 110.133 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -115.17 95.63 5.29 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.896 -0.779 . . . . 75.22 108.896 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.605 ' HB2' ' HG3' ' A' ' 166' ' ' GLN . 29.8 t0 58.46 -174.0 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.842 -1.072 . . . . 75.35 109.793 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -75.69 -6.73 82.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.617 -0.801 . . . . 72.01 111.783 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 186' ' ' ASP . 7.2 t -89.59 -27.42 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.455 0.539 . . . . 64.22 112.455 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.45 114.26 15.33 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 119.911 -0.716 . . . . 52.25 111.023 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -133.83 132.85 40.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.783 0.325 . . . . 72.3 110.583 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -166.34 -159.31 11.98 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.785 -0.721 . . . . 63.12 112.088 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.19 153.78 24.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.889 -0.672 . . . . 64.11 111.979 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.0 m -126.8 139.34 53.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.087 0.47 . . . . 62.41 110.255 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.744 HG13 HD12 ' A' ' 180' ' ' LEU . 4.5 mp -119.47 129.72 74.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.874 -0.603 . . . . 75.35 109.724 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -125.19 119.13 27.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.395 -0.594 . . . . 74.33 109.395 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.744 ' HG2' ' HD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -125.56 120.04 29.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.156 -0.475 . . . . 71.03 110.405 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.916 ' HG3' ' HG2' ' A' ' 203' ' ' GLU . 58.1 tttm -106.11 116.03 31.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.295 -0.631 . . . . 73.53 109.295 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 200' ' ' LYS . 16.1 t -86.33 143.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.714 -0.846 . . . . 72.53 108.714 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -73.36 6.33 3.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.61 0.719 . . . . 73.41 110.508 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.59 ' H ' HG12 ' A' ' 198' ' ' VAL . 49.0 tptt -98.19 37.71 1.41 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.062 -0.972 . . . . 73.23 108.911 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 200' ' ' LYS . 34.6 mmtp 75.95 -55.54 0.6 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.992 -1.004 . . . . 63.14 112.884 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.14 132.62 53.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.768 0.794 . . . . 73.2 112.752 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.916 ' HG2' ' HG3' ' A' ' 197' ' ' LYS . 31.3 mt-10 -110.7 142.97 41.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.611 -1.177 . . . . 75.43 109.303 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.9 m -131.68 138.99 48.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.661 -0.245 . . . . 52.24 110.58 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -131.01 148.94 52.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.655 -0.248 . . . . 51.33 110.657 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.81 HG22 HG22 ' A' ' 221' ' ' ILE . 92.1 t -135.11 140.45 45.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.998 -0.371 . . . . 65.23 109.998 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -124.76 127.07 46.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.76 0.314 . . . . 71.12 110.513 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.3 mm? -123.01 136.57 54.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.619 . . . . 61.4 110.016 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.416 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.21 129.58 14.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.371 -0.377 . . . . 52.51 110.22 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -114.66 126.78 55.28 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.989 -0.745 . . . . 74.24 108.989 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 188' ' ' THR . 6.4 t -101.82 112.99 25.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.441 0.639 . . . . 60.21 109.638 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.24 126.42 27.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.303 -0.862 . . . . 75.4 110.922 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 156.44 -78.55 0.19 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.642 -0.789 . . . . 31.32 112.484 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.76 50.52 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.43 . . . . 71.04 111.367 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.0 m 58.54 18.88 6.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.955 0.724 . . . . 70.12 112.955 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.455 ' HB3' ' CG2' ' A' ' 211' ' ' THR . 48.1 t-20 -75.94 114.31 14.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.989 0.423 . . . . 60.43 110.053 -176.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.5 m -113.34 130.87 56.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.778 -0.646 . . . . 72.05 110.862 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -106.04 125.89 51.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 74.21 110.121 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 239' ' ' ASN . 9.5 t80 -130.44 141.52 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.233 -0.894 . . . . 64.33 109.25 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.27 147.78 15.66 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.445 -0.883 . . . . 73.44 112.0 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.81 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -128.24 144.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.725 0.298 . . . . 75.31 110.213 177.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -130.51 142.25 50.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.979 -0.555 . . . . 64.32 110.851 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -116.42 135.16 54.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.798 -0.637 . . . . 62.2 109.627 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 64.6 tttt -129.63 117.32 20.19 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.283 -0.417 . . . . 64.43 110.285 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -132.78 125.85 31.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.042 0.448 . . . . 54.31 111.005 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -91.92 100.77 13.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.042 -0.725 . . . . 74.23 109.042 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 17.4 tt -71.03 -30.2 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 71.22 111.061 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.715 ' HB2' ' HD2' ' A' ' 229' ' ' PRO . 3.4 p30 -156.22 164.07 22.7 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.722 -0.844 . . . . 71.4 108.722 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 228' ' ' ASP . 13.6 Cg_endo -56.26 -20.42 31.78 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.865 2.377 . . . . 70.24 114.53 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -104.62 -19.42 13.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.904 -0.318 . . . . 62.31 111.58 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -124.3 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.322 0.582 . . . . 63.33 112.312 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.4 m -125.09 133.34 52.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.637 -0.711 . . . . 64.42 110.262 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -114.42 133.15 55.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.88 0.371 . . . . 72.33 110.159 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 11.3 p -137.97 149.33 46.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.123 -0.489 . . . . 72.14 110.42 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -144.55 155.99 43.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.867 -0.42 . . . . 74.44 109.867 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -144.87 149.64 35.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.441 . . . . 61.52 111.067 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 1.2 t -127.28 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.774 -0.648 . . . . 72.35 110.017 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.7 m120 -106.06 150.16 26.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.106 -0.497 . . . . 55.13 109.956 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 219' ' ' PHE . 22.5 p-10 -45.07 -32.24 1.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.807 1.317 . . . . 75.12 113.692 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.659 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 19.7 m -82.23 25.64 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.873 0.368 . . . . 73.5 110.748 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.405 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 22.2 m 69.84 31.1 3.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.591 -0.731 . . . . 63.41 110.863 174.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 262' ' ' LEU . 5.2 mp -88.17 126.95 35.4 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 120.686 -0.406 . . . . 73.13 110.618 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.71 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.88 116.65 53.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 123.884 0.74 . . . . 73.14 109.859 -177.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 262' ' ' LEU . . . -129.84 151.87 19.46 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.157 -1.021 . . . . 63.13 112.929 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.499 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -136.7 154.22 50.67 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.431 . . . . 72.11 110.952 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.71 120.76 1.32 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.253 -0.739 . . . . 60.22 111.253 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -112.36 119.07 37.01 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.992 -0.373 . . . . 73.24 109.992 -177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -119.73 121.93 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.471 0.653 . . . . 71.35 110.661 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 24.7 tt0 -123.9 131.07 53.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.854 -0.612 . . . . 73.22 109.802 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.0 m -87.21 114.37 23.76 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.435 -0.348 . . . . 73.43 110.456 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.796 ' HG ' ' HD2' ' A' ' 253' ' ' PRO . 19.2 tp -75.71 139.7 42.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.555 -0.906 . . . . 71.25 108.555 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -55.94 -43.94 99.46 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.787 1.032 . . . . 73.04 113.787 -168.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.796 ' HD2' ' HG ' ' A' ' 251' ' ' LEU . 72.4 Cg_exo -43.8 -64.33 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 75.23 113.703 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 163.95 38.65 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 120.721 -0.752 . . . . 15.43 111.696 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 279' ' ' LEU . 1.8 tp -143.46 122.2 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.821 -0.437 . . . . 71.01 109.821 -174.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.533 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 12.7 ptmm? -106.63 133.19 51.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.455 0.645 . . . . 74.24 110.534 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.7 tp -99.91 124.14 44.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.755 -1.111 . . . . 63.13 110.025 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.7 t -125.45 112.54 16.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.645 0.736 . . . . 64.32 110.671 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -100.17 124.78 45.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.893 -1.151 . . . . 74.03 107.893 175.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.2 p -129.94 139.55 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.981 0.42 . . . . 73.43 111.006 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.5 128.64 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 75.5 110.2 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -110.25 121.69 45.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.353 -0.98 . . . . 64.3 108.353 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.944 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -102.28 109.47 21.15 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.991 -0.744 . . . . 52.23 108.991 176.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.006 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 1.7 m-20 -68.64 106.09 2.49 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.69 -1.226 . . . . 65.32 107.69 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -53.49 -24.85 25.54 Favored Glycine 0 C--N 1.32 -0.355 0 O-C-N 123.517 0.511 . . . . 54.53 113.48 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -91.12 -26.48 19.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.672 0.272 . . . . 74.03 111.039 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 1.006 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 7.2 m-20 -96.69 -30.8 13.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.463 -0.335 . . . . 74.11 111.882 -173.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.944 HG11 ' HB3' ' A' ' 263' ' ' LEU . 21.7 m -62.95 -18.68 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 71.51 111.216 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -62.19 -31.08 71.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 63.24 109.783 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.27 9.99 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 74.21 110.63 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.17 15.94 63.73 Favored Glycine 0 CA--C 1.517 0.17 0 CA-C-N 115.969 -0.56 . . . . 71.34 112.985 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.69 96.12 2.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 61.13 112.479 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -110.18 142.82 41.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.082 -0.34 . . . . 74.1 110.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.928 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 58.4 mttm -101.06 134.48 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.006 -0.739 . . . . 75.51 109.006 170.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.31 132.42 37.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.795 -0.446 . . . . 72.44 109.795 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.49 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -148.07 132.69 4.32 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.872 -0.68 . . . . 43.32 111.611 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.976 HD23 HG23 ' A' ' 27' ' ' ILE . 45.4 tp -114.77 145.65 41.86 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 64.22 110.722 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.579 ' H ' HD12 ' A' ' 277' ' ' LEU . . . -142.32 125.47 2.67 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 63.41 112.006 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 255' ' ' ILE . 2.9 mm? -109.23 129.25 55.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.112 -0.699 . . . . 73.31 109.112 170.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.533 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 20.9 mt-10 -113.91 110.69 20.49 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.089 -0.708 . . . . 74.35 109.089 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.561 ' CD2' HD13 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -116.77 135.16 53.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.096 0.475 . . . . 73.33 110.155 -173.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -130.96 112.67 13.16 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.899 -0.778 . . . . 74.52 108.899 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.718 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -83.03 107.55 15.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 35.51 109.833 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 283' ' ' ALA . 3.4 mm? -137.9 -61.11 0.63 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.988 -1.006 . . . . 63.45 109.071 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.991 -0.528 . . . . 61.0 109.8 177.102 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.657 0.265 . . . . 63.05 111.274 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.32 148.68 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.316 . . . . 74.21 110.893 -175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.941 ' HB ' ' HD3' ' A' ' 119' ' ' LYS . 3.8 t -116.02 114.77 41.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.978 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.88 175.07 11.85 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.702 2.268 . . . . 74.31 111.993 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 13.2 Cg_exo -70.79 85.13 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.443 2.095 . . . . 75.15 111.298 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 p -69.38 -34.35 74.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 42.43 111.54 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.598 ' HB3' HG21 ' A' ' 143' ' ' VAL . 10.9 p90 -61.24 -28.71 69.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.139 0.495 . . . . 74.21 110.983 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -84.86 -20.78 30.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 64.34 110.892 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -102.43 -0.12 32.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.177 0.989 . . . . 53.04 108.48 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.857 HD21 ' HA3' ' A' ' 152' ' ' GLY . 8.6 tp -58.04 -24.12 57.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.618 -1.628 . . . . 71.33 110.519 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.64 51.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.619 -0.719 . . . . 52.04 111.916 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 13.8 ptmm? -62.38 -44.04 97.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.653 0.264 . . . . 72.23 111.504 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -65.23 -38.95 91.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.182 0.515 . . . . 74.31 110.971 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 193' ' ' SER . . . -70.08 -43.79 70.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 44.24 111.95 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.67 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 5.4 ptm180 -61.2 -28.38 69.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.477 -0.329 . . . . 73.41 111.104 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.89 -42.48 84.73 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.375 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -82.68 -31.46 9.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.155 -0.475 . . . . 70.44 110.794 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 94.6 t80 -71.47 -22.64 61.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 73.53 112.323 -174.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -29.86 117.04 0.13 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.213 0.946 . . . . 74.34 113.352 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -80.42 -9.47 59.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.075 -0.966 . . . . 74.13 110.235 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.94 91.28 1.22 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.045 -0.822 . . . . 61.42 111.045 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -84.13 169.83 14.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.884 0.373 . . . . 72.32 111.055 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.4 112.39 3.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.097 -0.573 . . . . 63.11 112.656 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.432 ' HB2' HD13 ' A' ' 26' ' ' LEU . 45.7 m-85 -92.99 14.46 17.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.696 0.284 . . . . 71.1 110.905 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.7 13.57 53.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 54.34 112.065 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD13 ' HB2' ' A' ' 24' ' ' PHE . 10.7 mp -100.05 160.05 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.025 0.917 . . . . 63.45 112.376 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.715 HG13 HD23 ' A' ' 277' ' ' LEU . 1.7 mp -104.28 127.55 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.071 -1.422 . . . . 61.34 108.789 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -106.87 142.21 36.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.681 0.277 . . . . 71.43 110.47 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -123.68 148.17 46.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.298 -0.41 . . . . 51.43 110.031 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 13.8 t70 -155.16 134.62 12.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 74.45 109.95 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.871 -0.418 . . . . 73.33 109.871 -178.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -126.05 125.35 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.916 0.389 . . . . 73.5 110.087 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -137.68 120.04 15.85 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.025 -0.732 . . . . 63.03 109.025 170.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HE3' HD22 ' A' ' 284' ' ' LEU . 17.9 ptpt -133.41 144.58 49.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.546 . . . . 64.43 111.93 -176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 39' ' ' LEU . 18.8 m -141.21 164.83 29.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 72.24 109.297 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -80.03 26.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.968 0.413 . . . . 72.44 110.995 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 7.6 t-20 -107.28 21.08 18.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.116 0.484 . . . . 53.24 110.286 -173.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 77.11 -6.73 40.69 Favored Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.745 -0.74 . . . . 72.33 113.176 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 39' ' ' LEU . 2.0 pp -102.44 132.94 48.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.837 0.68 . . . . 72.24 112.837 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.066 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 39.3 mt-10 -137.2 124.88 22.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 54.51 109.124 165.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -107.06 120.13 41.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.1 -0.333 . . . . 74.33 110.1 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.861 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 29.5 m -128.77 132.16 47.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 62.24 111.125 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.0 t -125.04 135.28 52.58 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.749 -0.834 . . . . 75.34 108.749 174.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -148.56 125.76 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.007 -0.277 . . . . 73.13 110.708 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.89 168.22 40.99 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.951 -1.119 . . . . 32.42 113.001 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -137.48 135.53 36.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.448 -0.575 . . . . 74.35 109.448 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -149.94 150.62 32.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.266 0.555 . . . . 75.44 111.973 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -71.68 139.53 49.24 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.245 -1.02 . . . . 74.3 108.245 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -67.99 -8.55 38.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.41 0.624 . . . . 42.12 111.144 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -82.34 -3.25 55.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.75 -0.659 . . . . 71.03 109.968 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.9 p 54.48 21.01 3.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.181 0.992 . . . . 51.2 112.651 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 p -91.92 -26.65 18.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 74.51 110.976 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.41 95.99 4.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.502 -0.555 . . . . 74.21 109.502 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 47' ' ' ALA . 44.8 t -125.61 124.15 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.917 -0.583 . . . . 61.55 110.773 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 126.0 25.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.369 -0.604 . . . . 75.22 109.369 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.92 -178.01 37.9 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.263 -0.97 . . . . 63.55 112.786 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 5.0 p -138.4 153.23 48.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.169 0.509 . . . . 50.31 111.057 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.72 124.02 45.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.264 -1.384 . . . . 74.12 107.264 173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.861 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 46.0 mt-10 -110.16 118.06 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.965 -0.561 . . . . 55.52 110.302 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -103.52 120.16 40.31 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.021 -1.103 . . . . 62.45 108.021 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 1.066 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 59.7 mttm -118.41 147.18 43.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.117 -0.492 . . . . 70.1 109.772 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.766 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 67.2 m-85 -118.12 120.18 36.98 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.959 -0.564 . . . . 63.4 109.634 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.606 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 14.6 ttm180 -114.09 106.84 14.86 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.505 0.669 . . . . 73.13 111.606 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -115.2 91.86 3.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.739 -1.119 . . . . 71.52 109.003 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 93.2 m 69.33 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.903 0.752 . . . . 70.5 111.286 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.04 129.03 39.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.987 -0.551 . . . . 73.54 110.5 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HD2' ' HG3' ' A' ' 88' ' ' GLU . 32.2 m-85 62.57 35.05 14.66 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.613 -0.722 . . . . 75.32 110.587 -173.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.03 -90.52 0.97 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.655 -1.378 . . . . 32.25 109.655 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 69' ' ' LEU . 2.1 mm? -122.75 129.42 51.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.313 0.578 . . . . 74.24 111.199 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.6 p -137.78 121.4 17.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.261 -0.881 . . . . 60.52 110.371 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -122.39 123.48 41.43 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.534 -0.543 . . . . 74.34 109.534 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.71 ' HB ' ' HG2' ' A' ' 61' ' ' LYS . 7.4 p -128.3 130.63 48.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.853 -0.739 . . . . 71.33 111.123 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 35.7 tt0 -109.88 121.67 45.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.448 -0.575 . . . . 75.42 109.448 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -109.65 94.21 4.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.74 -0.467 . . . . 73.04 109.74 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.953 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 32.2 t90 -96.7 128.17 43.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.487 -0.324 . . . . 73.34 110.416 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 57' ' ' SER . 1.9 m-20 -106.61 134.21 50.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.862 -0.792 . . . . 71.23 108.862 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.8 m -72.11 -27.56 62.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.716 0.769 . . . . 71.11 109.764 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.54 -24.32 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.813 -1.085 . . . . 74.24 111.836 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.437 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 13.4 t-20 -131.16 -108.71 0.26 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.408 -0.517 . . . . 73.01 112.181 -171.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 104' ' ' SER . 16.4 p -115.46 144.58 43.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.006 0.743 . . . . 75.14 113.006 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.953 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -98.8 119.76 38.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.867 -0.79 . . . . 70.32 108.867 166.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.42 120.95 4.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.423 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -104.4 114.0 27.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.682 0.277 . . . . 72.43 110.576 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 13.6 pt-20 -120.06 132.71 55.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.073 0.463 . . . . 64.11 110.495 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.26 121.77 65.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.837 -0.619 . . . . 63.43 109.357 177.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -117.88 123.04 44.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.657 -0.702 . . . . 74.54 110.805 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -129.45 132.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 74.33 110.354 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.622 ' HG3' ' HD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -91.91 118.73 31.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.164 -1.421 . . . . 71.21 107.164 172.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.522 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 8.5 t70 -56.05 124.05 16.47 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.503 0.502 . . . . 71.35 111.081 -168.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -67.21 -23.31 65.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.874 -0.603 . . . . 74.24 111.222 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.99 -51.58 4.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.711 -0.478 . . . . 73.43 109.711 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.32 77.8 3.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.244 -0.435 . . . . 61.43 110.52 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 89' ' ' ASP . 30.0 mmm180 -63.26 128.45 35.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.961 -0.563 . . . . 75.14 110.031 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.2 8.57 44.03 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.24 -0.744 . . . . 74.43 111.24 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 118' ' ' TYR . 20.8 tp -123.19 120.24 32.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.213 -0.662 . . . . 63.33 109.213 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -118.01 121.0 39.51 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.989 -0.55 . . . . 71.31 109.764 -173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -104.64 127.09 52.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.709 . . . . 63.5 109.991 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 93.5 m -129.2 118.62 22.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.256 -0.429 . . . . 73.4 110.552 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -111.32 115.8 29.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.267 -0.642 . . . . 74.5 109.267 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 3.0 p30 -117.47 151.03 37.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.297 0.57 . . . . 71.01 110.613 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.508 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 50.4 m -142.13 121.49 13.15 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 71.0 110.033 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -102.93 122.23 44.16 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.872 -0.603 . . . . 35.21 109.546 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.553 ' HD2' HD21 ' A' ' 81' ' ' LEU . 82.4 t80 -110.24 130.54 55.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.718 -0.475 . . . . 61.04 109.718 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.437 ' HB2' HG22 ' A' ' 80' ' ' THR . 35.5 t -106.99 106.94 59.65 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 74.24 109.9 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 37.2 Cg_endo -66.58 -16.09 49.69 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.7 2.267 . . . . 62.11 111.992 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -74.52 -38.46 62.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 75.35 110.874 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.652 HG23 ' H ' ' A' ' 109' ' ' LYS . 3.0 t -108.31 -27.96 9.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.351 . . . . 63.34 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 2.89 67.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.748 -0.739 . . . . 54.32 112.227 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.652 ' H ' HG23 ' A' ' 107' ' ' THR . 51.2 mtmt -89.08 148.4 23.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 53.24 110.956 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.508 ' HE2' ' HB3' ' A' ' 101' ' ' SER . 61.7 tttm -123.08 136.94 55.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 73.42 109.939 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 101' ' ' SER . 14.4 t-20 -119.6 122.81 42.41 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.891 -0.411 . . . . 74.21 109.891 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.83 129.72 56.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.249 -0.432 . . . . 61.2 110.6 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.801 ' HG2' ' HA ' ' A' ' 130' ' ' ASP . 35.9 mtmm -127.85 138.47 52.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.207 -0.451 . . . . 63.44 110.336 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.8 tp -116.56 117.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.479 0.657 . . . . 53.21 110.166 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 46.0 mttp -107.32 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.223 -0.899 . . . . 72.23 110.959 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.7 t -123.73 117.62 25.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.902 -0.777 . . . . 61.4 108.902 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.08 114.99 2.19 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.201 -1.0 . . . . 73.34 112.731 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.446 ' HB3' HD13 ' A' ' 95' ' ' LEU . 5.1 p90 -109.79 122.65 47.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.367 0.603 . . . . 65.24 109.753 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.941 ' HD3' ' HB ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.538 -0.756 . . . . 65.02 112.186 -173.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 46.1 mmt-85 -106.45 152.93 22.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.668 -1.234 . . . . 74.34 107.668 165.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -29.57 59.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.955 0.724 . . . . 73.41 112.955 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.4 -5.94 15.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.001 0.371 . . . . 75.21 112.001 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 120' ' ' ARG . 9.0 tp -145.61 123.51 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.248 0.547 . . . . 63.5 111.48 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.636 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 4.1 t30 -119.97 117.05 27.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.2 -0.312 . . . . 74.5 110.53 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.0 mm? -112.97 127.1 56.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.909 0.385 . . . . 62.22 110.923 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -130.84 118.31 2.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.909 -0.587 . . . . 53.04 111.773 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.9 m -105.21 120.72 42.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.767 0.318 . . . . 73.1 110.678 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -114.85 117.4 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 72.14 110.162 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 77.6 mmm -99.02 117.07 32.71 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.441 -0.577 . . . . 64.14 109.441 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.801 ' HA ' ' HG2' ' A' ' 113' ' ' LYS . 11.0 t70 -102.81 118.5 36.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 72.23 110.696 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -97.84 97.85 9.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.436 -0.347 . . . . 72.51 110.844 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -105.1 144.38 31.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.972 -0.751 . . . . 63.52 108.972 170.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.02 -34.67 53.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.108 0.48 . . . . 71.32 111.977 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.22 -18.0 59.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.181 -0.463 . . . . 62.04 111.546 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.17 118.61 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.871 -0.681 . . . . 74.22 112.148 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.26 126.75 21.76 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.797 2.331 . . . . 62.03 112.04 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.9 m -107.63 150.82 26.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.275 -0.421 . . . . 64.0 110.363 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 33.4 mm -107.02 116.9 51.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.481 -0.562 . . . . 72.13 109.481 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -111.54 123.18 49.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.403 0.621 . . . . 72.4 110.348 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.34 132.93 11.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.307 -0.949 . . . . 73.31 111.959 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.27 23.76 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.197 -0.668 . . . . 64.41 109.197 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 143' ' ' VAL . 14.9 tp -124.16 131.67 53.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.107 -0.497 . . . . 61.55 110.608 -175.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 34.1 t -131.38 129.66 62.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.196 -0.456 . . . . 71.34 110.037 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 6.2 mp -109.48 138.66 45.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.117 -0.697 . . . . 64.04 109.117 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.553 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -119.55 119.32 4.23 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 121.04 -0.6 . . . . 75.11 112.888 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 63.4 t80 -126.99 149.07 50.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.684 -1.228 . . . . 74.33 107.684 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -49.31 101.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 74.52 111.55 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.48 -30.78 7.39 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.822 -0.626 . . . . 72.41 112.744 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 39.0 m95 -104.7 126.8 52.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 73.54 111.523 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.773 ' HB3' HD12 ' A' ' 10' ' ' LEU . 20.1 mt -120.32 146.98 45.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.022 0.439 . . . . 74.04 110.285 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -137.1 127.37 26.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.014 -0.736 . . . . 62.44 109.014 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.857 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -131.51 142.46 13.85 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.375 -0.917 . . . . 63.5 111.717 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.674 ' HD2' ' HD2' ' A' ' 169' ' ' PHE . 64.3 m-85 -136.0 121.76 19.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.743 0.306 . . . . 73.32 110.375 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.822 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 23.5 mp0 -106.05 122.58 46.45 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.961 -0.755 . . . . 65.4 108.961 173.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 49.1 ttm -127.96 141.87 51.41 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.735 -0.386 . . . . 73.53 110.464 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 51.5 t-20 -130.74 117.41 19.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.406 -0.59 . . . . 61.13 109.406 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.799 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 63.4 t80 -95.16 120.77 35.96 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.491 0.494 . . . . 72.01 110.053 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 43.4 tt0 -99.03 99.59 10.64 Favored 'General case' 0 C--O 1.26 1.649 0 CA-C-O 121.548 0.689 . . . . 73.31 110.678 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.0 m -70.59 -22.23 62.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 113.542 -1.663 . . . . 75.44 110.794 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.12 69.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.793 0.806 . . . . 54.43 109.119 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.653 ' HG3' ' H ' ' A' ' 162' ' ' SER . 21.5 tptp -113.41 -158.56 0.66 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.437 -1.32 . . . . 51.22 107.437 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.653 ' H ' ' HG3' ' A' ' 161' ' ' LYS . 17.2 m -108.72 28.08 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.918 -0.488 . . . . 44.22 110.813 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 163' ' ' ARG . 2.4 ptm180 -157.01 160.77 39.32 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.053 -1.059 . . . . 75.11 111.954 -164.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.799 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.6 m -74.0 133.4 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.165 -1.05 . . . . 75.13 108.165 169.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.7 t -93.39 -14.83 26.34 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.951 -0.3 . . . . 75.05 110.273 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.71 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 19.6 mt-30 -142.21 132.74 25.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.399 0.618 . . . . 72.42 111.796 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -123.0 105.98 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.058 -0.974 . . . . 74.42 109.388 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.822 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 13.7 m120 -114.42 136.06 53.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 64.35 110.176 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.674 ' HD2' ' HD2' ' A' ' 153' ' ' TYR . 36.5 m-85 -130.42 140.71 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 75.12 110.053 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -142.69 129.03 19.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.832 0.348 . . . . 73.5 110.282 175.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 45.8 t -124.54 127.13 72.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.004 -0.739 . . . . 60.33 109.004 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -140.49 115.39 1.05 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.85 -1.167 . . . . 74.23 112.293 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.49 ' CE2' HD22 ' A' ' 180' ' ' LEU . 54.2 p90 -115.47 134.48 55.05 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.422 -0.511 . . . . 64.11 110.241 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -119.25 124.95 47.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.311 -0.859 . . . . 62.11 110.225 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 51.1 m -134.78 112.69 10.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.893 -0.323 . . . . 74.32 110.301 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.6 t70 43.12 -87.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.35 1.031 . . . . 73.33 113.752 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 10.2 pt-20 -101.86 -12.13 18.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.213 0.449 . . . . 74.3 112.213 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.47 ' HD2' ' HG2' ' A' ' 196' ' ' GLN . 74.6 t80 -119.18 117.19 28.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 74.52 111.247 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -123.84 124.36 42.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 72.45 109.584 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.629 HD12 HG13 ' A' ' 194' ' ' ILE . 3.1 tt -119.49 135.41 54.78 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.512 -0.475 . . . . 74.35 110.677 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.58 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 47.7 t60 -129.75 115.11 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.373 -0.83 . . . . 75.42 110.225 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 7.0 m -92.48 142.8 27.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.492 -0.929 . . . . 75.35 108.492 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.15 139.83 33.98 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 63.53 110.754 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.35 121.06 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.714 -0.675 . . . . 61.21 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 75.2 m-20 -103.62 94.24 5.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.374 -0.83 . . . . 61.2 109.276 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.71 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 12.1 m-20 65.83 -169.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.836 -1.074 . . . . 71.22 110.907 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 212' ' ' ALA . . . -76.49 -6.5 84.32 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.425 -0.893 . . . . 72.12 111.714 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.2 m -96.8 -25.56 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 112.616 0.598 . . . . 74.24 112.616 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.4 tt0 -129.72 113.98 15.41 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.062 -0.655 . . . . 74.01 111.54 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -121.86 124.74 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.933 -0.765 . . . . 73.04 108.933 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.45 -160.75 11.36 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.788 -1.196 . . . . 72.33 112.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.66 175.8 44.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.539 -0.838 . . . . 75.15 112.389 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.641 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 26.2 m -148.68 138.09 21.87 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.391 -0.596 . . . . 61.43 109.391 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.76 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.6 mp -121.2 137.18 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.532 -0.544 . . . . 71.44 109.532 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -121.6 119.92 33.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.787 -0.82 . . . . 72.34 108.787 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.47 ' HG2' ' HD2' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -124.97 111.07 14.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.714 -0.847 . . . . 75.04 108.714 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 177' ' ' GLU . 60.1 tttp -97.23 119.48 35.82 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.811 -0.631 . . . . 74.0 109.745 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.84 146.0 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.467 -1.308 . . . . 74.42 107.467 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -74.54 56.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.769 0.795 . . . . 74.12 110.997 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.461 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 67.8 mttm -152.85 -146.78 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.848 -1.524 . . . . 74.32 108.028 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.801 ' HB3' ' HB3' ' A' ' 226' ' ' GLN . 1.2 mptm? -103.01 26.16 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.315 0.578 . . . . 75.51 109.587 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.55 110.32 19.06 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.464 -0.789 . . . . 75.23 110.269 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.947 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 12.8 mm-40 -107.01 134.39 50.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 52.45 109.795 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.5 m -123.38 143.11 50.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 64.2 109.919 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -142.32 158.58 43.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 65.15 111.114 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.76 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 71.5 t -132.45 141.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.533 -0.543 . . . . 55.31 109.533 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.46 125.4 16.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.038 -0.727 . . . . 64.32 109.038 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.662 HD13 ' HD1' ' A' ' 219' ' ' PHE . 2.5 pt? -146.6 150.65 35.9 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.415 -0.514 . . . . 73.14 111.036 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.38 130.88 22.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 72.02 110.194 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.671 ' HB2' HG23 ' A' ' 217' ' ' THR . 9.4 t90 -125.28 135.11 52.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.606 -0.724 . . . . 70.01 109.489 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.909 HG23 ' HB3' ' A' ' 214' ' ' ASN . 3.9 t -95.27 113.95 25.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.355 0.598 . . . . 72.34 110.457 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -64.94 144.71 57.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 72.35 110.846 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.58 -2.72 86.33 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.675 -0.97 . . . . 52.5 110.675 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.909 ' HB3' HG23 ' A' ' 211' ' ' THR . 37.2 t-20 -138.28 159.18 42.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.332 -0.988 . . . . 54.31 108.332 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.1 t -93.41 -9.29 39.12 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.174 -0.329 . . . . 73.14 110.542 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.97 108.92 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.213 0.53 . . . . 70.14 110.951 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 210' ' ' TRP . 28.1 m -117.13 135.07 54.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.281 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -126.1 117.5 23.31 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.899 -0.32 . . . . 72.45 110.255 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.662 ' HD1' HD13 ' A' ' 208' ' ' LEU . 74.5 t80 -113.27 138.42 50.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.567 -0.742 . . . . 74.41 109.241 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.82 157.21 26.98 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.527 -0.844 . . . . 42.41 112.705 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.65 136.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 64.31 109.649 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 205' ' ' ALA . . . -114.51 152.66 31.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.783 -0.451 . . . . 53.11 109.783 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.78 140.2 34.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.397 -0.365 . . . . 75.32 110.498 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.947 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 28.9 ttmt -123.1 113.84 19.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.128 -0.693 . . . . 63.13 109.128 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -105.2 116.47 32.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.48 -0.327 . . . . 71.51 110.535 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.801 ' HB3' ' HB3' ' A' ' 201' ' ' LYS . 63.1 tt0 -91.99 104.17 16.61 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.461 -0.94 . . . . 72.43 108.461 171.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.83 -49.06 60.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.472 -0.785 . . . . 73.35 110.991 -172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.747 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.1 t70 -164.78 -59.64 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 74.42 111.491 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 72.1 Cg_endo -89.38 -139.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.023 1.815 . . . . 63.35 113.443 -174.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 1.8 m-20 -92.13 13.38 19.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.815 -1.084 . . . . 71.13 110.37 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.09 124.93 45.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 63.25 110.154 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.644 ' HB2' HG23 ' A' ' 248' ' ' THR . 59.6 m -113.09 145.09 41.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.191 -0.913 . . . . 74.44 110.173 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.24 125.98 39.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.962 -1.125 . . . . 75.11 107.962 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.8 t -106.45 144.56 32.95 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.166 -0.47 . . . . 72.15 110.013 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -148.57 147.69 29.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.34 -0.391 . . . . 61.1 110.431 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -148.01 138.53 22.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.132 -0.692 . . . . 63.53 109.132 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.33 152.92 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 242' ' ' LEU . 11.7 p30 -133.4 152.43 51.92 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.965 -0.694 . . . . 74.02 110.777 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.58 5.02 0.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.539 -1.209 . . . . 64.33 112.982 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.601 ' HB3' HD13 ' A' ' 242' ' ' LEU . 32.3 t -89.01 13.83 12.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.506 -0.924 . . . . 52.21 108.506 170.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 49.9 m 69.26 31.72 3.83 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 114.626 -1.17 . . . . 70.32 111.357 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.999 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 10.2 mp -99.75 142.62 31.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.287 -0.565 . . . . 74.23 111.202 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -125.59 118.0 51.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.695 -0.684 . . . . 63.21 110.317 -169.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.07 143.57 16.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.739 -0.743 . . . . 74.23 112.436 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.37 156.72 43.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.845 0.355 . . . . 71.14 110.153 176.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.92 -177.73 36.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.435 -0.888 . . . . 42.24 113.049 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.711 ' HB3' HE21 ' A' ' 249' ' ' GLN . 87.6 m-85 -117.15 115.93 26.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.603 -0.517 . . . . 71.12 109.603 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 232' ' ' CYS . 6.3 t -111.06 113.93 26.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.075 -0.713 . . . . 74.44 109.075 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.711 HE21 ' HB3' ' A' ' 247' ' ' TYR . 53.2 mt-30 -132.82 150.4 52.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.222 -0.444 . . . . 65.31 111.463 -168.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 8.9 t -124.78 132.83 53.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.117 -1.068 . . . . 71.23 108.117 167.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.636 HD23 HD12 ' A' ' 255' ' ' ILE . 36.8 tp -72.27 -65.15 0.81 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.5 -0.48 . . . . 60.12 109.851 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.654 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 0.5 OUTLIER 174.72 -57.91 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.466 -0.788 . . . . 62.12 110.137 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 83.5 Cg_endo -80.4 52.35 4.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.308 2.005 . . . . 64.42 113.403 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.96 64.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.666 -0.778 . . . . 75.44 112.596 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.636 HD12 HD23 ' A' ' 251' ' ' LEU . 61.7 mt -107.27 122.25 61.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 122.733 -0.275 . . . . 70.14 110.262 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.673 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 17.2 tptm -121.17 122.64 40.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.645 . . . . 74.04 110.75 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.76 124.08 51.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.136 -0.938 . . . . 73.42 109.815 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 277' ' ' LEU . 38.0 m -119.75 110.22 16.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.177 0.513 . . . . 74.22 110.743 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -111.13 125.77 54.13 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.86 -1.163 . . . . 72.24 107.86 173.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.9 p -139.08 141.01 38.18 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.762 -0.375 . . . . 41.32 110.742 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.42 127.62 19.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.325 -0.62 . . . . 63.21 109.325 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.729 HD21 HD23 ' A' ' 242' ' ' LEU . 0.4 OUTLIER -108.75 128.91 55.29 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.445 0.641 . . . . 74.3 109.466 177.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.895 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.4 mm? -102.1 106.96 17.91 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.252 -0.885 . . . . 70.05 108.957 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.999 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 6.3 t70 -73.48 98.99 2.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.754 -1.112 . . . . 62.43 108.329 172.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.83 -9.36 3.67 Favored Glycine 0 C--N 1.314 -0.673 0 CA-C-N 115.725 -0.671 . . . . 74.35 113.38 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -92.46 -21.84 19.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.867 -0.166 . . . . 65.2 111.025 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.89 -23.74 0.92 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.441 1.115 . . . . 73.41 110.831 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 273' ' ' HIS . 1.0 OUTLIER -63.21 -26.7 41.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 113.748 -1.569 . . . . 61.55 112.844 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.48 -26.32 68.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.055 -0.52 . . . . 73.25 110.274 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -88.29 -16.5 32.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.196 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.63 -1.2 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.521 -0.847 . . . . 43.2 113.637 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.86 51.79 4.36 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.561 -0.828 . . . . 75.33 113.046 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.921 ' HA ' HG22 ' A' ' 268' ' ' VAL . 0.6 OUTLIER -78.31 144.44 36.09 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.767 0.318 . . . . 72.3 111.389 -175.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.51 138.18 38.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 60.34 110.878 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.575 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -128.32 144.13 51.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 62.0 109.699 -174.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -146.32 119.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.933 -0.651 . . . . 55.43 111.821 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.715 HD23 HG13 ' A' ' 27' ' ' ILE . 54.0 tp -114.68 146.93 40.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 70.45 110.874 177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.77 124.47 1.67 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.893 -0.594 . . . . 70.22 111.693 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.434 HD21 HD21 ' A' ' 277' ' ' LEU . 2.8 mm? -111.04 130.28 55.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.065 -0.717 . . . . 63.4 109.065 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.673 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 16.9 pt-20 -137.1 122.73 19.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.467 0.651 . . . . 72.02 110.459 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.681 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.2 m-85 -114.43 110.48 19.93 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.863 -0.791 . . . . 71.13 108.863 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.54 111.0 19.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.103 0.477 . . . . 63.41 111.497 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -104.19 109.75 21.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.453 -0.943 . . . . 73.32 108.453 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.485 HD22 ' HE3' ' A' ' 34' ' ' LYS . 56.9 mt -120.34 -98.42 0.45 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.381 -0.372 . . . . 71.31 111.535 -171.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.492 -0.766 . . . . 74.21 109.981 -176.562 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.193 0.521 . . . . 74.21 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.72 94.92 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.523 -0.547 . . . . 53.34 109.523 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.777 ' HB ' ' HD2' ' A' ' 119' ' ' LYS . 16.3 t -117.89 117.09 35.82 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.924 -0.58 . . . . 74.42 110.705 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.43 161.9 14.88 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.539 2.159 . . . . 73.31 111.433 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 102.75 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.354 2.036 . . . . 54.04 111.63 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.539 ' HB ' HG11 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -70.09 -42.67 72.41 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.943 -0.571 . . . . 54.02 111.01 -176.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.918 ' HA ' ' HB3' ' A' ' 10' ' ' LEU . 64.4 t80 -50.15 -25.82 3.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.467 0.707 . . . . 74.52 111.68 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.683 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -76.65 -17.61 59.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.929 -0.578 . . . . 51.02 110.487 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -105.89 -31.36 8.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.547 -1.279 . . . . 61.35 107.547 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.918 ' HB3' ' HA ' ' A' ' 7' ' ' TYR . 2.5 tt -58.4 -36.09 73.02 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 112.351 -2.204 . . . . 73.24 110.738 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.12 -21.89 0.14 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 119.181 -1.485 . . . . 74.45 115.753 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.683 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 16.8 ttmm -57.15 -52.59 64.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.448 1.124 . . . . 74.33 112.358 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -56.62 -38.81 72.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.114 0.483 . . . . 72.4 111.073 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 181' ' ' HIS . . . -70.3 -42.65 71.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.563 -0.744 . . . . 42.15 111.156 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 5.2 tmm_? -59.66 -34.59 73.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.125 -0.488 . . . . 62.14 111.385 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -47.15 84.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 73.31 111.635 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.521 ' HA ' ' HE1' ' A' ' 22' ' ' TYR . 78.9 t -82.7 -32.03 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.922 0.391 . . . . 51.33 110.966 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.485 ' HA ' HD22 ' A' ' 207' ' ' ASN . 86.8 t80 -60.54 -35.36 75.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 73.23 112.171 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -79.43 131.0 35.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 60.02 111.464 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.974 ' H ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -69.87 151.05 46.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.009 -0.996 . . . . 64.14 110.236 175.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.75 78.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.853 -0.689 . . . . 55.43 112.291 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.521 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 72.1 m-85 -70.28 -23.36 62.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.609 0.242 . . . . 74.33 111.454 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -123.72 133.25 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.798 -0.715 . . . . 73.33 111.756 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -104.21 2.12 31.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.085 0.469 . . . . 72.12 110.687 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.95 12.57 57.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.919 -0.658 . . . . 63.44 112.172 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.56 158.65 17.05 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 122.592 1.187 . . . . 75.34 113.656 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.803 HG23 HD12 ' A' ' 277' ' ' LEU . 46.2 mm -105.63 121.82 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 113.016 -1.902 . . . . 65.14 108.924 173.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 25.2 ttpp -109.64 129.07 55.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 75.42 110.65 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tm? -128.43 127.39 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.338 -0.986 . . . . 74.31 108.338 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.0 p30 -142.94 140.92 31.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.223 0.535 . . . . 73.14 110.989 175.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' THR . 7.2 tp -127.06 124.38 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.13 -0.941 . . . . 73.41 109.87 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 ptmm? -127.35 125.78 41.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.756 . . . . 63.34 110.385 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 9.9 t -131.73 132.21 43.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.8 -0.636 . . . . 75.13 110.221 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HA ' ' HG2' ' A' ' 40' ' ' GLU . 28.9 mtpp -111.77 132.04 54.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.206 -0.664 . . . . 73.21 109.206 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 17.6 m -133.6 169.21 17.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 72.11 110.446 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -86.5 158.74 19.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.052 -0.522 . . . . 73.32 109.704 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.29 55.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.607 0.567 . . . . 71.54 111.991 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 85.16 -5.16 84.05 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 116.108 1.203 . . . . 73.24 116.108 168.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 2.7 mm? -100.31 124.75 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.024 1.912 . . . . 62.45 112.769 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.867 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 35.9 mt-10 -142.35 139.87 31.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 64.03 108.542 159.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' HB3' ' CG2' ' A' ' 33' ' ' THR . 90.3 t80 -131.51 121.84 25.14 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 122.061 -0.399 . . . . 71.14 110.547 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.769 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 18.2 m -127.33 131.38 50.43 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.991 0.424 . . . . 73.43 110.488 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -126.51 126.19 43.31 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.06 -0.718 . . . . 53.14 109.06 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.1 p -126.54 126.22 43.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 63.12 111.159 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.04 139.7 9.16 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 53.24 112.36 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 p -132.21 136.59 47.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.058 0.456 . . . . 72.22 110.67 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.8 51.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.793 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -84.83 137.89 32.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.542 -0.54 . . . . 73.35 109.542 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.3 m -80.33 -27.5 38.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.005 0.431 . . . . 62.42 110.991 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.13 -71.37 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 74.23 110.52 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 p -93.24 159.82 15.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.249 -0.432 . . . . 52.31 110.603 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -79.81 88.48 5.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.468 0.652 . . . . 75.01 110.34 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -138.0 104.46 5.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.273 -0.876 . . . . 73.34 109.518 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.31 119.6 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.145 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -114.05 126.24 54.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.839 -0.619 . . . . 75.25 109.777 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.73 123.84 3.63 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.476 -0.869 . . . . 52.13 112.415 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 p -114.1 142.65 45.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.68 -0.489 . . . . 64.22 109.68 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -121.31 123.33 41.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.955 -0.757 . . . . 60.22 108.955 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.769 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 2.1 pm0 -114.16 118.97 35.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.076 0.941 . . . . 73.33 111.226 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -99.25 120.94 40.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.597 -1.183 . . . . 65.31 108.947 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 43.6 mtpt -112.56 126.92 55.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.219 0.533 . . . . 64.11 110.814 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 84.4 m-85 -103.3 120.28 40.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.55 -0.907 . . . . 75.25 108.55 173.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 36.0 ttt180 -110.71 108.2 18.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 73.23 110.742 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.501 ' HE3' ' HB3' ' A' ' 69' ' ' LEU . 5.3 m-90 -107.09 99.35 8.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.791 -0.64 . . . . 74.2 110.577 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 m 70.59 133.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.512 -0.767 . . . . 64.33 111.084 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.6 pm0 -64.73 124.58 22.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 62.14 110.559 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 63.4 35.49 12.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.433 -0.803 . . . . 73.41 111.077 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.37 -77.77 0.38 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.207 -0.757 . . . . 74.22 111.207 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.8 mm? -124.86 132.63 53.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.095 0.474 . . . . 71.43 111.378 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -134.34 112.59 11.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.83 -0.623 . . . . 61.22 110.248 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.565 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 58.5 t80 -111.6 120.26 41.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.007 -0.542 . . . . 70.12 109.745 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 t -124.27 117.29 24.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.308 0.575 . . . . 75.3 110.93 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 34.5 tt0 -102.76 120.62 40.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.108 -0.496 . . . . 63.12 109.697 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -107.19 113.98 27.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 63.24 110.336 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.848 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 70.4 t90 -103.1 134.89 45.78 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.776 -0.453 . . . . 70.01 109.776 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -110.22 156.19 21.0 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.481 -0.563 . . . . 73.13 109.481 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -61.35 -16.0 41.69 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.832 0.678 . . . . 61.45 112.832 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.6 -1.47 57.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.828 -0.169 . . . . 54.43 111.333 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 87.81 11.51 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.241 1.016 . . . . 72.14 112.432 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -81.83 126.38 31.8 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.775 -0.37 . . . . 44.45 110.099 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.848 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -105.63 119.48 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.33 -0.395 . . . . 60.2 110.155 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.83 98.65 0.92 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.352 -1.099 . . . . 65.15 110.352 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' HG3' ' A' ' 73' ' ' GLU . 9.7 t -106.63 120.86 43.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.516 0.674 . . . . 73.34 111.641 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 40.5 tt0 -109.3 123.47 49.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.376 -0.829 . . . . 52.31 110.169 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.565 ' HB ' ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -112.58 124.13 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 63.35 109.496 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 m -111.4 130.04 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 63.53 111.17 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 5.9 t -110.45 120.28 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.556 -0.747 . . . . 74.31 109.51 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.88 116.98 34.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.243 -0.28 . . . . 63.51 110.243 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 52.19 62.99 2.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.596 -0.729 . . . . 73.4 111.326 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.681 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 23.7 tp60 -62.42 -74.7 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.606 . . . . 75.11 111.24 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.681 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 88.5 mt -115.61 -31.93 5.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 64.44 110.111 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.92 125.64 51.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 64.04 110.268 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -63.64 135.38 56.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.124 0.488 . . . . 74.54 110.822 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.72 -15.23 58.59 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.556 -0.747 . . . . 72.15 112.257 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.2 131.4 36.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.501 . . . . 73.15 111.442 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -119.25 111.08 17.77 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.613 -0.884 . . . . 74.2 108.613 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -103.65 127.47 51.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.493 -0.558 . . . . 64.35 109.493 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.894 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 21.9 m -127.84 119.25 25.25 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.642 0.258 . . . . 74.13 110.579 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . 82.5 m-85 -117.46 114.95 24.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.593 . . . . 70.35 109.4 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.961 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.9 t70 -111.14 122.65 48.43 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.183 -0.673 . . . . 75.04 109.183 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -118.2 120.47 37.8 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.016 0.436 . . . . 65.13 110.01 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 111' ' ' ASN . 53.7 m -109.55 121.48 45.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.138 -0.483 . . . . 64.31 109.922 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -123.66 125.07 44.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.968 -0.56 . . . . 75.33 110.186 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 t -114.03 101.75 54.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 N-CA-C 109.683 -0.488 . . . . 73.12 109.683 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.05 -9.16 19.25 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.932 2.421 . . . . 75.04 110.577 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -72.03 -55.48 7.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.887 -1.051 . . . . 61.23 109.89 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.5 t -103.92 -19.77 14.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 63.54 111.556 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.16 22.79 18.91 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.691 -0.766 . . . . 52.1 112.604 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HE3' ' OD1' ' A' ' 111' ' ' ASN . 60.6 tttp -95.35 146.49 24.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.537 0.208 . . . . 75.31 110.774 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 140.66 45.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.873 0.368 . . . . 75.33 110.023 173.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.2 m120 -128.81 132.57 47.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.3 110.376 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -111.0 114.76 28.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.047 -0.524 . . . . 70.22 110.106 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.961 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 56.8 tttp -113.25 135.39 53.88 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.485 -0.561 . . . . 64.44 109.485 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.529 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -136.37 135.66 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 74.52 110.053 -178.052 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.6 ttpm? -131.2 121.36 24.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.187 0.518 . . . . 75.43 110.582 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 p -112.63 121.17 44.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.437 -0.801 . . . . 73.51 109.278 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.46 154.52 21.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.004 -1.093 . . . . 63.44 112.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.38 116.64 21.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.454 -0.943 . . . . 74.31 108.454 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.777 ' HD2' ' HB ' ' A' ' 3' ' ' VAL . 24.4 pttm -110.18 121.94 46.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.42 0.628 . . . . 75.32 111.252 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.6 mpt_? -107.48 148.63 28.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.954 -1.128 . . . . 63.14 107.954 168.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.34 -27.9 50.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.986 0.422 . . . . 64.35 110.972 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -93.08 -31.2 14.92 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.272 0.471 . . . . 73.41 112.272 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 ' HB2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -144.21 132.32 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.822 -0.751 . . . . 63.31 110.974 -167.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.73 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 7.4 t30 -120.92 125.65 48.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.366 0.506 . . . . 72.51 112.366 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.94 131.64 55.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.936 -0.574 . . . . 63.24 110.049 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -141.38 117.07 1.17 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.331 -0.938 . . . . 43.31 112.626 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 42.0 t -109.78 108.57 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.323 . . . . 31.15 110.483 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.719 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 10.7 t70 -108.29 138.55 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 55.11 109.592 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.543 ' HG2' HG13 ' A' ' 138' ' ' ILE . 73.7 mtm -138.14 128.04 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.819 -0.551 . . . . 62.12 111.241 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -97.73 117.27 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.187 -0.672 . . . . 64.12 109.187 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 84.6 t80 -97.02 114.87 26.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.174 0.511 . . . . 74.24 111.048 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.3 153.9 45.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.595 -0.891 . . . . 72.51 108.595 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.435 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.8 pp -69.62 -17.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 73.25 111.1 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.56 -10.38 57.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.781 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.87 125.25 1.79 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.775 -0.726 . . . . 65.33 112.374 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 6.3 Cg_exo -80.03 122.07 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.23 2.62 . . . . 72.52 111.921 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 m -97.2 135.73 38.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.014 -0.365 . . . . 70.53 110.014 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.543 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -106.1 119.27 55.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.133 0.492 . . . . 64.35 110.026 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -117.62 111.73 19.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.945 -0.571 . . . . 75.14 109.98 -174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.46 132.99 11.3 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.907 -1.14 . . . . 73.4 112.096 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 116.36 24.09 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.186 0.517 . . . . 75.1 109.946 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.476 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.1 tp -116.87 123.58 47.4 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 73.35 109.889 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 53.0 t -117.01 128.76 74.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.196 -0.456 . . . . 61.52 110.415 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -107.78 137.9 44.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.259 -1.015 . . . . 74.14 108.259 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.37 121.05 2.33 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.312 -0.947 . . . . 54.32 113.529 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.14 149.36 41.41 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.072 -1.084 . . . . 74.32 108.072 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.47 105.15 0.08 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.655 0.741 . . . . 73.4 111.718 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.39 -32.18 7.85 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.273 -0.876 . . . . 64.12 112.441 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -105.35 122.47 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.777 0.322 . . . . 53.14 111.602 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 150' ' ' LEU . 6.6 mt -115.05 136.32 53.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.684 -1.228 . . . . 55.42 107.684 163.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.657 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -136.28 152.72 51.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.55 ' HA3' HD11 ' A' ' 10' ' ' LEU . . . -157.21 133.18 3.47 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.193 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.664 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 67.8 m-85 -124.02 114.68 20.07 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.429 -0.582 . . . . 74.44 109.429 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -105.45 120.88 42.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.697 -0.683 . . . . 73.22 109.71 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.415 ' SD ' HG11 ' A' ' 164' ' ' VAL . 58.4 ttp -132.48 129.0 38.62 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.42 -0.355 . . . . 74.44 110.444 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.461 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 73.6 m-20 -111.16 115.87 30.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.941 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.5 t80 -97.28 127.1 42.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.993 -1.003 . . . . 75.12 110.273 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 6.6 tp10 -94.39 100.23 12.29 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-N 115.858 -0.61 . . . . 61.42 109.593 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 -19.95 62.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.769 -1.56 . . . . 74.05 111.008 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.72 77.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.613 -0.884 . . . . 24.25 108.613 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -102.77 -160.45 0.78 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.296 -1.32 . . . . 65.14 108.026 167.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.1 m -109.48 27.07 9.92 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.047 -0.408 . . . . 74.53 110.929 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -163.24 161.64 24.93 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 118.912 -1.115 . . . . 72.22 111.596 -165.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.941 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -72.95 136.1 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.137 0.494 . . . . 74.0 109.865 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 5.1 t -93.61 -23.45 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.897 -0.592 . . . . 75.14 110.317 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -140.1 132.88 29.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.61 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 p -121.07 109.31 14.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.805 -0.634 . . . . 70.13 110.274 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -111.69 127.56 55.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.387 0.613 . . . . 44.12 110.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.664 ' HD2' ' HD1' ' A' ' 153' ' ' TYR . 80.0 m-85 -121.03 144.29 48.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.701 -0.481 . . . . 74.34 109.701 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -147.26 137.25 23.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.524 0.678 . . . . 42.04 111.091 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.994 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 99.5 t -133.44 152.7 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.267 -1.012 . . . . 72.12 108.267 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 181' ' ' HIS . . . -147.88 123.16 1.66 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.101 -1.047 . . . . 61.12 112.271 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.07 120.59 42.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.171 -0.677 . . . . 73.44 109.171 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.04 126.86 53.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.793 0.806 . . . . 74.22 111.867 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -116.94 163.26 16.47 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.78 -1.563 . . . . 62.3 106.78 168.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -53.64 -42.08 67.45 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.239 0.459 . . . . 41.3 112.239 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -107.3 -14.02 14.98 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.288 0.477 . . . . 72.24 112.288 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.471 ' HD2' ' NE2' ' A' ' 196' ' ' GLN . 7.5 m-85 -132.11 120.85 22.89 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.125 -0.359 . . . . 64.12 110.941 -173.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -135.19 124.08 24.03 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.785 -0.366 . . . . 64.02 110.683 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.785 ' HB2' ' HA ' ' A' ' 194' ' ' ILE . 0.0 OUTLIER -124.53 138.43 54.33 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.775 -0.578 . . . . 65.14 110.472 175.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 95.3 m-70 -115.46 117.85 31.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 74.44 110.385 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.994 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 90.0 m -78.79 122.84 26.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 71.25 109.685 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.35 139.66 53.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.369 0.604 . . . . 72.42 111.432 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 90.3 t -131.2 117.1 35.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.594 -0.73 . . . . 74.15 110.146 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.28 105.67 15.81 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.9 -0.778 . . . . 72.14 108.9 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.8 t70 63.36 -172.4 0.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.539 -0.755 . . . . 73.3 108.968 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.52 -6.76 88.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 64.42 110.842 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 211' ' ' THR . 1.2 p -88.68 -24.49 22.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.416 0.895 . . . . 63.35 113.416 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.26 110.67 11.28 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.876 0.762 . . . . 71.25 111.111 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -121.48 124.63 44.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.005 -0.543 . . . . 74.22 109.999 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -176.42 -149.75 7.78 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.545 -1.312 . . . . 60.12 113.672 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -158.54 175.07 35.68 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.291 -0.723 . . . . 70.01 111.291 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.496 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 55.9 m -148.3 138.42 22.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.095 0.448 . . . . 74.43 110.032 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 1.012 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.1 mp -117.88 129.73 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.833 0.349 . . . . 74.33 110.681 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -108.18 120.04 41.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.388 -0.967 . . . . 75.24 108.388 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 1.05 HE21 ' HA ' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -120.48 132.18 55.09 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.085 0.402 . . . . 71.43 112.085 -172.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -103.51 108.79 20.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.166 -0.679 . . . . 73.14 109.166 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.872 ' HB ' HD12 ' A' ' 202' ' ' LEU . 59.5 t -95.23 -26.9 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.39 0.614 . . . . 62.04 109.762 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -158.47 -179.92 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.236 -1.024 . . . . 64.25 108.236 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.36 -40.83 75.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.455 0.539 . . . . 72.3 112.455 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.91 ' HB2' ' HB3' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -126.78 13.53 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.014 0.435 . . . . 71.21 111.072 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.872 HD12 ' HB ' ' A' ' 198' ' ' VAL . 2.3 tm? -107.12 103.03 12.33 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 75.51 108.664 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -117.6 153.92 32.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.784 -0.644 . . . . 54.51 110.159 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 196' ' ' GLN . 16.6 m -130.06 149.6 51.7 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.988 -0.551 . . . . 51.33 109.92 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.54 136.15 50.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 53.32 109.672 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 1.012 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -119.82 136.87 55.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.646 -0.706 . . . . 62.44 111.005 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.485 HD22 ' HA ' ' A' ' 18' ' ' PHE . 20.1 t-20 -114.31 127.66 55.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 62.51 110.436 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 208' ' ' LEU . 1.7 mm? -130.94 129.71 42.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.18 -0.674 . . . . 74.51 109.18 171.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.455 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -156.49 149.01 23.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.13 0.49 . . . . 74.31 111.193 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -131.19 124.92 31.67 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.154 -0.684 . . . . 71.21 109.154 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 188' ' ' THR . 9.7 t -101.83 117.88 35.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.397 0.618 . . . . 74.54 110.132 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.76 130.85 47.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.597 -0.729 . . . . 75.25 110.835 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -15.84 27.5 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.919 -0.657 . . . . 43.02 111.789 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -138.86 150.16 45.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.148 -0.316 . . . . 72.05 110.148 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.8 m -86.28 -16.47 37.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.408 -0.36 . . . . 65.43 111.067 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -67.79 111.21 4.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.0 0.429 . . . . 73.32 110.825 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.0 t -87.99 138.43 31.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.536 -0.913 . . . . 63.33 108.536 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 30.0 mtt-85 -88.28 116.67 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.292 -0.633 . . . . 74.04 109.292 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -115.17 129.37 56.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.864 -1.162 . . . . 71.02 107.864 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -141.11 150.85 22.12 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.895 -1.145 . . . . 54.35 112.46 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.933 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 3.5 mp -132.58 132.35 59.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.017 -1.105 . . . . 71.43 108.017 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.829 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . . . -124.93 130.23 51.94 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.328 1.018 . . . . 71.1 109.837 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.598 ' H ' ' HB2' ' A' ' 236' ' ' LYS . . . -113.87 126.34 55.07 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.117 -0.633 . . . . 74.31 111.187 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 62.23 110.71 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.63 ' HD1' HD13 ' A' ' 227' ' ' ILE . 90.6 t80 -120.81 127.85 52.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 71.12 110.077 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.91 ' HB3' ' HB2' ' A' ' 201' ' ' LYS . 29.2 tt0 -79.92 100.88 8.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.962 -0.563 . . . . 74.22 109.537 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.63 HD13 ' HD1' ' A' ' 225' ' ' TYR . 26.2 mm -68.82 -42.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.869 0.842 . . . . 73.11 109.297 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -137.05 146.77 56.09 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.533 -1.284 . . . . 71.13 107.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -44.97 -25.63 1.73 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.88 2.387 . . . . 60.42 114.185 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.87 -3.32 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.348 0.499 . . . . 75.12 112.348 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.76 123.42 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.977 0.418 . . . . 70.54 112.002 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 35.7 m -120.76 122.64 40.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 74.24 110.399 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.734 ' HD2' ' HB3' ' A' ' 247' ' ' TYR . 87.6 t80 -104.7 133.13 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.06 -0.348 . . . . 73.24 110.06 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 12.5 p -131.0 140.62 50.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 64.45 111.487 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -156.66 136.71 12.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 70.13 109.127 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.933 ' HB3' ' O ' ' A' ' 221' ' ' ILE . 2.7 mmtm -173.29 179.0 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.865 0.466 . . . . 74.05 110.908 166.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.8 152.03 27.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.129 0.49 . . . . 63.11 111.674 -160.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -109.01 150.74 27.32 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.889 -0.596 . . . . 71.24 110.324 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 241' ' ' SER . 4.4 t-20 -39.46 -33.54 0.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.477 1.511 . . . . 72.42 114.03 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 13.5 m -77.52 24.55 0.2 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.562 0.22 . . . . 62.24 110.651 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.3 p 58.0 29.54 17.86 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.563 1.145 . . . . 73.33 110.937 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 1.056 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.1 mp -99.39 128.98 45.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 116.221 -0.445 . . . . 73.03 111.926 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.887 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -110.42 116.35 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.699 -0.682 . . . . 65.03 110.525 -171.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.58 133.46 11.59 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.743 -0.742 . . . . 74.24 112.419 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.8 pp -134.23 149.06 50.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 62.15 109.98 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.72 145.86 11.14 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.885 -0.674 . . . . 40.32 111.776 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.734 ' HB3' ' HD2' ' A' ' 233' ' ' PHE . 22.1 p90 -124.61 122.34 37.26 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.297 0.57 . . . . 74.1 110.097 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 10.0 t -111.62 124.25 51.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.341 -0.845 . . . . 64.43 109.445 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -135.77 124.26 23.52 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.58 -0.737 . . . . 73.42 110.487 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 2.3 t -78.64 103.86 8.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.818 -1.178 . . . . 74.41 107.818 171.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 71.0 mt -60.92 -54.5 44.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.511 -0.768 . . . . 72.42 109.654 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.605 ' HB2' HD11 ' A' ' 255' ' ' ILE . 96.8 mttt -145.17 152.16 50.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 106.93 -1.508 . . . . 74.43 106.93 174.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.61 98.84 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.51 2.14 . . . . 51.22 112.566 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.32 -24.44 2.94 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.889 -0.596 . . . . 64.21 112.662 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -134.34 122.08 39.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.394 0.616 . . . . 62.31 112.002 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.859 ' HG2' ' HB2' ' A' ' 280' ' ' GLU . 14.8 ptpt -114.13 133.28 55.68 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 72.42 110.299 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.71 126.89 52.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.25 -0.886 . . . . 72.15 109.713 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.8 t -127.51 111.0 13.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.556 0.693 . . . . 72.45 110.423 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.816 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.68 123.22 45.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 175.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 26.4 t -131.95 140.86 49.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.894 0.378 . . . . 53.15 110.039 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.72 128.48 20.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.914 -0.584 . . . . 71.53 110.433 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.755 HD11 HD23 ' A' ' 242' ' ' LEU . 2.3 tm? -102.48 117.67 35.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.511 -1.292 . . . . 65.11 107.511 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.887 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.3 mm? -92.72 107.71 19.42 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.559 -1.274 . . . . 73.14 107.559 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.056 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.1 m-20 -70.46 104.02 2.62 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.356 -0.979 . . . . 53.32 108.356 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.28 -19.1 38.31 Favored Glycine 0 C--O 1.229 -0.166 0 CA-C-N 115.94 -0.573 . . . . 75.33 112.497 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.36 -24.19 20.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.368 . . . . 73.35 111.016 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 93.8 m-20 -113.34 -30.54 6.87 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.645 0.98 . . . . 72.21 113.645 -170.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.449 HG11 ' HB3' ' A' ' 263' ' ' LEU . 30.8 m -62.62 -26.41 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.041 0.756 . . . . 63.14 113.041 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -70.31 -23.72 62.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.961 0.41 . . . . 54.24 110.369 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.81 6.02 36.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 72.52 110.123 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.65 102.54 0.79 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.752 -0.658 . . . . 54.35 111.831 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 165.15 78.68 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.258 -0.972 . . . . 62.21 112.519 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -113.48 146.68 39.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.504 -0.554 . . . . 75.14 109.504 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 74.2 mmtt -95.39 137.69 34.09 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.586 -0.446 . . . . 62.2 110.231 -175.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.4 tm? -117.7 134.5 54.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.179 -0.464 . . . . 65.35 109.91 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.478 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -135.17 104.27 0.5 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.959 -0.856 . . . . 74.13 110.959 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.816 HD23 HD22 ' A' ' 259' ' ' LEU . 2.4 tm? -114.76 130.95 56.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.51 -0.552 . . . . 63.34 109.51 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.506 ' N ' HD22 ' A' ' 277' ' ' LEU . . . -143.24 136.75 7.19 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.175 -1.012 . . . . 35.42 112.888 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.602 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.6 mm? -114.91 131.08 56.99 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.325 -0.62 . . . . 75.34 109.325 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.859 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 52.6 mt-10 -111.82 112.12 23.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.418 -0.586 . . . . 74.12 109.418 173.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -99.2 125.15 44.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.809 -1.182 . . . . 70.21 107.809 177.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 75.4 mt-30 -132.53 116.87 17.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.127 0.489 . . . . 42.12 109.985 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -115.61 131.97 56.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.809 -0.632 . . . . 45.15 110.471 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 285' ' ' GLU . 65.9 mt -122.09 -45.17 2.25 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.062 -0.718 . . . . 74.21 109.062 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 284' ' ' LEU . 42.5 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.633 -1.167 . . . . 63.51 109.395 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 4' ' ' PRO . 22.3 ptp . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.762 0.315 . . . . 74.23 110.35 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.01 -35.11 43.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.045 0.45 . . . . 64.33 110.521 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 121' ' ' GLU . 21.3 t -118.58 101.98 50.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 54.34 109.735 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 4.4 Cg_exo -77.54 138.63 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.006 2.471 . . . . 72.01 112.075 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 35.2 Cg_exo -61.94 91.15 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.814 2.343 . . . . 74.13 111.683 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p -81.24 -15.99 54.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.684 -0.689 . . . . 74.13 111.321 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.853 ' HB3' HG21 ' A' ' 143' ' ' VAL . 45.8 p90 -62.75 -24.78 67.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.538 0.685 . . . . 74.11 109.677 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 12' ' ' LYS . . . -75.79 -30.0 58.93 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.157 -0.929 . . . . 74.05 110.855 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -104.26 9.34 36.05 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 119.978 -0.689 . . . . 62.35 111.717 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.531 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 94.8 mt -56.78 -35.68 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.377 . . . . 71.01 111.721 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.32 39.8 0.7 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.705 -1.236 . . . . 50.22 114.162 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 9.1 mtmp? -69.17 -48.68 61.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.896 0.848 . . . . 75.4 109.7 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -64.36 -38.37 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 71.24 110.971 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.17 -35.55 74.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 70.41 111.987 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -58.11 -38.07 75.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 60.02 112.177 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.85 -42.9 80.64 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.912 0.338 . . . . 74.25 111.912 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 t -84.47 -32.41 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.297 0.48 . . . . 43.14 112.297 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.96 -21.69 63.23 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.623 0.601 . . . . 70.12 112.623 -171.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 p -57.84 152.61 15.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 62.11 112.493 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 2.8 mptp? -86.37 -21.29 27.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.577 -0.738 . . . . 74.43 109.185 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.73 113.29 1.74 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.016 -0.993 . . . . 55.31 111.132 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' HB2' HD23 ' A' ' 262' ' ' LEU . 81.7 m-85 -85.79 -14.36 45.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.098 0.475 . . . . 71.42 110.688 -176.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.48 118.58 4.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.042 -0.823 . . . . 65.24 111.042 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -80.21 -4.67 54.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.94 0.37 . . . . 74.14 111.341 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.94 -3.57 69.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.273 -0.489 . . . . 64.24 113.262 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.7 pp -149.07 -178.12 6.2 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.707 0.765 . . . . 74.3 112.555 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -99.88 133.13 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.529 -1.214 . . . . 62.01 109.689 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.587 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.0 ttpp -124.87 146.26 49.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.768 -0.456 . . . . 72.2 109.768 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.695 HD23 ' HB2' ' A' ' 279' ' ' LEU . 3.1 tm? -131.9 128.33 38.35 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.71 -0.478 . . . . 65.1 109.71 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.665 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 11.1 m-20 -134.32 120.37 19.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.11 -0.7 . . . . 75.02 109.11 171.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 tp -140.88 128.23 21.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 65.4 110.477 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 15.3 ptpt -118.14 127.29 53.63 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.972 0.415 . . . . 72.24 111.103 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.664 HG22 ' HB3' ' A' ' 283' ' ' ALA . 38.7 p -89.7 121.69 32.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.338 -0.986 . . . . 63.03 108.338 168.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -105.04 132.04 51.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.325 0.583 . . . . 73.34 111.784 -169.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 28.8 t -138.97 141.05 38.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.293 -0.867 . . . . 64.45 108.851 172.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.9 13.96 21.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.47 0.653 . . . . 75.53 109.586 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.92 37.18 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.364 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.47 -9.64 76.94 Favored Glycine 0 C--O 1.221 -0.694 0 CA-C-O 119.008 -0.884 . . . . 60.31 114.976 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -103.9 127.57 51.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 119.279 1.54 . . . . 73.3 112.84 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 37.6 tt0 -141.74 117.59 10.48 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.48 -0.934 . . . . 72.33 108.48 158.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 93.4 m-85 -107.08 120.36 41.87 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.225 -0.59 . . . . 72.51 110.296 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 68.4 m -112.85 117.32 31.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.116 0.484 . . . . 74.42 110.665 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 p -105.03 124.28 49.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.826 -0.624 . . . . 75.31 109.502 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.0 t -133.86 125.99 29.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.827 -0.434 . . . . 72.12 109.827 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 159.09 27.92 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.375 -0.917 . . . . 41.22 112.411 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -129.32 134.77 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.746 -0.464 . . . . 52.14 109.746 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.621 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -129.81 127.68 40.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.136 0.493 . . . . 62.52 111.018 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 50' ' ' GLU . 45.9 m-80 -90.92 144.86 25.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.387 -0.824 . . . . 72.54 109.885 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -70.19 18.87 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.315 0.579 . . . . 44.41 111.921 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 48' ' ' ASN . 21.7 mm-40 -89.25 -167.24 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 73.22 110.075 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -68.13 90.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.64 -0.254 . . . . 74.34 111.54 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p 48.21 45.71 19.9 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.117 0.567 . . . . 75.43 112.246 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 29.1 mmmt -91.12 75.78 6.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 70.23 109.61 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 47' ' ' ALA . 13.3 t -120.54 123.51 70.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.162 -0.926 . . . . 64.23 110.859 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.7 p -109.44 137.04 47.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.085 -0.507 . . . . 52.34 109.669 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.94 136.41 8.82 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.464 -0.874 . . . . 71.0 112.773 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 p -127.63 145.18 50.97 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.878 -0.416 . . . . 65.3 109.878 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.3 tm? -120.68 124.97 46.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.708 -0.479 . . . . 72.55 109.708 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.7 tt0 -107.01 118.19 36.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.076 -0.712 . . . . 51.33 109.076 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.2 m -100.45 119.85 39.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.195 -0.668 . . . . 71.22 109.195 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 42.3 mtpt -121.66 127.58 50.95 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.057 0.456 . . . . 72.01 110.408 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.72 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 94.6 m-85 -106.89 120.79 43.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.897 -0.592 . . . . 73.21 109.653 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 17.5 tpt180 -111.8 106.99 15.89 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.534 0.683 . . . . 70.1 110.643 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 40.0 t-105 -105.59 108.16 19.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.574 -1.194 . . . . 75.14 109.876 -174.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -58.6 -36.24 73.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.221 -0.899 . . . . 71.42 111.943 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 14.3 mm-40 -66.25 120.46 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.437 -0.347 . . . . 75.43 110.324 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 74.57 -44.55 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.015 0.822 . . . . 72.12 111.384 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.95 64.45 0.46 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.904 -0.665 . . . . 42.13 111.899 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.02 134.72 53.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.867 0.365 . . . . 71.5 110.839 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 29.6 m -136.19 112.66 9.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.384 . . . . 73.43 110.647 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 77.6 t80 -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.683 -0.488 . . . . 71.13 109.683 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 84' ' ' GLU . 60.9 p -125.66 116.03 21.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.853 0.359 . . . . 54.22 111.011 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 40.7 tt0 -123.93 122.42 37.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.106 -0.331 . . . . 74.21 110.106 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 55.8 tttm -113.21 116.76 30.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 71.04 111.122 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -103.6 131.78 50.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 65.12 110.395 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.424 ' HB2' HG22 ' A' ' 80' ' ' THR . 7.4 m-20 -101.69 161.8 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 73.14 111.063 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.5 m -62.29 -22.21 65.84 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.584 0.707 . . . . 72.4 110.215 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 3.8 m-20 -72.23 -4.0 26.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.22 -0.9 . . . . 71.01 111.177 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 10.4 m-80 69.64 40.95 1.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.493 0.663 . . . . 74.45 110.677 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 76' ' ' ASN . 9.9 t -114.35 135.47 54.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.373 -0.83 . . . . 74.35 109.613 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.1 mm? -99.59 135.87 40.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.609 -0.723 . . . . 71.42 110.872 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -117.22 89.93 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.504 -1.039 . . . . 52.21 110.504 171.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -95.48 105.43 17.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.862 0.363 . . . . 63.44 111.773 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 26.2 mt-10 -110.07 131.6 54.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.18 -0.464 . . . . 70.02 109.895 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -119.36 121.78 67.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.005 -0.739 . . . . 74.14 109.005 173.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.0 m -112.0 124.31 52.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.296 0.569 . . . . 74.33 111.664 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 97' ' ' LEU . 66.6 t -111.03 121.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.136 -0.938 . . . . 75.25 109.663 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.32 142.67 28.18 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.77 -0.826 . . . . 32.11 108.77 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 94' ' ' GLY . 5.1 p-10 -49.69 143.89 6.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.216 0.821 . . . . 70.25 113.216 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -126.99 -56.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.814 -1.084 . . . . 73.51 108.974 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.45 -67.05 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.661 -0.7 . . . . 71.14 109.582 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.36 86.77 5.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 73.0 110.187 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.447 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -52.92 135.43 36.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.443 -0.798 . . . . 74.4 111.702 -177.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . 102.9 -22.91 35.38 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.577 -0.738 . . . . 63.14 113.726 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 35.8 tp -80.69 131.56 35.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.329 1.065 . . . . 65.24 112.18 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -123.73 120.63 33.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.917 -0.583 . . . . 64.42 109.72 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.753 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . 2.0 mm? -109.89 129.8 55.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.689 0.281 . . . . 74.21 110.434 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.932 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.2 m -131.27 119.89 22.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.661 0.267 . . . . 72.23 110.456 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.538 ' HB2' HG22 ' A' ' 85' ' ' ILE . 80.6 m-85 -111.19 115.41 29.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.759 -0.46 . . . . 75.5 109.759 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 2.3 t70 -109.39 136.01 49.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.143 -0.48 . . . . 74.4 110.343 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.0 m -144.08 122.74 12.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.022 0.439 . . . . 63.23 110.881 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 22.8 t -95.97 125.55 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.401 -0.592 . . . . 70.22 109.401 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . 98.6 m-85 -111.48 123.56 50.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.818 -0.628 . . . . 74.23 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -115.58 103.14 54.19 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 70.31 109.465 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.53 -19.15 63.52 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.354 2.703 . . . . 65.52 113.007 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -57.12 -48.11 79.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 64.51 110.811 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.6 m -109.28 -21.71 12.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.314 0.578 . . . . 64.13 111.011 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.03 23.84 43.55 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.848 -0.901 . . . . 73.31 110.848 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -78.76 148.1 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 73.21 111.852 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.27 116.47 23.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.167 -0.924 . . . . 72.02 109.165 172.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -118.41 121.16 39.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.876 -1.157 . . . . 73.53 107.876 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.19 149.67 46.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.65 0.611 . . . . 73.22 112.65 -165.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 54.0 mttp -115.23 138.01 51.4 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.149 -1.056 . . . . 65.51 108.149 169.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.905 HG22 ' HB3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -114.96 119.39 61.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.565 -0.902 . . . . 62.31 108.565 174.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.932 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 22.9 tttp -115.11 119.5 36.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.631 -0.713 . . . . 63.44 109.631 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.5 m -127.94 116.83 20.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.438 -0.578 . . . . 64.41 109.438 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -137.1 122.94 2.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.94 -1.124 . . . . 63.33 112.009 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 125' ' ' LEU . 10.5 p90 -107.4 135.41 48.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.316 0.579 . . . . 74.52 110.349 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.417 ' HB3' HG11 ' A' ' 3' ' ' VAL . 19.3 mtmm -109.31 120.43 42.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.925 -1.034 . . . . 74.41 110.142 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.584 ' HB3' HG22 ' A' ' 123' ' ' ILE . 8.3 tpt180 -108.52 157.73 18.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.939 -1.134 . . . . 61.42 107.939 169.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.641 ' HA ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -54.32 -29.27 47.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.723 0.638 . . . . 73.05 112.723 -170.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -112.37 -12.19 13.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 64.43 112.381 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 142' ' ' LEU . 9.8 tp -143.45 132.8 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.821 -0.752 . . . . 62.3 112.47 -168.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -118.76 119.16 33.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.811 -0.44 . . . . 70.3 109.811 179.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 124' ' ' ASN . 3.9 mm? -111.87 119.96 40.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.229 -0.441 . . . . 73.25 110.277 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.88 127.51 5.97 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.673 -0.775 . . . . 64.44 112.872 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 57.0 m -111.08 121.61 45.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.619 -0.511 . . . . 74.41 109.619 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 t70 -124.23 117.69 25.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.169 -0.678 . . . . 65.11 109.169 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.905 ' HB3' HG22 ' A' ' 114' ' ' ILE . 36.1 ttm -118.33 130.38 55.99 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.854 -0.529 . . . . 72.22 111.668 -172.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.35 118.78 31.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.725 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.641 ' HE2' ' HB ' ' A' ' 114' ' ' ILE . 92.6 m-85 -96.26 96.53 8.84 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.855 -1.165 . . . . 72.42 107.855 167.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -136.72 155.44 49.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.271 -0.422 . . . . 63.42 110.587 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -30.0 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 63.34 110.97 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.08 -14.08 60.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.049 0.452 . . . . 75.44 110.859 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.67 128.49 2.18 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.626 -0.797 . . . . 73.13 112.731 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.81 118.56 5.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.604 2.203 . . . . 70.42 110.653 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -125.96 144.77 50.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.866 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.05 118.15 54.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.324 0.583 . . . . 55.12 109.842 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 21.5 ttp-105 -106.94 129.8 54.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.618 -0.719 . . . . 62.42 109.799 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.33 133.23 11.38 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.312 -0.947 . . . . 73.32 111.875 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -126.07 116.47 21.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.758 -0.46 . . . . 61.14 109.758 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 123' ' ' ILE . 8.8 tp -120.62 123.94 44.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.666 -0.494 . . . . 74.3 109.666 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.853 HG21 ' HB3' ' A' ' 7' ' ' TYR . 94.0 t -127.41 129.41 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.312 -0.404 . . . . 72.35 110.715 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.632 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.54 136.72 48.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.973 -0.751 . . . . 63.32 108.973 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.67 118.93 4.18 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.598 -0.81 . . . . 55.21 112.07 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -141.58 147.35 37.53 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.475 -0.565 . . . . 75.33 109.475 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.64 101.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 70.42 111.703 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 174' ' ' LYS . . . 88.22 -32.35 4.43 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.098 -0.955 . . . . 74.34 112.692 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -105.92 122.37 45.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 73.43 111.175 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 151' ' ' ALA . 5.3 tp -138.42 135.1 34.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.359 -0.608 . . . . 74.23 109.359 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -136.73 132.54 34.97 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.843 -0.343 . . . . 72.03 111.227 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.531 ' HA3' ' CD1' ' A' ' 10' ' ' LEU . . . -132.98 133.82 7.22 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.971 -0.633 . . . . 44.31 112.034 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.535 ' HA ' ' HD2' ' A' ' 169' ' ' PHE . 22.6 m-85 -122.8 119.7 31.36 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.421 -0.585 . . . . 71.22 109.421 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -118.63 130.22 55.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 75.34 110.077 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 21.8 ptp -143.73 143.74 31.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.162 -0.472 . . . . 53.15 110.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -112.36 118.41 35.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.231 -1.026 . . . . 71.23 108.231 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -107.23 118.36 36.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.74 -0.467 . . . . 54.53 109.74 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -86.83 95.35 9.83 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.589 -0.893 . . . . 74.34 108.589 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 m -72.57 -25.16 61.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 113.532 -1.667 . . . . 70.52 111.435 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.55 -31.16 69.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.719 0.771 . . . . 54.44 109.083 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -109.9 -159.79 0.69 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.378 -1.283 . . . . 72.21 108.112 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.0 p -109.47 26.77 10.26 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.132 -0.355 . . . . 72.53 111.111 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 mtp85 -133.66 171.25 14.38 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 114.828 1.418 . . . . 71.21 114.828 -160.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.1 t -104.37 132.22 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.286 -1.325 . . . . 73.52 108.651 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -94.38 -33.91 12.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 45.33 111.245 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -151.87 132.74 14.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.435 -0.348 . . . . 73.05 110.102 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.9 t -124.34 106.94 10.64 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.417 -0.586 . . . . 73.41 109.417 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.91 135.17 55.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.306 0.574 . . . . 75.31 110.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 153' ' ' TYR . 57.5 m-85 -125.83 155.9 40.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.242 -0.436 . . . . 72.41 110.555 -176.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . . . -150.65 127.96 11.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.158 -0.473 . . . . 73.53 109.795 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 63.7 t -129.77 127.59 64.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.918 0.39 . . . . 75.24 110.491 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.02 111.25 4.19 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.05 -0.82 . . . . 61.54 111.05 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -112.06 120.44 41.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.794 -0.817 . . . . 71.34 108.794 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 148' ' ' GLY . 11.5 tmtt? -103.23 126.5 50.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.373 0.606 . . . . 74.34 109.89 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 3.9 m -116.91 164.08 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.913 -1.04 . . . . 70.3 108.398 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -34.13 -66.82 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.177 0.806 . . . . 54.24 113.177 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.89 13.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.898 -0.321 . . . . 72.14 111.694 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.497 ' HD1' ' NE2' ' A' ' 196' ' ' GLN . 10.3 m-85 -126.5 137.97 53.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.577 -0.283 . . . . 73.42 110.269 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -122.11 122.73 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.832 -0.747 . . . . 73.2 109.81 170.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 194' ' ' ILE . 4.9 tt -123.77 139.19 54.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.737 -0.665 . . . . 72.31 111.068 -172.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.84 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 58.4 m80 -116.45 117.13 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.36 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.6 m -96.02 110.83 23.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.228 -0.656 . . . . 71.05 109.228 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -124.42 160.63 27.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 41.11 110.919 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.504 HG22 ' HD1' ' A' ' 190' ' ' PHE . 16.6 t -131.72 124.4 53.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.872 -0.604 . . . . 73.15 109.764 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 30.2 t30 -99.89 95.45 6.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.622 -0.717 . . . . 53.44 109.705 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.63 178.82 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.282 -0.872 . . . . 44.23 109.381 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.21 -7.14 71.09 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.075 -1.06 . . . . 72.21 111.404 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.9 m -95.01 -25.71 16.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.762 0.653 . . . . 71.52 112.762 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 43.2 tt0 -132.38 145.05 50.95 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.467 -0.771 . . . . 61.41 111.957 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.504 ' HD1' HG22 ' A' ' 184' ' ' VAL . 22.9 m-85 -117.17 150.27 39.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.459 -0.941 . . . . 65.41 108.459 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.32 155.81 24.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.176 -1.012 . . . . 62.14 113.491 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -141.14 126.0 2.95 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.271 -0.732 . . . . 52.15 111.271 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.84 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 46.8 t -112.1 136.6 51.26 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.895 0.379 . . . . 51.42 110.075 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.75 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.6 mm -120.53 124.3 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.868 -0.606 . . . . 63.51 109.542 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.457 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 0.3 OUTLIER -118.23 121.47 40.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.425 -0.583 . . . . 75.42 109.425 173.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.497 ' NE2' ' HD1' ' A' ' 178' ' ' PHE . 14.5 mm100 -124.45 132.04 53.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 63.4 111.635 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -86.53 122.57 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.216 -0.661 . . . . 74.02 109.216 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.5 m -136.22 173.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.317 -0.401 . . . . 71.22 110.896 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -97.51 -41.92 7.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.095 0.474 . . . . 45.11 110.098 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -69.93 -33.19 71.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 73.12 112.345 -177.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.437 ' HB3' ' HB1' ' A' ' 223' ' ' ALA . 94.1 mttt -123.54 11.77 9.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.264 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 -85.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.787 0.679 . . . . 60.43 110.892 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.835 ' HG3' ' HB3' ' A' ' 224' ' ' LYS . 9.5 pt-20 -127.1 128.75 46.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.171 -0.678 . . . . 74.33 109.171 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 196' ' ' GLN . 15.4 t -123.44 148.82 45.78 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.374 -0.53 . . . . 75.44 110.419 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.45 136.59 49.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.67 -0.696 . . . . 63.31 110.964 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.83 HG22 HG22 ' A' ' 221' ' ' ILE . 61.1 t -118.8 137.96 51.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.447 -0.797 . . . . 53.43 109.159 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.416 ' OD1' ' HA3' ' A' ' 220' ' ' GLY . 2.9 p-10 -124.6 134.19 53.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 71.21 110.715 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.46 141.36 49.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.054 -0.976 . . . . 75.54 109.397 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -142.21 130.61 22.38 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.182 -0.463 . . . . 31.21 110.036 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.9 122.37 37.18 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.906 -0.405 . . . . 74.44 109.906 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 216' ' ' ASN . 27.0 m -95.21 107.96 20.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.584 -0.524 . . . . 74.25 109.584 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.16 146.21 48.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.723 -0.671 . . . . 55.54 111.162 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.95 -46.42 3.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.134 -0.555 . . . . 30.2 112.261 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 216' ' ' ASN . 21.1 t-20 -86.59 -21.2 26.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.896 0.379 . . . . 75.32 110.271 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.5 m 66.74 17.42 10.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.577 -0.738 . . . . 61.44 110.758 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.432 ' HB2' ' OD1' ' A' ' 214' ' ' ASN . 53.7 t-20 -69.48 121.18 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 73.41 109.526 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.3 m -113.71 122.56 47.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.069 0.461 . . . . 73.22 110.031 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.747 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 37.4 mmt180 -105.31 125.0 50.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.959 -0.564 . . . . 74.43 109.924 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.755 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 46.9 m-85 -113.9 133.6 55.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.909 -0.775 . . . . 65.13 108.909 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.416 ' HA3' ' OD1' ' A' ' 207' ' ' ASN . . . -145.03 141.15 9.66 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.31 -0.948 . . . . 52.43 112.044 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.83 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -132.36 133.3 60.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 64.13 110.857 178.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -132.51 138.37 47.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.875 -0.602 . . . . 55.04 111.062 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.65 125.56 54.28 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.84 -0.43 . . . . 53.04 109.84 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.835 ' HB3' ' HG3' ' A' ' 203' ' ' GLU . 4.3 ttpp -113.34 113.32 25.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.252 0.549 . . . . 63.44 109.691 -177.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -131.9 116.54 17.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 74.32 110.144 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.686 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 12.0 pt20 -85.07 103.1 13.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.382 0.61 . . . . 61.21 109.987 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.3 -29.33 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.487 -0.779 . . . . 40.43 110.561 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.723 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 23.2 m-20 -123.47 163.29 35.28 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.625 . . . . 72.41 109.542 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.21 -29.73 64.52 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.172 1.915 . . . . 71.23 111.916 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -109.81 -2.27 17.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 64.14 111.607 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -134.7 124.53 25.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.476 . . . . 72.41 111.891 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 43.3 t -123.43 135.41 54.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 63.41 109.668 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -115.79 133.61 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.126 0.489 . . . . 62.13 110.534 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.3 p -125.26 123.85 40.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.912 -0.585 . . . . 63.34 110.325 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -107.6 140.01 41.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.323 -0.991 . . . . 54.41 108.323 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -148.88 150.07 32.34 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.828 -0.349 . . . . 74.23 110.745 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 10.0 p -145.64 142.91 21.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 72.13 109.943 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 15.4 t-20 -105.31 149.45 26.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.475 -0.784 . . . . 73.22 109.11 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.755 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 20.8 t-20 -57.04 -21.59 32.35 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.996 0.81 . . . . 43.11 112.251 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.5 p -79.24 21.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.958 0.409 . . . . 54.12 110.842 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 239' ' ' ASN . 25.9 t 68.59 31.28 4.79 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.461 -0.79 . . . . 63.02 110.641 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.892 ' HB3' HD11 ' A' ' 262' ' ' LEU . 36.1 mt -99.73 116.01 30.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.344 -0.542 . . . . 71.04 110.468 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 243' ' ' ILE . 3.4 mp -99.76 117.83 45.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 N-CA-C 109.896 -0.409 . . . . 74.14 109.896 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.41 141.46 16.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.013 -0.613 . . . . 61.01 113.21 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 260' ' ' SER . 8.0 mt -116.18 137.95 51.69 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -141.4 120.71 1.73 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.32 -0.943 . . . . 33.3 111.875 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.5 115.42 18.11 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.847 -0.427 . . . . 73.12 109.847 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 9.0 t -114.74 130.57 56.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.15 0.5 . . . . 63.22 110.351 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 58.1 tt0 -143.66 131.65 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.938 -0.574 . . . . 75.12 110.289 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 23.2 p -78.67 129.1 34.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.591 0.234 . . . . 55.12 110.89 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 251' ' ' LEU . 1.6 pp -140.8 145.23 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.864 -0.421 . . . . 75.41 109.864 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 92.3 mttt 67.74 156.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 123.619 0.574 . . . . 74.01 110.51 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 36.3 Cg_endo -66.71 86.7 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.21 1.94 . . . . 71.05 113.366 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.759 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 105.46 29.54 5.03 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.904 -0.665 . . . . 74.1 113.926 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 251' ' ' LEU . 64.7 mt -132.76 133.95 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 117.384 0.592 . . . . 74.3 110.72 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.14 133.63 53.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.76 0.314 . . . . 43.33 110.323 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.3 tp -98.06 132.57 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 73.14 109.765 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 15.3 m -126.06 111.15 14.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.347 -0.388 . . . . 72.02 110.201 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.977 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.09 124.58 47.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.664 -0.865 . . . . 64.01 108.664 176.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 45.0 m -133.63 140.41 47.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.907 0.384 . . . . 64.35 110.435 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.16 -0.473 . . . . 72.42 110.013 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.892 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -106.87 115.91 31.01 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.082 -0.71 . . . . 64.14 109.082 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.588 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -95.0 106.25 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.48 -1.304 . . . . 54.54 107.48 175.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.607 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 42.7 m-20 -71.95 104.77 3.62 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.759 -0.83 . . . . 73.42 108.759 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.62 -20.66 25.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.246 -0.502 . . . . 34.12 112.996 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -90.8 -3.51 57.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.811 0.338 . . . . 70.24 110.936 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.607 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 62.9 t30 -133.03 -35.53 1.05 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.754 0.65 . . . . 73.35 112.754 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' ' 263' ' ' LEU . 29.4 m -62.46 -18.41 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.747 0.647 . . . . 72.14 112.747 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -68.38 -25.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 65.11 110.324 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -101.33 -5.98 24.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.431 0.634 . . . . 63.25 110.005 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 91.95 103.48 1.42 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.608 -0.724 . . . . 72.02 111.809 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 173.81 85.62 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.54 -0.838 . . . . 72.31 112.17 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -113.47 147.18 38.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.881 -0.414 . . . . 73.45 109.881 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 7.1 mmpt? -95.15 137.08 34.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.062 -0.718 . . . . 64.23 109.062 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.75 127.61 54.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.82 -0.437 . . . . 73.51 109.82 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.55 104.96 0.83 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.56 -1.016 . . . . 34.14 110.56 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.977 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -113.76 125.35 54.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.905 -0.776 . . . . 72.33 108.905 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -145.68 133.64 5.1 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.6 -1.286 . . . . 54.2 112.98 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.695 ' HB2' HD23 ' A' ' 29' ' ' LEU . 2.3 mm? -108.7 128.01 54.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.248 -1.019 . . . . 64.33 108.248 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 10.5 pt-20 -140.86 137.92 33.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 119.328 -0.368 . . . . 55.11 110.594 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.759 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.6 OUTLIER 166.56 -148.96 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.124 0.89 . . . . 75.52 111.213 168.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 22.3 pt20 -137.68 119.11 14.76 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.208 -0.451 . . . . 61.12 110.776 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.664 ' HB3' HG22 ' A' ' 33' ' ' THR . . . -82.58 109.98 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.169 0.509 . . . . 60.11 110.004 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 284' ' ' LEU . 3.8 mm? -125.29 164.04 21.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.768 -0.651 . . . . 71.33 110.542 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.551 -0.907 . . . . 74.11 108.551 178.302 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.96 -0.385 . . . . 73.25 109.96 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.14 116.08 8.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.231 -0.44 . . . . 75.21 111.448 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 76.5 t -123.18 124.63 26.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 54.41 109.948 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 31.2 Cg_exo -59.42 143.83 99.59 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.097 2.531 . . . . 62.5 112.835 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 4.9 Cg_exo -77.17 69.17 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.198 2.599 . . . . 74.35 111.283 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -68.46 -29.61 68.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.802 -0.636 . . . . 72.32 112.075 -173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.89 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.9 p90 -64.56 -26.72 68.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.924 0.392 . . . . 73.23 111.089 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.64 35.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.052 0.453 . . . . 63.14 110.033 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -94.9 4.03 54.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.949 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 ' HA3' ' A' ' 152' ' ' GLY . 92.4 mt -63.94 -33.2 75.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.401 . . . . 73.22 110.216 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 61.91 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.012 -0.613 . . . . 63.21 112.143 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.12 -39.08 79.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 70.45 110.239 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 m -59.24 -36.47 75.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.226 -0.897 . . . . 72.43 111.836 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.47 69.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.324 -0.398 . . . . 52.45 112.052 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -62.33 -31.53 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.519 -0.31 . . . . 72.25 110.934 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 62.2 111.392 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 222' ' ' ALA . 40.0 t -78.59 -46.18 24.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.966 -0.294 . . . . 62.32 110.797 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 218' ' ' ARG . 90.9 t80 -64.79 -42.6 94.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.17 0.509 . . . . 74.31 110.807 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 20' ' ' LYS . 1.8 m -108.55 -142.98 0.38 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.237 -1.023 . . . . 74.33 108.237 174.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.577 ' H ' HG22 ' A' ' 19' ' ' THR . 43.2 mmtm -141.59 106.02 4.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.909 -0.404 . . . . 73.45 109.909 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.73 -44.02 21.53 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.67 -0.972 . . . . 62.42 110.67 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 28' ' ' LYS . 30.0 m-85 -135.15 -179.24 5.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.402 -0.592 . . . . 72.11 109.402 173.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 51.91 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.487 -0.863 . . . . 51.22 112.215 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -103.55 11.01 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.919 0.39 . . . . 71.32 110.819 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.667 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 93.52 13.75 54.81 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.444 -0.884 . . . . 72.12 111.854 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.6 pp -126.89 179.16 5.53 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-O 122.239 1.019 . . . . 75.53 113.317 -170.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.696 HD12 HD12 ' A' ' 277' ' ' LEU . 29.9 mm -98.58 142.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.888 -1.505 . . . . 62.43 109.855 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.595 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 3.9 tmtm? -122.47 135.82 54.75 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 74.34 109.424 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.0 tp -123.78 148.5 46.6 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.727 -0.389 . . . . 74.32 110.507 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 43' ' ' SER . 10.4 t70 -145.22 127.66 15.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.306 -0.861 . . . . 74.2 108.886 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.4 OUTLIER -126.65 124.61 40.26 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.839 -0.8 . . . . 62.13 108.839 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -125.61 138.16 53.92 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.706 -0.479 . . . . 73.01 109.706 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 33.4 m -136.34 128.71 30.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.697 0.284 . . . . 65.25 110.374 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -104.59 141.84 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 70.45 110.798 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.925 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 31.1 m -134.03 170.02 16.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.099 -0.704 . . . . 73.15 109.099 172.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.98 -62.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.258 0.836 . . . . 73.23 113.258 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -144.23 126.86 16.07 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.177 -0.609 . . . . 70.41 111.654 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 86.84 -10.5 67.71 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 119.084 -0.842 . . . . 74.11 114.806 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.925 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 3.0 mm? -103.03 129.38 49.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.782 1.291 . . . . 74.3 112.41 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.872 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 38.4 tt0 -139.77 118.08 12.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.242 -0.651 . . . . 75.31 109.242 165.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.78 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 66.7 t80 -104.9 121.33 43.47 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.798 -0.361 . . . . 75.04 110.325 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 87.2 m -127.3 128.22 45.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 72.3 111.385 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.7 t -122.48 132.33 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.824 -0.806 . . . . 70.32 108.824 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 p -134.33 125.61 27.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.104 -0.332 . . . . 71.54 110.104 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.67 151.27 23.19 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.803 -1.189 . . . . 65.34 113.04 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 27.3 m -138.12 134.23 34.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.766 -0.828 . . . . 62.44 108.766 172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.573 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -144.39 131.98 21.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.581 -0.448 . . . . 70.32 111.914 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.9 143.85 55.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.633 -0.712 . . . . 74.44 109.164 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 m -54.69 -27.12 38.02 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.451 0.537 . . . . 63.53 112.451 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -88.52 6.56 37.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.152 0.501 . . . . 63.43 110.529 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.5 p 52.41 24.98 3.22 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.812 0.845 . . . . 70.23 112.507 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 p -85.06 -50.81 7.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.192 0.52 . . . . 42.33 111.101 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.61 100.22 9.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.745 -0.835 . . . . 75.32 108.745 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 47' ' ' ALA . 15.1 t -125.31 132.65 70.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.466 -0.788 . . . . 54.51 110.798 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 124.7 52.09 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 42.45 108.98 173.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.16 103.84 0.54 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.885 -0.674 . . . . 64.11 111.725 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 t -111.15 139.28 46.66 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.11 0.481 . . . . 73.41 110.177 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -119.38 124.59 46.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.936 -1.135 . . . . 53.4 107.936 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 56.5 mt-10 -120.24 119.11 32.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.328 0.585 . . . . 73.11 110.331 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' ' 73' ' ' GLU . 5.0 t -110.83 120.59 42.89 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.153 -0.684 . . . . 73.14 109.153 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.872 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 2.7 mptp? -110.21 137.67 47.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 64.11 109.496 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 18.2 m-85 -115.23 118.86 34.5 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.079 -1.082 . . . . 74.03 108.079 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.537 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ptt180 -131.57 108.41 9.52 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.388 -0.925 . . . . 64.12 111.879 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -95.7 100.74 12.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.124 -1.398 . . . . 74.54 108.745 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m 72.8 124.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.348 1.03 . . . . 65.23 111.556 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.84 130.58 46.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.048 -0.723 . . . . 63.11 109.048 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 63.34 66.15 0.72 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.289 -0.634 . . . . 72.14 109.289 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.55 -107.26 0.21 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.972 -0.632 . . . . 73.31 111.578 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.582 ' CD1' HG12 ' A' ' 87' ' ' VAL . 2.0 mm? -117.51 132.75 56.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.236 0.458 . . . . 61.41 112.236 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 60.0 m -136.34 119.18 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.28 0.562 . . . . 62.32 111.204 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 59.0 m-85 -109.87 133.36 53.25 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.972 -0.751 . . . . 73.24 108.972 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -125.14 132.66 53.04 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.509 -0.476 . . . . 54.13 111.573 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 60' ' ' THR . 37.3 mt-10 -125.34 123.25 38.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 73.21 109.439 171.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.44 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 63.0 tttp -122.76 109.66 14.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.288 -0.264 . . . . 62.43 110.288 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -107.29 134.3 50.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.959 -0.386 . . . . 71.53 109.959 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -120.1 155.13 33.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 73.34 110.529 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -58.24 -22.88 54.01 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.226 0.536 . . . . 74.41 111.38 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HB3' HG23 ' A' ' 107' ' ' THR . 46.6 m-20 -71.51 -1.39 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.569 -0.741 . . . . 71.34 111.829 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 20.5 m120 78.98 21.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.543 0.737 . . . . 71.13 109.925 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.861 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 3.6 m -90.72 118.99 30.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.559 -0.746 . . . . 64.53 110.757 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 102' ' ' SER . 4.2 mm? -101.13 118.14 36.41 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.411 -0.359 . . . . 71.3 110.556 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -116.78 96.14 0.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.606 -0.997 . . . . 41.24 110.606 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -143.59 156.1 44.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.088 0.403 . . . . 72.33 112.088 -169.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 mm-40 159.52 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 125.207 1.567 . . . . 64.32 110.047 167.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.501 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.55 137.71 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.644 0.609 . . . . 62.21 112.644 -161.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 98' ' ' THR . 12.8 t -129.38 140.39 51.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.977 0.418 . . . . 53.21 110.946 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 97' ' ' LEU . 6.2 m -117.88 138.44 48.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.11 -0.496 . . . . 72.34 109.834 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -114.42 116.57 29.11 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.507 -0.477 . . . . 74.32 110.827 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.589 ' HB3' ' H ' ' A' ' 94' ' ' GLY . 7.3 p-10 39.71 31.35 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.679 1.191 . . . . 72.22 113.612 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -75.2 -47.84 26.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 61.21 109.957 176.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -70.07 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.197 -0.668 . . . . 74.22 109.197 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -99.2 122.72 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.219 -0.446 . . . . 63.11 110.2 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 89' ' ' ASP . 10.1 tpp85 -63.66 124.87 22.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.289 -0.414 . . . . 73.02 110.559 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.589 ' H ' ' HB3' ' A' ' 89' ' ' ASP . . . 97.0 -22.74 39.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.058 -0.591 . . . . 45.53 112.093 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.6 tp -89.92 136.93 32.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.009 0.433 . . . . 74.13 110.244 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.95 ' HE3' ' HD2' ' A' ' 119' ' ' LYS . 63.8 mmtt -121.66 116.5 24.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.186 -0.672 . . . . 73.03 109.186 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.4 mm? -108.0 127.52 53.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.937 -0.394 . . . . 72.02 109.937 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.916 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 22.3 m -129.35 119.55 24.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 72.12 111.42 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 87.4 m-85 -104.82 121.09 42.93 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.983 -1.118 . . . . 64.43 107.983 171.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 113' ' ' LYS . 9.4 t70 -130.45 127.54 39.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.83 0.706 . . . . 72.12 109.35 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 p -140.24 130.68 25.39 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.275 -0.97 . . . . 75.31 112.156 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 45.1 t -113.32 122.27 46.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.57 -0.741 . . . . 43.4 109.448 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.689 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 36.5 p90 -138.03 119.24 14.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.877 0.846 . . . . 71.35 112.162 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.861 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 43.3 t -132.24 137.02 29.08 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.592 -1.186 . . . . 61.11 109.244 166.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 3.4 Cg_exo -81.89 -1.85 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.626 2.217 . . . . 42.42 111.183 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -110.2 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.676 -0.693 . . . . 73.24 110.173 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.589 HG23 ' HB3' ' A' ' 78' ' ' ASP . 3.3 t -146.89 133.86 20.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.433 -0.951 . . . . 71.14 108.433 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' HG23 ' A' ' 80' ' ' THR . . . 100.07 36.03 4.31 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 118.33 -1.891 . . . . 50.21 111.2 -164.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 104' ' ' SER . 11.7 mptt -55.61 155.95 5.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.481 0.658 . . . . 72.34 112.143 -168.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 103' ' ' PHE . 52.7 tttp -71.03 115.06 9.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.856 -1.065 . . . . 72.55 111.869 -159.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -133.44 132.8 41.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.455 -1.248 . . . . 65.31 109.167 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.58 127.9 54.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.032 -0.531 . . . . 62.42 110.593 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 30.6 mmtp -111.82 137.29 49.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.01 -0.541 . . . . 74.42 110.126 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.428 HG23 ' CG ' ' A' ' 129' ' ' MET . 3.4 tp -120.58 116.9 51.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.878 -0.786 . . . . 63.35 108.878 171.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.916 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 5.1 ttmp? -114.79 121.26 42.73 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.251 -0.886 . . . . 63.32 110.048 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.4 t -116.61 118.15 31.8 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.344 0.593 . . . . 61.02 109.448 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.95 151.5 17.02 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.749 -0.739 . . . . 60.21 112.087 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -132.87 127.68 34.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.316 -0.624 . . . . 73.43 109.316 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.95 ' HD2' ' HE3' ' A' ' 96' ' ' LYS . 68.3 mttm -110.77 120.26 41.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.139 -0.624 . . . . 71.24 111.465 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.646 ' HB2' HG22 ' A' ' 123' ' ' ILE . 80.5 mtp180 -109.58 162.56 14.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.079 -0.964 . . . . 75.23 108.612 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.54 -38.87 60.64 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.404 0.52 . . . . 65.32 112.404 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -120.86 8.27 10.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.569 -0.287 . . . . 63.24 111.737 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.755 HD11 ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -139.58 131.39 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.178 0.514 . . . . 74.04 111.234 -173.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.4 t30 -122.15 119.4 31.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.044 -0.526 . . . . 63.4 110.764 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.684 HD13 HD13 ' A' ' 142' ' ' LEU . 4.5 mm? -110.66 134.26 52.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 72.13 109.368 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.77 116.01 0.83 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.338 -0.934 . . . . 75.31 112.217 176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 73.5 m -110.33 107.45 17.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.999 0.428 . . . . 72.4 110.54 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 27.3 t70 -111.91 118.35 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.685 -0.689 . . . . 72.54 109.313 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.428 ' CG ' HG23 ' A' ' 114' ' ' ILE . 23.8 ptp -129.25 147.97 51.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.673 -0.811 . . . . 65.32 112.061 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 3.1 m-20 -76.04 119.72 20.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.535 -1.283 . . . . 75.45 107.535 174.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -86.53 109.41 19.09 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.265 0.839 . . . . 73.23 113.265 -163.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 136' ' ' PRO . 20.1 t70 43.34 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.87 1.433 . . . . 74.54 114.87 161.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -60.95 -26.15 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.663 0.616 . . . . 74.11 112.663 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -93.21 -5.18 50.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.048 0.452 . . . . 75.5 110.57 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.05 109.79 3.31 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.042 -0.823 . . . . 70.14 111.042 -174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.542 ' HG3' ' HA ' ' A' ' 132' ' ' ASP . 27.4 Cg_exo -61.38 100.62 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.802 2.335 . . . . 62.42 112.553 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 45.0 t -126.87 128.77 47.02 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 74.42 108.943 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.98 117.12 52.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.184 -0.606 . . . . 72.34 110.868 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 156' ' ' ASN . 24.1 mtt180 -108.08 121.64 45.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.021 -0.733 . . . . 73.31 109.021 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.68 131.55 10.45 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.791 -1.195 . . . . 73.15 111.603 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -122.24 116.24 23.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.764 -0.458 . . . . 71.12 109.764 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.684 HD13 HD13 ' A' ' 125' ' ' LEU . 12.9 tp -122.24 124.53 44.01 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.262 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.89 HG21 ' HB3' ' A' ' 7' ' ' TYR . 57.3 t -122.38 121.86 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 74.42 109.983 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.755 ' HG ' HD11 ' A' ' 123' ' ' ILE . 4.3 mp -109.11 137.21 47.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.091 -0.707 . . . . 73.21 109.091 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.537 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -122.38 119.0 3.82 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.617 -0.801 . . . . 75.52 112.847 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.425 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 47.5 m-85 -129.71 147.56 51.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.402 -1.333 . . . . 74.51 107.402 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -56.45 101.2 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.452 0.644 . . . . 75.25 111.059 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.758 ' HA2' ' HB3' ' A' ' 174' ' ' LYS . . . 104.09 -33.49 6.53 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.984 -1.007 . . . . 52.32 112.107 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 2.2 m-90 -107.01 120.26 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.212 -0.581 . . . . 73.5 111.898 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.537 HD23 ' HA2' ' A' ' 145' ' ' GLY . 7.6 mt -123.2 138.17 54.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.274 -0.421 . . . . 73.2 109.892 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -143.06 124.38 14.65 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.875 -0.33 . . . . 61.41 110.174 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.8 131.71 4.42 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.503 -0.856 . . . . 71.12 111.405 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 37.9 p90 -142.65 144.66 32.87 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.095 -0.642 . . . . 74.42 111.952 -176.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 77.2 mt-30 -111.87 121.74 45.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.052 -0.976 . . . . 74.3 109.303 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.4 ' C ' HD22 ' A' ' 156' ' ' ASN . 87.8 mtp -118.94 129.84 55.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.874 -0.787 . . . . 64.5 108.874 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -109.99 114.56 28.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.969 -0.752 . . . . 74.54 108.969 -177.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 25.1 m-85 -94.34 118.49 31.7 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 74.45 110.355 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 161' ' ' LYS . 38.0 tt0 -86.71 100.68 12.65 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 108.967 -0.753 . . . . 73.52 108.967 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 m -70.56 -17.46 62.92 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.334 -1.757 . . . . 71.31 111.355 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.85 92.04 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.341 -0.985 . . . . 64.33 108.341 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 158' ' ' GLU . 61.4 mttp -99.95 -159.5 0.74 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.538 -1.21 . . . . 73.54 108.299 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 p -109.15 28.44 8.5 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.221 -0.3 . . . . 55.11 110.528 172.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -151.7 150.58 30.38 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 119.086 -1.045 . . . . 74.13 112.249 -161.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.3 m -74.3 134.95 28.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.079 0.466 . . . . 73.13 110.325 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 9.4 t -95.45 -23.12 17.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.999 -0.546 . . . . 53.13 111.03 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -139.72 132.63 29.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 75.52 110.617 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 14.4 m -122.34 129.91 52.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.492 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.94 121.41 21.63 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.964 -0.384 . . . . 73.42 109.964 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.682 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 91.2 m-85 -121.01 140.48 51.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.827 0.346 . . . . 70.24 110.964 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.91 128.58 24.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.132 0.491 . . . . 64.42 110.077 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.669 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -127.19 150.15 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.495 -0.557 . . . . 55.22 109.495 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.46 120.06 2.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.114 -0.565 . . . . 55.23 111.868 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -113.29 120.73 42.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.861 0.362 . . . . 74.02 110.085 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.758 ' HB3' ' HA2' ' A' ' 148' ' ' GLY . 29.7 ttmt -104.68 123.9 48.42 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.433 -0.58 . . . . 63.42 109.433 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.9 m -134.42 114.09 12.54 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.513 -0.551 . . . . 64.24 109.513 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 47.66 -93.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.816 0.673 . . . . 73.43 112.816 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -111.48 6.41 20.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.02 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.83 ' HD2' HE22 ' A' ' 196' ' ' GLN . 7.2 m-85 -113.34 127.37 56.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.503 -0.317 . . . . 72.21 110.794 -173.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.92 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.1 mm-40 -112.06 124.61 52.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.667 -0.864 . . . . 73.13 108.667 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.409 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 5.6 tt -122.22 134.09 54.71 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.725 -0.609 . . . . 73.51 110.577 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 41.0 t60 -119.97 116.7 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.876 -0.602 . . . . 71.13 110.575 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.669 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 12.3 m -90.46 141.01 29.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.988 -0.745 . . . . 74.34 108.988 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -142.4 138.77 31.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.358 -0.537 . . . . 72.22 111.187 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 61.0 t -132.39 125.8 54.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.41 -0.814 . . . . 52.12 110.067 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.61 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 26.2 t-20 -117.06 107.76 14.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.249 -0.648 . . . . 71.22 109.249 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.5 t70 62.93 -171.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.919 -0.771 . . . . 74.21 108.919 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.93 -6.33 89.16 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.452 -0.88 . . . . 73.02 111.356 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.5 m -97.83 -25.68 14.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.836 0.68 . . . . 73.42 112.836 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 3.7 tp10 -118.21 113.68 21.89 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.603 -0.686 . . . . 72.3 110.751 -175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 42.4 p90 -135.56 132.1 36.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.775 -0.37 . . . . 74.3 110.735 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -169.83 -158.91 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.238 -0.982 . . . . 64.0 113.404 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.14 178.43 23.85 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.527 -0.368 . . . . 25.44 112.528 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.63 ' HB2' ' HB3' ' A' ' 181' ' ' HIS . 18.8 m -149.84 147.43 27.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.654 -0.499 . . . . 70.11 109.654 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.6 mp -128.79 124.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.659 0.266 . . . . 75.41 110.942 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.92 ' HB2' ' HB2' ' A' ' 179' ' ' GLN . 43.8 m-85 -108.19 123.66 49.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.667 -0.494 . . . . 75.35 109.667 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 1.024 HE21 ' HA ' ' A' ' 196' ' ' GLN . 0.0 OUTLIER -120.7 124.67 45.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.313 -0.403 . . . . 71.33 111.763 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 203' ' ' GLU . 11.6 mmtp -96.0 107.51 19.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 52.43 109.532 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.89 92.43 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.911 -0.586 . . . . 63.13 110.642 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.7 26.5 11.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.255 -0.884 . . . . 52.3 111.553 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 68.41 5.12 4.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.345 -0.843 . . . . 71.41 112.539 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.42 -38.87 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 63.45 111.117 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.56 151.99 40.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.411 . . . . 73.2 110.759 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' A' ' 197' ' ' LYS . 41.6 tt0 -117.11 132.21 56.72 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.814 -0.81 . . . . 53.54 108.814 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -123.06 143.16 50.14 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.211 -0.292 . . . . 75.34 110.211 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -129.66 136.39 49.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.123 0.487 . . . . 75.45 110.848 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 193' ' ' SER . 39.3 t -112.89 130.91 65.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.652 . . . . 75.14 109.538 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 18' ' ' PHE . 14.2 m120 -114.52 128.95 56.6 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.277 -0.638 . . . . 73.23 109.277 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.707 HD13 ' HD2' ' A' ' 219' ' ' PHE . 5.5 tp -146.92 134.29 20.73 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.409 -0.359 . . . . 52.24 110.357 -170.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.7 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -157.74 150.44 22.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.849 0.357 . . . . 54.41 111.466 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.552 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 29.4 t-105 -115.79 133.03 56.44 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.985 -0.746 . . . . 70.24 108.985 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.854 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 20.9 m -95.54 108.23 20.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.709 -0.478 . . . . 74.35 109.709 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.589 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.62 147.5 49.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.463 -0.79 . . . . 63.13 111.706 -174.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.03 -74.74 0.21 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.717 -0.674 . . . . 62.54 111.677 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -173.8 85.07 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 74.05 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.854 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 49.0 m -156.7 165.85 35.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.716 . . . . 64.3 109.415 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.05 160.01 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.921 -0.4 . . . . 43.34 109.921 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.552 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 9.2 t -78.7 134.46 37.1 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.591 -0.522 . . . . 62.41 109.591 174.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.473 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 20.5 mtt180 -92.21 117.72 30.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.881 -0.415 . . . . 73.33 109.881 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.707 ' HD2' HD13 ' A' ' 208' ' ' LEU . 33.9 t80 -114.13 148.82 36.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.564 -0.532 . . . . 73.2 109.564 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -159.58 152.35 23.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.459 -0.877 . . . . 74.32 112.578 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.506 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.3 mp -135.92 130.23 48.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.816 -0.439 . . . . 72.01 109.816 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.597 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -120.99 154.29 36.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.835 -0.432 . . . . 65.35 109.835 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -138.44 124.31 19.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.906 0.384 . . . . 62.52 110.313 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -111.26 113.68 26.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.559 -0.904 . . . . 62.41 108.559 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -113.51 114.07 26.01 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.044 0.45 . . . . 74.45 110.037 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.72 ' H ' ' NE2' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -91.07 117.26 29.45 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.761 -0.829 . . . . 54.54 108.761 173.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 228' ' ' ASP . 3.2 mp -69.17 -53.28 26.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 64.52 109.546 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 227' ' ' ILE . 22.4 t70 172.66 -48.96 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 O-C-N 124.006 0.816 . . . . 71.4 110.929 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 86.1 Cg_endo -78.42 -144.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.337 2.024 . . . . 72.44 113.331 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 4.1 t0 -93.39 16.41 13.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 64.02 110.463 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.38 123.89 44.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.545 -0.752 . . . . 53.14 110.237 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.8 143.45 50.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 72.43 110.308 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -97.03 129.84 44.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.053 -0.521 . . . . 71.13 109.696 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -121.15 119.27 31.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.013 0.435 . . . . 63.25 110.135 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -123.5 152.14 42.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.078 -0.51 . . . . 43.54 110.012 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 19.9 ptpt -153.26 140.67 19.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.922 -0.399 . . . . 73.53 109.922 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 9.9 p -132.91 141.16 45.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.073 0.463 . . . . 55.11 109.959 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.645 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 20.7 m120 -108.46 150.22 27.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.126 -0.488 . . . . 62.24 109.796 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 241' ' ' SER . 9.0 p30 -50.51 -27.39 6.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.252 0.97 . . . . 74.45 113.241 -174.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.625 ' HB2' ' CD1' ' A' ' 242' ' ' LEU . 6.0 m -82.03 24.51 0.63 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.581 . . . . 73.12 109.938 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.467 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 57.6 m 66.05 39.33 4.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.926 -1.034 . . . . 75.03 111.297 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.7 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 5.5 mp -91.76 121.72 33.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 120.545 -0.462 . . . . 61.13 111.141 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 243' ' ' ILE . 2.3 mp -105.54 115.56 47.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 O-C-N 123.62 0.575 . . . . 53.13 110.024 -171.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.83 133.54 9.46 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.55 -0.833 . . . . 50.32 113.082 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.521 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -140.92 141.36 34.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.969 0.414 . . . . 73.04 110.201 177.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 260' ' ' SER . . . -162.97 165.51 36.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.358 -0.925 . . . . 64.11 112.547 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -129.87 129.95 44.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.055 0.455 . . . . 75.11 110.462 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.57 HG22 HG23 ' A' ' 258' ' ' THR . 19.8 p -113.46 115.61 28.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.702 . . . . 55.12 109.725 177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.3 132.88 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.092 0.472 . . . . 64.13 111.617 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 17.5 m -77.81 120.45 22.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.976 -0.556 . . . . 54.21 109.591 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 255' ' ' ILE . 16.1 tp -81.27 -55.28 4.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.582 0.706 . . . . 61.11 109.213 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.556 ' HB2' HG22 ' A' ' 255' ' ' ILE . 5.9 mtpm? -136.66 158.08 73.84 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 107.894 -1.15 . . . . 53.3 107.894 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.05 90.4 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.701 1.601 . . . . 74.45 110.422 171.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 282' ' ' GLN . . . 137.39 -9.51 3.78 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.848 -0.692 . . . . 62.23 111.786 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.556 HG22 ' HB2' ' A' ' 252' ' ' LYS . 6.5 tp -148.51 122.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.575 0.702 . . . . 73.01 111.464 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.56 135.25 53.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.591 -0.731 . . . . 73.23 110.527 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.65 126.76 45.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.465 -0.789 . . . . 44.54 110.419 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.57 HG23 HG22 ' A' ' 248' ' ' THR . 86.5 m -118.15 111.45 18.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 63.2 110.808 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.955 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -115.4 129.19 56.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.576 -0.898 . . . . 73.3 108.576 175.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.65 ' O ' ' HB2' ' A' ' 275' ' ' LEU . 11.0 t -151.11 146.25 26.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.624 -0.51 . . . . 60.1 109.624 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.563 ' HA ' ' CB ' ' A' ' 275' ' ' LEU . . . -139.72 127.51 21.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.636 0.255 . . . . 74.21 110.511 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.683 HD11 HD23 ' A' ' 242' ' ' LEU . 2.2 tm? -112.92 118.31 34.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.593 -0.891 . . . . 75.42 108.593 176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.695 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -101.45 110.07 22.0 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.603 -0.888 . . . . 64.23 108.603 176.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.745 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 1.9 m-20 -68.65 104.34 1.95 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.85 -1.167 . . . . 71.41 107.85 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.3 -27.37 46.79 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.908 -0.587 . . . . 70.2 113.298 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -90.84 -20.14 22.64 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.718 0.294 . . . . 73.23 110.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.745 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 66.2 t30 -101.89 -36.1 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.654 -0.248 . . . . 44.03 111.398 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.7 m -63.18 -18.72 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.722 0.267 . . . . 65.12 111.722 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.65 -44.75 85.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.14 110.796 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.59 10.23 37.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.943 0.401 . . . . 74.42 110.837 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.63 97.88 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.023 -0.608 . . . . 50.14 111.979 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.435 ' HA3' ' ND2' ' A' ' 267' ' ' ASN . . . -175.99 75.63 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.824 -0.703 . . . . 71.3 112.143 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -113.73 145.96 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 122.413 0.285 . . . . 74.31 110.269 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.59 131.18 48.13 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.117 -0.697 . . . . 71.21 109.117 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.667 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -140.68 158.12 44.43 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 65.23 113.974 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.56 117.19 3.53 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 114.552 -1.204 . . . . 45.2 111.317 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.955 HD23 HD22 ' A' ' 259' ' ' LEU . 2.2 tm? -114.36 121.87 44.95 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.909 -1.145 . . . . 75.11 107.909 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -142.46 137.28 7.71 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.89 -1.148 . . . . 44.52 113.309 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.39 130.51 55.67 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.306 -0.627 . . . . 71.12 109.306 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.32 111.18 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.627 -0.509 . . . . 52.12 109.627 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.72 ' HB3' HD22 ' A' ' 31' ' ' LEU . 42.3 t80 -112.99 110.33 20.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 71.14 109.812 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.775 HE21 HD21 ' A' ' 284' ' ' LEU . 49.9 tt0 -114.49 110.21 19.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.677 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -92.34 110.91 22.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.241 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.775 HD21 HE21 ' A' ' 282' ' ' GLN . 55.7 mt -108.69 97.66 7.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 75.14 110.41 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.594 -0.717 . . . . 75.22 109.127 176.828 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.682 ' HA ' ' HG3' ' A' ' 93' ' ' ARG . 72.5 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.337 0.113 . . . . 64.31 110.769 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.13 106.08 17.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.774 0.321 . . . . 71.13 110.491 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 121' ' ' GLU . 11.5 t -116.61 112.91 40.69 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.975 -0.557 . . . . 60.42 109.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.66 166.95 22.38 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.231 2.621 . . . . 41.01 112.786 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 81.95 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.924 2.416 . . . . 74.12 111.789 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.0 p -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.484 -0.78 . . . . 64.1 111.386 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -60.48 -29.87 69.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.914 -0.584 . . . . 63.12 111.572 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.53 -19.57 38.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 52.51 110.965 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -102.98 13.68 33.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.41 0.624 . . . . 73.3 110.008 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 150' ' ' LEU . 72.4 mt -66.09 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.911 -0.586 . . . . 73.32 110.578 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.89 75.12 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.083 -0.58 . . . . 70.44 112.05 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -44.89 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.933 -0.395 . . . . 72.22 109.933 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p -56.4 -36.91 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.64 -0.709 . . . . 51.4 111.541 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.72 -37.6 73.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 74.53 111.376 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -63.26 -37.94 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.612 0.244 . . . . 62.13 111.147 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.09 -49.1 63.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.598 . . . . 64.3 110.69 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.628 HG21 ' CB ' ' A' ' 205' ' ' ALA . 79.0 t -84.58 -47.77 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.695 0.998 . . . . 71.33 113.695 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.17 -28.08 67.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.589 0.589 . . . . 71.54 112.589 -166.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -73.88 -16.79 61.11 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.819 -0.352 . . . . 75.43 110.96 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 0.1 OUTLIER 64.51 -82.61 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.262 -0.644 . . . . 75.14 109.262 -170.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.19 165.43 12.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.819 -1.312 . . . . 35.42 109.819 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.923 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 2.0 t80 -57.12 -44.94 83.76 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.904 -0.776 . . . . 74.44 108.904 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.72 28.45 56.88 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.219 -0.9 . . . . 63.24 114.422 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.558 ' HD2' ' HB2' ' A' ' 26' ' ' LEU . 56.3 t80 -87.78 -4.97 58.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.415 0.626 . . . . 74.03 109.455 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' C ' HD12 ' A' ' 26' ' ' LEU . . . 75.31 0.99 63.19 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.378 -0.828 . . . . 53.54 112.41 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 mp -134.55 178.76 6.74 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.262 1.029 . . . . 72.22 112.358 -172.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 277' ' ' LEU . 12.5 mm -103.69 122.43 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.579 -1.646 . . . . 73.15 107.988 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 34.9 mtmt -120.73 126.93 51.42 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.07 -0.652 . . . . 72.23 110.97 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.3 tt -120.47 143.48 48.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.784 -0.644 . . . . 55.34 110.554 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.3 p30 -138.84 140.26 38.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.147 0.499 . . . . 73.31 109.844 174.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD13 ' HB3' ' A' ' 281' ' ' PHE . 14.5 tp -125.43 123.56 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.595 -0.729 . . . . 72.44 109.338 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -117.1 123.77 47.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.788 -0.642 . . . . 74.53 110.032 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 283' ' ' ALA . 2.1 t -137.88 122.4 18.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.695 -0.684 . . . . 54.43 110.19 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -104.45 158.21 16.63 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.616 -0.434 . . . . 64.42 110.316 177.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -134.24 135.95 43.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.286 -0.635 . . . . 71.32 109.286 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 39.64 -99.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 124.357 1.035 . . . . 73.42 112.333 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.601 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 9.4 p30 -147.57 149.13 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.144 -0.687 . . . . 75.41 109.144 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 75.64 -11.02 10.88 Favored Glycine 0 C--O 1.213 -1.199 0 CA-C-O 119.236 -0.758 . . . . 74.32 114.187 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.52 127.25 52.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 119.457 1.629 . . . . 71.34 112.158 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.861 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 27.5 tt0 -142.53 118.85 10.84 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.98 -0.378 . . . . 72.13 109.98 162.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.549 ' HB3' HG23 ' A' ' 33' ' ' THR . 67.3 t80 -97.31 121.45 39.21 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.183 -0.673 . . . . 62.43 109.183 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.6 m -120.79 115.91 24.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.228 0.537 . . . . 73.52 110.772 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 34.6 t -107.88 134.46 50.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 64.11 109.43 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 43.2 m -135.05 126.94 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 71.22 110.331 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 130.26 5.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.453 -0.879 . . . . 64.43 111.846 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.2 m -111.42 133.46 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.474 -0.565 . . . . 44.43 109.474 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.71 135.0 37.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.729 -0.214 . . . . 72.22 110.578 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.766 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 54.2 t30 -69.28 143.07 53.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.783 -0.451 . . . . 74.11 109.783 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -64.62 124.32 21.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.132 -0.486 . . . . 75.32 111.24 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 73.23 -65.41 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.313 -0.858 . . . . 74.14 111.11 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 3.1 m -78.5 113.13 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.213 -0.662 . . . . 65.24 109.213 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.0 p -75.44 93.08 2.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.068 0.766 . . . . 74.23 113.068 -168.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -113.78 99.6 7.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.868 -1.16 . . . . 75.13 107.868 165.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' SER . 13.9 t -114.21 120.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.818 -0.628 . . . . 71.21 111.115 -171.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -109.74 142.77 40.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.628 -0.715 . . . . 74.53 109.25 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.71 128.39 8.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.802 -0.713 . . . . 74.24 112.773 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 14.8 m -116.05 127.06 54.58 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.688 -0.856 . . . . 73.24 108.688 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 58' ' ' LEU . 1.5 tm? -120.84 123.84 43.57 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.42 -0.585 . . . . 71.03 109.42 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.752 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 43.0 mt-10 -110.36 118.53 36.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.843 -0.617 . . . . 54.01 109.691 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 73' ' ' GLU . 9.1 t -98.75 119.94 38.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.624 -1.25 . . . . 44.11 107.624 172.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 28.0 ttmt -125.27 138.74 54.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.36 0.6 . . . . 74.24 111.261 -168.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 98.9 m-85 -104.28 120.73 41.83 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.287 -0.87 . . . . 74.54 108.913 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.861 ' HG3' ' HB2' ' A' ' 40' ' ' GLU . 12.4 mtp85 -83.85 133.07 34.76 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.722 0.772 . . . . 72.44 111.304 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.747 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 8.8 p-90 -80.33 74.85 7.17 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 112.807 -1.997 . . . . 73.11 115.674 -161.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 37' ' ' ASN . 2.7 m -124.83 -17.8 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.655 -0.702 . . . . 74.14 111.03 -172.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.28 -36.12 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 62.02 109.881 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 69' ' ' LEU . 15.1 t80 -162.14 18.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 74.43 109.278 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.566 ' O ' HD12 ' A' ' 69' ' ' LEU . . . 80.81 56.59 3.06 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.072 -0.811 . . . . 53.43 111.072 -172.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' A' ' 64' ' ' TRP . 5.7 mp -139.59 127.98 22.79 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 113.749 1.018 . . . . 73.23 113.749 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.471 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 3.8 m -117.09 132.98 56.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.92 -0.488 . . . . 75.01 110.944 -173.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.572 ' HB3' ' HD2' ' A' ' 62' ' ' TYR . 44.7 t80 -123.19 120.36 32.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.981 -0.748 . . . . 54.43 108.981 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -126.7 117.29 22.42 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.813 -0.355 . . . . 74.41 110.915 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.5 tt0 -104.44 120.63 41.67 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.836 -0.802 . . . . 63.1 108.836 172.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -106.46 92.86 4.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.834 -0.621 . . . . 62.43 109.777 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.836 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 60.8 t90 -95.78 131.37 42.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.863 -0.335 . . . . 74.44 110.549 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.23 142.87 35.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.804 -0.813 . . . . 73.2 108.804 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.5 t -59.2 -9.82 2.42 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.618 0.97 . . . . 74.31 113.618 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 5.5 m-20 -71.24 -41.13 70.55 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.107 -0.237 . . . . 64.35 110.773 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 28.8 t-20 149.55 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.439 1.087 . . . . 61.24 109.745 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -80.7 132.19 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.782 -0.645 . . . . 75.43 111.467 -173.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.836 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.8 pt? -124.28 146.5 48.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 62.12 110.681 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.57 117.05 4.08 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.517 -0.633 . . . . 71.33 111.517 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' ASP . 29.2 m -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.601 0.239 . . . . 71.32 110.734 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -125.13 108.37 11.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 63.2 110.118 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -119.04 129.66 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 74.12 110.699 -178.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 70' ' ' THR . 44.8 p -118.37 134.39 55.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 53.12 110.741 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.705 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 m -116.66 131.67 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.631 -0.507 . . . . 72.42 109.631 172.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 122.86 48.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 175.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 93' ' ' ARG . 35.6 t0 70.01 85.15 0.14 Allowed 'General case' 0 C--O 1.223 -0.323 0 O-C-N 124.029 0.831 . . . . 73.12 109.983 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 6.6 tp60 -102.98 5.16 38.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.457 -0.942 . . . . 75.3 108.457 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.5 tp 178.6 -38.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.354 -1.294 . . . . 74.24 108.89 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.6 126.07 16.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.076 -0.965 . . . . 62.53 109.796 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.682 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -64.03 135.85 56.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 72.13 111.076 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.23 -14.78 54.95 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.003 -0.839 . . . . 44.31 111.003 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.24 126.22 38.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 73.23 109.293 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.3 ttpp -122.05 111.16 16.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.694 -0.685 . . . . 75.52 110.319 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.1 mm? -101.23 127.64 47.72 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.221 -0.659 . . . . 54.41 109.221 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 31.9 m -129.46 124.92 35.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.94 0.4 . . . . 62.33 111.437 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.28 116.05 31.29 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.234 -0.654 . . . . 73.51 109.234 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.716 ' HB3' ' HB3' ' A' ' 113' ' ' LYS . 10.2 t70 -111.68 133.51 53.87 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.003 -0.74 . . . . 75.03 109.003 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 24.4 m -141.44 121.87 14.07 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.941 0.4 . . . . 74.54 110.734 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.76 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 22.8 t -96.07 121.55 37.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.749 -1.204 . . . . 64.34 107.749 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.6 131.27 27.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.236 0.541 . . . . 73.22 111.22 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 16.5 m -119.8 103.43 45.89 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.542 -0.754 . . . . 74.45 109.293 173.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.423 ' HD2' ' OD1' ' A' ' 79' ' ' ASN . 47.6 Cg_exo -56.89 -33.91 95.92 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.972 2.448 . . . . 73.14 112.908 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -84.47 -40.47 17.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 52.55 111.01 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 104' ' ' SER . 5.8 m -81.99 -32.86 30.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.227 -0.442 . . . . 52.22 112.126 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.35 1.93 68.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.59 -0.814 . . . . 63.1 111.855 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.96 129.07 38.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.601 0.239 . . . . 71.02 110.426 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -139.39 122.27 16.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 73.52 110.464 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.76 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 8.5 m120 -121.54 123.51 42.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.924 -0.58 . . . . 74.55 109.812 172.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.91 113.8 27.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.067 -0.515 . . . . 71.52 109.68 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.716 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 4.8 ttmp? -122.67 138.1 54.71 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.073 -0.512 . . . . 75.34 110.05 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 tp -129.3 117.4 43.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.203 0.525 . . . . 64.31 110.16 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 1.7 mtpp -105.72 118.75 37.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.009 -0.737 . . . . 64.0 109.009 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 t -114.47 118.48 33.91 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.18 0.514 . . . . 63.41 109.739 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.93 118.24 2.96 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.466 -0.874 . . . . 71.11 112.184 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -106.76 117.59 34.45 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.018 -0.734 . . . . 72.42 109.018 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HB3' HG11 ' A' ' 3' ' ' VAL . 42.5 mtmt -109.22 122.11 46.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.31 0.576 . . . . 73.32 110.383 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -106.39 146.55 30.33 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.604 -1.628 . . . . 71.23 106.604 165.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HG3' HG22 ' A' ' 3' ' ' VAL . 2.2 mt-10 -55.23 -27.46 46.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.861 0.362 . . . . 75.21 111.758 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -88.99 -35.67 16.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.296 -0.411 . . . . 65.44 111.679 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 142' ' ' LEU . 8.7 tp -145.36 127.52 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 121.015 -0.274 . . . . 72.45 111.623 -167.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.523 HD21 ' HB ' ' A' ' 143' ' ' VAL . 3.6 p-10 -122.53 128.44 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.694 0.759 . . . . 65.31 111.807 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 142' ' ' LEU . 4.5 mm? -112.52 131.36 55.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.86 -1.064 . . . . 75.22 110.062 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.62 117.07 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.555 -0.831 . . . . 73.34 112.3 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.9 t -112.29 109.12 18.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.088 0.47 . . . . 70.32 110.135 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 115' ' ' LYS . 17.1 t70 -104.02 117.89 35.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.004 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.44 ' HG2' HG13 ' A' ' 138' ' ' ILE . 58.8 mtm -118.12 117.84 30.26 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.838 -0.345 . . . . 50.11 110.903 -176.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.451 ' HB2' ' HE3' ' A' ' 113' ' ' LYS . 30.4 t70 -107.87 120.42 42.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 63.11 110.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -94.47 109.68 21.53 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.26 -0.427 . . . . 73.42 110.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -116.24 156.39 26.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 71.23 109.501 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.8 pp -71.88 -17.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 111.961 0.356 . . . . 73.21 111.961 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.11 -17.37 32.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.117 0.484 . . . . 52.42 110.337 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.73 123.55 1.39 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.919 -0.657 . . . . 72.42 111.902 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.3 136.09 49.64 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.629 2.219 . . . . 61.01 112.135 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -117.12 137.57 52.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.54 . . . . 63.32 109.963 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.5 mp -107.46 117.98 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.049 0.452 . . . . 70.33 110.158 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HD2' ' OD2' ' A' ' 128' ' ' ASP . 71.6 mtt180 -105.93 111.61 24.33 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.929 -0.767 . . . . 75.13 108.929 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -110.62 133.36 11.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.094 -1.05 . . . . 72.44 112.108 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.41 116.63 20.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.225 0.536 . . . . 63.5 110.275 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 123' ' ' ILE . 8.6 tp -116.04 127.07 54.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.711 -0.677 . . . . 63.51 109.979 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 56.6 t -128.03 134.47 65.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.065 0.46 . . . . 74.31 110.625 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.0 mp -109.41 137.04 47.87 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.648 -0.871 . . . . 74.4 108.648 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.405 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -115.75 121.03 5.12 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 123.819 0.699 . . . . 53.53 113.59 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 1.055 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 92.2 m-85 -133.92 149.93 51.3 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.373 -0.973 . . . . 71.43 108.373 173.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.79 93.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.04 0.448 . . . . 75.51 111.339 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.09 47.72 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.999 -0.546 . . . . 35.2 112.336 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 1.055 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 18.8 m95 -105.83 122.38 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.348 -0.241 . . . . 72.33 110.348 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.468 ' HB3' HD23 ' A' ' 10' ' ' LEU . 19.9 mt -128.51 136.96 51.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.865 0.364 . . . . 72.44 111.142 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -127.63 128.61 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 55.24 110.253 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -132.97 133.04 6.82 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.437 -0.887 . . . . 71.51 113.373 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.2 119.29 29.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.744 -0.465 . . . . 75.11 109.744 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 77.9 mt-30 -113.07 121.62 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.22 0.533 . . . . 73.25 109.569 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 90.4 mtp -133.92 135.82 43.84 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.623 -0.51 . . . . 72.43 109.623 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 166' ' ' GLN . 0.9 OUTLIER -111.56 117.54 33.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.566 -0.531 . . . . 73.04 109.566 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 14.1 m-85 -94.18 130.57 40.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.203 -0.908 . . . . 74.31 110.276 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 163' ' ' ARG . 11.9 pt-20 -96.52 124.78 40.62 Favored 'General case' 0 C--O 1.264 1.839 0 CA-C-O 121.307 0.575 . . . . 74.22 109.843 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -70.64 -16.67 62.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 113.258 -1.792 . . . . 73.44 111.511 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.25 -43.71 98.44 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.657 -0.868 . . . . 74.11 108.657 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -98.86 -159.58 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.546 -1.279 . . . . 74.42 107.546 165.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.6 m -109.52 27.31 9.69 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.825 -0.547 . . . . 71.3 109.552 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 35.8 ttm180 -151.77 160.16 43.68 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 118.513 -1.275 . . . . 65.11 112.915 -155.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.864 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -78.95 135.91 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.29 0.567 . . . . 52.4 111.369 -177.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -33.68 12.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 74.35 109.684 175.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.728 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 49.4 mt-30 -108.26 133.0 53.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.686 -0.688 . . . . 72.23 110.715 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.4 m -121.2 109.95 15.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 32.41 109.263 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 10.7 m120 -113.8 126.82 55.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.885 -0.783 . . . . 72.44 108.885 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 94.0 m-85 -121.51 142.68 49.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.004 -0.678 . . . . 71.15 111.149 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -143.29 127.38 17.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.912 -0.585 . . . . 42.12 110.247 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 67.3 t -125.38 134.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.067 -0.346 . . . . 74.11 110.067 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -112.35 102.62 1.37 Allowed Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.288 -0.725 . . . . 63.51 111.288 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -112.79 119.42 37.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.799 -0.815 . . . . 72.44 108.799 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 174' ' ' LYS . 1.4 tmmt? -112.37 125.94 54.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 64.52 111.422 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.2 m -120.84 154.48 35.73 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.379 -1.341 . . . . 63.13 107.379 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.23 -45.13 53.68 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.37 0.507 . . . . 71.43 112.37 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -113.61 0.26 14.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.02 -0.272 . . . . 64.33 111.401 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -136.75 114.86 11.54 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.497 -0.319 . . . . 64.25 110.769 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.71 123.49 49.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.33 -0.619 . . . . 75.31 109.33 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.799 HD12 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -117.74 131.07 56.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.171 0.51 . . . . 65.25 111.132 -176.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 72.3 t60 -115.58 115.12 25.9 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.622 -0.717 . . . . 60.52 109.483 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.646 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 8.6 m -82.78 139.94 33.28 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.903 -1.147 . . . . 73.31 107.903 173.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.9 t30 -146.05 138.98 25.74 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.935 -0.706 . . . . 72.12 111.887 -173.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 59.4 t -131.55 120.94 46.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.482 -0.781 . . . . 62.52 109.962 172.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.03 111.15 21.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.59 -0.732 . . . . 73.01 110.154 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.584 ' H ' ' ND2' ' A' ' 168' ' ' ASN . 5.0 t70 63.4 -168.58 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.817 -1.083 . . . . 71.03 109.29 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.64 -6.93 89.06 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.589 -0.815 . . . . 63.33 112.218 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 211' ' ' THR . 19.0 p -102.39 -28.35 12.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.786 1.032 . . . . 52.12 113.786 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.14 115.41 28.81 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.582 -0.847 . . . . 61.11 112.185 -172.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -120.77 126.3 49.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.06 -0.973 . . . . 71.42 109.665 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.76 -122.51 0.87 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.544 -0.836 . . . . 74.1 112.262 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 158.17 -160.67 31.03 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.617 -0.801 . . . . 74.13 112.587 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.9 t -148.05 139.15 23.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.699 -0.482 . . . . 50.53 109.699 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.799 HG13 HD12 ' A' ' 180' ' ' LEU . 4.2 mp -119.9 135.49 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.123 -0.325 . . . . 61.01 110.123 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.778 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 38.8 t80 -122.3 118.35 28.3 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 61.55 109.836 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.34 134.58 49.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.642 -0.503 . . . . 70.43 109.642 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -99.73 127.12 45.86 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 71.24 110.569 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.5 HG12 ' HD3' ' A' ' 200' ' ' LYS . 10.8 t -102.53 139.38 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.707 -0.849 . . . . 70.23 108.707 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.24 34.28 0.25 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.424 0.631 . . . . 64.3 112.621 -172.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.5 ' HD3' HG12 ' A' ' 198' ' ' VAL . 2.5 mptp? -96.83 14.51 24.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.125 -1.065 . . . . 72.43 108.125 164.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 65.84 20.79 11.44 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.028 -0.987 . . . . 60.32 109.89 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.13 129.8 48.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.073 -0.967 . . . . 60.43 110.197 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.778 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 28.9 mt-10 -104.92 129.83 53.22 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.961 -1.126 . . . . 73.23 107.961 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -122.14 138.17 54.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.821 -0.352 . . . . 74.55 110.632 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.628 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -134.81 149.83 50.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.243 -0.435 . . . . 72.03 111.044 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.647 HG22 HG22 ' A' ' 221' ' ' ILE . 83.2 t -131.13 143.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.656 -0.702 . . . . 75.52 110.357 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -114.61 132.41 56.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.004 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 208' ' ' LEU . 2.1 mm? -125.17 129.48 50.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.219 -0.446 . . . . 72.24 110.21 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.01 127.71 12.47 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.078 -0.341 . . . . 61.34 110.078 171.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.506 ' CE3' ' HB ' ' A' ' 217' ' ' THR . 2.3 t90 -118.75 133.34 55.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.999 -0.741 . . . . 74.44 108.999 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 188' ' ' THR . 31.6 m -93.89 103.02 15.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.184 0.516 . . . . 60.31 109.767 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.71 127.11 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.397 -0.82 . . . . 74.22 110.612 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.4 43.68 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.21 -0.756 . . . . 61.03 111.21 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -126.8 155.84 42.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.008 -0.738 . . . . 41.54 109.008 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.0 m -95.4 -9.8 31.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.155 0.428 . . . . 61.53 112.155 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -91.54 131.53 36.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.889 0.376 . . . . 71.44 110.613 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.506 ' HB ' ' CE3' ' A' ' 210' ' ' TRP . 7.9 t -107.19 139.13 42.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.288 0.566 . . . . 75.13 110.19 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -89.06 127.27 35.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.633 . . . . 74.32 109.997 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.636 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 93.9 m-85 -112.35 150.9 30.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.704 -0.68 . . . . 64.12 109.823 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.95 143.17 10.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.749 -0.94 . . . . 73.35 110.749 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.647 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -137.78 134.07 45.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 117.316 0.558 . . . . 71.15 110.583 177.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.528 ' CB ' ' HG2' ' A' ' 236' ' ' LYS . . . -126.29 142.17 51.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.885 -0.598 . . . . 65.22 111.388 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.09 124.06 51.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.74 -0.664 . . . . 74.53 109.456 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 21.3 tptp -113.93 114.02 25.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.328 -0.851 . . . . 74.51 109.425 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -125.56 121.14 32.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.045 0.45 . . . . 62.04 110.738 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 7.5 pt20 -91.36 99.28 12.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.712 -0.677 . . . . 75.4 109.756 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.6 -35.41 7.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.939 -0.573 . . . . 71.13 111.416 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.454 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -140.21 154.76 70.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 75.31 109.295 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 10.1 Cg_endo -52.52 -26.39 28.59 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.113 2.542 . . . . 42.31 113.309 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -107.97 -15.39 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.613 0.227 . . . . 71.34 111.613 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.26 123.68 40.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.015 0.436 . . . . 71.44 111.84 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.9 t -133.75 121.85 22.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 70.12 109.832 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -101.23 134.35 44.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.056 -0.52 . . . . 74.42 110.655 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 24.3 p -132.01 121.31 23.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.341 -0.391 . . . . 74.23 110.889 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.6 140.16 43.75 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.495 -0.557 . . . . 62.05 109.495 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 222' ' ' ALA . 71.6 mttt -137.92 150.68 47.28 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.044 -0.354 . . . . 63.31 110.044 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.513 HG12 HG12 ' A' ' 221' ' ' ILE . 8.7 p -144.69 143.88 22.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.119 0.485 . . . . 51.54 110.873 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 25.7 t-20 -105.03 148.9 26.26 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.433 -0.803 . . . . 75.3 109.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.636 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 64.4 t30 -46.65 -31.22 2.74 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.849 1.343 . . . . 61.15 113.378 -174.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.619 ' HB2' HD13 ' A' ' 242' ' ' LEU . 19.3 m -80.01 19.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.979 0.419 . . . . 61.31 110.603 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 56.0 m 68.67 34.2 3.54 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.467 -0.788 . . . . 62.1 111.19 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.2 mp -98.84 131.81 44.67 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 120.389 -0.524 . . . . 74.55 111.605 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 243' ' ' ILE . 2.3 mp -109.66 116.95 53.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.837 -0.62 . . . . 64.41 110.264 -169.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -112.85 133.55 11.4 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.617 -0.801 . . . . 45.1 111.947 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.708 ' H ' HD23 ' A' ' 245' ' ' LEU . 2.3 pt? -118.66 134.39 55.15 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.817 -0.438 . . . . 55.31 109.817 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.1 121.39 2.71 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.796 -0.716 . . . . 35.31 112.14 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.407 ' HE2' HD12 ' A' ' 245' ' ' LEU . 90.4 m-85 -108.87 115.79 30.76 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.453 -0.573 . . . . 73.23 109.453 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.0 m -109.05 112.85 25.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.176 0.513 . . . . 62.45 110.205 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.91 134.11 55.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 73.33 110.189 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 15.6 m -122.54 98.25 5.83 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.084 -0.507 . . . . 75.15 109.706 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.767 ' HB2' HG23 ' A' ' 255' ' ' ILE . 3.2 mm? -88.97 77.37 7.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.345 -0.613 . . . . 70.54 109.345 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.618 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 30.7 mmtp 68.37 166.63 0.12 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.343 -0.844 . . . . 73.02 110.136 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 55.7 Cg_endo -70.9 57.68 2.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.359 2.04 . . . . 55.03 112.178 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -147.94 -45.98 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.834 -0.621 . . . . 45.25 112.097 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.767 HG23 ' HB2' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -132.26 124.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.78 0.8 . . . . 73.32 110.67 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 57.2 tttt -119.61 131.9 55.59 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.99 -1.004 . . . . 74.24 110.092 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.02 125.54 49.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.839 -0.618 . . . . 63.02 110.466 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.2 t -128.87 111.59 13.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.627 0.727 . . . . 70.51 110.46 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.741 HD22 ' HG ' ' A' ' 277' ' ' LEU . 0.1 OUTLIER -106.3 124.49 49.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.41 -0.959 . . . . 72.33 108.41 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 46.8 p -140.79 140.73 34.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.198 -0.601 . . . . 74.11 110.999 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' A' ' 245' ' ' LEU . . . -144.89 146.69 32.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.985 -0.552 . . . . 75.32 110.088 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 242' ' ' LEU . 2.0 tm? -114.6 116.58 28.98 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.653 -0.869 . . . . 64.42 108.653 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.47 HD21 HD22 ' A' ' 245' ' ' LEU . 1.0 OUTLIER -92.13 107.35 19.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.911 -1.144 . . . . 52.53 107.911 173.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.85 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -70.79 104.92 3.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.259 -1.015 . . . . 73.23 108.259 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.7 -22.92 34.77 Favored Glycine 0 N--CA 1.459 0.211 0 C-N-CA 121.16 -0.543 . . . . 52.4 112.2 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -90.68 -15.73 29.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.257 -0.471 . . . . 65.44 111.798 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 17.5 t-20 -117.41 -38.37 3.34 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.227 0.455 . . . . 70.11 112.227 -174.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 264' ' ' ASP . 30.7 m -61.87 -17.79 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.103 0.408 . . . . 63.32 112.103 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -59.81 -32.67 70.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.053 0.454 . . . . 72.52 110.314 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.99 -16.57 15.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 44.45 110.277 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.32 119.52 3.28 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.81 -0.632 . . . . 50.31 111.827 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 149.73 82.7 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.462 -0.875 . . . . 50.31 112.413 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -113.61 150.13 33.57 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.698 -0.482 . . . . 55.14 109.698 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.1 mptt -91.73 137.11 32.63 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.682 -0.859 . . . . 74.23 108.682 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -120.53 137.72 54.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.151 -0.477 . . . . 55.33 109.845 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.923 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -144.15 112.68 0.69 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 111.045 -0.822 . . . . 64.43 111.045 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.741 ' HG ' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -113.96 143.51 44.6 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.29 -0.564 . . . . 70.41 109.512 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.563 ' H ' HD23 ' A' ' 277' ' ' LEU . . . -140.56 124.43 2.61 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 115.387 -0.824 . . . . 55.43 111.362 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.511 ' HB2' HD12 ' A' ' 29' ' ' LEU . 3.0 mm? -113.41 131.2 56.09 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.624 -0.88 . . . . 72.13 108.624 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 69.3 tt0 -125.42 116.14 21.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.133 0.492 . . . . 63.53 110.038 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.589 ' HB3' HD13 ' A' ' 31' ' ' LEU . 50.1 m-85 -105.33 138.57 41.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.678 -0.692 . . . . 65.24 109.782 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.498 ' HB3' HD23 ' A' ' 284' ' ' LEU . 75.8 mt-30 -130.85 114.03 14.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.451 -0.795 . . . . 74.22 110.209 -176.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.752 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -104.8 107.45 18.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.209 -0.664 . . . . 61.34 109.209 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.547 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.3 mm? -139.27 -3.27 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.421 -0.808 . . . . 62.12 110.171 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.59 -0.719 . . . . 72.23 109.885 -178.205 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.932 -0.396 . . . . 73.13 109.932 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.27 125.73 44.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.095 0.474 . . . . 75.31 110.915 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.634 ' CG1' ' HB3' ' A' ' 119' ' ' LYS . 7.9 p -147.81 134.86 10.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.17 -0.678 . . . . 73.1 109.17 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 9.6 Cg_endo -52.65 133.85 51.35 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.282 2.655 . . . . 74.12 113.664 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 13.0 Cg_exo -71.13 75.32 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.142 2.561 . . . . 61.12 110.893 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 p -76.4 -11.85 59.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.565 -0.743 . . . . 75.44 111.928 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.69 ' HB3' HG21 ' A' ' 143' ' ' VAL . 21.7 p90 -60.15 -22.12 62.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.314 0.578 . . . . 70.34 110.039 171.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -27.25 61.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.709 -0.678 . . . . 73.34 109.747 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -84.74 -14.12 49.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.056 -0.52 . . . . 72.2 110.091 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 170' ' ' ALA . 61.0 mt -76.89 -35.56 57.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.385 -0.825 . . . . 73.14 110.575 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 -61.45 0.23 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.386 -0.911 . . . . 74.5 114.025 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.75 -43.87 81.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.922 0.361 . . . . 71.45 111.338 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.1 t -62.09 -46.37 89.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.862 -0.608 . . . . 65.02 110.961 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.91 73.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.071 -0.513 . . . . 64.2 111.776 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -59.32 -30.11 68.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.12 112.243 -173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.59 -44.5 85.45 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.935 0.398 . . . . 75.14 110.452 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.41 -35.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.939 -0.573 . . . . 72.44 110.962 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -68.84 -23.05 64.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.946 -0.57 . . . . 74.44 111.533 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.8 p -76.03 93.05 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.313 0.578 . . . . 71.14 111.085 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.32 79.13 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.525 -0.761 . . . . 74.44 112.214 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.4 63.92 3.11 Favored Glycine 0 C--N 1.335 0.479 0 O-C-N 123.984 0.803 . . . . 64.4 114.692 170.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -88.88 83.09 6.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.184 0.516 . . . . 74.34 110.732 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.3 121.84 5.77 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.531 -0.759 . . . . 53.12 111.465 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.81 5.61 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.645 0.239 . . . . 72.22 111.645 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.91 59.51 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.771 -0.728 . . . . 41.21 112.691 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 46' ' ' SER . 1.5 pp -129.04 -179.34 5.06 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 113.59 0.959 . . . . 74.34 113.59 -170.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.705 HG23 HD22 ' A' ' 277' ' ' LEU . 40.7 mm -99.1 132.79 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.061 -1.427 . . . . 75.21 109.802 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 17.9 ptpt -118.55 153.52 34.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.022 0.439 . . . . 72.14 109.906 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.804 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.3 tp -141.13 143.86 34.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.289 -0.414 . . . . 70.41 111.442 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 280' ' ' GLU . 8.1 t70 -137.38 124.28 21.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.617 -1.253 . . . . 71.44 107.617 168.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.3 tm? -136.72 124.16 22.08 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.388 -0.597 . . . . 71.41 109.388 -175.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 29.6 mtmm -116.77 124.51 49.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 72.23 110.572 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -121.22 125.36 46.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.897 -0.592 . . . . 75.14 109.538 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -113.35 145.55 40.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.794 0.331 . . . . 71.13 110.335 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 21.7 m -139.21 138.19 36.65 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.48 -0.563 . . . . 71.04 109.48 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 49.21 -120.12 1.34 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.802 0.689 . . . . 73.24 110.572 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -136.27 152.24 50.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.725 -0.472 . . . . 50.55 109.725 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.757 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 79.29 -9.3 41.5 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 119.335 -0.703 . . . . 51.03 113.648 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -101.64 128.55 47.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.613 1.207 . . . . 63.33 112.043 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.822 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 29.0 tt0 -141.02 117.12 10.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 74.1 109.66 164.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 92.1 t80 -99.05 121.93 41.63 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.546 -0.538 . . . . 65.54 109.546 176.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 6.8 m -125.5 125.21 42.92 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.083 0.468 . . . . 74.43 111.521 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 23.3 t -112.43 123.84 51.17 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.775 -0.824 . . . . 62.04 108.775 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 22.1 m -137.85 125.66 22.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.203 -0.295 . . . . 62.11 110.203 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 178.9 42.33 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.328 -1.415 . . . . 55.53 113.442 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 26' ' ' LEU . 21.9 m -138.01 134.82 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.687 -0.486 . . . . 64.23 109.687 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -139.8 132.8 29.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.918 0.39 . . . . 50.53 111.25 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -96.06 120.96 37.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.894 -0.593 . . . . 64.21 109.409 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 m -84.52 -33.42 23.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 62.24 110.751 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -63.61 -59.4 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 75.35 110.027 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 m -112.52 111.31 22.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.228 -0.656 . . . . 72.41 109.228 176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p -55.92 95.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.156 0.799 . . . . 55.24 113.156 -171.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -145.58 117.36 8.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.36 -0.978 . . . . 72.33 108.36 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' HB2' ' A' ' 47' ' ' ALA . 32.1 t -121.97 125.32 72.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.934 0.397 . . . . 71.34 110.821 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.6 m -109.54 125.08 52.14 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.493 -0.929 . . . . 73.02 108.493 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.56 5.33 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.947 -1.12 . . . . 73.24 113.267 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 75' ' ' TRP . 19.3 m -118.96 134.07 55.42 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.068 -0.715 . . . . 61.41 109.068 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -119.74 123.24 43.28 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.519 -0.919 . . . . 74.42 108.519 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.821 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 mt-10 -110.83 119.31 38.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.9 -0.591 . . . . 71.21 110.217 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -98.59 117.76 33.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.733 -1.21 . . . . 74.01 107.733 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.822 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 38.2 mttp -116.56 139.87 50.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.256 0.551 . . . . 62.44 110.75 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.757 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 96.6 m-85 -115.34 120.09 38.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.249 -0.887 . . . . 73.1 108.887 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.6 ptp180 -119.03 106.39 12.37 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 121.755 0.788 . . . . 72.43 111.224 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -116.11 92.67 3.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.919 -1.037 . . . . 74.12 109.994 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -81.22 1.22 33.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.748 -0.66 . . . . 70.4 111.448 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.43 14.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.524 0.678 . . . . 64.54 109.986 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -159.02 -49.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.875 -1.057 . . . . 62.33 108.578 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.64 0.29 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.366 -0.834 . . . . 72.1 111.306 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' CD1' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -106.93 131.86 53.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.796 0.331 . . . . 75.13 111.147 -174.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.9 m -129.99 111.93 13.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.002 -0.545 . . . . 74.05 109.993 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 33.4 t80 -112.88 123.76 51.05 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.547 -0.538 . . . . 71.45 109.547 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 61' ' ' LYS . 88.4 m -128.63 116.77 20.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.808 0.337 . . . . 74.32 111.018 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.38 121.52 45.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.892 -0.781 . . . . 71.54 108.892 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.711 ' HB3' ' HG2' ' A' ' 59' ' ' GLU . 17.4 ptmt -128.01 114.39 17.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.92 0.39 . . . . 54.45 111.442 -174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.662 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 78.6 t90 -99.9 139.23 35.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.524 -0.547 . . . . 72.4 109.524 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -119.7 160.86 21.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.422 -0.354 . . . . 51.55 110.276 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 p -62.41 -14.12 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.062 0.458 . . . . 72.32 111.95 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.683 ' HB3' HG22 ' A' ' 80' ' ' THR . 35.4 t70 -71.23 -4.75 27.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 71.04 110.108 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER 77.85 -3.3 2.39 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.122 -0.944 . . . . 60.1 110.019 -176.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.683 HG22 ' HB3' ' A' ' 78' ' ' ASP . 13.4 t -83.68 133.37 34.81 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.938 -0.574 . . . . 71.23 109.891 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.662 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 2.2 pt? -123.0 142.88 50.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.047 -0.524 . . . . 74.44 110.104 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.58 123.92 5.64 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.965 -0.636 . . . . 73.13 112.333 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 23.5 m -97.34 90.1 4.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.284 0.564 . . . . 71.44 109.679 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -91.57 110.0 21.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.123 -0.944 . . . . 71.43 109.482 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 85' ' ' ILE . 13.0 pt -124.36 134.84 65.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.734 0.778 . . . . 74.13 110.867 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -123.5 122.27 37.79 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.192 -0.913 . . . . 74.31 108.746 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.59 HG22 ' HB2' ' A' ' 97' ' ' LEU . 8.0 m -113.69 120.77 64.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.079 -0.51 . . . . 72.42 110.106 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -107.77 131.57 54.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.549 -0.908 . . . . 74.14 108.549 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -76.6 134.65 39.3 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.362 -0.535 . . . . 53.04 111.355 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.419 -0.809 . . . . 65.32 111.077 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.27 -53.22 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.687 -0.486 . . . . 63.12 109.687 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 71.87 10.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.34 110.719 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -63.37 133.35 53.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 73.5 110.219 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.5 -9.43 58.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.544 -0.836 . . . . 61.12 111.317 -173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -105.4 111.21 23.85 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.1 -0.704 . . . . 71.31 109.1 176.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.696 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -126.23 130.25 50.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.132 0.491 . . . . 73.43 110.404 177.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.724 HD12 HG22 ' A' ' 116' ' ' THR . 1.3 mm? -101.63 131.06 48.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.019 -0.537 . . . . 72.23 109.626 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -106.4 117.76 34.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.08 0.466 . . . . 62.24 110.494 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.785 ' HD1' ' HB ' ' A' ' 114' ' ' ILE . 82.3 t80 -126.21 115.95 20.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.279 -0.873 . . . . 75.54 110.295 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.691 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 1.3 t70 -112.18 138.6 48.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.765 -0.652 . . . . 64.53 110.768 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 33.2 m -126.93 120.74 29.89 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.951 -0.759 . . . . 54.14 108.951 169.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 111' ' ' ASN . 4.7 t -127.49 121.89 31.94 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.918 -0.401 . . . . 72.24 109.918 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' THR . 69.6 m-85 -125.45 120.51 31.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.557 -0.292 . . . . 74.31 110.285 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.2 t -123.05 103.14 36.71 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.29 -0.414 . . . . 61.41 109.961 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.74 -25.32 46.4 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.972 2.448 . . . . 62.11 111.387 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -67.06 -37.44 84.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 63.14 110.329 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.764 ' HB ' ' HG2' ' A' ' 109' ' ' LYS . 5.2 m -88.18 -28.25 21.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.148 0.499 . . . . 75.01 110.104 175.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.67 4.19 83.02 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.229 -0.748 . . . . 70.14 111.229 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.764 ' HG2' ' HB ' ' A' ' 107' ' ' THR . 21.3 pttm -94.96 148.63 22.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.154 0.502 . . . . 54.03 111.472 -175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 122.74 37.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.316 -0.856 . . . . 53.13 109.236 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 102' ' ' SER . 17.8 m120 -119.61 137.79 53.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 75.5 110.521 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -140.15 123.3 16.78 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.616 -0.513 . . . . 53.55 109.616 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.691 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -117.58 131.92 56.6 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 119.539 -0.864 . . . . 74.23 109.204 176.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.785 ' HB ' ' HD1' ' A' ' 99' ' ' PHE . 4.0 tp -140.09 114.66 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.635 -0.506 . . . . 74.43 109.635 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.947 ' HB3' ' O ' ' A' ' 127' ' ' CYS 0.461 13.1 tttt -154.41 170.12 22.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 116.128 1.899 . . . . 51.32 116.128 160.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.724 HG22 HD12 ' A' ' 97' ' ' LEU . 77.1 p -101.18 130.16 47.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.311 -1.313 . . . . 64.31 110.956 -163.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.89 123.81 5.87 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.534 -0.841 . . . . 52.33 112.238 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.444 ' C ' ' HD2' ' A' ' 119' ' ' LYS . 35.5 p90 -124.9 128.09 48.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.62 0.724 . . . . 72.4 110.282 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.696 ' HD3' ' HD3' ' A' ' 96' ' ' LYS . 3.8 mptp? -111.38 122.7 48.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.672 -0.695 . . . . 73.51 110.929 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 31.0 mtp180 -108.36 158.02 17.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.798 -0.637 . . . . 73.4 110.694 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.68 -32.8 44.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.39 0.885 . . . . 70.31 113.39 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -119.15 -6.33 10.42 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.73 -0.388 . . . . 74.42 111.297 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.812 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -144.4 123.3 6.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.52 0.676 . . . . 42.53 110.6 -173.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.787 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 5.9 t-20 -104.64 115.45 30.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.03 -0.532 . . . . 64.34 109.582 -175.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.05 130.06 56.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.516 0.674 . . . . 64.13 111.761 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.47 115.9 1.61 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.316 -0.856 . . . . 42.23 111.37 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.947 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 59.4 m -112.66 126.1 55.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.824 -0.806 . . . . 65.31 108.824 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.765 ' HA ' ' CB ' ' A' ' 115' ' ' LYS . 1.1 m-20 -128.92 133.22 47.79 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.843 1.339 . . . . 62.41 111.364 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.855 ' H ' ' HB2' ' A' ' 115' ' ' LYS . 60.1 ttp -107.39 118.39 36.59 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 119.413 -0.915 . . . . 73.43 109.791 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 9.2 t70 -106.2 115.3 29.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.739 -0.467 . . . . 73.11 109.739 -175.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 92.3 t80 -97.87 117.78 32.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.839 -0.344 . . . . 75.22 111.125 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 22.5 t70 -115.02 157.03 24.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.872 -0.788 . . . . 75.21 108.872 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.47 ' H ' HG13 ' A' ' 133' ' ' ILE . 2.6 pp -69.19 -17.19 21.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 111.705 0.261 . . . . 50.04 111.705 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.23 -19.34 24.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 71.31 111.073 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.482 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 168.93 148.45 5.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.528 -0.844 . . . . 74.3 112.527 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 2.8 Cg_endo -85.67 114.51 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.571 2.847 . . . . 65.12 111.749 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 m -104.0 144.44 31.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.018 -0.537 . . . . 74.54 110.612 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.35 118.52 55.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.41 -0.589 . . . . 71.21 109.41 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 139' ' ' ARG . 39.3 ttp-105 -103.57 126.31 50.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.773 -0.649 . . . . 70.33 110.23 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.14 132.02 10.1 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.181 -1.009 . . . . 74.31 111.643 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.09 116.09 23.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.713 -0.477 . . . . 53.3 109.713 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 123' ' ' ILE . 15.2 tp -124.26 124.53 42.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.356 -0.384 . . . . 74.02 110.621 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 46.5 t -125.1 128.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 72.31 109.821 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 5.2 mp -109.51 138.69 45.5 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.728 -0.841 . . . . 73.4 108.728 176.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.9 117.55 1.58 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.109 -1.043 . . . . 72.33 111.778 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -138.31 123.28 18.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.883 -0.327 . . . . 74.52 111.056 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 40.34 39.02 0.62 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.058 1.132 . . . . 73.14 114.058 171.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.09 6.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.26 -0.971 . . . . 71.33 113.512 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -98.66 137.01 37.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.904 0.852 . . . . 74.53 111.416 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 mt -115.59 140.17 49.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.442 -1.254 . . . . 74.41 110.56 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -127.17 125.88 41.88 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.275 -0.639 . . . . 61.3 109.275 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.63 134.02 7.59 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.26 -0.972 . . . . 52.54 112.572 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.472 ' HD2' ' CD2' ' A' ' 169' ' ' PHE . 13.7 m-85 -134.68 120.54 19.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.387 -0.407 . . . . 72.41 109.973 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.421 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . 73.1 mt-30 -119.92 123.12 42.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.426 0.631 . . . . 62.31 110.01 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -130.58 136.13 48.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.863 -0.608 . . . . 73.42 110.288 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -114.75 118.88 34.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.702 -0.481 . . . . 74.51 109.702 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 86.3 t80 -107.15 123.33 48.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.811 -0.631 . . . . 73.42 110.798 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -94.98 126.35 40.26 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.479 -0.563 . . . . 74.34 109.479 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 41.8 p -73.71 -48.24 33.47 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.083 -0.962 . . . . 63.35 112.993 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -65.58 -44.57 86.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.237 0.541 . . . . 62.35 110.189 -172.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 38.7 ttpt -101.64 112.91 25.63 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.941 -1.874 . . . . 73.23 105.941 160.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.4 p -75.5 38.07 0.14 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.355 1.243 . . . . 61.12 114.355 -152.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.567 ' HG2' ' N ' ' A' ' 164' ' ' VAL . 26.0 ttm180 -139.92 157.88 44.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.916 0.389 . . . . 71.23 111.085 -166.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 85.7 t -72.51 122.13 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.448 -0.945 . . . . 73.23 108.448 170.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.6 m -93.81 -31.08 14.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.354 -0.385 . . . . 63.12 110.826 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -132.94 129.7 38.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 64.5 110.321 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.5 m -124.75 106.67 10.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.562 -0.744 . . . . 74.51 109.632 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 154' ' ' GLN . 10.0 p30 -118.14 146.79 43.91 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.459 -0.496 . . . . 43.51 109.886 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' HD2' ' A' ' 153' ' ' TYR . 69.1 m-85 -135.21 162.1 33.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.45 -0.341 . . . . 75.22 110.648 -173.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 71.0 110.616 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.806 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 98.5 t -138.45 136.95 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.415 . . . . 73.23 109.878 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.73 111.28 1.9 Allowed Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.614 -0.803 . . . . 60.12 111.317 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.574 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 19.5 t80 -113.28 128.85 56.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.252 0.526 . . . . 62.31 109.976 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -102.15 130.82 48.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.981 0.896 . . . . 74.21 112.564 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 7.8 m -131.1 145.54 52.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 42.41 105.765 164.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.95 -30.25 67.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.328 0.513 . . . . 73.44 112.303 -168.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.08 -0.23 12.79 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.292 -0.255 . . . . 73.5 111.567 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.608 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 53.4 m-85 -136.84 119.93 16.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 73.35 110.57 -174.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -110.91 123.65 50.55 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.018 -0.426 . . . . 63.52 110.162 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 173' ' ' TYR . 2.0 tp -102.68 126.9 49.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.998 0.428 . . . . 50.21 110.077 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -118.55 114.83 23.42 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.627 -0.879 . . . . 75.31 108.627 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.806 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 26.6 m -99.94 137.57 38.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.406 -0.59 . . . . 40.41 109.406 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -136.97 139.05 41.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.137 0.494 . . . . 64.23 110.995 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 190' ' ' PHE . 84.2 t -128.04 111.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 63.5 109.546 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -96.54 103.8 15.73 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 108.672 -0.862 . . . . 54.34 108.672 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.435 ' HB3' HG22 ' A' ' 188' ' ' THR . 23.1 t70 64.82 172.61 0.2 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.03 -0.987 . . . . 70.02 109.64 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.8 56.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.435 -0.888 . . . . 34.42 111.785 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 186' ' ' ASP . 14.4 t -97.41 -24.14 15.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 113.14 0.792 . . . . 72.02 113.14 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.29 117.47 19.85 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.423 1.01 . . . . 62.42 111.33 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 184' ' ' VAL . 41.8 p90 -134.03 138.47 45.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.593 -0.276 . . . . 72.35 110.766 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . -163.45 -163.88 17.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.788 -0.72 . . . . 61.32 112.369 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.88 176.73 30.9 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 120.78 -0.724 . . . . 74.23 112.095 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 34.8 t -147.29 142.59 27.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.046 0.423 . . . . 75.21 110.881 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 194' ' ' ILE . 4.1 mp -119.31 118.4 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.194 -0.669 . . . . 70.51 109.194 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 9.2 t80 -108.24 121.07 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.588 -0.523 . . . . 72.5 109.588 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -116.96 126.69 53.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.424 -0.584 . . . . 73.34 109.424 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.647 ' HG2' ' HG2' ' A' ' 203' ' ' GLU . 2.9 tmtp? -108.69 114.17 27.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.982 -0.554 . . . . 51.15 110.24 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.461 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 43.6 t -73.89 159.75 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.462 -0.335 . . . . 73.4 110.319 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.405 ' N ' HG12 ' A' ' 198' ' ' VAL . 0.9 OUTLIER -57.62 -45.53 85.25 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.527 0.203 . . . . 63.13 111.041 178.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 172.47 13.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.906 -0.776 . . . . 55.05 108.906 172.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -78.08 70.1 4.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.756 0.788 . . . . 72.22 111.423 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.744 HD13 ' HD2' ' A' ' 225' ' ' TYR . 58.5 tp -133.58 113.01 11.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.465 -1.243 . . . . 75.0 108.759 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.647 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.6 mt-10 -117.12 129.09 55.74 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.512 -0.551 . . . . 55.21 109.512 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -124.36 139.41 53.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.725 0.298 . . . . 65.23 110.968 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.425 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -130.97 136.4 48.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.349 -0.387 . . . . 64.13 110.677 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 193' ' ' SER . 54.6 t -113.71 126.08 71.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.471 -0.566 . . . . 72.22 109.471 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.1 136.17 53.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.507 0.67 . . . . 74.45 111.004 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -119.55 141.1 49.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.029 -0.987 . . . . 62.5 109.325 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.11 130.37 25.18 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.283 -0.417 . . . . 64.2 110.872 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -116.48 132.84 56.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.981 -0.748 . . . . 71.31 108.981 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 10.1 t -114.2 122.72 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 63.11 110.691 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.64 135.62 57.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 74.44 111.14 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.38 -28.94 5.63 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.622 -0.717 . . . . 65.11 111.474 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.06 149.26 30.06 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.094 -0.706 . . . . 61.02 109.094 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.6 m -79.15 42.8 0.5 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.079 0.466 . . . . 64.34 110.667 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.57 120.88 40.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.573 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.6 t -105.8 136.89 44.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.14 0.495 . . . . 74.31 109.943 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 34.4 mmm-85 -102.0 138.19 39.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.445 -0.576 . . . . 75.22 109.445 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 239' ' ' ASN . 66.0 m-85 -114.7 146.9 40.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.982 -0.377 . . . . 73.21 109.982 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.88 146.23 15.21 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.34 -0.704 . . . . 62.44 111.34 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.6 mp -132.14 129.5 60.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.94 0.37 . . . . 71.22 110.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -118.57 138.9 52.23 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.117 -0.327 . . . . 72.33 110.117 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.97 125.8 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.922 0.391 . . . . 60.13 110.813 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -115.44 114.34 24.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.74 -0.664 . . . . 73.24 109.909 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.744 ' HD2' HD13 ' A' ' 202' ' ' LEU . 36.6 t80 -117.7 120.05 36.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.477 -0.564 . . . . 73.43 109.477 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 229' ' ' PRO . 52.7 tt0 -112.25 112.22 23.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.952 0.406 . . . . 70.33 110.652 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 227' ' ' ILE . 3.7 mp -86.82 -55.51 6.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 62.33 109.711 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -106.1 153.86 39.96 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 73.53 109.606 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.639 ' HA ' HE21 ' A' ' 226' ' ' GLN . 21.0 Cg_endo -60.33 -23.82 75.63 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.549 2.166 . . . . 74.31 112.79 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -102.61 -9.27 20.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.587 -0.279 . . . . 75.23 111.342 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.85 122.67 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 73.32 111.348 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.47 142.32 51.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.878 -0.601 . . . . 71.32 110.651 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -108.43 125.77 52.14 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.251 -0.648 . . . . 71.1 109.251 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.5 t -126.45 117.15 22.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.818 -0.438 . . . . 53.14 109.818 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -124.74 155.86 38.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.367 -0.379 . . . . 62.54 110.324 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 0.0 OUTLIER -154.25 139.84 17.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.478 . . . . 63.44 109.857 175.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 243' ' ' ILE . 7.9 p -128.64 144.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 63.13 110.406 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 240' ' ' SER . 9.2 t30 -108.46 148.79 29.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.066 -0.516 . . . . 73.42 109.96 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 219' ' ' PHE . 8.0 t30 -65.22 -3.78 4.35 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.182 0.808 . . . . 63.02 113.182 -170.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.667 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.6 m -85.76 17.06 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.946 -0.761 . . . . 73.34 108.946 172.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.594 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 51.0 m 69.77 30.45 3.82 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.691 -1.14 . . . . 74.21 111.585 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.848 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.7 mp -99.08 125.47 44.6 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 120.683 -0.407 . . . . 75.42 111.735 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.561 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.8 mp -113.2 115.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.721 -0.672 . . . . 74.23 110.506 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -111.08 133.78 11.75 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.74 -0.743 . . . . 23.43 111.748 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.56 151.71 50.57 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.687 -0.302 . . . . 75.13 110.527 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -146.45 137.8 7.03 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.63 -0.795 . . . . 63.0 113.026 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -103.63 120.19 40.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.742 -0.836 . . . . 64.45 108.742 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 2.0 m -121.93 115.76 23.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.737 0.303 . . . . 74.24 111.035 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -134.74 141.84 46.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.58 -0.282 . . . . 72.02 110.707 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.0 m -76.32 124.82 28.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.609 -0.515 . . . . 63.33 109.609 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.595 ' HG ' ' H ' ' A' ' 252' ' ' LYS . 17.9 tp -105.92 172.65 6.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.108 0.48 . . . . 72.35 111.804 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.595 ' H ' ' HG ' ' A' ' 251' ' ' LEU . 44.2 tptt -49.53 -54.54 29.73 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.998 1.11 . . . . 64.21 113.998 -172.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 13.1 Cg_exo -70.73 9.07 0.82 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.611 2.207 . . . . 61.22 114.295 -171.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 82.86 29.36 35.1 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.386 -0.911 . . . . 41.4 111.824 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 2.7 pp -121.94 146.02 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.447 -0.377 . . . . 70.43 110.35 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.581 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 73.7 tttt -91.64 126.17 36.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 74.52 108.864 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 248' ' ' THR . 15.6 tp -97.8 123.58 41.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.927 -0.398 . . . . 60.34 109.927 -176.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.4 m -124.75 111.5 15.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.789 -0.641 . . . . 65.44 110.543 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.638 ' CD2' HD12 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -98.92 122.8 42.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.553 -1.277 . . . . 74.21 107.553 170.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.8 m -131.47 143.91 50.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.932 0.396 . . . . 63.23 111.16 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.409 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -146.44 132.36 19.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 74.0 110.732 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.772 HD11 HD23 ' A' ' 242' ' ' LEU . 2.7 tm? -104.35 113.12 26.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.25 -1.018 . . . . 54.3 108.25 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.697 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.2 mm? -91.66 108.92 20.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.92 -1.141 . . . . 71.22 107.92 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.848 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 9.9 t0 -71.48 105.07 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.586 -1.265 . . . . 70.13 107.586 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.82 -25.03 43.4 Favored Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.907 -0.588 . . . . 44.31 113.497 -170.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 266' ' ' LYS . 46.0 mtpt -91.85 -26.63 18.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.627 0.251 . . . . 61.33 111.201 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 63.2 t30 -98.69 -28.57 13.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 61.25 112.357 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.738 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 26.9 m -62.51 -17.82 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.665 0.269 . . . . 74.25 111.315 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -55.57 -37.79 68.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.271 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.57 9.75 37.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 62.31 110.838 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.44 74.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.004 -0.617 . . . . 72.51 112.598 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.738 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -142.57 86.52 0.19 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.937 -0.649 . . . . 42.23 111.919 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -113.23 143.52 44.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.444 0.164 . . . . 72.42 110.642 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 65.5 mttm -97.47 137.91 35.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.252 -0.647 . . . . 75.33 109.252 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.1 tm? -121.94 142.55 50.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.814 -0.439 . . . . 74.33 109.814 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -157.37 123.81 1.33 Allowed Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.54 -0.838 . . . . 52.14 111.504 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.705 HD22 HG23 ' A' ' 27' ' ' ILE . 7.4 tt -114.05 145.2 41.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.005 -0.739 . . . . 74.45 109.005 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -149.4 125.37 1.99 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.944 -1.122 . . . . 75.53 113.012 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.804 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.1 mm? -99.18 128.0 45.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.418 -0.956 . . . . 70.5 108.418 168.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 13.8 pt-20 -140.05 125.07 18.55 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.045 -0.354 . . . . 64.41 110.045 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.688 ' HB3' ' HA ' ' A' ' 255' ' ' ILE . 1.3 t80 172.72 -142.4 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 71.34 111.547 170.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.506 ' HB3' HD23 ' A' ' 284' ' ' LEU . 74.9 mt-30 -136.32 122.07 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.28 -0.418 . . . . 72.31 111.396 -166.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.93 109.02 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.942 -0.762 . . . . 65.44 108.942 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 282' ' ' GLN . 2.9 mm? -131.75 158.92 39.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.12 -0.491 . . . . 73.15 110.709 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.938 -0.764 . . . . 72.21 108.938 176.298 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.973 -0.38 . . . . 71.23 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.642 ' HB1' ' HA2' ' A' ' 94' ' ' GLY . . . -88.89 -87.63 0.16 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.094 0.473 . . . . 32.55 112.096 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 119' ' ' LYS . 23.1 t -125.46 127.58 24.89 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 55.52 110.178 -174.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.98 123.23 9.54 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.494 2.796 . . . . 65.22 112.599 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.41 85.4 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.699 2.266 . . . . 73.52 112.564 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 5.5 p -72.0 -13.27 61.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 74.3 110.208 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.551 ' HE1' HE21 ' A' ' 154' ' ' GLN . 51.8 t80 -53.74 -34.98 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.995 -1.002 . . . . 72.2 110.126 169.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.22 -27.18 30.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 74.32 110.673 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' THR . 2.2 m-20 -85.22 0.98 50.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.589 -0.732 . . . . 75.5 111.196 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.67 -34.48 77.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 75.23 110.386 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.52 59.81 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.544 -0.836 . . . . 64.32 112.699 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -59.26 -53.28 60.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 62.34 110.839 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -55.53 -36.48 66.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.634 -0.712 . . . . 62.55 112.132 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.57 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 72.13 112.205 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -67.79 -40.1 83.98 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.993 0.425 . . . . 71.21 110.682 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -68.73 -44.43 73.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.675 -0.693 . . . . 64.11 110.979 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 p -68.98 -26.67 32.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.128 0.49 . . . . 74.02 110.435 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.99 -39.91 83.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.944 -0.571 . . . . 54.33 109.727 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 58.26 39.36 25.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.78 -0.646 . . . . 65.35 111.248 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 67.82 4.39 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.954 -0.567 . . . . 55.3 111.451 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.09 -78.27 0.68 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.164 -0.541 . . . . 44.32 112.695 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -122.09 170.08 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.812 0.339 . . . . 72.02 111.03 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 122.54 6.79 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.826 -0.702 . . . . 73.11 111.621 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' HD1' HD13 ' A' ' 26' ' ' LEU . 22.2 t80 -89.35 2.91 53.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.127 0.489 . . . . 64.3 110.894 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.01 59.25 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.579 -0.82 . . . . 50.44 112.72 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.621 ' HG ' ' HA ' ' A' ' 48' ' ' ASN . 9.3 mp -102.0 156.07 17.77 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.625 0.726 . . . . 74.31 112.288 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.687 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -104.71 122.04 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.402 -1.272 . . . . 75.22 108.74 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 27.7 mtpp -102.74 127.78 49.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.877 -0.601 . . . . 75.15 110.59 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.31 126.65 53.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.337 -0.986 . . . . 73.11 108.337 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.584 ' HB3' ' HD1' ' A' ' 281' ' ' PHE . 4.5 t0 -142.49 133.08 25.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.303 -0.999 . . . . 74.14 108.303 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.013 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -139.12 123.98 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.755 0.252 . . . . 53.21 110.575 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 32.1 ttpt -121.15 122.56 40.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.221 0.534 . . . . 75.53 110.28 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -138.82 120.66 15.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.308 -0.86 . . . . 74.02 109.381 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HB2' ' HG2' ' A' ' 40' ' ' GLU . 3.5 pttp -144.28 155.16 43.72 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.856 -0.738 . . . . 64.12 111.684 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -133.68 169.54 16.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.805 . . . . 61.33 109.782 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -89.07 13.79 12.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.056 0.391 . . . . 74.33 112.056 -172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.07 52.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.685 0.254 . . . . 61.13 111.685 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.94 -7.59 50.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 118.896 -0.947 . . . . 63.14 115.232 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.9 126.65 47.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.307 1.553 . . . . 63.22 112.186 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 23.9 mt-10 -139.36 118.49 12.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.308 -0.627 . . . . 74.44 109.308 165.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.98 126.07 53.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 74.23 111.244 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.9 m -126.17 117.11 22.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 63.43 110.655 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -116.63 133.54 55.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.714 -0.476 . . . . 73.35 109.714 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 31.7 m -139.96 149.93 43.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.911 0.386 . . . . 73.24 110.805 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.7 129.41 2.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.105 -0.569 . . . . 55.31 111.847 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -112.89 133.84 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.758 -0.83 . . . . 60.14 108.758 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.72 129.91 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.04 0.448 . . . . 71.42 111.208 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.621 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 37.7 t-20 -91.11 143.73 26.38 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.55 -0.908 . . . . 62.24 108.55 177.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -65.12 -6.34 8.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.877 0.325 . . . . 75.1 111.877 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.15 168.12 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.428 -0.582 . . . . 74.51 109.428 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -52.65 -69.25 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.322 0.86 . . . . 65.3 113.322 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.8 m -122.3 92.18 3.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.314 0.578 . . . . 55.1 111.72 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 9.3 tmtm? -154.67 78.83 1.07 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.204 -1.035 . . . . 75.35 108.204 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.72 120.5 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.216 -0.902 . . . . 73.14 109.479 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -110.31 124.57 51.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.33 -0.395 . . . . 62.11 109.97 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.3 154.37 16.87 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.716 -0.754 . . . . 63.1 112.206 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 20.1 m -146.19 126.52 13.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.65 -0.5 . . . . 70.13 109.65 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 1.8 tm? -125.34 125.86 44.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.525 -0.546 . . . . 71.2 109.525 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 38.1 tt0 -129.53 126.19 38.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.035 0.445 . . . . 74.31 110.628 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 73' ' ' GLU . 3.9 m -120.1 129.45 54.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.851 -0.613 . . . . 64.5 109.758 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 68.6 mttm -117.52 133.99 55.36 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.856 -0.424 . . . . 61.53 109.856 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 50.1 m-85 -101.89 119.78 39.33 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.406 -0.961 . . . . 73.22 108.406 171.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 11.6 ttm180 -121.08 110.77 16.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 119.943 -0.703 . . . . 70.43 112.741 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -91.9 136.14 33.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 114.724 -1.125 . . . . 64.21 109.443 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -75.46 -11.57 60.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 72.13 112.695 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.84 106.27 2.63 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.081 -0.34 . . . . 75.1 110.081 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 66.87 -68.07 0.15 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.019 0.824 . . . . 73.42 110.476 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' HA3' ' HG2' ' A' ' 88' ' ' GLU . . . 154.66 72.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.672 -0.971 . . . . 61.23 110.672 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 63' ' ' ARG . 4.1 mm? -101.12 131.39 47.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.213 -0.292 . . . . 62.3 110.213 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 23.0 m -136.19 118.55 15.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.442 -0.344 . . . . 65.23 111.352 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.416 ' HB3' ' HD1' ' A' ' 62' ' ' TYR . 69.8 t80 -96.63 121.93 39.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.668 -0.864 . . . . 74.32 108.668 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 83' ' ' THR . 96.3 m -113.46 126.54 55.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.172 0.51 . . . . 73.24 112.158 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' CG ' ' HB ' ' A' ' 60' ' ' THR . 3.1 pt-20 -118.82 139.23 51.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.078 -0.964 . . . . 55.14 109.006 169.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.0 ttpp -142.01 142.41 32.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.917 -0.771 . . . . 74.22 108.917 177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 129.73 35.82 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.088 -0.645 . . . . 75.01 111.69 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -116.18 135.96 53.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.65 -0.87 . . . . 71.33 108.65 165.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -35.77 74.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.133 0.492 . . . . 71.04 111.221 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.57 -34.83 10.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.775 -0.648 . . . . 65.42 111.723 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -104.71 -104.17 0.31 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.663 -0.415 . . . . 74.13 111.814 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -116.43 145.33 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.544 0.687 . . . . 73.43 112.777 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -106.19 131.59 53.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.224 -1.028 . . . . 73.22 108.224 168.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.86 148.28 17.97 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.652 -0.785 . . . . 31.14 112.77 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 72' ' ' THR . 88.0 m -156.45 143.98 19.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.099 -0.704 . . . . 50.12 109.099 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.642 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 4.7 mm-40 165.36 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.19 0.931 . . . . 62.12 110.632 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.476 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -133.54 138.29 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 74.24 112.231 -162.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 70' ' ' THR . 25.7 m -122.85 123.46 41.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.134 -0.484 . . . . 73.1 109.906 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.16 137.44 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 73.24 111.336 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HG2' ' HA3' ' A' ' 68' ' ' GLY . 12.8 pt-20 -125.79 151.31 46.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.12 -0.232 . . . . 70.51 111.458 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.5 ' OD2' ' HG3' ' A' ' 93' ' ' ARG . 0.6 OUTLIER 66.92 1.19 2.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.809 1.04 . . . . 73.51 113.809 171.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.88 -58.85 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.172 -0.211 . . . . 70.13 111.412 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' HB3' HD23 ' A' ' 95' ' ' LEU . 58.9 tp -74.62 -49.26 22.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.001 0.429 . . . . 75.4 110.519 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.879 -0.6 . . . . 65.35 110.033 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 7.3 mpt_? -63.82 127.71 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 65.23 110.411 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.642 ' HA2' ' HB1' ' A' ' 2' ' ' ALA . . . 101.23 -7.47 56.67 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.668 -0.777 . . . . 71.04 112.436 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 91' ' ' LEU . 50.7 tp -94.56 129.78 41.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.18 0.514 . . . . 71.52 110.957 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -122.25 111.99 17.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.391 -0.822 . . . . 74.02 109.872 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -104.98 126.78 52.4 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.149 -0.686 . . . . 74.12 109.149 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.858 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 19.8 m -125.67 119.26 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.013 0.435 . . . . 63.53 110.851 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.642 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 56.1 m-85 -113.42 119.53 37.94 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.608 -0.886 . . . . 74.14 108.608 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 12.1 m-20 -125.32 122.79 37.86 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.729 0.643 . . . . 51.43 109.383 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -115.11 122.56 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.157 -0.617 . . . . 72.11 110.112 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.3 m -111.43 122.77 48.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 73.54 110.423 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.456 ' HD2' ' HG2' ' A' ' 110' ' ' LYS . 74.7 t80 -110.21 129.7 55.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.448 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 45.4 t -104.42 128.16 27.58 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.205 -0.665 . . . . 54.41 109.205 175.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 36.0 Cg_exo -60.58 -20.32 64.02 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.652 2.234 . . . . 71.2 111.786 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -78.7 116.69 19.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.538 -0.755 . . . . 63.11 110.611 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.4 p 56.01 12.39 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.266 1.026 . . . . 74.12 113.664 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.48 74.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.553 -0.832 . . . . 70.12 112.393 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 104' ' ' SER . 57.3 tttp -65.2 123.93 20.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.32 111.247 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' A' ' 103' ' ' PHE . 97.1 mttt -112.13 136.32 51.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 54.35 110.71 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.4 121.61 38.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.694 -0.854 . . . . 73.2 108.694 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.27 133.53 55.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.278 . . . . 50.11 111.264 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 8.6 mtpm? -117.0 136.98 52.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.859 0.361 . . . . 74.4 110.72 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.661 HG23 ' HB3' ' A' ' 129' ' ' MET . 2.8 tp -134.18 116.01 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.706 -0.679 . . . . 73.42 109.602 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 35.7 ttmt -114.58 121.75 44.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.675 -0.693 . . . . 64.31 110.524 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.5 t -114.54 117.18 30.2 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.055 -0.72 . . . . 60.33 109.055 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -126.07 123.31 4.78 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.456 -0.878 . . . . 63.02 112.549 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.07 117.3 33.71 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.25 -0.648 . . . . 75.54 109.25 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 1.01 ' HG3' ' HB2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -110.19 119.13 38.27 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.404 0.621 . . . . 73.52 109.878 177.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.637 ' HB2' HG23 ' A' ' 123' ' ' ILE . 17.7 mmm-85 -108.36 163.67 12.99 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.031 -0.986 . . . . 71.22 108.943 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -53.09 -34.19 55.53 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.551 0.532 . . . . 74.43 112.186 -170.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.01 -0.77 10.52 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.4 0.519 . . . . 65.02 112.4 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 120' ' ' ARG . 3.6 tp -145.49 120.72 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.937 -0.705 . . . . 65.15 111.463 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 1.01 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 7.2 p30 -129.44 116.12 18.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 63.1 111.136 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -129.65 144.42 51.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.106 0.479 . . . . 64.0 111.112 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.589 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -142.42 131.15 4.55 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.538 -0.755 . . . . 61.24 112.243 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.7 m -110.1 114.75 28.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.825 0.345 . . . . 62.32 110.54 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 32.4 t70 -106.63 116.14 31.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.265 -0.642 . . . . 74.13 109.265 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.661 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.7 ttt -97.67 122.78 41.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 75.33 110.615 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.88 116.74 31.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.353 -0.61 . . . . 62.12 109.353 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -97.3 115.07 26.98 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.918 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.83 149.8 36.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.919 -0.771 . . . . 74.52 108.919 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -32.33 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.679 0.276 . . . . 72.24 110.625 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.08 -18.33 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 75.5 111.1 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.58 116.6 0.37 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.716 -0.754 . . . . 74.31 112.517 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.16 144.83 34.08 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.026 2.484 . . . . 72.33 111.883 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 m -124.13 146.62 48.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.492 -0.322 . . . . 55.32 110.474 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 30.9 mm -107.53 116.13 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.766 -0.457 . . . . 73.1 109.766 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -110.16 110.33 21.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.974 0.416 . . . . 72.41 110.223 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.94 133.58 11.52 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.209 -0.996 . . . . 74.15 112.318 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.93 113.77 18.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.201 0.524 . . . . 64.2 109.905 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 125' ' ' LEU . 7.3 tp -115.67 123.74 49.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.611 -0.722 . . . . 73.34 110.351 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 7' ' ' TYR . 59.5 t -123.0 124.02 69.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.104 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.54 ' HG ' ' CD1' ' A' ' 123' ' ' ILE . 4.8 mp -109.17 138.2 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.029 -0.73 . . . . 75.31 109.029 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -119.47 119.16 4.19 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.747 -0.74 . . . . 75.54 113.039 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.797 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 55.3 m-85 -112.75 150.44 31.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.2 -1.407 . . . . 74.44 107.2 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -49.08 94.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.154 0.434 . . . . 71.35 111.386 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.55 -30.87 9.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.912 -0.585 . . . . 71.13 112.786 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 59.1 m95 -101.88 144.7 30.19 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.42 -0.459 . . . . 73.41 111.038 -173.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.458 HD23 ' HA2' ' A' ' 145' ' ' GLY . 16.3 mt -136.33 142.62 43.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.76 0.314 . . . . 73.23 111.424 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.26 126.13 24.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 51.25 109.943 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -131.9 133.54 7.21 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.655 -0.783 . . . . 70.25 112.157 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.557 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 92.1 m-85 -127.71 119.33 25.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.771 0.32 . . . . 73.55 110.723 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.551 HE21 ' HE1' ' A' ' 7' ' ' TYR . 85.8 mt-30 -106.52 123.04 47.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.215 -0.661 . . . . 74.1 109.215 173.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -137.44 129.8 29.56 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.549 -0.296 . . . . 65.31 110.255 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.404 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 48.3 t30 -112.57 118.98 36.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.502 -0.555 . . . . 61.13 109.502 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.888 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 27.7 m-85 -91.87 129.49 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 75.41 110.52 -173.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 23.8 tt0 -97.49 110.5 23.04 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 109.277 -0.638 . . . . 72.34 109.277 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -70.28 -16.04 62.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 112.777 -2.01 . . . . 71.21 111.822 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.86 66.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.871 0.843 . . . . 71.24 109.088 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.554 ' HG3' ' HB2' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -122.83 -153.97 0.58 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.36 -1.348 . . . . 74.42 107.36 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 p -107.31 28.3 8.23 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.916 -0.49 . . . . 71.3 110.452 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.554 ' HB2' ' HG3' ' A' ' 161' ' ' LYS . 14.4 mmt180 -139.75 149.11 43.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.051 -1.06 . . . . 72.1 112.355 -161.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.888 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.21 136.58 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.569 -0.53 . . . . 72.5 109.569 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 6.6 t -93.43 -23.52 18.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.903 -0.59 . . . . 71.21 110.41 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -141.14 133.19 27.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 64.25 110.599 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 2.7 m -121.89 115.91 23.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.574 -0.739 . . . . 63.14 109.759 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 51.7 t30 -118.77 120.46 37.46 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.881 -0.785 . . . . 73.43 108.881 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 24.8 m-85 -120.87 140.86 51.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.403 -0.519 . . . . 75.44 110.298 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -143.09 127.19 17.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.185 -0.461 . . . . 45.54 110.49 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' A' ' 182' ' ' THR . 49.0 t -126.39 136.97 59.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.866 -0.42 . . . . 74.25 109.866 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.55 124.81 7.0 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.22 -0.514 . . . . 52.31 112.111 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.57 125.6 54.44 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.327 -0.62 . . . . 63.14 109.327 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -102.94 125.63 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.379 0.609 . . . . 74.51 111.255 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 19.7 p -131.19 164.92 24.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.076 -0.965 . . . . 71.2 108.41 171.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.41 -46.93 76.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.248 0.462 . . . . 63.14 112.248 -170.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.444 ' HG3' HE22 ' A' ' 196' ' ' GLN . 3.7 tp10 -102.45 -22.79 14.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.691 -0.404 . . . . 74.05 111.778 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.556 ' HB2' ' OG1' ' A' ' 175' ' ' THR . 47.5 m-85 -113.51 135.82 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.101 0.477 . . . . 75.42 111.604 -172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -111.07 122.68 48.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.732 -1.21 . . . . 75.11 107.732 165.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.69 136.94 53.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.32 0.581 . . . . 62.42 111.174 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.531 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 13.3 t60 -126.68 113.72 17.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.227 -0.897 . . . . 72.04 109.061 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.718 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 7.3 t -93.66 141.45 28.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.329 -0.989 . . . . 73.21 108.329 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -133.6 140.1 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 72.41 109.991 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 41.5 t -126.87 120.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.065 -0.516 . . . . 64.3 111.013 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.2 t30 -99.32 90.0 4.4 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.6 0.714 . . . . 74.24 109.092 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 3.1 t70 55.73 -161.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.002 -1.454 . . . . 65.33 110.944 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.598 -0.81 . . . . 64.23 112.157 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.7 m -93.52 -25.56 17.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.627 0.603 . . . . 73.3 112.627 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.759 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 32.8 tt0 -134.49 124.42 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.601 -0.84 . . . . 65.14 112.364 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -121.18 126.2 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.188 -0.914 . . . . 71.2 108.545 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.24 -172.56 19.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.773 -1.204 . . . . 71.31 113.395 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -152.23 172.94 31.45 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.716 -0.554 . . . . 74.33 111.716 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 33.1 m -148.27 142.29 25.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.238 -0.282 . . . . 44.12 110.238 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.584 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 10.6 mm -119.52 118.82 58.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 73.11 109.4 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -108.24 120.98 43.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.417 -0.586 . . . . 63.14 109.417 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 199' ' ' ASN . 0.0 OUTLIER -121.78 111.69 17.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.787 -0.642 . . . . 71.31 111.41 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.601 ' HD2' ' O ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -89.85 130.8 36.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.485 -0.931 . . . . 73.33 108.485 169.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 197' ' ' LYS . 10.3 m 58.95 36.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.923 0.868 . . . . 75.34 110.95 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 196' ' ' GLN . 14.5 t30 -52.54 -50.35 63.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.68 -1.145 . . . . 63.2 108.827 170.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 200' ' ' LYS . 13.6 tppt? -144.31 71.19 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.73 -1.123 . . . . 75.43 107.981 169.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 70.25 -41.74 0.5 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.005 -0.998 . . . . 54.21 112.427 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.806 HD12 ' H ' ' A' ' 226' ' ' GLN . 2.5 mm? -92.74 -161.05 0.8 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.925 0.393 . . . . 75.45 111.089 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 224' ' ' LYS . 45.3 mt-10 -111.82 153.33 26.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.527 -0.306 . . . . 74.34 110.565 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -147.68 143.84 27.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.495 -0.321 . . . . 74.41 110.279 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -134.61 136.76 43.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.83 0.347 . . . . 70.2 110.407 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 45.1 t -123.25 145.42 30.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.074 -0.512 . . . . 74.54 110.088 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -131.98 136.28 47.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.876 0.37 . . . . 72.51 110.481 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.32 140.98 51.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.743 -0.662 . . . . 63.42 109.629 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -140.5 128.91 22.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.966 0.412 . . . . 41.2 111.399 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -115.39 132.88 56.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.737 -0.838 . . . . 74.31 108.737 174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 12.3 t -116.5 132.54 56.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.801 -0.444 . . . . 71.25 109.801 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -59.04 150.37 25.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.765 . . . . 70.02 111.457 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.01 15.07 13.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.464 -0.874 . . . . 52.04 112.392 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.26 87.34 0.11 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.268 0.556 . . . . 70.32 111.328 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.0 t -146.49 171.95 14.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 52.11 109.862 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.76 159.63 23.79 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.736 -0.468 . . . . 71.32 109.736 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.4 m -77.29 135.79 38.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.745 0.307 . . . . 61.23 110.329 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 55.2 mtm180 -88.96 136.39 33.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.923 -0.399 . . . . 73.34 109.923 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.647 ' HB2' ' HB3' ' A' ' 239' ' ' ASN . 79.7 m-85 -114.52 138.96 49.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.658 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.49 139.67 10.21 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.612 -0.995 . . . . 73.4 110.612 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.5 ' HB ' HG12 ' A' ' 237' ' ' VAL . 5.0 mp -136.14 130.48 48.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.2 0.5 . . . . 61.23 110.504 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.1 129.41 50.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.796 -0.446 . . . . 64.33 109.796 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.25 139.71 52.28 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.601 0.239 . . . . 62.34 110.59 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 203' ' ' GLU . 43.9 mtmt -117.28 114.75 24.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.465 ' HA ' ' HG ' ' A' ' 202' ' ' LEU . 47.4 m-85 -100.76 115.34 30.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.211 -0.662 . . . . 62.25 109.211 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.806 ' H ' HD12 ' A' ' 202' ' ' LEU . 35.7 tt0 -86.7 99.62 11.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.161 -0.472 . . . . 72.25 110.029 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.82 -37.31 12.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.499 0.666 . . . . 72.52 109.685 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.74 145.52 19.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.106 -0.952 . . . . 74.42 109.18 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.51 -30.73 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.955 2.437 . . . . 75.12 113.454 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.46 -18.62 21.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.085 0.402 . . . . 73.1 112.085 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.71 122.75 20.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.237 0.541 . . . . 50.33 111.797 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 52.0 t -124.49 136.44 54.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.21 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -99.99 128.82 46.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.743 -0.466 . . . . 74.32 109.743 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.9 m -113.95 152.79 30.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.844 0.354 . . . . 63.32 110.503 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -140.66 141.21 35.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.357 -0.609 . . . . 73.15 109.357 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 54.9 mtmt -134.46 154.51 51.37 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.309 -0.256 . . . . 75.42 110.309 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.1 p -149.98 147.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.966 0.413 . . . . 64.45 110.663 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.7 t-20 -117.63 149.55 40.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.655 -0.868 . . . . 61.32 108.655 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . 0.1 OUTLIER -56.63 -17.61 9.28 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.88 0.696 . . . . 65.42 112.88 -172.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 49.2 m -83.22 23.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.455 0.169 . . . . 71.04 111.021 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 50.1 m 64.9 39.66 5.8 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.299 0.571 . . . . 73.12 110.449 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.94 ' HB3' HD11 ' A' ' 262' ' ' LEU . 46.1 mt -98.15 115.61 28.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.748 -0.66 . . . . 73.21 109.5 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.9 OUTLIER -105.34 117.62 51.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 109.841 -0.429 . . . . 72.13 109.841 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -120.4 162.12 14.45 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.825 -0.702 . . . . 73.41 112.723 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 2.6 pp -142.01 160.39 40.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.032 -0.358 . . . . 72.25 110.032 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -150.54 150.86 22.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.751 -0.738 . . . . 71.44 112.905 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 258' ' ' THR . 81.7 m-85 -123.16 115.96 22.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.561 -0.533 . . . . 63.22 109.561 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 20.0 m -113.0 114.0 26.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.739 -0.467 . . . . 74.0 109.739 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -135.45 127.62 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 65.52 110.548 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 32.1 m -88.53 128.55 35.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.551 0.215 . . . . 74.04 110.468 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.463 HD23 ' HG3' ' A' ' 252' ' ' LYS . 3.3 tt -122.24 88.92 3.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.215 -0.661 . . . . 74.35 109.215 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.463 ' HG3' HD23 ' A' ' 251' ' ' LEU . 94.1 mttt 68.99 166.06 0.13 Allowed Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 115.545 -0.752 . . . . 74.21 111.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.09 71.77 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.64 2.227 . . . . 61.21 112.351 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.32 -59.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.062 -0.589 . . . . 64.14 111.885 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 279' ' ' LEU . 0.0 OUTLIER -119.24 122.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 71.44 111.992 -171.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 1.062 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 66.4 mttm -92.28 135.45 34.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.209 -1.034 . . . . 53.32 108.209 163.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.82 123.41 41.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.25 -0.648 . . . . 74.31 109.25 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 48.6 m -122.47 111.12 16.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.454 0.645 . . . . 73.35 110.462 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.728 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -100.21 125.62 46.4 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.664 -1.235 . . . . 64.13 107.664 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 60.1 m -131.44 140.02 49.51 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 73.44 110.927 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -145.77 139.83 26.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.817 -0.438 . . . . 73.33 109.817 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.94 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -118.4 121.99 41.7 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.816 -0.809 . . . . 65.32 108.816 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.626 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -103.08 106.72 17.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.605 -0.887 . . . . 74.53 108.605 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.953 ' H ' HG21 ' A' ' 268' ' ' VAL . 5.3 t70 -72.92 98.0 2.39 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.318 -0.993 . . . . 62.15 108.318 172.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.45 -8.46 2.66 Favored Glycine 0 C--N 1.307 -1.076 0 CA-C-N 115.078 -0.965 . . . . 54.14 114.044 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.42 -15.83 25.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.444 0.164 . . . . 60.41 110.981 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -152.84 -28.63 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.657 0.741 . . . . 74.45 110.906 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.953 HG21 ' H ' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -54.12 -22.25 7.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.595 -1.184 . . . . 63.43 113.021 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -55.9 -20.57 16.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.666 -0.697 . . . . 53.34 111.459 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.56 -16.58 59.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 63.42 111.43 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.35 -0.53 14.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 65.14 113.168 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -93.09 63.93 2.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 72.33 112.3 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.545 ' HB2' ' CD1' ' A' ' 263' ' ' LEU . 4.0 p-80 -79.27 147.92 32.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.68 -0.118 . . . . 74.45 110.68 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -95.3 138.02 33.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.533 -0.467 . . . . 71.43 109.759 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -132.84 140.57 48.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 75.31 110.631 -170.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.54 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -142.07 131.53 4.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.549 -0.62 . . . . 73.14 111.549 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.728 HD23 HD22 ' A' ' 259' ' ' LEU . 3.4 tm? -115.75 137.57 51.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.967 -0.753 . . . . 72.4 108.967 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.423 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -150.96 140.51 7.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.075 -1.059 . . . . 72.4 113.144 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.504 HD12 HD11 ' A' ' 255' ' ' ILE . 2.4 mm? -110.85 129.98 55.71 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.625 -0.88 . . . . 75.34 108.625 172.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 1.062 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 21.7 mm-40 -101.84 112.04 24.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.312 1.053 . . . . 72.3 112.997 -168.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 1.013 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 34.4 p90 -29.21 44.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 119.971 3.323 . . . . 43.2 119.971 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.858 ' HG2' ' HG3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -113.9 104.91 12.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 122.424 2.375 . . . . 74.1 112.332 -175.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.62 106.26 8.61 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.554 -0.906 . . . . 75.02 108.554 163.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -155.12 -166.06 2.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.383 -0.826 . . . . 61.43 109.122 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.778 -0.63 . . . . 74.33 109.739 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 ttm . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.084 0.469 . . . . 73.4 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.35 93.52 5.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.083 -0.508 . . . . 74.01 110.614 -177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.737 HG11 ' HB2' ' A' ' 119' ' ' LYS . 7.9 t -80.31 119.67 77.13 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.67 -0.695 . . . . 74.22 109.678 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.68 162.34 42.43 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.902 2.401 . . . . 71.53 112.824 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.63 79.85 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.764 2.31 . . . . 74.33 111.003 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.554 ' HB ' ' CG1' ' A' ' 143' ' ' VAL . 26.7 p -69.84 -46.95 64.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.434 -0.803 . . . . 73.31 111.995 -172.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -58.37 -28.4 65.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.058 -0.519 . . . . 71.3 111.41 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.26 -22.99 35.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.094 0.473 . . . . 74.41 110.839 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.27 -15.66 45.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.843 -0.617 . . . . 71.23 109.737 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.61 HD21 HG13 ' A' ' 143' ' ' VAL . 75.1 mt -63.72 -29.23 70.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.65 -0.705 . . . . 55.33 110.263 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.49 62.96 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.73 -0.668 . . . . 42.33 112.263 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 64.0 tttp -63.87 -49.4 72.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 65.23 110.183 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 m -64.55 -38.32 90.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.296 0.569 . . . . 72.41 110.529 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.439 -0.801 . . . . 75.44 112.254 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.638 ' HG3' ' N ' ' A' ' 16' ' ' ASP . 1.7 ptt180 -59.7 -36.99 77.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.563 0.22 . . . . 71.2 111.171 -175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.638 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 69.7 m-20 -68.47 -37.0 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 72.11 110.677 -175.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -72.43 -40.42 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 70.15 110.809 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -70.71 -33.75 71.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.812 -0.631 . . . . 71.21 110.983 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 m -70.04 133.72 47.51 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.71 -0.478 . . . . 73.31 109.71 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -69.53 79.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.72 0.772 . . . . 64.1 111.632 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.98 70.42 2.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.28 -0.728 . . . . 55.35 111.28 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' A' ' 274' ' ' LYS . 17.7 p90 -85.04 -53.62 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.568 0.223 . . . . 72.43 110.884 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.56 129.39 4.17 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.661 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -104.33 5.64 34.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.297 0.57 . . . . 71.32 110.463 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 89.39 12.6 62.8 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.543 -1.023 . . . . 72.34 110.543 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 46' ' ' SER . 0.5 OUTLIER -102.78 153.5 20.1 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.943 -0.628 . . . . 62.54 111.423 -169.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.783 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.8 mp -106.9 124.46 62.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.002 -0.999 . . . . 71.33 110.545 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.8 tptm -102.06 119.47 38.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.484 -0.562 . . . . 65.41 109.484 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -113.84 128.63 56.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.005 0.431 . . . . 75.01 110.132 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -120.76 136.35 54.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.735 . . . . 71.22 109.066 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.909 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -133.39 123.84 26.07 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.197 -0.668 . . . . 62.32 109.197 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 14.3 pttm -137.08 125.58 23.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.203 0.525 . . . . 75.54 111.498 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.758 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 18.9 m -109.71 121.27 44.84 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.512 -0.922 . . . . 61.4 108.512 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -109.82 124.45 51.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.933 -0.307 . . . . 74.25 111.165 -170.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.82 ' HB3' ' HB2' ' A' ' 39' ' ' LEU . 12.2 t -140.41 169.66 17.26 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.277 -1.008 . . . . 45.24 108.277 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.21 179.83 4.25 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.091 -0.707 . . . . 72.42 109.091 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.59 43.63 7.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.14 0.495 . . . . 75.41 111.27 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 94.49 -4.84 70.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 116.984 1.554 . . . . 73.43 116.984 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.82 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 3.0 mm? -100.2 124.13 45.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 120.971 2.385 . . . . 73.21 112.141 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.893 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.9 tt0 -143.08 118.02 9.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.987 -0.746 . . . . 52.24 108.987 162.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 97.4 m-85 -108.34 121.78 45.63 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.546 -0.462 . . . . 73.55 110.473 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 33.0 m -125.19 132.65 52.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.104 0.478 . . . . 72.35 111.062 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.685 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 44.3 t -125.32 143.11 51.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.729 -0.841 . . . . 75.15 108.729 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 m -135.67 126.55 27.56 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.04 -0.356 . . . . 51.22 110.04 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' HA2' ' HA2' ' A' ' 56' ' ' GLY . . . -141.78 157.13 26.21 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.171 -1.014 . . . . 65.4 112.47 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB3' HD21 ' A' ' 26' ' ' LEU . 39.8 m -131.82 139.27 48.81 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.978 -0.749 . . . . 73.42 108.978 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -119.46 129.08 54.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.224 0.535 . . . . 63.14 110.574 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.83 145.93 24.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.043 -0.98 . . . . 60.43 108.852 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.06 76.19 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.371 0.605 . . . . 54.55 111.457 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -167.22 154.14 8.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.915 -1.143 . . . . 73.14 107.915 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.7 m -56.22 -45.94 79.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.097 0.777 . . . . 74.23 113.097 -172.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.3 p -129.29 47.31 2.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 72.13 112.496 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.33 73.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.384 0.612 . . . . 71.14 110.991 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.57 120.57 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.47 -0.787 . . . . 72.13 109.633 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -109.2 126.53 53.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.709 -0.478 . . . . 71.35 109.709 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HA2' ' A' ' 45' ' ' GLY . . . -132.74 170.72 21.94 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.343 -0.932 . . . . 74.2 113.07 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.5 m -147.56 157.66 43.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.421 -0.585 . . . . 74.54 109.421 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 58' ' ' LEU . 1.2 tm? -120.22 125.02 47.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.371 -0.603 . . . . 74.04 109.371 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 42.8 tt0 -118.82 119.25 33.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.582 -0.736 . . . . 61.42 109.504 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 m -110.23 120.02 41.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.431 -0.349 . . . . 73.34 110.527 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.893 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mptt -106.61 131.45 53.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.224 0.535 . . . . 64.13 110.359 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.5 m-85 -103.21 118.48 36.87 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.305 -1.369 . . . . 74.23 107.305 170.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.447 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 33.3 ttm-85 -113.46 109.69 19.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.424 0.631 . . . . 75.33 111.876 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.21 91.2 8.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.161 -0.927 . . . . 71.54 109.254 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -16.42 61.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.299 -0.864 . . . . 71.21 110.679 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -66.89 -41.31 87.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.193 -0.912 . . . . 74.41 111.031 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.489 ' HB2' ' HG ' ' A' ' 69' ' ' LEU . 67.6 m-85 -108.14 -33.94 7.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.33 111.186 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.624 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 101.95 44.44 1.91 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.947 -0.861 . . . . 53.41 110.947 -173.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 87' ' ' VAL . 13.4 mt -126.91 147.21 50.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.804 -0.443 . . . . 75.44 109.804 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -136.57 135.3 38.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.691 0.281 . . . . 75.53 111.13 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 70.1 t80 -115.17 120.73 40.72 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.429 -0.582 . . . . 74.25 109.429 173.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 17.7 m -109.57 117.74 34.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.236 -0.438 . . . . 52.33 110.305 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 42.8 tt0 -109.15 120.34 42.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.355 -0.609 . . . . 72.31 109.355 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -107.81 97.6 7.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.095 -0.502 . . . . 71.0 109.7 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.585 ' HD1' HD13 ' A' ' 81' ' ' LEU . 46.4 t90 -100.35 131.84 46.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.345 0.593 . . . . 71.52 111.279 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.38 154.11 35.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.521 -0.763 . . . . 43.23 109.861 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 m -57.6 -18.4 19.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.016 0.436 . . . . 61.12 111.9 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 20.2 t70 -67.57 -3.86 10.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.095 -0.502 . . . . 73.44 110.906 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 8.1 m120 79.66 22.84 0.51 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.876 0.87 . . . . 70.11 110.02 -175.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 25.7 m -88.83 118.14 28.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.54 -0.754 . . . . 61.31 111.015 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.585 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.8 mm? -97.19 118.37 33.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 63.41 109.213 172.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.68 92.83 0.85 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.512 -0.851 . . . . 43.24 111.21 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 p -91.39 103.5 16.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.986 0.422 . . . . 73.21 111.414 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 25.4 tt0 -106.73 111.63 24.25 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.456 -0.793 . . . . 70.25 109.565 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.9 121.52 64.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.437 -0.579 . . . . 74.34 109.437 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 98' ' ' THR . 14.3 t -128.2 129.66 46.81 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.54 0.686 . . . . 73.22 111.537 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.678 ' HA ' HD22 ' A' ' 69' ' ' LEU . 32.5 m -111.01 129.89 65.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.417 -0.81 . . . . 74.24 109.631 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.28 118.71 36.62 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 71.11 112.131 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 47.27 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.319 1.012 . . . . 73.24 112.804 171.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.511 ' HB2' ' H ' ' A' ' 91' ' ' LEU . 1.5 mp0 -116.97 -92.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.317 -0.401 . . . . 74.34 110.09 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' H ' ' HB2' ' A' ' 90' ' ' GLN . 8.1 mp -95.2 -44.72 7.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.982 -0.747 . . . . 71.51 108.982 175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.65 103.71 5.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 63.05 109.376 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.83 124.26 21.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.693 -0.685 . . . . 74.3 110.756 -173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.77 5.73 87.77 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.869 -0.681 . . . . 61.35 113.085 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 128.16 38.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.238 0.519 . . . . 71.32 111.638 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -118.28 111.39 18.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.61 -0.885 . . . . 64.21 108.61 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.633 ' HB2' HG22 ' A' ' 87' ' ' VAL . 2.2 mm? -102.52 124.78 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.514 -0.551 . . . . 54.51 109.514 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 7.8 m -131.21 119.69 22.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.54 -0.3 . . . . 71.04 111.015 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 72.5 t80 -111.2 115.32 29.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.473 -0.566 . . . . 72.13 109.473 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -112.02 122.63 48.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.189 -0.459 . . . . 62.4 109.775 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.4 t -138.16 123.83 19.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.43 -0.508 . . . . 71.54 111.004 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 13.0 m -104.17 122.69 45.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.064 -0.516 . . . . 51.31 110.264 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.81 124.87 48.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.556 -0.293 . . . . 64.25 110.786 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.9 t -127.6 102.42 22.97 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.437 -0.579 . . . . 54.01 109.437 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.23 -9.13 22.93 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.074 2.516 . . . . 74.15 112.755 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -78.52 -40.12 36.1 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.034 -0.358 . . . . 64.22 110.034 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 p -100.22 -25.61 14.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 73.0 111.171 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.936 -0.575 . . . . 74.23 111.897 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -79.12 123.93 27.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 71.42 111.275 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -132.66 124.63 28.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.934 -0.575 . . . . 73.43 109.495 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 101' ' ' SER . 7.4 m120 -120.45 128.37 53.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.825 -0.625 . . . . 65.12 110.353 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 131' ' ' PHE . . . -114.07 114.79 26.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.259 -0.428 . . . . 64.11 110.366 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -111.13 136.95 49.43 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.158 -0.682 . . . . 74.13 109.158 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -119.47 117.62 54.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 72.03 109.833 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 23.2 tttp -115.26 119.13 35.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.495 -0.775 . . . . 72.44 109.285 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -127.2 118.59 24.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.679 -0.489 . . . . 63.13 109.679 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -127.13 122.84 4.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.333 -0.937 . . . . 63.53 112.577 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -110.0 121.03 44.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.375 0.607 . . . . 74.24 109.501 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.737 ' HB2' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.6 124.23 51.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.649 -0.705 . . . . 64.11 110.673 179.231 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 120' ' ' ARG . 10.0 tpp180 -104.96 167.68 9.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.559 -1.274 . . . . 75.41 107.559 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 120' ' ' ARG . 37.7 tt0 -53.16 -33.33 52.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.475 0.546 . . . . 63.15 112.475 -167.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -120.25 0.32 10.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.801 0.667 . . . . 71.41 112.801 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.926 HG13 HD21 ' A' ' 142' ' ' LEU . 7.7 tt -145.25 136.01 19.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 O-C-N 121.74 -0.6 . . . . 74.14 111.985 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.774 ' O ' HD23 ' A' ' 142' ' ' LEU . 5.4 t30 -129.19 109.84 11.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.088 -0.645 . . . . 62.45 111.308 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.049 ' HG ' ' HG ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -112.89 142.48 45.51 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.449 0.642 . . . . 64.52 111.719 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -143.33 127.06 2.97 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.78 -1.1 . . . . 51.42 112.737 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.22 111.85 24.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.952 -0.388 . . . . 73.32 109.952 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -113.52 118.23 33.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.495 -0.557 . . . . 73.0 109.495 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.635 ' HG2' HG13 ' A' ' 138' ' ' ILE . 59.3 mtt -120.94 119.37 32.39 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.747 -0.381 . . . . 53.43 111.391 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 15.3 m-20 -90.65 118.39 30.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 109.811 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 74.3 t80 -96.87 104.55 16.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.966 0.412 . . . . 65.22 110.014 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.26 157.27 30.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.865 -0.607 . . . . 70.31 109.717 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.2 pp -73.85 -15.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.209 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.441 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -88.88 -17.59 29.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.013 0.435 . . . . 74.14 110.714 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.44 117.54 0.67 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.926 -0.654 . . . . 73.12 112.08 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 56.1 Cg_endo -72.01 134.36 23.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.463 2.109 . . . . 72.0 111.781 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -119.37 144.14 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.458 -0.337 . . . . 75.41 110.397 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 129' ' ' MET . 1.9 mp -107.29 117.12 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.459 -0.571 . . . . 75.44 109.459 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -114.63 113.85 24.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.745 -0.661 . . . . 74.5 109.532 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.71 129.57 9.35 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.375 -1.393 . . . . 71.14 111.365 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . . . -124.7 118.72 27.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.651 0.263 . . . . 65.03 110.704 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.049 ' HG ' ' HG ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -117.08 144.76 44.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.332 -0.394 . . . . 55.45 110.624 175.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.628 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 45.4 t -128.5 115.43 37.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.52 -1.289 . . . . 74.32 107.52 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -120.93 137.27 54.69 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.547 -1.206 . . . . 74.14 110.117 -169.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.54 135.7 13.06 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 120.604 -0.808 . . . . 50.12 113.2 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -143.8 125.36 14.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.011 0.434 . . . . 73.31 111.4 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 59.22 23.35 11.68 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.987 0.736 . . . . 64.22 112.987 168.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.69 -18.18 51.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.378 -0.915 . . . . 63.41 113.062 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -105.17 146.65 28.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.891 -0.411 . . . . 72.11 109.891 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.541 HD22 HG12 ' A' ' 143' ' ' VAL . 5.0 mt -108.9 148.39 30.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 72.11 110.637 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 144' ' ' LEU . . . -141.85 124.26 15.72 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.73 -1.211 . . . . 54.44 107.73 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -156.05 131.82 3.15 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.58 -0.819 . . . . 74.23 111.965 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.983 ' CB ' ' HA ' ' A' ' 169' ' ' PHE 0.423 0.1 OUTLIER -165.06 171.76 13.48 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 116.209 1.929 . . . . 74.11 116.209 167.326 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 26.4 pt20 -106.85 134.37 50.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.416 -1.72 . . . . 64.35 111.498 -166.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.8 ttp -110.84 141.53 44.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 51.34 109.576 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.53 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 43.4 m-80 -114.51 117.92 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.024 -0.27 . . . . 71.02 110.351 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.851 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 74.1 t80 -102.08 122.27 43.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.684 -0.689 . . . . 74.12 110.759 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 163' ' ' ARG . 32.4 tt0 -88.78 99.93 12.75 Favored 'General case' 0 C--O 1.259 1.574 0 CA-C-N 115.567 -0.742 . . . . 64.45 109.044 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.46 HG23 ' HE1' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -70.29 -19.98 63.06 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 113.446 -1.706 . . . . 71.12 111.664 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.18 -26.65 64.99 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.047 0.927 . . . . 62.13 108.732 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -122.39 -157.5 0.74 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.136 -1.393 . . . . 70.43 107.839 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -107.64 27.76 8.84 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.32 -0.622 . . . . 52.53 109.32 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -133.64 129.36 36.77 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.64 -0.824 . . . . 62.51 112.857 -159.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.851 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.8 m -73.54 136.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 168.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 2.0 m -90.01 -34.53 15.94 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.518 -0.473 . . . . 63.54 110.371 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -149.89 133.29 16.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 73.33 110.017 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.7 m -103.14 111.76 24.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.557 -0.905 . . . . 62.5 108.557 172.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.932 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 46.5 m-20 -106.4 121.67 44.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.863 -0.791 . . . . 73.22 108.863 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.983 ' HA ' ' CB ' ' A' ' 153' ' ' TYR . 51.4 p90 -131.17 138.94 49.65 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.057 0.848 . . . . 74.12 111.31 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.779 ' H ' ' HB2' ' A' ' 153' ' ' TYR . . . -130.25 145.84 51.8 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 120.883 0.373 . . . . 71.41 110.547 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 151' ' ' ALA . 48.8 t -127.56 131.28 70.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.276 -0.42 . . . . 75.14 110.635 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.3 95.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.655 -0.978 . . . . 72.3 110.655 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -110.92 119.62 39.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.853 -0.795 . . . . 72.25 108.853 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 34.0 mtmm -114.84 127.92 56.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.331 -0.395 . . . . 73.13 111.46 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 56.7 m -132.09 113.44 13.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.137 -0.483 . . . . 75.01 110.347 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 40.4 -93.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.266 1.21 . . . . 75.51 114.266 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.1 -11.85 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.672 0.619 . . . . 74.3 112.672 -170.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 175' ' ' THR . 48.4 p90 -129.97 135.94 48.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.622 0.725 . . . . 74.5 111.615 -178.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.405 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 75.8 mt-30 -114.46 123.18 48.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.231 -0.895 . . . . 63.42 108.924 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.24 137.55 33.28 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.281 0.562 . . . . 64.02 111.081 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -123.8 115.67 21.73 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.052 -0.976 . . . . 74.13 108.689 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 43.8 m -124.54 115.46 20.9 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.658 -0.417 . . . . 74.25 110.086 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.43 140.62 50.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.371 0.605 . . . . 71.44 109.852 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 6.4 t -126.31 130.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.521 -0.763 . . . . 73.14 110.757 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.852 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 11.9 m-20 -105.51 93.69 4.8 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.383 -0.969 . . . . 70.43 108.383 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.0 t70 61.47 -179.53 0.12 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.633 -0.506 . . . . 74.41 109.633 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.48 -6.35 61.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.795 -0.717 . . . . 50.32 112.174 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.8 p -96.4 -26.17 15.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.055 0.761 . . . . 65.23 113.055 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.852 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 24.8 mt-10 -118.45 124.99 48.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 119.697 -0.801 . . . . 63.03 112.23 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.8 125.52 53.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.398 -0.819 . . . . 75.52 109.745 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.18 113.52 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.899 -0.667 . . . . 73.32 112.089 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.99 139.28 15.02 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.934 -0.65 . . . . 64.44 111.883 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 14.5 m -140.52 138.39 34.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.914 0.388 . . . . 62.41 110.03 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.3 mp -124.56 128.33 73.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.666 -0.494 . . . . 62.52 109.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 42.9 t80 -106.67 119.75 40.14 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.622 -0.881 . . . . 75.3 108.622 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -122.51 131.1 53.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.414 -0.587 . . . . 74.54 109.414 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 197' ' ' LYS . 24.9 ttpp -103.29 109.05 20.52 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.786 -0.643 . . . . 73.34 109.678 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.541 HG23 ' HG ' ' A' ' 202' ' ' LEU . 0.0 OUTLIER -93.2 -17.36 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-O 121.555 0.693 . . . . 75.02 109.82 -176.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 14.2 t-20 -163.86 158.17 19.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.917 -1.038 . . . . 72.13 108.324 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -63.67 -13.24 41.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.014 0.435 . . . . 50.13 111.071 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 226' ' ' GLN . 19.0 tttp -116.05 3.98 13.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.001 -0.545 . . . . 54.41 110.642 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.541 ' HG ' HG23 ' A' ' 198' ' ' VAL . 47.8 tp -140.29 108.98 5.92 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.766 0.793 . . . . 62.22 111.307 -175.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.554 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 24.7 mt-10 -115.32 137.84 51.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.953 -1.021 . . . . 63.31 110.192 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 p -123.68 151.17 43.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.122 -0.325 . . . . 71.41 110.122 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -140.11 139.03 35.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.015 0.436 . . . . 73.14 111.306 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 193' ' ' SER . 53.3 t -112.11 137.43 44.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.313 -0.625 . . . . 51.01 109.313 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -132.84 128.34 36.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.263 -0.643 . . . . 65.23 109.263 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 218' ' ' ARG . 2.6 pt? -147.89 130.61 16.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.412 0.625 . . . . 74.44 111.082 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.2 132.87 55.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.33 -0.85 . . . . 75.2 110.363 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.779 ' HB2' HG23 ' A' ' 217' ' ' THR . 19.3 t90 -130.7 131.7 44.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.569 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 11.9 m -104.7 113.49 27.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.763 -0.653 . . . . 65.54 109.649 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.81 127.54 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.903 -0.406 . . . . 42.33 109.903 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 87.93 17.65 57.54 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 31.31 111.537 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 12.0 t-20 -129.93 -153.86 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.772 -0.825 . . . . 64.43 108.772 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 214' ' ' ASN . 17.2 m -85.95 -154.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.066 0.46 . . . . 71.44 111.747 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.72 163.47 7.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.497 -0.774 . . . . 72.1 112.553 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.779 HG23 ' HB2' ' A' ' 210' ' ' TRP . 32.7 m -76.39 134.55 39.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.605 -0.725 . . . . 63.0 109.18 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 69.3 mtt85 -101.05 116.12 32.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.723 -0.473 . . . . 71.44 109.723 -173.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.489 ' HD2' HD13 ' A' ' 208' ' ' LEU . 65.8 t80 -113.5 149.67 34.01 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.608 0.568 . . . . 74.04 110.493 -172.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -158.93 150.6 21.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.211 -0.519 . . . . 23.04 112.2 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.4 130.53 72.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.902 -0.407 . . . . 71.14 109.902 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . . . -119.5 154.52 33.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.811 0.339 . . . . 54.23 110.303 176.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -140.67 125.71 18.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.174 -0.467 . . . . 42.1 110.23 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -112.38 114.06 26.58 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.62 -0.511 . . . . 73.55 109.62 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.45 ' HD2' HD13 ' A' ' 202' ' ' LEU . 74.8 t80 -113.73 116.29 29.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.448 -0.575 . . . . 74.12 109.448 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 3.6 pt20 -95.94 99.58 11.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.716 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.4 tt -69.44 -24.92 28.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.527 0.68 . . . . 60.44 109.521 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 230' ' ' ASP . 18.9 t70 -166.6 146.31 4.93 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.199 -1.037 . . . . 75.01 108.199 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 228' ' ' ASP . 27.8 Cg_exo -64.1 12.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.793 2.329 . . . . 73.4 113.399 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 228' ' ' ASP . 23.3 t70 -104.92 -29.34 10.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.44 110.067 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.33 125.86 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 73.13 110.831 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 56.1 m -124.04 142.23 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.129 0.49 . . . . 73.43 110.755 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -108.86 127.33 53.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.213 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 5.5 p -129.39 117.21 20.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 53.42 110.965 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.43 158.67 23.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.111 -0.329 . . . . 75.12 110.111 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 26.2 pttm -152.94 141.86 21.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.019 0.438 . . . . 70.33 110.849 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 8.8 p -128.66 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 71.41 109.814 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 18.8 m120 -107.91 150.56 26.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.752 -0.462 . . . . 73.02 109.752 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.73 -8.79 16.13 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.672 0.607 . . . . 75.34 111.534 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.468 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 13.3 m -80.82 14.67 2.07 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.824 -0.436 . . . . 75.54 109.824 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 17.4 m 68.31 36.83 2.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.256 -0.883 . . . . 62.23 110.702 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 262' ' ' LEU . 40.5 mt -99.29 115.61 29.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 63.43 109.697 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.645 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -112.29 116.7 53.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.65 -0.42 . . . . 63.33 110.503 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -135.61 152.21 20.87 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.123 -1.036 . . . . 74.21 113.526 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -127.96 156.12 43.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 71.33 110.737 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -143.42 143.59 12.59 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.993 -0.622 . . . . 74.32 112.157 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 258' ' ' THR . 63.8 m-85 -114.47 115.6 27.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.784 -0.451 . . . . 72.44 109.784 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 17.9 m -109.91 114.38 27.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.504 -0.554 . . . . 75.01 109.504 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -135.53 143.18 45.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.757 0.313 . . . . 62.22 110.801 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.8 t -107.54 116.18 31.49 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.051 -0.722 . . . . 60.44 109.051 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.512 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 3.8 mm? -70.34 173.57 6.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.861 -0.609 . . . . 63.23 110.518 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.614 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 20.8 mtpp -67.63 -44.97 45.56 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.25 -0.432 . . . . 75.3 110.852 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 16.8 Cg_exo -70.37 -174.49 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.887 1.725 . . . . 40.45 111.025 165.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -81.35 69.6 3.25 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.701 -0.762 . . . . 53.22 112.393 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.493 HG12 ' CD2' ' A' ' 281' ' ' PHE . 37.6 mt -136.81 124.78 33.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 122.652 -0.322 . . . . 54.41 111.02 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 280' ' ' GLU . 51.3 mttp -109.99 113.37 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.273 -0.64 . . . . 41.12 109.273 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.91 130.57 46.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.264 -0.426 . . . . 71.15 110.665 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 25.3 m -125.17 111.43 15.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 74.2 110.147 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.92 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -105.03 125.39 50.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.022 -1.103 . . . . 62.44 108.022 176.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 53.2 m -134.17 140.8 46.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.972 0.415 . . . . 70.55 111.406 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.67 128.01 19.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.92 -0.582 . . . . 61.3 109.648 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 242' ' ' LEU . 3.0 tm? -110.03 113.35 25.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.932 -0.766 . . . . 63.55 108.932 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.592 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.089 -1.078 . . . . 65.33 108.089 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.563 ' HA ' HD22 ' A' ' 242' ' ' LEU . 10.7 t70 -72.49 103.61 3.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.242 -0.89 . . . . 75.11 108.937 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.6 38.24 Favored Glycine 0 N--CA 1.458 0.118 0 O-C-N 123.395 0.434 . . . . 64.22 113.617 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -91.03 -26.99 18.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.568 0.223 . . . . 72.11 111.304 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.442 ' ND2' ' HA3' ' A' ' 272' ' ' GLY . 64.1 t30 -115.19 -22.83 9.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.813 0.671 . . . . 72.21 112.813 -171.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.531 ' HA ' ' H ' ' A' ' 272' ' ' GLY . 29.4 m -62.17 -18.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.977 -0.452 . . . . 63.51 111.499 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.46 -39.73 80.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.123 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.51 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 41.3 110.862 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.57 89.29 1.69 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.826 -0.702 . . . . 41.14 111.673 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.531 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -157.92 38.83 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.812 -0.708 . . . . 52.21 112.137 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -80.05 145.7 32.33 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.221 -0.288 . . . . 74.3 110.221 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.723 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 14.3 mptt -96.72 138.07 34.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.173 -0.677 . . . . 74.22 109.173 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.453 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 tm? -125.93 131.14 52.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.961 -0.385 . . . . 54.44 109.961 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.437 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -137.08 125.21 3.31 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.473 -0.87 . . . . 40.3 112.092 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.92 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -114.96 138.1 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.771 -0.825 . . . . 73.42 108.771 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -158.18 122.21 1.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.349 -0.929 . . . . 74.45 111.13 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.477 HD13 HD11 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -144.91 138.87 27.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.015 0.436 . . . . 72.32 112.04 -175.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.558 ' CG ' ' HB2' ' A' ' 256' ' ' LYS . 6.8 pt-20 -110.71 120.66 43.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 62.35 110.502 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.909 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.7 t80 -98.78 118.7 36.1 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.991 -0.744 . . . . 75.33 108.991 175.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 4.1 pt20 -111.65 111.67 22.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.456 0.646 . . . . 71.42 110.447 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.65 111.59 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 73.11 109.592 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.99 135.91 53.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.942 -0.572 . . . . 63.41 109.771 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.106 -0.473 . . . . 61.32 110.757 -179.659 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 25.1 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.346 -0.242 . . . . 71.43 110.346 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -49.49 130.67 20.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.072 0.463 . . . . 44.53 111.917 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 15.9 t -68.16 125.63 91.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.222 -0.899 . . . . 73.41 111.369 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 28.3 Cg_exo -63.65 165.01 19.27 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.383 2.722 . . . . 65.42 112.565 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.84 71.33 4.15 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.204 2.603 . . . . 71.4 112.407 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.803 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.4 p -70.36 -48.84 54.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 74.41 111.606 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' HB2' HG21 ' A' ' 143' ' ' VAL . 70.9 t80 -60.84 -26.08 67.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.901 -0.59 . . . . 54.53 110.866 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . -82.08 -10.76 59.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 54.43 111.351 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.31 -22.3 19.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.01 0.433 . . . . 74.12 111.136 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.99 -35.34 71.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.716 0.636 . . . . 72.32 112.716 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.53 15.65 8.56 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 119.917 -1.135 . . . . 53.21 114.114 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 8' ' ' ALA . 33.5 mmtm -63.98 -54.77 29.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.347 0.574 . . . . 74.24 111.713 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -63.36 -38.72 92.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 65.34 110.949 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.5 -51.13 68.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 65.04 111.825 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -69.05 -35.72 76.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 64.0 111.297 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.11 -45.26 81.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.161 -0.472 . . . . 70.24 110.905 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.36 -25.34 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.185 -0.461 . . . . 44.23 110.991 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -59.87 -39.82 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 74.43 110.806 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -89.34 36.16 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.295 0.569 . . . . 51.44 110.282 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.9 pttt -52.47 114.48 1.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.27 -0.877 . . . . 74.02 111.84 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.74 96.97 1.45 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.651 -0.704 . . . . 72.42 112.362 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -133.0 -166.49 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.475 -0.565 . . . . 72.42 109.475 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.13 89.08 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.701 -0.761 . . . . 62.42 111.731 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -100.26 -3.77 30.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.492 . . . . 74.03 110.076 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.01 11.59 61.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.977 -0.63 . . . . 71.22 113.07 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.739 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 3.5 pp -147.8 179.76 7.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 113.459 0.911 . . . . 61.24 113.459 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 277' ' ' LEU . 28.7 mm -100.91 122.93 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.876 -1.511 . . . . 63.44 109.061 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 23.4 ttmm -120.76 121.25 37.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 72.13 110.517 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.6 tt -113.59 142.05 46.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.563 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -135.46 128.37 31.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.381 -0.827 . . . . 52.32 109.466 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 18.3 tp -122.07 123.73 42.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 74.1 110.551 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 63.9 mttp -108.14 125.07 51.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.69 . . . . 55.53 109.406 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.772 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 39.4 m -128.45 121.82 29.87 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.589 0.233 . . . . 71.33 110.988 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 53.2 mtmt -137.39 123.74 20.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.892 0.377 . . . . 70.04 110.531 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.603 ' H ' HD11 ' A' ' 39' ' ' LEU . 50.4 m -143.09 155.8 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 55.05 109.855 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 49.53 -131.28 1.86 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.593 0.558 . . . . 73.13 111.589 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.23 134.91 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.519 0.676 . . . . 63.4 111.493 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 93.15 -11.46 71.84 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.044 -0.98 . . . . 70.4 114.449 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.603 HD11 ' H ' ' A' ' 35' ' ' SER . 3.4 pp -103.96 133.86 48.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 118.646 1.223 . . . . 63.32 111.985 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.921 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 39.8 tt0 -138.5 128.71 25.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.609 -0.886 . . . . 71.12 108.609 161.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.772 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 84.1 m-85 -118.28 121.73 41.16 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.877 -0.515 . . . . 45.5 110.828 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.957 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 21.2 m -117.11 115.81 26.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 71.42 109.814 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 27.5 t -112.65 123.67 50.82 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.358 . . . . 71.44 110.035 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 51.1 m -119.43 125.95 50.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.119 0.485 . . . . 72.31 110.312 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.5 117.48 2.26 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.613 -0.803 . . . . 75.34 111.475 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.6 m -112.67 133.94 54.45 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.733 -0.387 . . . . 44.34 109.983 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -135.55 126.66 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.44 -0.578 . . . . 72.31 109.44 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.739 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 7.4 t-20 -78.28 134.89 37.46 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.396 -173.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -96.36 -19.31 19.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.092 0.472 . . . . 61.21 110.97 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.91 -53.79 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.283 0.563 . . . . 51.41 109.751 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.563 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 35.1 m -122.2 105.6 10.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.226 -0.657 . . . . 53.44 109.226 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -52.6 102.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.937 0.718 . . . . 62.21 112.937 -172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -154.76 135.67 13.73 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.025 -1.102 . . . . 72.41 108.025 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.26 132.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.01 0.434 . . . . 54.25 111.222 -174.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -123.97 126.15 45.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 75.24 110.096 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.25 135.24 12.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.843 -0.694 . . . . 60.41 112.565 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 16.9 m -125.65 125.92 43.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.623 -0.88 . . . . 64.12 108.623 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.96 124.51 45.08 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.685 -0.487 . . . . 51.05 109.685 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.957 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 41.7 tt0 -106.77 117.87 35.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.155 0.502 . . . . 71.02 109.77 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 15.6 m -93.27 119.31 32.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.043 -1.095 . . . . 75.11 108.043 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.921 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.8 tptm -122.85 138.01 54.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.142 0.496 . . . . 74.22 109.763 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.763 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 86.5 m-85 -116.69 120.76 39.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.864 -0.791 . . . . 75.31 108.864 172.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.49 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.0 ptm85 -115.73 105.86 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.124 -0.63 . . . . 53.21 110.586 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.875 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 76.0 t90 -112.43 106.06 14.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 64.2 110.088 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 m 66.46 153.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.58 1.175 . . . . 75.43 111.273 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -64.04 102.82 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.27 -0.423 . . . . 75.13 109.927 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 t80 63.73 81.47 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 72.41 110.875 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.47 -75.09 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.369 -1.092 . . . . 44.21 110.369 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 2.0 mm? -113.09 131.42 55.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.854 0.359 . . . . 71.21 110.794 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' HB ' ' A' ' 86' ' ' THR . 6.3 p -135.19 112.66 10.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.716 . . . . 62.11 110.337 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.763 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 21.7 t80 -109.68 121.34 44.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.503 -0.554 . . . . 75.4 109.503 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 m -116.69 127.71 54.66 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.2 0.313 . . . . 74.32 110.753 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 28.1 tt0 -130.66 121.29 25.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.511 -0.551 . . . . 65.34 109.511 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -111.22 97.83 7.06 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.037 -0.727 . . . . 73.05 109.037 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.93 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 41.5 t90 -108.8 129.71 55.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.176 -0.466 . . . . 63.33 111.466 -174.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -105.95 139.28 40.74 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.981 -0.748 . . . . 72.05 108.981 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -60.05 -36.67 77.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.639 0.607 . . . . 43.11 112.639 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -111.07 -23.82 10.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.066 0.395 . . . . 64.11 112.066 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.573 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 2.5 t-20 -104.0 -106.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.265 -0.574 . . . . 75.04 112.427 -169.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 p -116.43 144.64 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.765 0.654 . . . . 75.55 112.765 -170.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.93 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.5 OUTLIER -111.69 123.28 49.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.718 -0.475 . . . . 65.02 109.718 166.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.41 121.99 5.23 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.597 -0.729 . . . . 40.32 111.487 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 101' ' ' SER . 23.2 m -109.11 142.91 39.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.828 0.346 . . . . 62.32 111.059 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.54 113.73 7.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.808 -0.633 . . . . 54.01 109.406 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -112.27 136.41 48.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.801 -0.444 . . . . 71.44 109.801 179.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.403 ' HB ' ' OG1' ' A' ' 70' ' ' THR . 89.8 m -128.54 124.03 34.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 61.05 110.292 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 2.7 p -125.83 120.54 57.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.38 0.61 . . . . 61.4 111.051 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.26 118.54 35.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.157 -1.423 . . . . 65.2 107.157 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 11.6 t70 -55.91 133.35 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.515 -0.474 . . . . 73.23 110.681 -173.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.499 ' HG3' ' HG ' ' A' ' 91' ' ' LEU . 19.7 pt20 -68.95 -25.35 64.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 64.33 111.75 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 90' ' ' GLN . 85.6 mt -108.83 -52.2 2.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.128 0.49 . . . . 53.02 109.908 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.95 71.13 10.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 51.12 110.235 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 89' ' ' ASP . 36.3 mmt180 -59.72 135.14 57.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 73.32 109.899 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA2' ' HG3' ' A' ' 119' ' ' LYS . . . 102.49 7.18 46.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.633 -0.794 . . . . 74.43 111.492 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.48 114.75 22.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.629 -0.878 . . . . 75.23 108.629 173.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -122.49 111.8 17.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.934 -0.575 . . . . 61.52 110.705 -174.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.513 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.8 mm? -97.55 130.85 44.57 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.819 -0.808 . . . . 70.44 108.819 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -130.46 133.7 46.51 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.32 -0.4 . . . . 54.52 110.986 -177.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.56 ' H ' HG13 ' A' ' 85' ' ' ILE . 76.8 t80 -124.52 129.62 50.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.396 -0.366 . . . . 73.31 110.232 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 113' ' ' LYS . 6.3 m-20 -115.83 133.81 55.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.132 -0.485 . . . . 72.42 109.891 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.705 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 30.1 t -130.21 137.29 49.99 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.949 -0.389 . . . . 72.32 109.949 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -135.06 121.63 20.65 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.976 -0.379 . . . . 73.22 109.976 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' HD1' HD21 ' A' ' 81' ' ' LEU . 75.4 t80 -134.52 137.14 43.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 61.11 110.608 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 5.1 m -114.29 103.74 54.93 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.944 -0.571 . . . . 75.31 110.017 176.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 32.8 Cg_endo -65.46 152.14 82.82 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.533 2.155 . . . . 73.45 111.477 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.61 25.34 14.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.666 0.746 . . . . 73.13 109.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 m -140.3 -55.12 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.757 -0.656 . . . . 74.51 110.341 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.9 4.1 57.9 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 61.53 112.714 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -87.91 122.75 31.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.311 -0.625 . . . . 71.42 109.311 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 21.6 ptmt -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.101 0.477 . . . . 75.25 110.714 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -121.6 122.64 40.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.427 -0.806 . . . . 75.41 109.559 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.85 114.77 29.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.052 -0.522 . . . . 73.33 109.621 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.87 ' HG3' ' HB3' ' A' ' 130' ' ' ASP . 28.1 ttmt -118.38 135.4 54.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.234 0.54 . . . . 52.11 110.665 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.853 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 4.2 tp -129.99 132.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 107.739 -1.208 . . . . 73.44 107.739 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 16.6 ttpt -132.28 119.16 20.4 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 124.987 1.43 . . . . 64.4 110.662 -169.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.912 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 69.9 m -116.99 120.02 37.09 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 119.313 0.96 . . . . 60.25 111.251 -175.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.791 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -131.5 138.93 10.53 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.647 -1.263 . . . . 73.54 113.172 -174.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -115.27 130.65 56.97 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.435 -0.95 . . . . 75.14 108.435 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -110.58 122.29 47.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.616 0.722 . . . . 75.14 111.039 -175.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -105.65 153.17 22.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.358 -1.292 . . . . 64.54 107.825 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.44 -29.97 51.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.239 0.459 . . . . 74.04 112.239 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -108.95 -17.1 14.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.509 -0.314 . . . . 64.53 111.394 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -144.87 124.66 6.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 112.043 0.386 . . . . 74.54 112.043 -170.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.943 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.8 OUTLIER -112.79 116.66 30.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.197 -0.314 . . . . 74.44 110.523 176.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 142' ' ' LEU . 3.0 mm? -119.48 124.45 46.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.54 0.21 . . . . 73.4 111.04 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.791 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -136.57 114.16 1.13 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.943 -1.123 . . . . 51.44 113.029 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.1 t -116.97 122.98 45.81 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.941 -0.392 . . . . 50.34 109.941 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.912 ' HB2' ' H ' ' A' ' 116' ' ' THR 0.319 0.9 OUTLIER -154.15 169.91 22.47 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.659 -1.276 . . . . 75.22 112.924 159.588 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.0 mtt -101.79 140.09 36.54 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.781 0.324 . . . . 73.41 111.115 -162.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.87 ' HB3' ' HG3' ' A' ' 113' ' ' LYS . 9.9 p-10 -119.54 125.8 49.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 74.12 111.022 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.23 96.55 9.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.606 -0.516 . . . . 73.24 109.606 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.529 ' OD2' HG13 ' A' ' 133' ' ' ILE . 7.8 t70 -99.73 -165.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.789 -0.819 . . . . 73.44 108.789 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.529 HG13 ' OD2' ' A' ' 132' ' ' ASP . 2.9 pp -72.94 -13.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 70.32 110.421 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.62 4.69 52.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 73.53 110.569 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.47 -155.13 20.86 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.05 -0.595 . . . . 74.44 111.925 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.57 96.55 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.023 2.482 . . . . 51.41 112.094 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.438 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 16.0 m -92.96 162.89 13.88 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.992 -0.549 . . . . 55.45 109.636 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 36.2 mm -107.99 117.48 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.931 -0.396 . . . . 72.03 109.931 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.7 tpt180 -106.0 111.34 23.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.34 0.59 . . . . 75.22 110.338 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.16 10.09 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.987 -1.101 . . . . 75.22 111.524 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.25 116.84 23.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.974 0.416 . . . . 51.04 110.402 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -117.18 125.36 51.08 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.577 . . . . 75.24 110.637 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.943 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 77.4 t -117.45 133.89 62.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.11 0.481 . . . . 63.32 110.277 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -108.42 138.38 44.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.791 -0.818 . . . . 64.23 108.791 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.08 118.24 2.37 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.51 -0.852 . . . . 25.33 113.146 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 75.9 t80 -145.0 148.99 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.066 -0.346 . . . . 75.24 110.066 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -45.01 105.52 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.986 0.422 . . . . 74.32 111.866 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.13 -31.38 6.02 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.81 -0.632 . . . . 71.12 112.726 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 72.3 m95 -104.84 120.93 42.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 74.44 111.118 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.803 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -124.58 136.91 54.35 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.628 -1.249 . . . . 72.14 107.628 173.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HB3' HD23 ' A' ' 144' ' ' LEU . . . -143.1 160.79 39.74 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.628 -0.429 . . . . 72.05 110.877 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.58 137.2 5.46 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.833 -0.621 . . . . 60.53 111.566 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -143.83 118.35 9.73 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 122.539 -0.389 . . . . 75.31 110.229 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.801 ' HG3' ' HB2' ' A' ' 168' ' ' ASN . 12.2 pt20 -119.13 125.89 50.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.454 0.645 . . . . 75.44 111.02 176.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 81.7 mtp -118.3 142.68 47.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.822 -0.626 . . . . 52.23 109.998 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 50.8 t-20 -113.38 118.46 34.61 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.996 -0.742 . . . . 72.04 108.996 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.757 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.6 m-85 -94.4 120.39 34.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.665 -0.698 . . . . 74.2 111.029 -175.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 57.7 tt0 -87.34 103.2 15.25 Favored 'General case' 0 C--O 1.26 1.639 0 CA-C-O 121.469 0.652 . . . . 74.04 109.284 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 t -70.24 -14.51 62.64 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 113.127 -1.851 . . . . 71.32 111.904 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.8 68.23 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 121.559 0.695 . . . . 74.43 109.157 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.63 -147.68 0.4 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.532 -1.285 . . . . 75.23 107.532 162.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.7 m -107.94 28.18 8.49 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.46 -0.775 . . . . 60.34 111.155 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 163' ' ' ARG . 1.1 ptm180 -132.39 145.49 51.27 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 118.419 -1.313 . . . . 70.54 111.562 -163.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.64 134.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.092 0.473 . . . . 64.13 109.804 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 7.5 t -95.44 -9.79 31.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.126 -0.488 . . . . 75.12 111.016 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 39.3 mm-40 -149.94 132.25 15.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.869 0.366 . . . . 73.1 110.841 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.8 m -121.9 105.79 10.66 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.743 -0.662 . . . . 70.24 109.507 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.801 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 13.9 m120 -110.33 123.91 50.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.065 0.46 . . . . 54.34 109.844 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.78 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 45.9 t80 -120.4 149.99 41.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.224 -0.443 . . . . 72.44 109.867 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -144.33 142.31 30.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.069 0.461 . . . . 72.43 110.858 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 22.0 t -131.12 136.9 56.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.157 -0.474 . . . . 74.2 110.193 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.04 96.1 0.33 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.007 -0.837 . . . . 63.1 111.007 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -109.67 121.68 45.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.399 -0.593 . . . . 63.32 109.399 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.41 127.64 48.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.486 -0.779 . . . . 73.21 110.547 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 42.0 m -131.73 111.49 11.7 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.292 -0.632 . . . . 74.34 109.292 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.58 -87.42 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.379 1.049 . . . . 74.12 113.678 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.87 3.48 22.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.252 0.549 . . . . 52.33 111.416 -172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -112.86 126.57 55.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 73.43 110.134 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 55.0 mm-40 -121.16 123.68 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.173 -0.306 . . . . 64.4 110.173 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.9 tp -118.66 134.85 54.81 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.15 -0.344 . . . . 74.22 111.035 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -130.6 117.3 19.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 60.4 110.414 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 19.9 m -112.47 143.52 43.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.962 -0.385 . . . . 63.0 109.962 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -141.52 139.95 33.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 74.1 110.383 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.78 ' HB ' ' HB3' ' A' ' 169' ' ' PHE . 56.0 t -126.36 131.27 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.163 -0.471 . . . . 62.34 111.606 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 9.1 t30 -110.94 96.01 5.9 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.35 -0.841 . . . . 71.24 109.565 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.7 t70 62.09 -166.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.9 -1.046 . . . . 74.03 110.345 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.62 -6.67 89.21 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.05 -0.595 . . . . 64.41 111.839 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.7 p -94.13 -27.23 16.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.981 0.734 . . . . 73.03 112.981 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 38.8 mt-10 -134.48 125.04 26.59 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.934 -0.706 . . . . 71.12 111.201 -175.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.735 ' HB2' HG22 ' A' ' 184' ' ' VAL . 25.9 p90 -133.87 133.1 41.12 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.188 -0.605 . . . . 71.34 109.443 171.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -135.79 159.21 24.15 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.566 -0.826 . . . . 45.13 112.522 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -136.63 164.76 25.15 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.424 -0.67 . . . . 73.11 111.424 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 26.9 t -143.56 136.91 28.02 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.0 -0.741 . . . . 72.33 109.0 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 3.4 mp -120.31 117.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 75.55 109.743 -177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.751 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 84.2 t80 -108.04 120.76 43.25 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.513 0.673 . . . . 71.12 110.428 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -115.61 111.91 21.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.925 -1.034 . . . . 74.03 108.992 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 195' ' ' TYR . 84.1 tttt -103.93 107.19 17.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.141 -0.482 . . . . 70.13 109.973 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.47 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.183 -0.673 . . . . 72.45 109.183 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 199' ' ' ASN . 2.0 t-20 -76.24 10.08 2.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.301 0.572 . . . . 64.01 110.879 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -109.3 -10.37 14.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.776 -0.647 . . . . 71.25 109.361 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.435 ' HG3' HD22 ' A' ' 202' ' ' LEU . 15.6 tppt? -134.93 -68.55 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 74.2 110.528 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 201' ' ' LYS . 2.0 pt? -167.99 165.94 13.42 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.92 0.39 . . . . 72.32 110.484 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.435 ' HG3' ' HG3' ' A' ' 197' ' ' LYS . 23.6 mp0 -109.75 128.2 55.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.797 -0.816 . . . . 72.23 108.797 173.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 t -138.57 155.02 48.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.064 0.459 . . . . 72.32 111.377 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.85 148.05 36.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.723 -0.671 . . . . 75.3 110.61 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 193' ' ' SER . 55.7 t -110.86 138.23 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.033 -0.53 . . . . 55.33 109.617 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -113.9 127.8 56.13 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.284 -1.006 . . . . 60.13 108.284 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 219' ' ' PHE . 7.3 tp -144.56 140.88 29.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.558 -0.292 . . . . 64.32 110.3 -168.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.584 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -157.23 142.34 17.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.825 0.345 . . . . 65.24 111.223 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.507 ' HE3' ' HZ ' ' A' ' 190' ' ' PHE . 16.6 t90 -130.83 135.3 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.125 0.488 . . . . 74.31 110.071 173.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 53.2 m -94.47 105.31 17.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.43 -0.805 . . . . 65.23 109.971 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -58.25 136.76 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 70.53 111.127 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 122.24 -87.72 0.4 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.164 -0.774 . . . . 73.22 111.164 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -149.12 104.3 3.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.024 0.44 . . . . 73.2 110.484 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.9 t -176.4 149.0 0.79 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.08 159.34 29.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.226 -0.657 . . . . 75.02 109.226 173.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 8.8 t -77.58 123.24 26.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.076 -0.713 . . . . 75.43 109.076 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.442 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 1.1 tpp180 -94.18 115.06 27.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.589 -0.732 . . . . 75.33 109.262 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.746 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 52.1 p90 -120.42 160.33 23.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 61.22 111.49 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.39 157.49 28.86 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.298 -0.864 . . . . 50.13 111.355 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.651 ' HB ' HG12 ' A' ' 237' ' ' VAL . 55.9 mt -132.25 135.15 58.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.964 0.382 . . . . 74.32 110.298 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -128.47 129.84 46.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.918 -0.401 . . . . 52.42 109.918 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -128.24 133.05 48.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.747 0.308 . . . . 61.14 111.061 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.3 114.53 26.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.62 . . . . 75.31 109.629 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -128.9 119.36 24.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 72.21 110.726 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -76.59 124.61 27.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.71 -0.478 . . . . 75.41 109.71 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 63.4 mt -70.48 -55.79 13.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.388 -0.369 . . . . 72.52 110.306 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.849 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 34.0 t70 -172.45 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.019 -0.537 . . . . 54.52 111.771 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 56.7 Cg_endo -95.05 -101.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.372 2.048 . . . . 70.21 113.524 -172.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.93 3.92 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 51.32 111.227 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -123.07 131.98 53.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.238 0.542 . . . . 75.35 111.748 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.58 142.16 50.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 60.4 109.264 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -104.31 131.41 51.68 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.837 -0.431 . . . . 73.2 109.837 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 57.8 p -116.6 120.96 40.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.051 0.453 . . . . 74.44 110.087 176.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.21 139.88 42.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.218 -0.66 . . . . 71.32 109.218 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 44.4 mttp -144.22 141.57 29.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.664 -0.495 . . . . 71.32 109.664 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.651 HG12 ' HB ' ' A' ' 221' ' ' ILE . 4.4 p -137.24 158.65 35.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.357 -0.609 . . . . 73.23 109.357 174.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 14.3 t30 -135.5 150.57 49.81 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.196 -0.457 . . . . 72.35 110.087 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.746 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 5.8 p30 -46.44 -32.51 3.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.957 1.095 . . . . 72.33 113.957 -173.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.536 ' HB2' ' HG ' ' A' ' 242' ' ' LEU . 5.6 m -78.92 23.37 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.596 0.236 . . . . 55.15 111.097 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.4 m 64.53 36.27 8.76 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 121.371 0.605 . . . . 61.52 109.849 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 1.052 ' HB3' HD11 ' A' ' 262' ' ' LEU . 22.9 mt -98.04 116.71 30.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.729 -0.669 . . . . 63.12 110.075 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 243' ' ' ILE . 2.1 mp -106.69 116.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 62.22 110.007 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -121.12 133.47 9.64 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.576 -0.821 . . . . 75.21 112.685 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.467 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -119.37 154.25 33.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.376 -0.231 . . . . 71.43 110.376 178.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -149.24 134.32 4.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.444 -0.884 . . . . 64.32 112.675 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 258' ' ' THR . 59.1 m-85 -103.59 116.99 33.39 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.564 -0.532 . . . . 75.1 109.564 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.934 HG23 ' HB ' ' A' ' 258' ' ' THR . 3.2 m -117.36 115.25 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.121 -0.49 . . . . 74.42 110.31 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.99 150.73 44.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 73.24 111.83 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 19.6 m -83.37 128.41 34.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.864 -0.607 . . . . 61.33 110.155 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.803 HD23 HG12 ' A' ' 255' ' ' ILE . 3.3 mm? -73.73 -82.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.133 0.42 . . . . 64.23 112.133 -173.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 1.027 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 35.3 tttp -140.97 -62.67 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.948 -0.389 . . . . 74.35 109.948 -175.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 1.027 ' HD3' ' HB3' ' A' ' 252' ' ' LYS . 3.6 Cg_exo -79.45 -161.52 0.15 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.858 1.705 . . . . 71.14 110.861 166.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -80.82 62.21 4.43 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.663 -0.78 . . . . 73.53 113.162 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.803 HG12 HD23 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -136.49 142.26 38.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.084 0.468 . . . . 74.41 109.762 173.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.545 ' HG2' HG22 ' A' ' 248' ' ' THR . 36.0 ttpt -121.96 127.28 50.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.761 -0.654 . . . . 64.54 110.261 -176.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.609 ' HB2' HD21 ' A' ' 251' ' ' LEU . 28.6 tp -100.55 132.69 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 73.24 110.106 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.934 ' HB ' HG23 ' A' ' 248' ' ' THR . 7.7 t -129.52 112.48 13.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.615 0.722 . . . . 75.42 111.01 176.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.973 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -98.1 123.61 42.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.131 -1.063 . . . . 71.21 108.131 176.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 21.8 p -131.6 148.73 52.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.193 0.52 . . . . 62.34 111.454 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.436 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -140.89 133.15 28.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.732 -0.667 . . . . 65.31 109.907 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.052 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.2 tm? -102.88 121.28 42.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.674 -0.694 . . . . 70.5 109.133 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.596 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.4 mm? -104.1 108.01 19.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.431 -0.952 . . . . 74.4 108.431 175.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.517 ' O ' HG22 ' A' ' 268' ' ' VAL . 2.9 m-20 -71.59 103.87 3.14 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.906 -0.775 . . . . 72.53 108.906 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.77 -22.25 32.67 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.12 -0.562 . . . . 72.13 113.03 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -85.92 -23.47 26.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.671 0.272 . . . . 74.01 111.262 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 3.8 m-20 -115.61 -28.26 6.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.78 0.659 . . . . 50.41 112.78 -172.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 263' ' ' LEU . 24.6 m -62.82 -18.78 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.901 0.334 . . . . 64.31 111.901 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.6 -33.06 70.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 73.21 109.808 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.32 8.56 38.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.517 -0.765 . . . . 63.53 110.955 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.84 89.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.088 -0.577 . . . . 74.42 112.067 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.19 88.01 0.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.323 -0.942 . . . . 75.44 112.701 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -109.16 145.52 35.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.185 -0.302 . . . . 74.2 110.185 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 274' ' ' LYS . 30.6 tptt -103.85 137.89 41.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.009 -0.737 . . . . 72.5 109.009 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.3 tm? -110.11 137.9 47.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.647 0.261 . . . . 53.01 110.328 -174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.52 126.23 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.42 -0.672 . . . . 75.03 111.42 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.973 HD23 HD22 ' A' ' 259' ' ' LEU . 2.7 tm? -120.77 129.28 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.814 -0.439 . . . . 73.42 109.814 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -131.95 145.87 17.55 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.479 -0.867 . . . . 73.54 112.975 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.459 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.2 mm? -123.71 132.3 53.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.46 -0.57 . . . . 74.42 109.46 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -112.87 111.91 23.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.439 -0.578 . . . . 64.12 109.439 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.51 ' HB3' HD13 ' A' ' 31' ' ' LEU . 5.2 m-85 -102.32 141.48 35.09 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.115 -0.698 . . . . 73.5 109.115 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 284' ' ' LEU . 46.2 mt-30 -135.75 121.4 19.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.848 0.356 . . . . 55.4 110.566 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -105.35 109.26 21.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.206 -0.664 . . . . 65.45 109.206 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 282' ' ' GLN . 3.5 mm? -130.6 176.77 7.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.698 -0.683 . . . . 70.1 110.366 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.708 -0.678 . . . . 74.2 109.827 178.623 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.741 0.305 . . . . 75.24 110.486 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.74 -0.22 54.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.967 0.413 . . . . 75.43 110.314 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.841 HG11 ' HB3' ' A' ' 119' ' ' LYS . 2.2 t -82.15 115.19 56.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.688 -0.687 . . . . 70.24 109.643 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 6.6 Cg_endo -87.41 157.14 8.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.299 2.666 . . . . 74.33 113.157 -174.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 3.6 Cg_exo -75.92 64.62 6.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.135 2.556 . . . . 70.41 111.324 173.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.839 ' HB ' HD21 ' A' ' 150' ' ' LEU . 4.8 p -78.19 -18.97 54.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.728 -0.669 . . . . 53.01 111.548 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' HE2' HE21 ' A' ' 154' ' ' GLN . 81.0 t80 -56.11 -22.76 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 74.0 110.326 170.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.51 -25.62 54.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.456 -0.793 . . . . 73.5 109.569 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.636 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 39.5 m-20 -85.86 -10.94 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.99 -0.745 . . . . 64.02 108.99 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.844 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -77.1 -34.86 56.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.766 -1.106 . . . . 63.14 110.857 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.24 -47.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.934 -1.127 . . . . 55.15 113.701 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -55.43 -53.91 50.41 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.674 0.62 . . . . 64.31 112.674 -170.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 t -63.95 -48.47 76.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 71.3 111.474 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.78 60.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 72.41 111.794 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 1.049 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 99.2 mtt180 -60.37 -24.82 65.4 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.708 0.633 . . . . 73.22 112.708 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.36 -41.51 76.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 61.24 110.752 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.512 ' HB ' ' ND2' ' A' ' 207' ' ' ASN . 66.8 t -83.73 -37.41 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.164 0.507 . . . . 42.34 110.315 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.049 ' HB3' ' HA ' ' A' ' 15' ' ' ARG . 89.6 t80 -63.56 -24.51 67.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.123 -0.944 . . . . 72.14 112.497 -174.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -65.42 156.08 33.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 43.44 111.613 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.788 ' HD2' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.95 25.46 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.674 -0.693 . . . . 63.35 110.397 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.94 95.67 0.49 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.686 -0.688 . . . . 63.53 112.278 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -104.07 -162.4 0.89 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.797 -0.816 . . . . 74.42 108.797 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.55 108.18 2.38 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.142 -1.027 . . . . 23.44 111.131 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -80.7 -2.98 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.797 0.299 . . . . 75.12 111.573 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 12.79 83.81 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.458 -0.877 . . . . 54.15 112.434 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -142.35 179.97 6.62 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.866 0.841 . . . . 73.12 112.632 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.689 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.8 mp -106.91 129.52 60.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.148 -1.387 . . . . 71.33 109.859 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 8.9 ttpt -102.78 135.99 43.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.407 -0.59 . . . . 74.5 109.407 174.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 279' ' ' LEU . 2.9 tp -133.5 139.7 46.81 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.872 -0.331 . . . . 53.1 110.169 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.3 p30 -151.3 135.01 16.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 61.34 109.951 173.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.4 tp -128.31 124.14 35.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.509 -0.769 . . . . 73.11 109.679 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' N ' HD12 ' A' ' 31' ' ' LEU . 68.9 tttt -120.92 124.69 45.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.276 -0.874 . . . . 60.14 109.37 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 34.2 m -128.6 120.6 26.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.635 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -144.6 155.88 43.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.811 -0.756 . . . . 74.22 112.597 -176.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.4 t -139.92 154.31 47.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.523 -1.217 . . . . 74.04 107.991 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.27 20.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.991 0.424 . . . . 62.13 111.262 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 35' ' ' SER . 66.0 t30 -110.65 30.08 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.544 0.688 . . . . 75.33 110.212 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 96.39 1.17 60.83 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.864 -0.607 . . . . 45.51 112.513 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.0 tp -100.68 125.9 47.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.699 0.629 . . . . 64.24 112.699 -173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.857 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 28.0 mt-10 -142.32 118.17 10.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.962 -0.384 . . . . 65.34 109.962 160.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 50.4 m-85 -111.87 124.87 53.29 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.871 -0.518 . . . . 74.2 110.308 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.978 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 19.0 m -126.85 118.61 24.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.741 0.305 . . . . 73.4 111.383 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 29.0 t -120.35 123.6 43.5 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.273 -0.64 . . . . 73.23 109.273 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 p -134.73 130.44 36.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 43.21 111.468 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.43 148.02 19.38 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.507 -0.854 . . . . 64.33 112.541 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 m -119.83 134.17 55.33 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.821 -0.807 . . . . 72.41 108.821 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.7 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -154.85 141.29 18.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.984 0.421 . . . . 55.33 111.804 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 145.96 51.53 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.184 -0.672 . . . . 72.43 109.184 172.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -43.82 -39.74 4.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.538 0.524 . . . . 73.44 111.95 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -103.41 165.87 10.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.342 -0.614 . . . . 54.13 109.342 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -70.55 61.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.342 0.591 . . . . 70.1 112.052 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -97.84 -39.93 8.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 73.3 110.352 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -165.42 116.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 62.42 109.918 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.7 HG13 ' HB2' ' A' ' 47' ' ' ALA . 39.6 t -125.63 119.62 55.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.93 -0.577 . . . . 72.15 109.938 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -120.47 126.54 50.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.845 -0.428 . . . . 73.3 109.845 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -131.41 148.16 18.84 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.198 -1.001 . . . . 74.12 113.258 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 6.6 p -146.31 147.2 31.12 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.792 -0.447 . . . . 55.42 109.792 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 59' ' ' GLU . 1.8 tp -122.09 149.33 43.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.176 0.512 . . . . 72.42 111.196 -176.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.978 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 37.7 mt-10 -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.257 -0.883 . . . . 75.23 109.421 172.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.9 m -95.62 118.31 32.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.889 -1.152 . . . . 63.23 107.889 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.652 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 26.5 mttp -126.07 145.68 50.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.411 0.624 . . . . 75.14 110.911 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 70' ' ' THR . 74.3 m-85 -120.7 120.33 35.38 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.476 -0.935 . . . . 63.41 108.476 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.857 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 8.8 tpt180 -114.73 108.26 16.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 74.24 111.136 -173.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -113.51 102.69 10.54 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.434 -0.803 . . . . 75.55 110.754 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m 63.81 72.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.941 -1.027 . . . . 72.34 112.409 172.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.816 ' HG3' ' H ' ' A' ' 67' ' ' TYR . 9.7 pt-20 30.3 -92.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.449 1.1 . . . . 74.03 113.764 173.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.816 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 93.9 m-85 -87.11 86.87 7.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.224 -0.658 . . . . 73.03 109.224 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.81 -94.1 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.353 -0.699 . . . . 71.43 111.353 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 87' ' ' VAL . 3.5 mm? -125.4 131.59 52.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.038 0.447 . . . . 63.51 111.488 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.696 HG23 ' HB ' ' A' ' 86' ' ' THR . 4.8 t -136.97 113.19 9.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.796 -0.638 . . . . 73.35 109.781 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 72.3 m-85 -98.2 132.26 43.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.872 -0.604 . . . . 73.11 109.527 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 84' ' ' GLU . 96.9 m -127.91 136.57 51.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.923 0.392 . . . . 75.51 111.757 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.69 121.13 24.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.949 -0.759 . . . . 73.54 108.949 165.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -106.88 109.73 21.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.771 -0.65 . . . . 72.01 109.581 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.632 ' HD1' HD13 ' A' ' 81' ' ' LEU . 77.1 t90 -109.7 133.92 52.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.425 -0.352 . . . . 74.22 110.492 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.481 ' HB3' ' OG1' ' A' ' 80' ' ' THR . 8.5 t30 -114.72 152.88 31.27 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.582 -0.525 . . . . 53.2 109.582 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 m -54.28 -22.15 11.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.116 0.484 . . . . 73.51 112.301 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.5 m-20 -68.69 -2.67 9.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.117 -0.492 . . . . 74.12 111.986 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.528 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 12.2 m120 77.8 27.69 0.58 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.461 0.704 . . . . 73.15 110.125 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 104' ' ' SER . 1.8 p -93.19 124.52 37.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.599 -0.728 . . . . 74.35 110.987 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD13 ' HD1' ' A' ' 75' ' ' TRP . 3.9 mm? -101.56 119.2 38.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.307 -0.86 . . . . 74.23 110.3 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.54 91.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.552 -0.832 . . . . 75.41 111.512 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 t -90.65 123.04 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 73.41 110.448 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 40.5 tt0 -135.3 118.69 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.983 -0.553 . . . . 74.35 110.027 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -112.03 138.68 39.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.709 0.29 . . . . 74.12 110.368 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.696 ' HB ' HG23 ' A' ' 70' ' ' THR . 25.8 m -122.73 123.63 41.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.297 0.57 . . . . 60.33 111.353 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 HD11 ' A' ' 69' ' ' LEU . 34.1 t -111.89 123.89 68.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.09 -0.959 . . . . 73.41 109.036 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -110.21 142.17 42.14 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.765 -0.457 . . . . 63.11 109.765 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 81.47 -66.5 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.95 0.781 . . . . 72.31 109.952 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.31 -78.11 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.29 0.636 . . . . 71.1 111.206 175.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -130.88 -58.73 1.01 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 74.31 109.624 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.23 27.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.857 -0.611 . . . . 72.43 109.399 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 5.8 ppt_? -52.97 132.67 37.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.467 0.651 . . . . 73.5 111.832 -175.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 119' ' ' LYS . . . 101.54 -12.43 58.19 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.593 -0.73 . . . . 70.24 112.08 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.646 HD23 ' HD1' ' A' ' 118' ' ' TYR . 1.0 OUTLIER -86.92 119.9 27.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.83 -0.804 . . . . 74.23 108.83 176.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' O ' HD13 ' A' ' 97' ' ' LEU . 54.7 pttt -123.06 144.47 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 74.44 110.658 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.4 mm? -122.38 126.87 48.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.551 -0.75 . . . . 71.21 109.286 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.857 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 15.2 m -130.0 118.28 21.34 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.682 -0.407 . . . . 72.4 109.982 176.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 50.4 t80 -120.33 115.56 23.8 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.777 -0.369 . . . . 74.12 110.442 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 10.4 t70 -115.0 137.85 51.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.668 -0.696 . . . . 71.12 109.373 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -142.2 121.81 13.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.963 0.411 . . . . 72.03 110.06 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 41.4 m -103.04 121.71 43.14 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.715 -0.675 . . . . 63.42 109.803 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -120.88 128.82 53.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 73.55 109.523 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB3' HG22 ' A' ' 80' ' ' THR . 47.6 p -119.86 103.14 46.12 Favored Pre-proline 0 C--N 1.315 -0.919 0 C-N-CA 120.828 -0.349 . . . . 61.15 110.551 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 21.0 Cg_exo -67.11 -22.89 46.64 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.452 2.102 . . . . 60.14 111.256 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -85.48 -49.12 8.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 73.11 110.992 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -81.88 -36.73 27.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.392 . . . . 63.32 111.296 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.44 -3.44 61.43 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.139 -0.553 . . . . 42.2 113.191 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.76 148.69 22.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.165 0.507 . . . . 61.54 111.628 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -123.82 148.58 46.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 74.21 109.805 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -144.07 122.49 12.38 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.967 -0.383 . . . . 62.13 109.967 172.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . . . -110.08 129.89 55.62 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.798 -0.445 . . . . 63.02 109.798 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 129' ' ' MET . 7.9 ttmm -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.694 -0.484 . . . . 63.12 109.694 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 129' ' ' MET . 5.3 tp -132.32 129.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.108 0.48 . . . . 62.42 111.07 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 50.1 mttp -111.19 121.66 45.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.35 -0.841 . . . . 63.41 109.706 176.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -116.27 117.95 31.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.57 -0.9 . . . . 75.43 108.57 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.81 135.45 11.47 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.39 -0.909 . . . . 51.42 112.473 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.646 ' HD1' HD23 ' A' ' 95' ' ' LEU . 76.9 t80 -121.65 118.43 29.15 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.844 -0.799 . . . . 75.41 108.844 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.841 ' HB3' HG11 ' A' ' 3' ' ' VAL . 37.5 mtmm -108.07 122.93 47.88 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.041 -0.663 . . . . 63.55 110.642 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -105.38 154.91 19.65 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.556 -1.276 . . . . 75.24 107.556 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' A' ' 3' ' ' VAL . 2.0 tp10 -52.74 -29.84 29.24 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.674 0.62 . . . . 72.33 112.674 -165.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -102.39 -26.14 13.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.105 0.78 . . . . 64.32 113.105 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.791 HG22 ' H ' ' A' ' 145' ' ' GLY . 19.2 pt -142.22 153.35 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 119.927 -0.709 . . . . 71.24 112.242 -171.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.633 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 1.7 m-20 -112.3 128.94 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.263 -0.88 . . . . 70.31 111.457 -172.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 118' ' ' TYR . 4.5 mm? -111.37 137.69 48.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.608 0.242 . . . . 73.14 110.616 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.38 121.17 1.34 Allowed Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.959 -0.639 . . . . 65.11 112.493 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.4 m -113.35 116.44 29.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.894 0.347 . . . . 73.3 111.815 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.733 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -97.81 143.16 28.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.804 -0.634 . . . . 72.33 110.128 175.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.521 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 65.3 mtt -133.74 118.4 18.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.168 -0.308 . . . . 74.12 110.168 174.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.691 ' HB2' ' HB3' ' A' ' 137' ' ' SER . 1.9 m-20 -99.38 119.26 37.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 72.14 110.067 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 96.7 m-85 -95.9 97.94 10.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.479 176.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -120.58 156.99 30.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 55.23 108.988 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.898 ' H ' HD12 ' A' ' 133' ' ' ILE . 1.1 mp -75.08 -30.25 23.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.133 0.492 . . . . 73.44 109.986 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.0 -9.93 59.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 43.12 111.042 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 155.15 133.09 1.67 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.534 -0.841 . . . . 74.45 112.666 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 7.8 Cg_exo -74.23 119.1 5.65 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.122 2.548 . . . . 74.44 111.651 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.691 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 9.3 t -103.46 131.07 50.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.164 -0.471 . . . . 54.44 110.091 -177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mp -115.77 118.51 59.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.55 -0.46 . . . . 65.3 110.09 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 24.7 mtt180 -107.42 115.19 29.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.859 -0.423 . . . . 73.05 109.859 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.36 131.67 10.64 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 119.505 -1.331 . . . . 61.34 111.083 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.54 115.7 19.94 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.079 0.466 . . . . 72.33 109.977 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD11 HD12 ' A' ' 123' ' ' ILE . 5.9 tp -117.66 122.9 44.79 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.761 -0.654 . . . . 72.13 109.813 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.814 HG22 HD22 ' A' ' 10' ' ' LEU . 54.5 t -108.55 130.28 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.853 -0.612 . . . . 73.11 109.743 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.962 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.3 mm? -108.14 136.48 47.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.957 -0.757 . . . . 74.41 108.957 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.791 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -115.96 119.2 4.47 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.275 -0.875 . . . . 52.41 112.743 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.947 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 34.0 m-85 -123.46 149.64 44.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.304 -0.999 . . . . 74.05 108.304 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.78 100.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.96 0.41 . . . . 62.21 110.96 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 174' ' ' LYS . . . 90.84 -24.12 19.63 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.974 -0.557 . . . . 60.35 112.372 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.947 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.6 m0 -105.37 131.81 52.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.107 0.48 . . . . 64.23 110.783 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.839 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.4 tm? -117.33 149.07 41.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.736 -0.839 . . . . 63.22 108.736 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -151.28 154.53 36.94 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.646 -0.421 . . . . 74.35 110.058 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.844 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -158.41 135.66 4.38 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.744 -0.662 . . . . 44.45 111.576 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.4 115.18 21.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.44 -0.578 . . . . 71.1 109.44 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.94 ' HB2' ' HB2' ' A' ' 168' ' ' ASN . 87.7 mt-30 -99.42 121.86 41.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.728 -0.471 . . . . 72.25 109.728 166.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.9 ttm -127.17 128.58 46.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.698 -0.482 . . . . 74.32 109.698 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 24.7 m-80 -112.65 119.13 37.05 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.548 -0.538 . . . . 75.14 109.548 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 56.9 m-85 -94.35 127.05 39.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.095 -0.502 . . . . 75.41 110.805 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.794 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.9 tp10 -97.42 98.48 9.99 Favored 'General case' 0 C--O 1.26 1.631 0 N-CA-C 109.269 -0.641 . . . . 63.34 109.269 174.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 m -72.59 -17.59 61.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.641 -1.618 . . . . 63.45 111.209 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -63.1 -29.08 70.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.732 -0.84 . . . . 75.55 108.732 173.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 13.8 mmmm -111.17 -160.26 0.71 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.16 -1.382 . . . . 70.24 107.839 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 p -108.45 28.76 8.03 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.551 -0.536 . . . . 53.24 109.551 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 25.0 tpt180 -142.95 145.78 33.33 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 119.812 -0.755 . . . . 75.31 111.378 -160.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.5 m -73.22 136.7 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.777 -0.823 . . . . 54.23 108.777 173.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.794 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 8.8 t -92.2 -24.36 19.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.869 -171.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.572 ' HA ' ' OD2' ' A' ' 186' ' ' ASP . 93.4 mt-30 -144.8 133.16 21.81 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.616 0.246 . . . . 55.1 110.711 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.2 m -114.54 106.27 14.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.532 -0.544 . . . . 75.24 109.532 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.94 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 54.5 m-20 -106.99 129.93 54.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.46 . . . . 73.14 109.926 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.36 144.52 48.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.474 -0.33 . . . . 65.13 110.445 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -142.43 128.65 19.84 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.862 0.363 . . . . 33.45 110.169 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.58 128.54 60.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 73.3 109.409 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.81 109.17 1.69 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.804 -0.712 . . . . 73.25 112.05 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.75 119.95 39.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.064 -1.087 . . . . 74.34 108.064 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.819 ' HB2' ' HG2' ' A' ' 179' ' ' GLN . 0.0 OUTLIER -136.21 144.83 45.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.182 0.991 . . . . 52.51 113.557 -171.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.433 ' HB ' ' OE2' ' A' ' 177' ' ' GLU . 3.7 m -109.9 163.88 13.12 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.582 -1.636 . . . . 75.34 106.582 167.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -27.4 60.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.849 0.685 . . . . 72.15 112.849 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -108.16 -20.51 13.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.569 0.581 . . . . 72.14 112.569 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -130.83 119.02 21.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.799 0.333 . . . . 72.34 111.074 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.819 ' HG2' ' HB2' ' A' ' 174' ' ' LYS . 45.1 mt-30 -116.35 124.31 49.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.496 -0.32 . . . . 71.42 110.418 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -107.9 132.24 53.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.063 0.458 . . . . 74.03 110.234 174.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.636 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 41.6 m-70 -125.03 116.81 22.72 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.252 -0.647 . . . . 74.42 109.252 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 28.7 m -99.39 123.0 43.29 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.717 -0.475 . . . . 74.3 109.717 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -121.24 139.73 52.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.01 0.433 . . . . 71.5 109.963 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 78.2 t -131.12 124.79 56.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.762 -0.654 . . . . 53.42 109.591 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 92.4 m-20 -106.88 106.42 16.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 61.41 109.36 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 166' ' ' GLN . 28.0 t70 59.64 -168.76 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.914 -1.039 . . . . 72.31 109.424 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -79.54 -6.35 89.01 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.542 -0.837 . . . . 71.43 112.128 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 211' ' ' THR . 26.9 p -101.28 -27.02 13.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.639 0.977 . . . . 73.21 113.639 -172.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 33.6 tt0 -113.1 115.15 27.85 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 119.274 -0.97 . . . . 71.54 111.909 -174.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.58 131.06 57.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 75.14 109.64 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -174.25 -139.82 3.08 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.552 -0.833 . . . . 64.33 112.107 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.86 -150.61 22.9 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.23 -0.986 . . . . 63.0 112.865 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 28.5 t -142.78 144.54 32.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.147 0.498 . . . . 71.22 110.97 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.718 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 17.3 mm -118.9 115.77 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.856 -0.794 . . . . 73.23 108.856 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.677 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 26.1 t80 -111.6 119.7 39.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.612 0.244 . . . . 71.25 110.652 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.681 ' CG ' ' HB2' ' A' ' 199' ' ' ASN . 23.0 tp60 -127.81 128.49 45.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.505 -0.316 . . . . 73.33 110.34 176.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 198' ' ' VAL . 19.0 ptpt -103.1 132.41 49.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.674 -0.239 . . . . 73.12 110.933 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 197' ' ' LYS . 3.9 m 64.85 23.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.495 1.518 . . . . 75.44 112.423 176.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.867 HD22 ' HG3' ' A' ' 200' ' ' LYS . 9.1 t30 -65.31 -48.62 72.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 64.51 110.764 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.867 ' HG3' HD22 ' A' ' 199' ' ' ASN . 98.7 mttt -125.18 -84.47 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.491 -0.322 . . . . 72.3 111.05 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -86.83 -66.18 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.461 -0.336 . . . . 74.15 110.449 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.2 tp -145.73 -84.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 64.02 110.164 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 224' ' ' LYS . 2.6 tp10 -107.25 142.03 37.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 13.5 t -143.38 138.67 29.57 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.19 -0.604 . . . . 73.42 110.775 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -138.61 137.29 36.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.778 -0.646 . . . . 54.34 110.678 -178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.718 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 70.5 t -111.32 140.65 29.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.116 -0.698 . . . . 71.31 109.116 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.512 ' ND2' ' HB ' ' A' ' 17' ' ' VAL . 18.5 m-80 -138.27 131.51 30.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.674 -0.491 . . . . 75.12 109.674 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.87 151.7 37.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.824 0.345 . . . . 62.55 111.789 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.536 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -141.07 134.54 29.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 71.25 110.334 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 217' ' ' THR . 24.1 t90 -128.71 123.41 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 64.11 110.384 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 188' ' ' THR . 1.0 OUTLIER -99.89 103.56 15.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.369 0.604 . . . . 70.35 110.473 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.29 136.69 56.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.07 -0.968 . . . . 35.1 111.8 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.24 -28.12 15.75 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.932 -0.651 . . . . 72.34 113.207 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -132.79 -47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.87 0.692 . . . . 45.55 112.87 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.8 t -110.67 -179.04 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.375 0.607 . . . . 70.33 111.861 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -102.94 166.12 10.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.957 -1.02 . . . . 73.4 109.983 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 210' ' ' TRP . 25.7 m -74.91 123.17 24.59 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.422 -0.584 . . . . 65.01 109.422 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 218' ' ' ARG . 43.2 mtp180 -114.16 117.15 30.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.394 -0.595 . . . . 71.11 109.394 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -124.24 145.74 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.386 0.612 . . . . 63.32 111.306 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.36 13.8 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.898 -1.046 . . . . 62.44 111.229 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.3 mp -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.941 -0.392 . . . . 72.15 109.941 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -116.41 145.15 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.946 0.403 . . . . 44.01 110.855 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -129.04 126.54 39.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.933 -0.576 . . . . 62.34 109.792 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.511 ' HG2' ' SG ' ' A' ' 232' ' ' CYS . 22.8 ttmm -118.17 112.41 20.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 63.34 109.427 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 233' ' ' PHE . 5.7 p90 -135.09 118.8 17.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 74.23 112.389 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 0.2 OUTLIER -88.01 112.36 22.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.805 -1.183 . . . . 72.22 107.805 172.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.22 -55.36 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.375 0.88 . . . . 65.23 113.375 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.733 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 13.5 t70 -138.73 -59.49 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 75.24 112.953 -164.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 62.4 Cg_endo -90.96 -139.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.161 1.908 . . . . 71.4 112.834 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.453 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.3 p-10 -92.56 12.22 23.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.213 -0.903 . . . . 74.32 109.498 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.519 ' CB ' ' HG2' ' A' ' 249' ' ' GLN . . . -121.46 123.69 42.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.634 0.73 . . . . 73.31 111.65 -169.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.511 ' SG ' ' HG2' ' A' ' 224' ' ' LYS . 44.8 t -97.29 128.17 43.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.634 -1.166 . . . . 64.12 108.318 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.486 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 53.0 m-85 -96.18 126.45 41.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.779 -0.452 . . . . 75.53 109.779 -173.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 19.6 m -126.38 117.15 22.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 70.32 109.93 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 245' ' ' LEU . . . -122.76 141.63 51.6 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.956 -0.387 . . . . 60.21 109.956 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 62.6 pttt -137.9 140.22 40.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.035 0.445 . . . . 75.34 110.401 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 243' ' ' ILE . 5.5 p -122.98 140.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.569 -0.53 . . . . 74.0 109.569 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -105.21 148.03 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.085 -0.709 . . . . 75.15 109.085 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.97 2.58 2.56 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.48 0.548 . . . . 74.22 112.48 -172.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.646 ' HB2' HD13 ' A' ' 242' ' ' LEU . 14.7 m -82.81 12.74 4.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.902 -0.777 . . . . 52.21 108.902 169.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 17.5 m 69.89 28.79 4.17 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 114.955 -1.021 . . . . 73.34 110.948 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.844 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 8.9 mp -101.15 129.39 47.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.902 0.334 . . . . 71.55 111.902 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.508 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -118.61 116.49 51.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.706 -0.679 . . . . 72.33 110.099 -169.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -127.99 133.81 7.94 Favored Glycine 0 C--N 1.315 -0.584 0 C-N-CA 120.276 -0.964 . . . . 53.04 113.12 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 235' ' ' ALA . 0.0 OUTLIER -123.94 156.54 36.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.693 0.282 . . . . 65.41 110.483 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.67 149.46 20.95 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.543 -0.836 . . . . 73.33 113.158 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.835 ' HD1' ' HB3' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -106.63 118.1 35.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.107 -0.701 . . . . 74.43 109.107 177.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 28.9 m -104.49 115.14 29.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.439 -0.578 . . . . 75.41 109.439 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.519 ' HG2' ' CB ' ' A' ' 231' ' ' ALA . 10.9 mt-30 -112.41 133.16 54.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.003 0.43 . . . . 70.32 111.013 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 11.7 m -104.16 102.51 12.23 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.884 -0.784 . . . . 71.14 108.884 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.86 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 8.9 mp -75.24 179.3 5.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.857 0.36 . . . . 44.12 110.855 -174.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 253' ' ' PRO . 1.4 tppp? -60.68 -52.52 71.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 54.33 111.09 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.598 ' HG2' HG12 ' A' ' 255' ' ' ILE . 72.3 Cg_endo -80.2 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.811 1.674 . . . . 73.43 111.617 172.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -75.94 64.58 2.68 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.915 -0.659 . . . . 74.33 112.553 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.86 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 41.7 mm -123.74 123.97 68.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.537 0.208 . . . . 54.42 110.869 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.798 ' HB3' ' HG3' ' A' ' 280' ' ' GLU . 26.6 ttmt -115.46 114.17 24.69 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.299 -0.63 . . . . 73.5 109.299 171.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 279' ' ' LEU . 13.9 tp -100.33 124.55 45.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.623 -0.717 . . . . 62.41 109.959 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 24.4 m -122.22 110.21 15.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.152 0.501 . . . . 75.14 110.793 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.989 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -106.85 123.58 48.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.464 -1.31 . . . . 75.51 107.464 173.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.7 p -137.72 150.62 47.45 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.64 -0.424 . . . . 71.21 111.228 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.408 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -145.55 128.68 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.35 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.725 HD11 HD23 ' A' ' 242' ' ' LEU . 2.6 tm? -104.81 115.89 31.07 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.354 -0.98 . . . . 71.33 108.354 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.822 ' HB3' HG11 ' A' ' 268' ' ' VAL . 1.3 mm? -92.27 108.77 20.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.353 -0.98 . . . . 73.21 108.353 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.844 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 3.2 m-20 -70.45 111.02 5.69 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.4 -0.963 . . . . 71.34 108.4 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.23 -27.68 40.17 Favored Glycine 0 C--N 1.319 -0.397 0 C-N-CA 121.207 -0.521 . . . . 41.4 112.995 -173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -91.79 -27.48 17.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.679 0.276 . . . . 75.41 111.19 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.832 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 14.4 m120 -92.46 -35.33 13.71 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.201 0.445 . . . . 70.23 112.201 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -63.04 -18.24 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.681 0.277 . . . . 60.34 111.649 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.71 -29.89 71.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.334 0.587 . . . . 53.12 109.653 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.22 0.18 31.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.541 -0.754 . . . . 64.15 110.594 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.34 8.06 57.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 74.41 113.066 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -84.33 86.92 1.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 42.44 112.567 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.444 ' HB3' HG12 ' A' ' 268' ' ' VAL . 6.6 p80 -114.39 144.9 42.55 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.76 -0.259 . . . . 61.54 110.537 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -99.24 138.02 36.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 63.22 111.179 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.2 tm? -113.05 139.4 48.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.818 -0.438 . . . . 74.14 109.818 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.546 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.06 117.8 1.53 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.883 -0.675 . . . . 64.53 111.631 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.989 HD23 HD22 ' A' ' 259' ' ' LEU . 3.0 tm? -115.51 141.97 47.35 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.418 -0.586 . . . . 71.53 109.418 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.571 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -153.31 129.37 2.68 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.381 -0.914 . . . . 75.42 113.11 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.798 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.7 mm? -112.49 131.52 55.54 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.874 -0.417 . . . . 44.34 109.874 172.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.798 ' HG3' ' HB3' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -124.06 112.01 16.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.736 0.779 . . . . 74.44 109.897 173.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.601 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -98.19 135.91 39.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.433 -1.258 . . . . 71.03 108.76 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.492 ' N ' ' HD2' ' A' ' 281' ' ' PHE . 7.4 tp60 -133.47 112.13 11.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 73.4 109.818 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.98 114.19 25.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.037 -0.529 . . . . 61.04 110.021 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.7 mt -120.53 115.97 24.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 55.03 110.598 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.379 -0.82 . . . . 72.13 109.868 178.103 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.668 -0.493 . . . . 55.24 109.668 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.528 ' CA ' ' HA2' ' A' ' 94' ' ' GLY . . . -74.8 121.16 21.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.706 0.288 . . . . 53.22 111.325 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.079 HG22 ' HB3' ' A' ' 119' ' ' LYS . 27.7 m -94.88 145.2 29.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.174 -0.466 . . . . 53.22 111.135 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 32.5 Cg_exo -58.88 161.69 14.9 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.481 2.121 . . . . 64.52 110.361 172.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.95 92.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.313 2.009 . . . . 65.21 112.385 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 p -67.02 -25.84 66.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.284 -0.416 . . . . 50.11 111.854 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.784 ' HB3' HG21 ' A' ' 143' ' ' VAL . 16.6 p90 -65.13 -29.25 70.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 71.45 110.922 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.72 -12.64 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.484 0.659 . . . . 55.12 109.986 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -104.26 -7.14 20.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.559 -0.904 . . . . 64.45 108.559 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.706 HD12 ' HB3' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -57.79 -33.78 68.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.786 -1.552 . . . . 74.53 110.83 178.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.72 63.61 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.082 -0.58 . . . . 50.52 112.175 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -62.05 -39.86 93.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.667 0.387 . . . . 75.43 111.753 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.0 m -61.0 -36.71 80.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 62.42 112.188 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.8 82.37 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.749 0.648 . . . . 73.24 112.749 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -67.74 -33.83 75.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.88 -0.328 . . . . 44.54 111.463 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 26.3 t70 -65.91 -47.99 72.93 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 109.5 -0.555 . . . . 70.11 109.5 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' A' ' 222' ' ' ALA . 11.3 t -58.22 -33.49 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.956 -0.566 . . . . 71.44 111.566 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HD2' ' HB2' ' A' ' 207' ' ' ASN . 66.9 t80 -60.69 -39.52 88.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.893 -0.594 . . . . 64.25 111.695 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 18' ' ' PHE . 1.1 p -131.42 12.19 4.97 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.335 0.865 . . . . 73.41 113.335 -172.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 34.4 tttp -65.38 -38.7 90.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.166 0.507 . . . . 75.44 110.65 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.34 45.79 1.27 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.852 -0.69 . . . . 23.22 111.765 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.29 130.29 42.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.81 113.63 3.69 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.79 -0.719 . . . . 62.25 112.548 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -84.46 -3.67 58.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.792 0.33 . . . . 75.43 111.063 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.51 85.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.14 -0.552 . . . . 61.2 113.344 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 46' ' ' SER . 2.1 pp -147.21 179.89 7.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.047 0.758 . . . . 70.12 113.047 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.664 HD12 HD12 ' A' ' 277' ' ' LEU . 37.6 mm -100.59 124.47 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.368 -1.287 . . . . 72.43 109.55 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 33.3 ttpt -107.53 121.82 45.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.97 -0.382 . . . . 75.33 109.97 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.47 128.04 56.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.417 -0.586 . . . . 65.33 109.417 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.8 136.67 51.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.039 -0.726 . . . . 72.01 109.039 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.567 HD13 ' HD1' ' A' ' 281' ' ' PHE . 12.1 tp -137.04 124.62 22.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.931 0.396 . . . . 62.43 110.341 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' N ' HD12 ' A' ' 31' ' ' LEU . 39.8 tttp -116.97 125.44 51.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.449 -0.574 . . . . 71.04 109.449 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 41' ' ' PHE . 25.4 m -126.06 149.51 48.83 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.335 -0.393 . . . . 63.33 110.5 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' HD3' HD22 ' A' ' 284' ' ' LEU . 55.0 mtpt -125.15 144.41 50.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.754 0.311 . . . . 63.13 110.878 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 39' ' ' LEU . 52.3 m -140.75 158.28 44.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.31 -0.405 . . . . 60.44 110.995 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.626 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 28.3 tt0 -76.46 99.1 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.45 111.91 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.745 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t30 160.44 26.59 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.631 1.172 . . . . 52.13 107.861 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.718 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.65 18.05 79.35 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.273 -0.876 . . . . 72.24 110.991 -172.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 37' ' ' ASN . 3.1 mt -86.74 134.33 33.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.758 0.79 . . . . 55.34 112.916 -167.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.65 130.61 30.27 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.012 -1.449 . . . . 71.32 109.173 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 93.7 m-85 -115.65 121.54 42.86 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.854 -0.425 . . . . 74.12 109.854 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.896 ' HB ' ' HG2' ' A' ' 59' ' ' GLU . 23.7 m -115.94 116.48 28.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.091 0.472 . . . . 44.51 110.058 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 25.2 t -113.15 131.31 55.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.708 -0.678 . . . . 75.15 109.726 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -130.97 135.63 47.81 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.686 -0.487 . . . . 34.35 109.686 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.62 110.13 0.43 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.611 -0.804 . . . . 73.02 112.067 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.457 ' HB3' HD13 ' A' ' 26' ' ' LEU . 15.2 m -108.39 133.18 52.94 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.67 -0.863 . . . . 71.2 108.67 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.495 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -151.57 136.7 17.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.235 0.54 . . . . 72.02 111.24 -174.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -80.87 129.27 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 74.23 108.748 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.8 m -62.46 -20.9 65.01 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.973 0.416 . . . . 64.1 111.675 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -84.46 6.05 24.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.156 0.503 . . . . 72.14 110.204 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 p 49.24 72.0 0.34 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.68 0.792 . . . . 75.5 112.098 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -126.74 -30.87 2.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.253 -0.885 . . . . 63.3 110.172 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -149.13 113.85 5.36 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.101 -0.703 . . . . 71.11 109.101 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 47' ' ' ALA . 25.7 t -125.99 127.47 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 72.13 109.843 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -134.18 137.61 44.57 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.958 -0.386 . . . . 64.24 109.958 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -142.49 154.82 25.39 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.29 -0.957 . . . . 72.24 112.884 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.765 ' HB2' HG23 ' A' ' 77' ' ' THR . 26.7 t -146.73 148.68 32.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.226 -0.657 . . . . 72.3 109.226 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 74' ' ' LYS . 1.7 tm? -146.57 125.47 12.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.896 ' HG2' ' HB ' ' A' ' 42' ' ' THR . 11.7 pt-20 -125.84 131.36 52.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.266 0.555 . . . . 63.11 110.195 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.419 HG23 ' CE1' ' A' ' 41' ' ' PHE . 48.3 m -107.62 119.4 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.813 -0.81 . . . . 75.31 108.813 172.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 19.9 mtpp -112.07 126.94 55.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 75.21 110.586 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.9 m-85 -110.77 120.97 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.36 -0.607 . . . . 54.34 109.36 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.718 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 39.5 mtp180 -114.61 110.9 20.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.809 0.814 . . . . 75.42 110.696 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -111.02 117.2 32.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.077 -1.42 . . . . 72.33 109.062 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m 73.64 122.85 0.04 OUTLIER 'General case' 0 C--O 1.231 0.108 0 O-C-N 124.021 0.826 . . . . 65.52 109.734 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.9 mp0 -63.01 106.47 0.84 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 74.44 110.037 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 87.2 m-85 68.0 84.77 0.15 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.207 -0.906 . . . . 71.44 109.37 -170.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.81 -83.05 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.309 -0.86 . . . . 71.14 111.443 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.8 mm? -121.26 131.71 54.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.985 0.421 . . . . 71.12 111.151 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 42.1 m -136.77 119.11 15.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.731 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 7.9 m-85 -107.98 133.38 52.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.239 -0.437 . . . . 74.21 110.115 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -128.35 119.44 25.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.074 0.397 . . . . 71.24 110.816 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 8.0 pt-20 -131.63 170.46 14.73 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.2 0.444 . . . . 64.01 112.2 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.625 ' HG3' HD12 ' A' ' 58' ' ' LEU . 72.5 mmtt 118.73 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.057 1.743 . . . . 64.23 113.452 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.535 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 13.2 t90 -135.0 143.57 46.89 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.484 0.55 . . . . 70.21 112.484 -163.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.501 ' ND2' ' H ' ' A' ' 78' ' ' ASP . 4.9 t30 -119.38 159.23 24.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.951 -0.568 . . . . 72.21 111.112 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.765 HG23 ' HB2' ' A' ' 57' ' ' SER . 17.9 p -61.67 -17.99 57.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.296 0.85 . . . . 72.1 113.296 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 5.5 m-20 -78.65 -1.61 35.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.658 -0.246 . . . . 74.22 110.89 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 78.9 13.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.762 0.825 . . . . 44.11 109.687 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -86.7 134.89 33.56 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.306 -0.861 . . . . 74.22 110.058 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.1 mp -107.72 161.09 15.2 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.375 -0.972 . . . . 74.42 108.375 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 102' ' ' SER . . . 148.23 -167.68 28.99 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.277 -1.439 . . . . 61.11 113.141 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 2.3 t -157.9 152.29 24.67 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.637 -0.282 . . . . 71.42 110.494 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.941 ' HA ' ' HB3' ' A' ' 100' ' ' ASP . 10.4 pt-20 -127.45 136.28 51.59 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 125.166 1.541 . . . . 71.22 109.678 171.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 99' ' ' PHE . 1.7 pp -111.4 133.11 58.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 118.658 -1.217 . . . . 71.35 110.815 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.93 ' HB ' ' HE3' ' A' ' 96' ' ' LYS . 21.1 p -114.8 137.52 51.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.727 -0.67 . . . . 64.44 110.783 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.75 135.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.32 -0.4 . . . . 73.34 110.672 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.05 127.33 36.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.378 -0.601 . . . . 74.13 109.378 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . 27.1 t70 -69.94 156.64 38.8 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.248 0.547 . . . . 74.2 111.601 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -95.56 -37.31 10.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.5 -0.773 . . . . 72.4 110.831 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.64 -55.07 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 74.24 111.018 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.8 64.32 5.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.772 -0.825 . . . . 72.33 108.772 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -48.88 126.53 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 74.23 111.221 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.528 ' HA2' ' CA ' ' A' ' 2' ' ' ALA . . . 104.1 -4.25 44.94 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.69 -0.687 . . . . 52.31 112.204 -173.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 89' ' ' ASP . 52.7 tp -79.72 130.43 35.34 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.686 . . . . 75.43 109.146 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.93 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 55.9 tptt -121.72 111.15 16.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.658 -0.701 . . . . 70.4 109.732 -174.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 116' ' ' THR . 1.1 mm? -112.77 125.71 54.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.365 -0.605 . . . . 43.05 109.365 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.862 ' HB ' HG22 ' A' ' 86' ' ' THR . 1.8 t -131.92 118.98 20.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.306 -0.558 . . . . 73.44 112.219 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.935 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 88.1 t80 -127.39 114.23 17.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.863 -0.608 . . . . 75.42 109.407 174.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.941 ' HB3' ' HA ' ' A' ' 84' ' ' GLU 0.355 1.2 t70 -153.82 172.95 16.55 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 120.845 -1.159 . . . . 64.24 112.804 159.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.749 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 23.3 t -116.78 147.79 41.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.931 0.396 . . . . 52.32 110.687 -165.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.679 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 33.4 t -114.8 134.81 54.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 75.31 110.368 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -95.52 124.9 39.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.059 0.457 . . . . 72.22 110.252 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 31.3 m -109.61 115.2 56.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 74.43 110.75 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 19.3 Cg_exo -66.22 -7.81 18.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.184 2.589 . . . . 63.0 112.326 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -55.92 -50.81 69.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.743 -0.662 . . . . 75.32 111.01 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 p -129.36 -2.67 4.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.854 0.359 . . . . 71.3 111.65 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.92 11.68 81.02 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.664 -0.779 . . . . 64.31 111.734 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.843 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 10.7 mmpt? -94.35 149.08 21.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.693 -0.254 . . . . 71.43 110.567 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -106.94 135.98 47.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.04 0.448 . . . . 74.12 110.405 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -119.54 122.9 42.66 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.443 -0.947 . . . . 75.21 108.443 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.749 ' HA ' ' HA ' ' A' ' 101' ' ' SER . . . -104.45 147.16 27.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.942 0.401 . . . . 64.24 111.596 -168.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -121.65 137.56 54.7 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.473 0.654 . . . . 74.52 110.433 177.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.935 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 2.5 tp -127.77 115.86 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.385 -1.279 . . . . 63.31 109.359 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.779 ' HB3' HG23 ' A' ' 98' ' ' THR . 4.4 ttmp? -113.65 121.27 43.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.725 -0.67 . . . . 54.43 110.579 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.68 HG22 HD12 ' A' ' 97' ' ' LEU . 21.7 p -112.68 117.29 31.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.367 -0.605 . . . . 61.52 109.367 175.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.82 134.93 5.34 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.052 -1.07 . . . . 44.54 112.885 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -107.51 125.36 51.18 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.616 -0.512 . . . . 65.53 109.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 1.079 ' HB3' HG22 ' A' ' 3' ' ' VAL . 41.7 mttp -110.26 121.78 46.09 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 121.182 0.515 . . . . 75.23 110.852 -173.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 120' ' ' ARG . 6.4 mmt180 -108.89 152.5 24.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.202 -0.908 . . . . 74.44 109.317 169.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.869 ' HA ' HG11 ' A' ' 3' ' ' VAL . 8.8 tm-20 -50.88 -27.93 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.907 0.883 . . . . 75.33 111.317 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -110.9 -15.4 13.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.091 -0.504 . . . . 74.33 112.143 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 144' ' ' LEU . 16.6 tt -149.29 122.12 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 118.813 -1.155 . . . . 70.14 113.482 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 1.6 t30 -102.83 119.01 38.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.445 -0.798 . . . . 64.21 110.793 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 142' ' ' LEU . 3.1 mm? -112.43 111.9 23.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.166 -0.679 . . . . 73.31 109.166 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.11 118.58 2.44 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.991 -1.1 . . . . 54.33 113.103 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 37.8 t -110.66 111.22 22.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.935 0.398 . . . . 70.43 110.204 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 13.6 t70 -100.7 134.74 43.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 75.14 109.728 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.83 117.78 24.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.838 0.352 . . . . 73.14 110.119 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.32 119.22 37.59 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -82.45 96.9 8.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.903 0.382 . . . . 74.34 111.007 -171.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.593 ' H ' ' HA ' ' A' ' 136' ' ' PRO . 13.0 t70 -96.82 145.31 25.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 65.31 109.638 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -29.17 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.544 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.72 58.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.944 0.402 . . . . 70.22 110.923 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.56 108.3 0.51 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.583 -0.607 . . . . 72.3 111.583 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.593 ' HA ' ' H ' ' A' ' 132' ' ' ASP . 77.0 Cg_exo -48.24 123.51 9.06 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.268 2.645 . . . . 70.14 112.755 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.2 t -84.68 136.67 33.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.251 -0.648 . . . . 63.34 109.251 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 45.5 mm -105.57 117.04 50.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 62.42 109.467 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -116.19 109.64 17.72 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.28 -0.637 . . . . 72.24 109.28 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.0 133.54 11.61 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.907 -1.139 . . . . 51.04 112.157 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.21 114.08 21.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.418 0.628 . . . . 75.02 109.491 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 144' ' ' LEU . 18.1 tp -116.47 122.94 46.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.362 -0.836 . . . . 72.54 109.569 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' A' ' 7' ' ' TYR . 48.3 t -133.9 120.26 35.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.958 -0.386 . . . . 74.32 109.958 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.665 HD12 HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -126.78 139.29 53.23 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.532 -0.867 . . . . 74.2 110.718 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -120.86 128.41 7.41 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 114.674 -1.148 . . . . 73.31 111.837 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -112.59 149.16 33.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.396 -1.705 . . . . 74.21 106.396 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -47.7 95.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 55.53 112.243 -171.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.3 -33.09 5.73 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.133 -0.94 . . . . 43.32 112.867 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.433 ' HD1' ' HB2' ' A' ' 173' ' ' TYR . 2.5 m0 -106.47 146.88 30.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.847 0.323 . . . . 74.34 111.463 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.706 ' HB3' HD12 ' A' ' 10' ' ' LEU . 7.5 mt -130.81 136.56 48.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.815 -0.809 . . . . 62.35 108.815 167.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.513 ' HB3' ' CD2' ' A' ' 144' ' ' LEU . . . -130.52 127.4 39.07 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.861 -0.422 . . . . 72.35 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.539 ' N ' HD21 ' A' ' 10' ' ' LEU . . . -131.85 133.54 7.21 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.986 -0.626 . . . . 75.11 111.791 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -129.36 118.72 22.68 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.212 -0.494 . . . . 75.34 110.538 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -111.6 121.83 46.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.508 -0.553 . . . . 45.23 109.508 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -135.48 146.69 48.41 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.065 -0.346 . . . . 74.2 110.065 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 166' ' ' GLN . 7.3 p30 -124.35 119.01 28.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.645 0.736 . . . . 71.12 110.966 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.856 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 82.8 t80 -97.03 123.1 40.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.527 -1.215 . . . . 71.42 109.298 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.708 ' HG2' ' H ' ' A' ' 161' ' ' LYS . 25.0 tt0 -94.04 105.25 17.26 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.747 -0.464 . . . . 71.43 109.747 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.7 m -70.78 -22.09 62.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 113.687 -1.597 . . . . 53.25 111.149 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.23 77.83 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.595 -0.891 . . . . 70.34 108.595 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.708 ' H ' ' HG2' ' A' ' 158' ' ' GLU . 17.6 ttmm -98.89 -164.91 1.18 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.92 -1.511 . . . . 72.41 106.92 169.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 15.5 m -110.38 25.52 11.69 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.223 -0.923 . . . . 71.14 110.509 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -155.31 151.28 27.8 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 119.398 -0.921 . . . . 74.33 112.727 -160.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.856 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -74.77 135.72 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.105 -1.072 . . . . 71.1 108.105 168.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -93.99 -32.84 13.68 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.421 -0.512 . . . . 74.51 110.929 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.695 ' HB3' HD21 ' A' ' 156' ' ' ASN . 35.3 tt0 -151.38 133.52 15.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.995 0.426 . . . . 54.45 111.066 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 m -118.69 120.22 36.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 61.01 109.984 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 185' ' ' ASN . 39.3 m-80 -116.82 121.95 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.806 -0.813 . . . . 62.22 108.806 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -139.8 155.48 47.25 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.567 -0.853 . . . . 61.25 111.797 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.574 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -144.81 152.71 40.74 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.616 -0.72 . . . . 75.0 110.23 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 181' ' ' HIS . 42.9 t -130.21 151.63 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.613 -1.254 . . . . 54.32 107.613 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -158.04 111.03 0.47 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.029 -1.081 . . . . 72.54 112.197 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.458 ' CE2' HD22 ' A' ' 180' ' ' LEU . 39.2 p90 -113.39 138.36 50.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.428 0.632 . . . . 71.53 110.957 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -104.63 127.17 52.31 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.695 -1.139 . . . . 62.11 110.486 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 178' ' ' PHE . 33.5 m -127.12 162.54 25.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.555 -0.906 . . . . 74.42 108.555 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.61 -54.7 11.1 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.522 0.564 . . . . 50.22 112.522 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.28 -21.93 13.44 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.896 -0.322 . . . . 63.4 111.698 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.519 ' O ' ' HB ' ' A' ' 175' ' ' THR . 91.4 m-85 -124.69 142.84 51.1 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.805 0.336 . . . . 73.32 110.913 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 29.2 tt0 -135.23 122.9 22.22 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.206 -1.035 . . . . 72.21 108.206 172.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.502 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 8.8 tt -121.54 137.45 54.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.987 -0.685 . . . . 64.31 111.2 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 19.9 t-80 -127.3 114.8 18.07 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.248 -0.887 . . . . 65.1 110.573 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -81.51 148.31 29.25 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.804 -0.813 . . . . 62.04 108.804 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.403 ' HB2' ' CE1' ' A' ' 181' ' ' HIS . 8.3 t30 -147.93 137.02 22.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.3 -0.56 . . . . 74.13 111.25 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.9 t -133.78 123.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.554 -0.748 . . . . 62.34 110.068 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 189' ' ' GLU . 11.7 m120 -117.08 112.44 20.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.641 -0.709 . . . . 74.42 109.529 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.548 ' HA ' ' HG3' ' A' ' 166' ' ' GLN . 21.0 t70 63.7 -173.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.418 -0.81 . . . . 71.53 109.072 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.9 -6.0 89.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.395 -0.907 . . . . 43.21 111.101 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.2 m -97.03 -26.95 14.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.0 0.741 . . . . 62.32 113.0 -171.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 185' ' ' ASN . 16.7 mm-40 -116.5 111.15 19.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.523 0.601 . . . . 72.13 110.427 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -127.63 123.62 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 74.25 109.371 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -174.13 -144.87 4.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.802 -1.19 . . . . 65.41 113.33 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -166.23 -172.08 33.13 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.613 -0.804 . . . . 44.0 113.038 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 4.1 m -148.76 139.0 22.39 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.544 0.738 . . . . 72.41 109.12 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 205' ' ' ALA . 4.1 mp -124.23 117.45 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 121.2 -0.2 . . . . 73.21 110.464 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.501 ' HD1' ' HB2' ' A' ' 205' ' ' ALA . 11.6 t80 -108.41 120.33 42.09 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.542 -0.54 . . . . 54.4 109.542 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -125.72 133.05 52.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.472 -0.331 . . . . 74.23 110.45 -175.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -101.15 114.41 28.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.477 -0.329 . . . . 73.43 110.378 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 199' ' ' ASN . 8.3 t -73.77 171.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.373 -0.603 . . . . 71.15 109.373 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.555 ' H ' HG12 ' A' ' 198' ' ' VAL . 12.9 m120 -66.11 -30.87 71.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.756 0.312 . . . . 44.13 111.31 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 201' ' ' LYS . 4.7 mptp? -92.81 -164.51 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 55.42 110.846 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 200' ' ' LYS . 32.0 tptt -79.11 39.09 0.37 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 73.44 110.496 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.965 ' HG ' ' HB3' ' A' ' 225' ' ' TYR . 4.5 tt -120.92 122.01 39.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 73.44 109.661 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.86 130.54 53.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.98 -0.555 . . . . 71.31 109.658 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.0 t -121.64 153.75 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.863 0.363 . . . . 73.4 110.63 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -142.02 147.79 37.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.498 0.666 . . . . 60.03 111.55 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 221' ' ' ILE . 71.3 t -112.13 132.79 59.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.158 -0.928 . . . . 71.1 109.517 177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.3 p-10 -114.2 127.3 55.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.934 -1.136 . . . . 71.52 107.934 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 tp -144.15 129.58 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.556 -0.458 . . . . 71.31 110.819 -169.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.453 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -150.57 129.42 12.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.534 . . . . 71.21 111.216 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.648 ' CZ2' ' HA ' ' A' ' 215' ' ' SER . 3.5 t-105 -95.1 125.33 39.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.281 -1.007 . . . . 62.15 108.281 174.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 t -101.56 123.02 44.9 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.495 0.664 . . . . 64.52 110.312 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.7 127.32 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.982 -1.008 . . . . 53.02 111.533 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 153.96 -70.51 0.29 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.875 -0.89 . . . . 70.45 110.875 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.9 -166.01 1.43 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.387 -0.597 . . . . 75.04 109.387 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.648 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . 64.6 m -95.57 24.8 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.094 0.474 . . . . 74.23 110.808 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.07 111.82 20.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 73.34 109.779 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 9.6 t -99.82 135.97 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.05 0.452 . . . . 72.24 110.007 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -96.5 115.12 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.459 -0.571 . . . . 74.21 109.459 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.627 ' H ' ' HB3' ' A' ' 239' ' ' ASN . 47.6 p90 -119.64 154.95 33.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.846 0.355 . . . . 74.34 110.736 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.39 23.12 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.849 -0.691 . . . . 73.31 111.943 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.854 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -135.49 140.64 44.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 121.035 -0.266 . . . . 74.34 110.458 177.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.763 ' HB3' HG13 ' A' ' 17' ' ' VAL . . . -133.69 131.13 39.13 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.345 0.403 . . . . 63.1 110.706 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.56 125.14 53.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.393 -0.367 . . . . 72.53 110.186 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -112.02 114.08 26.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 53.3 109.218 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.965 ' HB3' ' HG ' ' A' ' 202' ' ' LEU . 7.9 p90 -127.03 124.63 39.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.435 0.636 . . . . 53.31 111.24 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -82.32 106.87 14.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.048 -0.978 . . . . 72.32 108.946 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.54 HG21 ' HE1' ' A' ' 233' ' ' PHE . 14.8 tt -70.11 -43.98 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.692 0.627 . . . . 64.41 112.692 -167.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.773 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 14.4 t70 -171.79 -63.56 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.311 0.486 . . . . 73.23 112.311 -175.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 78.4 Cg_endo -93.4 -127.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.281 1.987 . . . . 53.32 112.911 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 7.5 p-10 -92.35 12.63 21.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.708 -0.678 . . . . 73.11 110.829 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -121.24 133.1 55.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.456 0.646 . . . . 62.14 111.322 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -121.36 140.26 52.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.833 -1.076 . . . . 54.21 109.34 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.54 ' HE1' HG21 ' A' ' 227' ' ' ILE . 88.1 m-85 -106.45 126.74 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.123 -0.325 . . . . 72.4 110.123 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 15.0 m -120.59 117.63 28.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.134 -0.484 . . . . 63.55 110.067 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -118.42 140.48 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.829 -0.434 . . . . 54.34 109.829 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.62 ' HB2' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -143.74 148.03 35.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.469 . . . . 62.25 111.251 -177.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.523 HG12 HG12 ' A' ' 221' ' ' ILE . 7.0 p -122.58 148.57 26.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 116.32 -0.4 . . . . 64.25 110.113 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -110.45 150.04 29.43 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.254 0.972 . . . . 71.05 109.591 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.627 ' HB3' ' H ' ' A' ' 219' ' ' PHE . 6.8 p30 -37.98 -36.39 0.2 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.61 1.564 . . . . 71.22 114.815 -172.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.699 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.1 m -81.83 21.19 0.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.772 0.32 . . . . 64.4 111.033 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.3 m 68.43 31.54 4.9 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.634 -0.712 . . . . 71.54 111.203 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.836 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.6 mp -96.86 129.53 44.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 120.566 -0.454 . . . . 71.4 111.536 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.575 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -111.49 116.52 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.3 0.572 . . . . 63.22 110.834 -172.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -116.28 133.72 10.95 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.739 -0.664 . . . . 73.22 111.867 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 245' ' ' LEU . 1.3 pp -119.9 146.51 45.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.42 . . . . 52.24 110.678 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -134.17 133.44 6.87 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.612 -0.722 . . . . 73.31 111.778 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.717 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 19.4 m-85 -102.86 114.48 28.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.666 -0.864 . . . . 73.54 108.666 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 22.1 m -116.84 114.95 24.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.811 0.339 . . . . 63.21 110.417 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -132.45 137.51 47.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.854 0.359 . . . . 74.22 110.676 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.9 m -112.37 95.71 5.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.001 -0.545 . . . . 60.34 110.159 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 43.7 tp -82.05 88.34 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.268 -0.642 . . . . 75.02 109.268 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 75.1 mmtt 67.93 163.82 0.13 Allowed Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.259 -0.882 . . . . 72.24 110.273 -175.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 40.8 Cg_endo -69.23 64.29 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.355 2.037 . . . . 31.24 112.3 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -158.68 -45.43 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.911 -0.586 . . . . 74.34 112.315 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.6 mt -124.08 121.44 62.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 64.15 111.652 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 280' ' ' GLU . 37.1 ttmt -117.47 115.44 25.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.367 -0.605 . . . . 64.0 109.367 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.5 tp -100.44 130.53 46.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.424 -0.353 . . . . 73.44 110.521 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 247' ' ' TYR . 30.0 m -129.98 111.25 12.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.554 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.922 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -102.21 122.84 44.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.892 -1.151 . . . . 72.24 107.892 174.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.9 m -124.39 139.58 53.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.971 0.415 . . . . 63.34 110.854 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.4 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -143.92 127.77 17.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.99 -0.55 . . . . 42.22 110.248 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.754 HD11 HD23 ' A' ' 242' ' ' LEU . 2.7 tm? -101.62 118.04 36.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.361 -0.977 . . . . 74.12 108.361 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.5 mm? -97.7 110.95 23.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.605 -0.887 . . . . 64.41 108.605 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.836 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.9 m-20 -68.62 102.34 1.47 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.711 -0.848 . . . . 53.32 108.711 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 242' ' ' LEU . . . -64.9 -10.06 43.65 Favored Glycine 0 C--N 1.321 -0.293 0 CA-C-N 115.64 -0.709 . . . . 71.3 111.844 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -90.59 -25.34 20.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.206 -0.497 . . . . 73.31 111.092 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -161.5 24.25 0.12 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.105 1.52 . . . . 74.43 115.105 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 264' ' ' ASP . 0.2 OUTLIER -64.18 -46.47 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 120.079 1.309 . . . . 73.42 112.878 176.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.43 -25.92 62.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.067 0.461 . . . . 61.53 110.594 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.87 2.37 32.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 52.51 111.067 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.63 -103.12 0.34 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.141 -1.028 . . . . 71.2 112.856 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -158.78 167.28 34.69 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.082 -1.056 . . . . 32.33 113.223 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -111.47 150.12 30.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.66 -0.77 . . . . 73.52 109.593 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.666 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 43.6 mttm -93.7 137.18 33.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.689 -0.856 . . . . 71.03 108.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.7 tm? -125.66 133.06 52.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.755 0.312 . . . . 72.21 110.294 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.469 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.24 122.39 2.18 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.062 -0.815 . . . . 61.35 111.062 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.922 HD23 HD22 ' A' ' 259' ' ' LEU . 2.2 tm? -115.82 125.32 52.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.644 -0.502 . . . . 64.33 109.644 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -134.9 138.43 10.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.429 -0.891 . . . . 70.14 112.895 -175.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -118.85 132.39 56.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.777 -0.453 . . . . 74.31 109.777 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.728 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 46.4 mt-10 -109.85 110.88 22.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.812 -0.81 . . . . 70.25 108.812 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.567 ' HD1' HD13 ' A' ' 31' ' ' LEU . 16.4 t80 -104.16 141.6 35.96 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.589 -0.893 . . . . 74.14 108.589 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -135.56 119.79 17.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.935 0.398 . . . . 52.01 110.639 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.22 108.43 19.05 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.156 -0.683 . . . . 53.04 109.156 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 34' ' ' LYS . 36.2 mt -121.13 -69.02 0.86 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.843 -0.799 . . . . 40.33 108.843 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 114.679 -1.146 . . . . 70.3 108.532 177.228 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.347 0.118 . . . . 74.31 111.034 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.58 145.43 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.683 0.278 . . . . 54.23 110.69 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.745 ' HB ' ' HE2' ' A' ' 119' ' ' LYS . 60.5 t -67.43 125.99 91.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.037 -0.529 . . . . 72.11 110.332 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 3' ' ' VAL . 46.7 Cg_exo -57.23 153.98 36.87 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.39 2.727 . . . . 52.13 113.279 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.03 64.34 6.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.114 2.543 . . . . 72.05 112.047 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.604 ' HB ' HD21 ' A' ' 150' ' ' LEU . 14.9 p -69.63 -37.74 76.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.466 -0.788 . . . . 52.22 111.096 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.742 ' HB3' HG21 ' A' ' 143' ' ' VAL . 3.5 p90 -64.12 -22.03 66.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 72.31 111.278 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.69 -19.79 44.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.066 -0.516 . . . . 54.4 110.367 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.49 11.91 37.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.032 0.92 . . . . 71.32 109.333 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.979 HD21 ' HA3' ' A' ' 152' ' ' GLY . 3.3 tp -76.53 -14.3 60.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.007 -0.997 . . . . 73.11 110.849 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.66 26.23 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.44 -0.886 . . . . 65.41 113.291 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -68.93 -50.17 51.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.151 0.476 . . . . 71.5 110.525 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -57.34 -38.86 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.836 -0.62 . . . . 72.52 111.027 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.65 72.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 72.32 111.402 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.77 -39.91 84.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.6 -0.273 . . . . 74.33 111.518 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 14.7 t70 -58.59 -49.83 76.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.642 -0.254 . . . . 73.12 111.353 -175.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -70.23 -31.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.015 0.436 . . . . 73.21 110.867 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -72.64 -32.19 65.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 74.03 110.71 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -81.87 -25.84 34.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 65.12 110.73 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' HD3' ' O ' ' A' ' 16' ' ' ASP . 1.9 mptm? -85.17 20.06 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 63.35 110.865 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.601 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -99.61 -19.47 20.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 53.43 113.286 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -87.16 138.28 31.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.267 0.556 . . . . 74.15 112.141 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -152.35 109.65 0.42 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.22 -0.9 . . . . 63.04 111.709 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -103.73 14.99 29.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.785 0.326 . . . . 74.42 111.005 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.33 14.61 53.52 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 109.226 -1.55 . . . . 72.42 109.226 -166.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 46' ' ' SER . 5.3 tt -99.47 145.6 27.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.944 -1.128 . . . . 64.43 110.688 -168.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 277' ' ' LEU . 28.3 mm -102.49 125.26 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.986 -1.006 . . . . 61.11 110.198 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -107.79 120.01 41.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.332 -0.618 . . . . 63.41 109.332 175.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 279' ' ' LEU . 22.5 tp -114.44 147.56 39.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.837 0.351 . . . . 73.1 110.554 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 43' ' ' SER . 4.6 t70 -150.82 131.65 14.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 55.14 109.768 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.942 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -126.84 123.59 37.67 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 97.1 mttt -132.65 124.97 29.29 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.839 -0.344 . . . . 63.34 110.988 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 41' ' ' PHE . 8.8 t -135.83 129.95 33.2 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.285 -0.635 . . . . 52.15 109.285 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.728 ' HB3' HH12 ' A' ' 63' ' ' ARG . 90.3 mttt -118.3 131.17 56.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.965 -0.562 . . . . 53.12 109.969 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -132.91 150.26 52.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.238 -0.437 . . . . 54.14 110.513 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.91 2.37 46.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.799 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -100.08 24.75 8.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 54.24 111.521 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.3 -5.89 82.64 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.328 -0.939 . . . . 64.42 113.451 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.42 127.78 46.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.179 0.99 . . . . 70.14 111.764 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.3 117.6 11.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.507 -0.923 . . . . 74.43 108.507 164.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' HB2' HG22 ' A' ' 33' ' ' THR . 96.0 m-85 -110.32 125.6 53.34 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.588 -0.445 . . . . 75.04 110.768 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 20.6 m -125.18 116.11 21.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.897 -0.592 . . . . 61.52 109.934 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 6.4 m -108.76 123.28 48.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.051 -0.722 . . . . 75.21 109.051 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -130.03 126.41 37.64 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.006 -0.368 . . . . 74.05 110.006 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.14 156.66 26.97 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.946 -1.121 . . . . 61.1 112.576 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.593 ' HB3' HD21 ' A' ' 26' ' ' LEU . 16.6 m -137.98 132.35 32.15 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.308 -0.627 . . . . 33.35 109.308 176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -144.32 130.04 19.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.862 0.363 . . . . 71.42 110.593 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 46.1 t30 -80.64 142.02 34.39 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.444 -0.576 . . . . 73.24 109.444 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -64.04 -19.37 65.16 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.968 0.413 . . . . 63.01 111.255 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -70.62 -13.6 62.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 64.14 110.442 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m 71.56 -3.52 2.12 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.726 -0.67 . . . . 70.51 111.726 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -73.06 -27.46 61.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.217 -0.447 . . . . 71.12 110.981 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.28 101.66 6.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 71.21 110.034 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -125.66 120.69 58.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.985 -0.552 . . . . 70.13 110.11 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -131.3 125.03 31.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.955 -0.387 . . . . 65.43 109.955 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.83 155.19 20.06 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.266 -0.969 . . . . 75.23 112.409 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 p -146.8 141.21 26.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.111 0.482 . . . . 74.53 110.441 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.38 122.54 42.03 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.926 -1.139 . . . . 73.25 107.926 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 28.0 mt-10 -116.98 119.96 36.91 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.956 -0.565 . . . . 73.1 109.82 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -109.78 120.99 44.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.724 -0.671 . . . . 70.15 109.841 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 42.9 tttp -117.08 132.51 56.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.067 -0.716 . . . . 65.3 109.067 176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 70' ' ' THR . 37.9 t80 -100.19 121.6 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.044 -1.095 . . . . 74.22 108.044 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.728 HH12 ' HB3' ' A' ' 34' ' ' LYS . 10.6 ttp180 -123.72 107.3 11.31 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.538 0.685 . . . . 73.05 111.094 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.4 ' HB2' ' HE2' ' A' ' 62' ' ' TYR . 63.3 t-105 -113.55 115.58 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.79 -1.096 . . . . 64.45 108.886 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m 70.93 139.13 0.04 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.961 0.788 . . . . 72.53 109.59 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 2.7 tp10 -65.58 101.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.692 -0.485 . . . . 71.53 109.692 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.24 68.92 0.59 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.378 -0.828 . . . . 72.14 110.684 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -137.04 -76.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.382 -1.087 . . . . 74.34 110.382 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -122.11 130.18 53.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.743 0.306 . . . . 61.13 110.247 173.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.797 HG23 ' HB ' ' A' ' 86' ' ' THR . 9.0 t -138.44 135.39 35.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.425 0.631 . . . . 75.41 112.089 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 85.2 m-85 -105.75 133.77 49.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.844 -0.798 . . . . 74.43 108.844 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.4 m -120.84 119.31 32.29 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.71 -0.396 . . . . 71.24 111.465 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 28.1 mt-10 -130.96 152.2 50.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.668 -0.697 . . . . 73.05 109.803 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -160.43 104.38 1.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 71.22 110.917 178.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.975 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 48.8 t90 -98.53 127.94 44.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.298 -0.41 . . . . 71.15 110.358 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.86 136.84 38.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.488 -0.93 . . . . 71.01 108.488 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -61.8 -25.83 67.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.982 0.42 . . . . 72.22 111.862 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.7 -38.17 5.71 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.118 0.784 . . . . 72.12 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.27 -90.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.347 0.869 . . . . 55.31 113.347 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 m -85.22 123.6 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.811 0.671 . . . . 73.33 112.811 -166.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.975 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -108.48 119.07 38.44 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.624 -0.51 . . . . 64.24 109.624 168.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 102' ' ' SER . . . -115.53 156.61 15.54 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.643 -0.789 . . . . 41.11 112.776 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 9.8 t -172.88 148.72 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.681 -0.489 . . . . 74.42 109.681 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 100' ' ' ASP . 12.2 mm-40 165.58 -155.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.585 1.154 . . . . 73.4 110.491 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.495 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -131.58 138.97 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.49 0.552 . . . . 64.5 112.49 -165.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.797 ' HB ' HG23 ' A' ' 70' ' ' THR . 23.1 m -127.77 131.75 49.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.337 -0.392 . . . . 53.1 110.003 175.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 97' ' ' LEU . 3.9 p -129.95 129.8 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.994 0.426 . . . . 64.41 111.672 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.56 117.87 30.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.278 -1.008 . . . . 73.44 108.278 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -87.28 140.18 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.26 -0.576 . . . . 71.42 111.642 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.84 -25.85 15.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.279 -0.873 . . . . 74.42 110.655 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.9 tp -67.13 -57.23 7.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.032 -0.729 . . . . 74.14 109.032 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.54 76.17 5.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.298 -1.001 . . . . 70.34 108.298 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -55.67 123.11 13.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.554 -0.748 . . . . 71.23 110.683 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . 100.6 -0.91 55.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.665 -0.698 . . . . 73.42 112.319 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.3 tp -91.41 131.1 37.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.115 0.483 . . . . 51.13 110.201 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -121.68 111.24 16.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.328 -0.851 . . . . 72.34 109.85 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.437 ' HB2' HG13 ' A' ' 87' ' ' VAL . 1.9 mm? -100.79 126.34 47.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.083 -0.71 . . . . 72.35 109.083 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 23.6 m -128.87 118.34 22.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.119 0.485 . . . . 75.3 111.749 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.637 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 77.7 m-85 -111.06 116.22 30.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.85 -1.167 . . . . 72.23 107.85 170.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.649 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.5 p-10 -130.56 128.19 40.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.846 0.355 . . . . 73.44 110.575 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 t -119.57 148.81 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.732 0.301 . . . . 63.25 110.528 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 7.9 p -133.04 134.54 44.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.301 -0.409 . . . . 60.14 110.478 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.637 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 9.8 m-85 -111.21 138.94 47.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.207 -0.294 . . . . 75.03 110.207 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.2 p -122.47 107.85 34.05 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.834 0.35 . . . . 64.21 110.195 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.91 -1.13 9.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.986 2.457 . . . . 74.33 112.76 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -63.86 -61.59 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.38 0.609 . . . . 73.52 109.51 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.516 ' HB ' ' HG3' ' A' ' 109' ' ' LYS . 42.7 m -91.76 -27.27 18.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.283 -0.871 . . . . 54.3 109.958 176.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.5 9.4 60.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.666 -0.778 . . . . 54.31 111.843 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.587 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -94.16 148.94 21.69 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.802 0.334 . . . . 61.04 110.617 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' CB ' ' HD1' ' A' ' 103' ' ' PHE . 18.6 ptpt -114.23 152.74 30.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 44.33 110.796 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.587 ' OD1' ' HE2' ' A' ' 109' ' ' LYS . 2.8 m-20 -116.7 122.58 44.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.952 -0.758 . . . . 71.31 108.952 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.33 114.92 29.33 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.343 -0.614 . . . . 53.42 109.343 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.408 ' HD2' ' OD2' ' A' ' 130' ' ' ASP . 50.1 tttm -115.03 137.98 51.38 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.211 0.529 . . . . 74.23 110.606 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.53 HG23 ' HB3' ' A' ' 129' ' ' MET . 3.2 tp -127.3 126.0 66.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.431 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.61 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 24.4 ttpp -118.9 120.31 36.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.202 0.525 . . . . 72.02 110.208 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.8 p -107.34 116.89 32.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.604 -0.887 . . . . 73.53 108.604 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.37 135.78 8.19 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.985 -1.103 . . . . 42.32 112.106 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -126.78 124.81 40.56 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.442 -0.577 . . . . 73.1 109.442 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.745 ' HE2' ' HB ' ' A' ' 3' ' ' VAL . 15.9 ptmt -109.08 121.71 45.73 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.486 0.66 . . . . 72.44 109.921 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 120' ' ' ARG . 22.2 mmt180 -104.56 155.92 18.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.013 -1.106 . . . . 72.1 108.013 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -54.68 -28.57 48.52 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.416 0.447 . . . . 74.21 112.184 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.34 -15.38 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.548 -0.296 . . . . 74.43 111.692 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 142' ' ' LEU . 9.1 tp -146.35 135.56 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 120.601 -0.44 . . . . 72.42 111.74 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.739 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 43.8 t30 -122.63 120.86 34.99 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.764 -0.585 . . . . 72.24 111.737 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.4 127.03 53.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.696 0.284 . . . . 73.14 111.213 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.39 125.64 4.08 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.037 -0.601 . . . . 54.21 112.047 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 49.7 m -113.32 112.11 23.14 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.578 -0.366 . . . . 63.41 111.275 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 9.9 m-20 -96.2 147.46 23.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 73.44 109.994 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.53 ' HB3' HG23 ' A' ' 114' ' ' ILE . 25.5 ttt -139.77 120.41 14.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.627 -0.261 . . . . 75.44 110.543 173.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 113' ' ' LYS . 35.4 m-20 -90.72 117.45 29.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.762 -0.829 . . . . 73.44 108.762 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.18 97.53 9.26 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.079 0.466 . . . . 63.43 110.142 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.03 150.23 26.73 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.629 -0.714 . . . . 55.34 109.212 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.77 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -72.27 -19.9 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.98 0.363 . . . . 74.24 111.98 -175.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.56 -18.96 21.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 74.4 111.047 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 167.8 128.93 1.03 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.519 -0.848 . . . . 73.21 112.578 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.0 150.56 26.65 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.77 2.314 . . . . 61.22 112.657 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 m -126.8 134.01 50.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.566 . . . . 61.1 110.08 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 118.72 56.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.017 0.437 . . . . 72.2 109.87 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 12.1 ttp180 -111.24 130.18 55.74 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.622 -0.51 . . . . 71.44 109.622 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.19 132.49 10.94 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.993 -1.099 . . . . 73.33 111.406 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.84 115.47 23.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.361 -0.607 . . . . 61.44 109.361 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 123' ' ' ILE . 8.9 tp -121.0 124.31 44.53 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.989 -0.55 . . . . 70.24 110.383 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.742 HG21 ' HB3' ' A' ' 7' ' ' TYR . 77.3 t -110.92 131.78 61.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 52.1 109.809 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.5 mm? -108.22 137.6 45.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.347 -0.842 . . . . 75.13 108.93 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -125.86 117.38 2.87 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.582 -0.736 . . . . 41.32 111.537 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 90.0 m-85 -136.32 148.42 47.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.022 -0.733 . . . . 64.23 109.022 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.69 99.84 0.07 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 65.13 110.673 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 102.97 -30.87 9.53 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.564 -0.744 . . . . 74.32 111.866 -176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.727 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 85.5 m95 -105.95 122.06 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.221 0.534 . . . . 74.52 111.703 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.604 HD21 ' HB ' ' A' ' 6' ' ' THR . 1.6 tm? -110.61 149.37 30.51 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.828 -1.545 . . . . 73.53 106.828 172.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -157.44 160.14 38.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.67 -0.812 . . . . 73.35 111.248 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.979 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -156.8 133.34 3.58 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.047 -0.979 . . . . 62.43 110.882 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.434 ' HD1' ' HD2' ' A' ' 169' ' ' PHE . 34.0 m-85 -130.75 117.81 19.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.087 0.47 . . . . 74.04 110.205 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 168' ' ' ASN . 39.7 mt-30 -113.77 129.06 56.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.639 -0.71 . . . . 74.04 109.976 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.4 133.59 34.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.534 -0.303 . . . . 73.42 110.2 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 166' ' ' GLN . 6.7 t30 -113.67 119.43 37.4 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.753 -0.462 . . . . 73.54 109.753 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.636 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 83.5 t80 -105.4 124.06 48.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.107 -0.497 . . . . 74.3 110.249 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.436 ' OE1' ' HE2' ' A' ' 161' ' ' LYS . 35.3 tt0 -86.96 97.73 10.86 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.672 -0.862 . . . . 75.41 108.672 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.1 m -71.53 -21.88 61.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 113.673 -1.603 . . . . 72.31 111.188 173.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.41 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -57.88 -34.01 69.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.735 -0.839 . . . . 63.5 108.735 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.574 ' HG2' ' H ' ' A' ' 162' ' ' SER . 17.0 ttmm -112.9 -157.45 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.52 -1.289 . . . . 60.02 107.52 170.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.574 ' H ' ' HG2' ' A' ' 161' ' ' LYS . 5.6 p -109.74 27.67 9.34 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 122.034 -0.416 . . . . 50.44 111.703 176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -143.83 147.65 34.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 117.747 -1.581 . . . . 75.43 114.406 -161.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.636 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 69.4 t -73.75 124.26 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.265 -0.88 . . . . 51.43 109.456 171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 14.8 p -95.94 -31.97 12.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.629 -0.26 . . . . 74.03 111.581 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 156' ' ' ASN . 64.2 mt-30 -127.31 131.71 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.743 0.306 . . . . 72.11 110.785 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 186' ' ' ASP . 17.7 m -121.86 129.35 52.52 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.754 -0.461 . . . . 65.25 109.754 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 154' ' ' GLN . 27.9 t-20 -136.87 121.33 18.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.766 -0.457 . . . . 70.13 109.766 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.645 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 46.4 m-85 -121.78 140.63 52.11 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.948 -0.301 . . . . 71.12 110.59 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -138.65 139.6 38.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.323 -0.399 . . . . 44.22 110.706 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 12.4 t -132.3 152.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.187 -0.672 . . . . 64.41 109.187 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.18 116.83 1.36 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.804 -0.712 . . . . 74.1 112.037 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -113.39 121.23 43.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.807 -0.812 . . . . 64.35 108.807 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 129.72 56.5 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.983 0.896 . . . . 74.15 111.892 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.9 m -110.13 161.8 15.21 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 106.591 -1.633 . . . . 75.53 106.591 166.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -57.51 -46.61 83.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.076 0.398 . . . . 73.43 111.9 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -106.18 -1.68 23.37 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.7 0.259 . . . . 71.01 111.7 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.2 117.42 14.52 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 110.489 -0.189 . . . . 70.24 110.489 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -118.86 124.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.145 -0.622 . . . . 74.52 110.987 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.8 tt -118.9 138.1 52.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.548 0.689 . . . . 74.23 111.652 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.812 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 64.2 m80 -114.72 150.51 35.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.124 -0.944 . . . . 74.21 108.98 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.572 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 27.8 m -123.33 138.68 54.56 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.265 -0.642 . . . . 72.41 109.265 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -134.27 140.97 46.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 65.0 111.322 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 47.0 t -133.47 115.55 22.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.283 -0.871 . . . . 72.4 110.019 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.782 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 9.0 t30 -103.62 99.46 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.384 0.611 . . . . 73.23 110.059 176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' A' ' 167' ' ' SER . 46.0 m-20 58.01 -161.48 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.886 -1.052 . . . . 73.41 110.804 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.52 -5.24 87.95 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.263 -0.881 . . . . 74.12 111.056 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 25.1 p -88.54 -24.65 22.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.039 0.755 . . . . 73.01 113.039 -173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 5.2 tm-20 -136.25 125.98 25.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.801 -0.36 . . . . 44.4 111.154 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.4 123.92 26.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 74.12 109.198 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.71 -146.2 4.82 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.238 -0.982 . . . . 61.24 113.003 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -172.82 -171.16 37.32 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.859 -0.686 . . . . 64.34 112.962 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.812 ' HB3' ' HB2' ' A' ' 181' ' ' HIS . 41.3 t -147.19 140.13 25.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.283 -0.636 . . . . 72.42 109.283 -177.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.9 mp -120.13 118.64 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 110.07 -0.344 . . . . 75.25 110.07 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -108.91 120.42 42.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.301 0.572 . . . . 75.52 109.796 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 196' ' ' GLN . 11.1 mm100 -123.02 112.59 17.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.45 -0.795 . . . . 64.14 110.812 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -108.68 127.76 54.26 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.097 -0.705 . . . . 75.35 109.097 177.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 202' ' ' LEU . 1.1 m -111.57 151.79 13.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.091 0.472 . . . . 64.43 110.473 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -63.4 -20.19 65.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.062 -0.972 . . . . 64.32 111.829 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.79 47.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.363 0.505 . . . . 53.23 112.363 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 226' ' ' GLN . 48.9 mmtm 64.58 23.23 12.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 63.02 113.08 169.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 225' ' ' TYR . 7.2 tt -126.79 134.61 50.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 73.33 110.764 -174.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -126.28 134.96 51.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.144 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 223' ' ' ALA . 24.7 m -122.91 141.75 51.56 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.324 -0.251 . . . . 64.31 110.324 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.41 135.58 48.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.235 0.541 . . . . 54.11 110.412 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.742 HG22 HG22 ' A' ' 221' ' ' ILE . 93.2 t -114.6 132.87 62.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.62 -0.718 . . . . 73.22 110.036 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -113.61 126.98 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.181 -1.044 . . . . 73.35 108.181 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 218' ' ' ARG . 5.0 tp -140.8 128.77 21.94 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 110.133 -0.321 . . . . 63.31 110.133 -170.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.435 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -148.96 135.83 19.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.0 0.428 . . . . 75.11 111.696 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -111.23 124.16 51.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.812 -0.631 . . . . 74.02 109.633 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.8 p -95.66 112.92 24.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 73.45 110.901 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.39 143.79 52.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 73.45 110.437 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.99 -18.19 50.3 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.978 -0.849 . . . . 54.31 110.978 -173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -136.36 164.24 28.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.395 -0.403 . . . . 70.31 110.136 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.6 p -92.46 16.4 11.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.416 0.627 . . . . 74.55 109.483 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.02 111.01 17.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.285 -0.87 . . . . 72.24 111.637 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 25.1 m -96.17 122.67 39.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.204 -1.036 . . . . 54.14 108.204 168.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.405 ' O ' HD12 ' A' ' 208' ' ' LEU . 28.8 mmm180 -105.52 116.9 32.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.592 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 23.9 p90 -114.03 152.53 30.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.243 0.544 . . . . 74.54 110.387 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.67 140.38 7.63 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.921 -1.036 . . . . 72.55 110.724 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 206' ' ' VAL . 15.8 pt -131.74 134.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.729 0.265 . . . . 63.13 110.512 -177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -138.63 130.07 27.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.827 0.346 . . . . 62.03 110.583 174.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -120.85 125.66 48.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.53 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -107.24 114.96 29.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.509 0.671 . . . . 62.2 110.025 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.694 ' HB2' ' HG ' ' A' ' 202' ' ' LEU . 45.3 t80 -129.17 126.84 40.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.227 -0.897 . . . . 74.0 110.542 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.411 ' CG ' ' HB3' ' A' ' 201' ' ' LYS . 16.8 pt20 -77.14 123.75 26.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.373 -0.603 . . . . 70.25 109.373 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 233' ' ' PHE . 73.7 mt -70.14 -55.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.933 -0.576 . . . . 75.43 111.22 -172.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.637 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 19.2 t70 177.07 -54.47 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.366 0 O-C-N 123.66 0.6 . . . . 72.31 110.806 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 96.5 Cg_endo -83.75 -133.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.984 1.789 . . . . 74.3 112.051 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 9.8 m-20 -92.39 11.83 24.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 54.23 110.709 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.1 133.8 54.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.54 . . . . 75.02 111.082 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.89 142.14 47.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.182 -0.917 . . . . 61.05 109.43 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.489 ' HB2' HD11 ' A' ' 227' ' ' ILE . 70.9 t80 -106.78 132.38 52.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.183 0.516 . . . . 72.44 110.262 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 17.7 m -123.12 127.2 48.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.528 -0.76 . . . . 63.4 110.028 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -111.94 141.35 45.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.65 -0.5 . . . . 63.43 109.65 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 20.9 pttm -141.1 153.87 45.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.521 0.2 . . . . 70.25 110.868 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.625 HG12 HG12 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -147.47 155.15 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 74.42 110.187 175.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.764 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 41.1 t-20 -125.55 148.01 49.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.899 -0.778 . . . . 63.43 108.899 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.592 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 7.6 t30 -41.29 -37.64 1.01 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.645 1.216 . . . . 64.23 113.36 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.1 m -78.49 27.45 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.752 -0.204 . . . . 61.32 111.285 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 239' ' ' ASN . 78.7 p 57.93 40.83 25.36 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.956 0.902 . . . . 64.51 110.605 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.819 ' HB3' HD11 ' A' ' 262' ' ' LEU . 56.4 mt -97.75 117.09 31.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.802 -0.635 . . . . 72.11 109.744 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.571 ' HA ' HG23 ' A' ' 237' ' ' VAL . 1.9 mp -103.27 117.99 49.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 109.776 -0.453 . . . . 52.41 109.776 -174.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -110.52 148.25 17.58 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.358 -0.925 . . . . 43.33 113.122 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.72 150.62 38.78 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.675 -0.861 . . . . 74.13 108.675 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.33 123.17 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.533 -0.841 . . . . 61.2 111.591 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.37 116.27 19.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.235 0.54 . . . . 72.32 110.225 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.8 t -116.05 136.72 52.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.543 -0.753 . . . . 74.54 110.732 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -132.87 134.28 44.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.981 -0.554 . . . . 65.24 110.68 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.2 t -89.03 115.34 26.51 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.943 -0.762 . . . . 73.23 108.943 172.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 251' ' ' LEU . 5.6 mp -75.19 -59.24 2.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.585 0.707 . . . . 45.01 109.517 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 255' ' ' ILE . 0.0 OUTLIER -119.73 149.69 48.87 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 106.991 -1.485 . . . . 55.11 106.991 171.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.8 99.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.391 2.061 . . . . 61.04 112.181 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.19 -22.05 6.03 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.769 -0.65 . . . . 72.12 112.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 252' ' ' LYS . 3.4 mp -106.26 119.25 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.376 -0.485 . . . . 71.05 109.981 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -120.62 120.65 36.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.679 . . . . 74.31 111.473 -172.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.2 tp -100.95 128.57 46.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.101 -0.703 . . . . 52.34 109.101 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.4 t -126.16 113.99 17.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.518 0.675 . . . . 73.32 111.125 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.955 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -99.64 124.12 44.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.21 -1.033 . . . . 75.52 108.21 175.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 22.6 t -127.32 143.16 51.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.945 0.402 . . . . 74.15 110.079 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.48 154.52 45.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.804 -0.443 . . . . 62.1 109.804 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.9 tm? -130.84 118.59 20.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.341 -0.985 . . . . 72.21 108.341 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.646 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -97.4 106.69 19.05 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.343 -1.355 . . . . 72.34 107.343 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 5.2 m-20 -71.62 105.76 3.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.126 -0.694 . . . . 62.32 109.126 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.14 -13.89 10.28 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.256 -0.497 . . . . 65.22 112.885 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.47 -18.39 26.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.728 0.299 . . . . 63.24 110.946 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 4.2 m-20 -120.89 -41.31 2.56 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.72 0.637 . . . . 73.41 112.72 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 263' ' ' LEU . 34.2 m -59.35 -25.81 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.429 0.529 . . . . 75.35 112.429 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 269' ' ' ASN . 2.4 t-20 -63.59 -30.36 71.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 72.03 110.431 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.34 -16.76 15.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 45.43 110.677 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 119.95 94.58 1.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 116.019 -0.537 . . . . 64.33 112.265 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 177.93 86.43 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.661 -0.78 . . . . 34.45 112.498 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -113.98 144.65 42.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.658 0.266 . . . . 65.24 110.639 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 25.6 mmtp -97.35 144.11 27.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.507 -0.315 . . . . 72.31 110.238 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 275' ' ' LEU . 1.7 tm? -134.85 126.28 28.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.835 0.35 . . . . 71.25 110.105 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.05 126.78 5.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 43.24 111.419 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.955 HD23 HD22 ' A' ' 259' ' ' LEU . 2.8 tm? -115.26 134.02 55.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.739 -0.467 . . . . 71.42 109.739 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -137.59 144.57 16.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.419 -0.896 . . . . 54.53 113.25 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.703 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.3 mm? -123.98 131.43 53.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.419 -0.585 . . . . 63.52 109.419 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.72 112.22 15.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.346 -0.613 . . . . 73.52 109.346 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.942 ' HB2' HD22 ' A' ' 31' ' ' LEU . 93.6 m-85 -106.9 106.38 16.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.112 -0.495 . . . . 70.12 110.308 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.556 ' HG2' HD23 ' A' ' 284' ' ' LEU . 29.7 tt0 -99.73 110.62 23.01 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.474 -0.565 . . . . 72.1 109.474 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 33' ' ' THR . . . -97.95 108.67 21.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.419 0.628 . . . . 63.31 110.967 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 282' ' ' GLN . 3.0 mm? -135.14 -38.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.837 -1.074 . . . . 72.11 108.779 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.825 -1.08 . . . . 74.14 109.519 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.743 0.306 . . . . 71.33 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.6 -44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.359 . . . . 75.41 110.178 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 119' ' ' LYS . 21.3 t 64.47 96.97 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.548 -0.751 . . . . 51.2 111.242 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.9 Cg_endo -69.42 142.23 48.84 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.794 2.329 . . . . 73.32 112.388 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 19.3 Cg_exo -66.39 90.96 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.807 2.338 . . . . 61.42 111.974 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.549 ' HB ' HD21 ' A' ' 150' ' ' LEU . 2.3 p -84.17 -2.57 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.443 0.639 . . . . 64.13 110.781 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -57.92 -24.63 58.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 72.23 109.753 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.98 -26.21 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.11 110.078 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.41 -4.53 48.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 71.33 110.574 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD23 ' CD1' ' A' ' 150' ' ' LEU . 66.3 mt -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 72.13 110.905 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.32 40.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.543 -1.313 . . . . 54.31 114.247 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 37.7 tttm -57.95 -54.57 45.47 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.462 0.631 . . . . 64.33 109.669 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 p -58.72 -39.33 80.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.568 -0.742 . . . . 62.11 111.676 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.39 70.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.532 -0.304 . . . . 72.32 111.195 -176.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -68.02 -36.23 79.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 73.13 110.588 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 9.9 t70 -68.43 -48.69 63.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.373 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.26 -39.33 78.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.445 -0.343 . . . . 71.53 111.213 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.8 -41.35 78.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.939 -0.393 . . . . 75.41 109.939 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m 70.78 94.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.378 -0.828 . . . . 62.22 111.998 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -110.76 -12.22 14.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 54.04 110.548 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.85 1.2 89.01 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.864 -0.684 . . . . 24.13 112.536 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.668 ' HB3' ' HA3' ' A' ' 276' ' ' GLY . 87.8 m-85 -133.84 144.17 48.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.344 -0.613 . . . . 73.1 109.344 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.94 34.0 0.4 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.182 -1.008 . . . . 51.2 112.796 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.2 -1.79 38.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.259 0.552 . . . . 75.32 109.973 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 275' ' ' LEU . . . 83.78 12.95 76.44 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.254 -1.139 . . . . 43.04 110.254 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 48' ' ' ASN . 6.8 tp -131.24 179.22 6.14 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.664 0.745 . . . . 63.43 112.015 -169.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.916 HG13 ' HB3' ' A' ' 277' ' ' LEU . 2.0 mp -110.26 147.66 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.815 -1.084 . . . . 75.45 109.492 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.562 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 14.6 ptpt -138.41 154.38 48.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 50.24 109.577 171.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 279' ' ' LEU . 3.7 tt -140.09 145.09 37.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.695 0.284 . . . . 73.25 111.12 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -131.11 128.35 39.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.553 0.692 . . . . 73.44 109.901 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -108.43 124.5 50.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.267 -0.879 . . . . 71.34 108.879 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -125.56 123.33 38.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.798 0.332 . . . . 63.23 110.122 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.9 m -137.95 121.56 17.37 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.643 -0.873 . . . . 63.44 108.643 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -137.07 143.82 42.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.551 0.691 . . . . 74.45 112.276 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -139.1 137.49 36.22 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.949 -1.13 . . . . 50.42 107.949 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.75 49.32 1.32 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.846 0.832 . . . . 72.44 110.756 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -122.46 22.64 9.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.677 -1.147 . . . . 71.02 109.099 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.695 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 91.14 -8.24 79.79 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 119.4 -0.667 . . . . 54.55 113.751 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.69 127.38 48.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.514 1.157 . . . . 73.42 112.643 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.677 ' HB2' ' HB2' ' A' ' 61' ' ' LYS . 22.9 mt-10 -139.54 118.85 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.891 -0.411 . . . . 63.52 109.891 165.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.95 121.31 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.79 0.329 . . . . 72.23 110.271 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.859 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.4 m -126.95 132.37 50.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 73.24 111.18 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 m -125.36 140.45 52.8 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.39 -0.596 . . . . 51.14 109.39 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.8 m -147.57 126.11 12.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.785 0.326 . . . . 51.42 110.479 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.681 ' HA3' ' HA2' ' A' ' 56' ' ' GLY . . . -164.17 -167.14 24.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 73.2 112.25 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 39.0 m -127.59 158.54 37.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 55.14 110.505 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -135.08 135.58 41.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 75.22 110.328 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.67 ' HA ' HD11 ' A' ' 26' ' ' LEU . 24.4 t-20 -76.23 138.06 40.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.977 -0.556 . . . . 44.3 109.648 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.499 ' HA ' HD13 ' A' ' 27' ' ' ILE . 1.9 m -46.63 138.95 5.54 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.14 0.9 . . . . 72.4 111.983 -176.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 72.05 29.74 2.3 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.899 0.749 . . . . 72.03 110.321 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p 49.95 37.73 14.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.651 0.781 . . . . 73.21 112.037 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -72.61 -35.14 67.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.268 -0.423 . . . . 62.2 111.39 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -160.5 118.73 2.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.935 -0.395 . . . . 54.22 109.935 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -117.01 120.97 66.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.844 0.354 . . . . 71.5 110.282 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.8 m -136.79 129.55 30.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.272 -0.422 . . . . 74.22 110.359 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.681 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -138.94 153.94 22.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.244 -0.979 . . . . 54.32 113.092 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.603 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 14.1 p -101.54 163.54 12.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.431 -0.581 . . . . 64.33 109.431 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 tp -121.03 150.19 41.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.515 0.674 . . . . 61.11 112.044 -170.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.859 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 61.8 mt-10 -126.94 120.07 28.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.981 -1.009 . . . . 70.4 108.832 174.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -103.52 118.82 37.63 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 34.1 mtmm -117.23 144.02 45.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.149 0.5 . . . . 74.31 110.322 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 32.9 m-85 -116.19 120.15 38.06 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.775 -0.824 . . . . 72.14 108.775 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.536 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 20.5 ttm-85 -106.72 107.27 18.21 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.56 0.695 . . . . 73.21 111.084 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 68.4 t-105 -114.35 107.62 15.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.375 -1.284 . . . . 74.02 110.12 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -94.28 66.78 3.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.322 0.582 . . . . 75.33 111.93 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -85.19 -37.36 20.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.791 -1.188 . . . . 70.43 107.791 166.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' CB ' ' HA ' ' A' ' 90' ' ' GLN . 3.7 m-85 -157.34 -43.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.153 -1.385 . . . . 74.43 108.717 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.8 74.81 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.5 -0.773 . . . . 24.13 112.072 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -111.44 130.05 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 75.24 110.502 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 41.7 m -137.93 113.15 9.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.033 -0.531 . . . . 73.31 110.434 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 43.4 t80 -99.65 132.08 45.22 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.857 -0.794 . . . . 65.03 108.857 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 28.6 m -128.05 121.4 29.61 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.023 0.44 . . . . 70.03 111.661 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.63 120.54 42.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.715 -0.846 . . . . 71.12 108.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 59' ' ' GLU . 26.1 ttpt -113.46 94.83 5.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.14 -0.482 . . . . 62.4 109.803 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.514 ' O ' ' HB2' ' A' ' 57' ' ' SER . 3.9 t90 -100.15 127.08 46.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.259 -0.428 . . . . 75.24 109.878 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.603 ' HA ' ' HB2' ' A' ' 57' ' ' SER . 15.3 m120 -105.46 166.99 10.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.214 -0.448 . . . . 75.13 110.477 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 p -67.5 -16.53 64.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.133 0.492 . . . . 54.53 111.593 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 13.4 m-20 -78.72 -2.53 39.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.642 . . . . 73.31 110.559 175.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 54.5 m-80 77.81 14.63 1.63 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.479 -0.782 . . . . 75.41 111.935 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -89.13 141.25 28.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.599 -0.519 . . . . 64.1 109.599 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.04 119.35 34.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.376 -0.375 . . . . 71.12 110.488 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.86 105.99 3.35 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.787 -0.925 . . . . 63.12 110.787 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -94.74 104.94 16.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.034 0.445 . . . . 73.35 110.501 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.738 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 40.7 mt-10 -110.84 125.46 53.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.627 -0.715 . . . . 63.21 110.363 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -113.95 120.94 65.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.653 -0.869 . . . . 62.33 108.653 171.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.1 m -120.92 123.61 42.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.851 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 97' ' ' LEU . 2.8 p -129.77 120.45 50.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 50.21 109.971 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' ' HB2' ' A' ' 96' ' ' LYS . 43.9 mt-10 -125.24 136.14 53.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.499 -0.318 . . . . 75.12 110.66 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 m-20 63.68 23.66 13.6 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.765 -0.652 . . . . 73.42 112.046 168.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 67' ' ' TYR . 56.5 tt0 -63.98 -79.31 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 73.34 111.227 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.93 -73.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.604 -0.517 . . . . 64.23 109.604 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.32 96.46 9.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.609 -0.515 . . . . 51.13 109.609 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 29.1 ptt180 -57.24 137.17 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.418 0.627 . . . . 75.12 110.744 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.655 ' HA2' ' HB2' ' A' ' 119' ' ' LYS . . . 103.02 -24.45 30.5 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.032 -0.985 . . . . 33.42 111.432 -169.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.34 -0.506 . . . . 64.44 109.711 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HG2' ' HA3' ' A' ' 117' ' ' GLY . 10.2 ptpp? -121.33 131.76 54.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 65.43 109.809 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 96' ' ' LYS . 2.1 mm? -124.53 126.34 45.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.566 -0.531 . . . . 62.04 109.566 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.8 ' HB ' ' HB3' ' A' ' 115' ' ' LYS . 18.5 m -130.19 119.02 22.29 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.519 -0.31 . . . . 75.32 110.346 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.578 ' HB3' HG22 ' A' ' 85' ' ' ILE . 86.6 t80 -109.72 114.93 28.93 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.624 -0.51 . . . . 71.24 109.624 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.738 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 4.1 t70 -110.86 122.62 48.3 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.576 -0.738 . . . . 71.41 109.55 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 8.9 t -126.31 120.41 29.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.81 -0.441 . . . . 74.51 109.81 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 18.5 m -95.8 122.16 38.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.317 -0.623 . . . . 64.4 109.317 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -120.79 119.28 32.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 64.23 110.328 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 t -120.02 103.15 45.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.31 -0.626 . . . . 64.31 109.31 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.44 -37.54 38.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.093 2.529 . . . . 54.43 112.873 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -60.25 -40.7 91.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 62.51 111.879 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 p -96.26 -29.2 14.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.867 0.365 . . . . 63.43 111.338 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.3 59.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.113 -0.795 . . . . 73.42 111.113 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -84.72 137.05 33.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.849 0.356 . . . . 70.41 110.726 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' SER . 60.1 pttt -144.8 129.47 18.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.844 -0.616 . . . . 71.01 109.99 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 101' ' ' SER . 19.0 m120 -119.97 149.84 41.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.726 -0.67 . . . . 72.03 109.385 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.83 122.49 17.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.352 -0.24 . . . . 74.45 110.352 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.738 ' HG2' ' HB3' ' A' ' 100' ' ' ASP . 14.0 pttp -128.37 147.56 50.64 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.26 -0.274 . . . . 74.23 110.26 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.41 HD13 ' N ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -126.61 126.36 68.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.777 0.799 . . . . 75.34 110.263 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HD3' ' HB2' ' A' ' 128' ' ' ASP . 2.8 tppp? -99.61 120.73 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.843 -1.071 . . . . 64.43 109.442 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.461 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 8.5 m -118.54 118.94 33.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.393 -0.595 . . . . 73.23 109.393 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.611 ' HA3' ' HG2' ' A' ' 96' ' ' LYS . . . -129.53 148.14 18.19 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.754 -1.213 . . . . 41.55 113.966 -173.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -125.57 121.73 34.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.021 -0.589 . . . . 71.51 109.496 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 9.7 mtmp? -117.84 121.66 41.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.317 0.579 . . . . 73.32 111.977 -177.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.616 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 22.3 tpp180 -108.6 164.22 12.55 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.532 -1.284 . . . . 64.11 107.532 165.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -55.55 -30.41 60.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.194 0.452 . . . . 74.43 112.167 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -116.76 8.07 13.6 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.901 -0.32 . . . . 72.22 111.365 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 2.1 mm -138.61 124.97 25.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.94 0.4 . . . . 72.23 111.708 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.775 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 52.3 t30 -123.45 116.16 22.77 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.344 -0.542 . . . . 73.14 110.572 175.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.454 ' CD2' HD13 ' A' ' 142' ' ' LEU . 3.6 mm? -109.88 137.26 47.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 61.43 110.298 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.49 114.66 0.69 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.77 -0.729 . . . . 63.21 112.169 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 116' ' ' THR . 22.3 p -112.59 116.8 30.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.095 0.448 . . . . 63.44 110.655 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.834 ' HB2' ' HD3' ' A' ' 115' ' ' LYS . 21.1 t70 -113.76 122.28 46.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 71.3 109.995 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 21.6 ptp -115.24 118.84 34.44 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.19 -0.3 . . . . 74.25 110.19 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' HA ' ' CB ' ' A' ' 113' ' ' LYS . 3.9 p30 -106.77 127.21 53.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.488 0.661 . . . . 74.22 111.267 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HD2' ' HG3' ' A' ' 136' ' ' PRO . 85.1 t80 -78.05 103.69 8.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.696 . . . . 74.11 110.074 177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 22.0 t70 -92.09 161.64 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.51 -0.922 . . . . 51.12 108.51 172.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 133' ' ' ILE . 2.5 mp -66.3 -28.76 44.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 70.42 110.125 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.07 54.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 71.53 110.625 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' ASP . . . 145.1 154.98 6.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 51.0 112.624 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.521 ' HG3' ' HD2' ' A' ' 131' ' ' PHE . 14.9 Cg_exo -69.11 113.72 3.36 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.193 2.595 . . . . 61.44 112.86 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.7 t -82.23 141.5 32.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.957 -0.565 . . . . 72.1 109.561 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.837 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 40.9 mm -107.21 116.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.564 -0.455 . . . . 64.41 110.126 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -115.31 111.39 20.82 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.922 0.392 . . . . 72.53 109.994 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.35 132.78 11.1 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.867 -1.159 . . . . 44.02 112.311 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.477 ' HB2' HE21 ' A' ' 154' ' ' GLN . . . -128.99 115.92 18.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.223 0.535 . . . . 52.5 110.261 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 143' ' ' VAL . 6.8 tp -116.85 123.89 48.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.674 -0.694 . . . . 74.12 110.245 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.775 ' HB ' ' HB3' ' A' ' 124' ' ' ASN . 88.8 t -110.64 131.37 61.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.956 -0.565 . . . . 75.54 110.061 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.74 137.24 46.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.242 -0.651 . . . . 74.34 109.242 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -112.8 121.01 5.43 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.707 -0.679 . . . . 74.2 112.337 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.894 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 79.0 m-85 -127.36 149.73 49.93 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.574 -0.528 . . . . 73.32 109.574 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -49.81 96.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.812 0.339 . . . . 73.2 111.051 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 174' ' ' LYS . . . 88.55 -26.1 8.59 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.194 -0.457 . . . . 73.23 112.706 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.894 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 4.1 m0 -104.54 146.29 29.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.28 0.562 . . . . 74.42 110.96 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 144' ' ' LEU . 2.6 tm? -134.18 145.21 49.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.727 -0.842 . . . . 73.44 108.727 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -144.13 161.4 38.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.579 -0.7 . . . . 45.04 111.373 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -155.99 133.78 3.84 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.317 -0.401 . . . . 52.11 112.562 -176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.541 ' HD2' ' HD1' ' A' ' 169' ' ' PHE . 98.3 m-85 -125.1 119.21 27.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.476 -0.564 . . . . 75.51 109.476 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 35.5 tt0 -128.56 122.25 30.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.018 0.437 . . . . 63.4 110.327 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 16.9 ptp -135.32 142.5 45.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.002 0.43 . . . . 73.11 111.027 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.446 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 16.5 m-80 -113.13 117.66 32.58 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.034 -0.728 . . . . 74.45 109.034 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.918 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 71.1 t80 -94.13 121.85 36.06 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 123.642 0.777 . . . . 75.15 110.95 -176.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.6 tp10 -89.28 108.87 19.87 Favored 'General case' 0 C--O 1.264 1.82 0 CA-C-N 115.557 -0.747 . . . . 71.52 109.877 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -71.52 -17.02 62.35 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 112.923 -1.944 . . . . 73.41 111.974 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.85 67.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.819 0.819 . . . . 62.42 109.112 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 162' ' ' SER . 13.6 mptt -118.05 -156.09 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.363 -1.29 . . . . 73.23 108.022 167.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 161' ' ' LYS . 50.1 m -105.9 30.13 6.09 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.299 -0.63 . . . . 73.24 109.299 172.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 158' ' ' GLU . 15.6 mmm180 -136.65 141.51 43.18 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.446 -0.902 . . . . 73.52 112.159 -161.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.918 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 4.6 m -73.66 136.19 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.235 -0.654 . . . . 73.32 109.235 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 3.0 t -91.64 -22.68 20.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.157 0.503 . . . . 71.11 110.143 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.74 132.27 20.93 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.577 -0.527 . . . . 72.53 109.577 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.6 p -121.18 105.97 11.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.135 0.493 . . . . 74.5 109.946 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 20.5 m120 -107.16 135.52 48.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.544 0.687 . . . . 64.45 110.889 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' HD1' ' HD2' ' A' ' 153' ' ' TYR . 60.2 m-85 -121.78 143.89 49.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.832 -0.622 . . . . 75.43 109.927 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.75 132.89 33.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.46 -0.336 . . . . 72.04 110.537 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 43.1 t -129.87 126.48 62.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.001 -0.37 . . . . 64.34 110.001 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.21 100.36 1.21 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.692 -0.963 . . . . 34.53 110.692 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.634 ' HB3' ' CD2' ' A' ' 180' ' ' LEU . 75.3 t80 -109.46 120.44 42.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.559 -0.904 . . . . 71.41 108.559 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 148' ' ' GLY . 13.0 ttmm -127.72 126.1 41.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.731 -1.122 . . . . 73.01 111.327 -167.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 39.8 m -132.96 110.39 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.795 -1.187 . . . . 62.41 107.795 160.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 25.37 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.023 1.49 . . . . 71.42 115.023 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -89.18 -7.84 54.82 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.852 0.686 . . . . 63.14 112.852 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -123.32 115.66 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 75.42 111.06 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -136.94 143.29 42.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 63.03 111.043 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.634 ' CD2' ' HB3' ' A' ' 173' ' ' TYR . 0.0 OUTLIER -123.92 141.94 51.58 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-O 122.522 1.153 . . . . 62.34 111.495 163.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 36.2 m80 -104.75 112.47 25.58 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.369 -2.196 . . . . 72.12 106.551 165.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 38.4 m -96.17 135.93 37.32 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.215 -0.661 . . . . 63.1 109.215 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.8 p30 -133.86 138.86 45.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.415 0.626 . . . . 71.31 110.124 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 54.2 t -127.56 125.62 65.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.34 -0.845 . . . . 62.2 109.837 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.865 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 63.1 t30 -103.92 90.01 3.48 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.048 -0.723 . . . . 72.24 109.048 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.97 -173.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.704 -1.134 . . . . 75.04 110.136 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.0 -7.42 70.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.365 -0.921 . . . . 72.12 112.335 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.8 p -95.47 -24.32 16.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.023 0.749 . . . . 72.0 113.023 -174.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.865 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 65.9 tt0 -129.48 125.23 35.92 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.89 -0.724 . . . . 62.42 111.125 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -134.88 140.25 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.638 0.256 . . . . 75.02 110.397 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 209' ' ' ALA . . . -167.91 -163.32 21.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.457 -0.878 . . . . 63.21 112.895 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -164.85 -174.3 34.43 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.696 -0.562 . . . . 53.12 111.696 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 41.0 m -148.76 136.95 20.99 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.617 -0.882 . . . . 63.44 108.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 13.3 mm -117.61 117.67 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 120.343 -0.543 . . . . 64.34 110.621 -171.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -107.53 119.42 39.36 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -125.0 131.16 53.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.53 -0.544 . . . . 71.44 109.53 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -107.56 114.97 29.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.42 -0.355 . . . . 61.33 111.582 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 202' ' ' LEU . 58.8 t -88.76 132.39 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.625 -0.879 . . . . 74.24 108.625 171.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.4 -25.9 62.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.948 0.351 . . . . 63.33 111.948 -173.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.482 ' H ' HG12 ' A' ' 198' ' ' VAL . 58.9 mtmt -84.6 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 73.23 111.653 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.05 24.43 14.5 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.625 0.77 . . . . 75.53 112.69 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 225' ' ' TYR . 4.7 tt -110.58 108.99 19.12 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.163 -0.68 . . . . 63.15 109.163 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.731 ' HB2' ' HG3' ' A' ' 224' ' ' LYS . 39.5 mt-10 -106.65 137.04 45.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.522 -0.548 . . . . 75.23 109.522 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.6 m -122.74 142.55 50.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.655 0.265 . . . . 72.42 110.596 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -130.54 136.58 49.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.986 -0.552 . . . . 64.03 109.863 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.879 HG22 HG22 ' A' ' 221' ' ' ILE . 39.6 t -111.83 137.07 45.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.004 -0.544 . . . . 70.43 109.62 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -112.75 127.55 56.18 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.557 -0.905 . . . . 63.25 108.557 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 219' ' ' PHE . 3.1 tp -142.64 129.89 20.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.612 -171.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.413 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . . . -154.58 139.11 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 73.21 111.192 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -128.87 132.7 47.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.985 -0.746 . . . . 74.13 108.985 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 m -95.04 107.21 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.918 0.389 . . . . 63.02 110.034 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.75 135.86 55.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.629 -0.714 . . . . 72.43 111.252 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.85 -2.43 66.58 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.163 -0.775 . . . . 72.12 111.163 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -131.01 167.61 18.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.236 -0.482 . . . . 70.31 109.767 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -102.51 -14.23 16.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.969 -0.752 . . . . 64.2 108.969 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.66 110.89 1.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.498 -0.773 . . . . 73.21 110.769 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 15.9 m -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 61.11 109.432 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.566 ' HA ' ' HE ' ' A' ' 218' ' ' ARG . 0.2 OUTLIER -114.63 116.06 28.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.579 -0.448 . . . . 73.31 109.866 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.452 ' HB3' HD13 ' A' ' 208' ' ' LEU . 53.3 p90 -134.14 146.91 50.66 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.972 -0.381 . . . . 72.3 109.972 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.61 160.88 32.27 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.49 -0.862 . . . . 51.14 112.123 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.879 HG22 HG22 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -129.55 130.49 67.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.259 0.552 . . . . 72.35 110.62 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.593 ' HB2' ' HG3' ' A' ' 236' ' ' LYS . . . -117.84 141.43 48.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.169 -0.923 . . . . 70.5 109.911 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -118.12 140.82 49.21 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.399 -0.364 . . . . 72.53 110.429 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.731 ' HG3' ' HB2' ' A' ' 203' ' ' GLU . 14.8 ptmt -125.47 114.66 19.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.836 -0.62 . . . . 72.44 109.5 174.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.551 ' HD2' ' HG ' ' A' ' 202' ' ' LEU . 17.2 t80 -119.22 117.23 28.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.503 -0.772 . . . . 75.13 109.426 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.59 105.9 18.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.176 0.512 . . . . 64.33 109.857 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 227' ' ' ILE . 13.4 pt -81.69 -33.5 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.506 -0.77 . . . . 64.24 111.067 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.41 162.15 28.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.017 -0.734 . . . . 72.53 109.017 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 -19.14 17.41 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.064 2.51 . . . . 70.03 114.323 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -112.2 7.94 19.67 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.049 -0.26 . . . . 73.21 111.659 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.04 123.64 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.289 0.566 . . . . 64.51 112.21 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -124.09 127.44 47.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 51.25 108.957 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -98.04 133.38 42.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.931 0.396 . . . . 74.33 110.654 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 48.4 t -115.9 138.06 51.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.844 -0.617 . . . . 44.44 109.994 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -133.12 141.73 48.32 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.467 -0.568 . . . . 51.05 109.467 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.593 ' HG3' ' HB2' ' A' ' 222' ' ' ALA . 3.3 mppt? -133.39 141.42 47.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.771 0.32 . . . . 72.32 110.791 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.584 HG12 HG12 ' A' ' 221' ' ' ILE . 3.7 p -140.49 136.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.218 -0.66 . . . . 71.35 109.218 170.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 13.1 m120 -115.67 152.93 32.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.164 -0.471 . . . . 73.05 110.993 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 241' ' ' SER . 1.1 t-20 -35.12 -42.49 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.967 1.417 . . . . 64.54 114.052 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.462 ' OG ' HD13 ' A' ' 242' ' ' LEU . 2.3 p -78.56 24.58 0.28 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.839 0.352 . . . . 62.11 111.448 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 239' ' ' ASN . 18.6 t 61.7 37.83 15.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.586 -0.734 . . . . 53.24 109.817 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.971 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 4.6 mp -92.23 140.12 29.94 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.851 -0.613 . . . . 53.05 110.51 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -122.88 118.74 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.012 -0.54 . . . . 72.05 110.898 -172.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -126.08 155.56 19.3 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.751 -0.738 . . . . 61.2 112.417 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -138.18 160.65 38.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.065 0.46 . . . . 53.32 110.79 177.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -151.43 141.03 8.24 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.752 -0.658 . . . . 51.24 111.559 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -129.08 115.27 17.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 110.131 -0.322 . . . . 60.14 110.131 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.3 m -109.34 115.7 30.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.326 -0.397 . . . . 74.35 110.015 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.78 145.01 50.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.946 0.403 . . . . 72.21 111.024 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.3 m -108.11 124.47 50.28 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.873 -0.603 . . . . 75.31 110.631 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 2.8 mm? -117.17 147.28 42.6 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.835 -1.172 . . . . 70.1 107.835 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.924 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 32.9 mmtp 61.84 -174.97 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 117.742 0.246 . . . . 64.45 110.439 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.924 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 67.6 Cg_endo -75.69 -2.91 13.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 121.618 1.546 . . . . 64.21 113.657 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.43 0.25 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.188 -1.482 . . . . 74.44 114.794 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.627 HG12 ' HB2' ' A' ' 252' ' ' LYS . 45.4 mm -112.24 120.67 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 117.759 0.78 . . . . 73.31 109.6 174.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 280' ' ' GLU . 0.0 OUTLIER -115.61 118.04 31.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.999 0.428 . . . . 54.14 110.413 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.94 124.31 45.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.994 -0.548 . . . . 64.34 109.776 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.2 m -118.56 110.26 17.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.082 0.468 . . . . 73.45 110.562 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 1.014 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -102.56 125.5 49.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.786 -1.19 . . . . 74.02 107.786 174.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.6 t -138.56 139.43 38.65 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.435 -0.506 . . . . 63.31 109.864 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 135.74 13.65 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.602 -0.518 . . . . 74.32 109.602 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.769 HD21 HD23 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -124.27 131.63 53.53 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.394 -0.595 . . . . 75.1 109.394 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.806 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -106.43 111.19 23.66 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.78 -1.193 . . . . 74.23 107.78 179.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.971 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 1.7 m-20 -71.54 106.96 4.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.871 -0.604 . . . . 72.44 109.418 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.06 -16.79 14.5 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 116.019 -0.537 . . . . 51.51 112.877 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 266' ' ' LYS . 1.6 tmtp? -91.15 -26.95 18.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.879 0.371 . . . . 64.22 110.783 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 10.3 m120 -106.44 -34.66 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.644 0.609 . . . . 75.15 112.644 -172.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.806 HG11 ' HB3' ' A' ' 263' ' ' LEU . 35.1 m -62.28 -17.49 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.537 0.208 . . . . 70.1 111.558 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.09 -44.65 83.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 75.41 110.722 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.59 -16.74 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.493 . . . . 71.31 110.828 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 123.66 90.52 0.93 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.321 -0.712 . . . . 64.54 111.321 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.637 ' HA3' ' HB3' ' A' ' 267' ' ' ASN . . . -164.7 69.72 0.2 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 65.52 112.358 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.619 ' HB2' HD12 ' A' ' 263' ' ' LEU . 24.0 p-80 -113.17 145.48 40.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.367 -0.605 . . . . 75.23 109.367 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.68 136.85 49.14 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.477 -0.489 . . . . 54.33 110.131 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -120.58 136.85 54.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.563 -0.744 . . . . 72.12 109.839 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.668 ' HA3' ' HB3' ' A' ' 22' ' ' TYR . . . -138.68 110.54 0.73 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.655 -0.783 . . . . 74.1 111.591 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 1.014 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -112.79 128.19 56.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.745 -0.835 . . . . 75.21 108.745 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.6 ' HA3' ' HE2' ' A' ' 22' ' ' TYR . . . -140.12 131.87 5.27 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.258 -0.973 . . . . 50.13 112.284 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.684 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.4 mm? -103.45 130.14 50.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.233 -0.654 . . . . 75.35 109.233 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 0.6 OUTLIER -113.73 109.71 19.01 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.881 -1.155 . . . . 72.14 107.881 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.647 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 2.4 t80 -106.39 124.41 49.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.717 -0.674 . . . . 62.1 109.891 -172.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -127.5 109.63 11.93 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.343 -0.614 . . . . 74.31 109.343 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.647 ' HB2' ' HE1' ' A' ' 281' ' ' PHE . . . -110.1 111.84 23.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 65.31 111.346 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.61 -70.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 75.45 108.926 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.991 -0.549 . . . . 75.45 109.585 172.691 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.763 0.316 . . . . 71.23 110.386 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.29 -64.44 1.22 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.185 -0.461 . . . . 54.3 110.252 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.851 HG22 ' HA ' ' A' ' 121' ' ' GLU . 13.7 t -120.48 112.16 34.38 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.488 -0.56 . . . . 74.12 109.488 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.9 161.04 19.73 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.035 2.49 . . . . 75.31 112.62 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.68 86.61 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.796 2.331 . . . . 53.21 111.189 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.021 ' HB ' HG11 ' A' ' 143' ' ' VAL . 9.2 p -70.18 -53.5 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.358 -0.837 . . . . 64.14 112.826 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -69.07 -23.92 64.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.243 0.544 . . . . 63.41 111.313 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.31 -20.71 36.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.62 . . . . 63.43 111.533 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -91.05 -11.5 38.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.917 0.389 . . . . 71.53 110.896 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 152' ' ' GLY . 45.9 mt -58.29 -34.97 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.328 0.492 . . . . 71.24 112.328 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.47 50.87 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.586 -1.292 . . . . 75.24 114.694 168.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -40.24 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.167 -1.049 . . . . 71.23 108.167 171.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -60.97 -35.48 76.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.726 -1.125 . . . . 63.35 110.751 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.07 73.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.12 -0.491 . . . . 62.11 111.883 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -69.61 -31.09 69.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.47 . . . . 71.31 110.51 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.17 -47.39 85.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.69 -0.686 . . . . 75.0 111.804 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.31 -31.4 52.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.95 0.405 . . . . 70.03 110.797 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.665 ' HE2' ' HA3' ' A' ' 220' ' ' GLY . 82.6 t80 -73.03 -41.82 63.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.681 -0.69 . . . . 70.22 111.331 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -83.44 -28.07 29.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.146 -0.479 . . . . 75.14 112.209 -173.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -66.78 91.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.527 . . . . 75.53 110.433 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.42 -23.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.916 -0.874 . . . . 75.35 110.916 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -73.85 76.16 1.62 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 74.24 110.386 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.94 119.1 4.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.72 -0.753 . . . . 41.11 111.3 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -80.34 8.04 8.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.065 0.459 . . . . 75.32 111.035 -175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.53 13.22 54.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.982 -0.847 . . . . 53.34 110.982 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 2.7 pp -107.45 177.97 4.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.946 0.879 . . . . 41.11 112.749 -173.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG13 HD12 ' A' ' 277' ' ' LEU . 1.7 mp -103.0 132.53 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.293 -1.321 . . . . 72.25 110.224 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 26.0 tptp -102.84 118.66 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.965 -1.016 . . . . 75.13 109.193 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.71 128.23 56.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.623 -0.51 . . . . 70.43 109.623 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 43' ' ' SER . 30.6 m-20 -133.28 134.14 43.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.104 0.478 . . . . 45.43 110.373 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.759 HD22 ' HB2' ' A' ' 281' ' ' PHE . 1.2 tm? -123.72 126.01 45.77 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.157 -1.053 . . . . 61.3 108.157 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.9 mtpp -132.29 129.7 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.858 0.361 . . . . 73.42 110.59 175.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.8 m -136.27 131.64 34.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.134 -0.484 . . . . 71.01 109.839 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -104.98 136.77 43.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 71.25 110.209 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.3 m -139.59 169.27 18.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.002 -0.545 . . . . 61.14 110.168 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.22 178.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 75.32 110.771 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 t30 65.21 24.43 12.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.578 0.704 . . . . 53.51 109.537 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 63' ' ' ARG . . . 73.32 19.81 79.74 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 120.618 -0.801 . . . . 60.15 111.988 175.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 62' ' ' TYR . 10.2 mt -85.55 137.3 32.97 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.222 1.011 . . . . 61.3 113.266 -171.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.736 ' HB2' HH12 ' A' ' 63' ' ' ARG . 43.4 tt0 -139.51 118.56 12.6 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.24 -1.8 . . . . 65.43 108.828 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 90.9 m-85 -103.6 120.09 40.2 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.695 -0.483 . . . . 75.33 109.695 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 25.9 m -126.05 126.07 43.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.234 -0.439 . . . . 75.35 110.397 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 22.8 t -119.66 123.25 43.37 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.858 -0.793 . . . . 74.53 108.858 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -123.78 124.88 43.67 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.081 -0.34 . . . . 75.22 110.081 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.06 153.61 24.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.463 -0.875 . . . . 75.4 111.857 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -137.52 133.92 35.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.919 -0.771 . . . . 75.2 108.919 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -148.92 129.26 13.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.969 0.414 . . . . 34.03 111.426 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.61 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -102.02 113.93 27.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.403 -0.962 . . . . 63.42 108.403 173.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 m -47.27 103.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.066 0.854 . . . . 74.34 113.069 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.47 17.08 10.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.209 -0.905 . . . . 72.33 112.296 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 48' ' ' ASN . 11.0 m -97.81 8.86 43.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 71.44 110.062 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m 62.91 31.47 16.24 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.338 -0.847 . . . . 75.53 111.305 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 54.7 mmtt -130.5 83.52 2.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.29 0.566 . . . . 51.44 110.112 175.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 47' ' ' ALA . 48.0 t -125.35 120.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.991 -1.004 . . . . 71.33 109.652 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.6 t -133.43 143.4 48.85 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.14 -0.318 . . . . 70.11 110.14 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.82 141.26 12.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.928 -0.653 . . . . 73.23 112.823 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -132.83 135.06 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.083 0.553 . . . . 73.05 109.663 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 2.9 tm? -121.74 125.63 47.02 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.239 -0.652 . . . . 62.22 109.239 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.764 ' HB3' ' HB ' ' A' ' 42' ' ' THR . 22.2 tt0 -117.68 120.36 37.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.395 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 3.3 m -113.45 118.37 34.31 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.873 -1.158 . . . . 73.43 107.873 168.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -116.82 120.64 39.15 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.01 -0.676 . . . . 61.42 110.242 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.703 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 1.4 m-85 -107.0 125.56 51.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 70.24 109.699 -175.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.736 HH12 ' HB2' ' A' ' 40' ' ' GLU . 1.6 mpp_? -129.51 106.49 8.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.328 -0.949 . . . . 72.34 111.807 169.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 49.0 t-105 -88.79 91.82 8.97 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.234 -1.024 . . . . 75.42 108.234 174.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 67' ' ' TYR . 9.4 m 67.8 141.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.614 -1.176 . . . . 44.42 110.486 -174.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.93 -8.54 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.432 0.634 . . . . 71.44 110.289 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.704 ' H ' HG22 ' A' ' 65' ' ' THR . 81.8 t80 -126.36 86.53 2.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.113 -0.949 . . . . 75.53 108.573 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 88' ' ' GLU . . . 170.91 -101.72 0.17 Allowed Glycine 0 C--O 1.242 0.649 0 C-N-CA 120.705 -0.76 . . . . 73.3 112.383 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 3.8 mm? -113.65 138.24 50.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.482 0.658 . . . . 45.2 111.77 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.1 m -135.74 111.31 9.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.191 -0.913 . . . . 53.14 109.469 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.703 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 12.2 t80 -119.77 125.75 49.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.811 0.338 . . . . 74.52 110.422 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 84' ' ' GLU . 28.2 m -110.85 117.65 33.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.937 0.399 . . . . 52.43 110.353 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 34.7 tt0 -111.94 123.85 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.698 -0.683 . . . . 75.02 109.911 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.8 ptmm? -127.26 133.22 50.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.22 0.533 . . . . 73.02 110.188 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.622 ' CD1' HD22 ' A' ' 81' ' ' LEU . 32.6 t90 -134.04 128.27 33.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.559 -0.534 . . . . 72.41 109.559 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -116.41 133.21 56.28 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.842 -0.743 . . . . 72.33 110.791 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -73.9 -25.71 60.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.739 0.78 . . . . 72.53 110.09 172.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -96.14 -16.2 21.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.501 -1.227 . . . . 61.24 111.779 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.8 -98.05 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.354 0.872 . . . . 64.51 113.354 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 p -115.85 144.72 43.63 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.869 1.063 . . . . 71.13 113.869 -166.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.622 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -87.94 157.05 19.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.326 -1.361 . . . . 74.14 107.326 165.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 101' ' ' SER . . . -171.01 147.69 10.62 Favored Glycine 0 C--N 1.322 -0.205 0 C-N-CA 119.79 -1.195 . . . . 35.11 113.173 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -148.98 128.52 13.12 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.254 0.222 . . . . 74.44 111.165 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.9 pt-20 -126.41 125.98 43.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 74.33 110.023 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -112.24 128.3 68.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.111 -0.495 . . . . 73.13 110.439 -176.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.592 ' CG2' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m -118.17 123.91 46.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.113 -0.494 . . . . 73.24 111.248 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.33 137.88 51.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.126 -0.488 . . . . 75.03 109.828 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 1.1 pp20? -89.52 161.95 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.986 -0.686 . . . . 61.4 110.879 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -95.67 124.73 39.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.813 -0.44 . . . . 71.42 109.813 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -68.4 -25.82 65.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 72.41 111.546 -175.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.74 -45.74 5.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.867 0.365 . . . . 73.21 110.248 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -92.01 77.17 5.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.36 -0.607 . . . . 63.43 109.36 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.455 ' HG2' ' OH ' ' A' ' 67' ' ' TYR . 56.2 mtt180 -64.1 134.65 55.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.349 -0.841 . . . . 71.4 111.623 -173.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 102.14 -12.2 57.27 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.016 -0.993 . . . . 72.54 111.681 -174.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -85.02 121.3 27.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.604 0.24 . . . . 75.31 110.402 178.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.592 ' HE3' ' CG2' ' A' ' 86' ' ' THR . 29.9 mmmt -121.96 112.05 17.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 64.53 109.443 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 86' ' ' THR . 1.9 mm? -94.85 128.2 41.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.47 . . . . 55.01 109.779 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 1.118 ' HB ' ' HG3' ' A' ' 115' ' ' LYS . 3.3 m -128.45 132.89 48.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.077 0.465 . . . . 75.13 111.534 -174.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 76.7 t80 -117.8 120.63 38.51 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.375 -0.602 . . . . 74.04 109.375 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 113' ' ' LYS . 6.9 t70 -111.62 143.07 43.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.401 . . . . 75.0 110.475 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.438 ' O ' ' HA2' ' A' ' 82' ' ' GLY . 72.9 m -142.86 122.19 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.835 0.35 . . . . 72.43 110.876 174.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 t -108.04 133.16 52.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.762 -0.829 . . . . 65.22 108.762 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 110' ' ' LYS . 35.6 t80 -122.87 125.13 44.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.819 0.342 . . . . 72.31 110.722 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.7 t -87.38 106.19 10.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.695 -0.854 . . . . 62.42 108.695 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.45 -39.92 79.38 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.04 2.493 . . . . 72.0 112.699 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.48 -49.9 24.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.592 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 m -66.06 -40.67 91.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 64.44 111.304 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.6 -5.7 80.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.89 -0.671 . . . . 71.1 111.791 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -94.62 148.16 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 60.53 110.355 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -126.42 151.33 47.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.875 -0.602 . . . . 74.22 111.019 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -119.25 121.01 38.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.566 -0.743 . . . . 75.42 109.01 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.56 28.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.871 0.367 . . . . 73.22 110.99 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 130' ' ' ASP . 17.3 mmtm -124.22 141.46 52.04 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.174 -0.676 . . . . 64.44 109.174 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.92 117.74 56.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.126 -1.065 . . . . 72.45 108.126 169.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 1.118 ' HG3' ' HB ' ' A' ' 98' ' ' THR . 8.0 ptmt -129.16 119.86 24.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.231 -0.895 . . . . 64.45 110.818 -171.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.0 p -109.23 117.75 34.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.354 -0.839 . . . . 71.41 109.531 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.456 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -128.82 114.23 1.73 Allowed Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.303 -0.951 . . . . 5.3 111.961 -174.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.791 ' HB3' HD22 ' A' ' 95' ' ' LEU . 12.9 p90 -118.77 131.81 56.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.167 0.508 . . . . 72.53 110.458 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.713 ' HE3' ' HB ' ' A' ' 3' ' ' VAL . 8.7 ptmt -109.11 121.32 44.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.576 -0.738 . . . . 74.15 110.213 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 120' ' ' ARG . 9.3 tpt180 -106.72 157.02 18.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.851 ' HA ' HG22 ' A' ' 3' ' ' VAL . 3.8 pm0 -53.22 -28.9 29.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.966 0.728 . . . . 71.24 112.966 -169.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -114.54 -16.03 11.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.884 -0.327 . . . . 63.44 111.542 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 142' ' ' LEU . 10.9 tp -145.03 130.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 120.298 -0.561 . . . . 75.41 111.809 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -117.95 117.31 28.89 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.058 -0.401 . . . . 63.43 110.637 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 124' ' ' ASN . 3.9 mm? -113.01 128.73 56.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.681 0.277 . . . . 75.23 111.145 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.456 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -135.43 123.53 3.08 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.528 -0.629 . . . . 72.13 111.528 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 60.3 m -113.78 108.28 16.88 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.678 -0.307 . . . . 54.15 111.091 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.831 ' HB2' ' HB3' ' A' ' 139' ' ' ARG . 3.2 m-20 -100.81 117.52 35.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.482 -0.562 . . . . 65.43 109.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.2 ptm -98.0 118.64 35.05 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.458 -0.897 . . . . 72.03 109.531 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 8.9 t70 -94.52 117.66 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 73.12 109.967 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -97.16 102.68 14.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.071 0.462 . . . . 64.1 111.465 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -105.29 146.72 28.97 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.171 -1.048 . . . . 74.41 108.171 167.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.601 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -62.68 -22.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.845 0.313 . . . . 70.3 111.845 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.2 -6.67 47.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.572 0.225 . . . . 75.22 111.602 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.457 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 160.82 121.47 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.339 -0.934 . . . . 75.34 112.921 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 2.9 Cg_exo -74.55 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 52.21 111.802 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -81.99 153.29 26.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.21 -0.45 . . . . 75.02 110.053 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.665 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 3.5 mp -107.11 117.43 52.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.945 -0.702 . . . . 73.4 109.94 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.831 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 59.8 ttt-85 -104.68 130.12 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.706 -0.479 . . . . 73.45 109.706 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -116.91 132.14 9.89 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 119.961 -1.114 . . . . 63.31 111.553 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.73 115.74 21.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.478 -0.564 . . . . 74.43 109.478 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 123' ' ' ILE . 11.6 tp -128.02 122.56 32.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.259 -0.428 . . . . 62.12 110.131 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 1.021 HG11 ' HB ' ' A' ' 6' ' ' THR . 21.8 t -119.59 130.51 73.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.075 0.464 . . . . 72.3 109.851 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 144' ' ' LEU . 5.1 mp -109.35 138.29 45.92 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 73.02 109.538 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.73 123.43 5.82 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.714 -0.755 . . . . 63.23 112.774 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.812 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 56.0 m-85 -125.9 148.32 49.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.007 -0.738 . . . . 72.32 109.007 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -53.44 102.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.952 0.406 . . . . 65.44 110.413 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.56 -31.1 7.45 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.746 -0.661 . . . . 62.43 112.492 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 5.5 m0 -105.89 134.56 48.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 75.33 110.837 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 6' ' ' THR . 3.2 tm? -139.41 134.59 32.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.237 -0.653 . . . . 63.24 109.237 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 171' ' ' VAL . . . -148.97 141.12 23.95 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.821 -0.352 . . . . 74.1 111.664 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -140.33 141.0 11.05 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.965 -0.454 . . . . 63.02 111.965 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.435 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 43.1 m-85 -124.08 121.26 34.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.182 -0.303 . . . . 73.21 110.182 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 2.1 mp0 -114.19 122.15 45.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 74.44 109.284 176.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.19 145.46 51.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.808 0.337 . . . . 73.1 111.002 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 166' ' ' GLN . 6.0 m-20 -112.55 118.34 34.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.845 -0.798 . . . . 72.22 108.845 175.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.665 ' HB3' ' HB ' ' A' ' 138' ' ' ILE . 76.7 t80 -95.64 121.87 37.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.479 -0.782 . . . . 54.31 111.007 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 9.8 tp10 -79.24 99.34 7.01 Favored 'General case' 0 C--O 1.254 1.317 0 CA-C-N 114.386 -1.279 . . . . 74.14 109.129 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.5 t -70.9 -23.83 62.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.442 -1.708 . . . . 71.54 112.212 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.7 -32.18 71.43 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.916 0.865 . . . . 71.21 109.165 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -114.6 -157.5 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.199 -1.364 . . . . 62.44 108.205 170.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 35.9 p -107.56 30.72 6.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.407 -0.59 . . . . 50.32 109.407 172.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.553 ' HA ' ' HE ' ' A' ' 163' ' ' ARG . 3.7 mmp_? -119.55 171.8 8.11 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 119.689 -0.804 . . . . 74.43 112.871 -159.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.61 127.09 59.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.166 -0.679 . . . . 44.35 109.166 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.3 t -95.86 -24.13 16.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.887 0.375 . . . . 50.15 110.935 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.591 ' HB3' ' HB2' ' A' ' 156' ' ' ASN . 32.8 tt0 -145.83 133.04 20.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 53.13 110.645 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 169' ' ' PHE . 17.0 p -122.54 106.43 11.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.109 -0.496 . . . . 63.22 110.617 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 26.0 t-20 -108.37 121.56 45.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.264 -0.643 . . . . 72.23 109.264 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 167' ' ' SER . 29.5 m-85 -123.86 156.83 35.49 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.386 -0.526 . . . . 65.32 111.027 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -150.75 128.25 11.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.963 -0.562 . . . . 33.51 109.796 171.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 151' ' ' ALA . 27.2 t -143.98 130.44 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.301 -0.629 . . . . 72.32 109.301 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.11 174.74 35.38 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.041 -1.552 . . . . 63.52 114.111 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -134.36 138.05 44.59 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -109.71 127.41 54.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.731 -0.668 . . . . 73.25 111.985 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 29.8 m -131.94 143.14 49.91 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.39 -1.337 . . . . 72.31 107.39 164.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.09 -1.98 6.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.138 0.792 . . . . 64.24 113.138 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.548 ' HG3' ' HD1' ' A' ' 178' ' ' PHE . 9.0 pt-20 -116.64 -26.08 7.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.537 -0.465 . . . . 65.41 111.478 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.548 ' HD1' ' HG3' ' A' ' 177' ' ' GLU . 41.3 p90 -140.87 127.93 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.705 0.288 . . . . 70.32 110.303 173.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.86 124.38 35.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.185 -0.302 . . . . 64.54 110.185 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.618 HD12 HG13 ' A' ' 194' ' ' ILE . 3.9 tt -110.86 128.26 55.72 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.062 -0.655 . . . . 73.44 110.031 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -131.81 115.83 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.906 -0.588 . . . . 65.42 109.769 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 84.8 m -99.51 123.16 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.127 -0.488 . . . . 72.11 110.213 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.3 p30 -119.86 141.49 49.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.142 0.496 . . . . 73.1 110.719 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 79.1 t -119.6 130.02 74.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.898 -0.592 . . . . 63.11 110.193 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 36.2 m-80 -113.24 106.96 15.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.838 -0.619 . . . . 65.43 109.34 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.01 -165.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.047 -0.979 . . . . 43.42 110.282 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.98 -6.99 89.09 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.385 -0.912 . . . . 73.31 111.947 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.2 p -102.23 -25.2 13.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.98 1.104 . . . . 71.42 113.98 -170.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 39.2 tt0 -120.41 112.74 19.36 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.17 -1.012 . . . . 72.44 112.19 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -106.26 124.88 50.27 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.393 -0.966 . . . . 70.0 108.393 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -136.6 131.6 5.71 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.037 -1.077 . . . . 34.41 113.677 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -114.79 121.76 5.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.115 -0.794 . . . . 71.41 111.115 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m -115.07 137.13 52.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.294 0.547 . . . . 72.14 110.931 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.618 HG13 HD12 ' A' ' 180' ' ' LEU . 4.3 mp -121.87 132.29 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.926 -0.579 . . . . 74.3 109.724 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -108.28 120.1 41.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.787 -0.82 . . . . 64.42 108.787 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -118.08 130.05 55.92 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.862 -0.608 . . . . 74.42 110.845 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -98.72 109.62 22.35 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 74.44 108.34 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.454 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 44.0 t -83.3 -40.22 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.538 0.685 . . . . 72.31 109.774 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 202' ' ' LEU . 54.3 t30 -155.72 161.64 40.69 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.792 -1.188 . . . . 70.33 107.792 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.63 126.46 27.71 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt 82.17 -1.01 1.46 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.077 0.86 . . . . 75.33 111.325 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 199' ' ' ASN . 39.9 tp -125.32 99.92 6.28 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.603 0.716 . . . . 72.53 111.015 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -106.43 158.57 16.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.062 -0.972 . . . . 75.31 109.892 -176.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.6 m -152.91 142.87 22.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.18 -0.304 . . . . 73.44 110.18 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -132.11 136.49 47.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.877 0.37 . . . . 34.13 110.94 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 77.6 t -119.42 131.65 71.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.85 -0.614 . . . . 74.11 110.105 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 27.3 t-20 -119.16 133.26 55.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.935 0.398 . . . . 74.31 110.998 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.477 ' O ' ' HA2' ' A' ' 191' ' ' GLY . 4.1 mm? -118.74 130.24 55.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 71.54 108.715 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.36 129.18 35.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.047 0.451 . . . . 63.31 110.85 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -120.06 129.71 54.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.874 -0.603 . . . . 73.14 109.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.514 ' HB ' ' OD1' ' A' ' 216' ' ' ASN . 29.1 m -95.39 106.8 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.117 0.484 . . . . 70.22 110.007 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -55.63 136.99 50.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.333 -0.849 . . . . 74.53 111.393 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 111.27 -33.77 5.66 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.055 -0.818 . . . . 54.42 111.055 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -125.83 -178.57 4.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.768 -0.456 . . . . 72.05 109.768 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.5 t -109.96 27.11 9.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.408 . . . . 72.24 110.641 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 211' ' ' THR . 23.6 p-10 -81.85 110.82 17.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.793 0.806 . . . . 75.0 110.271 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.8 p -107.87 123.49 48.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.067 -0.97 . . . . 70.33 110.108 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -106.59 116.44 31.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.99 -0.55 . . . . 75.43 109.751 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 37.0 p90 -115.05 146.83 40.88 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.544 -0.462 . . . . 65.0 110.101 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.665 ' HA3' ' HE2' ' A' ' 18' ' ' PHE . . . -146.57 139.87 8.34 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.992 -0.843 . . . . 71.1 110.992 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 4.2 mp -123.84 128.87 74.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.65 -0.5 . . . . 71.41 109.65 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -122.84 130.34 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.344 0.403 . . . . 73.55 110.407 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -112.25 126.04 54.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.229 -0.442 . . . . 70.42 109.981 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -113.48 113.3 24.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 73.33 109.904 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -130.89 128.32 40.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.915 0.388 . . . . 74.34 110.553 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 36.5 tt0 -78.72 98.45 6.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 74.41 108.922 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.4 tt -79.22 -24.86 12.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.276 0.56 . . . . 74.55 110.656 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.431 ' CG ' ' HD2' ' A' ' 229' ' ' PRO . 3.1 t70 -143.72 148.54 43.33 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.106 -1.072 . . . . 72.44 108.106 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 228' ' ' ASP . 52.6 Cg_exo -38.2 -40.35 1.15 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.846 3.031 . . . . 65.42 115.211 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' ' 250' ' ' THR . 6.8 m-20 -117.01 11.37 14.26 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.849 0.315 . . . . 73.14 111.849 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -129.73 123.17 30.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 70.13 111.415 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 0.8 OUTLIER -122.51 127.35 49.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.971 -0.559 . . . . 73.5 110.639 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.853 ' HD1' ' HB3' ' A' ' 247' ' ' TYR . 63.0 t80 -107.58 133.86 51.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.636 -0.711 . . . . 73.32 110.828 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 78.7 p -122.17 120.77 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 52.51 110.853 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.82 141.32 42.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.366 -0.605 . . . . 71.24 109.366 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 10.8 ptpt -148.19 149.24 31.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.041 0.448 . . . . 70.05 111.694 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 7.7 p -137.22 148.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.443 -0.344 . . . . 71.01 110.353 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.827 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -114.69 150.06 35.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.836 -0.62 . . . . 73.44 110.123 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 241' ' ' SER . 25.2 t30 -44.72 -36.11 3.0 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.476 1.11 . . . . 74.02 113.016 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 17.8 m -78.94 25.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.714 0.292 . . . . 65.35 111.036 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 239' ' ' ASN . 15.9 m 64.93 36.83 7.37 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.616 -0.72 . . . . 71.22 110.238 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 238' ' ' ASN . 26.3 mt -98.69 115.93 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.11 109.879 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.26 117.38 48.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 120.539 -0.465 . . . . 74.53 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -119.91 134.02 10.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.831 -0.699 . . . . 70.43 112.491 177.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 260' ' ' SER . 3.0 pp -128.91 141.74 51.17 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.805 -0.443 . . . . 54.52 109.805 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -155.95 121.58 1.11 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.542 -0.837 . . . . 73.34 111.988 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.853 ' HB3' ' HD1' ' A' ' 233' ' ' PHE . 36.2 p90 -114.45 130.85 56.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.255 0.55 . . . . 63.51 110.955 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.708 HG22 ' HB ' ' A' ' 258' ' ' THR . 18.2 p -100.19 115.08 29.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.96 -1.018 . . . . 73.0 109.557 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -123.87 123.24 40.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.269 -0.423 . . . . 54.34 110.53 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 230' ' ' ASP . 9.5 m -69.51 111.62 5.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.371 -0.603 . . . . 74.44 109.371 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 39.5 tp -79.49 -47.42 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 64.35 109.479 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.951 ' HB2' HD11 ' A' ' 255' ' ' ILE . 68.0 mttm -142.53 155.94 63.67 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.623 -1.251 . . . . 74.24 107.623 173.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.99 98.44 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.401 2.067 . . . . 74.35 111.79 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.46 -30.07 3.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.961 -0.638 . . . . 43.3 112.197 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.951 HD11 ' HB2' ' A' ' 252' ' ' LYS . 0.1 OUTLIER -124.42 121.87 62.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.707 0.765 . . . . 70.52 111.747 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.91 125.39 52.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.271 -0.877 . . . . 72.23 109.707 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.2 tp -99.89 125.26 45.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.95 -0.568 . . . . 74.21 109.925 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.708 ' HB ' HG22 ' A' ' 248' ' ' THR . 6.8 t -117.77 121.42 40.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.486 0.66 . . . . 72.12 110.478 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.666 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -107.31 123.98 49.12 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.885 -1.154 . . . . 72.44 107.885 176.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 23.5 m -134.18 152.38 51.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.8 0.333 . . . . 72.2 110.482 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.448 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -156.86 131.56 8.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.311 -0.404 . . . . 45.22 110.601 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.791 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -108.34 114.57 28.53 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.934 -1.136 . . . . 74.42 107.934 174.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.943 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -101.97 105.21 15.96 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.11 -1.441 . . . . 64.12 107.11 174.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.705 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 4.8 p-10 -76.01 98.49 4.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.233 -1.025 . . . . 72.14 108.233 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.35 -9.16 3.02 Favored Glycine 0 C--N 1.321 -0.28 0 CA-C-N 114.106 -1.407 . . . . 54.21 114.371 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -88.04 -20.23 26.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.034 0.445 . . . . 73.3 110.243 -173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.0 -33.9 0.9 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.778 0.799 . . . . 71.3 109.083 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.943 HG11 ' HB3' ' A' ' 263' ' ' LEU . 1.8 t -54.09 -29.65 19.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 113.8 -1.546 . . . . 72.31 112.529 176.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -66.24 -37.15 84.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.596 . . . . 54.55 111.251 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.43 -16.27 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.067 0.395 . . . . 72.23 112.067 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.21 -133.79 3.85 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.805 -0.712 . . . . 64.11 112.86 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -105.61 149.08 16.65 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 121.164 -0.541 . . . . 74.23 112.716 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.909 ' HB2' HD12 ' A' ' 263' ' ' LEU . 5.5 p-80 -103.83 149.15 25.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.844 -0.678 . . . . 62.44 110.208 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -96.27 138.62 33.61 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.084 -0.646 . . . . 71.31 110.764 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.0 tm? -120.77 144.72 48.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.676 -0.693 . . . . 70.13 110.443 -169.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.59 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -133.0 118.49 2.17 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.364 -0.694 . . . . 71.32 111.364 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -114.41 123.84 50.46 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.915 -0.772 . . . . 71.2 108.915 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -136.27 147.04 19.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.739 -1.219 . . . . 73.52 113.588 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.68 131.45 51.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.016 -0.735 . . . . 44.24 109.016 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -115.66 111.77 21.12 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.35 -0.611 . . . . 72.02 109.35 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.759 ' HB2' HD22 ' A' ' 31' ' ' LEU . 13.0 m-85 -95.32 101.85 13.61 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.686 -0.688 . . . . 72.51 109.22 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -103.73 110.93 23.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.966 -0.561 . . . . 64.13 110.031 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -90.37 110.06 21.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.857 -0.61 . . . . 73.41 109.712 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 61.5 mt -125.79 179.16 5.31 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.682 -0.69 . . . . 52.43 109.818 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.247 0.942 0 N-CA-C 109.186 -0.672 . . . . 71.11 109.186 176.893 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.861 0.362 . . . . 75.34 110.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 85.25 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.754 -0.461 . . . . 62.55 109.754 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.652 HG11 ' HB2' ' A' ' 119' ' ' LYS . 6.2 t -110.66 102.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 74.35 110.523 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 159.27 37.63 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.628 2.219 . . . . 52.44 112.076 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.89 85.6 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.653 2.236 . . . . 72.12 111.626 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.9 p -75.16 -29.17 60.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.042 -0.526 . . . . 63.4 111.303 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.439 ' HB2' HG21 ' A' ' 143' ' ' VAL . 73.2 t80 -57.45 -40.09 77.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.23 0.538 . . . . 73.21 110.796 174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.3 -24.05 34.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 71.13 110.4 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.21 8.32 33.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.701 . . . . 72.35 110.505 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.16 -14.89 61.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 74.25 110.422 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 15' ' ' ARG . . . 140.31 64.72 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 121.1 -0.571 . . . . 72.53 112.396 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -65.96 -43.1 88.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.988 0.394 . . . . 74.04 109.972 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -59.44 -38.75 81.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 75.05 110.489 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.09 74.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 70.31 111.032 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 11' ' ' GLY . 48.3 mtp85 -64.73 -29.84 70.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 53.45 111.161 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.19 -37.55 72.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.292 0.567 . . . . 63.32 110.425 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.555 ' HA ' ' HE2' ' A' ' 236' ' ' LYS . 13.6 t -83.26 -36.38 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 74.2 111.035 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.53 -41.82 65.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.659 . . . . 73.24 112.327 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 15' ' ' ARG . 3.5 t -95.45 172.69 7.93 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.972 -0.291 . . . . 64.3 110.504 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -79.99 73.6 6.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.626 0.726 . . . . 74.02 110.977 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.48 36.27 3.96 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.579 -0.737 . . . . 63.02 111.496 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.618 ' HA ' ' OG ' ' A' ' 260' ' ' SER . 15.4 p90 -147.9 136.06 21.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.287 . . . . 73.24 110.788 -176.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.31 64.92 3.39 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.034 -0.53 . . . . 42.11 113.235 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -80.61 -3.74 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 75.53 110.842 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.22 -1.87 78.89 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.011 -0.54 . . . . 74.52 112.898 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -147.98 -179.6 7.03 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.088 0.947 . . . . 71.31 113.441 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.621 HG23 HD12 ' A' ' 277' ' ' LEU . 36.8 mm -102.82 122.94 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.693 -1.594 . . . . 72.22 108.717 174.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -118.22 124.99 49.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.324 0.583 . . . . 71.31 110.432 178.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tp -124.19 144.12 50.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.0 -0.546 . . . . 64.23 110.057 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' SER . 1.8 p30 -144.66 140.03 28.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.116 0.484 . . . . 64.34 110.028 171.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.77 HD13 ' HD1' ' A' ' 281' ' ' PHE . 16.0 tp -119.07 123.32 44.17 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.351 -0.84 . . . . 44.32 109.494 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 4.1 ptpp? -116.64 124.41 49.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.476 -0.783 . . . . 71.4 109.841 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 283' ' ' ALA . 45.4 m -123.16 121.57 36.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.692 -0.686 . . . . 63.32 110.089 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.56 123.41 47.31 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.413 -0.515 . . . . 74.34 109.954 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 48.0 t -141.81 146.99 36.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 55.13 109.615 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.91 -148.09 0.49 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.421 0.451 . . . . 65.12 111.247 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.71 136.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.036 -0.529 . . . . 70.23 110.281 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.751 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 78.51 -9.24 36.36 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 118.799 -1.001 . . . . 53.21 115.243 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' SER . 2.7 mm? -100.57 127.47 46.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.465 1.633 . . . . 70.3 112.547 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 37.9 tt0 -140.13 118.11 11.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.762 -0.829 . . . . 65.04 108.762 162.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -100.64 120.79 40.58 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.63 -0.508 . . . . 74.33 109.63 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.963 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 10.5 m -125.91 116.89 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.882 0.372 . . . . 61.12 110.848 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 10.6 t -111.61 122.47 47.89 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.635 -0.876 . . . . 73.21 108.635 174.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -129.71 126.75 38.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.928 0.394 . . . . 41.34 110.301 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.47 16.08 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.757 -0.735 . . . . 71.43 111.773 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.4 m -125.02 134.32 52.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.49 -0.559 . . . . 74.51 109.49 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -137.02 128.56 28.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.005 0.431 . . . . 74.51 110.725 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 18.4 m120 -75.4 113.06 12.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.32 -0.622 . . . . 64.14 109.32 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.431 ' HB ' HG12 ' A' ' 27' ' ' ILE . 8.8 t -63.71 132.41 50.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 73.21 111.0 -174.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 60.48 15.07 5.27 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.165 -0.925 . . . . 71.23 111.05 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.479 ' HB ' ' CB ' ' A' ' 48' ' ' ASN . 5.1 m -119.84 -10.13 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.43 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p 52.94 34.81 17.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.574 0.75 . . . . 42.34 112.679 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 48' ' ' ASN . 35.3 mmtp -113.19 102.05 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.053 -0.721 . . . . 42.44 109.053 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 47' ' ' ALA . 13.7 t -123.78 123.42 67.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.123 -0.489 . . . . 74.11 111.661 -170.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -111.03 125.69 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 73.33 109.243 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.07 136.96 11.56 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.609 -0.805 . . . . 64.12 112.396 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 p -137.04 153.75 50.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.917 0.389 . . . . 73.41 110.56 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -127.27 124.79 39.66 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.142 -0.688 . . . . 75.54 109.142 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.963 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 87.0 mt-10 -108.41 119.97 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.298 -0.41 . . . . 53.11 110.386 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 73' ' ' GLU . 20.5 p -99.19 117.7 34.24 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.007 -1.109 . . . . 74.53 108.007 168.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 3.6 ttmp? -119.93 131.3 55.17 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.571 -0.529 . . . . 74.24 109.571 -174.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 25.8 m-85 -108.27 121.43 44.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.902 -0.59 . . . . 74.43 109.989 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.588 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 1.2 tmm_? -103.9 104.66 14.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.732 -0.84 . . . . 71.3 108.732 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 7.3 t-105 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.158 -0.928 . . . . 74.14 111.657 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 67' ' ' TYR . 25.1 m 69.84 144.99 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.93 0.769 . . . . 61.42 112.151 173.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -82.21 12.02 4.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.505 . . . . 54.13 111.145 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.453 ' H ' HG22 ' A' ' 65' ' ' THR . 54.3 m-85 -102.4 -46.8 4.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.481 -0.327 . . . . 72.12 110.424 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' HD12 ' A' ' 69' ' ' LEU . . . 144.95 71.86 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.125 -1.035 . . . . 70.31 113.393 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.688 ' HG ' ' HA ' ' A' ' 87' ' ' VAL . 8.3 mp -112.44 134.81 53.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.094 -0.651 . . . . 61.03 110.453 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -136.64 112.07 9.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.774 -0.648 . . . . 61.11 110.24 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 32.4 t80 -106.11 122.12 45.54 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.399 -0.593 . . . . 74.41 109.399 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 84' ' ' GLU . 14.8 m -117.15 117.36 29.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.798 0.332 . . . . 74.33 111.275 -175.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HB2' ' OG1' ' A' ' 60' ' ' THR . 43.3 mt-10 -103.14 120.42 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 53.23 108.452 168.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.928 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 3.4 tmtp? -114.53 98.04 6.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.95 -0.568 . . . . 62.43 109.592 -174.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.587 ' HE1' ' HA ' ' A' ' 79' ' ' ASN . 2.1 t90 -99.51 129.02 45.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.212 -0.449 . . . . 72.12 110.422 -175.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 39.5 t30 -97.78 154.24 17.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.221 -0.659 . . . . 45.25 109.221 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 t -65.31 -17.51 64.57 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.93 0.395 . . . . 73.02 111.348 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 12.8 m-20 -80.58 -1.28 41.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.054 -0.521 . . . . 72.04 110.371 174.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.587 ' HA ' ' HE1' ' A' ' 75' ' ' TRP . 4.1 m-20 77.7 35.16 0.31 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.979 0.912 . . . . 64.23 110.959 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 11.2 m -85.42 117.68 24.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.604 -0.725 . . . . 52.23 109.601 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.4 124.23 39.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.992 0.425 . . . . 72.14 111.352 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.85 109.31 2.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.745 -0.942 . . . . 43.34 110.745 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 m -104.62 99.64 9.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.918 0.359 . . . . 65.3 110.958 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.677 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 28.4 tt0 -111.73 132.26 54.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 72.42 110.209 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.8 tt -129.4 126.14 63.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 70.35 111.077 173.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 25.6 m -116.14 123.73 48.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.009 -0.541 . . . . 60.14 109.827 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . 2.7 p -128.54 121.88 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.371 -0.233 . . . . 72.12 110.371 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 mt-10 -99.0 137.52 37.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 75.12 110.798 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.77 151.82 27.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 45.43 111.274 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.01 -38.94 14.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 73.52 111.545 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.74 -45.69 13.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.57 0.7 . . . . 74.32 109.477 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -87.17 66.56 9.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.324 -0.853 . . . . 74.41 108.83 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.755 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -53.4 124.7 15.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 73.41 110.378 -177.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.48 -3.82 56.53 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.429 -0.891 . . . . 43.42 112.57 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.6 HD22 ' HD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -81.81 117.34 22.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.493 -0.558 . . . . 73.34 109.493 175.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HG2' ' HG2' ' A' ' 88' ' ' GLU . 26.6 mtpp -116.35 110.65 18.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 71.31 109.083 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.504 ' HB2' HG13 ' A' ' 87' ' ' VAL . 2.0 mm? -99.93 126.29 46.06 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.37 -0.604 . . . . 71.4 109.37 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' A' ' 115' ' ' LYS . 28.4 m -130.16 119.17 22.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.95 0.405 . . . . 74.33 110.61 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -115.32 113.26 23.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.516 -0.92 . . . . 70.44 108.516 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.518 ' OD1' ' HD2' ' A' ' 113' ' ' LYS . 9.8 p-10 -120.77 134.39 55.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.317 0.579 . . . . 75.1 110.109 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 14.9 m -131.2 134.32 46.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.777 -0.647 . . . . 74.52 111.289 -175.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.3 t -95.27 122.0 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.082 -1.081 . . . . 61.3 108.082 172.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HD1' ' HB3' ' A' ' 110' ' ' LYS . 82.1 t80 -127.51 129.52 47.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.217 0.532 . . . . 73.13 110.642 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.8 m -120.45 103.2 44.48 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.787 -0.642 . . . . 75.22 109.737 176.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.97 -16.42 55.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.023 2.482 . . . . 64.23 112.978 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -66.35 -45.15 81.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.966 0.412 . . . . 74.54 110.607 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.3 p -105.16 -13.54 15.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.89 -0.595 . . . . 72.24 111.571 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.95 85.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 73.53 111.531 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 87.0 tttt -74.2 137.9 43.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 75.23 111.123 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.91 132.81 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 64.5 110.706 177.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.635 HD22 ' HA ' ' A' ' 132' ' ' ASP . 16.3 m120 -120.33 122.93 41.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 64.32 109.494 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.94 126.86 52.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.136 0.493 . . . . 40.12 111.419 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.518 ' HD2' ' OD1' ' A' ' 100' ' ' ASP . 57.0 mttm -121.14 138.44 54.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.424 -0.584 . . . . 70.21 109.424 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mm -119.75 117.79 54.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.101 0.476 . . . . 73.3 110.524 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.805 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 40.3 mttp -115.02 119.81 37.73 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.8 -0.636 . . . . 64.45 109.729 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.489 HG22 HD12 ' A' ' 97' ' ' LEU . 27.8 p -116.36 117.61 30.44 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.078 -0.51 . . . . 73.25 110.125 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.83 130.27 9.42 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.55 -0.833 . . . . 72.31 112.034 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.6 ' HD1' HD22 ' A' ' 95' ' ' LEU . 71.4 t80 -123.14 115.26 21.5 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.027 -0.731 . . . . 63.22 109.027 174.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB2' HG11 ' A' ' 3' ' ' VAL . 22.0 pttm -111.69 122.64 48.34 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.605 -0.838 . . . . 64.03 110.962 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HB3' HG22 ' A' ' 123' ' ' ILE . 37.6 ttm180 -106.29 169.13 8.69 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.757 -1.201 . . . . 65.01 107.757 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 3' ' ' VAL . 41.5 tp10 -53.28 -34.1 55.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 73.42 112.219 -167.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.435 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 92.9 m-70 -119.96 3.85 10.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 113.189 0.811 . . . . 75.32 113.189 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 120' ' ' ARG . 18.8 tt -144.82 147.89 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.248 -0.981 . . . . 61.13 112.235 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.506 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -123.6 124.33 42.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.032 0.444 . . . . 63.12 110.8 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.457 ' CD1' HD13 ' A' ' 142' ' ' LEU . 4.2 mm? -111.06 139.89 46.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.129 -0.487 . . . . 75.25 109.975 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.17 116.83 0.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.598 -0.81 . . . . 63.45 112.14 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 60.9 m -112.1 115.28 28.61 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.545 -0.385 . . . . 73.53 110.377 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.96 116.84 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 75.25 110.472 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 44.9 mtt -103.59 117.59 34.77 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.686 -0.857 . . . . 73.14 108.686 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.17 114.8 29.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.431 -0.507 . . . . 75.12 109.928 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.447 ' HA ' ' HB3' ' A' ' 136' ' ' PRO . 53.0 t80 -99.29 97.56 8.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.954 0.406 . . . . 72.41 110.419 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.635 ' HA ' HD22 ' A' ' 111' ' ' ASN . 12.6 t70 -101.18 144.22 30.32 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.113 -1.069 . . . . 43.23 108.113 170.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -65.64 -25.74 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.78 -0.452 . . . . 73.21 109.78 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.05 -1.42 57.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 62.14 111.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.19 108.19 0.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.368 -0.92 . . . . 32.12 113.024 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 131' ' ' PHE . 2.3 Cg_endo -82.58 126.76 4.78 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.352 2.701 . . . . 70.24 112.096 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 p -126.49 162.94 24.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.812 0.339 . . . . 74.32 111.227 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' A' ' 157' ' ' PHE . 49.4 mm -108.9 123.58 64.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.479 -0.328 . . . . 74.54 110.65 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -118.06 113.23 21.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.931 0.396 . . . . 71.41 109.945 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.83 11.18 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.069 -1.062 . . . . 75.12 111.817 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.15 116.83 26.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.036 0.446 . . . . 71.12 110.015 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 143' ' ' VAL . 8.2 tp -116.51 123.83 48.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.142 -0.481 . . . . 64.23 110.289 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 124' ' ' ASN . 93.8 t -111.94 129.4 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 55.12 109.975 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.796 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.2 mm? -107.32 138.45 43.5 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.002 -0.74 . . . . 61.44 109.002 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 122' ' ' HIS . . . -117.78 118.55 4.12 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.439 -0.886 . . . . 53.31 112.641 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.564 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 25.0 t80 -131.66 146.42 52.17 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.483 -1.303 . . . . 73.31 107.483 175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.1 101.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.099 0.476 . . . . 72.53 111.403 -176.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.72 -31.2 8.11 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.378 -0.828 . . . . 63.3 112.512 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 33.3 m0 -105.12 122.81 46.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.62 0.248 . . . . 75.1 111.471 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.55 137.65 46.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 70.13 110.105 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.796 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -129.96 158.18 40.26 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.852 -0.425 . . . . 51.4 109.852 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -157.46 132.86 3.33 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.395 -0.682 . . . . 63.22 111.395 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.573 ' CD1' ' HD1' ' A' ' 169' ' ' PHE . 21.7 m-85 -127.13 118.96 25.38 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 117.271 0.535 . . . . 72.44 109.841 175.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.839 ' HG3' ' HB3' ' A' ' 168' ' ' ASN . 26.8 pt20 -105.55 122.86 46.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.655 0.741 . . . . 71.41 109.771 172.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 ptm -126.67 140.49 52.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 70.01 110.666 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 166' ' ' GLN . 22.0 t-20 -113.2 117.66 32.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.712 -0.477 . . . . 71.44 109.712 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 87.9 t80 -100.86 129.12 46.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.687 -0.688 . . . . 74.32 109.822 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.828 ' HG3' ' H ' ' A' ' 161' ' ' LYS . 9.0 tp10 -99.81 103.31 14.92 Favored 'General case' 0 C--O 1.257 1.464 0 CA-C-N 115.851 -0.613 . . . . 74.15 109.803 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 m -70.89 -27.01 63.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.548 -1.66 . . . . 73.03 111.327 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.05 75.05 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.777 0.799 . . . . 75.11 108.909 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.828 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 48.1 mmtm -95.28 -162.61 0.96 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.681 -1.229 . . . . 71.31 107.681 167.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -109.48 22.12 16.17 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.91 -0.494 . . . . 73.53 110.836 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -166.28 165.66 17.23 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 118.56 -1.256 . . . . 74.45 113.411 -163.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.855 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.4 m -77.7 136.39 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.66 -0.7 . . . . 64.32 110.096 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.1 m -94.63 -21.59 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 74.32 110.516 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 156' ' ' ASN . 22.0 tt0 -133.47 132.28 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 61.12 111.14 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -122.79 105.95 10.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.546 -0.752 . . . . 62.23 109.539 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.839 ' HB3' ' HG3' ' A' ' 154' ' ' GLN . 11.8 t-20 -117.09 128.84 55.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.928 -0.397 . . . . 73.14 109.928 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.573 ' HD1' ' CD1' ' A' ' 153' ' ' TYR . 47.4 m-85 -121.8 149.82 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.61 -0.268 . . . . 74.22 110.751 -173.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 181' ' ' HIS . . . -151.84 137.76 18.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.65 -0.25 . . . . 23.35 110.908 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.653 ' HB ' HG22 ' A' ' 182' ' ' THR . 63.7 t -135.03 127.07 47.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.439 -0.578 . . . . 50.12 109.439 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.37 108.46 0.88 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.103 -0.799 . . . . 62.41 111.103 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.544 ' CZ ' HD21 ' A' ' 180' ' ' LEU . 28.7 p90 -127.63 151.51 48.85 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.52 -0.872 . . . . 74.33 111.936 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.666 ' HG2' ' HG2' ' A' ' 179' ' ' GLN . 95.9 mttt -118.34 138.19 52.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.116 -1.402 . . . . 75.31 110.498 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -131.78 113.44 13.52 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.66 -0.867 . . . . 55.54 108.66 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.47 -95.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.823 0.702 . . . . 33.03 112.402 -172.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 197' ' ' LYS . 11.8 mm-40 -108.39 4.79 24.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.793 0.33 . . . . 75.12 111.235 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.84 122.5 47.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.42 -0.215 . . . . 61.21 110.42 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.666 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 3.8 mt-30 -135.9 123.17 21.79 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 119.48 -0.295 . . . . 62.41 110.606 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.574 ' O ' ' HA2' ' A' ' 172' ' ' GLY 0.262 0.0 OUTLIER -127.86 144.13 51.1 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.264 1.03 . . . . 61.32 113.728 171.396 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.575 ' CE1' ' HB1' ' A' ' 170' ' ' ALA . 22.0 t60 -108.38 114.29 28.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.117 -1.856 . . . . 72.22 108.587 169.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.653 HG22 ' HB ' ' A' ' 171' ' ' VAL . 14.0 t -96.83 157.94 15.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.153 -1.055 . . . . 42.2 108.153 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -147.95 149.71 32.7 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.722 -0.391 . . . . 75.41 110.157 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 9.5 t -131.41 116.03 30.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.509 -0.552 . . . . 65.05 109.509 170.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.786 ' HB3' ' HB3' ' A' ' 189' ' ' GLU . 57.7 t30 -94.33 97.02 9.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.591 -0.731 . . . . 73.23 109.812 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.23 -165.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.053 -0.976 . . . . 63.11 110.787 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.87 89.48 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.85 -0.691 . . . . 74.15 112.104 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -102.09 -25.72 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.157 0.799 . . . . 61.21 113.157 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.786 ' HB3' ' HB3' ' A' ' 185' ' ' ASN . 38.3 tt0 -129.82 139.92 51.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 119.698 -0.801 . . . . 74.51 113.066 -170.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.36 153.91 21.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.342 -0.844 . . . . 75.32 108.82 172.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 209' ' ' ALA . . . -149.64 162.92 29.22 Favored Glycine 0 C--N 1.314 -0.654 0 C-N-CA 120.669 -0.776 . . . . 70.22 112.629 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -159.1 154.82 25.9 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.609 -0.596 . . . . 61.44 111.609 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.0 m -148.73 135.18 19.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.93 -0.767 . . . . 70.31 108.93 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.0 mp -123.15 124.51 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 71.33 110.15 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.791 ' HE2' ' HB3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -112.61 119.86 39.59 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 73.41 109.932 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.494 ' HB3' ' CG2' ' A' ' 204' ' ' THR . 22.1 tp60 -108.82 111.92 23.9 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.112 -0.699 . . . . 72.41 109.112 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.607 ' HG2' ' HG3' ' A' ' 203' ' ' GLU . 8.7 tmtm? -97.28 108.62 21.38 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.534 -0.913 . . . . 63.53 108.534 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.82 ' HB ' ' HB3' ' A' ' 201' ' ' LYS . 15.0 t -77.94 123.57 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.181 -1.044 . . . . 65.4 108.181 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -38.95 -60.57 0.84 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.445 1.09 . . . . 62.53 112.234 -170.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -123.42 83.87 2.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.967 0.413 . . . . 71.1 109.913 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.82 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 20.2 tptm -167.99 -90.42 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 74.05 109.654 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.807 ' HB3' ' HD1' ' A' ' 225' ' ' TYR . 0.0 OUTLIER -163.18 -176.18 4.69 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.654 0.264 . . . . 71.05 110.525 173.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.791 ' HB3' ' HE2' ' A' ' 195' ' ' TYR . 3.2 mp0 -108.18 131.86 54.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 73.41 109.741 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.494 ' CG2' ' HB3' ' A' ' 196' ' ' GLN . 15.0 t -122.15 150.0 42.82 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.234 -0.654 . . . . 71.05 109.234 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 222' ' ' ALA . . . -129.79 159.38 36.7 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.489 0.661 . . . . 74.54 111.408 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 221' ' ' ILE . 2.3 t -132.58 124.86 52.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.382 -1.281 . . . . 65.2 108.428 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -114.64 131.07 56.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 70.33 109.197 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.621 HD13 ' HD1' ' A' ' 219' ' ' PHE . 5.0 tp -147.06 136.28 22.57 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.023 -0.535 . . . . 71.32 110.448 -171.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.474 ' HA ' ' HA2' ' A' ' 191' ' ' GLY . . . -154.97 132.03 10.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.665 0.269 . . . . 44.31 110.693 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -130.96 118.45 20.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.1 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 215' ' ' SER . 1.4 m -94.76 108.7 20.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.069 -0.514 . . . . 75.32 109.918 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.06 130.37 43.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 61.15 110.683 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.46 1.42 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.384 -0.686 . . . . 63.11 111.384 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 62.36 88.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.234 0.54 . . . . 73.54 111.39 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 211' ' ' THR . 62.5 m -144.32 167.03 23.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.574 . . . . 71.33 110.134 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.87 124.1 22.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 63.25 110.25 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 23.5 p -77.73 123.29 26.5 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.097 0.475 . . . . 71.45 110.024 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.534 ' O ' HD12 ' A' ' 208' ' ' LEU . 63.7 mtt85 -89.6 113.02 24.4 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.408 -0.59 . . . . 61.34 109.408 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.621 ' HD1' HD13 ' A' ' 208' ' ' LEU . 93.4 t80 -126.62 136.39 52.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.981 -0.748 . . . . 71.01 108.981 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.38 162.78 33.57 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.033 -1.079 . . . . 54.45 112.474 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.63 HG12 HG12 ' A' ' 237' ' ' VAL . 0.1 OUTLIER -137.72 147.55 26.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.008 0.432 . . . . 52.14 109.969 176.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 205' ' ' ALA . . . -136.99 157.75 46.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.656 -0.702 . . . . 71.31 110.564 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -141.57 126.27 17.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.685 0.278 . . . . 24.01 111.016 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 69.2 mttm -108.02 112.98 25.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.771 -0.826 . . . . 61.24 108.771 172.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.807 ' HD1' ' HB3' ' A' ' 202' ' ' LEU . 30.0 t80 -114.15 119.0 35.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.725 . . . . 72.33 111.471 -172.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -76.45 104.42 6.96 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.861 -1.163 . . . . 73.01 107.861 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.13 -56.69 10.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.142 -0.481 . . . . 72.03 111.513 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.627 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 35.8 t70 178.32 -54.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 74.25 111.145 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 228' ' ' ASP . 89.5 Cg_endo -83.16 -142.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.936 1.757 . . . . 74.44 112.586 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 14.7 p-10 -91.97 10.98 26.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 72.13 110.324 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 132.78 54.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.712 -0.676 . . . . 71.45 110.533 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.471 ' SG ' ' HB ' ' A' ' 248' ' ' THR . 11.9 p -122.23 142.6 50.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.45 -0.795 . . . . 64.04 109.813 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -101.94 132.89 47.48 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 62.42 110.008 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 52.0 p -122.95 120.74 34.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.952 0.406 . . . . 64.31 110.448 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -109.14 152.8 24.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.507 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 60.2 mttp -139.89 142.43 36.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.093 -0.706 . . . . 62.23 109.093 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.63 HG12 HG12 ' A' ' 221' ' ' ILE . 3.6 p -140.85 137.74 34.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.369 -0.532 . . . . 73.15 109.995 174.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.694 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 12.8 m120 -109.01 149.57 29.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.511 . . . . 71.22 110.045 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.59 ' ND2' ' H ' ' A' ' 219' ' ' PHE . 7.9 p30 -55.02 -24.18 23.23 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.257 0.973 . . . . 63.45 112.525 -175.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.691 ' HB2' HD13 ' A' ' 242' ' ' LEU . 9.5 m -79.59 20.5 0.57 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 70.45 110.165 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.486 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 40.7 m 65.97 36.99 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.352 -0.84 . . . . 44.1 110.771 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.3 mp -97.44 138.26 35.15 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.458 -0.497 . . . . 70.13 111.223 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 243' ' ' ILE . 3.0 mp -113.3 117.9 56.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.588 -0.733 . . . . 75.03 109.993 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -121.13 138.1 12.33 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.595 -0.812 . . . . 74.31 111.886 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.53 139.48 42.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 73.12 110.159 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.28 146.23 17.29 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.844 -0.693 . . . . 54.01 112.204 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.72 126.83 55.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.066 -0.346 . . . . 74.2 110.066 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.471 ' HB ' ' SG ' ' A' ' 232' ' ' CYS . 11.7 m -120.92 114.71 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 74.31 109.699 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 257' ' ' LEU . 48.1 tt0 -125.28 138.9 54.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.364 -0.38 . . . . 75.32 110.535 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 2.5 t -121.98 92.84 3.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.503 0.668 . . . . 75.34 110.032 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.812 ' HB3' HG23 ' A' ' 255' ' ' ILE . 53.6 tp -88.81 66.12 7.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.883 -0.599 . . . . 62.34 109.431 -175.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' A' ' 253' ' ' PRO . 40.9 ttmt 69.38 150.86 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.115 -0.948 . . . . 60.31 109.908 -174.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 252' ' ' LYS . 51.4 Cg_exo -54.44 84.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.324 2.016 . . . . 73.03 111.642 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 282' ' ' GLN . . . -178.6 -35.21 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.112 -0.949 . . . . 53.15 110.793 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.812 HG23 ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -149.08 122.3 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.75 0.786 . . . . 64.43 110.82 176.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 280' ' ' GLU . 99.2 mttt -116.99 131.65 56.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.056 -0.975 . . . . 74.45 109.827 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.679 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 28.8 tp -102.93 122.12 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.723 -0.473 . . . . 74.44 109.723 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.2 t -135.22 109.98 8.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 55.11 110.512 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.631 ' HB3' HD23 ' A' ' 277' ' ' LEU . 1.6 pp -135.08 158.38 44.5 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.085 -0.646 . . . . 72.53 110.54 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 22' ' ' TYR . 20.1 p -148.99 143.39 26.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.827 -0.624 . . . . 74.43 110.262 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.446 ' HB2' HD22 ' A' ' 275' ' ' LEU . . . -139.55 130.2 25.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.221 -0.659 . . . . 71.12 109.221 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.838 HD21 HD23 ' A' ' 242' ' ' LEU . 0.5 OUTLIER -119.91 127.34 52.6 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.633 0.73 . . . . 64.42 110.084 179.518 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.867 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -101.74 109.68 21.51 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.23 -1.396 . . . . 54.13 107.23 176.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.872 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 10.5 t0 -72.25 106.87 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.405 -0.961 . . . . 64.51 108.405 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -55.48 -21.43 27.5 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.367 -0.444 . . . . 72.11 113.115 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -90.95 -20.16 22.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.741 0.305 . . . . 64.14 110.786 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.612 ' HB3' ' HB3' ' A' ' 264' ' ' ASP . 29.3 t-20 -110.5 -29.06 8.24 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.914 0.388 . . . . 62.45 111.942 -173.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 263' ' ' LEU . 23.0 m -63.27 -16.55 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 122.063 -0.398 . . . . 73.44 111.804 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -53.93 -35.93 62.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.928 -0.397 . . . . 75.45 109.928 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -96.89 -16.78 20.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 61.23 110.53 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 117.62 7.21 12.22 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.8 -0.714 . . . . 54.32 113.176 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -70.2 85.71 0.32 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.258 -0.496 . . . . 44.43 113.041 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.552 ' HB2' HD12 ' A' ' 263' ' ' LEU . 55.8 p-80 -113.96 138.89 49.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.098 -0.334 . . . . 74.45 110.098 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 274' ' ' LYS . 9.5 mmpt? -105.76 137.44 43.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.276 -0.268 . . . . 74.51 110.276 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.3 tm? -129.26 132.54 47.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.57 -0.286 . . . . 50.03 110.275 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.505 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -138.89 118.95 1.65 Allowed Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.541 -0.624 . . . . 55.21 111.541 174.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 259' ' ' LEU . 1.7 tm? -118.57 124.59 47.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.903 0.352 . . . . 73.12 110.09 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -132.56 141.0 12.31 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.547 -0.835 . . . . 62.3 113.442 -177.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.913 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.4 mm? -122.7 132.4 54.23 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.523 0.201 . . . . 65.55 110.908 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 256' ' ' LYS . 16.2 mt-10 -105.43 111.54 24.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 64.12 109.169 167.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.77 ' HD1' HD13 ' A' ' 31' ' ' LEU . 5.6 t80 -107.64 133.68 51.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.436 -0.95 . . . . 75.22 108.436 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 pt20 -137.4 125.49 22.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.288 0.566 . . . . 74.42 111.758 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.438 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -106.36 112.4 25.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.514 -0.766 . . . . 61.32 109.493 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 74.9 mt -115.42 156.87 24.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.921 -0.581 . . . . 75.4 110.134 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 109.127 -0.694 . . . . 72.4 109.127 178.287 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.26 -0.274 . . . . 71.44 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.18 73.57 8.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.365 0.602 . . . . 62.44 109.457 173.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.022 HG12 ' HB3' ' A' ' 119' ' ' LYS . 9.9 p -88.09 142.81 32.2 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.191 -0.913 . . . . 72.42 110.087 -174.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 85.0 Cg_exo -48.47 146.66 10.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.167 2.578 . . . . 73.52 112.926 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 7.6 Cg_exo -72.08 91.58 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.97 2.447 . . . . 70.31 112.49 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -76.36 -20.22 57.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.504 . . . . 70.1 110.134 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' HA ' HG21 ' A' ' 143' ' ' VAL . 63.7 t80 -56.64 -38.36 72.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 63.41 110.081 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.56 -28.26 28.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.771 -0.649 . . . . 70.45 110.573 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.67 6.37 35.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.794 -0.639 . . . . 74.15 110.708 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 143' ' ' VAL . 89.3 mt -60.78 -15.93 35.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.39 0.614 . . . . 61.34 109.823 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.705 ' HA3' ' HB2' ' A' ' 181' ' ' HIS . . . 164.72 57.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.099 -1.201 . . . . 75.11 110.099 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 14.2 tmtt? -56.16 -54.32 46.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.875 0.47 . . . . 64.11 111.54 -170.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -65.19 -42.15 93.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.091 0.472 . . . . 60.14 111.485 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 -36.5 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 62.52 112.423 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.461 ' O ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.23 -31.45 70.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 64.21 111.574 -173.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 2.3 m-20 -65.75 -41.85 91.61 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 121.248 -0.181 . . . . 62.31 111.343 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.81 -38.97 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.329 0.585 . . . . 54.24 110.113 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -72.91 -41.39 64.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.442 -0.799 . . . . 72.43 112.186 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 20' ' ' LYS . 14.4 t -94.66 -6.6 42.98 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.321 0.489 . . . . 54.42 112.321 -173.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.511 ' HD2' HG23 ' A' ' 19' ' ' THR . 13.7 mptt -101.41 28.34 5.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 63.11 110.405 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.04 134.14 36.98 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.903 -0.665 . . . . 73.34 112.117 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.904 ' HB3' ' HD2' ' A' ' 274' ' ' LYS . 96.3 m-85 72.01 -57.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.498 0.719 . . . . 70.32 111.771 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.14 155.53 12.78 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.498 -1.041 . . . . 42.53 110.498 -173.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -83.18 -4.46 58.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.232 0.516 . . . . 73.14 111.174 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.99 4.0 84.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.945 -0.645 . . . . 62.55 113.377 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 3.5 pp -148.91 -177.83 6.02 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-O 122.199 1.0 . . . . 73.33 113.013 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.829 HG23 HD23 ' A' ' 277' ' ' LEU . 25.6 mm -90.97 129.06 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 113.858 -1.519 . . . . 74.43 109.637 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 87.5 tttt -118.18 133.23 56.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.786 0.327 . . . . 54.14 110.372 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 279' ' ' LEU . 35.7 tp -117.52 149.65 40.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.855 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 11.5 t70 -142.37 139.78 31.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.282 -0.872 . . . . 71.33 108.88 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.757 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -134.74 127.67 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.845 -0.428 . . . . 73.21 109.845 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -123.51 125.67 45.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.964 -0.754 . . . . 64.53 108.964 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.899 ' HB ' ' HB3' ' A' ' 41' ' ' PHE . 19.2 m -137.71 141.7 41.04 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.146 -0.222 . . . . 74.41 111.205 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -103.03 140.01 37.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.801 -0.444 . . . . 74.1 109.801 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 53.5 m -139.56 174.38 10.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.561 -0.533 . . . . 74.24 109.561 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -30.54 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 72.32 111.836 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -44.77 130.02 7.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.41 0.624 . . . . 61.44 111.929 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 89.19 -10.65 72.25 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.196 -0.911 . . . . 70.11 113.555 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 35' ' ' SER . 3.1 mm? -105.14 129.01 53.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.659 1.23 . . . . 64.24 111.488 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.963 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 34.2 tt0 -139.57 146.8 40.3 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.572 -0.899 . . . . 75.04 108.572 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.899 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 59.4 t80 -121.42 121.31 37.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.686 0.279 . . . . 75.34 110.776 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.882 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 24.0 m -126.08 132.39 51.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 64.13 110.322 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 19.4 m -132.28 143.25 49.76 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.975 -0.453 . . . . 75.22 110.799 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m -143.27 125.95 15.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.029 -0.36 . . . . 75.12 110.029 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.8 152.46 20.31 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.428 -0.891 . . . . 55.2 111.914 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -128.45 133.27 48.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.19 -0.67 . . . . 61.23 109.19 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -138.1 130.94 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.922 0.391 . . . . 62.13 111.533 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.58 142.93 42.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.881 -0.6 . . . . 64.22 109.42 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 t -75.36 141.75 43.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.727 0.298 . . . . 71.32 110.956 -176.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 mp0 73.12 -74.38 0.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.481 0.712 . . . . 74.14 111.93 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.38 139.0 45.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.399 . . . . 64.4 111.468 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 m -74.74 80.25 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.2 0.524 . . . . 61.4 111.916 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 24.2 mmmt -126.3 93.93 3.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.362 -0.607 . . . . 75.0 109.362 172.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.611 -0.722 . . . . 62.22 110.458 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 m -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 61.44 108.876 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.96 125.08 6.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.518 -0.849 . . . . 51.11 112.763 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.1 m -109.31 134.02 52.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.265 -0.642 . . . . 72.12 109.265 174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.11 124.68 46.39 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.834 -0.802 . . . . 73.51 108.834 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.882 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -107.96 117.35 33.89 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.536 0.684 . . . . 64.44 110.285 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 m -93.54 118.89 31.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.027 -1.101 . . . . 72.15 108.027 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 13.6 tptm -112.34 135.31 53.18 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.572 -0.451 . . . . 74.11 109.878 -173.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.849 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 81.0 m-85 -118.91 120.69 38.05 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.906 -0.776 . . . . 73.32 108.906 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 30.1 ttm-85 -122.91 109.27 13.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 70.22 111.533 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 69' ' ' LEU . 70.6 m95 -106.65 93.59 4.66 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.993 -1.003 . . . . 74.23 108.943 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -67.73 -38.29 83.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.058 . . . . 73.12 112.516 -170.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 tp10 -86.42 61.62 6.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.38 0.609 . . . . 64.24 111.235 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.588 ' HD1' HD23 ' A' ' 69' ' ' LEU . 47.9 t80 172.38 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.409 -1.269 . . . . 73.52 108.456 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.07 49.75 0.41 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.465 -0.789 . . . . 74.03 111.927 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.588 HD23 ' HD1' ' A' ' 67' ' ' TYR . 1.5 mm? -114.67 131.83 56.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.076 0.465 . . . . 75.32 111.228 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.2 m -134.43 112.73 11.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.669 -0.696 . . . . 73.21 110.28 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.849 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 16.0 t80 -109.46 125.4 52.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.942 -0.572 . . . . 73.44 109.572 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 84' ' ' GLU . 5.0 m -121.42 117.1 26.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.742 0.305 . . . . 75.23 110.655 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.721 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 32.4 tt0 -101.76 119.87 39.46 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.002 -0.74 . . . . 64.45 109.002 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 15.8 ttmm -107.99 86.67 2.34 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.421 -0.585 . . . . 43.44 109.421 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.728 ' HD1' ' HB3' ' A' ' 81' ' ' LEU . 11.9 t90 -101.06 129.42 46.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.127 -0.488 . . . . 75.12 111.088 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -108.07 164.1 12.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.551 . . . . 73.44 109.825 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -68.89 -18.23 64.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.278 0.561 . . . . 72.42 110.51 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 25.0 t70 -74.28 -4.4 35.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 64.25 109.94 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 10.8 m120 74.76 9.52 4.11 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 114.969 -1.014 . . . . 72.03 110.644 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 117.37 21.83 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 72.01 109.518 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.728 ' HB3' ' HD1' ' A' ' 75' ' ' TRP . 1.9 pt? -123.02 136.98 55.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 63.01 111.374 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.61 106.28 2.28 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.251 -0.886 . . . . 70.43 111.237 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 101' ' ' SER . 32.0 m -85.78 100.06 11.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.861 0.362 . . . . 64.55 110.664 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 35.2 mt-10 -99.11 108.04 20.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 41.42 109.722 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.4 pp -112.18 137.92 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.518 -0.473 . . . . 42.12 110.584 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.1 m -129.21 128.55 43.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.581 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.01 125.72 74.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.968 0.413 . . . . 71.44 110.316 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -90.28 127.91 36.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 73.12 109.295 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 22.1 t70 -82.92 144.05 30.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.885 -0.413 . . . . 73.4 109.885 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -100.63 -21.56 15.22 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.076 -0.25 . . . . 75.24 111.367 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.0 tp -71.49 -45.52 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 74.01 109.302 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.32 75.31 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.786 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 35.6 ttm180 -61.46 135.36 57.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.19 0.519 . . . . 73.0 110.25 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.99 -10.9 55.76 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.606 -0.998 . . . . 74.3 110.606 -169.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.54 112.78 25.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.491 -1.3 . . . . 64.12 107.491 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 138.75 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.128 0.49 . . . . 71.25 110.054 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.34 127.27 51.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.497 -0.927 . . . . 74.42 108.497 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 1.061 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -125.96 130.37 51.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.178 0.513 . . . . 74.42 110.064 -176.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' HB1' ' A' ' 112' ' ' ALA . 31.4 t80 -123.63 123.04 39.68 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.942 -0.762 . . . . 73.33 108.942 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.507 ' HB2' ' HD2' ' A' ' 113' ' ' LYS . 81.4 m-20 -108.54 121.25 44.59 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.372 -0.603 . . . . 72.14 109.372 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 83' ' ' THR . 20.2 m -111.51 120.79 43.33 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.816 -0.354 . . . . 72.25 110.152 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.5 m -101.54 120.05 39.71 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.624 -0.88 . . . . 64.33 108.624 175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.669 ' HD2' ' HB3' ' A' ' 110' ' ' LYS . 49.2 t80 -134.91 137.97 43.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.037 0.446 . . . . 72.52 110.652 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 m -127.96 102.49 21.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.853 -0.612 . . . . 75.04 109.734 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 36.5 Cg_exo -59.32 -34.25 97.79 Favored 'Trans proline' 0 N--CA 1.466 -0.09 0 C-N-CA 122.454 2.103 . . . . 73.33 111.417 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.69 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 73.55 111.175 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.3 m -76.9 -23.25 52.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.698 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.42 2.27 73.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.668 -0.777 . . . . 74.41 112.976 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.72 148.36 22.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 54.32 111.858 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.669 ' HB3' ' HD2' ' A' ' 103' ' ' PHE . 19.1 ptmt -145.88 124.98 12.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 74.2 110.612 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.57 140.27 51.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.509 -0.552 . . . . 74.22 109.509 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.446 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -119.51 130.67 55.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.056 0.455 . . . . 64.34 111.365 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.607 ' HG2' ' OD1' ' A' ' 130' ' ' ASP . 42.6 mttm -114.37 136.44 52.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.664 -0.495 . . . . 65.34 109.664 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 tp -120.6 117.93 54.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.433 0.635 . . . . 65.44 109.585 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 1.061 ' HB2' HG23 ' A' ' 98' ' ' THR . 21.4 mtpt -122.93 134.83 54.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.698 -0.683 . . . . 71.14 110.7 -170.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -112.17 127.91 56.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.276 -0.638 . . . . 74.31 109.276 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.91 126.04 4.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.105 -1.045 . . . . 62.52 112.748 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.99 133.86 47.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.099 -0.334 . . . . 65.41 110.099 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 1.022 ' HB3' HG12 ' A' ' 3' ' ' VAL . 76.5 mttt -122.01 122.72 39.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.775 0.797 . . . . 61.43 111.464 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.874 ' HB3' ' HB ' ' A' ' 123' ' ' ILE . 18.9 tpt180 -110.26 162.18 14.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.517 -1.22 . . . . 74.0 108.089 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 3' ' ' VAL . 1.2 pm0 -58.48 -27.9 64.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.54 0.609 . . . . 73.42 110.932 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -107.97 3.16 23.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.177 -0.465 . . . . 72.35 111.526 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.874 ' HB ' ' HB3' ' A' ' 120' ' ' ARG . 15.5 mm -139.15 131.54 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.765 0.654 . . . . 74.44 112.765 -169.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.417 HD21 HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -117.92 111.95 19.68 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.818 -1.179 . . . . 74.44 107.818 163.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 142' ' ' LEU . 4.8 tp -128.32 124.6 36.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.996 0.427 . . . . 73.22 111.389 -175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.72 115.39 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.944 -0.646 . . . . 74.02 111.975 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 63.2 m -114.43 116.4 28.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.82 -0.223 . . . . 71.44 110.467 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.654 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 3.3 p30 -105.76 122.74 46.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.431 0.634 . . . . 73.03 110.643 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 67.4 mtm -104.41 117.67 34.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 72.42 109.5 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.607 ' OD1' ' HG2' ' A' ' 113' ' ' LYS . 15.7 t0 -106.1 120.48 41.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.237 -0.438 . . . . 74.03 111.25 -173.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -93.89 97.25 10.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.303 0.573 . . . . 74.53 109.708 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.25 143.88 32.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.469 -0.787 . . . . 60.52 109.242 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.94 -12.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.513 0.56 . . . . 63.12 112.513 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.95 -9.43 37.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 33.13 110.981 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 144.48 120.75 1.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.92 -0.657 . . . . 75.42 112.231 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' A' ' 135' ' ' GLY . 29.2 Cg_exo -61.94 131.19 33.87 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.851 2.367 . . . . 72.43 112.37 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.4 m -126.55 129.95 49.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.942 -0.572 . . . . 33.11 110.182 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.707 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.2 mp -107.57 124.95 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.015 -0.365 . . . . 65.32 110.015 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.89 112.97 24.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.445 -0.576 . . . . 64.53 109.445 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 127' ' ' CYS . . . -111.69 131.93 10.55 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.722 -1.228 . . . . 73.14 111.757 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.88 116.8 23.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 62.54 110.26 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 125' ' ' LEU . 12.2 tp -122.57 123.64 41.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 62.42 110.344 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 7' ' ' TYR . 86.1 t -122.49 124.96 71.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.352 -0.84 . . . . 71.21 109.692 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.15 137.69 46.66 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 73.13 108.711 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.544 ' HA2' HD23 ' A' ' 150' ' ' LEU . . . -129.43 132.71 7.21 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.868 -1.158 . . . . 75.14 114.177 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.454 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 73.8 t80 -136.16 147.27 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.34 -0.985 . . . . 75.44 108.34 171.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -39.28 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.497 0.925 . . . . 71.34 113.497 -174.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.92 -35.19 4.92 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.205 -0.907 . . . . 43.42 113.668 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.454 ' CE2' ' HB3' ' A' ' 146' ' ' TYR . 55.9 p-90 -110.57 138.83 46.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.082 0.941 . . . . 72.23 112.014 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.544 HD23 ' HA2' ' A' ' 145' ' ' GLY . 12.9 mt -127.19 137.25 52.89 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.5 -0.773 . . . . 74.33 110.186 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.66 124.41 23.89 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.847 -0.427 . . . . 71.23 109.847 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 143' ' ' VAL . . . -141.83 151.21 22.62 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.439 -0.886 . . . . 65.2 111.937 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -145.31 133.31 21.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.252 0.549 . . . . 71.54 111.867 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.25 123.75 44.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.301 -0.863 . . . . 74.4 109.417 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 45.9 ttm -119.46 134.26 55.3 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.987 -0.375 . . . . 75.25 109.987 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -111.59 119.0 37.26 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.24 0.543 . . . . 75.3 110.373 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.707 ' HB2' ' HB ' ' A' ' 138' ' ' ILE . 69.1 m-85 -98.56 127.0 44.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.121 -0.945 . . . . 74.03 110.47 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.608 ' HB2' ' OG1' ' A' ' 165' ' ' THR . 81.7 tt0 -99.7 98.99 9.77 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 109.513 -0.551 . . . . 75.14 109.513 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.5 m -72.25 -17.56 61.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 113.949 -1.478 . . . . 70.24 111.278 171.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.03 -27.0 65.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.697 -0.853 . . . . 63.52 108.697 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.86 -153.51 0.57 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.214 -1.357 . . . . 71.04 108.095 168.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.7 p -109.79 28.0 9.01 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.93 -0.481 . . . . 74.25 112.098 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -140.87 171.54 13.93 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 118.035 -1.466 . . . . 64.35 114.433 -160.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.5 t -93.81 127.76 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.661 -1.154 . . . . 70.11 108.813 170.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.608 ' OG1' ' HB2' ' A' ' 158' ' ' GLU . 1.7 m -96.06 -36.24 11.08 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.227 -0.589 . . . . 54.34 111.196 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -130.13 133.19 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.065 -0.516 . . . . 74.4 110.307 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -119.42 107.0 12.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.111 -0.7 . . . . 73.22 109.111 173.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -105.95 133.1 51.22 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.655 -0.498 . . . . 73.32 109.655 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 87.8 m-85 -121.99 146.98 46.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.396 -0.365 . . . . 70.41 110.468 -176.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -140.1 128.96 23.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.126 0.488 . . . . 73.44 109.998 176.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.65 ' HB ' ' HB ' ' A' ' 182' ' ' THR . 39.6 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.506 -0.553 . . . . 74.44 109.506 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -121.95 135.57 10.47 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.376 -0.916 . . . . 52.33 112.597 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.574 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 68.4 t80 -117.12 120.32 37.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.561 -1.274 . . . . 72.5 107.561 171.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -115.41 121.64 43.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.032 0.92 . . . . 73.23 112.099 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.711 ' HB ' ' HB2' ' A' ' 178' ' ' PHE . 42.6 m -136.33 163.21 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.469 -1.678 . . . . 72.24 106.469 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.491 ' HB2' ' OE2' ' A' ' 177' ' ' GLU . 6.3 m-20 -63.28 -43.38 98.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.414 1.006 . . . . 72.55 110.363 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 176' ' ' ASP . 2.2 mp0 -85.96 -21.81 27.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 74.53 111.251 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.711 ' HB2' ' HB ' ' A' ' 175' ' ' THR . 54.3 m-85 -119.22 115.35 24.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.524 -0.307 . . . . 74.22 111.359 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 195' ' ' TYR . 1.5 mp0 -118.7 121.46 40.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.934 -0.765 . . . . 62.4 108.934 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.845 HD12 HG13 ' A' ' 194' ' ' ILE . 2.3 tt -124.11 131.9 53.59 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.574 -0.451 . . . . 54.55 110.553 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.705 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 19.5 t-80 -129.13 114.52 16.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.181 -0.463 . . . . 64.22 110.543 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.65 ' HB ' ' HB ' ' A' ' 171' ' ' VAL . 57.3 m -95.58 137.59 34.43 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.327 -0.99 . . . . 71.34 108.327 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -132.67 138.64 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.585 -0.446 . . . . 62.4 110.477 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 74.7 t -133.05 131.39 58.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.962 -0.563 . . . . 72.31 110.625 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 8.0 t30 -117.19 96.82 5.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.682 -0.859 . . . . 70.43 108.682 174.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 187' ' ' GLY . 9.6 t70 59.4 -162.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.169 -0.923 . . . . 61.4 109.656 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' A' ' 186' ' ' ASP . . . -80.26 -7.01 88.94 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 52.44 112.53 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 211' ' ' THR . 13.2 m -95.63 -26.94 15.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 -173.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 mp0 -119.48 114.77 22.8 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.84 -0.538 . . . . 64.24 111.286 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.484 ' HE1' ' HB2' ' A' ' 212' ' ' ALA . 28.1 p90 -135.67 129.14 32.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.782 0.325 . . . . 75.12 110.192 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.9 175.38 36.73 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.398 -0.906 . . . . 74.41 112.462 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 182' ' ' THR . . . -147.78 141.25 9.06 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.97 -0.633 . . . . 52.13 112.061 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 8.7 t -122.29 138.28 54.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.87 -0.418 . . . . 73.2 109.87 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.845 HG13 HD12 ' A' ' 180' ' ' LEU . 4.5 mp -120.21 122.72 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.918 -0.583 . . . . 63.34 109.953 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.551 ' HB3' ' HB2' ' A' ' 179' ' ' GLN . 59.5 t80 -108.09 120.42 42.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.851 -0.796 . . . . 73.51 108.851 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -121.29 116.52 25.01 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.9 -0.591 . . . . 72.12 111.136 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.97 116.72 24.37 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.346 -0.983 . . . . 71.31 108.346 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 199' ' ' ASN . 21.4 t -76.32 168.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.631 -0.507 . . . . 75.32 109.631 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.49 ' N ' HG12 ' A' ' 198' ' ' VAL . 16.6 t-20 -59.84 -37.1 78.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.109 0.48 . . . . 64.52 110.234 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.99 171.19 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.216 -0.661 . . . . 72.34 109.216 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 201' ' ' LYS . 36.7 mmtm -80.11 61.8 4.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.79 0.805 . . . . 74.41 111.464 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 203' ' ' GLU . 5.6 tt -137.02 132.37 34.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.322 -1.308 . . . . 73.24 107.753 175.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.451 ' N ' HD23 ' A' ' 202' ' ' LEU . 31.2 mt-10 -119.08 145.65 45.75 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.503 -0.555 . . . . 70.31 109.503 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.7 t -133.71 152.56 51.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.603 -0.439 . . . . 73.13 110.5 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB2' ' HD2' ' A' ' 195' ' ' TYR . . . -130.19 135.21 47.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.212 0.529 . . . . 63.13 110.153 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 193' ' ' SER . 33.9 t -121.87 125.63 73.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.484 -0.78 . . . . 74.13 109.603 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.79 127.68 54.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.74 0.305 . . . . 73.24 110.926 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.6 mm? -119.13 130.48 55.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 73.15 109.725 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 218' ' ' ARG . . . -132.71 129.68 39.05 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.627 -0.508 . . . . 31.23 109.627 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -127.04 121.52 31.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.478 -0.564 . . . . 73.31 109.478 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 215' ' ' SER . 5.4 t -106.24 117.87 35.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.616 0.722 . . . . 61.01 109.578 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.484 ' HB2' ' HE1' ' A' ' 190' ' ' PHE . . . -62.33 150.33 39.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.989 -1.005 . . . . 63.02 111.932 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 118.39 24.11 3.28 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.635 -0.711 . . . . 74.14 111.831 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.9 29.59 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.341 0.591 . . . . 60.41 110.471 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.663 ' HB2' HG23 ' A' ' 211' ' ' THR . 9.9 m -83.46 -170.34 3.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.48 -0.782 . . . . 75.44 110.537 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.61 149.62 38.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.376 -0.374 . . . . 70.21 110.6 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 38.7 m -95.91 123.0 39.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.681 -0.859 . . . . 64.11 108.681 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 43.7 ttt180 -101.2 117.62 35.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.392 -0.367 . . . . 74.43 110.808 -171.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.671 ' H ' ' HB2' ' A' ' 239' ' ' ASN . 40.7 p90 -114.87 154.1 29.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.067 -0.515 . . . . 71.04 110.194 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.0 140.31 7.67 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.194 -0.762 . . . . 74.41 111.194 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.86 128.96 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.711 -0.477 . . . . 73.14 109.711 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 236' ' ' LYS . . . -122.23 133.05 54.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.363 0.414 . . . . 72.24 110.555 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -113.0 124.91 53.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.787 -0.449 . . . . 52.12 109.787 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.115 -0.493 . . . . 75.52 109.922 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -128.03 133.07 49.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.113 0.482 . . . . 74.22 110.537 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.71 97.68 9.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.697 -0.683 . . . . 63.2 109.266 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.8 tt -71.78 -23.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.043 0.925 . . . . 75.44 108.529 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.72 137.91 13.45 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.199 -1.364 . . . . 72.34 107.525 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.18 -15.91 11.73 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 122.902 2.401 . . . . 72.41 113.814 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.39 -22.3 19.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.813 0.339 . . . . 74.11 111.256 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.51 128.76 36.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.152 0.501 . . . . 52.05 111.83 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.3 m -104.85 119.71 39.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 63.43 110.429 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -100.55 133.51 44.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 72.43 110.651 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 38.8 t -131.16 117.81 19.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 75.51 111.515 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.93 40.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.914 -0.772 . . . . 70.24 108.914 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 222' ' ' ALA . 9.8 pttm -152.66 159.52 43.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 74.31 112.231 -171.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 242' ' ' LEU . 5.0 p -143.5 154.25 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 60.33 109.438 176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 20.0 t-20 -130.75 153.82 48.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.683 -0.235 . . . . 71.43 110.87 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.671 ' HB2' ' H ' ' A' ' 219' ' ' PHE . 32.5 t30 -38.05 -41.83 0.6 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.972 1.309 . . . . 73.4 113.661 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.4 t -78.17 24.37 0.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 73.2 111.051 -173.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 239' ' ' ASN . 17.9 m 65.32 36.47 6.92 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 64.12 109.725 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.98 ' HB3' HD11 ' A' ' 262' ' ' LEU . 25.4 mt -93.6 115.39 27.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.906 -0.588 . . . . 51.13 110.098 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.5 mp -100.29 116.55 43.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.928 -0.767 . . . . 73.53 108.928 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -128.18 140.28 11.68 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.059 -1.067 . . . . 73.21 113.571 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.536 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -122.13 148.34 45.03 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.386 -0.598 . . . . 61.13 109.386 172.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -162.92 122.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.573 -0.822 . . . . 42.25 112.241 -177.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -118.47 133.07 56.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.274 0.559 . . . . 75.44 110.758 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 30.1 m -110.9 120.04 41.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.068 -0.969 . . . . 72.52 109.896 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -114.24 130.28 56.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.861 0.363 . . . . 65.21 110.136 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.5 p -104.79 107.7 18.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.819 -0.628 . . . . 74.2 109.909 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.63 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . 4.1 mm? -71.18 173.87 7.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.854 0.359 . . . . 43.04 110.909 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -47.87 57.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.046 -0.524 . . . . 75.4 110.65 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 13.5 Cg_exo -70.96 -177.62 2.36 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.619 1.546 . . . . 72.24 110.68 169.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -76.84 50.3 2.95 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.556 -0.831 . . . . 45.22 112.791 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.63 ' HB ' ' HB2' ' A' ' 251' ' ' LEU . 48.5 mt -108.75 121.42 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.408 -0.466 . . . . 75.11 110.338 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 280' ' ' GLU . 68.7 tttt -110.53 119.2 38.39 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.247 -0.433 . . . . 55.31 109.895 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 15.3 tp -101.66 126.78 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.437 -0.801 . . . . 74.13 109.983 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.451 ' O ' HD12 ' A' ' 277' ' ' LEU . 19.5 m -132.05 109.77 10.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.867 0.365 . . . . 74.1 110.376 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.648 ' CD2' HD13 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -112.77 125.14 54.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.768 -0.826 . . . . 65.35 108.768 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.408 ' N ' HD13 ' A' ' 259' ' ' LEU . 51.4 m -138.99 148.81 43.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.782 0.325 . . . . 63.14 110.532 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.4 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -145.06 128.69 17.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.69 -0.485 . . . . 41.25 109.69 176.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.98 HD11 ' HB3' ' A' ' 242' ' ' LEU . 1.7 tm? -111.44 118.31 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.205 -0.665 . . . . 73.02 109.205 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.694 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.7 OUTLIER -98.05 107.43 19.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.797 -1.186 . . . . 71.02 107.797 174.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.749 ' OD1' ' HG2' ' A' ' 266' ' ' LYS . 19.0 t0 -71.53 104.41 3.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.53 -0.915 . . . . 64.23 108.53 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.39 -27.1 39.52 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 115.709 -0.678 . . . . 64.31 114.159 -171.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.749 ' HG2' ' OD1' ' A' ' 264' ' ' ASP . 23.7 pttm -91.98 -13.55 30.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.078 0.439 . . . . 64.31 111.123 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.702 ' OD1' ' HA3' ' A' ' 272' ' ' GLY . 10.9 t-20 -116.22 -26.81 7.07 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.001 0.371 . . . . 71.45 112.001 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.694 HG11 ' HB3' ' A' ' 263' ' ' LEU . 24.1 m -62.07 -17.86 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 O-C-N 122.166 -0.334 . . . . 34.33 110.917 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -59.29 -29.37 67.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.773 -0.649 . . . . 75.21 109.999 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -100.04 -16.98 17.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 64.45 110.637 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.19 13.82 6.83 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.933 -0.651 . . . . 23.44 113.064 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.702 ' HA3' ' OD1' ' A' ' 267' ' ' ASN . . . -85.83 79.52 1.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.663 -0.78 . . . . 73.43 113.125 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.422 ' HB2' HD12 ' A' ' 263' ' ' LEU . 8.2 p80 -114.22 142.09 46.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.52 -0.548 . . . . 75.34 109.52 175.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.904 ' HD2' ' HB3' ' A' ' 22' ' ' TYR . 80.2 mttt -110.61 143.1 41.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.399 -0.52 . . . . 71.45 111.49 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.5 tm? -115.5 137.97 51.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.254 -0.884 . . . . 64.11 108.866 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.496 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -134.51 104.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.507 -0.854 . . . . 73.12 111.521 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.829 HD23 HG23 ' A' ' 27' ' ' ILE . 40.1 tp -114.12 145.46 41.6 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.33 -0.548 . . . . 73.14 110.677 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.669 ' H ' HD12 ' A' ' 277' ' ' LEU . . . -150.33 124.1 1.68 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.197 -0.911 . . . . 53.41 111.479 178.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.404 ' HB2' HD12 ' A' ' 29' ' ' LEU . 2.2 mm? -118.33 131.89 56.3 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.748 -0.834 . . . . 73.31 108.748 174.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.652 ' CG ' ' HB3' ' A' ' 256' ' ' LYS . 8.7 pt-20 -125.22 115.18 20.0 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.861 -0.736 . . . . 61.45 110.369 171.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.757 ' HB3' HD22 ' A' ' 31' ' ' LEU . 57.3 t80 -99.83 106.19 18.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.948 -1.024 . . . . 74.45 109.812 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -102.56 111.95 24.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.893 -0.594 . . . . 52.33 110.043 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -111.94 126.2 54.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.958 -0.564 . . . . 72.24 110.459 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.44 0.34 16.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.367 0.603 . . . . 73.24 110.243 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.585 -0.734 . . . . 71.24 109.731 179.398 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG3' ' HB2' ' A' ' 93' ' ' ARG . 26.3 ttt . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.573 0.225 . . . . 44.2 110.451 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.83 104.77 16.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.743 -0.466 . . . . 71.4 109.743 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 120' ' ' ARG . 9.1 p -163.33 137.06 4.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.409 -0.589 . . . . 73.33 109.409 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.4 Cg_exo -63.56 131.92 33.49 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.888 2.392 . . . . 63.42 113.397 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 6.5 Cg_exo -73.57 99.84 1.18 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.917 2.411 . . . . 63.23 111.565 175.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.543 ' HB ' HD11 ' A' ' 150' ' ' LEU . 5.2 p -94.82 -2.75 50.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.351 -0.386 . . . . 73.42 111.865 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.694 ' HB3' HG21 ' A' ' 143' ' ' VAL . 6.1 p90 -62.25 -21.32 65.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.66 0.743 . . . . 74.42 109.973 170.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.31 -25.25 54.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.135 -0.939 . . . . 72.22 110.143 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HB3' ' HE1' ' A' ' 181' ' ' HIS . 51.4 m-20 -91.58 -1.9 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 71.21 109.943 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.111 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 tp -76.39 -34.04 58.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.173 -0.921 . . . . 73.12 111.67 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.23 -36.07 0.51 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.08 -1.057 . . . . 74.51 113.892 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -56.77 -41.73 78.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.967 0.383 . . . . 62.14 111.981 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 m -58.15 -46.38 85.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.034 0.445 . . . . 74.43 111.244 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -35.03 72.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.934 -0.575 . . . . 54.25 111.4 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -58.55 -35.91 73.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 72.33 112.79 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.37 -49.87 75.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.978 0.418 . . . . 72.33 111.387 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HB ' ' HB2' ' A' ' 207' ' ' ASN . 2.8 t -85.21 -31.5 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 73.24 111.149 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.405 ' HB2' ' ND2' ' A' ' 207' ' ' ASN . 88.0 t80 -66.91 -38.24 85.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.189 -0.459 . . . . 75.23 112.001 -174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -57.24 150.85 16.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 74.43 111.191 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -116.59 -13.52 10.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.213 0.53 . . . . 62.4 110.224 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.77 51.76 4.48 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.607 -0.724 . . . . 63.42 111.755 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.6 -36.94 74.82 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.408 0.623 . . . . 74.15 109.582 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.05 101.58 0.44 Allowed Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.014 -0.994 . . . . 52.44 111.05 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -81.28 -3.81 53.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 75.11 110.14 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.89 7.33 78.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.815 -0.629 . . . . 71.21 112.643 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mp -123.34 168.36 12.6 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.966 0.889 . . . . 61.44 112.435 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.804 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.9 mp -108.27 124.14 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.047 -1.433 . . . . 64.11 108.925 174.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -105.61 136.31 45.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.963 0.411 . . . . 74.32 111.03 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.76 129.04 56.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.21 -1.033 . . . . 74.41 108.21 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.56 133.93 48.5 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.807 -0.812 . . . . 55.0 108.807 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.63 HD13 ' HD2' ' A' ' 281' ' ' PHE . 16.9 tp -138.41 126.02 22.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.21 111.78 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -114.86 127.25 55.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.55 109.6 172.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 41' ' ' PHE . 7.6 t -137.21 150.96 48.23 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.535 -0.466 . . . . 63.54 110.386 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HE2' HD11 ' A' ' 284' ' ' LEU . 18.3 ttmm -133.08 148.71 52.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.376 -0.374 . . . . 73.22 110.016 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -140.13 136.62 33.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.769 -0.196 . . . . 54.44 110.509 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 39.84 -97.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.294 1.038 . . . . 65.13 113.254 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -154.76 141.24 18.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.854 -0.795 . . . . 72.32 108.854 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 88.51 -9.08 77.12 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.586 -0.34 . . . . 52.22 112.71 -177.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.21 128.03 48.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.658 0.729 . . . . 74.22 111.803 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.959 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 3.5 tp10 -141.03 118.9 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.911 -1.144 . . . . 75.3 107.911 165.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.773 ' HB3' HG22 ' A' ' 33' ' ' THR . 59.3 t80 -116.96 124.86 50.41 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.25 -0.906 . . . . 74.0 111.107 -176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.7 m -126.84 117.73 23.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 65.15 110.911 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -116.25 127.23 54.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.607 -0.27 . . . . 75.31 110.297 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -125.9 126.06 43.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.282 -0.417 . . . . 61.33 109.933 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.45 138.17 8.01 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.224 -0.989 . . . . 74.1 111.858 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -121.01 133.18 55.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.889 -0.411 . . . . 70.44 109.889 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 135.31 45.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.133 0.492 . . . . 73.13 111.161 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.834 ' HB3' ' HB3' ' A' ' 53' ' ' LYS . 39.1 t30 -77.27 147.19 36.43 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.347 -0.842 . . . . 74.1 109.41 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -44.93 -37.66 4.12 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.987 0.423 . . . . 75.42 111.02 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.93 123.58 27.91 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.212 -0.662 . . . . 73.24 109.212 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -68.72 -5.3 19.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.241 0.544 . . . . 71.14 111.826 -172.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -83.59 5.33 24.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.117 0.484 . . . . 73.41 110.85 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.834 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 31.2 tptt -137.64 84.38 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 63.22 110.346 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.81 132.56 70.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.696 0.284 . . . . 73.43 110.785 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -125.16 142.69 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.22 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.19 155.72 22.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.102 -1.047 . . . . 52.24 113.206 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 m -146.31 127.33 14.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.343 -0.614 . . . . 42.14 109.343 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 74' ' ' LYS . 2.0 tm? -121.46 127.14 50.79 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.164 -0.31 . . . . 74.35 110.164 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 45.5 mt-10 -116.7 118.16 31.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.752 -0.658 . . . . 60.45 110.14 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.6 m -100.42 118.73 37.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.24 -1.022 . . . . 64.41 108.24 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.959 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 66.0 mttm -113.68 133.51 55.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.21 0.529 . . . . 71.54 110.543 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.75 ' HD2' ' HB2' ' A' ' 71' ' ' PHE . 38.4 m-85 -101.13 119.65 39.06 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.794 -1.187 . . . . 53.11 107.794 172.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 9.9 ttm180 -115.57 106.0 13.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.606 0.717 . . . . 75.34 109.971 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -113.7 104.14 11.92 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.516 -1.22 . . . . 75.54 109.335 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.7 p 60.57 126.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.692 1.245 . . . . 52.32 112.326 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.4 pm0 -60.72 130.31 45.86 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.11 -0.7 . . . . 74.21 109.11 174.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 62.12 75.67 0.4 Allowed 'General case' 0 C--N 1.332 -0.183 0 O-C-N 123.825 0.703 . . . . 71.01 109.598 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.95 -101.63 0.15 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.31 -0.859 . . . . 44.4 111.777 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.498 ' CD1' ' HB ' ' A' ' 87' ' ' VAL . 4.0 mm? -121.34 131.96 54.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.137 0.494 . . . . 54.43 112.325 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.608 HG23 ' HB ' ' A' ' 86' ' ' THR . 4.1 t -137.3 119.01 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 74.0 110.033 171.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.75 ' HB2' ' HD2' ' A' ' 62' ' ' TYR . 34.5 m-85 -114.81 121.58 43.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.671 -0.241 . . . . 72.34 110.435 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 83' ' ' THR . 57.6 m -109.96 115.56 30.01 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.997 -0.281 . . . . 55.4 110.585 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.91 143.69 47.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.681 -0.408 . . . . 75.45 111.619 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HG3' HD12 ' A' ' 58' ' ' LEU . 20.5 mmtt 159.41 -119.68 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.65 1.219 . . . . 72.04 111.479 162.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.783 ' HD1' ' HG ' ' A' ' 81' ' ' LEU . 15.5 t90 -135.18 140.31 45.25 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.588 -0.445 . . . . 75.44 112.081 -164.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -110.18 164.14 12.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 73.44 110.836 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 t -69.9 -7.37 39.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 51.44 111.328 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 14.1 m-20 -80.0 -2.27 43.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.856 -0.611 . . . . 40.41 110.39 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.543 HD21 ' HG2' ' A' ' 105' ' ' PRO . 9.0 t30 81.71 -8.53 1.32 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.96 0.788 . . . . 72.32 109.936 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.4 m -85.25 140.15 31.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.344 -0.844 . . . . 71.42 110.398 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.783 ' HG ' ' HD1' ' A' ' 75' ' ' TRP . 5.3 mp -92.52 126.56 37.66 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.337 -0.616 . . . . 74.22 109.337 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.35 13.67 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.172 -1.013 . . . . 64.53 113.044 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.1 t -136.16 104.41 5.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.743 0.782 . . . . 71.53 110.736 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 43.9 tt0 -106.78 115.66 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.194 -0.912 . . . . 74.43 109.448 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' THR . 2.7 pp -111.77 137.98 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 44.21 110.62 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.672 HG23 ' HB ' ' A' ' 98' ' ' THR . 16.9 m -129.17 129.92 45.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.899 0.38 . . . . 70.0 111.246 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.498 ' HB ' ' CD1' ' A' ' 69' ' ' LEU . 2.8 p -129.24 124.89 61.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.724 -0.671 . . . . 74.04 110.23 175.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -113.53 122.68 48.0 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.405 -0.591 . . . . 71.22 109.405 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.37 151.84 19.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.191 0.519 . . . . 52.13 111.85 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -102.21 -24.1 13.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.731 -0.668 . . . . 73.23 110.661 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.46 -56.88 8.83 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.449 -1.315 . . . . 73.35 107.449 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.45 61.2 6.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.27 -1.011 . . . . 53.23 108.27 167.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.417 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 14.5 ptp180 -53.03 124.4 14.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.061 -0.972 . . . . 74.24 112.612 -171.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 118' ' ' TYR . . . 100.98 -16.45 57.31 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.083 -0.962 . . . . 65.01 112.093 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' A' ' 118' ' ' TYR . 3.1 tm? -92.5 123.82 36.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.606 -0.516 . . . . 64.21 109.606 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.76 51.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.74 -0.664 . . . . 72.01 109.668 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -116.24 125.71 52.59 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.114 -0.699 . . . . 73.32 109.114 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 86' ' ' THR . 0.5 OUTLIER -130.49 119.91 23.32 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.195 0.521 . . . . 61.32 110.279 176.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.453 ' HD2' ' HB ' ' A' ' 114' ' ' ILE . 91.9 t80 -123.91 125.43 44.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.535 -0.757 . . . . 75.13 110.372 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 4.5 t70 -109.72 131.99 54.55 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.024 -0.534 . . . . 74.14 109.714 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.8 t -126.0 120.86 31.4 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.38 -0.6 . . . . 62.12 109.38 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.0 m -109.99 122.14 46.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.959 -0.564 . . . . 73.15 110.048 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.87 119.85 39.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.006 0.431 . . . . 74.21 110.714 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.477 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 8.2 t -99.77 139.77 21.06 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 108.506 -0.924 . . . . 71.24 108.506 176.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.543 ' HG2' HD21 ' A' ' 79' ' ' ASN . 31.3 Cg_exo -62.12 41.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 124.127 3.218 . . . . 71.32 114.832 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -123.86 150.02 45.09 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 60.12 108.822 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.0 m -66.55 105.19 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.099 0.475 . . . . 63.22 111.292 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.42 68.56 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.994 -0.622 . . . . 61.23 112.869 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -94.97 111.64 23.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.072 0.463 . . . . 64.24 109.945 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.47 143.57 26.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.869 -0.605 . . . . 74.33 110.618 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.37 122.47 40.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.049 -0.523 . . . . 75.03 109.705 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -129.13 141.8 51.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.976 -0.289 . . . . 74.43 111.389 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -124.68 137.38 54.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.947 -0.761 . . . . 62.25 108.947 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 99' ' ' PHE . 5.0 tp -124.75 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.188 0.518 . . . . 74.13 110.218 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -116.45 120.96 40.44 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.837 -0.62 . . . . 74.23 110.467 -178.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.6 m -107.19 116.89 32.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.599 -0.728 . . . . 74.43 109.083 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.556 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -133.74 125.71 4.04 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.694 -1.241 . . . . 72.34 113.145 -172.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.719 ' HB3' HD23 ' A' ' 95' ' ' LEU . 6.3 p90 -117.01 136.64 52.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.192 0.52 . . . . 74.2 110.032 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 43.6 pttt -119.74 124.66 46.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.866 0.841 . . . . 74.13 111.58 -175.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.514 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.3 mmt180 -100.32 166.37 11.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.256 -1.338 . . . . 74.21 109.06 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.11 -27.25 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.762 0.825 . . . . 75.44 112.813 -172.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -118.36 -12.1 9.93 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.699 0.629 . . . . 74.11 112.699 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 144' ' ' LEU . 19.5 pt -142.76 145.72 22.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.612 -0.835 . . . . 71.2 111.815 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.636 HD22 ' N ' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -129.02 115.82 18.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.759 -0.46 . . . . 64.23 109.759 178.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.534 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -130.52 143.07 50.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.331 -0.547 . . . . 70.32 111.634 -175.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.556 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -141.57 138.75 8.91 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 61.01 112.621 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 67.9 m -108.66 112.38 24.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.013 -0.365 . . . . 71.33 110.013 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 9.6 t70 -104.47 148.17 26.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.046 -0.525 . . . . 55.44 110.088 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.1 mtm -131.38 118.31 20.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.312 -0.625 . . . . 62.32 109.312 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 10.5 t70 -89.78 115.74 27.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.945 -0.761 . . . . 75.41 108.945 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -97.12 99.71 11.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.956 -0.565 . . . . 75.21 110.962 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.55 145.69 37.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.983 -1.117 . . . . 74.25 107.983 169.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.862 HD13 ' H ' ' A' ' 133' ' ' ILE . 0.2 OUTLIER -64.68 -21.67 29.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.613 0.244 . . . . 72.15 111.536 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.53 -18.83 34.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.542 0.21 . . . . 64.43 111.101 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.5 105.66 0.18 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.868 -0.682 . . . . 74.1 112.799 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 3.1 Cg_exo -76.2 109.45 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.092 2.528 . . . . 61.52 111.366 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -99.09 160.55 14.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.522 -0.308 . . . . 55.14 110.946 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mp -107.38 118.38 55.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.672 -0.411 . . . . 63.42 110.036 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 33.8 ttp180 -115.2 111.15 20.54 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.076 0.465 . . . . 54.04 110.102 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.95 144.29 17.3 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.955 -1.117 . . . . 54.22 112.382 -173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 153' ' ' TYR . . . -137.6 114.71 10.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.127 0.489 . . . . 73.3 110.184 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' A' ' 125' ' ' LEU . 4.2 tp -117.68 123.16 45.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.968 -0.56 . . . . 61.02 109.701 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.694 HG21 ' HB3' ' A' ' 7' ' ' TYR . 5.2 t -119.24 121.51 66.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.112 -0.494 . . . . 75.05 110.293 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 123' ' ' ILE . 5.0 mp -108.08 138.64 44.0 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.425 -0.583 . . . . 60.22 109.425 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.45 119.31 4.24 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.607 -0.724 . . . . 61.12 111.358 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.661 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 56.4 t80 -118.16 148.97 41.82 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.299 -1.0 . . . . 63.44 108.299 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -52.79 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.344 0.592 . . . . 74.44 110.973 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.04 -32.74 7.21 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.144 -0.935 . . . . 73.24 112.493 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 90.9 m95 -106.52 146.39 30.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.285 0.846 . . . . 74.4 113.285 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.543 HD11 ' HB ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -128.91 142.62 50.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.775 -1.194 . . . . 73.22 107.775 168.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -155.65 123.87 5.83 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.443 -0.577 . . . . 61.45 109.443 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.111 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -142.16 142.14 11.5 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.945 -1.121 . . . . 71.35 111.872 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 36.1 m-85 -123.47 117.17 24.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.032 -0.359 . . . . 75.32 110.032 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.28 122.58 43.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.525 -0.546 . . . . 63.21 109.525 166.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.752 ' HB2' HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -137.2 143.69 42.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.682 0.277 . . . . 72.12 110.485 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 t30 -118.62 118.88 32.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 65.02 110.471 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.943 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 93.1 m-85 -91.85 121.25 33.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.109 -0.951 . . . . 75.12 110.192 -175.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.37 109.89 14.14 Favored 'General case' 0 C--O 1.254 1.325 0 CA-C-N 114.449 -1.251 . . . . 75.1 109.172 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -71.72 -21.51 61.76 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 125.354 1.659 . . . . 73.21 111.775 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.31 -31.8 71.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.392 -0.966 . . . . 55.5 108.392 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -107.92 -161.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.979 -1.464 . . . . 70.41 107.984 168.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.9 m -111.04 26.76 10.37 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 121.89 -0.506 . . . . 52.41 110.476 171.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -149.31 150.31 32.3 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.99 1.108 . . . . 72.4 113.99 -159.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.943 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 p -73.16 128.91 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.537 -0.756 . . . . 72.44 110.231 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 3.9 p -102.49 -33.9 9.34 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.638 -0.71 . . . . 55.2 111.526 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -112.67 129.21 56.48 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.626 -0.43 . . . . 54.2 110.175 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.3 m -124.34 115.33 20.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.033 -0.531 . . . . 72.53 110.665 173.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 7.8 t30 -125.97 120.25 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.96 -0.756 . . . . 64.14 108.96 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -138.34 165.21 27.33 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.741 -0.784 . . . . 70.35 111.921 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -137.19 133.31 35.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.326 -0.852 . . . . 54.53 110.767 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.2 t -129.51 127.09 64.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.007 -0.738 . . . . 62.01 109.007 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.58 166.79 26.07 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 119.735 -1.221 . . . . 45.54 112.831 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.62 ' CE1' HD22 ' A' ' 180' ' ' LEU . 37.4 p90 -138.55 140.4 39.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.168 0.509 . . . . 73.3 110.649 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -103.4 132.62 49.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.132 -0.94 . . . . 74.22 109.935 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 m -131.37 163.2 28.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.782 -0.821 . . . . 74.34 108.782 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -51.75 -50.29 60.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.7 0.285 . . . . 53.35 111.541 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.722 ' HA ' ' HE3' ' A' ' 197' ' ' LYS . 27.0 mm-40 -101.41 -22.51 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.184 0.438 . . . . 72.43 112.184 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 194' ' ' ILE . 72.7 t80 -124.29 144.89 49.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.666 0.27 . . . . 75.03 111.681 -170.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 5.1 tp-100 -135.61 122.4 21.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.947 -0.39 . . . . 75.15 109.947 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.676 HD12 HG13 ' A' ' 194' ' ' ILE . 3.8 tt -125.88 138.15 53.78 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.261 -0.575 . . . . 70.4 111.786 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.643 ' HE1' ' HB3' ' A' ' 9' ' ' ASP . 12.4 m170 -128.31 114.17 16.56 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.889 -0.782 . . . . 53.21 108.889 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 95.0 m -90.86 141.42 28.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.856 -0.424 . . . . 72.31 109.856 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -129.83 141.22 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.992 0.425 . . . . 73.21 110.737 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 5.4 t -130.95 128.36 62.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.296 -0.411 . . . . 64.2 111.042 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 189' ' ' GLU . 0.2 OUTLIER -109.14 90.85 3.42 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.645 -0.872 . . . . 65.4 108.645 176.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 60.65 -169.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 71.45 111.718 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.83 -5.59 86.65 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.42 -0.809 . . . . 45.5 111.981 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 24.2 m -94.32 -27.1 16.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.64 0.607 . . . . 74.21 112.64 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 185' ' ' ASN . 51.5 mt-10 -135.02 129.6 34.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.931 -0.708 . . . . 74.34 112.223 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.445 ' HD2' HG22 ' A' ' 184' ' ' VAL . 44.3 m-85 -127.23 143.84 51.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.619 -0.718 . . . . 72.11 109.713 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 208' ' ' LEU . . . 179.74 -138.24 3.36 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.778 -0.725 . . . . 74.54 112.101 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 182' ' ' THR . . . 152.6 -155.61 26.23 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.168 -1.015 . . . . 71.45 113.037 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 19.1 p -142.09 138.55 31.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.291 0.567 . . . . 64.21 110.817 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.817 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 3.1 mp -119.8 118.76 58.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.645 -0.707 . . . . 72.15 109.612 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.438 ' HB3' ' HB3' ' A' ' 179' ' ' GLN . 44.8 t80 -108.71 119.69 40.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.108 0.48 . . . . 65.53 110.025 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.57 131.54 52.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.743 -0.662 . . . . 75.15 109.776 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.722 ' HE3' ' HA ' ' A' ' 177' ' ' GLU . 18.1 pttp -107.55 127.36 53.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 64.2 110.943 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 202' ' ' LEU . 47.6 t -82.99 155.74 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 45.45 109.446 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -61.77 -45.04 95.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.893 0.378 . . . . 61.32 110.083 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.66 148.35 48.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.722 -1.214 . . . . 72.32 107.722 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -63.41 86.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.562 0.696 . . . . 74.51 112.457 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 225' ' ' TYR . 36.2 mt -144.24 115.16 7.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.57 -1.195 . . . . 60.43 108.551 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -104.46 128.94 52.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.776 -0.824 . . . . 42.43 108.776 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -123.46 138.33 54.61 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.702 -0.399 . . . . 43.44 111.212 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 194' ' ' ILE . . . -130.39 135.5 48.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.024 -0.535 . . . . 75.43 110.177 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 221' ' ' ILE . 87.9 t -114.58 136.22 51.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.663 -0.699 . . . . 74.41 109.612 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.774 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 28.7 t-20 -114.71 132.34 56.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.802 0.334 . . . . 72.15 110.402 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.486 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 3.1 mm? -122.58 136.49 54.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.651 -0.704 . . . . 74.5 110.443 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.97 127.13 9.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.005 -0.543 . . . . 65.24 109.63 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.686 ' HB2' HG23 ' A' ' 217' ' ' THR . 28.4 t90 -130.72 126.11 35.62 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.529 -0.305 . . . . 64.42 110.472 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.585 HG23 ' HB2' ' A' ' 215' ' ' SER . 3.5 t -101.29 116.39 32.68 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 73.42 109.823 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.48 141.26 56.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.335 -0.848 . . . . 63.24 111.158 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 128.36 31.49 0.67 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.864 -0.684 . . . . 71.25 111.655 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 67.36 12.16 8.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.875 0.47 . . . . 63.1 111.826 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 211' ' ' THR . 17.8 m -80.45 160.84 25.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 70.21 109.777 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -77.66 153.37 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.379 . . . . 74.24 111.122 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 210' ' ' TRP . 26.4 m -84.54 131.23 34.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.555 . . . . 74.31 109.744 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -88.54 116.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.947 -0.76 . . . . 75.12 108.947 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 54.5 p90 -123.44 141.34 52.09 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -144.83 141.53 10.07 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.226 -0.75 . . . . 74.22 111.226 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.89 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -119.53 130.54 73.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.879 0.371 . . . . 72.25 110.426 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -129.82 129.48 44.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.605 -0.725 . . . . 72.15 109.954 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.672 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -117.97 129.15 55.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.288 -0.415 . . . . 63.33 110.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -115.66 115.83 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.021 -0.733 . . . . 71.23 109.021 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 233' ' ' PHE . 3.9 p90 -132.78 119.25 20.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.248 0.547 . . . . 64.44 111.77 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 232' ' ' CYS . 35.4 tt0 -89.54 97.94 11.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 71.31 109.075 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -97.15 -24.62 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 73.32 109.668 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 4.6 t70 -114.63 137.22 22.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.653 -0.869 . . . . 72.15 108.653 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -34.97 -51.89 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.381 3.388 . . . . 65.13 115.214 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -107.23 4.78 27.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.902 0.334 . . . . 75.32 111.902 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 228' ' ' ASP . . . -124.73 122.58 37.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.453 0.644 . . . . 50.24 111.958 -175.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 226' ' ' GLN . 50.7 t -113.18 119.09 36.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 75.2 108.84 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.517 ' HB2' ' CE2' ' A' ' 225' ' ' TYR . 57.6 m-85 -100.2 132.13 45.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.434 -0.348 . . . . 51.44 110.272 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 21.1 t -121.75 140.91 51.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.046 0.45 . . . . 32.1 110.349 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -127.16 140.8 52.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.095 -0.705 . . . . 74.33 109.095 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -135.6 141.4 45.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.693 -0.484 . . . . 55.23 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.588 HG12 HG12 ' A' ' 221' ' ' ILE . 5.4 p -140.6 140.13 34.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 120.488 -0.485 . . . . 70.31 110.028 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.589 ' HB2' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -107.27 150.36 26.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.573 -0.74 . . . . 44.42 110.381 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 241' ' ' SER . 28.3 p-10 -43.9 -33.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.95 1.406 . . . . 74.51 114.064 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.497 ' HB3' HD13 ' A' ' 242' ' ' LEU . 17.9 t -82.08 21.95 0.84 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 61.54 110.024 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.531 ' O ' ' HA3' ' A' ' 265' ' ' GLY . 50.1 m 68.5 36.33 2.95 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 115.232 -0.894 . . . . 64.02 111.265 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.817 ' HG ' ' HA ' ' A' ' 264' ' ' ASP . 7.2 mp -95.68 125.45 40.28 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.309 -0.556 . . . . 74.43 111.316 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -112.52 116.57 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.659 -0.701 . . . . 73.43 110.022 -170.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 261' ' ' ALA . . . -126.35 145.76 15.9 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.55 -0.833 . . . . 43.33 112.654 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -118.39 148.91 42.05 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.062 0.458 . . . . 52.34 110.247 175.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.94 121.79 2.42 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.604 -0.726 . . . . 52.3 111.544 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -108.13 118.84 37.8 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.963 -0.384 . . . . 72.54 109.963 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.644 HG22 HG22 ' A' ' 258' ' ' THR . 14.1 p -113.6 112.86 24.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 72.33 109.895 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 257' ' ' LEU . 22.4 mp0 -118.97 124.83 47.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.937 -0.574 . . . . 72.35 110.168 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 26.0 m -95.91 88.53 4.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.92 -0.77 . . . . 75.52 108.92 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 252' ' ' LYS . 44.8 tp -82.04 78.25 8.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.733 . . . . 74.43 109.511 -175.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 0.5 OUTLIER 68.1 152.71 0.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.058 -0.974 . . . . 73.44 109.901 -172.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.17 74.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.481 2.12 . . . . 62.51 112.059 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.64 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.34 -0.845 . . . . 72.51 111.441 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.2 122.0 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 54.12 110.695 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 280' ' ' GLU . 30.8 tttp -117.87 122.01 42.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.532 -0.544 . . . . 64.44 109.532 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 249' ' ' GLN . 52.3 tp -100.26 131.22 46.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.309 -0.405 . . . . 73.22 110.009 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.644 HG22 HG22 ' A' ' 248' ' ' THR . 18.5 p -128.91 110.87 12.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.326 0.584 . . . . 64.4 110.558 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.877 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -108.9 125.54 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.453 -0.943 . . . . 71.32 108.453 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.2 m -135.38 138.86 43.73 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.61 -0.436 . . . . 64.01 110.359 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.448 ' O ' ' HA2' ' A' ' 244' ' ' GLY . . . -148.05 128.07 13.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.111 -0.495 . . . . 72.11 109.766 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.785 HD11 HD23 ' A' ' 242' ' ' LEU . 2.4 tm? -111.44 115.22 28.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.474 -0.936 . . . . 75.01 108.474 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.607 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.9 OUTLIER -92.24 108.49 19.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.54 -1.282 . . . . 72.44 107.54 174.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.817 ' HA ' ' HG ' ' A' ' 242' ' ' LEU . 2.3 m-20 -69.79 105.06 2.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.888 -0.782 . . . . 71.31 108.888 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 241' ' ' SER . . . -59.84 -15.72 35.91 Favored Glycine 0 C--N 1.32 -0.31 0 C-N-CA 121.222 -0.513 . . . . 72.33 112.638 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -90.16 -25.83 20.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.747 0.308 . . . . 70.21 110.767 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 19.5 m120 -115.81 -27.96 6.86 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.362 0.875 . . . . 75.24 113.362 -170.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.607 HG11 ' HB3' ' A' ' 263' ' ' LEU . 27.8 m -62.62 -19.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 117.965 0.348 . . . . 73.3 111.522 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.72 -40.73 84.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.996 -0.547 . . . . 74.53 110.574 174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.94 -16.38 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 72.22 110.96 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.15 79.39 0.87 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.913 -0.66 . . . . 71.44 112.238 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.568 ' H ' ' HA ' ' A' ' 268' ' ' VAL . . . -159.27 87.34 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.865 -0.683 . . . . 61.12 112.235 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.08 147.07 39.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.373 -0.232 . . . . 72.2 110.373 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 46.5 mmtm -96.19 137.9 34.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.592 -0.522 . . . . 65.32 109.592 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -130.03 126.74 38.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.002 0.429 . . . . 72.22 110.245 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.41 117.74 2.21 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.892 -0.671 . . . . 71.23 111.473 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.877 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -115.12 135.85 53.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.181 -0.674 . . . . 72.52 109.181 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.35 137.91 6.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.107 -1.044 . . . . 74.43 112.984 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.78 131.38 55.71 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.6 -0.889 . . . . 54.24 108.6 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 256' ' ' LYS . 26.5 tt0 -114.95 111.31 20.97 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.59 -0.893 . . . . 72.1 108.59 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.63 ' HD2' HD13 ' A' ' 31' ' ' LEU . 26.3 t80 -112.83 145.86 39.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.799 -0.637 . . . . 73.53 109.805 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -138.04 142.89 40.32 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.86 0.362 . . . . 71.23 110.295 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.526 ' O ' HD22 ' A' ' 284' ' ' LEU . . . -122.83 107.29 11.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.463 -0.569 . . . . 73.23 109.463 172.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 283' ' ' ALA . 1.7 mm? -138.62 -0.57 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.229 -0.896 . . . . 53.42 109.676 -176.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.942 -1.026 . . . . 74.24 109.759 -172.566 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 tpp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.011 0.434 . . . . 74.24 110.36 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.84 178.49 4.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.147 -0.479 . . . . 65.12 109.973 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 14.9 p -100.52 131.96 23.07 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.965 -0.383 . . . . 71.23 109.965 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.75 143.51 99.62 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 40.12 111.836 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.93 89.66 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.582 2.188 . . . . 51.24 112.14 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.3 p -70.78 -30.91 67.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.684 -0.689 . . . . 52.22 110.724 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.785 ' HB3' HG21 ' A' ' 143' ' ' VAL . 30.5 p90 -61.05 -26.37 67.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.567 . . . . 64.15 110.892 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.4 -19.46 39.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.107 -0.497 . . . . 64.14 110.751 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.916 ' HA ' ' HB2' ' A' ' 12' ' ' LYS . 14.5 t70 -93.99 -13.77 26.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.383 . . . . 74.21 110.318 -177.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.624 HD11 HG22 ' A' ' 143' ' ' VAL . 86.8 mt -57.62 -36.09 71.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.22 0.533 . . . . 73.21 110.001 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.9 30.68 4.32 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.298 -0.864 . . . . 54.01 111.523 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.916 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 5.0 tppp? -61.84 -57.89 10.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.458 . . . . 73.34 110.191 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -67.02 -39.11 86.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.542 -0.754 . . . . 73.33 110.258 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.76 93.47 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.071 -0.968 . . . . 42.33 112.633 -171.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -60.68 -39.93 90.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.665 0.211 . . . . 75.34 111.405 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 38.5 t70 -68.16 -36.65 79.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 65.41 111.036 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 207' ' ' ASN . 26.9 t -84.03 -46.62 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.202 0.445 . . . . 52.55 112.202 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -72.38 -43.47 63.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.814 0.34 . . . . 71.15 110.906 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.6 p -111.97 71.94 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.141 0.972 . . . . 72.55 108.48 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 18.8 pttm -85.86 173.11 10.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.925 -1.489 . . . . 74.25 112.563 -166.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.58 97.11 0.2 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.517 -1.033 . . . . 53.41 110.517 170.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' HE2' ' HG ' ' A' ' 262' ' ' LEU . 56.2 t80 -115.81 146.03 42.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.827 0.346 . . . . 74.32 110.305 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 274' ' ' LYS . . . -72.23 90.12 0.52 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.763 -0.732 . . . . 43.52 111.918 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -80.68 -3.81 52.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.153 0.501 . . . . 64.34 110.308 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.18 12.93 58.19 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.627 -0.797 . . . . 73.5 113.57 174.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 pp -140.66 171.79 13.62 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.553 1.168 . . . . 74.23 113.862 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.921 HG23 HD12 ' A' ' 277' ' ' LEU . 33.3 mm -105.75 122.07 58.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 113.121 -1.854 . . . . 71.41 108.945 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.675 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 11.2 pttp -126.65 154.31 44.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.186 0.517 . . . . 71.44 110.644 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -148.03 149.86 32.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.753 -0.832 . . . . 63.45 108.753 169.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' SER . 3.4 p-10 -139.49 131.02 27.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.786 0.803 . . . . 65.44 111.419 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 281' ' ' PHE . 0.6 OUTLIER -94.16 124.85 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.577 -1.192 . . . . 71.23 108.487 -178.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HG3' ' HA ' ' A' ' 282' ' ' GLN . 0.2 OUTLIER -126.4 124.48 40.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 73.31 110.554 178.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 283' ' ' ALA . 88.3 m -137.07 120.96 17.56 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.535 -0.757 . . . . 71.21 109.121 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -136.78 126.12 24.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.107 0.48 . . . . 73.33 110.366 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.0 m -137.07 138.51 40.47 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.923 -0.769 . . . . 72.2 108.923 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.3 mt-10 -77.76 61.68 2.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.959 0.885 . . . . 64.54 110.194 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -137.61 18.92 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.149 -1.387 . . . . 75.13 108.341 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . 90.8 -8.55 79.64 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.21 -0.904 . . . . 63.12 113.943 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.4 126.02 48.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.777 1.288 . . . . 64.42 111.986 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.97 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 19.8 tt0 -142.68 126.48 17.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.381 -0.6 . . . . 75.01 109.381 166.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.5 127.82 38.08 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.031 -0.418 . . . . 75.01 111.56 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 21.8 m -127.38 116.78 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 54.22 110.344 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 32.4 t -118.01 122.88 44.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.59 -0.522 . . . . 64.34 109.59 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 m -120.72 126.76 50.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.669 0.271 . . . . 74.21 110.912 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.98 134.94 8.09 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.719 -0.753 . . . . 72.43 111.96 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -121.57 135.37 55.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.73 -0.47 . . . . 53.22 109.73 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.98 129.32 29.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.278 0.561 . . . . 72.03 111.614 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.799 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m120 -93.7 124.27 37.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.368 -0.833 . . . . 54.31 109.399 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 p -82.5 19.36 1.28 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.263 0.468 . . . . 75.41 112.263 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.05 -42.17 76.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.172 0.511 . . . . 73.21 109.799 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 52' ' ' THR . 1.6 t -160.15 -73.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 60.31 109.647 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.746 ' H ' HG23 ' A' ' 51' ' ' THR . 37.8 m -156.41 86.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.737 -0.468 . . . . 62.25 109.737 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.799 ' HB3' ' HB2' ' A' ' 48' ' ' ASN . 46.7 tptt -128.9 91.71 3.26 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.65 -0.5 . . . . 74.24 109.65 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.3 121.09 63.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.204 -0.453 . . . . 53.25 111.178 -174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 p -110.36 140.31 44.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.77 -0.65 . . . . 74.14 109.984 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.39 19.46 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.316 -0.945 . . . . 75.24 112.753 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -141.88 133.06 26.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.864 -0.791 . . . . 64.21 108.864 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.79 124.53 44.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.757 -0.461 . . . . 74.34 109.757 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 41.0 mt-10 -113.72 118.37 34.13 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.102 -0.499 . . . . 70.42 109.659 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -110.77 122.82 48.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.913 -0.773 . . . . 74.33 108.913 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.97 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 72.1 mttt -129.4 134.78 48.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.298 0.57 . . . . 72.12 111.337 -172.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 49.4 t80 -106.81 119.51 39.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.485 -0.931 . . . . 71.42 108.485 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.495 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 63.6 ttm-85 -118.55 110.18 17.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.356 0.598 . . . . 75.02 111.654 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.632 ' HD1' ' HE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.58 125.17 35.54 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 114.948 -1.024 . . . . 74.33 109.811 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -81.0 -178.71 7.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 125.047 1.467 . . . . 72.13 111.915 -172.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 65' ' ' THR . 49.4 mt-10 71.99 -50.27 0.69 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.662 0.785 . . . . 73.41 110.937 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -95.06 -139.94 0.24 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.682 -1.229 . . . . 72.15 107.682 169.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.8 67.8 0.42 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.115 -0.794 . . . . 61.31 111.115 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 64' ' ' TRP . 4.3 mm? -100.42 129.53 46.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.806 -0.757 . . . . 64.21 110.609 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 3.5 m -138.31 111.99 8.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.404 -0.362 . . . . 65.21 110.886 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -104.49 119.17 38.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.43 -0.952 . . . . 70.1 108.43 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 61' ' ' LYS . 11.9 p -128.53 138.08 52.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.953 0.406 . . . . 53.14 111.87 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 59' ' ' GLU . 43.1 mt-10 -117.54 120.63 38.65 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.809 -0.811 . . . . 72.13 108.809 166.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 7.0 pttp -110.83 105.4 14.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.355 0.598 . . . . 55.43 109.948 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -98.51 133.18 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.142 -0.936 . . . . 75.01 111.161 -174.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -110.47 143.55 40.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.937 -0.764 . . . . 70.52 108.937 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.8 t -56.4 -18.43 11.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.028 0.531 . . . . 71.12 112.149 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 24.7 t70 -67.21 -6.64 18.98 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.797 0.332 . . . . 72.35 110.738 175.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 51.7 m-80 79.79 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.155 0.982 . . . . 71.31 110.058 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -114.84 117.79 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.377 -0.829 . . . . 73.33 110.301 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.79 119.59 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.101 -0.333 . . . . 72.41 110.101 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -107.24 88.1 0.52 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.609 -0.805 . . . . 64.42 111.775 175.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.585 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 35.8 m -84.32 101.17 11.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.208 0.527 . . . . 75.22 110.275 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 3.7 tm-20 -114.75 128.25 56.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.604 -0.726 . . . . 75.51 109.683 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.98 121.74 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.297 0.57 . . . . 74.0 110.571 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.7 m -107.32 129.02 54.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 72.14 109.93 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.16 119.55 49.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.265 0.555 . . . . 73.54 110.842 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.57 118.98 36.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.629 -1.249 . . . . 71.14 107.629 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.71 169.34 11.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.681 0.753 . . . . 61.2 112.341 -166.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -111.91 -2.03 15.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.998 -1.001 . . . . 71.22 110.229 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 89' ' ' ASP . 53.2 tp -85.08 -55.43 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 74.12 110.026 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -118.81 79.63 1.42 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.978 -0.749 . . . . 75.33 108.978 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -47.39 129.08 12.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.475 -0.784 . . . . 74.31 112.435 -171.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.45 -4.25 47.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.205 -0.907 . . . . 70.52 111.973 -173.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -88.02 114.76 24.95 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.825 -0.435 . . . . 65.22 109.825 175.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.07 121.03 36.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.441 0.639 . . . . 72.24 110.119 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.5 mm? -109.46 127.66 54.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.457 -0.792 . . . . 52.5 109.245 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.911 HG23 ' HB2' ' A' ' 115' ' ' LYS . 1.2 t -129.13 128.92 44.44 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 73.32 109.984 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.752 ' HD2' HG12 ' A' ' 114' ' ' ILE . 80.4 t80 -121.38 125.84 47.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.842 -0.617 . . . . 73.45 110.242 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HB2' ' HB2' ' A' ' 113' ' ' LYS . 2.1 m-20 -108.23 121.72 45.46 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.765 -0.458 . . . . 65.12 109.765 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.585 ' OG ' ' HB ' ' A' ' 83' ' ' THR . 8.5 p -115.67 120.18 38.53 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.533 -0.543 . . . . 71.53 109.533 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.3 m -101.34 121.43 41.89 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.858 -0.61 . . . . 65.34 109.528 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -128.46 119.76 25.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.075 -0.512 . . . . 75.44 109.737 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -113.71 103.44 55.33 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.252 -0.431 . . . . 74.3 111.085 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.63 -14.31 34.97 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.209 2.606 . . . . 74.33 112.938 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 104' ' ' SER . 24.9 p30 -72.07 -21.0 61.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 72.12 110.924 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 p -126.54 -37.54 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.992 -0.549 . . . . 72.15 111.016 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.24 50.02 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.021 -0.609 . . . . 71.03 112.471 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -87.59 145.82 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 75.45 110.811 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.31 125.52 46.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.142 -0.688 . . . . 64.32 109.142 171.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -118.84 126.22 51.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.72 -0.474 . . . . 73.3 109.72 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.31 124.49 49.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.907 -0.588 . . . . 62.21 111.367 -173.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 54.8 mttp -111.55 136.24 51.01 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.101 -1.074 . . . . 73.21 108.101 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 129' ' ' MET . 0.4 OUTLIER -125.28 130.95 72.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.325 -0.62 . . . . 62.44 109.325 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.911 ' HB2' HG23 ' A' ' 98' ' ' THR . 3.1 mptp? -123.42 120.73 33.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.605 -0.517 . . . . 75.21 109.605 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.412 HG23 ' HB2' ' A' ' 127' ' ' CYS . 4.5 t -114.21 116.31 28.84 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.628 -0.879 . . . . 72.45 108.628 173.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 126' ' ' GLY . . . -130.08 121.66 3.44 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 119.541 -1.314 . . . . 32.41 112.574 -174.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.416 ' HB3' HD22 ' A' ' 95' ' ' LEU . 25.0 p90 -111.96 117.6 33.15 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.971 -0.751 . . . . 72.33 108.971 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -109.93 122.19 46.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.694 -0.684 . . . . 74.54 109.284 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -106.65 157.01 18.02 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.401 -0.592 . . . . 74.11 109.401 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.724 ' HG3' ' HD2' ' A' ' 122' ' ' HIS . 7.7 pt-20 -51.68 -27.03 10.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.634 0.774 . . . . 73.43 112.784 -172.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.724 ' HD2' ' HG3' ' A' ' 121' ' ' GLU . 66.5 m-70 -106.22 -24.09 12.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.212 0.449 . . . . 72.13 112.212 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.73 HD11 HD11 ' A' ' 142' ' ' LEU . 17.7 tt -147.25 141.61 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 120.324 -0.55 . . . . 64.11 111.992 -173.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.66 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -110.59 117.78 34.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.735 0.302 . . . . 65.22 111.717 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 142' ' ' LEU . 4.3 mm? -111.7 137.49 49.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.821 0.343 . . . . 55.52 111.104 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 117' ' ' GLY . . . -146.25 131.03 3.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.88 -0.676 . . . . 52.32 112.692 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.412 ' HB2' HG23 ' A' ' 116' ' ' THR . 58.1 m -113.35 119.7 38.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.966 0.412 . . . . 51.01 110.851 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.846 ' HB2' ' HB2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -105.29 136.39 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.898 -0.592 . . . . 62.21 110.289 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.769 ' HB2' HG22 ' A' ' 114' ' ' ILE . 64.9 mtt -133.86 121.49 21.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.954 -0.388 . . . . 65.52 109.954 174.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.41 120.13 41.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.108 -0.496 . . . . 73.01 110.038 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -93.35 105.73 17.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.277 0.56 . . . . 72.45 111.069 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.53 172.87 7.65 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.767 -0.827 . . . . 64.44 108.767 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 133' ' ' ILE . 3.5 mp -67.07 -33.12 61.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.309 -0.626 . . . . 70.23 109.309 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.47 -15.29 59.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.545 -0.752 . . . . 75.42 110.951 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.55 178.9 17.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.4 -0.905 . . . . 45.31 112.692 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -87.93 128.81 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.91 2.406 . . . . 75.43 112.812 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 t -99.36 140.75 33.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 62.4 108.757 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.82 118.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.551 -0.459 . . . . 73.3 111.071 -171.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.846 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 40.9 mtp180 -110.12 125.46 53.02 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.885 -0.783 . . . . 65.3 108.885 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -111.68 131.58 10.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 119.709 -1.234 . . . . 65.4 111.444 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.54 116.02 19.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.13 0.491 . . . . 63.42 110.926 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.73 HD11 HD11 ' A' ' 123' ' ' ILE . 6.6 tp -121.81 124.64 44.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 75.01 110.642 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' A' ' 7' ' ' TYR . 86.1 t -112.37 129.56 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.302 -0.863 . . . . 73.43 109.87 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.896 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 1.4 mm? -108.28 138.61 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.53 -0.759 . . . . 62.15 109.896 -170.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.22 118.53 5.59 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.561 -0.745 . . . . 42.3 112.058 176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.834 ' HB2' ' HB2' ' A' ' 149' ' ' TRP . 86.5 m-85 -127.87 148.4 50.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 75.3 109.723 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.71 98.42 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.481 -0.327 . . . . 72.54 111.054 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.13 -21.51 20.05 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 116.29 -0.414 . . . . 62.24 112.756 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 146' ' ' TYR . 24.8 m95 -105.54 131.82 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 75.2 111.209 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.4 mt -112.12 136.51 51.4 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.385 -0.598 . . . . 55.22 109.385 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -131.77 153.25 50.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.285 -0.416 . . . . 41.11 110.038 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -158.46 133.99 3.66 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.937 -0.865 . . . . 44.34 110.937 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -142.43 121.82 13.17 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.712 -0.795 . . . . 71.15 110.184 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.728 ' HG2' ' HB3' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -117.72 120.19 37.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.956 0.884 . . . . 71.13 110.102 176.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.451 ' C ' HD22 ' A' ' 156' ' ' ASN . 15.1 ptt? -117.72 133.46 55.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.153 -0.93 . . . . 74.31 109.304 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -110.54 116.53 31.52 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.781 -0.822 . . . . 74.53 108.781 -173.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 45.4 m-85 -94.36 118.38 31.52 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 123.577 0.548 . . . . 64.51 110.105 -176.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.981 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 7.3 tp10 -91.21 102.17 14.9 Favored 'General case' 0 C--O 1.262 1.752 0 CA-C-N 115.831 -0.622 . . . . 71.53 109.596 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 m -70.52 -25.2 63.01 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 112.893 -1.958 . . . . 71.32 110.93 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.87 71.84 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.01 -0.737 . . . . 43.13 109.01 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.666 ' H ' ' HG3' ' A' ' 158' ' ' GLU . 69.6 mmtt -104.72 -163.41 0.96 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.844 -1.169 . . . . 73.1 107.844 170.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.3 t -108.35 26.37 10.54 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 121.838 -0.539 . . . . 74.13 110.294 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -166.3 172.2 11.33 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 118.89 -1.124 . . . . 73.52 111.542 -166.03 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -74.11 135.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 64.44 110.168 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.981 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 12.4 t -94.41 -21.48 18.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.946 -0.57 . . . . 71.41 110.815 -174.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 165' ' ' THR . 46.2 mt-30 -143.58 134.66 25.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.854 0.359 . . . . 70.2 110.314 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -117.74 106.75 13.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.211 -0.45 . . . . 75.35 109.984 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.728 ' HB3' ' HG2' ' A' ' 154' ' ' GLN . 2.7 t-20 -115.94 122.58 45.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.69 -0.485 . . . . 74.22 109.69 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 184' ' ' VAL . 90.1 m-85 -122.05 156.74 32.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.53 -0.305 . . . . 74.2 110.518 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 182' ' ' THR . . . -152.0 129.0 11.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.041 0.448 . . . . 34.23 110.888 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.89 125.73 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.637 -0.875 . . . . 70.11 108.637 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -142.11 109.16 0.56 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.934 -1.126 . . . . 74.23 112.507 -176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.722 ' CZ ' HD21 ' A' ' 180' ' ' LEU . 11.4 p90 -114.16 133.34 55.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.036 -0.728 . . . . 61.24 109.036 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -132.55 130.86 40.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.963 -1.017 . . . . 74.13 113.066 -162.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 m -121.01 155.51 34.17 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.111 -1.44 . . . . 71.42 107.111 166.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -49.75 -46.45 50.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 75.11 112.417 -170.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.45 -22.98 20.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.665 0.617 . . . . 72.05 112.665 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.73 119.72 15.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.325 0.583 . . . . 74.41 111.895 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -135.28 143.01 46.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.739 -0.664 . . . . 62.42 109.984 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.948 ' HB3' HG13 ' A' ' 194' ' ' ILE 0.256 0.0 OUTLIER -127.45 139.0 53.1 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.382 1.087 . . . . 73.2 111.503 159.274 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 10' ' ' LEU . 45.3 m-70 -124.05 115.59 21.42 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 112.707 -2.042 . . . . 73.25 107.228 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 170' ' ' ALA . 23.8 m -111.93 134.79 53.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.479 -0.328 . . . . 72.35 110.489 -173.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -118.75 140.21 50.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.34 -0.615 . . . . 72.02 109.34 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 169' ' ' PHE . 25.5 t -121.56 118.61 56.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.239 -0.437 . . . . 41.22 110.959 -176.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 189' ' ' GLU . 80.5 m-20 -97.68 91.09 5.23 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.079 -0.964 . . . . 72.11 108.96 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 58.42 -168.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.754 -1.112 . . . . 73.51 110.214 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.44 -6.83 86.9 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.275 -0.964 . . . . 71.33 111.216 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 211' ' ' THR . 3.5 m -89.38 -26.75 20.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.566 0.58 . . . . 65.41 112.566 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 185' ' ' ASN . 40.4 tt0 -139.14 117.61 12.08 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 119.779 -0.768 . . . . 63.35 112.255 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -109.18 126.21 53.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 73.32 109.374 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 208' ' ' LEU . . . -129.23 109.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.844 -0.693 . . . . 55.44 112.503 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' A' ' 182' ' ' THR . . . -105.63 131.77 10.8 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.735 -0.745 . . . . 52.23 111.725 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 20.6 t -119.06 137.8 53.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.895 -0.409 . . . . 73.34 109.895 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 1.049 ' HB ' ' HB ' ' A' ' 206' ' ' VAL . 2.5 mp -118.91 132.56 68.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.445 . . . . 75.31 109.894 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -111.76 119.9 40.18 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.352 -0.981 . . . . 74.14 108.352 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 204' ' ' THR . 0.3 OUTLIER -122.39 112.43 18.07 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.184 -0.673 . . . . 70.51 109.184 -176.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -98.19 113.37 25.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.848 -0.615 . . . . 64.22 109.688 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 200' ' ' LYS . 47.9 t -80.63 150.16 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 54.11 109.129 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -61.13 -22.21 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 54.12 111.368 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 200' ' ' LYS . 4.4 mptp? -91.27 -165.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.567 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.99 46.16 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.839 0.352 . . . . 74.53 110.665 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.572 ' HG ' ' HD1' ' A' ' 225' ' ' TYR . 3.7 tt -132.51 119.81 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.109 0.48 . . . . 52.15 110.248 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 224' ' ' LYS . 49.0 mt-10 -111.53 138.41 48.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.113 -0.699 . . . . 54.04 109.113 171.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 196' ' ' GLN . 35.1 m -122.13 139.73 53.39 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.464 -0.569 . . . . 73.54 109.464 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 17' ' ' VAL . . . -129.74 136.95 50.25 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.942 0.401 . . . . 63.42 110.16 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 1.049 ' HB ' ' HB ' ' A' ' 194' ' ' ILE . 10.3 t -115.32 137.06 50.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.323 -176.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.519 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 27.1 t-20 -120.77 127.41 51.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.034 0.445 . . . . 65.45 110.965 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.5 mm? -122.78 129.75 52.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.363 -0.835 . . . . 63.21 109.57 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -132.75 126.22 31.95 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.618 -0.433 . . . . 72.01 109.865 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -131.68 124.22 29.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.03 0.443 . . . . 74.22 110.69 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.896 ' HB ' ' HB3' ' A' ' 214' ' ' ASN . 1.1 p -104.46 103.58 13.3 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.676 -0.693 . . . . 70.0 110.523 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.34 127.8 33.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.846 -0.615 . . . . 64.54 110.553 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.2 27.11 73.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.066 -0.587 . . . . 71.25 112.178 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.896 ' HB3' ' HB ' ' A' ' 211' ' ' THR . 10.7 t-20 -138.77 -147.36 0.23 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.533 -0.914 . . . . 72.32 108.533 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 51.5 m -77.58 178.72 7.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.176 0.512 . . . . 72.01 112.329 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.65 154.74 24.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.178 -0.919 . . . . 73.03 111.786 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 11.2 t -78.4 139.82 38.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 71.1 110.406 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.41 135.16 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.188 -0.46 . . . . 72.11 109.981 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -130.74 135.57 47.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.137 -0.483 . . . . 71.03 109.77 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.22 171.66 32.8 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.845 -0.693 . . . . 75.11 111.716 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -138.37 147.56 25.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.958 0.409 . . . . 53.41 111.333 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 235' ' ' ALA . . . -128.93 130.42 46.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.485 -0.779 . . . . 70.24 109.933 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 234' ' ' SER . . . -115.76 128.53 55.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.63 0.252 . . . . 72.22 111.128 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 203' ' ' GLU . 2.4 ttmp? -109.04 116.06 31.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 75.34 109.377 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.572 ' HD1' ' HG ' ' A' ' 202' ' ' LEU . 10.8 t80 -119.0 131.96 56.03 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.957 0.408 . . . . 63.25 110.389 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -96.73 99.62 11.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.919 -0.582 . . . . 62.35 110.132 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.85 HD13 ' H ' ' A' ' 227' ' ' ILE . 0.2 OUTLIER -94.38 -28.87 4.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.267 -0.424 . . . . 72.13 111.133 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.6 141.13 19.72 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.642 -0.503 . . . . 62.53 109.642 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.3 -30.62 20.37 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.158 2.572 . . . . 74.22 113.524 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.06 -9.46 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.111 0.412 . . . . 71.31 112.111 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.63 136.63 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.978 0.362 . . . . 63.14 111.978 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -131.26 142.42 50.14 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.32 -0.4 . . . . 53.31 110.538 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.11 134.15 52.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 70.23 111.052 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 223' ' ' ALA . 46.5 p -130.97 118.36 20.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.993 -0.549 . . . . 42.34 110.622 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 222' ' ' ALA . . . -109.12 141.5 41.23 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.743 -0.466 . . . . 73.34 109.743 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -142.34 140.92 32.28 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.868 -0.333 . . . . 75.21 110.787 -177.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.55 146.53 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.513 -0.312 . . . . 72.42 110.284 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -115.92 150.05 37.74 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.65 -0.704 . . . . 71.33 109.664 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 241' ' ' SER . 27.2 p-10 -53.82 -18.55 3.35 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.952 0.783 . . . . 73.33 112.83 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.463 ' HB3' ' HG ' ' A' ' 242' ' ' LEU . 34.4 t -78.85 21.37 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.713 0.292 . . . . 72.35 110.54 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 239' ' ' ASN . 46.1 t 64.31 32.24 12.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.198 0.523 . . . . 65.43 109.746 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 262' ' ' LEU . 58.5 mt -99.07 114.71 27.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.436 -0.506 . . . . 71.12 109.981 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.774 HG12 ' HB2' ' A' ' 263' ' ' LEU . 0.1 OUTLIER -109.68 117.96 55.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.929 0.395 . . . . 73.0 110.57 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -116.92 139.71 15.33 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.935 -0.65 . . . . 35.15 113.126 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.16 127.81 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.819 -0.808 . . . . 71.44 108.819 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -139.85 132.36 5.54 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.942 -1.123 . . . . 70.2 112.641 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -129.17 133.61 47.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.087 0.47 . . . . 73.5 110.16 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 257' ' ' LEU . 13.5 t -123.21 136.15 54.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.013 -0.539 . . . . 73.45 109.776 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -142.69 149.12 38.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.295 -0.411 . . . . 70.23 110.665 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 13.8 m -98.89 121.71 41.19 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.466 ' CB ' HG23 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.38 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.286 0.366 . . . . 72.51 110.817 -173.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.747 ' HB2' ' HD3' ' A' ' 253' ' ' PRO . 63.3 mttm -150.37 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.58 -0.282 . . . . 73.12 111.558 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 252' ' ' LYS . 3.0 Cg_exo -75.0 -76.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.91 1.74 . . . . 71.53 112.767 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -152.63 28.72 0.85 Allowed Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.85 -0.691 . . . . 71.32 112.038 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.504 HD12 ' CE2' ' A' ' 281' ' ' PHE . 1.0 OUTLIER -106.99 122.42 61.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.104 0.478 . . . . 63.21 110.485 -178.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -104.04 130.73 51.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.682 -0.69 . . . . 71.13 109.839 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.4 tp -98.39 124.37 43.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.213 -0.662 . . . . 64.43 109.213 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.8 m -116.11 110.33 18.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.933 -0.576 . . . . 73.44 109.907 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.845 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -114.23 124.82 52.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.919 -0.771 . . . . 75.45 108.919 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 62.8 m -138.65 139.95 38.68 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.812 0.339 . . . . 64.14 110.282 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.07 127.83 20.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.801 -0.444 . . . . 73.44 109.801 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 242' ' ' LEU . 2.1 tm? -107.61 121.8 45.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.43 -0.952 . . . . 73.5 108.43 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.774 ' HB2' HG12 ' A' ' 243' ' ' ILE . 1.1 mm? -98.78 106.16 18.4 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 107.847 -1.168 . . . . 61.25 107.847 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.568 ' HA ' HD22 ' A' ' 242' ' ' LEU . 4.8 m-20 -72.54 106.26 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.614 -0.884 . . . . 75.13 108.614 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.52 -22.56 24.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.991 -0.623 . . . . 61.24 113.121 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -90.88 -3.38 57.39 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.996 0.427 . . . . 74.34 111.193 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 264' ' ' ASP . 47.4 t-20 -123.79 -44.67 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.816 0.341 . . . . 60.04 110.969 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.626 HG11 ' HB3' ' A' ' 263' ' ' LEU . 26.5 m -61.24 -18.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.259 0.466 . . . . 71.33 112.259 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.02 -38.98 88.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.795 0.331 . . . . 72.43 110.443 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.49 29.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.539 . . . . 61.43 110.915 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.02 100.83 2.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.715 -0.755 . . . . 64.41 112.071 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.59 77.17 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.775 -0.726 . . . . 65.11 112.082 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -87.39 144.23 26.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 74.33 109.819 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 65.2 mttm -97.38 137.02 37.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.522 . . . . 74.11 109.887 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 276' ' ' GLY . 1.8 tm? -125.77 131.7 52.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.805 -0.634 . . . . 71.31 110.044 -173.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.435 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -125.2 113.07 1.84 Allowed Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.505 -1.038 . . . . 72.04 110.505 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.921 HD12 HG23 ' A' ' 27' ' ' ILE . 3.4 tm? -114.38 134.87 54.67 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 72.44 109.668 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.675 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -148.58 125.89 2.16 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.095 -1.05 . . . . 41.1 113.172 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 2.5 mm? -102.29 131.92 48.58 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.166 -0.679 . . . . 74.22 109.166 171.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.426 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 51.9 mt-10 -115.57 110.87 19.85 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.571 -0.529 . . . . 63.52 109.571 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.755 ' HB2' HD22 ' A' ' 31' ' ' LEU . 89.4 m-85 -101.26 100.98 11.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.933 -0.576 . . . . 72.31 110.483 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.538 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 52.9 tt0 -92.07 111.96 23.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.264 -0.643 . . . . 63.03 109.264 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 33' ' ' THR . . . -107.77 111.25 23.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.095 0.474 . . . . 73.05 110.985 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.12 133.75 55.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.709 -0.678 . . . . 73.42 109.322 173.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.43 -0.795 . . . . 72.13 110.7 -174.961 . . . . . . . . 0 0 . 1 stop_ save_